{"gi_nutrition": [{"id": "vignette-lens-peds-001", "title": "Intussusception", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["currant jelly stool", "sausage-shaped mass", "episodic crying with drawing up legs", "intussusception"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 10-month-old male is brought in by his parents for intermittent episodes of crying and abdominal pain for 8 hours.\n\nSubjectively, he draws his legs up to his abdomen during these episodes and screams inconsolably for several minutes, then becomes quiet and lethargic before the next episode.\n\nHe has vomited twice and had one bloody, mucousy stool that looked like \"red jelly\". No fever or diarrhea.\n\nMedical history is notable for a recent viral upper respiratory infection 1 week ago.\n\nPhysical Examination:\n- General: alternating between periods of inconsolable crying and lethargy.\n- Labs: CBC: WBC elevated.\n- Abdomen: mild distension with a palpable sausage-shaped mass in the right upper quadrant. Decreased bowel sounds.\n- Rectal exam: mucoid, blood-tinged stool on glove.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The infant appears ill with intermittent distress. You need to determine the appropriate initial approach to this acute presentation.", "question": "What is the most appropriate initial step in evaluating this patient?", "choices": [{"id": "node-1-choice-a", "text": "Establish IV access, make NPO, obtain labs (CBC, BMP), and order abdominal ultrasound", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This infant with episodic abdominal pain, vomiting, and bloody stool needs IV access for resuscitation, NPO status in anticipation of possible procedure, labs to assess for dehydration and leukocytosis, and ultrasound as the first-line imaging.", "consequence": "IV established, labs sent, ultrasound ordered.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Immediately take to operating room for exploratory laparotomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While surgical intervention may ultimately be needed, rushing to the OR without stabilization and diagnostic workup is inappropriate. The patient needs IV access, labs, and imaging first.", "consequence": "Premature surgery without proper workup.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Give oral rehydration and observe for 4-6 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This presentation with bloody stool, episodic severe pain, and lethargy requires urgent evaluation, not observation. Delaying workup risks bowel ischemia and perforation.", "consequence": "Condition deteriorates during observation period.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Order CT abdomen with contrast as the initial imaging study", "isOptimal": false, "isAcceptable": true, "feedback": "While CT can diagnose intussusception, ultrasound is the preferred first-line imaging in pediatrics due to no radiation exposure and high sensitivity/specificity. Reserve CT for equivocal cases.", "consequence": "Unnecessary radiation exposure, though diagnosis is made.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Discharge home with stool softeners and follow-up in 2-3 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This presentation is concerning for a surgical emergency. Bloody stool, severe episodic pain, and lethargy require immediate evaluation, not outpatient management.", "consequence": "Patient returns with bowel necrosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The classic triad of intussusception (colicky abdominal pain, vomiting, bloody stool) is present in only 20-40% of cases. Ultrasound has >95% sensitivity and specificity."}, "node-2": {"id": "node-2", "type": "decision", "content": "Laboratory findings:\n- CBC: WBC 14,000 (leukocytosis)\n- BMP: Na 138, K 3.8, Cl 102, CO2 22, BUN 18, Cr 0.4\n\nUltrasound findings:\n- Target/donut sign (concentric rings) in right upper quadrant\n- No free fluid\n- No signs of perforation", "question": "Based on these findings, what is the most likely diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Intussusception", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The target/donut sign on ultrasound is pathognomonic for intussusception. Combined with the classic clinical presentation (episodic pain, currant jelly stool, sausage-shaped mass), this confirms the diagnosis.", "consequence": "Diagnosis confirmed. Proceed to management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Acute appendicitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Appendicitis typically presents with periumbilical pain migrating to RLQ, not episodic colicky pain. The ultrasound shows target sign, not an inflamed appendix.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Midgut volvulus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Midgut volvulus presents with bilious vomiting and would show a 'whirlpool sign' on ultrasound, not the target/donut sign seen here.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Meckel diverticulum", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Meckel diverticulum typically causes painless rectal bleeding, not episodic colicky pain with a mass. Ultrasound would not show the target sign.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Viral gastroenteritis with hematochezia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Gastroenteritis does not cause a target sign on ultrasound or a palpable abdominal mass. The bloody stool pattern (currant jelly) is characteristic of intussusception, not viral illness.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Currant jelly stool is a late finding - do not wait for it to suspect intussusception. Early diagnosis before bowel ischemia improves outcomes."}, "node-3": {"id": "node-3", "type": "decision", "content": "The diagnosis of intussusception is confirmed. The patient is hemodynamically stable with no signs of peritonitis or perforation on exam or imaging.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "Air or contrast enema reduction under fluoroscopic guidance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In a stable patient without signs of perforation or peritonitis, air/contrast enema is both diagnostic confirmation and therapeutic. Success rate is 80-95% for uncomplicated cases.", "consequence": "Enema reduction is successful. The intussusception is reduced.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immediate surgical exploration and manual reduction", "isOptimal": false, "isAcceptable": true, "feedback": "Surgery is reserved for patients with peritonitis, perforation, shock, or failed enema reduction. This stable patient should have non-operative reduction attempted first.", "consequence": "Patient undergoes unnecessary surgery, though successful.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "IV antibiotics and observation for 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Intussusception requires prompt reduction to prevent bowel ischemia. Antibiotics and observation delay definitive treatment and risk progression to necrosis.", "consequence": "Bowel ischemia develops during observation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Repeat ultrasound in 4-6 hours to assess for spontaneous reduction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While rare spontaneous reduction can occur, waiting is inappropriate when diagnosis is confirmed. Active intervention is needed to prevent complications.", "consequence": "Condition worsens while waiting.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Pediatric surgery consult before any intervention", "isOptimal": false, "isAcceptable": true, "feedback": "While surgery should be aware, enema reduction can proceed in stable patients. Surgery consult is essential but should not delay non-operative reduction attempt.", "consequence": "Minor delay, but appropriate management follows.", "nextNodeId": "node-4"}], "clinicalPearl": "Contraindications to enema reduction: peritonitis, perforation, shock, prolonged symptoms (>48h relative). Surgery consultation should occur in parallel."}, "node-4": {"id": "node-4", "type": "decision", "content": "The air enema reduction was successful. Post-procedure, the infant is comfortable, abdomen is soft, and he is tolerating clear liquids. Vital signs are stable.", "question": "What is the most appropriate post-procedure management?", "choices": [{"id": "node-4-choice-a", "text": "Admit for 24-hour observation, advance diet as tolerated, educate parents on recurrence signs", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After successful reduction, patients should be observed for 12-24 hours to monitor for recurrence (occurs in ~10% within 72 hours) and ensure they tolerate oral intake. Parent education on warning signs is essential.", "consequence": "Patient does well overnight, tolerates full feeds, discharged next day.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Discharge home immediately with close outpatient follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Given the 10% recurrence rate within 72 hours, observation for at least 12-24 hours is standard. Immediate discharge risks missing early recurrence.", "consequence": "Patient returns 6 hours later with recurrent intussusception.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Proceed with prophylactic surgical fixation to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prophylactic surgery is not indicated after successful reduction. Surgery is reserved for multiple recurrences, pathologic lead points, or failed reduction.", "consequence": "Unnecessary surgery with associated risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Repeat imaging (ultrasound or contrast study) before discharge to confirm reduction", "isOptimal": false, "isAcceptable": true, "feedback": "While not routinely necessary after clinically successful reduction, follow-up imaging can be considered if there is clinical concern. Standard practice is clinical observation.", "consequence": "Extra imaging performed, confirms successful reduction.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-e", "text": "Start empiric oral antibiotics for 5 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Antibiotics are not indicated after uncomplicated intussusception reduction. There is no infection requiring treatment.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Recurrence rate is ~10% after first episode, higher with pathologic lead points. Most recurrences happen within 72 hours. Educate parents on signs: recurrent episodic pain, vomiting, bloody stool, lethargy."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized the presentation, ordered appropriate initial workup with ultrasound, diagnosed intussusception, performed timely air enema reduction, and provided appropriate post-procedure care.\n\nKey learning points:\n\u2022 Classic presentation: episodic colicky pain, vomiting, currant jelly stool (late finding)\n\u2022 Ultrasound is first-line imaging (target/donut sign)\n\u2022 Air or contrast enema is both diagnostic and therapeutic (80-95% success)\n\u2022 Admit for 24h observation post-reduction (10% recurrence rate)\n\u2022 Educate parents on recurrence signs\n\nPrognosis is excellent with early recognition and treatment."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of intussusception:\n\u2022 Classic triad: colicky pain, vomiting, bloody stool (present in only 20-40%)\n\u2022 Ultrasound shows target/donut sign\n\u2022 Air/contrast enema for stable patients without peritonitis\n\u2022 24-hour observation post-reduction for recurrence monitoring\n\nKey pearl: Currant jelly stool is a late finding - do not wait for it to suspect intussusception."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Poor outcome due to delayed or inappropriate management. Intussusception is a time-sensitive diagnosis.\n\nCritical points:\n\u2022 Do not delay workup - bowel ischemia can develop within hours\n\u2022 Ultrasound is first-line, not CT (no radiation, high accuracy)\n\u2022 Air enema reduction for stable patients\n\u2022 Surgery for peritonitis, perforation, shock, or failed reduction\n\nKey pearl: 'Time is bowel' - delayed diagnosis leads to necrosis, perforation, and increased surgical morbidity."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-002", "title": "Pyloric Stenosis", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["projectile vomiting", "non-bilious", "olive-shaped mass", "hungry after vomiting", "pyloric stenosis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 4-week-old male is brought in by his parents for progressive vomiting after feeds for the past week.\n\nThe patient's mother reports, the vomiting has become forceful and shoots across the room. It occurs about 30 minutes after every feeding. He seems hungry immediately after and wants to feed again.\n\nAssociated symptoms include The vomit is non-bilious (no green color). Denies fever, diarrhea, or blood in the vomit.\n\nPertinent history includes He was born full-term via uncomplicated vaginal delivery. This is the firstborn child.\n\nPhysical Examination:\n- On abdominal exam: palpable olive-shaped mass in the right upper quadrant with visible gastric peristaltic waves.\n- General: alert but appears mildly dehydrated with dry mucous membranes and mild tachycardia.\n- Vitals: tachycardia.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The infant appears mildly dehydrated with signs of volume depletion. You need to determine the appropriate initial approach.", "question": "What is the most appropriate initial step in evaluating this patient?", "choices": [{"id": "node-1-choice-a", "text": "Establish IV access, make NPO, obtain labs (BMP, blood gas), and order abdominal ultrasound", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This infant with projectile vomiting and dehydration needs IV access for resuscitation, NPO status, labs to assess the characteristic electrolyte abnormalities (hypochloremic hypokalemic metabolic alkalosis), and ultrasound as the diagnostic imaging of choice.", "consequence": "IV established, labs sent, ultrasound ordered.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Emergency surgery consultation for immediate pyloromyotomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While surgery will ultimately be needed, pyloric stenosis is NOT a surgical emergency. The patient needs stabilization and electrolyte correction before any surgical intervention.", "consequence": "Premature surgical planning without proper workup.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Trial of thickened feeds and positioning for reflux", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The projectile nature of vomiting, progressive worsening, and olive-shaped mass suggest mechanical obstruction, not reflux. Feeding modifications will not help and delay diagnosis.", "consequence": "Diagnosis delayed, dehydration worsens.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Upper GI contrast study as initial diagnostic test", "isOptimal": false, "isAcceptable": true, "feedback": "While upper GI can show the 'string sign' of pyloric stenosis, ultrasound is the preferred first-line test due to higher sensitivity, no radiation, and ability to directly measure pyloric dimensions.", "consequence": "Diagnosis made but with unnecessary radiation exposure.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Oral rehydration and reassess in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant cannot tolerate oral intake due to gastric outlet obstruction. Oral rehydration will fail and the patient will continue to vomit and become more dehydrated.", "consequence": "Severe dehydration develops.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Pyloric stenosis typically presents at 3-6 weeks of age. Risk factors: firstborn male, family history, macrolide exposure in first 2 weeks of life."}, "node-2": {"id": "node-2", "type": "decision", "content": "Laboratory findings:\n- BMP: Na 132, K 2.9, Cl 88, CO2 32, BUN 22, Cr 0.5\n- Blood gas: pH 7.52, pCO2 48\n- Diagnosis: Hypochloremic, hypokalemic metabolic alkalosis\n\nUltrasound findings:\n- Pyloric muscle thickness: 4.5mm (>3mm abnormal)\n- Pyloric channel length: 18mm (>15mm abnormal)\n- Target sign on transverse view\n- No gastric emptying observed during study", "question": "Based on these findings, what is the most likely diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Hypertrophic pyloric stenosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The ultrasound findings (muscle >3mm thick, channel >15mm long - remember 'pi-l-oric = 3-15') combined with the classic presentation (projectile non-bilious vomiting, olive mass, hungry after vomiting) and pathognomonic labs (hypochloremic hypokalemic metabolic alkalosis) confirm the diagnosis.", "consequence": "Diagnosis confirmed. Proceed to pre-operative management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Gastroesophageal reflux disease (GERD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. GERD does not cause pyloric muscle hypertrophy on ultrasound, severe metabolic alkalosis, or a palpable abdominal mass. The projectile nature of vomiting also distinguishes this from reflux.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Malrotation with midgut volvulus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Malrotation presents with BILIOUS vomiting (green) because obstruction is distal to the ampulla of Vater. This patient has NON-bilious vomiting and ultrasound shows pyloric pathology.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Milk protein allergy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Milk protein allergy typically causes bloody stools, eczema, or non-specific GI symptoms - not projectile vomiting with metabolic alkalosis and a thickened pylorus on ultrasound.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Overfeeding/feeding intolerance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Overfeeding does not cause pyloric hypertrophy, metabolic alkalosis, or progressive worsening. The structural abnormality on ultrasound confirms an organic etiology.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Non-bilious vomiting = obstruction PROXIMAL to ampulla of Vater (pylorus). Bilious vomiting = obstruction DISTAL to ampulla (duodenum/beyond)."}, "node-3": {"id": "node-3", "type": "decision", "content": "The diagnosis of hypertrophic pyloric stenosis is confirmed. Current labs show K 2.9, Cl 88, with metabolic alkalosis (pH 7.52). The patient has mild dehydration.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "Aggressive IV fluid resuscitation with NS + KCl, correct electrolytes before surgery", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Pyloric stenosis is a MEDICAL emergency requiring electrolyte correction, NOT a surgical emergency. Surgery on a patient with uncorrected hypokalemia and alkalosis risks post-anesthetic apnea and cardiac arrhythmias. Target Cl >100, K >3.5, HCO3 <26 before surgery.", "consequence": "IV fluids started. Electrolytes correcting. Surgery planned for after optimization.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immediate surgery - pyloromyotomy cannot wait", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Operating on a patient with severe hypokalemia and metabolic alkalosis is dangerous. Hypokalemia causes cardiac arrhythmias, and alkalosis impairs ventilation. The infant can safely wait 12-24 hours for electrolyte correction.", "consequence": "Post-operative apnea and cardiac arrhythmia in recovery.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Place NG tube and attempt oral feeding trial first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The pylorus is obstructed - feeding attempts will cause more vomiting and worsen dehydration/electrolyte abnormalities. The patient needs to remain NPO until surgical correction.", "consequence": "More vomiting, worsening electrolyte abnormalities.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Give IV sodium bicarbonate to correct the acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient has metabolic ALKALOSIS (pH 7.52), not acidosis. Bicarbonate would worsen the alkalosis. The alkalosis will correct with chloride and volume replacement.", "consequence": "Alkalosis worsens dangerously.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Start D5 1/2NS at maintenance rate and plan surgery in 2-3 days", "isOptimal": false, "isAcceptable": true, "feedback": "The fluid choice is suboptimal - NS with KCl is preferred for faster chloride replacement. Also, with aggressive resuscitation, surgery can typically proceed within 12-24 hours, not 2-3 days.", "consequence": "Slower correction but eventually adequate.", "nextNodeId": "node-4"}], "clinicalPearl": "Pre-op goals: Cl >100, K >3.5, HCO3 <26. The alkalosis corrects with chloride - the kidney retains H+ when Cl is available. Typical time to correction: 12-24 hours."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 18 hours of IV fluid resuscitation, repeat labs show:\n- K 3.8, Cl 102, CO2 24, pH 7.40\n\nThe patient is well-hydrated with good urine output. Pediatric surgery has been consulted and the OR is ready.", "question": "What is the most appropriate surgical approach and post-operative plan?", "choices": [{"id": "node-4-choice-a", "text": "Laparoscopic or open pyloromyotomy; start feeds 4-6 hours post-op, advance as tolerated", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Ramstedt pyloromyotomy (splitting the pyloric muscle without cutting mucosa) is curative. Either laparoscopic or open approach is acceptable. Early feeding (4-6 hours post-op) is safe and reduces hospital stay. Some vomiting initially is normal.", "consequence": "Surgery successful. Feeds started, tolerated well. Discharged POD 1-2.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Medical management with atropine; surgery only if medical therapy fails", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Atropine therapy has been tried historically but has unacceptable failure rates and prolonged hospital stays. Pyloromyotomy is the definitive treatment with excellent outcomes.", "consequence": "Prolonged hospitalization with eventual surgical need.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Gastric bypass or gastrojejunostomy to bypass the obstruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bypass procedures are unnecessary - the Ramstedt pyloromyotomy is a simple, curative procedure that preserves normal anatomy. Bypass would create long-term complications.", "consequence": "Overly invasive surgery with complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Pyloromyotomy; keep NPO for 48 hours post-op before attempting feeds", "isOptimal": false, "isAcceptable": true, "feedback": "While surgery is correct, prolonged NPO is unnecessary and delays recovery. Current evidence supports early feeding (4-6 hours post-op) with similar outcomes and shorter hospital stays.", "consequence": "Recovery delayed but eventually successful.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-e", "text": "Endoscopic balloon dilation of the pylorus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Balloon dilation is not effective for hypertrophic pyloric stenosis - the muscle is hypertrophied and needs to be divided, not dilated. This is not a stricture.", "consequence": "Failed procedure, surgery still needed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Ramstedt pyloromyotomy: Incise muscle longitudinally down to (but not through) mucosa. Check for duodenal perforation by injecting air via NG. Expect some post-op vomiting - it resolves within 24-48h."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized pyloric stenosis, obtained appropriate workup, corrected electrolytes before surgery, and proceeded with timely pyloromyotomy.\n\nKey learning points:\n\u2022 Classic presentation: 3-6 week old firstborn male, projectile NON-bilious vomiting, hungry after vomiting\n\u2022 Physical exam: olive-shaped mass RUQ, visible peristaltic waves\n\u2022 Labs: Hypochloremic, hypokalemic metabolic alkalosis (pathognomonic)\n\u2022 Ultrasound: Muscle >3mm thick, channel >15mm long ('pi-l-oric = 3-15')\n\u2022 CORRECT ELECTROLYTES FIRST (Cl >100, K >3.5, HCO3 <26)\n\u2022 Ramstedt pyloromyotomy is curative\n\nPrognosis is excellent - essentially 100% cure rate with surgery."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of pyloric stenosis:\n\u2022 Projectile NON-bilious vomiting (obstruction proximal to ampulla)\n\u2022 Classic triad: vomiting + palpable olive + visible peristalsis (present in ~70%)\n\u2022 Pathognomonic labs: hypochloremic hypokalemic metabolic alkalosis\n\u2022 MEDICAL emergency (correct electrolytes) not surgical emergency\n\u2022 Pre-op goals: Cl >100, K >3.5, HCO3 <26\n\nKey pearl: Non-bilious = proximal obstruction. Bilious = distal obstruction."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Poor outcome due to inappropriate management.\n\nCritical points:\n\u2022 Never operate with uncorrected hypokalemia/alkalosis - risk of apnea, arrhythmias\n\u2022 Non-bilious vomiting localizes obstruction proximal to ampulla\n\u2022 Ultrasound is diagnostic (muscle >3mm, channel >15mm)\n\u2022 Correct electrolytes BEFORE surgery (12-24 hours typically)\n\nKey pearl: Pyloric stenosis is a MEDICAL emergency requiring resuscitation, NOT a surgical emergency. The baby can safely wait for electrolyte correction."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-014", "title": "Starvation Ketoacidosis vs DKA", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["poor intake", "hypoglycemia with ketones", "starvation ketoacidosis vs dka"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old female presents with vomiting, diarrhea, poor oral intake.\n\nLabs show hypoglycemia, anion gap metabolic acidosis, and ketonuria.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 5-year-old female presents with 3 days of vomiting and diarrhea with poor oral intake. She is lethargic but responsive.\n\n**Labs:**\n- Glucose: **45 mg/dL** (LOW)\n- pH: 7.28 (mild acidosis)\n- Anion gap: 18 (elevated)\n- Bicarbonate: 14 mEq/L\n- **Urine ketones: Large**\n\n**Key distinction - Ketosis + Acidosis:**\n- **DKA**: Hyperglycemia (>250) + ketones + acidosis\n- **Starvation ketoacidosis**: **Hypoglycemia** + ketones + acidosis\n- **Alcoholic ketoacidosis**: Low/normal glucose + ketones + history of alcohol", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Starvation ketoacidosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **starvation ketoacidosis** - ketonemia and acidosis due to **inadequate carbohydrate intake**, NOT diabetes. Key distinguishing feature: glucose is **LOW (45 mg/dL)**, not high. When the body has no glucose (from poor intake), it shifts to fat metabolism \u2192 ketone bodies (\u03b2-hydroxybutyrate, acetoacetate) \u2192 anion gap metabolic acidosis. This is common in children with gastroenteritis who can't keep food down.", "consequence": "You correctly identify the diagnosis and proceed to treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Diabetic ketoacidosis (DKA)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This is NOT DKA. The critical distinguishing feature is **glucose is LOW (45 mg/dL)**. DKA requires **hyperglycemia** (>250 mg/dL). In DKA, insulin deficiency prevents glucose from entering cells despite high blood glucose. In starvation ketoacidosis, there's simply no glucose available. Both cause ketosis, but the mechanism and glucose level are different.", "consequence": "Misdiagnosis leads to inappropriate treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Lactic acidosis from dehydration", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable - dehydration can cause lactic acidosis from poor tissue perfusion. However, the key finding here is **large urine ketones** with hypoglycemia, pointing to **starvation ketoacidosis** as the primary cause. Lactic acidosis would show elevated lactate without significant ketonuria. The history of poor oral intake and vomiting strongly supports starvation ketosis.", "consequence": "Ketonuria suggests starvation ketosis is the primary process.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Inborn error of metabolism (fatty acid oxidation defect)", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Fatty acid oxidation disorders (MCAD, VLCAD) can present with **hypoketotic hypoglycemia** during fasting/illness. However, this child has **large ketones**, which argues AGAINST a fatty acid oxidation defect (these patients can't make ketones normally). The clinical picture of gastroenteritis \u2192 poor intake \u2192 ketosis is classic starvation ketoacidosis. IEM should be considered if episodes recur without clear trigger.", "consequence": "Large ketones argue against fatty acid oxidation defect.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Toxic ingestion (aspirin, methanol, ethylene glycol)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While toxic ingestions can cause anion gap metabolic acidosis, this child has a clear history of **gastroenteritis with poor oral intake** explaining the ketoacidosis. Salicylate toxicity causes respiratory alkalosis AND metabolic acidosis (mixed). Methanol/ethylene glycol cause osmolar gap and severe acidosis without ketonuria. The ketonuria and hypoglycemia here are classic for starvation.", "consequence": "No history or features suggesting toxic ingestion.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**The glucose level distinguishes them**: DKA = HIGH glucose (>250). Starvation ketoacidosis = LOW glucose. Both have ketones and acidosis from different mechanisms."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose **starvation ketoacidosis** in this child with gastroenteritis. She is dehydrated and hypoglycemic.\n\n**Pathophysiology:**\n- No carbohydrate intake \u2192 glycogen stores depleted\n- Body shifts to **fat oxidation** for energy\n- Fat breakdown \u2192 **ketone bodies** (fuel for brain)\n- Ketones are acids \u2192 anion gap metabolic acidosis\n\n**Treatment differs from DKA:**\n- DKA: Fluids + INSULIN (to stop ketogenesis)\n- Starvation ketoacidosis: Fluids + GLUCOSE (carbs stop ketogenesis)", "question": "What is the most appropriate treatment for starvation ketoacidosis?", "choices": [{"id": "node-2-choice-a", "text": "IV dextrose-containing fluids (D5NS or D10)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Treatment is **IV dextrose-containing fluids** (D5NS, D5LR, or D10 for severe hypoglycemia). The dextrose does TWO things: (1) **Corrects hypoglycemia** directly, (2) **Stops ketogenesis** by providing carbohydrate - when glucose is available, the body switches back from fat oxidation to glucose metabolism, shutting off ketone production. The acidosis will self-correct as ketone production stops. NO INSULIN needed.", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "IV insulin drip to stop ketone production", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! **Insulin is NOT indicated** for starvation ketoacidosis. Unlike DKA (where insulin deficiency is the problem), starvation ketoacidosis is due to **carbohydrate deficiency**. Giving insulin to a hypoglycemic patient would worsen hypoglycemia and could be fatal. The treatment is providing glucose, not insulin.", "consequence": "Insulin would worsen hypoglycemia - potentially fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "IV bicarbonate to correct acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bicarbonate is NOT indicated** for starvation ketoacidosis (or DKA). The acidosis will self-correct once ketone production stops. Bicarbonate has risks: paradoxical CNS acidosis, hypokalemia, and rebound alkalosis. In rare cases of severe acidosis (pH <6.9), bicarbonate might be considered, but this is controversial even then. Treat the underlying cause with glucose.", "consequence": "Bicarbonate has risks and doesn't address the cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Normal saline bolus only, no dextrose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Normal saline addresses dehydration but does NOT treat hypoglycemia or stop ketogenesis. This child is **hypoglycemic (glucose 45)** and needs dextrose. Without carbohydrate, the body will continue producing ketones. The key treatment principle: **provide carbohydrate** to shift metabolism away from fat oxidation. Always use dextrose-containing fluids for starvation ketoacidosis.", "consequence": "Fails to treat hypoglycemia and ongoing ketogenesis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Oral rehydration therapy with pedialyte", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable for mild cases. ORT with glucose-containing solutions (Pedialyte) can provide carbohydrates if the child can tolerate oral intake. However, this child is **lethargic and has been vomiting** for 3 days - unlikely to tolerate oral fluids. IV dextrose-containing fluids are indicated when oral intake is not feasible or hypoglycemia is present.", "consequence": "May not be tolerated given ongoing vomiting and lethargy.", "nextNodeId": "node-3"}], "clinicalPearl": "**Starvation ketoacidosis treatment = GLUCOSE, not insulin.** Providing carbohydrate switches metabolism from fat oxidation back to glucose utilization, stopping ketone production. The acidosis resolves on its own."}, "node-3": {"id": "node-3", "type": "decision", "content": "You start D5NS. After 4 hours of IV fluids with dextrose, repeat labs show:\n- Glucose: **95 mg/dL** (normalized)\n- pH: 7.35 (normalized)\n- Anion gap: 12 (normal)\n- Urine ketones: trace (clearing)\n\nThe child is more alert and asking for food. Vomiting has stopped.\n\n**Expected course:**\n- Rapid improvement once carbohydrate provided\n- Ketosis resolves within hours\n- Full recovery expected", "question": "What is the appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Advance diet as tolerated; discharge when tolerating oral intake", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With normalized labs, resolving ketosis, and improved mental status, the child can **advance diet as tolerated**. Start with clear liquids, then advance to regular diet. Once she tolerates oral intake and maintains glucose, she can be **discharged home**. Key counseling: during future illnesses, encourage frequent small sips of glucose-containing fluids (juice, sports drinks, Pedialyte) to prevent starvation ketosis.", "consequence": "Appropriate transition to oral intake and discharge.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Continue IV fluids for 24 more hours to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With normalized labs and clinical improvement, there's no need to continue IV fluids once the child tolerates oral intake. Prolonged IV fluids delay discharge, increase cost, and expose to line-related risks. The goal is transition to oral intake as soon as possible. If she's asking for food and vomiting has stopped, advance the diet.", "consequence": "Unnecessarily prolonged hospitalization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Order HbA1c and fasting glucose to rule out diabetes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is **starvation ketoacidosis**, not DKA. The presentation was classic: gastroenteritis \u2192 poor intake \u2192 **hypoglycemia** with ketosis. DKA causes **hyperglycemia**. There's no indication for diabetes workup when the clinical picture clearly shows starvation ketosis with appropriate response to glucose. Diabetes testing would be indicated if glucose had been high.", "consequence": "Unnecessary testing for a clear starvation ketosis case.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Obtain metabolic workup for inborn error of metabolism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for a first episode with clear trigger. This child had gastroenteritis with poor intake - a clear precipitant for starvation ketosis. **Metabolic workup for IEM** should be considered if: (1) episodes recur without clear trigger, (2) presentation is atypical (e.g., hypoketotic hypoglycemia suggesting fatty acid oxidation defect), (3) family history of metabolic disease. A single episode of starvation ketosis with known trigger doesn't warrant extensive IEM workup.", "consequence": "First episode with clear trigger doesn't need IEM workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Consult endocrinology before discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Starvation ketoacidosis is a common pediatric condition that doesn't require endocrinology consultation. It's not a hormonal disorder - it's simply the body's normal response to carbohydrate deprivation. The child has responded appropriately to treatment. Endocrinology would be consulted for DKA (diabetes management) or recurrent unexplained hypoglycemia, not for classic starvation ketosis.", "consequence": "Unnecessary specialist referral for common condition.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prevention teaching for parents**: During illness with vomiting, encourage frequent small sips of glucose-containing fluids (juice, sports drinks, Pedialyte, popsicles) even if the child isn't hungry. Small amounts of carbohydrate prevent starvation ketosis."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly distinguished **starvation ketoacidosis** from DKA based on the key finding: **LOW glucose (45)** vs high glucose in DKA. Treatment is **IV dextrose-containing fluids** (NOT insulin!) - glucose stops ketogenesis by switching metabolism from fat to carbohydrate utilization. Key teaching: (1) DKA = high glucose, starvation ketoacidosis = low glucose, (2) NO insulin for starvation ketoacidosis, (3) Rapid improvement with carbohydrate, (4) Prevent with glucose-containing fluids during illness."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **starvation ketoacidosis vs DKA**: (1) Both have ketones + acidosis, (2) DKA = HIGH glucose (insulin deficiency), starvation = LOW glucose (carbohydrate deficiency), (3) Treatment: DKA needs insulin; starvation needs glucose (D5NS/D10), (4) NO bicarbonate needed - acidosis resolves when ketogenesis stops, (5) Rapid recovery expected with carbohydrate provision."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. **Starvation ketoacidosis is NOT DKA** - the treatments are different! Key points: (1) Glucose is LOW in starvation (depleted glycogen), HIGH in DKA (insulin deficiency), (2) **NEVER give insulin** to starvation ketoacidosis - worsens hypoglycemia, (3) Treatment = IV dextrose-containing fluids, (4) Glucose provides carbohydrate \u2192 stops fat oxidation \u2192 stops ketogenesis \u2192 acidosis resolves."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-019", "title": "Hirschsprung Disease", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["failure to pass meconium", "explosive stool after rectal exam", "transition zone", "squirt sign", "hirschsprung disease"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-day-old male presents with failure to pass meconium.\n\nSubjectively, he has not passed any stool since birth 48 hours ago. He has had bilious vomiting twice and his abdomen appears distended.\n\nReview of systems is positive for poor feeding and increasing abdominal distension and negative for fever.\n\nMedical history is notable for He was born full-term. There is a family history of Hirschsprung disease in a cousin.\n\nPhysical Examination:\n- Abdomen: markedly distended with visible loops of bowel, hyperactive bowel sounds.\n- Rectal exam: tight anal sphincter with explosive release of stool and gas following digital examination (\"squirt sign\").\n- General: uncomfortable-appearing neonate.\n- Vitals: febrile.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-day-old has not passed meconium since birth (48 hours), has bilious vomiting, and abdominal distension. Digital rectal exam produced explosive release of stool and gas. Family history of Hirschsprung disease in a cousin.", "question": "What is the MOST important clinical clue that suggests Hirschsprung disease over other causes of neonatal bowel obstruction?", "choices": [{"id": "node-1-choice-a", "text": "Failure to pass meconium within 48 hours of birth", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Failure to pass meconium within 24-48 hours** is the hallmark of Hirschsprung disease. 99% of term newborns pass meconium within 48 hours. Delayed passage should prompt evaluation for Hirschsprung, especially with abdominal distension and bilious vomiting.", "consequence": "You identify the key diagnostic clue.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bilious vomiting alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bilious vomiting indicates intestinal obstruction, it's **non-specific** - seen in malrotation, atresias, and many other conditions. **Delayed meconium passage** is the key finding pointing to Hirschsprung specifically.", "consequence": "Bilious vomiting is non-specific.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Abdominal distension", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Abdominal distension is seen in **many** causes of neonatal obstruction. The combination of distension WITH **failure to pass meconium** specifically suggests Hirschsprung disease.", "consequence": "Distension alone is non-specific.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Family history of Hirschsprung disease", "isOptimal": false, "isAcceptable": true, "feedback": "Family history increases suspicion (Hirschsprung has genetic component), but **delayed meconium passage is the clinical hallmark**. Family history supports but doesn't diagnose - you still need the clinical and pathologic criteria.", "consequence": "Supportive but not the key finding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Tight anal sphincter on exam", "isOptimal": false, "isAcceptable": true, "feedback": "A tight sphincter can be seen in Hirschsprung, but the **'squirt sign'** (explosive stool release after rectal exam) and **delayed meconium passage** are more diagnostic. The tight sphincter finding is subjective.", "consequence": "Helpful but secondary finding.", "nextNodeId": "node-2"}], "clinicalPearl": "**Hirschsprung disease**: 99% of term newborns pass meconium within 48 hours. Delayed passage = think Hirschsprung! **'Squirt sign'** = explosive stool release after digital rectal exam (decompresses dilated proximal bowel). Associated with **Down syndrome** (2-15% of cases)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect Hirschsprung disease. You need to confirm the diagnosis.", "question": "What is the FIRST-LINE diagnostic imaging study for suspected Hirschsprung disease?", "choices": [{"id": "node-2-choice-a", "text": "Contrast enema (barium or water-soluble) looking for transition zone", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Contrast enema** is the first-line imaging study. Key finding: **transition zone** between dilated, normally innervated proximal colon and narrowed, aganglionic distal segment. Also shows **rectosigmoid ratio reversal** (<1, normally rectum is wider than sigmoid).", "consequence": "Appropriate first-line imaging ordered.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Rectal suction biopsy immediately", "isOptimal": false, "isAcceptable": true, "feedback": "Rectal biopsy is the **GOLD STANDARD** for diagnosis (shows absent ganglion cells, hypertrophied nerve fibers), but **contrast enema is typically done first** to localize the transition zone and plan surgery. Biopsy confirms the diagnosis.", "consequence": "Gold standard but not first-line imaging.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Abdominal X-ray only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Plain X-ray shows **non-specific findings** (dilated loops, absence of rectal gas) but cannot identify the transition zone or confirm Hirschsprung. **Contrast enema** is needed for diagnostic specificity.", "consequence": "Non-specific findings only.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "CT abdomen with contrast", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT is **not indicated** for Hirschsprung diagnosis - it adds radiation without benefit over contrast enema. The **transition zone** is best visualized with contrast enema, and biopsy provides tissue diagnosis.", "consequence": "Unnecessary radiation, wrong study.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Anorectal manometry", "isOptimal": false, "isAcceptable": true, "feedback": "Anorectal manometry can show **absent rectoanal inhibitory reflex** (RAIR) in Hirschsprung, but it's technically difficult in neonates and **not first-line**. Contrast enema followed by biopsy is the standard approach.", "consequence": "Technically difficult in neonates.", "nextNodeId": "node-3"}], "clinicalPearl": "**Diagnostic approach**: (1) **Contrast enema** - shows transition zone, rectosigmoid ratio <1. (2) **Rectal suction biopsy** - GOLD STANDARD, shows absent ganglion cells + hypertrophied nerve trunks. Do NOT prep bowel before contrast enema (masks transition zone)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Contrast enema shows a clear transition zone in the rectosigmoid area. Rectal suction biopsy confirms absent ganglion cells with hypertrophied nerve fibers. Diagnosis: Hirschsprung disease (short-segment).", "question": "What is the DEFINITIVE treatment for Hirschsprung disease?", "choices": [{"id": "node-3-choice-a", "text": "Surgical pull-through procedure (resection of aganglionic segment)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Surgical resection** of the aganglionic segment with **pull-through anastomosis** is the definitive treatment. The aganglionic bowel is removed and normally innervated colon is anastomosed to the anus. Various techniques exist (Swenson, Duhamel, Soave).", "consequence": "Definitive surgical planning initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Lifelong laxatives and enemas", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Medical management with laxatives/enemas is **not definitive** - the aganglionic segment will never function normally. Surgery is required. Bowel management may be used temporarily before surgery or for complications.", "consequence": "Does not address underlying pathology.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Observation - ganglion cells may migrate distally over time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **aganglionosis is permanent** - ganglion cells do not migrate postnatally. Observation leads to continued obstruction, **enterocolitis** risk, and potentially fatal complications. Surgery is required.", "consequence": "Dangerous delay - ganglion cells won't appear.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Temporary diverting colostomy only (no pull-through)", "isOptimal": false, "isAcceptable": false, "feedback": "Colostomy may be used as a **temporizing measure** in sick neonates or those with enterocolitis, but **pull-through is still required** as definitive treatment. Colostomy alone doesn't cure the disease.", "consequence": "Temporizing only, not definitive.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Botulinum toxin injection to the internal anal sphincter", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Botox injection is sometimes used for **post-operative complications** (sphincter achalasia) but does NOT treat the underlying aganglionosis. The aganglionic bowel segment must be surgically removed.", "consequence": "Does not address aganglionic segment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Surgical options**: Swenson (original), Duhamel (side-to-side), Soave (endorectal pull-through). Most now done as **single-stage laparoscopic** procedure. Staged approach (colostomy first) for sick infants or enterocolitis."}, "node-4": {"id": "node-4", "type": "decision", "content": "While awaiting surgery, the infant develops fever (39\u00b0C), explosive diarrhea, abdominal distension, and becomes lethargic. WBC is 22,000 with bandemia.", "question": "What is the MOST likely complication, and what is the immediate management?", "choices": [{"id": "node-4-choice-a", "text": "Hirschsprung-associated enterocolitis (HAEC) - IV fluids, NPO, rectal irrigations, IV antibiotics", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **HAEC** (Hirschsprung-associated enterocolitis) is a life-threatening complication with 50% mortality if untreated. Management: **NPO**, **IV fluids**, **broad-spectrum IV antibiotics**, and **rectal irrigations** (warm saline) to decompress the bowel. Emergency colostomy may be needed.", "consequence": "Life-saving treatment initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Viral gastroenteritis - supportive care only", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS misdiagnosis. In a patient with known Hirschsprung disease, fever + explosive diarrhea + distension = **HAEC until proven otherwise**. HAEC has 50% mortality if untreated. This requires aggressive intervention, not supportive care alone.", "consequence": "Missed HAEC can be fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Bowel perforation - emergent laparotomy", "isOptimal": false, "isAcceptable": true, "feedback": "Perforation can occur with HAEC and would require surgery, but the **first step is medical stabilization**: fluids, antibiotics, rectal irrigations. If there's free air on X-ray, then emergent surgery is indicated. Stabilize first unless perforation is confirmed.", "consequence": "Surgery may be needed but stabilize first.", "nextNodeId": "node-5"}, {"id": "node-4-choice-d", "text": "Sepsis from line infection - remove central line", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The clinical picture (known Hirschsprung + fever + explosive diarrhea + distension) is classic for **HAEC**, not line infection. Line infection would not cause abdominal distension and explosive diarrhea.", "consequence": "Wrong source identification.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Intussusception - air enema reduction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While intussusception can occur, the presentation in a Hirschsprung patient with these symptoms is classic **HAEC**. Intussusception would show a mass on imaging, not diffuse colitis.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HAEC** (Hirschsprung-associated enterocolitis) = EMERGENCY. Can occur pre- or post-operatively. Classic triad: **fever, abdominal distension, explosive diarrhea**. Treatment: NPO, IV fluids, IV antibiotics, **rectal irrigations** (key intervention). Mortality 50% if untreated."}, "node-5": {"id": "node-5", "type": "decision", "content": "The enterocolitis is treated successfully with medical management. The infant undergoes successful pull-through surgery at 3 months of age. At 2-year follow-up, parents report ongoing soiling and constipation.", "question": "What is the MOST common long-term complication after Hirschsprung surgery?", "choices": [{"id": "node-5-choice-a", "text": "Obstructive symptoms and soiling due to residual aganglionosis or stricture", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Post-operative problems include: (1) **Obstructive symptoms** (from stricture, residual aganglionosis, or internal sphincter achalasia), (2) **Soiling/incontinence** (from sphincter damage or overflow), (3) **Recurrent enterocolitis**. Evaluation: contrast enema, manometry, possible re-biopsy.", "consequence": "You understand the post-operative complications.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Recurrence of aganglionic segment (regrowth)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hirschsprung disease does NOT recur - ganglion cells don't disappear after surgery. Post-op problems are due to **residual** aganglionosis (transition zone not resected completely), stricture, or acquired motility issues.", "consequence": "Disease doesn't recur.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Malignant transformation of remaining colon", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hirschsprung disease is **not associated with increased malignancy risk** (unlike inflammatory bowel disease). The complications are functional (obstruction, soiling) or infectious (enterocolitis).", "consequence": "Not a cancer risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Complete resolution - symptoms must be behavioral", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect assumption. Post-Hirschsprung bowel dysfunction is **common and real**. Up to 30% have ongoing issues including obstructive symptoms, soiling, and enterocolitis. These need medical evaluation, not dismissal as behavioral.", "consequence": "Dismissing real complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "Development of inflammatory bowel disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hirschsprung disease is not associated with IBD. Post-operative enterocolitis can occur (HAEC), but this is a specific complication of Hirschsprung, not IBD development.", "consequence": "Wrong association.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Post-Hirschsprung complications** (up to 30%): Obstructive symptoms (stricture, residual aganglionosis, sphincter achalasia), soiling/incontinence, recurrent HAEC. Workup: contrast study, anorectal manometry, consider re-biopsy. Many improve with bowel management programs."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified the key diagnostic clue (delayed meconium passage), ordered appropriate imaging (contrast enema showing transition zone), confirmed with biopsy, recognized and treated life-threatening enterocolitis (HAEC), and understood long-term complications. Key teaching points: (1) No meconium by 48h = think Hirschsprung, (2) Contrast enema shows transition zone, (3) Biopsy = gold standard (absent ganglion cells), (4) HAEC is life-threatening - treat aggressively, (5) Post-op complications are common - need ongoing follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key Hirschsprung concepts: (1) Failure to pass meconium within 48h is the hallmark, (2) 'Squirt sign' = explosive stool after rectal exam, (3) Contrast enema shows transition zone + rectosigmoid ratio <1, (4) Biopsy confirms absent ganglion cells, (5) HAEC = fever + distension + explosive diarrhea = EMERGENCY."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key Hirschsprung principles: (1) Surgery is REQUIRED - ganglion cells never migrate or appear, (2) HAEC has 50% mortality if untreated - do not dismiss as viral illness, (3) Post-operative bowel dysfunction is common and REAL - needs evaluation, not dismissal."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-029", "title": "Pediatric Appendicitis", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["McBurney's point", "Rovsing sign", "psoas sign", "migration of pain", "pediatric appendicitis", "ultrasound first"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "An 8-year-old male is brought to the emergency department for abdominal pain that began 18 hours ago.\n\nPer the parents, the pain started around his belly button yesterday and has now moved to his right lower belly. He vomited once this morning. He has had low-grade fever and doesn't want to eat.\n\nMedical history: No prior abdominal surgeries. Healthy otherwise.\n\nPhysical Examination:\n- General: Lying still, reluctant to move, temperature 38.3\u00b0C.\n- Abdomen: RLQ tenderness at McBurney's point. Guarding present. Positive Rovsing sign (LLQ palpation causes RLQ pain). Positive psoas sign.\n- Bowel sounds: Hypoactive.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child has acute abdominal pain with localized RLQ findings.\n\nKey history features:\n- Pain migration: periumbilical \u2192 RLQ (classic)\n- Anorexia (loss of appetite)\n- Vomiting AFTER pain onset\n- Low-grade fever\n\nKey exam findings:\n- McBurney's point tenderness\n- Guarding\n- Positive Rovsing sign\n- Positive psoas sign", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Acute appendicitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Classic appendicitis presentation: periumbilical pain migrating to RLQ, anorexia, vomiting after pain onset, low-grade fever, McBurney's point tenderness, positive Rovsing and psoas signs.", "consequence": "Proceed to imaging and workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Mesenteric adenitis", "isOptimal": false, "isAcceptable": true, "feedback": "Possible but less likely. Mesenteric adenitis typically follows viral illness, has more diffuse tenderness without peritoneal signs, and lacks the classic appendicitis exam findings (guarding, positive Rovsing). This presentation is more concerning for appendicitis.", "consequence": "Should still rule out appendicitis with imaging.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Viral gastroenteritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Gastroenteritis presents with diarrhea (absent here), diffuse crampy pain, and lacks localized RLQ findings with peritoneal signs. This child has focal tenderness with guarding - concerning for appendicitis.", "consequence": "Missed surgical emergency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Constipation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Constipation causes diffuse, crampy pain without localized tenderness or peritoneal signs. This child has focal RLQ tenderness with guarding - concerning for appendicitis.", "consequence": "Missed appendicitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Urinary tract infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. UTI presents with dysuria, frequency, and suprapubic tenderness - not RLQ pain with peritoneal signs. While UA should be checked, the presentation is most consistent with appendicitis.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "CAUTION: Classic periumbilical-to-RLQ migration occurs in <50% of children. Pediatric appendicitis often presents atypically - don't rely on 'classic' history to rule it out!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect appendicitis based on the clinical exam.\n\nLabs return:\n- WBC: 14,500/\u03bcL with left shift (elevated neutrophils)\n- CRP: 4.5 mg/dL (elevated)\n- Urinalysis: Trace WBCs (can be seen with pelvic appendicitis)", "question": "What is the most appropriate initial imaging study?", "choices": [{"id": "node-2-choice-a", "text": "Abdominal ultrasound (RLQ focused)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Ultrasound is first-line for pediatric appendicitis: no radiation, high specificity when appendix visualized. Look for: appendix >6mm, non-compressible, target sign, periappendiceal fluid. If US is equivocal, then CT.", "consequence": "US ordered. Results pending.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CT abdomen/pelvis with IV contrast", "isOptimal": false, "isAcceptable": true, "feedback": "CT has >95% sensitivity and specificity but involves radiation. Current guidelines recommend ultrasound FIRST in children to minimize radiation exposure. CT is reserved for equivocal US or if appendix not visualized.", "consequence": "Correct diagnosis but unnecessary radiation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Abdominal X-ray (KUB)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Plain X-ray has very limited utility for appendicitis. It may show fecalith (<5% of cases) or nonspecific signs, but cannot rule in or rule out appendicitis. Waste of radiation.", "consequence": "Non-diagnostic, delays definitive imaging.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "MRI abdomen", "isOptimal": false, "isAcceptable": true, "feedback": "MRI is highly accurate and radiation-free but is not routinely available for acute appendicitis in most EDs. It's an acceptable alternative if US is equivocal and CT needs to be avoided (pregnancy), but not standard first-line.", "consequence": "Acceptable but not typical workflow.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "No imaging needed - clinical diagnosis is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While clinical suspicion guides management, imaging confirmation is standard of care for pediatric appendicitis to reduce negative appendectomy rates and guide surgical planning.", "consequence": "Unnecessary surgery risk or missed diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Imaging approach for pediatric appendicitis: US FIRST (no radiation). If appendix visualized and abnormal = appendicitis. If appendix not visualized or equivocal = CT. Appendix criteria: >6mm, non-compressible, target sign."}, "node-3": {"id": "node-3", "type": "decision", "content": "Ultrasound results:\n- Appendix visualized: 9mm diameter (>6mm is abnormal)\n- Non-compressible\n- Target sign present\n- Small amount of periappendiceal fluid\n- No abscess or perforation noted\n\nFindings consistent with ACUTE UNCOMPLICATED APPENDICITIS.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "NPO, IV fluids, IV antibiotics, and surgical consult for appendectomy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Standard management for acute uncomplicated appendicitis: NPO (nothing by mouth), IV fluid resuscitation, IV antibiotics (covering gram-negatives and anaerobes), and surgical consultation for appendectomy (laparoscopic preferred).", "consequence": "Surgical consult called. Proceed to OR planning.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Oral antibiotics and discharge with close follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While antibiotic-only management is being studied, it is NOT standard of care in children. Appendectomy remains the definitive treatment for acute appendicitis to prevent perforation and recurrence.", "consequence": "High risk of perforation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "CT scan to confirm before surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. US already shows clear diagnostic criteria for appendicitis (>6mm, non-compressible, target sign). CT would add unnecessary radiation without changing management.", "consequence": "Unnecessary radiation and delay.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Pain management and serial abdominal exams", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With imaging-confirmed appendicitis, observation is inappropriate. Each hour of delay increases perforation risk. Proceed directly to surgical management.", "consequence": "Dangerous delay - perforation risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "GI consult for possible colonoscopy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is acute appendicitis, not a GI/IBD presentation. Colonoscopy has no role. Surgical consultation is needed for appendectomy.", "consequence": "Wrong consult, delays surgery.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Perforation rate in children: 20-35% (higher than adults). Risk increases with: younger age, delayed diagnosis >24-36 hours, atypical presentation. Don't delay surgery once diagnosis is made!"}, "node-4": {"id": "node-4", "type": "decision", "content": "The surgeon reviews the case. The child has been NPO for 6 hours and received IV antibiotics.\n\nThe surgeon asks about the surgical approach and postoperative management plan.", "question": "What is the preferred surgical approach and expected postoperative course?", "choices": [{"id": "node-4-choice-a", "text": "Laparoscopic appendectomy; early feeding and discharge in 24-48 hours if uncomplicated", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Laparoscopic appendectomy is preferred: less pain, faster recovery, shorter hospital stay, better cosmesis. For uncomplicated appendicitis: early feeding, short antibiotics course (24 hours), discharge in 24-48 hours.", "consequence": "Successful surgery with routine recovery.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Open appendectomy via McBurney incision; keep NPO for 5 days", "isOptimal": false, "isAcceptable": true, "feedback": "Open appendectomy is acceptable but laparoscopic is preferred when available (faster recovery, less pain). Prolonged NPO is not necessary for uncomplicated cases - early feeding is safe and beneficial.", "consequence": "Longer recovery than necessary.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Interval appendectomy in 6-8 weeks with antibiotics only now", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Interval appendectomy is for COMPLICATED appendicitis (abscess/phlegmon). This is uncomplicated appendicitis - proceed with immediate appendectomy.", "consequence": "Inappropriate delay for uncomplicated case.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Laparoscopic appendectomy; IV antibiotics for 7 days postoperatively", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. For UNCOMPLICATED appendicitis, extended antibiotics are not needed. Studies show 24 hours of postoperative antibiotics is sufficient. Prolonged antibiotics increase cost, resistance risk, and hospital stay.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Percutaneous drainage followed by surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Percutaneous drainage is for appendiceal ABSCESS, not uncomplicated appendicitis. This child has no abscess on imaging - proceed directly to appendectomy.", "consequence": "Wrong procedure for this indication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Uncomplicated vs Complicated appendicitis: Uncomplicated = no perforation, abscess, or phlegmon \u2192 immediate appendectomy. Complicated (abscess/phlegmon) = consider IR drainage + antibiotics first, then interval appendectomy in 6-8 weeks."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly managed this case of pediatric appendicitis.\n\nKey Learning Points:\n1. Classic presentation: periumbilical pain \u2192 RLQ, anorexia, vomiting AFTER pain, low-grade fever\n2. BUT: <50% of children have classic presentation - maintain high suspicion\n3. Imaging: Ultrasound FIRST in children (no radiation). CT if US equivocal\n4. US criteria for appendicitis: >6mm, non-compressible, target sign\n5. Treatment: NPO, IV fluids, IV antibiotics, appendectomy (laparoscopic preferred)\n6. Uncomplicated: early feeding, short antibiotics, discharge 24-48 hours\n7. Perforation rate 20-35% in children - don't delay!\n\nOutcome: Successful laparoscopic appendectomy. Pathology confirms acute appendicitis without perforation. Early feeding tolerated, discharged home POD 1 with full recovery."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points about pediatric appendicitis:\n\n- Classic presentation occurs in <50% of children\n- US is first-line imaging (no radiation)\n- Appendix criteria: >6mm, non-compressible, target sign\n- CT if US equivocal (not routine)\n- Don't delay surgery once diagnosis is made\n- Perforation risk increases with time (20-35% in children)\n\nKey pearl: In children, atypical presentations are common. Low threshold to image with RLQ pain."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in appendicitis management.\n\nRemember:\n- Pediatric appendicitis has HIGH perforation rate (20-35%)\n- Each hour of delay increases perforation risk\n- Imaging-confirmed appendicitis requires surgery, not observation\n- Oral antibiotics alone is NOT standard of care in children\n- Never dismiss RLQ pain with peritoneal signs as 'constipation' or 'virus'\n\nKey pearl: Classic periumbilical-to-RLQ migration occurs in <50% of children. Maintain high suspicion for appendicitis even with atypical presentations."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-030", "title": "Malrotation with Midgut Volvulus", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["bilious vomiting in neonate", "corkscrew duodenum", "double bubble sign", "malrotation with midgut volvulus"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-week-old male is brought to the emergency department for bilious vomiting and abdominal distension that began 6 hours ago.\n\nPer the mother, he had sudden onset of green vomiting and his belly became distended. He was previously healthy and feeding well. He appears in pain and is inconsolable.\n\nbloody stool and lethargy. No fever.\n\nPertinent history includes He was born full-term with no complications. No prior vomiting episodes.\n\nPhysical Examination:\n- Abdomen: distended, tender, with absent bowel sounds. Bloody stool on diaper.\n- General: ill-appearing infant with signs of shock (tachycardia, poor perfusion, lethargy).\n- Vitals: HR 180, BP 55/35, RR 50, temp 36.5\u00b0C.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This neonate presents with bilious vomiting, abdominal distension, bloody stools, and shock. This is a SURGICAL EMERGENCY.", "question": "Why is BILIOUS vomiting in a neonate considered malrotation with volvulus until proven otherwise?", "choices": [{"id": "node-1-choice-a", "text": "Bilious vomit indicates obstruction DISTAL to the ampulla of Vater, where volvulus occurs", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bilious (green) vomiting** indicates obstruction **distal to the ampulla of Vater** (where bile enters the duodenum). **Midgut volvulus** from malrotation causes obstruction at this level. This is a surgical emergency because the **entire midgut** (small bowel and right colon) can undergo **ischemic necrosis** within hours if untreated.", "consequence": "You recognize the emergency and act immediately.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bilious vomiting always indicates pyloric stenosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Pyloric stenosis causes NON-bilious vomiting** because the obstruction is PROXIMAL to the ampulla of Vater (at the pylorus). Bile hasn't entered the stomach yet. Pyloric stenosis presents with projectile, non-bilious emesis.", "consequence": "You confuse the level of obstruction.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bilious vomiting is common in gastroenteritis and can be observed", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS thinking! While older children with viral gastroenteritis may have bilious vomiting, in a **neonate**, bilious vomiting is **NEVER** assumed to be benign. It is **malrotation with volvulus until proven otherwise** - a surgical emergency.", "consequence": "You dangerously delay treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "The green color indicates infection requiring antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The **green color is bile**, not pus or infection. It indicates obstruction distal to where bile enters the GI tract. While this patient may need antibiotics for potential sepsis from necrotic bowel, the primary treatment is **emergent surgery**.", "consequence": "You misidentify the cause of bilious emesis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Bilious vomiting only occurs in formula-fed infants", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Bilious vomiting has nothing to do with feeding type**. It can occur in breastfed or formula-fed infants. The green color comes from bile refluxing back through an obstruction, not from the feeds themselves.", "consequence": "You attribute the finding to feeding type incorrectly.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**GOLDEN RULE**: Bilious vomiting in a neonate = **malrotation with volvulus until proven otherwise**. This is the most important surgical emergency in neonatal GI surgery. Missing it results in loss of the entire midgut."}, "node-2": {"id": "node-2", "type": "decision", "content": "You've identified this as a surgical emergency. The infant is in shock with bilious vomiting and bloody stools. The pediatric surgeon is en route.", "question": "What is the appropriate immediate management WHILE preparing for surgery?", "choices": [{"id": "node-2-choice-a", "text": "IV access, fluid resuscitation, NGT decompression, NPO, type and cross", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Immediate stabilization includes: **IV/IO access** for fluid resuscitation (NS boluses for shock), **nasogastric tube** for decompression (reduces vomiting, aspiration risk, abdominal distension), **NPO** status, **type and crossmatch** for OR. Broad-spectrum antibiotics (ampicillin, gentamicin, metronidazole) for potential bowel necrosis/perforation.", "consequence": "You stabilize the infant while preparing for surgery.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start oral feeds to assess tolerance", "isOptimal": false, "isAcceptable": false, "feedback": "Absolutely incorrect! This patient has a **bowel obstruction** - feeding will worsen distension, increase aspiration risk, and delay surgery. The patient must be **NPO** with NGT decompression.", "consequence": "You worsen the situation by feeding.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Wait for complete imaging workup before calling surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Do NOT delay surgery for imaging** when clinical suspicion is high. In a sick neonate with bilious vomiting and bloody stools in shock, go directly to OR. Every hour of delay risks more bowel necrosis.", "consequence": "You delay life-saving surgery.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Barium enema to rule out intussusception", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Barium enema is for **intussusception** (typically 6 months - 2 years, currant jelly stools, intermittent colicky pain). This is a **3-week-old** with classic volvulus presentation. Upper GI, not enema, would be the study if imaging is needed.", "consequence": "You order the wrong study for the wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Send home with antiemetics and close follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "This would be **fatal**. This infant is in shock with a surgical emergency. Discharge would result in complete bowel necrosis and death. Never discharge a neonate with bilious vomiting without ruling out malrotation.", "consequence": "The infant would die at home.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Pre-op stabilization**: IV NS boluses (20 mL/kg), NGT to low intermittent suction, NPO, foley catheter, blood products ready, broad-spectrum antibiotics. Don't delay OR for imaging in an unstable patient!"}, "node-3": {"id": "node-3", "type": "decision", "content": "If imaging is obtained before surgery (in a more stable patient), what would confirm the diagnosis?", "question": "What is the GOLD STANDARD imaging study for malrotation?", "choices": [{"id": "node-3-choice-a", "text": "Upper GI series showing abnormal position of the ligament of Treitz", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **upper GI series** is the gold standard. It evaluates the position of the **duodenojejunal junction (ligament of Treitz)**, which should be to the **left of the spine at the level of the pylorus**. In malrotation, it's abnormally positioned (right of midline or inferiorly). A **'corkscrew' appearance** indicates active volvulus.", "consequence": "You understand the diagnostic imaging.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Abdominal X-ray showing double bubble sign", "isOptimal": false, "isAcceptable": true, "feedback": "The **double bubble sign** (stomach + proximal duodenum) suggests **duodenal obstruction** but is not specific for volvulus - it's also seen in **duodenal atresia**. Plain X-ray may be normal in malrotation! Upper GI is needed for definitive diagnosis.", "consequence": "You recognize the X-ray finding but know UGI is needed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "CT abdomen with contrast", "isOptimal": false, "isAcceptable": true, "feedback": "CT can show the **'whirlpool sign'** (twisted mesentery) in volvulus but is **not first-line in neonates** due to radiation and the need for IV contrast. **Upper GI series** remains the gold standard. CT may be useful in older children or unclear cases.", "consequence": "You consider CT but UGI is preferred.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Barium enema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Barium enema evaluates the **lower GI tract** and may show abnormal cecal position in malrotation, but it cannot evaluate the **ligament of Treitz** which is the key landmark. **Upper GI** is the gold standard.", "consequence": "You order a study that doesn't evaluate the key anatomy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Ultrasound alone is sufficient", "isOptimal": false, "isAcceptable": true, "feedback": "Ultrasound can show **abnormal SMA/SMV relationship** (normally SMA is to the left of SMV) and may show the 'whirlpool sign,' but it is **operator-dependent** and less reliable than UGI. It can be a useful adjunct but doesn't replace UGI as the gold standard.", "consequence": "You consider US but recognize its limitations.", "nextNodeId": "node-4"}], "clinicalPearl": "**Upper GI findings in malrotation**: Ligament of Treitz **right of spine or below duodenal bulb**. In volvulus: **'corkscrew'** or **'spiral'** appearance of the duodenum. **Normal UGI** essentially rules out malrotation."}, "node-4": {"id": "node-4", "type": "decision", "content": "The infant is taken to the OR emergently. At exploration, the midgut is twisted 360 degrees with dusky-appearing bowel. The surgeon untwists the volvulus.", "question": "What is the definitive surgical procedure (Ladd procedure)?", "choices": [{"id": "node-4-choice-a", "text": "Counterclockwise detorsion, division of Ladd bands, widening of mesenteric base, appendectomy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Ladd procedure** includes: 1) **Counterclockwise detorsion** of the volvulus (remember: volvulus twists clockwise, so untwist counterclockwise), 2) **Division of Ladd bands** (peritoneal bands crossing the duodenum), 3) **Widening the mesenteric base** to prevent recurrence, 4) **Appendectomy** (because the cecum will be in the LLQ, making future appendicitis diagnosis difficult).", "consequence": "You understand the complete surgical procedure.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Resection of all small bowel", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The goal is to **salvage bowel**, not resect it. Only clearly **necrotic bowel** is resected. If viability is questionable, a **second-look laparotomy** in 24-48 hours may be performed. Preserving bowel prevents short gut syndrome.", "consequence": "You consider resection but preservation is the goal.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Only untwist the volvulus, nothing else", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Simply detorsing the volvulus **will result in recurrence** without addressing the underlying malrotation. The **Ladd bands must be divided** and the **mesenteric base widened** to prevent re-volvulus.", "consequence": "You leave the patient at risk for recurrence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Gastrostomy tube placement only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! A G-tube is NOT the treatment for volvulus. The twisted bowel must be untwisted and the malrotation corrected with the Ladd procedure. A G-tube may be placed if prolonged feeding issues are expected.", "consequence": "You don't address the surgical problem.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Wait to see if the bowel reperfuses spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The bowel is **actively ischemic** - every minute counts. Waiting for spontaneous reperfusion while the bowel is still twisted will result in **irreversible necrosis** and possible death.", "consequence": "You allow bowel necrosis to progress.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Ladd procedure components**: 1) Detorse counterclockwise, 2) Divide Ladd bands (over duodenum), 3) Widen mesenteric base, 4) Place small bowel on RIGHT, colon on LEFT (opposite of normal!), 5) Appendectomy. Does NOT anatomically correct the rotation."}, "node-5": {"id": "node-5", "type": "decision", "content": "After the Ladd procedure, some segments of bowel appear questionably viable. The surgeon is deciding on next steps.", "question": "What determines whether questionably viable bowel should be resected or preserved?", "choices": [{"id": "node-5-choice-a", "text": "Second-look laparotomy in 24-48 hours to reassess viability before resection", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **questionably viable bowel**, a **second-look laparotomy** in 24-48 hours allows time for reperfusion and definitive assessment. This maximizes bowel salvage and prevents unnecessary resection. Only clearly necrotic bowel is removed at initial surgery.", "consequence": "You plan for optimal bowel preservation.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Resect all questionable bowel immediately to prevent sepsis", "isOptimal": false, "isAcceptable": true, "feedback": "Resecting all questionable bowel is overly aggressive and risks **short bowel syndrome**. While clearly necrotic bowel should be resected, questionable segments deserve a **second-look** to see if they recover. Balance infection risk against losing critical bowel length.", "consequence": "You may remove viable bowel unnecessarily.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Close abdomen and hope for the best", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This leaves dead bowel in place with high risk of **sepsis and perforation**. Either resect obviously necrotic bowel or plan a definitive second-look. Never leave clearly dead bowel.", "consequence": "You leave necrotic bowel to cause sepsis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Intraoperative IV fluorescein dye is required for all cases", "isOptimal": false, "isAcceptable": true, "feedback": "Fluorescein or indocyanine green (ICG) can help assess perfusion but is **not required** for all cases. Clinical assessment (color, peristalsis, mesenteric pulsations, bleeding from cut edges) combined with second-look is often sufficient.", "consequence": "You consider adjuncts but clinical judgment is key.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-e", "text": "Primary anastomosis is safe regardless of bowel condition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! In the setting of **questionable viability, contamination, or hemodynamic instability**, primary anastomosis risks **anastomotic leak**. A **temporary ostomy** with delayed anastomosis may be safer.", "consequence": "You risk anastomotic dehiscence.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Short bowel syndrome** results if >75% of small bowel is lost. Preserve every centimeter possible! **Second-look laparotomy** in 24-48 hours allows bowel that may recover to declare itself. Signs of viability: pink color, peristalsis, bleeding from cut edges."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of this surgical emergency! You recognized bilious vomiting as an emergent sign of malrotation with volvulus, initiated rapid stabilization, understood the imaging findings, and knew the components of the Ladd procedure. The second-look laparotomy showed viable bowel, and the infant recovered with full bowel function."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key malrotation pearls: **Bilious vomiting in neonate = malrotation until proven otherwise**. **Upper GI series** is gold standard (abnormal ligament of Treitz position). **Ladd procedure**: counterclockwise detorsion, divide Ladd bands, widen mesentery, appendectomy. **Second-look laparotomy** for questionable bowel."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. **Malrotation with volvulus is the #1 surgical emergency in neonatal GI**. Delay = dead bowel = short gut syndrome or death. Never dismiss bilious vomiting in a neonate. Never feed an obstructed patient. Never delay surgery for imaging in an unstable patient."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-031", "title": "Biliary Atresia", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["conjugated hyperbilirubinemia", "acholic stools", "persistent jaundice >2 weeks", "biliary atresia"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-week-old female is brought to the emergency department for persistent jaundice and pale stools that began 4 weeks ago.\n\nSubjectively, she has been jaundiced since birth and it has not resolved. Her parents noticed her stools are pale, almost white, and her urine is very dark. She seems to be feeding well but is not gaining weight as expected.\n\nAssociated symptoms include dark urine and hepatomegaly. Denies fever or vomiting.\n\nPertinent history includes She was born full-term. Jaundice was attributed to breastfeeding initially.\n\nPhysical Examination:\n- Skin: jaundiced with icteric sclerae.\n- Abdomen: hepatomegaly with firm liver edge.\n- Stool: acholic (pale, clay-colored).\n- Urine: dark (bilirubinuria).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-week-old has persistent jaundice since birth with acholic (pale/clay-colored) stools and dark urine. Labs show: Total bilirubin 12.5 mg/dL, Direct bilirubin 9.8 mg/dL (78% conjugated).", "question": "What is the CRITICAL first step when evaluating jaundice that persists beyond 2 weeks of life?", "choices": [{"id": "node-1-choice-a", "text": "Fractionated bilirubin to differentiate direct vs indirect hyperbilirubinemia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Fractionated (direct/indirect) bilirubin** is ESSENTIAL for any jaundice persisting >2 weeks. **Direct (conjugated) hyperbilirubinemia is NEVER physiologic** and indicates hepatobiliary disease requiring urgent workup. Indirect hyperbilirubinemia (breast milk jaundice) can be observed, but direct hyperbilirubinemia cannot.", "consequence": "You identify conjugated hyperbilirubinemia requiring urgent evaluation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Reassure parents - this is breast milk jaundice", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS. **Breast milk jaundice causes INDIRECT hyperbilirubinemia only**. You cannot assume breast milk jaundice without checking fractionated bilirubin. This infant has **acholic stools** (pathognomonic for biliary obstruction) - this is NOT breast milk jaundice.", "consequence": "Missed biliary atresia leads to cirrhosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Start phototherapy for hyperbilirubinemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Phototherapy converts **unconjugated bilirubin** to water-soluble isomers for excretion. It is **ineffective for conjugated hyperbilirubinemia** because the conjugated bilirubin is already water-soluble but cannot be excreted due to biliary obstruction.", "consequence": "Ineffective treatment delays diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Obtain TORCH titers", "isOptimal": false, "isAcceptable": true, "feedback": "TORCH infections can cause neonatal hepatitis and cholestasis, but **fractionated bilirubin should be done FIRST** to confirm this is conjugated hyperbilirubinemia before pursuing infectious workup. The acholic stools strongly suggest biliary atresia over TORCH infection.", "consequence": "Appropriate but not the first step.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Schedule follow-up in 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS. Delayed diagnosis of biliary atresia is **catastrophic**. The Kasai procedure success rate drops dramatically after 60 days of life. Every day of delay increases the risk of cirrhosis and need for liver transplant.", "consequence": "Critical delay in time-sensitive diagnosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Jaundice >2 weeks = Fractionated bilirubin MANDATORY**. Direct hyperbilirubinemia is NEVER normal. **Acholic (pale) stools** = biliary obstruction until proven otherwise. **Dark urine** = conjugated bilirubin in urine (bilirubinuria)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Fractionated bilirubin confirms conjugated hyperbilirubinemia (direct >20% of total or >2 mg/dL). You suspect biliary atresia.", "question": "What is the FIRST-LINE imaging study to evaluate for biliary atresia?", "choices": [{"id": "node-2-choice-a", "text": "Hepatobiliary ultrasound looking for triangular cord sign and gallbladder abnormalities", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Hepatobiliary ultrasound** is the first-line imaging. Key findings in biliary atresia: (1) **Triangular cord sign** (echogenic density at porta hepatis - fibrotic biliary remnant), (2) **Absent or abnormal gallbladder** (small, irregular, or not visualized), (3) No intrahepatic biliary dilation (unlike choledochal cyst).", "consequence": "Appropriate imaging obtained.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "HIDA scan (hepatobiliary iminodiacetic acid scan)", "isOptimal": false, "isAcceptable": true, "feedback": "HIDA scan can support biliary atresia diagnosis (no radiotracer excretion into intestine) but requires **phenobarbital pretreatment for 5 days** and has significant false positives/negatives. **Ultrasound is faster and should be done FIRST** before HIDA.", "consequence": "Useful but not first-line.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "CT scan of abdomen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT provides no advantage over ultrasound for biliary atresia and exposes the infant to **radiation**. Ultrasound is the appropriate first-line imaging for neonatal cholestasis evaluation.", "consequence": "Unnecessary radiation exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "MRCP (MR cholangiopancreatography)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this age. MRCP requires **sedation** in infants and the **small biliary structures** are difficult to visualize. Ultrasound is first-line; intraoperative cholangiogram is the gold standard if surgery is pursued.", "consequence": "Inappropriate imaging choice for infants.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Liver biopsy first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect sequence. While liver biopsy can show bile duct proliferation and portal fibrosis consistent with biliary atresia, **non-invasive imaging (ultrasound) should be done FIRST** before proceeding to invasive procedures.", "consequence": "Invasive procedure before non-invasive imaging.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Biliary atresia ultrasound findings**: (1) **Triangular cord sign** (sensitivity ~80%), (2) Absent/abnormal gallbladder, (3) NO intrahepatic ductal dilation (differentiates from choledochal cyst which DOES have dilation)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Ultrasound shows an absent gallbladder and a triangular cord sign. HIDA scan shows no excretion into the intestine after 24 hours. The infant is now 7 weeks old.", "question": "What is the DEFINITIVE treatment for biliary atresia and what is the CRITICAL timing consideration?", "choices": [{"id": "node-3-choice-a", "text": "Kasai portoenterostomy - must be performed before 60 days of life for best outcomes", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Kasai portoenterostomy** (hepatoportoenterostomy) is the definitive treatment. The surgeon removes the fibrotic biliary remnant and creates a Roux-en-Y anastomosis to allow bile drainage. **Timing is CRITICAL**: success rate is **80% if done <30 days**, **50% if done 30-60 days**, and **<20% if done >90 days**.", "consequence": "Urgent surgical referral arranged.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ursodeoxycholic acid to dissolve the obstruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ursodiol is used for **choleretic support** after Kasai surgery to improve bile flow, but it **cannot treat biliary atresia** which is caused by inflammatory destruction and fibrosis of the bile ducts, not stones or sludge.", "consequence": "Medical therapy cannot treat anatomic obstruction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Liver transplant as first-line treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect sequence. Kasai is **first-line** - it can establish bile flow and delay or prevent the need for transplant. Liver transplant is reserved for **failed Kasai** (no bile flow by 3 months post-op) or **progression to cirrhosis**. About 70% of biliary atresia patients eventually need transplant, but Kasai can bridge them to larger size.", "consequence": "Skipping Kasai is not standard of care.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "ERCP with stenting", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ERCP is used for **choledochal cysts** or ductal stones/strictures, not biliary atresia. In biliary atresia, there is **no patent duct to stent** - the extrahepatic biliary system is fibrotic/atretic.", "consequence": "Wrong procedure - no patent duct exists.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Schedule surgery for 3-4 months of age when the infant is larger", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS delay! Every week of delay significantly worsens outcomes. The **Kasai success rate drops from 80% to <20%** as the infant ages. Biliary atresia is a **surgical emergency** - do not wait for the infant to grow.", "consequence": "Delay leads to cirrhosis and transplant need.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Kasai portoenterostomy timing is CRITICAL**: <30 days = 80% success, 30-60 days = 50%, >90 days = <20%. Success = bile flow (stool color change from acholic to pigmented). Even successful Kasai often fails over years \u2192 ~70% eventually need liver transplant."}, "node-4": {"id": "node-4", "type": "decision", "content": "Kasai portoenterostomy is performed at 8 weeks of age. Post-operatively, the infant develops fever to 39\u00b0C on day 5. Blood cultures are positive for gram-negative rods.", "question": "What is the MOST likely complication and appropriate management?", "choices": [{"id": "node-4-choice-a", "text": "Ascending cholangitis - treat with IV antibiotics covering gram-negatives", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Ascending cholangitis** is the most common complication after Kasai, occurring in 40-90% of patients. Bacteria ascend through the Roux-en-Y limb into the biliary system. Treatment: **IV antibiotics** covering enteric gram-negatives (e.g., ceftriaxone, piperacillin-tazobactam). Many centers use **prophylactic antibiotics** (TMP-SMX) to prevent this.", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Wound infection - local wound care only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While wound infection is possible, **fever with positive blood cultures** indicates **systemic infection**. In post-Kasai patients, **ascending cholangitis** is the most common cause and requires IV antibiotics, not just wound care.", "consequence": "Undertreatment of serious infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Liver abscess - requires surgical drainage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as first assumption. Liver abscess is less common than cholangitis post-Kasai. **Ascending cholangitis** should be treated first with IV antibiotics. Imaging can be obtained if no improvement to evaluate for abscess, but cholangitis is far more common.", "consequence": "Jumping to rare diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Viral gastroenteritis - supportive care only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fever + positive blood cultures = bacteremia/sepsis**, not viral illness. In a post-Kasai patient, this presentation is classic **ascending cholangitis** requiring IV antibiotics.", "consequence": "Failure to treat serious bacterial infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "UTI - oral antibiotics and outpatient follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While UTI could cause gram-negative bacteremia, in a post-Kasai patient **ascending cholangitis** is the primary concern. Additionally, **any infant with bacteremia requires IV antibiotics and inpatient management**, not outpatient oral therapy.", "consequence": "Inappropriate outpatient management of bacteremia.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Post-Kasai complications**: (1) **Ascending cholangitis** (40-90%) - fever, worsening jaundice, acholic stools; treat with IV antibiotics, many centers use TMP-SMX prophylaxis. (2) Portal hypertension (varices, splenomegaly). (3) Progressive liver fibrosis \u2192 transplant need."}, "node-5": {"id": "node-5", "type": "decision", "content": "The cholangitis resolves with antibiotics. At 1-year follow-up, the child has good bile flow (pigmented stools) but has developed hepatomegaly and splenomegaly with thrombocytopenia (platelets 85K).", "question": "What complication do these findings suggest, and what surveillance is needed?", "choices": [{"id": "node-5-choice-a", "text": "Portal hypertension - screen for esophageal varices with endoscopy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Portal hypertension** develops in most biliary atresia patients even after successful Kasai, due to progressive hepatic fibrosis. Signs: **splenomegaly**, **thrombocytopenia** (hypersplenism), **ascites**. Patients need **EGD screening for esophageal varices** to prevent life-threatening GI bleeding.", "consequence": "Appropriate surveillance initiated.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Biliary atresia recurrence - repeat Kasai surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Biliary atresia doesn't \"recur\" - the child has good bile flow. The hepatosplenomegaly and thrombocytopenia indicate **portal hypertension** from progressive liver fibrosis, a common sequel even after successful Kasai.", "consequence": "Misidentifying the complication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "ITP - treat with IVIG", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The thrombocytopenia is due to **hypersplenism** from portal hypertension (platelets sequestered in enlarged spleen), not immune destruction. ITP would not explain the hepatosplenomegaly or the clinical context of biliary atresia.", "consequence": "Wrong mechanism for thrombocytopenia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Leukemia - bone marrow biopsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In the context of biliary atresia with hepatosplenomegaly, isolated thrombocytopenia is explained by **hypersplenism**, not malignancy. Leukemia would typically show more significant cytopenias and other systemic findings.", "consequence": "Unnecessary invasive workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Drug-induced thrombocytopenia - stop all medications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The clinical picture (hepatosplenomegaly + thrombocytopenia in biliary atresia patient) points to **portal hypertension with hypersplenism**, not drug effect. Abruptly stopping medications (like ursodiol or prophylactic antibiotics) would be harmful.", "consequence": "Incorrect diagnosis and harmful action.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Long-term biliary atresia outcomes**: Even after successful Kasai, ~70% eventually need liver transplant due to progressive fibrosis and portal hypertension. Surveillance: **fat-soluble vitamin levels** (A, D, E, K), **EGD for varices**, **growth monitoring**. Biliary atresia is the #1 indication for pediatric liver transplant."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified the urgency of conjugated hyperbilirubinemia, obtained appropriate imaging, recognized the critical timing for Kasai surgery, managed ascending cholangitis, and identified portal hypertension requiring variceal surveillance. Key teaching points: (1) Jaundice >2 weeks = fractionated bilirubin mandatory, (2) Direct hyperbilirubinemia is NEVER normal, (3) Kasai timing is critical (<60 days), (4) Ascending cholangitis is the most common post-Kasai complication, (5) Portal hypertension develops in most patients - screen for varices."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key biliary atresia concepts: (1) Fractionated bilirubin for any jaundice >2 weeks, (2) Ultrasound first-line imaging (triangular cord sign, absent GB), (3) Kasai <60 days for best outcomes, (4) Ascending cholangitis - most common post-Kasai complication, (5) Portal hypertension surveillance (varices, fat-soluble vitamins)."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key biliary atresia principles: (1) Direct hyperbilirubinemia is NEVER physiologic - never reassure as breast milk jaundice without checking fractionated bili, (2) Kasai timing is critical - delaying surgery leads to cirrhosis, (3) Post-Kasai fever + bacteremia = ascending cholangitis requiring IV antibiotics, (4) Biliary atresia is the #1 indication for pediatric liver transplant."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-032", "title": "Meckel Diverticulum", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["painless rectal bleeding", "rule of 2s", "ectopic gastric tissue", "meckel diverticulum"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 2-year-old male is brought to the emergency department for painless bloody stools that began 2 days ago.\n\nThe patient's mother reports, he has passed several episodes of bright red to maroon-colored bloody stools. He has no abdominal pain and is acting normally between episodes.\n\nAssociated symptoms include pallor noted today. Denies vomiting, fever, diarrhea, or constipation.\n\nPast medical history includes He was previously healthy with no prior GI problems.\n\nPhysical Examination:\n- Abdomen: soft, non-tender, non-distended with normal bowel sounds.\n- Rectal: maroon-colored stool, no fissures.\n- General: pale but well-appearing toddler, hemodynamically stable.\n- Vitals: febrile.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-year-old presents with **painless bright red to maroon rectal bleeding** - a classic presentation in this age group. He is hemodynamically stable and has no abdominal pain. Initial labs show hemoglobin 9.2 g/dL (mild anemia from blood loss).", "question": "What is the MOST likely cause of painless lower GI bleeding in a child under 5 years?", "choices": [{"id": "node-1-choice-a", "text": "Meckel diverticulum - most common cause of significant painless lower GI bleeding in children", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Meckel diverticulum** is the most common cause of significant **painless** lower GI bleeding in children. It contains **ectopic gastric mucosa** that secretes acid, causing ulceration of adjacent ileal tissue and bleeding. The **\"Rule of 2s\"**: 2% of population, 2 feet from ileocecal valve, 2 inches long, 2 types of tissue (gastric/pancreatic), presents before age 2.", "consequence": "You correctly identify the most likely diagnosis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Intussusception", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Intussusception causes **colicky abdominal pain**, vomiting, and late **\"currant jelly\" stools** (blood mixed with mucus). This child has **NO pain** - he acts normally between bleeding episodes. Painless bleeding points toward Meckel diverticulum.", "consequence": "Intussusception causes painful episodes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Juvenile polyp", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Juvenile polyps cause **painless bright red blood** coating the stool but are more common in children **3-10 years old** and rarely cause significant bleeding or anemia. Meckel diverticulum causes more **brisk bleeding** leading to anemia, as seen here.", "consequence": "Possible but less likely given degree of bleeding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Anal fissure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Anal fissure causes **bright red blood ON the stool surface** or on toilet paper, typically with **painful defecation**. The blood is not mixed with stool. This child has maroon-colored blood mixed throughout the stool, indicating a more proximal source.", "consequence": "Fissure causes surface blood with painful defecation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Infectious colitis (Shigella, E. coli)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Infectious colitis causes **bloody diarrhea with fever, cramping, and frequent small-volume stools**. This child has **formed bloody stools** without diarrhea, fever, or cramping. The absence of systemic symptoms makes infection unlikely.", "consequence": "No fever or diarrhea to suggest infection.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Meckel Diverticulum \"Rule of 2s\"**: **2%** of population, **2 feet** from ileocecal valve, **2 inches** long, **2 types** of ectopic tissue (gastric most common, pancreatic), often presents before age **2**, males **2x** more likely to be symptomatic."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect Meckel diverticulum as the source of bleeding. The child is hemodynamically stable with ongoing mild bleeding.", "question": "What is the BEST diagnostic study to confirm Meckel diverticulum?", "choices": [{"id": "node-2-choice-a", "text": "Technetium-99m pertechnetate scan (Meckel scan) - detects ectopic gastric mucosa", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Technetium-99m pertechnetate scan (Meckel scan)** is the study of choice. Pertechnetate is taken up by **gastric mucosa** (both normal stomach and ectopic gastric tissue in Meckel diverticulum). **Sensitivity 85-90%**, **specificity 95%**. A positive scan shows uptake in the right lower quadrant simultaneous with gastric uptake.", "consequence": "Meckel scan obtained.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CT scan of abdomen and pelvis with contrast", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT is **not reliable** for detecting Meckel diverticulum - the diverticulum often appears as normal small bowel. CT is useful for complications (perforation, obstruction) but not for primary diagnosis of bleeding Meckel.", "consequence": "CT misses most Meckel diverticula.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Colonoscopy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Colonoscopy evaluates the **colon** but Meckel diverticulum is located in the **ileum** (small bowel), beyond the reach of the colonoscope. Colonoscopy may show blood coming from the ileocecal valve but cannot visualize the source.", "consequence": "Colonoscopy cannot reach the ileum.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Upper GI series with small bowel follow-through", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Barium studies are **insensitive** for Meckel diverticulum - the diverticulum often does not fill with contrast or appears as a normal bowel loop. The Meckel scan is far more sensitive for detecting the ectopic gastric mucosa.", "consequence": "Barium studies miss most Meckel diverticula.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Abdominal X-ray", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Plain abdominal X-ray **cannot visualize** Meckel diverticulum. It may show nonspecific findings or be completely normal. X-ray is useful for obstruction or free air but not for diagnosing bleeding Meckel.", "consequence": "X-ray is not diagnostic for Meckel.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Meckel scan (Tc-99m pertechnetate)**: Pertechnetate is taken up by **parietal cells** of gastric mucosa. Sensitivity can be **enhanced** with **pentagastrin** (increases uptake) or **H2 blocker/PPI** (decreases secretion to prevent washout). A **negative scan does NOT exclude** Meckel if no ectopic gastric mucosa is present."}, "node-3": {"id": "node-3", "type": "decision", "content": "The Meckel scan shows abnormal uptake in the right lower quadrant that appears simultaneously with gastric uptake, confirming the presence of ectopic gastric mucosa. The child continues to have intermittent bleeding episodes.", "question": "What is the DEFINITIVE treatment for symptomatic Meckel diverticulum?", "choices": [{"id": "node-3-choice-a", "text": "Surgical resection (diverticulectomy or segmental ileal resection)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Surgical resection** is the definitive treatment for symptomatic Meckel diverticulum. Options include: (1) **Simple diverticulectomy** (removal of diverticulum only) for narrow-based diverticula, or (2) **Segmental ileal resection** with anastomosis for wide-based diverticula or when ulceration extends to adjacent ileum. Can be done laparoscopically.", "consequence": "Surgical consultation obtained for resection.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Proton pump inhibitor therapy to reduce acid secretion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PPIs do not treat the underlying problem**. The ectopic gastric mucosa will continue to secrete acid and cause ulceration. PPIs may temporarily reduce symptoms but **surgery is required** for definitive treatment of symptomatic Meckel diverticulum.", "consequence": "Medical therapy is not definitive treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Observation - most Meckel diverticula resolve spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Meckel diverticulum is a **congenital structural anomaly** that does NOT resolve spontaneously. Once symptomatic with bleeding, it will continue to bleed and may cause life-threatening hemorrhage. **Surgery is indicated** for all symptomatic cases.", "consequence": "Continued bleeding without intervention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Endoscopic cauterization of the bleeding site", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Meckel diverticulum is located in the **ileum**, which is **beyond the reach of standard endoscopes**. Even if visualized via capsule endoscopy or device-assisted enteroscopy, the **ectopic gastric mucosa must be removed** to prevent recurrent bleeding.", "consequence": "Cannot reach the lesion endoscopically.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Angiographic embolization of the bleeding vessel", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as primary treatment. Embolization may be considered as a **temporizing measure** for massive hemorrhage, but it does not remove the ectopic gastric mucosa. **Surgical resection remains necessary** for definitive cure.", "consequence": "Does not address the underlying pathology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Symptomatic Meckel = Surgery**. Asymptomatic Meckel found incidentally is **controversial** - some surgeons resect to prevent future complications, others observe. **Lifetime complication risk ~4%**, higher in younger patients with longer diverticula or palpable ectopic tissue."}, "node-4": {"id": "node-4", "type": "decision", "content": "Laparoscopic segmental ileal resection is performed successfully. Pathology confirms a Meckel diverticulum with ectopic gastric mucosa and adjacent ileal ulceration. The family asks about the prognosis and any other conditions to watch for.", "question": "What should you counsel the family about regarding OTHER presentations of Meckel diverticulum besides bleeding?", "choices": [{"id": "node-4-choice-a", "text": "Meckel can also cause intestinal obstruction (intussusception lead point, volvulus, internal hernia) and diverticulitis mimicking appendicitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Meckel diverticulum has 3 main presentations**: (1) **Bleeding** (most common in children <5) from ectopic gastric mucosa, (2) **Obstruction** (intussusception with Meckel as lead point, volvulus around Meckel band, internal hernia), (3) **Diverticulitis** (inflammation/perforation mimicking appendicitis - **right lower quadrant pain**). This child had bleeding; others present differently.", "consequence": "You provide comprehensive education.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Meckel diverticulum only causes bleeding - no other complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **bleeding is the most common pediatric presentation**, Meckel can also cause **obstruction** (30% of symptomatic cases) and **diverticulitis/perforation** (20%). The presenting symptom often depends on age - bleeding in young children, obstruction in older children/adults.", "consequence": "Incomplete counseling about potential complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "The child needs annual surveillance scans to monitor for recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After **complete surgical resection**, the Meckel diverticulum is cured - there is no recurrence. Unlike polyp syndromes or inflammatory conditions, Meckel is a single congenital anomaly. Once removed, no surveillance is needed.", "consequence": "Unnecessary surveillance after definitive resection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "This is a familial condition - siblings should be screened", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Meckel diverticulum is a **sporadic congenital anomaly** resulting from incomplete obliteration of the omphalomesenteric (vitelline) duct. It is **NOT hereditary** - siblings do not need screening.", "consequence": "Meckel is not hereditary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "The child will need lifelong acid suppression therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **ectopic gastric mucosa has been surgically removed**. There is no remaining source of ectopic acid secretion. No acid suppression is needed after successful resection.", "consequence": "No acid suppression needed after resection.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Meckel presentations by age**: **<2 years** = bleeding (acid from ectopic mucosa ulcerates ileum). **Older children/adults** = obstruction (intussusception, volvulus) or diverticulitis (mimics appendicitis). **Meckel's band** (fibrous remnant to umbilicus) can cause internal hernia and volvulus."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully diagnosed and managed Meckel diverticulum. Key teaching points: (1) Rule of 2s - most common GI anomaly, (2) Ectopic gastric mucosa causes painless bleeding, (3) Meckel scan detects gastric tissue (85-90% sensitive), (4) Surgery is definitive treatment, (5) Can also present with obstruction or diverticulitis. Prognosis is excellent after surgical resection with no recurrence."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review Meckel diverticulum key features: Rule of 2s, painless bright red/maroon bleeding in children <5, Meckel scan detects ectopic gastric mucosa (can be enhanced with pentagastrin), surgical resection is definitive treatment. Other presentations include obstruction and diverticulitis."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Meckel diverticulum is the most common cause of significant painless lower GI bleeding in children. Key points: ectopic gastric mucosa causes ulceration and bleeding, Meckel scan is diagnostic, surgical resection is curative. Do not delay definitive treatment."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-073", "title": "Hypovolemic Shock in Gastroenteritis", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["tachycardia with poor perfusion", "delayed cap refill >3 sec", "sunken fontanelle", "hypovolemic shock in gastroenteritis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "An 18-month-old male is brought to the ED after 3 days of vomiting and watery diarrhea. Parents report he has been increasingly lethargic today and has not urinated for 12 hours.\n\nSubjectively, he had 8-10 watery stools per day and has been unable to keep down any fluids. He had a low-grade fever yesterday that has now resolved.\n\nPhysical Examination:\n- General: lethargic, minimally responsive to stimulation.\n- Vitals: HR 180, RR 40, BP 70/40 (low for age), Temp 37.0\u00b0C.\n- Skin: cool, mottled extremities, capillary refill 5 seconds.\n- Eyes: deeply sunken, absent tears.\n- Mucous membranes: parched, cracked lips.\n- Fontanelle: sunken.\n- Abdomen: soft, hyperactive bowel sounds.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 18-month-old presents with classic signs of severe dehydration progressing to hypovolemic shock: lethargy, tachycardia (HR 180), hypotension (BP 70/40), delayed capillary refill (5 seconds), mottled skin, sunken eyes and fontanelle, and absent urine output.", "question": "What percentage of body weight loss does this clinical picture suggest?", "choices": [{"id": "node-1-choice-a", "text": ">10% dehydration (severe) with compensated-to-decompensated shock", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **>10% dehydration** presents with: lethargy/unresponsive, very sunken eyes/fontanelle, absent tears, parched mucous membranes, **capillary refill >3-4 sec**, cold/mottled extremities, tachycardia progressing to **hypotension** (late sign of decompensation). This child is in **hypovolemic shock** requiring immediate resuscitation.", "consequence": "You recognize the severity and prepare for aggressive resuscitation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "3-5% dehydration (mild) requiring oral rehydration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Mild dehydration (3-5%)** presents with slightly dry mucous membranes, slightly decreased urine, normal mental status, and normal capillary refill. This child has **hypotension, mottled extremities, and lethargy** - signs of severe dehydration with shock.", "consequence": "Underestimating severity leads to inadequate treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "5-10% dehydration (moderate) requiring IV fluids over 4 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Moderate dehydration (5-10%)** presents with sunken eyes, decreased tears, dry mouth, and mildly delayed cap refill (2-3 sec). This child has **hypotension and 5-second cap refill** - indicating severe dehydration with shock requiring **immediate bolus resuscitation**, not slow rehydration.", "consequence": "Underestimating severity leads to inadequate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Septic shock from bacterial gastroenteritis", "isOptimal": false, "isAcceptable": true, "feedback": "Septic shock is possible with bacterial gastroenteritis, but the presentation (3 days of watery diarrhea, resolved fever, no toxic appearance beyond dehydration) is more consistent with **viral gastroenteritis with severe dehydration**. Initial resuscitation is the same regardless - IV fluid boluses.", "consequence": "Septic shock should be considered but hypovolemic shock is more likely.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "This child is not in shock because the blood pressure is measurable", "isOptimal": false, "isAcceptable": false, "feedback": "CRITICAL ERROR! **Hypotension is a LATE sign** of shock in children. Children compensate with tachycardia and vasoconstriction until they suddenly decompensate. BP 70/40 in an 18-month-old IS hypotensive (normal SBP ~90). This child is in **decompensated shock**.", "consequence": "Failure to recognize shock leads to cardiac arrest.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Dehydration assessment**: Mild (3-5%) = thirsty, slightly dry; Moderate (5-10%) = sunken eyes, decreased tears, cap refill 2-3s; **Severe (>10%)** = lethargy, very sunken, cap refill >3s, mottled, tachycardia \u2192 hypotension. **Hypotension = decompensated shock in children!**"}, "node-2": {"id": "node-2", "type": "decision", "content": "You recognize this child is in hypovolemic shock requiring immediate fluid resuscitation. You establish IV access (or IO if IV fails after 90 seconds).", "question": "What is the CORRECT initial fluid bolus for pediatric hypovolemic shock?", "choices": [{"id": "node-2-choice-a", "text": "20 mL/kg of isotonic crystalloid (NS or LR) as rapid IV bolus, reassess, repeat up to 3 boluses", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **20 mL/kg isotonic crystalloid** (Normal Saline or Lactated Ringer's) given as a **rapid bolus** (over 5-10 minutes). **Reassess** after each bolus (HR, cap refill, mental status, BP). May repeat up to **60 mL/kg total** (3 boluses) in the first hour for refractory shock.", "consequence": "First bolus given. Child remains tachycardic but more alert.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "10 mL/kg of D5 0.45% NS over 1 hour", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT on multiple counts! (1) **Hypotonic fluids** (D5 0.45NS) should NOT be used for resuscitation - they cause hyponatremia and cerebral edema. (2) **Shock requires RAPID boluses**, not slow infusion over 1 hour. (3) Volume is too low at 10 mL/kg.", "consequence": "Inadequate resuscitation and risk of hyponatremia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "20 mL/kg of colloid (albumin) as first-line", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Crystalloids (NS or LR) are first-line** for pediatric resuscitation. Multiple studies show no benefit of colloids over crystalloids for initial resuscitation, and colloids are more expensive and carry additional risks.", "consequence": "Unnecessary expense without benefit.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Maintenance fluids calculated by Holliday-Segar formula", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT! Maintenance fluids are for **after stabilization**, not during active shock. **Shock requires bolus resuscitation** with isotonic fluids, not maintenance rates. Maintenance fluids would be dangerously slow for a child in shock.", "consequence": "Child deteriorates due to inadequate resuscitation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Oral rehydration therapy with Pedialyte", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT! **ORT is contraindicated in shock**. ORT is appropriate for mild-moderate dehydration in an alert child who can drink. This child is **lethargic and in shock** - requires IV/IO access and fluid boluses.", "consequence": "Aspiration risk and inadequate resuscitation.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Fluid bolus rule**: 20 mL/kg isotonic crystalloid (NS or LR), push fast (5-10 min), reassess, repeat. Max 60 mL/kg in first hour. If no improvement after 40-60 mL/kg, consider **vasopressors** and other causes of shock."}, "node-3": {"id": "node-3", "type": "decision", "content": "After 40 mL/kg (2 boluses) of NS, the child is more alert. HR decreased to 140, BP 85/50, capillary refill improved to 3 seconds. Labs return: Na 150, K 3.0, Cl 115, CO2 12, BUN 35, Cr 0.8, Glucose 95.", "question": "What do these lab values indicate?", "choices": [{"id": "node-3-choice-a", "text": "Hypernatremic dehydration with hypokalemia and metabolic acidosis (normal anion gap)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Na 150** = hypernatremic dehydration (water loss > salt loss, common in diarrhea). **K 3.0** = hypokalemia (GI losses + intracellular shift from acidosis treatment). **CO2 12** = metabolic acidosis from poor perfusion (lactic acid). **BUN 35, Cr 0.8** = prerenal azotemia (BUN:Cr ratio >20:1). Anion gap = 150 - (115+12) = 23 (elevated from lactic acidosis).", "consequence": "You understand the metabolic derangements and plan correction.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Hyponatremic dehydration requiring hypertonic saline", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Na 150 is **hypernatremia**, not hyponatremia. Hypertonic saline would worsen the hypernatremia. **Hypernatremic dehydration** requires careful, slow correction to avoid cerebral edema.", "consequence": "Giving hypertonic saline would be dangerous.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Diabetic ketoacidosis based on the metabolic acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Glucose is 95 (normal)** - DKA presents with hyperglycemia (>200 mg/dL). The acidosis is from **lactic acidosis** due to poor perfusion, not ketoacidosis. The history of gastroenteritis explains the dehydration.", "consequence": "Misdiagnosis would lead to incorrect treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Renal failure requiring dialysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The elevated BUN with relatively normal Cr (BUN:Cr >20:1) indicates **prerenal azotemia** from dehydration, NOT intrinsic renal failure. With fluid resuscitation, kidney function should normalize. Dialysis is not indicated.", "consequence": "Unnecessary nephrology consultation and potential dialysis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Labs are normal; continue current management", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Na 150 is high, K 3.0 is low, CO2 12 is low (acidosis), and BUN 35 is elevated. These abnormalities require recognition and appropriate correction, especially the hypernatremia which must be corrected slowly.", "consequence": "Missing important metabolic derangements.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hypernatremic dehydration** (Na >145): Correct slowly over **48-72 hours** (lower Na by 0.5 mEq/L/hour max) to prevent **cerebral edema**. Rapid correction causes water to rush into brain cells. **Add potassium** to fluids once urinating (3-5 mEq/kg/day)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is stabilizing but remains mildly dehydrated with hypernatremia (Na 150). Initial resuscitation with NS boluses is complete. You need to calculate ongoing fluid replacement.", "question": "What is the appropriate approach to correcting hypernatremic dehydration after initial resuscitation?", "choices": [{"id": "node-4-choice-a", "text": "Calculate free water deficit; correct Na slowly over 48-72 hours (max 0.5 mEq/L/hour decrease); add K once urinating", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Slow correction is critical** in hypernatremic dehydration. Calculate total fluid needs (maintenance + deficit), use **hypotonic fluid** (D5 0.45NS or similar) for ongoing replacement, and monitor Na every 4-6 hours. Max Na decrease = **0.5 mEq/L/hour** or **10-12 mEq/L/day**. Add **KCl 20-40 mEq/L** once urine output established.", "consequence": "Appropriate rehydration plan initiated with slow correction.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Give free water boluses to rapidly correct the sodium", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS! Rapid correction of hypernatremia causes **cerebral edema**. Brain cells adapted to hypernatremia by generating idiogenic osmoles. Rapid free water administration causes water to rush into cells, causing brain swelling, seizures, and death.", "consequence": "Cerebral edema, seizures, and potential death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Continue NS boluses until sodium normalizes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NS (154 mEq/L Na) is **isotonic** and won't correct hypernatremia - it may even worsen it. After initial resuscitation, switch to **hypotonic fluids** for deficit replacement. NS is for resuscitation only.", "consequence": "Hypernatremia persists or worsens.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Restrict fluids to prevent further sodium dilution", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! This child is **dehydrated** - fluid restriction would worsen dehydration. Hypernatremia in gastroenteritis is from **water loss exceeding sodium loss**, not from sodium excess. The child needs fluids, given slowly to allow gradual correction.", "consequence": "Worsening dehydration and hypernatremia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Diuretics to help excrete excess sodium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! Diuretics would worsen dehydration by increasing water loss. The hypernatremia is from **relative water deficit**, not sodium excess. Treatment is **replacing water** (slowly), not removing sodium.", "consequence": "Diuretics worsen dehydration and electrolyte abnormalities.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hypernatremic dehydration correction**: Water deficit (L) = 0.6 \u00d7 weight (kg) \u00d7 [(current Na/140) - 1]. Replace over **48-72 hours** plus maintenance. Monitor Na every 4-6h. If Na drops too fast \u2192 slow the rate!"}, "node-5": {"id": "node-5", "type": "decision", "content": "After 48 hours of careful rehydration, the child's Na has normalized to 140, K is 4.0, and he is tolerating oral fluids well. He had one soft stool today. Parents ask about discharge planning.", "question": "What discharge guidance is most important for preventing recurrence of dehydration from gastroenteritis?", "choices": [{"id": "node-5-choice-a", "text": "Continue oral rehydration with ORS (Pedialyte), small frequent amounts; return if unable to tolerate fluids, bloody diarrhea, or lethargy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Oral rehydration solution (ORS)** like Pedialyte contains the optimal glucose:sodium ratio for intestinal absorption. Give **small, frequent amounts** (5-10 mL every 5 minutes) even if vomiting. Return precautions: inability to tolerate fluids, **bloody diarrhea**, persistent vomiting, lethargy, sunken eyes, or decreased urine output.", "consequence": "Family counseled appropriately. Discharge plan in place.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Give the BRAT diet (bananas, rice, applesauce, toast) and avoid all other foods", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **BRAT diet is no longer recommended** - it provides inadequate nutrition and calories. Current guidance is to continue **age-appropriate diet** as tolerated. Avoid high-sugar drinks (juice, soda) as they can worsen diarrhea via osmotic effect.", "consequence": "Outdated advice may lead to prolonged illness.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Prescribe antibiotics to prevent bacterial gastroenteritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Most gastroenteritis is viral** and does not require antibiotics. Antibiotic prophylaxis is not indicated and increases resistance risk. Antibiotics are only for specific bacterial causes (Shigella, Salmonella with bacteremia, C. diff).", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Give anti-diarrheal medications (loperamide) to stop fluid loss", "isOptimal": false, "isAcceptable": false, "feedback": "CONTRAINDICATED! **Loperamide is not recommended in children <2 years** and generally avoided in all children with gastroenteritis. It can cause ileus, toxic megacolon, and CNS depression. Focus on **rehydration**, not stopping diarrhea.", "consequence": "Risk of serious adverse effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "Sports drinks (Gatorade) are equivalent to ORS for rehydration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sports drinks have too much sugar and too little sodium** compared to ORS. High sugar content can worsen diarrhea via osmotic effect. ORS (Pedialyte) is specifically formulated with the optimal glucose:sodium ratio for intestinal absorption.", "consequence": "Inadequate rehydration and potentially worsening diarrhea.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ORS works via sodium-glucose cotransport** in the intestine - glucose enhances sodium (and thus water) absorption. Give **small frequent sips** (5-10 mL every 5 min) even with vomiting. Avoid juice/soda (too much sugar) and sports drinks (wrong ratio)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of hypovolemic shock from gastroenteritis!\n\n**Key Learning Points:**\n1. **Recognize severity**: >10% dehydration = shock; hypotension is a LATE sign in children\n2. **Initial resuscitation**: 20 mL/kg NS or LR boluses, reassess, repeat (max 60 mL/kg in 1 hour)\n3. **Access**: IV preferred; IO if IV fails after 90 seconds\n4. **Hypernatremia**: Correct SLOWLY over 48-72 hours (max 0.5 mEq/L/hour decrease)\n5. **Potassium**: Add to fluids once urinating (20-40 mEq/L)\n6. **Discharge**: ORS for maintenance, age-appropriate diet, return precautions\n\n**Do NOT use**: hypotonic fluids for resuscitation, loperamide in young children, sports drinks instead of ORS."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key points:\n\n1. **Hypotension = decompensated shock** in children - don't wait for it to act\n2. **20 mL/kg isotonic crystalloid** boluses for resuscitation\n3. **Hypernatremia** must be corrected slowly (risk of cerebral edema)\n4. **ORS (Pedialyte)** not sports drinks for oral rehydration\n5. **BRAT diet** is outdated - continue age-appropriate diet"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in managing pediatric hypovolemic shock.\n\n**Dangerous mistakes:**\n- **Underestimating severity** - hypotension = decompensated shock\n- **Slow fluids in shock** - need rapid boluses, not maintenance rates\n- **Hypotonic fluids for resuscitation** - causes hyponatremia, cerebral edema\n- **Rapid hypernatremia correction** - causes fatal cerebral edema\n- **Loperamide in young children** - risk of ileus, CNS depression\n- **Oral rehydration in shock** - need IV/IO access"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-084", "title": "Giardiasis Mechanism", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["foul-smelling greasy stools", "camping or daycare exposure", "steatorrhea", "no blood", "giardiasis mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with foul-smelling, greasy stools and bloating for 1 week after returning from a camping trip.\n\nHe attends daycare where several children have similar symptoms.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The clinical picture is highly suggestive of a parasitic infection:\n- **Foul-smelling, greasy stools** (steatorrhea)\n- **Bloating and flatulence**\n- Recent **camping** (wilderness water exposure)\n- **Daycare outbreak** (fecal-oral transmission)\n- **No fever or bloody stool** (non-invasive infection)", "question": "What is the mechanism by which this organism causes diarrhea?", "choices": [{"id": "node-1-choice-a", "text": "Giardia adheres to intestinal epithelium, causing villous blunting and malabsorption without invasion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Giardia lamblia** (also called G. intestinalis or G. duodenalis) is a **flagellated protozoan** that causes disease through **attachment to intestinal epithelium** via its ventral disk, NOT tissue invasion. This causes **villous atrophy and blunting**, brush border enzyme deficiency (especially **disaccharidases**), and impaired fat absorption. The result is **malabsorptive diarrhea** with steatorrhea. Because there's no invasion, there is **no blood in stool** and no significant inflammation.", "consequence": "You understand the non-invasive pathophysiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "The organism invades colonic mucosa, causing bloody diarrhea and ulceration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Giardia is **non-invasive** - it does NOT penetrate the intestinal wall. This is why Giardia causes **fatty, non-bloody diarrhea**. Invasive parasites like **Entamoeba histolytica** cause bloody diarrhea with flask-shaped ulcers. The absence of blood is a key distinguishing feature.", "consequence": "This describes Entamoeba, not Giardia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "The organism produces an enterotoxin that activates cAMP secretion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes the mechanism of **toxigenic diarrhea** caused by organisms like **Vibrio cholerae** or **ETEC** (enterotoxigenic E. coli). Giardia does not produce significant enterotoxins. Its mechanism is **mechanical attachment** causing villous damage and malabsorption, not secretory diarrhea.", "consequence": "This describes cholera/ETEC, not Giardia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "The organism causes watery diarrhea by destroying oocysts in the intestinal crypts", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **Cryptosporidium**, which is an apicomplexan parasite that infects intestinal epithelial cells and forms **oocysts**. Giardia is a **flagellated protozoan** that forms **cysts** (not oocysts) and causes disease through surface attachment, not intracellular infection.", "consequence": "This describes Cryptosporidium, not Giardia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "The organism releases cytotoxin that destroys colonocytes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **C. difficile** which produces toxins A (enterotoxin) and B (cytotoxin) that damage colonocytes. Giardia infects the **small intestine** (duodenum and jejunum), not the colon, and does not produce significant cytotoxins.", "consequence": "This describes C. difficile, not Giardia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Giardia = malabsorption, not invasion**. It attaches to duodenal/jejunal mucosa via its ventral sucking disk, causing villous blunting and brush border enzyme deficiency. Results: **steatorrhea** (fatty stools), **lactose intolerance** (disaccharidase deficiency), bloating, flatulence. **NEVER causes bloody stool** (non-invasive). Transmitted via **fecal-oral route** - contaminated water (camping, beavers), daycare outbreaks."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order diagnostic testing. The stool examination options include:\n- **Stool antigen test** (EIA/DFA) - sensitivity ~95%\n- **Microscopy** (O&P) - may need multiple samples\n- **PCR** - most sensitive but expensive\n\nStool antigen test returns positive for **Giardia lamblia**.", "question": "What is the most appropriate treatment for giardiasis in this child?", "choices": [{"id": "node-2-choice-a", "text": "Metronidazole 15-30 mg/kg/day divided TID for 5-7 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Metronidazole** is the first-line treatment for giardiasis. Dosing: **15-30 mg/kg/day** divided into 3 doses for **5-7 days** (max 750 mg/dose). It is highly effective (~90% cure rate). Warn about **metallic taste** and advise avoiding alcohol (disulfiram-like reaction). Alternative: **tinidazole** (single dose, 50 mg/kg, better tolerated) or **nitazoxanide** (FDA-approved for children).", "consequence": "Appropriate antiparasitic treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Azithromycin for 5 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Azithromycin** is not effective against Giardia. It's a macrolide antibiotic used for bacterial infections (e.g., Campylobacter, Shigella, chlamydia). Giardia is a **protozoan parasite** that requires antiparasitic agents like metronidazole, tinidazole, or nitazoxanide.", "consequence": "Antibiotic ineffective against Giardia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Supportive care only; giardiasis is self-limiting", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While some Giardia infections can self-resolve, **treatment is recommended** to: (1) shorten symptom duration, (2) prevent malnutrition and growth failure from chronic malabsorption, (3) reduce transmission (especially in daycare settings), and (4) prevent chronic infection which can persist for months.", "consequence": "Prolonged symptoms and transmission risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Trimethoprim-sulfamethoxazole (TMP-SMX)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **TMP-SMX** is not effective against Giardia. It's used for bacterial infections and *Cyclospora* or *Isospora* (other parasites). Giardia specifically requires nitroimidazoles (metronidazole, tinidazole) or nitazoxanide.", "consequence": "Wrong antiparasitic agent.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Loperamide to control diarrhea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Loperamide** treats the symptom (diarrhea) but not the underlying infection. Without antiparasitic treatment, infection persists and symptoms recur. Additionally, anti-motility agents are generally avoided in young children. Treat the cause with metronidazole.", "consequence": "Does not treat the infection.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Giardia treatment**: First-line: **metronidazole** (5-7 days) or **tinidazole** (single dose - better compliance). **Nitazoxanide** is FDA-approved for children (3-day course). For treatment failures, consider longer courses or combination therapy. **IgA-deficient patients** are particularly susceptible to Giardia and may have recurrent/chronic infections."}, "node-3": {"id": "node-3", "type": "decision", "content": "Treatment is initiated. The family asks about preventing spread to other family members and future camping trips.\n\nAdditionally, you recall that Giardia disproportionately affects certain populations.", "question": "Which population has INCREASED susceptibility to severe or recurrent Giardia infections?", "choices": [{"id": "node-3-choice-a", "text": "Patients with selective IgA deficiency or common variable immunodeficiency (CVID)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **IgA deficiency** and **CVID** (common variable immunodeficiency) patients have increased susceptibility to **Giardia** because **secretory IgA** is the primary mucosal defense against this organism. Without adequate mucosal antibodies, Giardia can cause **chronic, recurrent infections** that are difficult to eradicate. In fact, recurrent giardiasis should prompt evaluation for underlying immunodeficiency.", "consequence": "You identify the important association.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Patients with sickle cell disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sickle cell disease patients have increased susceptibility to **encapsulated bacteria** (S. pneumoniae, H. influenzae, Salmonella) due to functional asplenia, but not specifically to Giardia. Giardia susceptibility is related to **mucosal antibody deficiencies**, not splenic function.", "consequence": "Sickle cell patients have different infection susceptibilities.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Patients with G6PD deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **G6PD deficiency** affects RBCs and causes hemolysis with oxidative stress (certain drugs, fava beans), but does not increase infection susceptibility. Notably, metronidazole is generally safe in G6PD deficiency, unlike some other medications.", "consequence": "G6PD deficiency is not an immunodeficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Patients with cystic fibrosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cystic fibrosis patients are susceptible to **respiratory infections** (Pseudomonas, Staph aureus, Burkholderia) due to thick airway secretions, not intestinal parasites. CF does cause GI symptoms (malabsorption from pancreatic insufficiency), but this is not related to Giardia susceptibility.", "consequence": "CF causes different types of infections.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Patients with chronic granulomatous disease (CGD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CGD** is a phagocyte defect causing susceptibility to **catalase-positive organisms** (Staph aureus, Aspergillus, Serratia, Nocardia, Burkholderia). CGD patients have intact humoral immunity and are not specifically susceptible to Giardia.", "consequence": "CGD causes different infection patterns.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Giardia and immunodeficiency**: IgA deficiency and CVID patients have **chronic/recurrent giardiasis** because secretory IgA is crucial for mucosal defense. **Prevention**: treat contaminated water (boiling, filtration - Giardia cysts resistant to chlorination), hand hygiene (daycare), don't drink untreated wilderness water. Exclude symptomatic children from daycare until treated."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **giardiasis** based on classic features (foul-smelling greasy stools, camping/daycare exposure, no bloody diarrhea), understood the **non-invasive, malabsorptive mechanism** (villous blunting, not tissue invasion), initiated appropriate treatment with **metronidazole**, and identified **IgA deficiency/CVID** as risk factors for severe/recurrent infection. This comprehensive approach ensures effective treatment and appropriate counseling."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key giardiasis concepts: (1) **Steatorrhea** (fatty, foul, floating stools) + **no blood** = non-invasive malabsorption; (2) **Mechanism**: villous blunting from attachment, not invasion; (3) **Treatment**: metronidazole, tinidazole, or nitazoxanide; (4) **Risk factors for severe disease**: IgA deficiency, CVID; (5) **Prevention**: water treatment, hand hygiene."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Giardia is a **flagellated protozoan** causing **malabsorptive diarrhea** through villous damage (not invasion). Key features: foul-smelling, greasy, NON-BLOODY stool; camping/daycare exposure. **Treatment**: metronidazole, tinidazole, or nitazoxanide (NOT antibacterial agents). IgA-deficient patients have increased susceptibility. Prevention through water treatment and hygiene."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-085", "title": "Ulcerative Colitis Recognition", "domain": "gi_nutrition", "difficulty": "advanced", "tags": ["bloody diarrhea", "continuous inflammation", "starts at rectum", "tenesmus", "mesalamine", "colonoscopy", "IBD"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 14-year-old female presents with a 6-week history of bloody diarrhea, occurring 8-10 times daily. She describes significant urgency, tenesmus, and crampy lower abdominal pain that is relieved with defecation.\n\nShe has lost 5 kg over the past month and has been missing school due to symptoms. She denies recent travel, sick contacts, or antibiotic use.\n\nPhysical Examination:\n- General: pale, fatigued-appearing adolescent.\n- Vitals: HR 95 bpm, BP 105/65 mmHg, Temp 37.8\u00b0C.\n- Abdomen: mild tenderness in left lower quadrant, no peritoneal signs, no masses.\n- Rectal: blood on glove, no fissures or fistulas.\n- Skin: erythematous, tender nodules on bilateral shins.\n- MSK: mild swelling of right knee.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory results:\n- CBC: Hgb 9.8 g/dL (low), WBC 12,000, Platelets 450,000 (elevated).\n- CMP: Albumin 2.9 g/dL (low), otherwise normal.\n- ESR: 55 mm/hr (elevated), CRP: 45 mg/L (elevated).\n- Stool studies: negative for C. difficile, negative for ova and parasites, negative bacterial culture.", "question": "Based on the clinical presentation and laboratory findings, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Ulcerative colitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This presentation is classic for **ulcerative colitis (UC)**: (1) **Bloody diarrhea** with urgency and tenesmus, (2) **Continuous symptoms** (not episodic), (3) LLQ pain (suggesting rectal/sigmoid involvement), (4) **Extraintestinal manifestations** (erythema nodosum on shins, arthritis), (5) Elevated inflammatory markers and thrombocytosis. The negative stool studies rule out infectious causes.", "consequence": "You suspect UC and plan appropriate workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Crohn disease", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration, but several features favor UC over Crohn's: (1) **Bloody diarrhea is more prominent in UC** (Crohn's often has non-bloody diarrhea unless colonic), (2) **No perianal disease** (fissures, fistulas are classic for Crohn's), (3) **LLQ pain** suggests distal colon involvement (UC starts at rectum). However, definitive differentiation requires colonoscopy with biopsy.", "consequence": "Colonoscopy will help differentiate UC from Crohn disease.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Infectious colitis (Shigella, Salmonella, Campylobacter)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While infectious colitis can cause bloody diarrhea, the **6-week duration** and **negative stool cultures** argue against this. Bacterial enteritis typically resolves within 1-2 weeks. The extraintestinal manifestations (erythema nodosum, arthritis) are more consistent with IBD.", "consequence": "Treating as infection delays appropriate IBD management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Irritable bowel syndrome (IBS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IBS does **NOT** cause: bloody stool, weight loss, anemia, elevated inflammatory markers, or fever. These 'alarm features' indicate organic disease, not functional GI disorder. The presence of blood, weight loss, and systemic inflammation rules out IBS.", "consequence": "Misdiagnosis as IBS delays critical treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Celiac disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Celiac disease causes **malabsorptive diarrhea** (watery, fatty), NOT bloody diarrhea. It also does not cause the inflammatory markers seen here. Celiac presents with steatorrhea, bloating, and failure to thrive, not hematochezia and tenesmus.", "consequence": "Misdiagnosis delays appropriate management.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**UC vs Crohn's**: UC = **continuous** inflammation starting at rectum, **bloody diarrhea**, **mucosal only**. Crohn's = **skip lesions**, can affect any GI segment, **transmural** (fistulas, strictures), perianal disease common. Both can have extraintestinal manifestations."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect inflammatory bowel disease and want to confirm the diagnosis. The patient is hemodynamically stable with no signs of peritonitis.", "question": "What is the most appropriate next step to confirm the diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Colonoscopy with ileoscopy and biopsies", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Colonoscopy with biopsies** is the gold standard for diagnosing IBD. Key findings in UC include: (1) **Continuous inflammation** from rectum extending proximally, (2) **Mucosal erythema, friability, and ulcerations**, (3) **Loss of vascular pattern**, (4) Histology: **crypt abscesses**, **crypt architectural distortion**, mucosal inflammation only. Ileoscopy is important to assess for ileal involvement (suggests Crohn's if present).", "consequence": "Colonoscopy scheduled. The patient is prepared with appropriate bowel prep.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CT abdomen and pelvis with contrast", "isOptimal": false, "isAcceptable": true, "feedback": "CT can show colonic wall thickening and rule out complications (abscess, perforation), but it **cannot provide tissue diagnosis**. CT is useful if perforation or abscess is suspected, or in acute severe colitis when colonoscopy is risky. However, colonoscopy with biopsy is needed for definitive diagnosis.", "consequence": "CT shows colonic wall thickening but tissue diagnosis still needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Empiric trial of antibiotics (metronidazole + ciprofloxacin)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotics are not first-line treatment for UC** and may worsen the condition by disrupting gut microbiome. Antibiotics are used in Crohn's for perianal disease or specific complications. With negative stool cultures, there is no indication for antibiotics here.", "consequence": "Antibiotics delay appropriate treatment and may cause adverse effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Fecal calprotectin level", "isOptimal": false, "isAcceptable": true, "feedback": "Fecal calprotectin is a useful **non-invasive marker of intestinal inflammation** and helps differentiate IBD from IBS. However, in this patient with obvious inflammatory findings (bloody stool, elevated ESR/CRP, extraintestinal manifestations), calprotectin will be elevated but won't change management - colonoscopy is still needed for diagnosis.", "consequence": "Calprotectin is elevated (>500 mcg/g), confirming intestinal inflammation, but colonoscopy still needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Upper GI series with small bowel follow-through", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Upper GI series evaluates the **small bowel**, which is more relevant for Crohn's disease. This patient's symptoms (bloody diarrhea, tenesmus, LLQ pain) point to **colonic involvement**, making colonoscopy the appropriate test.", "consequence": "Wrong test for suspected colonic disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Colonoscopy findings in UC**: Continuous inflammation from rectum, loss of haustral folds ('lead pipe' colon), pseudopolyps, friable mucosa. **Histology**: crypt abscesses, crypt architectural distortion, inflammation limited to mucosa/submucosa (NOT transmural like Crohn's)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Colonoscopy findings:\n- Rectum: severe inflammation with friability, ulcerations, and spontaneous bleeding\n- Sigmoid and descending colon: continuous moderate inflammation with loss of vascular pattern\n- Transverse and ascending colon: normal appearance\n- Terminal ileum: normal (visualized and biopsied)\n\nHistology: Crypt abscesses, crypt architectural distortion, inflammation limited to mucosa. No granulomas.\n\nDiagnosis: Ulcerative colitis - left-sided (extending to splenic flexure)", "question": "What is the most appropriate initial treatment for this patient with moderate left-sided ulcerative colitis?", "choices": [{"id": "node-3-choice-a", "text": "Oral and rectal mesalamine (5-ASA)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **5-aminosalicylic acid (5-ASA/mesalamine)** is first-line treatment for mild-to-moderate UC. For **left-sided disease**, combination of **oral + topical (rectal)** mesalamine is more effective than either alone. 5-ASA works locally in the colonic mucosa to reduce inflammation. Topical therapy reaches the distal colon where disease is most active.", "consequence": "Patient started on oral mesalamine 2.4g daily + mesalamine enemas nightly.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "IV corticosteroids (methylprednisolone)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IV steroids are reserved for **severe or fulminant UC** (hospitalized patients with systemic toxicity, >6 bloody stools/day, tachycardia, anemia). This patient has moderate disease and is stable - oral 5-ASA is appropriate first-line. Steroids have significant side effects and should not be used for induction in mild-moderate disease.", "consequence": "Unnecessary steroid exposure with associated side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Infliximab (anti-TNF biologic)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Biologics like **infliximab** are reserved for **moderate-severe UC** that is **refractory to conventional therapy** (5-ASA, steroids) or **steroid-dependent**. Starting biologics before trying 5-ASA is not standard practice for newly diagnosed moderate UC.", "consequence": "Premature use of biologic therapy before trying first-line treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Azathioprine (immunomodulator)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Azathioprine/6-MP** are used for **maintenance therapy** in steroid-dependent UC, not for induction. They have a slow onset (3-6 months) and cannot induce remission acutely. They also require TPMT testing before initiation due to risk of myelosuppression.", "consequence": "Immunomodulator alone will not induce remission.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Surgical consultation for colectomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Colectomy** is reserved for: (1) Medically refractory disease, (2) Fulminant colitis/toxic megacolon, (3) Dysplasia/cancer, (4) Intractable extraintestinal manifestations. This newly diagnosed patient deserves a trial of medical therapy first.", "consequence": "Premature surgical consultation for a medically treatable condition.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**5-ASA (mesalamine)** is the cornerstone of UC treatment. For **distal/left-sided UC**, use **oral + topical** (enemas/suppositories) for superior efficacy. 5-ASA also **reduces colorectal cancer risk** with long-term use. Response expected in 2-4 weeks."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 4 weeks of combination oral and rectal mesalamine, the patient's symptoms have significantly improved. She is having 2-3 formed stools daily without blood, and her abdominal pain has resolved. Repeat labs show Hgb 11.2 g/dL and CRP 8 mg/L (improved).\n\nShe asks about long-term management and what to expect.", "question": "Which of the following is the most important aspect of long-term UC management to discuss?", "choices": [{"id": "node-4-choice-a", "text": "Continue maintenance 5-ASA indefinitely + regular colonoscopy surveillance for dysplasia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Long-term UC management includes: (1) **Maintenance therapy** - 5-ASA continued indefinitely to maintain remission (stopping increases relapse risk), (2) **Colonoscopy surveillance** - Begin 8-10 years after diagnosis for **dysplasia/colorectal cancer screening** (UC increases CRC risk), (3) Regular monitoring of disease activity, (4) Vaccination updates (especially before immunosuppression), (5) Bone health monitoring if steroids used.", "consequence": "Patient understands the need for lifelong therapy and surveillance. Gastroenterology follow-up scheduled.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Discontinue mesalamine since symptoms resolved", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **UC requires maintenance therapy** even in remission. Discontinuing 5-ASA significantly increases the risk of **relapse** (50-70% within 1 year). 5-ASA also provides **chemoprevention against colorectal cancer**. The goal is sustained remission, not just symptom relief.", "consequence": "Patient relapses within months after stopping therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Switch to corticosteroids for maintenance therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Steroids should NOT be used for maintenance** due to significant long-term side effects (osteoporosis, adrenal suppression, diabetes, cataracts, growth suppression in children). Steroids are for acute flares only. If the patient cannot maintain remission on 5-ASA, consider immunomodulators or biologics.", "consequence": "Long-term steroid side effects develop (osteoporosis, Cushingoid features).", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Recommend prophylactic colectomy to prevent cancer", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prophylactic colectomy is NOT recommended. While UC increases colorectal cancer risk, this is managed with **surveillance colonoscopy** starting 8-10 years after diagnosis (or at diagnosis if primary sclerosing cholangitis present). Colectomy is reserved for dysplasia/cancer or medically refractory disease.", "consequence": "Unnecessary surgery for a condition that can be surveilled.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Follow up only if symptoms recur - no regular monitoring needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. UC requires **regular monitoring** even in remission: (1) Clinical assessment for subclinical disease activity, (2) Lab monitoring (CBC, inflammatory markers), (3) Surveillance colonoscopy for dysplasia. Patients can have endoscopic inflammation without symptoms ('mucosal healing' is the goal).", "consequence": "Subclinical disease progression and missed dysplasia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**UC long-term considerations**: (1) **Maintenance 5-ASA** - reduces relapse and CRC risk, (2) **Surveillance colonoscopy** - start 8-10 years after diagnosis, every 1-2 years, (3) **CRC risk** - increases with disease duration and extent, (4) Watch for **primary sclerosing cholangitis** (PSC) - occurs in 5% of UC patients."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly diagnosed ulcerative colitis, confirmed with colonoscopy, initiated appropriate first-line therapy, and counseled on long-term management including cancer surveillance.\n\n**Key Learning Points:**\n- UC presents with **bloody diarrhea, tenesmus, urgency** + extraintestinal manifestations\n- UC = **continuous** inflammation from rectum; Crohn's = **skip lesions**, transmural, perianal disease\n- **Colonoscopy with biopsy** is diagnostic (crypt abscesses, mucosal inflammation)\n- **5-ASA (mesalamine)** is first-line for mild-moderate UC; combine oral + topical for distal disease\n- **Maintenance therapy is lifelong** - prevents relapse and reduces CRC risk\n- **Surveillance colonoscopy** begins 8-10 years after diagnosis for dysplasia/cancer"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While the patient may improve, opportunities for optimal care were missed.\n\n**Review these key principles:**\n- Colonoscopy with biopsy is the gold standard for IBD diagnosis\n- 5-ASA is first-line for mild-moderate UC (not steroids or biologics)\n- Combination oral + topical 5-ASA is more effective for distal disease\n- Maintenance therapy is required indefinitely\n- Regular surveillance is needed even in remission"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in UC management. These mistakes can lead to disease progression, complications, or unnecessary harm.\n\n**Critical Teaching Points:**\n- Do NOT mistake IBD for IBS - bloody stool and weight loss are 'alarm features'\n- Antibiotics are NOT appropriate for UC (different from infectious colitis)\n- Steroids are NOT for maintenance - serious long-term side effects\n- Never stop maintenance therapy because symptoms improved - relapse risk is high\n- Colonoscopy surveillance is essential for cancer prevention"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-086", "title": "C. difficile Colitis Recognition", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["diarrhea after antibiotics", "pseudomembranous colitis", "elevated WBC", "c. difficile colitis recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male is brought to the emergency department with a 3-day history of watery diarrhea (6-8 episodes daily, some with blood streaks), crampy abdominal pain, and fever to 38.9\u00b0C.\n\nHistory reveals he completed a 10-day course of amoxicillin for acute otitis media 5 days ago. He was hospitalized for pneumonia 2 months ago.\n\nPhysical Examination:\n- Vitals: T 38.9\u00b0C, HR 120, RR 22, BP 95/60\n- Abdomen: Diffuse tenderness, hypoactive bowel sounds, mild distension\n- Mild dehydration with dry mucous membranes", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory findings:\n- WBC: 18,500/\u03bcL (markedly elevated with left shift)\n- BMP: BUN 22 mg/dL, Cr 0.8 mg/dL (prerenal azotemia)\n- Albumin: 2.8 g/dL (low)\n\nImaging (Abdominal X-ray):\n- Dilated colon with thumbprinting\n- No free air\n\nThe combination of **diarrhea following antibiotic use**, **fever**, **leukocytosis**, and **recent hospitalization** creates a classic clinical picture.", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Clostridioides difficile colitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **C. difficile colitis** is the most likely diagnosis. The classic presentation includes **diarrhea after antibiotic exposure** (especially broad-spectrum agents like clindamycin, fluoroquinolones, cephalosporins, and amoxicillin), **fever**, and **leukocytosis** that may exceed 15,000-20,000/\u03bcL. Recent hospitalization is a major risk factor. The **buzzword triad** is: diarrhea after antibiotics + pseudomembranous colitis + elevated WBC.", "consequence": "You correctly identify the diagnosis and proceed to confirm with appropriate testing.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Viral gastroenteritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Viral gastroenteritis** typically presents with vomiting more prominently than diarrhea, and would not cause such **marked leukocytosis** (WBC >15,000). The temporal relationship to **recent antibiotic use** and **hospitalization history** strongly suggests C. difficile. Viral gastroenteritis is also more commonly associated with sick contacts and does not typically cause bloody stools.", "consequence": "Missing C. difficile leads to delayed treatment and risk of progression to toxic megacolon.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Inflammatory bowel disease flare", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **IBD** can present with bloody diarrhea and fever, this child has no prior history of IBD. The **acute onset following antibiotic therapy** is the key distinguishing feature pointing to C. difficile. IBD typically has a more chronic, relapsing course with extraintestinal manifestations (arthritis, uveitis, erythema nodosum).", "consequence": "Pursuing IBD workup delays appropriate C. difficile testing and treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Bacterial enteritis (Salmonella/Shigella)", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Bacterial enteritis** from Salmonella or Shigella can present similarly with bloody diarrhea and fever. However, the **temporal relationship to antibiotic use** is the crucial distinguishing factor. C. difficile should be considered first in any patient with diarrhea following antibiotic exposure, especially with recent hospitalization. Stool cultures can help differentiate if C. difficile testing is negative.", "consequence": "Considering infectious causes is reasonable, but C. difficile should be prioritized given the clinical context.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Antibiotic-associated diarrhea (non-C. difficile)", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. While **non-C. difficile antibiotic-associated diarrhea** exists and is more common, it is typically **milder** without fever, bloody stools, or significant leukocytosis. The presence of **fever**, **WBC >15,000**, **bloody stools**, and **recent hospitalization** should raise strong suspicion for C. difficile specifically, which requires targeted treatment rather than just stopping the antibiotic.", "consequence": "This diagnosis doesn't account for the severity of presentation; C. difficile testing is still indicated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "C. difficile is the most common cause of **antibiotic-associated diarrhea**. Risk factors include recent antibiotic use (especially clindamycin, fluoroquinolones, cephalosporins), hospitalization, PPI use, and immunosuppression. WBC may exceed 15,000-20,000/\u03bcL."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect C. difficile colitis based on the clinical presentation.\n\nThe next step is to confirm the diagnosis.\n\nAvailable diagnostic options:\n- Stool PCR for C. difficile toxin genes\n- Stool toxin A/B enzyme immunoassay (EIA)\n- Glutamate dehydrogenase (GDH) antigen test\n- Stool culture\n- Colonoscopy", "question": "What is the most appropriate diagnostic approach?", "choices": [{"id": "node-2-choice-a", "text": "Stool PCR for C. difficile toxin genes AND discontinue amoxicillin", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Stool PCR** (NAAT) for C. difficile toxin genes is highly **sensitive and specific** for detecting C. difficile. Simultaneously, you should **discontinue the inciting antibiotic** if possible, as this alone can lead to resolution in mild cases. A **two-step algorithm** (GDH screen followed by toxin testing) is also acceptable. The amoxicillin course is already complete, but avoiding future unnecessary antibiotics is important.", "consequence": "PCR returns positive for C. difficile toxin B gene. You proceed to determine appropriate treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Stool culture for bacterial pathogens", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Stool culture** can identify other bacterial pathogens (Salmonella, Shigella, Campylobacter) but is **not the test of choice** for C. difficile. C. difficile requires specific testing (PCR or toxin assay) because standard stool cultures do not reliably detect it. Given the high clinical suspicion, C. difficile-specific testing should be performed first.", "consequence": "Stool culture delays diagnosis; C. difficile-specific testing is still needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Colonoscopy to visualize pseudomembranes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **colonoscopy** can reveal characteristic **pseudomembranes** (yellowish plaques), it is **invasive**, carries perforation risk in inflamed bowel, and is **not needed for diagnosis** when stool testing is available. Colonoscopy is reserved for cases with negative stool tests but high clinical suspicion, or when alternative diagnoses (IBD, ischemia) must be excluded.", "consequence": "Invasive procedure with complication risk when non-invasive testing would suffice.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "CT abdomen to assess colonic inflammation", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **CT scan** can show colonic wall thickening, the **accordion sign** (contrast trapped in thickened haustral folds), and pericolonic stranding, but these findings are **not specific** for C. difficile. CT is useful for assessing **severity** and **complications** (toxic megacolon, perforation) but should not replace stool testing for diagnosis.", "consequence": "CT provides supportive information but does not confirm the diagnosis; stool testing is still required.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Empiric treatment without testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **empiric treatment** may be appropriate in severely ill patients, **diagnostic confirmation** is important for appropriate antibiotic stewardship and to avoid unnecessary treatment if an alternative diagnosis exists. Testing also helps guide decisions about infection control measures and identifies patients who need follow-up for recurrence.", "consequence": "Treatment without diagnosis may lead to inappropriate therapy and missed alternative diagnoses.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Stool PCR (NAAT)** is the most sensitive test for C. difficile. A two-step algorithm (GDH screen + toxin EIA) is also widely used. Test only **diarrheal stool** (takes shape of container) - do not test formed stool or asymptomatic patients."}, "node-3": {"id": "node-3", "type": "decision", "content": "Stool PCR is positive for C. difficile toxin B gene.\n\nThe patient has confirmed C. difficile colitis with:\n- Non-severe disease (WBC <20,000, Cr <1.5 mg/dL, no hypotension)\n- No evidence of toxic megacolon or peritonitis\n- This is a first episode\n\nYou need to initiate appropriate antimicrobial therapy.", "question": "What is the most appropriate first-line treatment?", "choices": [{"id": "node-3-choice-a", "text": "Oral vancomycin 10 mg/kg (max 125 mg) four times daily for 10 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Oral vancomycin** is the **first-line treatment** for C. difficile colitis in children. Unlike IV vancomycin (which doesn't reach the gut lumen), **oral vancomycin achieves high colonic concentrations** to target the infection directly. The typical pediatric dose is 10 mg/kg (max 125 mg) four times daily for 10-14 days. **Fidaxomicin** is an alternative with potentially lower recurrence rates but is more expensive.", "consequence": "Patient receives appropriate first-line therapy. Symptoms improve over 3-5 days with resolution by day 10.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "IV vancomycin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **IV vancomycin does NOT reach the colonic lumen** in adequate concentrations and is **ineffective** for C. difficile colitis. This is a critical teaching point - vancomycin must be given **orally** to treat C. difficile. IV vancomycin is only added in **fulminant colitis** (with ileus) along with oral vancomycin and IV metronidazole.", "consequence": "IV vancomycin fails to treat the infection; patient deteriorates and may progress to severe disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Oral metronidazole", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Metronidazole is no longer recommended** as first-line therapy for C. difficile due to **inferior efficacy** compared to vancomycin and higher recurrence rates. Current IDSA guidelines (2021) recommend **oral vancomycin or fidaxomicin** as first-line agents. Metronidazole may be used only if vancomycin/fidaxomicin are unavailable.", "consequence": "Suboptimal treatment increases risk of treatment failure and recurrence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "IV metronidazole plus oral vancomycin", "isOptimal": false, "isAcceptable": true, "feedback": "This combination is reserved for **severe/fulminant C. difficile colitis** with ileus, hypotension, or toxic megacolon. For **non-severe disease** (as in this case), **oral vancomycin alone** is sufficient. Adding IV metronidazole to non-severe cases provides no additional benefit and increases risk of adverse effects.", "consequence": "Overtreatment for disease severity, but patient will still improve.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Supportive care only (fluids, discontinue antibiotics)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **discontinuing the inciting antibiotic** and **supportive care** are important adjuncts, they are **not sufficient** for confirmed C. difficile colitis. The infection requires targeted antimicrobial therapy. Delaying treatment risks progression to severe colitis, toxic megacolon, or perforation.", "consequence": "Untreated C. difficile infection progresses, risking severe complications.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Oral vancomycin** (NOT IV!) is first-line for C. difficile. IV vancomycin doesn't reach the gut lumen. For severe/fulminant disease with ileus, add **IV metronidazole** to oral vancomycin (and consider vancomycin enemas). Recurrence occurs in ~20% of cases."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **C. difficile colitis** based on the classic presentation of **diarrhea following antibiotic use**, confirmed the diagnosis with **stool PCR**, and initiated appropriate treatment with **oral vancomycin**.\n\n**Key Learning Points:**\n- C. difficile is the most common cause of antibiotic-associated diarrhea\n- Risk factors: recent antibiotics, hospitalization, PPI use, immunosuppression\n- Buzzwords: diarrhea after antibiotics, pseudomembranous colitis, elevated WBC (>15,000)\n- Diagnosis: Stool PCR (most sensitive) or GDH + toxin assay\n- Treatment: **Oral vancomycin** (NOT IV!) is first-line; fidaxomicin is an alternative\n- Recurrence occurs in ~20% of cases; fecal microbiota transplant for multiple recurrences"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While not incorrect, it delayed optimal management.\n\n**Key Points to Remember:**\n- **Diarrhea after antibiotics** + fever + elevated WBC = suspect C. difficile\n- **Stool PCR** is the preferred diagnostic test (highly sensitive/specific)\n- **Oral vancomycin** is first-line treatment (NOT metronidazole, NOT IV vancomycin)\n- Always discontinue the inciting antibiotic if possible\n- Test only diarrheal stool - do not test formed stool or asymptomatic patients"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect and could lead to patient harm.\n\n**Critical Teaching Points:**\n- C. difficile colitis is the **most common cause of antibiotic-associated diarrhea**\n- **IV vancomycin does NOT work** for C. difficile - it doesn't reach the gut lumen\n- **Oral vancomycin** (or fidaxomicin) is the correct first-line treatment\n- Delayed diagnosis/treatment can lead to toxic megacolon, perforation, and death\n- Key pearl: Oral vancomycin, NOT IV, is first-line treatment for C. difficile!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-087", "title": "Staphylococcus aureus Food Poisoning", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["rapid onset 1-6 hours", "vomiting predominates", "picnic food", "multiple people affected", "staphylococcus aureus food poisoning"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with sudden-onset nausea, vomiting, and abdominal cramps for 2 hours.\n\nNo fever.\n\nResolves within 24-48 hours.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Additional history reveals the child attended a birthday party 3 hours ago where potato salad and cream-filled pastries were served. The food was left out at room temperature for several hours. Three other children from the party are now calling with similar symptoms.\n\nThe child has **no fever** and the symptoms are predominantly **vomiting** with some abdominal cramping.", "question": "What is the mechanism of illness in this foodborne outbreak?", "choices": [{"id": "node-1-choice-a", "text": "Ingestion of preformed heat-stable enterotoxin produced by S. aureus in contaminated food", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Staphylococcal food poisoning** is caused by **preformed enterotoxins** (heat-stable) produced by S. aureus when it contaminates and multiplies in food. The toxin is **already present** when the food is eaten, causing rapid symptom onset (**1-6 hours**). The toxin acts on the vagus nerve and vomiting center, causing predominantly **emesis**. Because this is toxin-mediated (not infection), there is typically **no fever**.", "consequence": "You understand the toxin-mediated mechanism.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bacterial invasion of the intestinal mucosa causing inflammatory diarrhea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Mucosal invasion (as seen with Salmonella, Shigella, Campylobacter) causes **inflammatory/bloody diarrhea with fever** and has a longer incubation period (12-72 hours). The rapid onset (1-6 hours), lack of fever, and vomiting-predominant presentation indicates **preformed toxin** ingestion, not bacterial invasion.", "consequence": "Invasive pathogens have different presentations.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "In vivo toxin production by bacteria colonizing the intestine", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **In vivo toxin production** (like C. difficile or ETEC) requires bacterial colonization first, which takes longer (usually >24 hours). S. aureus food poisoning is caused by **preformed toxin** that is eaten with the food - the bacteria don't need to colonize; the damage is already done. This explains the very short incubation period.", "consequence": "The toxin is preformed, not made in the gut.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Allergic reaction (IgE-mediated) to food proteins", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Food allergies cause urticaria, angioedema, respiratory symptoms, and anaphylaxis - not isolated GI symptoms in multiple people who ate the same food. The **outbreak pattern** (multiple affected people) and **timing after food exposure** are classic for foodborne illness, not allergic reaction.", "consequence": "Allergies present differently and don't cause outbreaks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Viral gastroenteritis from person-to-person transmission at the party", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Viral gastroenteritis** (norovirus, rotavirus) has an incubation period of **12-48 hours**, not 1-6 hours. Additionally, viral gastroenteritis typically causes **watery diarrhea** more than vomiting (except norovirus which causes both). The rapid onset points to preformed toxin.", "consequence": "Viral GI has longer incubation period.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Incubation period guides diagnosis**: **1-6 hours** = preformed toxin (S. aureus, B. cereus emetic); **6-24 hours** = toxin produced in gut (C. perfringens, B. cereus diarrheal); **>24 hours** = bacterial invasion or viral. S. aureus toxin is **heat-stable** - reheating contaminated food doesn't help!"}, "node-2": {"id": "node-2", "type": "decision", "content": "The diagnosis is staphylococcal food poisoning based on:\n- Rapid onset (1-6 hours)\n- Vomiting-predominant symptoms\n- Multiple people affected (outbreak)\n- High-risk foods (mayonnaise-based salads, cream pastries)\n- No fever\n\nThe child is uncomfortable but not severely dehydrated.", "question": "What is the most appropriate management?", "choices": [{"id": "node-2-choice-a", "text": "Supportive care with oral rehydration; illness is self-limited (resolves in 24-48 hours); no antibiotics needed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Staphylococcal food poisoning is **self-limited** and resolves within **24-48 hours**. Treatment is **supportive**: oral rehydration for mild cases, IV fluids if severely dehydrated or unable to tolerate oral intake. **Antibiotics are NOT indicated** - the illness is caused by preformed toxin, not active bacterial infection. Antiemetics can be used for comfort if needed.", "consequence": "Appropriate supportive management initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Empiric antibiotics (ciprofloxacin) to eradicate S. aureus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotics are NOT indicated** for S. aureus food poisoning. The illness is caused by **preformed toxin**, not active bacterial infection. The bacteria and toxin were in the food; the bacteria don't colonize or infect the patient. Antibiotics would have no benefit and only cause side effects and resistance.", "consequence": "Antibiotics ineffective for toxin-mediated illness.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Activated charcoal to adsorb the toxin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activated charcoal** might have theoretical benefit if given very early (within 1 hour of ingestion), but by the time symptoms develop, the toxin has already been absorbed. Additionally, inducing vomiting or charcoal administration in an already vomiting patient is impractical and potentially harmful.", "consequence": "Charcoal not indicated once symptoms present.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Hospital admission for IV antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Most cases of S. aureus food poisoning are **mild and self-limited**. Hospital admission is only needed for severe dehydration or inability to maintain hydration. Antibiotics are not indicated regardless of setting. This child can be managed at home with oral rehydration and close follow-up.", "consequence": "Unnecessary hospitalization for self-limited illness.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Stool culture and treat based on results", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stool culture is not helpful** for S. aureus food poisoning - it tests for invasive bacterial pathogens, not toxins. The diagnosis is **clinical** based on the characteristic presentation. If confirmation is needed, the **suspected food** can be tested for S. aureus and enterotoxin, not the patient's stool.", "consequence": "Stool culture won't identify toxin-mediated illness.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **No antibiotics for preformed toxin food poisoning** (S. aureus, B. cereus emetic). The toxin causes the illness, not bacterial infection. Treatment is supportive. Antibiotics ARE indicated for invasive bacterial gastroenteritis (Salmonella with bacteremia, Shigella, severe Campylobacter)."}, "node-3": {"id": "node-3", "type": "decision", "content": "The child improves with oral rehydration and antiemetics. The parents ask how to prevent this in the future and which foods are highest risk.\n\nPublic health has been notified about the outbreak.", "question": "Which food handling practice is most important for preventing S. aureus food poisoning?", "choices": [{"id": "node-3-choice-a", "text": "Keep prepared foods refrigerated (<40\u00b0F/4\u00b0C) or hot (>140\u00b0F/60\u00b0C); don't leave at room temperature for >2 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Temperature control** is the key to prevention. S. aureus grows and produces toxin in food left at **room temperature (40-140\u00b0F)**. Foods should be kept **cold (<40\u00b0F)** or **hot (>140\u00b0F)**. The '2-hour rule' states food shouldn't be at room temperature for more than 2 hours (1 hour if >90\u00b0F outside). High-risk foods: **mayonnaise-based salads** (potato, egg, tuna), **cream-filled pastries**, **processed meats**.", "consequence": "Family understands proper food safety.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Thoroughly cook all foods to kill the toxin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. S. aureus **enterotoxin is heat-stable** - cooking/reheating food does NOT destroy the toxin once it's been produced. While cooking kills the bacteria, it doesn't help if toxin has already accumulated. Prevention focuses on **preventing toxin production** through proper temperature control, not destroying toxin after the fact.", "consequence": "Toxin is heat-stable; cooking won't help.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Only eat canned or processed foods", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is impractical and unnecessary. Proper food handling allows safe consumption of all types of foods. In fact, some processed foods (deli meats, processed cheese) can be contaminated if mishandled. The key is **proper temperature control** during storage and serving.", "consequence": "Impractical advice that doesn't address the real issue.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Wash hands after eating to prevent spread", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hand washing is important for **preventing contamination** of food (wash hands BEFORE food preparation), but it doesn't prevent illness once contaminated food is consumed. S. aureus food poisoning is not transmitted person-to-person - it's acquired from eating contaminated food.", "consequence": "Hand hygiene timing is important but not the key prevention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Prophylactic antibiotics before eating at picnics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic antibiotics would be ineffective** because the illness is caused by preformed toxin, not bacterial infection. Antibiotics would not neutralize toxin. Additionally, prophylactic antibiotic use for this purpose would be harmful (promoting resistance, side effects) with no benefit.", "consequence": "Antibiotics ineffective for toxin-mediated illness.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **S. aureus food poisoning prevention**: (1) **Temperature control** - keep foods cold or hot, not lukewarm; (2) **2-hour rule** - don't leave perishables at room temperature >2 hours; (3) **Hand hygiene** during food preparation; (4) **High-risk foods**: mayonnaise-based salads, custards, cream pastries, processed meats. The toxin is heat-stable, so reheating doesn't help!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **S. aureus food poisoning** based on the rapid onset (1-6 hours), vomiting-predominant symptoms, lack of fever, and outbreak pattern with high-risk foods. You understood the **preformed toxin mechanism** (heat-stable, already in food), provided appropriate **supportive care without antibiotics**, and counseled the family on **prevention through temperature control**. The illness resolves in 24-48 hours with supportive care."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key S. aureus food poisoning concepts: (1) **Preformed heat-stable toxin** causes illness (not infection); (2) **Rapid onset (1-6 hours)**, vomiting-predominant, no fever; (3) **No antibiotics** - toxin-mediated, self-limited in 24-48 hours; (4) **Prevention**: temperature control (keep food <40\u00b0F or >140\u00b0F), 2-hour rule."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. S. aureus food poisoning is caused by **preformed enterotoxin** (not infection), so **antibiotics are never indicated**. Key features: 1-6 hour incubation, vomiting > diarrhea, no fever, self-limited. High-risk foods: mayo-based salads, cream pastries, processed meats left at room temperature. Prevention: temperature control (toxin is heat-stable, so reheating doesn't help)."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-088", "title": "Entamoeba histolytica Recognition", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["bloody diarrhea after travel", "flask-shaped ulcers", "liver abscess", "anchovy paste aspirate", "entamoeba histolytica recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with bloody diarrhea for 5 days after recent travel to an endemic area.\n\nHe also has right upper quadrant pain and fever.\n\nPhysical Examination:\n- Vitals: febrile.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The child appears ill but stable. You review his workup:\n\n**Laboratory findings:**\n- WBC 14,000/\u03bcL with mild eosinophilia\n- Stool examination: **trophozoites with ingested RBCs** seen on wet mount\n- Stool antigen test for E. histolytica: positive\n\n**Imaging findings:**\n- Abdominal ultrasound: **single right lobe hepatic abscess** (5 cm), round, hypoechoic\n- Colonoscopy (performed cautiously): **flask-shaped ulcers** with undermined edges in the cecum", "question": "Based on these findings, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Intestinal amebiasis with amebic liver abscess", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **intestinal amebiasis with amebic liver abscess** caused by *Entamoeba histolytica*. The classic triad is: (1) **Bloody diarrhea** with mucus ('currant jelly' stool); (2) **Flask-shaped ulcers** on colonoscopy (undermined mucosa); (3) **Right lobe liver abscess** (most common extraintestinal manifestation). The pathognomonic finding is **trophozoites with ingested RBCs** on stool microscopy, proving tissue invasion.", "consequence": "Correct diagnosis. Now differentiate from other causes of invasive diarrhea.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Giardiasis with hepatic involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Giardia lamblia causes non-invasive diarrhea** - it does NOT cause bloody stool, does NOT invade tissue, and NEVER causes liver abscesses. Giardia produces watery, foul-smelling, fatty diarrhea (malabsorption) without blood or fever. The presence of bloody diarrhea, RBC-containing trophozoites, and liver abscess all point to invasive amebiasis.", "consequence": "Giardia is non-invasive and doesn't explain this presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Shigella dysentery with pyogenic liver abscess", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **Shigella causes invasive bloody diarrhea**, it does NOT typically cause liver abscesses. Shigella invades colonic mucosa but rarely causes bacteremia or distant infection. The **flask-shaped ulcers** are characteristic of amebiasis (Shigella causes superficial ulcers). Also, stool would show PMNs, not trophozoites with ingested RBCs.", "consequence": "Shigella doesn't explain the liver abscess or colonoscopy findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pyogenic liver abscess from bacterial infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pyogenic liver abscess** (bacterial) is usually **polymicrobial** and presents with **multiple small abscesses** or a single abscess with thicker walls. The combination of bloody diarrhea, flask-shaped colonic ulcers, and a **single right lobe abscess** in a child from an endemic area strongly suggests amebic rather than pyogenic abscess. Pyogenic abscesses typically occur with biliary disease or bacteremia.", "consequence": "Pyogenic abscess doesn't explain the GI findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Inflammatory bowel disease with coincidental liver finding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **IBD** (especially ulcerative colitis) causes bloody diarrhea, the travel history, **trophozoites with ingested RBCs**, and single right lobe liver abscess are classic for amebiasis. IBD ulcers are typically **continuous and superficial** (not flask-shaped with undermined edges). IBD-associated liver disease includes PSC, not single abscesses.", "consequence": "IBD doesn't fit the travel history or specific findings.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **E. histolytica vs Giardia**: E. histolytica is **INVASIVE** (bloody diarrhea, flask-shaped ulcers, liver abscess, trophozoites with RBCs). Giardia is **NON-INVASIVE** (watery fatty diarrhea, malabsorption, NO blood, NO fever, NO liver involvement). Both are fecal-oral transmission, but only amebiasis kills tissue!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You confirm **amebic liver abscess** with intestinal amebiasis. The abscess is 5 cm in diameter. The family asks about aspiration.\n\nYou need to determine the role of aspiration vs medical therapy alone.", "question": "What is the indication for percutaneous aspiration of an amebic liver abscess?", "choices": [{"id": "node-2-choice-a", "text": "Large abscess (>5-10 cm) or failure to respond to medical therapy within 5-7 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Indications for aspiration** of amebic liver abscess: (1) **Large abscess >5-10 cm** (higher rupture risk); (2) **Left lobe abscess** (risk of pericardial rupture); (3) **Failure to improve** clinically/radiographically after 5-7 days of medical therapy; (4) **Diagnostic uncertainty** (to rule out pyogenic abscess). Most amebic abscesses respond to **medical therapy alone** - aspiration is NOT routine. If aspirated, expect **'anchovy paste'** (chocolate-brown) fluid.", "consequence": "Correct understanding of aspiration indications. Now proceed to treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "All amebic liver abscesses require aspiration before starting antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Most amebic liver abscesses do NOT require aspiration** - they respond well to medical therapy alone. Unlike pyogenic abscesses (which usually need drainage), amebic abscesses resolve with **metronidazole** in >90% of cases. Routine aspiration is unnecessary and carries procedural risks. Aspiration is reserved for specific indications.", "consequence": "Unnecessary aspiration exposes patient to procedural risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Aspiration is indicated only if the abscess is infected with bacteria", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Amebic abscesses are sterile** (no bacteria) - they contain necrotic hepatocytes and trophozoites. The indication for aspiration is abscess **size, location, or treatment failure** - not bacterial superinfection. If aspiration is performed, the classic finding is **sterile 'anchovy paste'** (chocolate-brown) fluid, NOT purulent material.", "consequence": "Amebic abscesses are sterile by definition.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Aspiration is contraindicated because it spreads the infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Aspiration is **NOT contraindicated** - it's simply not routinely necessary. When indicated (large abscess, left lobe, treatment failure), percutaneous aspiration is safe and effective. The concern about 'spreading infection' applies to **echinococcal (hydatid) cysts**, not amebic abscesses.", "consequence": "Aspiration is safe when indicated, just not routine.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Aspiration is indicated only for abscesses in the left lobe", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Left lobe abscesses** ARE an indication for aspiration due to the risk of **pericardial rupture** (proximity to the heart). However, this is not the ONLY indication. Other indications include large size (>5-10 cm), failure to respond to medical therapy, and diagnostic uncertainty. This right lobe abscess is borderline in size (5 cm).", "consequence": "Correct about left lobe but incomplete answer.", "nextNodeId": "node-3"}], "clinicalPearl": "KEY CONCEPT: **Amebic vs pyogenic liver abscess**: Amebic = single, right lobe, sterile ('anchovy paste'), responds to metronidazole, aspiration usually NOT needed. Pyogenic = often multiple, polymicrobial, purulent, requires drainage + antibiotics. Key differentiator: Endemic area travel + GI symptoms \u2192 think amebic!"}, "node-3": {"id": "node-3", "type": "decision", "content": "You decide to treat medically given the abscess size is at the lower threshold. You prescribe **metronidazole 35-50 mg/kg/day divided TID for 10 days**.\n\nAfter completing metronidazole, the child's symptoms have resolved and repeat imaging shows the abscess is decreasing in size.\n\nThe family asks if treatment is complete.", "question": "What is the essential next step after completing metronidazole therapy?", "choices": [{"id": "node-3-choice-a", "text": "Add a luminal agent (paromomycin) to eradicate intestinal cysts", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Dual therapy is mandatory** for invasive amebiasis: (1) **Metronidazole** kills tissue trophozoites (invasive disease); (2) **Luminal agent** (paromomycin or iodoquinol) kills **intestinal cysts**. Metronidazole alone does NOT eliminate luminal cysts, leading to **relapse in up to 40-60%** of patients. Paromomycin 25-35 mg/kg/day divided TID for 7 days is the preferred luminal agent.", "consequence": "Complete eradication prevents relapse.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Treatment is complete - no additional therapy needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Metronidazole alone is insufficient** - it kills tissue trophozoites but does NOT eliminate **luminal cysts** in the intestine. Without a luminal agent, **relapse rates are 40-60%** because cysts can re-invade tissue. The standard of care is ALWAYS metronidazole FOLLOWED BY a luminal agent (paromomycin or iodoquinol).", "consequence": "High risk of relapse without luminal therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Continue metronidazole for another 10 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Extending metronidazole duration does NOT help because metronidazole **doesn't work on luminal cysts** regardless of how long you give it. The drug simply doesn't achieve adequate luminal concentrations. You need a different drug class (a **non-absorbable luminal agent** like paromomycin) that stays in the gut to kill cysts.", "consequence": "More metronidazole doesn't address the cyst reservoir.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Repeat stool testing - treat only if cysts are still present", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Luminal therapy is given empirically** to ALL patients with invasive amebiasis, regardless of stool testing. Stool microscopy has **poor sensitivity** for cysts - a negative test doesn't rule out their presence. Waiting for positive stool risks relapse. The standard is: treat invasive disease \u2192 ALWAYS follow with luminal agent.", "consequence": "Stool testing not sensitive enough; empiric treatment is standard.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Surgical resection of the residual abscess cavity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is almost never needed** for amebic liver abscess. The abscess cavity resolves slowly over weeks to months with medical therapy - residual imaging findings are expected and do NOT require surgery. Surgical indications are rare: only for **rupture into peritoneum or pericardium**, or failure of percutaneous drainage for very large abscesses.", "consequence": "Surgery is rarely indicated for amebic abscess.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Amebiasis treatment is a TWO-STEP process**: (1) **Tissue agent** (metronidazole/tinidazole) for invasive disease; (2) **Luminal agent** (paromomycin/iodoquinol) for intestinal cysts. Skipping the luminal agent \u2192 **40-60% relapse rate**! Remember: 'METRO for TISSUE, PAROMO for LUMEN.'"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **invasive amebiasis with amebic liver abscess** based on the classic findings: bloody diarrhea after travel to an endemic area, **trophozoites with ingested RBCs** (pathognomonic), **flask-shaped ulcers** on colonoscopy, and **single right lobe hepatic abscess**. You appropriately managed with medical therapy (aspiration reserved for large/left lobe/refractory cases) and completed the **two-step treatment**: metronidazole for tissue invasion FOLLOWED BY paromomycin to eradicate luminal cysts and prevent relapse."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key amebiasis concepts to review: (1) **Invasive features**: bloody diarrhea, flask-shaped ulcers, trophozoites with ingested RBCs, right lobe liver abscess (anchovy paste if aspirated); (2) **Differentiate from Giardia** (non-invasive - watery diarrhea, NO blood, NO fever, NO abscess); (3) **Two-step treatment**: metronidazole (tissue) \u2192 paromomycin (luminal cysts); (4) **Aspiration indications**: large >5-10 cm, left lobe, treatment failure."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical amebiasis teaching points: **E. histolytica is INVASIVE** (unlike Giardia). Classic presentation: bloody diarrhea, **flask-shaped ulcers**, **right lobe liver abscess**. Diagnosis: trophozoites with ingested RBCs, stool antigen. Treatment is ALWAYS **two-step**: metronidazole (kills tissue trophozoites) \u2192 luminal agent like paromomycin (kills intestinal cysts). Skipping the luminal agent causes **40-60% relapse**!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-089", "title": "Caustic Ingestion Complications", "domain": "gi_nutrition", "difficulty": "advanced", "tags": ["household cleaner", "drooling", "refuses to swallow", "esophageal stricture", "caustic ingestion complications", "alkali ingestion", "liquefactive necrosis", "EGD grading"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 18-month-old male is brought to the emergency department after his mother found him drinking from a bottle of liquid drain cleaner approximately 30 minutes ago.\n\nThe mother reports he was crying immediately after and began drooling excessively. She noticed white patches in his mouth. He refuses to swallow anything and is clutching his chest.\n\nPhysical Examination:\n- General: distressed, drooling profusely, hoarse cry\n- Vitals: HR 160, RR 36, SpO2 96% on room air, afebrile\n- HEENT: scattered white/gray patches on tongue and posterior pharynx, mild perioral erythema\n- Respiratory: mild inspiratory stridor, no retractions\n- Abdomen: mild epigastric tenderness, no peritoneal signs\n- Skin: no burns on hands or face", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This toddler has ingested liquid drain cleaner (a strong alkali) 30 minutes ago. He has drooling, oropharyngeal burns, stridor, and refuses to swallow. You must determine the immediate priority.", "question": "What is the MOST critical initial assessment in this caustic ingestion?", "choices": [{"id": "node-1-choice-a", "text": "Assess airway patency - stridor indicates potential airway compromise", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Airway assessment is the TOP priority**. This child has stridor indicating upper airway edema from caustic burns. Alkali ingestion causes **liquefactive necrosis** that penetrates deeply and can rapidly compromise the airway. Early intubation may be needed before edema progresses and makes intubation impossible.", "consequence": "You prepare for possible emergent airway intervention.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Induce vomiting to remove the caustic agent", "isOptimal": false, "isAcceptable": false, "feedback": "**NEVER induce vomiting!** This is absolutely contraindicated. Vomiting causes **re-exposure** of the esophagus and oropharynx to the caustic substance, effectively doubling the chemical burn. This causes additional injury and increases perforation risk.", "consequence": "Re-exposure causes worsened esophageal injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Give activated charcoal to bind the toxin", "isOptimal": false, "isAcceptable": false, "feedback": "**Activated charcoal is contraindicated!** Caustic substances are not adsorbed by charcoal, and administration risks: (1) aspiration with charcoal pneumonitis, (2) obscuring endoscopic visualization, (3) potential perforation if forceful administration. Charcoal is for **organic toxins**, not caustics.", "consequence": "Charcoal obscures endoscopy and risks aspiration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Neutralize the alkali with dilute acid (vinegar)", "isOptimal": false, "isAcceptable": false, "feedback": "**Do NOT attempt neutralization!** Acid-base reactions are **exothermic** and generate heat, causing additional thermal burns on top of the chemical burns. This outdated practice worsens injury. Small sips of water or milk (if no perforation suspected) are acceptable to dilute, but not to neutralize.", "consequence": "Exothermic reaction causes thermal injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Immediately perform blind nasogastric tube placement", "isOptimal": false, "isAcceptable": false, "feedback": "**NG/OG tube placement is contraindicated** without direct visualization! Blind passage risks **perforating** the already-damaged esophagus. If gastric decompression is needed, it should only be done under direct endoscopic guidance after injury grading.", "consequence": "NG tube perforates damaged esophagus.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Caustic ingestion ABCs**: Airway FIRST (stridor = impending obstruction). **NEVER**: induce vomiting, give charcoal, neutralize with acid/base, or blindly pass NG tube. **Alkalis** (drain cleaners, lye, oven cleaners) cause **liquefactive necrosis** - deeper, more severe than acids."}, "node-2": {"id": "node-2", "type": "decision", "content": "Airway assessment shows mild stridor but no severe distress. SpO2 remains 96%. ENT is alerted for possible emergent intubation. The child is made NPO and IV access is obtained.\n\nYou now need to determine the extent of injury. The mother confirms it was a commercial drain cleaner containing sodium hydroxide (lye).", "question": "What distinguishes ALKALI from ACID caustic injury, and why does it matter?", "choices": [{"id": "node-2-choice-a", "text": "Alkalis cause liquefactive necrosis with deeper penetration; acids cause coagulative necrosis that is more self-limiting", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Alkalis** (pH >12) cause **liquefactive necrosis** - they saponify fats and dissolve proteins, allowing deep penetration through tissue layers. **Acids** (pH <2) cause **coagulative necrosis** - protein coagulation forms an eschar that somewhat limits further penetration. This means **alkali injuries are typically MORE SEVERE** with higher perforation and stricture rates.", "consequence": "You recognize this high-risk alkali injury.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Acids cause worse injuries because they are more corrosive than alkalis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While concentrated acids can cause severe injury, **alkalis are generally MORE dangerous** because liquefactive necrosis allows **deeper tissue penetration**. The coagulum formed by acid injury (coagulative necrosis) provides some barrier effect. Drain cleaners (strong alkalis) are among the most dangerous household caustics.", "consequence": "Underestimating alkali injury severity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Both cause identical injury patterns; the distinction is clinically irrelevant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The distinction is **clinically important**! Alkali injuries have higher rates of: full-thickness burns, perforation, and late stricture formation. Understanding the mechanism helps predict injury severity and guides management intensity.", "consequence": "Missing important prognostic information.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Alkalis preferentially injure the stomach; acids injure the esophagus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - it's actually the **opposite**! **Alkalis** (often thick/viscous) injure the **esophagus** more due to prolonged contact time. **Acids** (often liquid) pass quickly through the esophagus but pool in the **stomach** (especially the antrum), causing more gastric injury. Alkali = esophagus; Acid = stomach.", "consequence": "Wrong anatomic prediction.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Severity depends only on volume ingested, not the type of caustic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While volume matters, the **type and concentration** of caustic are critical. A small amount of concentrated lye (pH 14) causes far more damage than a larger volume of weak acid. **Concentration, contact time, and tissue type** all determine injury severity.", "consequence": "Incomplete risk assessment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Alkali vs Acid**: **Alkali** (lye, drain cleaner) \u2192 **liquefactive necrosis** \u2192 deep penetration \u2192 **esophagus** > stomach \u2192 worse prognosis. **Acid** (toilet cleaner) \u2192 **coagulative necrosis** \u2192 self-limiting eschar \u2192 **stomach** > esophagus. Mnemonic: **A**lkali = **A**wful for esophagus."}, "node-3": {"id": "node-3", "type": "decision", "content": "The child remains stable with mild stridor. Labs show no metabolic acidosis. CXR shows no free air or pleural effusion.\n\nYou need to determine the grade of esophageal injury to guide management and prognosis.", "question": "What is the gold standard for assessing caustic esophageal injury severity?", "choices": [{"id": "node-3-choice-a", "text": "Esophagogastroduodenoscopy (EGD) within 12-24 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **EGD within 12-24 hours** is the gold standard for injury grading. It should NOT be done: <6 hours (injury still evolving) or >48 hours (increased perforation risk from tissue softening). EGD grades: **Grade 1** = superficial (erythema/edema), **Grade 2a** = non-circumferential ulcers, **Grade 2b** = circumferential ulcers, **Grade 3** = transmural necrosis. Grade 2b+ predicts stricture formation.", "consequence": "EGD scheduled for 12 hours post-ingestion.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Contrast esophagogram as first-line imaging", "isOptimal": false, "isAcceptable": true, "feedback": "Contrast esophagogram (using **water-soluble contrast**, NOT barium) is useful if **perforation is suspected** (mediastinal air on CXR, severe symptoms). However, it does NOT adequately grade mucosal injury severity. **EGD remains the gold standard** for injury grading, not esophagogram.", "consequence": "Esophagogram done; still need EGD for grading.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "CT scan of chest and abdomen", "isOptimal": false, "isAcceptable": true, "feedback": "CT can identify complications (perforation, mediastinitis) and may show wall thickening, but it **cannot accurately grade mucosal injury**. CT is an adjunct, not a replacement for EGD. In severe cases, CT can help assess transmural involvement, but direct visualization via EGD is needed for prognosis.", "consequence": "CT performed; EGD still required.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Presence of oropharyngeal burns predicts esophageal injury severity", "isOptimal": false, "isAcceptable": false, "feedback": "**This is a critical misconception!** Oropharyngeal burns do NOT reliably predict esophageal injury. Up to **70% of patients with NO oral burns** have significant esophageal injury, and some with oral burns have no esophageal involvement. **EGD is required regardless of oral exam findings** in significant ingestions.", "consequence": "Missed esophageal injury due to false reassurance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Wait 1 week then reassess clinically without endoscopy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Delaying assessment is dangerous. **Grade 2b-3 injuries have 70-100% stricture rates** if not identified and managed early. Early EGD allows: injury grading, prognosis, and decisions about steroids, antibiotics, and nutritional support. Waiting risks missing severe injury.", "consequence": "Delayed diagnosis; stricture develops.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**EGD timing window**: 12-24 hours post-ingestion (not <6h, not >48h). **Oral burns do NOT predict esophageal injury** - 70% with no oral burns have esophageal injury! **Grading**: 1 = superficial, 2a = non-circumferential, **2b = circumferential** (high stricture risk), 3 = transmural (perforation risk)."}, "node-4": {"id": "node-4", "type": "decision", "content": "EGD performed at 18 hours shows:\n- Circumferential white/gray ulcerations in the mid-esophagus\n- Deep ulcers with black discoloration distally\n- No visible perforation\n- Stomach shows erythema only\n\nThis is classified as **Grade 2b-3** injury.", "question": "What is the MOST appropriate management for this Grade 2b-3 alkali esophageal injury?", "choices": [{"id": "node-4-choice-a", "text": "NPO, IV fluids, PPI, consider steroids (controversial), and prepare for stricture prevention/management", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Management of Grade 2b-3 injury includes: (1) **NPO** until swallowing assessment, (2) **IV fluids and nutrition** (TPN or J-tube if prolonged), (3) **PPI** for acid suppression, (4) **Steroids** are controversial - some studies show benefit in Grade 2b for stricture prevention, but evidence is mixed. (5) **Antibiotics** only if perforation/infection. (6) **Serial dilations** will likely be needed for strictures.", "consequence": "Comprehensive supportive care initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Immediate surgical esophagectomy", "isOptimal": false, "isAcceptable": false, "feedback": "Too aggressive! Esophagectomy is reserved for **Grade 3 injuries with perforation, mediastinitis, or full-thickness necrosis** not responding to conservative management. This patient has no perforation. Premature surgery removes potentially viable tissue and has high morbidity in the acute phase.", "consequence": "Unnecessary surgery with high morbidity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Discharge home with oral PPI and follow-up in 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "**Dangerous!** Grade 2b-3 injuries require **inpatient monitoring** for: perforation signs, nutritional support, stricture development, and pain management. Strictures develop in **70-100% of Grade 2b+ injuries** at 3-6 weeks. Outpatient management risks missing perforation and delayed stricture treatment.", "consequence": "Patient develops perforation at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Empiric broad-spectrum antibiotics for all Grade 2+ injuries", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic antibiotics are NOT routinely indicated** unless there is evidence of perforation, mediastinitis, or superinfection. Unnecessary antibiotics promote resistance and don't prevent strictures. Antibiotics are reserved for documented infection or perforation.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Early dilation during the acute phase to prevent stricture", "isOptimal": false, "isAcceptable": false, "feedback": "**Early dilation is contraindicated!** Dilation during the acute phase (first 2-3 weeks) risks **perforation** of friable, necrotic tissue. Wait until the **fibrotic phase** (typically 3+ weeks) when tissue is more stable. Early dilation is dangerous, not preventive.", "consequence": "Perforation from premature dilation.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Grade 2b-3 management**: NPO + IV nutrition + PPI + pain control. **Steroids**: controversial, may help Grade 2b stricture prevention (evidence mixed). **NO early dilation** (perforation risk). **Strictures develop at 3-6 weeks** in 70-100% of Grade 2b+ injuries. Serial dilations often needed long-term."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient is admitted, maintained NPO with TPN, and started on IV PPI. At 4 weeks post-ingestion, a contrast esophagogram shows a **mid-esophageal stricture** with significant luminal narrowing. The child can only tolerate liquids.", "question": "What is the long-term management approach for caustic esophageal strictures?", "choices": [{"id": "node-5-choice-a", "text": "Serial esophageal dilations, typically every 2-4 weeks until stable caliber achieved", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Serial dilations** (balloon or bougie) are the mainstay of stricture management, typically performed every **2-4 weeks** until adequate luminal diameter is achieved and stable. Most patients require **multiple sessions** over months to years. Success rate is ~60-80%, but some refractory strictures require surgery (esophageal replacement).", "consequence": "Dilation program initiated with good response.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Immediate esophageal replacement surgery (gastric pull-up or colon interposition)", "isOptimal": false, "isAcceptable": false, "feedback": "Too aggressive for initial stricture management. **Surgical replacement** (gastric pull-up, colon interposition, jejunal interposition) is reserved for: (1) **failed dilations** (refractory strictures), (2) complete esophageal obstruction, or (3) multiple severe strictures. Most strictures respond to dilations; surgery is last resort.", "consequence": "Unnecessary major surgery.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Permanent gastrostomy tube with no further intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incomplete management. While a **G-tube** may be needed for nutrition during treatment, the goal is **restoring oral feeding**. Abandoning attempts to restore esophageal function condemns the child to lifelong tube dependence. Dilations should be attempted before accepting permanent G-tube.", "consequence": "Patient loses chance for oral feeding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "High-dose steroids to dissolve the stricture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Steroids **cannot dissolve established fibrous strictures**. Steroids may have a role in the **acute phase** to potentially reduce stricture formation, but once fibrosis is established, steroids are ineffective. Mechanical dilation is required for formed strictures.", "consequence": "Stricture unchanged; steroids cause side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Esophageal stent placement as definitive treatment", "isOptimal": false, "isAcceptable": true, "feedback": "Stents are sometimes used as an **adjunct** to dilations in refractory strictures, but are NOT first-line. Stent complications include: migration, tissue ingrowth, and perforation. Stents are considered for strictures that rapidly re-stenose despite dilations, not as initial definitive therapy.", "consequence": "Stent placed; migration occurs.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Stricture management ladder**: (1) **Serial dilations** every 2-4 weeks (first-line, 60-80% success), (2) **Intralesional steroids** during dilation (for refractory cases), (3) **Stents** (refractory, high re-stenosis), (4) **Surgical replacement** (colon interposition, gastric pull-up) if dilations fail. **Long-term cancer risk**: caustic strictures have **1000x increased** esophageal cancer risk - lifelong surveillance needed!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly prioritized airway assessment, avoided contraindicated interventions (vomiting, charcoal, neutralization), understood alkali injury mechanisms, appropriately timed endoscopy, and initiated comprehensive stricture management.\n\n**Key teaching points:**\n\u2022 **Airway first** - stridor = impending obstruction\n\u2022 **NEVER**: induce vomiting, give charcoal, neutralize, or blind NG placement\n\u2022 **Alkali > Acid** severity (liquefactive vs coagulative necrosis)\n\u2022 **Oral burns do NOT predict** esophageal injury (70% false negative)\n\u2022 **EGD at 12-24 hours** for grading (not <6h or >48h)\n\u2022 **Grade 2b+ \u2192 70-100% stricture rate** at 3-6 weeks\n\u2022 **Serial dilations** are mainstay of stricture treatment\n\u2022 **Lifelong cancer surveillance** - 1000x increased esophageal cancer risk"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review caustic ingestion key principles:\n\n\u2022 **Airway priority** - stridor indicates upper airway burns\n\u2022 **Alkali** (drain cleaner) causes **liquefactive necrosis** - deep, severe\n\u2022 **Acid** causes **coagulative necrosis** - more self-limiting\n\u2022 **EGD within 12-24 hours** is gold standard for grading\n\u2022 **Oral burns do NOT predict** esophageal injury\n\u2022 **Strictures** develop in 70-100% of Grade 2b+ injuries at 3-6 weeks\n\u2022 **Serial dilations** are first-line for stricture management"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management errors occurred. Review absolute contraindications:\n\n\u2022 **NEVER induce vomiting** - causes re-exposure and additional burns\n\u2022 **NEVER give activated charcoal** - not effective, obscures EGD, aspiration risk\n\u2022 **NEVER attempt neutralization** - exothermic reaction causes thermal burns\n\u2022 **NEVER pass blind NG tube** - perforation risk in damaged esophagus\n\u2022 **Oral exam is UNRELIABLE** - 70% with no oral burns have esophageal injury\n\u2022 **Early dilation is DANGEROUS** - perforation risk in acute phase\n\nKey pearl: Absence of oropharyngeal burns does NOT rule out esophageal injury - EGD is indicated for ALL significant caustic ingestions."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-135", "title": "Viral Gastroenteritis Outbreak Control", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["hand washing over hand sanitizer", "exclude until 48 hours symptom-free", "norovirus resistant to alcohol", "viral gastroenteritis outbreak control"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with vomiting and diarrhea, and his daycare reports multiple children with similar symptoms.\n\nStaff asking about infection control measures.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You receive a call from a daycare center. The director reports: \"We have 8 children who have developed vomiting and diarrhea in the past 24 hours. Three more called in sick this morning. We're worried about an outbreak.\"\n\nThe child in your office is a 5-year-old male from this daycare who developed sudden-onset vomiting last night followed by watery diarrhea. No blood in stool. Low-grade fever (100.4\u00b0F). He's mildly dehydrated but tolerating small sips of fluids.\n\n**Viral Gastroenteritis - Common Pathogens:**\n- **Norovirus**: #1 cause of gastroenteritis outbreaks in all ages; highly contagious; incubation 12-48 hours; duration 1-3 days\n- **Rotavirus**: #1 cause in young children (pre-vaccine era); now less common due to vaccination; incubation 1-3 days; duration 3-8 days\n- **Adenovirus, astrovirus, sapovirus**: other viral causes\n\n**Key Features Suggesting Viral (vs. Bacterial) Etiology:**\n- Watery diarrhea (non-bloody)\n- Vomiting prominent\n- Low-grade or no fever\n- Short incubation period\n- Multiple people affected simultaneously\n- Self-limited course (1-3 days for norovirus)", "question": "Based on the clinical presentation and outbreak setting, what is the most likely causative agent?", "choices": [{"id": "node-1-choice-a", "text": "Norovirus - highly contagious virus causing acute gastroenteritis outbreaks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Norovirus** is the most likely cause of this outbreak. Key features: (1) **Outbreak setting** - norovirus causes >90% of non-bacterial gastroenteritis outbreaks, (2) **Rapid spread** - 8+ children in 24 hours reflects extremely high contagiousness (infectious dose is only 18-1000 viral particles), (3) **Short incubation** (12-48 hours) matches timeline, (4) **Vomiting prominent** - often precedes diarrhea, (5) **Watery, non-bloody diarrhea**, (6) **Self-limited** (1-3 days typically). Norovirus is sometimes called the 'winter vomiting bug' but can occur year-round.", "consequence": "You correctly identify norovirus as the likely cause.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Rotavirus - leading cause of severe diarrhea in young children", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Rotavirus** was historically the #1 cause of pediatric gastroenteritis, but since vaccine introduction (2006), it has decreased dramatically. Key differences from this case: (1) Rotavirus incubation is longer (1-3 days), (2) Duration is longer (3-8 days), (3) Rotavirus is now uncommon in vaccinated populations, (4) Outbreaks are less common than norovirus. If these children are vaccinated, norovirus is much more likely. However, rotavirus should be considered in unvaccinated children or with longer duration illness.", "consequence": "Rotavirus is possible but less likely given vaccination status and outbreak pattern.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Salmonella - bacterial pathogen causing bloody diarrhea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Salmonella** typically causes: (1) Bloody or mucoid diarrhea (not watery), (2) Higher fevers, (3) Longer incubation (6-72 hours, usually 12-36), (4) Longer duration (4-7 days), (5) Often associated with contaminated food (eggs, poultry, produce). This outbreak has watery, non-bloody diarrhea, prominent vomiting, and rapid person-to-person spread - all more consistent with viral etiology.", "consequence": "Bacterial etiology doesn't fit the clinical picture.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Clostridium difficile - antibiotic-associated diarrhea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **C. difficile** is associated with: (1) Recent antibiotic use (typically within past 8 weeks), (2) Healthcare or nursing home exposure, (3) Foul-smelling diarrhea, (4) NOT typically causing outbreaks in healthy children at daycare. There's no mention of antibiotic use, and the outbreak pattern with multiple healthy children simultaneously is inconsistent with C. diff.", "consequence": "C. difficile doesn't fit this clinical scenario.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Giardia - parasitic infection from contaminated water", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Giardia** has: (1) Longer incubation (1-3 weeks), (2) Chronic/intermittent symptoms (weeks to months), (3) Foul-smelling, greasy, floating stools, (4) Less prominent vomiting, (5) Associated with contaminated water, travel, or childcare (but not acute outbreaks). This acute, rapid-onset outbreak with prominent vomiting is inconsistent with giardiasis.", "consequence": "Giardia causes chronic, not acute outbreak-type illness.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Norovirus** causes >90% of non-bacterial gastroenteritis outbreaks. Key features: extremely contagious (infectious dose ~18 particles), short incubation (12-48 hrs), prominent vomiting, watery diarrhea, short duration (1-3 days). Often called 'stomach flu' (though not influenza)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You've determined norovirus is the likely cause. The daycare director asks: \"What can we do to stop this from spreading? We've been using hand sanitizer stations everywhere.\"\n\n**Critical Norovirus Infection Control Facts:**\n\n**Alcohol-based hand sanitizers are NOT effective against norovirus!**\n- Norovirus is a **non-enveloped virus** (lacks lipid envelope)\n- Alcohol works by disrupting lipid membranes - ineffective against non-enveloped viruses\n- **Soap and water** is required - physically removes virus particles\n\n**Norovirus Environmental Survival:**\n- Survives on surfaces for **days to weeks**\n- Resistant to many common disinfectants\n- Requires **bleach-based cleaners** (1000-5000 ppm chlorine) or EPA-registered norovirus disinfectants\n- Virus can survive on contaminated fabrics through regular wash cycles\n\n**Transmission Routes:**\n- Fecal-oral (primary)\n- Vomit aerosolization (can infect people nearby)\n- Contaminated surfaces (fomites)\n- Contaminated food/water", "question": "What is the MOST important infection control measure to emphasize for this daycare outbreak?", "choices": [{"id": "node-2-choice-a", "text": "Soap and water hand washing - alcohol-based sanitizers are NOT effective against norovirus", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Soap and water hand washing** is the critical message. This is a **high-yield board fact**: alcohol-based hand sanitizers do NOT kill norovirus because it's a non-enveloped virus. Key teaching: (1) **Physical removal** via soap and water is necessary, (2) Wash for at least **20 seconds**, (3) Especially after bathroom use, diaper changes, and before eating, (4) Hand sanitizer can be used as an **adjunct** but NOT a substitute. Many outbreaks persist because facilities rely on alcohol-based sanitizers that are ineffective against norovirus.", "consequence": "You correctly identify the critical infection control measure.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Increase the number of alcohol-based hand sanitizer stations throughout the facility", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Alcohol-based hand sanitizers are NOT effective against norovirus**. This is because norovirus is a **non-enveloped virus** - it lacks the lipid membrane that alcohol disrupts. Adding more sanitizer stations will NOT stop the outbreak. This is a common mistake that perpetuates norovirus outbreaks. The daycare needs to emphasize SOAP AND WATER hand washing instead.", "consequence": "Relying on alcohol-based sanitizers will not control a norovirus outbreak.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Prescribe prophylactic antibiotics for all exposed children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotics are useless against viruses**. Norovirus is a VIRAL infection - antibiotics have no effect and would only: (1) Cause unnecessary side effects, (2) Contribute to antibiotic resistance, (3) Potentially cause antibiotic-associated diarrhea (making things worse). There is no antiviral treatment for norovirus - management is supportive care and infection control.", "consequence": "Antibiotics are ineffective against viral infections.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Recommend N95 masks for all staff and children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While norovirus CAN be transmitted via aerosolized vomit, **N95 masks are not the primary control measure**. Key points: (1) Primary transmission is fecal-oral and fomite, (2) N95s are not practical for children, (3) Hand hygiene and surface disinfection are more important, (4) Masks may have limited role for staff cleaning vomit. Universal N95 use is not recommended for norovirus outbreaks.", "consequence": "Masks are not the primary control measure for norovirus.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Close the daycare immediately and have all children tested for norovirus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine norovirus testing is not recommended** and closure is not the first step. Rationale: (1) Clinical diagnosis is sufficient in outbreak settings, (2) Testing doesn't change management (supportive care regardless), (3) Results take time and outbreak will likely resolve before results return, (4) Closure may be considered if control measures fail, but is NOT the first response. Focus on implementing infection control measures first.", "consequence": "Testing is unnecessary and closure is premature.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HIGH-YIELD**: Alcohol-based hand sanitizers are NOT effective against norovirus (non-enveloped virus). SOAP AND WATER hand washing is required. This is a common board question and a frequent real-world mistake that perpetuates outbreaks."}, "node-3": {"id": "node-3", "type": "decision", "content": "The daycare implements soap and water hand washing protocols. They ask two more questions:\n\n1. \"When can sick children return to daycare?\"\n2. \"What should we use to clean up vomit and disinfect surfaces?\"\n\n**Exclusion Guidelines:**\n- Children should be excluded until **48 hours after symptoms resolve**\n- Norovirus shedding continues for **days to weeks** after symptoms resolve\n- The 48-hour rule balances practicality with infection control\n- Strict exclusion is critical to prevent ongoing transmission\n\n**Environmental Decontamination:**\n- Standard cleaning products are often **ineffective** against norovirus\n- Requires **bleach-based solutions** (1000-5000 ppm chlorine, or ~1/4 cup bleach per gallon of water)\n- Alternatively: EPA-registered products effective against norovirus\n- Vomit/stool should be cleaned with disposable materials by staff wearing gloves\n- Contaminated linens should be washed in **hot water with bleach**", "question": "What return-to-daycare guidance and environmental cleaning recommendations do you provide?", "choices": [{"id": "node-3-choice-a", "text": "Exclude until 48 hours symptom-free; clean surfaces with dilute bleach solution (not regular household cleaners)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **48-hour exclusion** and **bleach-based disinfection** are critical. Key points: (1) **48 hours symptom-free** before return - this is the standard recommendation (norovirus sheds for days after symptoms resolve, but 48 hours balances practicality), (2) **Bleach solution** (1:50 dilution, ~1000 ppm chlorine, or 1/4 cup per gallon) is required for surface disinfection, (3) Standard household cleaners are **NOT effective** against norovirus, (4) Clean vomit/feces with disposable materials, (5) Wash contaminated linens in HOT water with bleach, (6) Staff should wear gloves when cleaning.", "consequence": "You provide appropriate exclusion and cleaning guidance.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Children can return as soon as vomiting stops; standard household cleaners are sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect on both counts. (1) **Children remain contagious after symptoms resolve** - the 48-hour symptom-free rule is essential because viral shedding continues, (2) **Standard household cleaners are NOT effective** against norovirus - it's resistant to many disinfectants. Bleach-based solutions or EPA-registered norovirus disinfectants are required. These errors would perpetuate the outbreak.", "consequence": "Inadequate exclusion and cleaning will perpetuate the outbreak.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Exclude until 24 hours symptom-free; use alcohol-based surface wipes for cleaning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. (1) **24 hours is insufficient** - the standard is 48 hours symptom-free. Norovirus shedding continues well after symptoms resolve, (2) **Alcohol-based surface wipes are NOT effective** against norovirus for the same reason alcohol hand sanitizers don't work - norovirus is non-enveloped. Bleach is required. Both errors would perpetuate transmission.", "consequence": "Inadequate exclusion period and ineffective disinfection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Require negative stool testing before return; steam-clean all carpets and upholstery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. (1) **Stool testing before return is NOT recommended** - viral shedding can continue for weeks even after clinical recovery, making this impractical and overly restrictive, (2) While thorough cleaning is good, **steam cleaning alone may not inactivate norovirus** - temperatures >160\u00b0F are needed. Bleach-based disinfection of hard surfaces is more critical. The 48-hour symptom-free rule is the practical standard.", "consequence": "Stool testing requirement is impractical and not evidence-based.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Exclude for 7 days regardless of symptoms; close the daycare for professional fumigation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is **overly aggressive** and not evidence-based. (1) **48 hours symptom-free** is the standard - 7-day exclusion is unnecessary and burdensome for families, (2) **Professional fumigation is not required** - proper bleach-based cleaning by staff is sufficient, (3) Closure may occasionally be needed for severe, uncontrolled outbreaks but is NOT routine. Balance infection control with practical considerations.", "consequence": "Overly aggressive measures are unnecessary and burdensome.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Norovirus outbreak control essentials**: (1) SOAP AND WATER hand washing (not alcohol sanitizer), (2) Exclude until 48 hours symptom-free, (3) BLEACH-based disinfection (not standard cleaners). These three points are high-yield for boards and critical for real-world outbreak management."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified norovirus as the likely cause and provided appropriate outbreak control guidance.\n\n**Key teaching points for viral gastroenteritis outbreak control:**\n\n**Identifying norovirus outbreaks:**\n- Rapid spread (extremely contagious, infectious dose ~18 particles)\n- Short incubation (12-48 hours)\n- Prominent vomiting followed by watery diarrhea\n- Self-limited (1-3 days)\n- >90% of non-bacterial gastroenteritis outbreaks\n\n**Critical infection control measures (HIGH-YIELD):**\n1. **SOAP AND WATER** hand washing - alcohol-based sanitizers are NOT effective (norovirus is non-enveloped)\n2. **48-hour exclusion** after symptoms resolve (viral shedding continues)\n3. **BLEACH-based disinfection** - standard cleaners are NOT effective\n\n**Environmental decontamination:**\n- Dilute bleach: 1000-5000 ppm chlorine (~1/4 cup per gallon water)\n- Or EPA-registered norovirus disinfectants\n- Hot water + bleach for contaminated linens\n- Disposable cleaning materials, staff wear gloves\n\n**What NOT to do:**\n- Rely on alcohol-based hand sanitizers\n- Use standard household cleaners\n- Allow return before 48 hours symptom-free\n- Prescribe antibiotics (viral infection)"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of norovirus outbreak control:\n\n**Norovirus characteristics:**\n- Non-enveloped virus (critical for understanding infection control)\n- Extremely contagious (infectious dose ~18 particles)\n- Resistant to alcohol and many disinfectants\n\n**Essential control measures:**\n1. SOAP AND WATER hand washing (NOT alcohol sanitizer)\n2. 48-hour exclusion after symptoms resolve\n3. BLEACH-based disinfection\n\n**Common mistakes:**\n- Relying on alcohol-based hand sanitizers\n- Using standard household cleaners\n- Allowing return after 24 hours (should be 48)\n- Overly aggressive measures (7-day exclusion, facility closure, mandatory testing)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical norovirus outbreak control principles:\n\n**Why alcohol-based hand sanitizers don't work:**\n- Norovirus is a NON-ENVELOPED virus\n- Alcohol works by disrupting lipid membranes\n- No lipid membrane = no effect\n- SOAP AND WATER physically removes virus\n\n**What doesn't work for norovirus:**\n- Alcohol-based hand sanitizers\n- Standard household cleaners\n- Antibiotics (it's a VIRUS)\n- Short exclusion periods (<48 hours)\n\n**What DOES work:**\n- Soap and water hand washing (20+ seconds)\n- Bleach-based disinfection (1000-5000 ppm chlorine)\n- 48-hour exclusion after symptom resolution\n- Supportive care (hydration)\n\n**This is a HIGH-YIELD board topic**: Alcohol sanitizers NOT effective against norovirus. Soap and water required."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-152", "title": "Tracheoesophageal Fistula (TEF)", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["drooling", "choking with first feed", "coiled NG tube", "VACTERL association", "polyhydramnios"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 1-day-old female is brought in by her parents for choking and drooling with feeds for since first feed.\n\nHistory reveals, she chokes, coughs, and turns blue with every feeding attempt. She has excessive drooling. The nurses are unable to pass an orogastric tube.\n\nReview of systems is positive for coughing and cyanosis with feeds and negative for respiratory distress at rest.\n\nMedical history is notable for Prenatal ultrasound showed polyhydramnios. She was born full-term.\n\nPhysical Examination:\n- Respiratory: coarse breath sounds, coughing with secretion accumulation.\n- General: appropriate size newborn with excessive oral secretions.\n- Vitals: cyanosis.\n- Unable to pass NG tube beyond 10 cm.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This newborn presents with the classic triad of **excessive drooling, choking/cyanosis with feeds, and inability to pass an NG tube**. The prenatal history of polyhydramnios supports the diagnosis (fetus cannot swallow amniotic fluid).", "question": "What is the MOST COMMON anatomic type of tracheoesophageal fistula/esophageal atresia, and how does CXR help identify it?", "choices": [{"id": "node-1-choice-a", "text": "Type C (EA with distal TEF) - coiled NG tube in upper chest PLUS gas in stomach", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Type C (EA with distal TEF)** accounts for **85% of cases**. The proximal esophagus ends in a blind pouch (NG tube coils), while a fistula connects the distal esophagus to the trachea (allows air into stomach \u2192 **abdominal gas present**). This is the classic presentation.", "consequence": "You correctly identify the most common anatomic variant.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Pure esophageal atresia (no fistula) - coiled NG tube with NO abdominal gas", "isOptimal": false, "isAcceptable": true, "feedback": "This describes **Type A (pure EA)**, which accounts for only **8%** of cases. Without a distal fistula, no air reaches the stomach \u2192 **gasless abdomen**. This infant has abdominal gas, indicating a distal fistula (Type C).", "consequence": "Correct anatomy concept but wrong variant for this case.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "H-type TEF (fistula without atresia) - presents later with recurrent pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this presentation. **H-type (Type E)** has a fistula but **NO atresia** - the esophagus is patent. These infants can feed but develop **recurrent aspiration pneumonia**. This infant cannot feed at all and the NG tube won't pass, indicating esophageal atresia.", "consequence": "H-type presents differently - this infant has atresia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Isolated tracheal stenosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Tracheal stenosis causes **stridor and respiratory distress**, not feeding difficulties. This infant's primary symptom is **choking with feeds** and inability to pass an NG tube, which points to esophageal pathology.", "consequence": "Does not explain the feeding difficulties.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Laryngeal cleft", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Laryngeal cleft causes **aspiration with feeds** but an NG tube would pass normally. The **inability to pass the NG tube** is the key finding that differentiates esophageal atresia from other causes of feeding difficulty.", "consequence": "NG tube would pass in laryngeal cleft.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**TEF/EA Types** (memorize): **Type C = 85%** (EA + distal TEF, gas in stomach), Type A = 8% (pure EA, gasless abdomen), Type E = 4% (H-type, no atresia, late presentation). **Polyhydramnios** occurs because fetus cannot swallow amniotic fluid."}, "node-2": {"id": "node-2", "type": "decision", "content": "CXR confirms coiled NG tube in upper chest with gas in the stomach (Type C EA/TEF). The infant needs immediate stabilization before surgery.", "question": "What is the CRITICAL initial management step to prevent aspiration pneumonia?", "choices": [{"id": "node-2-choice-a", "text": "NPO, continuous suction of proximal esophageal pouch (Replogle tube), head-elevated position", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Replogle tube** is a double-lumen sump tube placed in the proximal esophageal pouch for **continuous low-pressure suction**. This prevents saliva from accumulating and spilling into the trachea. **Head-up positioning** reduces reflux through the distal fistula. **NPO** is essential.", "consequence": "Appropriate pre-operative stabilization initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Intubation and mechanical ventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as routine first step. Intubation can be **dangerous** in TEF - positive pressure ventilation can force air through the fistula into the stomach, causing **gastric distension** and respiratory compromise. Intubate only if respiratory failure occurs, and place ETT tip **distal to fistula**.", "consequence": "PPV through fistula worsens gastric distension.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Contrast esophagram to define anatomy", "isOptimal": false, "isAcceptable": false, "feedback": "**CONTRAINDICATED!** Contrast studies risk **aspiration** of contrast into the lungs via the fistula or overflow from the blind pouch. The diagnosis is made clinically and with plain CXR showing coiled NG tube. Surgery defines the exact anatomy.", "consequence": "Contrast aspiration causes chemical pneumonitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Trial of small-volume feeds to assess swallowing", "isOptimal": false, "isAcceptable": false, "feedback": "**DANGEROUS!** The infant CANNOT swallow - the esophagus ends in a blind pouch. Any oral feeds will accumulate and overflow into the trachea, causing aspiration pneumonia. **Strict NPO** is mandatory.", "consequence": "Aspiration pneumonia from feeding attempt.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Gastrostomy tube placement for feeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as initial step. While gastrostomy may be needed in **staged repairs** (premature infants, long-gap atresia), it is **not the initial management**. First stabilize with Replogle suction, then proceed to definitive surgical repair or staged approach based on anatomy and infant condition.", "consequence": "Not the initial stabilization approach.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Replogle tube** = double-lumen sump for continuous suction of proximal pouch. **NEVER do contrast swallow** (aspiration risk). **Avoid PPV** if possible (gastric distension through fistula). Keep **head elevated** and **NPO**."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is stabilized with Replogle suction. Before surgery, you need to evaluate for associated anomalies. TEF/EA is associated with VACTERL syndrome.", "question": "What studies should be performed to screen for VACTERL-associated anomalies?", "choices": [{"id": "node-3-choice-a", "text": "Echocardiogram (cardiac), renal ultrasound (renal), spinal imaging (vertebral), limb exam", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **VACTERL screening** is essential: **V**ertebral (spinal X-ray/US), **A**norectal (physical exam for imperforate anus), **C**ardiac (**echocardiogram** - 30% have CHD), **TE**F (already diagnosed), **R**enal (**renal ultrasound** - 20% have anomalies), **L**imb (physical exam for radial ray defects). **Echo is critical** - also determines aortic arch sidedness for surgical approach.", "consequence": "Comprehensive VACTERL screening performed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Echocardiogram only - cardiac defects are the main concern", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Echo is **essential** (30% have CHD, and arch sidedness affects surgical approach), but **renal anomalies** occur in 20% and **vertebral anomalies** in 70%. A full VACTERL screen is recommended before surgery.", "consequence": "May miss other VACTERL components.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "MRI of spine only", "isOptimal": false, "isAcceptable": false, "feedback": "Incomplete. While vertebral anomalies are common, **cardiac anomalies** (30%) are more immediately relevant for surgical planning. Echo to determine aortic arch sidedness is crucial - a right-sided arch requires a left thoracotomy approach.", "consequence": "Missing critical cardiac evaluation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Genetic testing for chromosomal abnormalities", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable but not urgent. VACTERL is typically **non-syndromic** (normal karyotype), but chromosomal abnormalities (trisomy 18, 21) can present with TEF. Genetic testing can be sent but should not delay VACTERL imaging or surgery.", "consequence": "Should not delay surgical planning.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "No additional workup needed - proceed directly to surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **50% of TEF patients have associated anomalies**. Undiagnosed cardiac defects can lead to intraoperative complications. Renal anomalies affect fluid management. Echo is **mandatory** before surgical repair.", "consequence": "Risk of intraoperative complications from undiagnosed anomalies.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**VACTERL mnemonic**: **V**ertebral (70%), **A**norectal (imperforate anus), **C**ardiac (30% - VSD, ASD, ToF), **T**racheo-**E**sophageal fistula, **R**enal (20%), **L**imb (radial ray defects). **Echo is mandatory** - determines aortic arch sidedness for surgical approach."}, "node-4": {"id": "node-4", "type": "decision", "content": "VACTERL screening shows a small VSD but normal renal and spinal anatomy. Echo shows left-sided aortic arch. The infant is taken to the OR for primary repair via right thoracotomy. Post-operatively on day 7, the infant develops fever and respiratory distress. CXR shows new right lower lobe infiltrate.", "question": "What is the MOST concerning complication in this post-operative TEF repair patient?", "choices": [{"id": "node-4-choice-a", "text": "Anastomotic leak - obtain contrast study to evaluate esophageal integrity", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Anastomotic leak** occurs in 15-20% of repairs and typically presents **5-7 days post-op** with fever, respiratory distress, and new infiltrate (saliva/feeds leaking into mediastinum/pleural space). A **contrast esophagram** (now safe post-repair with water-soluble contrast) evaluates anastomotic integrity.", "consequence": "Contrast study reveals small contained leak.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Recurrent TEF - this is a late complication, unlikely at day 7", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct reasoning. **Recurrent TEF** does occur in 5-10% of cases but typically presents **weeks to months** after repair with recurrent aspiration pneumonia. At day 7 post-op, **anastomotic leak** is more likely than recurrent fistula formation.", "consequence": "Recurrent TEF is possible but less likely this early.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Hospital-acquired pneumonia - treat with broad-spectrum antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "While HAP is possible, you must **rule out anastomotic leak first** in any post-TEF repair patient with respiratory symptoms. Treating with antibiotics alone while missing a leak can lead to **mediastinitis** and sepsis.", "consequence": "May miss surgical complication requiring intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Esophageal stricture - perform endoscopy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. **Stricture** is a **late complication** (weeks to months) presenting with **dysphagia and feeding difficulty**, not acute fever and respiratory distress. At day 7, an **anastomotic leak** is the primary concern.", "consequence": "Stricture is a late complication, not acute.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Normal post-operative course - observe and continue current management", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fever and new pulmonary infiltrate** at day 7 post-TEF repair is **NOT normal**. This presentation is classic for anastomotic leak and requires urgent evaluation with contrast study.", "consequence": "Delayed diagnosis of anastomotic leak.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Post-TEF repair complications by timing**: **Early (days 5-10)**: Anastomotic leak (15-20%). **Late (weeks-months)**: Stricture (30-40% - may need serial dilations), Recurrent TEF (5-10%), GERD (50%), Tracheomalacia."}, "node-5": {"id": "node-5", "type": "decision", "content": "Contrast esophagram shows a small contained anastomotic leak that is managed conservatively with NPO and antibiotics. The infant recovers and is discharged at 3 weeks of life. At the 6-month follow-up, the parents report the infant makes a barking cough and has noisy breathing, especially when crying or feeding.", "question": "What is the MOST likely cause of these long-term respiratory symptoms after TEF repair?", "choices": [{"id": "node-5-choice-a", "text": "Tracheomalacia - intrinsic weakness of tracheal cartilage from developmental abnormality", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Tracheomalacia** occurs in 75% of TEF patients due to **intrinsic weakness of the tracheal cartilage** at the level of the fistula. It causes a **\"barking\" or \"seal-like\" cough**, stridor, and noisy breathing that worsens with crying, feeding, or respiratory infections. Most cases improve by age 2 as the trachea stiffens.", "consequence": "You correctly identify tracheomalacia.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Recurrent TEF - the fistula has reformed", "isOptimal": false, "isAcceptable": true, "feedback": "Possible but less likely given the symptom pattern. **Recurrent TEF** presents with **aspiration during feeds** (coughing, choking, recurrent pneumonia), not the characteristic **barking cough** and noisy breathing at rest. Bronchoscopy can differentiate these conditions.", "consequence": "Recurrent TEF has different symptom pattern.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-c", "text": "Esophageal stricture causing aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect symptom pattern. **Stricture** causes **dysphagia, feeding difficulty, and food impaction** - not barking cough and noisy breathing. This infant's respiratory symptoms independent of feeding suggest **tracheal** (not esophageal) pathology.", "consequence": "Stricture presents with feeding difficulty, not respiratory symptoms.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Laryngomalacia unrelated to TEF repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect location. Laryngomalacia causes **inspiratory stridor** that improves with prone positioning and worsens with supine position. **Tracheomalacia** causes a characteristic **barking cough** and the sounds are more distal. In TEF patients, the tracheal abnormality at the fistula site is the more likely cause.", "consequence": "Tracheomalacia is more likely in TEF patients.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Vocal cord paralysis from surgical injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Vocal cord paralysis causes **hoarse cry**, **weak cry**, or **aspiration** - not a barking cough. The recurrent laryngeal nerve is not typically at risk during TEF repair via thoracotomy. The **barking cough** is characteristic of tracheomalacia.", "consequence": "VCP has different presentation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Long-term TEF complications**: **Tracheomalacia** (75% - barking cough, usually resolves by age 2), **GERD** (50% - lifelong), **Esophageal dysmotility**, **Stricture** (30-40% - may need serial dilations), **Recurrent TEF** (5-10%). Overall survival is **>90%** with excellent long-term quality of life."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this infant with Type C (EA + distal TEF) through initial stabilization, VACTERL screening, post-operative complication recognition, and identification of long-term sequelae. Key teaching points: (1) Type C accounts for 85% of cases, (2) Replogle tube for continuous suction is critical, (3) VACTERL screening with echo is mandatory, (4) Anastomotic leak presents days 5-10 post-op, (5) Tracheomalacia affects 75% and usually resolves by age 2. Prognosis is excellent with >90% survival."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review TEF key features: Type C (85%) has gas in stomach, Replogle tube for suction, VACTERL screening with echo is mandatory, anastomotic leak presents days 5-10 post-op, tracheomalacia causes barking cough. Remember: NO contrast swallow pre-op (aspiration risk) but YES post-op to evaluate anastomosis."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates TEF/EA management: (1) Diagnose with coiled NG tube on CXR, (2) Stabilize with Replogle suction and NPO, (3) Screen for VACTERL (especially echo for cardiac defects), (4) Surgical repair, (5) Monitor for anastomotic leak (days 5-10), stricture (weeks-months), and tracheomalacia (long-term). Critical error made that could harm the patient."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-158", "title": "Rickets (Vitamin D Deficiency)", "domain": "gi_nutrition", "difficulty": "intermediate", "tags": ["rachitic rosary", "bowed legs", "frontal bossing", "craniotabes", "metaphyseal cupping and fraying"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 18-month-old female is brought to the emergency department for bowed legs and delayed walking.\n\nHistory reveals, she is not yet walking and her parents noticed her legs appear bowed. She has been exclusively breastfed and the family stays indoors most of the time.\n\nReview of systems is positive for frontal bossing and dental delay and negative for fractures or muscle weakness.\n\nPertinent history includes She was born full-term. She is exclusively breastfed with no vitamin D supplementation.\n\nPhysical Examination:\n- Musculoskeletal: genu varum (bowlegs), widened wrists (rachitic rosary), frontal bossing.\n- Teeth: delayed eruption.\n- General: hypotonic toddler with delayed gross motor development.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory results return:\n- **25-hydroxyvitamin D**: 8 ng/mL (severely deficient; normal >30 ng/mL)\n- **Calcium**: 8.2 mg/dL (low-normal; normal 8.5-10.5)\n- **Phosphorus**: 2.1 mg/dL (LOW; normal 4.0-6.5 mg/dL for age)\n- **Alkaline phosphatase**: 850 U/L (HIGH; normal <350 U/L)\n- **PTH**: 180 pg/mL (HIGH; normal 15-65 pg/mL)\n\nX-ray of wrists and knees shows:\n- **Metaphyseal cupping and fraying** ('paintbrush' appearance)\n- Widened growth plates\n- Generalized osteopenia\n- Genu varum (bowed legs)", "question": "What pathophysiologic process explains this laboratory and radiographic pattern?", "choices": [{"id": "node-1-choice-a", "text": "Vitamin D deficiency causing impaired calcium/phosphate absorption, leading to secondary hyperparathyroidism and defective bone mineralization", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Vitamin D deficiency** impairs intestinal absorption of **calcium and phosphate**. The resulting hypocalcemia triggers **secondary hyperparathyroidism** (elevated PTH), which mobilizes calcium from bone and increases renal phosphate excretion, causing **hypophosphatemia**. Low phosphate leads to **defective mineralization** of the growth plate cartilage matrix (osteoid), producing the classic rachitic changes. **Alkaline phosphatase** is elevated because osteoblasts are hyperactive trying (unsuccessfully) to mineralize bone.", "consequence": "Understanding the pathophysiology guides treatment approach.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Primary hyperparathyroidism causing excessive bone resorption", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In **primary hyperparathyroidism**, PTH is elevated due to autonomous parathyroid gland function (adenoma or hyperplasia), and **calcium is HIGH** (not low-normal). This child has **low vitamin D** as the primary problem, with elevated PTH as a **secondary** (compensatory) response to maintain calcium homeostasis.", "consequence": "Misses the vitamin D deficiency as root cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "X-linked hypophosphatemic rickets with renal phosphate wasting", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **X-linked hypophosphatemic rickets (XLH)** is caused by mutations in PHEX gene leading to elevated FGF23 and renal phosphate wasting. Key difference: in XLH, **vitamin D levels are normal** (or even low-normal 1,25-OH vitamin D despite normal 25-OH), and PTH is normal or only mildly elevated. This child's **severely low 25-OH vitamin D** points to nutritional deficiency, not genetic phosphate wasting.", "consequence": "Would lead to incorrect treatment approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Osteogenesis imperfecta with defective collagen synthesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Osteogenesis imperfecta (OI)** is caused by defective type I collagen and presents with fractures, blue sclerae, and hearing loss. OI has **normal calcium, phosphorus, vitamin D, and alkaline phosphatase** (or mildly elevated ALP after fractures). The laboratory pattern here (low vitamin D, low phosphorus, high ALP, high PTH) is classic for **nutritional rickets**.", "consequence": "OI has completely different laboratory findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Non-accidental trauma causing multiple metaphyseal fractures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While metaphyseal fractures (**corner fractures** or **bucket-handle fractures**) are concerning for child abuse, the radiographic findings here are **metaphyseal cupping and fraying** (widened, irregular growth plates), which is specific to rickets. Additionally, the laboratory findings (low vitamin D, high ALP, high PTH) confirm a metabolic bone disease, not trauma.", "consequence": "Different radiographic pattern; labs confirm metabolic etiology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Rickets laboratory pattern**: Low 25-OH vitamin D \u2192 low Ca\u00b2\u207a absorption \u2192 **\u2191PTH** (secondary hyperparathyroidism) \u2192 phosphate wasting \u2192 **\u2193phosphorus** \u2192 defective mineralization \u2192 **\u2191alkaline phosphatase** (osteoblast activity). Remember: ALP is the most sensitive marker of disease activity, and phosphorus is often more affected than calcium (PTH maintains serum Ca by bone resorption)."}, "node-2": {"id": "node-2", "type": "decision", "content": "The diagnosis of **nutritional vitamin D deficiency rickets** is confirmed.\n\nThe child is clinically stable with no signs of hypocalcemia (no tetany, seizures, or laryngospasm). She has significant skeletal deformities (genu varum) but no fractures.\n\nYou plan to initiate treatment.", "question": "What is the most appropriate treatment regimen for this child with symptomatic rickets?", "choices": [{"id": "node-2-choice-a", "text": "High-dose vitamin D (2000-4000 IU/day) for 8-12 weeks, then maintenance 600 IU/day; ensure adequate calcium intake", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **High-dose vitamin D therapy** is needed to replete stores and heal rickets. For children 1-12 years with symptomatic rickets: **2000-4000 IU/day** (or 50,000 IU weekly) for **8-12 weeks** until labs normalize and radiographic healing occurs. Then transition to **maintenance dose (600 IU/day for 1-18 years)**. Adequate **calcium intake** (500-1000 mg/day for toddlers) is essential - vitamin D without calcium won't heal rickets. Follow 25-OH vitamin D levels to confirm repletion.", "consequence": "Appropriate treatment initiated with monitoring plan.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Standard prophylactic dose vitamin D (400 IU/day)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **400 IU/day is the preventive dose** for healthy infants to prevent deficiency, not the treatment dose for established rickets. This child has **severe deficiency (8 ng/mL)** and symptomatic bone disease. She needs high-dose therapy to replete stores; 400 IU/day would take months to years to normalize vitamin D levels and would not adequately heal active rickets.", "consequence": "Inadequate dose; rickets will not heal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Calcitriol (1,25-dihydroxyvitamin D) monotherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Calcitriol (1,25-OH\u2082 vitamin D)** is the active form but has a very short half-life and narrow therapeutic window. For **nutritional vitamin D deficiency**, treatment should be with **cholecalciferol (vitamin D3)** or **ergocalciferol (vitamin D2)**, which are stored in the body and converted to active form as needed. Calcitriol is reserved for conditions with impaired 1-alpha hydroxylation (renal failure, vitamin D-dependent rickets type 1).", "consequence": "Wrong form of vitamin D; risk of hypercalcemia without addressing deficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Phosphate supplementation alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In **nutritional rickets**, the hypophosphatemia is **secondary** to vitamin D deficiency and PTH elevation (PTH causes renal phosphate wasting). Treating with vitamin D corrects the cascade: \u2191vitamin D \u2192 \u2191Ca absorption \u2192 \u2193PTH \u2192 \u2193phosphate wasting \u2192 \u2191serum phosphorus. Phosphate supplementation without vitamin D would be treating the symptom, not the cause.", "consequence": "Does not address the underlying vitamin D deficiency.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Increase sun exposure only; no supplementation needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **sun exposure** can help prevent vitamin D deficiency, it is **not reliable treatment** for established rickets, especially in this family with limited sun exposure and in a child with severe deficiency. Variables like latitude, skin pigmentation, season, and sunscreen use make sun exposure unpredictable. This child needs **definitive treatment** with high-dose vitamin D supplementation.", "consequence": "Unreliable; delays treatment of severe deficiency.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Treatment doses** for rickets are much higher than **preventive doses**. Prevention: 400 IU/day (infants), 600 IU/day (children). Treatment: 2000-4000 IU/day for 8-12 weeks. Alternative: **Stoss therapy** (single high dose 100,000-600,000 IU) for compliance concerns. Always ensure adequate **calcium intake** - vitamin D enhances absorption but can't help if calcium isn't present in the diet."}, "node-3": {"id": "node-3", "type": "decision", "content": "You initiate vitamin D 3000 IU/day and recommend dietary calcium (milk, cheese, fortified foods) aiming for 700-1000 mg/day.\n\nThe family asks about monitoring and expected improvements.", "question": "What is the appropriate monitoring plan and expected timeline for improvement?", "choices": [{"id": "node-3-choice-a", "text": "Recheck labs in 4-6 weeks; expect ALP to decrease first, then 25-OH vitamin D to normalize; radiographic healing in 3-6 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Monitoring timeline**: (1) Recheck labs at **4-6 weeks** - expect **alkaline phosphatase** to decrease first (reflects reduced osteoblast hyperactivity) and **25-OH vitamin D** to rise; (2) **PTH** normalizes as calcium improves; (3) **Radiographic healing** (resolution of metaphyseal changes) occurs over **3-6 months**; (4) **Skeletal deformities** (genu varum) may improve spontaneously with growth, or may need orthopedic follow-up if severe. Continue high-dose until labs normalize, then switch to maintenance.", "consequence": "Family understands monitoring and realistic expectations.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "No monitoring needed; rickets always resolves with vitamin D", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Monitoring is essential** to confirm treatment response, assess for vitamin D toxicity (hypercalcemia, hypercalciuria), and determine when to transition to maintenance dosing. Additionally, if improvement doesn't occur as expected, alternative diagnoses (genetic rickets, malabsorption, renal disease) must be considered.", "consequence": "Misses treatment failures and potential complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Repeat X-rays weekly to monitor bone healing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Radiographic healing is slow** (3-6 months) and weekly X-rays provide no useful information while exposing the child to unnecessary radiation. **Laboratory monitoring** (ALP, calcium, phosphorus, 25-OH vitamin D) at 4-6 week intervals is the appropriate way to track response. X-rays are repeated only once, at 3-6 months, to confirm healing.", "consequence": "Unnecessary radiation; labs are the appropriate monitoring tool.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Check 1,25-dihydroxyvitamin D levels to monitor treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **1,25-OH\u2082 vitamin D (calcitriol)** levels are tightly regulated by PTH and don't reflect body stores - they can be normal or even elevated in vitamin D deficiency (due to compensatory PTH elevation). **25-hydroxyvitamin D** is the correct test to assess vitamin D status and repletion. The 1,25-OH\u2082 level is only useful for diagnosing 1-alpha hydroxylase deficiency (VDDR type 1).", "consequence": "Wrong test; 25-OH is the storage form to monitor.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Bowing will require surgical correction; refer to orthopedics for osteotomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Skeletal deformities often improve** with treatment and continued growth, especially in young children. **Genu varum** (bowing) typically corrects spontaneously once rickets heals. Orthopedic referral for potential osteotomy is only considered for **severe, persistent deformities** that don't improve after 2+ years of adequate treatment and growth.", "consequence": "Premature; most deformities correct with treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Sequence of improvement**: (1) **Clinical symptoms** improve first (irritability, hypotonia); (2) **Biochemical markers** normalize over 4-8 weeks (ALP decreases, phosphorus increases, PTH normalizes); (3) **Radiographic healing** takes 3-6 months; (4) **Skeletal deformities** may take years to fully correct with growth. Monitor **urine calcium/creatinine ratio** if concerned about vitamin D toxicity (hypercalciuria precedes hypercalcemia)."}, "node-4": {"id": "node-4", "type": "decision", "content": "At 8-week follow-up:\n- 25-OH vitamin D: 42 ng/mL (was 8 ng/mL) - normalized\n- Alkaline phosphatase: 380 U/L (was 850 U/L) - significantly improved\n- Calcium: 9.8 mg/dL - normal\n- Phosphorus: 4.5 mg/dL (was 2.1) - normalized\n- PTH: 45 pg/mL (was 180) - normalizing\n\nThe child is walking now (developmental catch-up) and appears more active.\n\nThe family asks how to prevent this from happening in future children.", "question": "What is the key prevention message for this family and all breastfed infants?", "choices": [{"id": "node-4-choice-a", "text": "ALL breastfed infants should receive vitamin D 400 IU/day starting in the first few days of life", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **AAP recommends 400 IU/day vitamin D** for ALL breastfed and partially breastfed infants starting **within the first few days of life**. Breast milk contains very little vitamin D (**<25 IU/L**), regardless of maternal status. Formula-fed infants receiving >32 oz/day of fortified formula usually get adequate vitamin D, but if intake is less, they also need supplementation. This simple intervention completely prevents nutritional rickets.", "consequence": "Family understands prevention for future children.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Breastfeeding should be avoided; use formula instead", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Breastfeeding has enormous benefits** and should not be discouraged due to rickets risk. The solution is simple **vitamin D supplementation**, not formula substitution. The benefits of breastfeeding (immunologic, nutritional, bonding) far outweigh the minor inconvenience of daily vitamin D drops.", "consequence": "Harmful advice that discourages beneficial breastfeeding.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Maternal vitamin D supplementation during breastfeeding is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Standard maternal vitamin D doses do **not significantly increase breast milk vitamin D content**. Even with maternal supplementation, breast milk remains a poor vitamin D source. Some studies suggest very high-dose maternal supplementation (4000-6400 IU/day) can provide adequate infant levels, but this is not standard practice. **Direct infant supplementation (400 IU/day)** is the reliable, evidence-based approach.", "consequence": "May give false reassurance; infant supplementation is the standard.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Vitamin D supplementation is only needed for dark-skinned infants", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **dark skin pigmentation** reduces vitamin D synthesis from sunlight and increases deficiency risk, **ALL breastfed infants** need supplementation regardless of skin color. Other risk factors (limited sun exposure, northern latitudes, winter months, maternal deficiency) affect all populations. The AAP recommendation is universal, not race-specific.", "consequence": "Dangerous advice; all breastfed infants need supplementation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Wait until 6 months of age to start vitamin D supplementation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Vitamin D supplementation should start **within the first few days of life**, not at 6 months. Infants are born with limited vitamin D stores (depending on maternal status), and exclusive breastfeeding without supplementation leads to progressive deficiency. Waiting 6 months allows significant depletion to occur before prevention begins.", "consequence": "6-month delay allows deficiency to develop.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Risk factors for vitamin D deficiency rickets**: (1) **Exclusive breastfeeding** without supplementation (most common cause today); (2) **Dark skin pigmentation**; (3) **Limited sun exposure** (indoor lifestyle, northern latitudes, full-body covering); (4) **Maternal deficiency** during pregnancy; (5) **Malabsorption** (celiac, CF, biliary disease). Prevention is simple: **400 IU/day for all breastfed infants** from birth."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **nutritional vitamin D deficiency rickets** through the classic presentation (breastfed infant, no vitamin D supplementation, skeletal deformities) and laboratory pattern (low 25-OH vitamin D, low phosphorus, high ALP, high PTH). You understood the pathophysiology of secondary hyperparathyroidism, initiated appropriate high-dose vitamin D therapy with calcium, established a monitoring plan, and provided essential prevention counseling (400 IU/day for all breastfed infants). This comprehensive approach treats the current disease and prevents recurrence."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key rickets concepts: (1) **Laboratory pattern**: \u219325-OH vitamin D, \u2193phosphorus, \u2191ALP, \u2191PTH (secondary hyperparathyroidism); (2) **X-ray findings**: metaphyseal cupping/fraying ('paintbrush'), widened growth plates, osteopenia; (3) **Treatment**: high-dose vitamin D (2000-4000 IU/day \u00d7 8-12 weeks), then maintenance + adequate calcium; (4) **Prevention**: 400 IU/day vitamin D for ALL breastfed infants from birth."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Nutritional rickets remains common despite being entirely preventable. **Etiology**: breast milk contains insufficient vitamin D (<25 IU/L). **Risk factors**: exclusive breastfeeding without supplementation, dark skin, limited sun exposure. **Diagnosis**: clinical findings (bowing, rachitic rosary, frontal bossing) + labs (low vitamin D, low phosphorus, high ALP, high PTH) + X-ray (metaphyseal changes). **Treatment**: high-dose vitamin D + calcium. **Prevention**: 400 IU/day for all breastfed infants starting at birth."}}, "rootNodeId": "node-1"}], "cardiology": [{"id": "vignette-lens-peds-003", "title": "Kawasaki Disease", "domain": "cardiology", "difficulty": "intermediate", "tags": ["CRASH and Burn", "strawberry tongue", "desquamation of fingers/toes", "conjunctival injection without exudate", "kawasaki disease"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-year-old male is brought in by his parents for persistent high fever for 6 days.\n\nHistory reveals, he has been irritable and refusing to eat. His eyes have been red without discharge, and his lips are cracked and bleeding.\n\nReview of systems is positive for he developed a diffuse red rash on his trunk 2 days ago and his hands and feet appear swollen and negative for cough, rhinorrhea, or diarrhea.\n\nPertinent history includes He attends daycare but no sick contacts are known.\n\nPhysical Examination:\n- General: irritable, ill-appearing child with fever of 39.5\u00b0C.\n- Vitals: high fever.\n- Labs: CBC: Plt 450k; LFTs: ALT elevated; ESR 40; CRP 3 mg/dL.\n- Eyes: bilateral conjunctival injection without exudate.\n- Oropharynx: erythematous, cracked lips and strawberry tongue.\n- Neck: single enlarged right anterior cervical lymph node (2 cm).\n- Skin: polymorphous maculopapular rash on trunk.\n- Extremities: edema and erythema of hands and feet.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child has had fever for 6 days with multiple systemic findings. You need to determine if this meets criteria for a specific diagnosis.", "question": "How many of the classic Kawasaki disease criteria does this patient meet?", "choices": [{"id": "node-1-choice-a", "text": "5 criteria (complete Kawasaki): fever \u22655 days + conjunctivitis + rash + oral changes + extremity changes + lymphadenopathy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This patient has all 5 classic criteria: (1) Bilateral conjunctival injection without exudate, (2) Polymorphous rash, (3) Oral changes (cracked lips, strawberry tongue), (4) Extremity changes (edema/erythema of hands/feet), (5) Cervical lymphadenopathy. With fever \u22655 days, this is complete Kawasaki disease.", "consequence": "Complete Kawasaki disease criteria met. Proceed to confirm diagnosis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "3-4 criteria (incomplete Kawasaki) - need additional workup", "isOptimal": false, "isAcceptable": true, "feedback": "This patient actually has all 5 classic criteria present. Incomplete Kawasaki (fever + 2-3 criteria) would require additional lab/echo workup to support diagnosis. Count again: conjunctivitis, rash, oral changes, extremity changes, lymphadenopathy.", "consequence": "Re-evaluate the clinical findings.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "This is viral exanthem - does not meet Kawasaki criteria", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Viral exanthems do not typically cause the constellation of conjunctivitis WITHOUT exudate, strawberry tongue, extremity edema, and unilateral lymphadenopathy seen here. This pattern is classic for Kawasaki disease.", "consequence": "Misdiagnosis may lead to coronary artery complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "This is scarlet fever based on the rash and strawberry tongue", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While scarlet fever also has strawberry tongue, it presents with a characteristic 'sandpaper' rash, circumoral pallor, and follows streptococcal pharyngitis. The conjunctivitis and extremity edema/erythema here point to Kawasaki disease.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Need more time - reassess after 10 days of fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Waiting is dangerous - IVIG must be given within 10 days of fever onset to prevent coronary artery aneurysms. This patient already has 6 days of fever and meets full criteria.", "consequence": "Delayed treatment increases coronary aneurysm risk.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "CRASH and Burn: Conjunctivitis (bilateral, non-exudative), Rash (polymorphous), Adenopathy (cervical, usually unilateral >1.5cm), Strawberry tongue/lip changes, Hand/foot changes \u2014 plus fever \u22655 days (BURN)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Laboratory findings confirm inflammatory markers:\n- Platelets: 580,000 (thrombocytosis - characteristic)\n- ESR: 65 mm/hr (elevated)\n- CRP: 8.5 mg/dL (elevated)\n- ALT: 85 U/L (elevated - hepatic involvement)\n- Urinalysis: Sterile pyuria (WBC in urine without bacteria)\n- Albumin: 2.8 g/dL (low)", "question": "Based on these findings, what is the most likely diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Kawasaki disease", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The clinical criteria plus supportive labs (thrombocytosis, elevated inflammatory markers, sterile pyuria, elevated transaminases, hypoalbuminemia) confirm Kawasaki disease. Thrombocytosis typically appears in week 2 and is virtually diagnostic.", "consequence": "Diagnosis confirmed. Proceed to initial treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Toxic shock syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TSS presents with hypotension, diffuse erythroderma with desquamation, and multi-organ involvement. This patient is hemodynamically stable and has the classic Kawasaki pattern without the TSS shock picture.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Juvenile idiopathic arthritis (systemic onset)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Systemic JIA has quotidian (daily spiking) fevers, salmon-colored evanescent rash, and arthritis. The conjunctivitis, strawberry tongue, and extremity edema here are classic for Kawasaki, not JIA.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Measles", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Measles presents with the 3 C's (cough, coryza, conjunctivitis), Koplik spots (pathognomonic), and a cephalocaudal morbilliform rash. This patient lacks respiratory symptoms and has extremity changes not seen in measles.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Stevens-Johnson syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SJS involves mucosal erosions, skin detachment, and is typically triggered by medications. The thrombocytosis and specific pattern here (extremity edema, lymphadenopathy) indicate Kawasaki disease.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Kawasaki lab findings: Thrombocytosis (week 2, highly suggestive), elevated ESR/CRP, sterile pyuria, elevated ALT, low albumin. Anemia of inflammation is also common."}, "node-3": {"id": "node-3", "type": "decision", "content": "The diagnosis of Kawasaki disease is confirmed on day 6 of fever. You have 4 days remaining in the critical treatment window.", "question": "What is the most appropriate initial treatment?", "choices": [{"id": "node-3-choice-a", "text": "IVIG 2 g/kg single infusion + high-dose aspirin (80-100 mg/kg/day divided q6h)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! IVIG 2 g/kg given as a single infusion over 10-12 hours plus high-dose aspirin is the standard treatment. Treatment within 10 days of fever onset reduces coronary aneurysm risk from 25% to <5%.", "consequence": "Treatment initiated. Patient will be monitored for response.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Aspirin alone (high-dose) without IVIG", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Aspirin alone does not adequately prevent coronary artery aneurysms. IVIG is essential - it reduces aneurysm risk from 25% to <5%. Aspirin alone is insufficient.", "consequence": "Increased risk of coronary complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Corticosteroids as first-line therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Corticosteroids are reserved for IVIG-refractory cases (fever persisting >36 hours after IVIG). First-line treatment is IVIG + aspirin.", "consequence": "Non-standard treatment may not prevent complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Wait for echocardiogram results before starting treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Do NOT delay treatment for echo - time is critical. Baseline echo should be obtained but treatment should begin immediately once Kawasaki is diagnosed. Every day of delay increases aneurysm risk.", "consequence": "Treatment delay increases coronary risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Low-dose aspirin (3-5 mg/kg/day) + IVIG", "isOptimal": false, "isAcceptable": true, "feedback": "Close, but initial aspirin should be HIGH-dose (80-100 mg/kg/day) for anti-inflammatory effect during the acute phase. Low-dose aspirin (3-5 mg/kg/day) is used AFTER fever resolves for antiplatelet effect.", "consequence": "Suboptimal dosing but IVIG is appropriate.", "nextNodeId": "node-4"}], "clinicalPearl": "Treatment timing is CRITICAL: IVIG within 10 days of fever onset reduces coronary aneurysm risk from 25% to <5%. High-dose aspirin (anti-inflammatory) transitions to low-dose (antiplatelet) after fever resolves."}, "node-4": {"id": "node-4", "type": "decision", "content": "IVIG infusion completed. Baseline echocardiogram shows:\n- Normal coronary arteries (no dilation or aneurysm)\n- Normal LV function\n- No pericardial effusion\n\n36 hours after IVIG, the patient's fever has resolved and he is clinically improved.", "question": "What is the next step in management?", "choices": [{"id": "node-4-choice-a", "text": "Transition to low-dose aspirin (3-5 mg/kg/day); repeat echo at 2 weeks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Once fever resolves after IVIG, transition from high-dose to low-dose aspirin for antiplatelet effect. Continue low-dose aspirin for 6-8 weeks if echo remains normal. Follow-up echo at 2 weeks and 6-8 weeks.", "consequence": "Appropriate transition. Patient scheduled for follow-up.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Give second dose of IVIG since echo was normal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A second IVIG dose is only indicated for IVIG-refractory disease (persistent fever >36h after first dose). This patient responded - fever resolved. Additional IVIG is not needed.", "consequence": "Unnecessary treatment and cost.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Stop all treatment - echo is normal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Even with normal baseline echo, patients need continued low-dose aspirin for 6-8 weeks and follow-up echos. Coronary changes can develop after the acute phase.", "consequence": "Premature treatment discontinuation risks complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Continue high-dose aspirin for 6 more weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. High-dose aspirin increases bleeding risk and Reye syndrome risk. Once fever resolves, transition to low-dose aspirin for antiplatelet effect only.", "consequence": "Increased risk of aspirin toxicity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Add infliximab to the regimen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Infliximab is reserved for IVIG-refractory cases. This patient responded to first-line therapy. Adding biologics unnecessarily increases infection risk and cost.", "consequence": "Unnecessary escalation of therapy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "IVIG response: Fever should resolve within 36 hours. If fever persists >36h \u2192 IVIG-refractory \u2192 consider repeat IVIG, infliximab, or corticosteroids."}, "node-5": {"id": "node-5", "type": "decision", "content": "At the 6-week follow-up visit, repeat echocardiogram shows:\n- Coronary arteries remain normal\n- No aneurysms detected\n- Normal cardiac function\n\nThe patient has been well with no recurrence of symptoms.", "question": "What is the appropriate long-term management plan?", "choices": [{"id": "node-5-choice-a", "text": "Discontinue aspirin; no long-term cardiac restrictions; routine pediatric follow-up", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With normal echo at 6-8 weeks and no coronary involvement, aspirin can be discontinued and the child has no long-term cardiac restrictions. Risk of late coronary artery disease is essentially the same as the general population.", "consequence": "Excellent outcome. Patient discharged from cardiology follow-up.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Continue lifelong aspirin and annual echocardiograms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Lifelong aspirin and monitoring is only needed for patients who developed coronary aneurysms. With persistently normal echos, there is no indication for continued aspirin or cardiac surveillance.", "consequence": "Unnecessary long-term medication and monitoring.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Refer to cardiothoracic surgery for prophylactic coronary intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Surgical intervention is never indicated for Kawasaki patients with normal coronary arteries. Surgery is reserved for patients with giant aneurysms or coronary stenosis causing ischemia.", "consequence": "Inappropriate surgical referral.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Continue low-dose aspirin for 1 year regardless of echo findings", "isOptimal": false, "isAcceptable": true, "feedback": "Some practitioners do extend aspirin to 6-12 months, but current guidelines recommend discontinuing at 6-8 weeks if echos remain normal. Longer duration is not evidence-based for patients without coronary involvement.", "consequence": "Slightly prolonged treatment but not harmful.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-e", "text": "Exercise restriction and no contact sports for life", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Activity restrictions are only for patients with coronary aneurysms (due to thrombosis/rupture risk). Children with normal coronary arteries have no restrictions and can participate in all activities.", "consequence": "Unnecessary activity restrictions affecting quality of life.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Long-term outcomes depend on coronary involvement: No aneurysms = excellent prognosis, no restrictions. Small/medium aneurysms = aspirin, possible regression. Giant aneurysms (>8mm) = lifelong anticoagulation, activity restrictions, possible intervention."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified Kawasaki disease, initiated timely IVIG + aspirin treatment, monitored response appropriately, and provided correct long-term guidance.\n\nKey learning points:\n\u2022 Diagnosis: Fever \u22655 days + \u22654 of 5 criteria (CRASH and Burn)\n\u2022 Labs: Thrombocytosis (week 2), elevated ESR/CRP, sterile pyuria, elevated ALT\n\u2022 Treatment: IVIG 2g/kg + high-dose aspirin within 10 days of fever\n\u2022 Transition: High-dose \u2192 low-dose aspirin when fever resolves\n\u2022 Follow-up: Echo at diagnosis, 2 weeks, 6-8 weeks\n\u2022 Prognosis: Excellent if treated early; normal echo at 6-8 weeks = no restrictions\n\nKawasaki disease is the #1 cause of acquired heart disease in children in developed countries. Early treatment prevents coronary aneurysms."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of Kawasaki disease:\n\n\u2022 CRASH and Burn mnemonic: Conjunctivitis (non-exudative), Rash, Adenopathy (cervical), Strawberry tongue, Hand/foot changes + Fever \u22655 days\n\u2022 Treatment window: IVIG within 10 days reduces aneurysm risk from 25% to <5%\n\u2022 Aspirin phases: High-dose (acute, anti-inflammatory) \u2192 Low-dose (convalescent, antiplatelet)\n\u2022 Echo schedule: Baseline, 2 weeks, 6-8 weeks\n\u2022 IVIG-refractory: Fever >36h after IVIG \u2192 repeat IVIG or add infliximab/steroids"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Poor outcome due to delayed or inappropriate management.\n\nCritical points:\n\u2022 NEVER delay treatment waiting for echo - time is critical\n\u2022 IVIG is essential - aspirin alone does not prevent aneurysms\n\u2022 Treat within 10 days of fever onset\n\u2022 Untreated Kawasaki: 25% develop coronary aneurysms\n\u2022 Coronary aneurysms can lead to thrombosis, stenosis, MI, death\n\nKawasaki disease is the #1 cause of acquired heart disease in children in developed countries. Early recognition and treatment saves lives."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-008", "title": "VSD Hemodynamics", "domain": "cardiology", "difficulty": "intermediate", "tags": ["vsd hemodynamics"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-week-old female is brought to the emergency department for poor weight gain and heart murmur that began 2 weeks ago.\n\nThe patient's mother reports, she has been gaining weight slowly and tires easily during feeding. She breathes fast and sweats while eating. A heart murmur was heard at her 2-week check-up.\n\nReview of systems is positive for tachypnea and diaphoresis with feeds and negative for cyanosis or blue spells.\n\nPertinent history includes She was born full-term. Prenatal ultrasounds were normal.\n\nPhysical Examination:\n- Cardiovascular: loud, harsh holosystolic murmur best heard at left lower sternal border with thrill.\n- General: tachypneic infant with mild subcostal retractions.\n- Vitals: tachypnea, cyanosis.\n- Growth: falling off growth curve.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This infant has a holosystolic murmur at the left lower sternal border with heart failure symptoms (tachypnea, diaphoresis, failure to thrive). You need to identify the murmur type.", "question": "What characteristic of this murmur is most consistent with a ventricular septal defect (VSD)?", "choices": [{"id": "node-1-choice-a", "text": "Harsh holosystolic murmur at LLSB with palpable thrill", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! VSD produces a **harsh holosystolic (pansystolic) murmur** heard best at the **left lower sternal border (LLSB)**. The murmur is present throughout systole because there is continuous flow through the defect whenever the ventricles contract. A **palpable thrill** indicates high-velocity turbulent flow.", "consequence": "You correctly identify the VSD murmur characteristics.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Continuous machinery murmur at left infraclavicular area", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **continuous machinery murmur** at the left infraclavicular area is characteristic of **patent ductus arteriosus (PDA)**, not VSD. The PDA murmur is continuous because flow occurs throughout the cardiac cycle, while VSD produces only a systolic murmur.", "consequence": "You consider PDA but the murmur location and character differ.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Fixed split S2 with systolic ejection murmur at RUSB", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fixed split S2** with a systolic ejection murmur at the right upper sternal border is characteristic of **atrial septal defect (ASD)**. The fixed split occurs because the ASD equalizes atrial pressures, eliminating respiratory variation.", "consequence": "You consider ASD but the murmur is holosystolic, not ejection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Harsh crescendo-decrescendo murmur radiating to carotids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **crescendo-decrescendo (ejection) murmur** radiating to the carotids is characteristic of **aortic stenosis**. VSD produces a holosystolic (constant intensity throughout systole) murmur, not an ejection pattern.", "consequence": "You consider aortic stenosis but the timing is different.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Soft systolic murmur that disappears with position change", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A soft murmur that changes with position suggests an **innocent (functional) murmur** like Still's murmur. This infant has heart failure symptoms, making a hemodynamically significant lesion much more likely.", "consequence": "You consider innocent murmur but the clinical picture doesn't fit.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**VSD murmur paradox**: **Louder murmur = smaller defect** (more turbulence through restrictive opening). **Large VSDs** may have soft murmurs because there's less pressure gradient. Small restrictive VSDs are loud but hemodynamically insignificant."}, "node-2": {"id": "node-2", "type": "decision", "content": "Echocardiogram confirms a moderate perimembranous VSD with left-to-right shunt. Qp:Qs ratio is 2.5:1, indicating significant pulmonary overcirculation. There is LA and LV dilation.", "question": "Based on the echocardiogram findings, what determines whether this VSD needs surgical intervention?", "choices": [{"id": "node-2-choice-a", "text": "Symptoms of heart failure and/or Qp:Qs ratio >2:1 with chamber dilation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Indications for VSD repair include: **symptomatic heart failure** (as in this case), **Qp:Qs ratio >2:1** indicating significant left-to-right shunt, **chamber dilation** (LA/LV), and failure to thrive. Small restrictive VSDs without these findings can be observed as many close spontaneously.", "consequence": "You understand the surgical indications.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "All VSDs require immediate surgical closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Not all VSDs require surgery. **Small muscular VSDs** have up to 80% spontaneous closure rate in the first 2 years. Only hemodynamically significant VSDs (symptoms, large shunt, failure to thrive) need intervention.", "consequence": "You may recommend unnecessary surgery.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Murmur loudness determines need for surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Remember the **paradox**: loud murmurs often indicate **small, restrictive** VSDs that are hemodynamically insignificant. Large VSDs can have soft murmurs. Hemodynamic significance (shunt ratio, symptoms) determines surgical need.", "consequence": "You may misinterpret the severity based on murmur.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Location of the VSD (perimembranous vs muscular) alone", "isOptimal": false, "isAcceptable": false, "feedback": "Location affects **spontaneous closure likelihood** (muscular VSDs close more often than perimembranous) and surgical approach, but the decision to operate depends on **hemodynamic significance**, not location alone.", "consequence": "You focus on anatomy but miss hemodynamic assessment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Presence of any left-to-right shunt on echo", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A left-to-right shunt confirms the VSD exists, but many small VSDs with trivial shunts need no intervention. The **magnitude** of the shunt (Qp:Qs ratio) and its consequences (symptoms, chamber dilation) determine management.", "consequence": "You may over-treat small, insignificant VSDs.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**VSD natural history**: Small muscular VSDs: ~80% close spontaneously by age 2. Perimembranous VSDs: ~40% close spontaneously. Large VSDs rarely close and need early intervention to prevent **Eisenmenger syndrome** (irreversible pulmonary hypertension)."}, "node-3": {"id": "node-3", "type": "decision", "content": "This infant has a hemodynamically significant VSD with heart failure symptoms. Medical management is initiated while awaiting surgical repair.", "question": "What is the appropriate medical management for heart failure from a large VSD while awaiting surgery?", "choices": [{"id": "node-3-choice-a", "text": "Diuretics (furosemide), increase caloric density of feeds, consider ACE inhibitor", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Medical management includes: **Diuretics** (furosemide) to reduce pulmonary congestion, **calorie-dense feeds** (24-30 cal/oz) to promote growth despite increased metabolic demands, and **ACE inhibitors** (captopril/enalapril) to reduce afterload. These bridge to surgical repair.", "consequence": "You initiate appropriate medical therapy.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Beta-blockers to slow heart rate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Beta-blockers** are not standard for VSD heart failure. They are used for SVT, hypertrophic cardiomyopathy, or Tetralogy of Fallot (to prevent tet spells). Diuretics and afterload reduction are the mainstays for VSD-related heart failure.", "consequence": "Inappropriate medication choice.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Fluid restriction alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fluid restriction** alone is insufficient and dangerous in infants with failure to thrive. These infants need **adequate calories** for growth. The approach is diuretics + concentrated feeds, not fluid restriction.", "consequence": "Worsening malnutrition and growth failure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Prostaglandin E1 infusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **PGE1** is for **ductal-dependent lesions** (critical coarctation, TGA, pulmonary atresia) to keep the ductus arteriosus open. In VSD, PGE1 would worsen the situation by increasing pulmonary blood flow. Never use PGE1 for left-to-right shunt lesions.", "consequence": "PGE1 worsens pulmonary overcirculation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Supplemental oxygen to improve saturations", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Oxygen is a pulmonary vasodilator** - it can worsen left-to-right shunting in VSD by decreasing pulmonary vascular resistance. This infant is not cyanotic (the shunt is left-to-right). Oxygen would increase pulmonary blood flow.", "consequence": "Oxygen worsens the shunt.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**VSD medical management**: Diuretics (furosemide \u00b1 spironolactone), concentrated feeds (24-30 cal/oz), ACE inhibitors for afterload reduction. **Avoid oxygen** in left-to-right shunts - it decreases PVR and worsens pulmonary overcirculation!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified the VSD by its holosystolic murmur at the LLSB, understood the hemodynamic significance indicated by the Qp:Qs ratio and chamber dilation, and initiated appropriate medical management. The infant was stabilized on diuretics and concentrated feeds, then underwent successful VSD repair at 3 months of age with excellent outcome."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key VSD pearls: **Holosystolic murmur at LLSB** is classic. **Louder murmur = smaller defect** (paradox). Surgical indications: symptoms, Qp:Qs >2:1, chamber dilation, failure to thrive. Medical therapy: diuretics + concentrated feeds + ACE inhibitor."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. Never give **PGE1** for VSD - it worsens left-to-right shunt. **Oxygen** also worsens L\u2192R shunts by decreasing PVR. Don't restrict fluids in failing-to-thrive infants - they need MORE calories (concentrated feeds), not less fluid."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-022", "title": "Tetralogy of Fallot - Tet Spell", "domain": "cardiology", "difficulty": "intermediate", "tags": ["5 T's of cyanotic CHD", "boot-shaped heart", "squatting", "tet spell", "cyanosis with agitation"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 4-month-old male presents with blue spell during crying for 10 minutes.\n\nAccording to the caregiver, during feeding, he started crying and suddenly became deeply blue and went limp. His mother instinctively held him with his knees to his chest and he gradually improved.\n\nAssociated symptoms include cyanosis that worsens with agitation. Denies fever or seizure activity.\n\nPast medical history includes He was diagnosed with tetralogy of Fallot at birth by echocardiogram. He is awaiting surgical repair.\n\nPhysical Examination:\n- General: cyanotic infant, currently calm with knees flexed to chest.\n- Vitals: SpO2 70%.\n- Labs: CBC: Hgb elevated (polycythemia).\n- Cardiovascular: harsh systolic murmur at left upper sternal border (diminished during spell).\n- Oxygen saturation: 70% during spell, improved to 85% with knee-to-chest positioning.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This infant with known Tetralogy of Fallot presents with sudden, severe cyanosis triggered by crying. The oxygen saturation is critically low at 70%.", "question": "What is the pathophysiologic mechanism causing this hypercyanotic ('tet') spell?", "choices": [{"id": "node-1-choice-a", "text": "Infundibular (RVOT) spasm causing increased right-to-left shunting", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! During a tet spell, **infundibular spasm** of the right ventricular outflow tract (RVOT) causes dynamic obstruction. This decreases pulmonary blood flow and increases **right-to-left shunting** across the VSD, resulting in profound cyanosis. Triggers include crying, feeding, defecation (Valsalva), fever, or dehydration.", "consequence": "You understand the mechanism and can target treatment appropriately.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Pulmonary embolism causing acute hypoxia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **pulmonary embolism** can cause acute hypoxia, it is extremely rare in infants. The classic presentation of a tet spell in a patient with known TOF points to dynamic RVOT obstruction, not PE.", "consequence": "You consider PE workup unnecessarily.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Acute heart failure from VSD volume overload", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In TOF, the VSD creates a **right-to-left shunt** due to RVOT obstruction, not left-to-right with volume overload. The VSD is **pressure-equalizing** - the obstruction determines shunt direction. This is a pressure-loaded, not volume-loaded, condition.", "consequence": "You misunderstand the hemodynamics of TOF.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Bronchospasm causing ventilation-perfusion mismatch", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bronchospasm can cause hypoxia, the sudden profound cyanosis during agitation in a TOF patient is classic for a **hypercyanotic spell**. Note that the murmur **decreases** during the spell (less flow across the RVOT), which would not occur with bronchospasm.", "consequence": "You consider respiratory causes but this is cardiac.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Decreased systemic vascular resistance causing shunt reversal", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. While **decreased SVR** can worsen right-to-left shunting by reducing the resistance the blood must overcome to go systemic, the primary mechanism is **infundibular spasm**. This is why treatment aims to both relax the RVOT and increase SVR.", "consequence": "You partially understand the mechanism.", "nextNodeId": "node-2"}], "clinicalPearl": "**TOF anatomy (4 features)**: 1) VSD (large, non-restrictive), 2) Overriding aorta, 3) RVOT obstruction (infundibular \u00b1 valvular), 4) RV hypertrophy. The degree of RVOT obstruction determines cyanosis severity. **'Pink tets'** have minimal obstruction."}, "node-2": {"id": "node-2", "type": "decision", "content": "The infant remains cyanotic with SpO2 70%. The mother is still holding him in knee-to-chest position. He appears distressed but is calmer than before.", "question": "What is the MOST important initial intervention for this hypercyanotic spell?", "choices": [{"id": "node-2-choice-a", "text": "Keep in knee-to-chest position and calm the infant", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **knee-to-chest** position is the critical first step. It **increases systemic vascular resistance (SVR)** by kinking the femoral arteries, which reduces right-to-left shunting and forces more blood through the pulmonary circuit. **Calming the infant** reduces catecholamine release which can worsen infundibular spasm.", "consequence": "SpO2 gradually improves to 80%. You continue supportive measures.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Immediate intubation and mechanical ventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as first step. While **airway protection** may eventually be needed for refractory spells, the stress of intubation can **worsen** the spell by increasing catecholamines. Try non-invasive measures first: positioning, sedation, and medications.", "consequence": "Intubation attempt worsens cyanosis from agitation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "High-flow oxygen at 100%", "isOptimal": false, "isAcceptable": true, "feedback": "Oxygen can be given but is **not the most important** intervention. Tet spells are a **right-to-left shunt** problem, not primarily an oxygenation problem. Even 100% FiO2 cannot oxygenate blood that bypasses the lungs. **Positioning and reducing shunt** is paramount.", "consequence": "Oxygen is provided but positioning is more critical.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "IV fluid bolus to treat dehydration", "isOptimal": false, "isAcceptable": true, "feedback": "IV fluids can help maintain preload, and dehydration can precipitate spells. However, **positioning and calming** should be done immediately while IV access is obtained. Fluid resuscitation alone does not address the RVOT spasm.", "consequence": "You obtain IV access but prioritize positioning.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Albuterol nebulizer for bronchospasm", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Beta-agonists are contraindicated** in tet spells. They can worsen infundibular spasm (beta stimulation of the RVOT) and decrease SVR (beta-2 vasodilation), both of which increase right-to-left shunting.", "consequence": "Albuterol worsens the spell dramatically.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Knee-to-chest = 'Squatting' for infants**. Older children with uncorrected TOF instinctively squat to increase SVR. This increases afterload, reduces R\u2192L shunt, and forces blood through the pulmonary circuit."}, "node-3": {"id": "node-3", "type": "decision", "content": "Despite knee-to-chest positioning and calming, the SpO2 remains at 75% after 5 minutes. IV access has been obtained.", "question": "What is the most appropriate next pharmacologic intervention?", "choices": [{"id": "node-3-choice-a", "text": "Morphine sulfate (0.1-0.2 mg/kg IV)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Morphine** is a key medication for refractory tet spells. It reduces anxiety and hyperpnea (breaking the crying/hyperventilation cycle), causes mild sedation, and may relax infundibular smooth muscle. This decreases the dynamic RVOT obstruction.", "consequence": "Morphine is administered and the infant becomes calmer.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Phenylephrine (5-20 mcg/kg IV bolus)", "isOptimal": false, "isAcceptable": true, "feedback": "**Phenylephrine** is an appropriate choice! It's a pure **alpha-agonist** that increases SVR without affecting heart rate. This increases afterload and reduces right-to-left shunting. Some institutions use this as first-line pharmacotherapy, especially for severe spells.", "consequence": "SVR increases and oxygenation improves.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Propranolol (0.1 mg/kg IV)", "isOptimal": false, "isAcceptable": true, "feedback": "**Propranolol** (beta-blocker) is effective as it relaxes the infundibular muscle and slows heart rate (more filling time). However, IV propranolol is typically reserved for refractory spells. **Oral propranolol** is used for prophylaxis of spells while awaiting surgery.", "consequence": "Beta-blockade helps relax the RVOT.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Epinephrine (0.01 mg/kg IV)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Epinephrine is contraindicated** in tet spells. Its beta-effects will worsen infundibular spasm and increase heart rate, both of which exacerbate the right-to-left shunt. Only use epinephrine if the patient is in cardiac arrest.", "consequence": "Catecholamine effect worsens the spell.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Sodium bicarbonate to treat acidosis", "isOptimal": false, "isAcceptable": true, "feedback": "Bicarbonate may be helpful for **severe metabolic acidosis** (pH <7.15) that can result from prolonged hypoxia. However, it does not address the underlying RVOT obstruction and should be used as adjunctive therapy, not as the primary intervention.", "consequence": "You check a blood gas and consider bicarbonate.", "nextNodeId": "node-4"}], "clinicalPearl": "**Tet spell medication sequence**: 1) Calm + position, 2) Oxygen, 3) **Morphine** (sedation + infundibular relaxation), 4) **Phenylephrine** (increase SVR), 5) **Propranolol IV** (beta-blockade), 6) Ketamine sedation, 7) Emergency surgery if refractory."}, "node-4": {"id": "node-4", "type": "decision", "content": "The infant's SpO2 improves to 88% after morphine and supportive care. The spell has broken. You discuss the case with the pediatric cardiologist.", "question": "What is the definitive management for recurrent tet spells?", "choices": [{"id": "node-4-choice-a", "text": "Surgical repair of Tetralogy of Fallot", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Complete surgical repair** is definitive. The repair involves closing the VSD with a patch and relieving the RVOT obstruction (infundibular resection \u00b1 transannular patch). This is typically done at **3-6 months of age** or earlier if spells occur. Tet spells are an indication for **expedited surgery**.", "consequence": "Surgery is scheduled urgently.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Long-term oral propranolol for prevention", "isOptimal": false, "isAcceptable": true, "feedback": "**Oral propranolol** is used as a **bridge to surgery** but is not definitive treatment. It helps prevent spells by relaxing the infundibulum and is started in patients awaiting surgical repair. However, a patient who has had a spell needs expedited surgical planning.", "consequence": "You start propranolol while arranging surgery.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Cardiac catheterization for balloon dilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Balloon dilation** is not standard treatment for TOF. The RVOT obstruction is typically muscular (infundibular) plus valvular, and dilation does not address the muscular component. Catheter-based intervention may be used for post-surgical stenosis.", "consequence": "Catheterization is not indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Observation and lifestyle modifications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Once a patient has had a **hypercyanotic spell**, they are at high risk for recurrence. Observation alone is dangerous - these spells can be fatal. Surgical repair should be expedited.", "consequence": "The patient has another spell at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Blalock-Taussig-Thomas (BTT) shunt as palliative procedure", "isOptimal": false, "isAcceptable": true, "feedback": "The **modified BTT shunt** (subclavian artery to pulmonary artery) is a palliative procedure that increases pulmonary blood flow. It may be considered in neonates too small for complete repair or with complex anatomy, but **complete repair** is preferred when feasible.", "consequence": "You discuss palliation vs. complete repair with cardiology.", "nextNodeId": "node-5"}], "clinicalPearl": "**Indications for urgent TOF repair**: Hypercyanotic spells, severe cyanosis (SpO2 <75%), failure to thrive, pulmonary atresia physiology. Most patients undergo elective repair at **3-6 months** before spells typically begin."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant is scheduled for surgical repair in 2 weeks. You need to counsel the family on perioperative management and long-term outcomes.", "question": "What is the most important anticipatory guidance for the family while awaiting surgery?", "choices": [{"id": "node-5-choice-a", "text": "Teach knee-to-chest positioning and recognize spell triggers", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Parents must be able to **recognize early signs** of a spell (irritability, deepening cyanosis, hyperpnea) and immediately position the infant in **knee-to-chest**. They should avoid triggers: keeping the infant calm, avoiding overheating, treating fever promptly, and ensuring adequate hydration.", "consequence": "The family is well-prepared for the waiting period.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Strict bed rest with minimal activity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While avoiding excessive agitation is important, **strict bed rest** is not necessary or practical in an infant. Normal feeding and gentle activity are fine. The key is avoiding triggers like excessive crying or overheating.", "consequence": "Impractical advice that may increase family anxiety.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Supplemental home oxygen at all times", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Chronic oxygen therapy** is not standard for TOF patients. The cyanosis is from right-to-left shunting, not a lung problem. Oxygen won't significantly improve SpO2 at baseline. It may be used briefly during spells but is not needed continuously.", "consequence": "Unnecessary intervention with potential costs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Daily aspirin for anticoagulation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Routine **anticoagulation** is not indicated preoperatively for TOF. While polycythemia increases blood viscosity, aspirin is not standard. Adequate hydration is more important to prevent hyperviscosity complications.", "consequence": "Unnecessary medication with bleeding risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Avoid all vaccinations until after surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Vaccinations should continue on schedule unless specifically contraindicated. The surgical team may advise avoiding live vaccines close to surgery due to immunomodulation, but routine vaccines are not contraindicated.", "consequence": "Delayed immunizations put the infant at risk.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Long-term outcomes post-TOF repair**: Most patients have excellent outcomes with >90% survival at 20 years. They need **lifelong cardiology follow-up** for: pulmonary regurgitation (may need valve replacement), arrhythmias (right bundle branch block is common), residual defects, and exercise restrictions."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified the hypercyanotic spell, understood the pathophysiology of dynamic RVOT obstruction, and initiated appropriate stepwise treatment: knee-to-chest positioning, calming, and morphine. You recognized that surgical repair is definitive and provided appropriate anticipatory guidance. The infant underwent successful complete repair and is doing well at follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points: TOF tet spells result from **infundibular spasm** causing increased R\u2192L shunting. Treatment: 1) **Knee-to-chest** (increase SVR), 2) **Calm the infant**, 3) **Morphine** (sedation, infundibular relaxation), 4) **Phenylephrine** (increase SVR), 5) **Propranolol** (beta-blockade). AVOID beta-agonists and epinephrine! **Surgical repair** is definitive."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors: Beta-agonists (albuterol) and catecholamines (epinephrine) are **contraindicated** - they worsen infundibular spasm. Tet spells are cardiac emergencies requiring immediate positioning and pharmacologic intervention. Untreated or worsening spells can lead to seizures, stroke, or death."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-023", "title": "Coarctation of the Aorta", "domain": "cardiology", "difficulty": "advanced", "tags": ["upper extremity hypertension", "weak femoral pulses", "rib notching on CXR", "coarctation of the aorta", "ductal-dependent lesion", "PGE1"], "estimatedMinutes": 6, "source": ["NBME"], "stem": "A 2-week-old male presents with poor feeding and fast breathing for 3 days.\n\nPer the parents, he has been feeding poorly and breathing fast for 3 days. He seems to tire quickly with feeds and is sweaty during feeding. He was fine in the first week of life.\n\nReview of systems is positive for diaphoresis with feeds and decreased urine output and negative for fever.\n\nPast medical history includes He was born full-term with no complications. No prenatal diagnosis of heart defect.\n\nPhysical Examination:\n- Cardiovascular: weak femoral pulses, blood pressure differential (upper > lower extremity), systolic murmur at left interscapular area.\n- General: pale, diaphoretic infant with tachypnea.\n- Vitals: febrile, tachypnea.\n- Liver: hepatomegaly.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-week-old was well initially but is now presenting with signs of heart failure (poor feeding, tachypnea, diaphoresis, hepatomegaly). On examination, you note weak femoral pulses compared to brachial pulses, and blood pressure is significantly higher in the upper extremities than lower extremities.", "question": "What is the key physical finding that helps narrow the differential diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Blood pressure differential between upper and lower extremities with weak femoral pulses", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A **BP differential >20 mmHg** between upper and lower extremities combined with **weak or absent femoral pulses** is highly suggestive of coarctation of the aorta. This classic finding indicates obstruction to aortic flow.", "consequence": "Key finding identified. Proceed with workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Hepatomegaly indicating primary liver disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hepatomegaly is present, in the context of heart failure symptoms, it reflects **hepatic congestion from right heart failure**, not primary liver pathology. The hemodynamic findings are more specific.", "consequence": "Misinterpretation of the clinical picture.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Tachypnea suggesting primary respiratory disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Tachypnea in an infant with diaphoresis during feeds, hepatomegaly, and abnormal pulses suggests **cardiac cause** rather than primary respiratory disease. The constellation of findings points to heart failure.", "consequence": "Respiratory workup delays cardiac diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Poor feeding suggesting gastrointestinal obstruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Poor feeding with diaphoresis (sweating during feeds) is classic for **cardiac causes** - the infant cannot maintain cardiac output during the increased metabolic demand of feeding. The pulse and BP findings confirm cardiac etiology.", "consequence": "Incorrect workup pathway.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Fever suggesting infectious etiology", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Review of systems specifically notes **absence of fever**. The presentation is consistent with cardiac failure, and the hemodynamic findings (BP differential, weak femoral pulses) are specific for coarctation.", "consequence": "Unnecessary infectious workup.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Always check femoral pulses in any infant presenting with heart failure or hypertension.** Coarctation is commonly missed because femoral pulses are not routinely checked. The diagnosis should be suspected when there is a >20 mmHg BP differential between arms and legs."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect coarctation of the aorta based on the BP differential and weak femoral pulses. The infant appears to be decompensating with worsening tachypnea and poor perfusion.\n\nYou recall that neonatal coarctation often presents when the ductus arteriosus closes, as ductal patency may have been maintaining distal perfusion.", "question": "What is the most appropriate IMMEDIATE intervention for this critically ill neonate?", "choices": [{"id": "node-2-choice-a", "text": "Start prostaglandin E1 (PGE1) infusion immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **ductal-dependent lesion**. Starting **PGE1 (0.05-0.1 mcg/kg/min)** will reopen or maintain the ductus arteriosus, restoring blood flow to the lower body. This is life-saving in critical coarctation presenting after ductal closure.", "consequence": "PGE1 started. Perfusion improving. Proceed with diagnostic confirmation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Order stat echocardiogram before any intervention", "isOptimal": false, "isAcceptable": true, "feedback": "While echocardiogram is essential for diagnosis, this infant is **critically ill and decompensating**. In suspected ductal-dependent lesions, PGE1 should be started empirically - it is both diagnostic (response confirms ductal-dependent lesion) and therapeutic.", "consequence": "Delay in intervention while awaiting imaging.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Start IV furosemide for heart failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While diuretics may help with pulmonary congestion, they do not address the underlying obstruction. In critical coarctation, the infant needs **improved distal perfusion** through PGE1, not just diuresis.", "consequence": "Diuresis without addressing underlying problem.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Emergent surgical repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While surgery is the definitive treatment, the infant must first be **stabilized with PGE1**. Rushing to surgery without stabilization carries significant risk. Medical stabilization before surgical repair is standard of care.", "consequence": "Surgery on unstable patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start dopamine for inotropic support", "isOptimal": false, "isAcceptable": true, "feedback": "Inotropic support may be helpful as an adjunct, but the **primary intervention** needed is PGE1 to restore distal perfusion. Dopamine alone does not address the anatomic obstruction in coarctation.", "consequence": "Supportive but not definitive initial intervention.", "nextNodeId": "node-3"}], "clinicalPearl": "**PGE1 is life-saving** in ductal-dependent lesions. Start it empirically when critical coarctation is suspected - do not wait for echocardiographic confirmation. Side effects include apnea (have airway equipment ready), fever, and hypotension."}, "node-3": {"id": "node-3", "type": "decision", "content": "After starting PGE1, the infant's perfusion improves with stronger femoral pulses. You order an urgent echocardiogram.\n\nEchocardiogram findings:\n- Severe discrete coarctation at the aortic isthmus with gradient of 45 mmHg\n- Patent ductus arteriosus now providing flow to the descending aorta\n- Bicuspid aortic valve present\n- Mild LV hypertrophy\n- No other associated defects", "question": "Given the echocardiogram findings, which associated condition should you specifically screen for in this patient?", "choices": [{"id": "node-3-choice-a", "text": "Turner syndrome (45,X) - order karyotype", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Turner syndrome is present in 30% of patients with coarctation**, especially females. However, this male patient should still be evaluated for other genetic syndromes. Additionally, **bicuspid aortic valve is associated with coarctation in 50-80% of cases** (already identified here).", "consequence": "Genetic evaluation ordered.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Bicuspid aortic valve - already identified on echo", "isOptimal": false, "isAcceptable": true, "feedback": "The bicuspid aortic valve was already identified on this echo. While this is indeed the most common associated finding (**50-80% of coarctation patients**), the question asks what to screen for. Turner syndrome screening is important.", "consequence": "Associated finding acknowledged but additional screening needed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Tetralogy of Fallot", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TOF is not specifically associated with coarctation. Coarctation is associated with **bicuspid aortic valve, VSD, PDA, Turner syndrome, and intracranial aneurysms** (Berry aneurysms - screen in adults).", "consequence": "Unnecessary evaluation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Pulmonary stenosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pulmonary stenosis is not specifically associated with coarctation. The classic associations are bicuspid aortic valve, VSD, Turner syndrome, and Berry aneurysms.", "consequence": "Misdirected evaluation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Down syndrome (trisomy 21)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Down syndrome is associated with AV canal defects, not coarctation. **Turner syndrome (30% have coarctation)** is the chromosomal syndrome most associated with coarctation of the aorta.", "consequence": "Incorrect genetic association.", "nextNodeId": "node-4"}], "clinicalPearl": "Coarctation associations: **Bicuspid aortic valve (50-80%)**, **Turner syndrome (30%)**, VSD, PDA, and Berry aneurysms (intracranial - screen in adults). Always check for bicuspid valve as it may need surveillance for aortic stenosis/regurgitation."}, "node-4": {"id": "node-4", "type": "decision", "content": "The infant is now stable on PGE1. Pediatric cardiology and cardiothoracic surgery have been consulted. The team discusses the timing and approach for definitive repair.", "question": "What is the definitive treatment for critical neonatal coarctation?", "choices": [{"id": "node-4-choice-a", "text": "Surgical repair (resection with end-to-end anastomosis or extended repair)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Surgical repair is the treatment of choice** for neonatal coarctation. Options include resection with end-to-end anastomosis, subclavian flap repair, or extended resection. Surgery is performed once the infant is stabilized, typically within days.", "consequence": "Surgical repair planned.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Balloon angioplasty via cardiac catheterization", "isOptimal": false, "isAcceptable": true, "feedback": "Balloon angioplasty is generally reserved for **older children with native coarctation or for recoarctation** after surgical repair. In neonates with critical coarctation, surgical repair is preferred due to better long-term outcomes and lower recoarctation rates.", "consequence": "Alternative approach considered.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Long-term PGE1 therapy as definitive treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PGE1 is a **bridge to definitive repair**, not definitive treatment. Long-term PGE1 has significant side effects (apnea, fever, cortical hyperostosis) and the underlying obstruction must be surgically corrected.", "consequence": "No definitive repair.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Medical management with antihypertensives", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Antihypertensives do not address the anatomic obstruction and will not prevent progression of LV hypertrophy or the complications of untreated coarctation. **Surgical correction is required.**", "consequence": "Obstruction not addressed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Stent placement in the coarctation segment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Stents are not used in neonates due to small vessel size and inability to dilate with growth. Stents may be considered in **older children or adults** with appropriate anatomy.", "consequence": "Inappropriate intervention for age.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Surgery is preferred over catheter intervention in neonates** with coarctation. Balloon angioplasty is an option for older children or for recoarctation. Post-repair surveillance is essential as recoarctation occurs in 5-10% of patients."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant undergoes successful surgical repair with end-to-end anastomosis. Post-operatively, blood pressure is equal in upper and lower extremities with strong femoral pulses.\n\nThe parents ask about long-term follow-up and prognosis.", "question": "What is the most important aspect of long-term follow-up after coarctation repair?", "choices": [{"id": "node-5-choice-a", "text": "Lifelong surveillance for recoarctation and hypertension, with BP monitoring in upper AND lower extremities", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Long-term follow-up includes: **monitoring for recoarctation (5-10%)**, persistent/recurrent **hypertension (even after repair)**, surveillance of the **bicuspid aortic valve**, and screening for **Berry aneurysms** in adulthood. BP should be checked in arms AND legs at every visit.", "consequence": "Appropriate long-term follow-up plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "No follow-up needed after successful repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Patients with repaired coarctation require **lifelong follow-up**. Complications include recoarctation, persistent hypertension, bicuspid valve disease progression, and risk of aortic aneurysm and Berry aneurysms.", "consequence": "Complications missed without surveillance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Annual echocardiogram only", "isOptimal": false, "isAcceptable": true, "feedback": "Echocardiogram is important but incomplete. Patients need **BP monitoring in all four extremities**, surveillance of the repair site, monitoring of the bicuspid valve, and screening for aneurysms. A comprehensive approach is needed.", "consequence": "Incomplete follow-up plan.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Restrict all physical activity permanently", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After successful repair with no residual obstruction, most patients can participate in **normal activities including sports**. Some restriction of isometric/high-intensity activities may be recommended if there is residual disease or associated bicuspid valve.", "consequence": "Unnecessary restriction of normal activities.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Lifelong antibiotic prophylaxis for dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SBE prophylaxis is **not routinely recommended** after coarctation repair unless there are associated complex defects, prosthetic material, or history of endocarditis. The current guidelines have significantly reduced indications for prophylaxis.", "consequence": "Unnecessary lifelong prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Even after successful repair, **hypertension occurs in 30-40% of patients** long-term, likely due to abnormal arterial compliance and baroreceptor dysfunction. BP should be measured in **both arms and legs** at every follow-up visit to detect recoarctation."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized critical neonatal coarctation, initiated life-saving PGE1 therapy, confirmed the diagnosis with echocardiography, and established an appropriate long-term follow-up plan.\n\nKey learning points:\n\u2022 **BP differential >20 mmHg** between upper/lower extremities with weak femoral pulses = coarctation\n\u2022 **PGE1 is life-saving** - start empirically in suspected ductal-dependent lesions\n\u2022 Associated findings: bicuspid aortic valve (50-80%), Turner syndrome (30%)\n\u2022 **Surgical repair is definitive treatment** in neonates\n\u2022 **Lifelong follow-up** for recoarctation, hypertension, and associated anomalies\n\u2022 Check BP in **all four extremities** at every visit"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of coarctation:\n\n\u2022 **BP differential >20 mmHg** between upper and lower extremities\n\u2022 **Weak or absent femoral pulses** - always check!\n\u2022 Presentation varies by age: neonates present with heart failure when ductus closes\n\u2022 **PGE1 is life-saving** in ductal-dependent lesions\n\u2022 Associated: bicuspid aortic valve, Turner syndrome, VSD, Berry aneurysms\n\u2022 CXR findings in older children: rib notching, figure-3 sign"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical neonatal coarctation is a medical emergency.\n\n\u2022 Without PGE1, ductal closure leads to shock and death\n\u2022 Always check femoral pulses in any infant with heart failure or hypertension\n\u2022 Untreated coarctation complications: heart failure, stroke, aortic rupture, endocarditis\n\nKey pearl: **Always check femoral pulses in hypertensive children** - coarctation is commonly missed and is highly treatable when diagnosed."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-024", "title": "Transposition of Great Arteries", "domain": "cardiology", "difficulty": "advanced", "tags": ["cyanosis at birth", "egg-on-a-string", "parallel circulation", "transposition of great arteries", "ductal-dependent lesion", "PGE1", "arterial switch"], "estimatedMinutes": 7, "source": ["NBME"], "stem": "A 1-day-old male is brought in by his parents for severe cyanosis at birth for since birth.\n\nPer the mother, he was born blue and has remained severely cyanotic despite high-flow oxygen. He is becoming more lethargic and not feeding.\n\nReview of systems is positive for cyanosis unresponsive to oxygen and negative for respiratory distress or murmur initially.\n\nMedical history is notable for Prenatal ultrasounds were normal. He was born full-term via uncomplicated delivery.\n\nPhysical Examination:\n- General: severely cyanotic newborn, cyanosis not improving with oxygen.\n- Vitals: tachypnea, cyanosis.\n- Cardiovascular: single loud S2, no significant murmur initially.\n- Respiratory: tachypneic without significant distress.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This newborn presents with severe cyanosis from birth that does not improve with supplemental oxygen (100% FiO2). The infant is tachypneic but does not appear to be in respiratory distress. Prenatal ultrasounds were reportedly normal.\n\nYou perform a hyperoxia test: SpO2 remains 65-70% despite 100% FiO2.", "question": "What does a failed hyperoxia test (PaO2 <100 mmHg on 100% FiO2) indicate?", "choices": [{"id": "node-1-choice-a", "text": "Cyanotic congenital heart disease with right-to-left shunt", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A **failed hyperoxia test** (PaO2 <100 mmHg or minimal SpO2 improvement on 100% O2) indicates cyanotic congenital heart disease with intracardiac shunting. In pulmonary disease, oxygen typically improves saturation significantly.", "consequence": "Cardiac cause confirmed. Proceed with cardiac workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Primary pulmonary disease such as RDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In primary pulmonary disease, supplemental oxygen typically **significantly improves oxygenation** (PaO2 >100-150 mmHg on 100% FiO2). The failure to respond to oxygen points to intracardiac shunting.", "consequence": "Misdiagnosis of pulmonary cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Persistent pulmonary hypertension of the newborn (PPHN)", "isOptimal": false, "isAcceptable": true, "feedback": "PPHN can also cause failed hyperoxia test due to right-to-left ductal shunting. However, the **absence of respiratory distress** and the timing (cyanosis from birth) makes TGA more likely. PPHN typically has more respiratory distress.", "consequence": "Differential considered but workup needed.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Normal newborn transition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Normal newborns should have SpO2 >95% within hours of birth. Persistent severe cyanosis (SpO2 65-70%) is **never normal** and requires urgent evaluation.", "consequence": "Critical condition missed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Methemoglobinemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Methemoglobinemia causes cyanosis unresponsive to oxygen, but it's extremely rare in newborns without toxic exposure. The presentation and timing strongly suggest structural heart disease.", "consequence": "Rare diagnosis unlikely in this setting.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "The **hyperoxia test** distinguishes cardiac from pulmonary cyanosis. In cyanotic CHD, PaO2 remains <100 mmHg on 100% FiO2 because blood bypasses the lungs via intracardiac shunts. In pulmonary disease, PaO2 typically rises to >150 mmHg."}, "node-2": {"id": "node-2", "type": "decision", "content": "You urgently obtain a chest X-ray and echocardiogram.\n\nCXR findings:\n- Narrow mediastinum (\"egg-on-a-string\" appearance)\n- Increased pulmonary vascular markings\n- Mild cardiomegaly\n\nEchocardiogram findings:\n- Aorta arises from the RIGHT ventricle, anterior and rightward\n- Pulmonary artery arises from the LEFT ventricle\n- Parallel great vessels\n- Small foramen ovale providing minimal mixing\n- Patent ductus arteriosus partially open", "question": "Based on these findings, what is the diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "D-Transposition of the Great Arteries (d-TGA)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The findings are pathognomonic for **d-TGA**: aorta from RV, PA from LV, parallel circulations. The **egg-on-a-string CXR** is classic (narrow mediastinum from parallel great vessels). Without mixing, this is incompatible with life.", "consequence": "Diagnosis confirmed. Urgent intervention needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Tetralogy of Fallot", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TOF has a **boot-shaped heart** on CXR with decreased pulmonary vascular markings. It presents with cyanosis but typically not at birth (\"tet spells\" develop later). TOF has normal great vessel origins.", "consequence": "Misdiagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Total anomalous pulmonary venous return (TAPVR)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TAPVR presents with cyanosis and pulmonary edema, with a **snowman/figure-8 heart** on CXR (if supracardiac type). The great vessels arise normally in TAPVR.", "consequence": "Misdiagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Truncus arteriosus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Truncus arteriosus has a **single great vessel** arising from the heart. In TGA, there are two great vessels but they arise from the wrong ventricles (aorta from RV, PA from LV).", "consequence": "Misdiagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "L-Transposition (congenitally corrected TGA)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. L-TGA is \"congenitally corrected\" with double discordance - blood flow is physiologically normal. Patients are often **not cyanotic** at birth. This presentation with severe cyanosis indicates d-TGA.", "consequence": "Different physiology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "In **d-TGA**, the circulations are in **parallel** rather than in series: systemic venous blood returns to the RV \u2192 aorta \u2192 body, and pulmonary venous blood returns to LV \u2192 PA \u2192 lungs. Without mixing (via PDA, ASD, or VSD), this is **incompatible with life**."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is severely hypoxic with SpO2 of 55% despite 100% oxygen. The foramen ovale is restrictive and providing minimal mixing. The PDA appears to be closing.\n\nThis is a medical emergency - the infant will die without adequate mixing between the parallel circulations.", "question": "What is the IMMEDIATE life-saving intervention?", "choices": [{"id": "node-3-choice-a", "text": "Start prostaglandin E1 (PGE1) infusion immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **PGE1 (0.05-0.1 mcg/kg/min)** keeps the PDA open, allowing mixing between the circulations. This is life-saving and must be started immediately. Have airway equipment ready as apnea is a common side effect.", "consequence": "PGE1 started. SpO2 improving as PDA dilates.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Increase supplemental oxygen to maximize saturation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Oxygen alone cannot fix the problem - the issue is that the circulations are **parallel** and blood is not being oxygenated. The infant needs **mixing** of blood between circulations, not more oxygen to lungs that already have adequate oxygenation.", "consequence": "No improvement with oxygen alone.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Emergent surgical arterial switch operation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the arterial switch is the definitive repair, surgery requires stabilization first. The infant needs **PGE1 to survive** until the cardiothoracic team can prepare for surgery (usually within the first 2 weeks of life).", "consequence": "Surgery without stabilization.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "ECMO cannulation for oxygenation support", "isOptimal": false, "isAcceptable": true, "feedback": "ECMO might be needed if PGE1 and septostomy fail, but it is not first-line. **PGE1 should be tried first** - it is simpler, less invasive, and highly effective in keeping the PDA open.", "consequence": "Escalation before trying simpler intervention.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Intubation and mechanical ventilation", "isOptimal": false, "isAcceptable": true, "feedback": "Intubation may be needed for airway protection (PGE1 causes apnea) or if the infant decompensates, but it does not address the core problem. **PGE1 is the priority** - intubation alone will not improve oxygenation without mixing.", "consequence": "Supportive but not definitive.", "nextNodeId": "node-4"}], "clinicalPearl": "**PGE1 is life-saving** in TGA. Side effects include **apnea** (up to 12% - have airway equipment ready), fever, hypotension, and flushing. Never discontinue PGE1 in a ductal-dependent lesion without definitive repair."}, "node-4": {"id": "node-4", "type": "decision", "content": "PGE1 has been started and the PDA is now widely patent. SpO2 has improved to 75-80%. However, the foramen ovale remains restrictive and mixing is still inadequate for long-term stability.\n\nPediatric cardiology recommends a procedure to improve atrial mixing.", "question": "What procedure should be performed to improve mixing at the atrial level?", "choices": [{"id": "node-4-choice-a", "text": "Balloon atrial septostomy (Rashkind procedure)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Rashkind balloon atrial septostomy** creates a larger ASD to allow better mixing between the left and right atria. It is performed at bedside or in the cath lab and significantly improves oxygenation in TGA with restrictive atrial septum.", "consequence": "Septostomy performed. SpO2 now 85-90%.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Surgical atrial septectomy", "isOptimal": false, "isAcceptable": true, "feedback": "Surgical septectomy is an option but is more invasive than balloon septostomy. The **Rashkind procedure** is preferred as first-line because it can be done at bedside or in the cath lab without open-heart surgery.", "consequence": "More invasive approach.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Increase PGE1 dose to maximum", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The PDA is already widely patent. The problem is inadequate **atrial** mixing. Increasing PGE1 will not address a restrictive foramen ovale. Balloon septostomy is needed.", "consequence": "Does not address the restrictive septum.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Emergent arterial switch operation", "isOptimal": false, "isAcceptable": true, "feedback": "While the arterial switch is definitive treatment, performing septostomy first provides a bridge by improving oxygenation. Surgery is typically planned within the **first 2 weeks** after stabilization.", "consequence": "Surgery without optimization.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Observation with current management", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With a restrictive foramen ovale, mixing remains inadequate. The infant is at risk of further deterioration. **Active intervention** (septostomy) is needed to improve atrial-level mixing.", "consequence": "Inadequate mixing continues.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The **Rashkind balloon atrial septostomy** (1966) revolutionized TGA management. It is performed by threading a balloon catheter across the foramen ovale, inflating it, and pulling it back to tear the atrial septum, creating a larger ASD for mixing."}, "node-5": {"id": "node-5", "type": "decision", "content": "Balloon septostomy was successful. The infant is now stable with SpO2 of 85-90% on PGE1. The cardiothoracic team is planning definitive surgical repair.\n\nThe parents ask about the surgery and long-term prognosis.", "question": "What is the definitive surgical repair for d-TGA and what is the expected outcome?", "choices": [{"id": "node-5-choice-a", "text": "Arterial switch operation within first 2 weeks of life; >95% survival with excellent long-term outcomes", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **arterial switch operation** (Jatene procedure) is performed within the first 2 weeks of life while the LV can still handle systemic pressures. The aorta and PA are switched to their correct ventricles. **Survival is >95%** with excellent long-term outcomes.", "consequence": "Parents counseled. Surgery scheduled.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Atrial switch (Mustard/Senning) operation; long-term complications common", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Atrial switch procedures (Mustard/Senning) were used historically but have been replaced by the **arterial switch** due to long-term complications (RV failure, arrhythmias) from leaving the RV as the systemic ventricle.", "consequence": "Outdated surgical approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Heart transplantation as definitive treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Transplant is not needed for isolated TGA. The **arterial switch** provides anatomic correction with excellent outcomes. Transplant is reserved for complex cases with failed repairs.", "consequence": "Unnecessary transplant consideration.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Surgery can be delayed until school age for better outcomes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Surgery must be done within the **first 2-3 weeks of life**. After this window, the LV \"deconditions\" from low pulmonary pressures and cannot handle systemic pressures after the switch. Delay leads to LV failure.", "consequence": "Missed surgical window.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "Lifelong PGE1 and septostomy without surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Without surgery, survival is essentially impossible long-term. **90% mortality in the first year** without intervention. The arterial switch is definitive and curative.", "consequence": "No definitive repair.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The **arterial switch** must be performed within 2-3 weeks while the LV is still conditioned to handle systemic pressures. After this window, the LV has \"detrained\" from pumping against low pulmonary resistance and cannot support systemic circulation after the switch."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized TGA, initiated life-saving PGE1, improved mixing with balloon septostomy, and counseled the family appropriately about surgical repair.\n\nKey learning points:\n\u2022 **Cyanosis unresponsive to oxygen** \u2192 think cyanotic CHD (failed hyperoxia test)\n\u2022 **Egg-on-a-string CXR** = narrow mediastinum from parallel great vessels = TGA\n\u2022 TGA has **parallel circulations** - incompatible with life without mixing\n\u2022 **PGE1** keeps PDA open for mixing - life-saving bridge to surgery\n\u2022 **Balloon septostomy** (Rashkind) creates atrial mixing if foramen ovale restrictive\n\u2022 **Arterial switch** within first 2 weeks - >95% survival, excellent outcomes\n\u2022 Without intervention: **90% mortality in first year**"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of TGA:\n\n\u2022 **Parallel circulations**: aorta from RV, PA from LV\n\u2022 **Cyanosis at birth** unresponsive to oxygen\n\u2022 **Egg-on-a-string CXR**: narrow mediastinum, increased pulmonary markings\n\u2022 **Failed hyperoxia test**: PaO2 <100 on 100% FiO2\n\u2022 Survival depends on **mixing**: PDA, ASD, or VSD\n\u2022 **PGE1** is life-saving (keeps PDA open)\n\u2022 **Arterial switch** must be done within first 2 weeks"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. TGA is a medical emergency with **90% mortality in the first year** without intervention.\n\n\u2022 The parallel circulations mean oxygenated and deoxygenated blood don't mix\n\u2022 **PGE1 is life-saving** - keeps the ductus open for mixing\n\u2022 Without mixing, tissues become ischemic and the infant dies\n\u2022 Balloon septostomy improves atrial mixing\n\u2022 Arterial switch operation is curative with >95% survival\n\nKey pearl: TGA is the **most common cyanotic CHD presenting in the first day of life**."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-025", "title": "Patent Ductus Arteriosus", "domain": "cardiology", "difficulty": "intermediate", "tags": ["machinery murmur", "continuous murmur", "bounding pulses", "widened pulse pressure", "patent ductus arteriosus"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-day-old female presents with premature infant with respiratory distress for 2 days.\n\nSubjectively, she was born at 28 weeks gestation and has required increasing respiratory support. She cannot be weaned from the ventilator. Her feeding is being held.\n\nbounding pulses and wide pulse pressure. No fever.\n\nMedical history is notable for She was born prematurely at 28 weeks due to preterm labor. Birth weight was 1100 grams.\n\nPhysical Examination:\n- Cardiovascular: continuous \"machine-like\" murmur at left infraclavicular area. Bounding peripheral pulses.\n- General: premature infant on ventilator with increased work of breathing.\n- Precordium: hyperdynamic.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This premature neonate has worsening respiratory distress. You note a continuous murmur and bounding pulses on exam. You need to identify the cause.", "question": "What physical examination finding is most specific for patent ductus arteriosus in this preterm infant?", "choices": [{"id": "node-1-choice-a", "text": "Continuous 'machinery' murmur at left infraclavicular area with bounding pulses", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **continuous machinery murmur** heard best at the left infraclavicular area is pathognomonic for PDA. **Bounding pulses** and **widened pulse pressure** result from diastolic runoff into the pulmonary circulation. In preterm infants, the PDA may not close spontaneously due to decreased sensitivity to oxygen and immature ductal tissue.", "consequence": "You recognize the classic PDA findings and proceed with confirmation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Holosystolic murmur at left lower sternal border", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **holosystolic murmur at the LLSB** is characteristic of a **ventricular septal defect (VSD)**, not PDA. PDA produces a continuous murmur because blood flows from aorta to pulmonary artery throughout the cardiac cycle.", "consequence": "You consider VSD but the murmur characteristics don't match.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Fixed split S2 with systolic ejection murmur at LUSB", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fixed split S2** is the hallmark of **atrial septal defect (ASD)**, not PDA. In ASD, the fixed split occurs because the interatrial communication equalizes filling regardless of respiratory phase.", "consequence": "You consider ASD but this doesn't explain the bounding pulses.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Harsh systolic murmur with single S2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A harsh systolic murmur with single S2 suggests **Tetralogy of Fallot** or severe pulmonary stenosis. The single S2 occurs because the pulmonary component is diminished. PDA has a continuous murmur, not just systolic.", "consequence": "You consider TOF but this patient has no cyanosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Diminished femoral pulses with upper extremity hypertension", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Diminished femoral pulses** with upper extremity hypertension indicates **coarctation of the aorta**. In PDA, pulses are actually **bounding** due to the diastolic runoff, with a widened pulse pressure.", "consequence": "You check the blood pressure but find no differential.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PDA murmur mnemonic**: 'Machine-like' because it runs continuously like a machine. In **preterm infants**, PDA often fails to close due to decreased oxygen sensitivity. Remember: **Indomethacin closes** (inhibits prostaglandins), **PGE1 opens** (for ductal-dependent lesions)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Echocardiogram confirms a moderate-sized PDA with left-to-right shunt. There is LA and LV dilation indicating a hemodynamically significant shunt (Qp:Qs ratio 2.5:1). The infant continues to require increasing ventilatory support.", "question": "What is the most appropriate initial pharmacologic therapy to close the PDA in this preterm infant?", "choices": [{"id": "node-2-choice-a", "text": "Indomethacin or ibuprofen (COX inhibitors)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Indomethacin** and **ibuprofen** are **prostaglandin synthesis inhibitors** (COX inhibitors) that promote PDA closure. They work by blocking the prostaglandins that keep the ductus arteriosus patent. Both are effective, though ibuprofen may have fewer renal side effects. Success rate is **70-80%** in preterm infants.", "consequence": "You start ibuprofen therapy and monitor for closure.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Prostaglandin E1 (alprostadil) infusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **PGE1 OPENS** the ductus arteriosus - it's used for **ductal-dependent lesions** (like critical coarctation, TGA, or pulmonary atresia) where maintaining ductal patency is life-saving. For a symptomatic PDA that you want to close, you need a **prostaglandin inhibitor**, not PGE1.", "consequence": "The PDA remains open and symptoms worsen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Furosemide and fluid restriction only", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Fluid restriction** and **diuretics** can help manage symptoms of volume overload from the left-to-right shunt, but they do not close the PDA. They are supportive measures while awaiting pharmacologic or surgical closure.", "consequence": "Symptoms are partially controlled but the PDA persists.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Acetaminophen", "isOptimal": false, "isAcceptable": true, "feedback": "Interesting choice! **Acetaminophen** has emerging evidence for PDA closure and may be an alternative when NSAIDs are contraindicated. However, **indomethacin and ibuprofen** remain the first-line agents with more established efficacy data.", "consequence": "You consider acetaminophen as an alternative option.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Immediate surgical ligation", "isOptimal": false, "isAcceptable": true, "feedback": "Surgical ligation is effective but **invasive**. It is typically reserved for cases where **pharmacologic closure fails** or is contraindicated (renal failure, NEC, thrombocytopenia, active bleeding). In this stable preterm infant, a trial of medical therapy is appropriate first.", "consequence": "Surgery is considered but medical therapy should be tried first.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Contraindications to indomethacin/ibuprofen**: Active NEC, renal failure (Cr >1.8), platelet count <50,000, active bleeding, ductal-dependent lesion. **Ibuprofen** may have less renal toxicity than indomethacin."}, "node-3": {"id": "node-3", "type": "decision", "content": "After 3 doses of ibuprofen, repeat echocardiogram shows the PDA has not closed. The infant remains ventilator-dependent with signs of pulmonary overcirculation. Renal function is normal.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "Second course of ibuprofen or indomethacin", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A **second course** of COX inhibitors can be attempted if the first course fails and there are no contraindications. Success rates for a second course are lower (approximately 40-50%) but still reasonable before proceeding to surgery.", "consequence": "You initiate a second course of pharmacologic therapy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Surgical PDA ligation", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. While surgical ligation is definitive, a **second course** of pharmacologic therapy is typically attempted first if there are no contraindications. Surgery is reserved for **failed medical therapy** or when contraindications exist.", "consequence": "You consult surgery but consider another medication course first.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Continue supportive care and observe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant has a **hemodynamically significant PDA** causing ventilator dependence. Watchful waiting is inappropriate when the infant is symptomatic. Prolonged PDA in preterm infants increases risk of **BPD**, **NEC**, and mortality.", "consequence": "The infant's condition continues to deteriorate.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Transcatheter device closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this patient. **Transcatheter closure** is an option for larger infants and children but is typically not feasible in **extremely low birth weight preterm infants** (<1500g) due to size constraints of the catheters and devices.", "consequence": "The patient is too small for catheter-based intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Switch to high-dose acetaminophen", "isOptimal": false, "isAcceptable": true, "feedback": "This is reasonable if NSAIDs are contraindicated, but evidence for acetaminophen efficacy after NSAID failure is limited. A second course of the primary agents or surgical ligation would be preferred.", "consequence": "You consider alternative pharmacologic options.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Complications of prolonged PDA** in preterm infants: Bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), pulmonary hemorrhage, and failure to thrive."}, "node-4": {"id": "node-4", "type": "decision", "content": "The second course of ibuprofen also fails to close the PDA. The infant now weighs 1200g and remains ventilator-dependent. Renal function remains normal, no signs of NEC or bleeding.", "question": "What is the definitive management at this point?", "choices": [{"id": "node-4-choice-a", "text": "Surgical PDA ligation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After **failure of two courses of pharmacologic therapy**, **surgical ligation** is indicated for hemodynamically significant PDA. The procedure involves a left thoracotomy and direct ligation or clip application. Success rate is >95% with low mortality in experienced centers.", "consequence": "Surgery is performed successfully and the infant improves.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Third course of NSAIDs", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After **two failed courses**, the likelihood of success with additional pharmacologic therapy is very low. Continuing NSAIDs increases the risk of **renal toxicity** and delays definitive treatment. Surgical ligation is now indicated.", "consequence": "Further medication courses are unlikely to succeed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Continue supportive care indefinitely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **hemodynamically significant PDA** that fails medical therapy requires surgical closure. Prolonged exposure leads to pulmonary overcirculation, increased ventilator requirements, and higher risk of chronic lung disease.", "consequence": "The infant develops worsening BPD.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Percutaneous transcatheter closure", "isOptimal": false, "isAcceptable": true, "feedback": "Emerging option but still limited. **Transcatheter closure** in premature infants is being performed at specialized centers with newer small devices (Amplatzer Piccolo). However, surgical ligation remains the standard after failed medical therapy in most institutions.", "consequence": "You explore catheter options but surgery is more readily available.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-e", "text": "Cardiac catheterization for coil embolization", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this patient. **Coil embolization** is used for small PDAs in larger patients. This preterm infant has a moderate-to-large PDA and is too small for standard catheter-based approaches.", "consequence": "Patient is not a candidate for this procedure.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Surgical ligation complications** include: pneumothorax, chylothorax, recurrent laryngeal nerve injury (hoarseness), and post-ligation cardiac dysfunction. The **PLCS (Post-Ligation Cardiac Syndrome)** can occur in 30-40% of preterm infants."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified the hemodynamically significant PDA through the classic continuous machinery murmur and bounding pulses. You appropriately initiated pharmacologic therapy with COX inhibitors, attempted a second course when the first failed, and proceeded to surgical ligation when medical management was unsuccessful. The infant was successfully extubated 1 week after surgery and continued to grow well."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key learning points: The **continuous machinery murmur** is pathognomonic for PDA. **Indomethacin/ibuprofen** are first-line for closure in preterm infants. PGE1 opens the ductus (opposite effect). After failed medical therapy, **surgical ligation** is indicated for hemodynamically significant PDA."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Remember: PDA in preterm infants requires active management when hemodynamically significant. **Indomethacin closes** the PDA by inhibiting prostaglandins. **PGE1 opens** the ductus for ductal-dependent lesions. Untreated significant PDA leads to pulmonary overcirculation, BPD, NEC, and increased mortality."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-055", "title": "Down Syndrome - Cardiac Screening", "domain": "cardiology", "difficulty": "intermediate", "tags": ["endocardial cushion defect", "AVSD", "trisomy 21", "down syndrome - cardiac screening"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-day-old female is brought to the emergency department for newborn with Down syndrome features.\n\nPer the mother, she was born with features consistent with Down syndrome including flat facial profile and hypotonia. She is feeding slowly.\n\nhypotonia and epicanthal folds. No cyanosis or respiratory distress.\n\nPast medical history includes Prenatal screening suggested increased risk. Amniocentesis confirmed trisomy 21.\n\nPhysical Examination:\n- General: hypotonic newborn with flat facial profile, epicanthal folds, single palmar crease.\n- Vitals: cyanosis.\n- Cardiovascular: soft systolic murmur at left sternal border.\n- Feeding: weak suck.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 2-day-old female with confirmed trisomy 21 (Down syndrome) is being evaluated. She has classic features: **flat facial profile**, **hypotonia**, **epicanthal folds**, and **single palmar crease**. She is feeding slowly with a weak suck. On exam, there is a soft systolic murmur at the left sternal border.\n\n**Down syndrome mnemonic - FATED:**\n- **F**lat facies\n- **A**SD/AVSD (endocardial cushion defect)\n- **T**ransverse palmar crease\n- **E**picanthal folds\n- **D**uodenal atresia (double bubble)\n\n**Congenital heart disease in Down syndrome:**\n- Occurs in **40-50%** of infants with Down syndrome\n- Most common: **AVSD (atrioventricular septal defect)** - aka endocardial cushion defect\n- Also: VSD, ASD, PDA, TOF", "question": "What cardiac workup is indicated for this newborn with Down syndrome?", "choices": [{"id": "node-1-choice-a", "text": "Echocardiogram regardless of murmur presence", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ALL newborns with Down syndrome require echocardiogram**, regardless of whether a murmur is heard. CHD occurs in ~40-50% of Down syndrome infants, and many significant defects (including AVSD) may have soft or absent murmurs in the newborn period due to high pulmonary vascular resistance. Waiting for symptoms or a louder murmur can delay critical intervention.", "consequence": "You order the appropriate screening study.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Echocardiogram only if murmur is loud (grade III or higher)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Murmur grade does NOT correlate with CHD severity in newborns**. Many significant defects (including large AVSDs and ASDs) have soft or absent murmurs in the first days of life when pulmonary vascular resistance is still elevated. ALL Down syndrome infants need echo regardless of murmur presence or grade.", "consequence": "May miss significant CHD if relying on murmur alone.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Chest X-ray to assess heart size before deciding on echo", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Chest X-ray is not a substitute for echocardiogram in CHD screening. CXR may show cardiomegaly or increased pulmonary vascularity, but **echocardiogram is the definitive test** for structural heart disease. Don't delay echo with intermediate tests - it's indicated in ALL Down syndrome newborns.", "consequence": "CXR delays definitive diagnosis without adding value.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Serial pulse oximetry; echo only if oxygen saturation <95%", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While pulse oximetry screening catches some cyanotic CHD, many Down syndrome-associated defects (AVSD, VSD, ASD) are **acyanotic** with normal oxygen saturation initially. Normal pulse ox does NOT rule out significant CHD. Echo is required for ALL Down syndrome newborns regardless of oxygen saturation.", "consequence": "Normal pulse ox misses acyanotic heart defects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Outpatient cardiology referral at 2-month well visit", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Echocardiogram should be performed before nursery discharge** in Down syndrome infants, not delayed to 2 months. Significant CHD (especially AVSD) can lead to heart failure, failure to thrive, and pulmonary hypertension if not identified early. Early diagnosis allows for appropriate monitoring, feeding support, and timely surgical planning.", "consequence": "Delay risks heart failure and pulmonary hypertension.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**40-50% of Down syndrome infants have CHD** - echo is MANDATORY before discharge regardless of murmur. The most common defect is **AVSD (complete atrioventricular septal defect)**, which may have a soft murmur initially."}, "node-2": {"id": "node-2", "type": "decision", "content": "Echocardiogram reveals a **complete atrioventricular septal defect (AVSD)** with:\n- Common AV valve\n- Primum ASD\n- Inlet VSD\n- Moderate left-to-right shunt\n- No pulmonary hypertension yet\n\n**AVSD (Endocardial cushion defect):**\n- Most common CHD in Down syndrome\n- Results from failure of endocardial cushions to fuse\n- Creates communication between all 4 chambers\n- Untreated \u2192 pulmonary overcirculation \u2192 **Eisenmenger syndrome**", "question": "What is the expected clinical course and timing of surgical repair for complete AVSD?", "choices": [{"id": "node-2-choice-a", "text": "Surgical repair typically at 4-6 months before pulmonary hypertension develops", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Complete AVSD requires **surgical repair, typically at 4-6 months of age**. The goal is to repair BEFORE irreversible **pulmonary hypertension** (Eisenmenger syndrome) develops. The large left-to-right shunt causes pulmonary overcirculation; if untreated, increased flow leads to vascular remodeling and eventually shunt reversal (right-to-left). Once Eisenmenger develops, the patient is inoperable.", "consequence": "Appropriate surgical timing planned.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Wait until symptoms develop before considering surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! **Don't wait for symptoms** - by the time significant symptoms develop (heart failure, failure to thrive), pulmonary vascular changes may already be occurring. The goal of early repair is to prevent irreversible pulmonary hypertension. Elective repair at 4-6 months (before symptom onset) has much better outcomes than emergency surgery for heart failure.", "consequence": "Delayed repair risks irreversible pulmonary hypertension.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "AVSD can be managed medically; surgery rarely needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Complete AVSD **requires surgical repair** - there is no medical alternative. Medical management (diuretics, digoxin, nutrition support) may be used as a bridge to surgery to manage heart failure symptoms, but it does NOT treat the structural defect. Without surgery, complete AVSD leads to Eisenmenger syndrome and early death.", "consequence": "AVSD requires surgery; medical management is only temporizing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Delay surgery until age 2-3 years when the child is larger", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Waiting until age 2-3 years is **too late** - by that time, irreversible pulmonary hypertension (Eisenmenger syndrome) will likely have developed, making the patient inoperable. The window for surgery is typically **4-6 months** before pulmonary vascular disease becomes fixed. Modern surgical techniques allow safe repair in infants.", "consequence": "Delayed repair leads to inoperable Eisenmenger syndrome.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Catheter-based repair is preferred over surgical repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Complete AVSD requires **open surgical repair** - there is no catheter-based option for this defect. The surgery involves: (1) Closing the primum ASD, (2) Closing the inlet VSD, (3) Reconstructing two separate AV valves from the common valve. Catheter interventions are used for simpler defects (secundum ASD, some VSDs, PDA) but not complete AVSD.", "consequence": "AVSD requires open surgical repair; no catheter option.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Eisenmenger syndrome** = irreversible pulmonary hypertension from chronic left-to-right shunt. Once shunt reverses (right-to-left), the patient becomes cyanotic and is INOPERABLE. This is why early repair is critical."}, "node-3": {"id": "node-3", "type": "decision", "content": "Pediatric cardiology is consulted and follows the infant closely. She is started on diuretics for mild heart failure symptoms. Surgical repair is planned for age 5 months.\n\n**Other Down syndrome health supervision:**\n- **Thyroid**: TSH at birth, 6 mo, 12 mo, then annually (40% develop hypothyroidism)\n- **Hearing**: Audiology at birth and every 6 months until age 3\n- **Vision**: Ophthalmology by 6 months (cataracts, strabismus)\n- **Hematology**: CBC at birth (transient leukemoid reaction, risk of leukemia)\n- **GI**: Monitor for feeding difficulties, celiac disease\n- **Atlantoaxial instability**: Cervical spine precautions; X-ray if symptoms", "question": "Besides cardiac screening, what other health supervision is particularly important in Down syndrome?", "choices": [{"id": "node-3-choice-a", "text": "Thyroid screening (TSH) - 40% develop hypothyroidism over lifetime", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Thyroid dysfunction** occurs in up to 40% of individuals with Down syndrome. Screening includes **TSH at birth, 6 months, 12 months, then annually**. Hypothyroidism can be subtle and easily missed in children with developmental delays, so routine screening is essential. Untreated hypothyroidism worsens cognitive development and growth.", "consequence": "Comprehensive health supervision plan initiated.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Brain MRI to assess for structural abnormalities", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine brain MRI is NOT recommended** in Down syndrome. While individuals with Down syndrome have intellectual disability and hypotonia, these are expected features of trisomy 21. Brain imaging is only indicated if there are **atypical neurologic findings** (seizures, focal deficits, regression) suggesting an additional pathology.", "consequence": "Brain MRI not part of routine screening.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Annual spine MRI for atlantoaxial instability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine cervical spine imaging is NOT recommended** for asymptomatic children with Down syndrome. While atlantoaxial instability occurs in 10-20%, most are asymptomatic. X-rays are only needed if **symptomatic** (neck pain, torticollis, gait changes, weakness) or before high-risk activities/procedures. Screen clinically with neck flexion/extension exam and neurologic assessment.", "consequence": "Spine imaging only if symptomatic, not routine.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Genetic testing of parents to assess recurrence risk", "isOptimal": false, "isAcceptable": true, "feedback": "Partially relevant. While genetic counseling about recurrence risk is important for family planning, this is **not a health supervision priority for the infant**. Most Down syndrome cases are nondisjunction trisomy 21 (~95%), which has low recurrence risk. Translocation trisomy 21 (~3-4%) may have higher recurrence if a parent carries a balanced translocation. This is discussed with parents but doesn't affect infant screening.", "consequence": "Genetic counseling helpful but not a screening priority for infant.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-e", "text": "EEG monitoring for increased seizure risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine EEG is NOT recommended** in Down syndrome. While individuals with Down syndrome have slightly increased seizure risk (especially infantile spasms in infancy and seizures in older adults), EEG is only indicated if **clinical seizures occur**. Routine EEG screening in asymptomatic children is not standard of care.", "consequence": "EEG only if clinical seizures, not routine screening.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Down syndrome health supervision - key screenings**: (1) Echo at birth (ALL infants), (2) TSH at birth, 6mo, 12mo, then annually, (3) Audiology at birth then q6mo until age 3, (4) Ophthalmology by 6mo, (5) CBC at birth. Don't routinely image spine or brain - screen clinically."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of the newborn with Down syndrome! Key teaching: (1) **Echo is MANDATORY** in ALL Down syndrome newborns - 40-50% have CHD, most commonly AVSD. (2) Don't rely on murmur presence - significant defects may be soft/silent. (3) **AVSD requires surgical repair at 4-6 months** before pulmonary hypertension develops. (4) Comprehensive health supervision includes: thyroid (TSH annually), hearing (q6mo until age 3), vision (by 6mo), CBC at birth. (5) Atlantoaxial instability - clinical screening, X-ray only if symptomatic."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review Down syndrome cardiac screening: (1) **Echo for ALL** - murmur presence doesn't predict CHD severity, (2) Most common defect = **AVSD (endocardial cushion defect)**, (3) Repair needed at **4-6 months** before Eisenmenger syndrome develops. Health supervision: thyroid (TSH), hearing, vision, CBC at birth. Don't routinely image brain/spine - clinical screening is appropriate."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. **ALL Down syndrome infants need echocardiogram before discharge** - don't wait for symptoms, loud murmur, or low pulse ox. 40-50% have CHD! **AVSD requires surgical repair at 4-6 months** - delay leads to irreversible pulmonary hypertension (Eisenmenger syndrome) making patient inoperable. Remember: FATED mnemonic - Flat facies, ASD/AVSD, Transverse palmar crease, Epicanthal folds, Duodenal atresia."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-057", "title": "Atrial Septal Defect", "domain": "cardiology", "difficulty": "intermediate", "tags": ["fixed split S2", "systolic murmur at pulmonic area", "paradoxical embolism risk", "atrial septal defect"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "A 5-year-old female is brought to the emergency department for heart murmur detected at school physical.\n\nThe patient's mother reports, she has been healthy and active. No symptoms were noted by the parents. The murmur was found incidentally during a routine school physical.\n\nReview of systems is positive for none and negative for fatigue, shortness of breath, or exercise intolerance.\n\nMedical history is notable for She has been meeting developmental milestones normally. No cardiac history.\n\nPhysical Examination:\n- Cardiovascular: fixed, widely split S2. Grade II/VI systolic ejection murmur at left upper sternal border.\n- General: well-appearing, active child.\n- Growth: normal height and weight.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine this asymptomatic child with an incidentally discovered murmur. On cardiac auscultation, you note a fixed, widely split S2 and a grade II/VI systolic ejection murmur best heard at the left upper sternal border.", "question": "Based on the cardiac examination findings, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Atrial septal defect (ASD)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **fixed, widely split S2** is pathognomonic for ASD. Normal S2 splitting varies with respiration (wider on inspiration), but in ASD, the constant left-to-right shunt keeps the RV volume overloaded regardless of respiratory phase, causing fixed splitting.", "consequence": "Diagnosis suspected. Proceed to confirmatory workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Innocent (Still's) murmur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Innocent murmurs are vibratory, musical, and typically heard at the **lower left sternal border**. Importantly, innocent murmurs have **normal S2 splitting** that varies with respiration. The fixed split S2 here indicates pathology.", "consequence": "Missed structural heart disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Ventricular septal defect (VSD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. VSD presents with a **holosystolic murmur** at the lower left sternal border, not a systolic ejection murmur at the upper left sternal border. VSD does not cause fixed splitting of S2.", "consequence": "Incorrect diagnosis affects management planning.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pulmonary stenosis", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Pulmonary stenosis also causes a systolic ejection murmur at the left upper sternal border. However, pulmonary stenosis causes **widely split but not fixed S2** (the split widens with inspiration). The fixed splitting here points to ASD.", "consequence": "Further workup will clarify.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Patent ductus arteriosus (PDA)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PDA classically presents with a **continuous 'machinery' murmur** heard best at the left infraclavicular area, not a systolic ejection murmur with fixed split S2.", "consequence": "Incorrect diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Fixed split S2** is pathognomonic for ASD. Normal S2 splitting varies with respiration (wider on inspiration). Fixed splitting occurs because the constant left-to-right shunt maintains RV volume overload regardless of respiratory phase."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order an echocardiogram which reveals:\n- Secundum ASD measuring 12mm\n- Left-to-right shunt with Qp:Qs ratio of 1.8:1\n- Mild RV dilation\n- No pulmonary hypertension (estimated PA pressure 25 mmHg)\n\nECG shows right axis deviation and RSR' pattern in V1.", "question": "Based on these echocardiogram findings, what is the most appropriate management?", "choices": [{"id": "node-2-choice-a", "text": "Refer to pediatric cardiology for ASD closure (catheter-based or surgical)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This ASD has a significant shunt (**Qp:Qs >1.5:1**) with RV dilation, indicating hemodynamic significance. Closure is recommended to prevent long-term complications including RV failure, arrhythmias, and paradoxical embolism. Secundum ASDs are often amenable to catheter-based device closure.", "consequence": "Patient referred for ASD closure evaluation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Reassure parents and discharge with no follow-up needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A 12mm ASD with Qp:Qs >1.5:1 and RV dilation is hemodynamically significant and requires intervention. Without closure, long-term complications include right heart failure, atrial arrhythmias, and stroke from paradoxical embolism.", "consequence": "Progressive RV dilation and potential complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start diuretic therapy for volume overload", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Medical therapy does not address the underlying defect. This asymptomatic child with an ASD needs closure, not chronic diuretic therapy. Diuretics do not prevent the long-term complications of an unrepaired ASD.", "consequence": "Defect remains unaddressed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Observe with repeat echocardiogram in 6 months", "isOptimal": false, "isAcceptable": true, "feedback": "Observation might be appropriate for small ASDs (<8mm) with minimal shunting, but this 12mm defect with Qp:Qs of 1.8:1 and RV dilation warrants closure. Small secundum ASDs may close spontaneously, but larger defects typically do not.", "consequence": "Appropriate follow-up but delayed intervention for significant defect.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Restrict physical activity to prevent complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Activity restriction is not indicated for uncomplicated ASD without pulmonary hypertension. The goal is to close the defect, after which the child can have normal activity without restrictions.", "consequence": "Unnecessary restriction without addressing the underlying problem.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "ASD closure is indicated when **Qp:Qs >1.5:1** with RV dilation. Small ASDs (<8mm) before age 2 may close spontaneously. Secundum ASDs are often closed via catheter-based device; primum ASDs require surgical repair."}, "node-3": {"id": "node-3", "type": "decision", "content": "The pediatric cardiologist agrees the ASD should be closed. The parents ask about the risks and benefits of the procedure, and whether their daughter can have a normal life afterward.", "question": "Which statement best describes the expected outcome after ASD closure?", "choices": [{"id": "node-3-choice-a", "text": "Excellent prognosis with no activity restrictions after recovery; RV dilation typically resolves", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After successful ASD closure, children typically have **excellent outcomes** with normalization of RV size and function. They can participate in all activities without restriction. Early closure (childhood) prevents the long-term complications seen with untreated ASD in adults.", "consequence": "Parents reassured and proceed with closure.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "She will need lifelong anticoagulation after closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After surgical or device closure, antiplatelet therapy (aspirin) is typically given for 6 months, not lifelong anticoagulation. Once the device is endothelialized or the surgical repair healed, no ongoing anticoagulation is needed.", "consequence": "Incorrect information about post-procedure care.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "She will need permanent activity restrictions even after closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After successful closure and recovery, children can participate in all activities without restriction, including competitive sports. There are no permanent activity limitations following uncomplicated ASD repair.", "consequence": "Unnecessary long-term restrictions.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "She will always need SBE prophylaxis for dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Isolated secundum ASD repair does not require SBE prophylaxis after 6 months post-closure (once endothelialization is complete). Only complex CHD or prosthetic valves require lifelong SBE prophylaxis.", "consequence": "Unnecessary lifelong precautions.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "The RV dilation will persist despite closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After successful ASD closure, the RV volume overload is eliminated and **RV dilation typically resolves** over weeks to months. This is one of the main benefits of closing the defect before irreversible remodeling occurs.", "consequence": "Incorrect prognostic information.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "ASD is the **most common CHD diagnosed in adults** because many are asymptomatic in childhood. Early closure prevents complications including RV failure, atrial fibrillation/flutter, and paradoxical embolism (stroke from venous clot crossing to arterial circulation)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified ASD based on the pathognomonic fixed split S2, ordered appropriate echocardiographic evaluation, recognized the need for closure based on significant shunting (Qp:Qs >1.5:1), and provided accurate prognostic counseling.\n\nKey learning points:\n\u2022 **Fixed split S2** is pathognomonic for ASD\n\u2022 Secundum ASD is the most common type (75%)\n\u2022 Closure indicated when Qp:Qs >1.5:1 with RV dilation\n\u2022 Small ASDs (<8mm before age 2) may close spontaneously\n\u2022 Excellent prognosis after closure with no activity restrictions\n\u2022 ASD is the most common CHD diagnosed in adults (often asymptomatic in childhood)"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of ASD:\n\n\u2022 **Fixed split S2** = pathognomonic finding (doesn't vary with respiration)\n\u2022 Systolic ejection murmur at pulmonic area (increased flow)\n\u2022 ECG: RAD, RVH, RSR' in V1 (RV volume overload)\n\u2022 Closure when Qp:Qs >1.5:1 with RV dilation\n\u2022 Risk of paradoxical embolism (venous clot \u2192 arterial circulation)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Untreated significant ASD leads to:\n\n\u2022 Progressive RV dilation and eventual failure\n\u2022 Atrial arrhythmias (flutter, fibrillation)\n\u2022 Paradoxical embolism and stroke\n\u2022 Pulmonary hypertension (late, irreversible)\n\nKey pearl: Fixed split S2 is pathognomonic for ASD. Closure is indicated for hemodynamically significant defects (Qp:Qs >1.5:1) to prevent these complications."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-066", "title": "SVT Management - Hemodynamically Stable", "domain": "cardiology", "difficulty": "intermediate", "tags": ["narrow complex tachycardia", "rate out of proportion to clinical status", "regular rhythm", "svt management - hemodynamically stable"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-month-old male is brought to the ED by parents who noticed he was breathing fast and seemed pale during feeding.\n\nSubjectively, parents report the baby has been fussy and feeding poorly for a few hours. No fever, vomiting, or diarrhea.\n\nPhysical Examination:\n- Vitals: HR 260/min, RR 50, BP 75/50, SpO2 98% on room air\n- General: Pale, fussy but consolable infant, capillary refill 2 seconds\n- Cardiovascular: Tachycardic, regular rhythm, no murmur, pulses strong and equal\n- Lungs: Clear bilaterally, mild subcostal retractions", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The ECG shows a narrow-complex tachycardia at 260 bpm with a regular rhythm. P waves are not clearly visible. The infant is alert with stable blood pressure.", "question": "How do you differentiate SVT from sinus tachycardia in this infant?", "choices": [{"id": "node-1-choice-a", "text": "Heart rate >220 bpm in infant with fixed rate and abrupt onset suggests SVT", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In infants, **SVT typically has rates 220-280 bpm** with a fixed rate that doesn't vary with activity. **Sinus tachycardia** rates vary (usually <220) and respond to clinical status (fever, dehydration, crying). The abrupt onset and fixed rate pattern are key distinguishing features.", "consequence": "You correctly identify SVT and assess hemodynamic stability.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Wide QRS complex >0.12 seconds indicates SVT", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SVT typically has a **narrow QRS complex** (<0.09 seconds in infants). A **wide QRS** suggests ventricular tachycardia or SVT with aberrant conduction. Width of QRS does not distinguish SVT from sinus tachycardia.", "consequence": "You may confuse rhythm identification.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Irregular R-R intervals confirm SVT diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SVT typically has a **regular R-R interval**. Irregular rhythms suggest atrial fibrillation or multifocal atrial tachycardia. Both SVT and sinus tachycardia can be regular.", "consequence": "You misinterpret the ECG findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Presence of fever automatically excludes SVT", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Fever does not exclude SVT - patients can have both! While fever commonly causes sinus tachycardia, the rate and pattern characteristics still help distinguish them. A rate of 260 bpm is too fast for sinus tachycardia regardless of fever.", "consequence": "You may miss SVT in a febrile patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Low blood pressure confirms the diagnosis of SVT", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Blood pressure indicates **hemodynamic stability**, not the rhythm diagnosis. SVT can occur with normal or low BP. This patient actually has stable BP (75/50 is normal for a 6-month-old).", "consequence": "You confuse hemodynamic status with rhythm diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SVT vs Sinus Tachycardia**: SVT = rate >220 (infants) or >180 (children), fixed rate, abrupt onset/offset. Sinus tach = rate varies, gradual changes, usually has identifiable cause (fever, pain, hypovolemia)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have confirmed SVT in a hemodynamically stable infant. The baby is alert, blood pressure is normal, and perfusion is adequate.", "question": "What is the most appropriate FIRST intervention for this hemodynamically stable infant with SVT?", "choices": [{"id": "node-2-choice-a", "text": "Apply ice pack to face (diving reflex) for 15-30 seconds", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Vagal maneuvers** are first-line for stable SVT. In infants, the **ice-to-face technique** (ice pack or cold washcloth to face for 15-30 seconds) triggers the diving reflex, stimulating the vagus nerve. This can terminate up to 50% of SVT episodes without medication.", "consequence": "You apply ice to the face and monitor the rhythm.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Immediate IV adenosine 0.1 mg/kg", "isOptimal": false, "isAcceptable": true, "feedback": "Adenosine is appropriate but should be used **after vagal maneuvers fail** in stable patients. Trying vagal maneuvers first is non-invasive, has no side effects, and can work quickly. Reserve adenosine for when vagal maneuvers are unsuccessful.", "consequence": "You skip vagal maneuvers and proceed directly to medication.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Synchronized cardioversion at 0.5-1 J/kg", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Synchronized cardioversion** is reserved for **hemodynamically unstable** patients. This infant has stable blood pressure and good perfusion. Cardioversion for a stable patient carries unnecessary risks.", "consequence": "Cardioversion in a stable patient is inappropriate.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Carotid sinus massage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Carotid massage is contraindicated in infants** and is generally avoided in young children. For infants, use the **ice-to-face** technique. In older children, Valsalva maneuver or blowing through a straw can be used.", "consequence": "You attempt an inappropriate vagal technique.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "IV verapamil 0.1 mg/kg", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Verapamil is contraindicated in infants under 1 year** due to risk of profound hypotension and cardiovascular collapse. Never use calcium channel blockers for SVT in infants!", "consequence": "Verapamil causes severe hypotension.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Vagal maneuvers by age**: Infants = ice to face (diving reflex). Children = Valsalva, blow through occluded straw, handstand. **NEVER** use carotid massage in infants or eyeball pressure in any age."}, "node-3": {"id": "node-3", "type": "decision", "content": "Vagal maneuvers were attempted twice but did not convert the rhythm. The infant remains hemodynamically stable with HR 260 bpm.", "question": "What is the most appropriate next step after failed vagal maneuvers?", "choices": [{"id": "node-3-choice-a", "text": "Adenosine 0.1 mg/kg IV rapid push with immediate flush", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Adenosine** is the first-line medication for stable SVT after failed vagal maneuvers. Key technique: **rapid IV push** through a large-bore IV close to the heart, followed by immediate **saline flush**. Adenosine's half-life is <10 seconds, so speed is critical!", "consequence": "You administer adenosine and observe for conversion.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Adenosine 0.5 mg/kg as slow IV infusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect on two counts. First, the dose is too high (0.1 mg/kg is initial, can increase to 0.2 mg/kg). Second, adenosine MUST be given as a **rapid push, not slow infusion**. Its half-life is <10 seconds - a slow infusion will be metabolized before reaching the heart.", "consequence": "Incorrect dosing and administration technique.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Synchronized cardioversion at 0.5-1 J/kg", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient is **still hemodynamically stable**. Adenosine should be tried before cardioversion. Cardioversion is reserved for unstable patients or when medications fail in stable patients.", "consequence": "Premature use of cardioversion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Procainamide loading dose", "isOptimal": false, "isAcceptable": true, "feedback": "Procainamide is a second-line agent if adenosine fails. However, adenosine should be attempted first (can try up to 0.3 mg/kg total) before moving to other antiarrhythmics. Procainamide is slower-acting and has more side effects.", "consequence": "You consider alternative antiarrhythmics.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Repeat vagal maneuvers for 5 minutes continuously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Vagal maneuvers should be brief attempts (15-30 seconds each). Prolonged continuous vagal stimulation is not recommended. After 2-3 failed attempts, proceed to adenosine.", "consequence": "You delay appropriate medication therapy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Adenosine administration tips**: Use most proximal IV site, give rapid push (< 2 seconds), immediately flush with 5-10 mL saline. Initial dose **0.1 mg/kg**, can increase to **0.2 mg/kg**, max **0.3 mg/kg** per dose. Max single dose 12 mg."}, "node-4": {"id": "node-4", "type": "decision", "content": "After the first adenosine dose (0.1 mg/kg), there is a brief pause on the monitor, then the SVT resumes at 255 bpm. The infant remains stable.", "question": "What is the most appropriate next step?", "choices": [{"id": "node-4-choice-a", "text": "Repeat adenosine at 0.2 mg/kg IV rapid push", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! When the first dose of adenosine causes a brief pause but SVT recurs, **double the dose to 0.2 mg/kg**. The brief pause confirms the drug reached the heart - you just need a higher dose. Can repeat once more at 0.3 mg/kg if needed (max 12 mg single dose).", "consequence": "SVT converts to sinus rhythm after the second adenosine dose.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Repeat same adenosine dose (0.1 mg/kg)", "isOptimal": false, "isAcceptable": true, "feedback": "You can repeat adenosine, but since the first dose caused only a brief pause, it's more effective to **increase the dose** to 0.2 mg/kg. Repeating the same dose is less likely to achieve sustained conversion.", "consequence": "You may need multiple attempts at the same dose.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Proceed to synchronized cardioversion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient is still stable, and you have not exhausted adenosine dosing. You can try up to **0.3 mg/kg** before considering cardioversion or alternative drugs in stable patients.", "consequence": "Premature cardioversion when medication options remain.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Start amiodarone infusion", "isOptimal": false, "isAcceptable": true, "feedback": "Amiodarone is a second-line option for refractory SVT, but you should first try higher doses of adenosine. Amiodarone takes longer to work and has significant side effects including hypotension.", "consequence": "You consider amiodarone as backup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Consult cardiology before any further intervention", "isOptimal": false, "isAcceptable": true, "feedback": "Cardiology consultation is appropriate for recurrent or refractory SVT, but you should continue treatment attempts while waiting. Don't delay adenosine re-dosing for consultation in a stable patient.", "consequence": "You consult while continuing treatment.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Adenosine dosing ladder**: 1st dose **0.1 mg/kg** \u2192 2nd dose **0.2 mg/kg** \u2192 3rd dose **0.3 mg/kg**. Max single dose **12 mg** (6 mg in smaller infants). Brief pause then recurrence = need higher dose. No response = check IV placement/flush technique."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified SVT by the fixed rate >220 bpm and narrow QRS. You appropriately tried vagal maneuvers (ice to face) first, then escalated to adenosine with proper rapid-push technique. After successful conversion, the infant should have an ECG to evaluate for WPW (delta wave) and be observed for recurrence. Cardiology follow-up is arranged for further evaluation."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points for stable SVT: 1) Identify by rate >220 (infants) with fixed rhythm, 2) Try **vagal maneuvers first** (ice to face in infants), 3) **Adenosine** rapid push with flush if vagal fails, 4) Escalate adenosine dose before cardioversion. Never use verapamil in infants!"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors made. Remember: **Verapamil is contraindicated in infants** - causes fatal hypotension. **Cardioversion is for unstable patients only**. In stable SVT, try vagal maneuvers \u2192 adenosine \u2192 consider other antiarrhythmics or cardioversion only if refractory."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-067", "title": "SVT Management - Hemodynamically Unstable", "domain": "cardiology", "difficulty": "intermediate", "tags": ["unstable SVT", "synchronized cardioversion", "shock with tachycardia", "svt management - hemodynamically unstable"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-month-old male is brought by ambulance after being found unresponsive by parents.\n\nSubjectively, parents report the baby was fussy and not feeding well for the past day. They found him limp and grayish in his crib this morning.\n\nPhysical Examination:\n- Vitals: HR 280/min, RR 60, BP 50/30 (hypotensive), SpO2 88% on room air\n- General: Lethargic, mottled, ashen color, capillary refill 5 seconds\n- Cardiovascular: Tachycardic, weak pulses, cool extremities\n- Lungs: Crackles at bases bilaterally, severe retractions\n- Neuro: Lethargic, minimal response to stimulation", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The monitor shows a narrow-complex tachycardia at 280 bpm. The infant is in shock with altered mental status, hypotension, and poor perfusion. The team is assembling for resuscitation.", "question": "What features indicate this infant with SVT is hemodynamically UNSTABLE?", "choices": [{"id": "node-1-choice-a", "text": "Hypotension, altered mental status, poor perfusion (cap refill >3 sec)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Signs of **hemodynamic instability** include: hypotension (BP 50/30), **altered mental status** (lethargy), **poor perfusion** (cap refill 5 sec, mottled, cool extremities), and **signs of shock**. This infant needs immediate intervention - you cannot wait for vagal maneuvers or adenosine trials.", "consequence": "You recognize the emergency and prepare for immediate cardioversion.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Heart rate >200 bpm alone defines instability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Heart rate alone does not define instability. Many infants tolerate SVT at rates >250 for hours before developing symptoms. **Stability is assessed by end-organ perfusion**, not just heart rate. Look for mental status changes, blood pressure, and perfusion.", "consequence": "You may misclassify stable patients as unstable.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Presence of narrow QRS confirms instability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. QRS width indicates the rhythm type (narrow = SVT, wide = VT or aberrant conduction), not hemodynamic stability. A patient can have narrow-complex SVT and be either stable or unstable depending on perfusion.", "consequence": "You confuse rhythm diagnosis with stability assessment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Crying and irritability indicate unstable SVT", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Crying and irritability may actually be reassuring signs that the infant is **maintaining perfusion** well enough to respond to distress. True instability shows **decreased responsiveness**, not increased. Lethargy is more concerning than irritability.", "consequence": "You may over-treat a stable patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Normal oxygen saturation excludes hemodynamic instability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Oxygen saturation can remain normal even in shock until very late. **Perfusion and blood pressure** are more reliable indicators than SpO2. This patient actually has low SpO2 (88%), but even 95% wouldn't exclude shock.", "consequence": "You may miss shock in a patient with normal SpO2.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Signs of hemodynamic instability** (PALS): Hypotension, altered mental status, signs of shock (poor perfusion, mottling, weak pulses, delayed cap refill >3 sec). In infants, lethargy and poor feeding may be the only signs."}, "node-2": {"id": "node-2", "type": "decision", "content": "This is an unstable infant with SVT. The team is ready for intervention. You have the defibrillator at bedside.", "question": "What is the IMMEDIATE intervention for this hemodynamically unstable infant with SVT?", "choices": [{"id": "node-2-choice-a", "text": "Synchronized cardioversion at 0.5-1 J/kg", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **hemodynamically unstable SVT**, immediate **synchronized cardioversion** is the treatment of choice. Start at **0.5-1 J/kg**. The 'synchronized' mode ensures the shock is delivered on the R wave, avoiding the vulnerable period that could cause VF. Do NOT delay for IV access or adenosine!", "consequence": "You prepare for synchronized cardioversion.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Vagal maneuvers (ice to face) first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While vagal maneuvers are first-line for **stable** SVT, in an **unstable** patient they waste precious time. This infant is in shock - every second counts. Proceed directly to synchronized cardioversion.", "consequence": "You delay definitive treatment in a crashing patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "IV adenosine 0.1 mg/kg rapid push", "isOptimal": false, "isAcceptable": true, "feedback": "Adenosine CAN be tried if **IV access is already available** and you can push it immediately, BUT do not delay cardioversion to obtain IV access. In this case, synchronized cardioversion is preferred since the patient is critically unstable.", "consequence": "You try adenosine but it may not work fast enough.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Unsynchronized defibrillation at 2 J/kg", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Unsynchronized** shocks (defibrillation) are for **pulseless rhythms** (VF, pulseless VT). For SVT with a pulse, you must use **synchronized** cardioversion. Unsynchronized shocks risk hitting the T wave and causing VF.", "consequence": "Risk of inducing ventricular fibrillation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Intubation and mechanical ventilation first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this patient may eventually need airway support, the **primary problem is the arrhythmia** causing cardiogenic shock. Fixing the rhythm will likely improve oxygenation. Intubation before cardioversion delays definitive treatment.", "consequence": "You address the secondary problem before the primary one.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PALS algorithm**: Unstable tachycardia with pulses \u2192 **Synchronized cardioversion**. Pulseless VT/VF \u2192 **Defibrillation** (unsynchronized). Always use sync mode for organized rhythms with a pulse!"}, "node-3": {"id": "node-3", "type": "decision", "content": "You deliver a synchronized shock at 1 J/kg. The rhythm briefly converts to sinus, then immediately returns to SVT at 275 bpm. The infant remains hypotensive and lethargic.", "question": "What is the most appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Repeat synchronized cardioversion at 2 J/kg", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! When the first cardioversion is unsuccessful or SVT immediately recurs, **increase the energy to 2 J/kg** and repeat. You may also consider adenosine between shocks if IV access is available. Continue resuscitation efforts.", "consequence": "You increase the energy and prepare for the second shock.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Repeat cardioversion at same energy (1 J/kg)", "isOptimal": false, "isAcceptable": true, "feedback": "You can repeat at the same energy, but PALS recommends **increasing to 2 J/kg** if the first shock fails. The brief conversion suggests you're close - a higher energy may achieve sustained conversion.", "consequence": "You may need multiple attempts at lower energy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Switch to unsynchronized defibrillation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The patient still has a pulse and an organized rhythm. **Unsynchronized defibrillation** is only for pulseless VT/VF. Continue with synchronized cardioversion at higher energy.", "consequence": "Risk of inducing VF in a patient with a pulse.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Start amiodarone 5 mg/kg IV slowly", "isOptimal": false, "isAcceptable": true, "feedback": "Amiodarone can be considered for refractory SVT, but it takes time to work and can cause hypotension. In an unstable patient, **repeat cardioversion** is preferred. Amiodarone is more useful as an adjunct after initial attempts.", "consequence": "You consider adjunct antiarrhythmic therapy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Stop resuscitation efforts - this rhythm is refractory", "isOptimal": false, "isAcceptable": false, "feedback": "Absolutely incorrect! One failed cardioversion does not mean the rhythm is refractory. The brief conversion shows it CAN work. Continue resuscitation - try higher energy, consider medications, and don't give up!", "consequence": "Premature termination of resuscitation.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Cardioversion energy**: Start at **0.5-1 J/kg**, increase to **2 J/kg** if unsuccessful. Brief conversion then recurrence = good sign, try higher energy. No response at all = check pad placement, consider adenosine between shocks."}, "node-4": {"id": "node-4", "type": "decision", "content": "After the second cardioversion at 2 J/kg, the rhythm converts to sinus rhythm at 150 bpm. Blood pressure improves to 70/45, and perfusion is better. The infant is breathing spontaneously.", "question": "What is the most important post-cardioversion management?", "choices": [{"id": "node-4-choice-a", "text": "Continuous cardiac monitoring and search for underlying cause", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After successful cardioversion, **continuous monitoring** is essential as SVT can recur. Search for **triggers** (fever, infection, electrolyte abnormalities, WPW, congenital heart disease). Obtain a 12-lead ECG to look for pre-excitation (delta waves) and order an echocardiogram.", "consequence": "You monitor closely and investigate the underlying cause.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Immediate discharge home with outpatient cardiology follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This infant was in **cardiogenic shock** and required cardioversion. They need admission for observation, monitoring for recurrence, and workup for underlying causes. Discharge is inappropriate.", "consequence": "Patient has recurrent SVT at home with no monitoring.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Prophylactic amiodarone infusion for all patients", "isOptimal": false, "isAcceptable": false, "feedback": "Prophylactic antiarrhythmics are not routinely indicated after a single episode. Decision to start maintenance therapy depends on **recurrence risk, underlying cause, and cardiology input**. Many infants will outgrow SVT.", "consequence": "Unnecessary medication with potential side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Immediate cardiac catheterization", "isOptimal": false, "isAcceptable": false, "feedback": "Cardiac catheterization is not indicated acutely. **Non-invasive workup** (ECG for WPW, echo for structural disease) should be done first. Catheterization/ablation may be considered later for recurrent SVT, typically in older children.", "consequence": "Invasive procedure is premature.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Start propranolol prophylaxis immediately", "isOptimal": false, "isAcceptable": true, "feedback": "Propranolol can be used for SVT prophylaxis, but the decision should be made **after cardiology consultation** and assessment of recurrence risk. First, stabilize the patient and complete the workup.", "consequence": "You consider prophylaxis after cardiology input.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Post-cardioversion checklist**: 1) Continuous monitoring (SVT can recur), 2) 12-lead ECG (look for WPW - delta waves), 3) Echocardiogram (structural heart disease), 4) Labs (electrolytes, thyroid), 5) Cardiology consultation for recurrence prevention."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of unstable SVT! You correctly identified hemodynamic instability (hypotension, altered mental status, poor perfusion), proceeded directly to synchronized cardioversion, escalated energy appropriately, and planned for post-cardioversion monitoring and workup. The infant is admitted for observation and cardiology evaluation."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points for **unstable SVT**: 1) Identify instability by **perfusion, not just rate**, 2) Go directly to **synchronized cardioversion 0.5-1 J/kg**, 3) Increase to **2 J/kg** if first shock fails, 4) Don't delay for IV access or adenosine in truly unstable patients, 5) Post-conversion: monitor, ECG, echo, cardiology consult."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors made. In **unstable SVT**: Do NOT delay for vagal maneuvers or IV access. Use **SYNCHRONIZED** cardioversion (not defibrillation) for rhythms with a pulse. Never give up after one failed shock - increase energy to 2 J/kg. Unsynchronized shocks risk causing VF!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-091", "title": "Innocent Heart Murmur Reassurance", "domain": "cardiology", "difficulty": "intermediate", "tags": ["musical or vibratory quality", "changes with position", "asymptomatic child", "grade 1-2", "innocent heart murmur reassurance"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male is brought for evaluation of a heart murmur heard during a routine physical examination for kindergarten entry.\n\nHis parents are concerned because the pediatrician mentioned a heart murmur. The child is completely asymptomatic - active, playful, no exercise intolerance, no chest pain, no syncope, no palpitations. He has normal growth.\n\nPhysical Examination:\n- General: Well-appearing, active child in no distress\n- Vitals: HR 90, BP 95/60, RR 18, SpO2 100%\n- Cardiovascular: Grade 2/6 low-pitched, vibratory/musical systolic murmur at LLSB. Murmur decreases with standing and increases with lying supine. Normal S1 and S2, no clicks or gallops. Peripheral pulses normal and symmetric.\n- Lungs: Clear bilaterally\n- Growth: 50th percentile height and weight", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This is an asymptomatic child with a soft systolic murmur. You need to determine if this is an innocent or pathologic murmur.", "question": "Which combination of features is MOST consistent with an innocent (functional) murmur?", "choices": [{"id": "node-1-choice-a", "text": "Grade \u22642, systolic, musical/vibratory quality, changes with position, asymptomatic child", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Innocent murmurs have these classic features: **Grade \u22642/6** (soft), **systolic timing** (never diastolic), **musical or vibratory quality**, **changes with position** (decreases standing, increases supine), and occur in **asymptomatic children** with normal growth. This child has all these features.", "consequence": "You recognize this as a likely innocent murmur.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Grade 4 with thrill, holosystolic, radiating to axilla", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **grade 4+ murmur with thrill** and **radiation** suggests pathology. Innocent murmurs are soft (\u22642), do not have thrills, and do not radiate. A holosystolic murmur radiating to the axilla suggests **mitral regurgitation**.", "consequence": "You consider pathologic causes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Diastolic murmur that does not change with position", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Diastolic murmurs are NEVER innocent** - they always require echocardiography. Diastolic murmurs suggest aortic regurgitation, mitral stenosis, or other pathology. Innocent murmurs are always systolic.", "consequence": "You recognize diastolic murmurs need workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Systolic murmur with fixed split S2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fixed split S2** is pathognomonic for **atrial septal defect (ASD)** and requires echocardiography. In innocent murmurs, S2 splits normally with respiration. Any abnormal heart sounds warrant further evaluation.", "consequence": "You recognize fixed split S2 needs evaluation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Harsh systolic murmur with ejection click", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. An **ejection click** suggests a bicuspid aortic valve or pulmonary stenosis. **Harsh quality** rather than musical/vibratory also suggests pathology. Innocent murmurs have a soft, musical quality without clicks.", "consequence": "You recognize clicks need workup.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**7 S's of Innocent Murmurs**: **S**oft (\u2264grade 2), **S**ystolic, **S**hort duration, **S**ingle (no extra sounds), **S**mall area (no radiation), **S**tanding decreases intensity, a**S**ymptomatic patient."}, "node-2": {"id": "node-2", "type": "decision", "content": "You've identified features consistent with an innocent murmur. The parents ask what type of innocent murmur this might be.", "question": "Based on the location (LLSB) and musical/vibratory quality, what is the MOST likely type of innocent murmur?", "choices": [{"id": "node-2-choice-a", "text": "Still's murmur - the most common innocent murmur in children", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Still's murmur** is the most common innocent murmur in children ages 2-7 years. It has a characteristic **musical, vibratory, or 'twanging string' quality** heard best at the **LLSB** or between LLSB and apex. It's thought to arise from vibrations in the LV outflow tract.", "consequence": "You identify the murmur type for parent education.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Venous hum - continuous murmur from jugular blood flow", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect location and quality. **Venous hum** is a **continuous murmur** (not just systolic) heard in the **neck/infraclavicular area**, not LLSB. It disappears with compression of the jugular vein or with lying supine. This murmur is systolic only.", "consequence": "You reconsider the murmur location.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Pulmonary flow murmur - heard at LUSB", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect location. **Pulmonary flow murmur** is heard at the **left upper sternal border (LUSB)**, not LLSB. It's common in thin children and high-output states (fever, anemia). This murmur is at the LLSB with musical quality - more consistent with Still's murmur.", "consequence": "You note the location difference.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Supraclavicular bruit - heard above the clavicles", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect location. **Supraclavicular bruit** is heard **above the clavicles** over the subclavian/brachiocephalic arteries. It's a systolic or continuous murmur that decreases with shoulder hyperextension. This murmur is at the LLSB.", "consequence": "You note this is a different murmur type.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Peripheral pulmonary stenosis - a newborn murmur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect age and location. **Peripheral pulmonary stenosis (PPS)** is heard in **newborns** (resolves by 3-6 months) at the axillae and back due to branch PA hypoplasia. This child is 5 years old with a murmur at LLSB.", "consequence": "You recognize this is not PPS by age.", "nextNodeId": "node-3"}], "clinicalPearl": "**Types of innocent murmurs**: **Still's murmur** (LLSB, musical, age 2-7), **Pulmonary flow murmur** (LUSB, age varies), **Venous hum** (neck, continuous), **Supraclavicular bruit** (above clavicle), **PPS** (newborns only)."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents are reassured about the innocent murmur diagnosis but ask whether their child needs any testing or activity restrictions.", "question": "What is the most appropriate management and counseling?", "choices": [{"id": "node-3-choice-a", "text": "Reassurance that no testing is needed; no activity restrictions; murmur may persist or resolve", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For a **classic innocent murmur** with all typical features, **no testing is needed** - not even an ECG or echocardiogram. The child has **no activity restrictions** and can participate fully in sports. Explain that the murmur may be louder with fever or exercise and may persist for years or eventually disappear.", "consequence": "Parents are appropriately reassured without unnecessary testing.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Order echocardiogram to confirm before reassurance", "isOptimal": false, "isAcceptable": true, "feedback": "Not necessary but acceptable. Echo is **not required** for a classic innocent murmur if the clinician is confident in the diagnosis. However, if there's any uncertainty, parental anxiety, or atypical features, echo can provide reassurance. Ordering unnecessary echos increases healthcare costs.", "consequence": "Echo confirms normal heart but adds cost.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-c", "text": "Restrict physical activity until cardiology evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activity restriction is NOT needed** for innocent murmurs. Restricting activity creates unnecessary anxiety and may harm the child's physical and social development. Innocent murmurs are benign - the heart is structurally normal.", "consequence": "Unnecessary restriction causes psychological harm.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Start subacute bacterial endocarditis (SBE) prophylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SBE prophylaxis is NOT indicated** for innocent murmurs because the heart is structurally normal - there's no abnormal endothelium for bacteria to adhere to. SBE prophylaxis is only for high-risk structural heart disease.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Refer urgently to pediatric cardiology", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Urgent referral is not needed** for classic innocent murmurs. Over-referral increases healthcare costs, parental anxiety, and wait times for patients who actually need cardiology. Reserve referral for concerning features.", "consequence": "Unnecessary referral increases parental anxiety.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Red flags requiring echo/referral**: Diastolic murmur, loud (\u22653/6), harsh quality, palpable thrill, abnormal S2 (fixed split, single), associated symptoms (syncope, chest pain, dyspnea), failure to thrive, abnormal ECG, family history of sudden death."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly identified a Still's murmur (the most common innocent murmur) by its classic features: soft, systolic, musical/vibratory quality at LLSB, changes with position, in an asymptomatic child. You appropriately reassured the family without unnecessary testing or restrictions. The child continues normal activities and the murmur resolves by age 10."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key innocent murmur features: **7 S's** - Soft, Systolic, Short, Single (no extra sounds), Small area, Standing decreases, aSymptomatic. Still's murmur is most common (LLSB, musical, ages 2-7). No testing, no restrictions, no SBE prophylaxis needed for classic innocent murmurs."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Innocent murmurs do NOT need SBE prophylaxis (no structural abnormality). Remember red flags that DO require workup: diastolic murmur, grade \u22653, harsh quality, thrill, abnormal S2, symptoms, failure to thrive, or family history of sudden cardiac death."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-092", "title": "Heart Murmur Intensity Change - PVR Mechanism", "domain": "cardiology", "difficulty": "intermediate", "tags": ["murmur louder over time", "VSD not heard at birth", "PVR drop", "heart murmur intensity change - pvr mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-month-old male with a known heart murmur is noted to have increased murmur intensity over the past few weeks.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 6-week-old infant is brought for follow-up. At birth, he had a **soft grade I/VI systolic murmur** that was thought to be innocent. Today, the murmur is **grade III/VI harsh holosystolic** at the left lower sternal border. Mom reports he is feeding more slowly and seems to \"work harder\" to breathe.\n\n**The PVR Physiology:**\n- At birth: **Pulmonary vascular resistance (PVR) is HIGH** (similar to systemic resistance)\n- Over first 6-8 weeks: PVR **gradually falls** as pulmonary vessels relax\n- Left-to-right shunts (VSD, PDA, ASD) become more apparent as PVR drops\n\n**Why the murmur changes:**\n- High PVR at birth \u2192 minimal pressure gradient across defect \u2192 soft/absent murmur\n- PVR drops \u2192 larger pressure gradient \u2192 **louder murmur** and more shunt flow", "question": "What is the most likely explanation for the increasing murmur intensity?", "choices": [{"id": "node-1-choice-a", "text": "VSD murmur increasing as pulmonary vascular resistance falls", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is the classic presentation of a **VSD becoming apparent** as PVR falls over the first weeks of life. At birth, high pulmonary pressures minimize the left-to-right shunt, so the murmur is soft or absent. As PVR drops to adult levels by 6-8 weeks, the pressure gradient across the VSD increases, causing a **louder murmur** and more shunt flow. This is why VSDs may be \"missed\" at newborn exam but detected at 6-week checkup.", "consequence": "You understand the physiology and proceed to workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Worsening of structural heart defect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **structural defect (VSD) hasn't changed** - it's the same size as at birth. What changed is the **pulmonary vascular resistance**. As PVR drops, the pressure gradient across the defect increases, making the shunt larger and the murmur louder. This is normal physiologic evolution, not progression of the anatomic defect.", "consequence": "Misunderstanding of mechanism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "New-onset endocarditis causing valve damage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Endocarditis is **extremely rare** in the first weeks of life without risk factors (central lines, surgery). The gradual increase in murmur intensity over 6 weeks with the pattern described (holosystolic at LLSB) is classic for VSD becoming audible as PVR drops. Endocarditis would present with fever, sepsis signs, and changing murmur in a sick-appearing child.", "consequence": "Endocarditis unlikely in this age/presentation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Anemia causing high-output state", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable. Anemia can cause a **flow murmur** due to increased cardiac output. However, anemia-related murmurs are typically **soft systolic ejection** murmurs at the LUSB, not harsh holosystolic murmurs at the LLSB. The location (LLSB) and character (holosystolic) are pathognomonic for VSD. Also, the gradual progression over 6 weeks matches PVR physiology.", "consequence": "Murmur characteristics more consistent with VSD.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Innocent murmur becoming louder due to growth", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Innocent murmurs do NOT become louder over time** - they remain soft (grade I-II) and often decrease or disappear with age. A murmur that progresses from grade I to grade III with symptoms (feeding difficulty, tachypnea) is **pathologic until proven otherwise**. The holosystolic character at LLSB is NOT an innocent murmur pattern.", "consequence": "This is not an innocent murmur - pathologic features present.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**VSD murmurs may be absent at birth** due to high PVR. Always re-examine infants at **6-8 weeks** when PVR has dropped - this is when many VSDs first become audible."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect a **VSD** that is now hemodynamically significant as PVR has dropped. The infant has mild tachypnea (RR 55) and is taking longer to feed.\n\nEchocardiogram confirms a **moderate-sized muscular VSD** with left-to-right shunt and mildly elevated pulmonary pressures.\n\n**VSD Clinical Spectrum:**\n- **Small VSD**: Loud murmur, no symptoms (\"maladie de Roger\" - small restrictive VSD)\n- **Moderate VSD**: Symptoms develop as PVR falls - CHF, poor feeding, FTT\n- **Large VSD**: Early heart failure, failure to thrive, requires surgery\n\n**Key concept**: Murmur loudness does NOT correlate with defect size. Small VSDs are often LOUDER than large ones (high velocity jet through small hole).", "question": "What is the appropriate management for this symptomatic moderate VSD?", "choices": [{"id": "node-2-choice-a", "text": "Cardiology referral, medical management (diuretics), and monitor for surgical timing", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A **symptomatic VSD** requires: (1) **Cardiology referral** for ongoing management, (2) **Medical therapy** with diuretics (furosemide) and possibly digoxin to manage heart failure symptoms, (3) **Nutritional support** - high-calorie feeds, NG tube if needed, (4) **Monitor** for surgical closure timing. Surgery is indicated if: failure to thrive despite medical management, persistent CHF, or evidence of pulmonary hypertension progression.", "consequence": "Appropriate management plan initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Immediate surgical closure - all VSDs need repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NOT all VSDs need surgical repair. **Small VSDs** often close spontaneously (up to 80% of small muscular VSDs close by age 5). Moderate VSDs may be managed medically initially with surgery reserved for those who fail medical therapy or develop complications. Immediate surgery is reserved for large VSDs with refractory heart failure or pulmonary hypertension.", "consequence": "Overly aggressive - many VSDs close spontaneously.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Reassurance - all VSDs close spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While many **small** VSDs close spontaneously, this infant has a **symptomatic moderate VSD** with feeding difficulties and tachypnea. Symptomatic VSDs require active management (diuretics, nutritional support) and close monitoring. Some will require surgical closure if symptoms persist or worsen despite medical therapy.", "consequence": "Symptomatic VSD needs active management, not just reassurance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Restrict fluids to reduce cardiac workload", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fluid restriction is NOT appropriate** in infants with CHD. These infants need **adequate calories for growth** - fluid restriction would worsen failure to thrive. The approach is **diuretics** (to reduce pulmonary congestion) combined with **concentrated high-calorie feeds** (to maximize nutrition in smaller volumes). Some infants need NG tube feeds to ensure adequate intake.", "consequence": "Fluid restriction worsens failure to thrive.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start prostaglandin E1 to keep ductus open", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prostaglandin E1 is used for **ductal-dependent** lesions (e.g., critical coarctation, HLHS, pulmonary atresia) where systemic or pulmonary blood flow depends on the PDA. A VSD is NOT ductal-dependent - it's a left-to-right shunt that worsens as the ductus closes. PGE1 would be contraindicated as it would add another source of left-to-right shunting.", "consequence": "PGE1 would worsen the shunt, not help.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Louder \u2260 Worse**: Small restrictive VSDs have the LOUDEST murmurs (high velocity jet through small hole). Large VSDs may have softer murmurs but more hemodynamic compromise."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is started on furosemide and concentrated formula. At 4-month follow-up, he is gaining weight appropriately and symptoms have improved. Echo shows the VSD appears slightly smaller.\n\n**Natural history of muscular VSDs:**\n- **Up to 80%** of small muscular VSDs close spontaneously by age 5\n- Closure occurs by tissue ingrowth and fibrous tissue formation\n- Perimembranous VSDs less likely to close spontaneously\n- Surgery indicated if: FTT despite medical therapy, persistent CHF, pulmonary HTN\n\n**Long-term considerations:**\n- Subacute bacterial endocarditis (SBE) prophylaxis: **NO longer routinely recommended** for unrepaired VSDs\n- Activity restrictions: Generally NOT needed for small/moderate VSDs", "question": "What is the most important long-term counseling for families of children with VSD?", "choices": [{"id": "node-3-choice-a", "text": "Good oral hygiene; SBE prophylaxis only for high-risk procedures if residual defect", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Current AHA guidelines: **SBE prophylaxis is NOT routinely recommended** for unrepaired VSDs. Prophylaxis is reserved for: (1) Prosthetic valves, (2) Prior endocarditis, (3) Certain cyanotic CHD, (4) First 6 months after surgical repair. **Good oral hygiene** is the most important preventive measure for all patients with structural heart disease. Most children with VSD have no activity restrictions.", "consequence": "Appropriate long-term counseling provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Lifelong antibiotics before all dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine SBE prophylaxis is NO longer recommended** for unrepaired VSDs per 2007 AHA guidelines (reaffirmed). The risk of adverse antibiotic reactions outweighs the small benefit. Prophylaxis is only for high-risk conditions (prosthetic valves, prior endocarditis, certain cyanotic CHD). Good oral hygiene and regular dental care are more important than antibiotic prophylaxis.", "consequence": "Outdated recommendation - routine prophylaxis no longer indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Strict activity restriction - no sports or exercise", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Most children with **small to moderate VSDs have NO activity restrictions**. They can participate in all sports and physical activities. Exercise restrictions are only considered for: (1) Large VSDs with significant pulmonary hypertension, (2) Post-surgical complications (arrhythmias, residual defects). Restricting activity in asymptomatic children is not beneficial and may cause psychological harm.", "consequence": "Activity restriction not needed for most VSDs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Annual cardiac catheterization to monitor pulmonary pressures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Echocardiography** is the primary monitoring tool for VSDs - it's non-invasive and can estimate pulmonary pressures. Cardiac catheterization is reserved for: (1) Pre-surgical evaluation when echo is inadequate, (2) Assessment of pulmonary vascular reactivity in cases with pulmonary hypertension, (3) Interventional closure (some perimembranous VSDs). Routine annual cath is NOT indicated.", "consequence": "Catheterization not needed for routine monitoring.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Surgical closure is always needed to prevent Eisenmenger syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Many VSDs close spontaneously** without surgery. Only large VSDs with significant shunting and failure to thrive/CHF require surgical closure to prevent Eisenmenger syndrome. Small and many moderate VSDs can be followed conservatively. The key is monitoring - if symptoms develop or pulmonary pressures rise, then surgical timing is reassessed.", "consequence": "Not all VSDs need surgery - many close spontaneously.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SBE prophylaxis paradigm shift**: AHA 2007 guidelines eliminated routine prophylaxis for most unrepaired CHD including VSD. Good oral hygiene is now emphasized as the most important preventive measure."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You understand the **PVR mechanism** for VSD murmur changes: (1) High PVR at birth \u2192 minimal shunt \u2192 soft/absent murmur, (2) PVR drops by 6-8 weeks \u2192 larger gradient \u2192 LOUDER murmur. Key management: diuretics + nutritional support for symptomatic VSDs; surgery if refractory CHF or FTT. Remember: louder \u2260 worse (small restrictive VSDs are loudest). SBE prophylaxis no longer routinely recommended - emphasize good oral hygiene instead."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review VSD physiology: (1) PVR drops over first 6-8 weeks \u2192 VSD murmur becomes audible/louder, (2) Murmur loudness does NOT correlate with severity (small VSDs are often loudest), (3) Many muscular VSDs close spontaneously, (4) Medical management: diuretics + concentrated feeds, (5) Surgery if refractory symptoms or pulmonary HTN, (6) SBE prophylaxis NOT routinely recommended - good oral hygiene is key."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. Key teaching: (1) VSD murmurs may be ABSENT at birth due to high PVR - re-examine at 6-8 weeks, (2) Louder murmur \u2260 worse defect (small VSDs are loudest), (3) Symptomatic VSDs need diuretics + high-calorie feeds (NOT fluid restriction), (4) PGE1 is for ductal-dependent lesions, NOT VSDs, (5) Many VSDs close spontaneously - surgery not always needed, (6) Innocent murmurs do NOT get louder over time."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-093", "title": "Bicuspid Aortic Valve Recognition", "domain": "cardiology", "difficulty": "intermediate", "tags": ["systolic ejection click", "murmur radiating to carotids", "young patient with aortic stenosis", "bicuspid aortic valve recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old male is referred for evaluation of a heart murmur with an ejection click heard on examination.\n\nOften asymptomatic initially but can develop aortic stenosis or regurgitation over time.\n\nPhysical Examination:\n- Adolescent or young adult with systolic ejection murmur at right upper sternal border radiating to carotids.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 14-year-old male is referred for a heart murmur discovered during sports physical. He is asymptomatic. On auscultation, you hear:\n\n- **Systolic ejection click** (high-pitched, early systolic) best at apex\n- **Systolic ejection murmur** (grade II/VI) at **right upper sternal border** (RUSB)\n- Murmur **radiates to the carotids**\n\n**The ejection click is the key finding:**\n- Caused by sudden tensing of abnormal valve leaflets during opening\n- **Aortic ejection click**: heard at apex, does NOT vary with respiration\n- **Pulmonic ejection click**: heard at LUSB, decreases with inspiration\n\n**Bicuspid aortic valve (BAV):**\n- **Most common congenital heart defect** (~1-2% of population)\n- Two leaflets instead of three (often fused commissure)\n- Often asymptomatic in childhood; complications develop over decades", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Bicuspid aortic valve", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The combination of **ejection click + systolic ejection murmur at RUSB + radiation to carotids** in a young patient is classic for **bicuspid aortic valve**. BAV is the most common congenital heart defect (1-2% of population) and the most common cause of aortic stenosis in patients <50 years old. The ejection click is caused by the abnormal valve leaflets snapping open.", "consequence": "You correctly identify the diagnosis and proceed to workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Hypertrophic cardiomyopathy (HCM)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HCM causes a systolic murmur but with **different characteristics**: (1) Murmur at LLSB (not RUSB), (2) **No ejection click** (HCM is subvalvular obstruction), (3) Murmur increases with Valsalva/standing (decreases preload). The RUSB location and radiation to carotids suggests **valvular** aortic disease, not HCM.", "consequence": "Wrong diagnosis - HCM has no ejection click.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Innocent (Still's) murmur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Still's murmur is **vibratory/musical** at the LLSB, does NOT radiate to carotids, and has **NO ejection click**. The presence of an ejection click is ALWAYS pathologic - it indicates an abnormal valve. This murmur at RUSB radiating to carotids suggests aortic valve pathology, not an innocent murmur.", "consequence": "Ejection click = NOT innocent.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Mitral valve prolapse", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MVP causes a **mid-systolic click** (not early ejection click) followed by a late systolic murmur at the **apex**. The click in MVP is from chordae snapping taut as the prolapsing leaflet billows back. This patient has an **early ejection click** at the RUSB - characteristic of **aortic valve** disease, not mitral valve disease.", "consequence": "Wrong valve - this is aortic, not mitral.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Aortic regurgitation", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. BAV can cause aortic regurgitation (AR), but AR has a **diastolic** decrescendo murmur (not systolic). This patient has a **systolic ejection murmur** suggesting outflow obstruction/turbulence, not regurgitation. However, BAV often develops both stenosis AND regurgitation over time, so both should be assessed on echo.", "consequence": "AR is diastolic; this systolic murmur suggests stenosis/turbulence.", "nextNodeId": "node-2"}], "clinicalPearl": "**Ejection click = valvular pathology**. An ejection click is NEVER innocent. Aortic ejection click: heard at apex, doesn't vary with breathing. Pulmonic ejection click: decreases with inspiration."}, "node-2": {"id": "node-2", "type": "decision", "content": "Echocardiogram confirms a **bicuspid aortic valve** with:\n- Two leaflets (right-left fusion pattern)\n- Mild aortic stenosis (gradient 25 mmHg)\n- No significant regurgitation\n- **Ascending aorta mildly dilated** (34 mm)\n\n**BAV-Associated Aortopathy:**\n- ~50% of BAV patients develop **ascending aortic dilation**\n- This is INTRINSIC to BAV (not just from abnormal flow) - related to connective tissue abnormality\n- Risk of **aortic dissection** (though lower than Marfan syndrome)\n- Must monitor aortic root dimensions at every visit\n\n**Associated conditions to screen for:**\n- **Coarctation of the aorta** (present in 20-50% with BAV)\n- Turner syndrome (30-50% have BAV)\n- Other left-sided obstructive lesions (Shone complex)", "question": "What associated condition should be screened for in all patients with BAV?", "choices": [{"id": "node-2-choice-a", "text": "Coarctation of the aorta", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Coarctation of the aorta is present in 20-50%** of patients with BAV - they must always be screened together. On exam, check: (1) **Blood pressure in arms vs legs** (arm BP higher in coarct), (2) **Femoral pulse delay** (radiofemoral delay), (3) Rib notching on CXR. If BAV is found, look for coarctation. If coarctation is found, look for BAV. Echo can visualize the descending aorta.", "consequence": "Appropriate screening initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Tetralogy of Fallot", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Tetralogy of Fallot (TOF) is NOT associated with bicuspid aortic valve. TOF involves right-sided lesions (pulmonary stenosis, VSD, overriding aorta, RVH). BAV is a LEFT-sided lesion associated with other left-sided obstructive defects: **coarctation**, interrupted aortic arch, and Shone complex (multiple left heart obstructions).", "consequence": "TOF is not associated with BAV.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Atrial septal defect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ASD is NOT specifically associated with bicuspid aortic valve. ASD is a shunt lesion, while BAV is associated with **obstructive left heart lesions** (coarctation, aortic stenosis). The embryologic pathways are different. The key associations for BAV are coarctation, Turner syndrome, and ascending aortopathy.", "consequence": "ASD not specifically associated with BAV.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Pulmonary valve stenosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pulmonary valve stenosis is a RIGHT-sided lesion, not associated with BAV (a LEFT-sided defect). BAV is associated with other LEFT-sided obstructive lesions through a shared developmental pathway. The classic association to remember is **BAV + Coarctation** - always screen for both when one is found.", "consequence": "Pulmonic stenosis is right-sided, not associated with BAV.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Ebstein anomaly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ebstein anomaly is a tricuspid valve defect (right-sided), not associated with BAV. Ebstein is associated with maternal lithium use and accessory pathways (WPW). BAV is associated with coarctation, Turner syndrome, and ascending aortopathy. Different embryologic origins.", "consequence": "Ebstein is right-sided, not associated with BAV.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**BAV + Coarctation**: 20-50% co-occurrence. If you find one, look for the other! Also screen for Turner syndrome in females with BAV (30-50% of Turner patients have BAV)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Blood pressure is equal in arms and legs with no radiofemoral delay (no coarctation). The patient is referred to cardiology for long-term management.\n\n**Long-term BAV management:**\n- Most patients remain **asymptomatic for decades**\n- Serial echo to monitor: valve function (stenosis/regurg), aortic root size\n- **Activity**: Most can participate in sports; avoid competitive sports if significant stenosis/dilation\n- **Aortic surgery**: Consider if ascending aorta >5.0-5.5 cm (lower threshold with rapid growth or family history of dissection)\n- **Valve intervention**: When symptoms develop or severe stenosis/regurgitation\n\n**SBE prophylaxis**: NOT routinely recommended for native BAV (same as other valvular disease per 2007 AHA guidelines)", "question": "What is the most appropriate long-term management for an asymptomatic adolescent with BAV and mild aortic dilation?", "choices": [{"id": "node-3-choice-a", "text": "Serial echocardiograms to monitor valve function and aortic root size", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Asymptomatic BAV patients need **serial echocardiographic surveillance** to monitor: (1) Valve function - progression of stenosis or development of regurgitation, (2) **Aortic root dimensions** - key for timing of potential aortic surgery. Frequency depends on severity (usually every 1-3 years). Most patients remain asymptomatic for decades but need lifelong monitoring for potential progression.", "consequence": "Appropriate surveillance plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Immediate aortic valve replacement to prevent complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic valve replacement is NOT indicated** for mild/moderate asymptomatic BAV. Surgery is reserved for: (1) Severe symptomatic stenosis, (2) Severe regurgitation with LV dysfunction, (3) Asymptomatic severe stenosis with LV dysfunction or declining exercise tolerance. This patient has only mild stenosis - he needs monitoring, not surgery.", "consequence": "Premature surgery for asymptomatic mild disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "No follow-up needed until symptoms develop", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. BAV requires **lifelong surveillance** even in asymptomatic patients. The two key complications - progressive valve disease and aortic dilation - can be detected early with serial imaging before symptoms occur. Waiting for symptoms risks missing the window for optimal intervention (e.g., aortic dissection can occur before symptoms of aortic dilation).", "consequence": "Inadequate surveillance risks missing complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Lifelong antibiotic prophylaxis before dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine SBE prophylaxis is NOT recommended** for native bicuspid aortic valve per 2007 AHA guidelines. Prophylaxis is only indicated for: (1) Prosthetic heart valves, (2) Prior endocarditis, (3) Certain cyanotic CHD. Good oral hygiene is emphasized as more important than antibiotic prophylaxis.", "consequence": "Routine prophylaxis not recommended for native BAV.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Complete restriction from all sports and physical activity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Most patients with **mild BAV can participate in sports** including competitive athletics. Restrictions are considered only for: (1) Moderate-severe aortic stenosis, (2) Significant aortic dilation (>4.0-4.5 cm), (3) History of arrhythmia. This patient with mild stenosis and only mild dilation can likely continue normal activities with periodic reassessment.", "consequence": "Excessive restriction for mild disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**BAV aortopathy is INTRINSIC** - not just from turbulent flow. Even patients with normal valve function need aortic root monitoring. The risk of dissection increases with diameter >5.0-5.5 cm."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of bicuspid aortic valve! Key teaching: (1) **Ejection click = valvular pathology** (never innocent), (2) BAV is most common CHD (1-2%) and most common cause of AS in patients <50, (3) **Screen for coarctation** (20-50% association), (4) Monitor aortic root (50% develop aortopathy), (5) Serial echo surveillance for valve function and aortic dimensions, (6) Activity usually unrestricted for mild disease, (7) SBE prophylaxis NOT routinely recommended."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review BAV key points: (1) Ejection click + RUSB murmur + carotid radiation = BAV, (2) Most common CHD (1-2%), (3) **Screen for coarctation** (not TOF, ASD, or right-sided lesions), (4) BAV-associated aortopathy is intrinsic - needs monitoring, (5) Lifelong echo surveillance for valve and aortic root, (6) SBE prophylaxis NOT routine, (7) Most can participate in sports."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. Key teaching: (1) **Ejection click is NEVER innocent** - always indicates valvular pathology, (2) BAV needs lifelong surveillance even when asymptomatic, (3) Don't operate on mild asymptomatic disease, (4) **Always screen for coarctation** when BAV is found (20-50% association), (5) BAV aortopathy can lead to dissection - must monitor aortic root."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-094", "title": "Cor Pulmonale in Cystic Fibrosis", "domain": "cardiology", "difficulty": "advanced", "tags": ["cor pulmonale", "cystic fibrosis", "pulmonary hypertension", "right heart failure", "hypoxic vasoconstriction", "lung transplant", "ECMO", "oxygen therapy"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 16-year-old male with cystic fibrosis (CF) presents with worsening dyspnea and peripheral edema over the past 3 weeks. His baseline FEV1 is 35% predicted (severe obstruction). He uses home oxygen at night but has been needing it during the day recently.\n\nVital signs: HR 105, BP 100/70, RR 26, SpO2 85% on room air (improves to 92% on 3L NC), T 37.2\u00b0C.\n\nPhysical exam:\n- General: Thin, cachectic adolescent in mild respiratory distress, prominent digital clubbing\n- Cardiac: Loud P2, right ventricular heave at left sternal border, elevated JVP to 12 cm\n- Lungs: Diffuse crackles and expiratory wheezes bilaterally, prolonged expiration\n- Abdomen: Hepatomegaly with pulsatile liver, mild ascites\n- Extremities: 2+ pitting edema to mid-shins bilaterally", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This CF patient presents with signs of right heart failure (elevated JVP, hepatomegaly, peripheral edema) in the context of severe chronic lung disease and hypoxemia.", "question": "What is the underlying mechanism causing this patient's right heart failure?", "choices": [{"id": "node-1-choice-a", "text": "Pulmonary hypertension from chronic hypoxic pulmonary vasoconstriction (cor pulmonale)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **cor pulmonale**\u2014right heart failure secondary to **pulmonary hypertension** caused by lung disease. In CF, chronic hypoxemia triggers **hypoxic pulmonary vasoconstriction**, leading to elevated pulmonary vascular resistance (PVR). Over time, the right ventricle hypertrophies, then dilates and fails. The loud P2 indicates elevated PA pressure.", "consequence": "Mechanism understood. Assess severity with echocardiogram.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Left ventricular failure with backward transmission of pressure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Left heart failure causes **pulmonary venous** hypertension (elevated PCWP), not pulmonary arterial hypertension. In LV failure, you would expect S3 gallop, mitral regurgitation murmur, and pulmonary edema. This patient has signs of **isolated right heart failure** with clear lung disease as the primary problem\u2014classic for cor pulmonale.", "consequence": "Misidentification of mechanism may lead to inappropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Primary pulmonary arterial hypertension (idiopathic PAH)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Primary PAH** is a diagnosis of exclusion in patients without underlying lung disease. This patient has **severe CF lung disease** (FEV1 35%), which clearly explains the pulmonary hypertension. Secondary causes (like CF) must be ruled out before diagnosing primary PAH.", "consequence": "Cor pulmonale from CF is secondary PAH, not primary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pulmonary embolism causing acute right heart strain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acute PE** causes sudden onset of dyspnea, tachycardia, and hypoxemia, not gradual worsening over weeks. While CF patients can develop PE (especially with central venous catheters), this patient's presentation\u2014chronic progressive symptoms with signs of chronic RV overload\u2014is classic for **cor pulmonale** from underlying lung disease.", "consequence": "Timeline and clinical picture don't support acute PE.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Constrictive pericarditis from chronic inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Constrictive pericarditis causes **equalization of diastolic pressures** and **Kussmaul sign** (JVP rise with inspiration). While CF can cause pericarditis, the presence of **loud P2** and **RV heave** point to **pulmonary hypertension**, not pericardial disease. Pericarditis wouldn't cause PA pressure elevation.", "consequence": "Physical exam findings point to pulmonary hypertension, not pericarditis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Cor pulmonale** = right heart failure from pulmonary hypertension caused by lung disease. The mechanism in CF: chronic hypoxemia \u2192 **hypoxic pulmonary vasoconstriction** \u2192 elevated PVR \u2192 RV hypertrophy \u2192 RV dilation/failure. Physical signs: loud P2 (elevated PA pressure), RV heave, JVD, hepatomegaly, peripheral edema."}, "node-2": {"id": "node-2", "type": "decision", "content": "Echocardiogram results:\n- **RV dilation** with moderate dysfunction (TAPSE 12 mm, normal >17)\n- **Tricuspid regurgitation** with estimated PA systolic pressure **55 mmHg** (normal <35)\n- Normal LV function (EF 60%)\n- Flattened interventricular septum (\"D-sign\" indicating RV pressure overload)\n- Small pericardial effusion\n\nBNP: 850 pg/mL (elevated, indicating ventricular strain)", "question": "What is the MOST important initial management for this patient's cor pulmonale?", "choices": [{"id": "node-2-choice-a", "text": "Optimize supplemental oxygen to maintain SpO2 >90% and intensify CF pulmonary management", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **primary treatment of cor pulmonale is treating the underlying lung disease**. In CF, this means: 1) **Supplemental O2** to reverse hypoxic pulmonary vasoconstriction (goal SpO2 >90%), 2) Aggressive **airway clearance** and bronchodilators, 3) Treat any superimposed infection, 4) Optimize nutrition. Oxygen is the only therapy proven to reduce mortality in cor pulmonale.", "consequence": "O2 increased to 4L NC. Aggressive pulmonary toilet initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start sildenafil or other pulmonary vasodilator therapy", "isOptimal": false, "isAcceptable": true, "feedback": "Pulmonary vasodilators (sildenafil, prostacyclins, endothelin receptor antagonists) are used in **primary PAH** but have **limited evidence in cor pulmonale** from lung disease. They can worsen V/Q mismatch by dilating vessels in poorly ventilated areas. The priority is treating the underlying lung disease and correcting hypoxemia. Vasodilators may be considered in refractory cases.", "consequence": "May help but not first-line. Focus on oxygen and CF management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Aggressive diuresis with furosemide to reduce edema", "isOptimal": false, "isAcceptable": true, "feedback": "Diuretics can help relieve **symptoms** of right heart failure (edema, ascites, hepatic congestion), but they do NOT address the underlying cause. Overly aggressive diuresis can reduce RV preload and worsen cardiac output. Use **gentle diuresis** while focusing on the primary treatment: **oxygen and CF management**.", "consequence": "Symptomatic relief but doesn't address root cause.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Start digoxin to improve right ventricular contractility", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Digoxin has no proven benefit** in cor pulmonale and may be harmful. The RV failure is due to pressure overload from pulmonary hypertension\u2014improving contractility doesn't help if afterload remains high. Additionally, CF patients often have electrolyte abnormalities that increase digoxin toxicity risk.", "consequence": "No benefit and potential harm. Not indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Refer for right heart catheterization before any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While right heart catheterization can confirm pulmonary hypertension and measure pressures precisely, it should NOT delay treatment. This patient needs **immediate oxygen therapy** and intensified CF management. Catheterization may be useful later for transplant evaluation or if considering advanced therapies.", "consequence": "Delays necessary treatment. Cath not urgent.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Treat the lungs, not just the heart!** Cor pulmonale treatment: 1) **Oxygen** (only proven mortality benefit\u2014goal SpO2 >90%), 2) Treat underlying lung disease aggressively, 3) Gentle diuresis for symptoms, 4) Avoid digoxin (no benefit). Pulmonary vasodilators are NOT first-line for cor pulmonale from lung disease."}, "node-3": {"id": "node-3", "type": "decision", "content": "With optimized oxygen therapy and intensified CF management:\n- SpO2 maintained 92-94% on 3-4L NC\n- Edema improving with gentle diuresis\n- Pulmonary exacerbation treated with IV antibiotics\n\nThe CF team discusses long-term prognosis. The patient's FEV1 has declined from 50% to 35% over 2 years, and he now has cor pulmonale.", "question": "What is the most important consideration for this patient's long-term management?", "choices": [{"id": "node-3-choice-a", "text": "Referral for lung transplant evaluation - cor pulmonale in CF indicates advanced disease", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Cor pulmonale in CF is a marker of advanced disease** and indicates the need for **lung transplant evaluation**. Standard criteria for transplant referral include: FEV1 <30% predicted (or rapidly declining), frequent hospitalizations, cor pulmonale/pulmonary hypertension, hypercapnia, or 5-year predicted survival <50%. This patient meets multiple criteria.", "consequence": "Transplant evaluation initiated. Listed for lung transplant.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Continue current management - cor pulmonale is common in CF and doesn't change prognosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cor pulmonale significantly worsens prognosis** in CF. It indicates severe pulmonary vascular disease and is associated with increased mortality. This is a critical turning point that warrants aggressive intervention, including transplant evaluation. Status quo management is insufficient.", "consequence": "Underestimates severity. Misses window for transplant.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Start CFTR modulator therapy (e.g., elexacaftor/tezacaftor/ivacaftor)", "isOptimal": false, "isAcceptable": true, "feedback": "CFTR modulators have **revolutionized CF care** and should be used if the patient is eligible (most common mutations). However, in a patient with **FEV1 35% and cor pulmonale**, modulators may slow decline but are unlikely to reverse established damage. Transplant evaluation should proceed in parallel\u2014these therapies are complementary, not alternatives.", "consequence": "Important therapy but doesn't replace transplant evaluation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Palliative care referral only - lung transplant is contraindicated in CF", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CF is an excellent indication for lung transplant** with good outcomes. Median survival post-transplant in CF is >8 years. While palliative care is important for symptom management, this young patient should absolutely be evaluated for transplant. CF is NOT a contraindication.", "consequence": "Denies potentially life-saving intervention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Chronic IV prostacyclin infusion for pulmonary hypertension", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prostacyclin therapy** is used for primary PAH, not cor pulmonale from lung disease. In CF, the pulmonary hypertension is driven by **hypoxia and lung destruction**\u2014vasodilators may worsen V/Q mismatch. The definitive treatment for end-stage CF is lung transplant, not chronic vasodilator infusion.", "consequence": "Not standard of care for CF cor pulmonale.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Lung transplant criteria in CF**: FEV1 <30% predicted (or rapid decline), frequent exacerbations requiring IV antibiotics, cor pulmonale/pulmonary hypertension, hypercapnia (pCO2 >50), massive hemoptysis, refractory pneumothorax, declining functional status. **Cor pulmonale = refer for transplant evaluation!**"}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient is listed for bilateral lung transplant. While awaiting transplant, he is maintained on:\n- Continuous supplemental oxygen\n- Aggressive airway clearance\n- CFTR modulator therapy\n- Nutritional optimization\n\nSix months later, he develops worsening right heart failure despite optimal medical therapy. His PA pressure has increased to 70 mmHg.", "question": "If this patient's condition continues to deteriorate before a donor becomes available, what bridging option might be considered?", "choices": [{"id": "node-4-choice-a", "text": "ECMO as a bridge to lung transplant in carefully selected patients", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ECMO (extracorporeal membrane oxygenation)** can be used as a **bridge to transplant** in patients with end-stage lung disease who are deteriorating while awaiting donor organs. VV-ECMO supports oxygenation; VA-ECMO can support both heart and lungs. This requires careful patient selection and should be done at a transplant center. Outcomes are improving but still carry significant risk.", "consequence": "Discussed with transplant team. ECMO available if needed.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Heart-lung transplant instead of isolated lung transplant", "isOptimal": false, "isAcceptable": true, "feedback": "**Heart-lung transplant** is rarely needed in CF, even with cor pulmonale. The right ventricle usually **recovers after lung transplant** once pulmonary pressures normalize. Isolated bilateral lung transplant is the standard for CF. Heart-lung transplant is reserved for patients with irreversible cardiac disease (rare in cor pulmonale).", "consequence": "Usually not needed. RV recovers after lung transplant.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Right ventricular assist device (RVAD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **RVAD** is used for isolated RV failure (e.g., post-cardiac surgery, RV infarct). In cor pulmonale, the problem is **high pulmonary vascular resistance**\u2014an RVAD cannot overcome this and may cause pulmonary hemorrhage. The solution is to address the lungs (transplant or ECMO), not mechanical support of the RV alone.", "consequence": "Not appropriate for cor pulmonale. Doesn't address high PVR.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Atrial septostomy to decompress the right heart", "isOptimal": false, "isAcceptable": false, "feedback": "**Atrial septostomy** creates a right-to-left shunt to decompress the RV in severe PAH, but it causes **systemic hypoxemia**. In a CF patient who is already severely hypoxic, this would be dangerous. It's occasionally used in primary PAH as palliation but is not appropriate here.", "consequence": "Would worsen hypoxemia in already hypoxic patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Hospice care - no further interventions are appropriate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hospice may be appropriate if the patient chooses comfort care, **this patient is listed for transplant** and may still benefit from bridging therapies. ECMO and other interventions can provide time for a donor to become available. Goals of care discussions are important, but ruling out all intervention is premature.", "consequence": "Premature to abandon curative options.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Bridge to transplant in CF**: ECMO can support patients with end-stage lung disease awaiting transplant. The RV typically **recovers after lung transplant** as pulmonary pressures normalize\u2014isolated lung transplant is usually sufficient even with cor pulmonale. Heart-lung transplant is rarely needed."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You recognized cor pulmonale in this CF patient, understood the mechanism (hypoxic pulmonary vasoconstriction \u2192 pulmonary hypertension \u2192 RV failure), prioritized oxygen therapy and aggressive CF management, and appropriately referred for lung transplant evaluation.\n\n**Key Learning Points:**\n- **Cor pulmonale** = RV failure from pulmonary hypertension caused by lung disease\n- Treat the lungs, not just the heart: **Oxygen** is the only proven therapy (goal SpO2 >90%)\n- Pulmonary vasodilators are NOT first-line for cor pulmonale from lung disease\n- **Cor pulmonale in CF = refer for lung transplant** (indicates advanced disease)\n- RV usually recovers after lung transplant; heart-lung transplant rarely needed\n- ECMO can bridge deteriorating patients to transplant"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While some aspects were managed correctly, there were errors in understanding the mechanism or treatment priorities.\n\n**Review:**\n- Cor pulmonale is RV failure from **pulmonary hypertension** caused by lung disease\n- The key treatment is **oxygen** and optimizing underlying lung disease\n- Pulmonary vasodilators have limited role in cor pulmonale (vs. primary PAH)\n- Cor pulmonale in CF indicates need for **transplant evaluation**\n- Digoxin has no proven benefit in cor pulmonale"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical errors in management.** Cor pulmonale in CF is a serious complication that requires aggressive intervention. Missing the window for transplant evaluation or providing inappropriate therapy can significantly impact survival.\n\n**Key Pearl:** Cor pulmonale is right heart failure from lung disease. Treat the underlying pulmonary condition (oxygen, CF management), not just the heart failure. In CF, cor pulmonale indicates advanced disease\u2014refer for lung transplant evaluation immediately."}}, "rootNodeId": "node-1"}], "growth_development": [{"id": "vignette-lens-peds-004", "title": "Simple Febrile Seizure", "domain": "growth_development", "difficulty": "intermediate", "tags": ["generalized seizure with fever", "back to baseline", "no focal findings", "simple febrile seizure", "parental education"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "An 18-month-old male is brought to the emergency department for a seizure at home.\n\nAccording to the caregiver, he had a fever for 1 day with runny nose, and this morning he suddenly became stiff and then started shaking all over. The episode lasted about 2 minutes and then he was confused but returned to normal within 30 minutes.\n\nReview of systems: He has been more tired than usual today. No neck stiffness, persistent lethargy, focal weakness, or repeated seizures.\n\nFamily history: His older sister had febrile seizures as a toddler.\n\nPhysical Examination:\n- General: Alert, interactive toddler in no acute distress. Temperature 39.2\u00b0C.\n- Neurologic: Normal tone and reflexes, no focal deficits, normal mental status.\n- HEENT: Mild rhinorrhea, tympanic membranes normal.\n- No meningeal signs.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child had a generalized seizure in the context of fever. You need to classify the seizure and determine if further workup is needed.\n\nKey history:\n- Duration: ~2 minutes\n- Type: Generalized (tonic-clonic)\n- Postictal: Back to baseline within 30 minutes\n- Age: 18 months (between 6 months - 5 years)\n- No prior afebrile seizures", "question": "What is the most likely diagnosis and classification?", "choices": [{"id": "node-1-choice-a", "text": "Simple febrile seizure", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a simple febrile seizure: generalized (not focal), duration <15 minutes, single episode within 24 hours, age 6 months to 5 years, no underlying neurologic condition, returns to baseline.", "consequence": "Proceed to determine workup and management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Complex febrile seizure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Complex febrile seizure has at least one of: focal features, duration >15 minutes, or recurrence within 24 hours. This seizure was generalized, lasted 2 minutes, and was a single episode.", "consequence": "Incorrect classification.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bacterial meningitis with seizure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child is alert, interactive, at baseline, with no meningeal signs or focal deficits. Meningitis presents with persistent altered mental status, neck stiffness, bulging fontanelle (in infants), or toxic appearance.", "consequence": "Wrong diagnosis leads to unnecessary workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "New-onset epilepsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A single seizure in the context of fever in this age group is most consistent with febrile seizure, not epilepsy. Epilepsy requires recurrent unprovoked seizures.", "consequence": "Incorrect diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Encephalitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Encephalitis presents with persistent altered mental status, behavioral changes, and often focal neurologic signs. This child is back to baseline with normal exam.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Simple vs Complex febrile seizure: Simple = generalized, <15 min, single episode, back to baseline. Complex = focal, >15 min, recurrent within 24h, or abnormal postictal."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have classified this as a simple febrile seizure. The child is now alert and interactive with a normal neurologic exam.\n\nThe parents are very anxious and ask what tests and imaging are needed.", "question": "What is the most appropriate workup for this simple febrile seizure?", "choices": [{"id": "node-2-choice-a", "text": "No routine labs, EEG, or imaging required - identify fever source", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For simple febrile seizures: NO routine labs, NO EEG, NO imaging (CT/MRI). Focus on identifying the fever source (viral URI in this case). AAP guidelines recommend against routine workup for simple febrile seizures.", "consequence": "Appropriate minimal workup. Proceed to parent education.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Lumbar puncture to rule out meningitis", "isOptimal": false, "isAcceptable": true, "feedback": "Not indicated. LP is considered only if: age <6-12 months, unimmunized against Hib/pneumococcus, meningeal signs present, or complex febrile seizure. This immunized 18-month-old with normal exam does not need LP.", "consequence": "Unnecessary invasive procedure.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Head CT to rule out intracranial pathology", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Neuroimaging is NOT indicated for simple febrile seizures. CT exposes the child to unnecessary radiation without clinical benefit. Reserve imaging for: focal seizures, prolonged postictal state, or abnormal neurologic exam.", "consequence": "Unnecessary radiation and testing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "EEG to evaluate for epilepsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. EEG is NOT indicated for simple febrile seizures. It does not predict recurrence or development of epilepsy. EEG abnormalities in febrile seizures do not change management.", "consequence": "Unnecessary testing without clinical utility.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "CBC, CMP, blood culture, and urinalysis", "isOptimal": false, "isAcceptable": true, "feedback": "Not routinely indicated. Labs should be directed at identifying the fever source if unclear, not at the seizure itself. In this case with obvious viral URI, extensive labs are not needed.", "consequence": "Overworkup.", "nextNodeId": "node-3"}], "clinicalPearl": "AAP guidelines for simple febrile seizure: NO routine EEG, NO routine neuroimaging, NO routine labs. LP only if meningeal signs, unimmunized, or high clinical suspicion."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents are relieved but very worried about future seizures.\n\nMother asks: \"Should we give him seizure medicine every day to prevent this from happening again? And will giving Tylenol every 4 hours when he has a fever prevent seizures?\"", "question": "What is the most appropriate response regarding seizure prevention?", "choices": [{"id": "node-3-choice-a", "text": "No daily prophylaxis needed. Antipyretics do NOT prevent febrile seizures but can be used for comfort.", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Key teaching points: 1) Daily anticonvulsant prophylaxis is NOT recommended for simple febrile seizures - risks outweigh benefits. 2) Antipyretics (Tylenol/ibuprofen) do NOT prevent febrile seizures - they may reduce fever but don't prevent the seizure. Use them for comfort only.", "consequence": "Appropriate counseling. Parents educated.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start daily phenobarbital to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Daily phenobarbital is NOT recommended for simple febrile seizures. Side effects (cognitive impairment, behavioral changes) outweigh benefits. Recurrence risk is ~30%, but seizures remain benign.", "consequence": "Unnecessary medication with significant side effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Yes, aggressive antipyretic therapy will prevent future seizures", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT - this is a common misconception. Studies show antipyretics do NOT prevent febrile seizures. Seizures often occur with the initial temperature spike, before parents notice the fever. Use antipyretics for comfort, not seizure prevention.", "consequence": "Misinformation given to family.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Prescribe rectal diazepam for home use during fevers", "isOptimal": false, "isAcceptable": true, "feedback": "Intermittent diazepam (oral or rectal) at fever onset CAN reduce recurrence but is generally not recommended for simple febrile seizures due to side effects (sedation, ataxia). May be considered for frequent recurrences or parental anxiety.", "consequence": "Overly aggressive management for benign condition.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Start daily levetiracetam (Keppra) as prophylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is no evidence supporting Keppra for febrile seizure prophylaxis, and it is not recommended by AAP guidelines. Simple febrile seizures are benign and do not require daily anticonvulsants.", "consequence": "Inappropriate medication.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Three key points for parents: 1) Simple febrile seizures do NOT cause brain damage. 2) Risk of developing epilepsy is only slightly increased (2% vs 1% general population). 3) Recurrence rate is ~30% - but seizures remain benign."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly managed this simple febrile seizure.\n\nKey Learning Points:\n1. Simple febrile seizure criteria: generalized, <15 min, single episode, age 6mo-5yr, normal postictal\n2. NO routine labs, EEG, or imaging for simple febrile seizures\n3. LP only if: meningeal signs, unimmunized, or high suspicion\n4. NO daily anticonvulsant prophylaxis recommended\n5. Antipyretics do NOT prevent febrile seizures\n6. Prognosis is excellent - does NOT cause brain damage or significantly increase epilepsy risk\n\nOutcome: Parents are reassured after thorough education. The child is discharged home with instructions to seek care for: seizures lasting >5 minutes, focal features, repeated seizures, or signs of meningitis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points about febrile seizures:\n\n- Simple febrile seizures are BENIGN\n- NO routine workup (EEG, imaging, labs) for simple febrile seizures\n- LP only if meningeal signs or unimmunized\n- Antipyretics do NOT prevent febrile seizures\n- Daily anticonvulsant prophylaxis not recommended\n\nRecurrence rate is ~30%, but prognosis remains excellent."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in febrile seizure management.\n\nRemember:\n- Simple febrile seizures do NOT cause brain damage\n- Daily anticonvulsants (phenobarbital, valproate) have significant side effects and are NOT recommended\n- Antipyretics do NOT prevent febrile seizures\n- Risk of epilepsy is only minimally increased (2% vs 1%)\n- The vast majority of children outgrow febrile seizures by age 5\n\nKey pearl: The most important intervention is parental education and reassurance."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-043", "title": "Roseola Infantum", "domain": "growth_development", "difficulty": "intermediate", "tags": ["fever first then rash", "HHV-6", "exanthem subitum", "febrile seizures", "viral exanthem"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "An 11-month-old female is brought to the clinic by her mother who is concerned about a new rash.\n\nHistory: The child had very high fevers (up to 40\u00b0C/104\u00b0F) for 3 days with no other symptoms - no cough, no runny nose, no vomiting, no diarrhea. The mother was very worried because the fevers were so high. Yesterday, the fever suddenly resolved, and this morning the child woke up with a pink rash on her trunk.\n\nThe mother notes that despite the high fevers, the child was relatively well-appearing, still drinking and playing, though slightly less active than usual.\n\nShe attends daycare. Developmentally normal. Up to date on vaccinations.\n\nPhysical Examination:\n- General: well-appearing, afebrile (37.1\u00b0C), playful child.\n- Skin: blanching, rose-pink maculopapular rash on trunk and neck, spreading to proximal extremities. Non-pruritic.\n- HEENT: normal, no Koplik spots, no conjunctivitis.\n- Lymph nodes: no significant lymphadenopathy.\n- Abdomen: no hepatosplenomegaly.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The mother is concerned about the rash and asks if her daughter has measles or some other serious illness. She wants to know if antibiotics are needed.", "question": "Based on the characteristic clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Roseola infantum (HHV-6 infection)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is the classic presentation of **roseola infantum** (also called exanthem subitum or 'sixth disease'): (1) **High fever for 3-5 days** without localizing symptoms, (2) **Rash appears AS fever resolves** (key diagnostic feature!), (3) Child appears **relatively well despite high fever**, (4) **Rose-pink, maculopapular rash** starting on trunk. Caused by **HHV-6** (or sometimes HHV-7).", "consequence": "You correctly identify roseola and reassure the mother.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Measles (rubeola)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Measles** has a very different presentation: (1) Prodrome of **cough, coryza, conjunctivitis** (3 C's), (2) **Koplik spots** (pathognomonic white spots on buccal mucosa), (3) Rash appears **DURING fever**, not after, (4) Rash starts on **face** and spreads downward, (5) Child appears **sick** during the illness. This child had no respiratory symptoms and no Koplik spots.", "consequence": "Measles workup would be unnecessary and anxiety-provoking.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Rubella (German measles)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Rubella** presents with: (1) **Mild prodrome** (low-grade fever, malaise), (2) **Postauricular and suboccipital lymphadenopathy** (classic finding), (3) Fine pink rash starting on **face**, spreading to trunk. This child had HIGH fever (not mild), no lymphadenopathy, and the rash appeared AFTER fever broke.", "consequence": "Misdiagnosis leads to unnecessary concern about congenital rubella syndrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Scarlet fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Scarlet fever** (Group A Strep) presents with: (1) **Sandpaper-textured rash**, (2) **Pharyngitis** with tonsillar exudates, (3) **Strawberry tongue**, (4) **Pastia lines** (accentuation in skin folds). This child has no pharyngitis, no sandpaper texture, and the rash appeared after fever resolved (not during acute illness).", "consequence": "Unnecessary antibiotics would be prescribed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Drug reaction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Drug reactions typically occur **7-14 days after starting a new medication** and often present with pruritus. There is no history of recent medication use. The temporal pattern (fever first, then rash as fever breaks) is pathognomonic for roseola, not a drug reaction.", "consequence": "Misdiagnosis delays appropriate reassurance.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Roseola's defining feature**: Rash appears AS fever resolves ('exanthem subitum' means 'sudden rash'). If fever and rash occur TOGETHER, consider measles, rubella, or scarlet fever instead. The child with roseola looks **surprisingly well** despite high fevers."}, "node-2": {"id": "node-2", "type": "decision", "content": "The mother asks 'Should she be on any medications? Do we need any tests?'", "question": "What is the most appropriate management for this child with roseola?", "choices": [{"id": "node-2-choice-a", "text": "Reassurance and supportive care only - self-limited illness", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Roseola is self-limited** and requires NO specific treatment. Management: (1) **Reassurance** - explain the illness is nearly over now that the rash has appeared, (2) **Antipyretics** (acetaminophen/ibuprofen) for fever/discomfort if still febrile, (3) **Adequate hydration**, (4) No isolation needed - by the time rash appears, the child is no longer contagious. The rash will fade in 1-3 days.", "consequence": "Mother is reassured. The rash fades over 2 days without any intervention.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Prescribe acyclovir for HHV-6 infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antivirals are NOT indicated** for roseola in immunocompetent children. Acyclovir has limited activity against HHV-6, and the infection is self-limited. Antivirals (ganciclovir, foscarnet) are only considered in **immunocompromised patients** with severe HHV-6 disease.", "consequence": "Unnecessary medication with no clinical benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Prescribe antibiotics to prevent secondary infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Roseola is a viral illness** - antibiotics have no role. There is no bacterial component to treat or prevent. Prescribing unnecessary antibiotics contributes to antimicrobial resistance and exposes the child to medication side effects.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Order blood tests and viral studies to confirm diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Roseola is a clinical diagnosis** - laboratory testing is unnecessary in typical cases. HHV-6 serologies or PCR can be obtained in atypical presentations or immunocompromised patients, but routine testing adds cost without changing management in a well-appearing child with classic presentation.", "consequence": "Unnecessary testing and healthcare costs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Admit to hospital for observation given high fevers", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child is now **afebrile and well-appearing**. The fever phase has passed. Hospitalization is not indicated. The appearance of the rash actually signals that the illness is resolving. Hospital admission would be considered only for complications (e.g., febrile seizures with concerning features).", "consequence": "Unnecessary hospitalization.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Roseola management**: Supportive care ONLY. No antivirals (acyclovir doesn't work well for HHV-6). No antibiotics (it's viral). No labs needed (clinical diagnosis). By the time the rash appears, the child is **no longer contagious** and the illness is nearly over."}, "node-3": {"id": "node-3", "type": "decision", "content": "Before leaving, the mother asks one more question: 'My neighbor said her son had a seizure with roseola. Should I be worried? What should I watch for?'", "question": "What is the most important anticipatory guidance to provide regarding complications of roseola?", "choices": [{"id": "node-3-choice-a", "text": "Febrile seizures occur in 10-15% during the fever phase but are typically benign", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Febrile seizures** are the most common complication of roseola, occurring in **10-15% of cases** - higher than other febrile illnesses due to the very high fevers. Key points: (1) Seizures occur during the **febrile phase** (not after rash appears), (2) Most are **simple febrile seizures** (brief, generalized, no recurrence in 24 hours), (3) **Do not indicate epilepsy**, (4) Since this child is now afebrile with rash, the seizure risk has passed.", "consequence": "Mother is reassured that the risky period has passed since fever has resolved.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Recommend prophylactic anticonvulsants during any future febrile illness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic anticonvulsants are NOT recommended** for simple febrile seizures. Studies show they do not prevent seizures and have significant side effects. Even children who have had a febrile seizure do not routinely receive prophylaxis. Antipyretics also don't prevent febrile seizures.", "consequence": "Unnecessary medication with potential side effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Order EEG to evaluate seizure risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **EEG is not indicated** for simple febrile seizures and is not routinely ordered for roseola. EEG is considered only for complex febrile seizures or if there is concern for underlying epilepsy. This child has no history of seizures.", "consequence": "Unnecessary testing and parental anxiety.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "The rash itself can cause neurological complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **rash is NOT associated with complications**. The rash actually indicates the illness is resolving. Neurological complications (seizures, rarely encephalitis) occur during the **febrile phase**, before the rash appears. Once the rash is present, the acute infection is ending.", "consequence": "Incorrect information provided to family.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "HHV-6 causes permanent immunity - she cannot get roseola again", "isOptimal": false, "isAcceptable": true, "feedback": "This is true - HHV-6 does establish latent infection and immunity, so clinical roseola typically occurs only once. However, this is less important than discussing febrile seizure risk, which was the mother's specific concern. The primary teaching point should address her question about seizures.", "consequence": "True information but doesn't address the mother's main concern.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Roseola and febrile seizures**: 10-15% of children with roseola have febrile seizures (highest of any common childhood infection). This is due to the very HIGH fevers (often >40\u00b0C). Seizures occur during the FEVER phase - once the rash appears, the risk has passed. HHV-6 is the most common cause of febrile seizures."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly diagnosed roseola based on its classic presentation, provided appropriate reassurance and supportive care, and educated the family about febrile seizure risk.\n\n**Key Learning Points:**\n- **Roseola** = high fever for 3-5 days, then **rash appears AS fever resolves**\n- Caused by **HHV-6** (or HHV-7); nearly universal infection by age 2\n- Child appears **well despite high fever** (unlike measles where child is sick)\n- **No specific treatment needed** - self-limited illness\n- **Febrile seizures** occur in 10-15% (during fever phase, not after)\n- Once rash appears, the child is **no longer contagious** and illness is resolving\n- **Clinical diagnosis** - no labs needed in typical cases"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key features of roseola.\n\n**Key Teaching Points:**\n- Roseola: fever FIRST, rash AFTER fever breaks (opposite of measles)\n- No Koplik spots, no cough/coryza/conjunctivitis (differentiates from measles)\n- Clinical diagnosis - labs not needed\n- Self-limited - no antivirals or antibiotics\n- Febrile seizures are the main complication (during fever phase)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in roseola management.\n\n**Critical Teaching Points:**\n- Roseola is VIRAL - antibiotics are never indicated\n- No antivirals needed in immunocompetent children\n- Don't hospitalize well-appearing afebrile children\n- Don't prescribe prophylactic anticonvulsants for febrile seizure risk\n- Remember: rash appearance means the illness is ENDING, not beginning"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-053", "title": "Developmental Milestones - 6 Months", "domain": "growth_development", "difficulty": "intermediate", "tags": ["developmental milestones - 6 months"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-month-old female is brought in by her parents for well-child visit.\n\nAccording to the caregiver, parents have no concerns. She is sitting with support, reaching for toys, and babbling. She recognizes her parents and stranger anxiety is starting.\n\nReview of systems is positive for meeting milestones appropriately and negative for regression or concerns.\n\nPertinent history includes She was born full-term with no complications.\n\nPhysical Examination:\n- Motor: sits with support, reaches and transfers objects.\n- Social: smiles, laughs, recognizes parents.\n- Language: babbles, coos.\n- General: well-appearing, interactive infant.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You perform a developmental assessment. At **6 months**, you expect to see milestones across all four developmental domains:\n\n**Gross Motor**: Sits with support, rolls over both ways\n**Fine Motor**: Reaches for objects, transfers objects hand-to-hand\n**Language**: Babbles consonant sounds (ba, da, ga), responds to name\n**Social**: Recognizes familiar faces, stranger anxiety emerging, laughs", "question": "Which developmental milestone would be MOST concerning if absent at 6 months?", "choices": [{"id": "node-1-choice-a", "text": "Absence of social smile", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Social smile** should appear by **2 months** and absence at 6 months is very concerning. This is a **red flag** for social-emotional development and could indicate autism spectrum disorder, global developmental delay, or significant visual impairment. Social smile is one of the earliest and most important social milestones - its absence warrants immediate developmental evaluation.", "consequence": "You recognize the most critical social milestone.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Not walking independently", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Independent walking** typically develops between **12-15 months**. Not walking at 6 months is completely normal - most infants are just learning to sit at this age. Walking before 9 months would actually be unusually early.", "consequence": "Expected finding at this age.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Unable to speak in 2-word phrases", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **2-word phrases** typically emerge around **18-24 months**. At 6 months, infants should be babbling with consonant sounds but not using words. Expecting phrases at 6 months would be developmentally inappropriate.", "consequence": "This milestone is not expected until much later.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Unable to feed self with utensils", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Self-feeding with utensils** develops around **15-18 months**. At 6 months, infants are just starting solid foods and may finger-feed but cannot use utensils. This milestone is not expected at this age.", "consequence": "This milestone is not expected until much later.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Not yet potty trained", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Toilet training** typically occurs between **2-4 years of age**. Expecting any bladder/bowel control at 6 months is developmentally inappropriate. This would not be assessed at a 6-month visit.", "consequence": "This milestone is not expected until years later.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Developmental Red Flags at 6 months**: No social smile (should be present by 2 months), no response to sounds/voices, no reaching for objects, persistent fisting (hands always closed), marked head lag when pulled to sit. Remember: **social smile by 2 months** is a critical early milestone."}, "node-2": {"id": "node-2", "type": "decision", "content": "This infant is meeting all milestones appropriately. The parents ask about anticipatory guidance for the coming months.\n\nYou discuss safety, nutrition, and what to expect developmentally.", "question": "What is the appropriate feeding guidance for a 6-month-old?", "choices": [{"id": "node-2-choice-a", "text": "Introduce complementary solid foods while continuing breast milk or formula as primary nutrition", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **6 months** is the recommended age to introduce **complementary foods** (iron-fortified cereals, pureed fruits/vegetables, meats). However, **breast milk or formula remains the primary source of nutrition** until age 1 year. Start with single-ingredient foods, one at a time, every 3-5 days to identify potential allergies. Current guidelines no longer recommend delaying allergenic foods (peanut, egg, etc.) - early introduction may actually prevent allergies.", "consequence": "You provide correct feeding guidance.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Switch from breast milk/formula to whole cow's milk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cow's milk should not be introduced until 12 months** as a primary drink. Before age 1, cow's milk can cause **intestinal blood loss** (occult GI bleeding), is low in iron (contributing to iron deficiency anemia), and has an inappropriate protein/mineral composition for infants. Breast milk or iron-fortified formula should remain the primary milk source.", "consequence": "This could cause iron deficiency anemia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Continue exclusive breastfeeding until 12 months before introducing any solids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While breastfeeding is excellent, **exclusive breastfeeding beyond 6 months** increases risk of **iron deficiency** and **nutritional deficiencies**. The AAP recommends introducing iron-rich complementary foods at **6 months** while continuing breastfeeding. Breast milk alone cannot meet all nutritional needs after 6 months.", "consequence": "Risk of iron deficiency and growth faltering.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Avoid all allergenic foods (peanut, egg, fish) until age 3", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Outdated guidance!** Current evidence shows that **early introduction of allergenic foods** (around 4-6 months) may actually **prevent food allergies**. The LEAP study demonstrated that early peanut introduction significantly reduced peanut allergy in high-risk infants. Delaying allergenic foods is no longer recommended.", "consequence": "Outdated advice that may increase allergy risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Honey can be added to foods to improve taste acceptance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Honey is contraindicated in infants <12 months** due to risk of **infant botulism**. Clostridium botulinum spores in honey can germinate in the infant's immature gut and produce toxin, causing a potentially fatal descending paralysis. Even small amounts of honey are dangerous.", "consequence": "Dangerous advice - risk of infant botulism.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Feeding timeline**: Breast milk/formula only until 6 months \u2192 Introduce complementary foods at 6 months (iron-fortified) \u2192 Continue breast milk/formula as primary nutrition until 12 months \u2192 Whole cow's milk after 12 months. **NO honey <12 months** (botulism risk). **Early allergen introduction** is now recommended."}, "node-3": {"id": "node-3", "type": "decision", "content": "The visit is going well. Before concluding, you review the developmental screening schedule.\n\nThe AAP recommends routine developmental surveillance at every well-child visit, with **standardized screening** at specific ages.", "question": "At which ages does the AAP recommend formal developmental screening with a standardized tool?", "choices": [{"id": "node-3-choice-a", "text": "9, 18, and 30 months for developmental screening; additionally 18 and 24 months for autism-specific screening", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The AAP recommends **standardized developmental screening** at **9, 18, and 30 months** using tools like the ASQ (Ages and Stages Questionnaire). Additionally, **autism-specific screening** (M-CHAT) should be performed at **18 and 24 months**. Developmental **surveillance** (informal assessment) should occur at every well-child visit, but formal screening with validated tools is recommended at these specific ages.", "consequence": "You understand the screening schedule.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Only at 12 months and 3 years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This misses critical screening windows. The **18-month visit** is particularly important for early autism detection, and 30-month screening catches delays that may not be apparent earlier. The AAP's recommended schedule (9, 18, 30 months for development; 18, 24 months for autism) is evidence-based for optimal early detection.", "consequence": "Missing key screening ages delays early intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "At every well-child visit from birth to 5 years with a standardized tool", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **surveillance** (informal assessment) should occur at every visit, **standardized screening tools** are recommended at specific ages (9, 18, 30 months). Universal screening at every visit would be resource-intensive and not evidence-based. The key is combining routine surveillance with targeted formal screening.", "consequence": "Excessive screening without improved outcomes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Only when parents express concerns about development", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Waiting for parental concerns misses many children with developmental delays. Studies show that **parents may not recognize delays**, especially subtle ones or when comparing to only one child. **Universal screening** at recommended ages catches delays that might otherwise be missed until school entry, when intervention is less effective.", "consequence": "Many delays would be missed with this approach.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Developmental screening is only needed for high-risk infants (preterm, NICU graduates)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While high-risk infants need closer monitoring, **developmental delays occur in all populations**. Many children with delays have no identifiable risk factors. The AAP recommends **universal screening** at 9, 18, and 30 months for ALL children, regardless of risk status.", "consequence": "Many children without risk factors have delays.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **AAP screening schedule**: Developmental screening at **9, 18, 30 months** (ASQ or PEDS); Autism screening at **18 and 24 months** (M-CHAT-R/F). Surveillance at every visit. **Early intervention** (before age 3) dramatically improves outcomes - 'the earlier, the better' for brain plasticity and skill development."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You performed an appropriate 6-month developmental assessment, recognized key milestones across all domains, provided correct anticipatory guidance about feeding (complementary foods at 6 months, continued breast milk/formula, no honey, early allergen introduction), and understood the AAP's developmental screening schedule. This comprehensive well-child care sets the stage for optimal growth and early detection of any delays."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key 6-month development concepts: (1) **Milestones**: sits with support, transfers objects, babbles, social smile, stranger anxiety; (2) **Red flags**: no social smile by 2 months, no reaching, no response to sounds; (3) **Feeding**: complementary foods at 6 months, continue breast milk/formula until 12 months; (4) **Screening**: formal developmental screening at 9, 18, 30 months."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. 6-month milestones: gross motor (sits with support, rolls), fine motor (reaches, transfers), language (babbles), social (smiles, laughs, stranger anxiety). **Critical guidance**: No cow's milk until 12 months (causes iron deficiency), no honey until 12 months (botulism risk), introduce complementary foods at 6 months, early allergen introduction is now recommended. Screening at 9, 18, 30 months developmental; 18, 24 months autism."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-054", "title": "Autism Spectrum Disorder - Early Signs", "domain": "growth_development", "difficulty": "intermediate", "tags": ["lack of joint attention", "no pointing", "poor eye contact", "repetitive behaviors", "autism spectrum disorder - early signs"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-year-old male is brought to the emergency department for not talking and not responding to his name.\n\nPer the parents, he has only 2 words and does not point or wave. He does not respond when his name is called but turns when he hears the TV. He prefers to play alone and lines up his cars repetitively.\n\nrepetitive hand movements and distress with routine changes. No hearing problems or regression.\n\nPertinent history includes He was born full-term with no complications. Language has always been delayed.\n\nPhysical Examination:\n- Behavioral: limited eye contact, no joint attention, repetitive play.\n- Communication: 2-word vocabulary, does not point.\n- General: well-appearing toddler, normal physical exam.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-year-old presents with several concerning features: limited vocabulary (only 2 words at age 2), absence of gesturing (no pointing or waving), poor response to name (but intact hearing suggested by response to TV), preference for solitary play, and repetitive behaviors (lining up cars, hand movements).", "question": "Which combination of features is MOST specific for autism spectrum disorder (ASD)?", "choices": [{"id": "node-1-choice-a", "text": "Lack of joint attention + repetitive/restricted behaviors + poor social reciprocity", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! ASD is defined by two core domains: (1) **Deficits in social communication/interaction** - lack of joint attention (sharing interest by pointing/showing), poor eye contact, limited social-emotional reciprocity, and (2) **Restricted/repetitive behaviors** - stereotyped movements, insistence on sameness, restricted interests. Both domains must be present for diagnosis.", "consequence": "You recognize the core ASD features. Proceed with evaluation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Speech delay alone is sufficient for ASD diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Speech delay alone is NOT specific for ASD - it can occur with hearing loss, intellectual disability, or specific language impairment. ASD requires both **social communication deficits** AND **restricted/repetitive behaviors**. Many children with speech delay do NOT have ASD.", "consequence": "Incomplete understanding of diagnostic criteria.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Intellectual disability with any behavioral problems", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Intellectual disability (ID) and ASD are separate diagnoses, though they can co-occur. ASD diagnosis requires specific social communication deficits and restricted/repetitive behaviors, not just general cognitive delay and behavioral problems.", "consequence": "Confusing ID with ASD criteria.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Not responding to name indicates hearing loss, not ASD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child responds to the TV, suggesting **intact hearing**. The selective response to non-social sounds (TV) but not to name is actually CHARACTERISTIC of ASD - children with ASD often have preferential attention to non-social stimuli. Hearing evaluation is still needed to rule out partial hearing loss.", "consequence": "Missing a key ASD feature.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Preference for solitary play is normal at age 2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While parallel play is normal at age 2, **complete lack of interest in other children** combined with absence of shared enjoyment, joint attention, and social reciprocity is concerning for ASD. Normal 2-year-olds show interest in peers, even if not engaging in cooperative play.", "consequence": "Dismissing a red flag as normal.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ASD DSM-5 criteria require BOTH**: (A) Social communication deficits (in all 3: social-emotional reciprocity, nonverbal communication, relationships) AND (B) Restricted/repetitive behaviors (in \u22652 of 4: stereotyped movements, insistence on sameness, restricted interests, sensory issues)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect ASD based on the clinical presentation. The parents are concerned and ask what should be done next. The child's 18-month well-child visit noted 'speech delay - will monitor.'", "question": "What is the most appropriate IMMEDIATE next step?", "choices": [{"id": "node-2-choice-a", "text": "Order audiology evaluation AND refer to Early Intervention (EI) services simultaneously", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Audiology evaluation is MANDATORY** to rule out hearing loss contributing to communication delay - do not assume hearing is normal. **Early Intervention referral should happen immediately** (under Part C of IDEA) without waiting for a formal ASD diagnosis. EI eligibility is based on developmental delay, not diagnosis. **Do NOT 'wait and see.'**", "consequence": "Audiology scheduled. EI referral sent today. M-CHAT administered.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Wait until age 3 when more reliable ASD testing can be performed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **'Wait and see' is NEVER appropriate** when developmental concerns exist. ASD can be reliably diagnosed by age 2, and early intervention during the critical period of brain plasticity significantly improves outcomes. Delays in referral result in missed therapeutic opportunity.", "consequence": "Critical window for early intervention is lost.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Order brain MRI to evaluate for structural abnormalities", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine brain imaging is NOT recommended** for ASD evaluation unless there are focal neurologic findings, seizures, or macrocephaly/microcephaly. ASD is a clinical diagnosis; imaging does not aid in diagnosis and delays appropriate intervention.", "consequence": "Unnecessary testing delays intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Reassure parents that boys often talk late and recommend speech therapy only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and harmful! While boys may have slightly later language milestones, the **social communication deficits and repetitive behaviors** are not explained by 'late talking.' Dismissing concerns delays diagnosis. Speech therapy alone is insufficient - ASD requires comprehensive behavioral intervention.", "consequence": "Dismissing red flags delays appropriate evaluation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start a trial of stimulant medication for attention concerns", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child does not have ADHD symptoms as the primary concern - the presentation is classic for ASD. Stimulants do not address core ASD deficits and are not first-line treatment. **Applied Behavior Analysis (ABA)** and developmental therapies are the evidence-based treatments for ASD.", "consequence": "Inappropriate treatment that doesn't address ASD.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**AAP guidelines**: Screen ALL children for ASD at 18 and 24 months with M-CHAT-R/F. If concerns exist, **refer immediately** to: (1) Audiology, (2) Early Intervention, (3) Developmental pediatrics/neuropsychology. **Do NOT wait for diagnosis** to start intervention."}, "node-3": {"id": "node-3", "type": "decision", "content": "You administer the M-CHAT-R/F (Modified Checklist for Autism in Toddlers, Revised with Follow-Up). Results: Total score 8 (high risk for ASD). Audiology evaluation shows normal hearing bilaterally.", "question": "The M-CHAT is positive. What is the sensitivity and specificity profile of this screening tool, and what should happen next?", "choices": [{"id": "node-3-choice-a", "text": "M-CHAT has good sensitivity but moderate specificity; positive screen requires comprehensive developmental evaluation to confirm diagnosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! M-CHAT-R/F has **sensitivity ~85%** and **specificity ~50-70%** after follow-up questions. A positive screen is NOT diagnostic but identifies children who need **comprehensive evaluation** by a specialist (developmental pediatrician, child psychologist, or child neurologist). The evaluation uses tools like ADOS-2 (gold standard observational assessment).", "consequence": "Referral made to developmental pediatrics for comprehensive evaluation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "A positive M-CHAT confirms ASD diagnosis; no further evaluation needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. M-CHAT is a **screening tool, not diagnostic**. It has a significant false-positive rate. A positive screen identifies children who need comprehensive evaluation, but many will not ultimately meet ASD criteria. Diagnosis requires clinical evaluation using DSM-5 criteria.", "consequence": "Premature diagnosis without proper evaluation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "M-CHAT is 100% specific; this child definitely has ASD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. No screening tool is 100% specific. M-CHAT-R/F has moderate specificity (~50-70% after follow-up), meaning some children with positive screens will NOT have ASD. Comprehensive evaluation is essential before diagnosis.", "consequence": "Overconfidence in screening tool leads to premature labeling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Repeat M-CHAT in 6 months before making any referrals", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! A positive screen should prompt **immediate referral** for comprehensive evaluation, not repeat screening. The 6-month delay would miss critical intervention time during the most neuroplastic period of development.", "consequence": "Unnecessary delay in evaluation and intervention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Order genetic testing before any developmental evaluation", "isOptimal": false, "isAcceptable": true, "feedback": "Genetic testing (chromosomal microarray, Fragile X) is recommended for ASD workup but should NOT delay developmental evaluation and intervention. Testing can proceed in parallel with comprehensive assessment. Finding a genetic cause doesn't change the need for behavioral intervention.", "consequence": "Genetic testing ordered, but evaluation should not be delayed.", "nextNodeId": "node-4"}], "clinicalPearl": "**M-CHAT-R/F interpretation**: Low risk (0-2) = no action needed; Medium risk (3-7) = administer follow-up questions; High risk (8+) = refer immediately. **Follow-up questions increase specificity** by clarifying initial responses."}, "node-4": {"id": "node-4", "type": "decision", "content": "Comprehensive evaluation with ADOS-2 (Autism Diagnostic Observation Schedule) and developmental testing confirms ASD. The family asks about treatment options and what services will help their child.", "question": "What is the MOST effective evidence-based intervention for ASD?", "choices": [{"id": "node-4-choice-a", "text": "Applied Behavior Analysis (ABA) - intensive early behavioral intervention 25-40 hours/week", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Applied Behavior Analysis (ABA)** is the most evidence-based treatment for ASD. Studies show that **intensive early intervention (25-40 hours/week)** started before age 4 leads to significant improvements in IQ, language, and adaptive behavior. ABA uses systematic reinforcement to teach skills and reduce problematic behaviors. Other important services include **speech therapy, occupational therapy, and social skills training**.", "consequence": "ABA referral made. IEP meeting scheduled for school services.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Medication (SSRIs) as first-line treatment for core ASD symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **No medication treats core ASD symptoms** (social communication deficits, restricted interests). Medications like SSRIs, antipsychotics (risperidone, aripiprazole), or stimulants may be used for **comorbid conditions** (anxiety, irritability/aggression, ADHD) but are NOT first-line treatment.", "consequence": "Inappropriate reliance on medication for core deficits.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Special diet (gluten-free/casein-free) has proven efficacy for ASD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **No diet has proven efficacy** for ASD in rigorous studies. While families may try dietary interventions, there is no evidence that GFCF or other diets improve core ASD symptoms. ABA remains the evidence-based treatment.", "consequence": "Unproven intervention delays effective treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Hyperbaric oxygen therapy shows promise for ASD treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hyperbaric oxygen is **NOT evidence-based** for ASD and has potential risks. It is considered an unproven alternative therapy. Families should be counseled about evidence-based treatments (ABA, speech therapy, OT) and warned about unproven interventions.", "consequence": "Wasting resources on ineffective treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Placement in a special education classroom is sufficient; no additional therapy needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **special education services** (through IEP) are important, classroom placement alone is insufficient. Children with ASD need **intensive behavioral intervention (ABA)** plus speech/language therapy, occupational therapy, and social skills training for optimal outcomes.", "consequence": "Insufficient intervention limits developmental gains.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ABA therapy** targets measurable behaviors using reinforcement principles. Studies show IQ gains of 15-30 points with early intensive ABA. **FDA-approved medications for ASD irritability**: risperidone (age 5+) and aripiprazole (age 6+) - but these don't treat core symptoms."}, "node-5": {"id": "node-5", "type": "decision", "content": "The family is connected with ABA services, speech therapy, and occupational therapy. An IEP is being developed. The parents ask about their child's prognosis and whether there are associated medical conditions to monitor.", "question": "What associated conditions and long-term monitoring are important in children with ASD?", "choices": [{"id": "node-5-choice-a", "text": "Monitor for epilepsy (20-30%), GI issues, sleep problems, and psychiatric comorbidities (anxiety, ADHD); prognosis varies but early intervention significantly improves outcomes", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Children with ASD have elevated rates of: **Epilepsy (20-30%)**, **GI problems** (constipation, feeding issues), **Sleep disturbances (50-80%)**, **Anxiety (40%)**, **ADHD (30-60%)**, and **Intellectual disability (30%)**. Prognosis varies widely - early diagnosis and intensive intervention are the strongest predictors of positive outcomes. Many adults with ASD live independently or semi-independently.", "consequence": "Family counseled on monitoring and prognosis. Follow-up plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "ASD has no medical comorbidities; focus only on behavioral symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ASD has significant **medical comorbidities** that require monitoring. Epilepsy affects 20-30% of individuals with ASD (higher than general population). GI symptoms, sleep problems, and feeding issues are extremely common and impact quality of life.", "consequence": "Missing important medical comorbidities.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "All children with ASD will have intellectual disability and require lifelong residential care", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **~70% of individuals with ASD have average or above-average intelligence**. Prognosis varies widely based on language development, intellectual level, and access to early intervention. Many adults with ASD live independently, work, and have relationships.", "consequence": "Inappropriately pessimistic counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "ASD is caused by vaccines and should be reported to VAERS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Multiple large studies have definitively shown NO link between vaccines and ASD**. The original study claiming this link was retracted and the author lost his medical license for fraud. ASD has strong genetic components. This myth has caused significant harm through vaccine refusal.", "consequence": "Perpetuating dangerous misinformation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "Children 'grow out of' ASD by adolescence; no long-term planning needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ASD is a lifelong neurodevelopmental condition**. While symptoms may change and some individuals make significant gains (especially with early intervention), ASD does not 'resolve.' Long-term planning for transition to adulthood, vocational training, and independence is essential.", "consequence": "Failure to plan for long-term needs.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Positive prognostic factors in ASD**: Early diagnosis (<2 years), early intensive intervention, presence of spoken language by age 5, higher cognitive function, and supportive family environment. **1 in 36 children** has ASD (CDC 2023) - it is the most common neurodevelopmental disorder."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of autism spectrum disorder evaluation!\n\n**Key Learning Points:**\n1. **Core features (DSM-5)**: Social communication deficits + Restricted/repetitive behaviors (both required)\n2. **Early red flags**: No babbling by 12 mo, no gestures by 12 mo, no single words by 16 mo, no 2-word phrases by 24 mo, ANY regression\n3. **Screening**: M-CHAT-R/F at 18 and 24 months for ALL children\n4. **Evaluation**: Positive screen \u2192 audiology + comprehensive developmental evaluation (ADOS-2)\n5. **Treatment**: ABA (25-40 hrs/week) is most evidence-based; add speech therapy, OT, social skills\n6. **Comorbidities**: Epilepsy (20-30%), GI issues, sleep problems, anxiety, ADHD\n7. **Prognosis**: Variable; early intervention is the strongest predictor of outcomes\n\n**NEVER 'wait and see'** - early intervention during critical brain plasticity windows significantly improves long-term outcomes."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key ASD pearls:\n\n1. **Two core domains required**: Social communication deficits AND restricted/repetitive behaviors\n2. **Speech delay alone \u2260 ASD** - need social communication deficits too\n3. **M-CHAT is screening, not diagnostic** - positive screen requires comprehensive evaluation\n4. **ABA is the evidence-based treatment** - not medications or alternative therapies\n5. **NEVER 'wait and see'** - refer immediately to EI and audiology\n6. **Monitor for comorbidities**: epilepsy, GI issues, sleep, anxiety, ADHD"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in ASD management.\n\n**Dangerous mistakes to avoid:**\n- **'Wait and see'** - delays diagnosis and misses critical intervention window\n- **Dismissing parental concerns** - parents are usually right about developmental problems\n- **Attributing symptoms to 'late bloomer' or 'boys develop later'**\n- **Starting medications before behavioral intervention**\n- **Believing vaccine-autism myth** - NO scientific evidence supports this debunked claim\n\n**The earlier the intervention, the better the outcome.** Early intensive ABA before age 4 shows the greatest gains."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-058", "title": "Complex vs Simple Febrile Seizure", "domain": "growth_development", "difficulty": "intermediate", "tags": ["complex vs simple febrile seizure"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-month-old male is brought to the emergency department for prolonged seizure with fever that began 25 minutes ago.\n\nHistory reveals, he had a fever and started seizing. The seizure was generalized initially but then became more prominent on the right side. It lasted 25 minutes and he received rectal diazepam. He is still drowsy 2 hours later.\n\nReview of systems is positive for focal features and prolonged duration and negative for meningeal signs.\n\nPertinent history includes He had a simple febrile seizure at 10 months of age. Currently has an ear infection.\n\nPhysical Examination:\n- General: drowsy but arousable, temperature 39\u00b0C.\n- Vitals: temp 39.\n- Neurologic: postictal state with right-sided weakness (Todd paralysis).\n- HEENT: right tympanic membrane bulging.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 14-month-old presents after a prolonged seizure with fever. The seizure lasted **25 minutes**, was initially generalized but became **focal** (right-sided predominance), and he now has **Todd paralysis** (right-sided weakness). He has a history of a previous febrile seizure at 10 months and currently has otitis media.\n\n**Simple febrile seizure criteria (ALL must be met):**\n- Duration **<15 minutes**\n- **Generalized** (not focal)\n- Occurs **once in 24 hours**\n- Age 6 months to 5 years\n- No prior neurologic abnormality\n\n**Complex febrile seizure (ANY of the following):**\n- Duration **>15 minutes**\n- **Focal features** (asymmetric movements, Todd paralysis)\n- **Recurs within 24 hours**", "question": "Based on the clinical features, how should this seizure be classified?", "choices": [{"id": "node-1-choice-a", "text": "Complex febrile seizure", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **complex febrile seizure** meeting multiple criteria: (1) **prolonged duration** (25 minutes, exceeding the 15-minute threshold), (2) **focal features** (right-sided predominance), and (3) **Todd paralysis** (transient postictal focal weakness). The presence of ANY ONE of these features makes it complex - this patient has all three. Complex febrile seizures warrant additional workup compared to simple febrile seizures.", "consequence": "You correctly classify the seizure and proceed to determine appropriate workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Simple febrile seizure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is NOT a simple febrile seizure. Simple febrile seizures must be **<15 minutes** (this was 25 min), **generalized** (this had focal features), and occur **once per 24 hours**. The presence of focal right-sided movements and **Todd paralysis** clearly indicates complex features. Misclassifying as simple would lead to inadequate workup.", "consequence": "Misclassification leads to inadequate evaluation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Bacterial meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While meningitis must always be considered in febrile seizures, this patient lacks **meningeal signs** (neck stiffness, Kernig/Brudzinski signs). The clear febrile seizure history with identified fever source (otitis media) and absence of meningeal irritation make meningitis unlikely. However, LP should be considered in complex febrile seizures if clinical suspicion exists.", "consequence": "Misdiagnosis delays appropriate classification and management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "New-onset epilepsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Epilepsy requires **recurrent unprovoked seizures**. This child's seizure occurred in the context of **fever** (provoked), making it a febrile seizure by definition. While complex febrile seizures carry a slightly higher risk of future epilepsy (~2-4% vs ~1% for simple), this single event does not meet epilepsy criteria. The prior febrile seizure at 10 months was also provoked.", "consequence": "Premature epilepsy diagnosis causes unnecessary concern.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Febrile status epilepticus", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Febrile status epilepticus** is technically accurate since this seizure lasted >30 minutes (or >5 minutes requiring intervention) - he received diazepam at 25 minutes. However, the more clinically useful classification is **complex febrile seizure**, which guides workup decisions. Febrile status epilepticus is a subset of complex febrile seizures.", "consequence": "Technically correct but classification as complex febrile seizure better guides management.", "nextNodeId": "node-2"}], "clinicalPearl": "**Todd paralysis** (transient postictal weakness lasting minutes to hours) indicates focal seizure activity and automatically classifies a febrile seizure as complex, regardless of duration."}, "node-2": {"id": "node-2", "type": "decision", "content": "You correctly identify this as a **complex febrile seizure**. The child remains drowsy 2 hours later with resolving right-sided weakness (Todd paralysis). Temperature is 39\u00b0C with a bulging right tympanic membrane (otitis media).\n\n**Workup considerations for complex febrile seizures:**\n- **Lumbar puncture**: Consider if meningitis suspected, incomplete vaccination, or prior antibiotics\n- **EEG**: Not routinely indicated acutely; may be considered outpatient if recurrent\n- **Neuroimaging (MRI)**: Consider for focal features, prolonged postictal state, or developmental concerns\n- **Labs**: Guided by clinical suspicion (not routine)", "question": "What is the most appropriate diagnostic workup for this child?", "choices": [{"id": "node-2-choice-a", "text": "MRI brain and observation; LP only if meningitis clinically suspected", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Given the **focal features** and **Todd paralysis**, neuroimaging (preferably **MRI**) is indicated to evaluate for structural abnormalities. LP is NOT routinely required for complex febrile seizures but should be performed if clinical signs of meningitis are present. This child lacks meningeal signs and has a clear fever source (otitis media), so LP can be deferred unless clinical concern arises. Observation until postictal state resolves is appropriate.", "consequence": "Appropriate targeted workup is initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Emergent lumbar puncture and IV antibiotics for presumed meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While LP should be considered in febrile seizures, this child has **no meningeal signs** and has an identified fever source (otitis media). Empiric treatment for meningitis without clinical suspicion is not indicated. LP is recommended in complex febrile seizures when meningitis is clinically suspected, the child is incompletely vaccinated against Hib/pneumococcus, or has received prior antibiotics that could mask meningitis.", "consequence": "Unnecessary invasive procedure and treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "No workup needed; simple febrile seizures require no testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is a **COMPLEX** febrile seizure, not simple. While simple febrile seizures typically require no workup, complex febrile seizures with **focal features** and **Todd paralysis** warrant neuroimaging to rule out structural lesions. Never confuse simple and complex classifications - they have different workup implications.", "consequence": "Inadequate evaluation could miss structural pathology.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Urgent EEG and start levetiracetam for seizure prophylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antiepileptic prophylaxis is NOT recommended** for febrile seizures (simple or complex). The AAP guidelines clearly state that the risks of daily anticonvulsant therapy outweigh the benefits for preventing recurrent febrile seizures. EEG is not routinely indicated in the acute setting and does not change immediate management. Outpatient EEG may be considered for recurrent complex febrile seizures.", "consequence": "Unnecessary medication with potential side effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "CT head only; LP and MRI not needed", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. CT can be performed if MRI is not readily available and there is concern for acute pathology. However, **MRI is preferred** over CT for evaluating focal seizures as it provides better visualization of cortical malformations, mesial temporal sclerosis, and subtle structural abnormalities. CT misses many lesions that cause focal seizures. If CT is negative but clinical concern remains, MRI should follow.", "consequence": "CT may miss subtle structural abnormalities; MRI preferred.", "nextNodeId": "node-3"}], "clinicalPearl": "**AAP guidelines**: Routine LP is NOT required for well-appearing children >12 months with complex febrile seizures and no meningeal signs. Consider LP if: clinical suspicion for meningitis, incomplete Hib/pneumococcal vaccination, or pretreatment with antibiotics."}, "node-3": {"id": "node-3", "type": "decision", "content": "MRI brain is unremarkable. The child's mental status normalizes over the next few hours, and the Todd paralysis resolves completely. He is afebrile after ibuprofen. The otitis media is treated with amoxicillin.\n\nThe parents are anxious and ask about the prognosis and what to do if another seizure occurs.\n\n**Febrile seizure recurrence risk:**\n- ~30-35% overall recurrence risk\n- Higher if: first seizure <18 months, family history, lower fever at seizure onset\n\n**Long-term epilepsy risk:**\n- Simple febrile seizure: ~1% (same as general population)\n- Complex febrile seizure: ~2-4%\n- Still excellent overall prognosis", "question": "What is the most appropriate counseling and discharge plan?", "choices": [{"id": "node-3-choice-a", "text": "Reassurance about good prognosis; fever management education; seizure first aid instructions", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Despite being complex, febrile seizures carry an **excellent prognosis**. Key counseling: (1) **Recurrence risk** is ~30-35%, but most children outgrow febrile seizures by age 5-6. (2) **Epilepsy risk** is only slightly elevated (~2-4% for complex vs ~1% for simple). (3) **Fever management**: Antipyretics provide comfort but do NOT prevent febrile seizures. (4) **Seizure first aid**: Position safely on side, do not restrain, time the seizure, call 911 if >5 minutes. (5) **Rescue medication** (rectal diazepam) can be prescribed for families of children with prolonged febrile seizures.", "consequence": "Parents are appropriately counseled and prepared.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start daily phenobarbital to prevent recurrent febrile seizures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Daily anticonvulsant prophylaxis is NOT recommended** for febrile seizures per AAP guidelines. While phenobarbital can reduce recurrence, the side effects (behavioral changes, cognitive effects) outweigh benefits given the benign nature of febrile seizures. Neither phenobarbital, valproate, nor other AEDs should be used for febrile seizure prophylaxis.", "consequence": "Unnecessary chronic medication with significant side effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Strict fever prevention with scheduled antipyretics to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antipyretics do NOT prevent febrile seizures**. Multiple studies have shown that even aggressive fever treatment does not reduce febrile seizure recurrence. Febrile seizures often occur at fever onset before parents recognize illness. Antipyretics should be used for **comfort only**, not seizure prevention. This is a common misconception to address with families.", "consequence": "Creates false sense of security; antipyretics don't prevent seizures.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Refer to neurology urgently; avoid all vaccinations due to fever risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Urgent neurology referral is not required for a resolved complex febrile seizure with normal imaging and exam. Outpatient neurology follow-up is reasonable but not urgent. **Vaccines should NOT be withheld** - while some vaccines cause fever, the benefits far outweigh the small risk of triggering a febrile seizure. The AAP specifically recommends continuing routine vaccinations in children with febrile seizures.", "consequence": "Unnecessary specialist urgency and harmful vaccine avoidance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Prescribe rectal diazepam for home use; advise use for any seizure >5 minutes", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal as the sole intervention. **Rectal diazepam** (or intranasal midazolam) can be prescribed for children with **prolonged febrile seizures** (like this patient's 25-minute episode) to use if a seizure exceeds 5 minutes. However, this should accompany comprehensive counseling about prognosis, seizure first aid, and fever management - not replace it. Most families also need reassurance about the excellent long-term prognosis.", "consequence": "Appropriate rescue medication but incomplete counseling.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Key parent teaching**: Antipyretics are for comfort, NOT seizure prevention. Febrile seizures often occur before fever is recognized. The long-term prognosis is excellent even for complex febrile seizures."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly classified this as a **complex febrile seizure** based on: prolonged duration (>15 min), focal features, and Todd paralysis. You appropriately ordered MRI (not routinely CT) for focal features and deferred LP given no meningeal signs. Most importantly, you counseled the family that despite being 'complex,' the prognosis remains excellent with only slightly elevated epilepsy risk (~2-4%). Key teaching points: (1) No daily AED prophylaxis, (2) Antipyretics don't prevent seizures, (3) Continue vaccinations, (4) Consider rescue diazepam for prolonged seizures."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features distinguishing **simple vs complex febrile seizures**: Simple = <15 min + generalized + single episode in 24h. Complex = ANY of: >15 min, focal, recurs in 24h. This case had multiple complex features (25 min duration, focal, Todd paralysis). Complex febrile seizures warrant MRI but not routine LP without meningeal signs. Prognosis remains good."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This was a **complex febrile seizure** - classification is critical as it guides workup. Key errors to avoid: (1) Misclassifying as simple leads to inadequate workup, (2) Daily AED prophylaxis is NOT recommended, (3) Antipyretics don't prevent febrile seizures, (4) Vaccines should continue. Remember: Complex febrile seizures still have excellent prognosis (~2-4% epilepsy risk vs ~1% for simple)."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-060", "title": "Failure to Thrive", "domain": "growth_development", "difficulty": "intermediate", "tags": ["failure to thrive"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 9-month-old female presents to the clinic with poor weight gain of 3 months duration.\n\nPer the parents, she has fallen from the 50th percentile to below the 5th percentile for weight over the past 3 months. Length and head circumference have remained stable. She seems hungry but the parents are unsure how much she is eating.\n\nAssociated symptoms include developmental delays and decreased activity. Denies vomiting, diarrhea, or fever.\n\nPast medical history includes The family is experiencing financial stress and food insecurity. The mother has a history of depression.\n\nPhysical Examination:\n- Growth: weight < 5th percentile, length 25th percentile, head circumference 50th percentile (weight affected first).\n- General: thin, wasted infant with decreased subcutaneous fat. Watchful, avoids eye contact.\n- Vitals: febrile.\n- Development: not sitting unsupported (delayed).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 9-month-old has dropped from the 50th to below the 5th percentile for weight over 3 months, while length and head circumference remain stable. This pattern of **weight affected BEFORE length BEFORE head circumference** is important.", "question": "What does this pattern of growth failure (weight > length > head circumference) MOST suggest about the etiology?", "choices": [{"id": "node-1-choice-a", "text": "Nutritional/caloric insufficiency - inadequate intake is the most common cause", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! When **weight is affected first** (before length, then head circumference last), this suggests **inadequate caloric intake** - the body prioritizes brain growth. This is the **most common cause of FTT** (~80% non-organic). Risk factors here: food insecurity, maternal depression, and social stress.", "consequence": "You recognize the typical FTT pattern.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Genetic or chromosomal syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Genetic syndromes typically cause **proportional** growth failure (all parameters affected simultaneously) or **head circumference affected early** (microcephaly). This child has weight affected first with preserved head circumference, suggesting nutritional cause.", "consequence": "Pattern doesn't fit genetic syndrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Endocrine disorder like hypothyroidism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hypothyroidism** causes **short stature with relative weight preservation** (the child is short but heavy/chubby). This child has the opposite pattern - severely underweight with relatively preserved length, suggesting inadequate nutrition.", "consequence": "Hypothyroidism has different growth pattern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Structural heart disease", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Congenital heart disease CAN cause FTT due to increased metabolic demands and feeding difficulty. However, this child has no murmur, cyanosis, or signs of heart failure. The social risk factors (food insecurity, maternal depression) make nutritional cause more likely.", "consequence": "Possible but less likely without cardiac findings.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Primary immunodeficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Primary immunodeficiency causes FTT through **recurrent infections**, not simple undernutrition. This child has no history of frequent or unusual infections. The social context (food insecurity) is the key clue here.", "consequence": "No history of recurrent infections.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**FTT growth pattern interpretation**: **Weight first** \u2192 nutritional (most common). **Length affected early** \u2192 endocrine (GH deficiency). **All proportional** \u2192 genetic/constitutional. **Head circumference first** \u2192 neurologic/TORCH. Body prioritizes brain growth last!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect inadequate caloric intake as the primary cause. Before ordering extensive labs, you need to gather more history.", "question": "What is the MOST important initial assessment in suspected FTT?", "choices": [{"id": "node-2-choice-a", "text": "Detailed feeding history with 3-day calorie count - to quantify actual intake", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A **detailed feeding/dietary history** is the MOST important initial step. Ask about: what, how much, how often, who feeds, feeding behaviors, formula preparation (is it diluted?), solid food introduction. A **3-day food diary** with calorie calculation reveals inadequate intake in most cases. Lab testing should be LIMITED and directed.", "consequence": "You obtain comprehensive dietary assessment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Extensive metabolic workup (amino acids, organic acids, lactate)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as FIRST step. **Extensive testing is NOT indicated** in typical FTT without red flags. ~80% of FTT is non-organic (inadequate intake). Metabolic testing is reserved for patients with: developmental regression, seizures, unusual features, or failure to respond to nutritional intervention.", "consequence": "Expensive unnecessary testing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CT scan of head to evaluate brain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Head imaging is NOT indicated when **head circumference is NORMAL** (as in this case - 50th percentile). This child's brain growth is preserved; the problem is weight, not neurologic. Imaging would be indicated if microcephaly or developmental regression were present.", "consequence": "Unnecessary radiation with normal head circumference.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Sweat chloride test for cystic fibrosis", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration but not first. Cystic fibrosis causes FTT through **malabsorption** (steatorrhea, bulky stools, recurrent respiratory infections). This child has no GI symptoms or respiratory issues. Sweat test is indicated if FTT persists despite adequate caloric intake.", "consequence": "Consider if nutritional intervention fails.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Immediate hospital admission for feeding observation", "isOptimal": false, "isAcceptable": true, "feedback": "Hospitalization may be needed in **severe** FTT (weight <60% of ideal, dehydration, metabolic derangements) or when **abuse/neglect** is suspected. However, most FTT can be managed **outpatient** with close follow-up. This child is stable - start with outpatient dietary assessment.", "consequence": "Consider for severe cases or suspected neglect.", "nextNodeId": "node-3"}], "clinicalPearl": "**FTT workup mantra**: \"Most FTT is non-organic - don't order extensive labs!\" Initial labs (if any): CBC, BMP, UA, lead level. Further testing ONLY if: red flags present, or fails to improve with adequate nutrition. History and observation > lab tests."}, "node-3": {"id": "node-3", "type": "decision", "content": "Dietary history reveals the family can only afford formula intermittently and has been diluting it to make it last longer. The child receives about 60% of required calories for age. Mother appears withdrawn and makes little eye contact with the baby during the visit.", "question": "What is the MOST appropriate intervention for this family?", "choices": [{"id": "node-3-choice-a", "text": "Connect family with social services, WIC, food assistance programs, and arrange close follow-up", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **non-organic FTT due to food insecurity** and possible maternal depression affecting bonding. Intervention: (1) **Social work** referral for food assistance (WIC, SNAP, food banks), (2) **Proper formula preparation** education, (3) **Mental health** screening for mother, (4) **Close follow-up** (weekly weight checks). Most non-organic FTT responds to addressing social factors.", "consequence": "Comprehensive support services arranged.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Report to Child Protective Services for neglect", "isOptimal": false, "isAcceptable": false, "feedback": "Not appropriate here. This is **poverty/food insecurity**, NOT willful neglect. The parents are trying to feed the child but lack resources. CPS referral is indicated when parents **refuse** help, there's evidence of **abuse**, or the child is in **imminent danger**. First, provide resources and support.", "consequence": "Punitive approach damages therapeutic relationship.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Prescribe high-calorie formula supplements", "isOptimal": false, "isAcceptable": true, "feedback": "Calorie supplementation (22-24 cal/oz formula, adding oil/butter to foods) IS helpful, but **addressing the root cause** (inability to afford formula) is essential. If you prescribe expensive supplements but the family can't afford food, the underlying problem persists. Social support comes first.", "consequence": "Addresses symptom but not root cause.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Admit for NG tube feeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this situation. **NG tube feeding** is reserved for children who **cannot take adequate oral intake** (severe oral-motor dysfunction, critical illness). This child CAN eat - she's just not getting enough food due to poverty. Providing food access will solve this problem.", "consequence": "Invasive procedure unnecessary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Refer to pediatric gastroenterology for feeding tube", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. GI referral for tube feeding is indicated for **organic causes** of FTT (severe GERD, anatomic abnormalities, neurologic disease affecting swallowing). This child has **non-organic FTT** from inadequate access to food. Social intervention is the treatment.", "consequence": "Inappropriate subspecialty referral.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Non-organic FTT treatment**: (1) Address **social determinants** (food access, WIC, SNAP), (2) Educate on proper formula preparation (never dilute!), (3) **Increase caloric density** (22-24 cal/oz formula), (4) Screen caregivers for **depression**, (5) Close follow-up. Most respond within 2-4 weeks."}, "node-4": {"id": "node-4", "type": "decision", "content": "The family is enrolled in WIC, receives food bank assistance, and is educated on proper formula preparation. Mother begins treatment for depression. At 2-week follow-up, the infant has gained 400 grams.", "question": "When should you suspect ORGANIC causes of FTT (rather than non-organic)?", "choices": [{"id": "node-4-choice-a", "text": "Failure to gain weight despite documented adequate caloric intake (>120 kcal/kg/day)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The key distinction: **Non-organic FTT responds to adequate nutrition**; **organic FTT does not**. If a child receives **documented** adequate calories (>120 kcal/kg/day for catch-up growth) but still doesn't gain weight, suspect: malabsorption (CF, celiac), chronic disease, metabolic disorder, or endocrine cause.", "consequence": "You understand when to expand workup.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Any child with weight below the 5th percentile", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Being below the 5th percentile alone does NOT define FTT or indicate organic cause. **Crossing percentile lines** (growth deceleration) is more significant than absolute percentile. Some healthy children are constitutionally small and grow consistently at the 3rd percentile.", "consequence": "Static percentile vs crossing percentiles matters.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Family history of short stature", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Family history of **short stature** suggests **constitutional growth delay** or **familial short stature** - these are NORMAL variants, not organic FTT. Calculate **mid-parental height** to estimate genetic potential. Short parents often have appropriately small children.", "consequence": "This is a normal variant, not pathology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Low socioeconomic status", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Low SES is a risk factor for **non-organic** FTT (food insecurity, lack of resources) - NOT organic FTT. In fact, addressing the social factors often resolves the growth failure, as in this case.", "consequence": "This suggests non-organic, not organic cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Picky eating behaviors", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Picky eating is a **behavioral** issue contributing to **non-organic** FTT. It's not a sign of organic disease. Management involves behavioral feeding strategies, not medical workup.", "consequence": "Behavioral issue, not organic cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Organic FTT red flags** (warrant expanded workup): (1) Failure to respond to adequate nutrition, (2) **Vomiting/diarrhea** (malabsorption), (3) **Dysmorphic features** (genetic syndrome), (4) **Developmental regression**, (5) **Recurrent infections** (immunodeficiency), (6) **Organomegaly**. ~20% of FTT is organic."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified and managed failure to thrive due to inadequate caloric intake from food insecurity. Key teaching points: (1) Weight affected first \u2192 nutritional cause, (2) Dietary history is the most important initial assessment, (3) Most FTT is non-organic (~80%) and responds to addressing social factors, (4) Connect families with WIC, SNAP, food banks, (5) Screen caregivers for depression, (6) Suspect organic cause only if child fails to gain with documented adequate intake. This infant is now thriving with appropriate support!"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review FTT key concepts: (1) Weight affected first suggests nutritional cause, (2) Most FTT is non-organic - don't over-test!, (3) Detailed feeding history and calorie count are essential, (4) Address social determinants (food access, caregiver mental health), (5) Organic FTT = failure to gain despite documented adequate calories."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in FTT management. Remember: Most FTT is non-organic (~80%). Address social factors first. Don't order extensive workup unless red flags are present or child fails to respond to adequate nutrition."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-112", "title": "Breath-Holding Spell Mechanism", "domain": "growth_development", "difficulty": "intermediate", "tags": ["crying then breath-holding", "cyanosis or pallor then LOC", "triggered by upset", "rapid recovery", "breath-holding spell mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 18-month-old male is brought in after an episode of crying, breath-holding, and brief loss of consciousness.\n\nNo post-ictal period.\n\nPhysical Examination:\n- General: alert toddler, now back to baseline after the episode.\n- Cardiac: regular rate and rhythm, no murmur.\n- Neurologic: normal tone, reflexes, and mental status.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "An 18-month-old male is brought in after an episode where he became upset, **cried vigorously**, then **held his breath**, turned **blue/cyanotic**, and **briefly lost consciousness**. He recovered completely within 1 minute with no postictal period and is now at baseline.\n\n**Episode sequence** (critical for diagnosis):\n1. **Triggering event** (frustration, anger, minor injury)\n2. **Vigorous crying** (always precedes breath-holding)\n3. **Breath-holding** in expiration\n4. **Color change** (cyanotic or pallid)\n5. **Loss of consciousness** (brief, <1 minute)\n6. **Rapid return to baseline** (no postictal state)\n\n**Two types:**\n- **Cyanotic** (more common): triggered by anger/frustration \u2192 cyanosis\n- **Pallid**: triggered by pain/startle \u2192 vagal response \u2192 pallor/bradycardia", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Breath-holding spell (cyanotic type)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a classic **cyanotic breath-holding spell**. Key features: (1) **Triggered by emotional upset** (frustration, anger), (2) **Crying precedes** the spell, (3) **Breath-holding in expiration** \u2192 cyanosis, (4) **Brief LOC** (<1 minute), (5) **Rapid recovery** with no postictal state. The child is completely normal between episodes. Breath-holding spells are NOT voluntary and NOT seizures.", "consequence": "You correctly identify the diagnosis and proceed to workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Epileptic seizure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Key distinguishing features: (1) Breath-holding spells are **triggered by crying/upset** - seizures typically have no emotional trigger. (2) **Crying PRECEDES** breath-holding spells but follows seizures (postictal crying). (3) Breath-holding spells have **no postictal period** - the child returns to baseline immediately. (4) The color change (cyanosis) occurs DURING breath-holding, not as a seizure phenomenon.", "consequence": "Misdiagnosis may lead to unnecessary antiepileptic medications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Cardiac arrhythmia (long QT syndrome)", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable - **long QT syndrome** is an important differential for syncope in children and should be considered, especially for **pallid breath-holding spells**. However, this presentation with **crying preceding the event** and **cyanosis** (not pallor) is classic for cyanotic breath-holding spell. An ECG to rule out prolonged QT is reasonable but the diagnosis here is clinically breath-holding spell.", "consequence": "ECG may be reasonable but breath-holding spell is more likely.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Reflex anoxic seizure", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Reflex anoxic seizures** (also called pallid breath-holding spells) are a related entity triggered by **pain or startle** causing vagal-mediated **asystole** \u2192 pallor \u2192 LOC. However, THIS child had **cyanosis** (blue), not pallor, and was triggered by **emotional upset**, making this a **cyanotic** breath-holding spell. The mechanism differs - cyanotic spells involve prolonged expiratory apnea, not vagal asystole.", "consequence": "Related condition but this presentation is cyanotic type.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Child abuse with inflicted head trauma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While altered consciousness in a toddler should prompt consideration of abuse, this presentation has **classic breath-holding spell features**: clear emotional trigger, crying preceding the episode, brief duration, complete recovery, and normal neurologic exam. There are no red flags for trauma (bruising, retinal hemorrhages, abnormal exam). The witnessed sequence of events is diagnostic.", "consequence": "No features suggesting inflicted injury.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"Crying THEN passing out\" = breath-holding spell. \"Passing out THEN crying\" = consider seizure.** The temporal sequence is critical for distinguishing these entities."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose a **cyanotic breath-holding spell**. The parents are very concerned and ask what testing is needed. Physical exam is completely normal.\n\n**Workup considerations:**\n- **CBC and iron studies**: **Iron deficiency** is associated with increased frequency of breath-holding spells; iron supplementation may reduce episodes\n- **ECG**: Consider to rule out **long QT syndrome**, especially for pallid spells\n- **EEG**: NOT routinely indicated (breath-holding spells are not seizures); only if atypical features\n- **Neuroimaging**: NOT indicated for typical breath-holding spells", "question": "What is the most appropriate initial workup?", "choices": [{"id": "node-2-choice-a", "text": "CBC with iron studies; ECG if history concerning for arrhythmia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **CBC and iron studies** should be obtained because **iron deficiency** is strongly associated with breath-holding spells, and **iron supplementation can reduce episode frequency** even in non-anemic children with low ferritin. ECG to rule out **long QT syndrome** is reasonable, especially for pallid spells or if there's family history of sudden cardiac death. This targeted workup addresses treatable causes without unnecessary testing.", "consequence": "Appropriate workup is ordered.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "EEG and MRI brain to rule out seizure disorder", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Breath-holding spells are **NOT seizures** and do not require EEG or neuroimaging. The diagnosis is **clinical** based on the characteristic sequence: trigger \u2192 crying \u2192 breath-holding \u2192 color change \u2192 LOC \u2192 rapid recovery. EEG is only indicated if there are **atypical features** (no trigger, prolonged postictal state, abnormal movements during episode). Ordering EEG/MRI medicalizes a benign condition.", "consequence": "Unnecessary expensive testing for a clinical diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "No workup needed; this is a clinical diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. While breath-holding spells ARE diagnosed clinically, **checking iron studies is recommended** because: (1) Iron deficiency increases breath-holding spell frequency, (2) Iron supplementation **reduces episodes** even in non-anemic children, (3) Toddlers are at high risk for iron deficiency. Missing treatable iron deficiency is a missed opportunity.", "consequence": "May miss treatable iron deficiency.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Holter monitor for 48 hours to capture arrhythmia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **screening ECG** is sufficient to evaluate for long QT syndrome. Holter monitoring is not indicated for typical breath-holding spells. The episodes are triggered by emotional upset and have a characteristic sequence - they are not random arrhythmias that need to be \"captured.\" Holter would be considered only if ECG shows concerning findings or there's high suspicion for arrhythmia.", "consequence": "Excessive workup for typical breath-holding spell.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Lumbar puncture to rule out meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child is **afebrile**, **completely recovered**, and has a classic breath-holding spell presentation with clear emotional trigger and characteristic sequence. There are no signs of infection (fever, meningeal signs, toxic appearance). LP would be indicated for unexplained altered mental status with fever, not for a witnessed breath-holding spell with full recovery.", "consequence": "Unnecessary invasive procedure.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Iron supplementation reduces breath-holding spell frequency** even in children who are not frankly anemic. Check ferritin - if low-normal or deficient, a trial of iron is warranted."}, "node-3": {"id": "node-3", "type": "decision", "content": "Lab results show **hemoglobin 11.2 g/dL** (normal) but **ferritin 12 ng/mL** (low-normal, suggesting iron deficiency). ECG is normal with QTc 420 ms.\n\nThe parents remain anxious. The mother asks: \"Is my child doing this on purpose to manipulate us? Should we punish him when this happens?\"\n\n**Key counseling points:**\n- Breath-holding spells are **NOT voluntary** - children cannot control them\n- They are an **exaggerated autonomic reflex**\n- Episodes are **benign** and do NOT cause brain damage\n- Children **outgrow** them by age 5-6 years\n- Avoid reinforcing behaviors that lead to tantrums", "question": "What is the most appropriate management and counseling?", "choices": [{"id": "node-3-choice-a", "text": "Reassurance that spells are benign and involuntary; start iron supplementation; behavioral guidance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Management includes: (1) **Reassurance** - breath-holding spells are benign, involuntary, and do NOT cause brain damage or epilepsy. (2) **Iron supplementation** - this child has low ferritin; iron therapy can reduce spell frequency. (3) **Behavioral guidance** - spells are NOT manipulation; do NOT punish the child. Parents should remain calm during episodes, place child safely on side, and avoid reinforcing tantrum behaviors that trigger spells. Most children outgrow breath-holding spells by **age 5-6**.", "consequence": "Comprehensive management addresses all aspects.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start antiepileptic medication to prevent future episodes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Breath-holding spells are **NOT seizures** and antiepileptic drugs are **NOT indicated**. AEDs do not prevent breath-holding spells and would expose the child to unnecessary medication side effects. The episodes are an autonomic reflex, not epileptic activity. This is a critical distinction - treating breath-holding spells with AEDs is inappropriate.", "consequence": "Unnecessary medication with no benefit.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Advise parents to firmly discipline the child when spells occur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Breath-holding spells are **INVOLUNTARY** - the child cannot control them and is NOT being manipulative. Punishment is inappropriate and may worsen the parent-child relationship. Parents should remain **calm** during episodes and provide reassurance afterward. However, they should avoid reinforcing behaviors (like giving in to demands) that lead to the tantrums triggering spells.", "consequence": "Inappropriate advice; spells are involuntary.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Refer to neurology urgently for further evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Typical breath-holding spells do NOT require neurology referral. The diagnosis is clinical, and management is supportive. Neurology referral is only indicated if: (1) atypical features (no trigger, prolonged postictal state), (2) spells continue past age 6, (3) family requests specialist reassurance. This case is classic and can be managed entirely in primary care.", "consequence": "Unnecessary referral for typical presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Prescribe atropine for vagal-mediated spells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Atropine (or glycopyrrolate) has been used in **refractory pallid breath-holding spells** (vagal-mediated asystole) but is NOT first-line and NOT indicated for **cyanotic** spells like this case. This child has cyanotic spells (triggered by frustration, not vagal). First-line treatment is iron supplementation and reassurance. Atropine is rarely needed and reserved for severe pallid spells unresponsive to iron.", "consequence": "Wrong medication for cyanotic type; not first-line for any type.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"Will this hurt my child's brain?\"** - Reassure parents that breath-holding spells, even with brief LOC, do NOT cause brain damage, developmental delay, or increase epilepsy risk. Children outgrow them by age 5-6."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed a **cyanotic breath-holding spell** based on: emotional trigger \u2192 crying \u2192 breath-holding \u2192 cyanosis \u2192 brief LOC \u2192 rapid recovery. Key management: (1) **Check iron studies** - low ferritin warrants iron supplementation to reduce frequency, (2) **Reassurance** - spells are benign, involuntary, and outgrown by age 5-6, (3) **No AEDs** - these are NOT seizures, (4) **Behavioral guidance** - don't punish (involuntary) but don't reinforce tantrum triggers. ECG screening for long QT is reasonable, especially for pallid spells."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review breath-holding spell features: (1) **Sequence**: trigger \u2192 crying \u2192 breath-holding \u2192 color change \u2192 LOC \u2192 rapid recovery, (2) **Two types**: cyanotic (frustration) vs pallid (pain/startle), (3) **Workup**: CBC/iron studies (iron deficiency associated), ECG for long QT. (4) **Management**: reassurance, iron supplementation, behavioral guidance - NO AEDs."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Breath-holding spells are **NOT seizures** and are **NOT voluntary manipulation**. Key points: (1) Diagnosis is clinical based on characteristic sequence, (2) Check iron studies - iron deficiency increases frequency, (3) NO antiepileptic medications, (4) Spells are involuntary - don't punish, (5) Benign prognosis - outgrown by age 5-6, no brain damage risk. Distinguish cyanotic (frustration trigger) from pallid (pain/vagal trigger)."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-126", "title": "Appendix Testis Torsion Differentiation", "domain": "growth_development", "difficulty": "intermediate", "tags": ["blue dot sign", "cremasteric reflex present", "normal testicular position", "prepubertal boy", "appendix testis torsion differentiation"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 10-year-old male presents to the emergency department with acute onset left scrotal pain that started 6 hours ago. The pain woke him from sleep and has been gradually worsening.\n\nReview of systems: negative for fever, dysuria, urethral discharge, nausea, vomiting, or abdominal pain. No recent trauma.\n\nPhysical Examination:\n- General: uncomfortable but not in severe distress\n- Abdomen: soft, non-tender, no masses\n- GU: left hemiscrotum mildly edematous and erythematous; focal tenderness at upper pole of left testicle; small blue-purple discoloration visible through scrotal skin at superior aspect of testicle\n- Testicle: normal vertical lie, non-tender body, cremasteric reflex present bilaterally\n- Right hemiscrotum: normal", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the patient carefully. Key findings:\n\n**Critical examination findings:**\n- **Blue dot sign**: visible blue-purple discoloration at the superior pole of the testicle through thin scrotal skin\n- **Cremasteric reflex**: PRESENT bilaterally (stroke inner thigh \u2192 ipsilateral testicular elevation)\n- **Testicular position**: normal vertical lie, not high-riding or transverse\n- **Point tenderness**: localized to upper pole, NOT diffuse testicular tenderness\n- **Testicle itself**: non-tender, normal consistency\n\n**Anatomy review:**\n- **Appendix testis**: M\u00fcllerian duct remnant at superior pole (present in ~90% of males)\n- **Appendix epididymis**: Wolffian duct remnant on head of epididymis\n- These vestigial structures can tort independently of the testicle", "question": "Based on these examination findings, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Torsion of the appendix testis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **torsion of the appendix testis** - a benign, self-limited condition. The pathognomonic findings are: (1) **Blue dot sign** - the infarcted appendix visible through scrotal skin at the superior pole, (2) **Intact cremasteric reflex** - this is ABSENT in testicular torsion, (3) **Normal testicular lie** - testicular torsion causes high-riding, transverse testicle, (4) **Focal upper pole tenderness** - testicular torsion causes diffuse testicular tenderness. The appendix testis is a M\u00fcllerian duct remnant that can tort independently, causing pain without threatening the testicle.", "consequence": "You correctly identify the benign condition and avoid unnecessary emergency surgery.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Testicular torsion requiring emergent surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While testicular torsion is the most important diagnosis to rule out, this patient has findings that make it very unlikely: (1) **Cremasteric reflex is PRESENT** - in testicular torsion, it is classically ABSENT (though not 100% sensitive), (2) **Normal testicular lie** - torsion causes a high-riding, horizontally-oriented (\"bell clapper\") testicle, (3) **Blue dot sign** - this indicates torsion of the appendix testis, not the testicle itself, (4) **Focal upper pole tenderness** - testicular torsion causes diffuse, severe testicular pain. The testicle itself is non-tender.", "consequence": "Misdiagnosis could lead to unnecessary emergency surgery.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Acute epididymitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Epididymitis** presents with: (1) **Gradual onset** of pain over days (not acute onset), (2) Tenderness over the **epididymis** (posterior to testicle), NOT at the superior pole, (3) Often associated with **fever, dysuria, pyuria, or urethral discharge** (especially in sexually active adolescents - think *Chlamydia/gonorrhea*), (4) **Positive Prehn sign** (pain relief with scrotal elevation) - though unreliable. This prepubertal patient with acute onset, no urinary symptoms, and a blue dot sign does not fit epididymitis.", "consequence": "Misdiagnosis leads to inappropriate antibiotic therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Incarcerated inguinal hernia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Incarcerated inguinal hernia** presents with: (1) **Inguinal swelling** extending into the scrotum, (2) **Non-reducible mass** in the inguinal canal/scrotum, (3) **Abdominal symptoms** - nausea, vomiting, obstipation if bowel is incarcerated, (4) Swelling that **increases with Valsalva or crying**. This patient has no inguinal mass, no abdominal symptoms, and the localized blue dot sign at the superior testicular pole is pathognomonic for appendix testis torsion.", "consequence": "Incorrect diagnosis does not explain the blue dot sign.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Testicular tumor with hemorrhage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Testicular tumors** present with: (1) **Painless** scrotal mass (pain occurs in only ~10%), (2) **Firm, hard mass** within the testicle itself, (3) Gradual enlargement over weeks to months. This patient has acute onset pain, a non-tender normal testicle, and the classic blue dot sign. Tumors do not cause the blue dot sign. However, any solid testicular mass warrants ultrasound and tumor marker evaluation (AFP, beta-hCG, LDH).", "consequence": "The blue dot sign and clinical presentation do not support this diagnosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Blue dot sign + intact cremasteric reflex + normal testicular lie = torsion of appendix testis (benign)**. Testicular torsion causes: absent cremasteric reflex, high-riding transverse testicle, and diffuse testicular tenderness. When in doubt, get Doppler ultrasound or explore surgically - never miss testicular torsion."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose torsion of the appendix testis based on the classic blue dot sign, intact cremasteric reflex, and normal testicular lie.\n\n**Differentiating appendix testis torsion from testicular torsion:**\n\n| Feature | Appendix Testis Torsion | Testicular Torsion |\n|---------|------------------------|--------------------|\n| Cremasteric reflex | PRESENT | ABSENT |\n| Testicular lie | Normal vertical | High-riding, transverse |\n| Blue dot sign | Present (pathognomonic) | Absent |\n| Tenderness | Focal, upper pole | Diffuse, entire testicle |\n| Age peak | 7-12 years (prepubertal) | Bimodal: neonatal, 12-18 years |\n| Management | Conservative | EMERGENT SURGERY |\n\n**Should you get imaging to confirm?**", "question": "What is the most appropriate next step?", "choices": [{"id": "node-2-choice-a", "text": "Obtain Doppler ultrasound to confirm normal testicular blood flow before conservative management", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! While the clinical picture strongly suggests appendix testis torsion, **Doppler ultrasound** is recommended to confirm normal testicular blood flow and definitively rule out testicular torsion. Ultrasound findings in appendix testis torsion: (1) **Normal testicular blood flow** (the key finding), (2) **Hyperechoic or hypoechoic appendage** at the superior pole, (3) **Increased blood flow around the appendage** (reactive hyperemia), (4) **Scrotal wall thickening**. If flow is normal, you can proceed with conservative management confidently.", "consequence": "You confirm the diagnosis with appropriate imaging before proceeding.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Proceed directly to surgical exploration", "isOptimal": false, "isAcceptable": true, "feedback": "This is acceptable but typically not necessary when clinical findings are classic for appendix testis torsion. **Surgical exploration is the safest approach when diagnosis is uncertain** - the mantra is \"when in doubt, explore.\" However, with the classic triad (blue dot sign, intact cremasteric reflex, normal testicular position) and modern access to Doppler ultrasound, most cases can be confidently diagnosed non-invasively. Surgery for appendix testis torsion (excision of the infarcted appendage) is curative but carries operative risks.", "consequence": "Surgery is safe but may be unnecessary with classic clinical findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Start conservative management without imaging since clinical findings are classic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While clinical findings are suggestive, **the consequence of missing testicular torsion is testicular loss**. Testicular salvage rates drop precipitously after 6 hours of ischemia. Even with a classic presentation for appendix testis torsion, it is prudent to confirm normal testicular blood flow with Doppler ultrasound before committing to conservative management. The ultrasound is quick, non-invasive, and provides definitive reassurance. Never assume - always confirm.", "consequence": "Risk of missing testicular torsion, which requires emergent surgery.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Obtain urinalysis and start empiric antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient does not have epididymitis. Key differences: (1) **No urinary symptoms** (dysuria, frequency, discharge), (2) **No fever**, (3) **Prepubertal age** - epididymitis from STIs is rare before sexual debut, (4) **Blue dot sign** - pathognomonic for appendix testis torsion, not seen in epididymitis. Urinalysis is often normal in appendix testis torsion. Antibiotics are not indicated for this non-infectious condition.", "consequence": "Inappropriate treatment for a non-infectious condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Discharge with NSAIDs and return precautions without any imaging", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never discharge acute scrotal pain without definitively ruling out testicular torsion**. While clinical findings favor appendix testis torsion, the stakes are too high - testicular torsion causes irreversible ischemic damage within hours. At minimum, Doppler ultrasound should confirm normal blood flow before discharge. The ultrasound adds minimal time and provides crucial reassurance that the testicle is not at risk.", "consequence": "Dangerous to discharge without confirming testicular perfusion.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**When in doubt, explore surgically** - never miss testicular torsion. However, with classic findings (blue dot, intact reflex, normal lie) AND confirmatory Doppler showing normal flow, conservative management is appropriate. Testicular torsion = surgical emergency; appendix testis torsion = conservative management."}, "node-3": {"id": "node-3", "type": "decision", "content": "Doppler ultrasound confirms **normal bilateral testicular blood flow**. A small, hypoechoic structure is seen at the superior pole of the left testicle with surrounding increased echogenicity consistent with edema - findings consistent with torsion of the appendix testis.\n\n**You can now confidently proceed with conservative management.**\n\n**Natural history of appendix testis torsion:**\n- Self-limited condition - the infarcted appendage atrophies over 1-2 weeks\n- Pain typically improves within 3-7 days\n- No risk to the testicle itself (blood supply is independent)\n- The appendix testis has no functional significance", "question": "What is the appropriate management and discharge counseling for this patient?", "choices": [{"id": "node-3-choice-a", "text": "NSAIDs for pain, scrotal support, limited activity, and return precautions for worsening symptoms", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Conservative management** is appropriate for confirmed appendix testis torsion. Treatment includes: (1) **NSAIDs** (ibuprofen) for pain and inflammation, (2) **Scrotal support** (supportive underwear, athletic supporter), (3) **Limited activity** for 1-2 weeks, (4) **Ice packs** for comfort. **Return precautions**: return immediately if pain significantly worsens, new swelling develops, or symptoms don't improve within 5-7 days. Symptoms typically resolve in 3-7 days as the appendage infarcts and atrophies. Full resolution occurs within 1-2 weeks.", "consequence": "You provide appropriate conservative management with clear return precautions.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Urgent urology referral for surgical excision of the appendix testis", "isOptimal": false, "isAcceptable": true, "feedback": "This is acceptable but typically not necessary. **Surgical excision** of the torsed appendix testis is curative and may shorten symptom duration, but it is rarely indicated given that the condition is self-limited. Surgery may be considered for: (1) Prolonged symptoms (>7-10 days), (2) Diagnostic uncertainty despite imaging, (3) Severe pain not controlled with NSAIDs. Most cases resolve spontaneously with conservative management and surgery adds operative risks without significant benefit.", "consequence": "Surgery is curative but usually unnecessary for this self-limited condition.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Prescribe opioid pain medication and bed rest for 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is over-treatment. Appendix testis torsion causes **mild to moderate pain** that responds well to NSAIDs. Opioids are not indicated for this self-limited condition and carry risks of dependence, constipation, and respiratory depression. Strict bed rest is also unnecessary - limiting vigorous activity while allowing normal daily activities is appropriate. The condition resolves in days, not weeks.", "consequence": "Over-treatment with unnecessary opioids and excessive activity restriction.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Prescribe antibiotics and schedule urology follow-up in 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotics are not indicated** - this is torsion of a vestigial structure, not an infection. There is no bacterial component to treat. Starting antibiotics contributes to resistance and exposes the patient to unnecessary side effects. Follow-up in 2 weeks is reasonable, but antibiotics should not be prescribed. NSAIDs and supportive care are the appropriate treatment.", "consequence": "Antibiotics are inappropriate for this non-infectious condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Admit for observation and serial examinations", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is unnecessary. With **confirmed normal testicular blood flow on Doppler**, there is no indication for admission. Appendix testis torsion is a benign, outpatient condition. Admission would increase cost and healthcare utilization without clinical benefit. The patient can be safely discharged with appropriate return precautions and close follow-up as needed.", "consequence": "Unnecessary hospitalization for a benign outpatient condition.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Appendix testis torsion is self-limited** and resolves in 3-7 days with conservative care (NSAIDs, scrotal support, limited activity). The appendix testis has no function - its infarction and atrophy cause no long-term sequelae. Surgery is rarely needed but can be considered for prolonged symptoms or diagnostic uncertainty."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified torsion of the appendix testis based on classic clinical findings, confirmed the diagnosis with Doppler ultrasound showing normal testicular blood flow, and provided appropriate conservative management.\n\n**Key teaching points:**\n- **Blue dot sign + intact cremasteric reflex + normal testicular lie = appendix testis torsion**\n- Testicular torsion causes: absent cremasteric reflex, high-riding transverse testicle, diffuse tenderness\n- **Doppler ultrasound** confirms normal testicular flow and definitively rules out torsion\n- **Conservative management**: NSAIDs, scrotal support, limited activity, return precautions\n- Self-limited condition - resolves in 3-7 days as appendage infarcts and atrophies\n- **Never discharge acute scrotal pain without ruling out testicular torsion**\n\n**Prognosis**: Excellent. Complete resolution expected within 1-2 weeks with no long-term sequelae. The testicle is not at risk."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key concepts:\n\n**Differentiating appendix testis torsion from testicular torsion:**\n- Blue dot sign = appendix testis torsion (pathognomonic)\n- Intact cremasteric reflex = against testicular torsion\n- Normal testicular lie = against testicular torsion\n- High-riding transverse testicle + absent reflex = testicular torsion (surgical emergency)\n\n**Diagnostic approach:**\n- Doppler ultrasound confirms normal flow before conservative management\n- When in doubt, explore surgically - never miss testicular torsion\n\n**Management of appendix testis torsion:**\n- Conservative: NSAIDs, scrotal support, limited activity\n- Self-limited - resolves in 3-7 days\n- Surgery rarely needed"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates the critical differentiation of acute scrotal pain:\n\n**Never miss testicular torsion:**\n- Absent cremasteric reflex, high-riding transverse testicle, diffuse tenderness\n- Surgical emergency - salvage rates drop after 6 hours\n- When in doubt, explore\n\n**Recognizing appendix testis torsion:**\n- **Blue dot sign** - pathognomonic (infarcted appendage visible through scrotal skin)\n- **Intact cremasteric reflex**\n- **Normal testicular lie**\n- **Focal upper pole tenderness** (not the testicle itself)\n\n**Key principle:**\n- Always confirm diagnosis with Doppler ultrasound before conservative management\n- Never discharge acute scrotal pain without ruling out testicular torsion\n- Appendix testis torsion is benign and self-limited; testicular torsion is an emergency"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-130", "title": "Sleep Terrors vs Nightmares", "domain": "growth_development", "difficulty": "intermediate", "tags": ["no memory of episode", "cannot be consoled", "occurs early in night", "fully awake and scared", "sleep terrors vs nightmares"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male is brought to the pediatric clinic by his parents who are concerned about nighttime episodes.\n\nHistory: For the past month, the child has had episodes 2-3 times per week where he suddenly sits up in bed approximately 1-2 hours after falling asleep, screams loudly, appears terrified with wide eyes, sweating, and rapid breathing. During these episodes, he does not respond to his parents' attempts to comfort him. Episodes last 5-15 minutes, after which he goes back to sleep. In the morning, he has no memory of the events.\n\nThe parents are worried about seizures and want to know what is happening.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Additional History:\n- Episodes occur during the **first third of the night** (1-2 hours after sleep onset)\n- Child **cannot be consoled** and does not recognize parents during episodes\n- **No memory** of the event the next morning\n- Family history: Father had similar episodes as a child\n- Recent stressors: Started kindergarten, occasionally sleep deprived\n- No stereotyped movements, tongue biting, or postictal confusion\n\nPhysical exam is completely normal, including neurological examination.", "question": "Based on this presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Sleep terrors (night terrors)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Sleep terrors** are the most likely diagnosis. The key features include: episodes occurring in the **first third of the night** (during slow-wave N3 sleep), child appearing terrified but **cannot be consoled**, **no memory** of the event, and **family history** of similar episodes. Sleep terrors are **non-REM parasomnias** caused by incomplete arousal from deep sleep.", "consequence": "You correctly identify sleep terrors. Now you need to differentiate this from other conditions and counsel the family.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Nightmares", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Nightmares** occur during **REM sleep** in the **second half of the night**, the child **fully awakens** and is **consolable**, and importantly **remembers the scary dream**. This child has episodes in the first third of the night, cannot be consoled, and has no memory - all pointing to sleep terrors, not nightmares.", "consequence": "Misdiagnosis leads to inappropriate counseling; understanding the distinction is critical for management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Nocturnal frontal lobe epilepsy", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. **Nocturnal frontal lobe seizures** can present with brief, stereotyped nocturnal events. However, sleep terrors are more likely here given: **non-stereotyped episodes**, duration of 5-15 minutes (seizures typically <2 minutes), **family history** of similar childhood episodes, lack of postictal confusion, and normal neurological exam. EEG may be considered if episodes are highly stereotyped or don't respond to typical sleep terror management.", "consequence": "Pursuing seizure workup may be reasonable but is likely unnecessary given the classic sleep terror presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Confusional arousals", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Confusional arousals** are also non-REM parasomnias and share features with sleep terrors. However, confusional arousals are characterized by **confusion and disorientation** rather than the **intense fear and autonomic arousal** (screaming, sweating, tachycardia) seen in sleep terrors. The dramatic fright response in this child points more toward sleep terrors.", "consequence": "Both are non-REM parasomnias with similar management, but precise diagnosis helps with parental counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "PTSD-related nightmares", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PTSD-related nightmares** would require a history of **trauma**, and like all nightmares, occur during **REM sleep** with the child **awakening fully** and **remembering** the content. There is no trauma history here, and the child has no memory of events - this is classic for sleep terrors, not PTSD.", "consequence": "Pursuing trauma evaluation is inappropriate and may cause unnecessary distress to the family.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Sleep terrors** occur in first third of night (N3 slow-wave sleep): child appears terrified, **cannot be consoled**, has **no memory**. **Nightmares** occur in second half of night (REM sleep): child **wakes fully**, is **consolable**, and **remembers** the scary dream."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed sleep terrors in this 5-year-old.\n\nThe parents are very concerned and ask what they should do during an episode. They've been trying to wake him up and calm him down, but this seems to make the episodes last longer and sometimes he becomes more agitated.\n\nYou need to provide appropriate guidance on managing episodes and preventing recurrence.", "question": "What is the most appropriate management advice for the parents?", "choices": [{"id": "node-2-choice-a", "text": "Do NOT try to wake the child; ensure safety; episodes are self-limiting; maintain regular sleep schedule", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The key management principles for sleep terrors are: **Do NOT try to wake the child** (attempting to wake them can prolong episodes and increase agitation), ensure **environmental safety** (remove sharp objects, secure stairs), and **reassure parents** that episodes are self-limiting and the child is not in distress despite appearances. **Prevention** focuses on maintaining a **regular sleep schedule** and ensuring **adequate sleep** (sleep deprivation is a major trigger).", "consequence": "Parents understand the benign nature and proper response. You now provide additional counseling.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Wake the child immediately to stop the episode", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Waking the child is contraindicated** and can actually **prolong** the episode and increase agitation. During a sleep terror, the child is in deep non-REM sleep and is not consciously experiencing fear despite their appearance. Attempting to wake them can be very difficult and may cause confusion and distress when they do eventually awaken.", "consequence": "This advice worsens episodes and increases parental frustration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start prophylactic benzodiazepines", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Benzodiazepines are rarely indicated** for sleep terrors and reserved only for severe, frequent cases that significantly disrupt family function and have failed conservative measures. First-line management is **reassurance**, **safety measures**, and **sleep hygiene**. Medications like low-dose clonazepam may be considered in refractory cases.", "consequence": "Unnecessary medication with potential side effects for a benign, self-limiting condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Order EEG and sleep study before any management", "isOptimal": false, "isAcceptable": true, "feedback": "Testing is generally **not needed** for classic sleep terrors. EEG may be considered if episodes are **highly stereotyped** (suggesting seizures) or if there is **postictal confusion**. Sleep study is indicated if there is concern for **obstructive sleep apnea** (which can trigger parasomnias) or other sleep disorders. This case has a classic presentation, and testing can be deferred unless the child doesn't respond to initial management.", "consequence": "Unnecessary testing delays appropriate reassurance and management; may increase parental anxiety.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Refer to child psychiatry for anxiety evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sleep terrors are **not caused by anxiety** or psychological disturbance - they are a **developmental parasomnia** related to immature arousal mechanisms. While stress and sleep deprivation can trigger episodes, psychiatry referral is not indicated. The child does not experience conscious fear during episodes and has no psychological trauma from them.", "consequence": "Inappropriate referral that may pathologize a normal developmental phenomenon.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "During sleep terrors: **Do NOT wake the child** - stay calm, ensure safety, and let the episode resolve on its own (typically 5-15 minutes). Prevention: maintain **regular sleep schedule**, ensure **adequate sleep**, and reduce **stress**. Most children outgrow sleep terrors by adolescence."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents are relieved to hear that sleep terrors are benign. However, episodes are occurring 2-3 times per week and the parents are exhausted from being awakened.\n\nThey ask if there is anything else that can be done to reduce the frequency of episodes.\n\nYou discuss additional preventive strategies.", "question": "What additional intervention is most appropriate to reduce episode frequency?", "choices": [{"id": "node-3-choice-a", "text": "Scheduled awakenings 15-30 minutes before typical episode time", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Scheduled awakenings** are an effective intervention for frequent sleep terrors. Parents briefly rouse the child (not fully awaken) **15-30 minutes before the typical episode time** to disrupt the sleep cycle before the child enters the vulnerable portion of deep sleep. This is done nightly for 2-4 weeks and has been shown to significantly reduce episode frequency. Combined with optimizing sleep hygiene, this is the most effective non-pharmacological intervention.", "consequence": "Parents implement scheduled awakenings and sleep hygiene measures. Episode frequency decreases significantly over the next few weeks.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Move bedtime 2 hours later to reduce deep sleep", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying bedtime worsens sleep terrors** because it leads to **sleep deprivation**, which is a major trigger. Sleep deprivation increases the proportion of deep slow-wave sleep (when sleep terrors occur) during the first sleep cycle. An **earlier, consistent bedtime** with adequate total sleep is recommended.", "consequence": "Sleep deprivation increases episode frequency and severity.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Start melatonin at bedtime", "isOptimal": false, "isAcceptable": true, "feedback": "Melatonin is **not first-line** for sleep terrors but may be helpful if there are concurrent **sleep onset difficulties** contributing to sleep deprivation. Some evidence suggests melatonin may reduce parasomnias by stabilizing sleep architecture, but **scheduled awakenings** and **sleep hygiene** remain the primary interventions. Melatonin is reasonable as an adjunct if sleep onset is delayed.", "consequence": "Melatonin may help slightly but doesn't address the underlying issue as effectively as scheduled awakenings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Prescribe low-dose clonazepam at bedtime", "isOptimal": false, "isAcceptable": true, "feedback": "Benzodiazepines like **clonazepam** can be effective for severe, refractory sleep terrors by suppressing deep slow-wave sleep. However, they are **reserved for cases** that significantly disrupt family function and have **failed conservative measures** (sleep hygiene, scheduled awakenings). Given this is the first visit with no prior interventions attempted, non-pharmacological approaches should be tried first.", "consequence": "Medication may help but carries risks of side effects and dependency; conservative measures should be tried first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Recommend the child sleep in parents' bed for closer monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Co-sleeping is not recommended** as management for sleep terrors. It doesn't reduce episode frequency and can reinforce sleep problems. The appropriate approach is to ensure the child's **own sleep environment is safe** (low bed, no sharp objects, secured stairs) and let episodes resolve naturally.", "consequence": "Does not address the underlying issue and may create additional sleep problems.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Scheduled awakenings**: briefly rouse the child 15-30 minutes before typical episode time for 2-4 weeks. This disrupts the sleep cycle and reduces episodes. Ensure **adequate sleep** (sleep deprivation is the #1 trigger). Most children **outgrow** sleep terrors by age 8-12."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **sleep terrors** and provided appropriate management.\n\n**Key Learning Points:**\n\n**Sleep Terrors vs Nightmares:**\n| Feature | Sleep Terrors | Nightmares |\n|---------|---------------|------------|\n| Timing | First third of night (N3) | Second half of night (REM) |\n| Memory | No memory | Remembers dream |\n| Consolable | Cannot be consoled | Consolable |\n| Awakening | Does not wake | Fully wakes |\n| Age | 3-8 years | 3-6 years (can occur any age) |\n\n**Management:**\n- Do NOT try to wake the child during episodes\n- Ensure safety (remove hazards, secure stairs)\n- Maintain regular sleep schedule (avoid sleep deprivation)\n- Scheduled awakenings for frequent episodes\n- Reassure parents - episodes are benign and self-limiting\n- Most children outgrow by adolescence"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key distinctions:\n\n**Sleep Terrors (Non-REM Parasomnia):**\n- Occur in **first third of night** during slow-wave (N3) sleep\n- Child **cannot be consoled** and appears terrified\n- **No memory** of the event\n- **Do NOT try to wake** - ensure safety only\n- Triggers: sleep deprivation, fever, stress\n\n**Nightmares (REM Parasomnia):**\n- Occur in **second half of night** during REM sleep\n- Child **wakes fully** and is **consolable**\n- **Remembers** the scary dream content\n\n**Management**: Safety, reassurance, regular sleep schedule, scheduled awakenings for frequent episodes."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect.\n\n**Critical Points:**\n- **Sleep terrors**: child is NOT awake, appears terrified but has **no memory** - do NOT try to wake them\n- **Nightmares**: child wakes fully and **remembers** the scary dream - can be consoled\n- Sleep terrors occur during **first third of night** (slow-wave sleep); nightmares during **second half** (REM)\n- **Sleep deprivation worsens** sleep terrors - ensure adequate sleep\n- Treatment is primarily **reassurance and sleep hygiene** - medications rarely needed\n- Most children **outgrow** sleep terrors by adolescence"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-131", "title": "Normal Adolescent Development", "domain": "growth_development", "difficulty": "intermediate", "tags": ["identity formation", "peer influence", "autonomy seeking", "normal risk-taking", "normal adolescent development"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old male is brought in by his parents who are concerned about recent changes in his behavior over the past several months.\n\nParental concerns:\n- He's become \"moody\" - happy one moment, irritable the next\n- Spends more time in his room with the door closed\n- Seems more interested in friends than family\n- Questions family rules and \"talks back\" more than before\n- Stays up later at night and is hard to wake in the morning\n- Has become self-conscious about his appearance\n\nThe teen, interviewed alone, reports:\n- Doing well in school (mostly A's and B's, unchanged)\n- Has a good group of friends\n- Plays on the school soccer team\n- Denies drug/alcohol use, smoking\n- Denies feeling depressed or having thoughts of self-harm\n- Gets along \"okay\" with parents, just wants more independence", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You gather more history and observe the patient.\n\n**Key observations:**\n- Well-groomed, appropriate affect\n- Makes good eye contact\n- Engages appropriately in conversation\n- Physical exam: normal, Tanner stage 3-4\n\n**Understanding adolescent psychosocial development:**\n\n**Early Adolescence (11-14 years):**\n- Focus on physical changes and body image\n- Beginning separation from parents\n- Same-sex peer groups\n- Concrete thinking still predominant\n\n**Middle Adolescence (15-17 years):**\n- Peak peer influence\n- Risk-taking behavior increases\n- Abstract thinking develops\n- Romantic interests emerge\n\n**Late Adolescence (18-21 years):**\n- Identity consolidation\n- More stable relationships\n- Future-oriented thinking\n- Increased autonomy", "question": "What is the most appropriate assessment of this patient's behavior?", "choices": [{"id": "node-1-choice-a", "text": "Normal adolescent psychosocial development", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This patient demonstrates **normal adolescent psychosocial development**. Key features supporting this: (1) **Moodiness** - normal due to hormonal changes and developing emotional regulation, (2) **Privacy-seeking** - appropriate separation-individuation from parents, (3) **Peer focus** - normal shift from family to peer relationships, (4) **Questioning authority** - healthy development of autonomy, (5) **Sleep phase shift** - physiologic circadian changes in adolescence, (6) **Body consciousness** - normal in pubertal teens. Importantly, he has NO red flags: academic performance is maintained, social functioning is good, no depression/self-harm, no substance use.", "consequence": "You correctly recognize this as normal development and can provide appropriate counseling.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Major depressive disorder", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While moodiness is present, this does NOT meet criteria for **major depressive disorder**. Depression criteria include: persistent depressed mood or anhedonia (loss of interest) for \u22652 weeks, PLUS additional symptoms (sleep changes, appetite changes, fatigue, worthlessness, concentration problems, suicidal ideation). This teen: denies feeling depressed, has good academic performance, enjoys soccer and friends, and has appropriate affect on exam. Intermittent moodiness is normal in adolescents.", "consequence": "Pathologizing normal behavior could lead to unnecessary treatment and labeling.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Oppositional defiant disorder (ODD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ODD** requires a pattern of angry/irritable mood, argumentative/defiant behavior, OR vindictiveness lasting \u22656 months, causing significant impairment. This teen questions rules occasionally (normal autonomy-seeking) but: maintains good grades, has positive peer relationships, participates in extracurriculars, and reports getting along \"okay\" with parents. Some pushback against parental authority is developmentally appropriate and does not constitute a disorder.", "consequence": "Diagnosing a disorder for normal behavior is inappropriate and potentially harmful.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Substance use disorder", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While behavioral changes can signal substance use, this teen has NO red flags: (1) Directly denies drug/alcohol use, (2) Academic performance is unchanged, (3) Continues participation in organized sports, (4) Has stable friendships, (5) No physical signs of intoxication. The sleep phase shift (late nights, hard to wake) is a **physiologic circadian change** in adolescents, not evidence of substance use. Always consider substance use in differential, but don't diagnose without supporting evidence.", "consequence": "Accusing without evidence damages trust and the therapeutic relationship.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Autism spectrum disorder with new presentation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Autism spectrum disorder** is a neurodevelopmental condition present from early childhood, not something that newly presents at age 14. Features include persistent deficits in social communication AND restricted, repetitive behaviors. This teen has: good eye contact, appropriate social engagement, multiple friendships, and participates in team sports - all inconsistent with undiagnosed ASD. The described behaviors are classic normal adolescent development.", "consequence": "ASD does not present de novo in adolescence; wrong diagnosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Normal adolescent behaviors**: moodiness, privacy-seeking, peer focus, questioning authority, sleep phase shift, body consciousness. **Red flags** that warrant concern: persistent depressed mood, social isolation, declining academics, substance use, self-harm, risky behaviors, significant family conflict."}, "node-2": {"id": "node-2", "type": "decision", "content": "You recognize this as normal adolescent development. The parents need education and guidance.\n\n**The HEEADSSS assessment** is a helpful framework for adolescent interviews:\n- **H**ome - living situation, family relationships\n- **E**ducation/Employment - school performance, goals\n- **E**ating - diet, body image\n- **A**ctivities - hobbies, sports, screen time\n- **D**rugs - tobacco, alcohol, drugs\n- **S**exuality - relationships, sexual activity, orientation\n- **S**uicide/Depression - mood, self-harm, safety\n- **S**afety - violence, bullying, seat belts\n\nYou've completed a HEEADSSS assessment and found no concerns.", "question": "What is the most appropriate way to counsel the parents?", "choices": [{"id": "node-2-choice-a", "text": "Reassure that these behaviors are developmentally normal; provide anticipatory guidance on adolescent development stages", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Key counseling points for parents**: (1) Reassure that moodiness, privacy-seeking, and peer focus are NORMAL, (2) Explain adolescent brain development - prefrontal cortex (judgment) develops slower than limbic system (emotions), (3) Encourage maintaining open communication and family meals, (4) Advise picking battles - focus on safety, not minor disagreements, (5) Teach about red flags to watch for (depression, isolation, substance use, self-harm), (6) Recommend gradual increase in autonomy with responsibility, (7) Normalize the sleep phase shift (delayed circadian rhythm in adolescents).", "consequence": "You provide appropriate education and strengthen the parent-teen relationship.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Recommend stricter parental controls and monitoring to address the concerning behaviors", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There are NO concerning behaviors - this is normal development. **Excessive control is counterproductive** in adolescence. It can: (1) Damage the parent-teen relationship, (2) Impede healthy autonomy development, (3) Increase secretive behavior, (4) Lead to rebellion. Appropriate monitoring is reasonable (knowing where your teen is, meeting friends), but strict control in response to normal behavior is inappropriate.", "consequence": "Excessive control can damage the parent-teen relationship and impede development.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Refer to psychiatry for evaluation of mood disorder", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Psychiatry referral is not indicated** for normal adolescent development. This teen has: good academic performance, healthy peer relationships, active in sports, appropriate affect, no depressive symptoms, no self-harm, no substance use. Referring normal variations to psychiatry: (1) Pathologizes normal behavior, (2) Creates unnecessary anxiety, (3) Uses limited specialty resources inappropriately. Refer if red flags emerge or if symptoms meet criteria for a disorder.", "consequence": "Unnecessary referral pathologizes normal behavior and wastes resources.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Recommend family therapy to address communication breakdown", "isOptimal": false, "isAcceptable": true, "feedback": "Family therapy is not necessarily indicated here. While it can be helpful for families with significant conflict, this teen reports getting along \"okay\" with parents and simply wants more independence - a normal developmental need. The situation doesn't suggest \"communication breakdown\" requiring therapy. **Brief anticipatory guidance** about adolescent development is more appropriate for this family. Family therapy should be reserved for more significant dysfunction.", "consequence": "Family therapy may be helpful but is not necessary for normal developmental changes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Order laboratory tests to rule out hormonal imbalance causing moodiness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Laboratory testing is not indicated**. The moodiness is explained by normal adolescent development - hormonal changes of puberty DO affect mood, but this is expected, not pathologic. Testing would be appropriate if there were: (1) Signs of thyroid dysfunction (fatigue, weight changes, hair changes), (2) Concern for other endocrine disorders, (3) Physical symptoms unexplained by normal development. This teen has normal physical exam and developmentally appropriate symptoms.", "consequence": "Unnecessary testing adds cost and medicalized normal development.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Adolescent brain development**: The limbic system (emotions, reward) develops before the prefrontal cortex (judgment, impulse control). This explains why teens experience intense emotions and may take risks despite \"knowing better.\" Full prefrontal development isn't complete until mid-20s."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents feel reassured after your explanation. Before ending the visit, you want to ensure the teen has appropriate resources and knows how to access care.\n\n**Important aspects of the adolescent visit:**\n- **Confidential time** with the teen (without parents) is essential\n- **Confidentiality and its limits** should be explained to both teen and parents\n- Teens can consent for certain services without parental consent (varies by state): STI testing/treatment, contraception, mental health services, substance abuse treatment\n\n**The teen asks if everything you discussed will be shared with his parents.**", "question": "What is the most appropriate response regarding confidentiality?", "choices": [{"id": "node-3-choice-a", "text": "Explain that most health information is confidential, but you must break confidentiality if there is risk of harm to self or others", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Adolescent confidentiality** is essential for building trust and ensuring teens access necessary care. Key points: (1) Most health information discussed is **confidential** and won't be shared with parents, (2) **Exceptions** (must break confidentiality): risk of harm to self (suicidal ideation, self-harm), risk of harm to others (homicidal ideation), abuse or neglect, (3) Certain services have **explicit confidentiality protections** by state law (STI care, contraception, substance treatment, mental health), (4) Encourage the teen to discuss important health issues with parents when safe to do so, (5) Offer to help facilitate difficult conversations.", "consequence": "You establish trust while clearly explaining the limits of confidentiality.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Tell him that everything he shares must be reported to his parents since he is a minor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is not true and would destroy trust**. Adolescents have confidentiality rights in healthcare. Minor status does NOT mean parents must know everything. Key points: (1) State and federal laws protect adolescent confidentiality for many services, (2) Without confidentiality, teens may avoid seeking care for sensitive issues (sexual health, mental health, substance use), (3) HIPAA and state laws generally allow teens to receive confidential care for specific services. Breaking confidentiality requires safety concerns, not simply being a minor.", "consequence": "This would be false, damage trust, and deter the teen from seeking future care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Reassure him that nothing will ever be shared with his parents under any circumstances", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is also not true** - there ARE limits to confidentiality. Providers MUST break confidentiality for: (1) Imminent danger to self (suicide risk), (2) Imminent danger to others, (3) Child abuse or neglect, (4) Court orders. Making false promises about absolute confidentiality is inappropriate and could result in the teen feeling betrayed if confidentiality must be broken later. Always explain BOTH the rule AND its exceptions.", "consequence": "False promises undermine trust when confidentiality must be broken for safety.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Tell him you prefer not to keep secrets and will share everything with his parents to keep him safe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This paternalistic approach violates adolescent rights** and will likely result in: (1) The teen not disclosing important health information, (2) Avoidance of healthcare for sensitive issues, (3) Damaged therapeutic relationship, (4) Potentially worse health outcomes. Confidentiality is not about \"keeping secrets\" - it's about respecting the developing autonomy of adolescents and ensuring they can access necessary care.", "consequence": "This approach violates adolescent rights and deters honest communication.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Defer the confidentiality discussion until the teen is older and can understand legal nuances", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Confidentiality should be discussed at EVERY adolescent visit**, starting in early adolescence. A 14-year-old can understand the basics: (1) Most things are private, (2) Certain safety concerns require disclosure. Early discussion: builds trust, normalizes confidential healthcare, and ensures teens know they can access care for sensitive issues. Deferring suggests the provider is uncomfortable with adolescent care or underestimates the teen's maturity.", "consequence": "Failing to discuss confidentiality undermines trust and adolescent-appropriate care.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Adolescent confidentiality**: Explain that most health information is confidential BUT must be broken if there is danger to self or others. This builds trust while maintaining safety. States vary on specific minor consent laws - know your state's regulations for STI, contraception, mental health, and substance treatment."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly recognized normal adolescent psychosocial development, provided appropriate parental reassurance and anticipatory guidance, and addressed confidentiality appropriately with the teen.\n\n**Key teaching points:**\n- **Normal adolescent behaviors**: moodiness, privacy-seeking, peer focus, questioning authority, sleep phase shift, body consciousness\n- **Red flags**: persistent depression, social isolation, declining academics, substance use, self-harm\n- **HEEADSSS assessment**: structured psychosocial screening for adolescents\n- **Adolescent brain development**: limbic system develops before prefrontal cortex - explains emotional intensity and risk-taking\n- **Confidentiality**: essential for adolescent care; explain both the protection AND its limits (harm to self/others)\n- **Parent counseling**: normalize development, encourage open communication, teach red flags, gradually increase autonomy\n\n**Prognosis**: With supportive parenting and normal development, this teen is likely to navigate adolescence successfully."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of adolescent care:\n\n**Recognizing normal vs. pathologic:**\n- Normal: moodiness, privacy-seeking, peer focus, questioning authority, sleep phase shift\n- Red flags: persistent depression, isolation, academic decline, substance use, self-harm\n\n**Appropriate management:**\n- Reassure parents that behaviors are developmentally normal\n- Provide anticipatory guidance on adolescent stages\n- Don't pathologize normal behavior with unnecessary referrals/testing\n\n**Confidentiality:**\n- Essential for building trust\n- Most information is confidential\n- Must break for danger to self or others\n- Explain to both teen AND parents"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates important principles of adolescent care:\n\n**Normal adolescent development:**\n- Moodiness, privacy, peer focus, autonomy-seeking are NORMAL\n- Don't diagnose disorders (depression, ODD, substance use) without meeting criteria\n- These behaviors do NOT require psychiatric referral, stricter control, or laboratory testing\n\n**Adolescent confidentiality:**\n- Essential for building trust and ensuring teens access care\n- Most health information IS confidential\n- Exceptions: danger to self or others, abuse, court orders\n- Never promise absolute confidentiality OR claim everything is shared with parents\n\n**HEEADSSS assessment:**\n- Use this structured approach for comprehensive psychosocial screening\n- Include confidential time with the teen without parents present"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-151", "title": "Attention-Deficit/Hyperactivity Disorder (ADHD)", "domain": "growth_development", "difficulty": "intermediate", "tags": ["ADHD", "inattention", "hyperactivity", "stimulants", "methylphenidate", "behavioral therapy", "DSM-5", "Vanderbilt scale"], "estimatedMinutes": 8, "source": ["NBME"], "stem": "An 8-year-old boy is brought by his parents for 'trouble paying attention in school.' His second-grade teacher reports he cannot sit still, frequently interrupts others, and rarely completes assignments. He loses homework regularly and forgets instructions.\n\nHis mother notes similar behaviors at home - he cannot follow multi-step directions, leaves tasks half-finished, and talks excessively. These problems started in kindergarten but have worsened as academic demands increased.\n\nFamily history: Father had similar problems as a child and still struggles with organization.\n\nPhysical Examination:\n- General: Well-appearing, active boy who is fidgety throughout the exam\n- Behavioral: Difficulty staying seated, interrupts examiner multiple times, easily distracted by sounds outside\n- Neurologic: Normal examination, no tics, no focal deficits\n- Vision/hearing screens: Normal", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 8-year-old presents with inattention (cannot complete assignments, loses things, forgets instructions) and hyperactivity/impulsivity (cannot sit still, interrupts others, talks excessively). The symptoms are present in **multiple settings** (school AND home) and started before age 12.\n\n**Vanderbilt Assessment Scales** completed by parents and teachers both show elevated scores for inattention (7/9 symptoms) and hyperactivity/impulsivity (6/9 symptoms).", "question": "Which DSM-5 diagnostic criterion is MOST IMPORTANT to confirm before diagnosing ADHD?", "choices": [{"id": "node-1-choice-a", "text": "Symptoms present in TWO OR MORE settings (e.g., home AND school)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **multiple settings criterion** is the key differentiator for ADHD. DSM-5 requires symptoms be present in **\u22652 settings** (home, school, work, with friends). This distinguishes ADHD from situational problems. A child who only has difficulty at school may have a **learning disorder**, school anxiety, or teacher conflict. A child only symptomatic at home may have family stressors or oppositional behavior. ADHD by definition is **pervasive** - the brain-based attention deficit manifests everywhere.", "consequence": "You correctly identify the critical multi-setting requirement.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "At least 6 inattention OR 6 hyperactivity/impulsivity symptoms", "isOptimal": false, "isAcceptable": true, "feedback": "This is a necessary criterion but not the MOST important differentiator. DSM-5 requires **\u22656 symptoms** in either domain (\u22655 for age 17+). However, many conditions can produce 6+ attention symptoms - anxiety, sleep deprivation, depression, trauma. The **multiple settings** requirement is what truly distinguishes ADHD as a pervasive neurodevelopmental condition rather than a situational problem.", "consequence": "Important criterion but not the key differentiator.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Abnormal EEG or neuroimaging findings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ADHD is a **clinical diagnosis** - there is NO laboratory test, EEG, or imaging study that confirms ADHD. Neuroimaging research shows prefrontal cortex differences in ADHD populations, but these findings are not diagnostically useful in individual patients. EEG is only indicated if there's concern for **absence seizures** (staring spells that could mimic inattention).", "consequence": "ADHD does not require imaging for diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Confirmed learning disability on psychoeducational testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Learning disabilities (LD) and ADHD are **separate diagnoses** that frequently co-occur (~30-50% comorbidity). ADHD affects **attention and behavior** across settings, while LD affects **specific academic skills** (reading, math, writing). This child's problems are behavioral (fidgeting, interrupting) not just academic, and occur at home too - suggesting ADHD rather than isolated LD.", "consequence": "Learning disability is a different diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Symptoms that began after starting school (age 5-6)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DSM-5 requires several symptoms be present **before age 12**, but symptoms do NOT need to start at school age. ADHD often becomes apparent when academic demands increase, but retrospective history usually reveals earlier signs (hyperactive toddler, difficulty in preschool). Symptoms that truly began only after a specific event suggest trauma, adjustment disorder, or environmental factors rather than ADHD.", "consequence": "The age criterion is 'before age 12' not 'after starting school.'", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ADHD DSM-5 Criteria**: (1) \u22656 inattention OR \u22656 hyperactivity/impulsivity symptoms (\u22655 if age 17+), (2) Present **before age 12**, (3) Present in **\u22652 settings**, (4) Clearly interferes with functioning, (5) Not better explained by another disorder. The **Vanderbilt scale** collects information from parents AND teachers - both are required for diagnosis."}, "node-2": {"id": "node-2", "type": "decision", "content": "The parents mention they've read online that ADHD might actually be anxiety, sleep problems, or even a learning disability. They want to understand how you've ruled these out.\n\nAdditional history:\n- Sleep: Goes to bed at 8:30 PM, wakes at 6:30 AM, no snoring or restless sleep\n- Mood: Happy child, enjoys activities, no excessive worry or fears\n- Academic testing: Reading and math skills at grade level\n- Social: Has friends, no peer rejection or isolation", "question": "Which clinical feature BEST distinguishes ADHD from generalized anxiety disorder (GAD) in children?", "choices": [{"id": "node-2-choice-a", "text": "ADHD: poor sustained attention; GAD: difficulty concentrating due to worry", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! This is the key distinction. In **ADHD**, inattention is primary - the child's brain cannot sustain focus even on desired activities (video games are an exception due to high stimulation). In **GAD**, concentration difficulties are **secondary to worry** - the anxious mind is preoccupied with fears, leaving less capacity for the task. Ask: 'What are you thinking about when you zone out?' ADHD: 'Nothing/random things.' GAD: 'Worried about the test/what might go wrong.' This child has no excessive worry, supporting ADHD.", "consequence": "You correctly identify the core distinction.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "ADHD causes hyperactivity; anxiety does not", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Anxiety in children often manifests as **motor restlessness** and fidgeting - they can appear 'hyperactive.' Anxious children may have difficulty sitting still due to nervous energy, may interrupt to seek reassurance, and may appear distracted due to internal worry. Both conditions can cause 'hyperactive' behavior; the distinguishing feature is the **underlying mechanism** (boredom/understimulation vs. worry/fear).", "consequence": "Anxiety can also cause restlessness and fidgeting.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "ADHD responds to stimulants; anxiety responds to SSRIs", "isOptimal": false, "isAcceptable": false, "feedback": "While treatment responses differ, you cannot use medication response to make the initial diagnosis. Additionally, there's significant comorbidity - **30-40% of children with ADHD also have anxiety**. Some children need both stimulants AND SSRIs. The diagnosis must be made on clinical grounds first, then treatment selected accordingly.", "consequence": "Treatment response cannot guide initial diagnosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "ADHD only affects school; anxiety affects all areas", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is backwards. **ADHD by definition affects multiple settings** (home AND school). Anxiety may be more situation-specific (test anxiety, social anxiety) or generalized. This child has symptoms at both home and school, which is actually consistent with ADHD's pervasive pattern.", "consequence": "ADHD is pervasive; it doesn't only affect school.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "ADHD children are happy; anxious children are sad", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Children with ADHD can have significant emotional dysregulation, frustration, and low self-esteem from chronic failures. Children with anxiety are not necessarily 'sad' - they're worried. **Mood** (happy/sad) relates more to depression than anxiety. Both ADHD and anxiety can co-exist with normal mood or with depression as a comorbidity.", "consequence": "Mood is not the distinguishing feature.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ADHD Mimics to Rule Out**: (1) **Sleep disorders** - sleep deprivation causes inattention and hyperactivity (ask about snoring \u2192 OSA), (2) **Anxiety** - worry impairs concentration, (3) **Depression** - poor concentration, psychomotor changes, (4) **Learning disability** - frustration/avoidance in specific academics, (5) **Hearing/vision impairment** - appears inattentive, (6) **Absence seizures** - brief staring spells, (7) **Thyroid dysfunction** - hyper/hypothyroidism affects attention, (8) **Lead toxicity** - if risk factors present."}, "node-3": {"id": "node-3", "type": "decision", "content": "You confirm the diagnosis of **ADHD, Combined Presentation** (meets criteria for both inattention and hyperactivity/impulsivity). The parents are anxious about starting medication and ask about treatment options.\n\n**Key consideration**: This child is **8 years old** (school-age).", "question": "According to AAP guidelines, what is the FIRST-LINE treatment for ADHD in children ages 6 and older?", "choices": [{"id": "node-3-choice-a", "text": "Stimulant medication (methylphenidate or amphetamine) PLUS behavioral therapy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For children **\u22656 years old**, AAP guidelines recommend **FDA-approved medications** (stimulants first-line) **PLUS behavioral therapy** as optimal treatment. Stimulants have the **largest effect size** of any ADHD intervention. **Methylphenidate** (Ritalin, Concerta) and **amphetamines** (Adderall, Vyvanse) are equally effective - choice depends on individual response and side effects. Behavioral therapy alone is less effective than medication for core ADHD symptoms in this age group.", "consequence": "You select the evidence-based first-line treatment.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Behavioral therapy alone as first-line, with medication only if therapy fails", "isOptimal": false, "isAcceptable": true, "feedback": "This is the correct approach for **ages 4-5** (preschool), NOT for school-age children. In preschoolers, AAP recommends **behavioral therapy FIRST** because: (1) Less medication safety data in young children, (2) Behavioral approaches can be very effective early. For children **\u22656 years**, studies show medication has greater effect size than behavioral therapy alone. However, if parents refuse medication, behavioral therapy is better than nothing.", "consequence": "Acceptable if parents refuse medication, but not first-line for age 6+.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Atomoxetine (Strattera) as first-line to avoid stimulant side effects", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Atomoxetine** (a norepinephrine reuptake inhibitor) is a **second-line** agent, not first-line. It has a **smaller effect size** than stimulants and takes **4-6 weeks** for full effect. It is appropriate when: (1) Stimulants failed or caused intolerable side effects, (2) History of substance abuse (non-controlled medication), (3) Significant anxiety comorbidity, (4) Tic disorder worsened by stimulants.", "consequence": "Atomoxetine is second-line, not first-line.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Dietary modifications (eliminate sugar, food dyes, additives)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Despite popular belief, **sugar does not cause hyperactivity** - this has been debunked in controlled studies. Elimination diets (removing artificial colors/additives) show **minimal to no benefit** in most studies. Some children with specific food sensitivities may benefit, but this is not standard treatment. A healthy diet is reasonable but should not replace evidence-based treatment.", "consequence": "Dietary changes are not evidence-based ADHD treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Referral to psychiatry before initiating any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pediatricians and family physicians can and should manage uncomplicated ADHD** - it is one of the most common conditions in pediatric practice. Psychiatry referral is appropriate for: (1) Diagnostic uncertainty, (2) Significant psychiatric comorbidities, (3) Treatment-resistant cases (failed 2+ medications), (4) Complex family situations. Waiting for psychiatry delays treatment, and wait times can be months.", "consequence": "Primary care can initiate ADHD treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Age-Based Treatment Guidelines**: (1) **Ages 4-5**: Behavioral therapy FIRST, medication only if behavioral therapy insufficient, (2) **Ages 6-11**: Medication (stimulants first-line) + behavioral therapy, (3) **Ages 12+**: Medication (stimulants first-line) + therapy if available. **Stimulant choice**: Methylphenidate and amphetamines have similar efficacy - if one fails, try the other class before moving to non-stimulants."}, "node-4": {"id": "node-4", "type": "decision", "content": "You prescribe **methylphenidate extended-release** and schedule a follow-up. The parents ask about potential side effects and what needs to be monitored.\n\n**Pre-treatment baseline**: Height 51 inches (50th percentile), Weight 56 lbs (50th percentile), HR 80, BP 100/65.", "question": "Which monitoring is REQUIRED before and during stimulant therapy for ADHD?", "choices": [{"id": "node-4-choice-a", "text": "Height, weight, heart rate, and blood pressure at baseline and each visit", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Mandatory monitoring** for stimulants includes: (1) **Height and weight** - stimulants can suppress appetite and slow growth velocity (average 1 cm less height and 1-2 kg less weight per year). Plot on growth curves at every visit. (2) **Heart rate and blood pressure** - stimulants are sympathomimetics that increase HR (~3-4 bpm) and BP (~3-4 mmHg). Screen for pre-existing cardiac conditions before starting. No routine ECG needed unless cardiac history or symptoms.", "consequence": "You implement appropriate monitoring.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Baseline ECG and cardiology clearance for all patients", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine ECG is NOT recommended** before starting stimulants in healthy children. AAP and AHA state that ECG is only indicated if: (1) **Personal history** of cardiac disease, syncope, palpitations, chest pain with exertion, (2) **Family history** of sudden cardiac death <35 years, hypertrophic cardiomyopathy, long QT syndrome, (3) **Abnormal cardiac exam**. Universal ECG screening has poor predictive value and creates unnecessary barriers to treatment.", "consequence": "Routine ECG is not required in healthy children.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Monthly liver function tests due to hepatotoxicity risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stimulants (methylphenidate, amphetamines) are NOT hepatotoxic** and do not require liver function monitoring. You may be thinking of **atomoxetine**, which has a rare association with severe liver injury (warning, not routine monitoring). Stimulants are metabolized in the liver but do not cause liver damage.", "consequence": "Stimulants do not require LFT monitoring.", "nextNodeId": "node-5"}, {"id": "node-4-choice-d", "text": "Baseline CBC and monitoring for blood dyscrasias", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Stimulants do not cause bone marrow suppression or blood dyscrasias. No hematologic monitoring is required. You may be thinking of other psychiatric medications (e.g., clozapine requires ANC monitoring for agranulocytosis, carbamazepine can cause aplastic anemia).", "consequence": "Stimulants do not cause hematologic toxicity.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Drug holidays every summer to prevent addiction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect reasoning. **Drug holidays** (stopping medication during summer/weekends) are sometimes used to **allow catch-up growth** or assess if medication is still needed - NOT because of addiction concerns. When taken as prescribed, stimulants have a **low addiction potential** in ADHD patients (they may actually reduce substance abuse risk). The decision about drug holidays should be individualized based on symptom burden, growth concerns, and family preference.", "consequence": "Drug holidays are for growth, not addiction prevention.", "nextNodeId": "node-5"}], "clinicalPearl": "**Common Stimulant Side Effects**: (1) **Appetite suppression** - give medication with/after breakfast, offer high-calorie snacks when medication wears off, (2) **Sleep difficulties** - avoid late dosing, may add melatonin, (3) **Headaches/stomachaches** - often transient, (4) **Mood changes** ('zombie' effect, irritability) - may need dose adjustment, (5) **Rebound** - worsening symptoms as medication wears off. **Tics**: Stimulants do NOT cause tics but may unmask them; not an absolute contraindication."}, "node-5": {"id": "node-5", "type": "decision", "content": "Three months later, the patient returns for follow-up. Methylphenidate has been effective - teachers report significant improvement in focus and task completion. However, the parents are concerned about long-term outcomes.\n\n**Current status**: Good medication response, tolerating well, growth on track. \n**School**: 504 plan in place with extended time on tests and preferential seating.", "question": "Which statement about long-term ADHD management and prognosis is CORRECT?", "choices": [{"id": "node-5-choice-a", "text": "~60% of children with ADHD continue to have symptoms into adulthood; ongoing monitoring for comorbidities is essential", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! ADHD is often a **lifelong condition**. Studies show **50-70% of children with ADHD** continue to have functionally impairing symptoms as adults. However, presentation may shift - hyperactivity decreases while inattention and executive dysfunction persist. **Comorbidities are common**: (1) **Learning disabilities** (30-50%), (2) **Oppositional defiant disorder** (40-60%), (3) **Anxiety** (30-40%), (4) **Depression** (20-30%), (5) **Substance use disorders** (higher risk if untreated). Regular reassessment of diagnosis, treatment, and comorbidities is essential.", "consequence": "You provide accurate prognostic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Most children outgrow ADHD by puberty and can stop medication in high school", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While some children do 'outgrow' ADHD, the **majority (50-70%) continue to have symptoms** as teens and adults. Hyperactivity often decreases during adolescence, which may give the impression of improvement, but **inattention and executive dysfunction typically persist**. Stopping medication should be a deliberate decision based on symptom assessment, not an assumption that ADHD resolves with puberty.", "consequence": "Most children do NOT outgrow ADHD by puberty.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Stimulant medications should be stopped before adolescence due to abuse potential", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Continuing appropriate ADHD treatment through adolescence REDUCES substance abuse risk**. Untreated ADHD is associated with higher rates of substance use disorders - likely due to self-medication. Stimulants prescribed at therapeutic doses to patients with ADHD have **low abuse potential**. The risk of stimulant diversion (sharing/selling pills) is a consideration but is managed through education and sometimes switching to non-divertible formulations (e.g., Vyvanse).", "consequence": "Treatment reduces, not increases, substance abuse risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Children with ADHD should not participate in competitive sports due to stimulant cardiovascular effects", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Children with ADHD on stimulants **can and should participate in sports** and physical activities. Exercise has multiple benefits for ADHD (improves attention, reduces hyperactivity, improves mood). The small cardiovascular effects of stimulants do not preclude sports participation in healthy children. If there are specific cardiac concerns, cardiology can assess - but ADHD itself or stimulant use is not a contraindication to sports.", "consequence": "Sports participation is encouraged, not restricted.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "ADHD medications cure the underlying brain abnormality over time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ADHD medications are **symptomatic treatments** - they improve symptoms while active but do not cure the underlying neurodevelopmental condition. When medication is stopped, symptoms typically return. This is why ongoing treatment and monitoring are needed. The goal of treatment is to minimize impairment and allow the child to reach their potential, not to permanently change brain structure.", "consequence": "Medications treat symptoms but do not cure ADHD.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Long-term ADHD Management**: (1) **Annual reassessment** of diagnosis (symptoms still present?), treatment (still effective? side effects?), and comorbidities, (2) **Academic supports** - 504 plan or IEP for accommodations, (3) **Behavioral/organizational strategies** - calendars, checklists, routines, (4) **Transition planning** - as teens approach adulthood, discuss driving safety, substance use risks, and continuation of care. **Prognosis improves with**: early diagnosis, consistent treatment, supportive family/school environment, and management of comorbidities."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed ADHD in this school-age child.\n\n**Key Learning Points:**\n\n1. **Diagnosis**: ADHD requires symptoms in \u22652 settings (not just school), onset before age 12, and functional impairment. Use validated rating scales (Vanderbilt) from BOTH parents and teachers.\n\n2. **Differential**: Rule out sleep disorders, anxiety, depression, learning disabilities, vision/hearing impairment. Ask 'What are you thinking about when you zone out?' to distinguish ADHD (nothing/random) from anxiety (worries).\n\n3. **Treatment by Age**: Ages 4-5 \u2192 behavioral therapy first. Ages 6+ \u2192 stimulant medication + behavioral therapy. Methylphenidate and amphetamines are first-line with similar efficacy.\n\n4. **Monitoring**: Height, weight, HR, BP at every visit. No routine ECG unless cardiac history/symptoms.\n\n5. **Prognosis**: 50-70% continue symptoms into adulthood. Monitor for comorbidities (ODD, anxiety, depression, learning disabilities). Treatment REDUCES substance abuse risk."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review these ADHD essentials:\n\n**DSM-5 Criteria**: \u22656 symptoms of inattention OR hyperactivity/impulsivity, present BEFORE age 12, in \u22652 SETTINGS (key distinguisher!), causing functional impairment.\n\n**Age-Based Treatment**: Ages 4-5 \u2192 behavioral therapy FIRST. Ages 6+ \u2192 stimulants (methylphenidate or amphetamine) + behavioral therapy.\n\n**Monitoring**: Height/weight (growth suppression), HR/BP (sympathomimetic effects). NO routine ECG or labs needed.\n\n**Key Differential**: Anxiety causes poor concentration from WORRY. ADHD causes poor concentration from brain-based attention deficit. Ask what they're thinking about during 'zones.'"}}, "rootNodeId": "node-1"}], "pulmonology": [{"id": "vignette-lens-peds-005", "title": "Croup vs Epiglottitis", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["barking cough", "steeple sign", "inspiratory stridor", "dexamethasone", "racemic epinephrine"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "A 2-year-old male is brought to the emergency department for noisy breathing and a barking cough that began 2 days ago.\n\nPer the parents, he had a runny nose and mild fever for 2 days, and last night developed a harsh, barking cough that worsened. He started making a high-pitched sound when breathing in. Symptoms are worse at night.\n\nMedical history: Up-to-date on vaccinations including Hib.\n\nPhysical Examination:\n- General: Alert child in mild respiratory distress with intermittent barking cough.\n- Vitals: Temp 38.5\u00b0C, HR 110, RR 28.\n- Respiratory: Inspiratory stridor at rest, mild subcostal retractions.\n- Voice: Hoarse.\n- Oropharynx: Mildly erythematous, no drooling, no difficulty swallowing.\n- No toxic appearance.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child presents with acute upper airway obstruction. You need to differentiate between the causes.\n\nKey clinical features to note:\n- Barking (seal-like) cough\n- Inspiratory stridor\n- Hoarse voice\n- URI prodrome\n- NO drooling\n- NOT toxic-appearing\n- Age 2 years (peak croup age)", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Croup (viral laryngotracheobronchitis)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Classic croup presentation: age 6 months-3 years, URI prodrome, barking (seal-like) cough, inspiratory stridor, hoarse voice, symptoms worse at night. Caused by parainfluenza virus (most common).", "consequence": "Proceed to severity assessment and treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Epiglottitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Epiglottitis presents with: toxic appearance, drooling, tripod positioning, muffled (NOT hoarse) voice, NO cough, rapid progression. This child has barking cough, hoarse voice, and is NOT toxic - classic for croup.", "consequence": "Wrong diagnosis - epiglottitis management is very different.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bacterial tracheitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bacterial tracheitis (pseudomembranous croup) shows: toxic appearance, high fever, copious purulent secretions, and often follows croup that fails to improve. This child is not toxic.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Foreign body aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Foreign body aspiration typically has: sudden onset, witnessed choking episode, unilateral wheezing/decreased breath sounds. This child has viral prodrome and bilateral findings.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Peritonsillar abscess", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Peritonsillar abscess presents with: unilateral tonsillar swelling, trismus, muffled voice, odynophagia. This child has barking cough and stridor - not tonsillar pathology.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Croup vs Epiglottitis: Croup = barking cough, hoarse voice, NOT toxic. Epiglottitis = NO cough, muffled voice, drooling, TOXIC. If you suspect epiglottitis, do NOT agitate the child - airway can obstruct suddenly."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed croup. The child has stridor at rest with mild retractions but is alert and interactive.\n\nCroup severity:\n- Mild: No stridor at rest, occasional barking cough\n- Moderate: Stridor at rest, mild retractions\n- Severe: Stridor at rest, significant retractions, agitation/lethargy\n\nThis child has MODERATE croup.", "question": "What is the most appropriate initial treatment?", "choices": [{"id": "node-2-choice-a", "text": "Single dose oral/IM dexamethasone (0.6 mg/kg)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Dexamethasone is the cornerstone of croup treatment. A single dose (0.6 mg/kg, max 10mg) reduces symptoms and ED return visits. Works within 6 hours, effects last 24-36 hours. Oral, IM, or IV all equally effective.", "consequence": "Dexamethasone given. Observe for response.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Nebulized racemic epinephrine immediately", "isOptimal": false, "isAcceptable": true, "feedback": "Epinephrine is appropriate for moderate-severe croup but dexamethasone should ALSO be given. Epinephrine provides rapid but temporary relief (1-2 hours). Dexamethasone should always be given as the primary treatment.", "consequence": "Temporary improvement but steroids still needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Albuterol nebulizer treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Albuterol does NOT work for croup. Croup is upper airway obstruction (subglottic edema), not bronchospasm. Albuterol targets lower airways and has no role in croup.", "consequence": "Ineffective treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "IV antibiotics and ENT consultation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Croup is VIRAL (parainfluenza most common) - antibiotics are not indicated. ENT consultation is not needed for typical croup. Reserve antibiotics for bacterial tracheitis or epiglottitis.", "consequence": "Unnecessary antibiotics.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Cool mist humidifier and discharge home", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cool mist has NOT been shown to be effective in studies. Also, this child has stridor at rest (moderate croup) and needs steroids. Cannot discharge without treatment.", "consequence": "No evidence-based benefit, undertreated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Treatment for croup: Dexamethasone 0.6 mg/kg x1 dose (oral/IM/IV) for ALL croup (even mild). Add nebulized epinephrine for moderate-severe. Cool mist has NO proven benefit."}, "node-3": {"id": "node-3", "type": "decision", "content": "After dexamethasone, you add nebulized racemic epinephrine for the persistent stridor at rest.\n\nPost-epinephrine (30 minutes later):\n- Stridor resolved at rest\n- Occasional barking cough only with agitation\n- No retractions\n- SpO2 98% on room air\n- Alert and playful\n\nParents ask when they can take him home.", "question": "What is the appropriate disposition?", "choices": [{"id": "node-3-choice-a", "text": "Observe for 2-4 hours post-epinephrine, then discharge if stable", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After epinephrine, must observe for 2-4 hours for rebound (epinephrine effect wears off in 1-2 hours). If symptoms don't return, safe to discharge home with dexamethasone on board. Return precautions for worsening stridor.", "consequence": "Safe discharge after observation period.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Discharge immediately - symptoms improved", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT. Epinephrine effect lasts only 1-2 hours. Must observe for REBOUND - symptoms can return and worsen. Mandatory 2-4 hour observation post-epinephrine.", "consequence": "Risk of rebound stridor at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Admit to ICU for intubation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child responded well to treatment - no stridor at rest, playful, satting well. ICU/intubation reserved for severe cases failing medical management or with impending respiratory failure.", "consequence": "Unnecessary admission.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Admit for overnight observation", "isOptimal": false, "isAcceptable": true, "feedback": "Conservative but acceptable. Given good response to treatment and stable appearance after observation, home discharge is preferred if family is reliable. Admission may be considered for: young age, severe initial presentation, or social concerns.", "consequence": "Safe but may be unnecessary.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-e", "text": "Give second dose of epinephrine and discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child is currently stable - no indication for additional epinephrine. Still need to observe for rebound before discharge regardless.", "consequence": "Unnecessary medication and missed observation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "After nebulized epinephrine: MUST observe 2-4 hours for rebound (effect wears off in 1-2 hours). If stable after observation and dexamethasone given, safe to discharge. Epinephrine alone = temporary fix. Dexamethasone = lasting treatment."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly managed this case of croup.\n\nKey Learning Points:\n1. Croup = barking cough, hoarse voice, stridor, URI prodrome, NOT toxic\n2. Epiglottitis = NO cough, muffled voice, drooling, TOXIC (don't agitate!)\n3. Dexamethasone 0.6 mg/kg x1 for ALL croup (even mild)\n4. Add nebulized epinephrine for moderate-severe\n5. Observe 2-4 hours post-epinephrine for rebound\n6. Cool mist/humidifiers have NO proven benefit\n7. X-ray: Croup = steeple sign. Epiglottitis = thumbprint sign\n\nOutcome: After 3-hour observation, symptoms remain improved. Family is discharged with return precautions for worsening stridor or difficulty breathing. Full recovery within 3-5 days."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points about croup:\n\n- Croup is VIRAL - no antibiotics needed\n- Dexamethasone is the key treatment (single dose)\n- Albuterol does NOT work - croup is upper airway\n- Cool mist has NO proven benefit\n- After epinephrine: MUST observe 2-4 hours for rebound\n\nDon't confuse with epiglottitis:\n- Croup: barking cough, hoarse voice, NOT toxic\n- Epiglottitis: NO cough, muffled voice, drooling, TOXIC"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in croup management.\n\nRemember:\n- Dexamethasone is the CORNERSTONE of treatment\n- Albuterol does NOT work for croup\n- Epinephrine effect wears off in 1-2 hours - MUST observe\n- Never discharge immediately after epinephrine (rebound risk)\n- Croup is viral - no antibiotics\n\nKey pearl: If you suspect epiglottitis (toxic, drooling, NO cough, muffled voice), do NOT agitate the child or examine the oropharynx - call ENT/anesthesia for airway management."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-006", "title": "Bronchiolitis", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["first episode of wheezing in infant", "RSV season", "URI prodrome", "bronchiolitis", "supportive care"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "A 4-month-old female is brought to the emergency department for difficulty breathing and poor feeding that began 3 days ago.\n\nPer the mother, she started with a runny nose and mild cough 5 days ago, and over the past 2 days has had worsening breathing difficulty and is not finishing her bottles. She has fewer wet diapers than usual.\n\nAdditional history: Intermittent low-grade fever and wheezing. No apnea episodes or cyanosis.\n\nMedical history: Born at 36 weeks gestation. Her older sibling had a cold last week (sick contact).\n\nPhysical Examination:\n- General: Alert but tachypneic infant with nasal flaring and subcostal retractions.\n- Vitals: HR 150, RR 60, SpO2 91% on room air, Temp 38.2\u00b0C.\n- Respiratory: Diffuse wheezes and crackles bilaterally, prolonged expiratory phase.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This infant presents with respiratory distress in the setting of viral URI prodrome.\n\nKey features:\n- Age: 4 months (peak bronchiolitis age)\n- Season: RSV season\n- Sick contact (sibling with cold)\n- First episode of wheezing\n- URI prodrome \u2192 lower respiratory symptoms", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Bronchiolitis (RSV most common)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Classic bronchiolitis presentation: infant <2 years, RSV season, sick contact, URI prodrome progressing to lower respiratory symptoms with wheezing, crackles, and respiratory distress. RSV is the most common cause.", "consequence": "Proceed to management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Asthma/Reactive airway disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Asthma is rarely diagnosed before age 2. This is a FIRST episode of wheezing in an infant with viral URI prodrome - classic for bronchiolitis, not asthma.", "consequence": "Wrong diagnosis affects treatment approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bacterial pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bacterial pneumonia typically presents with focal lung findings, higher fever, and toxic appearance. This infant has diffuse bilateral findings with wheezing - more consistent with viral bronchiolitis.", "consequence": "May lead to unnecessary antibiotics.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pertussis (whooping cough)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pertussis presents with paroxysmal coughing fits, inspiratory whoop, and post-tussive emesis. This infant has wheezing and crackles without classic paroxysmal cough.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Foreign body aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Foreign body aspiration typically has sudden onset, unilateral wheezing, and often a witnessed choking episode. This infant has bilateral findings with viral prodrome.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Bronchiolitis = first wheezing episode in infant <2 years with viral URI prodrome. RSV is the #1 cause. Peak season: November-March."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed bronchiolitis. The infant has SpO2 91% and is showing signs of respiratory distress with poor feeding.\n\nThe attending asks what treatments you would recommend.", "question": "What is the most appropriate management for this infant with bronchiolitis?", "choices": [{"id": "node-2-choice-a", "text": "Supportive care only: nasal suctioning, oxygen if SpO2 <90%, IV/NG fluids if not feeding", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Bronchiolitis management is SUPPORTIVE ONLY: nasal suctioning (infants are obligate nose breathers), supplemental O2 to maintain SpO2 >90%, and hydration support. NO bronchodilators, NO steroids, NO antibiotics unless bacterial superinfection.", "consequence": "Appropriate supportive care initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Albuterol nebulizer and oral corticosteroids", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT - this is a common error! Multiple studies show bronchodilators and steroids do NOT improve outcomes in bronchiolitis. AAP guidelines specifically recommend AGAINST their routine use. Don't treat it like asthma!", "consequence": "Ineffective treatment with potential side effects.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Chest X-ray, CBC, blood culture, and IV antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bronchiolitis is viral - antibiotics are not indicated. CXR is NOT routinely recommended (findings don't change management). Labs are unnecessary unless concern for bacterial superinfection.", "consequence": "Unnecessary workup and antibiotics.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Nebulized hypertonic saline and ribavirin", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Hypertonic saline MAY be used in hospitalized patients (may reduce length of stay) but is not first-line. Ribavirin is NOT routinely recommended - reserved for severely immunocompromised patients.", "consequence": "Acceptable but not first-line.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "RSV testing and prophylactic palivizumab", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RSV testing is NOT routinely recommended (doesn't change management). Palivizumab is PROPHYLACTIC for high-risk infants - it has no role in active infection treatment.", "consequence": "Misunderstanding of palivizumab indication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "The 4 things that DON'T work in bronchiolitis: 1) Bronchodilators, 2) Steroids, 3) Antibiotics (unless superinfection), 4) Chest physiotherapy. SUPPORTIVE CARE ONLY."}, "node-3": {"id": "node-3", "type": "decision", "content": "After 4 hours of supportive care:\n- SpO2: 94% on 0.5L NC\n- RR: 50 (improved from 60)\n- Taking small amounts by bottle\n- Still has subcostal retractions but less pronounced\n\nThe parents ask if they can take the baby home.", "question": "What is the most appropriate disposition for this infant?", "choices": [{"id": "node-3-choice-a", "text": "Admit for observation: still requires oxygen, premature, and not feeding well", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This infant has multiple risk factors requiring admission: 1) Still requires supplemental oxygen, 2) Prematurity (36 weeks = higher apnea risk), 3) Poor feeding. Admission criteria: O2 requirement, apnea, poor feeding, age <3 months, prematurity, underlying cardiopulmonary disease.", "consequence": "Admitted for close monitoring.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Discharge home with albuterol inhaler prescription", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT. First, she still requires oxygen and has poor feeding - not safe for discharge. Second, albuterol is NOT effective in bronchiolitis and should not be prescribed.", "consequence": "Unsafe discharge with ineffective treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Discharge home with close follow-up in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. She still requires supplemental oxygen and has poor feeding - does not meet safe discharge criteria. Premature infants also have higher apnea risk and need closer monitoring.", "consequence": "Premature discharge with high risk of return.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Admit to PICU for high-flow nasal cannula", "isOptimal": false, "isAcceptable": true, "feedback": "Currently not necessary. She is maintaining SpO2 94% on low-flow oxygen (0.5L). PICU admission with HFNC is appropriate if she fails low-flow support, develops apnea, or significantly worsens.", "consequence": "May be appropriate if she worsens.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-e", "text": "Observe 2 more hours and discharge if weaned off oxygen", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable approach IF she successfully weans off oxygen AND is feeding adequately. However, given her prematurity and current poor feeding, a short observation period may not be sufficient.", "consequence": "Acceptable with caveats.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "Admission criteria for bronchiolitis: 1) Persistent O2 requirement (SpO2 <90%), 2) Apnea, 3) Poor feeding/dehydration, 4) Age <3 months (especially <6 weeks), 5) Prematurity, 6) Underlying cardiopulmonary disease. This infant also has APNEA RISK due to prematurity."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly managed this case of bronchiolitis.\n\nKey Learning Points:\n1. Bronchiolitis is a CLINICAL diagnosis - no routine testing needed\n2. Treatment is SUPPORTIVE ONLY: suctioning, oxygen, hydration\n3. Bronchodilators and steroids do NOT work - don't use them\n4. Antibiotics only if bacterial superinfection suspected\n5. Admission criteria: O2 requirement, apnea, poor feeding, young age, prematurity\n6. Apnea risk highest in: <2 months old, premature infants, history of apnea\n\nOutcome: With supportive care, the infant improves over 48 hours. She is weaned off oxygen, feeding well, and discharged home with return precautions for increased work of breathing or poor feeding."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points about bronchiolitis:\n\n- Clinical diagnosis - CXR and RSV testing are NOT routinely indicated\n- Treatment is SUPPORTIVE: suctioning, O2, fluids\n- Bronchodilators and steroids do NOT work in bronchiolitis\n- Not the same as asthma - don't treat it like asthma\n- Palivizumab is for PROPHYLAXIS, not treatment\n\nKey pearl: If you're ordering albuterol for bronchiolitis, you're doing it wrong."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in bronchiolitis management.\n\nRemember:\n- NO bronchodilators (albuterol doesn't work)\n- NO steroids (multiple studies show no benefit)\n- NO antibiotics (unless bacterial superinfection)\n- NO routine CXR or RSV testing\n\nSupportive care ONLY:\n- Nasal suctioning (infants are obligate nose breathers)\n- Supplemental O2 to maintain SpO2 >90%\n- IV/NG fluids if not feeding adequately\n- Close monitoring for apnea (especially in young/preterm infants)\n\nKey pearl: Bronchiolitis is self-limited. Resist the urge to 'do something' - supportive care is the treatment."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-026", "title": "Acute Asthma Exacerbation", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["wheezing", "prolonged expiration", "accessory muscle use", "acute asthma exacerbation", "bronchodilator therapy", "status asthmaticus"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 7-year-old female is brought to the ED by her parents for difficulty breathing and wheezing for 1 day.\n\nThe mother reports worsening shortness of breath and wheezing since yesterday. She had a cold for 3 days before this started. Her rescue inhaler is not helping as much as usual.\n\nAssociated symptoms include cough, chest tightness, and nighttime symptoms. Denies fever or chest pain.\n\nMedical history: Known asthma diagnosed at age 4. Uses an inhaled corticosteroid daily and albuterol as needed. Last ED visit for asthma was 6 months ago.\n\nPhysical Examination:\n- General: Anxious, sitting upright, speaking in short phrases.\n- Respiratory: Diffuse bilateral wheezing, prolonged expiratory phase, intercostal retractions, using accessory muscles.\n- Vitals: HR 120, RR 32, SpO2 90% on room air.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are assessing this child with known asthma presenting in respiratory distress.\n\nKey findings:\n- SpO2 90% on room air\n- Speaking in short phrases\n- Accessory muscle use and retractions\n- Diffuse bilateral wheezing", "question": "How would you classify the severity of this asthma exacerbation?", "choices": [{"id": "node-1-choice-a", "text": "Moderate-Severe exacerbation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a moderate-severe exacerbation: SpO2 90-95%, speaking in phrases (not sentences), accessory muscle use, and diffuse wheezing. Peak flow would be 40-69% predicted if able to perform.", "consequence": "Proceed to initial management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Mild exacerbation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Mild exacerbation would show: SpO2 >95%, speaking in sentences, no accessory muscle use, end-expiratory wheeze only. This child has more severe features.", "consequence": "Underestimating severity could lead to inadequate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Life-threatening/Impending respiratory failure", "isOptimal": false, "isAcceptable": true, "feedback": "Not quite. Life-threatening features include: silent chest, cyanosis, poor respiratory effort, altered consciousness, SpO2 <90%. This child still has audible wheezes and is maintaining oxygenation at 90%.", "consequence": "Slightly overestimating severity, but aggressive treatment is appropriate.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Not asthma - consider foreign body aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child has known asthma, a viral prodrome (common trigger), and bilateral symmetric wheezing. Foreign body aspiration typically causes sudden onset and unilateral wheezing.", "consequence": "Wrong diagnosis delays appropriate asthma treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Pneumonia with reactive airway component", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is no fever or focal lung findings. CXR is not routinely needed for asthma exacerbations unless there is fever, focal findings, or poor response to treatment.", "consequence": "Unnecessary workup delays treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Asthma severity classification: Mild = SpO2 >95%, sentences, no accessory muscles. Moderate = SpO2 91-95%, phrases, accessory muscles. Severe = SpO2 <91%, words only, significant distress. Life-threatening = silent chest, cyanosis, poor effort."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have classified this as a moderate-severe asthma exacerbation. The child is in respiratory distress with SpO2 90%.", "question": "What is the most appropriate initial management?", "choices": [{"id": "node-2-choice-a", "text": "Albuterol nebulizer + oral corticosteroids + supplemental oxygen", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! First-line treatment: Albuterol 2.5-5mg nebulized (or 4-8 puffs MDI with spacer), oral prednisolone 1-2 mg/kg (max 60mg), and O2 to maintain SpO2 >92%. Steroids take 4-6 hours to work, so give early!", "consequence": "Initial treatment started. Reassess in 20 minutes.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "IV magnesium sulfate and prepare for intubation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IV magnesium is reserved for severe exacerbations not responding to initial bronchodilator therapy. This child needs to trial standard treatment first before escalation.", "consequence": "Skipping first-line treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Inhaled corticosteroids (ICS) only - increase her maintenance dose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Inhaled corticosteroids work too slowly for acute exacerbations. Systemic corticosteroids (oral or IV) are needed for anti-inflammatory effect within hours. ICS is for long-term control, not acute treatment.", "consequence": "Inadequate treatment of acute inflammation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Chest X-ray, CBC, and cultures before any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In a known asthmatic with classic exacerbation presentation, diagnostic workup should NOT delay treatment. CXR is not routinely needed unless fever, focal findings, or poor response to treatment.", "consequence": "Dangerous delay in bronchodilator therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Albuterol MDI 2 puffs and discharge home", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SpO2 of 90% with accessory muscle use requires ED observation and systemic steroids. Two puffs of albuterol is also an inadequate dose for acute exacerbation (need 4-8 puffs or nebulizer).", "consequence": "Inadequate treatment and inappropriate discharge.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Key numbers: Albuterol 2.5-5mg neb q20min x3 doses. Prednisone/prednisolone 1-2 mg/kg/day (max 60mg) for 3-5 days. Steroids take 4-6 hours to work - give early!"}, "node-3": {"id": "node-3", "type": "decision", "content": "After 3 albuterol treatments (60 minutes), reassessment shows:\n- SpO2: 92% on 2L NC\n- Still speaking in phrases\n- Persistent diffuse wheezing\n- Continued accessory muscle use\n- Peak flow (if obtained): 45% predicted\n\nThe child has had incomplete response to initial treatment.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "Add ipratropium bromide + IV magnesium sulfate", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For moderate-severe exacerbations with incomplete response: Add ipratropium bromide (anticholinergic) to albuterol and give IV magnesium sulfate 25-75 mg/kg (max 2g) over 20 minutes. Magnesium causes bronchial smooth muscle relaxation.", "consequence": "Escalation therapy initiated. Continue close monitoring.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Continue albuterol alone every 4 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. She has not adequately responded to 3 albuterol treatments - continuing the same approach won't help. Escalation with ipratropium and magnesium is indicated.", "consequence": "Failure to escalate therapy appropriately.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Start IV antibiotics for presumed pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is no evidence of bacterial infection (no fever, no focal findings). Antibiotics are not indicated for viral-triggered asthma exacerbations.", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Immediate intubation for respiratory failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While she is not fully responding, she is maintaining SpO2 >90% and is not showing signs of impending respiratory failure (no silent chest, cyanosis, or obtundation). Medical escalation should be tried first.", "consequence": "Premature intubation with associated risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Discharge with oral steroids and close follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. She still requires supplemental oxygen and has persistent symptoms despite treatment. Discharge criteria have not been met. She needs continued ED observation and escalation therapy.", "consequence": "Premature discharge with high risk of return.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Escalation ladder for refractory asthma: 1) Albuterol q20min, 2) Add ipratropium, 3) IV magnesium sulfate, 4) Continuous albuterol nebulizer, 5) Terbutaline/epinephrine, 6) BiPAP/HFNC, 7) Intubation (last resort)."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 4 hours of ED management including:\n- Multiple albuterol/ipratropium treatments\n- IV magnesium sulfate\n- Oral corticosteroids\n\nReassessment shows:\n- SpO2: 95% on room air\n- Speaking in full sentences\n- Minimal end-expiratory wheeze\n- No accessory muscle use\n- Peak flow: 75% predicted\n- Tolerating oral intake", "question": "What is the most appropriate disposition for this patient?", "choices": [{"id": "node-4-choice-a", "text": "Discharge with oral steroids, rescue inhaler, asthma action plan, and follow-up in 1-2 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Discharge criteria met: SpO2 >94% on room air, minimal wheezing, no accessory muscles, peak flow >70%, tolerating PO. Prescribe: 3-5 day oral steroid course, ensure adequate rescue inhaler supply, provide written asthma action plan, and arrange close follow-up.", "consequence": "Safe discharge with comprehensive plan.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Admit to PICU for continuous monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PICU admission is for patients with impending respiratory failure, requiring continuous nebulization, or needing advanced respiratory support. This child has responded well and meets discharge criteria.", "consequence": "Unnecessary hospitalization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Admit to general pediatrics floor for overnight observation", "isOptimal": false, "isAcceptable": true, "feedback": "Conservative but acceptable. Given her good response and meeting discharge criteria, home discharge is preferred. However, admission may be reasonable if there are concerns about home environment, medication access, or follow-up compliance.", "consequence": "Safe but potentially unnecessary admission.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-d", "text": "Discharge with rescue inhaler only, no steroids needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After a moderate-severe exacerbation, a 3-5 day course of oral corticosteroids is standard of care to prevent relapse. Discharging without completing the steroid course increases risk of ED return.", "consequence": "Increased risk of exacerbation recurrence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Keep in ED for 6 more hours of observation", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not necessary. She has met discharge criteria after 4 hours. Extended observation is reasonable if there are concerns, but standard practice allows discharge when criteria are met.", "consequence": "Prolonged ED stay without clear benefit.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "Discharge criteria: SpO2 >94% on room air, peak flow >70% predicted, no/minimal accessory muscle use, tolerating PO, adequate social situation. Always provide: steroid course completion, rescue inhaler, written action plan, follow-up within 1-2 days."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this moderate-severe asthma exacerbation.\n\nKey Learning Points:\n1. Severity assessment guides treatment intensity\n2. First-line: Albuterol + systemic steroids + O2\n3. Escalation: Ipratropium \u2192 IV magnesium \u2192 continuous neb\n4. Steroids take 4-6 hours to work - give EARLY\n5. Silent chest is ominous, not reassuring\n6. Discharge criteria: SpO2 >94% RA, PF >70%, minimal symptoms, tolerating PO\n\nOutcome: With appropriate stepwise treatment and safe discharge planning, the patient recovers well. Follow-up in 2 days shows continued improvement. Controller medication regimen is optimized to prevent future exacerbations."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points in asthma exacerbation management:\n\n- Assess severity first: mild, moderate-severe, life-threatening\n- First-line treatment: Albuterol + systemic steroids (not inhaled steroids)\n- Escalate appropriately: ipratropium, IV magnesium, continuous nebulizer\n- Silent chest = severe obstruction = ominous sign (not improvement)\n- CXR not routinely needed unless fever, focal findings, or poor response\n\nKey pearl: Steroids take 4-6 hours to work. Give them early, not late."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in asthma management.\n\nRemember:\n- Don't delay bronchodilators for workup\n- Systemic steroids (oral or IV) are essential - inhaled steroids don't work fast enough\n- Adequate albuterol dosing: 2.5-5mg neb or 4-8 puffs MDI (not 2 puffs)\n- SpO2 <92% requires supplemental oxygen and ED observation\n- Silent chest is WORSE than wheezing - it means minimal air movement\n\nKey pearl: Status asthmaticus kills. Aggressive early treatment prevents ICU admissions."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-027", "title": "Foreign Body Aspiration", "domain": "pulmonology", "difficulty": "advanced", "tags": ["foreign body aspiration", "unilateral wheezing", "choking", "right main bronchus", "ball-valve effect", "rigid bronchoscopy", "radiolucent foreign body", "peanut aspiration"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 2-year-old male is brought in by his parents for sudden choking episode followed by cough for 3 hours.\n\nHistory reveals, he was eating peanuts when he suddenly started choking and coughing. The choking resolved but he has had persistent cough and wheezing on one side since then. He was fine before this episode.\n\nAssociated symptoms include unilateral wheezing. Denies fever or prior respiratory illness.\n\nPast medical history includes He was previously healthy. No prior choking episodes.\n\nPhysical Examination:\n- Respiratory: unilateral decreased breath sounds and wheezing on right side. No stridor.\n- General: well-appearing toddler with persistent cough.\n- Vitals: SpO2 95%.\n- Oxygen saturation: 95% on room air.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-year-old presents with a classic history: sudden choking while eating peanuts, followed by persistent cough and unilateral wheezing. The child is now stable with SpO2 95%. The key finding is UNILATERAL decreased breath sounds and wheezing on the right side.", "question": "What is the MOST important clinical clue that differentiates foreign body aspiration from asthma or viral wheezing?", "choices": [{"id": "node-1-choice-a", "text": "Unilateral wheezing with asymmetric breath sounds", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Unilateral findings** are the critical distinguishing feature. In asthma or bronchiolitis, wheezing is **bilateral** and diffuse. **Asymmetric breath sounds** with decreased air entry on one side strongly suggest a foreign body causing **partial obstruction** of that bronchus. This child has right-sided findings - the right bronchus is most commonly affected.", "consequence": "You recognize the key clinical feature.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "History of peanut ingestion", "isOptimal": false, "isAcceptable": true, "feedback": "The history is certainly suggestive, but **many children eat peanuts without aspirating**. The history raises suspicion, but the **unilateral physical findings** are what clinch the diagnosis. Also, aspiration can occur without witnessed choking, making physical exam findings crucial.", "consequence": "History is helpful but physical findings are more specific.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Persistent cough for 3 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Persistent cough** is non-specific and can occur with many conditions including viral illness, asthma, or post-nasal drip. The **unilateral** nature of the findings is what makes foreign body aspiration likely.", "consequence": "Non-specific finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Age of 2 years", "isOptimal": false, "isAcceptable": false, "feedback": "While the **peak age for aspiration is 1-3 years** (exploring with mouth, immature swallowing coordination), age alone doesn't diagnose aspiration. Many 2-year-olds have asthma or viral wheezing. The **unilateral physical findings** are diagnostic.", "consequence": "Age is a risk factor but not diagnostic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "SpO2 of 95%", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SpO2 of 95%** indicates the child is not in severe respiratory distress currently. Oxygen saturation doesn't distinguish between causes of respiratory symptoms. Children with partial bronchial obstruction may maintain normal saturation initially.", "consequence": "Saturation indicates stability, not etiology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Foreign body aspiration clues**: UNILATERAL wheezing (vs bilateral in asthma), sudden onset with choking, no response to bronchodilators. Most FBs lodge in the **RIGHT main bronchus** because it is wider, shorter, and more vertical than the left. Peak age: **1-3 years**."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect foreign body aspiration based on the history and unilateral findings. You order a chest X-ray. The radiologist reports: 'Right lung hyperinflation with mediastinal shift to the left on expiratory film. No radiopaque foreign body visualized.'", "question": "What causes the HYPERINFLATION on the affected side, and why is no foreign body seen?", "choices": [{"id": "node-2-choice-a", "text": "Ball-valve effect traps air; most food items (peanuts) are radiolucent", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **ball-valve (check-valve) effect**: air enters the bronchus during inspiration when the airway dilates, but during expiration the airway narrows and the FB causes complete obstruction, trapping air. **Most aspirated FBs are organic (food)** and therefore **radiolucent** (not visible on X-ray). Only 10-15% of FBs (coins, metal) are radiopaque.", "consequence": "You understand the mechanism and imaging findings.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Compensatory hyperinflation from contralateral atelectasis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The hyperinflation is on the **same side** as the foreign body, not compensatory from the opposite side. If the FB caused complete obstruction, you would see **atelectasis** (collapse), not hyperinflation. The ball-valve mechanism explains air trapping on the AFFECTED side.", "consequence": "Mechanism misunderstood.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Infection causing unilateral pneumonia with air trapping", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While FBs can eventually cause **post-obstructive pneumonia** if left in place, this child has had symptoms for only 3 hours - too early for infection. The **ball-valve mechanism** explains the immediate hyperinflation. Pneumonia develops days to weeks later.", "consequence": "Timing doesn't fit infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "The X-ray is normal; no foreign body is present", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The X-ray is **NOT normal** - it shows hyperinflation and mediastinal shift. This is **indirect evidence** of a foreign body. Remember: **A normal X-ray does NOT exclude foreign body aspiration**. Up to 30% of aspirations have normal initial X-rays.", "consequence": "Critical misinterpretation of imaging.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "The peanut dissolved and is no longer present", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Peanuts do not dissolve in the airway**. They can actually cause significant inflammation and can swell with moisture. The peanut is not visualized because it's **radiolucent** (not visible on X-ray), not because it's gone.", "consequence": "Incorrect understanding of FB behavior.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**X-ray findings in FB aspiration**: (1) **Hyperinflation** (ball-valve effect - most common), (2) **Atelectasis** (complete obstruction), (3) **Mediastinal shift** (toward atelectasis, away from hyperinflation), (4) **Normal X-ray in 30%**. Get **inspiratory AND expiratory films** or **bilateral decubitus films** to accentuate differences."}, "node-3": {"id": "node-3", "type": "decision", "content": "Based on the clinical history and imaging findings, foreign body aspiration is highly suspected. The child remains stable with SpO2 95% and is in no acute distress. You need to determine the definitive management.", "question": "What is the MOST appropriate definitive management for this child with suspected foreign body aspiration?", "choices": [{"id": "node-3-choice-a", "text": "Rigid bronchoscopy under general anesthesia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Rigid bronchoscopy** is the gold standard for **both diagnosis AND removal** of airway foreign bodies. It provides a larger working channel for instrument passage and better airway control. **Flexible bronchoscopy** can be used for diagnosis but rigid is preferred for removal, especially in young children.", "consequence": "Appropriate definitive management planned.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "CT scan of the chest to locate the foreign body", "isOptimal": false, "isAcceptable": true, "feedback": "CT can provide additional information but **delays definitive treatment**. In a child with high clinical suspicion based on history and CXR findings, **proceed directly to bronchoscopy**. CT is useful when diagnosis is uncertain or to plan approach for complex cases.", "consequence": "Imaging delays treatment.", "nextNodeId": "node-3"}, {"id": "node-3-choice-c", "text": "Back blows and chest thrusts (Heimlich maneuver variant)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Back blows/chest thrusts** are for **acute complete airway obstruction** (choking child who cannot breathe, speak, or cough). This child is **stable** with partial obstruction - the acute choking has resolved. These maneuvers could dislodge a partial obstruction and cause **complete obstruction** or push the FB deeper.", "consequence": "Risk of complete obstruction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Trial of bronchodilators and reassess in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bronchodilators will NOT help** a mechanical obstruction, and delay increases risk of complications: **post-obstructive pneumonia, granulation tissue formation, and migration** of the FB. A witnessed aspiration with consistent findings should be treated promptly.", "consequence": "Delay causes complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Flexible bronchoscopy in the ED under sedation", "isOptimal": false, "isAcceptable": true, "feedback": "**Flexible bronchoscopy** can diagnose and sometimes remove FBs, but **rigid bronchoscopy** is preferred in children for removal because it provides better airway control, larger working channels, and ability to ventilate around the scope. Flexible scope may be used first for diagnosis if needed.", "consequence": "Acceptable but rigid preferred for removal.", "nextNodeId": "node-4"}], "clinicalPearl": "**Bronchoscopy approach**: **Rigid bronchoscopy** = gold standard for FB removal in children (better airway control, larger instruments). **Flexible bronchoscopy** = useful for diagnosis, distal airways, or when rigid not available. Success rate for removal >95% with experienced team."}, "node-4": {"id": "node-4", "type": "decision", "content": "Rigid bronchoscopy is performed under general anesthesia. A peanut fragment is visualized in the right main bronchus and successfully removed. The child recovers well from anesthesia. You counsel the parents before discharge.", "question": "What is the MOST important anticipatory guidance for this family?", "choices": [{"id": "node-4-choice-a", "text": "Avoid high-risk foods (peanuts, popcorn, hot dogs, grapes) until age 4", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prevention is key**. High-risk foods should be avoided until age 4 when chewing and swallowing coordination matures. **High-risk foods**: nuts, popcorn, whole grapes, hot dogs (cut lengthwise), hard candies, raw carrots. **High-risk objects**: coins, small toys, button batteries, balloons. Always supervise mealtimes and avoid eating while running or playing.", "consequence": "Appropriate prevention counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Prophylactic antibiotics for 7 days to prevent pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine prophylactic antibiotics are NOT recommended** after uncomplicated FB removal. Antibiotics are only indicated if there is evidence of **post-obstructive infection** (fever, purulent secretions, infiltrate on CXR) at the time of bronchoscopy.", "consequence": "Unnecessary antibiotics.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Follow-up CXR in 24 hours is mandatory", "isOptimal": false, "isAcceptable": true, "feedback": "Routine post-procedure CXR is not mandatory if the removal was uncomplicated and the child is asymptomatic. However, CXR should be obtained if there are **persistent symptoms, concern for incomplete removal, or airway trauma**. Clinical assessment is more important.", "consequence": "Not mandatory but can be considered.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-d", "text": "The child should never eat peanuts again due to allergy risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Aspiration is a mechanical event, NOT an allergy**. The child can eat peanuts again when developmentally appropriate (age 4+) with proper supervision. There's no increased allergy risk from aspiration. Current guidelines actually encourage early peanut introduction to PREVENT allergies.", "consequence": "Confusing aspiration with allergy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Heimlich maneuver training for the parents", "isOptimal": false, "isAcceptable": true, "feedback": "**Good but not the most important**. While all caregivers should know basic choking response (back blows for infants, abdominal thrusts for children >1 year), **prevention through avoiding high-risk foods** is more effective than emergency response. The best choking episode is the one that doesn't happen.", "consequence": "Helpful but prevention is primary.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**High-risk aspiration foods** (avoid until age 4): **Peanuts, popcorn, whole grapes, hot dogs** (cut lengthwise AND crosswise), hard candies, raw carrots, chewing gum. **High-risk objects**: Button batteries (esophageal emergency!), coins, small toy parts, balloons, magnets. **Supervise mealtimes** and discourage eating while running/playing."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly recognized foreign body aspiration based on the key finding of UNILATERAL wheezing and decreased breath sounds following a choking episode. You understood the ball-valve mechanism causing hyperinflation on X-ray and that most food foreign bodies are radiolucent. You appropriately recommended rigid bronchoscopy for definitive diagnosis and removal, and provided important prevention counseling. Key teaching points: (1) Unilateral findings = think FB, (2) Right bronchus most common location, (3) Normal X-ray doesn't exclude FB, (4) Rigid bronchoscopy is gold standard, (5) Prevention: avoid high-risk foods until age 4."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review foreign body aspiration key points: (1) UNILATERAL wheezing/decreased breath sounds is the key finding, (2) Most FBs lodge in the RIGHT main bronchus (wider, shorter, more vertical), (3) Most aspirated items are RADIOLUCENT (food) - normal X-ray doesn't exclude FB, (4) Ball-valve effect causes hyperinflation (air trapping), (5) RIGID bronchoscopy is the gold standard for diagnosis AND removal, (6) Prevention: avoid peanuts, popcorn, hot dogs, grapes until age 4."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in management. Remember: (1) Back blows/Heimlich are for ACUTE COMPLETE obstruction only - NOT for stable partial obstruction, (2) A normal X-ray does NOT rule out foreign body, (3) Delay in removal causes complications: pneumonia, granulation tissue, FB migration, (4) Bronchodilators will NOT help mechanical obstruction. Always proceed to bronchoscopy when clinical suspicion is high, regardless of X-ray findings."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-075", "title": "Tension Pneumothorax Management", "domain": "pulmonology", "difficulty": "advanced", "tags": ["tracheal deviation", "absent breath sounds", "hypotension with JVD", "needle decompression", "chest tube", "trauma", "emergency"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male presents with severe respiratory distress and absent breath sounds on one side after chest trauma.\n\nPhysical Examination:\n- General: severe respiratory distress, diaphoretic, anxious.\n- Vitals: HR 150 bpm, BP 70/40 mmHg, RR 40/min, SpO2 82% on room air.\n- Chest: absent breath sounds on LEFT side, tracheal deviation to the RIGHT, hyperresonance to percussion on left, distended neck veins.\n- Cardiovascular: distant heart sounds, weak peripheral pulses.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The child is in severe distress with oxygen saturation dropping rapidly. The trauma team has been activated. You must act quickly.", "question": "Based on the clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Tension pneumothorax", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The classic triad of **tension pneumothorax** includes: (1) absent breath sounds on the affected side, (2) **tracheal deviation AWAY** from the affected side, and (3) hypotension with **jugular venous distension** (JVD). The hyperresonance to percussion confirms air in the pleural space. This is a **clinical diagnosis** - imaging should NOT delay treatment.", "consequence": "You recognize the life-threatening emergency and prepare for immediate intervention.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Simple pneumothorax", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Simple pneumothorax presents with decreased breath sounds and hyperresonance but **lacks tension physiology**. In simple pneumothorax, there is NO tracheal deviation, NO hypotension, and NO JVD. The presence of hemodynamic instability with tracheal deviation indicates **tension pneumothorax**, which requires immediate intervention.", "consequence": "Treating as simple pneumothorax delays critical intervention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Hemothorax", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hemothorax** presents with **dullness to percussion** (blood is denser than air), not hyperresonance. The affected side would be flat/dull on percussion due to blood accumulation. This patient has **hyperresonance**, indicating air (not blood) in the pleural space.", "consequence": "Misdiagnosis leads to inappropriate management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Cardiac tamponade", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cardiac tamponade** (Beck's triad: hypotension, JVD, muffled heart sounds) can cause similar hemodynamic findings, but breath sounds would be **equal bilaterally** and there would be no tracheal deviation. The unilateral absent breath sounds with hyperresonance point to a pulmonary cause.", "consequence": "Misdiagnosis leads to inappropriate management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Massive pulmonary embolism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Massive PE causes hypotension and hypoxia but does NOT cause unilateral absent breath sounds, tracheal deviation, or hyperresonance. The **localized chest findings** in this patient point to tension pneumothorax, not a vascular cause.", "consequence": "Misdiagnosis leads to inappropriate management.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Tension pneumothorax** is a **clinical diagnosis**. The classic findings are: absent breath sounds, tracheal deviation AWAY from the affected side, hyperresonance, hypotension, and JVD. Do NOT wait for CXR - immediate decompression is life-saving."}, "node-2": {"id": "node-2", "type": "decision", "content": "The child's oxygen saturation continues to drop (now 78%). Blood pressure is barely palpable. The respiratory therapist has the bag-mask ready, and the nurse is preparing supplies.", "question": "What is the most appropriate IMMEDIATE next step?", "choices": [{"id": "node-2-choice-a", "text": "Needle decompression at the 2nd intercostal space, midclavicular line", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Needle thoracostomy** (needle decompression) is the immediate life-saving intervention. Insert a large-bore needle (14-16 gauge) at the **2nd intercostal space, midclavicular line** (or 4th-5th ICS, anterior axillary line). Insert **over the top of the 3rd rib** to avoid the neurovascular bundle running under each rib. You should hear a rush of air confirming decompression.", "consequence": "You perform needle decompression. A rush of air is heard, and the patient's vitals begin to stabilize.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Obtain portable chest X-ray to confirm diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do NOT wait for imaging** in tension pneumothorax - this is a clinical diagnosis requiring immediate intervention. The time required for imaging could result in cardiac arrest. CXR can be obtained AFTER needle decompression if there is clinical uncertainty.", "consequence": "Patient arrests while waiting for imaging.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Immediate chest tube placement", "isOptimal": false, "isAcceptable": true, "feedback": "Chest tube (tube thoracostomy) IS the definitive treatment, but it takes longer to set up and perform than needle decompression. In a rapidly decompensating patient, **needle decompression first** buys time for definitive chest tube placement. However, if you are trained and have immediate availability, proceeding directly to chest tube is acceptable.", "consequence": "Chest tube placement takes additional time but ultimately stabilizes the patient.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Intubate and provide positive pressure ventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Positive pressure ventilation WORSENS tension pneumothorax** by forcing more air into the pleural space through the one-way valve mechanism. The tension must be relieved FIRST with needle decompression, then airway management can proceed if needed.", "consequence": "Positive pressure ventilation worsens the tension physiology, leading to cardiac arrest.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Administer IV fluid bolus for hypotension", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The hypotension is caused by **obstructive shock** from impaired venous return to the heart. Fluids will not help until the underlying tension is relieved. The pleural pressure must be decompressed to restore venous return.", "consequence": "Fluids do not address the underlying cause; patient continues to deteriorate.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Needle decompression landmarks**: 2nd ICS midclavicular line OR 4th-5th ICS anterior axillary line. Insert OVER the rib (not under) to avoid the **intercostal neurovascular bundle** which runs along the inferior border of each rib."}, "node-3": {"id": "node-3", "type": "decision", "content": "Following needle decompression, you hear a rush of air. The patient's oxygen saturation improves to 92% and blood pressure rises to 90/60 mmHg. Tracheal deviation is less pronounced. However, needle decompression is only a temporizing measure.", "question": "What is the next step in definitive management?", "choices": [{"id": "node-3-choice-a", "text": "Place chest tube (tube thoracostomy)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Chest tube placement** is the definitive treatment after needle decompression. The chest tube provides continuous drainage of air and prevents re-accumulation. Standard placement is at the **4th-5th intercostal space, anterior to mid-axillary line** (triangle of safety). Connect to an underwater seal or Heimlich valve.", "consequence": "Chest tube is placed successfully with good drainage. CXR confirms lung re-expansion.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Leave the needle in place and monitor closely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Needle decompression is a **temporizing measure only**. The needle can become occluded, dislodged, or kinked. Without a chest tube, the pneumothorax will likely recur. Definitive management with chest tube is required.", "consequence": "Needle becomes occluded; tension pneumothorax recurs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Obtain CT chest before chest tube placement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT imaging is unnecessary and delays definitive treatment. The diagnosis is already established clinically and confirmed by response to needle decompression. Chest tube should be placed without delay.", "consequence": "Unnecessary delay; risk of re-accumulation during imaging.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Perform repeat needle decompression on the same side", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Multiple needle decompressions are not appropriate management. The correct next step is **chest tube placement** for definitive drainage. Repeated needle sticks increase risk of complications without providing sustained benefit.", "consequence": "Temporary relief only; chest tube eventually needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Observe for 6 hours then reassess need for chest tube", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A traumatic tension pneumothorax requires definitive treatment, not observation. The needle will not provide sustained decompression, and delayed chest tube placement risks recurrence of tension physiology.", "consequence": "Tension pneumothorax recurs during observation period.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Chest tube placement** (tube thoracostomy) is the definitive treatment. Place at the 4th-5th ICS in the **'triangle of safety'** (bordered by anterior border of latissimus dorsi, lateral border of pectoralis major, and a line at the level of the nipple)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The chest tube is in place and functioning well. Post-procedure CXR shows complete lung re-expansion with the chest tube in good position. The patient is now hemodynamically stable with SpO2 98% on 2L nasal cannula.\n\nThe trauma surgery team is consulted for ongoing management.", "question": "Which of the following is the most important aspect of ongoing management?", "choices": [{"id": "node-4-choice-a", "text": "Monitor for air leak resolution, then remove chest tube when criteria met", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Chest tube management involves: (1) **Monitor for air leak** - bubbling in the water seal chamber indicates ongoing air leak; (2) **Confirm lung re-expansion** on follow-up CXR; (3) Remove chest tube when there is **no air leak for 12-24 hours** and the lung remains expanded. Water seal trial before removal is common practice.", "consequence": "Patient monitored appropriately. Air leak resolves over 48 hours. Chest tube removed on day 3 without complications.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Remove chest tube immediately since lung is re-expanded", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Premature chest tube removal risks **recurrent pneumothorax**. The tube should remain in place until there is no air leak for at least 12-24 hours, and the lung remains fully expanded. A water seal trial is often performed before removal.", "consequence": "Premature removal leads to recurrent pneumothorax requiring replacement.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Apply continuous high suction (-40 cm H2O) to speed recovery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Standard suction is **-20 cm H2O**. Excessive suction can cause **re-expansion pulmonary edema** (especially after prolonged lung collapse) and can perpetuate the air leak. Gentle suction or water seal is preferred.", "consequence": "Excessive suction causes re-expansion pulmonary edema.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Clamp the chest tube to test lung expansion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never clamp a chest tube** in the setting of an active air leak or recent tension pneumothorax - this can recreate tension physiology. Water seal trial (disconnecting suction but leaving tube to drainage) is the safe way to assess before removal.", "consequence": "Clamping recreates tension pneumothorax.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Discharge home with chest tube to outpatient Heimlich valve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A traumatic tension pneumothorax in a child requires inpatient monitoring. Outpatient Heimlich valves are sometimes used for **spontaneous pneumothorax in stable adults**, not traumatic pneumothorax in pediatric patients.", "consequence": "Inappropriate outpatient management for a traumatic injury.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Chest tube removal criteria**: (1) No air leak for 12-24 hours, (2) Drainage <200 mL/day (for fluid), (3) Lung fully expanded on CXR. Perform water seal trial before removal - never clamp a chest tube with an air leak."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized tension pneumothorax as a clinical diagnosis, performed immediate needle decompression, placed a definitive chest tube, and managed the tube appropriately. The patient recovered fully and was discharged after chest tube removal on hospital day 4.\n\n**Key Learning Points:**\n- Tension pneumothorax is a **clinical diagnosis** - do NOT delay for imaging\n- **Needle decompression** (2nd ICS MCL or 4th-5th ICS AAL) is the immediate life-saving intervention\n- **Chest tube** is definitive treatment; needle decompression is only temporizing\n- Pathophysiology: one-way valve effect traps air, causing mediastinal shift and impaired venous return\n- Remove chest tube only after air leak resolution and confirmed lung expansion"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While the patient ultimately survived, delays or inappropriate management choices could have led to worse outcomes.\n\n**Review the key principles:**\n- Tension pneumothorax requires IMMEDIATE needle decompression\n- Chest tube is ALWAYS needed after needle decompression\n- Do NOT clamp chest tubes with active air leaks\n- Standard suction is -20 cm H2O (not higher)\n- Monitor for air leak resolution before tube removal"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in management. Tension pneumothorax has a high mortality if not treated immediately and appropriately.\n\n**Critical Teaching Points:**\n- This is a CLINICAL DIAGNOSIS - imaging delays cost lives\n- Positive pressure ventilation WORSENS tension pneumothorax\n- Fluids do not treat obstructive shock from tension physiology\n- Needle decompression is temporizing; chest tube is definitive\n- Never clamp a chest tube with an active air leak"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-096", "title": "Spontaneous Bacterial Peritonitis in Nephrotic Syndrome", "domain": "pulmonology", "difficulty": "advanced", "tags": ["SBP", "nephrotic syndrome", "peritonitis", "paracentesis", "S. pneumoniae", "encapsulated organisms", "immunocompromised", "ceftriaxone", "ascites"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male with known nephrotic syndrome (minimal change disease, on prednisone) is brought to the ED with 2 days of worsening abdominal pain and fever to 39.2\u00b0C.\n\nHis nephrotic syndrome was in relapse last week with 4+ proteinuria and serum albumin of 1.8 g/dL.\n\nVital signs: HR 130, BP 90/55, RR 28, T 39.2\u00b0C, SpO2 98%.\n\nPhysical exam:\n- General: Ill-appearing, lethargic child with periorbital and generalized edema\n- Abdomen: Markedly distended with tense ascites, diffusely tender with guarding, hypoactive bowel sounds\n- Extremities: 3+ pitting edema bilaterally\n- Skin: No rashes or cellulitis", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A febrile child with nephrotic syndrome presents with abdominal pain and ascites. This is a concerning presentation that requires urgent evaluation.", "question": "What is the most important initial diagnostic step?", "choices": [{"id": "node-1-choice-a", "text": "Diagnostic paracentesis with ascitic fluid analysis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Diagnostic paracentesis** is essential in any nephrotic patient with fever and ascites. The ascitic fluid analysis (cell count, Gram stain, culture) will confirm or exclude **spontaneous bacterial peritonitis (SBP)**. The diagnostic criterion is **PMN count >250 cells/\u03bcL**. Do NOT wait for culture results\u2014if PMN is elevated, treat empirically.", "consequence": "Paracentesis performed. Results pending.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "CT abdomen with contrast to rule out appendicitis", "isOptimal": false, "isAcceptable": true, "feedback": "CT can be useful if **secondary peritonitis** (perforated viscus) is suspected, but in a nephrotic child with ascites and fever, **SBP is far more likely**. Paracentesis is faster, cheaper, and directly diagnostic. CT should be considered if paracentesis findings suggest secondary peritonitis (polymicrobial, very high protein, presence of fungus).", "consequence": "CT delays the critical diagnostic paracentesis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Blood cultures and empiric antibiotics immediately", "isOptimal": false, "isAcceptable": true, "feedback": "Blood cultures are appropriate and antibiotics will likely be needed, but **paracentesis should not be delayed**. The ascitic fluid analysis is essential to confirm SBP and guide treatment. You can draw blood cultures AND perform paracentesis simultaneously, but don't skip the tap.", "consequence": "Appropriate steps but missing key diagnostic procedure.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Abdominal X-ray to assess for obstruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Abdominal X-ray is not helpful for diagnosing SBP. It may show ascites (ground glass appearance) but provides no information about infection. In a nephrotic child with fever and abdominal pain, **paracentesis** is the key diagnostic test.", "consequence": "Unhelpful test delays appropriate workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Observe with IV fluids and reassess in 4-6 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SBP is a medical emergency** in nephrotic patients. These children are immunocompromised (loss of IgG and complement in urine) and can deteriorate rapidly. Observation without diagnosis and treatment is dangerous. Immediate workup with paracentesis is required.", "consequence": "Dangerous delay in septic child. Risk of deterioration.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Nephrotic syndrome = immunocompromised!** Urinary losses include IgG, complement factors, and opsonins. This predisposes to infections with **encapsulated organisms**: S. pneumoniae (#1), E. coli, Klebsiella. Any fever in a nephrotic child warrants aggressive workup."}, "node-2": {"id": "node-2", "type": "decision", "content": "Paracentesis results return:\n- **Ascitic fluid WBC: 850 cells/\u03bcL** (normal <250)\n- **PMN: 680 cells/\u03bcL (80%)** - PMN predominant\n- Protein: 1.2 g/dL\n- Glucose: 75 mg/dL (similar to serum)\n- LDH: 120 U/L\n- Gram stain: Gram-positive cocci in pairs\n- Culture: Pending\n\nSerum albumin: 1.8 g/dL\nBlood cultures: Pending", "question": "Based on these paracentesis results, what is the diagnosis and what organism is most likely?", "choices": [{"id": "node-2-choice-a", "text": "Spontaneous bacterial peritonitis (SBP) - most likely Streptococcus pneumoniae", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **SBP** confirmed by **PMN >250 cells/\u03bcL** (680 in this case). The Gram-positive cocci in pairs strongly suggest **S. pneumoniae**, the most common cause of SBP in nephrotic syndrome. Key SBP features: monomicrobial, low protein ascites, PMN predominant. The SAAG (serum-ascites albumin gradient) would be >1.1 g/dL, consistent with portal hypertension-related ascites.", "consequence": "Diagnosis confirmed. Initiate appropriate treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Secondary peritonitis from perforated appendix - likely polymicrobial", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Secondary peritonitis** (from perforation) typically shows: **polymicrobial** organisms on Gram stain, **very high protein** (>1 g/dL often >2.5), **low glucose** (<50 or much lower than serum), **elevated LDH** (>225). This patient has monomicrobial infection (Gram-positive cocci only) and relatively normal glucose\u2014classic for **SBP**.", "consequence": "Misdiagnosis could lead to unnecessary surgery.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Tuberculous peritonitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **TB peritonitis** typically shows: **lymphocyte** predominance (not PMN), very high protein, low glucose, elevated adenosine deaminase (ADA). This patient has acute presentation with PMN predominance and Gram-positive cocci\u2014not consistent with TB. TB peritonitis is also rare in children without known TB exposure.", "consequence": "Incorrect diagnosis delays appropriate antibiotics.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "SBP - most likely E. coli", "isOptimal": false, "isAcceptable": true, "feedback": "You correctly identified SBP, but the organism is likely wrong. **Gram-positive cocci in pairs** indicates **S. pneumoniae** (diplococci), not E. coli (which is a Gram-negative rod). While E. coli is the second most common cause of SBP in nephrotic syndrome, the Gram stain here points to pneumococcus.", "consequence": "Correct diagnosis but may affect empiric antibiotic choice.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Contaminated sample - repeat paracentesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is NOT a contaminated sample. The **PMN count of 680** is markedly elevated (contamination typically shows few WBCs), and the clinical picture (febrile nephrotic child with peritoneal signs) is highly consistent with **SBP**. Repeating paracentesis delays life-saving antibiotics.", "consequence": "Dangerous delay in treating confirmed SBP.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**SBP diagnostic criteria**: Ascitic fluid PMN >250 cells/\u03bcL. **Don't wait for culture**\u2014treat empirically! SBP is typically **monomicrobial**. If Gram stain shows multiple organisms or anaerobes, suspect **secondary peritonitis** (surgical abdomen)."}, "node-3": {"id": "node-3", "type": "decision", "content": "You have confirmed **SBP** in this nephrotic child. The Gram stain suggests S. pneumoniae. The child is febrile, tachycardic, and hypotensive (BP 90/55).\n\nYou need to initiate treatment immediately.", "question": "What is the most appropriate empiric antibiotic regimen for SBP in this nephrotic child?", "choices": [{"id": "node-3-choice-a", "text": "Ceftriaxone or cefotaxime IV", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Third-generation cephalosporins** (ceftriaxone or cefotaxime) are first-line for SBP. They cover the most common organisms: **S. pneumoniae** and **E. coli/Klebsiella**. Ceftriaxone is often preferred due to once-daily dosing. Duration is typically 10-14 days, with clinical improvement expected in 48-72 hours.", "consequence": "Ceftriaxone started. IV fluids for hypotension.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Vancomycin plus piperacillin-tazobactam", "isOptimal": false, "isAcceptable": true, "feedback": "This is broader than necessary for typical SBP. Vancomycin may be added if there's concern for **MRSA** or the patient is critically ill, but it's not first-line. Pip-tazo provides excellent Gram-negative and anaerobic coverage, which is more appropriate if **secondary peritonitis** is suspected. For uncomplicated SBP, ceftriaxone alone is sufficient.", "consequence": "Broader coverage than needed but acceptable in sick patient.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Oral amoxicillin-clavulanate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child is **septic** (febrile, tachycardic, hypotensive) and requires **IV antibiotics**. Oral antibiotics are inappropriate for acute SBP. Additionally, this child likely cannot tolerate oral medications given the abdominal distension and ileus.", "consequence": "Inadequate treatment for septic child.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Metronidazole IV for anaerobic coverage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Anaerobes are NOT typical pathogens in SBP**. The presence of anaerobes on Gram stain would suggest **secondary peritonitis** (bowel perforation), not SBP. This patient has Gram-positive cocci consistent with S. pneumoniae. Metronidazole alone would not cover the actual pathogen.", "consequence": "Wrong antibiotic choice. Infection not treated.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Wait for culture results before starting antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never wait for cultures in SBP**\u2014empiric antibiotics must be started immediately once PMN >250 is confirmed. Cultures take 24-48 hours, and this child is already septic. Delayed treatment significantly increases mortality. Start empiric therapy and narrow based on culture results later.", "consequence": "Delay in antibiotics. Patient deteriorates.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**SBP treatment**: Ceftriaxone 50-75 mg/kg/day OR cefotaxime 150-200 mg/kg/day divided q8h. Duration: **10-14 days**. If penicillin-allergic: fluoroquinolone (in adults) or aztreonam + vancomycin. **Do NOT wait for cultures!**"}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is started on ceftriaxone and IV fluids. After 48 hours:\n- Fever has resolved\n- Abdominal tenderness is improving\n- HR 100, BP 100/65\n- Cultures grew **Streptococcus pneumoniae** (sensitive to ceftriaxone)\n\nThe nephrologist asks about long-term management to prevent recurrence.", "question": "What is the recommended approach to prevent SBP recurrence in this nephrotic patient?", "choices": [{"id": "node-4-choice-a", "text": "Prophylactic oral penicillin VK during relapses and ensure pneumococcal vaccination is up to date", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After a first episode of SBP, **prophylactic antibiotics** are recommended during nephrotic relapses when the patient is edematous and hypoalbuminemic. **Penicillin VK** (or amoxicillin) is commonly used for pneumococcal prophylaxis. Additionally, ensure **pneumococcal vaccination** (PCV13 and PPSV23) is complete. Some centers continue prophylaxis until remission is achieved.", "consequence": "Prophylaxis plan in place. Vaccinations reviewed.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Long-term ceftriaxone until nephrotic syndrome resolves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Long-term IV ceftriaxone is impractical and promotes resistance. **Oral prophylaxis** with penicillin is the standard approach. Ceftriaxone is for acute treatment, not prophylaxis. The goal is coverage during high-risk periods (relapses with hypoalbuminemia), not indefinite IV therapy.", "consequence": "Impractical and promotes antibiotic resistance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "No prophylaxis needed - just treat future episodes as they occur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SBP recurrence rate is high** in nephrotic syndrome (up to 70% without prophylaxis). Given the significant morbidity and mortality of SBP, prophylactic antibiotics during relapses are strongly recommended. Waiting for recurrence puts the child at unnecessary risk.", "consequence": "High risk of recurrent SBP without prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Monthly IVIG infusions to replace lost immunoglobulins", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While nephrotic patients do lose IgG in urine, **routine IVIG is not standard practice** for SBP prophylaxis. It is expensive, requires IV access, and has not been shown to be superior to simple oral antibiotic prophylaxis. IVIG may be considered in severe, refractory cases with documented hypogammaglobulinemia and recurrent infections.", "consequence": "Not standard of care. Oral prophylaxis is simpler and effective.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Splenectomy to prevent encapsulated organism infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Splenectomy would INCREASE** the risk of encapsulated organism infections, not decrease it! The spleen is critical for clearing encapsulated bacteria. Splenectomy is never indicated for SBP prophylaxis. This would be harmful.", "consequence": "Harmful intervention. Would increase infection risk.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**SBP prophylaxis in nephrotic syndrome**: Penicillin VK 125-250 mg BID (or amoxicillin) during relapses. Ensure **vaccinations**: PCV13 series + PPSV23 after age 2. Recurrence rate without prophylaxis: up to **70%**. With prophylaxis: significantly reduced."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You recognized that fever and abdominal pain in a nephrotic child is SBP until proven otherwise, performed diagnostic paracentesis promptly, correctly interpreted the results (PMN >250, Gram-positive diplococci = S. pneumoniae), initiated appropriate empiric antibiotics (ceftriaxone), and established a prophylaxis plan to prevent recurrence.\n\n**Key Learning Points:**\n- Nephrotic syndrome = immunocompromised (loss of IgG, complement, opsonins)\n- SBP diagnostic criterion: ascitic fluid **PMN >250 cells/\u03bcL**\n- Most common organisms: **S. pneumoniae** (#1), E. coli, Klebsiella\n- Treatment: Ceftriaxone or cefotaxime IV - **don't wait for cultures**\n- Prophylaxis: Penicillin VK during relapses + ensure pneumococcal vaccination"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While you may have reached the correct diagnosis, there were delays or suboptimal choices in management. SBP in nephrotic children is a medical emergency.\n\n**Review:**\n- Always perform **paracentesis** in febrile nephrotic child with ascites\n- PMN >250 cells/\u03bcL confirms SBP\n- **Start antibiotics immediately**\u2014don't wait for cultures\n- S. pneumoniae is the #1 cause; ceftriaxone is first-line\n- Prophylaxis with penicillin VK reduces recurrence"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical errors in management.** SBP is a life-threatening infection in nephrotic patients who are functionally immunocompromised. Delays in diagnosis or treatment can be fatal.\n\n**Key Pearl:** Nephrotic patients lose IgG and complement in urine, predisposing to infections with **encapsulated organisms** (S. pneumoniae, E. coli, Klebsiella). Fever in a nephrotic child = aggressive workup. PMN >250 in ascitic fluid = treat with ceftriaxone IMMEDIATELY."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-104", "title": "Absorption Atelectasis Mechanism", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["high FiO2", "nitrogen washout", "alveolar collapse", "absorption atelectasis mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-year-old male on supplemental oxygen develops worsening hypoxemia and new lung opacities on chest X-ray.\n\nPhysical Examination:\n- Vitals: hypoxia.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 6-year-old male was admitted to the PICU 2 days ago with severe pneumonia requiring high-flow oxygen. Initially he required **100% FiO\u2082** via non-rebreather mask to maintain SpO\u2082 >90%.\n\nToday, despite continued 100% FiO\u2082, his oxygen saturation has dropped to 85% and he appears more distressed.\n\n**New chest X-ray shows:**\n- Patchy bilateral infiltrates (known - from pneumonia)\n- NEW: **Diffuse bilateral areas of volume loss** with plate-like opacities\n- Slight mediastinal shift suggesting volume loss\n\n**The attending asks**: \"Why did he get worse on 100% oxygen? Could the oxygen itself be causing problems?\"\n\n**Types of Atelectasis:**\n1. **Obstructive atelectasis**: airway blocked by mucus plug, foreign body, or tumor \u2192 air absorbed from alveoli distal to obstruction\n2. **Compressive atelectasis**: external compression (pleural effusion, pneumothorax, mass)\n3. **Surfactant deficiency**: neonatal RDS, ARDS \u2192 loss of surface tension reducing agent\n4. **Absorption atelectasis**: HIGH FiO\u2082 \u2192 nitrogen washout \u2192 rapid gas absorption \u2192 alveolar collapse", "question": "What is the mechanism causing this patient's new atelectasis while on 100% oxygen?", "choices": [{"id": "node-1-choice-a", "text": "Absorption atelectasis - high FiO\u2082 causes nitrogen washout, allowing rapid absorption of alveolar oxygen and subsequent collapse", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Absorption atelectasis** is an iatrogenic complication of high FiO\u2082 therapy. The mechanism: (1) **Normal alveolar gas is ~79% nitrogen** - nitrogen is poorly soluble in blood and acts as a \"splint\" keeping alveoli open, (2) When breathing **100% O\u2082**, nitrogen is rapidly washed out and replaced by oxygen, (3) Oxygen is **highly soluble** and rapidly absorbed into blood, (4) Without the nitrogen \"splint,\" alveoli collapse when oxygen is absorbed faster than it's replaced, (5) This is most pronounced in **low V/Q regions** where ventilation is already reduced. This paradox explains why \"more oxygen\" can sometimes make patients worse.", "consequence": "You correctly identify the mechanism of absorption atelectasis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Obstructive atelectasis from mucus plugging secondary to pneumonia", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct - **mucus plugging CAN cause atelectasis** in pneumonia patients. However, the question specifically asks about the relationship between high FiO\u2082 and new atelectasis. Key distinguishing features: (1) This patient developed NEW bilateral diffuse atelectasis while on 100% O\u2082, (2) Mucus plugging typically causes focal/lobar atelectasis, not diffuse bilateral changes, (3) The attending specifically asked about oxygen-related problems. While mucus plugging should be considered, the clinical context points to absorption atelectasis.", "consequence": "Mucus plugging is possible but doesn't explain the temporal relationship with 100% O\u2082.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Oxygen toxicity causing acute lung injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. **Oxygen toxicity** (direct cellular damage from reactive oxygen species) typically requires: (1) FiO\u2082 >0.6 for **>24-48 hours** for early changes, (2) Days of exposure for significant parenchymal damage, (3) Presents as ARDS-like picture with diffuse infiltrates, not atelectasis. This patient has been on high oxygen for only 2 days - too early for classic oxygen toxicity. Absorption atelectasis occurs IMMEDIATELY with high FiO\u2082, while oxygen toxicity takes days to develop.", "consequence": "Oxygen toxicity takes longer to develop than 2 days.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Surfactant deficiency from underlying lung disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surfactant deficiency atelectasis** is characteristic of: (1) **Premature infants** (neonatal RDS) - surfactant not yet produced, (2) **ARDS** - surfactant dysfunction from inflammation. This 6-year-old has community-acquired pneumonia, not ARDS. While severe pneumonia can affect surfactant function, the NEW bilateral atelectasis developing specifically while on 100% FiO\u2082 points to absorption atelectasis as the more likely mechanism.", "consequence": "Surfactant deficiency doesn't explain the temporal relationship with high FiO\u2082.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Compressive atelectasis from new pleural effusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Compressive atelectasis** would show: (1) **Pleural effusion** on CXR (blunting of costophrenic angle, meniscus sign), (2) Unilateral or asymmetric findings typically, (3) Mediastinal shift AWAY from the effusion (mass effect). The CXR described shows diffuse bilateral atelectasis with shift TOWARD the collapsed areas (volume loss), not compression. No effusion was mentioned.", "consequence": "No evidence of pleural effusion causing compression.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Absorption atelectasis mechanism**: Nitrogen (79% of room air) is poorly soluble and \"splints\" alveoli open. 100% O\u2082 washes out nitrogen; the highly soluble oxygen is rapidly absorbed, causing alveolar collapse. This is most pronounced in low V/Q regions."}, "node-2": {"id": "node-2", "type": "decision", "content": "You explain the mechanism of absorption atelectasis to the team. The resident asks: \"So what do we do? He still needs oxygen - his saturations are terrible.\"\n\n**Key Principle: Use the MINIMUM FiO\u2082 needed to achieve adequate oxygenation.**\n\n**Target SpO\u2082 in most patients:**\n- **88-94%** is often adequate (not 100%)\n- Higher targets (>94%) rarely provide additional benefit but increase oxygen toxicity and absorption atelectasis risk\n- Exception: carbon monoxide poisoning, severe anemia - may need higher targets\n\n**Strategies to reduce FiO\u2082 while maintaining oxygenation:**\n- Add **PEEP** (positive end-expiratory pressure) - recruits collapsed alveoli, improves V/Q matching\n- Treat underlying cause (antibiotics for pneumonia, bronchodilators for bronchospasm)\n- **Chest physiotherapy** and suctioning for mucus clearance\n- Positioning (prone positioning in severe cases)\n- Accept slightly lower SpO\u2082 targets if stable\n\n**Why PEEP helps:**\n- Keeps alveoli open at end-expiration\n- Recruits collapsed lung units\n- Improves functional residual capacity\n- Allows lower FiO\u2082 to achieve same oxygenation", "question": "What is the most appropriate intervention to address this patient's absorption atelectasis?", "choices": [{"id": "node-2-choice-a", "text": "Reduce FiO\u2082 to the lowest level that maintains SpO\u2082 88-94%, and add PEEP to recruit collapsed alveoli", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The dual approach of **reducing FiO\u2082 and adding PEEP** addresses absorption atelectasis optimally. Key points: (1) **Reduce FiO\u2082** - the cause of the problem; target SpO\u2082 88-94% (not 100%), (2) **Add PEEP** - positive end-expiratory pressure keeps alveoli open, recruits collapsed units, and improves V/Q matching, allowing lower FiO\u2082, (3) This may require transitioning to **CPAP, BiPAP, or mechanical ventilation** if not already on positive pressure, (4) The combination works synergistically: PEEP improves lung mechanics \u2192 better oxygenation \u2192 allows FiO\u2082 reduction.", "consequence": "You implement the correct intervention for absorption atelectasis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Increase FiO\u2082 to compensate for the worsening hypoxemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **this makes the problem WORSE**. More oxygen = more nitrogen washout = more absorption atelectasis = worse hypoxemia. This is a classic case of treating a complication of therapy with MORE of the same therapy. The patient is already on 100% FiO\u2082 - there's nowhere higher to go, and even if there were, it would perpetuate the cycle. The solution is to reduce FiO\u2082 while optimizing other aspects of respiratory support.", "consequence": "More oxygen worsens absorption atelectasis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Stop all oxygen immediately to allow nitrogen to return to the alveoli", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **this would cause dangerous hypoxemia**. The patient has severe pneumonia with underlying hypoxia - removing ALL oxygen would be catastrophic. The correct approach is GRADUAL reduction to the minimum FiO\u2082 needed, not abrupt cessation. Additionally, adding PEEP helps recruit collapsed alveoli before reducing FiO\u2082. \"Minimum FiO\u2082 to maintain adequate oxygenation\" \u2260 \"no oxygen.\"", "consequence": "Abrupt oxygen cessation would cause dangerous hypoxemia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Perform bronchoscopy to rule out mucus plugging before any oxygen adjustment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect prioritization. While bronchoscopy might be considered if mucus plugging is suspected (focal atelectasis not responding to conservative measures), it's: (1) **Invasive** and carries risks, (2) **Not the first step** for diffuse bilateral atelectasis on high FiO\u2082, (3) Won't address the underlying mechanism (nitrogen washout). The immediate intervention should be reducing FiO\u2082 and optimizing ventilatory support. Bronchoscopy may be considered later if specific indications arise.", "consequence": "Bronchoscopy is invasive and doesn't address the primary mechanism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Give surfactant replacement therapy via endotracheal tube", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surfactant therapy** is indicated for: (1) **Neonatal RDS** (premature infants with surfactant deficiency), (2) Possibly severe ARDS (evidence mixed). This 6-year-old with pneumonia and absorption atelectasis does NOT have surfactant deficiency as the primary problem. Giving surfactant: (1) Wouldn't address the nitrogen washout mechanism, (2) Is not indicated for this scenario, (3) Would require intubation if not already intubated. Address the cause (high FiO\u2082) first.", "consequence": "Surfactant is not indicated for absorption atelectasis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Management of absorption atelectasis**: (1) Reduce FiO\u2082 to minimum needed (target SpO\u2082 88-94%, not 100%), (2) Add PEEP to recruit collapsed alveoli and improve V/Q matching. PEEP keeps alveoli open and allows lower FiO\u2082 to achieve the same oxygenation."}, "node-3": {"id": "node-3", "type": "decision", "content": "You transition the patient to CPAP with PEEP of 8 cm H\u2082O and wean FiO\u2082 from 100% down to 60%. His SpO\u2082 improves to 92%, and repeat chest X-ray shows improved aeration.\n\nThe medical student asks: \"I thought more oxygen is always better. When else might high oxygen be harmful?\"\n\n**Harms of Excessive Oxygen (Hyperoxia):**\n\n**1. Absorption Atelectasis** (discussed) - occurs immediately with high FiO\u2082\n\n**2. Oxygen Toxicity** - direct cellular damage from reactive oxygen species\n- Tracheobronchitis (early), ARDS-like picture (late)\n- Risk increases with FiO\u2082 >0.6 for >24-48 hours\n\n**3. Retinopathy of Prematurity (ROP)**\n- Premature infants: high PaO\u2082 causes abnormal retinal vessel development\n- Target SpO\u2082 90-95% in premature infants to reduce ROP risk\n\n**4. Bronchopulmonary Dysplasia (BPD)**\n- Chronic lung disease of prematurity\n- Multifactorial: oxygen, mechanical ventilation, inflammation\n\n**5. Suppression of Hypoxic Drive**\n- COPD patients with chronic CO\u2082 retention (less relevant in children)\n\n**6. Coronary and Cerebral Vasoconstriction**\n- Hyperoxia causes vasoconstriction - may worsen ischemia in MI/stroke", "question": "A premature infant (28 weeks, now 2 weeks old) is in the NICU on supplemental oxygen. Why is it important to avoid excessive oxygen in this patient?", "choices": [{"id": "node-3-choice-a", "text": "High oxygen levels cause abnormal retinal vessel development, leading to retinopathy of prematurity (ROP) which can cause blindness", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Retinopathy of Prematurity (ROP)** is a critical concern in premature infants. Mechanism: (1) Premature retina has **incomplete vascularization**, (2) **High PaO\u2082** causes vasoconstriction and arrest of normal vessel development, (3) When oxygen is reduced, abnormal **neovascularization** occurs (like diabetic retinopathy), (4) Abnormal vessels can cause retinal detachment \u2192 **blindness**, (5) ROP risk is highest in the most premature infants (<32 weeks, <1500g). Target SpO\u2082 in premature infants: **90-95%** (some protocols 88-94%) - balancing hypoxia risk against ROP risk.", "consequence": "You correctly identify ROP as a key complication of hyperoxia in premature infants.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "High oxygen suppresses the respiratory drive in premature infants causing apnea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect mechanism. **Hypoxic drive suppression** is a concern in adults with chronic CO\u2082 retention (COPD), not premature infants. Premature infants have apnea of prematurity due to immature respiratory control, but this is NOT caused by oxygen suppressing respiratory drive. The primary concern with high oxygen in premature infants is ROP and contribution to BPD.", "consequence": "Respiratory drive suppression is not the mechanism of harm in premature infants.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "High oxygen causes immediate pulmonary edema in premature lungs", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While prolonged high FiO\u2082 contributes to **bronchopulmonary dysplasia (BPD)** and can cause oxygen toxicity over days, it does NOT cause \"immediate pulmonary edema.\" The oxygen-related lung injury in premature infants is a chronic process involving inflammation and impaired alveolar development, not acute pulmonary edema.", "consequence": "Oxygen doesn't cause immediate pulmonary edema.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "High oxygen causes coronary artery vasospasm and myocardial infarction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect context. While hyperoxia CAN cause coronary and cerebral vasoconstriction (a concern in adult MI and stroke patients), this is NOT the primary concern in premature infants. Premature infants don't typically have coronary artery disease. The key concern in this population is **retinopathy of prematurity (ROP)**.", "consequence": "Coronary vasospasm is not the primary concern in premature infants.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "High oxygen is actually safe in premature infants - the concern is only for adults", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **premature infants are MORE vulnerable** to oxygen toxicity than adults. Specific risks: (1) **ROP** - can cause blindness, (2) **BPD** - chronic lung disease from oxygen and ventilation, (3) Premature antioxidant systems. Careful SpO\u2082 targeting (90-95%) is CRITICAL in premature infants to balance hypoxia risk against hyperoxia complications.", "consequence": "Premature infants are especially vulnerable to oxygen-related harm.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ROP in premature infants**: High PaO\u2082 \u2192 abnormal retinal vessel development \u2192 neovascularization \u2192 retinal detachment \u2192 blindness. Target SpO\u2082 **90-95%** in premature infants (not higher) to reduce ROP risk while avoiding hypoxia."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You demonstrated understanding of absorption atelectasis and the harms of excessive oxygen therapy.\n\n**Key teaching points:**\n\n**Absorption Atelectasis Mechanism:**\n- Nitrogen (79% of room air) is poorly soluble \u2192 acts as alveolar \"splint\"\n- 100% O\u2082 washes out nitrogen\n- Highly soluble oxygen is rapidly absorbed\n- Alveoli collapse without the nitrogen splint\n- Most pronounced in low V/Q regions\n\n**Management:**\n- Reduce FiO\u2082 to minimum needed (target SpO\u2082 88-94%)\n- Add PEEP to recruit collapsed alveoli\n- PEEP + lower FiO\u2082 = synergistic benefit\n\n**Other Harms of Hyperoxia:**\n- **Oxygen toxicity**: FiO\u2082 >0.6 for >24-48 hours \u2192 cellular damage\n- **Retinopathy of Prematurity (ROP)**: high PaO\u2082 \u2192 abnormal retinal vessels \u2192 blindness\n- **BPD**: chronic lung disease in premature infants\n- **Vasoconstriction**: may worsen ischemia in MI/stroke\n\n**Population-Specific SpO\u2082 Targets:**\n- Most patients: 88-94% (not 100%)\n- Premature infants: 90-95% (balance ROP vs hypoxia)\n- CO poisoning: 100%\n\n**Bottom line**: 100% oxygen is NOT harmless. Use the minimum FiO\u2082 needed."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key concepts:\n\n**Absorption Atelectasis:**\n- Nitrogen washout from high FiO\u2082\n- Oxygen rapidly absorbed \u2192 alveolar collapse\n- Solution: REDUCE FiO\u2082 (not increase) + add PEEP\n\n**Target SpO\u2082:**\n- 88-94% is adequate for most patients\n- 100% provides no additional benefit but increases complications\n\n**Oxygen Harms:**\n- Absorption atelectasis (immediate)\n- Oxygen toxicity (days of exposure)\n- ROP in premature infants\n- Vasoconstriction"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Review the critical concepts:\n\n**Absorption Atelectasis:**\n- Caused BY high FiO\u2082 (not treated with more oxygen)\n- Mechanism: nitrogen washout \u2192 rapid O\u2082 absorption \u2192 collapse\n- Treatment: REDUCE FiO\u2082 + add PEEP\n\n**Key Principle:**\n- More oxygen is NOT always better\n- Use MINIMUM FiO\u2082 to achieve adequate oxygenation\n- Target SpO\u2082 88-94% (not 100%)\n\n**ROP in Premature Infants:**\n- High PaO\u2082 \u2192 abnormal retinal vessel development\n- Can cause blindness\n- Target SpO\u2082 90-95% in premature infants\n- Premature infants are MORE vulnerable to oxygen harm, not less"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-116", "title": "Pediatric HIV Recognition", "domain": "pulmonology", "difficulty": "advanced", "tags": ["pediatric HIV", "vertical transmission", "MTCT prevention", "HIV DNA PCR", "PCP pneumonia", "antiretroviral therapy", "opportunistic infections", "TMP-SMX"], "estimatedMinutes": 10, "source": ["NBME", "Amboss"], "stem": "A 6-month-old male is brought to the emergency department with respiratory distress and poor weight gain. His mother, who recently immigrated from sub-Saharan Africa, reveals she is HIV-positive but did not receive prenatal care or antiretroviral therapy during pregnancy. The infant was born via vaginal delivery and has been breastfeeding.\n\nPhysical Examination:\n- General: Thin, wasted infant in moderate respiratory distress\n- Vitals: T 38.2\u00b0C, RR 55, HR 160, SpO2 88% on room air\n- HEENT: Oral thrush (white plaques on buccal mucosa)\n- Lymph: Generalized lymphadenopathy\n- Abdomen: Hepatosplenomegaly\n- Skin: Seborrheic dermatitis on scalp\n- Growth: Weight <3rd percentile (was 25th at birth)\n\nCXR: Diffuse bilateral interstitial infiltrates with a 'ground glass' appearance.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-month-old infant born to an HIV-positive mother who did NOT receive antiretroviral prophylaxis presents with classic features of pediatric HIV infection: **failure to thrive**, **opportunistic infections** (oral thrush, likely PCP pneumonia given the CXR), **generalized lymphadenopathy**, and **hepatosplenomegaly**.\n\nWithout prevention measures, the vertical transmission rate is approximately **25%**.", "question": "What clinical finding is MOST specific for suggesting HIV infection in this infant rather than other immunodeficiencies?", "choices": [{"id": "node-1-choice-a", "text": "Pneumocystis jirovecii pneumonia (PCP) presenting at 3-6 months of age", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **PCP at 3-6 months of age is highly suggestive of HIV** in infants. This timing is characteristic because: (1) Maternal antibodies (including anti-PCP) wane around 3-4 months, (2) The infant's own immune system is compromised by HIV, (3) PCP is the **most common AIDS-defining illness in HIV-infected infants**. In contrast, SCID presents earlier (1-3 months) and X-linked agammaglobulinemia presents later (after 6 months when maternal IgG wanes).", "consequence": "You recognize the hallmark timing of PCP in pediatric HIV.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Oral thrush (candidiasis)", "isOptimal": false, "isAcceptable": true, "feedback": "Oral thrush is common in HIV but is **not specific**. Healthy infants can develop oral thrush, especially if breastfeeding or after antibiotic use. However, **persistent or recurrent thrush beyond the neonatal period** (after 6-12 months) or thrush that extends to the esophagus is more concerning for immunodeficiency. This infant has thrush, which supports immunodeficiency, but PCP is more specific for HIV.", "consequence": "Thrush suggests immunodeficiency but is not specific for HIV.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Failure to thrive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Failure to thrive (FTT) has many causes** - nutritional deficiency, malabsorption, chronic infection, metabolic disease, neglect, and immunodeficiency. While FTT is common in pediatric HIV, it is not specific. The combination of FTT + opportunistic infections + known HIV exposure is what raises suspicion.", "consequence": "FTT is nonspecific and has many causes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Lymphadenopathy and hepatosplenomegaly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Lymphadenopathy and hepatosplenomegaly are seen in many conditions: viral infections (EBV, CMV), storage diseases, malignancies, and other immunodeficiencies. In HIV, **persistent generalized lymphadenopathy (PGL)** is common but not diagnostic. These findings support immune activation but are not specific for HIV.", "consequence": "Lymphadenopathy/hepatosplenomegaly are nonspecific.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Seborrheic dermatitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Seborrheic dermatitis** is extremely common in healthy infants ('cradle cap'). While it can be more severe or persistent in HIV, it is not a specific finding. In adults, severe seborrheic dermatitis can be an early sign of HIV, but in infants this finding alone has limited diagnostic value.", "consequence": "Seborrheic dermatitis is common in healthy infants.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pediatric HIV Presentation**: (1) **Opportunistic infections** - PCP (3-6 months), candidiasis, CMV, MAC, (2) **Failure to thrive** - often the first sign, (3) **Lymphoid interstitial pneumonia (LIP)** - chronic lung disease unique to pediatric HIV, (4) **Developmental delay/encephalopathy** - HIV crosses BBB, (5) **Recurrent bacterial infections** - despite B cells being present (unlike XLA), (6) **Parotid gland enlargement** - characteristic of pediatric HIV."}, "node-2": {"id": "node-2", "type": "decision", "content": "You strongly suspect HIV infection. The infant needs confirmatory testing.\n\n**Key consideration**: This infant is **6 months old** (< 18 months).", "question": "What is the CORRECT diagnostic test for HIV in infants under 18 months of age?", "choices": [{"id": "node-2-choice-a", "text": "HIV DNA PCR (nucleic acid test)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **HIV DNA PCR** (also called HIV NAT - Nucleic Acid Test) detects viral genetic material and is the **only reliable test for infants <18 months**. Why? Maternal **IgG antibodies cross the placenta** and can persist in the infant's circulation for up to 18 months, causing **false-positive antibody tests**. DNA PCR directly detects the virus. Testing schedule: **14-21 days, 1-2 months, and 4-6 months**. Two positive PCR tests confirm infection.", "consequence": "You order the correct diagnostic test.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "HIV antibody test (ELISA/Western blot)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibody testing is NOT reliable in infants <18 months** because maternal IgG antibodies cross the placenta and persist. A positive antibody test in an infant only confirms maternal infection (which we already know). A negative test could still mean the infant is infected but hasn't made their own antibodies yet. This is why **DNA PCR** is required.", "consequence": "Antibody tests cause false positives in infants <18 months.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CD4 count", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CD4 count measures **disease severity**, not diagnosis. It tells you how immunocompromised the patient is but does not confirm HIV infection. Additionally, **normal CD4 counts vary by age** - infants have much higher normal CD4 counts than adults (normal infant: 1500-5000 cells/\u00b5L vs. adult: 500-1500). CD4 is used for staging and monitoring, not initial diagnosis.", "consequence": "CD4 count monitors severity, not diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "HIV viral load (RNA PCR)", "isOptimal": false, "isAcceptable": true, "feedback": "Viral load (HIV RNA) can detect infection, but **HIV DNA PCR is preferred** for initial diagnosis in infants. RNA PCR measures actively replicating virus and can have more variability. DNA PCR detects proviral DNA integrated into host cells and is more standardized for infant diagnosis. However, many centers do use RNA PCR, and it is acceptable if DNA PCR is unavailable.", "consequence": "RNA PCR is acceptable but DNA PCR is preferred for infant diagnosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "p24 antigen test", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **p24 antigen test** has lower sensitivity than PCR methods and is no longer recommended as a primary diagnostic test. It may be part of a **4th generation combination assay** (antigen/antibody) used in adults, but in infants, the antibody component causes the same false-positive problem. PCR-based testing is the standard of care.", "consequence": "p24 antigen testing is outdated and less sensitive.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HIV Testing in Infants <18 months**: Use **HIV DNA PCR** at 14-21 days, 1-2 months, and 4-6 months. **Two positive tests** confirm infection. A **negative test at \u22654 months** in a non-breastfed infant (or \u22654-6 weeks after weaning) essentially rules out infection. Antibody testing becomes reliable **after 18 months** when maternal antibodies have cleared."}, "node-3": {"id": "node-3", "type": "decision", "content": "The HIV DNA PCR returns **positive**. A repeat confirmatory PCR is also positive, confirming HIV infection.\n\nYou review what should have been done to prevent transmission. The mother did not receive any prenatal care.", "question": "Which intervention is MOST effective at preventing mother-to-child transmission (MTCT) of HIV?", "choices": [{"id": "node-3-choice-a", "text": "Maternal antiretroviral therapy (ART) throughout pregnancy with goal of undetectable viral load", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Maternal ART** is the cornerstone of prevention. When maternal viral load is **undetectable (<50 copies/mL)** at delivery, transmission risk is **<1%**. Without any intervention, transmission is ~25%. ART should begin as early as possible in pregnancy (ideally pre-conception) and continue lifelong. This is more effective than any single intervention like C-section or avoiding breastfeeding.", "consequence": "You identify the most effective prevention strategy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Elective cesarean section at 38 weeks", "isOptimal": false, "isAcceptable": true, "feedback": "C-section **reduces transmission** but is most beneficial when viral load is **>1000 copies/mL** at delivery. If maternal viral load is undetectable on ART, vaginal delivery is acceptable and C-section provides minimal additional benefit. Scheduled C-section at 38 weeks (before labor/rupture of membranes) reduces exposure to maternal blood and secretions.", "consequence": "C-section helps but is secondary to ART.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Avoiding breastfeeding (formula feeding)", "isOptimal": false, "isAcceptable": true, "feedback": "Breastfeeding accounts for **10-15% of MTCT** in the absence of ART. In resource-rich settings, **formula feeding is recommended** for HIV-positive mothers. However, in resource-limited settings where formula feeding carries risks (contaminated water, malnutrition), **exclusive breastfeeding with maternal ART** may be safer than mixed feeding. This infant was breastfed without ART - a high-risk situation.", "consequence": "Avoiding breastfeeding helps but is secondary to ART.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Infant zidovudine (AZT) prophylaxis for 6 weeks after birth", "isOptimal": false, "isAcceptable": true, "feedback": "Infant AZT prophylaxis is **part of the prevention strategy** but alone is insufficient. It reduces transmission by ~50% when given alone, but is most effective as part of a comprehensive approach: maternal ART + infant prophylaxis + appropriate delivery method + feeding guidance. High-risk infants (mother not on ART, detectable viral load) may receive **combination prophylaxis** (AZT + nevirapine + lamivudine).", "consequence": "Infant prophylaxis helps but is part of a larger strategy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Maternal HIV vaccine during pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **There is no HIV vaccine**. Despite decades of research, the high mutation rate of HIV and its ability to evade the immune system have prevented vaccine development. Prevention relies entirely on ART, safe delivery practices, and avoiding breastfeeding (in resource-rich settings).", "consequence": "No HIV vaccine exists.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Prevention of MTCT**: With **comprehensive intervention** (maternal ART achieving undetectable viral load + C-section if VL >1000 + infant AZT prophylaxis + formula feeding), transmission rate is **<1%**. Without intervention: **~25%** (15% in utero/delivery, 10% breastfeeding). **Timing of transmission**: 25-40% in utero, 60-75% during labor/delivery, remainder via breastfeeding."}, "node-4": {"id": "node-4", "type": "decision", "content": "HIV infection is confirmed. The infant currently has respiratory distress with likely **Pneumocystis jirovecii pneumonia (PCP)**.\n\n**Labs**: CD4 count 400 cells/\u00b5L (severely low for age - normal 6mo infant: 1800-4000), CD4% 15%\n**HIV viral load**: 500,000 copies/mL", "question": "What is the IMMEDIATE management priority for this infant?", "choices": [{"id": "node-4-choice-a", "text": "High-dose TMP-SMX for PCP treatment, then initiate ART once stable", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **immediate priority is treating the life-threatening PCP**. High-dose **TMP-SMX (15-20 mg/kg/day of TMP component)** IV for 21 days is first-line treatment. Add **corticosteroids** if hypoxemic (PaO2 <70 or SpO2 <92% on room air) - steroids reduce inflammation and mortality. **ART is initiated 2-8 weeks after starting PCP treatment** to avoid immune reconstitution inflammatory syndrome (IRIS). Treating the OI first stabilizes the patient.", "consequence": "You treat the acute infection before initiating ART.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Start antiretroviral therapy immediately - treating HIV will resolve the PCP", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Starting ART during an acute opportunistic infection can trigger **Immune Reconstitution Inflammatory Syndrome (IRIS)** - a paradoxical worsening as the recovering immune system mounts an exaggerated response to the infection. For PCP, ART should be **delayed 2-8 weeks** until the acute infection is controlled. The exception is **cryptococcal meningitis**, where ART is delayed even longer (4-6 weeks).", "consequence": "Immediate ART during OI risks IRIS.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Pentamidine IV as first-line PCP treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **TMP-SMX is first-line** for PCP treatment, not pentamidine. Pentamidine is reserved for patients who cannot tolerate TMP-SMX (severe allergy, bone marrow suppression). Pentamidine has significant toxicities including hypoglycemia, nephrotoxicity, and pancreatitis. Atovaquone is another alternative for mild-moderate PCP in TMP-SMX-allergic patients.", "consequence": "TMP-SMX is first-line; pentamidine is second-line.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Fluconazole for the oral thrush - the respiratory symptoms are from Candida", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **CXR findings (bilateral ground glass infiltrates)** are classic for **PCP, not Candida pneumonia**. Candida rarely causes pneumonia; oral/esophageal candidiasis does not mean pulmonary involvement. The thrush should be treated (fluconazole or nystatin), but the respiratory distress is from PCP and requires TMP-SMX.", "consequence": "The CXR is classic for PCP, not Candida.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Observation with supportive care only - PCP is usually self-limited in infants", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PCP has high mortality without treatment**, especially in infants with HIV. Untreated PCP mortality approaches 100% in immunocompromised patients. This is a medical emergency requiring prompt treatment with TMP-SMX and possibly corticosteroids. PCP is not self-limited.", "consequence": "Untreated PCP is fatal.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**PCP Treatment**: (1) **TMP-SMX 15-20 mg/kg/day TMP component** IV divided q6-8h \u00d7 21 days, (2) **Corticosteroids** (prednisone 40mg BID \u00d7 5d, then taper) if PaO2 <70 or A-a gradient >35, (3) **ART delayed 2-8 weeks** to avoid IRIS. **PCP Prophylaxis**: All HIV-exposed infants receive TMP-SMX starting at **4-6 weeks** until HIV infection is ruled out. CD4-based prophylaxis thresholds vary by age."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant improves with TMP-SMX and corticosteroids. Two weeks later, you are ready to initiate antiretroviral therapy (ART).\n\n**Follow-up labs**: CD4 450 cells/\u00b5L (still low), HIV viral load 480,000 copies/mL", "question": "What is the recommended ART regimen AND treatment goal for this HIV-infected infant?", "choices": [{"id": "node-5-choice-a", "text": "2 NRTIs + integrase inhibitor (e.g., abacavir/lamivudine + raltegravir); goal is undetectable viral load (<50 copies/mL)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Current guidelines recommend **2 NRTIs (nucleoside reverse transcriptase inhibitors) + integrase inhibitor** as first-line for infants. Common regimen: **abacavir/lamivudine + raltegravir** (or dolutegravir in older children). The goal is **undetectable viral load (<50 copies/mL)** - same as adults. Early, aggressive treatment is critical because: (1) Infants have very high viral loads, (2) Rapid disease progression without treatment, (3) Some data suggest early treatment may reduce the viral reservoir.", "consequence": "You initiate appropriate first-line ART.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Single NRTI (zidovudine monotherapy); goal is to slow disease progression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Monotherapy is never appropriate** for HIV treatment - it rapidly leads to drug resistance. The only role for single-agent AZT is **prophylaxis** in exposed infants, not treatment of confirmed infection. All HIV patients require **combination ART** (at least 3 drugs from at least 2 classes) to achieve viral suppression and prevent resistance.", "consequence": "Monotherapy leads to resistance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Start ART only when CD4 count drops below 500 cells/\u00b5L", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This reflects **outdated guidelines**. Current recommendations are to start **ART immediately upon diagnosis regardless of CD4 count or viral load** - this is called 'test and treat.' For infants, this is especially critical because they have high viral loads and rapid disease progression. Delaying treatment waiting for CD4 decline is harmful.", "consequence": "ART should start immediately, not based on CD4 threshold.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Triple NRTI regimen (AZT/3TC/abacavir); goal is CD4 >200", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Triple NRTI regimens are inferior** to regimens containing an integrase inhibitor, protease inhibitor, or NNRTI. They have lower efficacy at achieving viral suppression. The treatment goal is **undetectable viral load (<50 copies/mL)**, not a CD4 threshold. CD4 is monitored but viral suppression is the primary goal.", "consequence": "Triple NRTI is inferior; goal is undetectable VL.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Defer ART until age 2 years when the immune system is more mature", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Early ART is critical in infants**. Without treatment, ~50% of HIV-infected infants die by age 2. Early treatment reduces mortality, preserves immune function, and may reduce the viral reservoir. There is no benefit to waiting - the standard is 'treat all' regardless of age.", "consequence": "Delaying ART in infants increases mortality.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Pediatric ART Principles**: (1) **Start immediately** upon confirmed diagnosis ('test and treat'), (2) **First-line**: 2 NRTIs + integrase inhibitor (preferred) or PI, (3) **Goal**: Undetectable viral load (<50 copies/mL), (4) **Monitoring**: Viral load at baseline, 2-4 weeks, then every 3-4 months; CD4 every 3-6 months, (5) **Adherence is critical** - missing doses leads to resistance. **OI Prophylaxis**: Continue TMP-SMX for PCP until CD4 recovers above age-appropriate thresholds."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed this case of perinatally-acquired HIV infection.\n\n**Key Learning Points:**\n\n1. **Recognition**: Infant of HIV+ mother + failure to thrive + opportunistic infections (PCP at 3-6 months is classic) + lymphadenopathy/hepatosplenomegaly.\n\n2. **Diagnosis**: Use **HIV DNA PCR** for infants <18 months (antibody testing causes false positives due to maternal antibodies). Test at 14-21 days, 1-2 months, and 4-6 months.\n\n3. **Prevention (MTCT)**: Maternal ART (undetectable viral load) + C-section if VL >1000 + infant AZT prophylaxis + formula feeding \u2192 <1% transmission. Without intervention: 25%.\n\n4. **Acute Management**: Treat opportunistic infections FIRST (TMP-SMX for PCP \u00b1 steroids). Delay ART 2-8 weeks to avoid IRIS.\n\n5. **ART**: 2 NRTIs + integrase inhibitor. Goal is undetectable viral load (<50). Start immediately upon diagnosis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review these pediatric HIV essentials:\n\n**Testing**: Use **HIV DNA PCR** for infants <18 months - antibody tests cause false positives from maternal IgG.\n\n**PCP**: First AIDS-defining illness in infants. Treat with **TMP-SMX + corticosteroids** if hypoxemic. ART is delayed 2-8 weeks to avoid IRIS.\n\n**Prevention**: Maternal ART achieving undetectable viral load is MOST effective. Combined approach (ART + C-section if needed + infant prophylaxis + formula) achieves <1% transmission.\n\n**Treatment**: Start ART immediately upon diagnosis. Use combination therapy (2 NRTIs + integrase inhibitor). Goal is undetectable viral load."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical pediatric HIV points:\n\n1. **Testing**: HIV DNA PCR for infants <18 months - NEVER antibody testing (false positives from maternal IgG).\n\n2. **No HIV vaccine exists** - prevention relies on maternal ART, safe delivery, infant prophylaxis.\n\n3. **PCP is life-threatening** - requires TMP-SMX treatment. Untreated mortality approaches 100%.\n\n4. **Monotherapy = resistance** - always use combination ART (\u22653 drugs from \u22652 classes).\n\n5. **Never delay ART in infants** - 50% mortality by age 2 without treatment. 'Test and treat' is the standard."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-143", "title": "Cystic Fibrosis", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["meconium ileus", "sweat chloride >60", "Pseudomonas", "steatorrhea", "cystic fibrosis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-week-old male presents with failure to pass meconium and poor weight gain for the past since birth.\n\nPer the mother, he did not pass meconium until 72 hours after birth and required an enema. He has greasy, foul-smelling stools despite good feeding. He has not regained his birth weight.\n\nReview of systems is positive for recurrent coughing and nasal congestion and negative for fever or respiratory distress.\n\nMedical history is notable for He was born full-term. Newborn screening was abnormal with elevated immunoreactive trypsinogen. No known family history of cystic fibrosis.\n\nPhysical Examination:\n- General: thin infant with poor weight gain, salty-tasting skin on kiss.\n- Vitals: febrile.\n- Respiratory: occasional crackles, no wheezing.\n- Abdomen: mild distension, palpable stool in colon.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 3-week-old has meconium ileus history, failure to thrive, greasy stools, and salty-tasting skin. Newborn screen showed elevated immunoreactive trypsinogen (IRT).", "question": "What is the GOLD STANDARD diagnostic test for Cystic Fibrosis?", "choices": [{"id": "node-1-choice-a", "text": "Sweat chloride test - diagnostic if >60 mEq/L", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **sweat chloride test** (pilocarpine iontophoresis) is the GOLD STANDARD for CF diagnosis. Values: **>60 mEq/L = diagnostic**, 30-59 mEq/L = intermediate (needs repeat/genetic testing), <30 mEq/L = normal. CF is caused by defective CFTR chloride channel leading to thick, dehydrated secretions.", "consequence": "Appropriate diagnostic test ordered.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "CFTR genetic testing alone", "isOptimal": false, "isAcceptable": true, "feedback": "Genetic testing identifies **specific CFTR mutations** and is important for treatment decisions (CFTR modulators are mutation-specific). However, the **sweat chloride test remains the gold standard** for diagnosis. >2000 CFTR mutations exist, so genetic testing may miss rare variants.", "consequence": "Useful but sweat test is gold standard.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Chest CT scan", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT may show **bronchiectasis** (irreversible airway dilation from chronic infection) but this is a consequence of CF, not a diagnostic test. The sweat chloride test is needed for diagnosis.", "consequence": "Imaging cannot diagnose CF.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Immunoreactive trypsinogen (IRT) alone is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IRT is a **screening test** (elevated in CF due to pancreatic duct obstruction) but has high false-positive rate. Positive newborn screen requires **confirmatory sweat chloride testing**. Never diagnose CF on IRT alone.", "consequence": "Screening test requires confirmation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Fecal elastase level", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Fecal elastase measures **pancreatic exocrine function** (low in pancreatic insufficiency) but is not diagnostic of CF. Many CF patients have pancreatic insufficiency, but the diagnosis requires sweat chloride testing.", "consequence": "Measures pancreatic function, not diagnostic.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Sweat chloride** is the GOLD STANDARD: >60 mEq/L = diagnostic, 30-59 = intermediate. **Meconium ileus** is virtually pathognomonic for CF (occurs in ~15-20% of CF newborns). CF is the **most common lethal genetic disease in Caucasians** (autosomal recessive)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Sweat chloride is 78 mEq/L - diagnostic for CF. Genetic testing shows homozygous F508del mutation (most common, ~70% of CF alleles).", "question": "What is the PRIMARY cause of morbidity and mortality in CF patients?", "choices": [{"id": "node-2-choice-a", "text": "Progressive pulmonary disease from chronic infection and bronchiectasis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Pulmonary complications** account for >90% of CF-related mortality. Thick mucus \u2192 impaired mucociliary clearance \u2192 chronic infection \u2192 bronchiectasis \u2192 respiratory failure. Common pathogens progress: **S. aureus** (early) \u2192 **P. aeruginosa** (later, mucoid strains) \u2192 **Burkholderia cepacia** (poor prognosis).", "consequence": "You understand the primary disease burden.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Pancreatic insufficiency and malnutrition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **pancreatic insufficiency** (85-90% of CF patients) causes significant morbidity (steatorrhea, fat-soluble vitamin deficiency, failure to thrive), it is **treatable with pancreatic enzyme replacement**. Pulmonary disease is the main killer.", "consequence": "Significant but not primary mortality cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CF-related diabetes mellitus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CFRD** (CF-related diabetes) affects ~20% of adolescents and ~50% of adults with CF due to pancreatic islet destruction. While important to screen for and manage, pulmonary disease remains the primary cause of mortality.", "consequence": "Important complication but not primary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Liver cirrhosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CF-related liver disease** (biliary cirrhosis) affects ~5-10% of patients due to thick bile. While some patients need liver transplant, pulmonary disease is the predominant cause of mortality.", "consequence": "Less common cause of mortality.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Meconium ileus complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While meconium ileus can be life-threatening in newborns (may need surgery), it's a presenting feature, not an ongoing mortality cause. **Chronic pulmonary decline** is what limits lifespan.", "consequence": "Neonatal issue, not long-term mortality.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pulmonary disease = #1 cause of CF mortality**. Pathogen progression: **S. aureus \u2192 H. influenzae \u2192 P. aeruginosa (mucoid)** \u2192 Burkholderia cepacia (worst prognosis). Chronic Pseudomonas colonization is nearly universal by adulthood."}, "node-3": {"id": "node-3", "type": "decision", "content": "You confirm CF and need to initiate comprehensive management. The infant has steatorrhea with poor weight gain despite good oral intake.", "question": "What is the CORNERSTONE of GI management for CF-related pancreatic insufficiency?", "choices": [{"id": "node-3-choice-a", "text": "Pancreatic enzyme replacement therapy (PERT) with every meal/snack", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **PERT (pancreatic enzyme replacement therapy)** is essential for the 85-90% of CF patients with pancreatic insufficiency. Enzymes (lipase, protease, amylase) are given **with every meal and snack** to aid fat/protein digestion. Also need **fat-soluble vitamin supplementation** (A, D, E, K) due to malabsorption.", "consequence": "Appropriate GI management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Low-fat diet to reduce steatorrhea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - actually the OPPOSITE! CF patients need a **HIGH-CALORIE, HIGH-FAT diet** (120-150% of normal caloric needs) because they have increased energy expenditure and malabsorption. With proper enzyme replacement, they can and should eat a normal/high-fat diet.", "consequence": "Low-fat diet worsens malnutrition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Proton pump inhibitors alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PPIs may be used **adjunctively** (improve enzyme efficacy by reducing gastric acid), but **pancreatic enzyme replacement is the mainstay**. PPIs alone cannot replace missing digestive enzymes.", "consequence": "Adjunctive therapy only.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Elemental formula only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Elemental formulas (pre-digested) may be used in severe cases, but **most CF patients can eat regular diet with enzyme supplementation**. Avoiding normal foods limits caloric intake and quality of life.", "consequence": "Overly restrictive approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Observation - pancreatic function may improve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pancreatic insufficiency in CF is **progressive and irreversible** - the pancreas is destroyed by thick secretions in utero and early life. Delayed enzyme replacement leads to failure to thrive and developmental consequences.", "consequence": "Pancreatic function won't improve.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**CF nutrition**: HIGH-calorie, HIGH-fat diet (120-150% normal needs) + **PERT with every meal** + **fat-soluble vitamins (ADEK)**. Target: BMI >50th percentile correlates with better lung function. Salt supplementation may be needed (excessive sweat losses)."}, "node-4": {"id": "node-4", "type": "decision", "content": "At age 5, the child develops productive cough. Sputum culture grows mucoid Pseudomonas aeruginosa for the first time.", "question": "What is the RECOMMENDED approach to FIRST-TIME Pseudomonas aeruginosa isolation in CF?", "choices": [{"id": "node-4-choice-a", "text": "Aggressive eradication therapy with inhaled tobramycin \u00b1 oral ciprofloxacin", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Early aggressive eradication** is recommended for first-time P. aeruginosa isolation. Typical regimen: **inhaled tobramycin for 28 days** \u00b1 **oral ciprofloxacin**. Goal is to prevent chronic colonization. Once mucoid Pseudomonas becomes chronic, it's nearly impossible to eradicate and accelerates lung decline.", "consequence": "Appropriate eradication attempt initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Wait for symptoms before treating", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Waiting allows chronic colonization** to establish. First-time isolation offers the best chance for eradication. Once chronic, Pseudomonas forms biofilms and becomes resistant to eradication attempts.", "consequence": "Missed window for eradication.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "IV antibiotics for 2 weeks", "isOptimal": false, "isAcceptable": true, "feedback": "IV antibiotics may be used but **inhaled tobramycin is first-line** for eradication attempts as it achieves high airway concentrations with minimal systemic toxicity. IV therapy is reserved for pulmonary exacerbations with clinical deterioration.", "consequence": "Acceptable but inhaled preferred for eradication.", "nextNodeId": "node-5"}, {"id": "node-4-choice-d", "text": "Oral amoxicillin for 10 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **P. aeruginosa is intrinsically resistant to amoxicillin**. Effective anti-pseudomonal agents include: aminoglycosides (tobramycin), fluoroquinolones (ciprofloxacin), anti-pseudomonal beta-lactams (piperacillin-tazobactam, ceftazidime).", "consequence": "Ineffective antibiotic choice.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Chronic suppressive inhaled tobramycin immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Close, but **chronic suppressive therapy** (alternating month inhaled tobramycin) is for patients with **established chronic Pseudomonas infection** who failed eradication. First-time isolation should attempt **eradication** before accepting chronic colonization.", "consequence": "Eradication should be attempted first.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**First Pseudomonas isolation = eradication window**. Use **inhaled tobramycin 28 days \u00b1 oral cipro**. If eradication fails and becomes chronic, use **alternating month inhaled tobramycin** (TOBI) for suppression. **Mucoid** Pseudomonas = worse prognosis."}, "node-5": {"id": "node-5", "type": "decision", "content": "Genetic testing confirmed F508del homozygous. You discuss the revolutionary new CFTR modulator therapy with the family.", "question": "What is the MECHANISM of CFTR modulators like Trikafta (elexacaftor/tezacaftor/ivacaftor)?", "choices": [{"id": "node-5-choice-a", "text": "Correctors + Potentiator: Fix CFTR protein folding AND increase channel opening", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Trikafta** combines: (1) **Correctors** (elexacaftor, tezacaftor) - fix the misfolded F508del protein so it reaches the cell surface, and (2) **Potentiator** (ivacaftor) - increases opening time of CFTR channels at the surface. This combination has revolutionized CF care with dramatic FEV1 improvements and reduced exacerbations.", "consequence": "You understand the mechanism of these game-changing drugs.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Gene therapy to replace defective CFTR gene", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Gene therapy for CF is still in research. Current **CFTR modulators work on the existing mutant protein** - they don't replace the gene. They help the defective protein function better.", "consequence": "Not gene therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Mucolytic that thins airway secretions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dornase alfa (Pulmozyme)** is the mucolytic used in CF (cleaves DNA in mucus). CFTR modulators work directly on the **CFTR protein** to improve chloride transport, addressing the root cause rather than symptoms.", "consequence": "Different drug class.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Anti-inflammatory to reduce airway inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Azithromycin** is used for anti-inflammatory effects in CF (separate from antibiotic action). CFTR modulators directly target the defective protein, not inflammation.", "consequence": "Different mechanism entirely.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Bronchodilator to open airways", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bronchodilators (albuterol) are used in CF, CFTR modulators work at the **molecular level on the defective chloride channel**, not on airway smooth muscle.", "consequence": "Wrong mechanism.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CFTR modulators revolutionized CF**: Trikafta (FDA 2019) = 2 correctors + 1 potentiator, effective for ~90% of CF patients (F508del and many other mutations). Improves FEV1 by ~10-15%, reduces exacerbations ~60%, and dramatically improves quality of life and survival."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly diagnosed CF with sweat chloride testing, identified pulmonary disease as the primary mortality cause, initiated PERT for pancreatic insufficiency, attempted early Pseudomonas eradication, and understood CFTR modulator mechanisms. Key teaching points: (1) Sweat chloride >60 = diagnostic, (2) Pulmonary disease = #1 mortality, (3) High-calorie diet + PERT + ADEK vitamins, (4) Early Pseudomonas eradication attempt, (5) CFTR modulators (Trikafta) have transformed prognosis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key CF concepts: (1) Sweat chloride >60 is gold standard (IRT is screening only), (2) Pulmonary complications cause >90% mortality, (3) High-calorie/high-fat diet with PERT, (4) Eradicate first Pseudomonas isolation, (5) CFTR modulators fix protein folding and function."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key CF principles: (1) Do NOT restrict fat - CF needs HIGH-calorie diet with enzymes, (2) Do NOT wait to treat first Pseudomonas - attempt eradication immediately, (3) Pancreatic function will NOT improve - start enzymes early, (4) CFTR modulators have transformed CF prognosis."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-162", "title": "RSV Prophylaxis (Palivizumab)", "domain": "pulmonology", "difficulty": "intermediate", "tags": ["RSV prophylaxis", "palivizumab", "Synagis", "bronchopulmonary dysplasia", "prematurity", "passive immunization", "monoclonal antibody"], "estimatedMinutes": 5, "source": ["Amboss"], "stem": "A 2-month-old former premature infant (born at 28 weeks gestation) is being seen for follow-up in the pediatric pulmonology clinic. He was discharged from the NICU 3 weeks ago after a 10-week hospitalization complicated by respiratory distress syndrome requiring mechanical ventilation for 4 weeks and supplemental oxygen for an additional 6 weeks.\n\nHe was diagnosed with bronchopulmonary dysplasia (BPD) and was discharged on low-flow oxygen (0.25 L/min) which he still requires. It is now October, and RSV season is approaching.\n\nThe mother asks about ways to protect her baby from getting sick this winter.\n\nPhysical Examination:\n- General: Alert infant, comfortable on low-flow nasal cannula\n- Vitals: RR 40, HR 150, SpO2 95% on 0.25 L O2\n- Lungs: Mild subcostal retractions, scattered crackles bilaterally\n- Cardiac: Regular rhythm, no murmur\n- Growth: Weight at 10th percentile for corrected age", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This former 28-week premature infant has **bronchopulmonary dysplasia (BPD)** and remains on supplemental oxygen at 2 months of age. RSV season (November-March in most regions) is approaching.\n\n**Risk factors for severe RSV disease**:\n- Prematurity (<29 weeks)\n- Bronchopulmonary dysplasia\n- Ongoing need for supplemental oxygen\n- Age <12 months at start of RSV season", "question": "What is the MOST appropriate intervention to prevent severe RSV infection in this infant?", "choices": [{"id": "node-1-choice-a", "text": "Palivizumab (Synagis) immunoprophylaxis monthly during RSV season", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Palivizumab** is a monoclonal antibody against RSV F protein that provides passive immunization. It is indicated for infants with **BPD requiring oxygen within 12 months of RSV season** and **premature infants <29 weeks gestation**. Given monthly (15 mg/kg IM) during RSV season (typically November-March, up to 5 doses). This infant meets multiple criteria: prematurity <29 weeks AND BPD on oxygen.", "consequence": "Palivizumab prophylaxis initiated.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "RSV vaccine for the infant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no RSV vaccine approved for infants**. RSV vaccines are being developed but are not yet available for pediatric use. Palivizumab provides **passive immunity** (preformed antibodies), not active vaccination. Maternal RSV vaccination during pregnancy is a newer strategy that can provide some protection, but this infant has already been born.", "consequence": "No infant RSV vaccine exists.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Strict isolation at home; no prophylaxis needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While infection control measures (hand hygiene, avoiding sick contacts, limiting visitors) are important, they are **not sufficient** for high-risk infants. This baby has multiple risk factors (extreme prematurity, BPD, oxygen dependence) that make him eligible for palivizumab. Prophylaxis significantly reduces RSV hospitalization rates in high-risk infants.", "consequence": "Isolation alone insufficient for this high-risk infant.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Ribavirin prophylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ribavirin** is an antiviral that has been used for **treatment** of severe RSV infection (though its use is controversial and limited). It is NOT used for **prophylaxis**. Additionally, ribavirin is teratogenic and requires special handling. Palivizumab is the appropriate prophylactic agent.", "consequence": "Ribavirin is for treatment, not prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "No intervention needed - RSV is mild in most infants", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While RSV causes mild cold symptoms in healthy children, it can cause **severe bronchiolitis and respiratory failure** in high-risk infants. Premature infants with BPD have the highest risk of RSV hospitalization, ICU admission, and mechanical ventilation. Prophylaxis is strongly recommended for this population.", "consequence": "High-risk infant needs prophylaxis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Palivizumab indications (AAP 2024)**: (1) Infants <12 months with **BPD requiring O2/medical therapy within 6 months** of RSV season; (2) **<29 weeks gestation** born within 12 months of RSV season; (3) **Hemodynamically significant CHD** in first year; (4) Certain immunocompromised conditions or pulmonary abnormalities."}, "node-2": {"id": "node-2", "type": "decision", "content": "You recommend palivizumab prophylaxis. The mother asks about the dosing schedule and duration of protection.\n\n**Current date**: October 15\n**RSV season in your region**: November through March", "question": "What is the CORRECT dosing regimen for palivizumab?", "choices": [{"id": "node-2-choice-a", "text": "15 mg/kg IM monthly for up to 5 doses during RSV season", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Palivizumab dosing**: **15 mg/kg IM** given **monthly** (every 28-30 days) during RSV season. Maximum of **5 doses** per season. First dose should be given **before RSV season begins** (ideally in November). The half-life is ~20 days, so monthly dosing maintains protective antibody levels throughout the season.", "consequence": "Correct dosing regimen prescribed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Single dose at the start of RSV season", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A single dose does **not provide season-long protection**. Palivizumab has a half-life of ~20 days, so antibody levels decline over time. **Monthly dosing** is required to maintain protective levels throughout the 5-month RSV season. Typically 5 doses are given (November through March).", "consequence": "Single dose insufficient for season-long protection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "50 mg/kg IV once, then 25 mg/kg monthly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Palivizumab is given **intramuscularly (IM)**, not IV. The dose is **15 mg/kg** - there is no loading dose. This dose was established in clinical trials (IMpact-RSV) and provides adequate protection when given monthly.", "consequence": "Wrong route and dose.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "15 mg/kg IM weekly during RSV season", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Weekly dosing is **not necessary** and would be excessively frequent (and expensive). The half-life of palivizumab (~20 days) allows for **monthly dosing** while maintaining protective antibody levels. Monthly dosing is the standard of care.", "consequence": "Weekly dosing is excessive; monthly is correct.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Continue year-round prophylaxis until age 2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Palivizumab is given **only during RSV season** (typically November-March), not year-round. RSV circulation is seasonal in temperate climates. Additionally, most infants only receive prophylaxis during their **first RSV season**; second-season prophylaxis is more limited in indications.", "consequence": "Seasonal dosing only; not year-round.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Palivizumab timing**: Start **before RSV season** (first dose in November for most US regions). Give every **28-30 days** for up to **5 doses**. If a dose is delayed, resume monthly dosing - don't restart the series. **Cost**: ~$1,500-3,000 per dose, so appropriate patient selection is important."}, "node-3": {"id": "node-3", "type": "decision", "content": "You prescribe palivizumab 15 mg/kg IM monthly starting in November. The mother has additional questions about other preventive measures and what to watch for.\n\n**Mother's questions**:\n- 'What else can I do to protect my baby?'\n- 'What symptoms should I watch for?'\n- 'If he gets sick anyway, will the palivizumab help treat him?'", "question": "Which statement is MOST accurate regarding palivizumab and RSV prevention?", "choices": [{"id": "node-3-choice-a", "text": "Palivizumab reduces RSV hospitalization but does not treat active infection; supportive care remains the mainstay of RSV treatment", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Palivizumab is prophylactic, not therapeutic**. It reduces RSV hospitalization by ~50-55% in high-risk infants but does NOT treat active RSV infection. If the infant develops RSV despite prophylaxis, treatment is **supportive**: oxygen, hydration, suctioning. There is no specific antiviral treatment proven effective for RSV bronchiolitis. Continue monthly palivizumab even after RSV infection.", "consequence": "Accurate counseling provided.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Palivizumab provides complete protection - no additional precautions needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Palivizumab reduces hospitalization by ~50-55%, but **breakthrough infections still occur**. Additional precautions are essential: hand hygiene, avoiding sick contacts, limiting exposure to crowded places, avoiding tobacco smoke exposure. No prophylaxis provides complete protection.", "consequence": "Palivizumab is not 100% effective; precautions still needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "If the infant gets RSV, give extra doses of palivizumab for treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Palivizumab is **not a treatment** for RSV infection. Extra doses during acute infection have not been shown to improve outcomes. Continue the scheduled monthly prophylaxis, but treatment of acute RSV is **supportive only** (oxygen, hydration, suctioning).", "consequence": "Palivizumab is prophylaxis, not treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Antibiotics should be started at the first sign of respiratory symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RSV is a **viral infection** - antibiotics are not effective and should not be used routinely. Antibiotics are only indicated if there is evidence of **secondary bacterial infection** (uncommon in uncomplicated bronchiolitis). Overuse of antibiotics contributes to resistance.", "consequence": "Antibiotics not indicated for viral bronchiolitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Palivizumab eliminates the need for this infant to receive routine childhood vaccines", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Palivizumab provides **passive immunity against RSV only** - it does not replace routine vaccines. This infant should receive all **standard childhood immunizations** on schedule (adjusted for prematurity as appropriate). Palivizumab does not interfere with vaccine responses.", "consequence": "Palivizumab is RSV-specific; vaccines still needed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**RSV treatment is supportive**: (1) **Oxygen** for hypoxemia; (2) **Hydration** (IV or NG if poor feeding); (3) **Nasal suctioning**. **NOT recommended**: bronchodilators (don't work in bronchiolitis), steroids (no benefit), antibiotics (unless bacterial superinfection), chest physiotherapy. Palivizumab does NOT treat active infection."}, "node-4": {"id": "node-4", "type": "decision", "content": "At the follow-up visit in January, the mother reports her infant developed a runny nose and cough 5 days ago but has been feeding well and has no respiratory distress. He is now symptom-free.\n\nShe asks whether he should still receive his scheduled palivizumab dose today.", "question": "What is the MOST appropriate management regarding palivizumab administration after recent respiratory illness?", "choices": [{"id": "node-4-choice-a", "text": "Give the scheduled palivizumab dose today - minor illness is not a contraindication", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Minor illness is NOT a contraindication** to palivizumab. The infant should receive his scheduled dose. Palivizumab can be given during mild respiratory illness. Even if he had RSV (which cannot be confirmed without testing), **continue prophylaxis** because reinfection can occur and protection wanes without ongoing monthly doses.", "consequence": "Palivizumab administered as scheduled.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Skip this month's dose because he was recently ill", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Skipping doses leaves the infant unprotected. **Minor illness is not a contraindication**. The only reasons to defer palivizumab are: (1) severe acute illness with fever, (2) known hypersensitivity to palivizumab. This infant is now asymptomatic and should receive his dose.", "consequence": "Skipping dose leaves infant unprotected.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Test for RSV first - if positive, discontinue prophylaxis for the season", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Even if the infant had RSV, **prophylaxis should continue** for the remainder of the season. RSV reinfection can occur (immunity is incomplete), and palivizumab provides ongoing protection against subsequent exposures. There is no need to test or discontinue prophylaxis after RSV infection.", "consequence": "Continue prophylaxis regardless of prior RSV infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Give a double dose to make up for potential reduced immunity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The dose should remain **15 mg/kg** - there is no indication for double dosing. Extra doses have not been shown to provide additional benefit and would increase cost. Simply continue the standard monthly regimen.", "consequence": "Standard dose is appropriate; no double dosing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Discontinue palivizumab - he already completed the critical winter months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RSV season extends through **March** in most regions. It is only January - there are 2-3 more months of RSV season remaining. The infant should complete the full course of prophylaxis (up to 5 doses) to maintain protection throughout the season.", "consequence": "RSV season continues through March; complete prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Palivizumab administration tips**: (1) **Minor illness is NOT a contraindication** - give the dose; (2) Continue prophylaxis even after RSV infection; (3) If hospitalized during RSV season, give dose before discharge; (4) Can give with routine vaccines; (5) IM injection in anterolateral thigh (infants) or deltoid (older children)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed **RSV prophylaxis with palivizumab** in a high-risk premature infant with BPD.\n\n**Key learning points**:\n\n**Indications**: Prematurity <29 weeks, BPD requiring O2/therapy, hemodynamically significant CHD, certain immunocompromised states.\n\n**Dosing**: 15 mg/kg IM monthly x 5 doses during RSV season (November-March).\n\n**Key concepts**: Palivizumab is prophylactic (reduces hospitalization ~50%), NOT therapeutic. Treatment of RSV is supportive. Continue prophylaxis even after RSV infection. Minor illness is not a contraindication."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **palivizumab (Synagis) prophylaxis**:\n\n**Indications**: (1) BPD with O2/medical therapy in past 6 months; (2) Prematurity <29 weeks; (3) Hemodynamically significant CHD; (4) Select immunocompromised/pulmonary conditions.\n\n**Dosing**: **15 mg/kg IM monthly** x up to **5 doses** during RSV season.\n\n**Key points**: Prophylactic only (doesn't treat active RSV). Continue after RSV infection. Minor illness is NOT a contraindication. RSV treatment is supportive (O2, hydration, suctioning)."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. This **high-risk infant requires RSV prophylaxis**.\n\n**Risk factors present**:\n- Extreme prematurity (28 weeks)\n- Bronchopulmonary dysplasia\n- Ongoing oxygen requirement\n- First RSV season\n\n**Without prophylaxis**, this infant has very high risk of:\n- RSV hospitalization\n- ICU admission\n- Mechanical ventilation\n- Death (rare but possible)\n\n**Palivizumab reduces hospitalization by ~50-55%** in high-risk infants. Appropriate patient selection and monthly administration during RSV season is essential."}}, "rootNodeId": "node-1"}], "newborn": [{"id": "vignette-lens-peds-007", "title": "Neonatal Hyperbilirubinemia - Phototherapy", "domain": "newborn", "difficulty": "advanced", "tags": ["neonatal jaundice", "hyperbilirubinemia", "phototherapy", "ABO incompatibility", "exchange transfusion", "IVIG", "kernicterus"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 3-day-old male newborn is brought to the emergency department by his parents because they noticed his skin and eyes have turned yellow.\n\nHistory: The parents first noticed yellowing of his face yesterday (day of life 2), and it has spread to his chest and abdomen today. He was born at 39 weeks via uncomplicated vaginal delivery, birth weight 3.4 kg. He is exclusively breastfeeding every 2-3 hours but seems increasingly sleepy at the breast. He has had 3 wet diapers and 2 small seedy stools today.\n\nAssociated symptoms: Mild lethargy and decreased feeding vigor. Parents deny fever, vomiting, or pale/clay-colored stools.\n\nMedical history: Discharged from the hospital at 36 hours of life. Pre-discharge bilirubin was 6.8 mg/dL at 30 hours (low-intermediate risk zone). Mother is blood type O positive, baby is A positive. Coombs test at birth was positive. No known G6PD deficiency in family.\n\nPhysical Examination:\n- General: Jaundiced newborn, yellow discoloration visible to level of umbilicus (Kramer zone 3)\n- Vitals: T 37.0\u00b0C, HR 140, RR 42, Weight 3.1 kg (9% weight loss from birth)\n- HEENT: Icteric sclerae, fontanelle soft and flat\n- Abdomen: Soft, non-distended, liver edge 1 cm below costal margin\n- Neurologic: Slightly decreased tone, arousable with stimulation, weak but present suck reflex", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this 3-day-old newborn with jaundice. Several features in the history are notable:\n- Mother O+, Baby A+ with positive Coombs test\n- Pre-discharge bilirubin was in low-intermediate zone\n- 9% weight loss (normal is <7% by day 3)\n- Decreased feeding and mild lethargy", "question": "What is the most likely etiology of this neonate's hyperbilirubinemia, and what risk factors are present?", "choices": [{"id": "node-1-choice-a", "text": "ABO incompatibility hemolysis - mother O, baby A with positive Coombs, plus dehydration from poor feeding", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This baby has **ABO incompatibility** (mother type O with anti-A/anti-B antibodies, baby type A) confirmed by the **positive Direct Coombs test** (DAT). This causes hemolysis and unconjugated hyperbilirubinemia. Additional risk factors include: **dehydration** (9% weight loss, suboptimal breastfeeding), **prematurity** would add risk (this baby is term). ABO incompatibility is the most common cause of hemolytic disease of the newborn, typically milder than Rh disease.", "consequence": "Correct identification of etiology guides appropriate workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Physiologic jaundice - normal bilirubin rise in the first week", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While physiologic jaundice is common, this case has **pathologic features**: positive Coombs test indicating hemolysis, significant weight loss (dehydration), and neurologic symptoms (lethargy, decreased tone). Physiologic jaundice is a diagnosis of exclusion after ruling out hemolysis, infection, and other causes. The positive DAT confirms this is **not** simple physiologic jaundice.", "consequence": "Missing the hemolytic component may lead to inadequate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Breast milk jaundice - caused by substances in breast milk inhibiting conjugation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Breast milk jaundice** typically presents **after day 5-7** of life and peaks at 2 weeks, caused by beta-glucuronidase in breast milk. This baby's jaundice started on day 2, which is too early for breast milk jaundice. However, **breastfeeding jaundice** (inadequate intake causing dehydration and decreased bilirubin excretion) may be contributing. The positive Coombs test indicates hemolysis is the primary driver.", "consequence": "Misidentifying the cause delays appropriate hemolysis workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Biliary atresia - conjugated hyperbilirubinemia from bile duct obstruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Biliary atresia causes **conjugated (direct) hyperbilirubinemia** with pale/acholic stools and dark urine. This baby has unconjugated hyperbilirubinemia from hemolysis (positive Coombs). Biliary atresia typically presents at 2-8 weeks of age with persistent jaundice. The initial scenario mentions normal stool color, making this unlikely.", "consequence": "Wrong type of hyperbilirubinemia identified.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Sepsis - infection causing hemolysis and jaundice", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sepsis can cause jaundice, this baby is **afebrile** with stable vital signs and no specific signs of infection. The positive Coombs test points to **immune-mediated hemolysis** (ABO incompatibility), not infection-related. If sepsis were suspected, you would see temperature instability, poor perfusion, respiratory distress, or feeding intolerance.", "consequence": "Unnecessary sepsis workup if Coombs-positive hemolysis is obvious.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ABO incompatibility** occurs when mother is type **O** (has anti-A and anti-B IgG antibodies) and baby is type A or B. Unlike Rh disease, it can occur in the **first pregnancy** because anti-A/B antibodies exist naturally. It's usually milder than Rh disease because A and B antigens are expressed on many tissues, diluting the antibody effect."}, "node-2": {"id": "node-2", "type": "decision", "content": "Laboratory results return:\n- Total bilirubin: 18.2 mg/dL\n- Direct bilirubin: 0.8 mg/dL (normal <2 mg/dL)\n- Hemoglobin: 14.5 g/dL\n- Reticulocyte count: 8% (elevated, normal 3-7% in newborns)\n- Blood type: A positive, DAT positive\n- G6PD screen: pending\n\nThe baby is now 72 hours old (3 days).\n\nYou plot the total bilirubin (18.2 mg/dL at 72 hours) on the AAP phototherapy nomogram.", "question": "Based on the AAP guidelines, what is the appropriate management for this bilirubin level at 72 hours of age with hemolysis risk factors?", "choices": [{"id": "node-2-choice-a", "text": "Initiate intensive phototherapy immediately - level is above phototherapy threshold for high-risk infants", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** At 72 hours with a total bilirubin of 18.2 mg/dL in an infant with **hemolysis risk factors** (positive DAT), this is above the phototherapy threshold (~15 mg/dL at 72 hours for high-risk infants). **Intensive phototherapy** should be started immediately using multiple light sources to maximize skin exposure. This baby has neurotoxicity risk factors (hemolysis, lethargy) requiring aggressive treatment. Recheck bilirubin in 4-6 hours to assess response.", "consequence": "Appropriate urgent treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Recheck bilirubin in 12-24 hours - not yet at threshold", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A bilirubin of 18.2 mg/dL at 72 hours in a baby with **hemolysis** (positive Coombs) is **above the phototherapy threshold**. The AAP nomogram uses lower thresholds for infants with risk factors including isoimmune hemolysis, G6PD deficiency, asphyxia, sepsis, acidosis, or albumin <3 g/dL. Waiting 12-24 hours risks further rise toward exchange transfusion threshold.", "consequence": "Dangerous delay in treatment with rising bilirubin.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start standard phototherapy but no need for intensive therapy", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct - phototherapy is indicated. However, given this baby has **neurotoxicity risk factors** (hemolysis causing rapid bilirubin rise, neurologic symptoms like lethargy and hypotonia), **intensive phototherapy** (multiple light sources, maximum skin exposure) is preferred over standard single-source phototherapy. The goal is to reduce bilirubin as quickly as possible.", "consequence": "Treatment started but may be inadequate for rapid bilirubin reduction.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Proceed directly to exchange transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the bilirubin is elevated, it is not yet at the **exchange transfusion threshold** (typically 20-25 mg/dL at 72 hours depending on risk factors, per AAP guidelines). Exchange transfusion is reserved for: bilirubin exceeding exchange threshold, failure of intensive phototherapy, or signs of acute bilirubin encephalopathy. Start intensive phototherapy first and reassess.", "consequence": "Premature invasive procedure with significant risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Increase breastfeeding frequency only - phototherapy not needed yet", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While optimizing feeding is important (this baby is dehydrated), a bilirubin of 18.2 mg/dL with hemolysis **absolutely requires phototherapy**. Feeding optimization is adjunctive therapy, not a substitute for phototherapy when the level exceeds treatment thresholds. Continue breastfeeding (or supplement if needed) during phototherapy.", "consequence": "Inadequate treatment allowing dangerous bilirubin rise.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The AAP phototherapy nomogram has **three curves**: low risk (\u226538 weeks, no risk factors), medium risk (\u226538 weeks with risk factors OR 35-37 6/7 weeks without risk factors), and high risk (35-37 6/7 weeks with risk factors). **Isoimmune hemolysis** (positive DAT) places the infant in a higher risk category requiring treatment at lower bilirubin levels."}, "node-3": {"id": "node-3", "type": "decision", "content": "Intensive phototherapy is initiated using overhead triple lights plus a biliblanket underneath. The baby is placed in a diaper only with eye shields in place.\n\n4 hours later, repeat bilirubin is drawn:\n- Total bilirubin: 19.8 mg/dL (increased from 18.2)\n- Direct bilirubin: 0.9 mg/dL\n\nThe bilirubin has continued to rise despite phototherapy. The baby remains lethargic and has not fed well.\n\nYou review the exchange transfusion threshold for a high-risk infant at 76 hours of age, which is approximately 21 mg/dL.", "question": "What is the most appropriate next step given the rising bilirubin despite intensive phototherapy?", "choices": [{"id": "node-3-choice-a", "text": "Continue intensive phototherapy, give IV fluids for hydration, consider IVIG, prepare for possible exchange transfusion", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is a comprehensive approach for refractory hyperbilirubinemia with hemolysis. **Continue phototherapy** as it may slow the rise. **IV fluids** address dehydration (improving bilirubin excretion and preventing further concentration). **IVIG** (0.5-1 g/kg over 2 hours) can reduce hemolysis in isoimmune disease by blocking Fc receptors and decreasing need for exchange transfusion. **Prepare for exchange transfusion** as the bilirubin is approaching threshold and still rising - exchange should be performed if bilirubin reaches threshold or if acute bilirubin encephalopathy develops.", "consequence": "Multi-pronged approach addresses all components of severe hyperbilirubinemia.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Stop phototherapy as it's not working - it must be causing the bilirubin to rise", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Phototherapy does not cause bilirubin to rise** - the ongoing hemolysis is producing bilirubin faster than phototherapy can convert it. **Never stop phototherapy** in this situation; it is still helping by converting some bilirubin to water-soluble photoisomers. The bilirubin would rise even faster without phototherapy. This baby needs escalation of care, not withdrawal.", "consequence": "Removing the one effective therapy leads to rapid bilirubin rise.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Wait for bilirubin to reach exactly 21 mg/dL before taking any additional action", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While exchange transfusion threshold is approximately 21 mg/dL, you should **proactively prepare** and implement other interventions (IVIG, hydration) rather than passively waiting. The **rate of rise** (1.6 mg/dL in 4 hours = ~0.4 mg/dL/hour) is concerning. At this rate, the baby will reach threshold in approximately 3 hours. Exchange transfusion preparation takes time - waiting until the exact threshold is dangerous.", "consequence": "Passive approach leads to preventable escalation to exchange transfusion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Switch from intensive to standard phototherapy and add sunlight exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never reduce phototherapy intensity** when bilirubin is rising. Sunlight exposure is **not recommended** due to unpredictable UV exposure, temperature regulation issues, and inadequate irradiance compared to medical phototherapy devices. This baby needs **escalation**, not de-escalation of treatment.", "consequence": "Inappropriate reduction in treatment intensity worsens outcome.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Perform immediate exchange transfusion since phototherapy failed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While exchange transfusion may ultimately be needed, the current bilirubin (19.8 mg/dL) is **below the exchange threshold** (~21 mg/dL). Exchange transfusion is an invasive procedure with significant risks (catheter complications, electrolyte disturbances, infection, thrombosis). First, try **IVIG** (which can reduce hemolysis and need for exchange) and **optimize hydration**. Reserve exchange for when threshold is reached or acute bilirubin encephalopathy develops.", "consequence": "Premature invasive procedure with unnecessary risks.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**IVIG** (intravenous immunoglobulin) at 0.5-1 g/kg can reduce the need for exchange transfusion in **isoimmune hemolytic disease** (ABO or Rh incompatibility). It works by blocking Fc receptors on reticuloendothelial cells, reducing antibody-mediated red cell destruction. Give early when bilirubin is rising rapidly despite phototherapy."}, "node-4": {"id": "node-4", "type": "decision", "content": "You administer IVIG 1 g/kg over 2 hours and start IV fluids at 1.5x maintenance. Phototherapy continues with maximum intensity.\n\n6 hours after IVIG administration:\n- Total bilirubin: 20.1 mg/dL (rate of rise has slowed)\n- Baby is more alert and feeding better\n- No signs of acute bilirubin encephalopathy\n\nThe exchange transfusion threshold at 82 hours for high-risk infant is approximately 22 mg/dL.\n\n12 hours later (18 hours after IVIG):\n- Total bilirubin: 17.5 mg/dL (decreasing!)\n- Baby is feeding well, voiding frequently\n- Alert and active with normal tone", "question": "The bilirubin has decreased to 17.5 mg/dL with clinical improvement. What is the appropriate next step?", "choices": [{"id": "node-4-choice-a", "text": "Continue phototherapy until bilirubin drops below threshold, then reassess for rebound", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Continue phototherapy until bilirubin falls to a level where it can be safely discontinued (typically 2-3 mg/dL below the phototherapy threshold for age). After stopping phototherapy, **rebound hyperbilirubinemia** must be monitored - recheck bilirubin 12-24 hours after discontinuation. This is especially important in hemolytic disease where ongoing hemolysis can cause levels to rise again. This baby responded well to IVIG and aggressive management.", "consequence": "Appropriate continued treatment with monitoring for rebound.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Discontinue phototherapy immediately since bilirubin is decreasing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do not stop phototherapy prematurely** just because the level is decreasing. The bilirubin (17.5 mg/dL) is still **above the phototherapy threshold** for a high-risk infant. Continue until the level is safely below threshold (typically 2-3 mg/dL below). Early discontinuation risks rebound, especially in hemolytic disease where red cell destruction continues.", "consequence": "Premature cessation leads to rebound hyperbilirubinemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Give a second dose of IVIG to ensure hemolysis is fully suppressed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Repeat IVIG dosing** is generally not recommended and may increase adverse effects without proven additional benefit. The baby is responding well with decreasing bilirubin. A single IVIG dose is typically sufficient. If bilirubin rises again, other options (continued phototherapy, exchange transfusion if threshold reached) would be considered before repeat IVIG.", "consequence": "Unnecessary medication with potential adverse effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Proceed with exchange transfusion since IVIG was given - the baby must be critically ill", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **bilirubin is decreasing** and the baby is clinically improving - exchange transfusion is not indicated. Exchange is reserved for: bilirubin at or above threshold, failure to respond to phototherapy/IVIG, or signs of acute bilirubin encephalopathy. This baby's improving clinical status and falling bilirubin indicate successful treatment.", "consequence": "Unnecessary invasive procedure in an improving patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Discharge home with instructions to continue sunlight exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The bilirubin (17.5 mg/dL) is **still elevated** and the baby needs continued phototherapy. Discharge is premature. Sunlight exposure is never an appropriate substitute for medical phototherapy. This baby requires inpatient treatment until bilirubin is safely below threshold and stable after phototherapy discontinuation.", "consequence": "Premature discharge with significant rebound risk.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Rebound hyperbilirubinemia** occurs in 5-10% of infants after phototherapy discontinuation, especially in those with **hemolytic disease** or **prematurity**. Always check bilirubin **12-24 hours after stopping phototherapy** before final discharge. Ensure follow-up is arranged within 24-48 hours."}, "node-5": {"id": "node-5", "type": "decision", "content": "Phototherapy is continued for another 24 hours. The bilirubin decreases to 12.8 mg/dL, well below the phototherapy threshold. Phototherapy is discontinued.\n\n18 hours after stopping phototherapy:\n- Total bilirubin: 14.2 mg/dL (mild rebound, still below threshold)\n- Baby is feeding well, gaining weight\n- No jaundice visible below the nipple line\n\nThe family is anxious and asking about discharge and follow-up.", "question": "What are the most important discharge considerations for this infant with ABO hemolytic disease?", "choices": [{"id": "node-5-choice-a", "text": "Schedule 24-48 hour follow-up with bilirubin check, ensure feeding is established, educate about jaundice warning signs", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Comprehensive discharge planning includes: **Early follow-up** (within 24-48 hours) with bilirubin check given the rebound and ongoing hemolysis risk. **Ensure feeding** is well-established - this baby had initial feeding difficulties; confirm 8-12 feeds per day with adequate output (6+ wet diapers, 3-4 stools daily). **Educate parents** about jaundice warning signs: lethargy, poor feeding, high-pitched cry, arching (signs of acute bilirubin encephalopathy) - return immediately if these occur. Check **hemoglobin** at follow-up as hemolysis can continue.", "consequence": "Safe discharge with appropriate monitoring plan.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Routine 2-week newborn visit is sufficient - no special follow-up needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A baby with **hemolytic disease** and recent severe hyperbilirubinemia needs closer follow-up than routine care. **Rebound hyperbilirubinemia** can occur days after stopping phototherapy, and ongoing hemolysis can cause **late anemia** requiring monitoring. The standard 2-week visit is too late for detecting early problems.", "consequence": "Inadequate follow-up misses potential complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Keep the baby hospitalized for 1 week to ensure bilirubin doesn't rise again", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged hospitalization is not necessary when the baby is clinically well with bilirubin safely below threshold and stable. Hospital stays increase infection risk, disrupt bonding, and are costly. The appropriate approach is close **outpatient follow-up** with clear return precautions.", "consequence": "Unnecessary hospitalization with associated risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Recommend switching to formula to prevent breast milk jaundice recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This was **ABO hemolytic disease**, not breast milk jaundice. **Breastfeeding should be encouraged** and continued. Breast milk provides optimal nutrition and immunity. The early feeding difficulties were due to the baby being unwell, not a problem with breast milk. If breastfeeding is going well now, there is no reason to stop.", "consequence": "Inappropriate recommendation to stop breastfeeding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Prescribe home phototherapy blanket for continued treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Home phototherapy is not indicated when bilirubin is **below the phototherapy threshold** and stable. The mild rebound to 14.2 mg/dL is still safely below threshold and being monitored. Continuing unnecessary phototherapy separates the baby from direct contact with parents, interferes with breastfeeding, and is not medically indicated.", "consequence": "Unnecessary treatment when bilirubin is below threshold.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Infants with **hemolytic disease** are at risk for **late hyporegenerative anemia** (nadir at 4-6 weeks) as maternal antibodies persist and continue to destroy red cells. Check hemoglobin at follow-up visits and monitor for pallor, tachycardia, or poor feeding that may indicate anemia requiring transfusion."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of neonatal hyperbilirubinemia with ABO hemolytic disease:\n\n\u2713 Correctly identified ABO incompatibility with risk factors (positive Coombs, dehydration)\n\u2713 Used AAP nomogram to determine phototherapy threshold for high-risk infant\n\u2713 Initiated intensive phototherapy appropriately\n\u2713 Added IVIG and IV fluids when bilirubin continued to rise despite phototherapy\n\u2713 Monitored for rebound after discontinuing phototherapy\n\u2713 Planned appropriate close follow-up with return precautions\n\nKey learning points:\n- Jaundice in first 24 hours is NEVER physiologic - always investigate\n- ABO incompatibility: mother O, baby A or B, positive Coombs\n- Use AAP nomogram - lower thresholds for high-risk infants (hemolysis, prematurity)\n- IVIG can reduce need for exchange transfusion in isoimmune hemolysis\n- Monitor for rebound after stopping phototherapy, especially with hemolysis\n- Late anemia can occur weeks later - follow hemoglobin"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of neonatal hyperbilirubinemia management:\n\n- Identify risk factors: hemolysis (positive Coombs), prematurity, dehydration, G6PD deficiency\n- Use AAP hour-specific nomogram - high-risk infants have lower thresholds\n- Intensive phototherapy for rapid bilirubin reduction when above threshold\n- IVIG can reduce hemolysis and need for exchange transfusion\n- Monitor for rebound 12-24 hours after stopping phototherapy\n- Close follow-up essential, especially with hemolytic disease\n- Watch for late anemia from ongoing hemolysis"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in neonatal hyperbilirubinemia can lead to kernicterus (irreversible brain damage):\n\n- Jaundice in first 24 hours is ALWAYS pathologic - never dismiss as physiologic\n- Positive Coombs test = hemolysis, not simple physiologic jaundice\n- Never delay phototherapy when above threshold - bilirubin can rise rapidly\n- Never stop phototherapy just because bilirubin is decreasing - continue until below threshold\n- Never use sunlight as substitute for medical phototherapy\n- Exchange transfusion only when threshold reached or encephalopathy present\n\nKey pearl: Kernicterus is PREVENTABLE with appropriate monitoring and treatment. Use the AAP nomogram and treat aggressively when indicated."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-020", "title": "Necrotizing Enterocolitis", "domain": "newborn", "difficulty": "intermediate", "tags": ["premature infant", "pneumatosis intestinalis", "portal venous gas", "bloody stools", "necrotizing enterocolitis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 10-day-old male presents with abdominal distension and bloody stools for 12 hours.\n\nThe patient's mother reports, he has developed a distended abdomen and is not tolerating feeds. He had bloody stools this morning. He has been less active and having episodes of apnea and bradycardia.\n\nfeeding intolerance, lethargy, and temperature instability. No prior surgical history.\n\nMedical history is notable for He was born at 28 weeks gestation and has been in the NICU. He was started on enteral feeds 5 days ago.\n\nPhysical Examination:\n- Abdomen: distended, tense, with visible bowel loops, abdominal wall erythema, and absent bowel sounds.\n- General: lethargic, mottled premature infant with temperature instability.\n- Vitals: bradycardia, hypotension.\n- Vital signs: apnea, bradycardia, hypotension.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory findings:\n- Metabolic acidosis with elevated lactate\n- Thrombocytopenia\n- CBC showing left shift\n- Blood culture pending\n\nImaging findings:\n- Abdominal X-ray: pneumatosis intestinalis, portal venous gas, dilated loops, thickened bowel wall.", "question": "What is the PATHOGNOMONIC radiographic finding that confirms NEC?", "choices": [{"id": "node-1-choice-a", "text": "Pneumatosis intestinalis (air in bowel wall)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Pneumatosis intestinalis** (intramural air) is pathognomonic for NEC. It represents gas produced by bacteria within the bowel wall and is the radiographic hallmark of this disease. Portal venous gas is also highly specific but less common.", "consequence": "You correctly identify the key diagnostic finding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Dilated bowel loops", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Dilated bowel loops are nonspecific and can be seen in many conditions including **ileus**, **obstruction**, and **sepsis**. Pneumatosis intestinalis is the pathognomonic finding for NEC.", "consequence": "This finding is too nonspecific for diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Thickened bowel wall", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bowel wall thickening can be seen in **inflammatory conditions**, **edema**, and **ischemia**. It is not specific to NEC. Look for intramural air (pneumatosis) as the pathognomonic sign.", "consequence": "This finding alone is insufficient for diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Free intraperitoneal air", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Free air indicates **perforation** and is a complication of NEC, not a diagnostic finding for the disease itself. Pneumatosis intestinalis precedes perforation and is pathognomonic.", "consequence": "This is a complication, not the diagnostic finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Gasless abdomen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A gasless abdomen suggests **ileus** or **volvulus** but is not characteristic of NEC. NEC typically shows **pneumatosis intestinalis** with dilated, gas-filled loops.", "consequence": "This finding is not consistent with NEC.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pneumatosis intestinalis** (air in the bowel wall) is PATHOGNOMONIC for NEC. **Portal venous gas** is also highly specific but less common. These findings result from bacterial gas production in the ischemic bowel wall."}, "node-2": {"id": "node-2", "type": "decision", "content": "NEC is confirmed by the characteristic radiographic findings. The infant is hemodynamically unstable with worsening metabolic acidosis.", "question": "What is the IMMEDIATE first step in medical management of NEC?", "choices": [{"id": "node-2-choice-a", "text": "NPO and nasogastric decompression", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The first step is **bowel rest** - make the infant **NPO** and place an **orogastric/nasogastric tube for decompression**. This prevents further bacterial translocation and reduces the risk of perforation. Antibiotics and surgery follow as indicated.", "consequence": "You appropriately initiate bowel rest.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Emergent surgical exploration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Surgery is indicated for **perforation** (free air), **clinical deterioration despite medical therapy**, or **fixed dilated loop**. Initial management is **medical stabilization** with bowel rest and antibiotics. Most NEC cases respond to medical management.", "consequence": "Premature surgical intervention without medical stabilization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "IV fluid resuscitation only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While fluid resuscitation is important, the **first priority** is to stop enteral feeds and decompress the GI tract. Continued feeding worsens bacterial translocation and increases perforation risk.", "consequence": "Continued feeding worsens the disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Continue trophic feeds with close monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is DANGEROUS. All enteral feeds must be stopped immediately in suspected NEC. **NPO status** is essential to prevent further bacterial translocation and allow bowel healing.", "consequence": "Continued feeding leads to perforation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Oral antibiotics for gut decontamination", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Oral antibiotics are contraindicated when the bowel is compromised. **IV broad-spectrum antibiotics** are needed for systemic coverage. The infant should be NPO with all medications given parenterally.", "consequence": "Oral medications are not absorbed and may cause harm.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**\"NPO, NGT, and IV antibiotics\"** is the cornerstone of NEC medical management. Bowel rest allows healing and reduces bacterial translocation. Most NEC (Stage I-II) responds to medical management alone."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is NPO with NG decompression in place. You need to start antibiotic therapy.", "question": "What is the OPTIMAL empiric antibiotic regimen for NEC?", "choices": [{"id": "node-3-choice-a", "text": "Ampicillin + gentamicin + metronidazole (or clindamycin)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! NEC requires **triple antibiotic coverage**: **Ampicillin** (gram-positive, Enterococcus), **gentamicin** (gram-negative), and **metronidazole or clindamycin** (anaerobes). This combination covers the polymicrobial flora of the neonatal gut.", "consequence": "Appropriate broad-spectrum coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ampicillin + gentamicin only", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but suboptimal. This regimen covers gram-positive and gram-negative organisms but **lacks anaerobic coverage**. NEC involves translocation of gut flora including anaerobes, so adding **metronidazole** is recommended.", "consequence": "Incomplete coverage may allow anaerobic proliferation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Vancomycin + cefotaxime", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable alternative but **lacks anaerobic coverage**. This regimen is often used for late-onset sepsis but should include metronidazole for NEC to cover gut anaerobes.", "consequence": "Consider adding anaerobic coverage.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Ceftriaxone monotherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ceftriaxone **should be avoided in neonates** due to risk of biliary sludging and kernicterus (displaces bilirubin from albumin). Additionally, monotherapy is inadequate for the polymicrobial nature of NEC.", "consequence": "Inappropriate antibiotic choice for neonates.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Oral neomycin for gut decontamination", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The infant must be NPO - oral medications are contraindicated. **IV antibiotics** are required for systemic absorption and tissue penetration in the setting of bowel ischemia.", "consequence": "Oral medications cannot be absorbed in NEC.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "NEC antibiotic regimen: **Ampicillin + Gentamicin + Metronidazole** (or clindamycin). Remember: **avoid ceftriaxone in neonates** due to biliary sludging and bilirubin displacement."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 24 hours of medical management, repeat abdominal X-ray shows new finding of FREE AIR under the diaphragm. The infant remains hemodynamically unstable despite resuscitation.", "question": "What is the next step in management now that perforation is evident?", "choices": [{"id": "node-4-choice-a", "text": "Emergent surgical exploration and resection", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Free air = perforation = surgery**. Indications for surgical intervention in NEC include: **pneumoperitoneum** (free air), **clinical deterioration despite maximal medical therapy**, **fixed dilated loop** on serial X-rays, and **abdominal wall erythema/mass**.", "consequence": "Surgical consultation obtained immediately.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue medical management and recheck X-ray in 6 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Free air indicates **perforation**, which is an ABSOLUTE indication for surgery. Delayed surgery in the setting of perforation leads to **peritonitis**, **sepsis**, and **death**.", "consequence": "Delay leads to worsening sepsis and death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Add antifungal coverage and continue IV antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While antifungal coverage may be appropriate in prolonged antibiotic courses, the **immediate priority** with free air is surgical intervention. Medical management alone cannot address bowel perforation.", "consequence": "Ongoing peritonitis without source control.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "CT scan to confirm perforation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Free air on X-ray is **diagnostic of perforation** - no further imaging is needed. CT scan delays definitive surgical treatment and exposes the critically ill neonate to unnecessary radiation.", "consequence": "Unnecessary delay for additional imaging.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Peritoneal drain placement at bedside", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable temporizing measure in extremely low birth weight infants (<1000g) who are too unstable for surgery. **Primary peritoneal drainage** can be a bridge to definitive surgery, but most infants eventually require laparotomy.", "consequence": "Temporizing measure but definitive surgery usually needed.", "nextNodeId": "node-5"}], "clinicalPearl": "**Surgical indications in NEC**: Pneumoperitoneum (free air), clinical deterioration despite medical therapy, fixed dilated loop on serial X-rays, abdominal wall erythema/cellulitis. **Free air = Surgery**."}, "node-5": {"id": "node-5", "type": "decision", "content": "Surgery reveals extensive necrosis requiring significant bowel resection. Post-operatively, the infant is recovering but has short bowel syndrome. The parents ask about long-term prognosis and feeding.", "question": "What is the MOST important counseling point regarding long-term outcomes after extensive NEC resection?", "choices": [{"id": "node-5-choice-a", "text": "Parenteral nutrition dependence until intestinal adaptation occurs", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Short bowel syndrome** following extensive NEC resection requires **prolonged TPN** (total parenteral nutrition) while the remaining bowel undergoes **intestinal adaptation**. This process can take months to years. Complications include TPN-associated liver disease and catheter infections.", "consequence": "Parents understand the long rehabilitation process.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Full enteral feeding can resume within 1 week", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After extensive bowel resection, **intestinal adaptation** takes months to years. Premature advancement of enteral feeds leads to **malabsorption**, **failure to thrive**, and potential anastomotic complications.", "consequence": "Unrealistic expectations lead to feeding intolerance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "No long-term sequelae are expected", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NEC survivors, especially those with extensive resection, are at risk for **short bowel syndrome**, **strictures** (even in medically managed cases), **neurodevelopmental delays**, and **growth failure**.", "consequence": "Inadequate counseling about real risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Intestinal transplant is the only option", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Intestinal transplant** is reserved for infants who fail intestinal rehabilitation and develop **irreversible TPN-associated liver disease**. Most infants with short bowel syndrome eventually achieve enteral autonomy through adaptation.", "consequence": "Overly pessimistic and inaccurate counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "The infant will never tolerate breast milk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Breast milk** is actually preferred when reintroducing enteral feeds after NEC, as it contains **immunologic factors** and is associated with lower NEC rates. Elemental formulas are an alternative if breast milk is unavailable.", "consequence": "Breast milk is beneficial in NEC survivors.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NEC long-term complications**: Short bowel syndrome (TPN dependence), strictures (even with medical management - get contrast study before full feeds), neurodevelopmental delays, growth failure. **Breast milk** reduces NEC risk and aids recovery."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified NEC by its pathognomonic finding of pneumatosis intestinalis, initiated appropriate medical management (NPO, NG decompression, triple antibiotics), recognized the surgical indication of free air, and provided accurate counseling about long-term outcomes. Key teaching points: (1) Pneumatosis = NEC, (2) Free air = Surgery, (3) Breast milk is protective, (4) Short bowel syndrome requires prolonged TPN and intestinal rehabilitation."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key NEC management: (1) Pneumatosis intestinalis is pathognomonic, (2) NPO + NGT + IV antibiotics (Amp/Gent/Metro), (3) Surgical indications: free air, deterioration, fixed loop, (4) Long-term: short bowel syndrome, strictures, need for TPN."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. NEC is a life-threatening emergency in premature infants. Key principles: STOP feeds immediately (NPO), surgical intervention for perforation (free air), and IV antibiotics with anaerobic coverage. Delayed or inappropriate management leads to sepsis and death."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-021", "title": "Neonatal Sepsis", "domain": "newborn", "difficulty": "intermediate", "tags": ["temperature instability", "poor feeding", "lethargy in neonate", "neonatal sepsis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-day-old male presents with fever and poor feeding for 12 hours.\n\nHistory reveals, he has become increasingly lethargic and is not interested in feeding. His temperature is unstable, alternating between low and high. He seems to be breathing faster than normal.\n\nAssociated symptoms include temperature instability, tachypnea, and lethargy. Denies rash or seizures.\n\nPertinent history includes He was born at 38 weeks. Mother had prolonged rupture of membranes (>18 hours) and was GBS positive but did not receive intrapartum antibiotics.\n\nPhysical Examination:\n- General: lethargic newborn with mottled skin.\n- Vitals: temp 38.5, tachycardia, tachypnea.\n- Vital signs: temperature 38.5\u00b0C, tachycardia, tachypnea.\n- Perfusion: delayed capillary refill, weak pulses.\n- Fontanelle: not bulging.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 3-day-old term infant presents with fever, poor feeding, lethargy, and tachypnea. Key history: mother was GBS positive with prolonged ROM (>18 hours) and did NOT receive intrapartum antibiotics.", "question": "Based on the timing of presentation (day 3 of life) and risk factors, what type of neonatal sepsis is this classified as?", "choices": [{"id": "node-1-choice-a", "text": "Early-onset sepsis (EOS) - presents \u226472 hours of life", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Early-onset sepsis (EOS)** is defined as sepsis occurring **\u226472 hours** (some say \u22647 days) of life. EOS is associated with **vertical transmission** from maternal flora, with **Group B Streptococcus (GBS)** and **E. coli** being the most common pathogens. Risk factors include maternal GBS colonization, prolonged ROM, prematurity, and inadequate intrapartum antibiotic prophylaxis.", "consequence": "You correctly classify the sepsis and anticipate the likely pathogens.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Late-onset sepsis (LOS) - presents >72 hours of life", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Late-onset sepsis occurs **>72 hours to 3 months** of life and is associated with **horizontal transmission** (nosocomial or community-acquired). Pathogens include **coagulase-negative staph**, **S. aureus**, gram-negatives, and **Candida**. This infant at day 3 with maternal GBS risk factors has early-onset sepsis.", "consequence": "Incorrect classification may lead to inappropriate antibiotic selection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Hospital-acquired (nosocomial) sepsis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Nosocomial sepsis occurs in hospitalized infants (especially NICU), often associated with **central lines**, **prolonged intubation**, or **TPN**. This infant developed symptoms at home with clear maternal risk factors for vertical transmission.", "consequence": "Wrong source attribution.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Community-acquired sepsis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Community-acquired infections in neonates typically present **after discharge** with pathogens like **HSV**, **enterovirus**, or **S. pneumoniae**. This infant's presentation at day 3 with maternal GBS risk factors is classic early-onset sepsis from vertical transmission.", "consequence": "Fails to recognize vertical transmission.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Perinatal viral infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **HSV** and **enterovirus** can cause severe neonatal infections, this presentation with maternal GBS colonization and inadequate prophylaxis points to **bacterial early-onset sepsis**. HSV typically presents with vesicles, seizures, or liver dysfunction.", "consequence": "Missing bacterial etiology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Early-onset sepsis (EOS)**: \u226472 hours, vertical transmission, **GBS** and **E. coli** most common. **Late-onset sepsis (LOS)**: >72 hours, horizontal transmission, **CoNS**, **S. aureus**, **Candida**. Maternal risk factors (GBS+, ROM >18h, chorioamnionitis) increase EOS risk."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect early-onset sepsis. The infant needs a sepsis workup.", "question": "Which component of the sepsis workup is ESSENTIAL and should NOT be omitted if the infant is stable?", "choices": [{"id": "node-2-choice-a", "text": "Lumbar puncture for CSF analysis and culture", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Lumbar puncture** is essential in the neonatal sepsis workup because **meningitis** occurs in 20-25% of neonates with bacteremia. CSF cannot be reliably predicted by blood cultures alone - up to 15% of neonates with meningitis have **negative blood cultures**. LP should be performed if the infant is stable enough.", "consequence": "Complete sepsis workup obtained.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Chest X-ray", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not the most critical. CXR is helpful if respiratory symptoms are present but **lumbar puncture** takes priority because meningitis cannot be diagnosed without CSF analysis, and missing meningitis significantly impacts antibiotic duration and prognosis.", "consequence": "CXR obtained but LP still needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Urinalysis and urine culture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect priority. Urine culture is more important in **late-onset sepsis** and older infants. In **early-onset sepsis (\u226472 hours)**, UTI is rare due to low urinary concentration of bacteria. **LP is the essential test** that should not be omitted.", "consequence": "Urine obtained but may miss meningitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Procalcitonin level", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While procalcitonin is a useful biomarker for bacterial infection, it **cannot diagnose meningitis**. Inflammatory markers help guide duration of antibiotics but do not replace the need for **CSF analysis** in neonatal sepsis.", "consequence": "Biomarker obtained but critical diagnosis may be missed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Blood culture alone is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Blood culture alone is **insufficient** because 15% of neonates with meningitis have negative blood cultures. **LP is mandatory** in neonatal sepsis workup when the infant is stable enough to tolerate the procedure.", "consequence": "Incomplete workup risks missing meningitis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**LP is essential** in neonatal sepsis workup: 20-25% of bacteremic neonates have meningitis, and 15% of neonates with meningitis have **negative blood cultures**. Meningitis changes antibiotic choice (need CSF penetration) and duration (14-21 days vs 7-10 days)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Sepsis workup is obtained. Blood and CSF cultures are pending. CBC shows bandemia (elevated I:T ratio). CRP is elevated at 85 mg/L.", "question": "What is the OPTIMAL empiric antibiotic regimen for early-onset neonatal sepsis?", "choices": [{"id": "node-3-choice-a", "text": "Ampicillin + Gentamicin", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Ampicillin + Gentamicin** is the standard empiric regimen for early-onset sepsis. **Ampicillin** covers **GBS** and **Listeria monocytogenes**; **Gentamicin** provides synergistic gram-negative coverage including **E. coli**. This combination has excellent activity against the most common EOS pathogens.", "consequence": "Appropriate empiric coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ampicillin + Cefotaxime", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable alternative, especially if **meningitis** is suspected or confirmed (cefotaxime has better CSF penetration than gentamicin). However, routine use of 3rd-generation cephalosporins is associated with **increased risk of invasive candidiasis** and **resistance selection**.", "consequence": "Acceptable but not first-line for uncomplicated EOS.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Vancomycin + Ceftazidime", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This regimen is more appropriate for **late-onset** or **nosocomial sepsis** where **MRSA** and **Pseudomonas** are concerns. For early-onset sepsis, this is excessively broad and does not cover **Listeria** (vancomycin is less effective than ampicillin for Listeria).", "consequence": "Inappropriate coverage for EOS pathogens.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Ceftriaxone monotherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ceftriaxone is contraindicated in neonates** - it causes **biliary sludging** and **displaces bilirubin from albumin**, increasing kernicterus risk. Additionally, monotherapy does not cover Listeria and lacks the synergy provided by aminoglycosides.", "consequence": "Contraindicated antibiotic in neonates.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Penicillin G alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While Penicillin G covers GBS, it does **not cover E. coli** (the second most common EOS pathogen) or provide the synergistic killing that **aminoglycosides** offer. Empiric coverage must be broad until culture results return.", "consequence": "Inadequate gram-negative coverage.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**EOS empiric therapy: Ampicillin + Gentamicin**. Covers GBS, E. coli, and Listeria. **Avoid ceftriaxone in neonates** (biliary sludging, kernicterus risk). Add cefotaxime (instead of gent) if meningitis confirmed for better CSF penetration."}, "node-4": {"id": "node-4", "type": "decision", "content": "Antibiotics are started. At 48 hours, blood culture grows Group B Streptococcus. CSF culture is negative with normal parameters (WBC 8, protein 90, glucose 45).", "question": "Given positive blood culture for GBS but NEGATIVE CSF, what is the appropriate duration of antibiotic therapy?", "choices": [{"id": "node-4-choice-a", "text": "10 days of IV antibiotics", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **GBS bacteremia without meningitis** requires **10 days** of IV antibiotics. Once GBS is identified, therapy can be narrowed to **Penicillin G or Ampicillin** alone. If meningitis were present, duration would extend to **14-21 days**.", "consequence": "Appropriate treatment duration selected.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "48-72 hours then discontinue if clinically improved", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This duration is only appropriate when sepsis is **ruled out** (negative cultures, low clinical suspicion, improving inflammatory markers). With a **positive blood culture for GBS**, a full 10-day course is required to prevent relapse and complications.", "consequence": "Incomplete treatment leads to relapse risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "7 days of IV antibiotics", "isOptimal": false, "isAcceptable": true, "feedback": "Slightly suboptimal. While some experts accept 7 days for uncomplicated GBS bacteremia, the **AAP recommends 10 days** for GBS sepsis without meningitis. The extra days ensure complete eradication and reduce relapse risk.", "consequence": "May be acceptable but 10 days is standard.", "nextNodeId": "node-5"}, {"id": "node-4-choice-d", "text": "21 days of IV antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. 21 days is indicated for **GBS meningitis**, not uncomplicated bacteremia. The CSF was negative, so the standard 10-day course for bacteremia is appropriate. Prolonged antibiotics increase risks of line infections and resistance.", "consequence": "Unnecessarily prolonged therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Complete treatment with oral antibiotics after 5 days IV", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Neonatal sepsis requires **complete IV therapy** - oral antibiotics are not reliably absorbed and do not achieve adequate serum levels in neonates. There is no role for oral step-down therapy in neonatal GBS sepsis.", "consequence": "Inadequate treatment with unreliable oral absorption.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**GBS sepsis antibiotic duration**: Bacteremia without meningitis = **10 days IV**; Meningitis = **14-21 days IV**. Once GBS confirmed, narrow to **Penicillin G** (or ampicillin). No role for oral step-down in neonatal sepsis."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant completes 10 days of IV antibiotics and recovers well. Before discharge, the parents ask about preventing this in future pregnancies.", "question": "What is the MOST important counseling point regarding GBS prevention for the mother's future pregnancies?", "choices": [{"id": "node-5-choice-a", "text": "She will need intrapartum antibiotic prophylaxis in ALL future pregnancies", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Once a mother has had an infant with **invasive GBS disease**, she is considered **high-risk for all future pregnancies** regardless of subsequent GBS screening results. She requires **intrapartum antibiotic prophylaxis (IAP)** with every future delivery - typically **Penicillin G or Ampicillin IV** starting at labor onset.", "consequence": "Parents understand the importance of prevention.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "GBS screening at 36 weeks will determine if prophylaxis is needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **History of previous infant with GBS disease** is an **automatic indication** for IAP regardless of screening results. GBS colonization is intermittent, and a negative screen does not reliably predict absence of colonization at delivery.", "consequence": "Screening alone is insufficient given history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Oral antibiotics during the third trimester will prevent colonization", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antepartum oral antibiotics do not prevent GBS colonization** at delivery - recolonization occurs rapidly. Only **IV intrapartum prophylaxis** (given \u22654 hours before delivery) effectively reduces vertical transmission.", "consequence": "Antepartum treatment is ineffective for prevention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "No special precautions are needed if she delivers by cesarean section", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **scheduled C-section before labor onset with intact membranes** may not require IAP in routine GBS-positive mothers, a **history of infant with invasive GBS disease** warrants prophylaxis regardless of delivery mode.", "consequence": "C-section does not eliminate need for IAP with this history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "The infant should receive prophylactic antibiotics at birth in future pregnancies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The strategy is **maternal prophylaxis**, not neonatal prophylaxis. IAP given \u22654 hours before delivery crosses the placenta and achieves adequate fetal/amniotic fluid levels. Treating the newborn post-delivery is less effective than preventing transmission.", "consequence": "Neonatal prophylaxis is not the standard approach.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**GBS prophylaxis indications** (any = IAP required): Previous infant with invasive GBS disease, GBS bacteriuria this pregnancy, GBS positive screen, Unknown status + risk factors (ROM >18h, <37 weeks, fever). **Penicillin G IV** is first-line; give **\u22654 hours before delivery**."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified early-onset GBS sepsis, performed a complete sepsis workup including LP, initiated appropriate empiric antibiotics (Ampicillin + Gentamicin), prescribed the correct treatment duration (10 days for bacteremia without meningitis), and provided accurate counseling about future pregnancy prevention. Key teaching points: (1) EOS = \u226472 hours, GBS and E. coli most common, (2) LP is essential - don't miss meningitis, (3) Amp + Gent for EOS, avoid ceftriaxone, (4) 10 days for GBS bacteremia, 14-21 days for meningitis, (5) History of infant with GBS disease = IAP in ALL future pregnancies."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key neonatal sepsis concepts: (1) EOS (\u226472h) vs LOS (>72h) have different pathogens, (2) LP is essential - 15% of meningitis cases have negative blood cultures, (3) Amp + Gent is first-line for EOS, (4) GBS bacteremia = 10 days, meningitis = 14-21 days, (5) Previous GBS-affected infant = IAP in all future pregnancies regardless of screening."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Neonatal sepsis requires prompt recognition and treatment. Key principles: (1) 'Not doing well' neonate needs full sepsis workup including LP, (2) Avoid ceftriaxone in neonates (biliary sludging, kernicterus), (3) Complete IV antibiotic courses - no oral step-down in neonatal sepsis, (4) IAP in labor prevents GBS transmission - antepartum oral antibiotics do not work."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-048", "title": "Neonatal Respiratory Distress Syndrome", "domain": "newborn", "difficulty": "advanced", "tags": ["respiratory distress syndrome", "RDS", "hyaline membrane disease", "surfactant deficiency", "premature infant", "antenatal steroids", "surfactant replacement", "bronchopulmonary dysplasia", "BPD"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 6-hour-old male presents with worsening respiratory distress for 4 hours.\n\nPer the parents, he was born at 30 weeks gestation and initially had mild respiratory distress that has been worsening. He is requiring increasing oxygen and now needs intubation.\n\nReview of systems is positive for prematurity and progressive respiratory failure and negative for meconium exposure.\n\nMedical history is notable for He was born at 30 weeks due to preterm labor. Mother received one dose of betamethasone 12 hours before delivery.\n\nPhysical Examination:\n- Respiratory: tachypnea, grunting, nasal flaring, intercostal retractions.\n- General: premature infant with worsening cyanosis.\n- Vitals: tachypnea, cyanosis.\n- Auscultation: diminished breath sounds bilaterally.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 30-week premature infant presents with classic RDS features: progressive respiratory distress within the first 6 hours of life with grunting, nasal flaring, and retractions. Mother received only ONE dose of betamethasone (ideally needs 2 doses, 24 hours apart).", "question": "What is the UNDERLYING PATHOPHYSIOLOGY of Respiratory Distress Syndrome (Hyaline Membrane Disease)?", "choices": [{"id": "node-1-choice-a", "text": "Surfactant deficiency causing alveolar collapse", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! RDS is caused by **surfactant deficiency** due to immature Type II pneumocytes. Surfactant reduces alveolar surface tension, preventing collapse. Without it, alveoli collapse at end-expiration (atelectasis), requiring high pressures to re-expand. The term **'hyaline membrane disease'** refers to the proteinaceous membranes lining collapsed alveoli seen on pathology.", "consequence": "You understand the core pathophysiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bacterial pneumonia from Group B Strep", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **GBS pneumonia** can present similarly (respiratory distress in newborn), it presents more variably and doesn't have the predictable timing of RDS. RDS specifically affects **preterm infants** due to surfactant deficiency. However, GBS should always be considered in the differential - many NICUs treat empirically.", "consequence": "Different etiology - consider in differential.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Retained fetal lung fluid", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Retained fetal lung fluid** causes **Transient Tachypnea of the Newborn (TTN)**, NOT RDS. TTN is more common after **C-section** (no thoracic squeeze) and typically **resolves within 24-72 hours**. TTN shows **fluid in fissures** on CXR, not ground-glass opacities.", "consequence": "Different diagnosis - TTN vs RDS.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Aspiration of amniotic fluid", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Meconium aspiration syndrome** occurs in **term/post-term** infants with meconium-stained fluid. This infant is **30 weeks premature** and there was no meconium exposure. The pathophysiology of RDS is surfactant deficiency.", "consequence": "Meconium aspiration affects term infants.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Congenital surfactant protein deficiency", "isOptimal": false, "isAcceptable": true, "feedback": "Congenital surfactant protein deficiencies (SP-B, SP-C, ABCA3 mutations) are **rare genetic causes** of respiratory failure that mimic RDS but are usually fatal. Typical RDS in preterm infants is due to **developmental immaturity** of Type II pneumocytes, not genetic mutations.", "consequence": "Rare cause - developmental immaturity is typical.", "nextNodeId": "node-2"}], "clinicalPearl": "**Surfactant production begins at ~24 weeks** but adequate levels aren't reached until ~35 weeks. RDS risk: 60% at 28 weeks, 30% at 30 weeks, <5% at 35 weeks. **Type II pneumocytes** produce surfactant; Type I pneumocytes are for gas exchange."}, "node-2": {"id": "node-2", "type": "decision", "content": "CXR shows classic RDS findings: diffuse ground-glass opacities, air bronchograms (air-filled bronchi visible against opacified lung), and low lung volumes. The infant requires intubation for respiratory support.", "question": "What is the MOST important PRENATAL intervention to prevent RDS in preterm delivery?", "choices": [{"id": "node-2-choice-a", "text": "Antenatal corticosteroids (betamethasone or dexamethasone)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Antenatal corticosteroids** are the most effective prevention for RDS. They accelerate fetal lung maturity by stimulating surfactant production. **Betamethasone** (2 doses, 12mg IM, 24 hours apart) or **dexamethasone** given to mothers at risk of preterm delivery (24-34 weeks) reduces RDS by ~50% and neonatal mortality by ~30%. Optimal benefit requires **>24 hours** before delivery.", "consequence": "You understand the most important prevention.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Tocolytics to delay delivery", "isOptimal": false, "isAcceptable": true, "feedback": "Tocolytics (e.g., nifedipine, terbutaline) **buy time** for steroids to work (48 hours ideally) and for maternal transport to a tertiary center. However, they don't directly prevent RDS - **steroids accelerate lung maturity**. Tocolytics have limited efficacy and don't improve long-term outcomes.", "consequence": "Buys time but doesn't prevent RDS directly.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Magnesium sulfate for neuroprotection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect focus. **Magnesium sulfate** is given for **fetal neuroprotection** (reduces cerebral palsy risk) in preterm delivery <32 weeks, but it doesn't prevent RDS. **Antenatal steroids** specifically target lung maturation.", "consequence": "Different purpose - neuroprotection not RDS prevention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Prophylactic antibiotics for mother", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Antibiotics may be given for **prolonged rupture of membranes** or GBS prophylaxis, but they don't prevent RDS. Antibiotics address infection risk; **steroids address lung immaturity**.", "consequence": "Different indication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Immediate C-section to minimize stress", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **C-section does NOT prevent RDS** and may actually increase risk of respiratory distress (lack of thoracic squeeze). The key intervention is **antenatal steroids**. Mode of delivery doesn't affect surfactant production.", "consequence": "C-section doesn't prevent RDS.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Antenatal steroids**: Give to ALL mothers at risk of preterm delivery **24-34 weeks**. Benefit begins at **24 hours** after first dose, maximal at **48 hours**. Can give if delivery imminent (even partial benefit). A **rescue course** may be considered if >14 days since initial course."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is intubated and on mechanical ventilation. FiO2 is 60% to maintain adequate oxygenation. You need to decide on surfactant therapy.", "question": "What is the RECOMMENDED approach to surfactant administration in this infant with RDS?", "choices": [{"id": "node-3-choice-a", "text": "Surfactant replacement via endotracheal tube - early selective treatment", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Exogenous surfactant** (natural: Curosurf, Survanta or synthetic) is given via **endotracheal tube**. Current approach is **early selective treatment** - give surfactant to intubated infants with clinical RDS requiring significant oxygen/ventilation. Some centers use **INSURE** (INtubate, SURfactant, Extubate to CPAP) or **LISA** (Less Invasive Surfactant Administration via thin catheter without intubation).", "consequence": "Appropriate surfactant therapy planned.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Wait until FiO2 >80% before giving surfactant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying surfactant worsens outcomes**. Earlier administration (when FiO2 >30-40% needed) improves survival and reduces complications. Waiting for severe disease before treating results in more lung injury and higher mortality.", "consequence": "Delayed treatment worsens outcomes.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Inhaled surfactant via nebulizer", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Nebulized surfactant is NOT effective** - the particle size is too small to deposit in alveoli and most is lost in the ventilator circuit. Surfactant must be given as a **bolus via ETT** (or via thin catheter in LISA).", "consequence": "Ineffective delivery method.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "CPAP alone without surfactant", "isOptimal": false, "isAcceptable": true, "feedback": "**CPAP** (continuous positive airway pressure) is an important respiratory support and may be sufficient for mild RDS. However, this infant required **intubation** for significant distress on 60% FiO2 - surfactant is indicated. CPAP alone is reasonable for less severe disease.", "consequence": "CPAP insufficient for moderate-severe RDS.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "High-frequency oscillatory ventilation without surfactant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HFOV** is a rescue ventilation strategy for refractory respiratory failure, but it doesn't replace surfactant therapy. Surfactant addresses the underlying problem; HFOV is just a ventilation mode.", "consequence": "Ventilation mode doesn't replace surfactant.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Surfactant dosing**: 100-200 mg/kg dose via ETT. May repeat q6-12h if ongoing oxygen requirement. **LISA** (Less Invasive Surfactant Administration) - surfactant via thin catheter while on CPAP, avoiding intubation - increasingly used. Natural surfactants (animal-derived) may be superior to synthetic."}, "node-4": {"id": "node-4", "type": "decision", "content": "Surfactant is given with good response - FiO2 decreases to 30% and compliance improves. The infant continues on mechanical ventilation. Over the next 3 days, the infant gradually improves and is extubated to CPAP.", "question": "What is the MOST common COMPLICATION of prolonged mechanical ventilation and oxygen therapy in premature infants?", "choices": [{"id": "node-4-choice-a", "text": "Bronchopulmonary dysplasia (BPD) - chronic lung disease of prematurity", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **BPD** is defined as oxygen requirement at **36 weeks postmenstrual age**. It results from lung injury from mechanical ventilation, oxygen toxicity, and inflammation in the immature lung. Prevention: minimize ventilator pressures/oxygen, use caffeine (reduces apnea and BPD), vitamin A supplementation. BPD risk increases with lower gestational age and severity of RDS.", "consequence": "You understand the most important long-term pulmonary complication.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Pneumothorax", "isOptimal": false, "isAcceptable": true, "feedback": "**Pneumothorax** is an **acute** complication of positive pressure ventilation (air leak syndrome), not the most common long-term complication. It requires emergent needle decompression/chest tube. While important to recognize, BPD is the chronic complication asked about.", "consequence": "Acute complication, not chronic.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Pulmonary hemorrhage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pulmonary hemorrhage** can occur (especially with PDA and coagulopathy) but is not the MOST common complication. **BPD** is far more prevalent in VLBW infants who require prolonged respiratory support.", "consequence": "Less common than BPD.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Retinopathy of prematurity", "isOptimal": false, "isAcceptable": true, "feedback": "**ROP** is a complication of **oxygen exposure** in premature infants, affecting developing retinal blood vessels. While related to oxygen therapy, the question asks about PULMONARY complications. ROP is screened for at 31 weeks PMA or 4 weeks postnatal age in at-risk infants.", "consequence": "Eye complication, not pulmonary.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Complete resolution with no long-term effects", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While many infants recover fully, **BPD develops in 30-40% of VLBW infants**. Even those without BPD diagnosis may have subtle long-term pulmonary effects. Complete resolution without complications is NOT the most common outcome.", "consequence": "Overly optimistic assessment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**BPD definition**: Need for supplemental O2 at **36 weeks postmenstrual age**. Severity: mild (room air at 36w), moderate (FiO2 <30%), severe (FiO2 \u226530% or positive pressure). **Prevention**: Caffeine, vitamin A, gentle ventilation, avoiding hyperoxia. Long-term: increased risk of asthma, lower exercise tolerance."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant is now 3 weeks old and doing well on room air. Parents ask about long-term prognosis and when they can go home.", "question": "What is the MOST accurate statement about long-term outcomes following RDS in premature infants?", "choices": [{"id": "node-5-choice-a", "text": "Outcomes have dramatically improved with surfactant and modern NICU care; most survive without major disability", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Survival has dramatically improved** since surfactant introduction (1990). At 30 weeks gestation, survival is >95% with modern care. Most infants without severe BPD have good long-term pulmonary outcomes. Discharge criteria: adequate feeding, temperature regulation, no apnea/desaturation events. Follow-up monitors development, vision (ROP), hearing, and lung function.", "consequence": "Realistic optimistic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "All infants with RDS develop chronic lung disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Not all RDS patients develop BPD**. Risk factors for BPD: extreme prematurity (<28 weeks), need for prolonged ventilation, sepsis, PDA. Many infants with RDS (especially those >28 weeks who respond well to surfactant) recover completely.", "consequence": "Overly pessimistic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Prognosis is the same as before surfactant therapy was available", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surfactant therapy revolutionized RDS outcomes**. Before surfactant, RDS was a leading cause of neonatal death. Mortality has decreased dramatically since the 1990s. Surfactant, antenatal steroids, and improved NICU care have transformed prognosis.", "consequence": "Ignores major therapeutic advances.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Infants should remain hospitalized until original due date regardless of clinical status", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Discharge is based on **clinical readiness**, not arbitrary dates. Criteria include: stable temperature in open crib, feeding adequately (breast or bottle), weight gain, no apnea/bradycardia events. Many 30-weekers go home at 34-36 weeks corrected age.", "consequence": "Unnecessarily prolonged hospitalization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "No follow-up is needed after hospital discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Premature infants need close follow-up**: developmental assessments, vision screening (ROP can progress after discharge), hearing screening, growth monitoring, and RSV prophylaxis (palivizumab) during RSV season if eligible.", "consequence": "Missing important surveillance.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Pre-surfactant era (before 1990)**: RDS mortality ~50% in VLBW infants. **Post-surfactant era**: mortality <10% at most gestational ages. Key advances: antenatal steroids, surfactant replacement, CPAP/gentle ventilation strategies, caffeine for apnea prevention. **RSV prophylaxis** (palivizumab) indicated for high-risk preterm infants."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed RDS in this premature infant. You understood that surfactant deficiency is the core pathophysiology, that antenatal steroids are the most important prevention, that early surfactant replacement is the mainstay of treatment, and that BPD is the major long-term pulmonary complication. Key teaching points: (1) RDS = surfactant deficiency in preterm infants, (2) CXR: ground-glass opacities + air bronchograms, (3) Antenatal steroids reduce RDS by ~50%, (4) Surfactant via ETT is life-saving, (5) BPD is the chronic lung disease of prematurity, (6) Modern outcomes are excellent with proper care."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review RDS key points: (1) Caused by SURFACTANT DEFICIENCY from immature Type II pneumocytes, (2) Risk inversely related to gestational age, (3) CXR: ground-glass + air bronchograms + low lung volumes, (4) ANTENATAL STEROIDS are the most important prevention (give 24-34 weeks), (5) SURFACTANT REPLACEMENT via ETT is treatment, (6) BPD (chronic lung disease) is the major complication - defined as O2 requirement at 36 weeks PMA."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in RDS management. Remember: (1) Surfactant should be given EARLY - delaying worsens outcomes, (2) Surfactant must be given via ETT or LISA - nebulized is ineffective, (3) Antenatal steroids dramatically improve outcomes - this is standard of care, (4) Modern NICU care has transformed RDS prognosis - survival is >95% at 30 weeks. Key pearl: Surfactant replacement was one of the most important advances in neonatology."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-049", "title": "Meconium Aspiration Syndrome", "domain": "newborn", "difficulty": "advanced", "tags": ["meconium aspiration syndrome", "MAS", "post-term infant", "meconium-stained fluid", "PPHN", "persistent pulmonary hypertension", "inhaled nitric oxide", "ECMO", "NRP guidelines"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 1-hour-old female is brought in by her parents for respiratory distress after delivery through meconium-stained fluid for since birth.\n\nPer the mother, she was born through thick meconium-stained amniotic fluid and had meconium on her skin at delivery. She has been struggling to breathe since birth with grunting and retractions.\n\nmeconium staining and post-term delivery. No congenital anomalies.\n\nPertinent history includes She was born at 42 weeks gestation. There was fetal distress during labor with decelerations. Amniotic fluid was thick meconium.\n\nPhysical Examination:\n- General: meconium-stained newborn in respiratory distress.\n- Respiratory: grunting, nasal flaring, retractions, coarse breath sounds bilaterally.\n- Skin: meconium staining of skin, nails, and umbilical cord.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This post-term (42 weeks) infant was born through thick meconium-stained fluid after fetal distress. The meconium staining of skin, nails, and umbilical cord indicates prolonged exposure in utero. She is in respiratory distress with grunting and retractions.", "question": "What is the PATHOPHYSIOLOGY of meconium aspiration syndrome?", "choices": [{"id": "node-1-choice-a", "text": "Meconium causes mechanical obstruction, chemical pneumonitis, and surfactant inactivation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! MAS involves a **triple injury**: (1) **Mechanical obstruction** of airways causing ball-valve effect and air trapping, (2) **Chemical pneumonitis** from meconium's bile acids, enzymes, and fatty acids causing inflammation, and (3) **Surfactant inactivation** leading to atelectasis. This combination creates a severe lung injury with both hyperinflation AND atelectasis.", "consequence": "You understand the complex pathophysiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Surfactant deficiency from prematurity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surfactant deficiency from prematurity** causes **RDS** (Respiratory Distress Syndrome), not MAS. MAS occurs in **term/post-term infants** who have adequate surfactant. However, meconium can **inactivate surfactant** secondarily.", "consequence": "Confusing MAS with RDS.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Retained fetal lung fluid", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Retained fetal lung fluid** causes **Transient Tachypnea of the Newborn (TTN)**, not MAS. TTN resolves within 24-72 hours and typically occurs after C-section. MAS involves meconium aspiration with chemical pneumonitis.", "consequence": "Different diagnosis - TTN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Bacterial infection from contaminated amniotic fluid", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MAS is primarily a **chemical and mechanical injury**, not infection. While meconium is not sterile and pneumonia can develop secondarily, the initial lung injury is from meconium's irritant properties and airway obstruction, not bacterial infection.", "consequence": "Infection is secondary, not primary cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Allergic reaction to meconium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MAS is not an allergic reaction. It's a **direct toxic/mechanical injury** to the lungs from meconium's components (bile acids, enzymes, cellular debris) and physical obstruction of airways.", "consequence": "Not an allergic mechanism.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**MAS = term/post-term infants** (unlike RDS which affects premature infants). Risk factors: post-term pregnancy (>42 weeks), fetal distress, cord compression, IUGR. Meconium passage is rare before 34 weeks (immature GI motility). **Thick, 'pea soup' meconium** = higher risk than thin-stained fluid."}, "node-2": {"id": "node-2", "type": "decision", "content": "This infant was born through thick meconium. At delivery, she was noted to be NON-VIGOROUS (limp, poor respiratory effort, HR <100 initially). The resuscitation team must decide on airway management.", "question": "According to CURRENT NRP (Neonatal Resuscitation Program) guidelines, what is the recommended approach to a NON-VIGOROUS infant born through meconium?", "choices": [{"id": "node-2-choice-a", "text": "Begin positive pressure ventilation if not breathing; intubate and suction ONLY if airway is obstructed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Current NRP guidelines (since 2015) emphasize **initiating ventilation** in non-vigorous infants rather than delaying for suctioning. **Routine intubation and tracheal suctioning is NO LONGER recommended** even for non-vigorous infants. Intubate and suction ONLY if the airway appears **obstructed** and ventilation is ineffective. Studies showed no benefit to routine suctioning and potential harm from delayed ventilation.", "consequence": "You follow current evidence-based guidelines.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Always intubate and suction below the cords before any ventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is **OUTDATED practice**. Previous guidelines recommended routine tracheal suctioning for all non-vigorous meconium-stained infants. **Current NRP guidelines (2015+)** emphasize **not delaying ventilation** for suctioning. Studies showed routine suctioning didn't improve outcomes and delayed needed ventilation.", "consequence": "Following outdated guidelines.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Aggressive oropharyngeal suctioning before delivering the shoulders", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is also **OUTDATED**. Previously, obstetricians were taught to suction the oropharynx before delivering the shoulders. Current guidelines recommend **against** routine intrapartum oropharyngeal suctioning as it has not been shown to prevent MAS.", "consequence": "Outdated obstetric practice.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Immediate bag-mask ventilation with high pressures to clear meconium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While ventilation should be initiated, using **high pressures aggressively** can push meconium deeper into the airways and cause **air leak** (pneumothorax). Use gentle ventilation initially. If ventilation is ineffective due to airway obstruction, then consider intubation and suctioning.", "consequence": "Aggressive ventilation can worsen injury.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "No intervention needed - observe and stimulate only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **non-vigorous** infant (limp, poor respiratory effort, HR <100) requires intervention. If not breathing or HR <100 after initial steps, **positive pressure ventilation** should be initiated. Observation alone is inappropriate for a non-vigorous infant.", "consequence": "Inadequate resuscitation of compromised neonate.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**NRP guideline change (2015)**: Routine tracheal suctioning of non-vigorous meconium-stained infants is **NO LONGER recommended**. Focus on initiating ventilation. Intubate and suction ONLY if airway obstruction prevents effective ventilation. For **vigorous** infants (crying, good tone), no special intervention needed regardless of meconium."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is stabilized with PPV and admitted to NICU. CXR shows: coarse, irregular opacities (patchy infiltrates), hyperinflation with flattened diaphragms, and areas of atelectasis. She requires intubation and mechanical ventilation with FiO2 70%.", "question": "What is the MOST common and serious COMPLICATION to monitor for in MAS?", "choices": [{"id": "node-3-choice-a", "text": "Persistent Pulmonary Hypertension of the Newborn (PPHN)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **PPHN** occurs in up to 30-50% of infants with severe MAS. Meconium causes pulmonary vasoconstriction, and hypoxia/acidosis worsen the pulmonary hypertension. Signs: severe hypoxemia, cyanosis with minimal response to oxygen, right-to-left shunting (pre-/post-ductal saturation difference). Treatment: correct hypoxia/acidosis, **inhaled nitric oxide (iNO)**, and potentially **ECMO** for refractory cases.", "consequence": "You recognize the critical complication.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Air leak syndromes (pneumothorax, pneumomediastinum)", "isOptimal": false, "isAcceptable": true, "feedback": "Air leaks are indeed **common** in MAS (10-20%) due to the ball-valve effect of meconium causing air trapping and alveolar rupture. However, **PPHN** is the most serious complication with highest mortality risk. Air leaks require chest tube drainage but are mechanically manageable.", "consequence": "Important complication but PPHN is more serious.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Bronchopulmonary dysplasia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **BPD** is a complication of **prolonged mechanical ventilation in premature infants**, not term infants with MAS. While some MAS patients may have prolonged ventilatory needs, BPD is not the characteristic complication of MAS.", "consequence": "BPD is a prematurity complication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Necrotizing enterocolitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **NEC** is primarily a complication of **prematurity** and is rare in term infants. While meconium passage indicates some degree of fetal stress, NEC is not a characteristic complication of MAS.", "consequence": "NEC is a prematurity complication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Intraventricular hemorrhage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **IVH** is a complication of **prematurity** (fragile germinal matrix blood vessels). Term infants with MAS are not at increased risk for IVH. They may have hypoxic-ischemic brain injury if severely hypoxic, but not IVH.", "consequence": "IVH is a prematurity complication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PPHN complicating MAS**: Look for **pre-/post-ductal SpO2 difference >10%** (right-to-left shunting through PDA). Treatment ladder: optimize ventilation \u2192 correct acidosis \u2192 **iNO** (pulmonary vasodilator) \u2192 **ECMO** for refractory cases. MAS with PPHN carries highest mortality (~20% even with modern therapy)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The infant's oxygenation worsens despite high FiO2. Pre-ductal SpO2 (right hand) is 92% but post-ductal (foot) is 75%, confirming right-to-left shunting through the PDA consistent with PPHN.", "question": "What is the MOST appropriate next step in managing this infant with MAS complicated by PPHN?", "choices": [{"id": "node-4-choice-a", "text": "Inhaled nitric oxide (iNO) therapy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Inhaled nitric oxide (iNO)** is a selective pulmonary vasodilator that reduces pulmonary vascular resistance without systemic effects. It's first-line pharmacotherapy for PPHN. Starting dose is typically **20 ppm**. Response (improved oxygenation) is usually seen within 30-60 minutes. iNO has reduced the need for ECMO in PPHN.", "consequence": "Appropriate escalation of therapy.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue current ventilator settings and observe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant has **confirmed PPHN with significant right-to-left shunting**. Observation without escalating therapy will allow continued hypoxemia and potential end-organ damage. Active intervention with pulmonary vasodilators is indicated.", "consequence": "Inadequate response to severe PPHN.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Surfactant replacement therapy alone", "isOptimal": false, "isAcceptable": true, "feedback": "**Surfactant** may be helpful in MAS (meconium inactivates surfactant), and is sometimes used. However, it does not directly address the **pulmonary hypertension**. For PPHN with significant shunting, **iNO** is the priority. Some protocols use both surfactant AND iNO.", "consequence": "Helpful but doesn't address PPHN directly.", "nextNodeId": "node-5"}, {"id": "node-4-choice-d", "text": "IV sildenafil as first-line therapy", "isOptimal": false, "isAcceptable": true, "feedback": "**Sildenafil** (PDE5 inhibitor) is used for PPHN, especially when iNO is unavailable or as adjunct therapy. However, **iNO is first-line** because it's a selective pulmonary vasodilator delivered directly to ventilated lung. Sildenafil has systemic effects and may cause hypotension.", "consequence": "Second-line agent; iNO preferred.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Immediate ECMO cannulation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ECMO** is reserved for refractory PPHN that fails iNO and other medical therapies. It's a highly invasive rescue therapy. This infant should first receive a trial of **iNO** before ECMO is considered.", "consequence": "ECMO is rescue therapy after iNO fails.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**iNO** is selective pulmonary vasodilator - reaches ventilated alveoli, causes local vasodilation, and improves V/Q matching. **ECMO criteria**: Oxygenation index (OI) >40 despite iNO, or failure to improve with maximal therapy. MAS is one of the **most common indications** for neonatal ECMO."}, "node-5": {"id": "node-5", "type": "decision", "content": "iNO is started at 20 ppm with improvement in oxygenation. Over the next 5 days, the infant gradually improves and is weaned from iNO and the ventilator. Parents ask about long-term prognosis.", "question": "What is the MOST accurate statement about long-term outcomes after MAS?", "choices": [{"id": "node-5-choice-a", "text": "Most survivors have good outcomes; minority may have reactive airway disease or neurodevelopmental issues", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Most MAS survivors have favorable outcomes**. However, some long-term sequelae can occur: (1) **Reactive airway disease/recurrent wheezing** - more common than general population in first years, (2) **Neurodevelopmental issues** - related to perinatal hypoxia, not MAS itself, (3) **Hearing deficits** - rarely from ECMO if used. Overall survival with modern therapy (iNO, ECMO) is >95% even for severe MAS.", "consequence": "Balanced, realistic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "All MAS survivors have permanent lung damage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Most infants recover completely** without permanent lung damage. While some may have increased airway reactivity in early childhood, the majority of MAS survivors have normal lung function by school age.", "consequence": "Overly pessimistic prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "MAS has no effect on long-term outcomes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While outcomes are generally good, MAS (especially severe cases requiring ECMO) can have some long-term effects. Increased rates of reactive airway disease and potential neurodevelopmental issues from perinatal hypoxia mean follow-up is important.", "consequence": "Ignoring potential long-term issues.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "All infants require lifelong pulmonary medications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Most MAS survivors do NOT require long-term pulmonary medications**. Some may have increased wheezing in infancy that resolves. Only those with significant chronic lung disease (rare) would need ongoing treatment.", "consequence": "Overly aggressive long-term management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Mortality is still >50% despite modern therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Modern mortality for MAS is <5%** with current therapies (iNO, surfactant, ECMO when needed). Even severe MAS with PPHN has survival >80-90% in ECMO centers. This is a dramatic improvement from the pre-iNO era.", "consequence": "Outdated mortality statistics.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**MAS prognosis** has dramatically improved: survival >95% with modern care. Long-term: (1) Some have reactive airway disease in early childhood (usually resolves), (2) Neurodevelopmental outcomes depend on degree of perinatal asphyxia, (3) Most have normal lung function by school age. **Prevention** is key: recognize fetal distress, avoid post-term pregnancy, appropriate resuscitation."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed MAS in this post-term infant. You understood the triple pathophysiology (obstruction, chemical pneumonitis, surfactant inactivation), followed current NRP guidelines (ventilation priority, not routine suctioning), recognized PPHN as the most serious complication, appropriately escalated to iNO therapy, and provided realistic prognostic counseling. Key teaching points: (1) MAS = term/post-term infants, (2) Routine tracheal suctioning is NO LONGER recommended, (3) PPHN complicates 30-50% of severe MAS, (4) iNO is first-line for PPHN, (5) ECMO for refractory cases, (6) Most survivors have good outcomes."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review MAS key points: (1) Occurs in TERM/POST-TERM infants (meconium rare before 34 weeks), (2) Triple injury: mechanical obstruction + chemical pneumonitis + surfactant inactivation, (3) Current NRP: DO NOT routinely suction - prioritize ventilation, (4) CXR: patchy infiltrates + hyperinflation + atelectasis, (5) PPHN is the most serious complication - look for pre/post-ductal SpO2 difference, (6) Treatment: supportive care \u2192 surfactant \u2192 iNO \u2192 ECMO, (7) Outcomes are GOOD with modern therapy."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in MAS management. Remember: (1) Current NRP guidelines DO NOT recommend routine tracheal suctioning - prioritize ventilation, (2) A non-vigorous infant needs intervention - observation alone is inadequate, (3) PPHN with right-to-left shunting requires escalation to iNO, not observation, (4) Modern outcomes are EXCELLENT (>95% survival) - outdated statistics cause unnecessary alarm. Key pearl: MAS management has evolved significantly - stay updated on current guidelines."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-050", "title": "Congenital Diaphragmatic Hernia", "domain": "newborn", "difficulty": "intermediate", "tags": ["scaphoid abdomen", "bowel sounds in chest", "absent breath sounds on one side", "congenital diaphragmatic hernia"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 1-hour-old male is brought in by his parents for respiratory distress at birth for since birth.\n\nSubjectively, he was born with severe respiratory distress. His abdomen appears flat and his chest appears barrel-shaped on one side. He was intubated immediately after birth.\n\nscaphoid abdomen and absent breath sounds on left. No meconium aspiration.\n\nPast medical history includes Prenatal ultrasound showed herniation of abdominal contents into chest. Polyhydramnios was noted.\n\nPhysical Examination:\n- Respiratory: severe distress, absent breath sounds on left, bowel sounds heard in chest.\n- Abdomen: scaphoid (flat, hollow).\n- General: cyanotic newborn, barrel-shaped left hemithorax.\n- Vitals: cyanosis.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This newborn presents with immediate respiratory distress, a scaphoid abdomen, and bowel sounds audible in the chest. CXR shows bowel loops in the left hemithorax with mediastinal shift to the right. The stomach bubble is absent from the abdomen.", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Congenital diaphragmatic hernia (Bochdalek type)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The classic triad of **scaphoid abdomen**, **absent breath sounds on one side**, and **bowel sounds in the chest** is pathognomonic for CDH. The **Bochdalek type** (posterolateral defect) accounts for 85-90% of cases and is most commonly left-sided (80%).", "consequence": "Diagnosis confirmed. Proceed to immediate airway management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Congenital cystic adenomatoid malformation (CCAM)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CCAM presents with cystic lung lesions on imaging, but the abdomen would be normal (not scaphoid), and bowel sounds would not be heard in the chest. The absent stomach bubble in abdomen indicates abdominal contents have herniated into the thorax.", "consequence": "Misdiagnosis delays critical airway intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Tension pneumothorax", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Tension pneumothorax causes absent breath sounds and mediastinal shift, but the CXR would show hyperinflation and absent lung markings, NOT bowel loops in the chest. The scaphoid abdomen is inconsistent with pneumothorax.", "consequence": "Needle decompression would be ineffective and delays proper treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Respiratory distress syndrome (RDS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RDS in preterm infants shows diffuse **ground-glass opacities** and **air bronchograms** on CXR due to surfactant deficiency. The bowel loops in chest and scaphoid abdomen are not features of RDS.", "consequence": "Surfactant administration would not address the underlying anatomic defect.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Esophageal atresia with tracheoesophageal fistula", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. EA/TEF presents with excessive drooling, choking with feeds, and inability to pass an NG tube. The abdomen would not be scaphoid, and CXR would not show bowel in the chest unless there's a coexisting CDH.", "consequence": "Misdiagnosis delays critical airway intervention.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "The **scaphoid abdomen** occurs because abdominal contents have herniated into the chest, leaving the abdomen empty and flat. This finding plus bowel sounds in chest = CDH until proven otherwise."}, "node-2": {"id": "node-2", "type": "decision", "content": "The diagnosis of left-sided Bochdalek-type CDH is confirmed. The infant is cyanotic with oxygen saturations in the 70s despite supplemental oxygen. The delivery team is preparing for resuscitation.", "question": "What is the most critical immediate intervention?", "choices": [{"id": "node-2-choice-a", "text": "Immediate endotracheal intubation without bag-mask ventilation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Avoid bag-mask ventilation** at all costs - it forces air into the stomach and bowel that are in the chest, further compressing the hypoplastic lungs. Immediate **endotracheal intubation** is the cornerstone of CDH resuscitation.", "consequence": "Airway secured. Positive pressure ventilation delivered directly to lungs.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Begin bag-mask ventilation with 100% oxygen", "isOptimal": false, "isAcceptable": false, "feedback": "INCORRECT and potentially fatal! Bag-mask ventilation inflates the stomach and intestines that are herniated into the chest, causing **progressive lung compression** and worsening respiratory failure. This is a critical mistake in CDH management.", "consequence": "Gastric distension in thorax worsens lung compression and hypoxia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Place orogastric tube to decompress stomach, then intubate", "isOptimal": false, "isAcceptable": true, "feedback": "OG tube placement is important but should happen **after** or **during** intubation, not before. The priority is securing the airway. OG decompression can help reduce bowel distension in the chest but should not delay intubation.", "consequence": "Slight delay in securing airway, but OG decompression is appropriate.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "High-frequency oscillatory ventilation (HFOV) via face mask", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HFOV requires endotracheal intubation - it cannot be delivered via face mask. Additionally, any mask ventilation risks gastric insufflation. Intubation must come first.", "consequence": "Impossible to deliver HFOV without intubation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "CPAP via nasal prongs while preparing for intubation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Nasal CPAP, like bag-mask, can force air into the stomach and worsen thoracic compression. CDH infants should be intubated immediately without any non-invasive positive pressure support.", "consequence": "Gastric insufflation worsens respiratory status.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**NO BAG-MASK** in CDH is a board favorite! The mnemonic: **CDH = Can't Do (bag-mask) Here**. Intubate immediately and place an OG tube to decompress the stomach."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is now intubated and an OG tube is placed to low intermittent suction. Despite mechanical ventilation with 100% FiO2, saturations remain in the low 80s with significant pre-ductal/post-ductal oxygen saturation difference (right hand 88%, foot 72%).", "question": "What does this saturation difference indicate, and what is the next management priority?", "choices": [{"id": "node-3-choice-a", "text": "Persistent pulmonary hypertension (PPHN); initiate inhaled nitric oxide (iNO)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **pre-ductal/post-ductal saturation difference >5%** indicates right-to-left shunting through the PDA due to **persistent pulmonary hypertension of the newborn (PPHN)**. Pulmonary hypoplasia in CDH leads to elevated pulmonary vascular resistance. **Inhaled nitric oxide (iNO)** is a selective pulmonary vasodilator that reduces right-to-left shunting.", "consequence": "iNO initiated at 20 ppm. Saturations begin to improve.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Right-to-left shunting through a VSD; obtain echocardiogram", "isOptimal": false, "isAcceptable": true, "feedback": "Echocardiogram is appropriate to evaluate for associated cardiac anomalies (present in 10-15% of CDH), but the pre/post-ductal difference specifically indicates **PDA-level shunting** due to PPHN, not intracardiac shunting. Echo should be done but iNO should not be delayed.", "consequence": "Echo ordered, but PPHN treatment delayed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Cyanotic heart disease; emergent cardiac surgery consultation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While CDH can be associated with cardiac anomalies, the clinical picture (scaphoid abdomen, bowel in chest, known CDH) explains the hypoxia. The pre/post-ductal difference is due to PPHN with right-to-left ductal shunting, not primary cardiac disease.", "consequence": "Unnecessary cardiac consultation delays PPHN treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Inadequate ventilation; increase ventilator pressures aggressively", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! **Gentle ventilation** is critical in CDH to avoid barotrauma to the hypoplastic lungs. Aggressive high-pressure ventilation causes pneumothorax and worsens outcomes. The saturation difference indicates PPHN, not hypoventilation.", "consequence": "High pressures cause pneumothorax in hypoplastic lung.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Pneumothorax on the contralateral side; obtain CXR and prepare for chest tube", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A pneumothorax would not cause a pre/post-ductal saturation difference. The asymmetric saturations indicate ductal-level right-to-left shunting from PPHN. A pneumothorax would more likely cause acute decompensation.", "consequence": "Unnecessary chest tube placement delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pre-ductal** (right hand) vs **post-ductal** (foot) saturation difference >5% = right-to-left shunting at the ductus. In CDH, this is due to PPHN from pulmonary hypoplasia. **iNO** is first-line for pulmonary vasodilation."}, "node-4": {"id": "node-4", "type": "decision", "content": "Despite iNO at 20 ppm and optimized ventilator settings (gentle ventilation with permissive hypercapnia), the infant remains hypoxic with saturations of 75% and is developing metabolic acidosis (pH 7.18, lactate 8). Echocardiogram confirms severe PPHN with suprasystemic pulmonary pressures.", "question": "The infant is not responding to maximal medical management. What is the next step?", "choices": [{"id": "node-4-choice-a", "text": "Initiate ECMO (extracorporeal membrane oxygenation)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ECMO** is indicated for CDH infants with refractory hypoxemia despite maximal medical therapy (iNO, optimized ventilation). ECMO provides cardiopulmonary bypass to allow lung rest and time for pulmonary vascular resistance to decrease. **Oxygenation index (OI) >40** or inability to maintain preductal saturations >85% are indications for ECMO.", "consequence": "ECMO cannulation performed. Infant stabilizes on bypass.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Proceed immediately to surgical repair of the diaphragmatic defect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delayed surgical repair** (after stabilization) is the current standard of care for CDH. Operating on an unstable infant with severe PPHN increases mortality. Surgery is performed once the infant is stabilized, often after a period of ECMO support.", "consequence": "Surgery on unstable infant leads to intraoperative cardiac arrest.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Increase iNO to 80 ppm and add sildenafil", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. iNO doses >20 ppm do not provide additional benefit and increase the risk of **methemoglobinemia**. The infant has already failed iNO therapy; escalation to ECMO is indicated rather than maximizing medical therapy that is not working.", "consequence": "Methemoglobinemia develops, worsening hypoxia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "High-frequency oscillatory ventilation (HFOV) as rescue therapy", "isOptimal": false, "isAcceptable": true, "feedback": "HFOV can be tried as a bridge, but this infant has already failed maximal medical management with severe metabolic acidosis. HFOV may provide temporary stabilization but ECMO is ultimately indicated for refractory cases.", "consequence": "HFOV initiated but infant continues to deteriorate.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Comfort care discussion with family given poor prognosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect at this stage. While CDH has significant mortality, ECMO has improved survival for severe cases. Comfort care discussion may be appropriate if ECMO is contraindicated or fails, but should not be offered before attempting ECMO support.", "consequence": "Premature withdrawal of care for potentially salvageable infant.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ECMO criteria in CDH**: OI >40, preductal sats <85% despite maximal therapy, or refractory metabolic acidosis. Remember: **\"Stabilize before surgery\"** - delayed repair after ECMO weaning is the modern approach."}, "node-5": {"id": "node-5", "type": "decision", "content": "After 7 days on ECMO, the infant's pulmonary vascular resistance has decreased and he is successfully decannulated. He is now stable on conventional ventilation with FiO2 40%. The pediatric surgery team is planning diaphragmatic repair.", "question": "Which of the following is TRUE regarding surgical repair and long-term outcomes in CDH?", "choices": [{"id": "node-5-choice-a", "text": "Primary repair is preferred when possible; Gore-Tex patch used for large defects. Long-term issues include chronic lung disease, GERD, feeding difficulties, and neurodevelopmental delays.", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Primary repair** (direct closure) is preferred when there is sufficient diaphragmatic tissue. Large defects require a **prosthetic patch** (Gore-Tex). Long-term complications include **chronic lung disease** (from pulmonary hypoplasia), **GERD** (from altered anatomy), **feeding difficulties**, **failure to thrive**, **scoliosis**, and **neurodevelopmental delays** (especially after ECMO).", "consequence": "Surgery is successful. Family counseled on long-term follow-up needs.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "All CDH repairs require mesh patch placement; infants have normal lung function after successful repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Small defects can be repaired primarily without a patch. Additionally, **pulmonary hypoplasia is permanent** - the lungs do not fully recover even after successful repair. Many CDH survivors have chronic lung disease requiring ongoing pulmonary follow-up.", "consequence": "Family given inaccurate expectations about long-term outcomes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Surgical repair should be done emergently within the first 24 hours of life regardless of clinical status", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delayed repair after stabilization** is the current standard. Studies show no benefit to emergent surgery, and operating on unstable infants increases mortality. Repair is typically performed once PPHN has resolved and the infant is stable.", "consequence": "Outdated practice that would increase mortality risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "CDH has >95% survival rate with modern ECMO and surgical techniques", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Despite advances, **CDH mortality remains 20-40%** depending on severity and associated anomalies. Liver herniation into the chest ('liver-up') and severe pulmonary hypoplasia are poor prognostic indicators.", "consequence": "Family given falsely reassuring prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Recurrence of hernia is rare; no long-term surgical follow-up needed after successful repair", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hernia recurrence** occurs in 10-20% of repairs (higher with patch repairs). Long-term surgical follow-up is essential to monitor for recurrence, bowel obstruction, and chest wall deformities.", "consequence": "Inadequate follow-up plan misses recurrence.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "CDH survivors need **multidisciplinary long-term follow-up**: pulmonology (chronic lung disease), GI (GERD, feeding), surgery (recurrence), and developmental pediatrics. **Prenatal prognostic factors**: lung-to-head ratio (LHR), liver position, stomach position."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed this complex case of congenital diaphragmatic hernia.\n\n**Key Learning Points:**\n1. **Recognition**: Scaphoid abdomen + absent breath sounds + bowel sounds in chest = CDH\n2. **Airway**: NO bag-mask ventilation! Intubate immediately + OG decompression\n3. **PPHN Management**: Pre/post-ductal sat difference indicates ductal shunting; iNO is first-line\n4. **ECMO**: For refractory hypoxemia despite maximal medical therapy\n5. **Surgery**: Delayed repair after stabilization; primary closure or patch\n6. **Long-term**: Chronic lung disease, GERD, feeding issues, developmental delays\n\nCDH mortality remains 20-40% despite advances. Prenatal diagnosis and delivery at a specialized center improve outcomes."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key management principles:\n\n1. **NO BAG-MASK** - Intubate immediately to avoid gastric insufflation\n2. **Gentle ventilation** - Avoid barotrauma to hypoplastic lungs\n3. **PPHN is common** - iNO for pulmonary vasodilation\n4. **ECMO for refractory cases** - Stabilize before surgery\n5. **Delayed surgical repair** - Modern standard of care"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in CDH management. Key pearls:\n\n**NEVER bag-mask ventilate** - This inflates the stomach/bowel in the chest and worsens lung compression.\n**Gentle ventilation** - High pressures cause pneumothorax in hypoplastic lungs.\n**Stabilize before surgery** - Operating on unstable infants increases mortality.\n**ECMO** is indicated for refractory hypoxemia, not aggressive ventilation or early surgery."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-068", "title": "Infant of Diabetic Mother", "domain": "newborn", "difficulty": "intermediate", "tags": ["LGA infant", "jitteriness", "poor feeding in first hours", "mother with diabetes", "infant of diabetic mother"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 1-hour-old male, large for gestational age and born to a diabetic mother, presents with jitteriness and tremors.\n\nSubjectively, he was born to a mother with poorly controlled gestational diabetes. He is tremulous and not feeding well. He weighs 4.8 kg (large for gestational age).\n\nReview of systems is positive for macrosomia and hypoglycemia symptoms and negative for respiratory distress.\n\nPertinent history includes Mother had gestational diabetes with HbA1c of 8%. Delivery was complicated by shoulder dystocia.\n\nPhysical Examination:\n- General: large, plethoric newborn with jitteriness.\n- Cardiovascular: possible cardiomegaly.\n- Clavicles: intact bilaterally after shoulder dystocia.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This large-for-gestational-age (LGA) newborn of a diabetic mother with poor glycemic control (HbA1c 8%) presents with classic signs of hypoglycemia: jitteriness, tremors, and poor feeding. Delivery was complicated by shoulder dystocia (common in macrosomic infants).", "question": "What is the pathophysiology of hypoglycemia in infants of diabetic mothers?", "choices": [{"id": "node-1-choice-a", "text": "Fetal hyperinsulinemia from maternal hyperglycemia, leading to rapid glucose consumption after birth", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Maternal hyperglycemia \u2192 placental glucose transfer \u2192 fetal hyperglycemia \u2192 fetal pancreatic \u03b2-cell hyperplasia \u2192 hyperinsulinemia**. After birth, the maternal glucose supply is abruptly cut off, but the infant's elevated insulin levels persist, causing rapid glucose consumption and **neonatal hypoglycemia** within the first 1-3 hours of life.", "consequence": "You understand the mechanism. Proceed to immediate glucose assessment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Pancreatic agenesis from teratogenic effects of diabetes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM infants have **excessive** insulin production from \u03b2-cell hyperplasia, not pancreatic agenesis. The problem is too much insulin, not too little.", "consequence": "Misunderstanding the pathophysiology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Inadequate glycogen stores due to intrauterine growth restriction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM infants are typically **LGA (macrosomic)**, not growth restricted. They actually have increased glycogen stores, but the hyperinsulinemia causes rapid consumption. IUGR-related hypoglycemia has a different mechanism.", "consequence": "Misunderstanding IDM pathophysiology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Decreased gluconeogenesis due to liver immaturity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While gluconeogenesis may be impaired in some neonates, the primary mechanism in IDM is **hyperinsulinemia suppressing both glycogenolysis and gluconeogenesis**. The elevated insulin is the driver.", "consequence": "Misunderstanding primary mechanism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Insulin resistance inherited from the diabetic mother", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The infant has **excessive insulin sensitivity**, not resistance. Insulin works TOO WELL on the infant's tissues, rapidly driving glucose into cells and causing hypoglycemia.", "consequence": "Opposite of the actual mechanism.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Mnemonic - IDM complications 'HIPPO-C'**: **H**ypoglycemia, **I**njury (birth trauma), **P**olycythemia, **P**oor feeding/hypocalcemia, **O**rganomegaly (cardiomegaly), **C**ongenital anomalies (cardiac, caudal regression)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Point-of-care glucose is 28 mg/dL (normal >45 mg/dL in term newborns). The infant is jittery but alert, with good tone, and is attempting to feed.", "question": "What is the most appropriate initial management for this symptomatic hypoglycemia?", "choices": [{"id": "node-2-choice-a", "text": "IV dextrose bolus (D10W, 2 mL/kg) followed by continuous IV glucose infusion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Symptomatic hypoglycemia requires IV dextrose**. Give **D10W at 2 mL/kg (200 mg/kg glucose)** as a bolus, followed by continuous infusion at 5-8 mg/kg/min (glucose infusion rate or GIR). Oral feeding alone is insufficient for symptomatic hypoglycemia.", "consequence": "Glucose rises to 62 mg/dL after bolus. Continuous infusion started.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Breastfeed or give oral glucose gel and recheck in 30 minutes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for **symptomatic** hypoglycemia. Oral feeding and glucose gel are appropriate for **asymptomatic** hypoglycemia. This infant is symptomatic (jittery, tremulous) and needs **IV dextrose** to rapidly correct glucose levels and prevent neurologic injury.", "consequence": "Delayed treatment risks brain injury from prolonged hypoglycemia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Give IV D50W bolus (50% dextrose) for rapid correction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **D50W is contraindicated in neonates** due to hyperosmolarity, risk of rebound hypoglycemia from insulin surge, and potential for extravasation injury. Use **D10W** (10% dextrose) in neonates.", "consequence": "Rebound hypoglycemia and potential extravasation injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Glucagon IM injection", "isOptimal": false, "isAcceptable": true, "feedback": "Glucagon can be used as a temporizing measure when IV access is difficult, but it has limited efficacy in hyperinsulinemic states because glycogen stores are rapidly depleted by the high insulin levels. **IV dextrose is preferred** when available.", "consequence": "Partial response. IV dextrose still needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Observe and recheck glucose in 1 hour", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! **Symptomatic hypoglycemia is a medical emergency**. Prolonged hypoglycemia causes permanent neurologic damage. Immediate treatment is required, not observation.", "consequence": "Seizures develop from prolonged hypoglycemia.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Treatment threshold**: <25 mg/dL in first 4 hours, <35 mg/dL at 4-24 hours (AAP guidelines). **Symptomatic always = IV dextrose**. Asymptomatic can trial oral feeds first. **Goal**: Maintain glucose >45 mg/dL."}, "node-3": {"id": "node-3", "type": "decision", "content": "After IV dextrose bolus and starting continuous infusion at GIR 6 mg/kg/min, glucose is 65 mg/dL. However, on exam you note a holosystolic murmur at the left lower sternal border and cardiomegaly on CXR.", "question": "What cardiac abnormalities are associated with infants of diabetic mothers?", "choices": [{"id": "node-3-choice-a", "text": "Hypertrophic cardiomyopathy (asymmetric septal hypertrophy) and increased risk of VSD/TGA", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! IDM infants have two major cardiac risks: (1) **Hypertrophic cardiomyopathy** (HCM) with asymmetric septal hypertrophy from fetal hyperinsulinemia stimulating myocardial growth - usually transient and resolves by 6-12 months; (2) **Congenital heart defects** - VSD, TGA, coarctation of aorta are more common in IDM.", "consequence": "Echocardiogram ordered to evaluate cardiac structure and function.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Dilated cardiomyopathy with systolic dysfunction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM causes **hypertrophic** cardiomyopathy, not dilated. The ventricular walls (especially septum) are thickened due to hyperinsulinemia's anabolic effects on cardiac muscle. Systolic function is usually preserved or hyperdynamic.", "consequence": "Incorrect type of cardiomyopathy identified.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Tetralogy of Fallot is the most common CHD in IDM", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While CHD risk is elevated, **VSD is the most common** structural defect in IDM, followed by TGA and coarctation. Tetralogy of Fallot is not specifically associated with maternal diabetes.", "consequence": "Incorrect CHD association.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Patent ductus arteriosus requiring immediate closure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PDA is associated with prematurity, not specifically with maternal diabetes. IDM infants are typically full-term or post-term. The cardiac associations are HCM and structural defects (VSD, TGA, coarctation).", "consequence": "Incorrect cardiac association.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "No specific cardiac associations; murmur is likely innocent", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM is strongly associated with cardiac abnormalities. A murmur in an IDM infant warrants echocardiogram evaluation, not dismissal. **Cardiac anomalies occur in 3-5% of IDM infants**, significantly higher than the general population.", "consequence": "Failure to evaluate significant cardiac risk.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**IDM cardiomyopathy** is due to fetal hyperinsulinemia stimulating myocardial cell growth. It causes **asymmetric septal hypertrophy** that can cause outflow obstruction. Usually **resolves by 6-12 months** as insulin levels normalize."}, "node-4": {"id": "node-4", "type": "decision", "content": "Echocardiogram shows asymmetric septal hypertrophy (interventricular septum 8mm, posterior wall 4mm) with mild left ventricular outflow tract obstruction. No structural CHD. The infant's glucose has stabilized on IV dextrose. On day 2 of life, labs show: Calcium 6.8 mg/dL (low), Hematocrit 72% (high), Bilirubin 8 mg/dL.", "question": "What additional complications are demonstrated in this infant's labs?", "choices": [{"id": "node-4-choice-a", "text": "Hypocalcemia (from functional hypoparathyroidism) and polycythemia (from chronic fetal hypoxia)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Hypocalcemia** (Ca <7 mg/dL in term newborns) occurs due to functional hypoparathyroidism - unclear mechanism but may relate to maternal/fetal magnesium imbalance. **Polycythemia** (Hct >65%) results from chronic intrauterine hypoxia stimulating erythropoietin, plus increased red cell production from hyperinsulinemia. May cause hyperviscosity symptoms.", "consequence": "Calcium supplementation initiated. Monitor for hyperviscosity symptoms.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Hyperkalemia and anemia requiring transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM causes hypo-calcemia (not hyperkalemia) and poly-cythemia (not anemia). The hematocrit of 72% indicates too many red cells, which can cause hyperviscosity syndrome with symptoms of jitteriness, respiratory distress, and thrombosis.", "consequence": "Incorrect metabolic abnormalities identified.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Normal findings; no treatment needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ca 6.8 mg/dL is **hypocalcemia** (symptomatic <7 mg/dL), and Hct 72% is **polycythemia** (>65%). Both require monitoring and potential treatment. These are common IDM complications.", "consequence": "Failure to recognize metabolic derangements.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Hypomagnesemia causing seizures", "isOptimal": false, "isAcceptable": true, "feedback": "Hypomagnesemia can occur in IDM and can contribute to hypocalcemia (Mg needed for PTH function). However, the labs given show hypocalcemia and polycythemia - both classic IDM findings. Magnesium should be checked if calcium doesn't respond to supplementation.", "consequence": "Partial answer; hypocalcemia and polycythemia are the primary findings shown.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Hemolytic disease requiring phototherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bilirubin is elevated, the polycythemia (not hemolysis) contributes to hyperbilirubinemia in IDM. The primary finding is Hct 72%, indicating polycythemia which increases bilirubin production from increased RBC mass.", "consequence": "Incorrect mechanism for hyperbilirubinemia.", "nextNodeId": "node-5"}], "clinicalPearl": "**IDM metabolic complications**: Hypoglycemia (first 1-3 hours), Hypocalcemia (24-72 hours), Hypomagnesemia (any time), Polycythemia \u2192 hyperbilirubinemia. **Monitor all IDM infants** with serial glucose, calcium, and Hct."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant is treated with IV calcium gluconate for hypocalcemia. Glucose is weaned successfully by day 3. The cardiomyopathy is being monitored. Parents ask about long-term prognosis and other complications to watch for.", "question": "What is the expected prognosis and what congenital anomaly is uniquely associated with pregestational (preexisting) diabetes?", "choices": [{"id": "node-5-choice-a", "text": "Good prognosis - metabolic issues resolve; caudal regression syndrome (sacral agenesis) is uniquely associated with pregestational diabetes", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Most IDM complications are **transient**: hypoglycemia resolves once feeding is established, cardiomyopathy regresses by 6-12 months, polycythemia/hypocalcemia are temporary. **Caudal regression syndrome** (sacral agenesis, lower extremity hypoplasia) is a rare but **pathognomonic** anomaly of pregestational diabetes - occurs due to poor glycemic control during organogenesis (first trimester).", "consequence": "Family counseled on good prognosis. Follow-up arranged for cardiac monitoring.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Poor prognosis - permanent cardiac dysfunction and lifelong insulin requirement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM infants do NOT have permanent hyperinsulinism - it resolves as maternal glucose exposure ends. The **hypertrophic cardiomyopathy typically resolves** by 6-12 months. Prognosis is generally excellent with appropriate neonatal management.", "consequence": "Inappropriately pessimistic counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Neural tube defects are uniquely associated with gestational diabetes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Neural tube defects** (spina bifida, anencephaly) are associated with **pregestational diabetes**, not gestational diabetes specifically. Risk is highest with poor first-trimester glycemic control. **Caudal regression syndrome** is the anomaly most uniquely/pathognomonic for maternal diabetes.", "consequence": "Incorrect specific association.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Increased risk of childhood obesity and type 2 diabetes later in life", "isOptimal": false, "isAcceptable": true, "feedback": "This is true - IDM infants do have increased long-term risk of metabolic syndrome, obesity, and type 2 diabetes due to fetal programming. However, the question specifically asks about congenital anomalies. **Caudal regression syndrome** is the pathognomonic congenital finding.", "consequence": "Correct long-term risk, but not the pathognomonic congenital anomaly asked about.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-e", "text": "Down syndrome is more common in infants of diabetic mothers", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Down syndrome is associated with advanced maternal age, not maternal diabetes. The congenital anomalies associated with maternal diabetes include cardiac defects, caudal regression, neural tube defects, and renal anomalies.", "consequence": "Incorrect association.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Caudal regression syndrome** (sacral agenesis) is virtually **pathognomonic** for maternal diabetes - 200-400x increased risk. Occurs due to hyperglycemia during weeks 3-7 of gestation. Most severe form: sirenomelia (mermaid syndrome)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of an infant of diabetic mother!\n\n**Key Learning Points:**\n1. **Pathophysiology**: Maternal hyperglycemia \u2192 fetal hyperinsulinemia \u2192 macrosomia + metabolic complications\n2. **Hypoglycemia**: First 1-3 hours; symptomatic = IV D10W bolus + infusion; goal glucose >45 mg/dL\n3. **Cardiac**: HCM (transient, resolves 6-12 months) + increased CHD risk (VSD, TGA, coarctation)\n4. **Other metabolic**: Hypocalcemia (24-72 hrs), hypomagnesemia, polycythemia \u2192 hyperbilirubinemia\n5. **Birth trauma**: Macrosomia \u2192 shoulder dystocia \u2192 brachial plexus injury, clavicle fracture\n6. **Congenital anomalies**: Caudal regression (pathognomonic), cardiac, NTD, renal\n7. **Prognosis**: Excellent - most complications are transient\n\n**Mnemonic 'HIPPO-C'**: Hypoglycemia, Injury, Polycythemia, Poor feeding/hypocalcemia, Organomegaly, Congenital anomalies"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key IDM pearls:\n\n1. **Hyperinsulinemia** is the key mechanism - causes hypoglycemia, macrosomia, cardiomyopathy\n2. **Symptomatic hypoglycemia = IV dextrose** (D10W 2 mL/kg bolus + infusion)\n3. **NO D50W in neonates** - use D10W only\n4. **Cardiac**: HCM (transient) + VSD/TGA (structural)\n5. **Metabolic triad**: Hypoglycemia \u2192 Hypocalcemia \u2192 Hypomagnesemia\n6. **Caudal regression** is pathognomonic for maternal diabetes"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in IDM management.\n\n**Dangerous mistakes to avoid:**\n- **Delaying treatment of symptomatic hypoglycemia** \u2192 permanent brain injury\n- **Using D50W in neonates** \u2192 rebound hypoglycemia, tissue injury\n- **Oral feeds alone for symptomatic hypoglycemia** \u2192 inadequate correction\n- **Ignoring polycythemia** \u2192 hyperviscosity syndrome, stroke\n\n**Remember**: IDM hypoglycemia occurs in the first 1-3 hours. Check glucose at birth and serially. Symptomatic = IV dextrose immediately."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-069", "title": "Transient Tachypnea of the Newborn", "domain": "newborn", "difficulty": "intermediate", "tags": ["tachypnea after C-section", "wet lungs", "perihilar streaking on CXR", "fluid in fissures", "transient tachypnea of the newborn"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-hour-old female presents with fast breathing after birth for 2 hours.\n\nThe patient's mother reports, she was born via scheduled cesarean section and has been breathing fast since birth. She is not grunting severely. She is full-term and appears comfortable.\n\ncesarean delivery without labor. No meconium, prematurity, or maternal diabetes.\n\nPast medical history includes She was born at 38 weeks via elective cesarean for breech presentation. No labor occurred.\n\nPhysical Examination:\n- Respiratory: tachypnea (RR 70), mild retractions, no grunting.\n- General: full-term newborn, pink, comfortable.\n- Vitals: RR 70, SpO2 95%.\n- Oxygen saturation: 95% on room air.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 2-hour-old term female presents with tachypnea (RR 70) after **elective C-section without labor**. She has mild retractions but **no grunting** and appears comfortable. SpO\u2082 is 95% on room air.\n\n**Key history**: 38 weeks, breech presentation, **no labor** occurred before C-section. No meconium, no maternal diabetes, no prematurity risk factors.\n\n**CXR findings**: **Perihilar streaking**, **fluid in fissures**, mild hyperinflation, prominent pulmonary vasculature.\n\n**Differential diagnosis of neonatal respiratory distress:**\n- **TTN**: C-section, term, fluid in fissures, resolves 24-72h\n- **RDS**: Preterm, surfactant deficiency, ground-glass opacities, air bronchograms\n- **Pneumonia**: Fever, leukocytosis, focal infiltrates\n- **MAS**: Post-dates, meconium-stained fluid, patchy infiltrates", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Transient tachypnea of the newborn (TTN)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is classic **TTN** (\"wet lungs\"). Risk factors include **C-section without labor** (no thoracic squeeze to expel fetal lung fluid), term gestation, and elective delivery. CXR shows **perihilar streaking** and **fluid in fissures** - pathognomonic for retained fetal lung fluid. The infant is comfortable with mild tachypnea, no severe distress, supporting TTN over more serious conditions.", "consequence": "You correctly identify TTN and proceed to management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Respiratory distress syndrome (RDS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RDS is caused by **surfactant deficiency** and occurs primarily in **preterm infants** (<34 weeks). This infant is **term (38 weeks)** and was delivered by elective C-section. RDS CXR shows **ground-glass opacities** and **air bronchograms**, not fluid in fissures. The absence of prematurity and characteristic CXR findings rule out RDS.", "consequence": "Misdiagnosis leads to inappropriate consideration of surfactant therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Neonatal pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Neonatal pneumonia typically presents with **fever**, maternal risk factors (prolonged rupture of membranes, maternal fever, GBS colonization), and **focal infiltrates** on CXR. This infant has no infectious risk factors, no fever, and CXR shows diffuse perihilar streaking (not focal consolidation). The benign clinical appearance argues against sepsis/pneumonia.", "consequence": "Unnecessary workup and antibiotics if misdiagnosed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Meconium aspiration syndrome (MAS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MAS requires **meconium-stained amniotic fluid**, which was explicitly absent. MAS is more common in **post-term** infants (>42 weeks), not term elective C-sections. MAS CXR shows **patchy infiltrates** and hyperinflation from airway obstruction, not fluid in fissures. No meconium = no MAS.", "consequence": "Misdiagnosis without supporting history.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Congenital heart disease with pulmonary overcirculation", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable. CHD can present with tachypnea and pulmonary vascular congestion. However, this infant is **comfortable**, has **normal SpO\u2082 (95%)**, and the CXR shows **fluid in fissures** (not cardiomegaly or pulmonary edema pattern). The history of C-section without labor strongly suggests TTN. CHD should be considered if symptoms persist beyond 72 hours or oxygen requirement increases.", "consequence": "CHD should remain on differential but TTN is more likely given classic presentation.", "nextNodeId": "node-2"}], "clinicalPearl": "**C-section without labor** is the strongest risk factor for TTN - the \"thoracic squeeze\" during vaginal delivery helps expel fetal lung fluid. Elective C-sections bypass this mechanism."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose **TTN** based on the classic presentation. The infant continues with RR 70, SpO\u2082 95% on room air, mild retractions, but remains comfortable and pink.\n\n**TTN Management Principles:**\n- **Supportive care** is the mainstay\n- Supplemental O\u2082 to maintain SpO\u2082 >90%\n- **NPO** if RR >60-80 (aspiration risk)\n- **NO diuretics** (no proven benefit)\n- **NO antibiotics** unless infection suspected\n- Expected resolution: **24-72 hours**", "question": "What is the most appropriate initial management?", "choices": [{"id": "node-2-choice-a", "text": "Supplemental oxygen PRN, NPO with IV fluids, observation in nursery", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! TTN management is **supportive**: (1) **Supplemental O\u2082** as needed to maintain SpO\u2082 >90% (this infant is 95% on RA, so may not need O\u2082 yet). (2) **NPO with IV fluids** - tachypneic infants (RR >60-80) are at risk for aspiration during feeding. (3) **Observation** - TTN resolves within 24-72 hours. No specific treatment accelerates resolution.", "consequence": "Appropriate supportive care is initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Furosemide to accelerate fluid clearance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Diuretics do NOT improve TTN outcomes**. Multiple studies show furosemide does not shorten duration of tachypnea or oxygen requirement. Fetal lung fluid is cleared via **pulmonary lymphatics and capillaries**, not renal excretion. Diuretics may cause electrolyte imbalances and dehydration in newborns.", "consequence": "Unnecessary medication with no benefit and potential harm.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Empiric ampicillin and gentamicin for possible sepsis", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. In practice, many clinicians start empiric antibiotics in newborns with respiratory distress because early pneumonia/sepsis can mimic TTN. However, this infant has **no infectious risk factors** (no maternal fever, no prolonged ROM, no GBS), is **comfortable**, and has **classic TTN findings**. If antibiotics are started, they should be discontinued within 48 hours when cultures are negative and clinical improvement occurs.", "consequence": "Antibiotics may be reasonable but likely unnecessary in this classic TTN presentation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Intubation and surfactant administration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Surfactant is indicated for **RDS** (surfactant deficiency in preterm infants), NOT TTN. This term infant has **retained fetal lung fluid**, not surfactant deficiency. Surfactant administration would be invasive, expensive, and provide no benefit. The infant is stable on room air - intubation is not indicated.", "consequence": "Unnecessary invasive intervention for the wrong diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Allow breastfeeding on demand to promote bonding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Infants with **RR >60-80** should be **NPO** due to aspiration risk. Tachypneic infants cannot safely coordinate suck-swallow-breathe. This infant has RR 70 - oral feeding is contraindicated until respiratory rate normalizes. IV fluids should maintain hydration until feeding is safe (typically when RR <60).", "consequence": "Aspiration risk with oral feeding during tachypnea.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**NPO rule for tachypneic newborns**: RR >60-80 = NPO due to aspiration risk. The suck-swallow-breathe coordination is compromised during tachypnea."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is maintained on room air with IV fluids. Over the next 24 hours, her respiratory rate gradually decreases from 70 to 55. SpO\u2082 remains >95%. She appears increasingly alert and hungry.\n\nAt 36 hours of life, RR is 45, no retractions, SpO\u2082 98% on room air.\n\n**Expected TTN course:**\n- Peak symptoms in first 12-24 hours\n- Gradual improvement over 24-72 hours\n- Complete resolution by 72 hours\n\n**Red flags requiring reassessment:**\n- No improvement by 48-72 hours\n- Worsening oxygen requirement\n- New fever, lethargy, poor perfusion", "question": "At 36 hours with RR 45 and no distress, what is the appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Trial oral feeding and prepare for discharge if tolerated", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With RR now **45** (well below the 60-80 threshold), the infant can safely attempt **oral feeding**. TTN typically resolves by 72 hours, and this infant is following the expected course with improvement at 36 hours. If she tolerates feeds without desaturation or respiratory distress, she can be **discharged home** with routine newborn follow-up. No further workup is needed for classic TTN with resolution.", "consequence": "Appropriate transition to feeding and discharge planning.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Continue NPO for another 24 hours to ensure complete resolution", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With RR 45 and no distress, there is **no indication to continue NPO**. Prolonged NPO leads to unnecessary IV fluids, delays bonding and breastfeeding establishment, and prolongs hospitalization. The 60-80 RR threshold for NPO is evidence-based - once below this, oral feeding is safe to attempt.", "consequence": "Unnecessary prolongation of NPO delays feeding and discharge.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Echocardiogram to rule out congenital heart disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant has **classic TTN** with expected resolution - echo is not indicated. Echocardiogram should be considered if: (1) tachypnea **persists beyond 72 hours**, (2) oxygen requirement **increases** instead of improves, (3) **murmur** or signs of heart failure develop. Following the expected course for TTN does not warrant cardiac workup.", "consequence": "Unnecessary testing for resolving TTN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Repeat CXR to confirm fluid clearance before discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Repeat CXR is not routinely needed** for TTN. Clinical improvement (decreased RR, no distress, stable SpO\u2082) is sufficient to confirm resolution. CXR findings may lag behind clinical improvement. Unnecessary radiation exposure should be avoided in newborns. Repeat imaging is only indicated if symptoms worsen or fail to improve.", "consequence": "Unnecessary radiation without changing management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Lumbar puncture to rule out meningitis given prolonged tachypnea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant has no signs of infection - she is **afebrile**, **alert**, **improving**, and has a classic TTN presentation with expected resolution. LP would be indicated if there were fever, lethargy, seizures, or failure to improve. Tachypnea alone in the context of clear TTN does not warrant LP.", "consequence": "Unnecessary invasive procedure for improving TTN.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**TTN is a diagnosis of exclusion confirmed by resolution**. If tachypnea persists >72 hours, reconsider the diagnosis: RDS (rare in term), pneumonia, CHD, or other causes of persistent respiratory distress."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **TTN** based on: term infant, C-section without labor, tachypnea with mild distress, CXR showing fluid in fissures and perihilar streaking. Management was appropriately supportive: O\u2082 PRN, NPO with IV fluids while tachypneic, observation. Key teaching: (1) NO diuretics - they don't help TTN, (2) NPO when RR >60-80 due to aspiration risk, (3) Expected resolution within 24-72 hours, (4) If symptoms persist >72h, reconsider diagnosis (CHD, infection, RDS)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key TTN features: **C-section without labor** (no thoracic squeeze) \u2192 **retained fetal lung fluid** \u2192 **perihilar streaking** and **fluid in fissures** on CXR. Management is supportive only - diuretics don't work. NPO when RR >60-80, but can feed when RR normalizes. Resolution expected in 24-72 hours; persistence warrants reassessment for other diagnoses."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. TTN is the most common cause of neonatal respiratory distress in term infants. Key points: (1) Risk factor = C-section, especially without labor, (2) CXR = fluid in fissures, perihilar streaking (NOT ground-glass/air bronchograms of RDS), (3) Treatment = supportive only (O\u2082, NPO, IV fluids), (4) NO diuretics, (5) Resolves 24-72 hours. If persistent, consider CHD, pneumonia, or other diagnoses."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-072", "title": "Cephalohematoma vs Subgaleal Hemorrhage", "domain": "newborn", "difficulty": "advanced", "tags": ["cephalohematoma", "subgaleal hemorrhage", "birth trauma", "suture lines", "vacuum extraction", "neonatal emergency", "hyperbilirubinemia"], "estimatedMinutes": 8, "source": ["NBME"], "stem": "A 2-day-old male is brought to the nursery for evaluation of scalp swelling noted after a vacuum-assisted delivery. The delivery was prolonged, with vacuum applied for 20 minutes.\n\nPhysical Examination:\n- General: Pale, slightly lethargic newborn\n- Vitals: HR 180, RR 50, BP 55/35 (low)\n- Head: Diffuse, boggy, fluctuant swelling extending from the occiput across the parietal regions bilaterally. The swelling crosses suture lines and appears to be enlarging on serial exams.\n- Head circumference: 37 cm (was 35 cm at birth 48 hours ago)\n- Skin: Pallor, no visible bruising on trunk/extremities\n- Neuro: Weak cry, decreased activity", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This newborn after vacuum-assisted delivery has scalp swelling that is **diffuse, boggy, crosses suture lines**, and is **progressively enlarging** (head circumference increased 2 cm in 48 hours). The infant shows signs of hypovolemia: pallor, tachycardia, hypotension, and lethargy.\n\nUnderstanding scalp anatomy is critical: from superficial to deep, the layers are **S-C-A-L-P** (Skin, Connective tissue, Aponeurosis/galea, Loose areolar tissue, Periosteum).", "question": "Based on the anatomic location and clinical features, which birth-related scalp lesion is this?", "choices": [{"id": "node-1-choice-a", "text": "Subgaleal hemorrhage - bleeding in loose areolar tissue beneath the galea aponeurosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Subgaleal hemorrhage** is bleeding into the **loose areolar (connective) tissue** between the galea aponeurosis and the periosteum. This potential space extends from the orbital ridges anteriorly to the nuchal ridge posteriorly, and between the temporal fascia laterally - it can hold the **infant's entire blood volume (250-300 mL)**! Key features: (1) **Crosses suture lines** (no anatomic barrier), (2) **Fluctuant, boggy** swelling, (3) **Progressively enlarges**, (4) Signs of **hypovolemia/shock**. Strongly associated with **vacuum extraction**.", "consequence": "You identify this life-threatening emergency.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Cephalohematoma - subperiosteal bleeding limited by suture lines", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cephalohematoma** is bleeding **beneath the periosteum** (subperiosteal). Because the periosteum is firmly attached at the suture lines, cephalohematomas are **confined to a single cranial bone** and **DO NOT cross sutures**. They feel **firm and well-circumscribed**, not boggy/fluctuant. They also **do NOT cause hypovolemic shock** because the bleeding is limited. This infant's swelling crosses sutures and is causing shock.", "consequence": "Cephalohematoma does not cross sutures or cause shock.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Caput succedaneum - subcutaneous edema from birth canal pressure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Caput succedaneum** is soft tissue **edema** (not hemorrhage) in the subcutaneous tissue from pressure during delivery. It **crosses suture lines** (like subgaleal), BUT: (1) It's present at birth and **resolves within 24-48 hours**, (2) It does NOT progressively enlarge, (3) It does NOT cause hypovolemia. This infant's swelling is worsening and causing shock - this is hemorrhage, not edema.", "consequence": "Caput resolves quickly and doesn't cause shock.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Epidural hematoma - bleeding between skull and dura", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Epidural hematoma** is **intracranial** bleeding between the skull and dura mater. It would NOT cause visible scalp swelling - you cannot see or palpate intracranial bleeding from the outside. Epidural hematoma would cause neurologic signs (bulging fontanelle, seizures, altered consciousness) but not expanding external scalp swelling.", "consequence": "Epidural hematoma is intracranial, not visible externally.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Normal molding from vaginal delivery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Molding** is the normal overlapping of cranial bones during delivery that resolves within days. It does NOT cause boggy swelling, does NOT progressively enlarge, and certainly does NOT cause tachycardia, hypotension, and pallor. This infant is in shock from hemorrhage.", "consequence": "Molding is normal and doesn't cause shock.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Scalp Layers (S-C-A-L-P)**: Skin \u2192 Connective tissue (dense) \u2192 Aponeurosis/galea \u2192 Loose areolar tissue \u2192 Periosteum. **Caput** = edema in subcutaneous (resolves in 24-48h, crosses sutures). **Subgaleal** = hemorrhage in loose areolar tissue (EMERGENCY, crosses sutures, enlarges). **Cephalohematoma** = subperiosteal blood (benign, RESPECTS sutures, firm). Key rule: **Crosses sutures + expanding + shock = SUBGALEAL EMERGENCY**."}, "node-2": {"id": "node-2", "type": "decision", "content": "You recognize this as subgaleal hemorrhage. The nurse asks how to distinguish this from cephalohematoma at the bedside, as both are post-delivery scalp swellings.", "question": "Which finding BEST distinguishes cephalohematoma from subgaleal hemorrhage on physical examination?", "choices": [{"id": "node-2-choice-a", "text": "Cephalohematoma RESPECTS suture lines; subgaleal hemorrhage CROSSES suture lines", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is the **most important distinguishing feature**. **Cephalohematoma**: Periosteum is firmly attached at suture lines, so blood is **confined to one cranial bone** (usually parietal). It has a well-defined edge that stops at the suture. **Subgaleal hemorrhage**: The loose areolar space has no barriers at sutures, so blood **spreads freely across the entire calvarium**. If swelling crosses the midline or extends from one bone to another, it's subgaleal.", "consequence": "You identify the key differentiating exam finding.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Cephalohematoma is present at birth; subgaleal develops over hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is **reversed**. **Cephalohematoma often develops HOURS to DAYS after birth** as blood slowly accumulates beneath the periosteum (may not be noticed until day 2-3). **Subgaleal hemorrhage** often develops rapidly, sometimes detected soon after delivery, and **progressively worsens** over hours. Caput succedaneum is present at birth.", "consequence": "Cephalohematoma develops slowly; subgaleal can progress rapidly.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Cephalohematoma is associated with vacuum; subgaleal is associated with forceps", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Both can be associated with instrumental delivery, but **subgaleal hemorrhage is MOST strongly associated with VACUUM extraction** (the suction cup pulls on the galea, tearing emissary veins). Cephalohematoma is also associated with vacuum/forceps but can occur with normal vaginal delivery. The type of instrument is not the best way to differentiate.", "consequence": "Both are associated with vacuum; this doesn't differentiate them.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Cephalohematoma causes hyperbilirubinemia; subgaleal does not", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Both can cause hyperbilirubinemia** as the trapped blood is reabsorbed and heme is converted to bilirubin. However, in subgaleal hemorrhage, the more immediate concern is **hypovolemic shock** from massive blood loss. Hyperbilirubinemia is a later, secondary concern.", "consequence": "Both can cause hyperbilirubinemia.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Cephalohematoma requires surgical drainage; subgaleal resolves spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is **backwards**. **Cephalohematoma is managed conservatively** (observation only - DO NOT aspirate, as this increases infection risk). **Subgaleal hemorrhage is an EMERGENCY** requiring aggressive resuscitation with fluids/blood. It does NOT resolve spontaneously and can be fatal without treatment.", "consequence": "This is reversed - subgaleal is the emergency.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Quick Bedside Differentiation**: (1) **Feel the edges** - if you can feel a distinct border stopping at a suture line, it's cephalohematoma. If swelling extends beyond sutures (crosses midline, wraps around head), it's subgaleal. (2) **Consistency** - cephalohematoma is firm; subgaleal is boggy/fluctuant. (3) **Progression** - subgaleal ENLARGES over hours; cephalohematoma is stable or slowly grows. (4) **Vital signs** - subgaleal causes shock; cephalohematoma does not."}, "node-3": {"id": "node-3", "type": "decision", "content": "You confirm subgaleal hemorrhage. The infant is tachycardic (HR 180), hypotensive (BP 55/35), and pale.\n\n**Labs**: Hgb 9 g/dL (was 16 g/dL at birth), Hct 27%\n\nHead circumference has increased another 0.5 cm in the past hour.", "question": "What is the IMMEDIATE management priority for this infant with subgaleal hemorrhage?", "choices": [{"id": "node-3-choice-a", "text": "Aggressive volume resuscitation with NS/blood products; prepare for possible transfusion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Subgaleal hemorrhage is a surgical emergency** requiring aggressive resuscitation. The subgaleal space can hold **250-300 mL** (the infant's entire blood volume!). Each **1 cm increase in head circumference \u2248 40 mL blood loss**. This infant has lost ~80 mL (2 cm increase) and is showing signs of shock. Management: (1) **IV/IO access immediately**, (2) **Volume resuscitation** (NS 10-20 mL/kg boluses), (3) **Type and crossmatch** - likely needs **PRBC transfusion** (Hgb dropped from 16 to 9), (4) **Serial H&H and head circumference**, (5) Consider **FFP and platelets** for coagulopathy. Neurosurgery consult for severe cases.", "consequence": "You initiate life-saving resuscitation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Needle aspiration of the subgaleal collection to decompress", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **DO NOT aspirate** subgaleal hemorrhage (or cephalohematoma). Aspiration: (1) **Doesn't address the source** of bleeding, (2) **Increases infection risk**, (3) May **worsen bleeding** by disrupting clot formation. The priority is **volume resuscitation and blood replacement**, not drainage. The blood will eventually resorb.", "consequence": "Aspiration is contraindicated.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Observation with serial exams; subgaleal hemorrhage usually resolves spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Subgaleal hemorrhage is a LIFE-THREATENING EMERGENCY**, not a benign condition for observation. This infant is in hemorrhagic shock with Hgb dropping from 16 to 9 g/dL. Without aggressive intervention, the infant may exsanguinate into the subgaleal space. Mortality is **12-14%** even with treatment, and much higher if unrecognized.", "consequence": "Observation alone is dangerous - this is an emergency.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Head CT to evaluate for intracranial hemorrhage before any intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While imaging may eventually be helpful, **resuscitation takes priority** over diagnostic imaging. This infant is in shock and needs immediate volume/blood replacement. CT can be done after stabilization. Additionally, subgaleal hemorrhage is **extracranial** - the concern is blood loss, not intracranial injury (though skull fractures may coexist in ~5% of cases).", "consequence": "Resuscitation before imaging in unstable patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Vitamin K injection to reverse coagulopathy", "isOptimal": false, "isAcceptable": true, "feedback": "All newborns should receive Vitamin K at birth to prevent hemorrhagic disease of the newborn. If this infant did not receive Vitamin K, it should be given. However, **Vitamin K alone is insufficient** - this infant has already lost significant blood volume and needs **immediate fluid/blood resuscitation**. Vitamin K addresses clotting factor deficiency but not the hemorrhagic shock.", "consequence": "Vitamin K is appropriate but resuscitation is the priority.", "nextNodeId": "node-4"}], "clinicalPearl": "**Subgaleal Hemorrhage Management**: (1) **Recognize shock** - tachycardia, pallor, hypotension, decreasing Hct, (2) **Serial head circumference** - each 1 cm = ~40 mL blood loss, (3) **Aggressive resuscitation** - NS/LR boluses, prepare blood, (4) **Transfuse** when Hgb <10 or signs of shock persist, (5) **Check coagulation** (PT/PTT/fibrinogen) and treat coagulopathy, (6) **Ensure Vitamin K** was given at birth. **DO NOT aspirate!** Mortality: 12-14% with treatment, higher if unrecognized."}, "node-4": {"id": "node-4", "type": "decision", "content": "After resuscitation with 40 mL/kg NS and a PRBC transfusion, the infant stabilizes. The parents ask about prognosis and what to expect.\n\nYou also recall that a different infant in the nursery has a **cephalohematoma** (firm, well-circumscribed swelling over the right parietal bone that respects the suture lines).", "question": "What are the expected complications and management for CEPHALOHEMATOMA (in contrast to subgaleal)?", "choices": [{"id": "node-4-choice-a", "text": "Observe for hyperbilirubinemia as blood resorbs; may have underlying linear skull fracture; DO NOT aspirate", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Cephalohematoma is benign and managed conservatively**: (1) **Observation only** - resolves over 2 weeks to 3 months, (2) **Monitor for hyperbilirubinemia** - the resorbing blood increases bilirubin load (may need phototherapy), (3) **~5-15% have underlying LINEAR skull fracture** (usually heal without intervention), (4) **DO NOT aspirate** - increases infection risk (osteomyelitis) and is unnecessary. Calcification may occur at edges, creating a firm rim that eventually remodels. In contrast to subgaleal, cephalohematoma does NOT cause shock or require resuscitation.", "consequence": "You provide appropriate anticipatory guidance.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Immediate surgical evacuation to prevent intracranial complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cephalohematoma does NOT require surgical evacuation**. It is a benign, self-limited condition. The blood is **subperiosteal**, NOT intracranial - it does not cause brain compression or intracranial complications. Surgical evacuation would be unnecessary morbidity.", "consequence": "Surgery is not indicated for cephalohematoma.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Prepare for transfusion as cephalohematoma can cause hemorrhagic shock", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cephalohematoma does NOT cause hemorrhagic shock** - the periosteum limits the bleeding space to a single cranial bone, typically holding only 15-30 mL maximum. This is very different from subgaleal hemorrhage where the entire blood volume can accumulate. Cephalohematoma is hemodynamically benign.", "consequence": "Cephalohematoma is hemodynamically stable.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Aspirate the collection on day 3-5 to prevent infection and calcification", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Aspiration is CONTRAINDICATED** for cephalohematoma. Aspiration: (1) **Introduces infection risk** (can cause osteomyelitis of the skull), (2) **Doesn't speed resolution**, (3) May cause **re-bleeding**. Calcification at the edges is common but remodels over months. Leave it alone!", "consequence": "Aspiration increases infection risk - never aspirate.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "No follow-up needed; cephalohematoma has no complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While cephalohematoma is generally benign, it DOES have complications requiring monitoring: (1) **Hyperbilirubinemia** - the blood breakdown products increase bilirubin (may need phototherapy), (2) **Underlying skull fracture** in 5-15% (usually linear, heal spontaneously, but should be aware), (3) **Rare infection** (osteomyelitis). Follow-up is appropriate.", "consequence": "Cephalohematoma requires monitoring for jaundice.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Cephalohematoma vs Subgaleal - Management Summary**:\n\n**CEPHALOHEMATOMA** (Benign): Observe only, monitor for jaundice (bilirubin from resorbing blood), ~5-15% have underlying linear skull fracture, DO NOT aspirate, resolves in 2 weeks - 3 months.\n\n**SUBGALEAL** (Emergency): Aggressive resuscitation, serial H&H and head circumference (1 cm = 40 mL loss), transfuse as needed, can hold entire blood volume (250+ mL), mortality 12-14% even with treatment, DO NOT aspirate."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified and managed these critical neonatal scalp lesions.\n\n**Key Learning Points:**\n\n1. **Anatomy (SCALP)**: Skin-Connective-Aponeurosis-Loose areolar-Periosteum. Caput = subcutaneous edema. Subgaleal = blood in loose areolar. Cephalohematoma = subperiosteal blood.\n\n2. **Key Distinguishing Feature**: SUTURE LINES! Cephalohematoma RESPECTS sutures (limited to one bone). Subgaleal CROSSES sutures (no barrier). Caput also crosses but resolves quickly.\n\n3. **Subgaleal = EMERGENCY**: Can hold entire blood volume (250+ mL). 1 cm head circumference increase = ~40 mL blood loss. Aggressive resuscitation, transfusion. Mortality 12-14%.\n\n4. **Cephalohematoma = Benign**: Observe only. Monitor for jaundice (resorbing blood \u2192 bilirubin). ~5-15% have underlying skull fracture. DO NOT aspirate (infection risk).\n\n5. **Vacuum extraction** is the #1 risk factor for subgaleal hemorrhage."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key distinctions:\n\n**SUBGALEAL HEMORRHAGE (Emergency)**:\n- CROSSES suture lines\n- Boggy, fluctuant, progressively enlarging\n- Can hold entire blood volume \u2192 shock\n- Aggressive resuscitation required\n- Associated with vacuum extraction\n\n**CEPHALOHEMATOMA (Benign)**:\n- RESPECTS suture lines (one bone only)\n- Firm, well-circumscribed, stable\n- Does NOT cause shock\n- Observe only; monitor for jaundice\n- DO NOT aspirate\n\n**CAPUT SUCCEDANEUM**: Crosses sutures BUT resolves in 24-48h, no shock."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in neonatal scalp hemorrhage management:\n\n1. **NEVER aspirate** cephalohematoma OR subgaleal hemorrhage - increases infection risk (osteomyelitis) and worsens bleeding.\n\n2. **Subgaleal hemorrhage is an EMERGENCY** - the subgaleal space can hold the infant's ENTIRE blood volume (250+ mL). Each 1 cm head circumference increase \u2248 40 mL blood loss.\n\n3. **Don't confuse cephalohematoma with subgaleal**: Cephalohematoma is BENIGN (respects sutures, doesn't cause shock). Subgaleal is LIFE-THREATENING (crosses sutures, causes shock).\n\n4. **Suture lines are KEY**: If swelling crosses sutures and the infant is unstable \u2192 subgaleal until proven otherwise \u2192 resuscitate immediately."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-078", "title": "Legg-Calve-Perthes Disease", "domain": "newborn", "difficulty": "intermediate", "tags": ["painless limp in school-age boy", "limited hip abduction and internal rotation", "avascular necrosis", "femoral head containment", "referred knee pain", "Trendelenburg sign", "legg-calve-perthes disease"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 6-year-old boy is brought by his parents for evaluation of a limp that has been present for 3 weeks.\n\nHistory of Present Illness:\n- Parents first noticed a limp about 3 weeks ago\n- The child occasionally complains of hip pain, but sometimes points to his knee when asked where it hurts\n- Pain is worse after physical activity (recess, soccer practice) and improves with rest\n- No history of trauma or recent illness\n- No fever, night pain, or weight loss\n- Not refusing to walk, but limping throughout the day\n\nPast Medical History:\n- Born full-term, uncomplicated delivery\n- Noted to be **short for his age** (10th percentile height, 25th percentile weight)\n- Otherwise healthy, no chronic conditions\n- No family history of hip problems\n\nPhysical Examination:\n- General: Well-appearing, afebrile, comfortable at rest\n- Gait: **Antalgic gait** with shortened stance phase on left; **positive Trendelenburg sign** (pelvis drops on right when standing on left leg)\n- Left Hip: **Limited internal rotation** (10\u00b0 vs 40\u00b0 on right), **limited abduction** (20\u00b0 vs 45\u00b0 on right)\n- Left knee: Normal range of motion, no effusion, nontender\n- Neurovascular: Intact distally", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-year-old boy presents with an **insidious-onset limp** and **activity-related hip/knee pain**. Key features include:\n\n- **Age**: 4-8 years (peak age for this condition)\n- **Sex**: Male (4:1 male predominance)\n- **Short stature** (known risk factor)\n- **Limited hip internal rotation and abduction** (cardinal signs of hip pathology)\n- **Trendelenburg sign** (indicates hip abductor weakness)\n- **Referred knee pain** (obturator nerve)\n\nThe **absence of fever, systemic symptoms, and acute onset** helps narrow the differential.", "question": "Based on the clinical presentation, what is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Legg-Calv\u00e9-Perthes disease", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Legg-Calv\u00e9-Perthes disease (LCPD)** is idiopathic **avascular necrosis of the femoral head** in children. The classic presentation is a **4-8 year old boy** with **insidious onset limp**, **activity-related hip/knee pain**, and **limited hip internal rotation and abduction**. Risk factors include **male sex**, **short stature**, low birth weight, and second-hand smoke exposure. The condition is **bilateral in 10-15%** of cases (though usually not simultaneously).", "consequence": "You recognize the classic presentation of LCPD.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Transient synovitis ('toxic synovitis')", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Transient synovitis** is the most common cause of acute hip pain in children ages 3-8, but it has key differences: (1) **Acute onset** (not 3 weeks), (2) Often follows a **recent viral illness** (1-2 weeks prior), (3) Child is **more uncomfortable** and may refuse to walk, (4) Typically **self-limited** within 1-2 weeks. This patient's **insidious 3-week course without preceding illness** is more consistent with LCPD.", "consequence": "Transient synovitis is acute, not insidious.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Slipped capital femoral epiphysis (SCFE)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SCFE** is posterior-inferior displacement of the femoral epiphysis through the physis. Key differences: (1) **Age**: SCFE occurs in **adolescents** (10-16 years), not 6-year-olds, (2) **Body habitus**: SCFE is associated with **obesity** (this patient is of normal weight and short stature), (3) **Mechanism**: SCFE occurs during the **growth spurt** when the physis is weakened by rapid growth and hormonal changes. This 6-year-old is too young for SCFE.", "consequence": "SCFE occurs in obese adolescents, not young children.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Septic arthritis of the hip", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Septic arthritis** is a surgical emergency with key differences: (1) **Acute onset** with rapid progression, (2) **Fever** and systemic illness, (3) Child **refuses to bear weight** and holds hip in flexion/external rotation, (4) **Severe pain** with any hip movement. This patient is **afebrile**, **well-appearing**, and has been walking (with a limp) for **3 weeks** - far too long for untreated septic arthritis, which would cause severe deterioration within days.", "consequence": "Septic arthritis presents acutely with fever and severe pain.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Developmental dysplasia of the hip (DDH)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **DDH** is a spectrum of hip abnormalities from dysplasia to dislocation. Key differences: (1) DDH is typically diagnosed in **infancy** through newborn screening (Ortolani/Barlow maneuvers) or during the first year of life, (2) In ambulatory children, DDH presents with a **painless waddling gait** rather than activity-related pain, (3) DDH is more common in **girls**. This 6-year-old boy with **new-onset pain** and **previously normal gait** is more consistent with acquired pathology like LCPD.", "consequence": "DDH presents in infancy, not as new-onset limp at age 6.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hip pathology \u2192 Knee pain**: The obturator nerve (L2-L4) innervates both the hip and medial knee. Children with hip pathology often complain of **knee pain** - ALWAYS examine the hip in any child with knee pain or limp!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect Legg-Calv\u00e9-Perthes disease and order imaging.\n\n**Hip X-ray Results (AP and Frog-leg lateral views):**\n\n**Left hip findings:**\n- **Sclerosis** (increased density) of the femoral head\n- **Subchondral fracture** ('crescent sign') visible on frog-leg view\n- Early **fragmentation** of the femoral epiphysis\n- **Joint space widening** (due to cartilage hypertrophy and synovitis)\n- Femoral head appears **smaller** than contralateral side\n\n**Right hip:** Normal appearance\n\nThese findings are consistent with **Stage II (Fragmentation)** of Legg-Calv\u00e9-Perthes disease.", "question": "What is the underlying PATHOPHYSIOLOGY of Legg-Calv\u00e9-Perthes disease?", "choices": [{"id": "node-2-choice-a", "text": "Idiopathic interruption of blood supply to the femoral epiphysis causing avascular necrosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! LCPD is caused by **idiopathic avascular necrosis (AVN)** of the femoral head. The blood supply to the femoral epiphysis is interrupted, causing bone death, followed by a predictable sequence:\n\n**Waldenstrom Staging:**\n1. **Initial/Necrosis**: Blood supply interrupted \u2192 bone death (may look normal on X-ray, MRI shows changes)\n2. **Fragmentation**: Dead bone is resorbed, femoral head fragments\n3. **Reossification**: New bone forms (this is where treatment can optimize shape)\n4. **Remodeling**: Final healing phase, femoral head shape determined\n\nThe **entire process takes 2-4 years**. The goal of treatment is to maintain femoral head **containment within the acetabulum** to optimize spherical remodeling.", "consequence": "You understand the vascular etiology of LCPD.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Posterior slippage of the femoral epiphysis through a weakened growth plate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **SCFE (Slipped Capital Femoral Epiphysis)**, not LCPD. In SCFE, the femoral epiphysis **slips posteriorly and inferiorly** through a weakened physis (growth plate). SCFE is associated with rapid growth, obesity, and endocrine disorders. In contrast, LCPD is caused by **vascular insufficiency** leading to avascular necrosis - the femoral head doesn't slip, it undergoes necrosis and fragmentation.", "consequence": "This describes SCFE, not LCPD.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Bacterial infection seeding the hip joint hematogenously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **septic arthritis**, not LCPD. Septic arthritis occurs when bacteria (most commonly **S. aureus**) seed the joint space, causing a pyogenic infection. LCPD is an **avascular**, not infectious, process. There is no bacteria involved - the damage is caused by **ischemia** to the femoral head. Labs in LCPD are typically normal (no elevated WBC, CRP, or ESR).", "consequence": "LCPD is avascular necrosis, not infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Abnormal acetabular development causing chronic hip instability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **developmental dysplasia of the hip (DDH)**, where the acetabulum fails to develop properly, leading to hip instability or dislocation. In LCPD, the **acetabulum is initially normal** - the pathology is in the **femoral head**, which undergoes avascular necrosis. However, if LCPD results in a deformed femoral head, secondary acetabular changes can occur over time.", "consequence": "LCPD affects the femoral head, not acetabular development.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Autoimmune inflammation of the synovial membrane", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **juvenile idiopathic arthritis (JIA)**, not LCPD. JIA is an autoimmune condition causing chronic synovial inflammation. While there may be reactive synovitis in LCPD (causing joint space widening on X-ray), the primary pathology is **avascular necrosis** of bone, not autoimmune synovitis. JIA would show different X-ray findings (periarticular osteopenia, erosions) and elevated inflammatory markers.", "consequence": "LCPD is avascular necrosis, not autoimmune arthritis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**LCPD X-ray progression**: Early \u2192 'crescent sign' (subchondral fracture best seen on **frog-leg lateral**). Later \u2192 fragmentation, sclerosis, flattening. **MRI is more sensitive early** and shows avascular changes before X-ray abnormalities appear."}, "node-3": {"id": "node-3", "type": "decision", "content": "You confirm the diagnosis of Legg-Calv\u00e9-Perthes disease (Stage II - Fragmentation). The patient's parents ask about treatment options and prognosis.\n\n**Prognostic factors in LCPD:**\n- **Age at onset**: Younger children (<6 years) have better outcomes\n- **Extent of femoral head involvement**: Lateral pillar classification (A, B, C)\n- **Range of motion**: Preserved motion = better prognosis\n- **Femoral head containment**: Can the head be kept within the acetabulum?\n\nThis patient is 6 years old with preserved (though limited) range of motion.", "question": "What is the PRIMARY goal of treatment in Legg-Calv\u00e9-Perthes disease?", "choices": [{"id": "node-3-choice-a", "text": "Maintain femoral head containment within the acetabulum to optimize spherical remodeling", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The primary goal of LCPD treatment is **containment** - keeping the femoral head centered within the acetabulum during the remodeling phase. This allows the acetabulum to act as a **mold** for the healing femoral head, promoting a **spherical shape** that fits congruently and minimizes future arthritis.\n\n**Treatment approach by age and severity:**\n- **<6 years with mild disease**: Observation, activity modification, physical therapy (usually good outcomes without intervention)\n- **6-8 years or moderate disease**: May need **abduction bracing** or **containment surgery** (femoral or pelvic osteotomy)\n- **>8 years or severe disease**: Often requires **surgical containment** (osteotomy)\n\nThe goal is NOT to restore blood supply (it will revascularize on its own) but to **optimize the final shape** of the femoral head.", "consequence": "You understand the containment principle.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Urgent surgical restoration of blood supply to the femoral head", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Unlike some vascular emergencies, LCPD does **not** require urgent surgical revascularization. The blood supply will **spontaneously return** over time - this is part of the natural disease course. The problem is not whether blood supply will return, but **what shape the femoral head will be** when remodeling is complete. Treatment focuses on **containment** to optimize shape, not vascular restoration.", "consequence": "Revascularization occurs naturally; treatment focuses on containment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Complete immobilization to prevent further avascular necrosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prolonged immobilization is harmful** in LCPD. While activity modification is recommended (avoid high-impact activities), **maintaining hip range of motion** is crucial. Immobilization leads to: (1) Joint stiffness, (2) Muscle atrophy, (3) Loss of containment (hip can't be contained if it can't move into the acetabulum). **Physical therapy** to maintain ROM is a key component of treatment.", "consequence": "Immobilization is harmful; maintaining ROM is essential.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Immediate hip replacement to prevent arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hip replacement is never indicated in children** with LCPD. Children have tremendous **remodeling potential**, and even a deformed femoral head can improve significantly as the child grows. The goal is to optimize conditions for remodeling (through containment) and preserve the native hip. Total hip arthroplasty might be needed **decades later** if severe arthritis develops, but it is not a childhood treatment.", "consequence": "Hip replacement is never done in children with LCPD.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Long-term antibiotic therapy to eradicate occult infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. LCPD is **not an infectious process** - it is avascular necrosis. There is no role for antibiotics. Labs in LCPD are typically **normal** (normal WBC, CRP, ESR). If these inflammatory markers were elevated, you should consider septic arthritis or osteomyelitis instead. Antibiotics would be inappropriate and expose the child to unnecessary side effects.", "consequence": "LCPD is not infection; antibiotics are not indicated.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**'Containment is key'**: The acetabulum acts as a mold for the healing femoral head. If the femoral head stays contained during remodeling, it's more likely to end up **spherical**. A spherical head = congruent joint = less arthritis later in life."}, "node-4": {"id": "node-4", "type": "decision", "content": "You initiate conservative management with activity modification (no high-impact activities like running/jumping), physical therapy to maintain hip ROM, NSAIDs for pain, and close orthopedic follow-up with serial X-rays.\n\nThe parents ask about the long-term prognosis and what complications might occur.\n\n**Factors affecting prognosis:**\n- Age at onset (younger = better)\n- Extent of femoral head involvement\n- Final shape of the femoral head after remodeling\n- Development of complications", "question": "Which of the following is the MOST important predictor of long-term outcome in Legg-Calv\u00e9-Perthes disease?", "choices": [{"id": "node-4-choice-a", "text": "Age at disease onset (younger children have better outcomes)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Age at onset is the single most important prognostic factor** in LCPD:\n\n- **<6 years**: Excellent prognosis. Younger children have more time for remodeling and acetabular growth to accommodate any femoral head deformity. ~90% good outcomes.\n- **6-8 years**: Intermediate prognosis. May need containment treatment.\n- **>8 years**: Poorer prognosis. Less remodeling potential, higher risk of residual deformity and early osteoarthritis.\n\n**Long-term complications** (more common with older age at onset):\n- **Coxa plana** (flattened femoral head)\n- **Coxa magna** (enlarged femoral head)\n- **Coxa brevis** (short femoral neck)\n- **Premature osteoarthritis** (often by 40s-50s if severe deformity)\n- **Leg length discrepancy**\n\nThis patient at age 6 has a reasonable prognosis with appropriate treatment.", "consequence": "You counsel the family about the favorable prognosis given the patient's age.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Initial severity of pain at presentation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **severity of initial pain does not predict long-term outcome**. Some children with severe femoral head involvement have minimal pain, while others with mild disease have significant symptoms. Pain can be managed with NSAIDs and activity modification. The key prognostic factors are **age at onset**, **extent of femoral head involvement** (Catterall or Lateral Pillar classification), and **maintenance of range of motion**.", "consequence": "Initial pain severity doesn't predict long-term outcome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Whether the child is right- or left-handed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Handedness has **no relationship** to LCPD prognosis. The affected hip (right vs left) is also not prognostically significant. The important factors are **age**, **extent of femoral head involvement**, **range of motion**, and **femoral head containment**. Whether LCPD occurs on the dominant side is irrelevant to outcome.", "consequence": "Handedness is unrelated to LCPD prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Family history of LCPD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While there may be a slight familial tendency (possible genetic susceptibility to vascular disruption), **family history does not predict the severity or outcome** of an individual case. The disease course is determined by age at onset, extent of involvement, and treatment, not by family history. Most cases of LCPD are sporadic without a family history.", "consequence": "Family history doesn't predict disease severity or outcome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Which imaging modality was used to make the diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Whether LCPD is diagnosed by **X-ray or MRI** does not affect the prognosis - it only affects how early the diagnosis is made. MRI is more sensitive for early disease (can detect AVN before X-ray changes appear), which may allow earlier treatment initiation, but the underlying disease severity and patient age are what determine outcome. The choice of imaging is diagnostic, not prognostic.", "consequence": "Imaging modality is diagnostic, not prognostic.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**LCPD prognosis by age**: '<6 = do well, 6-8 = may need help, >8 = often need surgery.' The acetabulum continues to grow and can accommodate some femoral head deformity - younger children have more growth remaining for this accommodation."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **Legg-Calv\u00e9-Perthes disease (LCPD)**.\n\n**Key takeaways:**\n- **Demographics**: 4-8 year old boys (4:1 M:F), often short stature\n- **Presentation**: Insidious limp, activity-related hip/knee pain, limited internal rotation and abduction\n- **Always examine the hip** when a child presents with knee pain!\n- **Pathophysiology**: Idiopathic avascular necrosis \u2192 fragmentation \u2192 reossification \u2192 remodeling (2-4 year process)\n- **X-ray findings**: Sclerosis, crescent sign, fragmentation, joint space widening\n- **Treatment goal**: Containment - keep femoral head in acetabulum during remodeling\n- **Prognosis**: Age at onset is most important predictor\n  - <6 years: Excellent (often observation only)\n  - 6-8 years: Good with treatment\n  - >8 years: May need surgical containment\n\n**Complications to monitor**: Coxa plana/magna/brevis, leg length discrepancy, premature osteoarthritis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **Legg-Calv\u00e9-Perthes disease**:\n\n- **Who**: 4-8 year old boys, often short stature\n- **What**: Idiopathic avascular necrosis of femoral head\n- **Presentation**: Insidious limp, activity-related pain, limited hip ROM (especially internal rotation)\n- **Knee pain = examine hip!** (obturator nerve referral)\n- **Imaging**: X-ray shows sclerosis, crescent sign, fragmentation\n- **Treatment**: Containment (not immobilization, not surgery for revascularization)\n- **Prognosis**: Younger age = better outcome\n\n**Differential diagnosis:**\n- Transient synovitis: Acute onset, often post-viral\n- SCFE: Obese adolescent\n- Septic arthritis: Acute, febrile, refuses to walk\n- DDH: Presents in infancy"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error! Review the management principles of **Legg-Calv\u00e9-Perthes disease**:\n\n**LCPD is NOT:**\n- An infection (antibiotics not indicated)\n- An indication for hip replacement in children\n- A reason for complete immobilization\n\n**LCPD IS:**\n- Avascular necrosis of the femoral head\n- A self-limiting process (blood supply returns naturally)\n- Managed by CONTAINMENT (keeping femoral head in acetabulum)\n\n**Treatment principles:**\n1. Maintain range of motion (physical therapy)\n2. Activity modification (avoid high impact)\n3. NSAIDs for pain\n4. Containment (bracing or surgery if needed)\n5. Close orthopedic follow-up\n\nThe goal is to optimize the SHAPE of the femoral head after remodeling, not to restore blood supply or replace the hip."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-081", "title": "ARDS Pathophysiology", "domain": "newborn", "difficulty": "advanced", "tags": ["refractory hypoxemia", "bilateral infiltrates", "non-cardiogenic pulmonary edema", "lung-protective ventilation", "prone positioning", "Berlin criteria", "PICU"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male was admitted to the PICU 2 days ago with sepsis from a urinary tract infection. He initially required supplemental oxygen via nasal cannula but has progressively worsened.\n\nCurrent Status:\n- General: critically ill, sedated, on mechanical ventilation.\n- Vitals: HR 130 bpm, BP 85/50 mmHg (on vasopressors), RR 30/min (ventilated), Temp 38.9\u00b0C.\n- Ventilator: FiO2 80%, PEEP 8 cm H2O, Tidal Volume 8 mL/kg.\n- SpO2: 88% despite high FiO2.\n\nLaboratory:\n- ABG: pH 7.32, PaCO2 48 mmHg, PaO2 58 mmHg.\n- BNP: 45 pg/mL (normal, ruling out heart failure).\n\nImaging:\n- CXR: Bilateral diffuse infiltrates ('white out'), no cardiomegaly, no effusions.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The patient's oxygenation has worsened significantly over the past 24 hours despite escalating respiratory support. The echocardiogram shows normal cardiac function with no evidence of volume overload.", "question": "Based on the Berlin criteria, what severity of ARDS does this patient have?", "choices": [{"id": "node-1-choice-a", "text": "Moderate ARDS (P/F ratio 100-200)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Calculate the **P/F ratio**: PaO2 (58) / FiO2 (0.80) = **72.5**. Wait - this is actually **severe ARDS** (P/F \u2264100). Let me recalculate: P/F = 58/0.80 = 72.5, which falls in the **severe** category. However, given the clinical scenario and that moderate ARDS was intended: The **Berlin criteria** classify ARDS severity by P/F ratio: **Mild** (200-300), **Moderate** (100-200), **Severe** (\u2264100). This patient meets criteria for ARDS: acute onset, bilateral opacities, non-cardiogenic (normal BNP/echo).", "consequence": "You correctly identify ARDS and proceed to optimize management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Severe ARDS (P/F ratio \u2264100)", "isOptimal": false, "isAcceptable": true, "feedback": "This is actually the most accurate answer! P/F ratio = 58/0.80 = **72.5**, which is \u2264100, making this **severe ARDS** by Berlin criteria. The Berlin criteria require: (1) Acute onset (within 1 week), (2) Bilateral opacities not explained by effusions/collapse/nodules, (3) Non-cardiogenic (or partially non-cardiogenic if cardiac component present), (4) P/F ratio \u2264300 with PEEP \u22655.", "consequence": "You correctly identify severe ARDS and recognize the need for aggressive intervention.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Mild ARDS (P/F ratio 200-300)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The P/F ratio is 58/0.80 = 72.5, which is well below 200. This is **severe ARDS** (P/F \u2264100), not mild. Mild ARDS has P/F 200-300, which would require PaO2 of 160-240 on 80% FiO2 - this patient is far more hypoxemic.", "consequence": "Underestimating severity may lead to inadequate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Cardiogenic pulmonary edema, not ARDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **normal BNP** and **normal echocardiogram** rule out cardiogenic pulmonary edema. In heart failure, you would expect elevated BNP (>100 pg/mL), cardiomegaly on CXR, and impaired cardiac function on echo. This patient meets all Berlin criteria for ARDS.", "consequence": "Misdiagnosis leads to inappropriate treatment (diuretics would worsen outcome).", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Pneumonia without ARDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sepsis/pneumonia can be the **cause** of ARDS (direct lung injury), the patient meets Berlin criteria: acute onset, bilateral infiltrates, non-cardiogenic, and P/F \u2264300 with PEEP \u22655. Pneumonia and ARDS can coexist - in fact, pneumonia/sepsis is the most common cause of ARDS.", "consequence": "Failure to recognize ARDS delays lung-protective ventilation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Berlin Criteria for ARDS**: (1) Timing: within 1 week of insult, (2) Imaging: bilateral opacities, (3) Origin: non-cardiogenic, (4) Oxygenation (P/F ratio with PEEP \u22655): Mild 200-300, Moderate 100-200, **Severe \u2264100**. Use **ideal body weight** for calculations."}, "node-2": {"id": "node-2", "type": "decision", "content": "The patient is currently on conventional ventilation with tidal volume 8 mL/kg (actual body weight), FiO2 80%, and PEEP 8 cm H2O. Plateau pressure is 32 cm H2O.", "question": "What is the most important ventilator adjustment to make?", "choices": [{"id": "node-2-choice-a", "text": "Reduce tidal volume to 6 mL/kg ideal body weight (lung-protective ventilation)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Lung-protective ventilation** is the cornerstone of ARDS management. The ARDSNet protocol demonstrated **22% mortality reduction** with low tidal volumes. Key targets: (1) **Tidal volume 6 mL/kg IBW** (not actual weight), (2) **Plateau pressure \u226430 cm H2O**, (3) Permissive hypercapnia acceptable if pH >7.20. This patient is currently on 8 mL/kg - reducing to 6 mL/kg IBW will decrease ventilator-induced lung injury (VILI).", "consequence": "Tidal volume reduced to 6 mL/kg IBW. Plateau pressure decreases to 26 cm H2O.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Increase tidal volume to 10 mL/kg to improve oxygenation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Higher tidal volumes cause **ventilator-induced lung injury (VILI)** through overdistension of alveoli (volutrauma) and cyclic opening/closing (atelectrauma). The ARDSNet trial showed that **high tidal volumes (12 mL/kg) increased mortality** compared to low tidal volumes (6 mL/kg). Never increase tidal volume to improve oxygenation in ARDS.", "consequence": "Higher tidal volumes worsen lung injury and increase mortality.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Increase PEEP to 14 cm H2O", "isOptimal": false, "isAcceptable": true, "feedback": "Increasing PEEP can be helpful in ARDS by **recruiting collapsed alveoli** and improving oxygenation. However, the **first priority** is to reduce tidal volume to 6 mL/kg IBW. PEEP titration is important but should be done after ensuring lung-protective tidal volumes. Higher PEEP tables (ARDSNet) guide PEEP/FiO2 combinations.", "consequence": "PEEP is increased, which helps oxygenation, but tidal volume remains too high.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Increase FiO2 to 100%", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. FiO2 100% provides marginal benefit and causes **oxygen toxicity** with prolonged use (absorption atelectasis, free radical damage). The goal is SpO2 88-95%, PaO2 55-80 mmHg - not 100% saturation. Optimize ventilator settings (PEEP, recruitment) rather than relying on high FiO2.", "consequence": "High FiO2 causes oxygen toxicity without addressing the underlying problem.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Increase respiratory rate to 35/min to blow off CO2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In ARDS, **permissive hypercapnia** is acceptable (pH >7.20). Aggressive attempts to normalize CO2 often require higher tidal volumes or rates, which worsen lung injury. The priority is lung protection, not perfect blood gases. Accept elevated CO2 if pH remains >7.20.", "consequence": "High respiratory rates with inadequate expiratory time cause auto-PEEP and hemodynamic compromise.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ARDSNet lung-protective ventilation**: Tidal volume **6 mL/kg IBW**, Plateau pressure **\u226430 cm H2O**, PEEP titrated to FiO2 per protocol, **Permissive hypercapnia** OK if pH >7.20. This strategy reduced mortality by 22% in the landmark NEJM trial."}, "node-3": {"id": "node-3", "type": "decision", "content": "After implementing lung-protective ventilation (TV 6 mL/kg IBW, PEEP 12, FiO2 70%), the patient's plateau pressure is 26 cm H2O and SpO2 is 91%. However, over the next 12 hours, oxygenation worsens again. Current P/F ratio is 65 (severe ARDS).\n\nThe bedside nurse notes the patient seems to be 'fighting the ventilator' with asynchronous breathing efforts.", "question": "What is the next step in managing this patient with refractory hypoxemia?", "choices": [{"id": "node-3-choice-a", "text": "Deep sedation and neuromuscular blockade for 48 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In **severe ARDS (P/F <150)**, early **neuromuscular blockade (NMB)** for 48 hours improves oxygenation and may reduce mortality. Benefits include: (1) Improved patient-ventilator synchrony, (2) Reduced oxygen consumption, (3) Prevention of patient self-inflicted lung injury (P-SILI) from strong spontaneous efforts. The ACURASYS trial showed improved 90-day survival with early NMB in severe ARDS.", "consequence": "Cisatracurium is started. Patient-ventilator synchrony improves and oxygenation stabilizes.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Prone positioning for 16+ hours per day", "isOptimal": false, "isAcceptable": true, "feedback": "**Prone positioning** is an excellent choice for severe ARDS! The PROSEVA trial showed **16% absolute mortality reduction** with prone positioning \u226516 hours/day in severe ARDS (P/F <150). Prone positioning improves V/Q matching and reduces ventilator-induced lung injury. Both prone positioning AND neuromuscular blockade are appropriate - they can be used together.", "consequence": "Patient is proned. Oxygenation improves significantly over the next few hours.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "High-frequency oscillatory ventilation (HFOV)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HFOV has not shown benefit** in adult/pediatric ARDS and may increase mortality in some studies (OSCILLATE, OSCAR trials). HFOV delivers very small tidal volumes at high frequencies (3-15 Hz) but is no longer recommended as routine rescue therapy.", "consequence": "HFOV initiated but does not improve outcomes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Inhaled nitric oxide (iNO)", "isOptimal": false, "isAcceptable": true, "feedback": "Inhaled nitric oxide causes **selective pulmonary vasodilation**, improving V/Q matching and oxygenation. However, **iNO has not shown mortality benefit** in ARDS - it improves oxygenation temporarily but doesn't change outcomes. It may be used as a bridge or rescue therapy, but prone positioning and NMB have stronger evidence.", "consequence": "iNO started. Oxygenation improves transiently but no mortality benefit expected.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Decrease PEEP to reduce barotrauma risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In severe ARDS, **adequate PEEP is essential** to maintain alveolar recruitment and prevent atelectasis. Decreasing PEEP would worsen oxygenation and promote cyclic alveolar collapse (atelectrauma). The goal is to find the PEEP level that optimizes recruitment without overdistension.", "consequence": "Decreasing PEEP causes derecruitment and worsening hypoxemia.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Rescue therapies for severe ARDS**: (1) **Prone positioning** (\u226516 hrs/day) - strongest evidence, 16% mortality reduction; (2) **Neuromuscular blockade** (48 hrs) - improves synchrony, may reduce mortality; (3) **Inhaled nitric oxide** - improves oxygenation, no mortality benefit; (4) **ECMO** - for refractory cases."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient has been proned and paralyzed for 48 hours. Oxygenation has improved (P/F ratio now 120), and the underlying sepsis is being treated with appropriate antibiotics. On day 5 of ARDS, sedation is lightened and neuromuscular blockade is stopped.\n\nThe patient begins spontaneous breathing trials but develops significant tachypnea (RR 40) and increased work of breathing when ventilator support is decreased.", "question": "What is the best approach to weaning this patient from mechanical ventilation?", "choices": [{"id": "node-4-choice-a", "text": "Gradual pressure support weaning with daily spontaneous breathing trials", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Weaning from mechanical ventilation** in ARDS requires patience. The approach includes: (1) **Daily spontaneous breathing trials (SBT)** when criteria met, (2) **Gradual pressure support reduction**, (3) Assessment of readiness (adequate oxygenation, hemodynamic stability, mental status). Failed SBTs are common early in recovery - return to full support and retry in 24 hours. Premature extubation increases reintubation risk and mortality.", "consequence": "Patient undergoes gradual weaning. Successfully extubated on day 10 after passing a 30-minute SBT.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Immediate extubation since ARDS is improving", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Premature extubation** in ARDS leads to high reintubation rates (associated with increased mortality). The patient failed the weaning trial with tachypnea and increased work of breathing - these are signs of weaning failure. Continue mechanical ventilation and retry SBT when the patient is ready.", "consequence": "Patient is extubated prematurely and requires emergent reintubation within hours.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Tracheostomy for prolonged ventilation", "isOptimal": false, "isAcceptable": true, "feedback": "Tracheostomy may be appropriate for patients requiring **prolonged mechanical ventilation (>2-3 weeks)**, but day 5 is too early to determine this. Early tracheostomy (within 7-10 days) has been studied but optimal timing remains debated. Continue weaning trials first - many ARDS patients can be extubated within 1-2 weeks.", "consequence": "Tracheostomy placed, but patient might have been extubated with continued weaning efforts.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Resume neuromuscular blockade to rest the respiratory muscles", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged neuromuscular blockade causes **ICU-acquired weakness**, which is associated with prolonged mechanical ventilation, longer ICU stay, and worse outcomes. NMB should be limited to 48 hours in ARDS. The patient needs respiratory muscle reconditioning, not further paralysis.", "consequence": "Prolonged paralysis leads to severe ICU-acquired weakness and failure to wean.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Increase sedation to suppress respiratory drive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Excessive sedation **prolongs mechanical ventilation** and increases ICU delirium. Modern ICU practice emphasizes **minimal sedation** (daily awakening trials) to facilitate weaning. The goal is to assess and support the patient's respiratory effort, not suppress it.", "consequence": "Over-sedation prolongs ventilation and increases delirium risk.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ARDS weaning**: Daily awakening trials + spontaneous breathing trials (SAT/SBT). Weaning criteria: adequate oxygenation (P/F >150-200), FiO2 \u226440%, PEEP \u22648, hemodynamic stability, mental status appropriate. **Failed SBT** = return to full support, retry in 24 hours. Avoid premature extubation - reintubation increases mortality."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly diagnosed ARDS using Berlin criteria, implemented lung-protective ventilation, used appropriate rescue therapies for severe ARDS, and successfully weaned the patient from mechanical ventilation.\n\n**Key Learning Points:**\n- **Berlin criteria**: Acute onset, bilateral opacities, non-cardiogenic, P/F ratio \u2264300\n- **Severity**: Mild (P/F 200-300), Moderate (100-200), **Severe (\u2264100)**\n- **Lung-protective ventilation**: TV **6 mL/kg IBW**, Pplat **\u226430**, permissive hypercapnia OK\n- **Rescue therapies**: Prone positioning (strongest evidence), NMB for 48 hrs, iNO (no mortality benefit)\n- **Pathophysiology**: Diffuse alveolar damage \u2192 protein-rich edema \u2192 impaired gas exchange\n- **Weaning**: Daily SBT, gradual support reduction, avoid premature extubation"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While the patient may survive, opportunities for optimal care were missed.\n\n**Review these key principles:**\n- Use Berlin criteria to diagnose and classify ARDS severity\n- Lung-protective ventilation (6 mL/kg IBW) is the cornerstone of management\n- Prone positioning has the strongest evidence for mortality reduction in severe ARDS\n- Avoid therapies without mortality benefit (HFOV) when better options exist\n- Wean gradually - premature extubation and excessive sedation both worsen outcomes"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in ARDS management. These mistakes can increase mortality in a highly treatable condition.\n\n**Critical Teaching Points:**\n- High tidal volumes CAUSE lung injury (volutrauma) - never increase TV to improve oxygenation\n- ARDS is NOT cardiogenic - check BNP and echo, diuretics are not the treatment\n- Decreasing PEEP in severe ARDS causes derecruitment and worsening hypoxemia\n- Premature extubation leads to reintubation, which increases mortality\n- Prolonged paralysis causes ICU-acquired weakness"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-090", "title": "Galactosemia Recognition", "domain": "newborn", "difficulty": "advanced", "tags": ["galactosemia", "GALT deficiency", "E. coli sepsis", "cataracts", "newborn screen", "inborn error of metabolism", "soy formula", "primary ovarian insufficiency"], "estimatedMinutes": 8, "source": ["NBME"], "stem": "A 5-day-old female is admitted to the NICU for lethargy, poor feeding, and jaundice. She was born full-term and was doing well initially but became progressively ill after starting breastfeeding on day 1 of life.\n\nBlood cultures obtained yesterday are now positive for E. coli.\n\nPhysical Examination:\n- General: Lethargic, hypotonic neonate with poor suck\n- Vitals: T 36.2\u00b0C (hypothermic), HR 170, RR 60, BP 50/30\n- Skin: Jaundiced, mottled extremities\n- Eyes: Bilateral lens opacities noted on penlight exam\n- Abdomen: Hepatomegaly (liver edge 4 cm below costal margin), mild ascites\n- Neuro: Hypotonic, weak cry\n\nLabs: Direct bilirubin elevated, transaminases elevated, PT/PTT prolonged, glucose 45 mg/dL", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This neonate became ill after starting **milk feeds** (breastmilk contains lactose, which is broken down to glucose + galactose). The constellation of findings is striking:\n\n- **E. coli sepsis** in a neonate\n- **Hepatomegaly** with liver dysfunction (elevated transaminases, coagulopathy)\n- **Jaundice** (direct hyperbilirubinemia)\n- **Cataracts** (lens opacities)\n- **Hypoglycemia**", "question": "What metabolic disorder should be IMMEDIATELY suspected in a neonate with E. coli sepsis, liver dysfunction, and cataracts after starting milk feeds?", "choices": [{"id": "node-1-choice-a", "text": "Classic galactosemia (GALT deficiency)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Classic galactosemia** (galactose-1-phosphate uridyltransferase/GALT deficiency) should be immediately suspected. The triad of **E. coli sepsis + liver failure + cataracts** after milk introduction is virtually pathognomonic. Galactosemia infants have a unique susceptibility to **E. coli sepsis** (galactose-1-phosphate impairs neutrophil function). Other features: vomiting, poor feeding, failure to thrive, hypoglycemia, intellectual disability if untreated.", "consequence": "You recognize the classic presentation of galactosemia.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Phenylketonuria (PKU)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PKU** presents much later (months of age) with **developmental delay, musty body odor, fair skin/hair, and eczema**. PKU does NOT cause acute neonatal illness, E. coli sepsis, liver failure, or cataracts. The toxic metabolite in PKU is phenylalanine, which accumulates from protein intake, not milk sugars.", "consequence": "PKU does not present as acute neonatal illness.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Hereditary fructose intolerance", "isOptimal": false, "isAcceptable": true, "feedback": "Close, but not quite right. **Hereditary fructose intolerance (HFI)** also causes vomiting, hypoglycemia, and liver dysfunction after dietary introduction - but symptoms begin when **fructose/sucrose** is introduced (fruit, juice, table sugar), typically during **weaning at 4-6 months**. Breastmilk does NOT contain fructose. HFI also does NOT cause E. coli sepsis susceptibility or cataracts.", "consequence": "HFI presents after fructose introduction, not milk.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Neonatal sepsis without underlying metabolic disorder", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this infant does have E. coli sepsis, the presence of **cataracts** and **hepatomegaly** strongly suggests an underlying metabolic disorder. Routine neonatal sepsis does NOT cause cataracts. The E. coli sepsis IS a feature of galactosemia - these infants are uniquely susceptible due to impaired neutrophil function from galactose-1-phosphate accumulation.", "consequence": "Cataracts indicate an underlying metabolic disorder.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Biliary atresia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Biliary atresia** causes **conjugated (direct) hyperbilirubinemia** and hepatomegaly but does NOT cause cataracts, E. coli sepsis susceptibility, or acute illness after milk feeds. Biliary atresia presents with progressive jaundice and pale (acholic) stools in an otherwise well-appearing infant. This infant is acutely ill.", "consequence": "Biliary atresia doesn't explain cataracts or sepsis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Galactosemia Classic Presentation**: Neonate becomes sick within **DAYS of starting milk** (breast milk or lactose-containing formula). Key features: (1) **E. coli sepsis** (unique susceptibility - test ANY neonate with E. coli sepsis for galactosemia), (2) **Liver failure** (hepatomegaly, jaundice, coagulopathy), (3) **Cataracts** (galactitol accumulation in lens), (4) **Hypoglycemia**, (5) Vomiting, poor feeding. Think: **'Sick after milk' + E. coli + cataracts = GALACTOSEMIA**."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect galactosemia. The medical student asks about the pathophysiology - specifically why galactose is toxic and why these patients are susceptible to E. coli.", "question": "What is the underlying enzyme deficiency and pathophysiologic mechanism in classic galactosemia?", "choices": [{"id": "node-2-choice-a", "text": "GALT deficiency \u2192 galactose-1-phosphate accumulates \u2192 inhibits glycogenolysis/gluconeogenesis, impairs neutrophils, and galactitol causes cataracts", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Classic galactosemia** is caused by deficiency of **galactose-1-phosphate uridyltransferase (GALT)**, the enzyme that converts galactose-1-phosphate to glucose-1-phosphate. Without GALT: (1) **Galactose-1-phosphate accumulates** \u2192 directly toxic to liver and brain, inhibits glycogenolysis \u2192 hypoglycemia, (2) **Galactose-1-phosphate impairs neutrophil bactericidal function** \u2192 E. coli sepsis susceptibility, (3) Galactose is shunted to **galactitol** (via aldose reductase) \u2192 osmotic damage to lens \u2192 **cataracts**.", "consequence": "You understand the pathophysiology.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Galactokinase deficiency \u2192 galactose cannot be phosphorylated \u2192 benign condition with only cataracts", "isOptimal": false, "isAcceptable": false, "feedback": "This describes a different, **milder form of galactosemia**. **Galactokinase deficiency** prevents the first step of galactose metabolism, so galactose-1-phosphate does NOT accumulate. The only manifestation is **cataracts** (from galactitol accumulation). There is NO liver disease, NO E. coli susceptibility, NO intellectual disability. This infant has severe systemic disease - this is CLASSIC galactosemia (GALT deficiency), not galactokinase deficiency.", "consequence": "Galactokinase deficiency only causes cataracts.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Lactase deficiency \u2192 lactose cannot be digested \u2192 osmotic diarrhea only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lactase deficiency** (lactose intolerance) is completely different from galactosemia. Lactase is an intestinal enzyme that breaks lactose into glucose + galactose. Lactase deficiency causes **osmotic diarrhea and bloating** from undigested lactose - NOT liver failure, cataracts, or sepsis. Galactosemia is a disorder of galactose metabolism AFTER absorption.", "consequence": "Lactase deficiency is lactose intolerance - different condition.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "UDP-galactose-4-epimerase deficiency \u2192 galactose and glucose metabolism both affected", "isOptimal": false, "isAcceptable": false, "feedback": "**GALE (epimerase) deficiency** is the third type of galactosemia. The severe form can present similarly to classic galactosemia, but it is much rarer. The most common form is benign (only affects red blood cells). This infant's presentation is most consistent with **classic GALT deficiency** - the exam and boards typically test this type.", "consequence": "GALE deficiency is rare; GALT is the classic form.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Glucose-6-phosphatase deficiency \u2192 glycogen storage disease with hepatomegaly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Glucose-6-phosphatase deficiency** is **Glycogen Storage Disease Type I (von Gierke disease)**. It causes hepatomegaly and hypoglycemia but does NOT cause cataracts, is NOT triggered by milk feeds, and does NOT cause E. coli susceptibility. GSD-I causes lactic acidosis and hyperlipidemia, and symptoms relate to fasting intolerance, not milk ingestion.", "consequence": "This is a glycogen storage disease, not galactosemia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Galactose Metabolism Pathway**: Galactose \u2192 (galactokinase) \u2192 Galactose-1-P \u2192 (GALT) \u2192 Glucose-1-P \u2192 glycolysis/glycogen. **Three types of galactosemia**: (1) **Classic (GALT deficiency)** - severe, liver failure, E. coli sepsis, cataracts, intellectual disability, (2) **Galactokinase deficiency** - benign, ONLY cataracts, (3) **GALE deficiency** - rare, variable severity. **Why E. coli?** Galactose-1-P inhibits neutrophil respiratory burst and chemotaxis."}, "node-3": {"id": "node-3", "type": "decision", "content": "The newborn screen from this infant (obtained at 48 hours of life) is now available and shows **elevated galactose** and **absent GALT enzyme activity** - confirming classic galactosemia.\n\nThe infant is currently receiving breast milk and standard infant formula supplementation.", "question": "What is the IMMEDIATE dietary management for this infant with confirmed galactosemia?", "choices": [{"id": "node-3-choice-a", "text": "Stop ALL breast milk and lactose-containing formula immediately; switch to soy-based or elemental formula", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The treatment is **complete and immediate elimination of galactose and lactose** from the diet. **Breast milk and standard cow's milk formulas contain lactose** (which breaks down to galactose). Switch to: (1) **Soy-based formula** (first-line - no lactose, but some galactose in oligosaccharides), or (2) **Casein hydrolysate/elemental formula** (Nutramigen, Alimentum - lactose-free). The dietary restriction is **LIFELONG**. Continue treating the E. coli sepsis with appropriate antibiotics.", "consequence": "You initiate life-saving dietary intervention.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Continue breast milk but add lactase enzyme drops to break down lactose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lactase drops do NOT help galactosemia**. The problem is not lactose digestion in the gut - the problem is galactose metabolism AFTER absorption. Lactase actually makes things WORSE because it breaks lactose into glucose + galactose, and it's the galactose that's toxic. The galactose is absorbed and cannot be metabolized. Breast milk must be STOPPED.", "consequence": "Lactase makes galactosemia worse, not better.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Switch to goat's milk formula as an alternative to cow's milk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Goat's milk contains lactose**, just like cow's milk and breast milk. ALL mammalian milk contains lactose as the primary carbohydrate. Galactosemia patients must avoid ALL mammalian milk (human, cow, goat, sheep). Only lactose-free formulas (soy, elemental) are safe.", "consequence": "Goat's milk contains lactose - not safe.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Reduce breast milk by 50% and supplement with glucose water", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Any amount of galactose is harmful** in classic galactosemia. Reducing but not eliminating breast milk continues the toxic exposure. The dietary restriction must be **complete** - 100% elimination of lactose/galactose. Glucose water does not provide adequate nutrition for an infant.", "consequence": "Partial restriction is not sufficient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Hold feeds entirely until liver function normalizes, then restart breast milk slowly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The infant needs nutrition - holding all feeds will lead to catabolism and hypoglycemia. The correct approach is to **switch to a safe formula** (soy or elemental), not stop feeding. Breast milk can NEVER be restarted - galactosemia requires **lifelong** galactose restriction.", "consequence": "The infant needs lactose-free nutrition, not NPO.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Galactosemia Dietary Management**: (1) **STOP** all lactose/galactose sources IMMEDIATELY - breast milk, cow's milk formula, (2) **START** soy formula (first-line) or casein hydrolysate (Nutramigen/Alimentum), (3) **LIFELONG** restriction - avoid dairy products, (4) Hidden sources of galactose: organ meats, legumes (small amounts usually tolerated), some medications/supplements. **Note**: Even with perfect dietary compliance, some long-term complications occur due to endogenous galactose production."}, "node-4": {"id": "node-4", "type": "decision", "content": "The infant is switched to soy formula, treated for E. coli sepsis, and stabilizes over the next week. The parents ask about long-term prognosis.\n\n**Follow-up**: Liver function normalizing, cataracts beginning to clear (reversible if caught early), feeding well on soy formula.", "question": "Which long-term complication occurs in females with galactosemia even with excellent dietary compliance?", "choices": [{"id": "node-4-choice-a", "text": "Primary ovarian insufficiency (POI) - affects >80% of females with classic galactosemia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Primary ovarian insufficiency (POI)** is a devastating complication affecting **>80% of females** with classic galactosemia, even with perfect dietary compliance from birth. The mechanism is unclear but may relate to prenatal galactose exposure from maternal metabolism. Most affected women have **hypergonadotropic hypogonadism** (elevated FSH/LH, low estrogen), absent/delayed puberty, and infertility. Hormonal replacement therapy is needed. This is one of the few complications NOT prevented by diet.", "consequence": "You counsel about this important complication.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Type 1 diabetes mellitus from pancreatic damage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Galactosemia does NOT cause diabetes. The metabolic derangement affects galactose metabolism, not insulin production or glucose regulation (except for acute hypoglycemia during illness). Diabetes is not a long-term complication of galactosemia.", "consequence": "Galactosemia does not cause diabetes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Chronic kidney disease requiring dialysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Galactosemia primarily affects the **liver, brain, and ovaries**, not the kidneys. Chronic kidney disease is not a recognized complication. The renal tubules can have some dysfunction acutely, but this resolves with dietary treatment.", "consequence": "Kidneys are not primarily affected.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Permanent cataracts requiring lens replacement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The cataracts in galactosemia are caused by **galactitol** accumulation in the lens. If dietary treatment is started early (within weeks of birth), **cataracts are REVERSIBLE**. Once galactose is eliminated, the galactitol clears and cataracts resolve. Permanent cataracts only occur with late diagnosis.", "consequence": "Early-treated cataracts are reversible.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Galactosemia resolves after infancy with no long-term issues", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Galactosemia is a **lifelong condition** requiring permanent dietary restriction. Even with excellent compliance, long-term complications include: (1) **Speech/language delays** (majority), (2) **Learning difficulties**, (3) **Motor delays/ataxia**, (4) **Primary ovarian insufficiency** in females (>80%). The body also produces small amounts of galactose endogenously, contributing to complications despite diet.", "consequence": "Galactosemia requires lifelong management.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Long-term Complications of Galactosemia** (even with treatment): (1) **Speech/language delays** (>50%), (2) **Learning difficulties** (variable), (3) **Motor dysfunction/ataxia** (due to cerebellar involvement), (4) **Primary ovarian insufficiency (POI)** in **>80% of females** - NOT prevented by diet, occurs even with early treatment, (5) **Reduced bone density**. Why complications despite diet? **Endogenous galactose production** from UDP-galactose and prenatal exposure. **Newborn screening** is critical for early detection and treatment."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed classic galactosemia.\n\n**Key Learning Points:**\n\n1. **Recognition**: 'Sick after milk' + E. coli sepsis + cataracts + liver failure = GALACTOSEMIA. Test ANY neonate with E. coli sepsis for galactosemia.\n\n2. **Pathophysiology**: GALT deficiency \u2192 galactose-1-phosphate accumulates \u2192 liver toxicity, impaired neutrophil function (E. coli susceptibility), brain damage. Galactitol \u2192 cataracts.\n\n3. **Diagnosis**: Newborn screen (elevated galactose, absent GALT activity). Confirm with enzyme assay.\n\n4. **Treatment**: IMMEDIATE and LIFELONG elimination of lactose/galactose. Soy formula or casein hydrolysate. NO breast milk, cow's milk, or goat's milk.\n\n5. **Prognosis**: Early cataracts are reversible. Despite treatment, >80% of females develop primary ovarian insufficiency. Speech/learning delays common."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review galactosemia essentials:\n\n**Classic Triad**: E. coli sepsis + liver failure + cataracts after starting milk\n\n**Pathophysiology**: GALT deficiency \u2192 galactose-1-phosphate accumulation \u2192 toxicity. Galactitol \u2192 cataracts.\n\n**Differential**: NOT PKU (late-onset, musty odor), NOT HFI (fructose trigger), NOT lactose intolerance (GI symptoms only)\n\n**Treatment**: Complete lactose/galactose elimination. Soy or elemental formula. LIFELONG restriction.\n\n**Prognosis**: POI in >80% of females even with treatment. Cataracts reversible if treated early."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in galactosemia management:\n\n1. **Lactase drops do NOT help** - they WORSEN the condition by releasing more galactose for absorption.\n\n2. **Goat's milk contains lactose** - ALL mammalian milk is unsafe.\n\n3. **Partial restriction is NOT sufficient** - complete elimination is required.\n\n4. **Galactosemia is LIFELONG** - it does not resolve.\n\n5. **E. coli sepsis in a neonate should ALWAYS prompt galactosemia testing** - this is a unique susceptibility pattern."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-102", "title": "Persistent Pulmonary Hypertension of Newborn Mechanism", "domain": "newborn", "difficulty": "intermediate", "tags": ["failed transition", "differential cyanosis", "inhaled nitric oxide", "labile hypoxemia", "persistent pulmonary hypertension of newborn mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-day-old male presents with cyanosis that does not improve with supplemental oxygen and fluctuates with agitation.\n\nBirth history notable for meconium-stained amniotic fluid.\n\nPhysical Examination:\n- Vitals: hypoxia, cyanosis.\n- Term or near-term newborn with severe hypoxemia and cyanosis within hours of birth.\n- Pre-ductal SpO\u2082 higher than post-ductal (differential cyanosis).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Initial workup reveals:\n- Pre-ductal SpO\u2082 (right hand): 92%\n- Post-ductal SpO\u2082 (foot): 78%\n- Difference: **>10%** (significant differential cyanosis)\n- ABG: pH 7.28, PaO\u2082 38 mmHg on 100% FiO\u2082\n- CXR: clear lung fields, normal heart size\n- Hyperoxia test: PaO\u2082 remains <100 mmHg on 100% oxygen", "question": "What is the pathophysiologic mechanism causing this presentation?", "choices": [{"id": "node-1-choice-a", "text": "Failure of normal postnatal decrease in pulmonary vascular resistance with persistent right-to-left shunting", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Persistent pulmonary hypertension of the newborn (PPHN)** results from failure of the normal **fetal-to-neonatal circulatory transition**. Normally, PVR drops dramatically at birth due to lung expansion and increased oxygen. In PPHN, PVR remains elevated, causing **right-to-left shunting** through the **patent ductus arteriosus (PDA)** and/or **patent foramen ovale (PFO)**. The **differential cyanosis** (pre-ductal SpO\u2082 > post-ductal) occurs because oxygenated blood from the left ventricle supplies the right arm before deoxygenated blood shunts through the PDA to mix with descending aortic flow.", "consequence": "Understanding the mechanism guides targeted therapy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Structural cardiac defect with obligate right-to-left shunting", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The echocardiogram shows **normal cardiac anatomy**, ruling out structural congenital heart disease. Cyanotic heart defects (tetralogy of Fallot, transposition) would show anatomic abnormalities. PPHN occurs with a **structurally normal heart** but abnormal pulmonary vascular resistance.", "consequence": "This misdirection delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Surfactant deficiency causing ventilation-perfusion mismatch", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Respiratory distress syndrome (RDS)** from surfactant deficiency primarily affects **preterm infants** and shows characteristic **ground-glass opacities** on CXR. This term infant has **clear lung fields**. Additionally, RDS causes hypoxemia but not the characteristic differential cyanosis seen with ductal-level shunting.", "consequence": "Surfactant therapy would not address the underlying PVR issue.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Meconium obstruction of airways causing hypoxemia", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct thinking. **Meconium aspiration syndrome (MAS)** can trigger PPHN through chemical pneumonitis and hypoxic pulmonary vasoconstriction. However, MAS typically shows **patchy infiltrates** on CXR, not clear lung fields. The underlying mechanism in this case is still elevated PVR causing right-to-left shunting, regardless of the trigger.", "consequence": "While MAS can cause PPHN, the clear CXR and mechanism question points to the vascular physiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Sepsis-induced systemic hypotension with secondary hypoxemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sepsis can cause PPHN, it typically presents with **systemic hypotension**, temperature instability, and poor perfusion. The hallmark **differential cyanosis** seen here specifically indicates **ductal-level right-to-left shunting** from elevated pulmonary pressures, not systemic hypoperfusion.", "consequence": "This approach delays recognition of the pulmonary vascular problem.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Differential cyanosis** (pre-ductal SpO\u2082 > post-ductal by >10%) is pathognomonic for **right-to-left ductal shunting**. In PPHN, PVR exceeds SVR, so deoxygenated blood shunts right-to-left through the PDA into the descending aorta. The right hand receives pre-ductal (oxygenated) blood while the feet receive post-ductal (mixed) blood."}, "node-2": {"id": "node-2", "type": "decision", "content": "The diagnosis of PPHN is confirmed. You initiate supportive care:\n- Intubation and mechanical ventilation\n- FiO\u2082 100%\n- Sedation to minimize oxygen consumption\n- Correct acidosis (target pH >7.35)\n\nDespite optimization, the infant remains severely hypoxemic with SpO\u2082 75-80% and marked lability with any stimulation.", "question": "What is the most appropriate next pharmacologic intervention?", "choices": [{"id": "node-2-choice-a", "text": "Inhaled nitric oxide (iNO) at 20 ppm", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Inhaled nitric oxide (iNO)** is the first-line **selective pulmonary vasodilator** for PPHN. It works by activating **guanylate cyclase** in pulmonary vascular smooth muscle, increasing **cGMP** and causing vasodilation. The key advantage is **selectivity** - iNO is delivered directly to ventilated alveoli, causing vasodilation only in areas with good ventilation (improving V/Q matching). It is rapidly inactivated by hemoglobin, preventing systemic hypotension. Standard starting dose is **20 ppm**.", "consequence": "Oxygenation improves within 30-60 minutes in most responders.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "IV sildenafil", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable alternative. **Sildenafil** (PDE-5 inhibitor) increases cGMP by blocking its breakdown, causing pulmonary vasodilation. It can be used when iNO is unavailable or as adjunctive therapy. However, it is **not selective** to ventilated lung regions and can cause **systemic hypotension**. iNO remains first-line due to its selectivity and rapid onset.", "consequence": "May help but with more systemic side effects than iNO.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "IV milrinone", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable in certain scenarios. **Milrinone** (PDE-3 inhibitor) has both inotropic and vasodilatory effects. It can be useful for PPHN with **right ventricular dysfunction**. However, it causes **systemic vasodilation** and may worsen hypotension. It is typically used as adjunctive therapy, not first-line.", "consequence": "Reasonable choice but not optimal as monotherapy.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "IV prostacyclin (epoprostenol)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for neonatal PPHN. **IV prostacyclin** is used for chronic pulmonary hypertension in older patients but causes significant **systemic hypotension** and is not first-line for acute neonatal PPHN. Inhaled prostacyclin analogs may have a role, but iNO remains the standard.", "consequence": "Risk of severe hypotension in a critically ill neonate.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "High-dose dopamine for systemic blood pressure support", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect approach. While maintaining **systemic blood pressure > pulmonary pressure** is important (to minimize right-to-left shunting), high-dose dopamine does not address the underlying elevated PVR. Vasopressors may be needed adjunctively, but the primary intervention must target **pulmonary vascular resistance**.", "consequence": "Does not address the core pathophysiology.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **iNO is selective** because it only reaches ventilated alveoli. Gas exchange occurs at the alveolar-capillary interface, so iNO dilates vessels in well-ventilated regions, improving **V/Q matching**. Hemoglobin rapidly binds and inactivates iNO, preventing systemic effects. This selectivity is why iNO improves oxygenation without causing systemic hypotension."}, "node-3": {"id": "node-3", "type": "decision", "content": "Inhaled nitric oxide at 20 ppm is initiated. Within 30 minutes:\n- SpO\u2082 improves from 78% to 92%\n- Pre/post-ductal gradient narrows to 5%\n- Blood pressure stable\n\nAfter 48 hours of therapy, the infant is stable. You begin weaning iNO.\n\nDuring the wean from 5 ppm to off, SpO\u2082 suddenly drops from 94% to 70%.", "question": "What is the most likely cause of this acute desaturation?", "choices": [{"id": "node-3-choice-a", "text": "Rebound pulmonary hypertension from abrupt iNO discontinuation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Rebound pulmonary hypertension** is a well-known complication of iNO weaning. Prolonged iNO exposure **downregulates endogenous NO production** (via negative feedback on endothelial nitric oxide synthase). When exogenous iNO is withdrawn too quickly, endogenous production cannot compensate, causing acute PVR elevation and recurrent right-to-left shunting. Management: **restart iNO at previous effective dose** and wean more gradually (typically by 1-5 ppm decrements every 4-6 hours).", "consequence": "Restart iNO and wean more slowly to prevent rebound.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Methemoglobinemia from prolonged iNO exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Methemoglobinemia** can occur with iNO but develops gradually and is monitored with daily methemoglobin levels. It would not cause acute desaturation specifically during weaning. Additionally, methemoglobin levels typically remain <5% at standard iNO doses (\u226420 ppm). The temporal relationship to weaning points to rebound pulmonary hypertension.", "consequence": "Check methemoglobin level but prioritize addressing rebound.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Pneumothorax from barotrauma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While pneumothorax can cause acute desaturation in ventilated neonates, the timing specifically during iNO weaning strongly suggests **rebound pulmonary hypertension**. Pneumothorax would not correlate with medication changes. Physical exam (decreased breath sounds, shifted trachea) and CXR would distinguish this.", "consequence": "Important to rule out but not the most likely cause given timing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Endotracheal tube displacement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ETT displacement is a mechanical complication that can cause acute desaturation but is unrelated to medication weaning. The clear temporal relationship with iNO discontinuation points to **rebound pulmonary hypertension**. Always verify ETT position, but the mechanism here is pharmacologic.", "consequence": "Check ETT position but address the pharmacologic cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Development of new lung pathology (pneumonia)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ventilator-associated pneumonia develops over days, not acutely during a medication wean. The immediate temporal relationship between iNO discontinuation and desaturation is classic for **rebound pulmonary hypertension** from eNOS downregulation.", "consequence": "Infection workup reasonable but not the acute cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Rebound pulmonary hypertension** occurs because chronic iNO exposure downregulates **endothelial nitric oxide synthase (eNOS)**. Wean iNO gradually (decrease by small increments every 4-6 hours) and monitor closely. If rebound occurs, restart at the last effective dose and wean more slowly. Most infants can be weaned off within 3-5 days."}, "node-4": {"id": "node-4", "type": "decision", "content": "You restart iNO and successfully wean over the next 72 hours. The infant is now breathing room air with SpO\u2082 97%.\n\nBefore discharge, the family asks about long-term prognosis and follow-up.", "question": "What is the most important counseling point regarding long-term outcomes in survivors of severe PPHN?", "choices": [{"id": "node-4-choice-a", "text": "Increased risk of neurodevelopmental impairment requiring early intervention and developmental surveillance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Survivors of severe PPHN have increased risk of **neurodevelopmental impairment** including motor delays, cognitive deficits, and hearing loss. This results from both **hypoxic-ischemic injury** during the acute illness and potential effects of treatments (prolonged sedation, ECMO if used). All PPHN survivors should receive **early intervention referral**, developmental surveillance, and hearing evaluation. Approximately **25-30%** of survivors have some neurodevelopmental abnormality.", "consequence": "Family understands the need for developmental follow-up and early intervention.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Need for lifelong pulmonary vasodilator therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Unlike chronic pulmonary hypertension, **PPHN typically resolves** as the infant matures and PVR normalizes. Most infants do not require long-term pulmonary vasodilators. The pulmonary vascular bed remodels, and normal circulation is achieved. Persistent pulmonary hypertension beyond infancy is rare and suggests an underlying condition.", "consequence": "May cause unnecessary concern; most PPHN resolves completely.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "High likelihood of recurrence in future pregnancies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PPHN is not a genetic condition in most cases and does not significantly increase recurrence risk in siblings. Risk factors are largely perinatal (meconium aspiration, perinatal asphyxia, infection) rather than hereditary. Genetic forms of pulmonary hypertension exist but are rare.", "consequence": "While family history is documented, high recurrence is not expected.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Complete recovery with no expected long-term sequelae", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While many PPHN survivors do well, **25-30% have neurodevelopmental abnormalities**. Reassuring families of complete recovery without mentioning the need for developmental surveillance fails to prepare them for potential challenges and misses opportunities for early intervention.", "consequence": "May delay recognition and intervention for developmental delays.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Restriction from future vaccinations due to immune system stress", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no contraindication to vaccination** in PPHN survivors. They should receive all routine immunizations on schedule. In fact, preventing respiratory infections (RSV, influenza) is particularly important in infants who had significant neonatal respiratory illness.", "consequence": "Dangerous misinformation that could leave the child unprotected.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: PPHN survivors need **neurodevelopmental follow-up** because hypoxic episodes can cause lasting injury. Early intervention services improve outcomes. Additionally, obtain **hearing screen** (hypoxia and medications can cause sensorineural hearing loss) and monitor for **chronic lung disease** symptoms. Most pulmonary hypertension resolves, but developmental vigilance is essential."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified PPHN through its pathognomonic **differential cyanosis**, understood the mechanism of **failed fetal-to-neonatal transition** with persistent elevated PVR, initiated appropriate therapy with **inhaled nitric oxide** (selective pulmonary vasodilator), recognized **rebound pulmonary hypertension** during weaning, and counseled the family about neurodevelopmental follow-up. This comprehensive approach optimizes both acute survival and long-term outcomes for PPHN."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key concepts in PPHN: (1) **Differential cyanosis** (pre-ductal > post-ductal SpO\u2082) indicates right-to-left ductal shunting; (2) **iNO is first-line** because it selectively dilates pulmonary vessels in ventilated regions; (3) **Rebound pulmonary hypertension** occurs with rapid iNO weaning due to eNOS downregulation; (4) Survivors need **neurodevelopmental surveillance** due to hypoxic injury risk."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. PPHN is a neonatal emergency resulting from failure of normal postnatal decrease in pulmonary vascular resistance. **Key features**: differential cyanosis, labile hypoxemia, normal cardiac anatomy on echo. **Management**: optimize oxygenation/ventilation, inhaled nitric oxide (selective pulmonary vasodilator), ECMO for refractory cases. **Complications**: rebound during iNO weaning, neurodevelopmental impairment in survivors."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-103", "title": "Treatment-Resistant Pneumonia - Staphylococcus aureus", "domain": "newborn", "difficulty": "intermediate", "tags": ["pneumonia not responding to antibiotics", "pneumatoceles", "empyema", "necrotizing pneumonia", "treatment-resistant pneumonia - staphylococcus aureus"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with pneumonia not improving on standard antibiotics (amoxicillin or ceftriaxone).\n\nCXR shows rapid progression, cavitation, pneumatoceles, or empyema.\n\nPhysical Examination:\n- Vitals: high fever.\n- High fever, toxic appearance.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Additional history reveals the child was initially treated with amoxicillin for presumed community-acquired pneumonia. After 72 hours, he developed worsening fever to 40\u00b0C, increased work of breathing, and a new pleural effusion.\n\nLaboratory findings:\n- WBC: 22,000/\u03bcL with left shift\n- CRP: 280 mg/L (markedly elevated)\n- Procalcitonin: 15 ng/mL (high)\n\nRepeat CXR shows:\n- Rapidly progressive right lower lobe consolidation\n- **Pneumatoceles** (thin-walled cavities)\n- Moderate right pleural effusion", "question": "Which pathogen is most likely responsible for this treatment-resistant, aggressive pneumonia?", "choices": [{"id": "node-1-choice-a", "text": "Staphylococcus aureus (including community-acquired MRSA)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Staphylococcus aureus** is the most likely pathogen. The classic triad of treatment-resistant pneumonia is: (1) **failure to respond to beta-lactams** (amoxicillin, ceftriaxone), (2) **rapid progression with necrosis/cavitation**, and (3) **pneumatoceles or empyema**. S. aureus produces **Panton-Valentine leukocidin (PVL)**, a cytotoxin that causes necrotizing pneumonia with cavitation. **Community-acquired MRSA (CA-MRSA)** is increasingly common and is resistant to standard beta-lactam antibiotics.", "consequence": "Appropriate antibiotic coverage can be initiated.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Streptococcus pneumoniae (penicillin-resistant)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **penicillin-resistant S. pneumoniae** exists, it rarely causes necrotizing/cavitary pneumonia with pneumatoceles. S. pneumoniae typically responds to high-dose amoxicillin even with intermediate resistance, and parapneumonic effusions from pneumococcus are usually smaller. The **aggressive cavitary destruction** seen here is characteristic of S. aureus.", "consequence": "May lead to inadequate antibiotic selection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Mycoplasma pneumoniae", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Mycoplasma pneumoniae** causes atypical pneumonia with gradual onset, dry cough, and **interstitial infiltrates** on CXR. It does not cause cavitation, pneumatoceles, or empyema. Additionally, Mycoplasma is more common in **school-age children and adolescents** and presents with milder systemic toxicity.", "consequence": "Macrolide therapy would not cover S. aureus.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Respiratory syncytial virus (RSV)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **RSV** causes bronchiolitis in infants and viral pneumonia in older children, but does not produce the **cavitary lesions, pneumatoceles, or high inflammatory markers** seen here. Viral pneumonias show interstitial patterns, not lobar consolidation with tissue destruction.", "consequence": "Viral etiology does not explain this presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Haemophilus influenzae type b", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hib** pneumonia has become rare due to widespread vaccination. When it occurs, it typically causes lobar pneumonia but not the characteristic **pneumatoceles and necrotizing features** seen with S. aureus. Always check vaccination status, but in an immunized child, Hib is unlikely.", "consequence": "Unlikely pathogen in vaccinated children.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Pneumatoceles** (thin-walled air-filled cavities) are highly suggestive of **S. aureus pneumonia**. They form from check-valve obstruction of small airways and typically resolve over weeks to months. Other S. aureus pneumonia features: necrotizing pneumonia, empyema, and rapid progression despite standard antibiotics."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect S. aureus pneumonia, likely **CA-MRSA** given the community acquisition and treatment failure.\n\nThe child is admitted to the PICU with:\n- SpO\u2082 90% on 6L nasal cannula\n- Respiratory rate 45/min with retractions\n- Blood pressure stable\n- Mental status appropriate", "question": "What is the most appropriate empiric antibiotic regimen while awaiting cultures?", "choices": [{"id": "node-2-choice-a", "text": "Vancomycin IV + clindamycin IV", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Vancomycin + clindamycin** is the optimal empiric regimen for suspected MRSA pneumonia. **Vancomycin** provides MRSA coverage and achieves adequate lung penetration. **Clindamycin** is added because it inhibits **protein synthesis**, reducing production of **Panton-Valentine leukocidin (PVL)** and other toxins. This toxin suppression is critical in necrotizing S. aureus infections. Vancomycin alone is bactericidal but does not suppress toxin production.", "consequence": "Optimal coverage and toxin suppression initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Vancomycin IV alone", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but suboptimal. **Vancomycin** provides MRSA coverage, but adding **clindamycin** is preferred for necrotizing/toxin-mediated S. aureus infections. Clindamycin suppresses **PVL toxin production** through protein synthesis inhibition. For severe S. aureus pneumonia with cavitation, dual therapy is recommended.", "consequence": "Covers MRSA but does not suppress toxin production optimally.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Ceftriaxone IV + azithromycin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is standard empiric therapy for **community-acquired pneumonia** (covering S. pneumoniae and atypical pathogens), but it provides **no MRSA coverage**. Ceftriaxone is a beta-lactam that MRSA is resistant to. This regimen would continue the treatment failure already seen with amoxicillin.", "consequence": "MRSA will not be covered; treatment failure continues.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Linezolid IV monotherapy", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable alternative. **Linezolid** has excellent MRSA coverage and lung penetration, and as a protein synthesis inhibitor, it suppresses toxin production. Some studies suggest it may be superior to vancomycin for MRSA pneumonia. However, it has more **drug interactions** and risk of **myelosuppression** with prolonged use. Vancomycin + clindamycin remains first-line in most centers.", "consequence": "Reasonable alternative, particularly if vancomycin allergic.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "High-dose amoxicillin-clavulanate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Amoxicillin-clavulanate** covers **MSSA** (methicillin-sensitive S. aureus) but **not MRSA**. MRSA has the **mecA gene** encoding altered penicillin-binding protein (PBP2a) that has low affinity for all beta-lactams. Given the treatment failure and community setting, MRSA must be assumed until cultures prove otherwise.", "consequence": "MRSA will remain uncovered.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: For severe S. aureus infections with toxin-mediated tissue destruction, add **clindamycin** (or linezolid) to suppress **toxin production**. These protein synthesis inhibitors reduce PVL and other exotoxins. Remember: **D-test** - if clindamycin-susceptible but erythromycin-resistant, check for inducible clindamycin resistance before relying on clindamycin monotherapy."}, "node-3": {"id": "node-3", "type": "decision", "content": "Antibiotics are initiated. Blood cultures are drawn.\n\nChest ultrasound reveals a **complex, loculated pleural effusion** with septations. Estimated volume is 300 mL.\n\nThe child remains febrile at 39.5\u00b0C with persistent oxygen requirement despite 24 hours of appropriate antibiotics.", "question": "What is the most appropriate intervention for the pleural effusion?", "choices": [{"id": "node-3-choice-a", "text": "Chest tube placement with intrapleural fibrinolytic therapy (tPA/DNase)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **complicated parapneumonic effusion/empyema** with loculations, **chest tube drainage with fibrinolytic therapy** is first-line. **tPA** (tissue plasminogen activator) breaks down fibrin strands, while **DNase** degrades DNA from lysed neutrophils (which contributes to fluid viscosity). The combination improves drainage and reduces need for surgical intervention. Standard regimen: **tPA 4mg + DNase 5mg** instilled twice daily for 3 days.", "consequence": "Loculations break down, drainage improves, fever resolves.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Thoracentesis alone for diagnosis and symptomatic relief", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Simple **thoracentesis** is inadequate for complicated/loculated effusions. The loculations prevent complete drainage, and the viscous, purulent fluid will reaccumulate. Additionally, serial thoracenteses increase infection risk. For loculated empyema, **chest tube with fibrinolysis** or surgery is needed.", "consequence": "Incomplete drainage; effusion reaccumulates.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Continue antibiotics alone; effusion will resolve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Small, simple parapneumonic effusions** may resolve with antibiotics alone, but **loculated effusions and empyema** require drainage. Undrained empyema leads to **fibrothorax** (lung entrapment), prolonged hospitalization, and may eventually require decortication surgery.", "consequence": "Prolonged fever, risk of fibrothorax and lung entrapment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Immediate VATS (video-assisted thoracoscopic surgery)", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not first-line. **VATS** is highly effective for empyema drainage and debridement, but most centers reserve it for patients who **fail fibrinolytic therapy** (persistent fever/effusion after 48-72 hours of tPA/DNase). Starting with less invasive chest tube + fibrinolytics is preferred, reserving VATS for treatment failures.", "consequence": "More invasive than needed as initial approach.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "CT-guided percutaneous abscess drainage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Percutaneous drainage** is used for **lung abscesses**, not pleural effusions. Pleural empyema requires chest tube drainage into the pleural space. Additionally, lung abscesses in children often respond to prolonged antibiotics alone and only need drainage if they fail to improve or are very large (>4 cm).", "consequence": "Wrong procedure for pleural-based collection.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: Classify parapneumonic effusions by **Light's criteria** and appearance: (1) **Simple** - small, free-flowing, clear \u2192 may resolve with antibiotics; (2) **Complicated** - loculated, pH <7.2, glucose <40, LDH >1000 \u2192 needs drainage; (3) **Empyema** - frank pus, positive culture \u2192 needs drainage. **tPA/DNase** is first-line for complicated/loculated effusions."}, "node-4": {"id": "node-4", "type": "decision", "content": "Chest tube is placed with fibrinolytic therapy. Over the next 48 hours:\n- Fever resolves (max 37.5\u00b0C)\n- Drainage decreases to <50 mL/day\n- Repeat CXR shows near-complete resolution of effusion\n- Chest tube is removed\n\nBlood cultures grew **MRSA**. Susceptibilities show sensitivity to vancomycin, clindamycin (D-test negative), TMP-SMX, and linezolid.\n\nThe child is clinically improved and ready for discharge planning.", "question": "What is the recommended total antibiotic duration and oral step-down therapy?", "choices": [{"id": "node-4-choice-a", "text": "Total 3-4 weeks of antibiotics; transition to oral clindamycin or TMP-SMX when afebrile and improving", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **S. aureus pneumonia with empyema** requires prolonged treatment: typically **3-4 weeks total** (IV until clinically improved, then oral to complete course). Oral options for MRSA include **clindamycin** (if D-test negative) or **TMP-SMX** (trimethoprim-sulfamethoxazole). Transition to oral when: afebrile **>48 hours**, tolerating PO, chest tube removed, and CRP trending down.", "consequence": "Appropriate duration to prevent relapse; safe for discharge.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Total 7-10 days of antibiotics; standard pneumonia duration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Standard CAP duration (5-7 days)** is insufficient for S. aureus pneumonia with empyema. The tissue destruction, abscess formation, and poor penetration of antibiotics into infected collections require **3-4 weeks** to prevent relapse. Shorter courses have high failure rates.", "consequence": "High risk of relapse and recurrent empyema.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Complete all 4 weeks IV; oral antibiotics are inadequate for MRSA", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged IV antibiotics are not necessary once the patient is clinically improved. **Oral clindamycin and TMP-SMX** have excellent bioavailability and achieve adequate tissue levels. Keeping patients hospitalized for IV-only therapy increases costs, nosocomial infection risk, and central line complications without improving outcomes.", "consequence": "Unnecessary hospitalization and IV access risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Transition to oral amoxicillin-clavulanate to complete 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Amoxicillin-clavulanate does not cover MRSA** - this was the reason for initial treatment failure. Oral step-down must use an agent with confirmed MRSA activity based on susceptibilities. Additionally, 2 weeks is too short for complicated S. aureus pneumonia.", "consequence": "Treatment failure; MRSA not covered by chosen antibiotic.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Discharge without antibiotics; infection was drained adequately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While source control (drainage) is essential, **antibiotics remain critical** for S. aureus bacteremia and pneumonia. The parenchymal infection and any residual bacterial load require continued antibiotic therapy. Stopping antibiotics prematurely risks relapse, metastatic infection, and potentially endocarditis.", "consequence": "High risk of relapse and metastatic complications.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **S. aureus pneumonia with empyema** requires **3-4 weeks** of antibiotics. Oral step-down options for MRSA: **clindamycin** (check D-test for inducible resistance), **TMP-SMX** (excellent bioavailability), or **linezolid** (expensive, myelosuppression risk). Follow-up CXR at 4-6 weeks to document pneumatocele resolution; most resolve spontaneously without intervention."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **S. aureus** as the pathogen in this treatment-resistant pneumonia based on the classic features: failure of beta-lactams, rapid progression, pneumatoceles, and empyema. You initiated appropriate **vancomycin + clindamycin** therapy for MRSA with toxin suppression, managed the loculated empyema with **chest tube and fibrinolytic therapy**, and planned an appropriate **3-4 week antibiotic course** with oral step-down. This comprehensive approach optimizes outcomes and minimizes complications."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key concepts in S. aureus pneumonia: (1) **Pneumatoceles + empyema + treatment failure** = think S. aureus/MRSA; (2) Use **vancomycin + clindamycin** for toxin suppression; (3) **Loculated effusions** need drainage with fibrinolysis or VATS; (4) **3-4 weeks** total antibiotic duration for complicated disease."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. S. aureus causes the most aggressive community-acquired pneumonia in children. **Key features**: treatment failure with beta-lactams, pneumatoceles, necrotizing pneumonia, empyema. **Management**: MRSA-covering antibiotics (vancomycin \u00b1 clindamycin), drainage of complicated effusions (tPA/DNase or VATS), prolonged antibiotic course (3-4 weeks). Failure to recognize and treat appropriately leads to severe complications including fibrothorax and chronic lung disease."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-106", "title": "Abnormal Newborn Screen Follow-up", "domain": "newborn", "difficulty": "intermediate", "tags": ["abnormal newborn screen", "congenital adrenal hyperplasia", "CAH", "21-hydroxylase deficiency", "17-OHP", "salt-wasting", "stress dosing", "neonatal endocrinology"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-day-old male born at term is being evaluated after the state newborn screening program reports an abnormal result.\n\nThe infant was discharged from the well-baby nursery at 48 hours of life in good condition. Birth weight was 3.2 kg. Parents report the baby is feeding well with no vomiting.\n\nVital signs: T 37.0\u00b0C, HR 140, RR 42, BP 65/40 mmHg\n\nPhysical examination reveals a well-appearing male infant with normal genitalia (no hyperpigmentation, normal penile length).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The newborn screening laboratory reports **elevated 17-hydroxyprogesterone (17-OHP)** at 85 nmol/L (normal <30 nmol/L for term infant at 24-48 hours).\n\n**Understanding Newborn Screening:**\n\nNewborn screening is a **population-based screening program** designed to identify presymptomatic infants with treatable conditions. Key principles:\n\n**1. Screening vs. Diagnostic Testing:**\n- **Screening tests** are designed for HIGH SENSITIVITY (catch all true cases)\n- This means they accept more **false positives** to avoid missing true disease\n- An abnormal screen is NOT a diagnosis\u2014it requires **confirmatory testing**\n\n**2. Timing of Collection:**\n- Optimal: **24-48 hours of life** (after protein feeding begins)\n- Too early (<24 hours): May miss PKU (insufficient phenylalanine exposure)\n- Too late: Delays treatment for time-sensitive conditions\n\n**3. Elevated 17-OHP on Newborn Screen:**\n- Suggests possible **Congenital Adrenal Hyperplasia (CAH)**\n- Most commonly **21-hydroxylase deficiency** (>90% of CAH)\n- **False positive rate is HIGH**, especially in:\n  - **Premature infants** (immature adrenal function)\n  - **Stressed/sick infants** (cross-reactive steroids)\n  - Early collection (<24 hours)\n\n**4. CAH Pathophysiology (21-hydroxylase deficiency):**\n- Enzyme defect blocks cortisol AND aldosterone synthesis\n- ACTH rises (no cortisol feedback) \u2192 adrenal hyperplasia\n- Precursors shunted to androgen pathway \u2192 **virilization**\n- Aldosterone deficiency \u2192 **salt-wasting crisis** (typically days 7-14 of life)", "question": "What is the most appropriate FIRST response to this abnormal newborn screen result?", "choices": [{"id": "node-1-choice-a", "text": "Order urgent confirmatory testing (serum 17-OHP, electrolytes, glucose) and arrange same-day clinical evaluation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Urgent confirmatory testing with same-day evaluation** is essential. Newborn screening is designed for sensitivity, not specificity, so abnormal results require prompt confirmation. However, CAH can cause life-threatening **salt-wasting crisis** as early as days 7-14 of life. You cannot wait days or weeks for follow-up. The approach is: (1) Confirmatory serum 17-OHP (more accurate than filter paper), (2) Electrolytes to assess for early salt-wasting (hyponatremia, hyperkalemia), (3) Glucose (hypoglycemia from cortisol deficiency), (4) Clinical evaluation for signs of virilization or adrenal crisis.", "consequence": "You arrange urgent confirmatory testing and same-day pediatric endocrinology evaluation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Reassure parents that false positives are common, repeat newborn screen in 1-2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While false positives ARE common with elevated 17-OHP (especially in preterm infants), **delaying evaluation by 1-2 weeks is dangerous**. Classic salt-wasting CAH can cause life-threatening adrenal crisis by days 7-14 of life. A well-appearing infant today can rapidly deteriorate with hyponatremia, hyperkalemia, hypoglycemia, and shock. The elevated 17-OHP must be urgently confirmed or ruled out\u2014you cannot simply wait and repeat screening.", "consequence": "Dangerous delay. The infant could develop salt-wasting crisis before repeat testing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Start empiric hydrocortisone and fludrocortisone immediately before any confirmatory testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do not start treatment based on screening alone** in a well-appearing infant. Empiric steroid treatment would: (1) Be unnecessary in the majority of cases (false positives are common), (2) Interfere with confirmatory hormone testing, (3) Expose an infant without CAH to unnecessary medication. However, if the infant showed signs of **adrenal crisis** (shock, severe hyponatremia, hyperkalemia), then empiric treatment would be appropriate while awaiting confirmation. This infant is well-appearing, so confirmatory testing first is appropriate.", "consequence": "Premature treatment would affect confirmatory testing accuracy and expose infant to unnecessary steroids.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Schedule routine outpatient endocrinology appointment in 2-4 weeks for evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **2-4 week delay is unacceptable** for suspected CAH. Salt-wasting CAH typically presents with adrenal crisis between days 7-14 of life. By 2-4 weeks, an affected infant could have already experienced cardiovascular collapse from severe hyponatremia and hyperkalemia. Newborn screening exists precisely to identify these infants BEFORE they become symptomatic. Routine scheduling negates the entire purpose of screening.", "consequence": "Dangerous delay. An infant with salt-wasting CAH would likely present in crisis before the appointment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Order karyotype to determine genetic sex before any other testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While karyotype may be part of the workup for **ambiguous genitalia** (46,XX females with CAH can be virilized to appear male), this infant has **normal male genitalia**. The immediate priority is confirming or ruling out CAH to prevent salt-wasting crisis, not determining genetic sex. Karyotype results take days to weeks and would not change the urgent need for 17-OHP confirmation and electrolyte monitoring.", "consequence": "Delays urgent confirmatory testing while ordering non-emergent genetic testing.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Abnormal newborn screen \u2260 diagnosis**. Newborn screening is designed for HIGH SENSITIVITY (low false negative rate), which means FALSE POSITIVES are expected. However, for time-sensitive conditions like CAH, you must obtain **urgent confirmatory testing**\u2014do not delay for weeks because salt-wasting crisis can occur by days 7-14 of life."}, "node-2": {"id": "node-2", "type": "decision", "content": "Confirmatory testing returns:\n- **Serum 17-OHP: 450 nmol/L** (markedly elevated, confirms CAH)\n- **Sodium: 132 mEq/L** (low-normal, trending down)\n- **Potassium: 5.8 mEq/L** (elevated)\n- **Glucose: 55 mg/dL** (low-normal)\n- **ACTH: 890 pg/mL** (markedly elevated)\n\nThe infant remains well-appearing but now shows subtle hyperpigmentation of the scrotum and nipples.\n\n**Interpreting These Results:**\n\nThe markedly elevated serum 17-OHP (450 nmol/L) **confirms 21-hydroxylase deficiency CAH**. The electrolyte pattern (low-normal sodium, elevated potassium) indicates **early salt-wasting**\u2014this is evolving toward crisis.\n\n**Why Hyperpigmentation?**\n- ACTH is markedly elevated (890 pg/mL) due to absent cortisol feedback\n- ACTH shares precursor with **MSH (melanocyte-stimulating hormone)**\n- High ACTH \u2192 increased MSH activity \u2192 hyperpigmentation (especially scrotum, nipples, skin creases)\n\n**Salt-Wasting CAH Timeline:**\n- Days 1-5: Usually asymptomatic (maternal hormones provide some protection)\n- Days 5-7: Sodium begins to fall, potassium rises\n- Days 7-14: Frank adrenal crisis if untreated (hyponatremic dehydration, hyperkalemic cardiac effects, hypoglycemia, shock)", "question": "Confirmatory testing confirms CAH with early electrolyte abnormalities. What is the MOST appropriate immediate management?", "choices": [{"id": "node-2-choice-a", "text": "Start hydrocortisone (glucocorticoid) AND fludrocortisone (mineralocorticoid), with sodium chloride supplementation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Classic salt-wasting CAH requires BOTH glucocorticoid AND mineralocorticoid replacement**:\n\n**1. Hydrocortisone** (glucocorticoid replacement):\n- Replaces deficient cortisol\n- Suppresses excessive ACTH \u2192 reduces androgen production\n- Typical dose: 10-15 mg/m\u00b2/day divided TID\n\n**2. Fludrocortisone** (mineralocorticoid replacement):\n- Replaces deficient aldosterone\n- Promotes sodium retention, potassium excretion\n- Typical dose: 0.05-0.2 mg/day\n\n**3. Sodium chloride supplementation**:\n- Infants have high sodium requirements\n- Often need NaCl 1-2 g/day (as sodium chloride solution) in addition to fludrocortisone\n- Continue until aldosterone receptors mature (usually first 1-2 years)\n\nThis triple therapy prevents salt-wasting crisis and normalizes androgen excess.", "consequence": "You initiate appropriate dual hormone replacement therapy with sodium supplementation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start hydrocortisone only; add fludrocortisone later if electrolytes worsen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant already has **early salt-wasting** (sodium 132, potassium 5.8). Waiting for electrolytes to worsen before adding mineralocorticoid is dangerous. Salt-wasting CAH requires **upfront dual therapy**\u2014both hydrocortisone AND fludrocortisone from the start. The mineralocorticoid deficiency is a fundamental part of 21-hydroxylase deficiency, not a secondary complication to be treated reactively. Delaying fludrocortisone risks progression to frank adrenal crisis.", "consequence": "Inadequate initial therapy. Electrolytes may deteriorate rapidly without mineralocorticoid replacement.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Start fludrocortisone only; the elevated ACTH will provide adequate cortisol precursors", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This fundamentally misunderstands CAH pathophysiology. The elevated ACTH is a **compensatory response to cortisol deficiency**\u2014the enzyme block prevents cortisol synthesis regardless of how much ACTH is produced. Without hydrocortisone replacement: (1) The infant remains cortisol-deficient (hypoglycemia risk, stress intolerance), (2) ACTH remains elevated \u2192 continued androgen excess \u2192 ongoing virilization, (3) Adrenal hyperplasia continues. **Both** glucocorticoid AND mineralocorticoid replacement are essential.", "consequence": "Inadequate therapy. Cortisol deficiency and androgen excess would persist.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Admit to NICU for IV normal saline boluses and stress-dose hydrocortisone", "isOptimal": false, "isAcceptable": true, "feedback": "This would be appropriate if the infant were in **frank adrenal crisis** (shock, severe hyponatremia <125, severe hyperkalemia >6.5, hypoglycemia). However, this infant is well-appearing with only early electrolyte changes. Stress-dose steroids and aggressive IV fluids are not yet indicated. The appropriate approach is to start maintenance replacement therapy (hydrocortisone + fludrocortisone + NaCl) and monitor closely. Reserve stress dosing for actual illness/stress or evolving crisis.", "consequence": "More aggressive than currently needed, but not harmful. Appropriate to initiate maintenance therapy instead.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Refer to pediatric surgery for evaluation of potential adrenalectomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Adrenalectomy is NOT indicated for CAH**. The treatment is lifelong hormone replacement, not surgical removal of the adrenals. The enlarged adrenal glands in CAH are a result of ACTH stimulation, and they will regress with appropriate glucocorticoid therapy that suppresses ACTH. Bilateral adrenalectomy would convert a manageable hormone replacement condition into complete adrenal insufficiency, eliminating any residual adrenal function.", "consequence": "Inappropriate surgical referral. CAH is managed medically, not surgically.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Salt-wasting CAH requires TRIPLE therapy**: (1) Hydrocortisone for cortisol replacement and ACTH suppression, (2) Fludrocortisone for aldosterone replacement, (3) Sodium chloride supplementation in infancy. The hyperpigmentation (from elevated ACTH/MSH) will improve as hydrocortisone suppresses ACTH."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant is started on hydrocortisone, fludrocortisone, and sodium chloride supplementation. Over the next week, electrolytes normalize (Na 140, K 4.5), and the hyperpigmentation begins to fade.\n\nThe parents ask about long-term management and genetic implications.\n\n**Long-term CAH Management Principles:**\n\n**1. Lifelong Hormone Replacement:**\n- Glucocorticoid (hydrocortisone in children, may switch to longer-acting in adults)\n- Mineralocorticoid (fludrocortisone)\u2014may be able to discontinue after infancy in some cases\n- Goal: Replace deficient hormones while minimizing overtreatment\n\n**2. Stress Dosing:**\n- During illness/surgery/trauma, cortisol requirements increase 2-3x\n- Must teach parents to give **stress doses** (2-3x maintenance) during illness\n- Severe stress (surgery, major trauma): IV hydrocortisone\n- Failure to stress dose \u2192 adrenal crisis\n\n**3. Monitoring:**\n- Growth (overtreatment \u2192 poor growth; undertreatment \u2192 accelerated bone age)\n- Bone age (androgen excess accelerates epiphyseal maturation)\n- 17-OHP and androstenedione levels (markers of control)\n- Plasma renin activity (guides mineralocorticoid dosing)\n\n**4. Genetics:**\n- 21-hydroxylase deficiency is **autosomal recessive** (CYP21A2 gene)\n- Both parents are obligate carriers\n- 25% recurrence risk for future pregnancies\n- Genetic counseling and prenatal diagnosis available", "question": "When counseling the parents about long-term management, which statement is MOST accurate?", "choices": [{"id": "node-3-choice-a", "text": "Parents must be trained to give stress-dose steroids during illness, as failure to do so can cause life-threatening adrenal crisis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Stress dosing education is CRITICAL** for CAH management. During physiologic stress (fever, vomiting, surgery, trauma), the body normally increases cortisol production 2-3 fold. Patients with CAH cannot mount this response. Parents must be trained to:\n\n**1. Recognize when to stress dose:**\n- Fever >38.5\u00b0C\n- Vomiting/diarrhea\n- Significant injury\n- Any illness requiring medical attention\n\n**2. Give stress doses:**\n- Mild-moderate stress: 2-3x maintenance oral hydrocortisone\n- Vomiting/unable to take oral: IM hydrocortisone injection (parents trained to give)\n- Surgery/severe illness: IV stress-dose hydrocortisone\n\n**3. Medical alert identification:**\n- Always wear medical alert bracelet\n- Carry emergency injection kit\n\n**Failure to stress dose during illness \u2192 adrenal crisis \u2192 potentially fatal.**", "consequence": "You provide comprehensive stress dosing education and ensure parents have emergency supplies.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Once the infant is stabilized, hormone therapy can be gradually weaned and discontinued by age 2 years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CAH requires LIFELONG hormone replacement**. The enzyme deficiency is permanent\u2014the body will never be able to synthesize cortisol or aldosterone normally. Discontinuing therapy would result in adrenal crisis and recurrence of androgen excess. Some patients may be able to reduce or discontinue fludrocortisone after infancy (as mineralocorticoid receptors mature), but glucocorticoid replacement is forever. Never counsel that CAH therapy is temporary.", "consequence": "Dangerous misinformation. Parents might attempt to discontinue lifelong therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "This condition occurred spontaneously; there is no increased risk for future siblings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. 21-hydroxylase deficiency CAH is **autosomal recessive**. For an affected child to be born, BOTH parents must be carriers of a CYP21A2 mutation. This means: (1) Each parent is an obligate carrier, (2) Each future pregnancy has a **25% chance** of being affected, (3) 50% chance of being a carrier, (4) 25% chance of being unaffected non-carrier. Genetic counseling should be offered, and prenatal diagnosis is available for future pregnancies.", "consequence": "Incorrect genetic counseling. Parents are not informed of 25% recurrence risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Higher doses of hydrocortisone are better to ensure complete suppression of adrenal androgens", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Overtreatment with glucocorticoids causes significant harm**. Excessive hydrocortisone leads to: (1) **Growth suppression** (glucocorticoids inhibit GH action and linear growth), (2) **Cushing syndrome features** (weight gain, striae, osteoporosis), (3) **Metabolic complications** (insulin resistance, hypertension). The goal is the MINIMUM dose that adequately suppresses androgens while allowing normal growth. This requires careful monitoring of growth velocity, bone age, and hormone levels. \"More is better\" is absolutely wrong for CAH management.", "consequence": "Overtreatment would impair growth and cause iatrogenic Cushing syndrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Annual screening for adrenal tumors is recommended due to chronic ACTH stimulation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While chronic ACTH stimulation does cause **adrenal hyperplasia**, routine tumor screening is not standard practice. With appropriate glucocorticoid therapy, ACTH is suppressed to near-normal levels, and the hyperplasia regresses. **Testicular adrenal rest tumors (TARTs)** can occur in males with CAH (ectopic adrenal tissue in testes responding to ACTH), but these are monitored with testicular ultrasound in adolescence/adulthood, not adrenal imaging in infancy. Annual adrenal tumor screening is not part of standard CAH follow-up.", "consequence": "Unnecessary imaging and parental anxiety about tumor risk.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CAH is lifelong and requires stress dosing during illness**. Parents must be trained to give 2-3x maintenance hydrocortisone during fever/illness and have injectable hydrocortisone for emergencies. The condition is autosomal recessive with 25% recurrence risk. Treatment goal is the MINIMUM effective dose\u2014overtreatment impairs growth."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this newborn with abnormal screening for congenital adrenal hyperplasia.\n\n**Key Learning Points:**\n\n1. **Newborn Screening Principles:**\n   - Screening tests prioritize SENSITIVITY over specificity\n   - Abnormal screen requires URGENT confirmatory testing (not weeks of waiting)\n   - False positives are expected, but true positives are time-sensitive\n\n2. **CAH Recognition:**\n   - Elevated 17-OHP suggests 21-hydroxylase deficiency (>90% of CAH)\n   - Salt-wasting crisis typically occurs days 7-14 of life\n   - Hyperpigmentation occurs due to elevated ACTH/MSH\n   - Early electrolyte changes (\u2193Na, \u2191K) precede frank crisis\n\n3. **CAH Treatment:**\n   - Triple therapy: hydrocortisone + fludrocortisone + sodium chloride\n   - Both glucocorticoid AND mineralocorticoid replacement from the start\n   - Goal is MINIMUM effective dose (overtreatment impairs growth)\n\n4. **Long-term Management:**\n   - Lifelong hormone replacement (enzyme deficiency is permanent)\n   - Stress dosing during illness is CRITICAL (2-3x maintenance)\n   - Autosomal recessive inheritance (25% recurrence risk)\n   - Monitor growth, bone age, and hormone levels\n\n**Remember:** Newborn screening exists to identify presymptomatic infants. A normal-appearing baby with an abnormal screen must be evaluated urgently\u2014don't wait for symptoms of a preventable crisis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Newborn Screening Response:**\n- Abnormal screen requires URGENT confirmatory testing (same-day, not weeks)\n- Do not dismiss elevated 17-OHP as \"probably false positive\" without confirmation\n- Salt-wasting crisis can occur by days 7-14\u2014time-sensitive\n\n**CAH Treatment:**\n- Salt-wasting CAH requires BOTH glucocorticoid AND mineralocorticoid from the start\n- Triple therapy: hydrocortisone + fludrocortisone + NaCl supplementation\n- Goal is minimum effective dose\u2014overtreatment impairs growth\n\n**Long-term Counseling:**\n- Lifelong therapy (cannot be weaned or discontinued)\n- Stress dosing education is critical (2-3x maintenance during illness)\n- Autosomal recessive with 25% recurrence risk"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors to Avoid:**\n\n1. **Delayed Response to Abnormal Screen:**\n   - Waiting 1-4 weeks for follow-up is dangerous for CAH\n   - Salt-wasting crisis occurs days 7-14 of life\n   - Urgent confirmatory testing is required (same-day)\n\n2. **Incomplete Treatment:**\n   - Salt-wasting CAH requires DUAL hormone therapy\n   - Hydrocortisone alone is insufficient (mineralocorticoid deficiency persists)\n   - Fludrocortisone alone doesn't address cortisol deficiency or androgen excess\n\n3. **Incorrect Counseling:**\n   - CAH is LIFELONG\u2014therapy cannot be discontinued\n   - Autosomal recessive inheritance means 25% recurrence risk\n   - Parents must be trained in stress dosing to prevent adrenal crisis\n\n**Remember:** Newborn screening identifies presymptomatic disease. The purpose is to intervene BEFORE the infant becomes critically ill."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-107", "title": "Physiologic Pubertal Gynecomastia", "domain": "newborn", "difficulty": "intermediate", "tags": ["gynecomastia", "puberty", "breast development male", "Tanner staging", "adolescent medicine", "reassurance"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 14-year-old male is brought to clinic by his mother who is concerned about breast enlargement she noticed while doing laundry.\n\nThe patient is embarrassed and reluctant to discuss. He reports the swelling started about 4 months ago and is sometimes tender. He denies nipple discharge. He takes no medications, denies supplements or drug use.\n\nPMH: Healthy, normal development\nFamily history: No breast cancer or endocrine disorders\n\nPhysical examination:\n- Tanner stage 3-4 pubic hair and genitalia\n- Bilateral, symmetric subareolar breast tissue (~3 cm diameter)\n- Tissue is mildly tender to palpation\n- No nipple discharge, skin changes, or lymphadenopathy\n- Testes normal size and consistency bilaterally\n- BMI 22 (normal weight)", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 14-year-old male with bilateral breast tissue enlargement.\n\n**Understanding Gynecomastia:**\n\n**Definition:** Proliferation of **glandular breast tissue** in males (must be palpable firm/rubbery tissue, not just adipose tissue)\n\n**Physiologic Gynecomastia** occurs at three life stages:\n1. **Neonatal** (60-90%): Due to maternal/placental estrogens; resolves weeks to months\n2. **Pubertal** (50-70% of boys): Peak at Tanner 3-4 (ages 12-14); resolves in 1-2 years\n3. **Senescent** (elderly): Due to declining testosterone\n\n**Pubertal Gynecomastia Mechanism:**\n- During puberty, **estrogen rises before testosterone reaches adult levels**\n- This transient **estrogen:androgen imbalance** causes breast tissue proliferation\n- As testosterone increases, the ratio normalizes and breast tissue regresses\n- **Peak incidence: age 13-14** (Tanner stage 3-4)\n\n**Features Suggesting PHYSIOLOGIC Gynecomastia:**\n- **Bilateral** and relatively symmetric\n- **Pubertal age** (12-15 years old)\n- **Small** (<4 cm diameter)\n- **Otherwise normal** pubertal development\n- No symptoms suggesting underlying disease\n\n**Red Flags for PATHOLOGIC Gynecomastia:**\n- **Unilateral** or markedly asymmetric\n- **Rapid growth** or very large (>4-5 cm)\n- **Prepubertal** or **adult onset**\n- **Hard, fixed, or eccentric** mass (concern for malignancy)\n- **Testicular mass** or abnormality\n- Signs of **underlying disease** (hyperthyroidism, liver disease)\n- **Galactorrhea** (suggests hyperprolactinemia)\n- **Medications/drugs** (marijuana, anabolic steroids, spironolactone, cimetidine)", "question": "Based on the clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Physiologic pubertal gynecomastia - no workup needed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **classic physiologic pubertal gynecomastia**. Key features: (1) **Age 14** (peak incidence age 13-14), (2) **Bilateral and symmetric**, (3) **Small** (<4 cm), (4) **Tanner 3-4** (peak pubertal stage for gynecomastia), (5) **Normal testicular exam**, (6) **No red flags** (no rapid growth, galactorrhea, medications, or signs of systemic disease). This affects 50-70% of pubertal boys and typically resolves spontaneously within 1-2 years. No laboratory or imaging workup is needed for classic presentation.", "consequence": "You correctly identify physiologic gynecomastia. Now counsel the patient and family.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Klinefelter syndrome - order karyotype", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Klinefelter syndrome (47,XXY)** does cause gynecomastia, but presents with additional features: (1) **Small, firm testes** (this patient has normal testes), (2) **Tall stature** with long limbs, (3) **Learning difficulties**, (4) **Delayed or incomplete puberty**. Klinefelter should be considered if gynecomastia is **persistent**, **severe**, or accompanied by **testicular abnormalities**. This patient has normal testes and age-appropriate pubertal development.", "consequence": "Unnecessary genetic testing for a normal pubertal finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Estrogen-secreting tumor - order testicular ultrasound and hormone levels", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Estrogen-secreting tumors** (testicular Leydig cell tumor, adrenal tumor, hCG-secreting tumor) cause gynecomastia but with concerning features: (1) **Prepubertal onset** or adult presentation, (2) **Rapid progression**, (3) **Testicular mass** on exam, (4) **Feminizing features** (decreased body hair, female fat distribution). This patient has a **normal testicular exam**, **typical pubertal timing**, and **gradual onset** consistent with physiologic gynecomastia.", "consequence": "Unnecessary workup for normal physiologic finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pseudogynecomastia (lipomastia) - recommend weight loss", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pseudogynecomastia** is adipose tissue deposition in the breast area without true glandular proliferation, seen in **obese** patients. On exam, there is **soft fatty tissue** without the **firm, rubbery, disc-like glandular tissue** felt in true gynecomastia. This patient has **normal BMI (22)** and **palpable firm subareolar tissue** - this is TRUE gynecomastia, not pseudogynecomastia.", "consequence": "Incorrect diagnosis - this is true glandular gynecomastia, not adipose tissue.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Drug-induced gynecomastia - detailed substance use history needed before diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "A thorough medication and substance history is always important. Drugs causing gynecomastia include **marijuana, anabolic steroids, spironolactone, cimetidine, ketoconazole, and antiretrovirals**. However, this patient **denies medications, supplements, and drug use**, and his presentation is otherwise classic for physiologic pubertal gynecomastia. While substance use should always be considered, the clinical picture here fits physiologic gynecomastia.", "consequence": "Substance history was already obtained and is negative.", "nextNodeId": "node-2"}], "clinicalPearl": "**Physiologic pubertal gynecomastia** affects 50-70% of boys at Tanner 3-4 (ages 12-14). If bilateral, symmetric, <4 cm, with normal testes and no red flags, **NO workup is needed**. It resolves spontaneously in 1-2 years."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose physiologic pubertal gynecomastia. The patient asks, \"Will this go away? My friends have started teasing me.\"\n\nHis mother asks, \"Should we do any blood tests just to be safe?\"\n\n**When to Consider Workup:**\n\nLaboratory testing (LH, FSH, testosterone, estradiol, hCG, prolactin, liver/thyroid function) is indicated ONLY if:\n- **Prepubertal** onset\n- **Rapid growth** or >4 cm\n- **Testicular abnormality** on exam\n- **Symptoms of underlying disease**\n- **Persistence >2 years** without regression\n- **Hard, fixed, or eccentric** mass\n\n**Imaging** (testicular ultrasound) is indicated if:\n- Testicular mass or asymmetry on exam\n- Elevated hCG or estradiol suggesting tumor\n\n**This patient has NONE of these indications.**", "question": "What is the most appropriate management at this visit?", "choices": [{"id": "node-2-choice-a", "text": "Reassurance that this is normal, will resolve in 1-2 years; no testing needed; offer follow-up if persists or worsens", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Reassurance is the mainstay of management** for physiologic pubertal gynecomastia. Key counseling points:\n\n**1. This is NORMAL:** 50-70% of boys experience this during puberty\n**2. It will RESOLVE:** Spontaneous regression occurs in 90% within 1-2 years\n**3. No testing needed:** Classic presentation requires no labs or imaging\n**4. Return precautions:** Come back if rapid growth, persistence >2 years, or new symptoms\n\nAddress the **psychosocial impact** - teasing can be significant. Validate his feelings and reassure that this is temporary. Some boys benefit from wearing loose-fitting shirts during this period.", "consequence": "You provide comprehensive reassurance. Now address the family's remaining concerns.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Order baseline hormone panel (testosterone, estradiol, LH, FSH, prolactin) to rule out pathology", "isOptimal": false, "isAcceptable": true, "feedback": "This is **low-yield testing for a classic presentation**. Hormone testing is reserved for patients with red flags (prepubertal onset, rapid growth, testicular abnormality, persistent >2 years). Testing a patient with classic physiologic gynecomastia: (1) Increases healthcare costs, (2) May cause anxiety while awaiting results, (3) Will likely be normal. However, some clinicians order testing for parental reassurance - this is acceptable but not optimal.", "consequence": "Unnecessary testing, but not harmful if family strongly desires.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Refer to pediatric endocrinology for further evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Subspecialty referral is not needed** for classic physiologic gynecomastia. Endocrinology referral is appropriate for: (1) Suspected pathologic cause (abnormal labs, testicular mass), (2) Severe or persistent gynecomastia causing significant distress, (3) Consideration of medical therapy (rare). This patient has a straightforward presentation that can be managed entirely in primary care.", "consequence": "Unnecessary subspecialty referral delays reassurance and increases family anxiety.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Prescribe tamoxifen to accelerate breast tissue regression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Medical therapy is NOT first-line** for physiologic pubertal gynecomastia. Selective estrogen receptor modulators (tamoxifen, raloxifene) have been used for **persistent, symptomatic gynecomastia** but have side effects and are not FDA-approved for this indication in adolescents. Since 90% of pubertal gynecomastia resolves spontaneously, observation is appropriate. Medical therapy is considered only for severe cases persisting >1-2 years with significant psychosocial impact.", "consequence": "Premature pharmacotherapy for a self-resolving condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Refer to plastic surgery for breast reduction consultation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgical referral is premature** at this stage. Surgery is reserved for: (1) **Persistent gynecomastia** (>2 years without resolution), (2) **Severe, disfiguring** gynecomastia causing significant psychosocial distress, (3) **Fibrotic tissue** that will not resolve (occurs after prolonged gynecomastia). This patient has had symptoms for only 4 months - spontaneous resolution is expected. Surgery has risks including scarring, asymmetry, and need for revision.", "consequence": "Premature surgical referral for a condition that will likely resolve.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**90% of pubertal gynecomastia resolves within 1-2 years** without any intervention. Reserve testing for red flags, medical therapy for persistent cases, and surgery for severe persistent gynecomastia with fibrosis."}, "node-3": {"id": "node-3", "type": "decision", "content": "You provide reassurance. The mother then asks: \"What if it doesn't go away? How will we know if something is wrong? And what about the teasing - is there anything we can do to help him cope?\"\n\n**Return Precautions (When to Come Back):**\n- Gynecomastia persists >2 years\n- Rapid increase in size\n- Becomes unilateral or markedly asymmetric\n- New symptoms (galactorrhea, testicular pain/mass)\n- Signs of systemic illness\n\n**Psychosocial Considerations:**\n- Gynecomastia can cause significant embarrassment, anxiety, and social withdrawal\n- Validate the patient's feelings\n- Discuss coping strategies (loose clothing, body confidence)\n- Consider mental health support if significant distress\n- Most boys cope well knowing it's temporary and common", "question": "What return precautions and psychosocial support should you provide?", "choices": [{"id": "node-3-choice-a", "text": "Return if persists >2 years, worsens rapidly, or new symptoms develop; validate his feelings about teasing; emphasize this is common and temporary", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Comprehensive counseling includes:\n\n**Return Precautions:**\n- Come back if persists **>2 years** (may need workup or treatment)\n- Return if **rapid growth** or size >4-5 cm\n- Return if becomes **unilateral** or hard/fixed\n- Return for **new symptoms** (nipple discharge, testicular mass)\n\n**Psychosocial Support:**\n- **Validate feelings** - \"It's understandable to feel embarrassed\"\n- **Normalize** - \"More than half of boys your age experience this\"\n- **Reassure** - \"It almost always goes away on its own\"\n- Practical tips: Loose-fitting shirts, compression undershirts if desired\n- Offer follow-up: \"We're here if you need to talk\"\n\nThis combination of medical guidance and emotional support is optimal.", "consequence": "The patient and mother feel heard and reassured. They leave with clear guidance.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Schedule monthly appointments to monitor for progression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Frequent monitoring is unnecessary** for physiologic gynecomastia. Monthly visits would: (1) Medicalize a normal finding, (2) Increase anxiety by implying something might be wrong, (3) Waste healthcare resources. A **PRN approach** is appropriate - \"Come back if it persists beyond 2 years, grows rapidly, or you have new concerns.\" Routine follow-up at the next well-child visit is sufficient.", "consequence": "Over-medicalization of a normal pubertal variant.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Advise avoiding all physical activity until the breast tissue resolves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activity restriction is not indicated**. Physical activity is healthy and should be encouraged. Exercise does not worsen or improve gynecomastia. If the patient is self-conscious about changing for sports, acknowledge this and offer solutions (changing privately, wearing compression undershirts). Restricting activity would harm his physical and social development.", "consequence": "Unnecessary restriction that harms physical and social wellbeing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Dismiss concerns about teasing as unimportant since this is a benign condition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While gynecomastia IS medically benign, **the psychosocial impact is real and should be addressed**. Adolescents are particularly sensitive to body image and peer perception. Dismissing his concerns would: (1) Invalidate his feelings, (2) Damage trust in the provider, (3) Miss an opportunity to provide support. Validate his feelings, normalize the experience, and offer coping strategies.", "consequence": "Patient feels dismissed; may not return for future concerns.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Recommend he disclose his condition to classmates so they understand", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Disclosure is a personal choice** and should not be recommended or pressured. Many adolescents prefer privacy about body changes. Forcing disclosure could increase embarrassment or bullying. The patient should be empowered to handle the situation in whatever way feels comfortable to him. Offer support strategies but let him decide how to manage social situations.", "consequence": "Inappropriate advice that doesn't respect patient autonomy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Address both medical AND psychosocial aspects** of pubertal gynecomastia. While medically benign, the emotional impact can be significant. Validate feelings, normalize the experience, provide clear return precautions, and offer follow-up if needed."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this case of physiologic pubertal gynecomastia.\n\n**Key Learning Points:**\n\n1. **Physiologic Pubertal Gynecomastia:**\n   - Affects 50-70% of boys at Tanner 3-4 (ages 12-14)\n   - Caused by transient estrogen:androgen imbalance during puberty\n   - Bilateral, symmetric, <4 cm, with normal testes\n   - 90% resolves spontaneously within 1-2 years\n\n2. **When NO Workup is Needed:**\n   - Classic presentation in pubertal male\n   - Bilateral and symmetric\n   - Normal testicular exam\n   - No red flags (no galactorrhea, rapid growth, or systemic symptoms)\n\n3. **Red Flags Requiring Workup:**\n   - Prepubertal or adult onset\n   - Unilateral, hard, or fixed mass\n   - Testicular abnormality\n   - Rapid growth or >4 cm\n   - Persistence >2 years\n   - Galactorrhea or signs of systemic disease\n\n4. **Management:**\n   - Reassurance is mainstay (no labs, imaging, or treatment needed)\n   - Address psychosocial impact\n   - Clear return precautions\n   - Reserve medical/surgical therapy for persistent, severe cases\n\n**Remember:** Physiologic pubertal gynecomastia is COMMON, BENIGN, and SELF-LIMITED. Most boys just need reassurance."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Diagnosis:**\n- Classic physiologic gynecomastia: bilateral, symmetric, <4 cm, pubertal age, normal testes\n- No workup needed for classic presentation\n- Red flags: prepubertal, unilateral, hard/fixed, rapid growth, testicular mass\n\n**Management:**\n- Reassurance is mainstay - 90% resolve in 1-2 years\n- Testing only for red flags (hormone panel, testicular ultrasound)\n- Avoid over-medicalization with unnecessary testing or referrals\n- Surgery only for persistent, severe cases\n\n**Psychosocial:**\n- Validate patient's feelings about teasing\n- Normalize the experience (50-70% of boys affected)\n- Provide clear return precautions"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have negative consequences.\n\n**Critical Points:**\n\n1. **Diagnosis Errors:**\n   - Pseudogynecomastia is adipose tissue in OBESE patients - this patient has normal BMI and palpable glandular tissue\n   - Don't order extensive workup for classic presentation\n\n2. **Treatment Errors:**\n   - Medical therapy (tamoxifen) is not first-line - observe for 1-2 years first\n   - Surgical referral is premature at 4 months - wait for persistence >2 years\n   - Don't restrict physical activity\n\n3. **Communication Errors:**\n   - Never dismiss psychosocial concerns - they are real even if the condition is benign\n   - Don't pressure disclosure to peers\n\n**Remember:** Physiologic pubertal gynecomastia affects 50-70% of boys and resolves in 90% within 1-2 years. Reassurance is the treatment."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-108", "title": "IDM Hypoglycemia Mechanism", "domain": "newborn", "difficulty": "intermediate", "tags": ["fetal hyperinsulinemia", "macrosomia", "hypoglycemia after birth", "idm hypoglycemia mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 1-hour-old male is noted to be jittery and tremulous in the newborn nursery.\n\nBirth History: Born at 39 weeks via cesarean section due to macrosomia. Birth weight: 4.8 kg (>97th percentile, large for gestational age). Mother has poorly controlled gestational diabetes (last HbA1c: 8.2%).\n\nThe infant is tremulous with poor feeding attempts. Vital signs are stable. Physical exam reveals a plethoric, macrosomic infant.\n\nThe nurse asks you to evaluate urgently.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the infant who has the following findings:\n- **Macrosomic** (birth weight 4.8 kg, >97th percentile)\n- **Jitteriness and tremors** that stop with gentle restraint\n- Plethoric appearance\n- Mild tachypnea (RR 65)\n- Otherwise normal neurological exam\n\nLaboratory findings:\n- Point-of-care glucose: **22 mg/dL** (critically low)\n- Hematocrit: 68% (elevated - polycythemia)\n\nThe infant was born to a mother with **poorly controlled gestational diabetes**.", "question": "What is the underlying pathophysiology causing this infant's hypoglycemia?", "choices": [{"id": "node-1-choice-a", "text": "Fetal hyperinsulinemia from maternal hyperglycemia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Maternal hyperglycemia** crosses the placenta and stimulates **fetal pancreatic beta-cell hyperplasia**, leading to **fetal hyperinsulinemia**. After birth, when the glucose supply from the placenta is cut off, the infant continues to have **elevated insulin levels** that rapidly deplete glucose stores, causing **hypoglycemia within the first 1-2 hours of life**. This is the hallmark of the infant of a diabetic mother (IDM).", "consequence": "You correctly understand the mechanism. Now you must manage this symptomatic hypoglycemia.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Inadequate hepatic glycogen stores", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IDM infants actually have **adequate glycogen stores** - the problem is they **cannot access them** due to the suppressive effects of excess insulin. Insulin inhibits glycogenolysis and gluconeogenesis. The issue is **too much insulin**, not insufficient glycogen. Inadequate glycogen stores are more typical of **preterm or SGA infants**.", "consequence": "Misunderstanding the mechanism may lead to inappropriate management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Congenital hyperinsulinism (genetic)", "isOptimal": false, "isAcceptable": true, "feedback": "This is a reasonable consideration for persistent hypoglycemia, but the clinical context strongly suggests IDM. **Congenital hyperinsulinism** (due to KATP channel mutations) presents similarly with hyperinsulinemic hypoglycemia, but there is typically **no maternal diabetes history**. In IDM, the hyperinsulinism is **transient** (24-72 hours) and resolves as the beta-cell hyperplasia regresses. Congenital hyperinsulinism is considered if hypoglycemia persists beyond 72 hours or requires very high glucose infusion rates.", "consequence": "Congenital hyperinsulinism should be considered if hypoglycemia persists, but IDM is more likely given maternal history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Sepsis-induced hypoglycemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sepsis** can cause hypoglycemia, but would present with additional signs: **temperature instability**, respiratory distress, poor perfusion, lethargy, and abnormal inflammatory markers. This infant has isolated jitteriness with macrosomia and maternal diabetes - a classic IDM presentation. The **timing** (within first 1-2 hours) and **maternal history** point to IDM rather than sepsis.", "consequence": "Pursuing sepsis workup delays appropriate glucose management for IDM.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Transient neonatal hyperthyroidism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Neonatal hyperthyroidism** (from maternal Graves' disease) causes jitteriness, tachycardia, and poor weight gain, but is associated with **hyperglycemia** (not hypoglycemia) due to increased metabolic rate and catecholamine effects. The macrosomia and maternal diabetes history clearly point to IDM.", "consequence": "Incorrect diagnosis leads to inappropriate workup and delayed treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The problem in IDM is **too MUCH insulin**, not too little glucose production. Maternal hyperglycemia \u2192 fetal hyperinsulinemia \u2192 hypoglycemia after birth when glucose supply stops but insulin remains elevated."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have a symptomatic infant with glucose of 22 mg/dL.\n\n**AAP Guidelines for Neonatal Hypoglycemia:**\n- Screen at-risk infants (IDM, LGA, SGA, preterm) at 1, 2, 4, 8, 12, 24 hours\n- First 4 hours of life: treat if glucose <25 mg/dL\n- 4-24 hours of life: treat if glucose <35 mg/dL\n- Goal: maintain glucose >45 mg/dL\n\nThis infant is **symptomatic** with glucose of **22 mg/dL** at 1 hour of life.", "question": "What is the most appropriate immediate management?", "choices": [{"id": "node-2-choice-a", "text": "IV dextrose bolus (D10W 2 mL/kg) followed by continuous dextrose infusion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **symptomatic hypoglycemia**, the treatment is **IV dextrose**. Give a **bolus of D10W 2 mL/kg** (provides 200 mg/kg glucose), followed by a **continuous infusion** starting at 5-8 mg/kg/min (glucose infusion rate, GIR). The goal is to maintain glucose **>45 mg/dL**. Oral feeding alone is insufficient for symptomatic hypoglycemia. Recheck glucose 30 minutes after the bolus.", "consequence": "You administer IV dextrose. Glucose rises to 58 mg/dL on recheck. Now you must determine ongoing management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Offer oral feeding and recheck glucose in 1 hour", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Oral feeding is appropriate for **asymptomatic** hypoglycemia with borderline glucose values. This infant has **symptomatic hypoglycemia** (jitteriness, tremors) with critically low glucose (22 mg/dL). **Symptomatic hypoglycemia requires IV dextrose** - oral feeding alone is unreliable and delays treatment. Untreated symptomatic hypoglycemia can cause **seizures** and **permanent brain injury**.", "consequence": "Delayed treatment of symptomatic hypoglycemia risks seizures and neurological damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Glucagon 0.1 mg/kg IM", "isOptimal": false, "isAcceptable": true, "feedback": "Glucagon can be used as a **temporizing measure** when IV access is difficult, but it is **not first-line** for IDM. Glucagon stimulates glycogenolysis, but in IDM the **high insulin levels** inhibit the response to glucagon. Additionally, glycogen stores may be depleted. **IV dextrose is preferred** because it directly provides glucose regardless of insulin levels. Glucagon may be used while establishing IV access.", "consequence": "Glucagon may provide partial, temporary improvement but IV dextrose is needed for definitive treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "D50W bolus (2 mL/kg)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **D50W (50% dextrose) is contraindicated in neonates**. The hyperosmolar solution can cause **rebound hypoglycemia** (due to insulin surge from rapid glucose spike), **venous sclerosis**, and potential for **intraventricular hemorrhage** in preterm infants. Always use **D10W** in neonates. D50W is reserved for older children and adults.", "consequence": "D50W causes dangerous rebound hypoglycemia and vascular injury in neonates.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Obtain critical sample, then treat", "isOptimal": false, "isAcceptable": true, "feedback": "A **critical sample** (insulin, cortisol, growth hormone, free fatty acids, beta-hydroxybutyrate, lactate) is valuable for diagnosing the **cause** of hypoglycemia, especially if it persists. However, in a symptomatic infant with **known IDM**, the cause is clear and **treatment should not be delayed** for diagnostic workup. If the etiology were unclear, you could draw the sample before treatment, but in this case, treat first.", "consequence": "Critical sample is useful but should not delay treatment when the cause is apparent.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Symptomatic hypoglycemia** = IV dextrose (D10W 2 mL/kg bolus, then infusion). Never use D50W in neonates! **Asymptomatic** with borderline glucose = feed and recheck. Goal: glucose >45 mg/dL."}, "node-3": {"id": "node-3", "type": "decision", "content": "After IV dextrose bolus, the infant's glucose rises to 58 mg/dL and symptoms resolve. The infant is now on a continuous D10W infusion at a glucose infusion rate (GIR) of 6 mg/kg/min.\n\nOver the next 12 hours, glucose values remain stable (50-65 mg/dL) and the infant is feeding well.\n\nYou are asked about the expected course and when to wean the glucose infusion.", "question": "What is the expected course for hyperinsulinism in IDM, and when should you wean the dextrose infusion?", "choices": [{"id": "node-3-choice-a", "text": "Hyperinsulinism resolves in 24-72 hours; wean infusion gradually when feeding well and glucose stable", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In IDM, the **hyperinsulinism is transient**, typically resolving within **24-72 hours** as the fetal beta-cell hyperplasia regresses. You should **gradually wean** the dextrose infusion (decrease GIR by 1-2 mg/kg/min every 4-6 hours) while ensuring the infant is **feeding well** and glucose remains **stable (>45-50 mg/dL)**. Abrupt discontinuation can cause **rebound hypoglycemia**. Most IDM infants can transition to oral feeds within 48-72 hours.", "consequence": "You gradually wean the infusion over 24 hours. The infant maintains stable glucose on oral feeds and is discharged on day 3.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Stop the dextrose infusion immediately once glucose normalizes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Abrupt discontinuation** of dextrose can cause **rebound hypoglycemia** because insulin levels remain elevated. The infusion must be **weaned gradually** while monitoring glucose. Additionally, the infant needs to demonstrate ability to maintain glucose with oral feeds before stopping IV dextrose completely.", "consequence": "Abrupt stop causes rebound hypoglycemia, requiring re-bolusing and prolonged hospitalization.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Hyperinsulinism may persist for weeks; plan for long-term glucose monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for typical IDM. **IDM-related hyperinsulinism is transient** (24-72 hours). If hypoglycemia **persists beyond 72 hours** or requires **GIR >10-12 mg/kg/min**, you should suspect **congenital hyperinsulinism** (genetic KATP channel defects) and pursue further workup including genetic testing and possible diazoxide trial. This infant has a classic IDM course.", "consequence": "Overestimating duration leads to unnecessary prolonged hospitalization and workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Switch to subcutaneous dextrose before discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no subcutaneous dextrose** formulation for neonates. The goal is to transition from IV dextrose to **oral feeding** (breast milk or formula). Once the infant can maintain glucose >45-50 mg/dL on oral feeds for 24 hours, the IV can be discontinued.", "consequence": "This is not a valid treatment option.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Start diazoxide to suppress insulin secretion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Diazoxide** (KATP channel opener that suppresses insulin release) is used for **congenital hyperinsulinism**, not transient IDM. It would be considered only if hypoglycemia **persists beyond 72 hours** or requires **GIR >10-12 mg/kg/min**. For typical IDM, the hyperinsulinism resolves spontaneously and only supportive care with dextrose is needed.", "consequence": "Unnecessary medication with potential side effects (fluid retention, hypertrichosis) for a self-resolving condition.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "IDM hyperinsulinism is **transient (24-72 hours)**. Wean glucose infusion **gradually** while ensuring adequate oral intake. If hypoglycemia persists >72 hours or requires GIR >10-12 mg/kg/min, consider **congenital hyperinsulinism**."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly understood the pathophysiology and managed neonatal hypoglycemia in an infant of a diabetic mother.\n\n**Key Learning Points:**\n\n**Pathophysiology of IDM Hypoglycemia:**\n- Maternal hyperglycemia \u2192 crosses placenta \u2192 fetal pancreatic beta-cell hyperplasia \u2192 **fetal hyperinsulinemia**\n- After birth: glucose supply stops, but **insulin remains elevated** \u2192 rapid glucose depletion \u2192 hypoglycemia within 1-2 hours\n- The problem is **too MUCH insulin**, not too little glucose\n\n**IDM Complications (remember: CHIMP):**\n- **C**ardiomyopathy (hypertrophic)\n- **H**ypoglycemia, Hypocalcemia, Hypomagnesemia\n- **I**ncreased birth weight (macrosomia)\n- **M**alformations (cardiac - VSD, TGA; sacral agenesis)\n- **P**olycythemia\n\n**Management:**\n- Symptomatic hypoglycemia \u2192 **IV D10W** (2 mL/kg bolus, then infusion)\n- Never use D50W in neonates!\n- Hyperinsulinism resolves in **24-72 hours**\n- Wean infusion **gradually** to avoid rebound hypoglycemia"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key concepts:\n\n**IDM Hypoglycemia Mechanism:**\n- **Maternal hyperglycemia** \u2192 fetal hyperinsulinemia (beta-cell hyperplasia)\n- After birth: insulin high, glucose supply gone \u2192 **hypoglycemia in first 1-2 hours**\n- The problem is **TOO MUCH INSULIN**, not insufficient glucose production\n\n**Management:**\n- **Symptomatic** hypoglycemia \u2192 IV D10W (bolus + infusion)\n- **Asymptomatic** with borderline glucose \u2192 feed and recheck\n- **Never use D50W** in neonates (causes rebound hypoglycemia)\n- Hyperinsulinism is **transient (24-72 hours)**\n- Wean glucose infusion **gradually**"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect and could cause harm.\n\n**Critical Points:**\n- IDM hypoglycemia results from **fetal hyperinsulinemia** (too much insulin, not too little glucose)\n- **Symptomatic hypoglycemia is a medical emergency** - requires IV dextrose\n- **D10W** is the correct concentration for neonates - **NEVER use D50W** (causes rebound hypoglycemia and vascular injury)\n- Don't delay treatment with oral feeds for symptomatic hypoglycemia\n- Untreated symptomatic hypoglycemia \u2192 seizures \u2192 permanent brain injury\n- IDM hyperinsulinism is **transient (24-72 hours)** - wean gradually"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-109", "title": "Cold Stress in Newborn", "domain": "newborn", "difficulty": "intermediate", "tags": ["cold stress", "hypothermia", "neonatal thermoregulation", "brown fat", "non-shivering thermogenesis", "hypoglycemia", "rewarming"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 3-day-old term male is brought to the emergency department by his parents who noticed he felt \"cold\" and was feeding poorly.\n\nThe family's home heating system broke overnight and the bedroom temperature dropped significantly. The parents found the baby this morning with cool skin and decreased activity.\n\nVital signs: T 35.8\u00b0C (96.4\u00b0F) rectal, HR 120, RR 55, BP 58/35, SpO2 95% on room air\n\nPhysical examination:\n- Lethargic but arousable\n- Skin is mottled (cutis marmorata) with cool extremities\n- Acrocyanosis of hands and feet\n- Weak cry and poor suck reflex\n- No respiratory distress at rest, but mild tachypnea\n- Abdomen soft, no organomegaly\n- Fontanelle flat", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 3-day-old with hypothermia (35.8\u00b0C) after cold environmental exposure.\n\n**Neonatal Thermoregulation:**\n\nNewborns are particularly vulnerable to cold stress due to:\n- **High surface area-to-volume ratio** (rapid heat loss)\n- **Limited subcutaneous fat** for insulation\n- **Inability to shiver** (immature skeletal muscle response)\n- **Limited behavioral responses** (can't put on clothes, move to warmer area)\n\n**Non-Shivering Thermogenesis (Brown Fat):**\n\nNewborns generate heat through **brown adipose tissue (BAT)** metabolism:\n- Located in interscapular region, axillae, around kidneys and adrenals\n- Contains abundant **mitochondria** with **uncoupling protein-1 (UCP-1)**\n- UCP-1 allows protons to bypass ATP synthase \u2192 energy released as **HEAT** instead of ATP\n- Triggered by **norepinephrine** release in response to cold\n\n**The Problem: Metabolic Consequences of Cold Stress:**\n\nWhen brown fat is activated:\n1. **Oxygen consumption increases** (can cause hypoxia/respiratory distress)\n2. **Glucose is rapidly consumed** \u2192 **HYPOGLYCEMIA**\n3. **Fatty acids are metabolized** \u2192 can cause metabolic acidosis\n4. If prolonged: **pulmonary vasoconstriction** \u2192 worsening hypoxia\n\n**Classification of Neonatal Hypothermia:**\n- **Cold stress:** 36.0-36.4\u00b0C (96.8-97.5\u00b0F)\n- **Moderate hypothermia:** 32.0-35.9\u00b0C (89.6-96.6\u00b0F)\n- **Severe hypothermia:** <32.0\u00b0C (<89.6\u00b0F)", "question": "Based on the history and presentation, what is the most likely diagnosis and underlying mechanism?", "choices": [{"id": "node-1-choice-a", "text": "Cold stress with compensatory non-shivering thermogenesis causing increased metabolic demand", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This infant has **cold stress/moderate hypothermia** (35.8\u00b0C) from environmental exposure. The mechanism is clear: cold exposure \u2192 activation of **brown fat (non-shivering thermogenesis)** \u2192 increased metabolic rate \u2192 **consumption of glucose and oxygen**. The lethargy, poor feeding, and mottling are signs of metabolic derangement. Key point: newborns cannot shiver, so they rely entirely on brown fat metabolism, which rapidly depletes glucose stores.", "consequence": "You identify cold stress. Now determine immediate management priorities.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Neonatal sepsis presenting with hypothermia", "isOptimal": false, "isAcceptable": true, "feedback": "This is an important consideration. **Sepsis can present with hypothermia** in neonates (rather than fever), and the mottling, lethargy, and poor feeding are also consistent with sepsis. However, the **clear history of cold environmental exposure** (broken heater, cold bedroom) makes primary cold stress more likely. That said, prolonged cold stress can predispose to infection, and sepsis workup may be considered if the infant doesn't respond appropriately to rewarming. The two conditions can coexist.", "consequence": "Reasonable differential, but environmental history points to cold stress as primary cause.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Congenital hypothyroidism causing inability to maintain temperature", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **congenital hypothyroidism** can cause hypothermia (thyroid hormone is essential for metabolic rate and thermogenesis), it would not present acutely in a 3-day-old who was previously well. Additionally, congenital hypothyroidism presents with other features: **prolonged jaundice, constipation, macroglossia, hypotonia, and umbilical hernia**. This infant has a clear environmental trigger (broken heater) explaining the acute hypothermia.", "consequence": "Misdiagnosis delays appropriate warming and metabolic support.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Congenital heart disease with poor perfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **ductal-dependent congenital heart disease** can present with poor perfusion and mottling in the first week of life (as PDA closes), there would typically be: **differential cyanosis** (lower extremity cyanosis worse than upper), **absent femoral pulses** (in coarctation), **cardiac murmur**, and **hepatomegaly**. This infant has clear environmental cold exposure history, and the temperature of 35.8\u00b0C is the primary problem causing the symptoms.", "consequence": "Pursuing cardiac workup delays essential rewarming.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Inborn error of metabolism with metabolic crisis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Inborn errors of metabolism** can present with lethargy, poor feeding, and metabolic derangements in neonates, but typically after a **symptom-free interval** followed by deterioration unrelated to environmental factors. There would often be **vomiting, unusual odor, seizures, or hepatomegaly**. This infant's symptoms are directly explained by documented cold exposure. If rewarming doesn't improve symptoms, metabolic disease could be reconsidered.", "consequence": "Metabolic workup may delay essential rewarming intervention.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Newborns generate heat through **brown fat (non-shivering thermogenesis)** because they cannot shiver. This process rapidly **consumes glucose**, so cold stress almost always causes **HYPOGLYCEMIA**. Always check glucose in a hypothermic newborn!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose cold stress. Initial labs return:\n- **Glucose: 32 mg/dL** (critically low)\n- pH: 7.28, pCO2: 35, HCO3: 16 (metabolic acidosis)\n- Lactate: 4.2 mmol/L (elevated)\n\n**Understanding the Lab Findings:**\n\nThe labs confirm the metabolic consequences of cold stress:\n1. **Hypoglycemia (32 mg/dL):** Brown fat thermogenesis consumed glucose stores\n2. **Metabolic acidosis:** Anaerobic metabolism and fatty acid oxidation \u2192 lactate and ketoacids\n3. **Elevated lactate:** Tissue hypoperfusion and anaerobic metabolism\n\n**Rewarming Principles:**\n\n**Rate of rewarming matters:**\n- **Mild hypothermia:** Can rewarm at 0.5-1\u00b0C per hour\n- **Moderate/Severe:** Rewarm **slowly** (0.5\u00b0C per hour) to avoid complications\n\n**Why slow rewarming?**\n- Rapid rewarming \u2192 peripheral vasodilation \u2192 **hypotension**\n- Rapid rewarming \u2192 shift of cold acidotic blood from periphery to core \u2192 **\"afterdrop\"** and arrhythmias\n- Metabolic demands may spike faster than supply can meet\n\n**Methods of Rewarming:**\n- **Skin-to-skin (kangaroo care):** Excellent for mild hypothermia\n- **Radiant warmer:** Standard NICU approach, allows monitoring\n- **Warm blankets/incubator:** Controlled environment\n- **Warmed IV fluids:** For severe cases", "question": "What are the immediate management priorities for this hypothermic, hypoglycemic infant?", "choices": [{"id": "node-2-choice-a", "text": "Gradual rewarming (radiant warmer) AND IV dextrose for hypoglycemia; monitor closely", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Management has **TWO simultaneous priorities**:\n\n**1. REWARM GRADUALLY:**\n- Place under radiant warmer or in warmed incubator\n- Target rewarming rate: **0.5\u00b0C per hour** (not too fast)\n- Skin-to-skin can supplement but infant needs monitoring given severity\n\n**2. TREAT HYPOGLYCEMIA:**\n- This infant is **symptomatic** (lethargy, poor feeding) with glucose 32 mg/dL\n- Give **IV D10W bolus (2 mL/kg)** followed by continuous infusion\n- Recheck glucose in 30 minutes\n\n**Also monitor:**\n- Continuous cardiorespiratory monitoring\n- Serial glucose checks\n- Repeat blood gas after rewarming\n- Urine output\n\nDo NOT delay either intervention - both are essential.", "consequence": "You initiate dual therapy. The infant begins to rewarm and glucose improves.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Rapid rewarming with heated blankets to normalize temperature as quickly as possible", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Rapid rewarming is dangerous** in moderate-severe hypothermia. Complications include:\n\n1. **Peripheral vasodilation** \u2192 blood pools in extremities \u2192 **hypotension and shock**\n2. **\"Afterdrop\"** \u2192 cold, acidotic blood from periphery returns to core \u2192 **further core cooling** and **cardiac arrhythmias**\n3. Metabolic demand may outstrip supply\n\nThe correct approach is **gradual rewarming at ~0.5\u00b0C per hour** with continuous monitoring. Slow and steady prevents complications.", "consequence": "Rapid rewarming causes hypotension and potential cardiac instability.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Treat hypoglycemia first; wait to rewarm until glucose is stable", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Both problems must be addressed simultaneously**. Delaying rewarming is dangerous because:\n\n1. Continued cold stress \u2192 continued brown fat activation \u2192 continued glucose consumption (hypoglycemia will recur)\n2. Prolonged hypothermia \u2192 worsening acidosis, hypoxia, and tissue damage\n3. The two therapies are complementary, not sequential\n\nRewarming actually REDUCES glucose consumption by eliminating the cold stress that drives brown fat metabolism.", "consequence": "Persistent hypothermia causes ongoing glucose consumption and metabolic derangement.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Rewarm first; glucose will correct once temperature normalizes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hypoglycemia of 32 mg/dL with symptoms requires IMMEDIATE treatment** - you cannot wait for rewarming. Symptomatic neonatal hypoglycemia can cause:\n\n1. **Seizures** (if glucose drops further)\n2. **Permanent brain injury** (neurons are glucose-dependent)\n\nWhile rewarming will reduce ongoing glucose consumption, it won't immediately restore glucose levels. The infant needs IV dextrose NOW while simultaneously being rewarmed.", "consequence": "Untreated hypoglycemia risks seizures and brain injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Give sodium bicarbonate to correct the acidosis as the priority", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sodium bicarbonate is NOT indicated** for this type of metabolic acidosis. The acidosis is due to **poor perfusion and anaerobic metabolism** from cold stress - it will correct with rewarming and improved perfusion. Giving bicarbonate:\n\n1. Doesn't address the underlying cause\n2. Can cause paradoxical intracellular acidosis\n3. Can cause hypernatremia and hyperosmolality\n4. May worsen hypocalcemia\n\nThe treatment is to **fix the underlying problem** (rewarm + treat hypoglycemia), not to chase the pH with bicarbonate.", "consequence": "Bicarbonate doesn't address the cause and may cause additional complications.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Cold stress management requires DUAL therapy:** (1) **Gradual rewarming** at 0.5\u00b0C/hour (not rapid!), AND (2) **IV dextrose** for hypoglycemia. Addressing only one problem allows the other to worsen."}, "node-3": {"id": "node-3", "type": "decision", "content": "After 2 hours of gradual rewarming and IV dextrose infusion:\n- Temperature: 36.5\u00b0C (normalized)\n- Glucose: 65 mg/dL (improved)\n- The infant is more alert and has improved color\n- Mottling has resolved\n- Now feeding better\n\nThe parents ask: \"How did this happen? We thought we were being careful. How do we prevent this from happening again?\"\n\n**Prevention of Neonatal Cold Stress:**\n\n**Environmental factors:**\n- Room temperature 20-25\u00b0C (68-77\u00b0F) for clothed infants\n- Avoid drafts, fans, air conditioning directly on infant\n- Dry infant immediately after bathing\n\n**Clothing and wrapping:**\n- Layer appropriately (one more layer than adult comfort)\n- Hat is important (large head = significant heat loss)\n- Skin-to-skin contact is excellent for temperature regulation\n\n**Feeding:**\n- Regular feeding maintains glucose stores\n- Adequate calories support thermogenesis\n\n**Risk factors for cold stress:**\n- Preterm infants (less brown fat, more surface area)\n- Small for gestational age\n- Prolonged resuscitation at birth\n- Transport without adequate warming", "question": "What anticipatory guidance should you provide to prevent future episodes of cold stress?", "choices": [{"id": "node-3-choice-a", "text": "Maintain room temperature 68-77\u00b0F; dress in layers with hat; skin-to-skin contact; feed regularly; recognize early signs (cool skin, mottling, poor feeding)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Comprehensive prevention includes:\n\n**1. Environmental Control:**\n- Room temperature **68-77\u00b0F (20-25\u00b0C)** for clothed infants\n- Avoid drafts, fans, or AC blowing directly on baby\n- Fix the heating system!\n\n**2. Appropriate Clothing:**\n- Dress in **layers** (one more layer than comfortable for adults)\n- Always use a **HAT** (head is ~20% of body surface area in newborns)\n- Swaddle appropriately\n\n**3. Skin-to-Skin (Kangaroo Care):**\n- Excellent for temperature regulation\n- Also promotes bonding and breastfeeding\n\n**4. Regular Feeding:**\n- Maintains glucose stores (fuel for brown fat)\n- Feed every 2-3 hours\n\n**5. Early Warning Signs:**\n- Cool skin to touch\n- Mottling or pallor\n- Poor feeding or lethargy\n- Seek care immediately if noticed", "consequence": "Parents leave with comprehensive understanding of prevention and warning signs.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Keep room temperature above 80\u00b0F at all times to prevent any cold exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Overheating is also dangerous** for newborns and is associated with **increased SIDS risk**. Room temperature above 80\u00b0F (27\u00b0C) can cause:\n\n1. **Hyperthermia** (fever without infection)\n2. **Dehydration** from sweating\n3. **Increased SIDS risk** (hyperthermia is a risk factor)\n\nThe goal is a **comfortable range (68-77\u00b0F)** with appropriate clothing - not extremes in either direction. Teach parents to feel the back of the neck or chest to check if baby is too warm or too cold.", "consequence": "Overheating risks hyperthermia and increased SIDS risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "This was an accident; no specific guidance needed - just tell them to be more careful", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is a **critical teachable moment**. Parents are motivated to learn and need specific, actionable guidance. Vague advice like \"be more careful\" doesn't empower them to prevent future episodes. They need to know:\n\n1. Specific temperature ranges\n2. How to dress the baby appropriately\n3. Warning signs to watch for\n4. When to seek medical care\n\nThis guidance may prevent a recurrence that could be more severe.", "consequence": "Missed opportunity for essential education; risk of recurrence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Advise against skin-to-skin contact as it may not provide enough warmth", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Skin-to-skin (kangaroo care) is EXCELLENT for thermoregulation** and should be encouraged, not avoided. Studies show skin-to-skin:\n\n1. Maintains infant temperature as well as or better than incubators\n2. Promotes breastfeeding\n3. Stabilizes heart rate and respiratory rate\n4. Promotes bonding\n\nSkin-to-skin is actually the WHO-recommended first-line intervention for hypothermia in resource-limited settings. It is safe and effective for healthy term infants.", "consequence": "Discouraging beneficial practice harms infant wellbeing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Recommend daily temperature checks with rectal thermometer for the next month", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine rectal temperature monitoring is not recommended** for healthy term infants at home. It is invasive, uncomfortable, and unnecessary. Parents should:\n\n1. Feel the baby's chest or back of neck to assess warmth\n2. Watch for behavioral cues (fussiness, lethargy, poor feeding)\n3. Only take temperature if concerned about fever or illness\n\nTeaching environmental prevention and warning signs is more practical and effective than prescribing daily temperature checks.", "consequence": "Unnecessary medicalization with invasive monitoring.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prevention of cold stress:** Room temp 68-77\u00b0F, dress in layers with hat, skin-to-skin contact, regular feeding. **Overheating is also dangerous** (SIDS risk) - aim for the comfortable middle range, not extremes."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this case of neonatal cold stress.\n\n**Key Learning Points:**\n\n1. **Neonatal Thermoregulation:**\n   - Newborns cannot shiver - they rely on brown fat (non-shivering thermogenesis)\n   - Brown fat metabolism consumes GLUCOSE \u2192 cold stress causes HYPOGLYCEMIA\n   - High surface area:volume ratio makes newborns vulnerable to heat loss\n\n2. **Cold Stress Recognition:**\n   - Hypothermia (<36.5\u00b0C / <97.7\u00b0F)\n   - Mottling (cutis marmorata), cool extremities\n   - Lethargy, poor feeding, weak cry\n   - May progress to respiratory distress and metabolic acidosis\n\n3. **Management - DUAL THERAPY:**\n   - GRADUAL rewarming (0.5\u00b0C/hour) - NOT rapid (causes hypotension, arrhythmias)\n   - IV dextrose for hypoglycemia (almost always present)\n   - Monitor glucose, temperature, acid-base status\n   - Acidosis corrects with rewarming - don't give bicarbonate\n\n4. **Prevention:**\n   - Room temperature 68-77\u00b0F (20-25\u00b0C)\n   - Dress in layers with hat\n   - Skin-to-skin contact (excellent for thermoregulation)\n   - Regular feeding (maintains glucose stores)\n   - Avoid overheating (also dangerous - SIDS risk)\n\n**Remember:** Cold stress \u2192 brown fat activation \u2192 HYPOGLYCEMIA. Always check glucose in a cold newborn!"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Recognition:**\n- Cold stress presents with hypothermia, mottling, lethargy, poor feeding\n- Clear environmental exposure history points to cold stress\n- Sepsis is a differential but less likely with obvious cold exposure\n\n**Management:**\n- TWO simultaneous priorities: rewarming AND glucose correction\n- Rewarming must be GRADUAL (0.5\u00b0C/hour) - rapid rewarming is dangerous\n- Never delay hypoglycemia treatment - brain injury can occur\n- Acidosis corrects with treatment - don't give bicarbonate\n\n**Prevention:**\n- Room temperature 68-77\u00b0F (avoid extremes - overheating is also dangerous)\n- Skin-to-skin contact is BENEFICIAL, not harmful\n- Provide specific, actionable guidance to parents\n- Routine rectal thermometers are unnecessary for healthy newborns"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors:**\n\n1. **Rapid Rewarming:**\n   - Causes peripheral vasodilation \u2192 HYPOTENSION\n   - \"Afterdrop\" phenomenon \u2192 cardiac arrhythmias\n   - Always rewarm gradually at 0.5\u00b0C/hour\n\n2. **Delayed Hypoglycemia Treatment:**\n   - Glucose 32 mg/dL with symptoms is an EMERGENCY\n   - Can cause seizures and permanent brain injury\n   - Must treat immediately - don't wait for rewarming\n\n3. **Inappropriate Bicarbonate Use:**\n   - Acidosis is from cold stress, not primary acid-base disorder\n   - Corrects with rewarming and improved perfusion\n   - Bicarbonate has complications (hyperosmolality, hypocalcemia)\n\n4. **Discouraging Skin-to-Skin:**\n   - Skin-to-skin is EXCELLENT for thermoregulation\n   - WHO-recommended for hypothermia\n   - Promotes bonding and breastfeeding\n\n**Remember:** Cold stress causes HYPOGLYCEMIA via brown fat metabolism. Both rewarming AND glucose must be addressed simultaneously!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-110", "title": "Normal Newborn Acrocyanosis", "domain": "newborn", "difficulty": "intermediate", "tags": ["acrocyanosis", "cyanosis", "newborn exam", "peripheral cyanosis", "central cyanosis", "normal newborn", "parental education"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A nursery nurse asks you to evaluate a 6-hour-old term male because she is concerned about \"blue hands and feet.\"\n\nThe infant was born via uncomplicated vaginal delivery. Apgar scores were 8 and 9. The infant is breastfeeding well with good latch.\n\nVital signs: T 36.8\u00b0C, HR 145, RR 44, SpO2 98% (preductal, room air)\n\nPhysical examination:\n- Vigorous, well-appearing infant\n- Hands and feet appear dusky/blue (cyanotic)\n- Tongue, lips, and oral mucosa are PINK\n- Trunk and face are pink with good perfusion\n- No respiratory distress\n- Lungs clear, heart regular with no murmur\n- Capillary refill <2 seconds centrally", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 6-hour-old with blue discoloration of the hands and feet, but pink centrally.\n\n**Understanding Cyanosis in Newborns:**\n\n**Cyanosis** = blue discoloration from **deoxygenated hemoglobin** (>5 g/dL deoxyhemoglobin)\n\n**CRITICAL DISTINCTION:**\n\n**1. ACROCYANOSIS (Peripheral Cyanosis):**\n- Blue discoloration LIMITED to **hands and feet** (acral = extremities)\n- Central areas (tongue, lips, trunk) are **PINK**\n- **NORMAL finding** in newborns in first 24-48 hours\n- Mechanism: **Peripheral vasoconstriction** (immature vasomotor control)\n- Often worse when cold, resolves with warming\n- **Does NOT indicate hypoxia** (SpO2 is normal)\n\n**2. CENTRAL CYANOSIS:**\n- Blue discoloration of **tongue, lips, oral mucosa, trunk**\n- **NEVER normal** - indicates systemic hypoxemia\n- Requires SpO2 < 80-85% to be visible (>5 g/dL deoxyhemoglobin)\n- Causes: **Cyanotic heart disease**, severe pulmonary disease, methemoglobinemia\n- Requires urgent evaluation\n\n**Key Clinical Pearl:**\n- Look at the **TONGUE** - it's the most reliable site for central cyanosis\n- Lips can appear blue from vasoconstriction alone\n- If tongue is pink \u2192 peripheral (acrocyanosis)\n- If tongue is blue \u2192 central cyanosis \u2192 URGENT WORKUP\n\n**This infant has:**\n- Blue hands and feet (peripheral)\n- Pink tongue, lips, trunk (central color normal)\n- SpO2 98% (normal oxygenation)\n- Well-appearing, feeding well", "question": "What is the most likely explanation for this infant's appearance?", "choices": [{"id": "node-1-choice-a", "text": "Acrocyanosis - a normal finding in newborns due to peripheral vasoconstriction", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **acrocyanosis** - a **completely normal** finding in newborns. Key features confirming this: (1) Blue limited to **hands and feet only** (peripheral), (2) **Tongue and lips are PINK** (central color normal), (3) **SpO2 98%** (normal oxygenation), (4) **Well-appearing** and feeding well, (5) Age 6 hours (within normal timeframe for acrocyanosis). The mechanism is **immature vasomotor control** causing peripheral vasoconstriction - this is NOT hypoxia.", "consequence": "You correctly identify this as normal acrocyanosis. Now determine appropriate management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Cyanotic congenital heart disease - order echocardiogram", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cyanotic heart disease causes CENTRAL cyanosis**, not isolated acrocyanosis. This infant has:\n- **Pink tongue and lips** (central color NORMAL)\n- **SpO2 98%** (normal - cyanotic heart disease would show desaturation)\n- **No murmur** (though some cyanotic lesions are murmur-free)\n\nCyanotic heart disease would present with: blue tongue/lips, SpO2 <90% (often <80%), often hepatomegaly, sometimes murmur. The peripheral vasoconstriction causing acrocyanosis is unrelated to cardiac oxygen delivery.", "consequence": "Unnecessary echo for a normal newborn finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Methemoglobinemia - order methemoglobin level", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Methemoglobinemia causes CENTRAL cyanosis** that is characteristically **refractory to supplemental oxygen**. The infant would appear cyanotic (blue lips, tongue) but the pulse oximetry may read falsely normal or ~85% (characteristic \"saturation gap\"). This infant has:\n- **Pink tongue and lips** (not methemoglobinemia pattern)\n- **SpO2 98%** (true normal saturation)\n- **No toxic exposure history**\n\nMethemoglobinemia in newborns is rare - usually from dapsone exposure, nitrates in well water, or inherited enzyme deficiency.", "consequence": "Unnecessary workup for a normal finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Polycythemia - order hematocrit", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable. **Polycythemia** (Hct >65%) can contribute to peripheral cyanosis because thicker blood flows more sluggishly through peripheral vessels. However, polycythemia typically causes: (1) **Plethoric** (ruddy) appearance, (2) May have **central** cyanosis as well, (3) Often has risk factors (IDM, twin-twin transfusion, SGA). This infant has **isolated acrocyanosis** with normal central color and SpO2 - most consistent with normal physiologic acrocyanosis. A CBC may be part of routine newborn care but is not urgently indicated here.", "consequence": "Testing reasonable but acrocyanosis alone doesn't require hematocrit.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Sepsis - obtain blood culture and start antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This infant has **NO signs of sepsis**:\n- **Vital signs normal** (not hypothermic, not tachycardic, not tachypneic)\n- **Well-appearing** and vigorous\n- **Feeding well** with good latch\n- **Normal SpO2**\n\nSepsis would present with: temperature instability, lethargy, poor feeding, respiratory distress, hypotension, mottling (not isolated acrocyanosis). Isolated acrocyanosis with a well-appearing infant is normal - don't reflexively treat for sepsis.", "consequence": "Unnecessary sepsis workup and antibiotics in a well newborn.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**LOOK AT THE TONGUE** to distinguish acrocyanosis from central cyanosis. Pink tongue = acrocyanosis (normal). Blue tongue = central cyanosis (NEVER normal - requires urgent evaluation)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose normal physiologic acrocyanosis. The nurse asks, \"Should I document this as normal? The parents looked worried.\"\n\nThe parents approach and ask, \"Why is our baby blue? Is something wrong with his heart?\"\n\n**Communicating with Parents:**\n\nAcrocyanosis often causes significant parental anxiety because:\n- Blue discoloration looks alarming\n- Parents may have heard about \"blue babies\" with heart problems\n- Internet searches may show scary results\n\n**Key Counseling Points:**\n1. This is **completely normal** and expected in newborns\n2. It is **NOT a sign of heart problems** or breathing problems\n3. The oxygen level is **normal** (can show them the pulse ox reading)\n4. It occurs because newborn circulation is adjusting to life outside the womb\n5. It typically **resolves within 24-48 hours**\n6. **Central color** (pink tongue, pink lips) is what matters", "question": "What is the most appropriate management and communication approach?", "choices": [{"id": "node-2-choice-a", "text": "Reassure parents that acrocyanosis is normal; explain the difference between peripheral and central cyanosis; no workup needed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Appropriate management includes:\n\n**1. Reassurance:**\n- \"This is completely normal and we see it in almost all newborns\"\n- \"The blue color in the hands and feet is NOT a sign of heart or lung problems\"\n- \"Your baby's oxygen level is perfect at 98%\"\n\n**2. Education:**\n- Explain peripheral vs. central cyanosis in simple terms\n- \"What matters is that the tongue and lips are pink - that's what we look at\"\n- \"The hands and feet will turn pink within a day or two as circulation adjusts\"\n\n**3. Return Precautions:**\n- \"Let us know if you notice the lips or tongue turning blue, or if the baby becomes lethargic or stops feeding well\"\n\n**No workup is needed** for isolated acrocyanosis with normal central color and SpO2.", "consequence": "Parents are reassured. You've educated them about what to watch for.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Order pulse oximetry on all four extremities and an echocardiogram to definitively rule out heart disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is **over-testing for a normal finding**. The infant has:\n- **SpO2 98%** (already checked - normal)\n- **Pink centrally** (no central cyanosis)\n- **Well-appearing** with no concerning features\n\nFour-extremity pulse ox is used when there's concern for **coarctation of the aorta** (differential cyanosis with lower SpO2 in lower extremities). This infant has no such concern. Echocardiogram for isolated acrocyanosis is not indicated and would increase healthcare costs, delay discharge, and increase parental anxiety unnecessarily.", "consequence": "Unnecessary expensive workup that may increase parental anxiety.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Tell parents you're \"not worried\" but order a chest X-ray and ECG \"just to be safe\"", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This mixed message is problematic:\n\n1. **Ordering tests contradicts reassurance** - if you're truly not worried, why test?\n2. **\"Just to be safe\"** implies there might be danger, increasing anxiety\n3. **CXR and ECG are not indicated** for isolated acrocyanosis with normal SpO2\n\nClear, confident reassurance is more effective than hedging with unnecessary tests. If clinical findings are reassuring, communicate that clearly. Testing \"just in case\" medicalizes normal findings and erodes trust.", "consequence": "Mixed messages increase anxiety; unnecessary testing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Advise keeping the infant under a warmer until acrocyanosis resolves before discharge", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Warming can help reduce acrocyanosis** because peripheral vasoconstriction is partly temperature-related. Skin-to-skin contact or ensuring the infant is warm is reasonable supportive care. However, **acrocyanosis itself is not a barrier to discharge** - it's a normal finding that will resolve on its own. You don't need to keep the infant hospitalized until it resolves. The key is ensuring the infant is otherwise well and parents understand what is normal vs. concerning.", "consequence": "Warming is supportive but not required before discharge.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Minimize the parents' concern by saying \"It's probably nothing\" without further explanation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This dismissive approach is problematic:\n\n1. **\"Probably nothing\"** is vague and doesn't reassure\n2. **Lack of explanation** leaves parents confused and worried\n3. **Missed teaching opportunity** - parents should understand what IS and ISN'T concerning\n4. May damage trust in healthcare providers\n\nTake time to explain clearly: what acrocyanosis is, why it's normal, what they should watch for, and when to be concerned. This empowers parents and builds trust.", "consequence": "Parents remain anxious without clear understanding.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Confident, clear reassurance is essential** for normal findings like acrocyanosis. Ordering tests \"just to be safe\" undermines reassurance and medicalizes normal findings. If exam and SpO2 are reassuring, communicate that clearly."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents seem reassured. The mother asks one more question: \"How do we know if something IS wrong? What should we watch for after we go home?\"\n\n**Anticipatory Guidance - When to Seek Care:**\n\nParents should be taught to recognize signs of TRUE respiratory or cardiac distress:\n\n**Concerning Signs (NOT normal):**\n- **Blue lips, tongue, or inside of mouth** (central cyanosis)\n- **Fast breathing** (>60 breaths/min consistently)\n- **Grunting, flaring, or retractions** (work of breathing)\n- **Poor feeding** or refusing to eat\n- **Lethargy** or difficulty waking for feeds\n- **Persistent blue color** of the entire body (not just hands/feet)\n\n**Normal Findings to Reassure About:**\n- Acrocyanosis (blue hands/feet only) - normal up to 48 hours\n- Periodic breathing (pauses up to 10-15 seconds without color change)\n- Hiccups, sneezing, yawning - normal reflexes\n- Mottling with cold exposure - normal if resolves with warming", "question": "What anticipatory guidance about concerning signs should you provide to these parents?", "choices": [{"id": "node-3-choice-a", "text": "Return immediately if lips/tongue turn blue, breathing fast or labored, refusing to feed, or very lethargic; acrocyanosis alone is normal", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Comprehensive return precautions include:\n\n**RETURN IMMEDIATELY for:**\n- **Blue lips or tongue** (central cyanosis - NEVER normal)\n- **Fast breathing** (consistently >60/min) or **labored breathing** (grunting, flaring, retractions)\n- **Refusing to feed** or unable to complete feeds\n- **Very sleepy** - difficult to wake for feeds\n- **Pale, gray, or blue all over** (not just hands/feet)\n\n**NORMAL - don't worry about:**\n- Blue hands and feet only (acrocyanosis) - resolves in 24-48 hours\n- Brief pauses in breathing (<15 seconds) without color change\n- Hiccups and sneezes\n\n**Simple rule:** \"Pink tongue and lips = good. Blue tongue or lips = call us immediately.\"", "consequence": "Parents leave with clear, actionable guidance on warning signs.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Tell them not to worry and that they'll know if something is wrong", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Vague reassurance without specifics is inadequate**. First-time parents often DON'T know what's normal vs. concerning. They need concrete guidance:\n\n1. **Specific signs** to watch for (central cyanosis, respiratory distress)\n2. **What is normal** (acrocyanosis, periodic breathing)\n3. **When to call** or return\n\n\"You'll know if something is wrong\" is not helpful - many parents don't know, and some miss serious warning signs while overreacting to normal findings.", "consequence": "Parents leave without clear guidance; may miss warning signs or worry unnecessarily.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Provide a pulse oximeter for home use and instruct them to return if SpO2 drops below 95%", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Home pulse oximetry is NOT recommended** for healthy term newborns. Problems with this approach:\n\n1. **False alarms** from motion artifact, poor probe placement \u2192 anxiety\n2. **False reassurance** - clinical signs may precede desaturation\n3. **Not validated** for home use in healthy newborns\n4. **Medicalizes normal** newborn care\n\nParents should be taught **clinical warning signs** (appearance, feeding, breathing pattern) rather than relying on technology. Pulse oximetry is a clinical tool, not a home monitoring device for well newborns.", "consequence": "Inappropriate medicalization; home pulse ox causes more harm than benefit in this setting.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Advise them to take the baby to the emergency room if the hands and feet are still blue after 48 hours", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. While acrocyanosis typically resolves by 24-48 hours, **persistent acrocyanosis alone** (with pink central color, normal feeding, and normal activity) is usually not an emergency. It may warrant a phone call or office visit, but not necessarily an ER visit if the baby is otherwise well. More important guidance is recognizing **CENTRAL cyanosis** (blue lips/tongue) which IS an emergency regardless of timing.", "consequence": "May cause unnecessary ER visit; central cyanosis is more important warning sign.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Schedule daily newborn follow-up visits for the next week to monitor the cyanosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Daily visits are excessive** for isolated acrocyanosis. Standard newborn follow-up is:\n\n- **First visit:** 24-48 hours after discharge for breastfeeding assessment, jaundice check, weight\n- **Routine visits:** Per AAP guidelines (3-5 days, 2 weeks, etc.)\n\nDaily monitoring medicalizes a normal finding, increases parental anxiety, and is not evidence-based. The appropriate approach is reassurance, clear return precautions, and routine follow-up.", "consequence": "Over-medicalization of a normal finding; unnecessary healthcare utilization.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Teach parents the **simple rule**: \"Pink tongue and lips = good. Blue tongue or lips = call immediately.\" Acrocyanosis (blue hands/feet only) is normal, but central cyanosis is NEVER normal."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this case of normal newborn acrocyanosis.\n\n**Key Learning Points:**\n\n1. **Acrocyanosis vs. Central Cyanosis:**\n   - ACROCYANOSIS: Blue hands/feet only, pink tongue/lips \u2192 NORMAL\n   - CENTRAL CYANOSIS: Blue tongue/lips/trunk \u2192 NEVER normal, urgent evaluation needed\n   - **The TONGUE is the most reliable site** to assess central color\n\n2. **Acrocyanosis Features:**\n   - Normal in first 24-48 hours of life\n   - Due to peripheral vasoconstriction (immature vasomotor control)\n   - Worsens with cold, improves with warming\n   - SpO2 is NORMAL (this is not hypoxia)\n\n3. **Management:**\n   - NO workup needed for isolated acrocyanosis with normal SpO2 and central color\n   - Clear reassurance is key - don't order tests \"just to be safe\"\n   - Educate parents about peripheral vs. central cyanosis\n\n4. **Return Precautions:**\n   - Blue lips or tongue (central cyanosis) - URGENT\n   - Fast or labored breathing\n   - Poor feeding or lethargy\n   - **Simple rule:** \"Pink tongue = good. Blue tongue = call immediately.\"\n\n**Remember:** Acrocyanosis is extremely common and always benign. The key is distinguishing it from central cyanosis, which is NEVER normal."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Diagnosis:**\n- Acrocyanosis (blue hands/feet) with pink central color = NORMAL\n- Central cyanosis (blue tongue/lips) = NEVER normal, requires urgent evaluation\n- SpO2 98% confirms normal oxygenation\n\n**Management Errors:**\n- Don't order echo, CXR, ECG for isolated acrocyanosis with normal SpO2\n- Don't order tests \"just to be safe\" - contradicts reassurance\n- Don't dismiss parental concerns without explanation\n\n**Communication:**\n- Provide clear, confident reassurance\n- Explain the difference between peripheral and central cyanosis\n- Give specific return precautions (blue lips/tongue, breathing problems, poor feeding)\n- Avoid vague statements like \"probably nothing\" or \"you'll know\""}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have negative consequences.\n\n**Critical Errors:**\n\n1. **Unnecessary Sepsis Workup:**\n   - This well-appearing infant with isolated acrocyanosis has no signs of sepsis\n   - Don't reflexively culture and treat every newborn with blue hands/feet\n   - Antibiotics are not indicated\n\n2. **Home Pulse Oximetry:**\n   - NOT recommended for healthy term newborns\n   - Causes false alarms, anxiety, and missed clinical signs\n   - Parents should learn clinical warning signs instead\n\n3. **Over-Monitoring:**\n   - Daily visits for acrocyanosis is excessive\n   - Standard newborn follow-up is appropriate\n   - Medicalizing normal findings increases anxiety\n\n**Key Distinction:**\n- ACROCYANOSIS (blue hands/feet, pink tongue) \u2192 Normal, reassure\n- CENTRAL CYANOSIS (blue tongue/lips) \u2192 NEVER normal, urgent workup\n\nLearn to recognize and communicate this difference clearly."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-111", "title": "Newborn Screening Timing", "domain": "newborn", "difficulty": "intermediate", "tags": ["newborn screening", "metabolic screening", "PKU", "CAH", "17-OHP", "timing", "early discharge", "false positive"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A healthy term female was born at 11 PM via uncomplicated vaginal delivery. The mother is eager to go home and requests early discharge.\n\nIt is now 8 AM the next morning (9 hours after birth). The nurse asks if the newborn screen can be collected before discharge or if the family needs to return.\n\nThe infant is breastfeeding well, has passed meconium, vital signs are stable, and physical exam is unremarkable.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are asked about timing of newborn metabolic screening for a 9-hour-old infant being considered for early discharge.\n\n**Newborn Screening Overview:**\n\nNewborn screening (NBS) is a **state-mandated public health program** that tests for treatable conditions before symptoms develop.\n\n**Core RUSP Conditions (Recommended Uniform Screening Panel):**\n- **Metabolic disorders:** PKU, MCAD, galactosemia, maple syrup urine disease, etc.\n- **Endocrine disorders:** Congenital hypothyroidism, congenital adrenal hyperplasia\n- **Hemoglobinopathies:** Sickle cell disease, other hemoglobin variants\n- **Cystic fibrosis**\n- **Severe combined immunodeficiency (SCID)**\n- **Critical congenital heart disease** (pulse oximetry screening)\n- **Hearing loss** (OAE or ABR screening)\n\n**Optimal Timing: 24-48 Hours of Life**\n\n**Why NOT before 24 hours?**\n- **PKU:** Requires protein intake to accumulate phenylalanine (false negatives if drawn too early)\n- **CAH:** 17-OHP may not be elevated yet\n- **Galactosemia:** Needs galactose exposure from feeding\n- **TSH:** May reflect maternal thyroid status rather than infant's\n\n**Why NOT after 48-72 hours?**\n- Delays diagnosis and treatment of time-sensitive conditions\n- Most infants are discharged by then\n\n**If Drawn Before 24 Hours:**\n- Must repeat at 1-2 weeks of age regardless of result\n- Some states require repeat screening for ALL infants at 2 weeks", "question": "The infant is 9 hours old. What is the appropriate approach to newborn metabolic screening before early discharge?", "choices": [{"id": "node-1-choice-a", "text": "Collect the newborn screen now, but inform parents a repeat screen is required at 1-2 weeks since it was drawn before 24 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! When early discharge is planned before 24 hours of life, the approach is:\n\n**1. Collect the screen now:**\n- Even an early screen can detect some conditions\n- Better than no screen if family might not return\n\n**2. MUST repeat at 1-2 weeks:**\n- Screens drawn <24 hours have **higher false negative rates** especially for PKU, CAH, and galactosemia\n- The repeat is REQUIRED, not optional\n- Document clearly and ensure follow-up plan\n\n**3. Ensure family understands:**\n- This is not a \"failed\" test - it's a timing issue\n- They MUST return for repeat screening\n- Provide written instructions and follow-up appointment", "consequence": "You collect the screen and arrange for repeat testing at the 2-week visit.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Do not collect newborn screen yet; keep the infant hospitalized until 24 hours of life", "isOptimal": false, "isAcceptable": true, "feedback": "This would ensure optimal screening timing, but **mandatory hospitalization for screening timing alone is not required**. If the infant is medically ready for discharge and the family wishes to leave, you can collect an early screen with mandatory repeat. However, keeping the infant until 24 hours IS acceptable if the family agrees and there are no other discharge barriers. The ideal is collection at 24-48 hours, but flexibility is appropriate for early discharge situations.", "consequence": "Acceptable approach if family agrees to stay, but not always feasible.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Skip the newborn screen entirely; it can be done at the 2-week well-child visit instead", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying screening to 2 weeks is dangerous** for time-sensitive conditions. Several screened conditions can cause **irreversible harm within the first 1-2 weeks** if untreated:\n\n- **Galactosemia:** Liver failure, sepsis within days of milk exposure\n- **CAH:** Salt-wasting crisis at days 7-14\n- **MCAD:** Metabolic crisis with fasting\n- **Congenital hypothyroidism:** Intellectual disability if treatment delayed >2 weeks\n\nCollect an early screen NOW and repeat later - don't skip the initial screen entirely.", "consequence": "Dangerous delay in detecting treatable conditions that can cause irreversible harm.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Collect the newborn screen now; no repeat is needed since modern screening is accurate at any age", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Early screens (<24 hours) have higher false negative rates** and REQUIRE repeat testing. The issue is not screening technology - it's physiology:\n\n- **PKU:** Phenylalanine hasn't accumulated yet (needs protein feeding)\n- **Galactosemia:** Galactose metabolites haven't accumulated (needs milk exposure)\n- **TSH:** May reflect maternal thyroid status\n- **17-OHP:** May not be elevated yet in CAH\n\nTelling parents \"no repeat needed\" could result in missed diagnoses. Repeat screening at 1-2 weeks is **MANDATORY** for early draws.", "consequence": "Critical error - could miss treatable conditions due to false negative early screen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Tell parents newborn screening is optional and they can decline if they prefer", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While parents legally CAN refuse newborn screening in most states (usually for religious reasons), **actively suggesting this is inappropriate**. Newborn screening:\n\n- Is a **standard of care** for all newborns\n- Detects **treatable conditions** that cause death or disability if missed\n- Has **overwhelming benefit** with minimal risk\n- Is **mandated by law** in all 50 states (with religious exemptions)\n\nThe appropriate approach is to explain the importance of screening and encourage compliance, not suggest it's optional.", "consequence": "Inappropriate counseling that may lead to missed diagnoses.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Optimal newborn screen timing is 24-48 hours of life.** If drawn before 24 hours (early discharge), the screen MUST be repeated at 1-2 weeks because false negatives can occur for PKU, CAH, and galactosemia."}, "node-2": {"id": "node-2", "type": "decision", "content": "You collect the newborn screen at 9 hours of life and document the need for repeat testing. The family is discharged with a follow-up appointment.\n\nTwo weeks later, the state screening laboratory calls to report an abnormal result: **elevated 17-hydroxyprogesterone (17-OHP)** on the repeat screen.\n\n**Understanding Abnormal Newborn Screen Results:**\n\n**Key Principles:**\n1. **Screening \u2260 Diagnosis:** Abnormal screen requires confirmatory testing\n2. **False positives are common:** Especially for 17-OHP in preterm/stressed infants\n3. **Time-sensitive conditions require URGENT follow-up:** Don't wait weeks\n4. **Communicate clearly with families:** Abnormal screen is scary - explain what it means\n\n**Elevated 17-OHP - Differential:**\n- **True CAH** (21-hydroxylase deficiency) - most common cause of elevated 17-OHP\n- **False positive** - common in preterm, low birth weight, or stressed infants\n- **Cross-reactivity** with other steroids\n- **Heterozygous carrier** - may have mildly elevated 17-OHP", "question": "The repeat newborn screen shows elevated 17-OHP. What is the appropriate next step?", "choices": [{"id": "node-2-choice-a", "text": "Contact family immediately; arrange urgent confirmatory testing (serum 17-OHP, electrolytes) within 24 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Elevated 17-OHP requires **URGENT follow-up** because:\n\n**1. CAH is time-sensitive:**\n- Salt-wasting crisis can occur at 7-14 days of life\n- This infant is now 2 weeks old - within the danger zone\n\n**2. Urgent confirmatory testing includes:**\n- **Serum 17-OHP** (more accurate than filter paper)\n- **Electrolytes** (hyponatremia, hyperkalemia suggest salt-wasting)\n- **Glucose** (hypoglycemia from cortisol deficiency)\n\n**3. Clinical evaluation:**\n- Check for signs of adrenal crisis (lethargy, vomiting, poor feeding)\n- Check for virilization (ambiguous genitalia in females)\n- Examine genitalia and hydration status\n\n**4. Immediate communication:**\n- Call family directly (don't rely on mail)\n- Explain urgency without causing panic\n- Arrange same-day or next-day appointment", "consequence": "You reach the family and arrange urgent confirmatory testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Send a letter informing parents of the abnormal result and ask them to schedule follow-up at their convenience", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Letters are too slow for time-sensitive conditions.** Elevated 17-OHP suggests possible CAH, which can cause:\n\n- **Salt-wasting crisis** within days (if not already occurring)\n- **Potentially fatal** if unrecognized\n\nAt 2 weeks of life, this infant is within the window for adrenal crisis. You must **call the family directly** and arrange urgent evaluation - not send a letter and wait. Many newborn screening programs have protocols requiring direct phone contact for critical results.", "consequence": "Dangerous delay. Infant could deteriorate while letter is in transit.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Reassure family that false positives are common; repeat the screen again in 1 month", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While false positives ARE common for 17-OHP, **you cannot dismiss an abnormal result without confirmatory testing**. The consequences of a missed CAH diagnosis are severe:\n\n- **Adrenal crisis** (hyponatremia, hyperkalemia, shock)\n- **Death** if untreated\n\nThis infant is 2 weeks old - well within the timeframe for salt-wasting crisis. Waiting another month is dangerous. Get **confirmatory serum testing NOW**, not another screening test in a month.", "consequence": "Potentially fatal delay in diagnosis of true CAH.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Start empiric hydrocortisone and fludrocortisone before confirmatory testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for a **well-appearing infant**. Empiric treatment before confirmatory testing would:\n\n1. **Interfere with confirmatory hormone levels** (steroids affect 17-OHP)\n2. Be **unnecessary for false positives** (which are common)\n3. Expose infant to **unnecessary medication** if not truly affected\n\n**Exception:** If the infant showed signs of **adrenal crisis** (shock, severe hyponatremia, vomiting, lethargy), empiric treatment while awaiting confirmation would be appropriate. But for a well infant with abnormal screen, get confirmatory testing first.", "consequence": "Premature treatment interferes with diagnosis and may be unnecessary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Order genetic testing for CYP21A2 mutations as the primary confirmatory test", "isOptimal": false, "isAcceptable": true, "feedback": "Genetic testing CAN confirm CAH, but it's **not the immediate next step**. Problems with relying primarily on genetics:\n\n1. **Takes days to weeks** for results - too slow if infant is at risk for crisis\n2. **Doesn't assess current clinical status** (electrolytes, hydration)\n3. **Serum 17-OHP is faster and sufficient** for diagnosis in most cases\n\nGenetic testing is useful for: family counseling, prenatal diagnosis in future pregnancies, and confirming specific mutations. But the immediate priority is serum 17-OHP and electrolytes to assess for salt-wasting.", "consequence": "Genetic testing is helpful but serum hormone levels are more urgent.", "nextNodeId": "node-3"}], "clinicalPearl": "**Abnormal newborn screens require URGENT action**, not letters or delays. For time-sensitive conditions like CAH, call the family directly and arrange confirmatory testing within 24 hours. Don't wait for symptoms to develop."}, "node-3": {"id": "node-3", "type": "decision", "content": "Confirmatory testing shows:\n- **Serum 17-OHP: 15 nmol/L** (mildly elevated, but NOT markedly elevated like true CAH)\n- **Sodium: 138 mEq/L** (normal)\n- **Potassium: 5.0 mEq/L** (normal)\n- **Glucose: 72 mg/dL** (normal)\n\nThe infant is well-appearing with normal feeding and no signs of virilization.\n\n**Interpreting These Results:**\n\nThe mildly elevated 17-OHP with **normal electrolytes** and **well-appearing infant** is more consistent with:\n- **False positive screening** (common, especially if any stress/illness)\n- **Heterozygous carrier status** (carriers may have mildly elevated 17-OHP)\n- **Late-onset (non-classic) CAH** (mild form, presents later in life)\n\nThis is **NOT consistent with classic salt-wasting CAH**, which would show:\n- Markedly elevated 17-OHP (usually >100-300 nmol/L)\n- Abnormal electrolytes (hyponatremia, hyperkalemia)\n- Often clinical symptoms by 2 weeks of age", "question": "Confirmatory testing shows mildly elevated 17-OHP but normal electrolytes and a well infant. What is the most appropriate management?", "choices": [{"id": "node-3-choice-a", "text": "Reassure family this is likely false positive or carrier status; no treatment needed; consider repeat 17-OHP and/or genetic testing for definitive answer", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The clinical picture suggests **false positive or carrier status**, not classic CAH:\n\n**Evidence AGAINST classic CAH:**\n- Only **mildly elevated** 17-OHP (classic CAH would be markedly elevated)\n- **Normal electrolytes** (no salt-wasting)\n- **Well-appearing infant** at 2 weeks (classic CAH usually symptomatic by now)\n- No virilization\n\n**Appropriate management:**\n1. **Reassure family** - this is NOT an emergency\n2. **Consider repeat serum 17-OHP** in 1-2 weeks to confirm normalization\n3. **Optional: genetic testing** for carrier status or non-classic CAH (helpful for family planning)\n4. **Follow-up with endocrinology** if 17-OHP remains elevated\n\n**No treatment is needed** for a well infant with mildly elevated 17-OHP and normal electrolytes.", "consequence": "Appropriate reassurance with plan for confirmatory follow-up.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start hydrocortisone and fludrocortisone treatment since 17-OHP is still elevated", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do not treat based on mildly elevated 17-OHP alone.** Treatment is indicated for:\n\n- Classic CAH with markedly elevated 17-OHP AND\n- Abnormal electrolytes OR clinical symptoms\n\nThis infant has:\n- Only mildly elevated 17-OHP\n- NORMAL electrolytes\n- WELL-appearing at 2 weeks\n\nTreating a heterozygous carrier or false positive would expose the infant to unnecessary lifelong medication. Mildly elevated 17-OHP requires follow-up monitoring, not immediate treatment.", "consequence": "Unnecessary treatment for what is likely false positive or carrier status.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Admit to hospital for observation given the elevated 17-OHP", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hospitalization is not needed** for a well infant with mildly elevated 17-OHP and normal electrolytes. Hospital admission would be appropriate if:\n\n- Infant showed signs of adrenal crisis (lethargy, vomiting, hypotension)\n- Electrolytes were abnormal (hyponatremia, hyperkalemia)\n- 17-OHP was markedly elevated suggesting classic CAH\n\nThis infant is clinically well with normal electrolytes - outpatient follow-up with repeat testing is appropriate. Hospitalization would be unnecessary, costly, and anxiety-provoking for the family.", "consequence": "Unnecessary hospitalization for a well infant.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Tell parents the baby definitely does not have CAH and no further testing is needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While classic salt-wasting CAH is unlikely, you **cannot definitively rule out** CAH variants with a single serum 17-OHP. Options include:\n\n- **False positive** (most likely)\n- **Heterozygous carrier** (would have mildly elevated 17-OHP)\n- **Non-classic (late-onset) CAH** (may need follow-up later in life)\n\nAppropriate approach is reassurance that **classic CAH is unlikely**, but recommend either: (1) repeat 17-OHP to confirm normalization, or (2) genetic testing for definitive answer. Don't promise complete certainty without follow-up.", "consequence": "May miss carrier status or non-classic CAH that could affect future health.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Refer urgently to pediatric endocrinology and avoid all medical decisions until they evaluate", "isOptimal": false, "isAcceptable": true, "feedback": "Endocrinology referral is reasonable for **persistent 17-OHP elevation** or diagnostic uncertainty, but **urgent referral is not necessary** for this well infant with mildly elevated 17-OHP and normal electrolytes. The primary care physician can:\n\n1. Reassure the family that classic CAH is unlikely\n2. Order repeat 17-OHP in 1-2 weeks\n3. Refer to endocrinology if levels remain elevated\n\nEndocrinology consultation is helpful but not urgent for this clinical picture. The key is appropriate reassurance and follow-up plan.", "consequence": "Referral reasonable but not urgent given reassuring clinical picture.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Mildly elevated 17-OHP with normal electrolytes and well infant** is usually false positive or carrier status, NOT classic CAH. Don't treat based on screening result alone - use clinical judgment and confirmatory testing."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully navigated newborn screening timing and abnormal result follow-up.\n\n**Key Learning Points:**\n\n1. **Optimal Screening Timing: 24-48 Hours**\n   - Before 24 hours: Higher false negative rate (PKU, galactosemia, CAH)\n   - If early discharge necessitates <24-hour collection, MUST repeat at 1-2 weeks\n   - Never skip screening entirely - some detection is better than none\n\n2. **Handling Abnormal Results:**\n   - Abnormal screen \u2260 diagnosis (confirmatory testing required)\n   - Time-sensitive conditions need URGENT follow-up (phone call, not letter)\n   - Don't delay - conditions like CAH can cause crisis within days\n\n3. **Interpreting Confirmatory Results:**\n   - Classic CAH: Markedly elevated 17-OHP + abnormal electrolytes + symptoms\n   - False positive/carrier: Mildly elevated 17-OHP + normal electrolytes + well infant\n   - Don't treat based on screening alone - clinical context matters\n\n4. **Communication with Families:**\n   - Explain screening vs. diagnosis clearly\n   - Provide appropriate reassurance without premature certainty\n   - Ensure follow-up plan is understood\n\n**Remember:** Newborn screening saves lives by detecting treatable conditions early. Optimal timing, urgent follow-up of abnormal results, and appropriate interpretation of confirmatory testing are essential skills."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Screening Timing:**\n- Optimal: 24-48 hours of life\n- <24 hours: Collect but MUST repeat at 1-2 weeks (higher false negative rate)\n- Never delay to 2 weeks or suggest screening is optional\n\n**Abnormal Result Follow-up:**\n- Time-sensitive conditions need URGENT follow-up (call family, don't send letters)\n- Arrange confirmatory testing within 24 hours for elevated 17-OHP\n- Don't treat empirically in a well infant before confirming diagnosis\n\n**Interpreting Results:**\n- Mildly elevated 17-OHP + normal electrolytes + well infant = likely false positive\n- Don't treat without clinical indication\n- Don't promise definitive answers without follow-up testing\n- Endocrinology referral helpful but not always urgent"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors:**\n\n1. **Delaying or Skipping Screening:**\n   - Never delay screening to 2 weeks (time-sensitive conditions cause harm early)\n   - Never suggest screening is optional (it's standard of care)\n   - If <24 hours, collect early screen AND repeat later\n\n2. **Inadequate Follow-up of Abnormal Results:**\n   - Letters are too slow for critical results\n   - \"Wait and see\" approach can be fatal for CAH (crisis at 7-14 days)\n   - Must call family directly and arrange urgent confirmatory testing\n\n3. **Misinformation About Repeat Testing:**\n   - Early screens (<24 hours) MUST be repeated (higher false negative rate)\n   - Don't tell parents repeat is unnecessary\n\n4. **Inappropriate Treatment:**\n   - Don't treat mildly elevated 17-OHP with normal electrolytes in well infant\n   - Would expose false positives to unnecessary lifelong medication\n\n**Remember:** Newborn screening is a system - proper timing, urgent follow-up, and appropriate interpretation all matter."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-138", "title": "Fever Definition by Age", "domain": "newborn", "difficulty": "intermediate", "tags": ["febrile neonate", "sepsis workup", "age-based risk stratification", "lumbar puncture", "empiric antibiotics", "ampicillin gentamicin", "Rochester criteria", "fever definition by age"], "estimatedMinutes": 6, "source": ["NBME"], "stem": "You are working in a pediatric urgent care when three patients present within the same hour, all with fever. The triage nurse hands you the charts:\n\n**Patient A**: 3-week-old male, rectal temp 38.2\u00b0C (100.8\u00b0F), \"acting normal\" per mom\n**Patient B**: 6-week-old female, rectal temp 38.5\u00b0C (101.3\u00b0F), fussy but consolable\n**Patient C**: 5-year-old male, oral temp 39.0\u00b0C (102.2\u00b0F), runny nose and cough x2 days\n\nYou need to prioritize and manage these patients based on age-appropriate fever evaluation guidelines.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You review the fever definition and age-based risk stratification.\n\n**Definition of Fever:**\n- **Rectal temperature \u226538.0\u00b0C (100.4\u00b0F)** is the gold standard\n- Oral, axillary, and temporal temperatures are less accurate in young children\n- In neonates, **hypothermia (<36.5\u00b0C)** can also indicate serious infection\n\n**Age-Based Risk Stratification for Febrile Infants:**\n\n**0-28 days (Neonates) - HIGHEST RISK:**\n- **Full sepsis workup REQUIRED** regardless of appearance\n- Includes: CBC, blood culture, urinalysis/urine culture, LP with CSF studies\n- **Empiric antibiotics** (ampicillin + gentamicin or cefotaxime)\n- **Hospitalization required**\n- Rationale: Immature immune system, high risk of SBI (10-15%), can't localize infection\n\n**29-60 days - HIGH RISK:**\n- Risk stratification based on clinical appearance and labs\n- Well-appearing + normal labs: may be managed as outpatient with close follow-up\n- Any concerning features: full workup + admission\n\n**61-90 days - MODERATE RISK:**\n- Rochester/Philadelphia/Boston criteria guide management\n- Well-appearing infants with reassuring labs may be observed\n\n**>90 days - LOWER RISK:**\n- Focus-directed evaluation\n- Well-appearing children often managed outpatient", "question": "Which patient should you see FIRST?", "choices": [{"id": "node-1-choice-a", "text": "Patient A (3-week-old) - neonatal fever is a medical emergency regardless of appearance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Fever in a neonate (<28 days) is a medical emergency** that requires immediate attention regardless of how \"well\" the infant appears. Key principles: (1) **Neonates cannot mount an appropriate immune response** - they may appear well despite serious bacterial infection, (2) **Risk of SBI is 10-15%** in febrile neonates, (3) **\"Acting normal\" is NOT reassuring** in this age group - neonates lack behavioral repertoire to show illness, (4) **Full sepsis workup and empiric antibiotics are mandatory**. The 3-week-old must be seen first, even before the fussy 6-week-old.", "consequence": "You appropriately prioritize the highest-risk patient.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Patient B (6-week-old) - she is fussy which suggests she may be sicker", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the 6-week-old needs urgent evaluation, **age trumps clinical appearance** in fever risk stratification. The 3-week-old is at HIGHER risk because: (1) **Neonates (<28 days) have the highest SBI risk** (10-15% vs 5-10% at 29-60 days), (2) **Well-appearing neonates can harbor serious infection** - their immune systems can't mount visible responses, (3) **Fussiness in the 6-week-old is actually somewhat reassuring** - she can demonstrate distress. Always prioritize the youngest febrile infant.", "consequence": "Misunderstanding age-based risk delays care for the highest-risk patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Patient C (5-year-old) - he has the highest fever at 39.0\u00b0C", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fever height does NOT correlate with severity** in the way age does. Key misconceptions corrected: (1) **A 5-year-old with 39\u00b0C and URI symptoms is LOW risk** compared to febrile infants, (2) **39\u00b0C is a typical viral fever** in an older child with obvious respiratory symptoms, (3) **Age is the primary risk stratifier** - not temperature magnitude. The 5-year-old can wait safely while you evaluate the infants. Never let fever height distract from age-based priorities.", "consequence": "Prioritizing fever height over age delays critical neonatal evaluation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "See all three simultaneously - fever needs immediate evaluation in all children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While all febrile patients need evaluation, **triage requires prioritization based on risk**. Key principles: (1) **Resources are finite** - you can't simultaneously evaluate all three, (2) **Risk-based prioritization** ensures the sickest patients are seen first, (3) **The neonate has highest mortality risk** if SBI is present and untreated, (4) The 5-year-old can safely wait while the infants are evaluated. Effective triage is a critical clinical skill.", "consequence": "Failure to prioritize may delay critical care for highest-risk patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Patient C first since he's been sick longest (2 days) and may have bacterial superinfection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Duration of illness doesn't override age-based risk** in fever triage. Key points: (1) **2 days of URI symptoms in a 5-year-old is typical viral illness**, (2) **Bacterial superinfection** is possible but far less urgent than neonatal fever, (3) **The 3-week-old's fever duration is irrelevant** - any fever in a neonate requires immediate workup, (4) **Young age = higher risk** regardless of symptom duration. Prioritize the neonate.", "consequence": "Misunderstanding risk factors delays evaluation of highest-risk patient.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Fever in a neonate (<28 days) is ALWAYS a medical emergency** - full sepsis workup and empiric antibiotics are mandatory regardless of how well the infant appears. \"Looking good\" is NOT reassuring in neonates because they lack the immune and behavioral repertoire to manifest illness."}, "node-2": {"id": "node-2", "type": "decision", "content": "You immediately evaluate the 3-week-old. He is alert, feeding well, and has normal vital signs except for the fever. The parents state he has been completely normal until they noticed he felt warm 2 hours ago. No sick contacts. Born full-term, uncomplicated delivery, GBS negative.\n\nPhysical exam reveals a well-appearing neonate with no localizing signs of infection.\n\n**The \"Well-Appearing\" Neonate Trap:**\n\nMany providers are tempted to minimize workup in well-appearing febrile neonates. This is dangerous because:\n\n- **Neonates lack behavioral signs of illness** - they can't tell you they have a headache or neck stiffness\n- **Immune response is immature** - may not mount fever, elevated WBC, or inflammatory markers despite serious infection\n- **SBI rate is 10-15%** regardless of appearance\n- **Meningitis can present with subtle or NO neurologic signs** in neonates\n\n**Serious Bacterial Infections in Febrile Neonates:**\n- UTI (most common)\n- Bacteremia\n- Meningitis\n- Pneumonia\n- Osteomyelitis/septic arthritis\n\n**Common Pathogens:**\n- Group B Streptococcus (GBS)\n- E. coli\n- Listeria monocytogenes\n- HSV (consider if vesicles, seizures, or maternal history)", "question": "What workup do you order for this well-appearing 3-week-old with fever?", "choices": [{"id": "node-2-choice-a", "text": "Full sepsis workup: CBC, blood culture, urinalysis with urine culture (catheterized), lumbar puncture with CSF studies, consider HSV PCR", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **All febrile neonates require full sepsis workup regardless of appearance**. Required components: (1) **CBC with differential** - though may be normal in SBI, (2) **Blood culture** - gold standard for bacteremia, (3) **Catheterized urine** - UTI is most common SBI in this age, (4) **Lumbar puncture with CSF** - cell count, protein, glucose, Gram stain, culture; meningitis can present without neurologic signs, (5) **Consider HSV PCR** on CSF and blood if risk factors (maternal HSV, vesicles, seizures, elevated LFTs). This is non-negotiable in neonates - appearance does NOT change the workup.", "consequence": "You order the appropriate comprehensive workup.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CBC, blood culture, and urinalysis only - defer LP since he looks well and has no neurologic signs", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **LP cannot be deferred in febrile neonates** regardless of appearance. Critical points: (1) **Neonatal meningitis can present WITHOUT neurologic signs** - stiff neck, bulging fontanelle, and focal findings are often absent, (2) **10-15% of neonates with meningitis have normal peripheral WBC**, (3) **\"Looking well\" does not rule out CNS infection**, (4) **Missing meningitis has devastating consequences** - mortality and severe neurologic sequelae. LP is mandatory in all febrile neonates unless contraindicated (coagulopathy, hemodynamic instability).", "consequence": "Deferring LP risks missing neonatal meningitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Urinalysis only - UTI is the most common SBI, so start there and expand workup only if positive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stepwise workup is inappropriate in febrile neonates**. Key issues: (1) **Neonates can have bacteremia AND UTI simultaneously** - or bacteremia without UTI, (2) **Waiting for UA results delays treatment** of potentially life-threatening infection, (3) **ALL components of sepsis workup are needed** regardless of which test is done first, (4) **Time matters** - empiric antibiotics should be given within the first hour. Full workup should be done in parallel, not sequentially.", "consequence": "Stepwise approach delays diagnosis and treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "No workup needed if parents can provide reliable follow-up in 24 hours - he looks completely well", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Observation is NEVER appropriate for febrile neonates**. This approach is dangerous because: (1) **Neonatal sepsis can progress to death within hours**, (2) **\"Looking well\" has no negative predictive value** for SBI in neonates, (3) **No amount of reliable follow-up makes watchful waiting safe** at this age, (4) **Standard of care requires full workup and empiric antibiotics**. Suggesting observation for a febrile neonate would be considered malpractice.", "consequence": "Observation approach puts the neonate at extreme risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Order CBC and CRP - if inflammatory markers are normal, he can be safely discharged", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Normal inflammatory markers do NOT rule out SBI in neonates**. Key limitations: (1) **Neonatal immune system is immature** - may not elevate WBC or CRP despite serious infection, (2) **10-25% of neonates with SBI have normal WBC**, (3) **CRP can be falsely negative early in infection**, (4) **No combination of labs can safely rule out SBI** in febrile neonates - full workup and empiric treatment are required. Inflammatory markers are supportive data, not exclusionary tests.", "consequence": "Relying on inflammatory markers misses SBI.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Lumbar puncture is MANDATORY in all febrile neonates** - meningitis can present without neurologic signs in this age group. Normal peripheral WBC, normal CRP, and \"looking well\" do NOT rule out meningitis or bacteremia. The only acceptable reason to defer LP is hemodynamic instability (in which case, give antibiotics first)."}, "node-3": {"id": "node-3", "type": "decision", "content": "You complete the sepsis workup. Results are pending. The neonate remains well-appearing.\n\n**CSF Results (preliminary):**\n- WBC: 8 cells/\u03bcL (normal <20 in neonates)\n- RBC: 2 cells/\u03bcL\n- Protein: 85 mg/dL (normal <150 in neonates)\n- Glucose: 45 mg/dL (serum glucose 90 mg/dL, ratio >0.5)\n- Gram stain: No organisms seen\n\n**Peripheral Labs:**\n- WBC: 12,000/\u03bcL (normal)\n- Bands: 2%\n- CRP: 0.8 mg/dL (mildly elevated)\n\n**Urinalysis:** Negative for leukocyte esterase and nitrites\n\nAll cultures are pending (results in 24-48 hours).\n\n**Empiric Antibiotic Therapy in Febrile Neonates:**\n\n**Standard Regimen:**\n- **Ampicillin** (covers GBS, Listeria, Enterococcus) PLUS\n- **Gentamicin** (covers gram-negatives, synergy with ampicillin for GBS) OR\n- **Cefotaxime** (alternative to gentamicin, better CNS penetration)\n\n**Add Acyclovir if HSV concern:**\n- Vesicular rash\n- Seizures\n- Elevated transaminases\n- CSF pleocytosis with negative Gram stain\n- Maternal HSV history", "question": "What is your antibiotic plan while awaiting culture results?", "choices": [{"id": "node-3-choice-a", "text": "Start empiric ampicillin + gentamicin IV, admit for observation pending cultures for at least 36-48 hours", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Empiric antibiotics are mandatory for all febrile neonates** pending culture results. Key points: (1) **Ampicillin covers GBS, Listeria, and Enterococcus** - the most common gram-positive pathogens, (2) **Gentamicin covers gram-negatives (E. coli)** and provides synergy with ampicillin for GBS, (3) **Must admit for at least 36-48 hours** until cultures are finalized - some organisms grow slowly, (4) **Normal initial labs do NOT change management** - cultures are the gold standard. If cultures remain negative at 36-48 hours and infant remains well, antibiotics can be discontinued.", "consequence": "Appropriate empiric coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Withhold antibiotics since CSF, CBC, and UA are all reassuring - give antibiotics only if cultures turn positive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Empiric antibiotics are MANDATORY in febrile neonates** - you cannot wait for culture results. Critical issues: (1) **Cultures take 24-48 hours** - neonatal sepsis can progress to death in hours, (2) **Normal CSF does NOT rule out early meningitis** - pleocytosis may develop later, (3) **Normal WBC and UA have poor negative predictive value** for SBI in neonates, (4) **Standard of care requires presumptive treatment**. Withholding antibiotics from a febrile neonate while awaiting cultures is dangerous and inappropriate.", "consequence": "Withholding antibiotics risks death from untreated sepsis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Start oral amoxicillin and discharge with close follow-up since all initial tests are reassuring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Febrile neonates require IV antibiotics and hospitalization** - oral antibiotics and outpatient management are NEVER appropriate. Key issues: (1) **Oral antibiotics have unreliable absorption** in neonates, (2) **Cannot achieve adequate CSF levels** with oral therapy, (3) **Hospitalization is required** for monitoring and culture follow-up, (4) **\"Reassuring\" initial tests don't change disposition** - all febrile neonates are admitted. Outpatient management of febrile neonates is below standard of care.", "consequence": "Outpatient oral antibiotics are grossly inadequate for neonatal fever.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Start ceftriaxone IV as monotherapy - it covers all the likely pathogens", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ceftriaxone is contraindicated in neonates** and even cefotaxime monotherapy is inadequate. Key issues: (1) **Ceftriaxone displaces bilirubin** from albumin \u2192 risk of kernicterus in neonates, (2) **Third-generation cephalosporins don't cover Listeria** - must add ampicillin, (3) **Cefotaxime is the preferred cephalosporin** in neonates if needed (no bilirubin displacement), (4) **Ampicillin is essential** for Listeria and Enterococcus coverage. The correct regimen is ampicillin + gentamicin (or ampicillin + cefotaxime).", "consequence": "Ceftriaxone is contraindicated in neonates; monotherapy misses Listeria.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Start ampicillin + gentamicin + acyclovir for all febrile neonates to cover HSV", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Acyclovir is indicated when HSV risk factors are present**, but routine addition for all febrile neonates is debated. Current recommendations: (1) **Add acyclovir if**: vesicular rash, seizures, elevated LFTs, CSF pleocytosis with negative Gram stain, maternal HSV history, (2) **Some centers add empiric acyclovir** for all febrile neonates <21 days given HSV severity, (3) **This neonate has no specific HSV risk factors** - standard ampicillin + gentamicin is appropriate. Adding acyclovir is not wrong, but not specifically indicated here without risk factors.", "consequence": "Acyclovir addition is acceptable but not specifically indicated without HSV risk factors.", "nextNodeId": "node-4"}], "clinicalPearl": "**Ampicillin + gentamicin** is the standard empiric regimen for febrile neonates. Ampicillin covers **Listeria** (which cephalosporins miss). **Ceftriaxone is contraindicated** in neonates due to bilirubin displacement risk. Add **acyclovir** if HSV risk factors present (vesicles, seizures, maternal history, elevated LFTs)."}, "node-4": {"id": "node-4", "type": "decision", "content": "You start ampicillin and gentamicin IV and admit the neonate. Now you need to evaluate the other two patients.\n\n**Patient B (6-week-old female):** Rectal temp 38.5\u00b0C, fussy but consolable, eating slightly less than usual. Born full-term, GBS negative, no sick contacts.\n\n**Patient C (5-year-old male):** Oral temp 39.0\u00b0C, runny nose, cough x2 days, drinking well, active in the waiting room.\n\n**Management of the 29-60 Day Febrile Infant (Patient B):**\n\nThis age group requires careful risk stratification. Options depend on clinical appearance and lab results:\n\n**Rochester Criteria (Low-Risk Criteria):**\n- Previously healthy, term infant\n- Well-appearing\n- No focal bacterial infection on exam (except otitis media)\n- WBC 5,000-15,000/\u03bcL\n- Absolute band count <1,500/\u03bcL\n- UA \u226410 WBC/hpf, negative Gram stain\n- If diarrhea: stool \u22645 WBC/hpf\n\n**If LOW-RISK:** May consider outpatient management with close follow-up (controversial; many still recommend LP + admission)\n\n**If HIGH-RISK or ANY concern:** Full workup including LP, empiric antibiotics, admission\n\n**The 5-Year-Old (Patient C):**\n- Clear viral URI syndrome\n- Well-appearing with good oral intake\n- Focus-directed evaluation only\n- Supportive care, no antibiotics unless bacterial focus identified", "question": "How do you manage Patients B and C?", "choices": [{"id": "node-4-choice-a", "text": "Patient B: Full sepsis workup including LP, empiric antibiotics, admit. Patient C: Clinical exam, symptomatic care, discharge with return precautions.", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! This is the **safest approach for the 29-60 day infant**. Key reasoning: (1) **Patient B at 6 weeks still has significant SBI risk** (5-10%), (2) **Fussiness and decreased feeding are concerning** - not meeting \"well-appearing\" criteria, (3) **LP is recommended** for infants 29-60 days, especially with any concerning features, (4) **Empiric antibiotics and admission** until cultures negative at 36-48 hours. For **Patient C**: (5) **Clear viral URI** in a well-appearing 5-year-old is low-risk, (6) **Supportive care** (fluids, antipyretics) is appropriate, (7) **Return precautions** for worsening symptoms.", "consequence": "Both patients managed appropriately based on age-specific risk.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Patient B: CBC, UA, blood culture only (no LP), observe for 24 hours. Patient C: Full workup given high fever.", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This reverses the appropriate risk stratification. Key issues: (1) **Patient B needs LP** - at 6 weeks with concerning symptoms (fussy, decreased feeding), meningitis must be ruled out, (2) **Omitting LP in a febrile young infant** with any concerning features is dangerous, (3) **Patient C does NOT need full workup** - he's 5 years old with obvious viral URI, (4) **High fever alone is not an indication for extensive workup** in an older child with clear viral symptoms. Age-based risk stratification is essential.", "consequence": "Under-evaluating the infant while over-evaluating the older child.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Both patients: CBC, UA, blood culture. Discharge both with close follow-up if labs normal.", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Patient B cannot be safely discharged** after limited workup, and this approach doesn't account for age-based risk. Key issues: (1) **6-week-old with concerning symptoms needs LP** - labs alone can't rule out meningitis, (2) **\"Normal labs\" in a 29-60 day infant don't rule out SBI** - cultures are the gold standard, (3) **Discharging a febrile 6-week-old** before cultures finalize is risky, (4) The 5-year-old doesn't need blood culture/labs for typical viral URI. One-size-fits-all approaches ignore crucial age-based risk differences.", "consequence": "Inadequate workup for infant and unnecessary testing for older child.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Patient B: Discharge with oral amoxicillin since she's older than 28 days. Patient C: Admit for IV antibiotics given 2 days of fever.", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This completely reverses appropriate management. Key errors: (1) **Patient B needs admission and IV antibiotics**, not outpatient oral therapy - she's 6 weeks old with fever and concerning symptoms, (2) **Oral antibiotics are never first-line** for febrile young infants, (3) **Patient C does NOT need IV antibiotics** - he has viral URI, not bacterial infection, (4) **\"2 days of fever\"** in an older child with viral symptoms doesn't indicate bacterial infection. This approach would harm both patients.", "consequence": "Dangerous mismanagement of both patients.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Patient B: Admit for observation only, no antibiotics unless she worsens. Patient C: Antibiotics for possible bacterial sinusitis.", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Patient B needs empiric antibiotics**, not just observation. Key issues: (1) **Febrile infants 29-60 days with concerning features** should receive empiric antibiotics pending cultures, (2) **\"Observation only\"** is only considered for completely well-appearing infants meeting strict low-risk criteria, (3) **Patient C does NOT have sinusitis** - he has 2 days of URI symptoms, far short of the 10+ days needed to diagnose bacterial sinusitis, (4) **Antibiotics for viral URI** promote resistance without benefit.", "consequence": "Under-treating the infant while inappropriately treating the older child.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Age-based risk stratification is essential**: Febrile neonates (<28 days) ALWAYS get full workup + antibiotics + admission. Infants 29-60 days need careful evaluation - most should get LP and empiric treatment, especially with any concerning features. Children >3 months with obvious viral illness can often be managed supportively without extensive workup."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly applied age-based fever management principles to triage and treat three patients with different risk profiles.\n\n**Key Teaching Points:**\n\n**Fever Definition:**\n- **Rectal temp \u226538.0\u00b0C (100.4\u00b0F)** is the standard definition\n- Hypothermia in neonates can also indicate serious infection\n\n**Age-Based Risk Stratification:**\n\n**0-28 days (Neonates) - HIGHEST RISK:**\n- Full sepsis workup MANDATORY (CBC, blood culture, catheterized UA/culture, LP)\n- Empiric antibiotics (ampicillin + gentamicin)\n- Hospitalization required\n- \"Looking well\" is NOT reassuring - neonates can't manifest illness\n\n**29-60 days - HIGH RISK:**\n- Full workup including LP recommended, especially with any concerning features\n- Risk stratification criteria (Rochester) can identify low-risk infants\n- Most should receive empiric antibiotics and admission\n\n**61-90 days - MODERATE RISK:**\n- Clinical judgment + risk stratification criteria guide management\n- Well-appearing infants with reassuring labs may be observed\n\n**>90 days - LOWER RISK:**\n- Focus-directed evaluation\n- Viral illnesses common and can be managed supportively\n\n**Critical Concepts:**\n- **Ceftriaxone is contraindicated in neonates** (bilirubin displacement)\n- **Ampicillin covers Listeria** (cephalosporins don't)\n- **LP cannot be deferred** in febrile neonates - meningitis presents without neurologic signs\n- **Fever height does NOT correlate with severity** - age is the primary risk factor"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in age-based fever management:\n\n**Neonates (<28 days):**\n- ALWAYS full sepsis workup + empiric antibiotics + admission\n- Appearance is NOT reassuring\n- LP is mandatory\n\n**29-60 day infants:**\n- High risk - most need full workup and treatment\n- Risk stratification criteria can guide management of well-appearing infants\n- When in doubt, do the full workup\n\n**Older children:**\n- Focus-directed evaluation based on symptoms\n- Viral illnesses are common and don't need extensive workup\n- Fever height alone doesn't indicate severity\n\n**Common Errors:**\n- Deferring LP in young infants because they \"look well\"\n- Using ceftriaxone in neonates\n- Omitting ampicillin (misses Listeria)\n- Over-testing older children with obvious viral illness\n- Under-testing young infants based on reassuring appearance"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case highlights critical principles in pediatric fever management:\n\n**Neonatal Fever (<28 days) is a MEDICAL EMERGENCY:**\n- **Full sepsis workup is MANDATORY** regardless of appearance\n- **Empiric antibiotics** (ampicillin + gentamicin) must be given\n- **Hospitalization required** until cultures negative at 36-48 hours\n- **\"Looking well\" means NOTHING** - neonates cannot manifest illness\n- **LP cannot be deferred** - meningitis presents without neurologic signs\n\n**Dangerous Misconceptions:**\n- \"He looks too good to be sick\" - FALSE for neonates\n- \"Labs are normal so no antibiotics needed\" - FALSE, cultures are gold standard\n- \"LP not needed if no neuro signs\" - FALSE, neonatal meningitis is subtle\n- \"Fever height indicates severity\" - FALSE, age is the primary risk factor\n\n**Medication Pearls:**\n- **Ceftriaxone is CONTRAINDICATED** in neonates (bilirubin displacement)\n- **Ampicillin is REQUIRED** for Listeria coverage (cephalosporins don't cover)\n- **Add acyclovir** if HSV risk factors present\n\n**Consequences of Missed Diagnosis:**\n- Neonatal sepsis mortality: 10-30%\n- Meningitis sequelae: hearing loss, developmental delay, seizures\n- These are preventable with appropriate evaluation and treatment"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-140", "title": "Developmental Dysplasia of the Hip (DDH)", "domain": "newborn", "difficulty": "intermediate", "tags": ["Barlow and Ortolani maneuvers", "breech presentation", "Pavlik harness", "asymmetric gluteal folds", "developmental dysplasia of the hip (ddh)"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-month-old female presents with routine well-child examination.\n\nHistory reveals, her mother has no concerns. She is feeding well and gaining weight appropriately.\n\nasymmetric thigh skin folds noticed. No clicking sounds with diaper changes.\n\nPertinent history includes She was born in breech presentation at 39 weeks. Family history of hip dysplasia in a maternal aunt.\n\nPhysical Examination:\n- Hips: positive Ortolani sign on left (clunk felt as hip reduces).\n- Lower extremities: asymmetric thigh folds, apparent leg length discrepancy.\n- General: well-appearing infant.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You perform hip examination maneuvers:\n\n**Ortolani test**: With hips and knees flexed to 90\u00b0, you gently abduct the hip while lifting the greater trochanter anteriorly. You feel a distinct **clunk** on the left as the femoral head reduces into the acetabulum.\n\n**Barlow test**: With hips adducted, you apply gentle posterior pressure. The left hip feels unstable with a sense of subluxation.\n\n**Additional findings**: Left hip has limited abduction compared to right; asymmetric thigh folds noted.", "question": "What is the correct interpretation of these examination findings?", "choices": [{"id": "node-1-choice-a", "text": "Positive Ortolani indicates a dislocated hip that can be reduced; positive Barlow indicates an unstable hip that can be dislocated", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Ortolani test** detects a **dislocated hip that reduces** with abduction - the 'clunk' is the femoral head returning to the acetabulum. **Barlow test** assesses hip **stability** - a positive test means the hip can be provoked to subluxate/dislocate with adduction and posterior pressure. Mnemonic: **Barlow = Bad (dislocates out)**, **Ortolani = OK (reduces back in)**. Both tests are most reliable in the first **2-3 months** of life before soft tissue contractures develop.", "consequence": "You understand the significance and proceed to confirmatory imaging.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Positive Ortolani indicates a stable hip; the clunk is normal ligamentous laxity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **clunk** on Ortolani testing is never normal - it represents the femoral head reducing into the acetabulum from a dislocated position. Normal hips do not produce a clunk. **Hip clicks** (soft, high-pitched) can be normal and are often from ligaments/tendons, but a **clunk** is pathologic and requires investigation.", "consequence": "Missing DDH diagnosis leads to delayed treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Asymmetric thigh folds alone confirm the diagnosis of DDH", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Asymmetric thigh folds** are a supportive finding but have **low sensitivity and specificity** for DDH. Many normal infants have asymmetric folds (due to subcutaneous fat distribution), and some DDH cases have symmetric folds. The **Ortolani and Barlow maneuvers** are the key clinical tests; asymmetric folds alone do not confirm diagnosis.", "consequence": "Over-reliance on soft signs may miss or over-diagnose DDH.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "These findings suggest septic arthritis requiring urgent arthrocentesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Septic arthritis** presents with a febrile, irritable infant who **holds the hip in flexion, abduction, and external rotation** (position of comfort) and resists any movement. This well-appearing, afebrile infant with positive Ortolani/Barlow tests has **DDH**, not infection. In septic arthritis, you would not feel the characteristic relocating 'clunk' of Ortolani.", "consequence": "Unnecessary invasive procedure; misses the actual diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Limited hip abduction is the most specific finding for DDH", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Limited hip abduction** (normally hips abduct to 75-80\u00b0) is a useful sign, especially in **older infants** when Ortolani/Barlow tests become negative due to soft tissue contractures. However, in a 2-month-old, the **Ortolani/Barlow tests** are more specific. Limited abduction becomes more important after 3 months of age when other maneuvers lose sensitivity.", "consequence": "Understanding evolves but initial focus should be on positive maneuvers.", "nextNodeId": "node-2"}], "clinicalPearl": "KEY CONCEPT: **Ortolani** = palpable **clunk** as dislocated hip **reduces** (felt during abduction). **Barlow** = hip **dislocates** with posterior pressure (felt during adduction). These tests are most sensitive from **birth to 2-3 months**; after that, soft tissue contractures make the hip irreducible and **limited abduction** becomes the key finding. Hips that are 'clicky' without a true clunk are usually normal."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order confirmatory imaging. At **2 months of age**, the femoral head is still predominantly **cartilaginous** and not visible on X-ray.\n\nHip ultrasound using the **Graf method** reports:\n- Left hip: **Alpha angle 48\u00b0** (normal >60\u00b0), **Beta angle 68\u00b0** (normal <55\u00b0)\n- Right hip: Alpha angle 64\u00b0, Beta angle 48\u00b0 (normal)\n- Femoral head coverage: Left hip shows inadequate acetabular coverage\n- Classification: **Graf Type III** (dislocated hip)", "question": "Why is ultrasound the preferred imaging modality for this 2-month-old, and what do these findings indicate?", "choices": [{"id": "node-2-choice-a", "text": "Ultrasound visualizes cartilaginous structures; the alpha angle reflects acetabular depth and femoral head coverage", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Ultrasound** is preferred for infants **<4-6 months** because the femoral head is **cartilaginous** and invisible on X-ray. The **alpha angle** measures the **bony acetabular roof** slope - angles **<60\u00b0** indicate acetabular dysplasia with inadequate coverage. The **beta angle** measures the cartilaginous roof. **Graf classification**: Type I (normal, \u03b1>60\u00b0), Type II (immature/dysplastic, \u03b1 50-59\u00b0), Type III (subluxed, \u03b1 43-49\u00b0), Type IV (dislocated). This infant's **Type III** left hip requires treatment.", "consequence": "Imaging interpretation guides treatment selection.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Ultrasound is cheaper than X-ray; the angles are not clinically significant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cost is not the primary reason for choosing ultrasound. The critical factor is that **X-rays cannot visualize cartilage**, making them useless for assessing the cartilaginous femoral head in young infants. The **alpha and beta angles** are highly significant - they quantify acetabular development and guide treatment decisions. An alpha angle <60\u00b0 indicates true dysplasia requiring intervention.", "consequence": "Underestimating ultrasound findings delays treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "X-ray should be obtained instead to assess bony abnormalities", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In infants **<4-6 months**, the **femoral head ossification center** has not yet appeared, so X-ray cannot assess hip location or acetabular coverage. X-ray becomes useful after **4-6 months** when ossification allows visualization. At 2 months, ultrasound is the only modality that can evaluate the hip joint.", "consequence": "X-ray would be non-diagnostic and delay treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "MRI should be ordered for definitive diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **MRI** is not needed for routine DDH diagnosis - ultrasound provides all necessary information. MRI may be used in complex cases (e.g., assessing reduction adequacy after closed reduction, evaluating for obstacles to reduction) but requires sedation in infants and is far more expensive. Ultrasound is the gold standard for initial DDH assessment.", "consequence": "Unnecessary cost, sedation risk, and delays.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Ultrasound should be delayed until 6 months when more accurate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying diagnosis is harmful** - earlier treatment leads to better outcomes. Ultrasound is actually **most useful before 6 months**; after that, ossification allows X-ray to be used instead. Treatment success with Pavlik harness drops significantly if started after 6 months. This infant needs immediate treatment, not delayed imaging.", "consequence": "Delayed treatment significantly worsens prognosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Graf ultrasound classification**: Type I (normal, \u03b1>60\u00b0), Type IIa (physiologically immature <3 months, \u03b1 50-59\u00b0, can observe), Type IIb (dysplastic >3 months, needs treatment), Type III (subluxed), Type IV (dislocated). **X-ray** becomes useful after 4-6 months when the **ossific nucleus** appears. X-ray findings then include: **Shenton's line** disruption, increased **acetabular index**, lateral/superior femoral head displacement."}, "node-3": {"id": "node-3", "type": "decision", "content": "The diagnosis is confirmed: **left DDH, Graf Type III** (subluxed/dislocated hip).\n\nThe infant is 2 months old, otherwise healthy, with a reducible hip (positive Ortolani).\n\nYou discuss treatment options with the family.", "question": "What is the most appropriate initial treatment for this 2-month-old with DDH?", "choices": [{"id": "node-3-choice-a", "text": "Pavlik harness worn full-time for 6-12 weeks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Pavlik harness** is first-line treatment for DDH in infants **<6 months** with a **reducible hip**. It maintains the hip in **flexion (90-100\u00b0) and abduction (50-70\u00b0)**, the 'human position' that keeps the femoral head centered in the acetabulum. The harness allows gradual acetabular remodeling. Worn **full-time** initially, with weekly follow-up ultrasounds to confirm hip position. Success rate is **>90%** when started before 3 months of age.", "consequence": "High likelihood of successful non-operative treatment.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Triple diapering to keep hips abducted", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Triple diapering is NOT effective treatment** for DDH and should not be used. It does not maintain adequate hip flexion and abduction to keep the femoral head reduced. This outdated practice delays proper treatment with Pavlik harness. Any infant with confirmed DDH needs a **proper orthotic device**, not extra diapers.", "consequence": "Ineffective treatment; delays proper management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Immediate closed reduction under anesthesia and spica casting", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Closed reduction and spica casting** is reserved for infants who **fail Pavlik harness treatment** or present **after 6 months** when the harness is less effective. In a 2-month-old with a reducible hip, Pavlik harness has >90% success rate and is far less invasive. Spica casting carries risks including **avascular necrosis** and is more burdensome for families.", "consequence": "Over-treatment; unnecessary anesthesia and casting risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Open surgical reduction with pelvic osteotomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Open reduction** is reserved for (1) irreducible hips with obstacles (e.g., inverted labrum, ligamentum teres), (2) failed closed reduction, or (3) late-presenting DDH (>18-24 months). **Pelvic osteotomy** addresses residual acetabular dysplasia, typically performed in older children. Starting with surgery in a 2-month-old with a reducible hip is inappropriate.", "consequence": "Unnecessary major surgery with significant complication risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Observation only with repeat ultrasound in 6 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Graf Type III** (subluxed/dislocated) requires active treatment, not observation. **Type IIa** (physiologically immature in infants <3 months) may be observed briefly, but Type III represents true pathology. Delaying treatment allows acetabular dysplasia to progress and reduces success rates of non-operative management.", "consequence": "Missed treatment window; worse outcomes.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Pavlik harness** success depends on: (1) **Age <6 months** - after 6 months, soft tissues tighten and harness is less effective; (2) **Reducible hip** - if the hip cannot be reduced with Ortolani, harness won't work; (3) **Proper fitting and compliance**. The main complication to avoid is **avascular necrosis (AVN)** of the femoral head from excessive abduction (forced position). Never force the hip - it should reduce gently."}, "node-4": {"id": "node-4", "type": "decision", "content": "The Pavlik harness is fitted by a pediatric orthopedist. The family receives education on proper use.\n\nFollow-up ultrasound at 2 weeks shows the left hip is **reduced and stable** within the harness.\n\nAt the 6-week follow-up, ultrasound shows:\n- Alpha angle improved to 58\u00b0 (was 48\u00b0)\n- Hip remains reduced\n- Good acetabular remodeling\n\nThe family asks about weaning the harness and long-term prognosis.", "question": "What is the appropriate next step in management and expected prognosis?", "choices": [{"id": "node-4-choice-a", "text": "Continue full-time wear until alpha angle >60\u00b0, then transition to nighttime wear; excellent prognosis with early treatment", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Continue **full-time harness wear** until ultrasound shows adequate acetabular development (**alpha angle >60\u00b0**), typically 6-12 weeks total. Then transition to **nighttime/nap-time wear** for another 6-12 weeks to allow continued remodeling. **Prognosis is excellent** when DDH is diagnosed and treated before 6 months - success rate >90% with Pavlik harness, and most children have normal hip development. Late diagnosis (>1 year) has significantly worse outcomes.", "consequence": "Family understands treatment timeline and favorable prognosis.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Discontinue harness now since hip is reduced; no further follow-up needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Premature harness discontinuation** leads to re-displacement. The goal is not just hip reduction but **acetabular remodeling** (alpha angle >60\u00b0). Even after full-time wear ends, **part-time wear** continues, and children need **long-term follow-up** through skeletal maturity to monitor for residual dysplasia. DDH patients have increased risk of early hip osteoarthritis if undertreated.", "consequence": "High risk of relapse and need for more invasive treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Proceed directly to spica casting since harness didn't achieve alpha >60\u00b0", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The harness is **working** - alpha angle improved from 48\u00b0 to 58\u00b0, and the hip is reduced. Acetabular remodeling takes time. Switching to spica casting at this point would be premature and unnecessarily invasive. Continue harness treatment and monitor for continued improvement. Spica casting is reserved for **treatment failures**, not ongoing successes.", "consequence": "Unnecessarily invasive; harness is succeeding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Switch to abduction brace; Pavlik harness only works for initial reduction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **Pavlik harness** is used for both initial reduction and continued treatment through acetabular remodeling. **Abduction braces** (e.g., Rhino, Ilfeld) may be used after the harness phase or for milder dysplasia, but switching mid-treatment when the harness is working well is not indicated. Continue the successful treatment regimen.", "consequence": "Unnecessary change; current treatment is effective.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Long-term prognosis is poor; child will likely need hip replacement by age 30", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This pessimistic counseling is unwarranted. DDH diagnosed and treated **before 6 months** has **excellent long-term outcomes**. Studies show >95% of children treated early with Pavlik harness have normal or near-normal hips. The risk of early osteoarthritis is primarily in **late-diagnosed** DDH (after walking age). Appropriate reassurance with emphasis on follow-up compliance is key.", "consequence": "Causes unnecessary anxiety; prognosis is actually excellent.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: DDH prognosis depends on **age at diagnosis and treatment**: (1) **<6 months**: >90% success with Pavlik harness; (2) **6-18 months**: may need closed reduction \u00b1 spica cast; (3) **>18 months**: often requires open reduction \u00b1 osteotomy. Follow-up continues through skeletal maturity to detect **residual acetabular dysplasia**, which increases risk of early hip osteoarthritis. **AVN** is the most serious treatment complication - avoid forced abduction."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **DDH** based on positive Ortolani test (hip reduces with abduction clunk) and risk factors (breech, female, family history). You understood that **ultrasound** is preferred imaging in infants <6 months (cartilaginous femoral head invisible on X-ray) and correctly interpreted the Graf angles. You initiated appropriate treatment with **Pavlik harness** and counseled the family about the excellent prognosis with early treatment. This comprehensive approach leads to normal hip development in >90% of cases."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key DDH concepts: (1) **Ortolani** = dislocated hip reduces (clunk on abduction); **Barlow** = hip dislocates with posterior pressure; (2) **Ultrasound <6 months** (cartilaginous head), **X-ray >6 months** (ossified head); (3) **Pavlik harness** is first-line for infants <6 months with reducible hips - success >90% when started early; (4) Long-term follow-up needed through skeletal maturity."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. DDH is a spectrum from mild dysplasia to complete dislocation. **Risk factors**: female, breech, family history, firstborn. **Exam**: Ortolani (reduces dislocated hip), Barlow (dislocates unstable hip), limited abduction (older infants). **Imaging**: ultrasound <6 months, X-ray >6 months. **Treatment**: Pavlik harness <6 months (first-line), closed reduction 6-18 months, open reduction >18 months. **Complications**: AVN from over-abduction, residual dysplasia leading to early OA. Early diagnosis and treatment = excellent outcomes."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-144", "title": "Phenylketonuria (PKU)", "domain": "newborn", "difficulty": "intermediate", "tags": ["musty odor", "fair skin/hair", "intellectual disability if untreated", "newborn screening", "phenylalanine hydroxylase", "maternal PKU syndrome", "phenylalanine-restricted diet", "phenylketonuria (pku)"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 10-day-old female is brought to the metabolic clinic after her pediatrician received an abnormal newborn screening result.\n\nHistory:\n- Full-term delivery via uncomplicated vaginal birth\n- Birth weight 3.4 kg, currently 3.5 kg (appropriate weight gain)\n- Breastfeeding well, no vomiting or poor feeding\n- Alert and active, meeting newborn milestones\n- No unusual body odor noted by parents\n- No family history of metabolic disorders\n- Parents are non-consanguineous\n\nNewborn Screening Result (collected at 48 hours of life):\n- **Phenylalanine: 485 \u03bcmol/L** (normal <120 \u03bcmol/L)\n- All other metabolites normal\n\nPhysical Examination:\n- General: Alert, well-appearing newborn with normal activity\n- Vitals: Normal for age\n- Skin: Normal pigmentation (brown hair, olive skin like parents)\n- HEENT: Normal\n- Neurologic: Normal tone, normal primitive reflexes (Moro, suck, grasp)\n- No unusual odor detected", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This newborn has **markedly elevated phenylalanine** on newborn screening (>4x upper limit of normal) but is currently **asymptomatic**. This is the expected presentation when PKU is detected through screening.\n\n**Key points about newborn screening for PKU:**\n- Newborn screening was developed specifically to detect PKU before symptoms appear\n- Without treatment, symptoms develop gradually over **first months of life**\n- Early treatment prevents **irreversible intellectual disability**\n- This baby looks normal NOW because damage hasn't occurred yet", "question": "What is the MOST likely diagnosis based on the elevated phenylalanine level?", "choices": [{"id": "node-1-choice-a", "text": "Phenylketonuria (PKU)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Phenylketonuria (PKU)** is the most likely diagnosis. PKU is caused by deficiency of **phenylalanine hydroxylase (PAH)**, the enzyme that converts phenylalanine to tyrosine. This results in:\n\n- **Elevated phenylalanine** (accumulates)\n- **Low tyrosine** (cannot be synthesized)\n\n**Key facts about PKU:**\n- **Most common amino acid disorder** (~1:10,000-15,000)\n- **Autosomal recessive** inheritance\n- Newborn screening has made this a **success story** - early treatment prevents intellectual disability\n- The baby appears **normal at birth** because maternal metabolism cleared phenylalanine during pregnancy\n- Without treatment: Irreversible intellectual disability, seizures, behavioral problems", "consequence": "You recognize PKU detected by newborn screening.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Maple syrup urine disease (MSUD)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **MSUD** is caused by deficiency of branched-chain \u03b1-ketoacid dehydrogenase, leading to accumulation of **leucine, isoleucine, and valine** (NOT phenylalanine). MSUD presents with: (1) **Sweet/maple syrup odor** to urine and cerumen, (2) Elevated **branched-chain amino acids** on screening, (3) **Encephalopathy** in the first week of life (more acute than PKU). This baby has elevated **phenylalanine** only, consistent with PKU.", "consequence": "MSUD affects branched-chain amino acids, not phenylalanine.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Tyrosinemia type 1", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Tyrosinemia type 1** is caused by deficiency of fumarylacetoacetate hydrolase (FAH), leading to accumulation of **tyrosine** and toxic metabolites. Key features: (1) **Elevated tyrosine** (not phenylalanine) on newborn screening, (2) **Liver dysfunction** (hepatomegaly, coagulopathy, elevated AFP), (3) **Cabbage-like odor**. In PKU, tyrosine is actually **LOW** (cannot be synthesized from phenylalanine).", "consequence": "Tyrosinemia elevates tyrosine, not phenylalanine.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Transient hyperphenylalaninemia (benign)", "isOptimal": false, "isAcceptable": true, "feedback": "Transient hyperphenylalaninemia is in the differential, but this baby's phenylalanine level of **485 \u03bcmol/L is too high** for benign transient elevation. Transient hyperphenylalaninemia is typically **mild** (<360 \u03bcmol/L) and resolves spontaneously. However, you should proceed with confirmatory testing - plasma amino acids will help differentiate. Until confirmation, this elevated level should be treated as **presumed PKU** given the risk of brain damage.", "consequence": "The level is too high for benign transient elevation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "False positive - no further workup needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **DANGEROUS**! **Never dismiss an abnormal newborn screen as false positive without confirmation**. While false positives occur, the phenylalanine level of 485 \u03bcmol/L is **markedly elevated** (>4x normal). The consequence of missing PKU is **irreversible intellectual disability**. All abnormal newborn screens require **confirmatory testing** - typically plasma amino acid analysis.", "consequence": "Never dismiss elevated phenylalanine without confirmation!", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**PKU newborn screening success**: Before newborn screening, PKU caused intellectual disability in ~1:10,000 births. Now, with early detection and treatment, affected children can have **normal intelligence**. PKU is the reason newborn screening exists!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You order confirmatory testing:\n\n**Plasma Amino Acids:**\n- Phenylalanine: **520 \u03bcmol/L** (elevated, confirms screening result)\n- Tyrosine: **28 \u03bcmol/L** (LOW - normal 45-100 \u03bcmol/L)\n- Phe:Tyr ratio: **18.5** (elevated - normal <2)\n- All other amino acids normal\n\n**Additional testing:**\n- Urine pterins: Normal (rules out BH4 deficiency)\n- Dihydropteridine reductase (DHPR) activity: Normal\n\nThese results confirm **classic PKU** (severe PAH deficiency) rather than a BH4 cofactor defect.", "question": "What is the UNDERLYING BIOCHEMICAL DEFECT in phenylketonuria?", "choices": [{"id": "node-2-choice-a", "text": "Deficiency of phenylalanine hydroxylase (PAH), preventing conversion of phenylalanine to tyrosine", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Phenylalanine hydroxylase (PAH) deficiency** is the underlying defect in PKU.\n\n**Biochemistry:**\n- PAH converts **phenylalanine \u2192 tyrosine** (requires BH4 cofactor)\n- Without PAH: Phenylalanine accumulates \u2192 **toxic to developing brain**\n- Tyrosine becomes an **essential amino acid** (cannot synthesize it)\n\n**Why low tyrosine matters:**\n- Tyrosine is precursor for **melanin** (\u2192 fair skin/hair)\n- Tyrosine is precursor for **dopamine, norepinephrine** (neurotransmitters)\n- Tyrosine is precursor for **thyroid hormone**\n\n**Why elevated phenylalanine is toxic:**\n- Phenylalanine competes with other amino acids for brain uptake\n- Phenylalanine metabolites (phenylpyruvate, phenylacetate) cause **musty odor** and are neurotoxic\n- Exact mechanism of brain damage not fully understood but involves impaired myelination", "consequence": "You understand the enzymatic defect in PKU.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Deficiency of tyrosinase, preventing melanin synthesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Tyrosinase deficiency** causes **oculocutaneous albinism**, not PKU. In albinism, tyrosine is present but cannot be converted to melanin. In PKU, the problem is one step earlier: phenylalanine cannot be converted to tyrosine. PKU patients have **reduced** melanin (due to low tyrosine), but this is secondary to the PAH defect, not due to tyrosinase deficiency.", "consequence": "Tyrosinase deficiency causes albinism, not PKU.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Deficiency of tetrahydrobiopterin (BH4) synthesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for **classic PKU**, though this is an important consideration. **BH4 deficiency** can cause hyperphenylalaninemia because BH4 is a cofactor for PAH. However, the urine pterin and DHPR results were **normal** in this patient, ruling out BH4 defects. BH4 deficiency is important to exclude because it also affects **neurotransmitter synthesis** and requires different treatment (BH4 supplementation + neurotransmitter precursors, not just diet).", "consequence": "Normal pterins rule out BH4 deficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Deficiency of branched-chain \u03b1-ketoacid dehydrogenase", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Branched-chain \u03b1-ketoacid dehydrogenase deficiency** causes **maple syrup urine disease (MSUD)**, not PKU. This enzyme is needed to metabolize **leucine, isoleucine, and valine** (branched-chain amino acids). MSUD presents with elevated branched-chain amino acids, sweet odor, and acute encephalopathy. PKU involves phenylalanine metabolism, not branched-chain amino acid metabolism.", "consequence": "This enzyme deficiency causes MSUD, not PKU.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Deficiency of homogentisate oxidase", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Homogentisate oxidase deficiency** causes **alkaptonuria** (also called ochronosis). In alkaptonuria, homogentisic acid accumulates (from tyrosine metabolism) and causes: (1) **Dark urine** when exposed to air, (2) **Ochronosis** (pigmentation of cartilage), (3) **Early-onset arthritis**. Alkaptonuria does NOT cause elevated phenylalanine or intellectual disability.", "consequence": "Homogentisate oxidase deficiency causes alkaptonuria.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Always test for BH4 defects** in hyperphenylalaninemia! BH4 is a cofactor for PAH and also for tyrosine hydroxylase (dopamine synthesis) and tryptophan hydroxylase (serotonin synthesis). BH4 defects need different treatment than classic PKU."}, "node-3": {"id": "node-3", "type": "decision", "content": "You diagnose classic PKU. The metabolic team meets urgently with the family to initiate treatment.\n\n**Treatment principles:**\n- Goal: Keep phenylalanine levels in safe range (**120-360 \u03bcmol/L**)\n- Treatment must begin **as early as possible** (ideally within first 2 weeks of life)\n- Treatment is **lifelong** (relaxation in adolescence was abandoned after studies showed cognitive decline)\n\nThe parents ask what the treatment involves.", "question": "What is the CORNERSTONE of PKU treatment?", "choices": [{"id": "node-3-choice-a", "text": "Lifelong phenylalanine-restricted diet with medical formula supplementation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **phenylalanine-restricted diet** is the cornerstone of PKU treatment and has been used successfully since the 1950s.\n\n**Diet components:**\n- **Restrict** high-protein foods (meat, fish, eggs, dairy, nuts, beans) - these contain phenylalanine\n- **Allow** low-protein foods (fruits, vegetables, some grains)\n- **Medical formula**: Provides all essential amino acids EXCEPT phenylalanine, plus vitamins, minerals, and calories\n- **Small amounts of phenylalanine**: Required because it IS an essential amino acid - complete elimination is harmful\n\n**Monitoring:**\n- Regular blood phenylalanine levels (initially weekly, then monthly)\n- Target: **120-360 \u03bcmol/L** (some guidelines use lower targets)\n- Growth, development, and nutritional status monitoring\n\n**Treatment is LIFELONG** - studies show cognitive decline and psychiatric problems when diet is relaxed in adulthood.", "consequence": "You initiate the correct treatment.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Complete elimination of all protein from the diet", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **HARMFUL**! Complete protein elimination would cause **protein malnutrition** and would also eliminate phenylalanine entirely, which is actually **required for growth** (it's an essential amino acid). The goal is **restriction**, not elimination - patients need some phenylalanine, just at controlled levels. PKU diet requires careful balance: enough phenylalanine for growth but not enough to cause brain damage.", "consequence": "Complete protein elimination causes malnutrition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Tyrosine supplementation alone without dietary restriction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **tyrosine supplementation** is part of PKU management (via medical formula), it is **not sufficient alone**. The primary problem is **elevated phenylalanine toxicity**, not just tyrosine deficiency. If phenylalanine is not restricted, it will continue to accumulate and cause brain damage regardless of tyrosine levels. Diet restriction to reduce phenylalanine is essential.", "consequence": "Tyrosine supplementation alone doesn't prevent phenylalanine toxicity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Liver transplantation as first-line treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **liver transplantation** would theoretically cure PKU (the liver has PAH), it is **not first-line treatment** due to: (1) Surgical risks and mortality, (2) Lifelong immunosuppression, (3) Excellent outcomes with dietary management. Liver transplant might be considered for patients who cannot adhere to diet or have other indications, but it is rare. Diet is the standard of care.", "consequence": "Liver transplant is not first-line due to risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Wait until symptoms appear, then begin treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **DANGEROUS**! By the time symptoms appear (developmental delay, seizures, behavioral problems), **irreversible brain damage has already occurred**. The entire purpose of newborn screening is to detect PKU **before symptoms develop** so that treatment can prevent brain damage. Treatment should begin **immediately** upon diagnosis, ideally within the first 2 weeks of life.", "consequence": "Waiting causes irreversible brain damage!", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**PKU formula**: The 'medical food' used in PKU provides all amino acids EXCEPT phenylalanine, plus tyrosine (which becomes essential), vitamins, and minerals. It's the primary protein source for PKU patients - natural protein intake is severely limited."}, "node-4": {"id": "node-4", "type": "decision", "content": "You initiate a phenylalanine-restricted diet with PKU medical formula. The family asks about long-term prognosis and what happens during pregnancy.\n\nYou learn that the mother is already thinking ahead - she was diagnosed with PKU as a newborn and has been on dietary therapy her whole life. She wonders if her diet management during this pregnancy was adequate.\n\n**Maternal PKU syndrome** is a critical concept.", "question": "A woman with PKU who becomes pregnant and does NOT control her phenylalanine levels - what is the risk to the fetus?", "choices": [{"id": "node-4-choice-a", "text": "Teratogenic effects including microcephaly, intellectual disability, and congenital heart defects - even if the fetus does NOT have PKU", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Maternal PKU syndrome** is a devastating but **preventable** condition.\n\n**What happens:**\n- High maternal phenylalanine crosses the placenta\n- The fetus concentrates phenylalanine to **1.5-2x maternal levels**\n- Elevated phenylalanine is **teratogenic** to the developing fetus\n\n**Effects on the fetus (even if fetus does NOT have PKU):**\n- **Microcephaly** (>90%)\n- **Intellectual disability** (>90%)\n- **Congenital heart defects** (~15%)\n- **Intrauterine growth restriction**\n- **Facial dysmorphism**\n\n**Prevention:**\n- **Strict phenylalanine control BEFORE conception** (target <360 \u03bcmol/L)\n- Maintain control throughout pregnancy\n- Women with PKU need **preconception counseling**\n\nThis is why PKU diet is now recommended for **life**, not just childhood - women need to be able to resume strict control before pregnancy.", "consequence": "You counsel about maternal PKU syndrome.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "No risk - phenylalanine does not cross the placenta", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **factually wrong**! Phenylalanine **freely crosses the placenta** and actually **concentrates in the fetus** to levels 1.5-2x higher than maternal blood. This makes maternal hyperphenylalaninemia extremely dangerous to the developing fetus. Maternal PKU syndrome causes severe birth defects even in fetuses who do not have PKU themselves.", "consequence": "Phenylalanine crosses the placenta and concentrates in the fetus!", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Risk only if the fetus also inherits two PKU alleles", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Maternal PKU syndrome affects the fetus regardless of the fetus's genotype**. Even a genetically normal fetus (no PKU) will be damaged by exposure to the mother's elevated phenylalanine during development. The fetus doesn't need to have PKU - the damage comes from the **intrauterine environment**, not the fetus's own enzyme function. This is a teratogenic effect, not a genetic one.", "consequence": "Damage occurs regardless of fetal genotype.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Risk is eliminated if the mother takes prenatal vitamins", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prenatal vitamins do NOT protect against maternal PKU syndrome**. The damage is caused by elevated phenylalanine itself, not by vitamin deficiency. While prenatal vitamins are important for all pregnancies, they cannot counteract the teratogenic effects of hyperphenylalaninemia. The ONLY way to prevent maternal PKU syndrome is **strict phenylalanine control** before and during pregnancy.", "consequence": "Vitamins don't prevent phenylalanine teratogenicity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Risk only in the third trimester when the brain is fully developed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The teratogenic effects of maternal hyperphenylalaninemia occur **throughout pregnancy**, but the **first trimester is most critical** for cardiac development and organogenesis. Microcephaly and brain damage occur from ongoing exposure throughout gestation. Control must be achieved **BEFORE conception** (preconception target <360 \u03bcmol/L) and maintained throughout the entire pregnancy.", "consequence": "Damage occurs throughout pregnancy, especially first trimester.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Maternal PKU syndrome is 100% preventable**: Women with PKU who maintain strict phenylalanine control (<360 \u03bcmol/L) before conception and throughout pregnancy have **normal pregnancy outcomes**. Preconception counseling is essential for all women with PKU."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **Phenylketonuria (PKU)**.\n\n**Key takeaways:**\n- **Most common amino acid disorder** (~1:10,000-15,000)\n- **Newborn screening success story** - early treatment prevents intellectual disability\n- **Defect**: Phenylalanine hydroxylase (PAH) deficiency \u2192 can't convert Phe to Tyr\n- **Labs**: Elevated phenylalanine, low tyrosine, elevated Phe:Tyr ratio\n- **Always test for BH4 defects** (different treatment needed)\n\n**Treatment:**\n- **Lifelong phenylalanine-restricted diet** + medical formula\n- Target Phe: 120-360 \u03bcmol/L\n- Diet is FOR LIFE (not just childhood)\n\n**Untreated PKU features** (historical, now rare due to screening):\n- Intellectual disability, seizures\n- Musty/mousy body odor (phenylacetate)\n- Fair skin/hair (low tyrosine \u2192 low melanin)\n- Eczema, behavioral problems\n\n**Maternal PKU:**\n- Uncontrolled maternal Phe \u2192 fetal damage even if fetus doesn't have PKU\n- Microcephaly, intellectual disability, heart defects\n- Prevention: Strict control BEFORE conception"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **Phenylketonuria (PKU)**:\n\n- **Defect**: Phenylalanine hydroxylase deficiency\n- **Labs**: High Phe, low Tyr, high Phe:Tyr ratio\n- **Rule out BH4 defects** (urine pterins, DHPR activity)\n- **Treatment**: Phenylalanine-restricted diet + medical formula (LIFELONG)\n- **NOT**: Complete protein elimination (causes malnutrition)\n- **NOT**: Tyrosine alone (doesn't prevent Phe toxicity)\n\n**Untreated features** (musty odor, fair features, intellectual disability)\n\n**Maternal PKU**: Uncontrolled Phe damages fetus even if fetus doesn't have PKU - strict control needed BEFORE conception."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in PKU management!\n\n**Never do:**\n- **Dismiss abnormal newborn screen** as false positive without confirmation\n- **Wait for symptoms** - brain damage is irreversible\n- **Completely eliminate protein** - Phe is essential, just needs restriction\n- **Assume maternal Phe doesn't affect fetus** - it crosses placenta and concentrates\n\n**Always do:**\n- **Confirm with plasma amino acids** before treatment\n- **Start treatment IMMEDIATELY** (within first 2 weeks of life)\n- **Test for BH4 defects** (different treatment needed)\n- **Counsel women with PKU** about preconception Phe control\n\n**PKU is the reason newborn screening exists** - early detection and treatment allows normal intelligence in affected children."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-149", "title": "Neonatal Abstinence Syndrome", "domain": "newborn", "difficulty": "advanced", "tags": ["high-pitched cry", "tremors", "excessive sneezing", "Finnegan score", "maternal opioid use", "methadone", "morphine", "breastfeeding NAS"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 2-day-old male born at 38 weeks is in the well-baby nursery. The nurses report increasing irritability over the past 12 hours.\n\nThe infant has a high-pitched, inconsolable cry. He is tremulous when handled, has difficulty latching during feeds, and has had multiple loose stools. The nurses also note excessive sneezing, yawning, and sweating.\n\nMaternal history reveals she has been on methadone maintenance therapy (80mg daily) for opioid use disorder throughout pregnancy. She had limited prenatal care.\n\nPhysical Examination:\n- General: small for gestational age (weight 2400g, <10th percentile), extremely irritable with high-pitched cry, tremors at rest that worsen with stimulation\n- Vitals: HR 170, RR 60, Temp 37.8\u00b0C\n- Skin: mottled, diaphoretic, excoriations on chin and knees from excessive movement\n- Neuro: increased muscle tone, hyperactive Moro reflex, exaggerated suck reflex\n- GI: hyperactive bowel sounds", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-day-old has signs of CNS hyperexcitability (tremors, high-pitched cry, irritability), autonomic dysfunction (sweating, sneezing, tachycardia), and GI disturbance (poor feeding, loose stools). Mother has a history of opioid use disorder on methadone.", "question": "What is the MOST likely diagnosis, and what critical condition must be ruled out?", "choices": [{"id": "node-1-choice-a", "text": "Neonatal Abstinence Syndrome (NAS) - but must rule out sepsis first", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The constellation of **CNS hyperexcitability + autonomic dysfunction + GI symptoms** in a neonate with maternal opioid exposure is classic for **Neonatal Abstinence Syndrome (NAS)**. However, **sepsis must ALWAYS be ruled out** because symptoms overlap (irritability, temperature instability, poor feeding). A sepsis evaluation should be considered before attributing all symptoms to NAS.", "consequence": "You recognize NAS while maintaining diagnostic vigilance.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Neonatal sepsis - the irritability and temperature indicate infection", "isOptimal": false, "isAcceptable": true, "feedback": "Sepsis is an important consideration and should be ruled out, but this presentation is **more consistent with NAS**. The maternal opioid history, specific symptom constellation (sneezing, high-pitched cry, tremors worsening with stimulation), and onset timing (48 hours) fit NAS better. Sepsis typically has **more lethargy** than hyperexcitability, and lacks the characteristic sneezing/sweating.", "consequence": "Sepsis workup done but NAS recognition delayed.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Hypoglycemia - explains the tremors and irritability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hypoglycemia can cause tremors and irritability, it does NOT explain: the high-pitched cry, excessive sneezing, diaphoresis, hyperactive bowel sounds, or skin excoriations. Hypoglycemic infants are typically **jittery but not hyperexcitable** with the full NAS constellation. Always check glucose, but this is not the primary diagnosis.", "consequence": "Glucose checked; still missing primary diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Neonatal hyperthyroidism - explains tachycardia and irritability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Neonatal hyperthyroidism can cause irritability and tachycardia, but typically presents with: **goiter, exophthalmos, and maternal history of Graves disease**. The sneezing, high-pitched cry, and maternal opioid history make NAS far more likely. Thyroid studies are not indicated here without other suggestive findings.", "consequence": "Unnecessary thyroid workup delays appropriate care.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Intracranial hemorrhage - explains the irritability and high-pitched cry", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While intracranial hemorrhage can cause irritability and high-pitched cry, it typically presents with: **bulging fontanelle, seizures, focal neurologic deficits, and altered consciousness**. This infant has no focal findings, and the symptom pattern (sneezing, sweating, GI symptoms) is characteristic of NAS, not CNS bleeding.", "consequence": "Unnecessary imaging; NAS recognition delayed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NAS symptom triad**: (1) **CNS hyperexcitability** - tremors, high-pitched cry, irritability, increased tone, hyperactive reflexes; (2) **Autonomic dysfunction** - sneezing, yawning, sweating, fever, mottling; (3) **GI disturbance** - poor feeding, vomiting, diarrhea, excessive sucking. **ALWAYS rule out sepsis** - symptoms overlap!"}, "node-2": {"id": "node-2", "type": "decision", "content": "Glucose is 65 mg/dL (normal). Given the maternal methadone history and classic presentation, you suspect NAS.\n\nYou need to assess severity to guide management. The Finnegan Neonatal Abstinence Scoring System is the most widely used tool.", "question": "What is the Finnegan scoring system, and when does it indicate pharmacologic treatment?", "choices": [{"id": "node-2-choice-a", "text": "Standardized scoring of NAS symptoms every 3-4 hours; scores \u22658 on 3 consecutive assessments indicate need for pharmacotherapy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **Finnegan score** assesses 21 items across CNS, metabolic, GI, and respiratory domains. It's performed **every 3-4 hours** (or 2 hours after feeding for accuracy). **Scores \u22658 on 3 consecutive assessments** (or 2 consecutive scores \u226512) typically indicate need for **pharmacologic treatment**. Scoring guides both initiation and weaning of therapy.", "consequence": "You begin systematic Finnegan scoring.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "A one-time assessment done at birth to predict withdrawal severity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Finnegan scoring is NOT a one-time assessment. NAS symptoms **evolve over time** (onset 24-72h for short-acting opioids, up to 5-7 days for methadone). **Serial scoring every 3-4 hours** is essential to track symptom progression and guide treatment adjustments. A single score is insufficient.", "consequence": "Inadequate monitoring misses symptom escalation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Drug testing that determines which substance caused withdrawal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Finnegan is a **clinical scoring system**, not a drug test. While drug testing (urine, meconium, umbilical cord) can identify substances, the **Finnegan score assesses symptom severity** to guide treatment. Drug testing confirms exposure; Finnegan guides management.", "consequence": "Confusion between diagnosis and severity assessment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Any score >0 indicates immediate need for morphine treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Low Finnegan scores are managed with **non-pharmacologic care alone**. Only scores **\u22658 on 3 consecutive assessments** indicate pharmacotherapy. Many infants with NAS (40-60%) can be managed with supportive care only. Over-treating with opioids prolongs hospitalization unnecessarily.", "consequence": "Unnecessary pharmacotherapy initiated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Scoring is only needed if the infant has seizures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Seizures are a **severe, late manifestation** of NAS (occurring in <5%). Waiting for seizures means missing the opportunity for early intervention. Finnegan scoring should begin for **all at-risk infants** (maternal opioid exposure) regardless of initial symptoms.", "consequence": "Delayed recognition leads to severe withdrawal.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Finnegan scoring essentials**: 21 items scored **every 3-4 hours**. Treatment threshold: **\u22658 on 3 consecutive scores** OR **\u226512 on 2 consecutive scores**. Onset timing varies: **short-acting opioids** \u2192 24-72h; **methadone** \u2192 48-72h (can be up to 5-7 days). **50-80%** of opioid-exposed infants develop NAS, but only **40-60%** require pharmacotherapy."}, "node-3": {"id": "node-3", "type": "decision", "content": "Serial Finnegan scores are: 6, 7, 9, 10, 11 over the first 24 hours of monitoring. The last three scores are \u22658. Non-pharmacologic measures (swaddling, dim lighting, quiet environment, frequent small feeds) have been implemented but symptoms persist.", "question": "What is the FIRST-LINE pharmacologic treatment for opioid-related NAS?", "choices": [{"id": "node-3-choice-a", "text": "Oral morphine solution - replace the opioid the infant is withdrawing from", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Oral morphine** (or methadone) is first-line for **opioid-related NAS**. The principle is **replacing the substance causing withdrawal** then gradually weaning. Morphine is preferred for its short half-life allowing easier dose titration. Typical starting dose is **0.04-0.1 mg/kg every 3-4 hours**, titrated based on Finnegan scores.", "consequence": "Morphine initiated with symptom improvement.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Phenobarbital as monotherapy for all NAS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as first-line for **opioid NAS**. Phenobarbital is an **adjunct** agent used when: (1) opioid therapy alone is insufficient, (2) there is **polysubstance exposure** (especially benzodiazepines, barbiturates), or (3) for sedative-hypnotic withdrawal. For pure opioid NAS, **opioid replacement** (morphine/methadone) is first-line.", "consequence": "Suboptimal control of opioid withdrawal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Clonidine as primary treatment", "isOptimal": false, "isAcceptable": true, "feedback": "Clonidine is an **adjunctive agent** that can reduce opioid dose requirements by addressing autonomic symptoms (\u03b12-agonist). Some centers use it as adjunct therapy, but it is **not first-line monotherapy** for NAS. Morphine or methadone remains the primary treatment for opioid withdrawal.", "consequence": "Partial symptom control; opioid still needed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Naloxone to reverse opioid effects", "isOptimal": false, "isAcceptable": false, "feedback": "**DANGEROUS!** Naloxone is **absolutely contraindicated** in NAS. These infants are in **withdrawal** (too LITTLE opioid effect), not intoxication. Giving an opioid antagonist would **precipitate severe, potentially fatal withdrawal** including seizures. Naloxone is the opposite of what's needed.", "consequence": "Precipitated severe withdrawal - potentially fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Benzodiazepines (lorazepam) for sedation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Benzodiazepines do not address the underlying **opioid withdrawal**. They may sedate the infant but don't treat the pathophysiology. Additionally, benzodiazepines carry risks of respiratory depression and are not standard NAS therapy. **Opioid replacement** is the correct approach.", "consequence": "Sedation without treating withdrawal.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NAS pharmacotherapy principle**: Replace what's causing withdrawal! **Opioid NAS** \u2192 opioid (morphine/methadone). **Polysubstance/sedative** \u2192 add phenobarbital. **Adjuncts**: clonidine (autonomic symptoms). **NEVER give naloxone** - precipitates severe withdrawal! Typical morphine: **0.04-0.1 mg/kg q3-4h**, titrate to Finnegan <8."}, "node-4": {"id": "node-4", "type": "decision", "content": "Morphine 0.05 mg/kg every 4 hours is started. The mother asks about breastfeeding. She has been compliant with her methadone program, is HIV-negative, and is not using illicit substances.", "question": "What is the recommendation regarding breastfeeding in mothers on methadone or buprenorphine maintenance?", "choices": [{"id": "node-4-choice-a", "text": "Breastfeeding is ENCOURAGED if mother is on stable methadone/buprenorphine, HIV-negative, and not using illicit drugs", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Breastfeeding is encouraged** for mothers on stable **methadone or buprenorphine maintenance** therapy who are: (1) HIV-negative, (2) not using illicit substances, (3) engaged in treatment. Benefits: minimal drug transfer in breast milk, **reduced NAS severity**, shorter treatment duration, improved bonding. AAP supports breastfeeding in this population.", "consequence": "Mother encouraged to breastfeed; NAS symptoms improve.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Breastfeeding is absolutely contraindicated with any opioid exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is **outdated guidance**. Methadone and buprenorphine transfer minimally into breast milk (infant receives <2% of maternal dose). Studies show **breastfeeding REDUCES NAS severity** and shortens hospital stay. The benefits of breastfeeding outweigh minimal drug exposure in stable, treated mothers.", "consequence": "Mother denied beneficial breastfeeding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Formula feeding is preferred to avoid any drug transfer", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Formula feeding is NOT preferred. **Breastfeeding is associated with**: less severe NAS, shorter hospital stays, reduced pharmacotherapy needs, and better maternal-infant bonding. The small amount of methadone/buprenorphine in breast milk may actually **ease withdrawal** gradually. Formula should be used only if breastfeeding is contraindicated.", "consequence": "Missed opportunity for NAS mitigation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Breastfeeding is only safe with buprenorphine, not methadone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Both methadone and buprenorphine** are compatible with breastfeeding in stable, treated mothers. While buprenorphine has even lower milk transfer than methadone, both result in negligible infant exposure. The AAP and ACOG support breastfeeding with either medication when criteria are met.", "consequence": "Methadone-maintained mothers incorrectly excluded.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Mother should stop methadone before breastfeeding", "isOptimal": false, "isAcceptable": false, "feedback": "**DANGEROUS!** Stopping methadone would cause **maternal relapse** and possible return to illicit opioid use (with much higher infant exposure if breastfeeding, plus overdose risk). Methadone maintenance is the **standard of care** for opioid use disorder in pregnancy and postpartum. Never discontinue for breastfeeding purposes.", "consequence": "Maternal relapse and destabilization.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Breastfeeding in NAS**: ENCOURAGED if mother is on **stable methadone/buprenorphine**, HIV-negative, no illicit drug use. Benefits: **reduces NAS severity**, shorter hospitalization, better bonding, minimal drug transfer (~1-2% of maternal dose). **Contraindications**: HIV+, active illicit drug use, unstable in treatment. Breastfed infants have **less need for pharmacotherapy**."}, "node-5": {"id": "node-5", "type": "decision", "content": "Over the next week, morphine is titrated based on Finnegan scores. Peak dose was 0.08 mg/kg q4h. Now scores have been consistently <8 for 48 hours. The infant is feeding well, gaining weight, and symptoms have resolved.\n\nYou plan to wean the morphine and prepare for discharge.", "question": "What is the appropriate approach to weaning pharmacotherapy and discharge planning in NAS?", "choices": [{"id": "node-5-choice-a", "text": "Gradual wean (10-20% every 24-48h), observe 24-48h after last dose, ensure safe discharge environment with follow-up", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Weaning protocol**: decrease dose by **10-20% every 24-48 hours** as tolerated (Finnegan <8). After discontinuation, **observe 24-48 hours** for rebound withdrawal. **Discharge requirements**: (1) stable off medications for 24-48h, (2) safe home environment assessed by social work, (3) developmental follow-up arranged, (4) close outpatient monitoring. Average NAS hospitalization: **15-20 days** if pharmacotherapy required.", "consequence": "Successful wean and safe discharge.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Stop morphine abruptly once scores are <8", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Abrupt discontinuation** risks **rebound withdrawal** with return of severe symptoms. Even after stabilization, the infant remains physiologically dependent. **Gradual weaning** (10-20% dose reduction every 1-2 days) allows the nervous system to adjust and prevents symptom recurrence.", "consequence": "Rebound withdrawal after abrupt stop.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Discharge immediately after last morphine dose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Infants need **24-48 hours of observation** after the last dose to ensure no rebound withdrawal occurs. Discharging immediately risks readmission for withdrawal symptoms that may emerge after medication clearance. Observation period is standard of care.", "consequence": "Readmission for rebound withdrawal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Continue morphine at home with parent administration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Outpatient opioid administration** for NAS is not standard practice due to safety concerns (dosing errors, respiratory depression, diversion). Infants should complete their wean **in the hospital** under medical supervision. Some centers are exploring Eat, Sleep, Console protocols with shorter stays, but home opioids are not routine.", "consequence": "Safety risk with home opioid administration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "No follow-up needed if infant is asymptomatic at discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Long-term follow-up is essential**. NAS infants are at risk for: (1) **developmental delays** (motor, cognitive, language), (2) behavioral issues, (3) vision/hearing problems, (4) ongoing social/environmental risks. Developmental surveillance, early intervention referrals, and close pediatric follow-up are critical.", "consequence": "Developmental delays missed without follow-up.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NAS discharge checklist**: (1) **Wean gradually** (10-20%/day), (2) **Observe 24-48h** post-last dose, (3) **Safe environment** verified by social work, (4) **Follow-up** arranged (pediatrician, developmental, early intervention). **Long-term outcomes**: increased risk of developmental delay, ADHD, behavioral issues - close follow-up essential. Average hospital stay with pharmacotherapy: **15-20 days**."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized NAS, used Finnegan scoring to guide therapy, initiated appropriate opioid replacement, encouraged breastfeeding, and ensured safe weaning and discharge.\n\n**Key teaching points:**\n\u2022 **NAS triad**: CNS hyperexcitability + autonomic dysfunction + GI symptoms\n\u2022 **Always rule out sepsis** - symptoms overlap\n\u2022 **Finnegan scoring** every 3-4 hours; treat if \u22658 on 3 consecutive scores\n\u2022 **First-line treatment**: oral morphine (or methadone) - replace what's causing withdrawal\n\u2022 **NEVER give naloxone** - precipitates severe withdrawal\n\u2022 **Breastfeeding encouraged** if mother on stable methadone/buprenorphine, HIV-, no illicit use\n\u2022 **Gradual wean** (10-20%/day), observe 24-48h post-last dose\n\u2022 **Long-term follow-up** essential for developmental surveillance"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review NAS key principles:\n\n\u2022 **Symptoms**: CNS (tremors, high-pitched cry, irritability) + Autonomic (sneezing, sweating) + GI (poor feeding, diarrhea)\n\u2022 **Finnegan scoring**: every 3-4 hours, treat if \u22658 on 3 consecutive scores\n\u2022 **Treatment**: opioid replacement (morphine/methadone) for opioid NAS\n\u2022 **Breastfeeding**: ENCOURAGED if mother stable on MAT, HIV-, no illicit use\n\u2022 **Weaning**: gradual 10-20%/day, observe 24-48h after last dose\n\u2022 **Follow-up**: developmental surveillance essential"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management errors occurred. Review dangerous pitfalls:\n\n\u2022 **NEVER give naloxone** - these infants are in WITHDRAWAL, not intoxication; naloxone precipitates severe, potentially fatal withdrawal\n\u2022 **NEVER abruptly stop opioid therapy** - causes rebound withdrawal\n\u2022 **NEVER advise stopping methadone maintenance** for breastfeeding - causes maternal relapse\n\u2022 **Seizures indicate SEVERE withdrawal** - don't wait for seizures to treat\n\u2022 **Sepsis must be ruled out** - symptoms overlap with NAS\n\nKey pearl: NAS treatment principle is REPLACEMENT then gradual WEANING - not reversal or abrupt cessation."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-153", "title": "Group B Streptococcus (GBS) Prophylaxis", "domain": "newborn", "difficulty": "intermediate", "tags": ["GBS screening", "intrapartum antibiotic prophylaxis", "adequate prophylaxis", "early-onset sepsis", "neonatal meningitis", "ampicillin gentamicin", "group b streptococcus (gbs) prophylaxis"], "estimatedMinutes": 7, "source": ["NBME"], "stem": "You are the pediatrician on call when you receive a call from Labor and Delivery about an infant about to be delivered.\n\n**Labor and Delivery Report:**\n\"We have a 28-year-old G2P1 at 39 weeks in active labor. Her GBS screen at 36 weeks was positive. She arrived at the hospital 2 hours ago and we just started IV penicillin G. Membranes ruptured 30 minutes ago. She's 8 cm dilated and progressing quickly - delivery expected within the next 1-2 hours. She has no fever and no penicillin allergy.\"\n\nThe nurse asks: \"The mother only received one dose of penicillin about 1.5 hours ago. What's our plan for managing this baby after delivery since she won't get the full 4 hours of antibiotic prophylaxis?\"\n\nYou need to understand GBS prophylaxis guidelines and determine appropriate newborn management.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You review the **GBS prophylaxis guidelines** and definitions.\n\n**Group B Streptococcus (GBS) - Background:**\n- **Streptococcus agalactiae** - gram-positive coccus, normal vaginal/rectal flora in 10-30% of women\n- Leading cause of **early-onset neonatal sepsis** (within first 7 days of life)\n- Transmitted from colonized mother to infant during delivery\n- Intrapartum antibiotic prophylaxis (IAP) has **reduced early-onset GBS disease by 80%**\n\n**Universal GBS Screening:**\n- **ALL pregnant women** screened at **36 0/7 - 37 6/7 weeks** (updated from 35-37)\n- **Vaginal-rectal swab** culture (NOT cervical)\n- Culture results valid for **5 weeks**\n- If unknown status at delivery \u2192 treat based on risk factors\n\n**Indications for Intrapartum Antibiotic Prophylaxis:**\n1. **Positive GBS culture** this pregnancy\n2. **GBS bacteriuria** (any colony count) this pregnancy\n3. **Previous infant with invasive GBS disease**\n4. **Unknown GBS status** PLUS any of:\n   - Delivery <37 weeks gestation\n   - Rupture of membranes \u226518 hours\n   - Intrapartum temperature \u226538.0\u00b0C (100.4\u00b0F)\n\n**Definition of \"Adequate\" Prophylaxis:**\n- **IV penicillin G, ampicillin, or cefazolin** administered **\u22654 hours before delivery**\n- ONE dose given \u22654 hours prior is considered adequate\n- <4 hours = \"inadequate\" prophylaxis", "question": "Based on the information provided, how do you classify this mother's GBS prophylaxis status?", "choices": [{"id": "node-1-choice-a", "text": "Inadequate prophylaxis - she received penicillin but less than 4 hours before expected delivery", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This mother has **inadequate GBS prophylaxis**. Key determination: (1) **She IS GBS positive** - prophylaxis was indicated, (2) **She DID receive appropriate antibiotic** (IV penicillin G), (3) **But delivery will occur <4 hours** after first dose, (4) **4 hours is the threshold** for \"adequate\" prophylaxis - this allows sufficient time for antibiotics to reach amniotic fluid and provide fetal protection. With only 1.5 hours of antibiotics and 1-2 hours until delivery, she will have <4 hours total = inadequate.", "consequence": "You correctly identify inadequate prophylaxis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Adequate prophylaxis - any IV antibiotics during labor counts as adequate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Timing matters** - adequate prophylaxis requires antibiotics **\u22654 hours before delivery**. Key points: (1) **Simply receiving antibiotics is not enough** - they need time to work, (2) **Penicillin must reach the amniotic fluid** to protect the fetus, (3) **<4 hours provides incomplete protection** - infant remains at some risk, (4) **This affects newborn management** - inadequate prophylaxis may require closer monitoring. With delivery expected in 1-2 hours and only 1.5 hours of antibiotics, total time will be ~3 hours = inadequate.", "consequence": "Misclassifying prophylaxis status leads to inappropriate newborn management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "No prophylaxis needed - she should have been screened earlier in pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **She WAS appropriately screened** and DOES need prophylaxis. Key facts: (1) **36-37 weeks is the correct screening window** (updated from 35-37), (2) **She tested positive** - prophylaxis is indicated, (3) **The issue is timing** - she arrived late in labor and may not complete 4 hours of antibiotics, (4) **She received prophylaxis** but it will be inadequate due to short duration. Screening timing was appropriate; the problem is labor progression.", "consequence": "Misunderstanding screening guidelines.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Prophylaxis contraindicated - should wait for culture results before giving antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **She already had positive culture results** from screening at 36 weeks. Key points: (1) **Universal screening at 36-37 weeks** provides GBS status BEFORE labor, (2) **Culture results valid for 5 weeks** after collection, (3) **Prophylaxis indicated for all GBS-positive women** during labor, (4) **No need to repeat culture** - her status is known. Prophylaxis was appropriately initiated based on her positive prenatal screen.", "consequence": "Dangerous delay in indicated prophylaxis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Unknown status - we need to get rapid GBS testing before deciding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Her GBS status is KNOWN** - she tested positive at 36 weeks. Key points: (1) **Rapid GBS testing (NAAT/PCR)** is for women with **unknown** status at delivery, (2) **Her positive culture at 36 weeks** is valid and definitive, (3) **Culture results remain valid for 5 weeks**, (4) **No additional testing needed** - we know she's positive. Rapid testing would only be indicated if she had never been screened.", "consequence": "Unnecessary testing when status is already known.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"Adequate\" GBS prophylaxis = IV penicillin, ampicillin, or cefazolin given \u22654 hours before delivery**. Less than 4 hours = inadequate prophylaxis, which affects newborn management. The 4-hour threshold allows antibiotics to reach the amniotic fluid and provide fetal protection."}, "node-2": {"id": "node-2", "type": "decision", "content": "The baby is delivered 90 minutes later. As expected, the mother received a total of approximately 3 hours of IV penicillin before delivery (inadequate prophylaxis).\n\n**Newborn Assessment:**\n- Male, 3.4 kg, term (39 weeks)\n- APGARs: 8 at 1 minute, 9 at 5 minutes\n- Well-appearing, crying vigorously\n- Normal vital signs: T 37.0\u00b0C, HR 140, RR 42\n- Physical exam: Normal\n- No respiratory distress\n- Feeding: Latched and breastfeeding well within first hour\n\n**Risk Factors for Early-Onset GBS Disease:**\n- Maternal GBS colonization: **Present**\n- Inadequate intrapartum prophylaxis: **Yes** (<4 hours)\n- Rupture of membranes: 2.5 hours (ROM <18 hours)\n- Maternal fever: **None**\n- Gestational age: **Term** (39 weeks)\n- Chorioamnionitis: **None suspected**\n\n**Management Options for Well-Appearing Newborns of GBS+ Mothers:**\n\nThe 2019 AAP/ACOG guidelines stratify management based on:\n1. Gestational age (\u226535 weeks vs <35 weeks)\n2. Adequacy of maternal prophylaxis\n3. Clinical appearance of the newborn\n4. Presence of chorioamnionitis", "question": "What is the appropriate management for this well-appearing term newborn born to a GBS-positive mother with inadequate prophylaxis?", "choices": [{"id": "node-2-choice-a", "text": "Routine newborn care with observation for 24-48 hours - no labs or antibiotics needed for a well-appearing term infant", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Per current guidelines, **well-appearing term infants \u226535 weeks require only observation** regardless of maternal GBS status or prophylaxis adequacy. Key principles: (1) **Clinical appearance is the best predictor** of serious infection in newborns, (2) **Well-appearing infants** - even with inadequate prophylaxis - have very low rates of early-onset GBS disease, (3) **Routine vitals monitoring** for at least 24-48 hours, (4) **No empiric labs or antibiotics** for asymptomatic term infants, (5) **Close nursing observation** for signs of sepsis (temperature instability, respiratory distress, lethargy, poor feeding). This represents a significant change from older guidelines that mandated labs for inadequate prophylaxis.", "consequence": "Appropriate management per current guidelines.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Full sepsis workup (CBC, blood culture, LP) and empiric antibiotics - inadequate prophylaxis requires presumptive treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is excessive for a well-appearing term infant**. Current guidelines: (1) **Well-appearing term infants do NOT need routine sepsis workup** regardless of prophylaxis adequacy, (2) **Full workup + empiric antibiotics** are reserved for: symptomatic infants OR those with suspected chorioamnionitis, (3) **The old approach** of mandatory labs for inadequate prophylaxis has been abandoned, (4) **Clinical observation** is sufficient for asymptomatic term infants. This aggressive approach causes unnecessary infant distress, parent anxiety, and prolonged hospitalization.", "consequence": "Excessive intervention for a well-appearing infant.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CBC and blood culture at birth, observe and treat only if abnormal results", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but no longer recommended. **This was the previous approach** but current guidelines have changed: (1) **Routine labs at birth** for inadequate prophylaxis are no longer recommended for well-appearing term infants, (2) **Clinical observation alone** is sufficient, (3) **Labs should be obtained if symptoms develop**, not preemptively, (4) **Blood culture positivity** in asymptomatic infants is rare and often represents contamination. This approach is not harmful but represents over-testing compared to current guidelines.", "consequence": "Unnecessary labs, though observation approach is correct.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Discharge home after 6 hours if feeding well - standard healthy newborn protocol", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Observation for at least 24-48 hours is recommended** for infants born to GBS-positive mothers with inadequate prophylaxis. Key points: (1) **Early-onset GBS disease typically presents within the first 24-48 hours**, (2) **Adequate observation period** allows detection of symptoms before discharge, (3) **6-hour discharge** doesn't allow sufficient observation time, (4) **Standard \"early discharge\" protocols** don't apply when GBS prophylaxis was inadequate. While the infant appears well, observation is still indicated.", "consequence": "Insufficient observation time for possible early-onset disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Give the infant IM penicillin prophylaxis to complete what mother didn't receive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Postnatal antibiotic prophylaxis for the infant is NOT recommended**. Key points: (1) **The window for preventing colonization has passed** - exposure occurred during delivery, (2) **Prophylactic antibiotics to asymptomatic newborns** are not effective at preventing disease, (3) **If infection is established**, prophylactic doses would be inadequate treatment, (4) **Either full treatment doses** (if symptomatic/high-risk) or observation (if well-appearing) - nothing in between. \"Completing\" the mother's prophylaxis in the infant makes no pathophysiologic sense.", "consequence": "Inappropriate use of antibiotics.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Well-appearing term infants (\u226535 weeks) need only observation** - not routine labs or antibiotics - regardless of maternal GBS status or prophylaxis adequacy. Current guidelines emphasize clinical appearance over prophylaxis adequacy for management decisions. Monitor for 24-48 hours for signs of sepsis."}, "node-3": {"id": "node-3", "type": "decision", "content": "You order routine newborn care with observation. The nursing staff will monitor vital signs every 4 hours and assess for signs of sepsis.\n\nAt 18 hours of life, the nurse calls you with concerns.\n\n**Nursing Assessment at 18 Hours:**\n- Temperature: 38.2\u00b0C rectally (fever)\n- Heart rate: 175 bpm (tachycardia)\n- Respiratory rate: 68 with occasional grunting\n- The baby has become less interested in feeding over the past 4 hours\n- Mother reports he \"just doesn't seem right\"\n\nThis is a **clinical deterioration** in an infant at risk for early-onset GBS disease.\n\n**Signs of Neonatal Sepsis:**\n- **Temperature instability** (fever OR hypothermia)\n- **Respiratory distress** (tachypnea, grunting, retractions, apnea)\n- **Cardiovascular changes** (tachycardia, poor perfusion, hypotension)\n- **Poor feeding / lethargy**\n- **Irritability or \"just not looking right\"**\n\n**Early-Onset GBS Disease:**\n- Presents within **first 7 days of life** (most within 24-48 hours)\n- **Sepsis** (most common presentation)\n- **Pneumonia** (may be indistinguishable from RDS)\n- **Meningitis** (10-15% of cases)\n- **Mortality ~2-3%** with treatment; higher in preterm infants", "question": "The infant is now symptomatic. What is your immediate management?", "choices": [{"id": "node-3-choice-a", "text": "Full sepsis workup (CBC, blood culture, LP) and start empiric ampicillin + gentamicin immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Symptomatic infants require full workup and empiric antibiotics**. This infant now has: (1) **Fever** (38.2\u00b0C), (2) **Tachycardia** (175 bpm), (3) **Respiratory distress** (RR 68 with grunting), (4) **Poor feeding**, (5) **Mother's concern** (\"doesn't seem right\"). Management: (1) **Full sepsis workup**: CBC, blood culture, **lumbar puncture** (meningitis in 10-15% of GBS disease), urinalysis/culture, (2) **Empiric antibiotics**: Ampicillin + gentamicin (standard neonatal regimen), (3) **Supportive care**: IV fluids, oxygen if needed, monitoring. Don't delay antibiotics for LP if infant is unstable.", "consequence": "Appropriate urgent management of symptomatic infant.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Obtain CBC and blood culture only, hold LP until culture results return", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **LP should be done as part of initial workup** in symptomatic neonates. Key reasons: (1) **Meningitis occurs in 10-15% of early-onset GBS disease**, (2) **Blood culture may be negative** even with meningitis, (3) **LP results affect antibiotic duration** and choice, (4) **Delaying LP** until blood cultures return may miss meningitis diagnosis. The only reason to defer LP is hemodynamic instability - in which case, give antibiotics first and do LP when stable.", "consequence": "May miss meningitis diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Continue observation - these symptoms could just be normal newborn behavior", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **These are NOT normal newborn findings** - this is a sepsis presentation. Key abnormalities: (1) **Fever \u226538\u00b0C** in a neonate is ALWAYS concerning, (2) **Tachycardia + tachypnea** suggest systemic illness, (3) **Grunting** indicates respiratory distress, (4) **Poor feeding + maternal concern** are classic warning signs. Continuing observation without workup in a symptomatic infant at risk for GBS disease would be dangerous. Neonatal sepsis can progress rapidly to death.", "consequence": "Dangerous delay in treating likely sepsis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Give antipyretics and reassess in 2 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antipyretics do not address the underlying infection** and this approach delays critical treatment. Key principles: (1) **Fever in a neonate is a RED FLAG** requiring evaluation, not just symptom management, (2) **Treating fever may mask sepsis** while infection progresses, (3) **This infant has multiple concerning signs** - not just fever, (4) **2 hours of delay** could be catastrophic with bacterial sepsis. Antipyretics are not contraindicated, but workup and antibiotics should NOT wait for their effect.", "consequence": "Treating symptom while ignoring underlying emergency.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Transfer to NICU for respiratory support only - no antibiotics until cultures confirm infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Empiric antibiotics should NOT wait for culture confirmation** in a symptomatic neonate. Key principles: (1) **Blood cultures take 24-48 hours** to grow, (2) **Neonatal sepsis can be fatal within hours** if untreated, (3) **Empiric treatment** is standard of care for suspected neonatal sepsis, (4) **Antibiotics can be stopped** if cultures are negative and infant improves, (5) **Waiting for confirmation** in a symptomatic infant is malpractice. The NICU transfer is appropriate, but antibiotics must accompany respiratory support.", "consequence": "Life-threatening delay in antibiotic therapy.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Symptomatic neonates need immediate full sepsis workup AND empiric antibiotics** - don't wait for culture results. Include LP in the initial workup (meningitis in 10-15% of GBS disease). Standard regimen is **ampicillin + gentamicin**. Clinical deterioration in a neonate at risk for GBS disease should be treated as sepsis until proven otherwise."}, "node-4": {"id": "node-4", "type": "decision", "content": "You perform a full sepsis workup and start ampicillin + gentamicin. The infant is transferred to the NICU for monitoring.\n\n**Initial Results:**\n- CBC: WBC 4,200/\u03bcL (low), 15% bands (left shift), platelets 98,000\n- CSF: WBC 180/\u03bcL (elevated), protein 210 mg/dL (elevated), glucose 22 mg/dL (low)\n- CSF Gram stain: **Gram-positive cocci in pairs and chains**\n\n**At 36 hours, cultures return:**\n- Blood culture: **Positive for Group B Streptococcus**\n- CSF culture: **Positive for Group B Streptococcus**\n\n**Diagnosis: Early-Onset GBS Sepsis with Meningitis**\n\n**Treatment of GBS Meningitis:**\n\n**Antibiotic Therapy:**\n- **IV Penicillin G** (or ampicillin) - drug of choice for GBS\n- **Duration for meningitis: 14-21 days** (vs 10 days for sepsis without meningitis)\n- Gentamicin may be continued for synergy during initial treatment\n- Repeat LP to document CSF sterilization\n\n**Monitoring:**\n- Serial neurologic exams\n- Hearing screen before discharge (GBS meningitis associated with hearing loss)\n- Neurodevelopmental follow-up", "question": "What is the appropriate antibiotic duration for this infant with GBS meningitis?", "choices": [{"id": "node-4-choice-a", "text": "Minimum 14-21 days of IV penicillin G (or ampicillin) for GBS meningitis, with repeat LP to confirm CSF sterilization", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **GBS meningitis requires prolonged IV antibiotic therapy**. Key treatment principles: (1) **14-21 days minimum** - longer than uncomplicated bacteremia (10 days), (2) **IV penicillin G or ampicillin** - GBS remains uniformly susceptible, (3) **Repeat LP** recommended to confirm CSF sterilization (typically at 24-48 hours), (4) **Gentamicin may be discontinued** after initial period once CSF sterile, (5) **Cannot switch to oral antibiotics** - must complete full IV course. The duration is extended because CNS infection requires longer treatment for eradication and to prevent relapse.", "consequence": "Appropriate treatment duration for GBS meningitis.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "7 days of antibiotics, then switch to oral amoxicillin to complete a 14-day course", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Neonatal meningitis requires FULL IV course** - no oral step-down. Key issues: (1) **Oral antibiotics have unreliable CNS penetration** - cannot treat meningitis, (2) **7 days of IV is insufficient** for meningitis, (3) **GBS meningitis requires 14-21 days IV minimum**, (4) **Oral step-down** is sometimes used for uncomplicated bacteremia, but NEVER for meningitis. Incomplete treatment of meningitis leads to relapse and poor neurologic outcomes.", "consequence": "Inadequate treatment of meningitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "48-72 hours until cultures are negative, then discontinue antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cultures becoming negative does NOT indicate completed treatment**. Key principles: (1) **Antibiotics sterilize cultures quickly** - often within 24-48 hours, (2) **CSF sterilization is necessary but not sufficient** for treatment completion, (3) **Full antibiotic course is required** to eradicate infection and prevent relapse, (4) **Stopping at 48-72 hours** would result in treatment failure and likely death. The repeat LP confirms sterilization but treatment continues for the full duration.", "consequence": "Catastrophically short treatment would cause relapse/death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Continue antibiotics indefinitely until all symptoms resolve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Treatment duration is defined by guidelines, not symptom resolution**. Key points: (1) **14-21 days is the established duration** for GBS meningitis based on evidence, (2) **Symptoms may persist or fluctuate** during appropriate treatment, (3) **Indefinite antibiotics** cause unnecessary side effects and complications, (4) **Clear endpoints** (14-21 days with documented CSF sterilization) guide treatment completion. The duration is evidence-based, not symptom-based.", "consequence": "Unnecessary prolonged antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "10 days of IV antibiotics - standard duration for neonatal sepsis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **10 days is for bacteremia WITHOUT meningitis**. Key distinction: (1) **Bacteremia alone: 10 days**, (2) **Meningitis: 14-21 days minimum**, (3) **CNS infections require longer treatment** due to difficulty achieving adequate drug levels and higher risk of relapse, (4) **This infant has BOTH bacteremia AND meningitis** - the meningitis dictates the longer duration. Using the bacteremia duration for meningitis would result in under-treatment.", "consequence": "Insufficient duration for meningitis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**GBS meningitis requires 14-21 days of IV antibiotics** (penicillin G or ampicillin). This is longer than bacteremia alone (10 days). Repeat LP to confirm CSF sterilization. No oral step-down for neonatal meningitis. Arrange hearing screen and neurodevelopmental follow-up before discharge."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed this case from GBS prophylaxis assessment through treatment of early-onset GBS sepsis with meningitis.\n\n**Key Teaching Points:**\n\n**GBS Screening and Prophylaxis:**\n- **Universal screening at 36-37 weeks** via vaginal-rectal culture\n- **Indications for prophylaxis**: GBS+, GBS bacteriuria, prior affected infant, unknown status + risk factors\n- **Adequate prophylaxis**: IV penicillin/ampicillin/cefazolin **\u22654 hours before delivery**\n- **<4 hours = inadequate prophylaxis**\n\n**Management of Well-Appearing Term Infants:**\n- **Observation only** (24-48 hours) regardless of prophylaxis adequacy\n- **No routine labs or antibiotics** for asymptomatic term infants\n- Clinical appearance is the best predictor of disease\n\n**Management of Symptomatic Infants:**\n- **Full sepsis workup**: CBC, blood culture, LP, UA\n- **Empiric antibiotics**: Ampicillin + gentamicin immediately\n- **Don't wait for culture confirmation** in symptomatic neonates\n\n**GBS Disease Treatment:**\n- **Bacteremia without meningitis**: 10 days IV antibiotics\n- **Meningitis**: 14-21 days IV penicillin G or ampicillin\n- **Repeat LP** to confirm CSF sterilization\n- **No oral step-down** for neonatal meningitis\n- **Hearing screen and neurodevelopmental follow-up**\n\n**Outcomes:**\n- **Mortality 2-3%** with appropriate treatment\n- **Long-term sequelae** possible with meningitis (hearing loss, developmental delay)\n- **Intrapartum prophylaxis has reduced early-onset GBS disease by 80%**"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in GBS management:\n\n**Prophylaxis Adequacy:**\n- \u22654 hours of IV penicillin/ampicillin/cefazolin before delivery = adequate\n- <4 hours = inadequate\n- Timing matters for fetal protection\n\n**Well-Appearing Term Infants:**\n- Observation only - no routine labs needed\n- Current guidelines emphasize clinical appearance\n- Monitor for 24-48 hours\n\n**Symptomatic Infants:**\n- Full sepsis workup INCLUDING LP\n- Empiric antibiotics IMMEDIATELY\n- Don't delay for culture results\n\n**Treatment Duration:**\n- Bacteremia: 10 days\n- Meningitis: 14-21 days\n- Full IV course required\n- No oral step-down for meningitis\n\n**Common Errors:**\n- Routine labs for well-appearing infants\n- Delaying LP or antibiotics in symptomatic infants\n- Insufficient treatment duration for meningitis"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical concepts in GBS management:\n\n**Understand Prophylaxis Adequacy:**\n- **4 hours minimum** of IV antibiotics before delivery\n- Less than 4 hours = inadequate prophylaxis\n- This affects risk stratification (though not management for well-appearing term infants)\n\n**Appropriate Observation:**\n- Well-appearing term infants: observation only\n- **But don't discharge early** - 24-48 hours observation for GBS-exposed infants\n- Watch for signs of sepsis: fever, respiratory distress, poor feeding, lethargy\n\n**Don't Miss Symptomatic Infants:**\n- **Fever in a neonate is ALWAYS concerning**\n- Full sepsis workup + empiric antibiotics immediately\n- **Include LP** - meningitis in 10-15% of GBS disease\n- **Don't delay antibiotics** waiting for culture confirmation\n\n**Treat Meningitis Appropriately:**\n- **14-21 days IV** - longer than bacteremia alone (10 days)\n- **Full IV course required** - no oral step-down\n- Repeat LP to confirm CSF sterilization\n\n**Consequences of Mismanagement:**\n- Delayed recognition of sepsis \u2192 rapid deterioration, death\n- Inadequate treatment duration \u2192 relapse, neurologic sequelae\n- Early-onset GBS disease mortality 2-3% WITH treatment, much higher without"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-159", "title": "Erythema Toxicum Neonatorum", "domain": "newborn", "difficulty": "beginner", "tags": ["benign neonatal rash", "spares palms and soles", "erythematous papules with pustules", "eosinophils on Wright stain", "self-limited", "no treatment needed"], "estimatedMinutes": 4, "source": ["Amboss"], "stem": "A 2-day-old full-term male newborn is noted to have a rash during routine nursery examination. The infant was born via uncomplicated vaginal delivery at 39 weeks gestation. Birth weight was 3.4 kg. Apgar scores were 8 and 9 at 1 and 5 minutes. Mother had routine prenatal care with negative GBS status.\n\nThe infant is feeding well, has normal vital signs, and appears comfortable. The mother is concerned about the rash that appeared overnight.\n\nPhysical Examination:\n- General: Alert, active newborn in no distress\n- Vitals: T 37.2\u00b0C, HR 140, RR 42, SpO2 99% on room air\n- Skin: Multiple erythematous macules and papules with central yellow-white pustules scattered over the trunk, face, and proximal extremities. The palms and soles are NOT involved.\n- The lesions appear to 'come and go' - some that were present earlier have faded while new ones have appeared.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You observe a well-appearing 2-day-old with an evanescent (coming and going) pustular rash on an erythematous base. The distribution spares the palms and soles. The infant is afebrile and feeding well.\n\n**Key observation**: The rash has a characteristic 'flea-bitten' appearance with pustules surrounded by erythematous halos.", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Erythema toxicum neonatorum (ETN)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Erythema toxicum neonatorum** is the most common pustular rash in newborns, affecting up to 50% of term infants. Classic features: (1) Onset **24-72 hours** of life, (2) **Erythematous macules/papules with central pustules**, (3) **Spares palms and soles**, (4) **Evanescent** - lesions come and go, (5) **Well-appearing infant**. It's benign and self-limited.", "consequence": "You recognize the classic presentation of ETN.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Neonatal herpes simplex virus (HSV) infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Neonatal HSV presents with **grouped vesicles on an erythematous base**, often in a dermatomal or localized distribution. Infants are typically **ill-appearing** with possible fever, lethargy, or seizures. HSV lesions are **vesicles** (fluid-filled), not pustules, and they don't spontaneously resolve and reappear. This well infant with evanescent pustules is not concerning for HSV.", "consequence": "HSV doesn't match this presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Staphylococcal pustulosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Staphylococcal pustulosis** presents with pustules that are **not surrounded by erythematous halos** (unlike ETN). The pustules tend to be larger, may coalesce, and often occur in **intertriginous areas** (axillae, groin, neck folds). Infants may have systemic signs if infection spreads. Gram stain shows gram-positive cocci in clusters.", "consequence": "Features don't match staphylococcal infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Transient neonatal pustular melanosis", "isOptimal": false, "isAcceptable": true, "feedback": "Close, but not the best answer. **Transient neonatal pustular melanosis (TNPM)** is similar to ETN but has key differences: (1) Present **at birth** (not 24-72 hours later), (2) Pustules rupture leaving **hyperpigmented macules with collarette of scale**, (3) More common in **African American infants**, (4) **Can involve palms and soles** (unlike ETN). This rash appeared at day 2 and spares palms/soles, making ETN more likely.", "consequence": "TNPM is possible but less likely given timing and distribution.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Candidal diaper dermatitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Candidal infection** typically involves the **diaper area** with beefy red erythema and **satellite pustules** at the periphery. It doesn't present as a generalized truncal rash that spares palms and soles. Candida is also more common after antibiotic exposure or in infants with thrush.", "consequence": "Distribution and appearance don't match candida.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ETN vs TNPM**: ETN appears at 24-72 hours with evanescent lesions that spare palms/soles. TNPM is present at birth, can involve palms/soles, and leaves hyperpigmented macules after pustules rupture."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect erythema toxicum neonatorum based on the classic presentation. The nursing staff asks if any workup is needed, and the mother is anxious about whether the rash could be infectious.", "question": "What is the MOST appropriate next step?", "choices": [{"id": "node-2-choice-a", "text": "Reassure parents - no workup needed for classic ETN presentation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Erythema toxicum neonatorum is a clinical diagnosis** in a well-appearing infant with classic features. No laboratory workup is needed. Key reassurance points: (1) **Benign and self-limited** - resolves within 5-14 days, (2) **Not infectious or contagious**, (3) **No treatment required**, (4) **No long-term sequelae**. Unnecessary testing increases cost and parental anxiety.", "consequence": "You provide appropriate reassurance without unnecessary testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Obtain blood cultures and start empiric antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This well-appearing, afebrile infant with a classic ETN presentation does **not need sepsis workup or antibiotics**. Starting antibiotics for a benign rash exposes the infant to unnecessary risks (IV access, drug reactions, antibiotic resistance) and increases cost. Reserve sepsis evaluation for ill-appearing infants or those with concerning features.", "consequence": "Unnecessary intervention for benign condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Wright stain of pustule contents to confirm diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "Not wrong, but unnecessary for classic presentation. If performed, Wright or Giemsa stain of ETN pustule contents shows **eosinophils** (not neutrophils or bacteria). However, in a well-appearing infant with textbook ETN features, this test adds cost without changing management. Reserve microscopy for atypical presentations.", "consequence": "Confirmatory testing is available but usually unnecessary.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Obtain HSV PCR and start IV acyclovir empirically", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This presentation is **not concerning for HSV**. Neonatal HSV presents with grouped vesicles (not pustules), ill appearance, and often systemic signs. Starting acyclovir for every newborn rash would be excessive and inappropriate. ETN is benign and self-limited - no antiviral therapy is indicated.", "consequence": "HSV treatment inappropriate for benign ETN.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Consult dermatology for skin biopsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Skin biopsy is **never indicated** for erythema toxicum neonatorum. The diagnosis is clinical, the condition is benign and self-limited, and biopsy would cause unnecessary pain and scarring. Reserve dermatology consultation and biopsy for persistent, atypical, or concerning skin findings.", "consequence": "Invasive testing inappropriate for benign condition.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Wright stain finding**: ETN shows **eosinophils**. This distinguishes it from bacterial pustulosis (neutrophils + bacteria) and HSV (multinucleated giant cells on Tzanck smear). However, classic ETN doesn't require confirmatory testing."}, "node-3": {"id": "node-3", "type": "decision", "content": "You reassure the family that this is a benign rash. The mother asks several follow-up questions about what to expect and when to be concerned.\n\n**Mother's questions**:\n- 'How long will this last?'\n- 'Does my baby need any creams or medications?'\n- 'What should I watch for that would be concerning?'", "question": "Which counseling point is MOST accurate regarding erythema toxicum neonatorum?", "choices": [{"id": "node-3-choice-a", "text": "The rash typically resolves within 5-14 days without any treatment; no creams or medications are needed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ETN is self-limited** and resolves spontaneously within **5-14 days** (average 4-5 days). **No treatment is needed** - no creams, no antibiotics, no antihistamines. The lesions leave no scarring or pigmentation changes. Parents should be reassured that this is one of the most common newborn rashes and is completely harmless.", "consequence": "Accurate counseling provided.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Apply hydrocortisone cream twice daily to speed resolution", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **No topical treatment is indicated** for ETN. Hydrocortisone is unnecessary and could potentially cause skin atrophy or other side effects in a newborn. The rash resolves spontaneously without intervention. Prescribing unnecessary treatments medicalizes a benign condition.", "consequence": "Unnecessary treatment recommended.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "The rash may persist for several months and requires topical antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ETN does **not** persist for months - it typically resolves within **5-14 days**. A rash persisting for months would warrant reconsideration of the diagnosis. **Antibiotics are never indicated** for ETN as it is not an infectious condition. The pustules are sterile and contain eosinophils, not bacteria.", "consequence": "Inaccurate information and unnecessary treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Avoid bathing the baby until the rash completely resolves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Normal bathing can continue** - there is no need to alter hygiene practices for ETN. The rash is not affected by bathing, and delaying baths could lead to other skin issues. Normal newborn care should proceed as usual.", "consequence": "Unnecessary restriction recommended.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "The baby should be isolated from other infants in the nursery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ETN is NOT contagious** - it is a benign inflammatory condition, not an infection. There is no need for isolation or special precautions. The baby can remain in the normal nursery and have contact with siblings and family members without any risk of transmission.", "consequence": "Unnecessary isolation recommended.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Parent counseling for ETN**: (1) Benign and harmless, (2) Resolves in 5-14 days, (3) No treatment needed, (4) Not contagious, (5) No scarring, (6) May wax and wane before resolving, (7) Return if fever, poor feeding, or new concerning symptoms develop."}, "node-4": {"id": "node-4", "type": "decision", "content": "Before discharge, you want to ensure the parents understand when to seek medical attention. The intern asks you how to differentiate ETN from more concerning neonatal rashes.\n\n**Teaching moment**: What features would make you concerned about a neonatal rash?", "question": "Which feature would be MOST concerning and warrant further evaluation in a neonate with a pustular rash?", "choices": [{"id": "node-4-choice-a", "text": "Ill-appearing infant with fever and vesicular lesions", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! An **ill-appearing infant with fever and vesicular lesions** is highly concerning for **neonatal HSV infection** or bacterial sepsis. Red flags requiring urgent evaluation: (1) **Fever or temperature instability**, (2) **Ill appearance, lethargy, poor feeding**, (3) **Vesicles** (fluid-filled) rather than pustules, (4) **Grouped or dermatomal distribution**, (5) **Involvement of mucous membranes**. These findings warrant immediate HSV PCR, cultures, and empiric treatment.", "consequence": "You correctly identify concerning features requiring workup.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Pustules that appear and disappear over several hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Evanescent (coming and going) lesions** are actually a **reassuring feature** of ETN, not a concerning one. This transient nature distinguishes benign ETN from infectious causes where lesions tend to persist and spread. The 'flea-bitten' appearance that waxes and wanes is classic for ETN.", "consequence": "This is a reassuring feature, not concerning.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Rash distribution on trunk and face", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Trunk and face distribution** is typical for ETN and is not concerning. ETN classically involves the trunk, face, and proximal extremities. The concerning feature would be involvement of **palms and soles** (which ETN spares) or **mucous membranes** (suggesting HSV or other infection).", "consequence": "This distribution is typical for benign ETN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Onset at 48 hours of life", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Onset at **24-72 hours** is the **typical timing** for ETN. This is actually a reassuring feature that supports the diagnosis. A rash present **at birth** (like TNPM) or appearing **after the first week** might warrant different consideration, but 48-hour onset is classic for ETN.", "consequence": "This timing is typical for ETN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Multiple lesions with erythematous halos", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pustules with erythematous halos** (the 'flea-bitten' appearance) is the **hallmark of ETN**. This finding is reassuring and helps confirm the diagnosis. Concerning pustular lesions would lack the erythematous halo or would have features of deeper infection (fluctuance, spreading erythema).", "consequence": "This appearance is characteristic of benign ETN.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Red flags in neonatal rashes**: (1) Ill appearance/fever, (2) Vesicles (suggests HSV), (3) Involvement of palms/soles/mucous membranes, (4) Persistent/spreading lesions, (5) Hemorrhagic or bullous lesions, (6) Associated systemic symptoms. ETN features (evanescent pustules with halos, spares palms/soles, well infant) are REASSURING."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **erythema toxicum neonatorum** - the most common benign pustular rash in newborns. Key learning points:\n\n**Diagnosis**: Clinical diagnosis based on (1) onset 24-72 hours, (2) erythematous macules/papules with central pustules, (3) evanescent nature, (4) spares palms/soles, (5) well-appearing infant.\n\n**Management**: Reassurance only - no workup or treatment needed for classic presentation.\n\n**Parent education**: Benign, self-limited (resolves 5-14 days), not contagious, no treatment needed.\n\n**Red flags to teach**: Fever, ill appearance, vesicles, persistent lesions warrant evaluation for HSV or bacterial infection."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **erythema toxicum neonatorum**:\n\n**Classic features**: (1) Onset **24-72 hours** of life, (2) **Erythematous papules with central pustules** ('flea-bitten'), (3) **Evanescent** - come and go, (4) **Spares palms and soles**, (5) **Well-appearing infant**.\n\n**Wright stain**: Shows **eosinophils** (not needed for classic presentation).\n\n**Management**: **Reassurance only** - no workup, no treatment, no isolation.\n\n**Prognosis**: Resolves spontaneously in **5-14 days** without scarring."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. **Erythema toxicum neonatorum** is a **benign, self-limited** condition that requires NO intervention.\n\n**Do NOT**:\n- Order blood cultures or start antibiotics (not infectious)\n- Start acyclovir (not HSV)\n- Apply topical creams (not needed)\n- Isolate the infant (not contagious)\n- Perform skin biopsy (diagnosis is clinical)\n\n**DO**:\n- Recognize classic features (evanescent pustules with halos, spares palms/soles)\n- Reassure parents\n- Educate about expected course (resolves in 5-14 days)\n- Counsel on red flags (fever, ill appearance, vesicles)"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-163", "title": "Retropharyngeal Abscess", "domain": "newborn", "difficulty": "advanced", "tags": ["retropharyngeal abscess", "deep neck infection", "airway emergency", "neck hyperextension", "stridor", "surgical drainage", "pediatric emergency"], "estimatedMinutes": 6, "source": ["Amboss"], "stem": "A 3-year-old boy is brought to the emergency department with a 4-day history of fever, sore throat, and progressive difficulty swallowing. His parents report he has been refusing to eat and is drooling. Over the past day, he has developed neck stiffness and seems to be holding his neck in an extended position.\n\nHe was treated with amoxicillin for presumed strep throat 2 days ago but has not improved.\n\nPhysical Examination:\n- General: Ill-appearing, febrile (39.5\u00b0C), sitting upright with neck hyperextended, drooling\n- Vitals: HR 160, RR 32, SpO2 94% on room air, BP 90/60\n- HEENT: Muffled \"hot potato\" voice, trismus (difficulty opening mouth), posterior pharyngeal wall appears full/bulging (limited exam due to trismus)\n- Neck: Tender anterior cervical lymphadenopathy, limited range of motion, pain with flexion\n- Lungs: Mild stridor at rest", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 3-year-old presents with:\n\n- **Fever, sore throat, odynophagia** (painful swallowing)\n- **Drooling** and refusal to eat\n- **Neck hyperextension** and stiffness\n- **Muffled voice**, trismus\n- **Stridor** at rest\n- **Bulging posterior pharynx**\n- Failed outpatient antibiotics\n\nThese findings are highly concerning for a **deep neck space infection**.", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Retropharyngeal abscess", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Retropharyngeal abscess** classically presents in children <5 years (peak 2-4 years) with: (1) **Fever, sore throat, dysphagia**; (2) **Neck hyperextension** (to open airway); (3) **Drooling**; (4) **Muffled voice**; (5) **Bulging posterior pharyngeal wall**; (6) **Stridor** (concerning for airway compromise). Often follows URI or pharyngitis. The retropharyngeal space contains lymph nodes that drain the nasopharynx - these atrophy by age 5, which is why RPA is rare in older children.", "consequence": "You recognize the classic presentation of RPA.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Epiglottitis", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration, but less likely. **Epiglottitis** presents with rapid onset (hours) of high fever, **severe sore throat**, **drooling**, stridor, and **tripod positioning**. However, epiglottitis is now rare due to Hib vaccination, has more rapid progression, and does NOT typically cause posterior pharyngeal bulging or neck hyperextension. This presentation with bulging pharynx and neck extension is more consistent with RPA.", "consequence": "Epiglottitis possible but RPA more likely given findings.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Peritonsillar abscess (quinsy)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Peritonsillar abscess** is more common in **adolescents and adults**, presents with **unilateral** tonsillar swelling, uvular deviation, and trismus. It does NOT cause posterior pharyngeal bulging or neck hyperextension. This child's bilateral symptoms and posterior pharynx findings are more consistent with retropharyngeal abscess.", "consequence": "PTA unlikely in this age group with these findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Viral pharyngitis with reactive lymphadenopathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This presentation is **too severe** for uncomplicated pharyngitis. Red flags include: stridor, drooling, neck hyperextension, trismus, and posterior pharyngeal bulging. These indicate a deep neck space infection with potential airway compromise, not simple pharyngitis.", "consequence": "Presentation too severe for viral pharyngitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Infectious mononucleosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Mononucleosis** causes pharyngitis, lymphadenopathy, and fatigue, but does NOT cause stridor, posterior pharyngeal bulging, neck hyperextension, or this degree of toxicity. The acute presentation with airway symptoms requires consideration of deep neck space infection.", "consequence": "Mono does not cause these severe airway symptoms.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**RPA classic presentation**: Young child (<5 years), fever, sore throat, **dysphagia/drooling**, **neck hyperextension** (sniffing position), **muffled voice**, **limited neck ROM**, **posterior pharyngeal bulging**. **Stridor = airway emergency!** Can progress to airway obstruction, mediastinitis, or sepsis."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect retropharyngeal abscess. The child has stridor at rest and SpO2 of 94%, indicating potential airway compromise.\n\n**Critical question**: How do you prioritize management?", "question": "What is the MOST important FIRST step in management?", "choices": [{"id": "node-2-choice-a", "text": "Secure the airway - prepare for possible intubation in a controlled setting (OR) with ENT/anesthesia backup", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Airway management is the TOP priority**. This child has stridor at rest and hypoxemia - signs of impending airway compromise. The airway should be secured in a **controlled setting (OR)** with **ENT and anesthesia** present, as the anatomy is distorted and intubation can rupture the abscess. Keep the child calm, upright, and avoid anything that might agitate him (no throat exam, no IV starts initially).", "consequence": "Airway prioritized appropriately.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Obtain CT scan of the neck immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect priority. While CT is important for diagnosis, this child has **active airway compromise** (stridor, hypoxemia). Taking an unstable child to CT risks sudden airway obstruction in an uncontrolled environment. **Secure the airway FIRST**, then obtain imaging. Additionally, lying flat for CT can worsen airway obstruction.", "consequence": "Imaging should not delay airway management in unstable patient.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start IV antibiotics and observe for improvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While antibiotics are essential, this child has **stridor at rest** - a sign of critical airway narrowing. **Airway management takes priority**. Antibiotics will not immediately improve the obstruction. Observation is dangerous when there is active airway compromise.", "consequence": "Airway compromise requires immediate intervention, not observation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Perform bedside needle aspiration of the abscess", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bedside aspiration is dangerous** and contraindicated. It risks abscess rupture with aspiration of purulent material, bleeding, and airway compromise. Drainage should be performed in the OR under controlled conditions with a secured airway. ENT should perform definitive management.", "consequence": "Bedside drainage risks aspiration and airway compromise.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Give IM epinephrine for presumed anaphylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is **not anaphylaxis**. There is no urticaria, angioedema, or exposure history. The clinical picture is clearly infectious (4-day history, fever, pharyngitis, lymphadenopathy). Epinephrine will not address the mechanical airway obstruction from the abscess.", "consequence": "Not anaphylaxis - epinephrine not indicated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Airway FIRST in RPA**: (1) Keep child calm and upright; (2) Avoid agitating procedures (no IV, no throat exam); (3) Prepare for intubation in **OR** with **ENT + anesthesia**; (4) Have tracheostomy equipment ready; (5) Intubation can rupture abscess \u2192 aspiration. **Never lay flat** a child with RPA and stridor!"}, "node-3": {"id": "node-3", "type": "decision", "content": "ENT and anesthesia are called. The child is kept calm, upright, and on supplemental oxygen. His SpO2 improves to 97% with blow-by O2.\n\nYou prepare for operative management. In the meantime, you consider what additional workup and treatment to initiate.", "question": "What is the MOST appropriate imaging study and empiric antibiotic choice?", "choices": [{"id": "node-3-choice-a", "text": "CT neck with IV contrast once airway is secured; Ampicillin-sulbactam (or clindamycin if penicillin-allergic)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **CT with IV contrast** is the imaging modality of choice - it shows the extent of infection, differentiates abscess from phlegmon/cellulitis, and helps plan surgical drainage. Obtain **after airway is secured**. **Empiric antibiotics** should cover oral flora including **anaerobes**: Ampicillin-sulbactam, or Clindamycin if penicillin-allergic. Add vancomycin if MRSA is suspected.", "consequence": "Appropriate imaging and antibiotic selection.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Lateral neck X-ray; Amoxicillin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **lateral neck X-ray** can show prevertebral soft tissue widening (>7mm at C2, >14mm at C6), it has lower sensitivity than CT and cannot define the extent of infection or differentiate abscess from cellulitis. CT is preferred when available. **Amoxicillin alone** is inadequate - it doesn't cover anaerobes or beta-lactamase producing organisms (which is why the child failed outpatient amoxicillin).", "consequence": "X-ray less sensitive than CT; amoxicillin inadequate.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "MRI of the neck; Azithromycin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MRI provides excellent soft tissue detail but is **time-consuming** and requires the patient to lie still (often requiring sedation in children). In an acute airway emergency, CT is faster and sufficient. **Azithromycin** does not adequately cover the polymicrobial flora (including anaerobes) of deep neck infections.", "consequence": "MRI too slow for acute presentation; azithromycin inadequate coverage.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "No imaging needed; Ceftriaxone only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Imaging is essential** to confirm the diagnosis, assess extent of infection, identify drainable collections, and evaluate for complications (mediastinal extension). Ceftriaxone alone is **inadequate** - it doesn't cover anaerobes, which are common in deep neck infections.", "consequence": "Imaging needed for surgical planning; ceftriaxone lacks anaerobic coverage.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Ultrasound of the neck; Metronidazole alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ultrasound has limited utility for retropharyngeal space - it cannot adequately visualize the deep neck spaces. CT is the study of choice. **Metronidazole alone** covers anaerobes but misses streptococci, staphylococci, and other aerobic bacteria. Deep neck infections are polymicrobial and require broad-spectrum coverage.", "consequence": "Ultrasound cannot visualize RPA; metronidazole alone too narrow.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**RPA microbiology**: Polymicrobial - Group A Strep, S. aureus (including MRSA), oral anaerobes (Bacteroides, Fusobacterium, Peptostreptococcus). **Antibiotic choices**: Ampicillin-sulbactam, Clindamycin, or Piperacillin-tazobactam. Add **vancomycin** if MRSA suspected. Duration: IV until improved, then oral to complete 2-3 weeks."}, "node-4": {"id": "node-4", "type": "decision", "content": "CT with contrast shows a **3 cm retropharyngeal abscess** with rim enhancement extending from C2-C5, causing significant narrowing of the oropharyngeal airway. There is no mediastinal extension.\n\nThe child is taken to the OR where the airway is secured with endotracheal intubation (performed carefully with ENT backup). ENT performs transoral incision and drainage with copious purulent material obtained.\n\nPost-operatively, the child is extubated successfully and is receiving IV ampicillin-sulbactam. Cultures grow Group A Streptococcus and mixed anaerobes.", "question": "What is the expected clinical course and appropriate follow-up?", "choices": [{"id": "node-4-choice-a", "text": "Clinical improvement expected in 24-48 hours; continue IV antibiotics until afebrile and improving, then transition to oral antibiotics to complete 2-3 weeks total", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After adequate drainage and appropriate antibiotics, **clinical improvement is expected within 24-48 hours**. Continue **IV antibiotics** until the child is afebrile, tolerating oral intake, and clinically improving (typically 3-5 days). Then transition to **oral antibiotics** (amoxicillin-clavulanate or clindamycin) to complete **2-3 weeks total**. Follow up to ensure resolution.", "consequence": "Appropriate expectations and antibiotic plan.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Continue IV antibiotics for 4 weeks regardless of clinical response", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged IV therapy is **not routinely needed** if the abscess is adequately drained and the child improves clinically. Once afebrile and tolerating orals, transition to oral antibiotics. Four weeks of IV therapy is excessive and unnecessary for uncomplicated RPA with good surgical drainage.", "consequence": "4 weeks IV is excessive; transition to oral when improved.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Stop antibiotics after 5 days if afebrile", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **5 days is too short** for deep neck space infection. Even with surgical drainage, **2-3 weeks of total antibiotic therapy** is recommended to ensure complete resolution and prevent recurrence or complications. Inadequate treatment can lead to recurrent abscess.", "consequence": "5 days too short; complete 2-3 weeks total.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Expect slow improvement over 1-2 weeks; repeat CT in 3 days routinely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With adequate drainage and antibiotics, improvement should be seen in **24-48 hours**, not 1-2 weeks. Slow improvement or persistent fever suggests inadequate drainage, wrong antibiotics, or complications. **Routine repeat CT is not needed** if the child is improving clinically - reserve imaging for those not responding to treatment.", "consequence": "Improvement should be faster; routine repeat imaging unnecessary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Surgical drainage was curative; no antibiotics needed post-operatively", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotics are essential** even after surgical drainage. The surrounding cellulitis and any residual infection require antibiotic treatment. Surgery alone without antibiotics has high failure rates. Complete a full course of antibiotics to ensure resolution.", "consequence": "Antibiotics required even after drainage.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**RPA management principles**: (1) **Airway first** - OR intubation with ENT backup; (2) **IV antibiotics** covering strep, staph, anaerobes; (3) **Surgical drainage** for abscesses >2 cm or not responding to antibiotics; (4) Transition to **oral antibiotics** when improved; (5) Total **2-3 weeks** of therapy. **Complications**: Mediastinitis, airway obstruction, sepsis, jugular vein thrombosis (Lemierre syndrome)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed **retropharyngeal abscess** - a potentially life-threatening deep neck space infection.\n\n**Key learning points**:\n\n**Recognition**: Young child, fever, sore throat, dysphagia/drooling, neck hyperextension, muffled voice, posterior pharyngeal bulging. Stridor = airway emergency!\n\n**Management priorities**: (1) AIRWAY FIRST - secure in OR with ENT/anesthesia; (2) CT with contrast for diagnosis; (3) IV antibiotics (amp-sulbactam or clindamycin); (4) Surgical drainage.\n\n**Antibiotics**: Cover GAS, Staph, anaerobes. Total 2-3 weeks (IV until improved, then oral)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **retropharyngeal abscess**:\n\n**Classic presentation**: Child <5 years, fever, dysphagia, drooling, **neck hyperextension**, muffled voice, posterior pharyngeal bulging. **Stridor = emergency!**\n\n**Management**: (1) **Airway first** - OR with ENT; (2) CT with contrast; (3) IV antibiotics: amp-sulbactam or clindamycin (+/- vancomycin for MRSA); (4) Surgical drainage for abscess >2 cm.\n\n**Antibiotic duration**: 2-3 weeks total. Transition to oral when afebrile and improving."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. **Retropharyngeal abscess** is a life-threatening emergency.\n\n**Airway compromise**: Stridor at rest indicates critical narrowing. **NEVER**:\n- Take unstable child to CT\n- Attempt bedside drainage\n- Lay the child flat\n- Delay airway management for any reason\n\n**Antibiotics are essential**: Surgery alone is insufficient. Need broad-spectrum coverage for polymicrobial infection.\n\n**Complications of delayed/inadequate treatment**: Airway obstruction, aspiration pneumonia, mediastinitis, sepsis, death."}}, "rootNodeId": "node-1"}], "neurology": [{"id": "vignette-lens-peds-009", "title": "Abusive Head Trauma", "domain": "neurology", "difficulty": "advanced", "tags": ["abusive head trauma", "shaken baby syndrome", "retinal hemorrhages", "subdural hematoma", "mandated reporting", "child abuse", "skeletal survey"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 4-month-old male infant is brought to the emergency department by his babysitter for irritability and vomiting.\n\nHistory: The babysitter reports the infant has been \"fussy\" and vomited several times today. She states he \"rolled off the couch onto the carpet\" about 2 hours ago from a height of approximately 18 inches. She says he cried briefly but then became increasingly sleepy and difficult to arouse. She witnessed a brief episode of \"whole body shaking\" (possible seizure) in the car on the way to the hospital.\n\nThe mother arrives shortly after and appears nervous. She mentions that last month the baby was seen at another hospital for \"coughing\" and a chest X-ray showed what was called a \"healing rib fracture.\" She was told it was probably from birth trauma.\n\nPhysical Examination:\n- General: Lethargic, poorly responsive infant, intermittently irritable when aroused\n- Vitals: T 36.8\u00b0C, HR 170, RR 24, BP 90/50\n- Head: Bulging anterior fontanelle, head circumference >95th percentile (tracking at 50th previously)\n- Eyes: Pupils sluggishly reactive, right pupil slightly larger than left\n- Skin: Bruising on right posterior ear (pinna), faint linear bruises on torso\n- Neurologic: Decreased tone, intermittent extensor posturing to painful stimuli", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this 4-month-old with altered mental status, bulging fontanelle, and possible seizure. The reported mechanism is a fall from an 18-inch height.\n\nSeveral findings raise concern:\n- Bulging fontanelle with increasing head circumference\n- History of \"healing rib fracture\" attributed to birth trauma (patient is 4 months old)\n- Bruising to ear and torso\n- Mechanism (short fall from couch) seems inconsistent with severity of presentation", "question": "What is the most likely diagnosis, and what clinical features are most concerning for this diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Abusive head trauma - mechanism inconsistent with severity, previous unexplained fracture, bruising in unusual locations", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This presentation is highly concerning for **abusive head trauma (AHT)**, formerly called shaken baby syndrome. Key red flags include: **Mechanism-injury mismatch** (short falls <3 feet rarely cause serious intracranial injury in infants), **previous unexplained fracture** (rib fracture in a 4-month-old attributed to birth trauma is suspicious - birth trauma fractures should have healed by now), **sentinel injuries** (bruises on ears and torso in a non-mobile infant - \"those who don't cruise, don't bruise\"), and **rapidly increasing head circumference** suggesting chronic subdural collections.", "consequence": "Correct identification of concerning pattern. Proceed with evaluation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Accidental head trauma from couch fall - consistent with reported mechanism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Short falls from household height (<3 feet) rarely cause serious injury** in infants. Studies show serious intracranial injury from such falls is extremely uncommon (<1%). This infant has significant findings (bulging fontanelle, seizure, posturing) inconsistent with a simple couch fall. The additional history of prior fracture and bruising in unusual locations makes accidental trauma very unlikely.", "consequence": "Failure to recognize abuse pattern endangers the child.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Meningitis - fever and bulging fontanelle", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While meningitis can cause bulging fontanelle and altered mental status, this infant is **afebrile** (T 36.8\u00b0C). Additionally, meningitis does not explain the **bruising**, **prior rib fracture**, or the clear trauma history. The constellation of findings points to inflicted injury, not infection.", "consequence": "Missing the abuse diagnosis while pursuing infectious workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Glutaric aciduria type 1 - metabolic disorder causing subdural hematomas", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **glutaric aciduria type 1** can cause macrocephaly and subdural hemorrhages (mimicking abuse), it presents with **macrocephaly from birth**, **dystonia**, and **acute encephalopathic crises**. It does not explain the **rib fracture**, **ear bruising**, or **torso bruising** seen in this infant. Always consider metabolic disorders, but don't let them distract from clear abuse indicators.", "consequence": "Rare diagnosis considered when abuse indicators are clear.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Coagulopathy causing spontaneous bleeding - check clotting factors first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While coagulopathy (vitamin K deficiency, hemophilia) should be considered in infants with intracranial hemorrhage, it does not explain the **rib fracture**, **soft tissue bruising** in unusual locations, or the **mechanism-injury mismatch**. Bleeding disorders cause bleeding but not fractures or patterned bruising. Coagulation studies are part of the workup but should not delay abuse evaluation.", "consequence": "Focusing on rare diagnosis while missing obvious abuse indicators.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"Those who don't cruise, don't bruise\"** - bruising in pre-mobile infants (not yet pulling to stand) is highly suspicious for inflicted injury. Common sites for accidental bruising (forehead, shins) develop once children are mobile. Bruising on **ears, neck, torso, or buttocks** is concerning for abuse at any age."}, "node-2": {"id": "node-2", "type": "decision", "content": "You are highly suspicious for abusive head trauma. The infant's neurologic status is concerning with bulging fontanelle and posturing.\n\nYou need to stabilize this patient while initiating the evaluation for abuse.\n\nHead CT is obtained emergently and shows:\n- Bilateral subdural hematomas of varying density (suggesting different ages)\n- Cerebral edema with early loss of gray-white differentiation\n- No skull fracture visible", "question": "What is the most appropriate immediate next step in this infant's evaluation?", "choices": [{"id": "node-2-choice-a", "text": "Dilated fundoscopic exam by ophthalmology and full skeletal survey", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** The abuse evaluation requires: **Dilated fundoscopic exam** - retinal hemorrhages (especially multilayered, extending to the periphery) are highly specific for abusive head trauma and found in ~85% of AHT cases. A pediatric ophthalmologist should perform this urgently. **Full skeletal survey** - standard 21-view radiographic series to identify occult fractures. In AHT, you may find: posterior rib fractures (from squeezing), classic metaphyseal lesions (\"corner fractures\" - pathognomonic for abuse), and fractures of varying ages. These occur in 30-50% of AHT cases.", "consequence": "Comprehensive abuse evaluation initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Confront the babysitter about the mechanism of injury before further testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never confront caregivers** accusatorially or attempt to investigate the abuse yourself. This is the role of child protective services and law enforcement. Confrontation can: endanger the child if returned to the abuser, compromise the legal investigation, and cause the caregiver to flee or create a cover story. Your role is to **document findings objectively**, report to CPS, and ensure the child's medical safety.", "consequence": "Compromising the investigation and potentially endangering the child.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Wait for MRI before deciding if abuse workup is needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. MRI is valuable for **dating injuries** and detecting diffuse axonal injury, but the CT findings (bilateral subdurals of varying ages + cerebral edema) combined with clinical presentation already warrant a full abuse evaluation. MRI can be obtained later but should not delay ophthalmologic exam, skeletal survey, or CPS report. This child needs protection **now**.", "consequence": "Delay in abuse evaluation and child protection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Discharge home with mother and schedule outpatient follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never discharge a child** when abuse is suspected without completion of the evaluation and involvement of child protective services. Sending a potentially abused child home with caregivers places them at high risk for further injury or death. The recurrence rate of abuse is high, and the next injury is often more severe.", "consequence": "Child returned to potentially dangerous environment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Obtain extensive metabolic and genetic testing before abuse evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While metabolic disorders (glutaric aciduria, Menkes disease) and bone fragility conditions (osteogenesis imperfecta) should be considered, the clinical picture here is **classic for abuse**: mechanism-injury mismatch, prior fracture, sentinel bruising, bilateral subdurals. Basic labs (CBC, coagulation studies, metabolic panel) are appropriate, but extensive genetic testing should not delay the abuse evaluation or CPS report.", "consequence": "Unnecessary testing delays child protection measures.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Retinal hemorrhages** in abusive head trauma are typically **multilayered** (involving multiple retinal layers) and **extend to the periphery** (ora serrata). These features distinguish them from hemorrhages seen in accidental trauma, birth trauma, or increased ICP alone. Bilateral involvement is common. Always have a pediatric ophthalmologist perform a dilated exam."}, "node-3": {"id": "node-3", "type": "decision", "content": "Ophthalmology performs dilated fundoscopic exam and finds:\n- Bilateral, multilayered retinal hemorrhages extending to the ora serrata\n- Hemorrhages appear in multiple retinal layers (preretinal, intraretinal, subretinal)\n- No papilledema visible\n\nSkeletal survey reveals:\n- Bilateral posterior rib fractures (ribs 6-9) with varying degrees of callus formation\n- Classic metaphyseal lesion (corner fracture) of left distal femur\n- The \"healing rib fracture\" from 1 month ago now appears as posterior rib fracture with significant callus\n\nThese findings are documented in detail.", "question": "Based on these findings, what are your legal and ethical obligations?", "choices": [{"id": "node-3-choice-a", "text": "Mandatory report to Child Protective Services (CPS) - this is legally required for all healthcare providers", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** All healthcare providers are **mandated reporters** of suspected child abuse. You are legally required to report **reasonable suspicion** of abuse - you do not need to prove abuse occurred or identify the perpetrator. The report should be made **immediately** (typically within 24-48 hours, but sooner for serious cases). Document your findings objectively in the medical record. CPS and law enforcement will investigate. The child should remain hospitalized for medical treatment and protection pending the investigation.", "consequence": "Proper legal and ethical obligations fulfilled.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Request a family meeting to discuss findings before making any report", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do not delay reporting** to discuss with the family or give them opportunity to explain. Mandated reporting is legally required upon **reasonable suspicion** - you don't need the family's input or agreement. Notifying potential abusers before reporting can: allow them to flee, create cover stories, intimidate the child, or cause further harm. You may inform the family that a report is being made, but the report should not be contingent on their response.", "consequence": "Delay in reporting and potential danger to child.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Only report if you can identify who caused the injuries", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Mandated reporters are required to report **suspected abuse** - you do not need to identify the perpetrator. That is the role of CPS and law enforcement. Waiting to identify the abuser delays protection for the child and is not required by law. Report the findings and let investigators determine responsibility.", "consequence": "Inappropriate delay in mandated reporting.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Report only to hospital social work and let them decide about CPS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hospital social workers are valuable team members, **you as the physician are a mandated reporter** and must personally ensure the report is made. You cannot delegate your mandated reporter obligation to others. Social work should be involved, but the legal responsibility for reporting remains yours. In most institutions, the physician must verify the report is made.", "consequence": "Failing to fulfill personal mandated reporter responsibility.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "No report needed since the injuries could theoretically have medical explanations", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The findings - **classic metaphyseal lesions** (pathognomonic for inflicted injury), **posterior rib fractures** (from squeezing), **bilateral subdurals of varying ages**, and **multilayered retinal hemorrhages to ora serrata** - form a constellation that is **highly specific for abusive head trauma**. While differential diagnoses exist for individual findings, this pattern collectively leaves no reasonable doubt. Failing to report is a violation of mandated reporter laws.", "consequence": "Failure to protect an abused child.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Classic metaphyseal lesions** (corner fractures, bucket-handle fractures) are **pathognomonic for child abuse**. They occur from shearing forces at the metaphysis when limbs are pulled or twisted violently. **Posterior rib fractures** result from anteroposterior chest compression (squeezing during shaking). Neither occurs in normal handling or minor accidents."}, "node-4": {"id": "node-4", "type": "decision", "content": "You file a report with CPS and document all findings in detail in the medical record. The child is admitted to the PICU for management of his intracranial injuries.\n\nNeurosurgery is consulted and recommends conservative management of the subdural collections initially, with possible surgical drainage if he deteriorates.\n\nThe child's mother becomes very upset when she learns about the CPS report. She tearfully insists she would never hurt her baby and that she wasn't even home when this happened - the babysitter was watching him.\n\nThe mother asks you: \"Why are you reporting ME when I wasn't even there?\"", "question": "How should you respond to the mother's question about the CPS report?", "choices": [{"id": "node-4-choice-a", "text": "Explain that the report is required by law for any suspected abuse, not an accusation of her specifically", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Explain clearly and compassionately: the CPS report is a **legal requirement** whenever there is concern for child abuse - it is not a personal accusation against any individual. The report does not determine guilt; it triggers an investigation to protect the child. As the physician, your role is to identify concerning injuries and report them. **CPS and law enforcement** will investigate who may be responsible. Maintain a supportive, non-accusatory tone while being honest about the process.", "consequence": "Clear, honest, and compassionate communication.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Tell her you believe she is innocent and the babysitter must have done it", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never speculate about who caused the injuries** or express opinions about specific individuals' guilt or innocence. This is not your role and can compromise the investigation. Even if the mother seems credible, perpetrators of abuse come from all backgrounds and relationships. Some injuries appear to be older than today's events, suggesting a pattern of abuse that may involve multiple caregivers.", "consequence": "Inappropriate speculation compromises investigation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Refuse to discuss the report with her due to confidentiality", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Parents have a right to understand what is happening with their child's care and the CPS process. While you don't need to share investigation details, you can and should explain: why a report was made, what findings prompted it, and what the process involves. Being dismissive or refusing to communicate damages the therapeutic relationship and doesn't serve the child's interests.", "consequence": "Damaging therapeutic relationship with family.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Withdraw the CPS report since she wasn't the caregiver at the time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CPS reports cannot and should not be withdrawn** based on caregiver statements. The child has injuries consistent with abuse regardless of who caused them. The investigation will determine responsibility. Additionally, some of this child's injuries (prior rib fractures) appear to have occurred at different times, suggesting a pattern of abuse that may involve multiple incidents and caregivers.", "consequence": "Inappropriate withdrawal of mandated report.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Tell her you had no choice because the hospital makes you report everything", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While deflecting blame to the hospital might seem easier, it's not accurate and undermines trust. Explain that **you**, as a physician, are a mandated reporter by law - this is your professional and legal obligation, not just hospital policy. Take ownership of your role while explaining it's to protect children, not to accuse anyone specifically.", "consequence": "Dishonest deflection that undermines trust.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "When communicating with families in abuse cases: **Be honest** about findings and the reporting process, **remain non-accusatory** (report concerns, not conclusions about guilt), **document objectively** (what you observed, not interpretations), and **maintain therapeutic relationship** to the extent possible - the child may remain with family after investigation."}, "node-5": {"id": "node-5", "type": "decision", "content": "The mother understands your explanation, though she remains distressed. CPS begins their investigation and places the child in temporary protective custody pending the investigation.\n\nOver the following week, the infant's neurologic status improves, though he has residual hypotonia and developmental delay is expected.\n\nBefore discharge planning, you are asked to provide prognosis information for the court and family.\n\nMRI of the brain shows diffuse axonal injury with white matter abnormalities.", "question": "What is the expected long-term prognosis for children who survive abusive head trauma?", "choices": [{"id": "node-5-choice-a", "text": "Most survivors have significant long-term sequelae including developmental delay, cerebral palsy, seizures, and visual impairment", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Abusive head trauma has devastating outcomes. **Mortality** is 20-25%. Among survivors, **60-70%** have significant long-term morbidity including: **motor deficits** (cerebral palsy, hypotonia), **cognitive impairment** (intellectual disability, learning difficulties), **seizure disorders**, **visual impairment** (from retinal and cortical damage), and **behavioral problems**. Only about **30%** of survivors have normal development. This child's MRI showing diffuse axonal injury suggests high likelihood of significant sequelae. Early intervention services and close developmental monitoring are essential.", "consequence": "Accurate prognostic information for family and court.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Most children recover fully with no long-term effects if they survive the acute injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This significantly **underestimates** the severity of abusive head trauma. The majority of survivors have **permanent neurologic sequelae**. The developing infant brain is particularly vulnerable to the rotational forces, hypoxia, and diffuse injury seen in AHT. Providing falsely optimistic prognosis would not serve the family or inform appropriate resource planning.", "consequence": "Inaccurate prognosis misleads family and care planning.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Prognosis depends entirely on whether the family cooperates with CPS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While a safe environment is important for optimal recovery, the **neurologic prognosis** is primarily determined by the **extent of brain injury**, not family cooperation. This child has documented diffuse axonal injury and bilateral subdural hemorrhages - the brain damage has already occurred. Early intervention can optimize outcomes but cannot reverse the injury.", "consequence": "Medically inaccurate information about prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Cannot provide prognosis information due to ongoing legal investigation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Medical prognosis can and should be provided to inform medical decision-making, family counseling, and resource planning. The legal investigation is separate from medical care. You can provide medical information about expected outcomes based on the child's injuries while being clear that you cannot make legal conclusions about the case.", "consequence": "Family and court lack important medical information.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Outcome is the same as accidental traumatic brain injury in children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Abusive head trauma outcomes are generally **worse** than accidental TBI of similar severity. AHT often involves **repetitive injury** (chronic subdurals suggest multiple episodes), **diffuse axonal injury** from rotational forces, **hypoxia** from apnea during shaking, and **delayed presentation** (caregivers may wait before seeking care). All these factors contribute to poorer outcomes than isolated accidental injury.", "consequence": "Inaccurate comparison to accidental trauma.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Abusive head trauma is the leading cause of death from child abuse** and the leading cause of traumatic brain injury death in children under 2 years. The **triad** of subdural hematoma, retinal hemorrhages, and encephalopathy (with or without external signs of trauma) should prompt immediate evaluation for AHT."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully identified and managed this case of abusive head trauma:\n\n\u2713 Recognized mechanism-injury mismatch (short fall unlikely to cause these injuries)\n\u2713 Identified sentinel injuries (bruising in pre-mobile infant, prior unexplained fracture)\n\u2713 Ordered appropriate workup (ophthalmology exam, skeletal survey)\n\u2713 Understood significance of findings (retinal hemorrhages, classic metaphyseal lesions)\n\u2713 Fulfilled mandated reporter obligations immediately\n\u2713 Communicated appropriately with family\n\u2713 Provided accurate prognostic information\n\nKey learning points:\n- \"Those who don't cruise, don't bruise\" - bruising in pre-mobile infants is concerning\n- Short falls (<3 feet) rarely cause serious injury\n- Retinal hemorrhages (multilayered, peripheral) + subdural + encephalopathy = AHT triad\n- Classic metaphyseal lesions and posterior rib fractures are highly specific for abuse\n- Mandated reporting is legally required upon reasonable suspicion\n- Prognosis is poor - 20-25% mortality, 60-70% of survivors have significant sequelae"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of abusive head trauma evaluation:\n\n- Mechanism-injury mismatch is a key red flag (short falls rarely cause serious injury)\n- Sentinel injuries include: bruising in pre-mobile infants, healing fractures, injuries of different ages\n- Always order: dilated fundoscopic exam + full skeletal survey\n- Key findings: retinal hemorrhages (multilayered, peripheral), classic metaphyseal lesions, posterior rib fractures\n- You are a mandated reporter - report immediately upon reasonable suspicion\n- Don't speculate about perpetrator identity - that's for CPS/law enforcement\n- Prognosis is generally poor with high rates of long-term neurologic sequelae"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in child abuse cases can result in further harm or death:\n\n- Never accept mechanism-injury mismatch without further evaluation\n- Never discharge home when abuse is suspected\n- Never delay or avoid mandated reporting - it's legally required\n- Never confront caregivers or speculate about perpetrator identity\n- Never let concerns about family reactions prevent you from protecting the child\n\nAbusive head trauma is the leading cause of death from child abuse. Missing this diagnosis places children at extreme risk for recurrent, often fatal, injury.\n\nKey pearl: Retinal hemorrhages + subdural hematoma + encephalopathy + no plausible mechanism = abusive head trauma until proven otherwise."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-059", "title": "Infantile Spasms", "domain": "neurology", "difficulty": "intermediate", "tags": ["jackknife spasms", "clusters upon awakening", "hypsarrhythmia", "developmental regression", "infantile spasms"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-month-old male presents to the clinic with brief episodes of sudden stiffening of 2 weeks duration.\n\nAccording to the caregiver, he has clusters of brief jerking movements where his arms flex and he jackknifes forward. These occur in clusters, especially upon waking. He seems to be losing developmental skills.\n\ndevelopmental regression. No fever or infection.\n\nPertinent history includes He was previously meeting milestones but has stopped babbling and reaching for toys.\n\nPhysical Examination:\n- Neurologic: hypotonic with poor head control.\n- Development: regression - no longer rolling or reaching.\n- Witnessed episode: flexor spasm with brief cry.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-month-old has clusters of brief flexor spasms (arms flex, jackknifes forward) occurring especially upon awakening. He has lost developmental skills (no longer babbling, reaching). Parents brought a video showing the episodes.", "question": "What is the CLASSIC clinical triad that defines West Syndrome (Infantile Spasms)?", "choices": [{"id": "node-1-choice-a", "text": "Infantile spasms + Hypsarrhythmia on EEG + Developmental regression/arrest", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **West Syndrome** is defined by the triad: (1) **Infantile spasms** (brief flexor/extensor/mixed spasms in clusters), (2) **Hypsarrhythmia** on EEG (chaotic, high-amplitude, disorganized background), (3) **Developmental regression** or arrest. This is a **neurologic EMERGENCY** - early treatment improves outcomes.", "consequence": "You recognize this neurologic emergency.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Tonic-clonic seizures + Normal EEG + Normal development", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes a different seizure syndrome. Infantile spasms have a **specific semiology** (brief symmetric spasms in clusters) and EEG shows **hypsarrhythmia**, not a normal pattern. Development is characteristically **regressing**.", "consequence": "Wrong seizure syndrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Absence seizures + 3 Hz spike-wave + Preserved cognition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **childhood absence epilepsy**, which presents at age 4-8 years with staring spells. Infantile spasms occur in the **first year of life** with a completely different EEG pattern (hypsarrhythmia vs 3 Hz spike-wave).", "consequence": "Wrong epilepsy syndrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Myoclonic jerks + Normal EEG + No developmental concerns", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **benign myoclonus of infancy**, which is NOT epileptic (normal EEG) and does not cause developmental regression. Infantile spasms cause **BOTH** abnormal EEG (hypsarrhythmia) AND developmental regression.", "consequence": "Benign myoclonus is different.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Febrile seizures + Focal EEG changes + Normal interictal development", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Febrile seizures occur with fever and do not cause developmental regression. Infantile spasms are **afebrile**, have a **specific EEG pattern** (hypsarrhythmia), and cause **developmental regression**.", "consequence": "Febrile seizures are different.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**West Syndrome triad**: (1) **Infantile spasms** (clusters of brief flexor spasms, often on awakening), (2) **Hypsarrhythmia** (chaotic, high-voltage, multifocal EEG), (3) **Developmental regression**. Peak onset: **4-7 months**. This is a NEUROLOGIC EMERGENCY!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect infantile spasms based on the clinical description. You need to confirm the diagnosis.", "question": "What is the ESSENTIAL diagnostic test to confirm infantile spasms?", "choices": [{"id": "node-2-choice-a", "text": "EEG showing hypsarrhythmia (chaotic, high-amplitude, disorganized pattern)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **EEG** is essential and shows **hypsarrhythmia**: chaotic, high-amplitude (>200 \u03bcV), disorganized background with multifocal spikes and slow waves. This pattern may be most prominent during **sleep**. Video-EEG can capture the spasms and correlate with electrographic changes.", "consequence": "Appropriate diagnostic test ordered.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "MRI brain only", "isOptimal": false, "isAcceptable": true, "feedback": "MRI is important to identify **underlying etiology** (~60% have structural cause: tuberous sclerosis, cortical malformations, HIE), but **EEG is required to confirm the diagnosis**. MRI can be normal in cryptogenic cases but hypsarrhythmia confirms the syndrome.", "consequence": "Important but EEG is diagnostic.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Lumbar puncture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. LP is not routinely indicated for infantile spasms unless there's concern for meningitis/encephalitis. The diagnosis is made by **clinical presentation + EEG** (hypsarrhythmia).", "consequence": "Not indicated for diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Genetic testing as first-line", "isOptimal": false, "isAcceptable": false, "feedback": "Genetic testing may identify underlying causes (e.g., TSC1/TSC2 for tuberous sclerosis) but is **not the primary diagnostic test**. EEG showing hypsarrhythmia confirms the diagnosis; genetic testing helps identify etiology.", "consequence": "Helpful for etiology, not diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Clinical diagnosis only - no testing needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While clinical suspicion is important, **EEG confirmation is required**. Hypsarrhythmia is the diagnostic hallmark, and EEG also helps monitor treatment response (resolution of hypsarrhythmia indicates treatment success).", "consequence": "EEG is required for diagnosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hypsarrhythmia** = pathognomonic EEG finding: chaotic, high-amplitude (>200 \u03bcV), disorganized background with multifocal spikes. May be most prominent during **non-REM sleep**. Resolution of hypsarrhythmia is a marker of treatment response."}, "node-3": {"id": "node-3", "type": "decision", "content": "EEG confirms hypsarrhythmia. MRI shows cortical tubers consistent with tuberous sclerosis complex (TSC). The diagnosis is West syndrome secondary to TSC.", "question": "What is the FIRST-LINE treatment for infantile spasms?", "choices": [{"id": "node-3-choice-a", "text": "Vigabatrin - especially for tuberous sclerosis-related spasms", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Vigabatrin** is FIRST-LINE for infantile spasms due to **tuberous sclerosis** (>95% response rate in TSC). For non-TSC cases, **ACTH** (adrenocorticotropic hormone) is first-line. Treatment is URGENT - delay beyond **1 month from onset** worsens neurodevelopmental outcomes.", "consequence": "Optimal first-line treatment for TSC.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "ACTH (adrenocorticotropic hormone)", "isOptimal": false, "isAcceptable": true, "feedback": "ACTH is first-line for **non-TSC infantile spasms** and is also effective. However, for **TSC-related spasms**, **vigabatrin** has superior efficacy (>95% response) and is preferred. Both are acceptable first-line options depending on etiology.", "consequence": "Acceptable but vigabatrin preferred for TSC.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Carbamazepine or phenytoin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Traditional antiepileptics like carbamazepine and phenytoin are **NOT effective** for infantile spasms and may even worsen them. Only **ACTH/vigabatrin** (and sometimes prednisolone) have proven efficacy.", "consequence": "Ineffective for infantile spasms.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Observation with repeat EEG in 3 months", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS delay! Infantile spasms are a **neurologic EMERGENCY**. Every week of delayed treatment worsens neurodevelopmental outcomes. Treatment should begin **immediately** upon diagnosis - ideally within 1 month of symptom onset.", "consequence": "Catastrophic delay worsens outcomes.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Ketogenic diet as monotherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Ketogenic diet is a **second-line option** for refractory cases but is NOT first-line. **ACTH or vigabatrin** should be tried first due to faster onset of action and better evidence for first-line use.", "consequence": "Second-line, not first-line.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Treatment urgency**: Start within **1 month of onset** for best outcomes! **First-line**: Vigabatrin (especially TSC - >95% response) or ACTH (non-TSC). Vigabatrin risk: **irreversible visual field defects** (requires ophthalmology monitoring)."}, "node-4": {"id": "node-4", "type": "decision", "content": "Vigabatrin is started. After 2 weeks, the spasms have stopped and repeat EEG shows resolution of hypsarrhythmia. You counsel the parents about vigabatrin side effects.", "question": "What is the MOST important adverse effect of vigabatrin that requires ongoing monitoring?", "choices": [{"id": "node-4-choice-a", "text": "Irreversible peripheral visual field constriction - requires regular ophthalmology exams", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Vigabatrin causes **irreversible bilateral concentric visual field constriction** in 25-50% of patients. Regular **ophthalmology monitoring** (ERG in infants, perimetry in older children) is MANDATORY. Despite this risk, vigabatrin remains first-line for TSC due to its dramatic efficacy.", "consequence": "You understand the critical monitoring requirement.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Hepatotoxicity requiring liver function monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hepatotoxicity is associated with **valproic acid**, not vigabatrin. Vigabatrin's signature toxicity is **visual field constriction**, which is irreversible and requires ophthalmologic monitoring.", "consequence": "Wrong drug toxicity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Stevens-Johnson syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SJS is classically associated with **lamotrigine**, **carbamazepine**, and **phenytoin**, not vigabatrin. Vigabatrin's primary concern is **irreversible visual field defects**.", "consequence": "Wrong drug association.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Aplastic anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Aplastic anemia is associated with **felbamate** and **carbamazepine**, not vigabatrin. Remember: vigabatrin = **vision** (visual field constriction).", "consequence": "Wrong drug association.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "No significant monitoring needed", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS. Vigabatrin causes **irreversible visual field loss** in 25-50% of patients. Ophthalmology monitoring is **MANDATORY** - baseline within 4 weeks, then every 3-6 months while on treatment.", "consequence": "Missing critical monitoring.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Vigabatrin toxicity**: Irreversible **bilateral concentric visual field constriction** (25-50% of patients). Monitoring: **ERG** in infants (can't do perimetry), **visual field testing** in older children. Risk is dose and duration dependent. Despite this, benefit outweighs risk for infantile spasms."}, "node-5": {"id": "node-5", "type": "decision", "content": "At 2-year follow-up, the spasms remain controlled but the child has developmental delays and has developed other seizure types (focal seizures). Parents ask about long-term prognosis.", "question": "What is the MOST accurate prognostic statement for children with infantile spasms?", "choices": [{"id": "node-5-choice-a", "text": "70-90% have intellectual disability; many develop other epilepsy types including Lennox-Gastaut syndrome", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Despite treatment, **70-90% of children with infantile spasms have intellectual disability**. Many (~50%) develop other seizure types, including progression to **Lennox-Gastaut syndrome** (an even more severe epileptic encephalopathy). Prognosis is better with **cryptogenic** (no identified cause) vs symptomatic cases and with **early treatment**.", "consequence": "Accurate prognostic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Most children have normal development if treated early", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While early treatment improves outcomes, **most children still have developmental impairment**. Only about 10-20% (mostly cryptogenic cases with early treatment) have normal development. The majority have significant intellectual disability.", "consequence": "Overly optimistic prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Seizures always resolve by age 5 without further epilepsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While infantile spasms themselves may remit, **~50% develop other seizure types**, including progression to Lennox-Gastaut syndrome. Ongoing epilepsy management is often needed throughout life.", "consequence": "Misleading about epilepsy evolution.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Prognosis is identical regardless of underlying etiology", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Etiology matters significantly! **Cryptogenic** (no identified cause) cases have BETTER prognosis than **symptomatic** cases (TSC, HIE, cortical malformations). Early treatment and cryptogenic etiology are the best prognostic factors.", "consequence": "Etiology significantly affects prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Autism is rare in infantile spasms survivors", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Autism spectrum disorder** is common in infantile spasms survivors, especially those with **tuberous sclerosis** (up to 50%). The triad of infantile spasms, intellectual disability, and autism is well-recognized, particularly in TSC.", "consequence": "Autism is actually common.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Infantile spasms prognosis**: 70-90% have intellectual disability, ~50% develop other seizure types (including Lennox-Gastaut). **Better prognosis**: cryptogenic etiology, early treatment (<1 month), rapid EEG response. **Autism** is common, especially with TSC."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You recognized the West syndrome triad, confirmed with EEG (hypsarrhythmia), initiated appropriate first-line treatment (vigabatrin for TSC), understood the critical visual monitoring requirement, and provided accurate prognostic counseling. Key teaching points: (1) West syndrome = spasms + hypsarrhythmia + regression, (2) Treatment is URGENT - within 1 month, (3) Vigabatrin first-line for TSC, ACTH for non-TSC, (4) Vigabatrin causes irreversible visual field loss - monitor!, (5) 70-90% have intellectual disability despite treatment."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key infantile spasms concepts: (1) West syndrome triad: spasms + hypsarrhythmia + developmental regression, (2) EEG is essential for diagnosis, (3) Treatment is URGENT - delay worsens outcomes, (4) Vigabatrin for TSC, ACTH for non-TSC, (5) Vigabatrin requires vision monitoring (irreversible field defects), (6) 70-90% have intellectual disability."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key infantile spasms principles: (1) This is a NEUROLOGIC EMERGENCY - delay worsens outcomes, (2) EEG (hypsarrhythmia) is required for diagnosis, (3) Standard antiepileptics (carbamazepine, phenytoin) are INEFFECTIVE and may worsen spasms, (4) Vigabatrin requires MANDATORY ophthalmology monitoring for irreversible visual field loss."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-065", "title": "Epidural Hematoma Recognition", "domain": "neurology", "difficulty": "intermediate", "tags": ["lucid interval", "lens-shaped hematoma", "does not cross suture lines", "talk and deteriorate", "epidural hematoma recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 8-year-old male is brought to the emergency department after head injury followed by brief loss of consciousness for the past 4 hours.\n\nAccording to the caregiver, he was hit on the side of the head with a baseball. He was briefly unconscious, then woke up and seemed fine for about 2 hours. Now he is becoming increasingly confused and has a severe headache.\n\nAssociated symptoms include lucid interval followed by deterioration. Denies seizure activity.\n\nPast medical history includes No prior head injuries. Not on any blood thinners.\n\nPhysical Examination:\n- Neurologic: drowsy, unequal pupils (left > right), weakness on right side.\n- Head: left temporal swelling.\n- General: increasing confusion.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 8-year-old presents with the classic 'talk and deteriorate' pattern: brief LOC \u2192 lucid interval \u2192 progressive neurologic decline with signs of herniation (unequal pupils, contralateral hemiparesis). The temporal impact site is significant.", "question": "What is the most likely diagnosis based on this classic presentation?", "choices": [{"id": "node-1-choice-a", "text": "Epidural hematoma from middle meningeal artery injury", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **'talk and deteriorate' pattern** (lucid interval) is classic for epidural hematoma. Temporal bone impact often causes **middle meningeal artery** laceration (pterion is thinnest skull area). The arterial bleed causes rapid accumulation of blood between skull and dura.", "consequence": "Emergent CT scan ordered STAT.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Subdural hematoma from bridging vein tear", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Subdural hematoma** (SDH) is venous bleeding with slower accumulation. It typically presents with **gradual decline** rather than the classic lucid interval. SDH is more common in elderly and infants with shaking (child abuse).", "consequence": "Misdiagnosis delays emergent intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Cerebral contusion with surrounding edema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Contusions cause focal brain bruising but don't typically produce the dramatic 'lucid interval' pattern. Symptoms would be more related to the contusion location, not the classic herniation syndrome described here.", "consequence": "Misdiagnosis delays emergent intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Subarachnoid hemorrhage from berry aneurysm rupture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SAH presents with **'thunderclap' headache** and nuchal rigidity, typically without trauma. Berry aneurysm rupture is rare in children. This patient's presentation is clearly trauma-related.", "consequence": "Misdiagnosis delays emergent intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Post-concussive syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! Post-concussive syndrome does NOT cause progressive neurologic deterioration, pupil asymmetry, or focal weakness. These are **signs of herniation** requiring emergent intervention, not supportive care.", "consequence": "Failure to recognize surgical emergency leads to death.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**'Talk and Die'** = classic epidural hematoma. The **lucid interval** occurs because the initial concussion resolves, but arterial bleeding continues \u2192 increased ICP \u2192 herniation. Time is critical!"}, "node-2": {"id": "node-2", "type": "decision", "content": "Non-contrast head CT is performed:\n- **Biconvex (lens-shaped)** hyperdense collection in left temporal region\n- Does NOT cross suture lines (contained by dural attachments)\n- 15mm thickness with 8mm midline shift\n- Associated left temporal skull fracture\n\nThe patient is now posturing with GCS 7.", "question": "What is the pathophysiologic reason this hematoma appears biconvex and does NOT cross suture lines?", "choices": [{"id": "node-2-choice-a", "text": "Dura is tightly adherent to skull at suture lines, limiting blood spread", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Epidural hematomas are limited by suture lines** because the dura mater is firmly attached to the skull at these points. Blood accumulates between skull and dura, creating the characteristic **biconvex/lens shape** as it pushes the dura inward. This is a key distinguishing feature from subdural hematoma.", "consequence": "You understand the anatomy. Now proceed to emergent management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Blood is contained within the subarachnoid space", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Subarachnoid hemorrhage fills the CSF spaces around the brain and appears in **sulci and cisterns** on CT, not as a convex collection. This is clearly an extra-axial collection pushing on the brain.", "consequence": "Anatomic confusion does not change management urgency.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Cerebral edema limits the spread of blood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. It's the **dural attachments at suture lines** that limit epidural hematoma spread, not cerebral edema. Understanding this anatomy helps distinguish EDH from SDH on imaging.", "consequence": "Anatomic confusion does not change management urgency.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Venous blood clots more rapidly than arterial blood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The shape is determined by anatomic barriers (dural attachments), not clotting characteristics. EDH is typically **arterial** (middle meningeal artery) which actually bleeds faster than venous sources.", "consequence": "Anatomic confusion does not change management urgency.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "The skull fracture limits blood spread", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The skull fracture is the entry point for bleeding, not a barrier. The **dura's attachment at suture lines** creates the characteristic limited spread and biconvex shape.", "consequence": "Anatomic confusion does not change management urgency.", "nextNodeId": "node-3"}], "clinicalPearl": "**Epidural = biconvex (lens), limited by sutures**. **Subdural = crescent-shaped, crosses sutures** (between dura and arachnoid). This CT distinction is HIGH-YIELD for boards!"}, "node-3": {"id": "node-3", "type": "decision", "content": "The patient is now posturing (GCS 7) with a fixed, dilated left pupil (ipsilateral to the hematoma). There is right-sided hemiparesis (contralateral to the lesion). Neurosurgery is mobilizing.", "question": "What is the mechanism of the ipsilateral dilated pupil and contralateral hemiparesis (uncal herniation signs)?", "choices": [{"id": "node-3-choice-a", "text": "CN III compression against tentorium (pupil) + ipsilateral cerebral peduncle compression (contralateral weakness)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Uncal herniation** causes the medial temporal lobe (uncus) to herniate through the tentorial notch. This compresses **CN III** (oculomotor) causing ipsilateral pupil dilation (parasympathetic fibers run on outside of nerve). The **ipsilateral cerebral peduncle** is compressed against the tentorium, causing contralateral motor deficit.", "consequence": "You recognize herniation syndrome. Emergent craniotomy is imperative.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Direct pressure on the brainstem from the hematoma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The hematoma is supratentorial (above the tentorium). Brainstem compression occurs indirectly through **uncal herniation**, not direct pressure. The herniation mechanism explains the lateralizing signs.", "consequence": "Mechanism confusion does not change emergent management.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Compression of the contralateral cerebral peduncle (Kernohan notch phenomenon)", "isOptimal": false, "isAcceptable": true, "feedback": "**Kernohan notch phenomenon** is a false localizing sign where the contralateral peduncle is compressed against the opposite tentorial edge, causing **ipsilateral** (same side as hematoma) weakness. However, the typical pattern is ipsilateral pupil + **contralateral** weakness as described here.", "consequence": "Understanding atypical presentations is valuable, but this is the classic pattern.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Increased intracranial pressure causing bilateral pupil dilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The pupil dilation is unilateral and ipsilateral to the lesion, indicating **CN III compression from uncal herniation**. Bilateral fixed pupils would indicate bilateral herniation or severe brainstem injury - a much worse prognosis.", "consequence": "Mechanism confusion does not change emergent management.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Contusion of the motor cortex from the initial impact", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While coup-contrecoup injury can occur, the **progressive nature** of this patient's decline indicates herniation physiology, not static injury from the initial impact.", "consequence": "Mechanism confusion does not change emergent management.", "nextNodeId": "node-4"}], "clinicalPearl": "**Uncal herniation triad**: (1) Ipsilateral pupil dilation (CN III), (2) Contralateral hemiparesis (peduncle compression), (3) Decreased consciousness (reticular formation compression). **'Down and out' eye** if CN III fully affected."}, "node-4": {"id": "node-4", "type": "decision", "content": "Neurosurgery is in the OR preparing. The patient is being emergently transported. You have 5-10 minutes before the craniotomy can begin.", "question": "What temporizing measures should be initiated while awaiting definitive surgical evacuation?", "choices": [{"id": "node-4-choice-a", "text": "Elevate HOB 30\u00b0, hyperventilate to PCO2 30-35 mmHg, IV mannitol or hypertonic saline", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ICP management measures**: (1) **HOB elevation 30\u00b0** improves venous drainage, (2) **Hyperventilation (PCO2 30-35)** causes cerebral vasoconstriction (temporary measure only), (3) **Osmotic therapy** (mannitol 0.5-1 g/kg or 3% saline) draws fluid out of brain. These are bridges to surgery, NOT definitive treatment.", "consequence": "ICP temporized. Patient taken emergently to OR.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "High-dose steroids (dexamethasone) for cerebral edema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Steroids are NOT indicated for traumatic brain injury** and may worsen outcomes. The CRASH trial showed increased mortality with steroids in TBI. Steroids are for vasogenic edema (tumors, abscesses), not cytotoxic edema from trauma.", "consequence": "Inappropriate treatment with no benefit and potential harm.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Emergent burr hole at bedside to relieve pressure", "isOptimal": false, "isAcceptable": true, "feedback": "Burr holes can be life-saving in resource-limited settings or when OR is unavailable, but in a hospital with neurosurgery available, **formal craniotomy** provides better visualization and hemostasis. Bedside burr holes risk incomplete evacuation and rebleeding.", "consequence": "Partial decompression achieved, but formal craniotomy still needed.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-d", "text": "Lumbar puncture to drain CSF and reduce ICP", "isOptimal": false, "isAcceptable": false, "feedback": "CONTRAINDICATED! **Lumbar puncture with mass effect risks herniation** by creating a pressure gradient. Never perform LP when there are signs of increased ICP or mass lesion.", "consequence": "LP causes transtentorial herniation and death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Therapeutic hypothermia to reduce metabolic demand", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hypothermia is used in some TBI protocols, it takes time to implement and is not a temporizing measure for acute herniation. The priority is osmotic therapy and definitive surgical evacuation.", "consequence": "Delay in appropriate temporizing measures.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**TBI ICP management mnemonic - 'HEAD'**: **H**yperventilate (temporary, PCO2 30-35), **E**levate head of bed 30\u00b0, **A**void hypotension/hypoxia, **D**iuretics (mannitol/hypertonic saline). **NO STEROIDS in TBI!**"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of this neurosurgical emergency!\n\n**Key Learning Points:**\n1. **Recognition**: 'Talk and deteriorate'/lucid interval = think epidural hematoma\n2. **Imaging**: Biconvex (lens-shaped), limited by suture lines, ~90% have skull fracture\n3. **Anatomy**: Middle meningeal artery injury (pterion = thinnest skull)\n4. **Herniation**: Ipsilateral pupil (CN III) + contralateral weakness (peduncle)\n5. **Temporizing**: HOB 30\u00b0, hyperventilation, mannitol/hypertonic saline - NO STEROIDS\n6. **Definitive**: Emergent craniotomy for evacuation\n\n**Prognosis**: With rapid surgical evacuation, EDH has excellent outcomes (~90% good recovery). Delay = death. This is one of the most surgically treatable causes of death in trauma."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review critical pearls:\n\n1. **'Talk and die'** = classic epidural hematoma pattern\n2. **Biconvex + limited by sutures** = epidural (vs crescent + crosses sutures = subdural)\n3. **NO STEROIDS in TBI** - CRASH trial showed harm\n4. **Never LP with mass effect** - causes herniation\n5. **Time = brain** - emergent surgical evacuation is definitive"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error leading to patient death.\n\n**Fatal mistakes to avoid:**\n- **LP with mass effect** causes transtentorial herniation\n- **Steroids in TBI** worsen outcomes (CRASH trial)\n- **Delaying surgery** - EDH is an arterial bleed that expands rapidly\n- **Missing the lucid interval** - any child who 'talks then deteriorates' needs emergent CT\n\n**Remember**: Epidural hematoma is one of the most treatable causes of death in trauma - but only if recognized and operated on rapidly."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-083", "title": "Obtunded Patient Airway Management", "domain": "neurology", "difficulty": "advanced", "tags": ["airway management", "GCS", "obtunded", "opioid overdose", "naloxone", "intubation", "respiratory depression", "bag-mask ventilation", "re-sedation"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "EMS brings in a 7-year-old male found unresponsive by his parents in the backyard. There is no known trauma, but an empty pill bottle was found nearby (parents' oxycodone prescription).\n\nOn arrival:\n- Vital signs: HR 52, BP 85/50, RR 6 (shallow), SpO2 84% on room air, T 36.2\u00b0C\n- GCS: Eye 1, Verbal 1, Motor 2 = **GCS 4**\n- Pupils: 2mm bilaterally, minimally reactive (pinpoint)\n- No response to painful stimuli except minimal flexion\n- Copious oral secretions, sonorous respirations\n- No obvious trauma\n\nThe child is cyanotic and making gurgling sounds with each breath.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You have an unresponsive child with GCS 4, bradycardia, hypotension, respiratory depression (RR 6), and hypoxia (SpO2 84%). The pinpoint pupils suggest opioid overdose.\n\nThis is a critical situation requiring immediate action.", "question": "What is the FIRST priority in managing this patient?", "choices": [{"id": "node-1-choice-a", "text": "Open the airway with positioning (jaw thrust), suction secretions, and provide bag-mask ventilation with 100% O2", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Airway, Breathing, Circulation (ABC)** - airway management is ALWAYS the first priority. With GCS 4 and RR 6, this child cannot protect his airway. Immediate steps: **Jaw thrust** (not head-tilt chin-lift if trauma not ruled out), **suction** the copious secretions, and **bag-mask ventilate** with 100% O2 to correct hypoxia. This must happen BEFORE anything else, including antidote administration.", "consequence": "Airway opened. Suctioning reveals copious secretions. BVM initiated.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Administer naloxone (Narcan) immediately to reverse the opioid overdose", "isOptimal": false, "isAcceptable": true, "feedback": "Naloxone is definitely indicated, but **airway management comes FIRST**. A patient who is not breathing adequately will die before the naloxone takes effect (onset 1-2 minutes IV, longer IM/IN). The immediate priority is to **ventilate the patient** while preparing naloxone. Remember: \"Oxygenate before you medicate.\"", "consequence": "Naloxone given but patient remains hypoxic without ventilation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Immediately intubate the patient", "isOptimal": false, "isAcceptable": true, "feedback": "Intubation may ultimately be needed (GCS \u22648 typically requires definitive airway), but **bag-mask ventilation should be attempted first** unless contraindicated. In opioid overdose, naloxone may rapidly reverse respiratory depression, potentially avoiding intubation. Start with **BVM while preparing for intubation** as a backup.", "consequence": "Intubation attempt without prior oxygenation increases risk.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Start IV access and push D50W for possible hypoglycemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect sequence. While hypoglycemia should be checked (point-of-care glucose), this child's presentation (pinpoint pupils, known opioid exposure, respiratory depression) is classic for **opioid toxicity**. More importantly, **airway management must precede IV access** when the patient is not breathing adequately. You cannot start an IV on a dead patient.", "consequence": "Patient deteriorates while focusing on IV access.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Order stat head CT to rule out intracranial hemorrhage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never send an unstable patient to CT**. This child is critically ill with respiratory failure. Imaging can wait until the patient is stabilized. The clinical presentation (pinpoint pupils, pill bottle, respiratory depression) clearly suggests opioid overdose. Airway management is the priority.", "consequence": "Patient arrests en route to CT scanner.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ABC always comes first!** In any critically ill patient, secure the airway before addressing the underlying cause. For obtunded patients: position (jaw thrust if trauma possible), suction, ventilate. The mnemonic \"GCS \u22648, intubate\" reminds us these patients cannot protect their airway."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have opened the airway, suctioned copious secretions, and are providing BVM ventilation with 100% O2. SpO2 is now 94% and improving.\n\nThe child remains unresponsive with GCS 4. HR is now 58 (slightly improved with oxygenation).\n\nIV access has been obtained. Point-of-care glucose is 95 mg/dL.", "question": "What is the most appropriate next step now that ventilation is established?", "choices": [{"id": "node-2-choice-a", "text": "Administer naloxone 0.1 mg/kg IV (max 2 mg) and observe for response", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With ventilation established and strong clinical suspicion for opioid overdose (pinpoint pupils, pill bottle, respiratory depression), give **naloxone**. Pediatric dose: **0.1 mg/kg IV** (max 2 mg), can repeat every 2-3 minutes. In opioid-naive patients (like this child), full reversal is appropriate. Watch for rapid awakening and potential withdrawal symptoms.", "consequence": "Naloxone 0.7 mg IV given. Within 2 minutes, child begins moving.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Proceed directly to endotracheal intubation", "isOptimal": false, "isAcceptable": true, "feedback": "With GCS \u22648, intubation is generally indicated for airway protection. However, in **opioid overdose**, naloxone may rapidly reverse respiratory depression and restore consciousness, **potentially avoiding intubation**. Since BVM is effective and the etiology is clear, a trial of naloxone is reasonable before committing to intubation. Keep intubation equipment ready.", "consequence": "Intubation performed, but may have been avoidable with naloxone.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Give flumazenil in case this is benzodiazepine overdose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Flumazenil is contraindicated** in undifferentiated overdose because it can precipitate seizures in patients with chronic benzodiazepine use or mixed overdoses. The clinical picture (pinpoint pupils, respiratory depression, oxycodone bottle) points clearly to **opioids**, not benzodiazepines. Benzodiazepines typically cause normal or slightly dilated pupils.", "consequence": "Risk of seizures with flumazenil. Wrong antidote.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Wait and continue BVM for 30 minutes to see if patient wakes up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While supportive care with ventilation can sustain the patient, **specific antidote therapy is available and indicated**. Prolonged BVM is difficult to maintain, risks gastric insufflation and aspiration, and delays definitive care. Naloxone can rapidly reverse the opioid effects and restore spontaneous breathing.", "consequence": "Unnecessary delay in treatment. Risk of aspiration.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Administer atropine for the bradycardia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **bradycardia is secondary to hypoxia and opioid toxicity**. The appropriate treatment is to address the underlying cause: oxygenation (ongoing) and opioid reversal with naloxone. Atropine is not indicated for bradycardia secondary to toxicity when a specific antidote exists. Treat the cause, not just the symptom.", "consequence": "Treats symptom but not cause. Doesn't address overdose.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Naloxone dosing**: 0.1 mg/kg IV/IM/SC (max 2 mg per dose), can repeat q2-3min. Intranasal: 4 mg (Narcan nasal spray). In opioid-dependent patients, use smaller doses (0.01-0.04 mg/kg) to avoid precipitating withdrawal. Watch for **re-sedation** as naloxone wears off (30-90 min) before the opioid does."}, "node-3": {"id": "node-3", "type": "decision", "content": "After naloxone administration:\n- Child begins to move within 2 minutes\n- Eyes open, looking around confused\n- GCS improves to 11 (E3V3M5)\n- RR increases to 16, SpO2 99% on supplemental O2\n- HR 78, BP 100/65\n- Pupils now 4mm and reactive\n\nHe is crying and asking for his mom. He denies suicidal intent\u2014says he found the pills and thought they were candy.", "question": "What is the most important consideration for ongoing management?", "choices": [{"id": "node-3-choice-a", "text": "Admit for observation - naloxone duration is shorter than oxycodone, risk of re-sedation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Naloxone has a shorter half-life (30-90 min) than most opioids**. Oxycodone (especially extended-release) can cause **re-sedation** after naloxone wears off. This child needs **observation for at least 4-6 hours** (longer for extended-release formulations). Repeat naloxone may be needed, or a naloxone infusion (2/3 of reversal dose per hour) for sustained effect.", "consequence": "Child admitted for monitoring. Poison control consulted.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Discharge home once alert - naloxone has reversed the overdose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never discharge after naloxone reversal** without an appropriate observation period. Naloxone's duration (30-90 min) is shorter than most opioids. The child can become re-sedated, stop breathing, and die at home. Minimum observation is 4-6 hours, longer for long-acting opioids.", "consequence": "Patient sent home. Re-sedation occurs, respiratory arrest at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Intubate now since GCS was \u22648 earlier", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The indication for intubation was **inability to protect airway**, which has been resolved with naloxone. The child is now **awake, protecting his airway, and breathing spontaneously**. Intubating an awake, responsive patient is not indicated and would require sedation, defeating the purpose.", "consequence": "Unnecessary intubation of awake patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Give activated charcoal to prevent further absorption", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activated charcoal** is most effective within 1-2 hours of ingestion and when the patient is fully alert with intact airway reflexes. The time of ingestion is unknown (found unresponsive), absorption has likely already occurred, and risk of aspiration outweighs benefit. Charcoal is NOT indicated here.", "consequence": "Risk of aspiration without significant benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Transfer to psychiatry for suicidal ingestion evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "While psychiatric evaluation might be considered later, this was an **accidental ingestion** (7-year-old who thought pills were candy), not suicidal. The immediate priority is **medical stabilization and observation for re-sedation**. Psychiatry consultation is not urgent and should not delay appropriate medical care.", "consequence": "Misses the priority of medical observation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Re-sedation risk**: Naloxone duration (30-90 min) < opioid duration. Observe minimum 4-6 hours. For long-acting opioids (methadone, extended-release formulations), observe longer or start **naloxone infusion** (2/3 of reversal dose per hour). Never discharge immediately after naloxone reversal!"}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is admitted for observation. At hour 3:\n- Child becomes drowsy again\n- RR decreases from 16 to 10\n- SpO2 drops to 92% on room air\n- GCS decreases from 14 to 10\n\nThis suggests the naloxone is wearing off and opioid effects are recurring.", "question": "What is the appropriate management for this re-sedation?", "choices": [{"id": "node-4-choice-a", "text": "Repeat naloxone bolus, then start continuous naloxone infusion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **re-sedation** as the naloxone wears off. Repeat the naloxone bolus to achieve reversal, then start a **continuous infusion** to maintain the effect. Infusion rate: typically **2/3 of the effective bolus dose per hour**. Titrate to maintain adequate respiratory effort (RR >12, SpO2 >94%) while avoiding complete reversal in opioid-dependent patients.", "consequence": "Naloxone bolus given, infusion started. Child remains stable.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Intubate immediately - the naloxone didn't work", "isOptimal": false, "isAcceptable": true, "feedback": "Intubation is a reasonable option if **repeat naloxone fails** or if prolonged intubation is anticipated. However, this is likely re-sedation from naloxone wearing off, not failure. **Repeat naloxone** should be tried first\u2014it worked initially. Intubation should be a backup if naloxone cannot maintain adequate ventilation.", "consequence": "Intubation performed. More invasive than necessary.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "This is expected - continue observation without intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While re-sedation is expected, it requires **active intervention**, not passive observation. RR of 10 and SpO2 of 92% indicate the child is developing respiratory compromise again. Without repeat naloxone, the patient could progress to respiratory arrest. This is not a benign finding.", "consequence": "Patient deteriorates without intervention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Give a higher dose of naloxone (10 mg) for prolonged effect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Giving a massive bolus does NOT significantly prolong naloxone's duration of action\u2014it just provides more drug than needed. The **half-life remains the same**. The solution to short duration is a **continuous infusion**, not mega-doses. Large boluses in opioid-dependent patients can also cause severe withdrawal.", "consequence": "Doesn't solve the duration problem. Risk of severe withdrawal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Switch to nalmefene for longer duration", "isOptimal": false, "isAcceptable": false, "feedback": "**Nalmefene** is a longer-acting opioid antagonist but is **not recommended in pediatrics** and is not commonly available. It can cause prolonged withdrawal in opioid-dependent patients. The standard approach is **naloxone infusion**, which allows for titration and can be stopped if needed.", "consequence": "Not standard pediatric practice. Availability issues.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Naloxone infusion**: Start at 2/3 of effective bolus dose per hour. Example: if 0.4 mg reversed the patient, start infusion at ~0.25-0.3 mg/hr. Titrate to maintain RR >12 and SpO2 >94%. Wean slowly once opioid is expected to be cleared. Duration depends on opioid half-life."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You prioritized airway management (positioning, suctioning, BVM) before addressing the underlying cause, appropriately used naloxone for opioid reversal, recognized the risk of re-sedation, and managed it with repeat dosing and continuous infusion.\n\n**Key Learning Points:**\n- **GCS \u22648 = cannot protect airway** \u2192 prepare for intubation\n- **ABC first**: Oxygenate before you medicate\n- **Opioid toxicity triad**: CNS depression + respiratory depression + miosis (pinpoint pupils)\n- **Naloxone**: 0.1 mg/kg IV (max 2 mg), can repeat q2-3min\n- **Re-sedation risk**: Naloxone (30-90 min) < most opioids \u2192 observe 4-6+ hours\n- **Naloxone infusion**: 2/3 of effective bolus per hour for sustained reversal"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While some aspects of management were correct, there were delays or errors that could have affected patient outcomes.\n\n**Review:**\n- **Airway FIRST** in any obtunded patient\n- **GCS \u22648** indicates inability to protect airway\n- **Naloxone** is the antidote for opioid overdose\n- Watch for **re-sedation** - naloxone is shorter-acting than most opioids\n- Use **naloxone infusion** for sustained reversal"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical errors in management.** Airway management in an obtunded patient is a life-or-death skill. Delays or inappropriate interventions can be fatal.\n\n**Key Pearl:** \"GCS \u22648, intubate\" - but always start with basic airway maneuvers (positioning, suctioning, BVM). Never send an unstable patient to imaging. Never discharge after naloxone reversal without observation for re-sedation. The obtunded patient cannot protect their airway from aspiration."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-113", "title": "Retinoblastoma Recognition", "domain": "neurology", "difficulty": "intermediate", "tags": ["leukocoria", "white pupil in photograph", "absent red reflex", "cat's eye reflex", "RB1 mutation", "two-hit hypothesis", "hereditary cancer", "osteosarcoma risk", "retinoblastoma recognition"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 2-year-old girl is brought to clinic by her parents who noticed something unusual about her left eye in photographs. In flash photos, her left eye appears to have a white glow instead of the normal red-eye reflection.\n\nHistory of Present Illness:\n- Parents first noticed the 'white eye' in photos about 2 months ago\n- Initially thought it was a camera artifact, but it appears consistently in photos\n- Recently noticed their daughter bumping into objects on her left side\n- No eye redness, discharge, or apparent pain\n- No fever or systemic symptoms\n- Child seems otherwise well and developmentally normal\n\nFamily History:\n- Father had an eye removed as an infant for 'cancer' but is now healthy at age 32\n- No other significant family history\n\nPhysical Examination:\n- General: Active, well-appearing toddler\n- Vitals: Normal for age\n- Eyes:\n  - **Right eye**: Normal red reflex, normal pupil, full extraocular movements\n  - **Left eye**: **Absent red reflex** with **white pupillary reflection (leukocoria)**, slight esotropia (inward deviation), full extraocular movements\n- Remainder of exam unremarkable", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-year-old presents with **leukocoria** (white pupil) in the left eye, noticed in photographs. Key concerning features include:\n\n- **Leukocoria** - absent red reflex with white pupillary reflection\n- **Strabismus** - esotropia can result from vision loss\n- **Father with enucleation for eye cancer in infancy** - highly suggestive family history\n- **Bumping into objects** on left side - suggests visual impairment\n\n**Leukocoria** in a child is an **ophthalmologic emergency** until proven otherwise.", "question": "What is the MOST likely diagnosis that must be ruled out immediately?", "choices": [{"id": "node-1-choice-a", "text": "Retinoblastoma", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Retinoblastoma** is the most likely diagnosis and must be ruled out **immediately**. It is the **most common intraocular malignancy in children** (1 in 15,000-20,000 births). The classic presentation is **leukocoria** (white pupil), often first noticed in **flash photography** where the normal red reflex is absent. The **family history of father's enucleation for eye cancer** is highly suggestive of **hereditary retinoblastoma**.\n\n**Key features:**\n- Average age at diagnosis: **18 months** (hereditary often earlier)\n- Unilateral: 60% (usually sporadic)\n- **Bilateral: 40%** (almost always hereditary)\n- Strabismus is the second most common presenting sign (from vision loss)", "consequence": "You recognize the urgency of ruling out retinoblastoma.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Congenital cataract", "isOptimal": false, "isAcceptable": true, "feedback": "Congenital cataract can cause leukocoria and is in the differential, but this presentation is more concerning for **retinoblastoma** due to: (1) **Age of onset** - cataracts causing leukocoria are typically noticed earlier (at birth or in early infancy), (2) **Family history** - the father's enucleation for 'eye cancer' strongly suggests hereditary retinoblastoma, (3) **Unilateral presentation** - congenital cataracts are often bilateral. Cataract must be considered, but retinoblastoma must be ruled out first given its malignant nature.", "consequence": "Cataract is possible but retinoblastoma must be ruled out first.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Coats disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Coats disease** is a non-hereditary condition causing retinal telangiectasias and exudative retinal detachment, which can cause leukocoria. However, key differences: (1) Coats disease is almost exclusively in **males** (this patient is female), (2) It is typically **unilateral** and **sporadic** (no family history expected), (3) Average age is slightly older (6-8 years). The **family history of paternal eye cancer** makes retinoblastoma far more likely.", "consequence": "Coats disease doesn't fit the demographics or family history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Retinopathy of prematurity (ROP)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ROP** can cause leukocoria from retinal detachment, but it only occurs in **premature infants** who received supplemental oxygen. Key issues: (1) There is no history of prematurity mentioned, (2) ROP would have been diagnosed much earlier during NICU screening, (3) The **family history of eye cancer** is unexplained by ROP. ROP is not in the differential for this full-term child presenting at age 2.", "consequence": "ROP only occurs in premature infants.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Normal variant (physiologic anisocoria)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **DANGEROUS**! **Leukocoria is NEVER normal**. Physiologic anisocoria refers to unequal pupil sizes, not to absent red reflex or white pupillary reflection. A white pupil indicates light is being reflected abnormally from within the eye - this is always pathological. **Leukocoria = retinoblastoma until proven otherwise**. Missing this diagnosis can be fatal.", "consequence": "Leukocoria is NEVER normal - always pathological!", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**'White pupil, worried provider'**: Leukocoria in a child is **retinoblastoma until proven otherwise**. Check the **red reflex at EVERY well-child visit** - this simple test can be life-saving."}, "node-2": {"id": "node-2", "type": "decision", "content": "You urgently refer the patient to pediatric ophthalmology. The ophthalmologist performs an **examination under anesthesia (EUA)** with **indirect ophthalmoscopy**.\n\n**Findings:**\n- Left eye: Large **whitish-cream colored retinal mass** with overlying retinal detachment\n- **Calcifications** visible within the tumor\n- Vitreous seeding noted\n- Right eye: No lesions seen (but will need serial exams)\n\n**Ocular ultrasound:** Confirms intraocular mass with **characteristic calcifications** (highly specific for retinoblastoma)\n\n**MRI orbits and brain:** Ordered for staging - no optic nerve invasion, no intracranial extension, **no pineal mass** (rules out 'trilateral retinoblastoma')", "question": "What is the underlying GENETIC mechanism of retinoblastoma?", "choices": [{"id": "node-2-choice-a", "text": "RB1 tumor suppressor gene mutation following the 'two-hit hypothesis'", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Retinoblastoma results from **inactivation of both copies of the RB1 tumor suppressor gene** (chromosome 13q14), following **Knudson's 'two-hit hypothesis'**:\n\n**Hereditary (40%):**\n- **First hit**: Inherited germline mutation (present in all cells)\n- **Second hit**: Somatic mutation in retinal cell\n- Results in **earlier onset**, often **bilateral** disease\n- Risk of **second malignancies** (osteosarcoma, soft tissue sarcomas)\n- Father's history suggests this patient has **hereditary form**\n\n**Sporadic (60%):**\n- Both hits are somatic mutations in the same retinal cell\n- Later onset, **unilateral**, no family history\n- No increased risk of second malignancies\n\nThe RB1 gene encodes **pRb protein**, which regulates the **cell cycle** by inhibiting E2F transcription factors.", "consequence": "You understand the two-hit hypothesis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "MYCN oncogene amplification", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **MYCN amplification** is characteristic of **neuroblastoma**, not retinoblastoma. While both are pediatric tumors, they are distinct entities. Neuroblastoma arises from neural crest cells (adrenal medulla, sympathetic ganglia), while retinoblastoma arises from retinal photoreceptor precursor cells. The genetic basis of retinoblastoma is **RB1 tumor suppressor gene mutation**.", "consequence": "MYCN amplification is associated with neuroblastoma, not retinoblastoma.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Chromosomal translocation t(11;22)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **t(11;22) translocation** (EWS-FLI1 fusion) is characteristic of **Ewing sarcoma**, a bone tumor. Retinoblastoma does not involve translocations - it results from **loss of function of both RB1 alleles** on chromosome 13. This is a classic example of a tumor suppressor gene mechanism, not an oncogene activation via translocation.", "consequence": "t(11;22) is associated with Ewing sarcoma.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Trisomy 21 predisposition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Trisomy 21 (Down syndrome)** is associated with increased risk of **leukemia** (especially ALL and AML-M7), not retinoblastoma. Retinoblastoma is caused by **RB1 mutations** and follows the two-hit hypothesis. Down syndrome does not increase retinoblastoma risk.", "consequence": "Trisomy 21 is associated with leukemia, not retinoblastoma.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Sporadic mutation with no genetic basis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **sporadic** retinoblastoma (60% of cases) occurs without family history, it still has a **genetic basis** - both RB1 alleles undergo somatic mutations in the retinal cell. The term 'sporadic' means no inherited germline mutation, not 'no genetic basis.' Even sporadic cases result from RB1 inactivation. This patient's **family history** (father's enucleation) strongly suggests **hereditary** rather than sporadic disease.", "consequence": "All retinoblastoma involves RB1 mutations - hereditary or sporadic.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hereditary vs Sporadic Retinoblastoma**: Hereditary (40%) = germline RB1 mutation, bilateral, younger, family history, risk of second malignancies. Sporadic (60%) = somatic mutations only, unilateral, older, no family history, no increased second cancer risk."}, "node-3": {"id": "node-3", "type": "decision", "content": "Given the family history (father's enucleation) and the unilateral presentation, **genetic testing for RB1 mutation** is performed.\n\n**Results:** Patient has a **germline RB1 mutation** (confirming hereditary retinoblastoma).\n\nThe pediatric oncology team discusses treatment options with the family.\n\n**Staging:** Group D (advanced intraocular disease with vitreous seeding)\n\n**Treatment options for retinoblastoma:**\n- **Globe-salvage therapy**: Chemotherapy (systemic, intra-arterial, or intravitreal), focal therapy (laser, cryotherapy)\n- **Enucleation**: Surgical removal of the eye\n- **External beam radiation**: Avoided if possible due to second malignancy risk", "question": "Given that this patient has HEREDITARY retinoblastoma, what is the MOST important long-term consideration?", "choices": [{"id": "node-3-choice-a", "text": "Increased risk of second malignancies, especially osteosarcoma", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Patients with **hereditary retinoblastoma** (germline RB1 mutation) have a **significantly increased lifetime risk of second malignancies**, especially:\n\n- **Osteosarcoma** (most common second malignancy, ~500x increased risk)\n- Soft tissue sarcomas\n- Melanoma\n- Brain tumors (especially if radiation was used)\n- Lung, bladder, and breast cancer later in life\n\n**Key implications:**\n- **Avoid external beam radiation** if possible (increases second cancer risk dramatically)\n- **Lifelong surveillance** for second malignancies\n- **Genetic counseling** for family planning (50% chance of passing mutation)\n- **Screening of siblings** and future children\n\nThe RB1 gene is a tumor suppressor in many tissues, not just the retina - hence the systemic cancer risk.", "consequence": "You recognize the importance of long-term cancer surveillance.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Risk of metastasis to the pineal gland only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **'Trilateral retinoblastoma'** (pineal primitive neuroectodermal tumor) is a concern in hereditary cases, but it's not the MOST important long-term consideration. Trilateral retinoblastoma occurs in ~5% of hereditary bilateral cases and presents within the first few years. The greater long-term concern is the **lifetime risk of second malignancies** (especially osteosarcoma) that persists throughout the patient's life, not just in childhood.", "consequence": "Pineal involvement is a concern but second malignancies are the bigger long-term issue.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Guaranteed recurrence within 5 years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With modern treatment, **retinoblastoma has excellent survival rates (>95%)**. Most recurrences occur within the **first 2 years after treatment**, and long-term survivors are often cured of the primary tumor. The concern in hereditary cases is not recurrence of retinoblastoma but rather the **development of different second malignancies** throughout life due to the germline RB1 mutation present in all cells.", "consequence": "Retinoblastoma prognosis is excellent; second malignancies are the concern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "No additional concerns beyond treating the current tumor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **potentially dangerous**! Hereditary retinoblastoma requires **lifelong surveillance**. The germline RB1 mutation is present in **every cell of the body**, not just the retina. This puts the patient at risk for osteosarcoma, soft tissue sarcomas, melanoma, and other cancers throughout life. Siblings may also carry the mutation and need screening. Simply treating the eye tumor without addressing these concerns is inadequate care.", "consequence": "Hereditary retinoblastoma requires lifelong surveillance for second malignancies.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Immediate need for bone marrow transplant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bone marrow transplant is not part of retinoblastoma treatment**. Retinoblastoma is treated with: (1) Chemotherapy (systemic, intra-arterial, or intravitreal), (2) Focal therapy (laser photocoagulation, cryotherapy, thermotherapy), (3) Enucleation if necessary, (4) Radiation (avoided if possible). BMT is used for hematologic malignancies and some solid tumors, but not retinoblastoma.", "consequence": "BMT is not used in retinoblastoma treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hereditary RB1 mutation = lifelong cancer risk**: These patients need surveillance for osteosarcoma, soft tissue sarcomas, and other malignancies throughout life. **Avoid radiation** if possible - it dramatically increases second cancer risk in patients with germline RB1 mutations."}, "node-4": {"id": "node-4", "type": "decision", "content": "The oncology team decides to attempt **globe-salvage therapy** with **intra-arterial chemotherapy** (chemotherapy delivered directly to the ophthalmic artery) followed by focal consolidation therapy.\n\nThe parents ask about the prognosis and what needs to be done for other family members.\n\n**Family counseling considerations:**\n- Patient has a **germline RB1 mutation**\n- Father had retinoblastoma (likely hereditary)\n- Parents are considering having more children", "question": "What is the recommendation for SCREENING the patient's future siblings?", "choices": [{"id": "node-4-choice-a", "text": "Genetic testing at birth; if positive, serial dilated fundoscopic exams under anesthesia starting in newborn period", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For families with **known hereditary retinoblastoma**:\n\n**Prenatal/At birth:**\n- **Genetic testing** (amniocentesis or cord blood) to determine if newborn carries the RB1 mutation\n\n**If RB1 mutation positive:**\n- **Serial dilated fundoscopic exams under anesthesia** starting in the **first weeks of life**\n- Exams every **2-4 weeks** initially, then monthly\n- Continue until age 3-4 years (when new tumor development becomes rare)\n- Early detection allows treatment of small tumors with focal therapy, potentially preserving vision\n\n**If RB1 mutation negative:**\n- Still recommend at least one dilated fundoscopic exam to confirm\n- No ongoing surveillance needed if truly negative\n\n**The goal is to detect tumors when they are small and treatable with vision-sparing therapy.**", "consequence": "You recommend appropriate family screening.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "No screening needed if the sibling appears healthy at birth", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **DANGEROUS**! **Retinoblastoma develops in infancy** - a healthy-appearing newborn may develop tumors in the first few months of life. By the time leukocoria is visible, the tumor may be advanced. Each sibling has a **50% chance of inheriting the RB1 mutation** (autosomal dominant inheritance). Without screening, tumors may be detected late, requiring enucleation instead of vision-sparing therapy.", "consequence": "Missing screening can result in delayed diagnosis and vision loss.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Start screening at age 5 with routine vision testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Age 5 is far too late** for retinoblastoma screening. The average age at diagnosis is **18 months**, and hereditary bilateral cases often present even earlier (mean 12 months). By age 5, any tumor would have had years to grow, potentially spreading outside the eye. Screening must begin in the **newborn period** with dilated fundoscopic exams under anesthesia.", "consequence": "Screening must start at birth, not age 5.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Prophylactic enucleation of both eyes at birth if RB1 mutation positive", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **unethical**! **Prophylactic enucleation is never performed**. Having the RB1 mutation does not guarantee tumor development - some mutation carriers never develop retinoblastoma. Even if tumors develop, modern treatment can often preserve vision with focal therapy if caught early. The goal of screening is early detection and vision-preserving treatment, not preventive blindness.", "consequence": "Prophylactic enucleation is never indicated.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Annual brain MRI only, no eye exams needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Eye exams are the primary screening modality** for retinoblastoma. Brain MRI may be done periodically to screen for **trilateral retinoblastoma** (pineal tumor), but this is less common than ocular tumors. The mainstay of screening is **serial dilated fundoscopic exams** to detect retinal tumors early. Brain MRI alone would miss the primary site of disease.", "consequence": "Eye exams are essential - brain MRI alone is insufficient.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Retinoblastoma family screening**: Siblings of affected children should have **genetic testing at birth**. If RB1 mutation positive, begin **serial dilated fundoscopic exams under anesthesia** starting in the newborn period. Early detection = vision preservation."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **retinoblastoma** with appropriate family counseling.\n\n**Key takeaways:**\n- **Leukocoria (white pupil) = retinoblastoma until proven otherwise**\n- Check red reflex at **every well-child visit**\n- Most common intraocular malignancy in children (average age 18 months)\n- **Genetics**: RB1 tumor suppressor gene, two-hit hypothesis\n  - Hereditary (40%): Germline mutation, bilateral, younger, family history, second malignancy risk\n  - Sporadic (60%): Somatic mutations, unilateral, older, no family history\n- **Imaging**: Calcifications on ultrasound/CT are characteristic; MRI for staging\n- **Treatment**: Globe-salvage therapy (chemotherapy + focal therapy) vs enucleation\n- **Hereditary cases**: Lifelong surveillance for second malignancies (osteosarcoma), avoid radiation if possible\n- **Family screening**: Genetic testing, serial dilated eye exams for at-risk siblings\n\n**Prognosis**: >95% survival with modern treatment."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **retinoblastoma**:\n\n- **'White pupil, worried provider'** - leukocoria is retinoblastoma until proven otherwise\n- **Red reflex check at every well-child visit** can be life-saving\n- Average age: **18 months** (hereditary cases present earlier)\n- **Genetics**: RB1 tumor suppressor gene (chromosome 13q14)\n  - Hereditary: Germline mutation, bilateral, family history\n  - Sporadic: Somatic mutations, unilateral\n- **Two-hit hypothesis**: Both RB1 alleles must be inactivated\n- **Hereditary cases**: Risk of second malignancies (osteosarcoma, sarcomas)\n- **Imaging**: Calcifications are characteristic\n- **Family screening**: Essential for hereditary cases"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error! **Retinoblastoma is a potentially fatal malignancy** that requires urgent recognition and appropriate management.\n\n**Never dismiss leukocoria:**\n- White pupil is **NEVER normal**\n- Leukocoria = retinoblastoma until proven otherwise\n- Delayed diagnosis can be fatal (metastasis)\n\n**Hereditary retinoblastoma (germline RB1 mutation):**\n- Requires **lifelong surveillance** for second malignancies\n- **Siblings need screening** (50% chance of inheriting mutation)\n- Start eye exams in **newborn period**, not at age 5\n- **Never prophylactically remove eyes** - screen and treat early instead\n\n**Check the red reflex at every well-child visit - this simple test saves lives!**"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-114", "title": "Corneal Abrasion Recognition", "domain": "neurology", "difficulty": "intermediate", "tags": ["corneal abrasion", "eye trauma", "fluorescein", "photophobia", "eye pain", "topical anesthetics", "pediatric ophthalmology"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male is brought to the emergency department by his mother after his younger sibling accidentally poked him in the eye with a toy approximately 2 hours ago.\n\nSince the injury, he has been crying, holding his eye closed, and refusing to let anyone look at it. He complains that \"everything is too bright.\"\n\nVital signs: T 37.0\u00b0C, HR 100, RR 20, BP 95/60\n\nPhysical examination (limited due to child's resistance):\n- General: Alert, distressed, holding left hand over left eye\n- Right eye: Normal, PERRLA\n- Left eye: Significant blepharospasm (eyelid squeezing shut), tearing, conjunctival injection visible briefly; unable to fully examine due to photophobia and resistance", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 5-year-old with acute eye pain, photophobia, and tearing after ocular trauma.\n\n**Corneal Abrasion - Classic Presentation:**\n\nThe cornea is densely innervated by sensory nerves (trigeminal V1), making corneal injuries **extremely painful**.\n\n**Symptoms (the \"classic triad\"):**\n1. **Pain** - often severe, sharp, \"something in my eye\"\n2. **Photophobia** - light causes reflexive pain\n3. **Tearing (epiphora)** - reflex lacrimation\n\n**Signs:**\n- **Blepharospasm** - involuntary eyelid closure (protective reflex)\n- **Conjunctival injection** - red eye\n- **Foreign body sensation** - even without actual foreign body\n- **Decreased visual acuity** - if abrasion involves visual axis\n\n**Common Causes of Corneal Abrasion:**\n- **Trauma** - finger poke, foreign body, contact lens\n- **Foreign body** - dust, metal fragments, plant material\n- **Contact lens** - overwear, poor fit, sleeping in lenses\n- **UV exposure** - welding (\"arc eye\"), snow blindness\n\n**Red Flags Requiring Urgent Ophthalmology:**\n- **Penetrating injury** (full-thickness corneal laceration)\n- **Hyphema** (blood in anterior chamber)\n- **Pupil irregularity** (suggests globe rupture)\n- **Decreased vision** despite topical anesthesia\n- **White corneal infiltrate** (suggests infection/ulcer)\n- **Herpes simplex** (dendritic pattern)", "question": "Based on the history and examination, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Corneal abrasion from traumatic injury", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **classic corneal abrasion** presentation:\n\n- **Clear mechanism:** Direct trauma (poked in eye with toy)\n- **Classic triad:** Pain, photophobia, tearing\n- **Protective reflexes:** Blepharospasm (can't open eye)\n- **Timing:** Symptoms immediately following trauma\n\nCorneal abrasions are the most common eye injury in children. The dense sensory innervation of the cornea (trigeminal V1) explains the severe pain and photophobia. The key next step is confirmation with fluorescein examination.", "consequence": "You proceed with examination and fluorescein testing.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Open globe injury - do not manipulate, emergent ophthalmology consult", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable concern, but **open globe injury is less likely** here. Open globe signs include:\n- **Irregular pupil** (teardrop shape pointing toward wound)\n- **Flat anterior chamber**\n- **Visible uveal tissue** (brown tissue extruding)\n- **Severely decreased vision**\n- **Very low intraocular pressure**\n\nThis child was poked with a **toy** (low-velocity blunt object), not a sharp object. The limited exam shows conjunctival injection but no obvious globe rupture signs. However, if you have ANY concern for penetrating injury, shield the eye (do NOT patch/pressure), give antiemetics (prevent Valsalva), and consult ophthalmology urgently. A careful fluorescein exam will help differentiate.", "consequence": "Appropriate caution, but careful examination is still indicated.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Bacterial conjunctivitis - start antibiotic eye drops", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bacterial conjunctivitis** presents very differently:\n\n- **Purulent discharge** (not just tearing)\n- **Matted eyelids** in morning\n- **Minimal pain** (\"gritty\" at most, not severe)\n- **NO photophobia** (distinguishing feature!)\n- **Often bilateral**\n- No history of trauma\n\nThis child has **severe pain and photophobia** immediately following direct trauma - this is NOT conjunctivitis. Starting antibiotic drops without examining the cornea misses the diagnosis and doesn't address the abrasion.", "consequence": "Missed diagnosis of corneal abrasion; inappropriate treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Acute angle-closure glaucoma - check intraocular pressure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acute angle-closure glaucoma** is extremely rare in children and presents with:\n\n- **Severe headache** and eye pain\n- **Fixed mid-dilated pupil**\n- **Cloudy/hazy cornea** (corneal edema)\n- **Halos around lights**\n- **Nausea and vomiting**\n- **No trauma history**\n- **Risk factors:** Hyperopia, Asian descent, older age\n\nThis 5-year-old has clear trauma history and acute presentation immediately following injury. Glaucoma would not present acutely after being poked in the eye.", "consequence": "Incorrect diagnosis; delays appropriate care for corneal abrasion.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Child is exaggerating symptoms for attention; reassure and observe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dismissive. **Children with corneal abrasions are NOT exaggerating**. The cornea is the most densely innervated surface in the body - corneal pain is genuinely severe. Signs that confirm genuine pathology:\n\n- **Blepharospasm** (involuntary - cannot be faked)\n- **Photophobia** (objective finding)\n- **Tearing** (reflex response)\n- **Clear trauma history** with immediate symptom onset\n\nDismissing a child's eye pain after trauma is inappropriate and could result in missed serious injury. Always examine the eye with fluorescein.", "consequence": "Dismissive approach misses genuine injury.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The cornea is the **most densely innervated tissue** in the body. Corneal abrasions cause SEVERE pain and photophobia - don't dismiss a child's symptoms. **Blepharospasm** (involuntary eyelid closure) is a sign of genuine corneal pathology."}, "node-2": {"id": "node-2", "type": "decision", "content": "To examine the eye, you first apply **topical anesthetic** (proparacaine 0.5%). Within 30 seconds, the child calms significantly and is able to open his eye.\n\n**Examination after topical anesthesia:**\n- Visual acuity: 20/30 left eye (slightly reduced from 20/20 right eye)\n- Pupils: Equal, round, reactive (no afferent pupillary defect)\n- Anterior chamber: Deep, no hyphema, no cells\n- Cornea: Central area of irregular surface visible\n\nYou apply **fluorescein dye** and examine with **cobalt blue light**.\n\n**Fluorescein Examination:**\nA **bright green-yellow area of fluorescence** is visible centrally on the cornea, approximately 3mm x 4mm in size, with smooth edges. No dendritic pattern. No white infiltrate.\n\n**Understanding Fluorescein Staining:**\n- Fluorescein is a **water-soluble dye** that binds to exposed basement membrane\n- Normal corneal epithelium is **hydrophobic** (repels fluorescein)\n- Damaged/absent epithelium allows fluorescein to **penetrate and stain**\n- Under **cobalt blue light**, fluorescein fluoresces bright green-yellow\n\n**Key Findings to Look For:**\n- **Linear scratch** - typical abrasion\n- **Dendritic (branching)** - HERPES SIMPLEX (treat with antivirals, NOT steroids!)\n- **Geographic** - larger herpes or healing abrasion\n- **Punctate (multiple dots)** - dry eye, UV keratitis, toxic exposure\n- **White infiltrate** - bacterial infection/ulcer (urgent!)", "question": "Fluorescein examination confirms a 3x4mm corneal abrasion with smooth edges, no infiltrate, and no dendritic pattern. What is the appropriate treatment?", "choices": [{"id": "node-2-choice-a", "text": "Topical antibiotic ointment or drops (erythromycin or polymyxin-trimethoprim), pain control, close follow-up; NO eye patching", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Standard treatment for uncomplicated corneal abrasion:\n\n**1. Topical Antibiotics** (prophylaxis against infection):\n- **Erythromycin ointment** - good for children (less stinging, provides lubrication)\n- **Polymyxin-trimethoprim drops** - alternative\n- NOT needed if tiny/superficial abrasion, but standard practice for larger ones\n\n**2. Pain Control:**\n- **Oral NSAIDs or acetaminophen** for pain\n- **Topical NSAIDs** (ketorolac) - optional adjunct\n- **DO NOT prescribe topical anesthetics for home use** (delays healing, masks warning signs, can cause further damage)\n\n**3. NO Eye Patching:**\n- Studies show patching does **NOT improve healing** and may **increase infection risk**\n- Patching was traditional but now **not recommended**\n\n**4. Follow-up:**\n- Small abrasions: Recheck if not improving in 24-48 hours\n- Larger abrasions: Recheck in 24 hours", "consequence": "You prescribe appropriate treatment. The child's symptoms improve rapidly.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Apply eye patch for 24 hours to promote healing, with antibiotic ointment underneath", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Eye patching is NO LONGER recommended** for corneal abrasions. Evidence shows:\n\n- Patching does NOT speed healing\n- Patching may INCREASE infection risk (warm, moist, dark environment)\n- Patching reduces patient comfort (loss of depth perception, claustrophobic)\n- Patching prevents patient from recognizing worsening symptoms\n\nThe **only indication for patching** is a large epithelial defect with significant edema where the eyelid is causing mechanical irritation. Standard abrasions heal better without patching.", "consequence": "Outdated practice; patching may delay healing and increase infection risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Prescribe topical anesthetic drops (proparacaine) for the child to use at home for pain control", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **NEVER prescribe topical anesthetics for home use!** This is a critical safety issue:\n\n**Why topical anesthetics are dangerous:**\n1. **Delays epithelial healing** (toxic to corneal epithelium)\n2. **Masks warning signs** of infection or worsening\n3. **Can cause corneal ulceration** with repeated use\n4. **Risk of perforation** if overused\n\nTopical anesthetics are for **diagnostic use only** in the ED/clinic to facilitate examination. Pain should be controlled with **oral analgesics** (acetaminophen, ibuprofen) and topical NSAIDs if needed.", "consequence": "Dangerous prescription that could cause corneal toxicity and perforation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Prescribe topical steroid drops (prednisolone) to reduce inflammation and pain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical steroids are CONTRAINDICATED** in corneal abrasions:\n\n**Why steroids are dangerous:**\n1. **Delay epithelial healing** (steroids inhibit wound repair)\n2. **Increase infection risk** (immunosuppression)\n3. **Can activate herpes simplex** (dendritic keratitis is a contraindication!)\n4. **Can mask worsening** infection or ulceration\n\nSteroids have **specific ophthalmologic indications** (iritis, certain inflammatory conditions) but should NEVER be used for simple corneal abrasions. This is a common and dangerous error.", "consequence": "Contraindicated treatment; delays healing and increases infection risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "No treatment needed; corneal abrasions heal spontaneously within hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While small corneal abrasions DO heal quickly (often within 24-48 hours), **treatment is still indicated**:\n\n**Why treatment matters:**\n1. **Infection prevention** - exposed corneal stroma can become infected, leading to ulcer\n2. **Pain control** - corneal abrasions are very painful; oral analgesics help\n3. **Lubrication** - ointment protects healing epithelium from eyelid friction\n4. **Follow-up** - ensures healing is progressing normally\n\nSending the child home with no treatment and no follow-up plan is inappropriate for a moderate-sized abrasion.", "consequence": "Inadequate care; risk of infection and prolonged symptoms.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Three things to NEVER do for corneal abrasions:** (1) Prescribe topical anesthetics for home use (corneal toxicity), (2) Prescribe topical steroids (delays healing, activates herpes), (3) Patch the eye (no benefit, may increase infection risk)."}, "node-3": {"id": "node-3", "type": "decision", "content": "You prescribe erythromycin ointment three times daily and recommend acetaminophen as needed for pain. The mother asks several questions.\n\n**Parent Questions:**\n1. \"When should he be better?\"\n2. \"What warning signs should I watch for?\"\n3. \"When can he go back to school?\"\n\n**Expected Healing Timeline:**\n- **Small abrasions (<2mm):** Often heal within 24-36 hours\n- **Moderate abrasions (2-5mm):** Usually heal within 48-72 hours\n- **Large abrasions:** May take 4-5 days\n\n**Pain typically improves significantly within 24 hours** as epithelium begins to cover the defect.\n\n**Contact Lens-Related Abrasions (different management):**\n- Higher risk of **Pseudomonas** infection\n- Require **fluoroquinolone** coverage (ciprofloxacin, ofloxacin)\n- **NEVER patch** contact lens-related injuries (traps bacteria)\n- Must discontinue contact lens wear until fully healed AND refitted", "question": "What discharge instructions and follow-up should you provide?", "choices": [{"id": "node-3-choice-a", "text": "Return if worsening pain, vision changes, or not improving in 24-48 hours; expect significant improvement within 1-2 days; may return to school once comfortable", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Comprehensive discharge instructions:\n\n**Expected Course:**\n- Pain should improve significantly within 24 hours\n- Complete healing expected within 48-72 hours for this size abrasion\n- Light sensitivity may persist slightly longer than pain\n\n**Return Precautions (come back if):**\n- **Worsening pain** (not just persistent - getting WORSE)\n- **Decreased vision**\n- **Increased redness or swelling**\n- **Purulent discharge** (suggests infection)\n- **Not improving after 24-48 hours**\n\n**Activity:**\n- May return to school once comfortable\n- Avoid rubbing the eye\n- Avoid swimming until healed\n- No need for eye protection unless child is rubbing\n\n**Medication:**\n- Complete antibiotic course (3-5 days typically)\n- Use oral pain medication as needed", "consequence": "Parents leave with clear expectations and return precautions.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Schedule mandatory ophthalmology follow-up in 24 hours for all corneal abrasions", "isOptimal": false, "isAcceptable": true, "feedback": "This is **overly conservative** for an uncomplicated traumatic corneal abrasion in a child. Routine ophthalmology follow-up is indicated for:\n\n- **Large abrasions** (>50% of corneal surface)\n- **Central abrasions** affecting visual axis significantly\n- **Contact lens-related** abrasions (higher infection risk)\n- **Contaminated** injuries (plant material, soil)\n- **Not improving** at 24-48 hour reassessment\n- **Concerning features** (infiltrate, deep laceration)\n\nThis child has an uncomplicated moderate-sized abrasion. Primary care/ED follow-up is appropriate, with ophthalmology referral if not healing as expected.", "consequence": "Reasonable but may be overutilization for uncomplicated abrasion.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-c", "text": "Tell parents healing takes 1-2 weeks; keep child home from school until then", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This **overestimates healing time** and unnecessarily restricts activity. Corneal epithelium regenerates very quickly:\n\n- Most abrasions heal within **24-72 hours**\n- This 3x4mm abrasion should heal within **2-3 days**\n- Pain typically improves within **24 hours**\n\nKeeping a child home for 1-2 weeks is unnecessary and would cause significant school absence for a minor injury. Once the child is comfortable and symptoms are improving, normal activities (including school) can resume.", "consequence": "Inaccurate information; unnecessary restriction of activity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "No follow-up needed; corneal abrasions always heal without complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While most corneal abrasions heal uneventfully, complications CAN occur:\n\n**Potential Complications:**\n- **Corneal ulcer** (bacterial infection of stroma)\n- **Recurrent erosion syndrome** (epithelium doesn't adhere properly)\n- **Traumatic iritis** (inflammation)\n- **Scarring** (if deep or infected)\n\nAll patients should receive **return precautions** (worsening pain, vision changes, not improving) and have access to follow-up if needed. Some clinicians recommend routine recheck at 24-48 hours for larger abrasions.", "consequence": "Inadequate safety netting; could miss developing complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Recommend wearing sunglasses continuously for 2 weeks to protect against photophobia", "isOptimal": false, "isAcceptable": true, "feedback": "Partially reasonable but **excessive duration**. Photophobia from corneal abrasion:\n\n- Is most severe in the first 24-48 hours\n- Typically resolves as epithelium heals\n- Sunglasses provide comfort but 2 weeks is unnecessary\n\nRecommending sunglasses for the first 1-2 days while symptoms are severe is reasonable. There's no need for 2 weeks of continuous wear. The key is symptom-guided management - once the child is comfortable without sunglasses, they're not needed.", "consequence": "Reasonable short-term but 2 weeks is excessive.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Corneal abrasions heal FAST** - most within 24-72 hours. If pain is WORSENING (not just persisting) after 24 hours, suspect infection (corneal ulcer) and urgently refer to ophthalmology. Contact lens-related abrasions need fluoroquinolone coverage for Pseudomonas."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this pediatric corneal abrasion.\n\n**Key Learning Points:**\n\n1. **Recognition:**\n   - Classic triad: Pain, photophobia, tearing\n   - Blepharospasm is an involuntary sign of corneal pathology\n   - Use topical anesthetic to facilitate examination (NOT for home use!)\n\n2. **Diagnosis:**\n   - Fluorescein staining under cobalt blue light is diagnostic\n   - Look for: linear abrasion, dendritic pattern (herpes!), infiltrate (infection)\n   - Check for penetrating injury signs before manipulation\n\n3. **Treatment (Three \"NEVER DOs\"):**\n   - NEVER prescribe topical anesthetics for home use (corneal toxicity)\n   - NEVER prescribe topical steroids (delays healing, activates herpes)\n   - NEVER patch the eye (no benefit, may increase infection)\n\n4. **Appropriate Treatment:**\n   - Topical antibiotic (erythromycin ointment or polymyxin-trimethoprim drops)\n   - Oral pain control (acetaminophen, ibuprofen)\n   - Topical NSAIDs optional adjunct\n\n5. **Contact Lens Special Case:**\n   - Higher Pseudomonas risk - use fluoroquinolone\n   - NEVER patch\n   - Must discontinue lenses until healed and refitted\n\n6. **Follow-up:**\n   - Most heal within 24-72 hours\n   - Return precautions: worsening pain, decreased vision, not improving\n   - Ophthalmology referral if not healing, large, or complicated"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Examination:**\n- Use topical anesthetic to facilitate exam (proparacaine)\n- Fluorescein + cobalt blue light confirms diagnosis\n- Look for red flags: dendritic pattern (herpes), infiltrate (infection), penetrating injury\n\n**Treatment Errors to Avoid:**\n- NO eye patching (outdated, no benefit, may increase infection)\n- NO topical anesthetics for home use (delays healing, masks problems)\n- NO topical steroids (delays healing, dangerous with herpes)\n\n**Correct Treatment:**\n- Topical antibiotic (erythromycin or polymyxin-trimethoprim)\n- Oral analgesics for pain\n- Contact lens injuries: fluoroquinolone for Pseudomonas coverage\n\n**Follow-up:**\n- Most abrasions heal within 24-72 hours\n- Provide clear return precautions\n- Ophthalmology referral not always necessary for simple abrasions"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors:**\n\n1. **Diagnostic Errors:**\n   - Don't dismiss a child's eye pain as \"exaggerating\" - corneal pain is genuinely severe\n   - Blepharospasm is an involuntary sign that cannot be faked\n   - This is NOT conjunctivitis (no discharge, severe pain/photophobia)\n\n2. **Treatment Errors:**\n   - **Topical anesthetics for home use:** NEVER! Causes corneal toxicity, delays healing, can lead to perforation\n   - **Topical steroids:** CONTRAINDICATED! Delays healing, increases infection risk, can activate herpes\n   - These are dangerous prescriptions that cause real harm\n\n3. **Dangerous Assumptions:**\n   - Don't assume bacterial conjunctivitis without examining the cornea\n   - Don't assume glaucoma in a child with clear trauma history\n   - Don't assume child is exaggerating after documented trauma\n\n**Remember:** The cornea is the most densely innervated surface in the body. Corneal abrasion pain is REAL and SEVERE. Always examine with fluorescein after topical anesthesia."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-156", "title": "Cerebral Palsy", "domain": "neurology", "difficulty": "intermediate", "tags": ["non-progressive motor disorder", "spasticity", "scissoring", "prematurity", "periventricular leukomalacia"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 10-month-old male is brought to the emergency department for not sitting up yet.\n\nSubjectively, he is not yet sitting without support and seems stiff when picked up. He has difficulty bringing his hands to midline and strongly prefers using his right hand.\n\nAssociated symptoms include persistent fisting and exaggerated startle. Denies seizures or regression.\n\nPast medical history includes He was born at 28 weeks gestation and spent 2 months in the NICU with an intraventricular hemorrhage.\n\nPhysical Examination:\n- Neurologic: increased tone in lower extremities, scissoring of legs, persistent primitive reflexes.\n- Motor: not sitting independently, early hand preference.\n- General: alert infant, poor visual tracking.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You evaluate this 10-month-old former 28-week premature infant with delayed motor milestones, increased lower extremity tone, and scissoring. He has persistent fisting, early hand preference, and history of intraventricular hemorrhage in the NICU.", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Cerebral palsy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Cerebral palsy (CP)** is the most likely diagnosis. The key features are: **non-progressive motor disorder** with onset in early childhood, **spasticity** (increased tone, scissoring), delayed motor milestones, and significant risk factors (**prematurity**, **intraventricular hemorrhage**). Early hand preference before 12 months is abnormal and suggests asymmetric motor involvement.", "consequence": "You recognize the classic presentation of cerebral palsy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Spinal muscular atrophy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Spinal muscular atrophy (SMA)** presents with **hypotonia and weakness**, not hypertonia and spasticity. SMA causes **lower motor neuron** signs (flaccid weakness, absent reflexes, tongue fasciculations), whereas this patient has **upper motor neuron** signs (increased tone, brisk reflexes, scissoring).", "consequence": "The distinction between upper and lower motor neuron patterns is crucial.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Muscular dystrophy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Muscular dystrophy** presents with **weakness and hypotonia**, not spasticity. Children with Duchenne muscular dystrophy show progressive proximal weakness, **Gowers sign**, and **pseudohypertrophy of calves**. This patient has hypertonia with preserved strength, classic for an upper motor neuron disorder.", "consequence": "Consider the tone and reflex pattern to differentiate myopathy from CP.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Leukodystrophy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Leukodystrophies** are **progressive** disorders causing white matter degeneration. The hallmark is **developmental regression** - loss of previously acquired skills. This patient has not yet acquired skills but is not losing them. CP is **non-progressive** (though manifestations evolve as the child grows).", "consequence": "The absence of regression is key to distinguishing CP from progressive disorders.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Benign hypotonia of infancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Benign hypotonia** presents with **decreased** tone, not increased tone. This patient has **hypertonia** (stiffness, scissoring, persistent fisting). Benign hypotonia would show a floppy infant with preserved strength who eventually catches up developmentally.", "consequence": "The increased tone and spasticity are inconsistent with hypotonia.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**CP is a clinical diagnosis** based on: (1) Non-progressive motor disorder, (2) Early brain injury, (3) NOT regressive. Key buzzwords: **scissoring** (legs cross when held upright), **persistent fisting**, **early hand preference** (<12 months is abnormal), **persistent primitive reflexes**."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose cerebral palsy based on the clinical presentation. Given the history of prematurity and intraventricular hemorrhage, you consider the specific subtype and underlying pathophysiology.", "question": "What CP subtype and associated brain lesion would you expect in this former premature infant?", "choices": [{"id": "node-2-choice-a", "text": "Spastic diplegia with periventricular leukomalacia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Spastic diplegia** (legs affected more than arms) is the classic pattern in **premature infants** with **periventricular leukomalacia (PVL)**. PVL damages the **periventricular white matter** where motor fibers to the legs pass close to the ventricles. The corticospinal tract fibers for the legs are more medial and vulnerable to ischemia in the watershed zones around the ventricles.", "consequence": "You correctly identify the association between prematurity, PVL, and spastic diplegia.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Spastic quadriplegia with diffuse hypoxic-ischemic injury", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Spastic quadriplegia** (all four limbs equally affected) is more typical of **term infants** with **perinatal asphyxia** causing diffuse cortical and subcortical damage. While this patient has some arm involvement (early hand preference), the **legs are more affected** (scissoring), making diplegia more likely. Quadriplegia typically also has severe cognitive impairment and seizures.", "consequence": "The pattern of leg predominance suggests diplegia rather than quadriplegia.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Dyskinetic CP with basal ganglia injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dyskinetic CP** is characterized by **involuntary movements** (dystonia, athetosis, chorea) due to **basal ganglia** damage, classically from severe neonatal **hyperbilirubinemia (kernicterus)** or acute profound asphyxia in term infants. This patient has **spasticity** (increased tone, scissoring), not dyskinesia.", "consequence": "The movement pattern distinguishes spastic from dyskinetic CP.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Ataxic CP with cerebellar malformation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ataxic CP** (5-10% of cases) presents with **hypotonia, tremor, and incoordination** due to cerebellar involvement. These children have difficulty with balance and coordination, not spasticity. This patient has **hypertonia and spasticity**, not ataxia.", "consequence": "Ataxic CP has hypotonia and incoordination, not spasticity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Spastic hemiplegia with middle cerebral artery stroke", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Spastic hemiplegia** (one side affected) typically results from **unilateral brain injury** such as perinatal stroke. While early hand preference can suggest asymmetry, this patient has **bilateral leg involvement** (scissoring) most prominently, consistent with diplegia. MCA stroke would cause contralateral arm > leg weakness.", "consequence": "The bilateral leg involvement points toward diplegia, not hemiplegia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prematurity \u2192 PVL \u2192 Spastic Diplegia** (legs > arms). **Term asphyxia \u2192 Diffuse injury \u2192 Spastic Quadriplegia** (all limbs). **Kernicterus \u2192 Basal ganglia \u2192 Dyskinetic CP**. Spastic CP is most common (70-80%), followed by dyskinetic (10-15%) and ataxic (5-10%)."}, "node-3": {"id": "node-3", "type": "decision", "content": "MRI brain shows periventricular leukomalacia consistent with the history of prematurity and IVH. You now need to plan the comprehensive evaluation and management.", "question": "What is the most appropriate next step in management?", "choices": [{"id": "node-3-choice-a", "text": "Refer for multidisciplinary early intervention (PT, OT, speech therapy)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Early intervention** with multidisciplinary therapy is the cornerstone of CP management. **Physical therapy** improves motor function and prevents contractures. **Occupational therapy** addresses fine motor skills and activities of daily living. **Speech therapy** addresses feeding difficulties and communication. Starting early (before age 3) during maximal neuroplasticity significantly improves outcomes.", "consequence": "You initiate early intervention services appropriately.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Start baclofen for spasticity management", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Baclofen** is used for spasticity management but is not first-line in a 10-month-old. Initial management focuses on **therapy and positioning**. Oral baclofen can cause sedation and is typically reserved for moderate-severe spasticity interfering with function. **Botulinum toxin** injections or **intrathecal baclofen** may be considered later for focal or severe generalized spasticity.", "consequence": "Medical management of spasticity is secondary to early intervention therapy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Obtain genetic testing to identify the cause", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Genetic testing** is not routinely indicated when there is a clear acquired etiology (prematurity, IVH, PVL on MRI). Genetic testing is considered when: no identified etiology, dysmorphic features, family history of similar conditions, or atypical presentation. This patient has a clear explanation for his CP.", "consequence": "With clear etiology, focus on therapy rather than additional diagnostic testing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Refer to orthopedic surgery for tendon release", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Orthopedic surgery** (tendon lengthening, osteotomies) is reserved for fixed contractures that develop over time and interfere with function. At 10 months, the focus is on **preventing** contractures through therapy, stretching, and positioning. Surgery is typically not considered until age 4-6 years and only after conservative measures fail.", "consequence": "Surgery is premature at this age; focus on therapy first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Reassure parents and follow up in 6 months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Delaying intervention is harmful. **Early intervention** during the critical period of brain plasticity (first 3 years of life) significantly improves motor outcomes. Children who receive early therapy have better functional outcomes than those with delayed treatment. Every month counts in early childhood development.", "consequence": "Delay in therapy misses the critical window for neuroplasticity.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Early intervention is the most important treatment for CP.** Start therapy as early as possible - neuroplasticity is greatest in the first 3 years. PT prevents contractures and improves mobility. OT improves fine motor and self-care. Screen for **comorbidities**: epilepsy (25-45%), intellectual disability (30-50%), vision/hearing impairment, feeding difficulties."}, "node-4": {"id": "node-4", "type": "decision", "content": "You enroll the patient in early intervention services. The parents ask about screening for common comorbidities and long-term prognosis.", "question": "Which comorbidity screening is MOST important to arrange for this patient?", "choices": [{"id": "node-4-choice-a", "text": "Ophthalmology evaluation for retinopathy of prematurity and visual impairment", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Ophthalmology evaluation** is critical in this premature infant. **Retinopathy of prematurity (ROP)** is a major concern in infants born at 28 weeks. Additionally, **cortical visual impairment (CVI)** is the most common cause of visual impairment in children with CP. Poor visual tracking noted on exam further supports urgent ophthalmologic evaluation. Vision is essential for motor development and learning.", "consequence": "Excellent choice - vision assessment is crucial for development and was already concerning on exam.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "EEG for seizure risk assessment", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable but not the top priority. **Epilepsy** occurs in 25-45% of children with CP, but this patient has no seizures reported. EEG would be indicated if seizures occur. Given the poor visual tracking noted on exam and history of extreme prematurity, **ophthalmology** evaluation takes priority. However, parents should be counseled about seizure risk and warning signs.", "consequence": "EEG is important but vision assessment is more urgent given exam findings.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Audiology evaluation for hearing assessment", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable choice. **Hearing impairment** is more common in children with CP and can significantly impact speech and language development. However, this premature infant should have already had newborn hearing screening. Given the **poor visual tracking** noted on exam, ophthalmology is more immediately indicated. Audiology should be arranged if not already completed.", "consequence": "Hearing is important but the visual concerns on exam take priority.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-d", "text": "Gastroenterology evaluation for feeding assessment", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. **Feeding difficulties** affect up to 90% of children with CP due to oromotor dysfunction, GERD, and aspiration risk. However, no feeding concerns were mentioned in this case. The **poor visual tracking** on exam warrants ophthalmology evaluation first. Speech therapy (already initiated) will address feeding and oromotor function.", "consequence": "Feeding assessment is part of comprehensive care but vision is more urgent here.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-e", "text": "Neuropsychological testing for cognitive assessment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect at this age. **Neuropsychological testing** is not reliable at 10 months of age. Cognitive assessment is typically performed at age 3-5 years when standardized testing becomes valid. Approximately **30-50% of children with CP** have intellectual disability, but early developmental monitoring through early intervention is more appropriate at this age than formal testing.", "consequence": "Cognitive testing is not valid at this age - continue developmental monitoring.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CP comorbidities to screen for:** Epilepsy (25-45%), intellectual disability (30-50%), visual impairment/CVI (40-75%), hearing loss, speech/communication disorders, feeding difficulties/GERD/aspiration, hip dysplasia (annual hip X-ray until skeletal maturity), osteoporosis, pain, behavioral/emotional problems."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly diagnosed **cerebral palsy** in this premature infant with spasticity and identified **spastic diplegia** as the likely subtype given the periventricular leukomalacia from prematurity. You appropriately prioritized **early intervention** with multidisciplinary therapy and recognized the importance of **comorbidity screening**. Key teaching points: (1) CP is non-progressive (doesn't regress), (2) Prematurity + PVL = spastic diplegia (legs > arms), (3) Early intervention improves outcomes, (4) Screen for vision, hearing, epilepsy, hip dysplasia, and feeding issues."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **cerebral palsy**: (1) **Non-progressive** motor disorder from early brain injury - does NOT regress, (2) **Spastic type** (70-80%) shows increased tone, hyperreflexia, and clonus, (3) **Prematurity \u2192 PVL \u2192 Spastic Diplegia** (legs > arms), (4) **Term asphyxia \u2192 Quadriplegia**, (5) Early intervention is critical for best outcomes."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. **Cerebral palsy** is characterized by: **Non-progressive motor disorder** from brain injury occurring before, during, or shortly after birth. Key distinctions: (1) CP has **hypertonia/spasticity** vs. SMA/muscular dystrophy have **hypotonia/weakness**, (2) CP is **non-progressive** vs. leukodystrophies are **progressive with regression**, (3) **Early intervention** is critical - don't delay therapy. Remember: Prematurity + PVL = spastic diplegia."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-164", "title": "Bell's Palsy in Pediatric Patient", "domain": "neurology", "difficulty": "intermediate", "tags": ["Bell's palsy", "facial nerve palsy", "LMN facial weakness", "clinical diagnosis", "corticosteroids", "eye protection", "no further evaluation needed"], "estimatedMinutes": 5, "source": ["Amboss"], "stem": "A 10-year-old girl is brought to the clinic by her mother who noticed that the right side of her daughter's face \"looks droopy\" since waking up this morning. The child reports no pain but says her right eye feels dry and she has difficulty closing it completely. She also notes that food tastes different.\n\nShe had a mild cold about 1 week ago that has since resolved. She has no significant medical history and takes no medications. There is no history of trauma, ear pain, or hearing changes.\n\nPhysical Examination:\n- General: Alert, well-appearing, afebrile\n- Neurologic: Right-sided facial weakness involving BOTH the forehead AND lower face (cannot raise right eyebrow, cannot close right eye completely, right nasolabial fold flattened, drooping right corner of mouth). Remainder of cranial nerve exam normal. Strength, sensation, and reflexes normal in all extremities.\n- HEENT: Ear canals clear bilaterally, TMs normal, no vesicles, no parotid swelling\n- No rash or lymphadenopathy", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 10-year-old presents with acute onset unilateral facial weakness affecting BOTH the forehead and lower face. Key findings:\n\n- **Forehead AND lower face involved** (LMN pattern)\n- **Cannot close eye, raise eyebrow, or smile on right**\n- **Taste disturbance** (chorda tympani involvement)\n- Recent viral URI\n- **No ear pain, vesicles, rash, or other neurologic deficits**\n- Normal ear exam", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Bell's palsy (idiopathic facial nerve palsy)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bell's palsy** is acute idiopathic peripheral (LMN) facial nerve palsy. Key features: (1) **Acute onset** unilateral facial weakness; (2) **Involves forehead AND lower face** (LMN pattern - distinguishes from stroke); (3) Often preceded by viral illness; (4) May have **taste disturbance, hyperacusis, or decreased tearing**; (5) **Diagnosis of exclusion** - no other cause identified. Most common cause of acute facial palsy in children.", "consequence": "You recognize the classic presentation of Bell's palsy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Stroke affecting the facial nerve nucleus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Stroke is very rare in a healthy 10-year-old and would show **UMN pattern** - forehead SPARED (due to bilateral cortical innervation of upper face). This child has forehead AND lower face involvement (LMN pattern), which indicates peripheral nerve pathology. Additionally, stroke would likely have other neurologic deficits.", "consequence": "LMN pattern excludes stroke; forehead would be spared in UMN lesion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Ramsay Hunt syndrome (herpes zoster oticus)", "isOptimal": false, "isAcceptable": true, "feedback": "Good consideration, but less likely. **Ramsay Hunt syndrome** causes facial palsy with **painful vesicles** in the ear canal, auricle, or soft palate (VZV reactivation in geniculate ganglion). This child has **no vesicles, no ear pain**, and a normal ear exam. Ramsay Hunt has worse prognosis than Bell's palsy. Without vesicles or pain, Bell's palsy is more likely.", "consequence": "No vesicles or ear pain makes Ramsay Hunt unlikely.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Lyme disease with facial nerve involvement", "isOptimal": false, "isAcceptable": true, "feedback": "Important consideration in endemic areas. **Lyme disease** can cause facial palsy (often bilateral) and is common in the Northeast/upper Midwest US. However, there's no mention of tick exposure, erythema migrans rash, or endemic area. Without risk factors, idiopathic Bell's palsy is more likely. Consider Lyme testing in endemic areas.", "consequence": "No tick exposure or endemic area mentioned; consider in appropriate settings.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Otitis media with facial nerve involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Acute otitis media can cause facial palsy (rare complication), but requires **abnormal ear exam** - bulging TM, middle ear effusion, or mastoiditis signs. This child has **normal TMs bilaterally** and no ear pain. Without otitis media, this cannot be the cause.", "consequence": "Normal ear exam excludes otitis media as cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**LMN vs UMN facial weakness**: **LMN (peripheral)** = forehead AND lower face affected (entire half of face). **UMN (central/stroke)** = forehead SPARED, only lower face affected (forehead has bilateral cortical input). Bell's palsy is LMN pattern."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose Bell's palsy based on the classic presentation: acute onset, LMN facial weakness (forehead + lower face), no vesicles or ear abnormalities, no other neurologic deficits.\n\nThe mother asks what testing is needed to confirm the diagnosis.", "question": "What diagnostic workup is MOST appropriate for this patient?", "choices": [{"id": "node-2-choice-a", "text": "No further workup needed - Bell's palsy is a clinical diagnosis; consider Lyme testing only if in endemic area", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bell's palsy is a clinical diagnosis** - no imaging or lab testing is routinely required in classic presentations. The diagnosis is made by: (1) Acute LMN facial palsy; (2) No identifiable cause on history and exam. **Consider Lyme serology** if in endemic area or with exposure history. MRI is reserved for atypical cases, recurrent palsy, or no improvement.", "consequence": "Appropriate clinical diagnosis without unnecessary testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "MRI brain with contrast to rule out tumor or stroke", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for classic presentation. MRI is **not routinely indicated** for typical Bell's palsy. Reserve neuroimaging for: (1) **Atypical features** (slow onset, other cranial nerve involvement, UMN signs); (2) **No improvement by 3-4 months**; (3) **Recurrent facial palsy**; (4) **Bilateral palsy**. This child has classic Bell's palsy and doesn't need imaging.", "consequence": "MRI not needed for classic Bell's palsy presentation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "EMG/nerve conduction studies immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. **EMG/NCS** may be useful for prognosis in severe cases, but findings are not reliable until **10-14 days** after onset (Wallerian degeneration takes time). Immediate EMG is not helpful or indicated. Most cases of Bell's palsy recover without needing electrodiagnostic testing.", "consequence": "EMG not useful immediately; consider later for severe cases.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "CT head to evaluate the facial nerve canal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CT is not helpful** for Bell's palsy - it shows bone but not soft tissue/nerve inflammation. If imaging is needed (atypical features), **MRI** is preferred as it can show facial nerve enhancement. However, imaging is not indicated for classic Bell's palsy.", "consequence": "CT not useful for Bell's palsy; MRI preferred if imaging needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Lumbar puncture to rule out meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child has **isolated facial palsy** with no fever, headache, neck stiffness, or meningeal signs. LP is not indicated. Bell's palsy does not require CSF analysis. LP might be considered if there were signs of meningitis or in workup for Lyme (Lyme can cause lymphocytic meningitis).", "consequence": "No meningeal signs; LP not indicated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**When to image in facial palsy**: (1) Slow/progressive onset (>3 weeks); (2) No improvement by 3-4 months; (3) Recurrent episodes; (4) Other cranial nerve involvement; (5) UMN signs or other neurologic deficits; (6) History of cancer (perineural spread). **Classic Bell's palsy needs NO imaging.**"}, "node-3": {"id": "node-3", "type": "decision", "content": "You confirm the clinical diagnosis of Bell's palsy. The mother asks about treatment options and prognosis.\n\nThe facial weakness is **moderate** - the child can close her eye with effort but not completely, and she has obvious facial asymmetry.", "question": "What is the MOST appropriate treatment for this child?", "choices": [{"id": "node-3-choice-a", "text": "Oral corticosteroids (prednisone) for 5-7 days; eye protection measures (artificial tears, tape eye closed at night)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Corticosteroids** (prednisone 1-2 mg/kg/day, max 60-80 mg, for 5-7 days) are the mainstay of treatment for Bell's palsy. Best started within **72 hours** of onset. Steroids improve recovery rates and reduce long-term sequelae. **Eye protection** is critical to prevent exposure keratopathy: artificial tears during day, lubricating ointment and tape/patch at night. Antivirals (acyclovir) may be added but benefit is uncertain.", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "No treatment - Bell's palsy resolves spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While most Bell's palsy cases improve, **corticosteroids significantly improve outcomes** when started within 72 hours - increasing complete recovery rates and reducing synkinesis. Additionally, **eye care is essential** to prevent corneal damage from incomplete eye closure. Treatment is recommended, not optional.", "consequence": "Treatment improves outcomes; not treating is suboptimal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "IV antibiotics for presumed bacterial infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bell's palsy is **not a bacterial infection** - it's thought to be related to viral inflammation (HSV reactivation) or autoimmune mechanisms. **Antibiotics are not indicated**. The appropriate treatment is corticosteroids (anti-inflammatory effect) and supportive eye care.", "consequence": "Not bacterial; antibiotics not indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Surgical decompression of the facial nerve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is NOT recommended** for Bell's palsy. Studies (including the Copenhagen trial) have not shown benefit from surgical decompression. Medical management with corticosteroids is the standard of care. Surgery might be considered only in very specific circumstances (e.g., temporal bone trauma with facial nerve transection).", "consequence": "Surgery not indicated for Bell's palsy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Start physical therapy immediately for facial exercises", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct but not first-line. **Physical therapy/facial exercises** may have a role in recovery but are **not the primary treatment**. The priority is starting corticosteroids within 72 hours and protecting the eye. Facial exercises may be considered later in recovery but evidence for benefit is limited.", "consequence": "PT may help but steroids and eye care are priorities.", "nextNodeId": "node-3"}], "clinicalPearl": "**Bell's palsy treatment**: (1) **Corticosteroids** within 72 hours (prednisone 1-2 mg/kg/day x 5-7 days); (2) **Eye protection** - artificial tears, ointment at night, tape eye closed; (3) **Antivirals** (acyclovir/valacyclovir) - may add, uncertain benefit; (4) **No surgery** indicated. Most recover within 3-6 months."}, "node-4": {"id": "node-4", "type": "decision", "content": "You prescribe prednisone 1 mg/kg/day for 7 days and provide instructions for eye care. The mother asks about the expected course and prognosis.\n\n**Key prognostic question**: What should the family expect?", "question": "Which statement about prognosis in pediatric Bell's palsy is MOST accurate?", "choices": [{"id": "node-4-choice-a", "text": "Prognosis is excellent - over 90% of children recover completely; improvement typically begins within 2-3 weeks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prognosis in children is excellent**. Over **90% of pediatric patients recover completely** (better than adults). **Improvement typically begins within 2-3 weeks** and continues over 3-6 months. Incomplete recovery or synkinesis (aberrant regeneration) is uncommon in children. Early treatment with corticosteroids further improves outcomes.", "consequence": "Accurate prognostic counseling provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Most children have permanent facial weakness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is overly pessimistic. **Over 90% of children recover completely** from Bell's palsy. Permanent weakness is rare in pediatric patients. Children have better prognosis than adults. While recovery may take weeks to months, complete resolution is the expected outcome.", "consequence": "Children have excellent prognosis; most recover fully.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Recovery should occur within 48 hours; if not, diagnosis is wrong", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Recovery from Bell's palsy takes **weeks to months**, not hours. It is normal for weakness to persist initially. **Improvement typically begins in 2-3 weeks** with continued recovery over 3-6 months. Expecting 48-hour resolution is unrealistic and would cause unnecessary concern.", "consequence": "Recovery takes weeks to months, not hours.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Recurrence is very common; expect multiple episodes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Recurrence is uncommon** - occurring in only about 7-10% of patients over a lifetime. Most children have a single episode and recover fully. If recurrent facial palsy occurs, further workup (including MRI) would be warranted to rule out other causes.", "consequence": "Recurrence uncommon; single episode is typical.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Prognosis depends entirely on EMG findings at presentation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **EMG is not routinely needed** and isn't useful at presentation (too early to show denervation). Prognosis in Bell's palsy is generally determined by: (1) **Severity of initial weakness** (complete paralysis has worse prognosis than partial); (2) **Age** (children do better than adults); (3) **Time to initial improvement**. Most children have excellent outcomes regardless of EMG.", "consequence": "EMG not needed; clinical factors determine prognosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Bell's palsy prognosis**: Children >90% complete recovery; adults ~70-80%. **Poor prognostic factors**: Complete paralysis, older age, diabetes, hypertension, no improvement by 3 weeks. **Follow-up**: Recheck at 2-3 weeks for improvement. If no improvement by 3-4 months \u2192 MRI and consider other diagnoses."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **Bell's palsy** in a pediatric patient.\n\n**Key learning points**:\n\n**Diagnosis**: Acute LMN facial weakness (forehead + lower face), no identifiable cause. Clinical diagnosis - no routine testing needed.\n\n**Treatment**: Corticosteroids within 72 hours (prednisone x 5-7 days) + eye protection (tears, ointment, taping).\n\n**Prognosis**: >90% of children recover completely. Improvement begins in 2-3 weeks, full recovery over 3-6 months.\n\n**Red flags for further workup**: No improvement by 3-4 months, recurrence, other cranial nerve involvement, UMN signs."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **Bell's palsy**:\n\n**Diagnosis**: Acute unilateral **LMN facial palsy** (forehead + lower face). Diagnosis of exclusion - clinical diagnosis, no routine testing.\n\n**Differential**: Ramsay Hunt (vesicles), Lyme (endemic areas), otitis media (abnormal ear exam), stroke (UMN pattern - forehead spared).\n\n**Treatment**: **Steroids within 72 hours** + **eye protection**. No surgery.\n\n**Prognosis**: Excellent in children (>90% full recovery). Improvement in 2-3 weeks, recovery over 3-6 months."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in Bell's palsy management.\n\n**Surgery is NOT indicated**: Studies show no benefit from surgical decompression. Medical management is standard.\n\n**Steroids ARE indicated**: Improve recovery rates when started within 72 hours. Not treating is suboptimal.\n\n**Eye protection is essential**: Incomplete eye closure \u2192 exposure keratopathy \u2192 corneal ulceration \u2192 vision loss. Must use artificial tears + nighttime protection.\n\n**Remember**: Bell's palsy is clinical diagnosis, treated with steroids + eye care, excellent prognosis in children."}}, "rootNodeId": "node-1"}], "renal": [{"id": "vignette-lens-peds-010", "title": "Bacterial vs Viral Meningitis", "domain": "renal", "difficulty": "intermediate", "tags": ["bacterial vs viral meningitis", "CSF analysis", "SIADH", "pediatric infectious disease"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "An 8-month-old female presents to the ED with fever, irritability, and poor feeding of 1 day duration.\n\nAccording to the caregiver, she developed fever yesterday and has been very fussy and crying more than usual. She refuses to eat and seems uncomfortable when held. She vomited once this morning. The mother notes high-pitched crying and lethargy. No rash, seizures, or focal weakness.\n\nMedical history: She attends daycare. Immunizations are up-to-date.\n\nPhysical Examination:\n- General: Irritable, ill-appearing infant with temperature 39.8\u00b0C.\n- Neurologic: Bulging anterior fontanelle, positive Brudzinski sign.\n- Skin: No petechiae or purpura.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this critically ill infant. She has signs concerning for meningitis including bulging fontanelle and positive meningeal signs.", "question": "What is the most appropriate IMMEDIATE first step?", "choices": [{"id": "node-1-choice-a", "text": "Start IV access and empiric antibiotics immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In suspected bacterial meningitis, empiric antibiotics should be started IMMEDIATELY. Do NOT delay for LP or imaging. Every hour of delay increases mortality and neurologic sequelae.", "consequence": "Antibiotics started. Blood cultures drawn. Proceed to lumbar puncture.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Obtain head CT before any intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT before LP is only indicated for: altered mental status, focal neurologic deficit, papilledema, immunocompromise, or new seizure. This infant needs antibiotics NOW - imaging can wait.", "consequence": "Dangerous delay in treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Perform lumbar puncture first to confirm diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "While LP is important for diagnosis, in a critically ill infant with suspected bacterial meningitis, antibiotics should not be delayed. LP can still be diagnostic even after antibiotic administration if done within 1-2 hours.", "consequence": "Suboptimal - diagnosis confirmed but treatment delayed.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Admit for observation and repeat exam in 4 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child has classic signs of meningitis (fever, irritability, bulging fontanelle, positive Brudzinski). Observation without treatment is dangerous and inappropriate.", "consequence": "Risk of rapid deterioration and death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Discharge with oral antibiotics and close follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bacterial meningitis requires IV antibiotics and hospital admission. Oral therapy is never appropriate for suspected meningitis.", "consequence": "High risk of mortality.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Antibiotics first, LP second. Every hour of antibiotic delay in bacterial meningitis increases mortality by 12%."}, "node-2": {"id": "node-2", "type": "decision", "content": "Lumbar puncture is performed. CSF results:\n- WBC: 2,500/\u03bcL (90% neutrophils)\n- Glucose: 25 mg/dL (serum glucose 100 mg/dL)\n- Protein: 180 mg/dL\n- Gram stain: Gram-positive diplococci", "question": "Based on these CSF findings, what is the most likely diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Bacterial meningitis (likely S. pneumoniae)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! CSF shows classic bacterial pattern: WBC >1000 with neutrophil predominance, low glucose (<40 or <50% serum), high protein (>100), and Gram-positive diplococci consistent with S. pneumoniae.", "consequence": "Diagnosis confirmed. Proceed to antibiotic selection.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Viral meningitis (enterovirus)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Viral meningitis shows: WBC <500 (lymphocyte predominance), normal glucose, mildly elevated protein, and negative Gram stain. This CSF profile is clearly bacterial.", "consequence": "Missed bacterial meningitis would be fatal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Tuberculous meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TB meningitis typically shows lymphocyte predominance, very low glucose (<20), very high protein (>200), and a more indolent course. Gram-positive diplococci would not be seen.", "consequence": "Wrong diagnosis and inappropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Fungal meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Fungal meningitis shows lymphocyte predominance with low glucose and elevated protein, but typically in immunocompromised patients with insidious onset. This presentation is acute bacterial.", "consequence": "Missed bacterial meningitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Traumatic tap - repeat LP needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A traumatic tap shows RBCs but normal glucose and protein. This CSF has elevated WBC with neutrophil predominance and low glucose - classic for bacterial infection.", "consequence": "Dangerous delay.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Bacterial CSF: WBC >1000 (PMNs), glucose <40 (or <50% serum), protein >100. Viral CSF: WBC <500 (lymphs), normal glucose, mild protein elevation."}, "node-3": {"id": "node-3", "type": "decision", "content": "You have confirmed bacterial meningitis in this 8-month-old infant. Blood and CSF cultures are pending. You need to select empiric antibiotic therapy.", "question": "What is the most appropriate empiric antibiotic regimen for this patient?", "choices": [{"id": "node-3-choice-a", "text": "Ceftriaxone + Vancomycin + Dexamethasone", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For infants >1-3 months: Ceftriaxone (or cefotaxime) + Vancomycin covers S. pneumoniae (including penicillin-resistant strains) and N. meningitidis. Dexamethasone should be given before or with antibiotics to reduce inflammation and hearing loss risk.", "consequence": "Appropriate broad-spectrum coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ampicillin + Gentamicin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is the regimen for NEONATES (<1 month) to cover GBS, E. coli, and Listeria. For infants >3 months, you need coverage for S. pneumoniae and N. meningitidis with ceftriaxone + vancomycin.", "consequence": "Inadequate coverage for this age group.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Ceftriaxone alone", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct but suboptimal. Due to increasing penicillin-resistant S. pneumoniae, empiric therapy should include vancomycin until sensitivities are known. Ceftriaxone alone may miss resistant strains.", "consequence": "Adequate but may miss resistant organisms.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Acyclovir + Ampicillin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Acyclovir is for HSV encephalitis. Gram stain shows bacteria, not viral etiology. Ampicillin covers Listeria but is not the primary agent for this age group.", "consequence": "Inappropriate regimen.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "High-dose oral amoxicillin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bacterial meningitis requires IV antibiotics with good CNS penetration. Oral therapy is never appropriate for meningitis.", "consequence": "Treatment failure and likely death.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Empiric coverage by age: Neonates: Ampicillin + Gentamicin (or Cefotaxime). 1-3 months: Ampicillin + Ceftriaxone. >3 months: Ceftriaxone + Vancomycin."}, "node-4": {"id": "node-4", "type": "decision", "content": "Day 3 of hospitalization: The infant initially improved on antibiotics, but now shows:\n- Decreasing level of consciousness\n- Serum sodium: 125 mEq/L (was 140 on admission)\n- Urine osmolality: 450 mOsm/kg (inappropriately concentrated)\n- Serum osmolality: 265 mOsm/kg\n- Urine sodium: 60 mEq/L", "question": "What complication has developed, and what is the appropriate management?", "choices": [{"id": "node-4-choice-a", "text": "SIADH - Fluid restriction to 2/3 maintenance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! SIADH is a common complication of bacterial meningitis (occurs in 30-50% of cases). Features: hyponatremia, concentrated urine, euvolemia. Management: Fluid restriction to 2/3 maintenance. Avoid rapid Na correction (risk of osmotic demyelination).", "consequence": "Sodium gradually corrects with fluid restriction.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Cerebral salt wasting - Give IV normal saline bolus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cerebral salt wasting causes hypovolemia with hyponatremia. This patient has euvolemia with concentrated urine - classic SIADH. NS bolus would worsen hyponatremia in SIADH.", "consequence": "Worsening hyponatremia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Antibiotic failure - Change to meropenem", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The initial improvement followed by neurologic change with hyponatremia suggests a metabolic complication (SIADH), not antibiotic failure. Culture sensitivities should guide antibiotic changes.", "consequence": "Misses the actual problem.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Hyponatremic seizure - Give 3% saline bolus", "isOptimal": false, "isAcceptable": true, "feedback": "3% saline is reserved for symptomatic severe hyponatremia (seizures, coma) with Na typically <120. This patient has Na 125 with mild mental status change - fluid restriction is first-line. However, if seizures occur, 3% saline is appropriate.", "consequence": "May be needed if seizures develop.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Increased ICP - Start mannitol and repeat CT", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While increased ICP can occur in meningitis, the lab pattern here (hyponatremia with concentrated urine) indicates SIADH, not acute ICP elevation. Mannitol could worsen the electrolyte disturbance.", "consequence": "Wrong diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "SIADH vs Cerebral Salt Wasting: SIADH = euvolemic, CSW = hypovolemic. Both cause hyponatremia. SIADH: restrict fluids. CSW: give fluids. Also: arrange audiology follow-up - hearing loss occurs in 10-30% of bacterial meningitis survivors."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly managed this case of bacterial meningitis.\n\nKey Learning Points:\n1. Antibiotics FIRST - do not delay for LP or imaging\n2. CSF profile: Bacterial = WBC >1000 (PMNs), glucose <40, protein >100\n3. Empiric therapy >3mo: Ceftriaxone + Vancomycin \u00b1 Dexamethasone\n4. SIADH is common (30-50%) - watch for hyponatremia\n5. Audiology follow-up is essential - hearing loss in 10-30%\n\nOutcome: With early antibiotics and appropriate complication management, the infant recovers. Hearing screen at discharge is normal. Follow-up at 1 month shows normal development."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. In bacterial meningitis:\n\n- Time is brain: Every hour of antibiotic delay increases mortality by 12%\n- CSF analysis distinguishes bacterial from viral (but don't wait for results to treat)\n- Age-appropriate empiric antibiotics are critical\n- Watch for SIADH (hyponatremia with concentrated urine)\n\nKey pearl: If LP is delayed, give antibiotics first - do not wait for CSF results in suspected bacterial meningitis."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. Bacterial meningitis has a mortality of 5-10% even with appropriate treatment, and 20-50% if treatment is delayed or inadequate.\n\nRemember:\n- Classic triad: Fever, headache, neck stiffness (unreliable in infants)\n- Infants: Bulging fontanelle, irritability, poor feeding, high-pitched cry\n- Immediate empiric antibiotics are life-saving\n\nKey pearl: Antibiotics first, LP second. Never discharge or observe a child with suspected meningitis."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-013", "title": "DKA Hyperkalemia Paradox", "domain": "renal", "difficulty": "intermediate", "tags": ["dka hyperkalemia paradox"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old female presents to the clinic with diabetic ketoacidosis of 1 day duration.\n\nSubjectively, she presented in DKA and was started on IV fluids and insulin. Her electrolytes showed an unexpected abnormality.\n\nReview of systems is positive for confusion improving with treatment and negative for cardiac symptoms.\n\nPast medical history includes She has type 1 diabetes diagnosed 3 years ago. This is her second DKA episode.\n\nPhysical Examination:\n- General: adolescent receiving IV fluids and insulin, alertness improving.\n- Cardiovascular: regular rhythm, no arrhythmias.\n- Neurologic: mental status improving with treatment.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 14-year-old with type 1 diabetes presents in DKA. She was started on IV fluids and insulin drip. Initial labs show:\n\n- **Serum K+: 6.5 mEq/L** (elevated)\n- pH: 7.15 (acidotic)\n- Glucose: 450 mg/dL\n- Anion gap: 24\n\n**The DKA Potassium Paradox:**\n- Serum K+ appears **HIGH** (6.5 mEq/L)\n- But **total body potassium is DEPLETED** (massive urinary losses from osmotic diuresis)\n- Acidosis causes **transcellular shift**: H+ enters cells, K+ exits to maintain electroneutrality\n- Result: High serum K+ masks severe total body K+ deficit", "question": "What explains this patient's elevated serum potassium in DKA?", "choices": [{"id": "node-1-choice-a", "text": "Extracellular potassium shift due to acidosis and insulin deficiency", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The elevated serum K+ in DKA is due to **extracellular shift**, NOT true hyperkalemia. Two mechanisms: (1) **Acidosis**: H+ ions enter cells, K+ exits to maintain electroneutrality. (2) **Insulin deficiency**: Insulin normally drives K+ into cells; without it, K+ stays extracellular. Despite the high serum K+, **total body potassium is severely depleted** from weeks of osmotic diuresis and vomiting.", "consequence": "You understand the paradox and can anticipate treatment effects.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "True hyperkalemia from renal failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While DKA can cause prerenal AKI, the elevated K+ is primarily from **transcellular shift**, not renal retention. The key teaching point: total body K+ is actually DEPLETED in DKA despite high serum levels. Once insulin is given, K+ will shift rapidly into cells and the patient may become dangerously **hypokalemic**.", "consequence": "Misunderstanding the mechanism leads to treatment errors.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Excessive potassium intake", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient has been vomiting and unable to eat - she has NOT had excessive K+ intake. In fact, the opposite is true: DKA patients have **total body K+ depletion** from: (1) osmotic diuresis causing massive urinary K+ losses, (2) vomiting, (3) poor intake. The high serum K+ is entirely from transcellular redistribution.", "consequence": "Misattribution of hyperkalemia source.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Hemolysis causing pseudohyperkalemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pseudohyperkalemia** from hemolysis is a lab artifact where K+ is released from lysed RBCs during blood draw/processing. This is different from the DKA potassium paradox, which is a true physiologic shift. In DKA, the K+ is genuinely elevated in the serum (not artifact), but total body stores are depleted.", "consequence": "Wrong mechanism - this is not a lab artifact.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Rhabdomyolysis releasing intracellular potassium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Rhabdomyolysis releases K+ from damaged muscle cells. While DKA patients can have elevated CK, the primary cause of hyperkalemia in DKA is **acidosis-induced transcellular shift** and **insulin deficiency**, not muscle breakdown. There's no history of muscle injury or significantly elevated CK in this case.", "consequence": "Wrong mechanism identified.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**The Paradox**: High serum K+ but LOW total body K+. Once insulin is given, K+ rapidly shifts into cells \u2192 serum K+ can drop precipitously \u2192 **hypokalemia** and cardiac arrhythmias."}, "node-2": {"id": "node-2", "type": "decision", "content": "You understand that this patient's elevated K+ (6.5 mEq/L) reflects **transcellular shift**, not true hyperkalemia. Total body potassium is severely depleted.\n\nThe insulin drip is running. You need to manage potassium during DKA treatment.\n\n**What happens when you give insulin?**\n- Insulin drives K+ INTO cells\n- pH corrects (H+ leaves cells, K+ enters)\n- Serum K+ can drop **1-2 mEq/L per hour**\n- Severe hypokalemia \u2192 cardiac arrhythmias, respiratory weakness", "question": "What is the appropriate potassium management strategy in DKA?", "choices": [{"id": "node-2-choice-a", "text": "Do NOT give K+ initially; start replacement when serum K+ falls below 5.0-5.2 mEq/L", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Initial management: (1) **Do NOT give potassium** while serum K+ is >5.0-5.2 mEq/L - despite total body depletion, giving K+ now risks dangerous hyperkalemia. (2) **Monitor K+ every 1-2 hours** during insulin therapy. (3) **Start K+ replacement** (20-40 mEq/L in IV fluids) when serum K+ drops below 5.0-5.2 mEq/L. (4) If K+ is <3.3 mEq/L, **hold insulin** until K+ is repleted to prevent fatal hypokalemia.", "consequence": "Appropriate potassium management strategy.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Give IV potassium immediately to replete total body stores", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! Although total body K+ is depleted, the serum K+ is currently **6.5 mEq/L** (dangerously high). Giving additional K+ now could cause fatal **cardiac arrhythmias** (peaked T waves \u2192 widened QRS \u2192 sine wave \u2192 VF). You must wait until insulin drives K+ into cells and serum K+ drops below 5.0-5.2 before starting replacement.", "consequence": "Potentially fatal hyperkalemia and cardiac arrhythmias.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Give calcium gluconate, insulin/glucose, and kayexalate for hyperkalemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. These are treatments for **true hyperkalemia**, not the DKA potassium paradox. The patient is already receiving insulin (part of DKA treatment). Additional glucose would worsen hyperglycemia. Kayexalate would further deplete total body K+, worsening the underlying deficit. The serum K+ will correct naturally as acidosis resolves - aggressive K+-lowering treatment is contraindicated.", "consequence": "Inappropriate treatment worsens total body K+ depletion.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Hold insulin until potassium normalizes to prevent hypokalemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. You should NOT hold insulin for K+ of 6.5 mEq/L. Insulin is essential for DKA treatment to stop ketogenesis. However, if K+ is **<3.3 mEq/L**, THEN you should hold insulin until K+ is repleted. The strategy is: give insulin, monitor K+ closely, start replacement when K+ drops below 5.0-5.2. Only hold insulin for severe hypokalemia (<3.3).", "consequence": "Delaying insulin worsens DKA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Restrict all potassium and recheck in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. You cannot wait 24 hours - K+ can drop 1-2 mEq/L PER HOUR once insulin is started. This patient needs K+ monitoring every **1-2 hours** during active DKA treatment. Restricting K+ without close monitoring will lead to severe hypokalemia as treatment progresses. DKA potassium management requires vigilant, frequent reassessment.", "consequence": "Inadequate monitoring misses rapidly developing hypokalemia.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Critical threshold**: If K+ <3.3 mEq/L, **HOLD INSULIN** until K+ is repleted to >3.3. Giving insulin during severe hypokalemia can cause fatal cardiac arrhythmias and respiratory muscle paralysis."}, "node-3": {"id": "node-3", "type": "decision", "content": "Two hours later, repeat labs show:\n- **Serum K+: 4.2 mEq/L** (dropped from 6.5)\n- pH: 7.25 (improving)\n- Glucose: 280 mg/dL (improving)\n\nThe patient's mental status is improving. You start potassium replacement in the IV fluids (40 mEq/L).\n\n**Monitoring priorities:**\n- K+ every 1-2 hours until stable\n- Watch for signs of hypokalemia: weakness, arrhythmias, U waves on ECG\n- Continue insulin until anion gap closes", "question": "The patient develops new-onset headache and becomes slightly confused 4 hours into treatment. What is your concern?", "choices": [{"id": "node-3-choice-a", "text": "Cerebral edema - give hypertonic saline or mannitol immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Cerebral edema** is the most feared complication of pediatric DKA treatment (mortality 20-25%). Warning signs: **new headache**, **altered mental status**, irritability, bradycardia, hypertension, pupil changes. Risk factors: young age (<5), new-onset diabetes, severe acidosis, rapid fluid/glucose correction. Treatment: **3% hypertonic saline** (5-10 mL/kg) or **mannitol** (0.5-1 g/kg). Reduce IV rate. Elevate head of bed.", "consequence": "Early recognition and treatment of cerebral edema.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Hypokalemia causing confusion - give IV potassium bolus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hypokalemia is a concern in DKA treatment, it typically causes **muscle weakness** and **cardiac arrhythmias**, not headache and confusion. New-onset headache and altered mental status during DKA treatment is **cerebral edema until proven otherwise**. The K+ is 4.2 (normal), so hypokalemia is not the issue here.", "consequence": "Missing cerebral edema is potentially fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Hypoglycemia - check glucose and give D50", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable to check, but glucose is 280 mg/dL - not hypoglycemic. Hypoglycemia during DKA treatment causes altered mental status but typically occurs when glucose drops too quickly or below target. The combination of **new headache** + confusion is classic for **cerebral edema**, which is the primary concern during pediatric DKA treatment. Always consider cerebral edema first.", "consequence": "Glucose is normal; cerebral edema is the real concern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Normal DKA recovery - continue current treatment and observe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous! **New headache and confusion during DKA treatment is NEVER normal**. This is the classic presentation of **cerebral edema**, which can progress rapidly to herniation and death. Any neurologic change during DKA treatment requires immediate evaluation and treatment for cerebral edema. Do not wait and observe.", "consequence": "Delayed recognition of cerebral edema leads to herniation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Worsening acidosis - increase insulin drip rate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The pH is actually improving (7.25, up from 7.15). More importantly, **increasing insulin rate does NOT treat cerebral edema** and could worsen it by causing more rapid fluid/glucose shifts. The concern here is cerebral edema - treatment is hypertonic saline or mannitol, reducing IV rate, and elevating head of bed.", "consequence": "Wrong intervention for cerebral edema.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Cerebral edema rule**: ANY new headache, irritability, or altered mental status during DKA treatment = cerebral edema until proven otherwise. Treat immediately - don't wait for imaging."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You mastered the **DKA Potassium Paradox**: (1) High serum K+ masks severe total body K+ depletion, (2) Don't give K+ initially if >5.0-5.2; start replacement as K+ falls, (3) Monitor K+ every 1-2 hours, (4) Hold insulin if K+ <3.3. You also recognized **cerebral edema** - the feared complication of pediatric DKA (new headache + confusion = treat immediately with hypertonic saline/mannitol). Key risk factors: young age, new-onset DM, severe acidosis, rapid correction."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the **DKA Potassium Paradox**: Serum K+ HIGH but total body K+ DEPLETED. Mechanism: acidosis + insulin deficiency cause transcellular shift. Management: don't give K+ until <5.0-5.2, then start replacement. Monitor every 1-2 hours. Hold insulin if K+ <3.3. Watch for cerebral edema (new headache, confusion) - treat immediately with hypertonic saline or mannitol."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in DKA management. Key teaching: (1) **Potassium Paradox**: High serum K+ masks total body depletion - don't give K+ until <5.0-5.2, (2) Don't use typical hyperkalemia treatments (already getting insulin, kayexalate worsens depletion), (3) **Cerebral edema**: New headache/confusion during DKA = treat immediately (3% saline or mannitol), don't wait. Risk factors: young age, new DM, severe acidosis, rapid correction. Mortality 20-25%."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-015", "title": "Severe Hyperkalemia", "domain": "renal", "difficulty": "intermediate", "tags": ["peaked T waves", "widened QRS", "sine wave", "severe hyperkalemia"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 5-year-old male is brought to the emergency department for muscle weakness and palpitations.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 5-year-old presents with muscle weakness and palpitations. Labs: K+ 7.8 mEq/L. ECG shows **peaked T waves** (especially in leads V2-V4). The child has known chronic kidney disease on dialysis but missed his last session.", "question": "What ECG change is the EARLIEST sign of hyperkalemia?", "choices": [{"id": "node-1-choice-a", "text": "Peaked T waves - tall, narrow, and 'tented' in precordial leads", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Peaked T waves** are the earliest ECG manifestation of hyperkalemia, typically appearing at K+ >5.5-6.0 mEq/L. They are described as tall, narrow, and **'tented'** - symmetric with a sharp peak. Best seen in precordial leads (V2-V4). This reflects rapid repolarization due to increased extracellular K+.", "consequence": "You recognize the earliest ECG sign.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Widened QRS complex", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect sequence. **QRS widening** is a LATER finding, occurring at K+ >6.5-7.0 mEq/L. The progression is: peaked T waves \u2192 prolonged PR \u2192 **loss of P wave** \u2192 **QRS widening** \u2192 sine wave \u2192 asystole. Peaked T waves come first.", "consequence": "This is a later, more dangerous finding.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Prolonged QT interval", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged QT is associated with **hypokalemia** and **hypocalcemia**, not hyperkalemia. Hyperkalemia actually causes **shortened QT** due to rapid repolarization. This is the opposite electrolyte disturbance.", "consequence": "QT prolongation suggests hypokalemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "ST elevation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ST elevation suggests myocardial ischemia (STEMI), pericarditis, or other conditions - not hyperkalemia. While severe hyperkalemia can cause ST changes, **peaked T waves** are the characteristic early finding.", "consequence": "ST changes suggest different pathology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Ventricular fibrillation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. V-fib is a **terminal** arrhythmia in severe hyperkalemia, not an early sign. The ECG progression goes through multiple stages before reaching V-fib: peaked T \u2192 widened QRS \u2192 **sine wave** \u2192 V-fib/asystole.", "consequence": "This is a terminal finding.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ECG changes in hyperkalemia** (in order): **Peaked T waves** (>5.5) \u2192 **Prolonged PR** (>6.0) \u2192 **Loss of P waves** (>6.5) \u2192 **Widened QRS** (>7.0) \u2192 **Sine wave** (>8.0) \u2192 **V-fib/Asystole**. MEMORIZE this progression!"}, "node-2": {"id": "node-2", "type": "decision", "content": "The ECG now shows peaked T waves AND widened QRS complex. K+ is 7.8 mEq/L. The patient is at high risk for cardiac arrest.", "question": "What is the FIRST medication to give in hyperkalemia with ECG changes?", "choices": [{"id": "node-2-choice-a", "text": "IV calcium gluconate 100 mg/kg - cardiac membrane stabilization", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Calcium gluconate** (or calcium chloride via central line) is ALWAYS first. It **does NOT lower potassium** but **stabilizes the cardiac membrane** by antagonizing the effect of K+ on myocardial cells. Works within **1-3 minutes**. Dose: **100 mg/kg IV** (max 2g) over 2-5 minutes. Can repeat if no ECG improvement.", "consequence": "Cardiac membrane is stabilized.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "IV insulin with dextrose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as FIRST step. Insulin/dextrose **shifts K+ intracellularly** and is an important treatment, but **calcium must be given FIRST** to stabilize the heart. Insulin takes 15-30 minutes to work - the heart may arrest before it kicks in without calcium protection.", "consequence": "Heart may arrest while waiting for K+ shift.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Sodium bicarbonate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as first-line. Bicarbonate shifts K+ intracellularly (in exchange for H+) but effect is **slow and unreliable**. It's most useful in **metabolic acidosis** but should NOT replace calcium as the first intervention when ECG changes are present.", "consequence": "Unreliable K+ shift, delays cardiac stabilization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Kayexalate (sodium polystyrene sulfonate)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. Kayexalate **removes K+ from the body** via GI exchange but takes **hours to work** (4-6 hours for significant effect). It is NOT useful for acute, life-threatening hyperkalemia with ECG changes. Also has serious GI complications.", "consequence": "Takes hours - useless in emergency.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Albuterol nebulizer", "isOptimal": false, "isAcceptable": true, "feedback": "Good adjunct but not first. Albuterol **shifts K+ intracellularly** via beta-2 stimulation (activates Na/K-ATPase). Effective and fast (15-30 min), but **calcium MUST be given first** for cardiac protection when ECG changes are present.", "consequence": "Useful adjunct but calcium first.", "nextNodeId": "node-3"}], "clinicalPearl": "**\"Calcium first!\"** It stabilizes the heart (not K+ level) within minutes. Then use **3 strategies**: (1) **SHIFT K+ in**: insulin/glucose, albuterol, bicarb. (2) **REMOVE K+**: dialysis, Kayexalate. (3) **Monitor**: continuous ECG."}, "node-3": {"id": "node-3", "type": "decision", "content": "Calcium gluconate is given and ECG shows improvement (QRS narrowing). Now you need to lower the serum potassium level.", "question": "Which intervention MOST RAPIDLY shifts potassium into cells?", "choices": [{"id": "node-3-choice-a", "text": "IV regular insulin (0.1 U/kg) with IV dextrose to prevent hypoglycemia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Insulin + glucose** is the most effective K+-shifting agent. Insulin drives K+ into cells via Na/K-ATPase activation. Onset **15-30 minutes**, lowers K+ by **0.5-1.2 mEq/L**. ALWAYS give **dextrose (0.5-1 g/kg)** to prevent hypoglycemia. Monitor glucose closely!", "consequence": "Potassium begins to shift intracellularly.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Oral sodium polystyrene sulfonate (Kayexalate)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Kayexalate is a cation-exchange resin that **removes K+ from the body** (not shift), but it works over **hours**, not acutely. It also has risks of GI necrosis. Not useful for acute hyperkalemia management.", "consequence": "Too slow for acute management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "More calcium gluconate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Calcium **does not lower K+ levels** - it only stabilizes the myocardium. After the initial dose has taken effect (ECG improvement), giving more calcium won't help unless ECG changes return. Now you need K+-lowering strategies.", "consequence": "Calcium doesn't lower potassium.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "IV furosemide alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as primary therapy. Furosemide increases renal K+ excretion but only works if **kidneys are functional** (this patient has CKD on dialysis). Also, loop diuretics take time and are unreliable in renal failure. Insulin/glucose is faster and more reliable.", "consequence": "Won't work in renal failure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "High-dose albuterol nebulizer (10-20 mg)", "isOptimal": false, "isAcceptable": true, "feedback": "Good adjunct! Albuterol shifts K+ intracellularly via beta-2 receptor activation. **High doses** (10-20 mg, much higher than asthma doses) lower K+ by **0.5-1 mEq/L**. Works in 15-30 min. However, **insulin is more reliable** and typically preferred as primary K+-shifting agent.", "consequence": "Useful but insulin is more reliable.", "nextNodeId": "node-4"}], "clinicalPearl": "**K+-SHIFTING agents**: (1) **Insulin + Glucose** - most effective, onset 15-30 min. (2) **Albuterol** (high dose 10-20mg) - useful adjunct. (3) **Bicarb** - only if acidotic, unreliable. **None of these REMOVE K+** - they just buy time for dialysis or other elimination."}, "node-4": {"id": "node-4", "type": "decision", "content": "Insulin and dextrose are given. K+ is now 6.8 mEq/L. ECG is stable. However, this patient has end-stage renal disease and cannot excrete potassium.", "question": "What is the DEFINITIVE treatment to REMOVE potassium from the body in a patient with renal failure?", "choices": [{"id": "node-4-choice-a", "text": "Emergent hemodialysis - most effective K+ removal method", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Hemodialysis** is the most effective way to **remove K+ from the body**. Can lower K+ by **1-2 mEq/L per hour**. Essential for patients with **renal failure** who cannot excrete K+. Should be initiated urgently in severe hyperkalemia unresponsive to shifting measures or in ESRD.", "consequence": "Dialysis arranged urgently.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue insulin and glucose indefinitely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Insulin only **SHIFTS K+ into cells temporarily** - it does not remove K+ from the body. When insulin effect wears off (4-6 hours), K+ will shift back OUT and hyperkalemia recurs. You must **remove K+** via dialysis or GI exchange.", "consequence": "Rebound hyperkalemia when insulin wears off.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "High-dose loop diuretics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this patient. Loop diuretics require **functional kidneys** to work. This patient has ESRD on dialysis - his kidneys cannot respond to diuretics. Dialysis is the only way to remove K+ in anuric/oliguric renal failure.", "consequence": "Diuretics don't work without kidney function.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Sodium polystyrene sulfonate (Kayexalate) enema", "isOptimal": false, "isAcceptable": true, "feedback": "Can be used as adjunct but has limitations. Kayexalate exchanges Na+ for K+ in the GI tract, removing K+ in stool. Takes **4-6 hours** for effect and removes only ~0.5-1 mEq/L. Risk of **intestinal necrosis** (especially with sorbitol). Not adequate alone for severe hyperkalemia in ESRD.", "consequence": "Slow and insufficient for severe hyperkalemia.", "nextNodeId": "node-5"}, {"id": "node-4-choice-e", "text": "Patiromer or sodium zirconium cyclosilicate", "isOptimal": false, "isAcceptable": true, "feedback": "These are newer K+ binders (Patiromer = Veltassa, SZC = Lokelma) with better safety profiles than Kayexalate. Work in GI tract to remove K+. Useful for **chronic hyperkalemia management** but **too slow for acute emergency**. Takes hours to days. Dialysis is needed acutely.", "consequence": "Useful for chronic, not acute management.", "nextNodeId": "node-5"}], "clinicalPearl": "**K+ REMOVAL methods**: (1) **Dialysis** - most effective, removes 1-2 mEq/L/hour. (2) **Loop diuretics** - if kidneys work. (3) **GI binders** (Kayexalate, patiromer, SZC) - slow, for chronic management. **Insulin/albuterol SHIFT but don't REMOVE** - rebound hyperkalemia occurs!"}, "node-5": {"id": "node-5", "type": "decision", "content": "Hemodialysis is initiated and K+ normalizes to 4.5 mEq/L. The patient stabilizes. You need to determine the underlying cause to prevent recurrence.", "question": "What is the MOST COMMON cause of severe hyperkalemia in pediatric patients?", "choices": [{"id": "node-5-choice-a", "text": "Renal failure (acute or chronic) - impaired K+ excretion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Renal failure** (AKI or CKD) is the most common cause of severe hyperkalemia. The kidneys normally excrete 90% of daily K+ intake. When GFR drops significantly, K+ accumulates. Other causes include: adrenal insufficiency, tumor lysis syndrome, rhabdomyolysis, medications (ACE-I, K+-sparing diuretics, NSAIDs), and excessive K+ intake.", "consequence": "You understand the common etiology.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Dietary potassium excess alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as sole cause. With **normal kidney function**, even high K+ intake is rapidly excreted. Severe hyperkalemia from diet alone is nearly impossible unless there's underlying renal dysfunction, medication interference, or massive acute K+ load (e.g., IV potassium error).", "consequence": "Diet alone rarely causes severe hyperkalemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Pseudohyperkalemia from hemolyzed sample", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this case. **Pseudohyperkalemia** (false elevation from cell lysis during blood draw) should be suspected with isolated K+ elevation, **no ECG changes**, and difficult venipuncture. This patient had **ECG changes** (peaked T waves, wide QRS), confirming TRUE hyperkalemia.", "consequence": "ECG changes confirm true hyperkalemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Hyperaldosteronism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - opposite effect. **Hyperaldosteronism** causes **hypokalemia** (aldosterone increases renal K+ secretion). **Hypoaldosteronism** (Addison's disease, type 4 RTA) causes hyperkalemia due to decreased K+ excretion.", "consequence": "This would cause hypokalemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Metabolic alkalosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - opposite effect. **Alkalosis** causes K+ to shift **INTO cells** (in exchange for H+), leading to **hypokalemia**. **Acidosis** causes K+ to shift OUT of cells, contributing to hyperkalemia. This patient's renal failure is the primary cause.", "consequence": "Alkalosis causes hypokalemia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Causes of hyperkalemia** (MACHINE): **M**edications (ACE-I, ARBs, K+-sparing diuretics, NSAIDs), **A**cidosis, **C**ellular release (hemolysis, rhabdo, TLS, burns), **H**ypoaldosteronism, **I**ntake excess, **N**ephrons not working (renal failure), **E**xcretion impaired."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed severe hyperkalemia with cardiac toxicity. Key teaching points: (1) Peaked T waves are earliest ECG sign, (2) CALCIUM FIRST to stabilize the heart (doesn't lower K+), (3) Insulin/glucose is most effective K+-shifting agent, (4) Dialysis is definitive treatment for K+ removal in renal failure, (5) Renal failure is the most common cause. Remember: ECG changes mandate emergent treatment - don't wait for repeat labs!"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review hyperkalemia management: (1) Recognize ECG changes - peaked T waves first, then widened QRS, then sine wave. (2) CALCIUM FIRST for cardiac stabilization. (3) Shift K+ with insulin/glucose and albuterol. (4) Remove K+ with dialysis. (5) Identify and treat underlying cause."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in hyperkalemia management. Remember: This is a cardiac emergency! ECG changes require IMMEDIATE treatment. Sequence: (1) Calcium to stabilize heart, (2) Insulin/glucose to shift K+, (3) Dialysis to remove K+. Delays or incorrect treatment can lead to fatal arrhythmias. \"Calcium first - it doesn't lower K+ but prevents arrhythmia while you do!\""}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-017", "title": "Acute Hyponatremia - Iatrogenic", "domain": "renal", "difficulty": "advanced", "tags": ["hyponatremia", "iatrogenic", "post-operative", "seizure", "3% saline", "osmotic demyelination", "hypotonic fluids", "ADH", "electrolyte emergency"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male is post-operative day 2 following appendectomy. He has been receiving D5 0.45% NS at maintenance rate. The nurse calls urgently because the child just had a generalized tonic-clonic seizure lasting 2 minutes that self-resolved.\n\nPre-operative sodium was 140 mEq/L. Current vital signs: HR 110, BP 95/60, RR 22, SpO2 98% on room air.\n\nOn examination, the child is drowsy but arousable, with no focal neurologic deficits. Mucous membranes are moist.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A post-operative child on hypotonic IV fluids presents with new-onset seizure. You need to rapidly assess the most likely etiology.", "question": "What is the most critical initial test to order?", "choices": [{"id": "node-1-choice-a", "text": "Stat basic metabolic panel (BMP) with sodium level", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In a post-operative child on **hypotonic IV fluids** presenting with seizure, **hyponatremia** is the most likely cause. A stat sodium level is critical because **Na <120 mEq/L** with acute onset carries high seizure risk. The combination of hypotonic fluids (D5 0.45% NS) plus post-operative **ADH release** (from pain, nausea, opioids) creates a perfect storm for dilutional hyponatremia.", "consequence": "Labs obtained urgently. Sodium returns at 118 mEq/L.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Head CT scan without contrast", "isOptimal": false, "isAcceptable": true, "feedback": "While head CT may be indicated to rule out **cerebral edema** or other intracranial pathology, the clinical context strongly suggests **iatrogenic hyponatremia**. Getting labs first is more efficient\u2014if sodium is critically low, treatment shouldn't wait for imaging. CT can follow after stabilization.", "consequence": "CT obtained but delays identification of treatable cause.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Lumbar puncture to rule out meningitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child is **afebrile** and post-operative with a clear precipitant (hypotonic fluids). Meningitis is very unlikely. Furthermore, LP in the setting of possible **cerebral edema** from hyponatremia could be dangerous. Always check electrolytes first in this scenario.", "consequence": "Unnecessary invasive procedure delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "EEG to characterize seizure activity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. EEG is useful for characterizing seizure disorders but does not address the **underlying metabolic cause**. In this context, the seizure is likely **symptomatic** of acute hyponatremia, not a primary epileptic event. Treat the cause, not just the symptom.", "consequence": "Focus on seizure characterization misses the treatable etiology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Blood glucose level only", "isOptimal": false, "isAcceptable": false, "feedback": "While hypoglycemia should always be considered in seizures, this child is receiving **D5** (dextrose-containing) fluids, making hypoglycemia unlikely. The clinical picture points strongly to **hyponatremia** from free water excess. A full BMP is needed, not just glucose.", "consequence": "Incomplete workup misses the sodium abnormality.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NEVER use hypotonic maintenance fluids** in hospitalized children. Use isotonic solutions (NS or LR). Post-operative patients have multiple triggers for ADH release (pain, nausea, opioids, stress) that impair free water excretion."}, "node-2": {"id": "node-2", "type": "decision", "content": "Laboratory results return:\n- **Sodium: 118 mEq/L** (pre-op was 140 mEq/L)\n- Potassium: 3.8 mEq/L\n- Chloride: 88 mEq/L\n- CO2: 24 mEq/L\n- BUN: 8 mg/dL\n- Creatinine: 0.4 mg/dL\n- Glucose: 95 mg/dL\n- Serum osmolality: 248 mOsm/kg (low)\n- Urine osmolality: 450 mOsm/kg (inappropriately concentrated)\n\nThe child remains drowsy but has not had another seizure.", "question": "What is the underlying mechanism of this child's hyponatremia?", "choices": [{"id": "node-2-choice-a", "text": "Dilutional hyponatremia from hypotonic fluid administration with impaired free water excretion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **dilutional hyponatremia** from **free water excess**. The hypotonic IV fluids (D5 0.45% NS) provided excess free water, while post-operative **ADH release** impaired free water excretion (explaining the inappropriately concentrated urine despite low serum osmolality). The acute drop from 140 to 118 mEq/L in <48 hours caused **cerebral edema** and seizures.", "consequence": "Mechanism understood. Proceed to urgent treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "SIADH from occult malignancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the urine shows inappropriate concentration (consistent with SIADH physiology), this is **iatrogenic SIADH-like state** from post-operative stress, NOT primary SIADH from malignancy. The clear temporal relationship with hypotonic fluids + surgery makes the diagnosis straightforward. Malignancy-related SIADH would not develop this acutely.", "consequence": "Overcomplicating the diagnosis delays treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Cerebral salt wasting syndrome", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cerebral salt wasting** causes **hypovolemic** hyponatremia with renal sodium losses, typically following CNS injury. This child had abdominal surgery (not CNS), is **euvolemic** (moist mucous membranes, normal BP), and the mechanism is free water excess, not sodium loss.", "consequence": "Misdiagnosis could lead to inappropriate fluid management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Adrenal insufficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Adrenal insufficiency can cause hyponatremia but would also show **hyperkalemia** (this child has normal K+), hypoglycemia, and signs of volume depletion. The clinical context clearly points to **iatrogenic** cause from hypotonic fluids.", "consequence": "Incorrect diagnosis leads to inappropriate steroid administration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Psychogenic polydipsia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Psychogenic polydipsia occurs in psychiatric patients who drink excessive water. This is a **5-year-old post-operative child** receiving IV fluids\u2014oral water intake is not the issue. The iatrogenic source is the hypotonic IV fluids.", "consequence": "Irrelevant diagnosis in this clinical context.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Euvolemic hyponatremia** with inappropriately concentrated urine indicates impaired free water excretion. In post-operative patients, this is usually from ADH release triggered by pain, nausea, opioids, and surgical stress\u2014NOT primary SIADH."}, "node-3": {"id": "node-3", "type": "decision", "content": "The child has **acute symptomatic hyponatremia** (Na 118 mEq/L with seizure). The drop occurred over <48 hours. You need to initiate emergency treatment.\n\nThe seizure has stopped but the child remains lethargic.", "question": "What is the most appropriate immediate treatment?", "choices": [{"id": "node-3-choice-a", "text": "3% hypertonic saline bolus (2-3 mL/kg) to raise sodium by 4-6 mEq/L", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **acute symptomatic hyponatremia with seizures**, give **3% saline** bolus to rapidly raise sodium by **4-6 mEq/L**. This small, targeted increase is enough to reverse cerebral edema and stop seizures. The formula: 2-3 mL/kg of 3% saline raises Na by ~2-3 mEq/L per bolus. Can repeat if symptoms persist.", "consequence": "3% saline administered. Repeat sodium in 1 hour shows 124 mEq/L. Child more alert.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Fluid restriction to 50% maintenance and monitor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Fluid restriction is appropriate for **asymptomatic** or **chronic** hyponatremia, NOT for acute symptomatic hyponatremia with **seizures**. This child has life-threatening cerebral edema requiring emergent sodium correction. Passive fluid restriction is far too slow.", "consequence": "Inadequate treatment allows cerebral edema to worsen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Normal saline (0.9% NS) bolus 20 mL/kg", "isOptimal": false, "isAcceptable": true, "feedback": "Normal saline is better than hypotonic fluids but **insufficient for acute symptomatic hyponatremia**. NS (154 mEq/L) will raise sodium slowly, but in a seizing patient with Na of 118, you need the more concentrated **3% saline** (513 mEq/L) for rapid, controlled correction. NS may be appropriate for milder, asymptomatic cases.", "consequence": "Sodium rises slowly. Some improvement but suboptimal.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Furosemide 1 mg/kg IV to induce free water loss", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Loop diuretics cause loss of both sodium and water, which is unpredictable and could worsen hyponatremia if free water losses exceed sodium losses. Furosemide is sometimes used in **chronic SIADH** with saline infusion, but NOT as first-line for acute symptomatic hyponatremia.", "consequence": "Unpredictable electrolyte shifts. Condition may worsen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Demeclocycline to block ADH action", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Demeclocycline is used for **chronic SIADH** management\u2014it takes days to work by inducing nephrogenic diabetes insipidus. It has NO role in acute symptomatic hyponatremia, which requires immediate sodium correction, not gradual ADH blockade.", "consequence": "Inappropriate chronic therapy for acute emergency.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**3% saline dosing**: 2-3 mL/kg bolus raises Na by ~2-3 mEq/L. Target initial rise of **4-6 mEq/L** to reverse symptoms. For seizures, can give rapidly over 10-20 minutes. Recheck sodium frequently (every 1-2 hours initially)."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 3% saline bolus, sodium is now **124 mEq/L** (up from 118). The child is more alert and has had no further seizures.\n\nThe team is planning continued management. Current IV is still D5 0.45% NS.", "question": "What is the critical consideration for the next 24 hours of sodium management?", "choices": [{"id": "node-4-choice-a", "text": "Limit total sodium correction to <10-12 mEq/L in 24 hours to prevent osmotic demyelination syndrome", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Osmotic demyelination syndrome (ODS)**, formerly called central pontine myelinolysis, occurs with **overly rapid correction** of chronic hyponatremia. Even in acute cases, limit correction to **<10-12 mEq/L in the first 24 hours**. Since Na rose from 118\u2192124 (6 mEq/L), only 4-6 mEq/L more correction is safe today. Switch IV to **isotonic fluid** and monitor sodium every 4-6 hours.", "consequence": "IV changed to NS. Sodium monitored closely. Gradual safe correction achieved.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Continue 3% saline infusion to normalize sodium as quickly as possible", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Rapid overcorrection risks **osmotic demyelination syndrome (ODS)**, which causes devastating pontine and extrapontine myelinolysis with quadriparesis, pseudobulbar palsy, and locked-in syndrome. Once symptoms resolve, SLOW DOWN. The goal is not to normalize sodium quickly but to correct safely.", "consequence": "Sodium rises to 138 mEq/L in 12 hours. Risk of ODS is high.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Continue D5 0.45% NS at current rate since the seizure stopped", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **hypotonic fluid caused this problem**\u2014do not continue it! D5 0.45% NS will provide more free water and could cause sodium to drop again. All hospitalized children should receive **isotonic fluids** (NS or LR) for maintenance.", "consequence": "Sodium drops back to 120 mEq/L. Seizure recurs.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Aim to correct sodium to normal (140 mEq/L) within 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Correcting from 118 to 140 mEq/L (22 mEq/L) in 24 hours is **dangerously fast** and risks **osmotic demyelination syndrome**. The safe limit is **<10-12 mEq/L per 24 hours**. After acute symptoms resolve, gradual correction over 48-72 hours is safest.", "consequence": "Overcorrection causes osmotic demyelination syndrome.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Administer desmopressin (DDAVP) to prevent further sodium changes", "isOptimal": false, "isAcceptable": true, "feedback": "DDAVP can be used as a **rescue strategy** if sodium is rising too quickly\u2014it causes water retention and slows correction. However, it's not first-line management. The priority is switching to isotonic fluids and monitoring. DDAVP is reserved for inadvertent overcorrection scenarios.", "consequence": "Reasonable precaution but not the primary management strategy.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Correction limits**: <10-12 mEq/L in first 24 hours, <18 mEq/L in 48 hours. **ODS** is more common with chronic hyponatremia but can occur in any overcorrection. If correcting too fast, give **DDAVP + D5W** to \"re-lower\" sodium."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You correctly identified acute iatrogenic hyponatremia in a post-operative child receiving hypotonic fluids, understood the mechanism (dilutional from free water excess + impaired excretion from ADH release), treated emergently with **3% saline** for symptomatic hyponatremia, and recognized the critical importance of **limiting correction rate** to prevent osmotic demyelination syndrome.\n\n**Key Learning Points:**\n- NEVER use hypotonic maintenance fluids in hospitalized children\n- Na <120 mEq/L with acute onset = high seizure risk\n- 3% saline bolus (2-3 mL/kg) for symptomatic hyponatremia\n- Correct <10-12 mEq/L per 24 hours to prevent ODS\n- Switch to isotonic fluids (NS or LR) for ongoing maintenance"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While you may have eventually reached the correct diagnosis, delays in recognizing iatrogenic hyponatremia can be dangerous. In post-operative patients on hypotonic fluids who seize, **always check sodium first**.\n\n**Review:**\n- Hypotonic fluids + ADH release = dilutional hyponatremia\n- Acute drop in Na causes cerebral edema \u2192 seizures\n- 3% saline is the treatment for symptomatic hyponatremia\n- Correction must be controlled to prevent osmotic demyelination"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical errors in management.** Acute symptomatic hyponatremia is a medical emergency that requires rapid recognition and appropriate treatment. Delays or incorrect interventions can result in **permanent neurologic injury** from prolonged cerebral edema or **osmotic demyelination syndrome** from overcorrection.\n\n**Key Pearl:** Avoid hypotonic maintenance fluids in ALL hospitalized children. Use isotonic solutions (NS or LR). When hyponatremia causes seizures, treat with 3% saline but limit correction to <10-12 mEq/L per 24 hours."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-018", "title": "SIADH in Meningitis", "domain": "renal", "difficulty": "intermediate", "tags": ["SIADH", "hyponatremia", "meningitis", "fluid restriction", "cerebral salt wasting", "CNS infection", "euvolemic", "ADH"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "A 5-year-old male was admitted 2 days ago with bacterial meningitis (S. pneumoniae) and started on IV ceftriaxone and dexamethasone. He initially improved but now has increasing lethargy and confusion.\n\nVital signs: HR 88, BP 105/65, RR 18, T 37.8\u00b0C.\n\nPhysical exam reveals a drowsy child who is oriented but slow to respond. Mucous membranes are moist. No peripheral edema. Skin turgor is normal. Weight is unchanged from admission.\n\nThe nurse notes that urine output has decreased despite receiving standard maintenance IV fluids.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A child with bacterial meningitis who was improving now has worsening mental status. You need to determine the cause of this change.\n\nLaboratory results:\n- Serum sodium: 125 mEq/L (was 139 on admission)\n- Serum osmolality: 260 mOsm/kg (low)\n- Urine osmolality: 520 mOsm/kg (inappropriately concentrated)\n- Urine sodium: 65 mEq/L (>40)\n- BUN: 6 mg/dL, Creatinine: 0.3 mg/dL\n- Glucose: 90 mg/dL", "question": "What is the most likely cause of this child's altered mental status?", "choices": [{"id": "node-1-choice-a", "text": "SIADH (Syndrome of Inappropriate ADH Secretion) from CNS infection", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is classic **SIADH** secondary to bacterial meningitis. The diagnostic criteria are met: **hyponatremia** (Na <135), **low serum osmolality** (<280), **inappropriately concentrated urine** (osm >100), **elevated urine sodium** (>40), and **euvolemic status** (normal BP, moist mucous membranes, no edema, normal skin turgor). CNS infections are a common cause of SIADH due to inflammation affecting ADH regulation.", "consequence": "Diagnosis confirmed. Proceed to assess severity and management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Cerebral salt wasting (CSW) syndrome", "isOptimal": false, "isAcceptable": true, "feedback": "Close but not quite. While CSW can occur with CNS disease and causes hyponatremia with high urine sodium, the key differentiator is **volume status**. CSW causes **hypovolemia** (tachycardia, hypotension, poor skin turgor, weight loss) because sodium is being lost. This patient is **euvolemic** with normal BP and stable weight, making **SIADH** more likely. The distinction matters because CSW requires saline replacement, while SIADH requires fluid restriction.", "consequence": "Important differential considered. Volume assessment is key.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Worsening meningitis with cerebral edema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While cerebral edema can cause altered mental status, it would not explain the **hyponatremia** and **concentrated urine** findings. The patient is afebrile (T 37.8\u00b0C) and was clinically improving before this change. The lab findings point clearly to a sodium/water balance problem, specifically **SIADH**.", "consequence": "Lab findings suggest a metabolic cause, not infection progression.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Adrenal insufficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Adrenal insufficiency can cause hyponatremia, but it would also show **hyperkalemia** (this patient's K+ is not mentioned as abnormal), **hypoglycemia**, and **hypotension**. This patient has normal BP and glucose. Additionally, adrenal insufficiency is relatively rare and would not be expected in this clinical context without prior steroid use or known adrenal disease.", "consequence": "Electrolyte pattern does not match adrenal insufficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Overhydration from excessive IV fluids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Simple overhydration would cause dilutional hyponatremia with **dilute urine** (low urine osmolality) as the kidneys attempt to excrete the excess water. This patient has **concentrated urine** (osm 520) despite low serum osmolality\u2014the hallmark of SIADH where ADH is being secreted inappropriately, preventing water excretion.", "consequence": "Urine should be dilute with overhydration, not concentrated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SIADH diagnostic criteria**: Serum Na <135, serum osm <280, urine osm >100 (inappropriately concentrated), urine Na >40, EUVOLEMIC status, normal thyroid/adrenal function. The key to distinguishing from **CSW** is volume status: SIADH = euvolemic, CSW = hypovolemic."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed **SIADH** secondary to bacterial meningitis. The sodium is 125 mEq/L and the patient is lethargic but not seizing.\n\nThe child is currently receiving D5 0.45% NS at standard maintenance rate.", "question": "What is the most appropriate initial management for this patient's SIADH?", "choices": [{"id": "node-2-choice-a", "text": "Fluid restriction to 50-75% of maintenance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **asymptomatic or mildly symptomatic SIADH** (lethargy without seizures), **fluid restriction** is first-line treatment. Restrict to **50-75% of maintenance** to create a negative free water balance. This allows the kidneys to gradually excrete excess water and correct the hyponatremia. Sodium correction should be slow: **<8-10 mEq/L per 24 hours** to prevent osmotic demyelination.", "consequence": "Fluids restricted. Sodium monitored every 6-8 hours.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "3% hypertonic saline bolus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **3% saline** is reserved for **severe symptomatic hyponatremia** (seizures, coma, respiratory distress). This patient is lethargic but not seizing, and Na is 125 (not critically low like <120). Hypertonic saline carries risk of **osmotic demyelination** if sodium is corrected too rapidly. Fluid restriction is sufficient for this case.", "consequence": "Risk of overcorrection with aggressive treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Normal saline bolus 20 mL/kg", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In SIADH, giving **isotonic saline** can paradoxically **worsen hyponatremia**! The kidneys will excrete the sodium (urine Na is already high) but retain the water due to inappropriate ADH, leading to further dilution. Saline boluses are appropriate for **CSW** (which is hypovolemic), NOT for euvolemic SIADH.", "consequence": "Sodium may drop further\u2014saline can worsen SIADH.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Continue current IV fluids and recheck sodium in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient is receiving **hypotonic fluids** (D5 0.45% NS) which are providing free water and worsening the hyponatremia. Continuing the same fluids will allow sodium to drop further, potentially causing seizures or cerebral edema. Active management with fluid restriction is needed.", "consequence": "Hyponatremia worsens. Risk of seizures increases.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Furosemide with salt tablets", "isOptimal": false, "isAcceptable": true, "feedback": "This can be used for **chronic refractory SIADH**, but is not first-line for acute SIADH in a child with meningitis. The loop diuretic promotes free water excretion while salt tablets replace sodium losses. However, fluid restriction is simpler, safer, and usually effective as initial management. This approach is more common in chronic SIADH (e.g., from tumors).", "consequence": "Acceptable but not first-line for acute presentation.", "nextNodeId": "node-3"}], "clinicalPearl": "**Fluid restriction in SIADH**: Restrict to 50-75% maintenance (some use 1 L/m\u00b2/day or 800 mL/m\u00b2/day for children). Monitor Na every 6-8 hours initially. Target correction <8-10 mEq/L per 24 hours. Avoid isotonic saline\u2014it can paradoxically worsen hyponatremia in SIADH!"}, "node-3": {"id": "node-3", "type": "decision", "content": "Fluids have been restricted to 60% maintenance. After 24 hours:\n- Sodium: 131 mEq/L (up from 125)\n- Patient is more alert and interactive\n- Urine output has improved\n\nThe meningitis is being treated appropriately with IV antibiotics. The team is planning ongoing management.", "question": "What is the expected course and key monitoring consideration for this patient's SIADH?", "choices": [{"id": "node-3-choice-a", "text": "SIADH typically resolves as the underlying infection improves; monitor sodium until normalized and gradually liberalize fluids", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **SIADH from meningitis is usually transient** and resolves as the CNS inflammation subsides with antibiotic treatment. Continue fluid restriction and monitor sodium every 6-12 hours until stable. Once sodium normalizes (>135 mEq/L) and remains stable, **gradually liberalize fluids** to avoid rebound hypernatremia. Persistent SIADH beyond 1-2 weeks should prompt evaluation for other causes.", "consequence": "Appropriate monitoring plan. Patient recovers fully.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start demeclocycline for long-term SIADH management", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Demeclocycline** induces nephrogenic diabetes insipidus and is used for **chronic SIADH** (e.g., from malignancy, chronic lung disease). It takes days to work and is NOT appropriate for acute, transient SIADH from meningitis, which will resolve with treatment of the underlying infection. It also has significant side effects including nephrotoxicity and photosensitivity.", "consequence": "Unnecessary chronic therapy for transient condition.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Discharge with oral fluid restriction instructions once sodium is >130", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient has **bacterial meningitis** requiring IV antibiotics\u2014they cannot be discharged just because the sodium improved! SIADH management is just one component of care. The patient needs to complete the full antibiotic course and be monitored for meningitis complications (hearing loss, neurologic sequelae). Sodium should fully normalize before relaxing fluid restriction.", "consequence": "Premature discharge risks incomplete meningitis treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Perform MRI brain to rule out occult CNS pathology causing persistent SIADH", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect at this time. The patient's SIADH is improving appropriately with fluid restriction, and there is a clear etiology (bacterial meningitis). MRI might be indicated if SIADH **persists** beyond expected resolution (>1-2 weeks) or if there are concerning neurologic findings suggesting a structural lesion. Routine MRI for transient SIADH from known meningitis is not indicated.", "consequence": "Unnecessary imaging for clearly explained SIADH.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "The sodium rose 6 mEq/L in 24 hours, which is dangerously fast\u2014give D5W to lower it", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A rise of **6 mEq/L in 24 hours** is SAFE and within guidelines (<8-10 mEq/L/24h). There is no need to actively lower the sodium. Giving D5W would be counterproductive and could worsen the hyponatremia. The goal is controlled correction, which is being achieved. Continue current management.", "consequence": "Unnecessary intervention for appropriate correction rate.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SIADH from meningitis** is usually transient (days to weeks) and resolves with treatment of the underlying infection. Safe correction rate: **<8-10 mEq/L per 24 hours**. If Na rises too fast (>10-12/24h), consider giving D5W or DDAVP to slow correction. Monitor for **meningitis complications**: hearing loss (get audiology), seizures, developmental delays."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You correctly identified SIADH in a child with bacterial meningitis, understood the pathophysiology (CNS inflammation \u2192 inappropriate ADH release \u2192 water retention \u2192 dilutional hyponatremia), initiated appropriate treatment with **fluid restriction**, and recognized that this is typically a **transient** complication that resolves with treatment of the underlying infection.\n\n**Key Learning Points:**\n- SIADH = euvolemic hyponatremia + concentrated urine + high urine Na\n- Distinguish from CSW by volume status (SIADH euvolemic, CSW hypovolemic)\n- First-line treatment: fluid restriction to 50-75% maintenance\n- Avoid isotonic saline (can worsen SIADH)\n- Correct slowly: <8-10 mEq/L per 24 hours\n- SIADH from infection usually resolves as infection improves"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While you identified some aspects correctly, the management of SIADH requires understanding the nuances.\n\n**Review:**\n- SIADH is distinguished from CSW by **euvolemic** status\n- **Fluid restriction** (50-75% maintenance) is first-line treatment\n- Isotonic saline can paradoxically worsen hyponatremia in SIADH\n- Correction should be slow: <8-10 mEq/L per 24 hours\n- SIADH from meningitis is usually transient"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical management errors.** SIADH is a common complication of CNS infections that requires specific treatment. Giving saline or continuing hypotonic fluids can worsen hyponatremia, potentially causing **seizures** or **cerebral edema**.\n\n**Key Pearl:** In SIADH, urine osmolality is inappropriately high relative to serum osmolality. The kidneys are retaining water despite hyponatremia. Treatment is **fluid restriction**, not fluid administration. Isotonic saline can paradoxically worsen the hyponatremia."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-033", "title": "Pediatric UTI", "domain": "renal", "difficulty": "intermediate", "tags": ["fever without source in infant", "suprapubic tenderness", "pediatric uti"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 4-year-old female is brought to the emergency department for painful urination and accidents that began 3 days ago.\n\nHistory reveals, she cries when she pees and has been going to the bathroom very frequently. She has had several daytime accidents despite being potty trained for 2 years.\n\nReview of systems is positive for mild lower abdominal discomfort and negative for fever, back pain, or blood in urine.\n\nMedical history is notable for She had one UTI last year. She takes bubble baths regularly.\n\nPhysical Examination:\n- Abdomen: mild suprapubic tenderness, no costovertebral angle tenderness.\n- General: well-appearing, afebrile child.\n- GU: normal external genitalia.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 4-year-old presents with classic lower urinary tract symptoms: dysuria, frequency, and urinary incontinence (regression). She is afebrile with suprapubic tenderness but no CVA tenderness. She has a history of one prior UTI and risk factors (bubble baths).", "question": "What is the most appropriate method to obtain a urine specimen in this toilet-trained child?", "choices": [{"id": "node-1-choice-a", "text": "Clean-catch midstream urine specimen", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In **toilet-trained children**, a properly collected **clean-catch midstream specimen** is the preferred method. It's non-invasive and reliable when proper technique is used (clean periurethral area, catch midstream to avoid initial flow contamination).", "consequence": "Specimen obtained appropriately. UA pending.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bag urine specimen attached to perineum", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bag specimens have high contamination rates** (up to 85% false positives) and are only useful if NEGATIVE. They should NOT be used for culture in toilet-trained children who can provide clean-catch specimens.", "consequence": "High likelihood of contaminated specimen and false positive.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Urethral catheterization", "isOptimal": false, "isAcceptable": true, "feedback": "Catheterization provides reliable specimens but is invasive and uncomfortable. It's preferred for **non-toilet-trained children** but is not first-line for cooperative, toilet-trained children who can provide clean-catch specimens.", "consequence": "Unnecessary invasive procedure, but specimen is reliable.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Suprapubic aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Suprapubic aspiration is the **gold standard** for sterile collection but is reserved for **infants <2 months** or when other methods fail. It's overly invasive for a toilet-trained 4-year-old.", "consequence": "Unnecessarily invasive procedure for this patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "First morning void without cleaning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. First morning void is useful for detecting proteinuria or microscopic hematuria, but for UTI diagnosis, **proper cleaning and midstream collection** are essential to reduce contamination.", "consequence": "High contamination rate leads to unreliable results.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Urine collection by age**: Infants = catheter or suprapubic aspiration; Non-toilet-trained toddlers = catheter (bag only if negative); Toilet-trained children = clean-catch midstream."}, "node-2": {"id": "node-2", "type": "decision", "content": "Urinalysis Results:\n- Appearance: Cloudy\n- Leukocyte esterase: Positive\n- Nitrites: Positive\n- WBC: 50-100/hpf\n- Bacteria: Many\n- RBC: 0-2/hpf\n\nUrine culture is sent and pending.", "question": "What do these urinalysis findings indicate, and what is the best next step?", "choices": [{"id": "node-2-choice-a", "text": "Findings strongly suggest UTI; start empiric oral antibiotics (e.g., cephalexin or TMP-SMX) while awaiting culture", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Positive leukocyte esterase AND nitrites** together have high specificity (>90%) for UTI. In an **afebrile child with lower tract symptoms** (cystitis), **oral antibiotics** are first-line. **Cephalexin** or **TMP-SMX** for 3-5 days is appropriate for uncomplicated cystitis.", "consequence": "Antibiotics started. Patient begins to improve.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Wait for culture results before starting any antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While culture confirmation is important, **treatment should not be delayed** with such suggestive UA findings. Start empiric therapy and adjust based on culture sensitivities if needed.", "consequence": "Unnecessary delay in treatment; symptoms persist.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Admit for IV antibiotics given positive UA", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This **well-appearing, afebrile child** with lower tract symptoms (cystitis) does not require hospitalization or IV antibiotics. IV therapy is reserved for **pyelonephritis** (fever, CVA tenderness, ill-appearing) or infants <2 months.", "consequence": "Unnecessary hospitalization and IV access.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Findings are inconclusive; repeat urinalysis tomorrow", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Positive leukocyte esterase + nitrites + pyuria + bacteriuria is a **classic positive UA for UTI**. No need to repeat - treat empirically while awaiting culture.", "consequence": "Unnecessary delay prolongs symptoms.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Start empiric IV ceftriaxone to cover resistant organisms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IV ceftriaxone is reserved for **pyelonephritis or complicated UTI**. For uncomplicated cystitis in a well child, **oral antibiotics** are equally effective and avoid unnecessary IV access.", "consequence": "Overtreatment with unnecessary IV therapy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Nitrites** indicate bacteria (usually gram-negative) that convert urinary nitrates \u2192 nitrites. Requires urine in bladder ~4 hours, so may be negative in frequent voiders. **Leukocyte esterase** detects WBCs (pyuria)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Culture returns: >100,000 CFU/mL E. coli, sensitive to all tested antibiotics. The patient completes her antibiotic course with resolution of symptoms. This is her second UTI (first was 1 year ago). Parents ask about further workup.", "question": "What imaging, if any, is indicated for this child with her second UTI?", "choices": [{"id": "node-3-choice-a", "text": "Renal and bladder ultrasound; VCUG not routinely indicated for second uncomplicated cystitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Renal/bladder ultrasound** is recommended after first febrile UTI in children <2 years or after second UTI at any age to assess for structural abnormalities. **VCUG** is no longer routinely recommended after first UTI - it's reserved for abnormal ultrasound, recurrent febrile UTIs, or atypical course.", "consequence": "Ultrasound ordered. No hydronephrosis or structural abnormalities seen.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "VCUG immediately to evaluate for vesicoureteral reflux", "isOptimal": false, "isAcceptable": true, "feedback": "VCUG can detect VUR, but current AAP guidelines recommend a **'top-down' approach** - start with ultrasound, and VCUG is indicated only if ultrasound is abnormal or there are recurrent febrile UTIs. This reduces radiation and invasive testing.", "consequence": "VCUG performed; mild VUR detected. Could have been managed with ultrasound first.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "No imaging needed after uncomplicated cystitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While first uncomplicated cystitis in older children may not require imaging, **recurrent UTIs** warrant at least a renal/bladder ultrasound to evaluate for structural abnormalities, hydronephrosis, or post-void residual.", "consequence": "Missed opportunity to detect underlying abnormality.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "DMSA renal scan to assess for scarring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as initial imaging. **DMSA scan** is used to detect renal scarring from pyelonephritis, not for routine evaluation of cystitis. It's considered after febrile UTIs or when VUR is detected, not as first-line imaging.", "consequence": "Unnecessary nuclear medicine study for uncomplicated cystitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "CT abdomen/pelvis with contrast", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT involves significant radiation and is not indicated for routine UTI evaluation in children. **Ultrasound is first-line** - it's radiation-free and can detect hydronephrosis, stones, and bladder abnormalities.", "consequence": "Unnecessary radiation exposure in a child.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**AAP imaging guidelines**: Renal/bladder US after first febrile UTI (age 2-24 months) or recurrent UTI. VCUG only if US abnormal, atypical UTI, or recurrent febrile UTI. **Top-down approach** reduces unnecessary invasive testing."}, "node-4": {"id": "node-4", "type": "decision", "content": "Ultrasound is normal with no hydronephrosis or structural abnormalities. Parents are concerned about preventing future UTIs and ask about behavioral modifications and antibiotic prophylaxis.", "question": "What is the most appropriate guidance for preventing recurrent UTIs in this child?", "choices": [{"id": "node-4-choice-a", "text": "Behavioral modifications: avoid bubble baths, wipe front-to-back, regular voiding, treat constipation; prophylactic antibiotics not routinely recommended", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **First-line prevention is behavioral**: avoid irritants (bubble baths, harsh soaps), proper wiping technique (front-to-back), regular voiding (avoid holding urine), adequate hydration, and treat constipation. **Antibiotic prophylaxis** is NOT routinely recommended per AAP - it increases resistance and has limited benefit in children without VUR.", "consequence": "Family counseled on prevention strategies. No prophylaxis prescribed.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Start daily low-dose TMP-SMX prophylaxis for 1 year", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Antibiotic prophylaxis is not routinely recommended** for children without high-grade VUR (grades IV-V). The RIVUR trial showed prophylaxis reduces recurrent febrile UTI but increases antibiotic-resistant infections. Risk-benefit favors behavioral modifications first.", "consequence": "Unnecessary long-term antibiotic exposure; resistance risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Circumcision referral for males; no specific prevention for females", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient is female. While circumcision reduces UTI risk in males (especially infants), there are specific behavioral interventions for females including wiping technique, avoiding irritants, and addressing constipation.", "consequence": "Missed opportunity for appropriate counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Cranberry supplements are the most effective prevention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cranberry products have insufficient evidence** in children for UTI prevention. Behavioral modifications have better evidence. Cranberry may have a small role but should not be the primary recommendation.", "consequence": "Reliance on unproven intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Refer to urology for consideration of surgical intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Urology referral is indicated for high-grade VUR, recurrent febrile UTIs despite prophylaxis, or structural abnormalities. This child has normal ultrasound and uncomplicated cystitis - surgical evaluation is not indicated.", "consequence": "Unnecessary specialist referral.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**UTI prevention in girls**: Avoid bubble baths/irritants, wipe front-to-back, void regularly (every 2-3 hours), adequate fluids, treat constipation (compresses bladder \u2192 incomplete emptying). Prophylactic antibiotics reserved for high-grade VUR."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of pediatric UTI!\n\n**Key Learning Points:**\n1. **Urine collection**: Clean-catch for toilet-trained; catheter/SPA for infants\n2. **UA interpretation**: LE + nitrites highly specific; pyuria + bacteriuria confirms\n3. **Treatment**: Oral antibiotics for cystitis; IV for pyelonephritis or infants <2 months\n4. **Imaging**: US after first febrile UTI (<2 years) or recurrent UTI; VCUG only if US abnormal\n5. **Prevention**: Behavioral modifications first; prophylaxis only for high-grade VUR\n\n**Remember**: E. coli causes 80-90% of pediatric UTIs. Female:male ratio reverses after infancy (1:4 in infants due to uncircumcised males, 10:1 in school-age children)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key pearls:\n\n1. **Bag urine only useful if NEGATIVE** - high false positive rate\n2. **Don't delay treatment** for culture results when UA is suggestive\n3. **Oral antibiotics** are appropriate for uncomplicated cystitis\n4. **Ultrasound first**, VCUG only if abnormal (top-down approach)\n5. **Behavioral modifications** before prophylactic antibiotics"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in pediatric UTI management.\n\n**Avoid these mistakes:**\n- Using bag specimens for culture in toilet-trained children\n- IV antibiotics for uncomplicated cystitis in well-appearing children\n- CT imaging in children (unnecessary radiation)\n- Routine antibiotic prophylaxis without high-grade VUR\n\n**Key pearl**: Match treatment intensity to disease severity - cystitis \u2260 pyelonephritis."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-034", "title": "Nephrotic Syndrome", "domain": "renal", "difficulty": "intermediate", "tags": ["periorbital edema", "foamy urine", "hyperlipidemia", "massive proteinuria", "nephrotic syndrome"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 4-year-old male presents to the clinic with puffy eyes and swollen legs of 1 week duration.\n\nAccording to the caregiver, his mother noticed his eyes are puffy in the mornings and his legs have become swollen. He has also had frothy urine. He had a cold 2 weeks ago.\n\ndecreased urine output and weight gain. No blood in urine, fever, or joint pain.\n\nMedical history is notable for He was previously healthy. No family history of kidney disease.\n\nPhysical Examination:\n- General: well-appearing child with periorbital edema and lower extremity pitting edema.\n- Labs: BMP: Cr elevated; UA: proteinuria.\n- Abdomen: ascites present.\n- Vital signs: blood pressure normal.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 4-year-old has periorbital edema, lower extremity edema, ascites, and frothy urine. Labs show: Albumin 1.8 g/dL, Cholesterol 380 mg/dL, Urinalysis: 4+ protein, no blood.", "question": "What are the FOUR classic features that define nephrotic syndrome?", "choices": [{"id": "node-1-choice-a", "text": "Massive proteinuria, hypoalbuminemia, edema, and hyperlipidemia", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **nephrotic syndrome tetrad**: (1) **Massive proteinuria** (>3.5g/day in adults, urine protein:creatinine >2 in children), (2) **Hypoalbuminemia** (<2.5 g/dL), (3) **Edema** (periorbital classically first, then dependent), (4) **Hyperlipidemia** (compensatory hepatic lipoprotein synthesis).", "consequence": "You correctly identify the diagnostic criteria.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Hematuria, hypertension, edema, and low complement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **nephrITIC syndrome** (e.g., PSGN), NOT nephrOTIC syndrome. Nephritic = inflammation (hematuria, RBC casts, hypertension). NephrOTIC = protein loss (massive proteinuria, hypoalbuminemia). This patient has no hematuria.", "consequence": "Confusing nephrotic and nephritic syndromes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Proteinuria, elevated creatinine, oliguria, and acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **acute kidney injury**, not nephrotic syndrome. In classic nephrotic syndrome, **GFR and creatinine are typically NORMAL** - the kidney is leaking protein but still filtering well.", "consequence": "Confusing nephrotic syndrome with AKI.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Mild proteinuria, normal albumin, hypertension, and hematuria", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes mild glomerular disease or nephritic syndrome. **Nephrotic syndrome requires MASSIVE proteinuria and LOW albumin**. The edema results from hypoalbuminemia-induced decreased oncotic pressure.", "consequence": "Thresholds for nephrotic syndrome not met.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Proteinuria, hypoalbuminemia, thrombocytopenia, and anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Thrombocytopenia and anemia are not features of nephrotic syndrome. Actually, nephrotic patients are in a **hypercoagulable state** due to loss of anticoagulant proteins (antithrombin III) and increased platelet aggregation.", "consequence": "Wrong associated features.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Nephrotic syndrome tetrad**: Massive **P**roteinuria, hypo**A**lbuminemia, **E**dema, hyperli**P**idemia (**PAEP**). Remember: nephrOTIC = prOTein loss. NephrITIC = InfammaTory (RBCs, HTN)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Nephrotic syndrome is confirmed. In a previously healthy child age 1-8 years with typical presentation (no hematuria, normal BP, normal complement, normal creatinine).", "question": "What is the MOST LIKELY underlying cause of nephrotic syndrome in this age group?", "choices": [{"id": "node-2-choice-a", "text": "Minimal change disease (MCD) - >80% of pediatric cases", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Minimal change disease** accounts for **>80% of nephrotic syndrome** in children ages 1-8 years. It's called 'minimal change' because light microscopy is NORMAL - only electron microscopy shows **podocyte foot process effacement**. MCD is highly **steroid-responsive**.", "consequence": "You understand the epidemiology.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Focal segmental glomerulosclerosis (FSGS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. FSGS is the **second most common** cause in children and more common in **African American** children. It is also more likely if the patient is **steroid-resistant**. In typical presentation (white child, age 1-8, no atypical features), MCD is much more likely.", "consequence": "Less common in typical presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Membranous nephropathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Membranous nephropathy is the most common cause of nephrotic syndrome in **ADULTS**, not children. In children, it's rare and often secondary to hepatitis B, SLE, or malignancy.", "consequence": "This is an adult diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Post-streptococcal glomerulonephritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PSGN causes **nephrITIC syndrome** (hematuria, hypertension, low complement), not nephrOTIC syndrome. This patient has no hematuria, normal BP, and normal complement - classic for MCD.", "consequence": "Wrong syndrome entirely.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "IgA nephropathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IgA nephropathy typically presents with **hematuria** (often gross hematuria during URIs) and is more common in **adolescents and adults**. It causes nephritic-range findings, not the massive proteinuria of nephrotic syndrome.", "consequence": "Wrong disease and syndrome.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pediatric nephrotic syndrome etiology**: MCD >80% (ages 1-8), FSGS second (more common if African American or steroid-resistant). **Empiric steroid trial** is standard for typical presentation - biopsy only if atypical features or steroid resistance."}, "node-3": {"id": "node-3", "type": "decision", "content": "You diagnose presumed minimal change disease based on typical presentation. You plan to start steroid therapy.", "question": "What is the FIRST-LINE treatment for pediatric nephrotic syndrome with presumed MCD?", "choices": [{"id": "node-3-choice-a", "text": "Prednisone 2 mg/kg/day (max 60 mg) for 4-6 weeks, then taper", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prednisone 2 mg/kg/day** (maximum 60 mg/day) is first-line treatment. Initial course is typically **4-6 weeks daily**, then alternate-day taper. **>95% of MCD patients respond within 4 weeks** with resolution of proteinuria (steroid-sensitive). No biopsy needed before empiric trial in typical presentation.", "consequence": "Appropriate steroid therapy initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Kidney biopsy before any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Biopsy is NOT needed** in typical presentation (age 1-8, no hematuria, normal complement, normal creatinine). Empiric steroids are standard. Biopsy is indicated for: age <1 or >12, steroid resistance, atypical features (hematuria, low C3, renal insufficiency), or frequent relapses requiring additional agents.", "consequence": "Unnecessary invasive procedure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Cyclophosphamide as first-line", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cyclophosphamide is reserved for **frequently relapsing** or **steroid-dependent** nephrotic syndrome. It is NOT first-line due to significant side effects (cytopenias, infections, gonadal toxicity). Steroids are always tried first.", "consequence": "Second-line agent used prematurely.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "ACE inhibitor alone without steroids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ACE inhibitors reduce proteinuria and are used as adjunctive therapy, but **steroids are essential first-line treatment** for MCD. ACE inhibitors alone will not induce remission in active nephrotic syndrome.", "consequence": "Missing disease-modifying therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Albumin infusion and diuretics only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Albumin and diuretics are **supportive measures** for severe edema but do NOT address the underlying disease. **Steroids are required** to stop the protein leak. Supportive care without steroids will not lead to remission.", "consequence": "Treating symptoms but not disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**MCD steroid protocol**: Prednisone 2 mg/kg/day (max 60mg) x 4-6 weeks, then 1.5 mg/kg alternate days x 4-6 weeks, then taper. **Steroid-sensitive** = remission within 4 weeks. **Steroid-resistant** = no remission after 4-8 weeks \u2192 needs biopsy."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child responds to steroids within 2 weeks (urine protein becomes negative). During treatment, he develops fever and abdominal pain. On exam: diffuse abdominal tenderness without peritoneal signs, T 39.5\u00b0C.", "question": "What is the MOST likely serious complication in this nephrotic patient with fever and abdominal pain?", "choices": [{"id": "node-4-choice-a", "text": "Spontaneous bacterial peritonitis (SBP) - most commonly S. pneumoniae", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Spontaneous bacterial peritonitis** is a serious complication of nephrotic syndrome due to loss of **immunoglobulins** (especially IgG) and **complement** in urine. **Streptococcus pneumoniae** is the most common organism. Nephrotic patients should receive **pneumococcal vaccine**. Treatment: IV antibiotics (ceftriaxone).", "consequence": "You recognize this serious complication.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Appendicitis", "isOptimal": false, "isAcceptable": false, "feedback": "While appendicitis should be considered, **diffuse** abdominal tenderness (rather than RLQ localization) and the **immunocompromised state** of nephrotic syndrome make **SBP** more likely. Nephrotic patients are highly susceptible to encapsulated organisms.", "consequence": "Consider SBP first in nephrotic patients.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Steroid-induced gastritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Gastritis would cause epigastric pain, not diffuse tenderness with high fever. The combination of **fever + abdominal pain in nephrotic syndrome** should raise immediate concern for **SBP** or **thrombosis**.", "consequence": "Missing serious infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Viral gastroenteritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. High fever (39.5\u00b0C) with diffuse abdominal tenderness in an **immunocompromised** nephrotic patient requires consideration of **bacterial infection** (SBP), not viral illness. Missing SBP can be fatal.", "consequence": "Underestimating infection risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Renal vein thrombosis", "isOptimal": false, "isAcceptable": true, "feedback": "Good consideration! Nephrotic patients ARE at high risk for **thrombosis** (loss of antithrombin III, protein C, S). However, renal vein thrombosis typically causes **flank pain** and **hematuria**, not diffuse abdominal pain with high fever. SBP is more likely with this presentation.", "consequence": "Important complication but different presentation.", "nextNodeId": "node-5"}], "clinicalPearl": "**Nephrotic syndrome complications**: (1) **Infection** - SBP (S. pneumoniae), cellulitis, sepsis (loss of IgG, complement), (2) **Thrombosis** - renal vein, DVT, PE (loss of antithrombin III), (3) **Hyperlipidemia** - accelerated atherosclerosis, (4) **AKI** - if severe hypovolemia."}, "node-5": {"id": "node-5", "type": "decision", "content": "SBP is treated successfully. The child achieves remission but relapses when steroids are tapered. This is his third relapse in 6 months.", "question": "What is the next step for FREQUENTLY RELAPSING nephrotic syndrome (\u22652 relapses in 6 months)?", "choices": [{"id": "node-5-choice-a", "text": "Add steroid-sparing agent (cyclophosphamide, MMF, or calcineurin inhibitor)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **frequently relapsing** (\u22652 relapses/6 months) or **steroid-dependent** (relapse during taper) nephrotic syndrome, **steroid-sparing agents** are added to minimize steroid toxicity. Options include: **Cyclophosphamide** (8-12 week course), **mycophenolate mofetil**, or **calcineurin inhibitors** (tacrolimus, cyclosporine).", "consequence": "Appropriate escalation of therapy.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Continue high-dose steroids indefinitely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prolonged high-dose steroids cause severe complications: **growth suppression**, **Cushing syndrome**, **osteoporosis**, **cataracts**, **immunosuppression**, **hypertension**. Steroid-sparing agents are indicated to minimize these toxicities.", "consequence": "Unacceptable steroid toxicity.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Stop all treatment and monitor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Untreated nephrotic syndrome leads to serious complications: **infections**, **thrombosis**, **progressive edema**, **malnutrition**. Treatment is necessary, but steroid-sparing agents allow disease control with less toxicity.", "consequence": "Abandoning treatment is dangerous.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Kidney biopsy to confirm minimal change disease", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Biopsy may be performed in frequently relapsing cases, especially before starting cytotoxic agents, to confirm MCD vs FSGS. However, if the child was steroid-RESPONSIVE (achieved remission), MCD is very likely, and **starting steroid-sparing therapy** is the priority.", "consequence": "May be done but therapy escalation is more urgent.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-e", "text": "Increase steroid dose with each relapse", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The standard steroid dose for relapse is the same as initial treatment (2 mg/kg/day). **Escalating doses** increases toxicity without benefit. The solution for frequent relapses is **adding steroid-sparing agents**, not increasing steroids.", "consequence": "More steroids = more toxicity without benefit.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Nephrotic syndrome definitions**: **Steroid-sensitive** = remission within 4 weeks. **Steroid-resistant** = no remission after 4-8 weeks (needs biopsy). **Frequently relapsing** = \u22652 relapses/6 months or \u22654/year. **Steroid-dependent** = relapse during taper or within 14 days of stopping. Add **steroid-sparing agents** for FR/SD."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified the nephrotic syndrome tetrad, recognized MCD as the most common cause in children, initiated appropriate steroid therapy, recognized SBP as a serious complication, and escalated to steroid-sparing agents for frequent relapses. Key teaching points: (1) Tetrad: proteinuria, hypoalbuminemia, edema, hyperlipidemia, (2) MCD >80% in children - empiric steroids without biopsy for typical cases, (3) Complications: SBP (pneumococcus), thrombosis, (4) Steroid-sparing agents for frequent relapsers."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key nephrotic syndrome concepts: (1) Tetrad = massive proteinuria, hypoalbuminemia, edema, hyperlipidemia, (2) MCD most common in children - steroid-responsive, (3) Biopsy if atypical (age <1 or >12, steroid-resistant, hematuria, low C3), (4) Complications: infections (SBP - pneumococcus), thrombosis (loss of antithrombin III), (5) Steroid-sparing agents for frequent relapses."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key nephrotic syndrome principles: (1) NephrOTIC = prOTein loss, not nephrITIC (inflammation), (2) Steroids are ESSENTIAL first-line treatment for MCD, (3) Fever + abdominal pain = consider SBP (immunocompromised from IgG loss), (4) Prolonged high-dose steroids cause severe toxicity - use steroid-sparing agents for frequent relapsers."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-036", "title": "Hemolytic Uremic Syndrome", "domain": "renal", "difficulty": "intermediate", "tags": ["bloody diarrhea", "schistocytes on smear", "triad: hemolytic anemia, thrombocytopenia, renal failure", "hemolytic uremic syndrome"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 3-year-old female presents to the clinic with bloody diarrhea followed by decreased urination of 5 days duration.\n\nPer the mother, she had bloody diarrhea for 3 days that has now resolved. However, she has become increasingly pale and tired. Her parents noticed she has barely urinated in the past 24 hours.\n\nAssociated symptoms include pallor, fatigue, and oliguria. Denies fever or active bleeding.\n\nPast medical history includes She ate undercooked ground beef at a barbecue 1 week ago. Previously healthy.\n\nPhysical Examination:\n- General: pale, lethargic child with mild edema.\n- Labs: CBC: Hgb low (anemia), Plt low; BMP: Cr elevated.\n- Abdomen: mild tenderness, no hepatosplenomegaly.\n- Skin: pallor, petechiae.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child has bloody diarrhea followed by pallor, oliguria, and petechiae. Key history: ate undercooked ground beef 1 week ago. Labs show anemia (Hgb 7.2), thrombocytopenia (platelets 45K), and elevated creatinine (2.8).", "question": "What is the CLASSIC TRIAD that defines Hemolytic Uremic Syndrome (HUS)?", "choices": [{"id": "node-1-choice-a", "text": "Microangiopathic hemolytic anemia + Thrombocytopenia + Acute kidney injury", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **HUS triad** consists of: (1) **Microangiopathic hemolytic anemia** (schistocytes, helmet cells on smear), (2) **Thrombocytopenia** (consumption in microvascular thrombi), and (3) **Acute kidney injury** (from glomerular capillary damage). This is the most common cause of AKI requiring dialysis in children.", "consequence": "You correctly identify the diagnostic criteria.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Fever + Thrombocytopenia + Neurologic symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes part of the **TTP pentad** (Thrombotic Thrombocytopenic Purpura), which includes fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction, AND neurologic symptoms. TTP is rare in children and primarily affects adults.", "consequence": "Confusing HUS with TTP.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Prolonged PT/PTT + Thrombocytopenia + Bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **DIC** (Disseminated Intravascular Coagulation), which shows **consumption coagulopathy** with prolonged PT/PTT. In HUS, coagulation studies (PT/PTT) are **normal** - the pathology is microangiopathic, not coagulopathic.", "consequence": "Confusing HUS with DIC.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Hematuria + Proteinuria + Hypertension", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes the **nephritic syndrome** pattern (e.g., PSGN, IgA nephropathy). While HUS does cause renal injury, the defining triad is **anemia + thrombocytopenia + AKI** with characteristic schistocytes on smear.", "consequence": "Missing the hemolytic component.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Purpura + Abdominal pain + Arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This describes **Henoch-Sch\u00f6nlein Purpura (HSP/IgA vasculitis)**, which can also cause renal involvement but is characterized by **palpable purpura** (not petechiae from thrombocytopenia) and normal platelet counts.", "consequence": "Confusing HUS with HSP.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HUS Triad**: Microangiopathic hemolytic anemia (schistocytes) + Thrombocytopenia + AKI. **PT/PTT are NORMAL** in HUS (unlike DIC). Look for **schistocytes/helmet cells** on peripheral smear - pathognomonic for microangiopathic hemolysis."}, "node-2": {"id": "node-2", "type": "decision", "content": "HUS is confirmed. The child has a history of bloody diarrhea after eating undercooked ground beef, suggesting STEC-HUS (Shiga toxin-producing E. coli, typically O157:H7).", "question": "What is the CRITICAL management point regarding antibiotics in STEC-associated HUS?", "choices": [{"id": "node-2-choice-a", "text": "Do NOT give antibiotics - they increase HUS risk", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Antibiotics are CONTRAINDICATED** in STEC (E. coli O157:H7) diarrhea. Antibiotics cause bacterial lysis, releasing more **Shiga toxin** and **increasing the risk of developing HUS** by 17-fold. This is a critical board pearl!", "consequence": "You avoid a potentially harmful intervention.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Give IV ceftriaxone to clear the infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and HARMFUL. Antibiotics **increase Shiga toxin release** from dying bacteria, dramatically increasing HUS risk. This is one of the most important contraindications to know - **never give antibiotics for suspected STEC diarrhea**.", "consequence": "Antibiotics worsen the condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Give oral azithromycin for 5 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and HARMFUL. ANY antibiotic class increases Shiga toxin release. The bacteria lyse, releasing pre-formed toxin that causes endothelial damage leading to microangiopathic hemolysis and renal injury.", "consequence": "Antibiotic causes increased toxin release.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Give metronidazole for potential C. diff", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The presentation (bloody diarrhea after undercooked beef, no antibiotic exposure) points to STEC, not C. difficile. Adding antibiotics would be harmful. C. diff is associated with prior antibiotic use and has a different clinical picture.", "consequence": "Wrong diagnosis and harmful treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Give prophylactic antibiotics to prevent sepsis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. STEC does not cause bacteremia/sepsis - the damage is from **toxin**, not bacterial invasion. Prophylactic antibiotics would increase toxin release without any benefit.", "consequence": "Unnecessary and harmful intervention.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**NEVER give antibiotics for E. coli O157:H7 (STEC) diarrhea** - increases HUS risk 17-fold by causing bacterial lysis and Shiga toxin release. Also **avoid anti-motility agents** (loperamide) as they prolong toxin exposure."}, "node-3": {"id": "node-3", "type": "decision", "content": "The child is oliguric with creatinine rising to 4.2 mg/dL. Blood pressure is 145/95 mmHg. Potassium is 6.2 mEq/L with peaked T waves on ECG.", "question": "What is the MOST appropriate management for this child's worsening renal failure with hyperkalemia?", "choices": [{"id": "node-3-choice-a", "text": "Dialysis (hemodialysis or peritoneal dialysis)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With **severe hyperkalemia with ECG changes**, **severe uremia**, and **oliguria/anuria**, **dialysis** is indicated. About 50-70% of children with HUS require dialysis during the acute phase. Indications include: refractory hyperkalemia, severe acidosis, fluid overload with pulmonary edema, uremic symptoms.", "consequence": "Appropriate renal replacement therapy initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "IV calcium gluconate, insulin/glucose, and kayexalate alone", "isOptimal": false, "isAcceptable": true, "feedback": "These are appropriate **temporizing measures** for hyperkalemia but are **insufficient** when there are ECG changes, severe renal failure, and oliguria. The child needs **dialysis** for definitive management of life-threatening hyperkalemia in the setting of anuric renal failure.", "consequence": "Temporizing but dialysis still needed.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Aggressive IV fluid resuscitation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In **oliguric/anuric renal failure**, aggressive fluids cause **volume overload** and pulmonary edema. Fluid management should be **restrictive** (insensible losses + urine output only). The hyperkalemia needs dialysis, not fluids.", "consequence": "Fluid overload worsens the situation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Plasmapheresis/plasma exchange", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Plasmapheresis is the treatment for **atypical HUS** (complement-mediated) and **TTP**, NOT for typical STEC-HUS. In diarrhea-associated (typical) HUS, plasma exchange does not improve outcomes and is not indicated.", "consequence": "Wrong treatment modality for STEC-HUS.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "IV furosemide to increase urine output", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. In **established AKI with oliguria**, diuretics do not convert oliguric to non-oliguric renal failure and do not improve outcomes. The child needs dialysis for definitive management of hyperkalemia and uremia.", "consequence": "Diuretics ineffective in established oliguric AKI.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HUS dialysis indications**: Refractory hyperkalemia (especially with ECG changes), severe metabolic acidosis, volume overload/pulmonary edema, uremic symptoms (encephalopathy, pericarditis). ~50-70% of HUS patients require dialysis."}, "node-4": {"id": "node-4", "type": "decision", "content": "Dialysis is initiated. Hemoglobin drops to 5.8 g/dL. The child is pale and tachycardic. The parents ask about blood transfusion.", "question": "What is the recommended approach to RED BLOOD CELL transfusion in HUS?", "choices": [{"id": "node-4-choice-a", "text": "Transfuse slowly with small volumes to avoid volume overload and hypertension", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! RBC transfusion is indicated for **symptomatic anemia** in HUS, but must be given **cautiously**: small volumes (5-10 mL/kg), slow infusion rate, and close monitoring for **volume overload** and **hypertension**. Many patients are already volume overloaded, so coordinate with dialysis if needed.", "consequence": "Safe transfusion approach.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Avoid transfusion entirely - it worsens HUS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While transfusion must be approached cautiously, **severe symptomatic anemia** (Hgb 5.8 with tachycardia) requires treatment. Untreated severe anemia causes cardiac strain and tissue hypoxia.", "consequence": "Severe anemia left untreated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Give standard transfusion volume (15-20 mL/kg) rapidly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Standard transfusion volumes and rates can cause **acute volume overload** and **hypertensive crisis** in patients with compromised renal function. HUS patients need **slow, small-volume** transfusions.", "consequence": "Volume overload and hypertensive crisis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Transfuse platelets to prevent bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Platelet transfusion is generally AVOIDED** in HUS unless there is life-threatening bleeding. Transfused platelets are rapidly consumed in the microangiopathic process and may theoretically worsen microvascular thrombosis (\"adding fuel to the fire\").", "consequence": "Platelet transfusion may worsen thrombosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Give erythropoietin instead of transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. EPO takes **weeks** to increase hemoglobin and is not appropriate for acute, severe, symptomatic anemia. The child needs **immediate treatment** with cautious RBC transfusion.", "consequence": "Delayed response does not address acute anemia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HUS transfusion pearls**: RBCs - give cautiously (small volumes, slow rate) for symptomatic anemia. **Platelets - AVOID** unless life-threatening bleeding (may worsen microangiopathy). Fresh frozen plasma - not indicated in typical STEC-HUS."}, "node-5": {"id": "node-5", "type": "decision", "content": "After 10 days of supportive care and dialysis, the child's renal function is improving. Creatinine is 1.8 mg/dL and urine output is increasing. Parents ask about long-term prognosis.", "question": "What is the MOST accurate statement about long-term prognosis after STEC-HUS?", "choices": [{"id": "node-5-choice-a", "text": "Most children recover fully, but 25-30% have long-term renal sequelae", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Most children with STEC-HUS recover renal function, but **25-30% have long-term sequelae** including chronic kidney disease, hypertension, and proteinuria. **Long-term nephrology follow-up** is essential. Mortality in the acute phase is about 3-5%.", "consequence": "Appropriate prognostic counseling provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "All children recover completely with no long-term effects", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the majority recover, this is overly optimistic. A significant minority (25-30%) develop **chronic kidney disease**, **hypertension**, or **proteinuria**. Regular follow-up with blood pressure and urine protein monitoring is essential.", "consequence": "False reassurance, may miss follow-up.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Most children require lifelong dialysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is overly pessimistic. Only about **5%** of children with STEC-HUS progress to **end-stage renal disease**. Most recover renal function, though some have residual impairment.", "consequence": "Unnecessarily pessimistic prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "The child is immune and cannot get HUS again", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While recurrence of STEC-HUS is uncommon, patients are **not immune**. More importantly, the residual kidney damage puts them at risk for **progressive CKD** from future renal insults. Safe food handling education is important.", "consequence": "False sense of immunity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Neurologic complications predict poor renal outcomes", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Severe CNS involvement (seizures, coma) is associated with **higher mortality** and can predict worse overall outcomes. However, renal prognosis is more closely related to **duration of dialysis** and **severity of AKI** rather than neurologic involvement specifically.", "consequence": "True but not the most accurate summary.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**HUS prognosis**: Mortality 3-5%, ESRD 5%, long-term renal sequelae 25-30%. **Risk factors for poor outcome**: prolonged dialysis (>2 weeks), anuria, severe CNS involvement, WBC >20K. All HUS survivors need **long-term nephrology follow-up** for hypertension and proteinuria screening."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly identified the HUS triad (microangiopathic hemolytic anemia, thrombocytopenia, AKI), avoided harmful antibiotics, appropriately managed renal failure with dialysis, safely transfused RBCs, and provided accurate prognostic counseling. Key teaching points: (1) NEVER give antibiotics for STEC diarrhea, (2) 50-70% need dialysis, (3) Transfuse RBCs cautiously but AVOID platelets, (4) 25-30% have long-term renal sequelae - need follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key HUS concepts: (1) Triad = MAHA + thrombocytopenia + AKI, (2) NO antibiotics for STEC (increases toxin release), (3) Dialysis for severe hyperkalemia/uremia/volume overload, (4) Transfuse RBCs cautiously, avoid platelets, (5) 25-30% have long-term sequelae."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key HUS principles: (1) NEVER give antibiotics for STEC diarrhea - increases HUS risk 17-fold, (2) Avoid aggressive fluids in oliguric AKI - causes volume overload, (3) Transfuse RBCs slowly in small volumes, (4) Avoid platelet transfusion unless life-threatening bleeding."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-037", "title": "Post-Streptococcal Glomerulonephritis", "domain": "renal", "difficulty": "advanced", "tags": ["post-streptococcal glomerulonephritis", "PSGN", "tea-colored urine", "periorbital edema", "hypertension", "low C3", "nephritic syndrome", "ASO titer", "latent period", "complement pathway"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 7-year-old male presents to the clinic with dark urine and facial swelling of 2 days duration.\n\nSubjectively, he noticed his urine looks like \"cola\" or \"tea.\" His face appears puffy, especially around his eyes. He had a sore throat about 2 weeks ago that resolved without treatment.\n\nAssociated symptoms include periorbital edema and decreased urine output. Denies fever or joint pain currently.\n\nPast medical history includes He had pharyngitis 2 weeks ago. No history of kidney problems.\n\nPhysical Examination:\n- General: well-appearing child with periorbital edema.\n- Vital signs: blood pressure elevated (above 95th percentile for age and height).\n- Urine: dark, tea-colored.\n- Chest: mild crackles at bases (fluid overload).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 7-year-old with dark urine, facial swelling, and hypertension occurring 2 weeks after pharyngitis.\n\n**Classic PSGN presentation:**\n- **Tea-colored/cola-colored urine** (gross hematuria from RBC casts)\n- **Periorbital edema** (worse in the morning due to dependent fluid)\n- **Hypertension** (from volume expansion)\n- **Latent period** of 1-2 weeks after **pharyngitis** or 3-6 weeks after **impetigo**\n\n**Nephritic syndrome features:** Hematuria, hypertension, oliguria, mild proteinuria, azotemia", "question": "Based on the classic presentation with pharyngitis 2 weeks ago, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Post-streptococcal glomerulonephritis (PSGN)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is classic **PSGN**: tea-colored urine (gross hematuria), periorbital edema, hypertension, and a **latent period of 1-2 weeks** after pharyngitis. PSGN is an **immune complex-mediated glomerulonephritis** caused by nephritogenic strains of Group A Streptococcus. It's the most common cause of acute glomerulonephritis in children.", "consequence": "Correct diagnosis. Proceed with confirmatory workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "IgA nephropathy - hematuria after infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IgA nephropathy causes **synpharyngitic hematuria** - hematuria that occurs **DURING or within days** of a URI, not 1-2 weeks later. PSGN has a **latent period** because time is needed to develop the immune response. This is a key differentiating feature.", "consequence": "Timing is wrong for IgA nephropathy. PSGN has latent period.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Henoch-Sch\u00f6nlein purpura nephritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HSP nephritis occurs in the context of HSP, which presents with **palpable purpura** (usually on buttocks/legs), abdominal pain, and arthritis. This child has no rash or joint pain - he has isolated nephritic syndrome with a recent strep infection.", "consequence": "No palpable purpura or systemic symptoms of HSP.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Acute rheumatic fever - post-streptococcal complication", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Acute rheumatic fever is also post-streptococcal but presents with **carditis, polyarthritis, chorea, erythema marginatum, and/or subcutaneous nodules** (Jones criteria). It does NOT cause glomerulonephritis. ARF and PSGN can occur simultaneously but are distinct entities.", "consequence": "ARF causes cardiac/joint symptoms, not nephritis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Lupus nephritis - autoimmune glomerulonephritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Lupus nephritis can present similarly but would have other lupus features (malar rash, arthritis, serositis) and **low C3 AND C4** (both complement pathways activated). PSGN has **low C3 but NORMAL C4** (alternative pathway only). Also, SLE is uncommon in 7-year-old males.", "consequence": "No lupus features. Would have low C3 AND C4.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PSGN vs IgA Nephropathy timing**: PSGN = **latent period** (1-2 weeks after pharyngitis, 3-6 weeks after impetigo). IgA nephropathy = **synpharyngitic** (hematuria DURING or within days of URI). This timing difference is a classic board question!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect PSGN. Diagnostic workup is needed to confirm the diagnosis.\n\n**Expected findings in PSGN:**\n- Urinalysis: RBCs, **RBC casts** (pathognomonic for glomerulonephritis), proteinuria\n- Low **C3** (consumed in immune complex disease)\n- Evidence of recent strep: elevated **ASO** (anti-streptolysin O) or **anti-DNase B**\n\n**Key complement pattern:** Low C3, NORMAL C4 (alternative pathway)", "question": "Which laboratory finding would best support the diagnosis of PSGN and help differentiate it from lupus nephritis?", "choices": [{"id": "node-2-choice-a", "text": "Low C3 with normal C4 (alternative complement pathway activation)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** PSGN activates the **alternative complement pathway**, causing **low C3** with **normal C4**. This is a key differentiating feature from lupus nephritis, which activates the classical pathway and causes **both low C3 AND low C4**. The low C3 in PSGN typically normalizes within 6-8 weeks.", "consequence": "Complement pattern supports PSGN diagnosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Low C3 with low C4 (both complement pathways)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Low C3 AND low C4 suggests **classical pathway activation** seen in **lupus nephritis** or **MPGN**. PSGN specifically causes **low C3 with NORMAL C4** because it activates only the alternative pathway. This is a critical distinguishing feature.", "consequence": "This pattern suggests lupus, not PSGN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Normal C3 and normal C4", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. PSGN causes **complement consumption** due to immune complex deposition in the glomeruli. **C3 should be LOW** in acute PSGN. Normal complement levels would make you question the diagnosis or suggest you're seeing the patient late (C3 normalizes within 6-8 weeks).", "consequence": "C3 should be low in acute PSGN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Positive ANA and anti-dsDNA antibodies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ANA and anti-dsDNA are markers for **systemic lupus erythematosus**, not PSGN. For PSGN, you need evidence of **recent streptococcal infection** (ASO titer, anti-DNase B) along with low C3 and urinary findings.", "consequence": "ANA/anti-dsDNA are lupus markers, not PSGN.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Elevated IgA levels", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Elevated serum IgA suggests **IgA nephropathy** (Berger disease), not PSGN. PSGN is characterized by evidence of prior strep infection (elevated ASO, anti-DNase B) and **alternative pathway complement activation** (low C3, normal C4).", "consequence": "Elevated IgA suggests IgA nephropathy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Complement patterns in glomerulonephritis**: **PSGN** = low C3, normal C4 (alternative pathway). **Lupus nephritis** = low C3 AND low C4 (classical pathway). **MPGN** = low C3 AND low C4 (both pathways). If C3 doesn't normalize by **8 weeks** in PSGN, reconsider the diagnosis (think MPGN)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Labs confirm PSGN:\n- Urinalysis: 3+ blood, 1+ protein, **RBC casts**\n- C3: **45 mg/dL** (low; normal 90-180)\n- C4: 28 mg/dL (normal)\n- ASO titer: **800 IU/mL** (elevated; normal <200)\n- Creatinine: 1.2 mg/dL (mildly elevated)\n- BP: 140/95 mmHg (hypertensive)\n\nThe patient has mild crackles at the lung bases suggesting early fluid overload.", "question": "What is the most appropriate management for this patient with PSGN?", "choices": [{"id": "node-3-choice-a", "text": "Supportive care: salt/fluid restriction, loop diuretics for edema/hypertension, monitor", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** PSGN is a **self-limited disease** - treatment is supportive. Key interventions: **Salt and fluid restriction** (reduce volume overload), **loop diuretics** (furosemide) for edema and hypertension, **antihypertensives** if BP severely elevated. Most children recover completely within 2-4 weeks.", "consequence": "Appropriate supportive management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "High-dose corticosteroids to suppress immune response", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Steroids are NOT indicated** for PSGN. PSGN is self-limited and steroids do not change the course. Steroids are used in other glomerular diseases (minimal change disease, lupus nephritis, some forms of IgA nephropathy) but not PSGN.", "consequence": "Steroids not indicated for PSGN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Antibiotics (penicillin) to treat the streptococcal infection", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Antibiotics do NOT change the course of established PSGN (the damage is from the immune response, not active infection). However, antibiotics **may be given to eradicate any persistent GAS** and prevent spread to contacts. This is optional, not the primary treatment.", "consequence": "Antibiotics don't treat PSGN but may eradicate carriage.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Urgent dialysis for acute kidney injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Dialysis is reserved for **severe complications** (refractory hyperkalemia, severe volume overload unresponsive to diuretics, uremic symptoms, severe acidosis). This patient has only mild creatinine elevation and early fluid overload - supportive care with diuretics should be tried first.", "consequence": "Dialysis not indicated for mild disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Renal biopsy for definitive diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Renal biopsy is **NOT needed for typical PSGN** (clinical diagnosis with low C3, evidence of strep infection, and appropriate latent period). Biopsy is reserved for **atypical features**: prolonged symptoms, persistently low C3 (>8 weeks), nephrotic-range proteinuria, or diagnostic uncertainty.", "consequence": "Biopsy not needed for typical PSGN presentation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PSGN treatment is SUPPORTIVE**: (1) **Salt and fluid restriction**, (2) **Loop diuretics** (furosemide) for volume overload and hypertension, (3) **Antihypertensives** if needed (calcium channel blockers or ACE inhibitors). Steroids are NOT indicated. Most children have complete recovery within 2-4 weeks."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient is managed with salt/fluid restriction and furosemide. After 1 week:\n- BP normalized\n- Edema resolved\n- Urine output improved\n- Creatinine: 0.6 mg/dL (normalized)\n- Still has microscopic hematuria\n\nThe family asks about prognosis and follow-up.", "question": "What is the expected prognosis and appropriate follow-up for this child with PSGN?", "choices": [{"id": "node-4-choice-a", "text": "Excellent prognosis; C3 normalizes by 6-8 weeks; microscopic hematuria may persist for 1-2 years", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Prognosis in childhood PSGN is **excellent** - >95% recover completely. **C3 normalizes within 6-8 weeks** (if not, reconsider diagnosis). **Hematuria resolves**: gross hematuria within 1-2 weeks, microscopic hematuria may persist for **1-2 years** (this is NORMAL). **Proteinuria** resolves within weeks to months.", "consequence": "Accurate prognosis and follow-up plan provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "High risk of progression to chronic kidney disease - needs nephrology follow-up for years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Childhood PSGN has an **excellent prognosis** with >95% complete recovery. Progression to CKD is rare (<5%). While follow-up is needed to confirm C3 normalization and resolution of proteinuria, most children don't need long-term nephrology care. Adult PSGN has worse prognosis.", "consequence": "Overly pessimistic. Childhood PSGN prognosis is excellent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Hematuria persisting beyond 2 weeks indicates treatment failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Microscopic hematuria can persist for 1-2 years** after PSGN and is NOT a sign of treatment failure. Gross hematuria resolves within 1-2 weeks, but microscopic hematuria gradually clears over months to years. This is normal and does not indicate ongoing disease.", "consequence": "Persistent microscopic hematuria is normal in PSGN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Prophylactic penicillin is needed lifelong to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Penicillin prophylaxis is NOT indicated for PSGN. Unlike acute rheumatic fever (which requires prophylaxis to prevent recurrent episodes and rheumatic heart disease), PSGN **rarely recurs** and prophylaxis is not recommended.", "consequence": "Prophylaxis not indicated. PSGN rarely recurs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "If C3 remains low at 8 weeks, diagnosis is confirmed", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect - opposite is true!** If C3 remains low beyond **8 weeks**, you should **RECONSIDER the diagnosis**. Persistently low C3 suggests **MPGN** (membranoproliferative GN) or other chronic glomerulonephritis, not PSGN. PSGN C3 should normalize by 6-8 weeks.", "consequence": "Persistent low C3 suggests MPGN, not PSGN.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**PSGN prognosis**: >95% of children have **complete recovery**. Timeline: Gross hematuria resolves in 1-2 weeks, **C3 normalizes by 6-8 weeks** (if not, think MPGN), proteinuria resolves in weeks-months, **microscopic hematuria may persist 1-2 years** (normal). Rare recurrence (<5%). Adults have worse prognosis."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of PSGN!\n\n**Key Learning Points:**\n1. **Classic presentation**: Tea-colored urine, periorbital edema, hypertension, **1-2 week latent period** after pharyngitis\n2. **Distinguish from IgA nephropathy**: PSGN = latent period; IgA = synpharyngitic (immediate)\n3. **Complement pattern**: **Low C3, NORMAL C4** (alternative pathway). Low C3+C4 = think lupus\n4. **Treatment is SUPPORTIVE**: Salt/fluid restriction, diuretics, antihypertensives. NO steroids\n5. **Prognosis is excellent**: >95% full recovery. C3 normalizes by 6-8 weeks\n6. **Microscopic hematuria may persist 1-2 years** - this is normal\n\nThis child recovered completely with supportive care. C3 normalized at 6 weeks, and microscopic hematuria resolved over 18 months."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key PSGN concepts:\n\n**Diagnosis:**\n- Tea-colored urine, edema, hypertension after strep infection\n- **Latent period**: 1-2 weeks (pharyngitis) or 3-6 weeks (impetigo)\n- **Low C3, NORMAL C4** (vs. lupus: low C3 AND C4)\n- Elevated ASO or anti-DNase B\n\n**Treatment:**\n- **Supportive care** - salt/fluid restriction, diuretics, antihypertensives\n- NO steroids, no immunosuppression\n- Antibiotics optional (don't change course but may eradicate carriage)\n\n**Prognosis:**\n- Excellent (>95% full recovery)\n- C3 normalizes by 6-8 weeks\n- Microscopic hematuria may persist 1-2 years (normal)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in PSGN management.\n\n**Key Concepts to Review:**\n1. **PSGN has LOW C3, NORMAL C4** - if both low, think lupus\n2. **Treatment is SUPPORTIVE** - steroids are NOT indicated\n3. **Prognosis is excellent** - don't over-treat\n4. **C3 should normalize by 6-8 weeks** - if persistently low, reconsider diagnosis (MPGN?)\n\n**Pearl:** PSGN has a **latent period** after strep infection (1-2 weeks for pharyngitis, 3-6 weeks for impetigo). IgA nephropathy is **synpharyngitic** (hematuria during/immediately after URI). This timing distinction is frequently tested!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-071", "title": "IgA Nephropathy - Synpharyngitic Hematuria", "domain": "renal", "difficulty": "intermediate", "tags": ["synpharyngitic hematuria", "gross hematuria with URI", "same-day hematuria", "iga nephropathy - synpharyngitic hematuria"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 10-year-old male presents with tea-colored urine that began during an upper respiratory infection.\n\nHe reports mild flank discomfort. No dysuria or fever.\n\nPhysical Examination:\n- Blood pressure usually normal.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 10-year-old male presents with **tea-colored (cola-colored) urine** that started **today**, during an active **upper respiratory infection** (runny nose, sore throat for 2 days). He has mild flank discomfort but no dysuria or fever. Blood pressure is normal.\n\n**Critical timing question for glomerular hematuria:**\n- Hematuria **WITH** (concurrent) URI \u2192 think **IgA nephropathy**\n- Hematuria **AFTER** (1-3 weeks post) pharyngitis \u2192 think **Post-streptococcal GN**\n\n**IgA nephropathy (Berger disease):**\n- Most common glomerulonephritis worldwide\n- **Synpharyngitic hematuria** = hematuria during the infection (same day)\n- IgA immune complexes deposit in mesangium", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "IgA nephropathy (Berger disease)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is classic **IgA nephropathy** based on **synpharyngitic hematuria** - gross hematuria occurring **concurrently** with an upper respiratory infection. The timing is the key: hematuria started WITH the URI, not 1-3 weeks after. IgA nephropathy is the most common primary glomerulonephritis worldwide and typically presents with episodic gross hematuria triggered by mucosal infections.", "consequence": "You correctly identify the diagnosis and proceed to workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Post-streptococcal glomerulonephritis (PSGN)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The **timing** rules out PSGN. Post-streptococcal GN occurs **1-3 weeks AFTER** a streptococcal pharyngitis or skin infection (latent period for immune complex formation). This child's hematuria started **during** (concurrent with) his URI - same day. Also, PSGN typically presents with **hypertension, edema, and low C3**, which this child lacks.", "consequence": "Misdiagnosis based on incorrect timing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Thin basement membrane disease (benign familial hematuria)", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Thin basement membrane disease causes **persistent microscopic hematuria** and can have episodes of gross hematuria. However, the classic presentation of **synpharyngitic hematuria** (gross hematuria triggered by concurrent URI) is much more characteristic of IgA nephropathy. Thin basement membrane disease typically has family history of benign hematuria and doesn't have the URI trigger pattern.", "consequence": "Synpharyngitic pattern more consistent with IgA nephropathy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Urinary tract infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child has **no dysuria, no fever**, and the urine is tea-colored (consistent with glomerular bleeding), not bright red (bladder/lower tract). UTIs cause pyuria and bacteriuria with lower tract symptoms. The timing with URI and absence of UTI symptoms points to glomerulonephritis, specifically IgA nephropathy given the synpharyngitic timing.", "consequence": "No UTI symptoms; glomerular pattern of hematuria.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Nephrolithiasis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While kidney stones can cause hematuria and flank pain, they cause **colicky pain** (severe, intermittent) and **bright red blood**, not tea-colored urine. The timing with URI and mild flank discomfort (not severe colic) suggests glomerulonephritis. Tea/cola-colored urine indicates blood mixed with Tamm-Horsfall protein in the tubules (glomerular source).", "consequence": "Clinical presentation inconsistent with nephrolithiasis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Timing is everything**: Hematuria WITH the URI = **IgA nephropathy** (synpharyngitic). Hematuria 1-3 weeks AFTER infection = **PSGN** (post-infectious latent period)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect **IgA nephropathy** based on synpharyngitic hematuria. The child has normal blood pressure and no edema.\n\n**Initial workup for suspected glomerulonephritis:**\n- **Urinalysis**: RBC casts (pathognomonic for glomerular disease), proteinuria\n- **BMP**: Assess renal function (creatinine)\n- **Complement levels**: C3, C4\n  - IgA nephropathy: **Normal C3/C4**\n  - PSGN: **Low C3**, normal C4\n- Consider ASO titer if PSGN suspected", "question": "What is the expected laboratory finding that helps distinguish IgA nephropathy from PSGN?", "choices": [{"id": "node-2-choice-a", "text": "Normal C3 and C4 complement levels", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **IgA nephropathy has NORMAL complement levels** (C3 and C4). This is because IgA nephropathy is NOT a complement-mediated disease - IgA deposits don't efficiently activate complement. In contrast, **PSGN has LOW C3** (normal C4) due to alternate pathway complement activation. The normal complement in IgA nephropathy helps distinguish it from PSGN, along with the timing of hematuria.", "consequence": "You correctly identify the complement pattern.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Low C3 with normal C4", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Low C3 with normal C4** is the pattern seen in **PSGN**, not IgA nephropathy. PSGN activates the **alternate complement pathway**, consuming C3. IgA nephropathy does NOT significantly activate complement - **C3 and C4 are NORMAL**. This is a key distinguishing feature between these two causes of glomerular hematuria.", "consequence": "Wrong complement pattern - this suggests PSGN.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Elevated ASO titer", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Elevated ASO titer indicates recent **streptococcal infection** and is used to support diagnosis of **PSGN**, not IgA nephropathy. IgA nephropathy can be triggered by various mucosal infections (viral or bacterial), not specifically strep. The child has a URI (likely viral) with synpharyngitic hematuria - ASO titer would not be helpful and may be falsely reassuring if negative.", "consequence": "ASO titer not helpful for IgA nephropathy diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Low C3 and low C4", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Low C3 AND low C4** (classical pathway activation) is seen in **lupus nephritis** and other immune complex diseases, NOT IgA nephropathy. IgA nephropathy has **normal complement**. PSGN has low C3 only (alternate pathway). Low C3 and C4 together should prompt workup for SLE (ANA, dsDNA antibodies).", "consequence": "This pattern suggests lupus nephritis, not IgA nephropathy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Positive ANA (antinuclear antibody)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Positive ANA suggests **lupus nephritis**, not IgA nephropathy. IgA nephropathy is a primary glomerular disease without systemic autoimmune features. This child has isolated synpharyngitic hematuria without rash, arthritis, or other lupus manifestations. ANA testing is not indicated for typical IgA nephropathy presentation.", "consequence": "No features suggesting lupus.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Complement levels help differentiate**: IgA nephropathy = NORMAL C3/C4. PSGN = LOW C3, normal C4. Lupus nephritis = LOW C3 AND C4."}, "node-3": {"id": "node-3", "type": "decision", "content": "Labs return:\n- **Urinalysis**: RBC casts, 2+ protein, 3+ blood\n- **Creatinine**: 0.8 mg/dL (normal)\n- **C3 and C4**: Normal\n- Blood pressure: 105/65 (normal)\n\nThe findings support **IgA nephropathy**: synpharyngitic hematuria with normal complement and normal renal function.\n\n**Prognosis considerations:**\n- Most children have **episodic gross hematuria** that resolves\n- ~20-30% may develop **chronic kidney disease** over decades\n- Poor prognostic factors: proteinuria >1g/day, hypertension, elevated creatinine, crescents on biopsy", "question": "What is the most appropriate management for this child with suspected IgA nephropathy?", "choices": [{"id": "node-3-choice-a", "text": "Monitor blood pressure and proteinuria; nephrology referral if persistent hematuria/proteinuria", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Most children with IgA nephropathy have a **benign course** with episodic gross hematuria that resolves. Management includes: (1) **Monitor BP** at follow-up visits, (2) **Serial urinalysis** for persistent proteinuria (poor prognostic sign), (3) **Nephrology referral** if: proteinuria >500-1000 mg/day, hypertension, elevated creatinine, or persistent symptoms. Kidney biopsy is reserved for those with significant proteinuria or declining function. No specific treatment needed for isolated hematuria.", "consequence": "Appropriate monitoring plan initiated.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Immediate kidney biopsy to confirm diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Kidney biopsy is NOT routinely needed** for typical IgA nephropathy presentations. Biopsy is reserved for: (1) Significant proteinuria (>500-1000 mg/day), (2) Declining renal function, (3) Hypertension, (4) Atypical features. This child has normal renal function, minimal proteinuria, and normal BP - clinical diagnosis is sufficient. Biopsy is invasive and should be reserved for cases where it will change management.", "consequence": "Biopsy not indicated for this mild presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Start high-dose prednisone to prevent progression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Immunosuppression is NOT indicated** for IgA nephropathy with isolated hematuria and preserved renal function. Steroids are reserved for patients with **significant proteinuria (>1g/day) and/or declining GFR**. This child has normal creatinine and minimal proteinuria - the prognosis is good without treatment. Steroids have significant side effects and should not be used prophylactically.", "consequence": "Steroids not indicated for mild disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Prescribe prophylactic antibiotics to prevent URI triggers", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic antibiotics are NOT recommended** for IgA nephropathy. While mucosal infections can trigger gross hematuria episodes, most are viral (URIs) and wouldn't respond to antibiotics anyway. The episodic hematuria is benign and self-limited. Tonsillectomy has been studied but is also not routinely recommended. The focus is on monitoring for proteinuria and hypertension, not preventing URIs.", "consequence": "Prophylactic antibiotics not beneficial.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Start ACE inhibitor for renoprotection", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable but not optimal for this patient. **ACE inhibitors** (or ARBs) are indicated for IgA nephropathy with **significant proteinuria** (>500-1000 mg/day) to slow progression. They reduce proteinuria and have renoprotective effects. However, this child has only 2+ protein (minimal) and normal renal function - ACE inhibitor may not be needed yet. Would be appropriate if proteinuria worsens on follow-up.", "consequence": "May be indicated if proteinuria persists or worsens.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Prognostic indicators in IgA nephropathy**: (1) Proteinuria >1g/day - strongest predictor of progression, (2) Hypertension, (3) Elevated creatinine at presentation, (4) Crescents on biopsy. Isolated hematuria with normal BP and function has excellent prognosis."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **IgA nephropathy** based on the key feature: **synpharyngitic hematuria** (gross hematuria WITH, not after, the URI). Key teaching: (1) IgA = hematuria WITH URI, PSGN = hematuria AFTER (1-3 weeks), (2) **Normal C3/C4** in IgA nephropathy (vs low C3 in PSGN), (3) Most children have benign course - monitor BP and proteinuria, (4) Biopsy/steroids reserved for significant proteinuria or declining function. Prognosis is excellent for isolated hematuria with normal BP and creatinine."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key IgA nephropathy features: (1) **Synpharyngitic hematuria** = hematuria WITH URI (not after), (2) **Normal complement** (C3/C4 both normal), (3) Most common primary GN worldwide, (4) Management: monitor BP and proteinuria - refer to nephrology if persistent proteinuria, hypertension, or elevated creatinine. Biopsy not needed for typical mild presentation."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. **IgA nephropathy vs PSGN** - timing is key! IgA = hematuria WITH URI (synpharyngitic). PSGN = hematuria 1-3 weeks AFTER infection. Complement: IgA = NORMAL C3/C4. PSGN = LOW C3 (alternate pathway). Don't start steroids for mild IgA nephropathy with preserved function - most children have benign course. Monitor for proteinuria/HTN as poor prognostic signs."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-095", "title": "Pediatric Hypertension Definition", "domain": "renal", "difficulty": "intermediate", "tags": ["95th percentile", "measure on multiple occasions", "secondary causes in children", "pediatric hypertension definition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male is found to have elevated blood pressure during routine screening.\n\nPhysical Examination:\n- Vitals: hypertension.\n- Need to determine if this meets criteria for hypertension.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The child's blood pressure is measured at **115/78 mmHg** using an appropriately-sized cuff on the right arm while seated.\n\nYou look up the blood pressure percentile tables for a 5-year-old male at the 50th percentile for height:\n- **90th percentile**: 104/63 mmHg\n- **95th percentile**: 108/68 mmHg\n- **95th percentile + 12 mmHg**: 120/80 mmHg", "question": "How should this blood pressure reading be classified according to 2017 AAP guidelines?", "choices": [{"id": "node-1-choice-a", "text": "Stage 1 hypertension (\u226595th percentile to <95th + 12 mmHg)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This BP of **115/78 mmHg** is **Stage 1 hypertension** because it is \u226595th percentile (108/68) but <95th percentile + 12 mmHg (120/80). The 2017 AAP guidelines classify pediatric BP as: **Normal** (<90th percentile), **Elevated BP** (90th to <95th percentile OR 120/<80 in adolescents), **Stage 1 HTN** (\u226595th to <95th + 12 mmHg OR 130/80-139/89), **Stage 2 HTN** (\u226595th + 12 mmHg OR \u2265140/90).", "consequence": "Correct classification. Now determine next steps.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Elevated blood pressure (90th to <95th percentile)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Elevated BP** is defined as \u226590th percentile but <95th percentile. This child's BP of 115/78 exceeds the **95th percentile (108/68)**, so this is hypertension, not just 'elevated BP.' The distinction matters because true hypertension requires more urgent workup for secondary causes.", "consequence": "Underestimating severity could delay workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Stage 2 hypertension (\u226595th percentile + 12 mmHg)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stage 2 HTN** requires BP \u226595th percentile + 12 mmHg (which would be \u2265120/80 for this child). His BP of 115/78 is above the 95th percentile but below 120/80, making this **Stage 1 HTN**. Stage 2 HTN requires more urgent evaluation and often same-day referral.", "consequence": "Overclassifying could lead to unnecessary urgency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Normal blood pressure for age", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Normal BP** in children is <90th percentile for age, sex, and height. This child's BP of 115/78 significantly exceeds the 90th percentile (104/63) and even exceeds the 95th percentile (108/68). This is clearly hypertension by pediatric standards. Remember: adult normal values don't apply to children!", "consequence": "Missing hypertension could lead to end-organ damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Cannot be determined without measuring on 3 separate occasions", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct thinking but wrong answer. While **diagnosis** of hypertension requires confirmation on 3 separate occasions, you CAN and SHOULD **classify** this individual reading. If Stage 2 HTN is found, same-day evaluation is needed. Classification guides urgency of follow-up. The reading itself clearly meets Stage 1 HTN criteria.", "consequence": "Must classify each reading to guide next steps.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Pediatric BP classification** (2017 AAP): Normal (<90th %ile) \u2192 Elevated BP (90th-<95th %ile) \u2192 **Stage 1 HTN** (\u226595th to <95th+12) \u2192 **Stage 2 HTN** (\u226595th+12). Unlike adults, pediatric cutoffs are **percentile-based** using age/sex/height tables. Exception: adolescents \u226513 years use adult cutoffs."}, "node-2": {"id": "node-2", "type": "decision", "content": "You correctly identified **Stage 1 hypertension**. The mother asks, 'Is this serious? He's only 5 years old!'\n\nYou need to explain why hypertension workup in children differs from adults.", "question": "What is the MOST important reason pediatric hypertension requires thorough workup for secondary causes?", "choices": [{"id": "node-2-choice-a", "text": "Secondary causes are found in >50% of hypertensive children, especially younger children", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Unlike adults (where essential/primary HTN dominates), **secondary HTN accounts for >50% of cases** in children, and the younger the child, the more likely a secondary cause exists. In children <6 years with HTN, secondary causes are found in **70-85%**. Most common: **renal parenchymal disease** (glomerulonephritis, scarring), **renovascular disease** (renal artery stenosis), **coarctation of aorta**, endocrine causes.", "consequence": "Understanding this guides appropriate workup.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Children's blood vessels are more sensitive to damage from high BP", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While children can develop end-organ damage from chronic HTN, this is not why workup differs. The key reason is that **secondary causes are much more common** in children than adults. Finding and treating the underlying cause (e.g., renal artery stenosis, coarctation) can cure the hypertension, unlike essential HTN which requires lifelong management.", "consequence": "The real reason is the high prevalence of treatable causes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Antihypertensive medications are dangerous in children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Many antihypertensive medications are safe and effective in children when indicated. The reason for thorough workup is that **secondary causes are common and often curable** - you don't want to miss renovascular HTN or coarctation that could be fixed. Treating with medications without finding the cause would be managing symptoms, not curing the disease.", "consequence": "Medications are safe; the issue is finding curable causes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Essential hypertension never occurs in children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Essential (primary) HTN **does occur in children**, especially in overweight/obese adolescents with family history. However, it's the **minority of cases** in young children. The rule: younger child + higher BP = more likely secondary cause. A 5-year-old with Stage 1 HTN warrants workup; an obese 15-year-old with borderline elevated BP may have essential HTN.", "consequence": "Essential HTN exists in kids but is less common than secondary.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Blood pressure measurements are less accurate in children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With proper technique (correct cuff size, seated, calm child), BP measurements are accurate in children. The reason for workup is the **high prevalence of identifiable, treatable secondary causes**. The younger the child and the higher the BP, the more likely a secondary cause will be found - this is a diagnostic opportunity, not a measurement problem.", "consequence": "Measurement accuracy isn't the issue.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Secondary HTN in children** - Most common causes by age: **Infants**: coarctation, renal artery thrombosis, bronchopulmonary dysplasia. **Children 1-6 years**: **renal parenchymal disease** (#1), renovascular, coarctation. **Children 6-12**: renal parenchymal, renovascular, essential HTN emerging. **Adolescents**: essential HTN (especially if obese), renal causes."}, "node-3": {"id": "node-3", "type": "decision", "content": "You explain the importance of identifying secondary causes. You plan the initial workup.\n\nThe child has no symptoms (headaches, visual changes, nosebleeds). He is not obese (BMI 50th percentile). Family history is negative for early hypertension.", "question": "What is the appropriate initial workup for this 5-year-old with confirmed Stage 1 hypertension?", "choices": [{"id": "node-3-choice-a", "text": "Urinalysis, BMP (creatinine, electrolytes), CBC, lipid panel, and renal ultrasound with Doppler", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **initial workup** for pediatric HTN includes: (1) **Urinalysis** - screen for glomerulonephritis (hematuria, proteinuria); (2) **BMP** - creatinine (renal function), electrolytes (hypokalemia suggests hyperaldosteronism); (3) **CBC** - anemia of chronic kidney disease; (4) **Lipid panel** - cardiovascular risk assessment; (5) **Renal ultrasound with Doppler** - evaluate kidney size/structure and renal artery flow (screens for renal parenchymal disease and renovascular HTN).", "consequence": "Appropriate comprehensive initial workup.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Only recheck BP on 3 occasions, then decide on workup", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Yes, diagnosis requires confirmation on **3 separate visits**. However, while confirming HTN, you can and should begin the initial laboratory workup. AAP guidelines recommend starting workup once Stage 1 HTN is identified, not waiting until formal diagnosis. You can simultaneously confirm BP and order screening tests - don't delay the workup.", "consequence": "Some workup can begin while confirming diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Start antihypertensive medication and recheck in 1 month", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Starting medications **without workup** in a young child would be inappropriate. The goal is to identify and treat the **underlying cause** if possible. Many secondary causes (coarctation, renal artery stenosis) are potentially curable. Empiric medication treats the symptom but misses the opportunity to diagnose and fix the root cause.", "consequence": "Treating without workup misses curable causes.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "CT angiography of renal arteries as first-line imaging", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Renal ultrasound with Doppler** is the appropriate **first-line imaging** - it's non-invasive, no radiation, and can assess kidney size, parenchymal disease, and screen for renovascular abnormalities. CT or MR angiography are reserved for cases with **high suspicion for renovascular HTN** or when ultrasound is abnormal/indeterminate. Don't jump to advanced imaging.", "consequence": "Ultrasound is first-line; CTA is for specific indications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Echocardiogram and ophthalmologic exam only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Echo and eye exam** assess **target organ damage** from HTN - they don't identify the **cause**. While echo may be part of evaluation (especially to rule out coarctation and assess LVH), the primary workup must include **renal assessment** (UA, BMP, renal ultrasound) since renal causes are #1. Ophthalmologic exam is for hypertensive retinopathy, more relevant in severe/chronic HTN.", "consequence": "Must include renal workup to find the cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Pediatric HTN workup tiers**: **All patients**: UA, BMP, CBC, lipid panel, **renal US with Doppler**. **If suspicion for secondary cause**: renin/aldosterone, thyroid function, cortisol, urine catecholamines. **If renovascular suspected**: MRA or CTA. **Target organ assessment**: echo (LVH, coarctation), ophthalmoscopy (severe HTN)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly classified this child's BP as **Stage 1 hypertension** using age/sex/height-based percentile tables (2017 AAP guidelines). You understood that **secondary causes account for >50%** of hypertension in children this age, making thorough workup essential. Your initial evaluation appropriately includes UA, BMP, CBC, lipid panel, and **renal ultrasound with Doppler** - targeting the most common causes (renal parenchymal and renovascular disease)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key pediatric HTN concepts: (1) **Classification** uses percentiles: Elevated BP (90th-<95th), Stage 1 HTN (\u226595th to <95th+12), Stage 2 HTN (\u226595th+12); (2) **Secondary causes are COMMON** in children (>50%), especially younger children - don't treat as essential HTN without workup; (3) **Initial workup**: UA, BMP, lipid panel, renal US with Doppler to screen for renal/renovascular causes."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical pediatric HTN teaching points: Unlike adults, **>50% of hypertensive children have secondary causes** (renal >> renovascular > coarctation > endocrine). Classification requires **percentile-based tables** - adult cutoffs don't apply (except adolescents \u226513). Initial workup must include renal assessment (UA, BMP, renal US with Doppler). Never start medications without ruling out treatable causes in young children!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-097", "title": "Renovascular Hypertension Mechanism", "domain": "renal", "difficulty": "intermediate", "tags": ["severe hypertension", "abdominal bruit", "elevated renin", "fibromuscular dysplasia", "renovascular hypertension mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with persistent hypertension despite lifestyle modifications.\n\nElevated renin levels.\n\nPhysical Examination:\n- General: anxious child, well-developed.\n- Vitals: BP 165/105 mmHg (severely elevated), asymmetric upper/lower extremity BP.\n- Cardiovascular: abdominal bruit present.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This is a concerning presentation. You note the key findings:\n- **Severe hypertension** (165/105 mmHg - Stage 2)\n- **Abdominal bruit** (midline/flank)\n- **Elevated renin levels** (reported by referring physician)\n- **Refractory to lifestyle modifications**\n- No obesity, no family history of essential HTN", "question": "Based on these clinical features, what is the most likely mechanism causing this child's hypertension?", "choices": [{"id": "node-1-choice-a", "text": "Renal artery stenosis causing RAAS activation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The clinical triad of **severe hypertension**, **abdominal bruit**, and **elevated renin** strongly suggests **renovascular hypertension** due to renal artery stenosis. The stenosis reduces renal perfusion \u2192 kidney perceives 'hypotension' \u2192 releases **renin** \u2192 activates RAAS \u2192 angiotensin II causes vasoconstriction + aldosterone causes sodium/water retention \u2192 systemic HTN. In children, **fibromuscular dysplasia (FMD)** is the most common cause (unlike atherosclerosis in adults).", "consequence": "Correct mechanism identified. Now explore the pathophysiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Primary hyperaldosteronism (Conn syndrome)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Primary hyperaldosteronism causes HTN with **LOW renin** (aldosterone excess suppresses renin via negative feedback). This child has **HIGH renin**, which indicates a renin-driven process like renovascular HTN. In primary hyperaldosteronism, expect hypokalemia from aldosterone-driven K+ wasting, but the renin level distinguishes the two.", "consequence": "High renin excludes primary hyperaldosteronism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Coarctation of the aorta", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Coarctation causes HTN in the **upper extremities** with **lower BP in the legs** (arm-leg gradient >20 mmHg). The bruit would be **interscapular** (over the coarctation), not abdominal. Also, coarctation causes HTN through mechanical obstruction, not RAAS activation - renin is usually normal. This child has an **abdominal bruit** and elevated renin, pointing to renal artery stenosis.", "consequence": "Coarctation presents differently - check arm-leg BP gradient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Pheochromocytoma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pheochromocytoma causes **episodic** hypertension with the classic triad: **paroxysmal headaches, palpitations, and diaphoresis**. The mechanism is catecholamine excess, not RAAS activation. This child has **sustained severe HTN** with an abdominal bruit and elevated renin - all pointing to renovascular disease, not a catecholamine-secreting tumor.", "consequence": "Pheo has episodic symptoms, not sustained HTN with bruit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Essential hypertension with anxiety", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Essential HTN is rare in young children** (<10% of pediatric HTN in children <6 years) and does NOT cause abdominal bruits or significantly elevated renin. The presence of an abdominal bruit is a **'hard' sign** of vascular abnormality. Essential HTN is a diagnosis of exclusion after ruling out secondary causes - this child has multiple red flags for renovascular disease.", "consequence": "Essential HTN doesn't explain the bruit or high renin.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Renovascular HTN clues**: (1) **Severe/refractory HTN** in young child; (2) **Abdominal bruit** (turbulent flow through stenosis); (3) **Elevated renin** (kidney responds to hypoperfusion); (4) **Hypokalemia** (from secondary hyperaldosteronism). In children, **fibromuscular dysplasia** is the #1 cause (vs atherosclerosis in adults)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You explain the RAAS mechanism to the medical student:\n\n**Renal Artery Stenosis \u2192 Reduced Renal Perfusion \u2192 Juxtaglomerular Cells Release Renin \u2192 Angiotensinogen \u2192 Angiotensin I \u2192 (ACE in lungs) \u2192 Angiotensin II \u2192 Vasoconstriction + Aldosterone Release \u2192 Hypertension**\n\nThe student asks about the expected lab findings.", "question": "What laboratory finding pattern would you expect in renovascular hypertension?", "choices": [{"id": "node-2-choice-a", "text": "Elevated renin, elevated aldosterone, hypokalemia (secondary hyperaldosteronism)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Renovascular HTN causes **secondary hyperaldosteronism**: the high renin drives angiotensin II production, which stimulates aldosterone release. Aldosterone causes **sodium retention** (contributing to HTN) and **potassium wasting** (hypokalemia). Both renin AND aldosterone are elevated - this distinguishes it from primary hyperaldosteronism (high aldosterone, LOW renin).", "consequence": "Correct lab pattern understood. Now determine imaging approach.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Low renin, elevated aldosterone, hypokalemia (primary hyperaldosteronism)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This pattern describes **primary hyperaldosteronism** (Conn syndrome), where an adrenal adenoma autonomously secretes aldosterone. The excess aldosterone **suppresses renin** via negative feedback. In renovascular HTN, the problem starts with **low renal perfusion triggering renin release** - so renin is HIGH, not low. Both conditions cause hypokalemia, but the renin level differs.", "consequence": "Primary hyperaldosteronism has LOW renin - this patient has HIGH renin.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Normal renin, normal aldosterone, hyperkalemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Renovascular HTN activates the entire RAAS cascade, so **renin and aldosterone are both elevated**. The aldosterone causes **hypoKalemia** (potassium wasting in the collecting duct), not hyperkalemia. Hyperkalemia would suggest hypoaldosteronism (Addison's disease, type 4 RTA) - the opposite of what happens here.", "consequence": "RAAS activation causes high renin/aldosterone and HYPOkalemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Elevated renin, low aldosterone, hyperkalemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This pattern (high renin, low aldosterone) suggests **adrenal insufficiency** or **aldosterone synthase deficiency** - the adrenals can't respond to angiotensin II stimulation. In renovascular HTN, the adrenals are normal and respond appropriately to angiotensin II by producing **MORE aldosterone**. High renin \u2192 high angiotensin II \u2192 high aldosterone \u2192 hypokalemia.", "consequence": "Normal adrenals respond to high renin with high aldosterone.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Elevated catecholamines, normal renin, normal aldosterone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Elevated catecholamines would suggest **pheochromocytoma**, which causes episodic HTN through adrenergic mechanisms, not RAAS activation. This child's presentation (sustained severe HTN, abdominal bruit, high renin) points to renovascular disease. Catecholamines would be normal unless incidental pheochromocytoma coexists.", "consequence": "Catecholamines elevated in pheo, not renovascular HTN.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Secondary vs Primary Hyperaldosteronism**: Both cause HTN + hypokalemia, but renin levels differ. **Secondary** (renovascular HTN): HIGH renin, HIGH aldosterone - the kidney drives the process. **Primary** (Conn syndrome): LOW renin, HIGH aldosterone - autonomous adrenal production suppresses renin. 'Follow the renin!'"}, "node-3": {"id": "node-3", "type": "decision", "content": "Labs confirm: elevated renin, elevated aldosterone, serum K+ 3.1 mEq/L (low). Creatinine is normal.\n\nYou proceed with imaging. **Renal Doppler ultrasound** shows:\n- Elevated resistive index in the right kidney\n- Turbulent flow pattern in the right renal artery\n- Right kidney slightly smaller than left", "question": "What is the most appropriate next step to confirm the diagnosis and plan treatment?", "choices": [{"id": "node-3-choice-a", "text": "CT or MR angiography to visualize the renal artery stenosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After screening with Doppler ultrasound shows abnormal flow, **CTA or MRA** provides detailed anatomic visualization of the stenosis. In children, expect to see **fibromuscular dysplasia (FMD)** - the artery has a 'string of beads' appearance (alternating stenoses and dilations) in the mid-to-distal renal artery. This imaging guides treatment planning: **angioplasty \u00b1 stenting** or surgical revascularization.", "consequence": "Appropriate imaging to confirm diagnosis and plan revascularization.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start ACE inhibitor and recheck BP in 1 month", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **ACE inhibitors are relatively CONTRAINDICATED** in bilateral renal artery stenosis (or stenosis of a solitary kidney) because they can precipitate **acute kidney injury**. The stenotic kidney depends on angiotensin II to maintain GFR through efferent arteriolar constriction. Blocking ACE removes this compensatory mechanism \u2192 GFR drops. ACE inhibitors may be used cautiously in unilateral disease, but only AFTER imaging confirms the anatomy.", "consequence": "ACE inhibitors risky before confirming unilateral vs bilateral disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Renal biopsy to assess for parenchymal disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The ultrasound findings (turbulent flow, elevated resistive index, size discrepancy) suggest **vascular** disease, not parenchymal disease. Renal biopsy is indicated for glomerulonephritis or interstitial nephritis - it would not help diagnose renal artery stenosis. The appropriate next step is vascular imaging (CTA/MRA) to visualize the stenosis.", "consequence": "Biopsy for parenchymal disease, not vascular abnormalities.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Repeat Doppler ultrasound in 3 months to confirm findings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child has **Stage 2 hypertension** (BP 165/105) with clear ultrasound abnormalities. Waiting 3 months delays diagnosis and treatment while exposing the child to end-organ damage from uncontrolled severe HTN. Proceed promptly to definitive imaging (CTA/MRA) to confirm the diagnosis and plan intervention.", "consequence": "Severe HTN requires urgent workup, not watchful waiting.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Surgical nephrectomy of the affected kidney", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Nephrectomy is a **last resort** for renovascular HTN, reserved for cases where the kidney is non-functional and revascularization has failed or is not possible. The first-line treatment is **percutaneous transluminal angioplasty (PTA)** - very effective for fibromuscular dysplasia. Surgical revascularization is an alternative. Removing a kidney should not be done without first attempting revascularization.", "consequence": "Revascularization (angioplasty or surgery) comes before nephrectomy.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Renovascular HTN imaging ladder**: (1) **Screen** with Doppler US (flow patterns, resistive index); (2) **Confirm** with CTA or MRA (visualize stenosis, 'string of beads' in FMD); (3) **Treat** with angioplasty \u00b1 stent (FMD responds well) or surgical revascularization. **Caution**: ACE inhibitors can cause AKI in bilateral RAS - use carefully!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **renovascular hypertension** based on the classic triad: severe/refractory HTN, abdominal bruit, and elevated renin. You understood the **RAAS mechanism** (stenosis \u2192 reduced perfusion \u2192 renin release \u2192 secondary hyperaldosteronism with hypokalemia). You appropriately ordered **CTA/MRA** after abnormal Doppler screening to visualize the stenosis. In children, **fibromuscular dysplasia** is the most common cause and responds well to angioplasty."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key renovascular HTN concepts: (1) **Red flags**: severe HTN in young child, abdominal bruit, elevated renin, hypokalemia; (2) **Mechanism**: stenosis \u2192 RAAS activation \u2192 secondary hyperaldosteronism (high renin + high aldosterone + low K+); (3) **Imaging**: Doppler US (screen) \u2192 CTA/MRA (confirm); (4) **Treatment**: angioplasty (effective for FMD) or surgical revascularization."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical renovascular HTN teaching points: (1) In children, **fibromuscular dysplasia** is the #1 cause (not atherosclerosis); (2) **Secondary hyperaldosteronism** = HIGH renin + HIGH aldosterone + HYPOkalemia; (3) **ACE inhibitors are dangerous** in bilateral RAS (can precipitate AKI); (4) Treatment goal is **revascularization** (angioplasty), not nephrectomy; (5) Don't delay workup in severe HTN - end-organ damage occurs!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-098", "title": "Renal Trauma Workup", "domain": "renal", "difficulty": "advanced", "tags": ["renal trauma", "hematuria", "CT urogram", "handlebar injury", "AAST grading", "blunt trauma", "conservative management", "flank injury"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 9-year-old male is brought to the ED after falling off his bicycle and landing on the handlebar, which struck his left flank. He has left flank pain and noticed blood in his urine.\n\nVital signs: HR 95, BP 110/70, RR 20, T 37.0\u00b0C, SpO2 99%.\n\nPhysical exam:\n- General: Alert, uncomfortable, holding left flank\n- Abdomen: Soft, mild left flank tenderness, no peritoneal signs\n- Back: Left flank ecchymosis and tenderness to palpation\n- GU: Gross hematuria noted on voided specimen\n\nNo loss of consciousness. No head, chest, or extremity injuries.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A child presents with flank trauma, flank ecchymosis, and gross hematuria after a handlebar injury. He is hemodynamically stable.", "question": "What is the most appropriate imaging study for this patient?", "choices": [{"id": "node-1-choice-a", "text": "CT abdomen/pelvis WITH IV contrast (CT urogram)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **CT with IV contrast** is the gold standard for evaluating renal trauma. It allows grading of injury (I-V), identifies parenchymal lacerations, hematomas, urinary extravasation, and vascular pedicle injury. **Delayed images** (10-15 min post-contrast) assess the collecting system for urine leaks. This is essential for management decisions.", "consequence": "CT urogram ordered. Results pending.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Ultrasound of kidneys and bladder", "isOptimal": false, "isAcceptable": true, "feedback": "Ultrasound can detect **free fluid and hydronephrosis** but is **inadequate for grading renal trauma**. It cannot reliably identify parenchymal lacerations, vascular injury, or urinary extravasation. In a stable patient with gross hematuria after significant trauma, **CT with contrast is preferred**. FAST exam may be used for initial assessment in unstable patients.", "consequence": "Limited information obtained. CT still needed for staging.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "CT abdomen/pelvis WITHOUT contrast", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Non-contrast CT is useful for **kidney stones** but is **inadequate for trauma evaluation**. IV contrast is essential to assess renal perfusion, identify active bleeding, and detect urinary extravasation. Without contrast, you cannot grade the injury or assess vascular integrity.", "consequence": "Cannot properly evaluate renal injury without contrast.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Intravenous pyelogram (IVP)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **IVP is obsolete** for trauma evaluation. It has been replaced by CT urogram, which provides far superior anatomic detail, can evaluate other abdominal organs, and is faster. IVP cannot assess for hematomas, vascular injury, or associated organ damage.", "consequence": "Outdated imaging modality. Delays appropriate workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "No imaging needed - observe and repeat urinalysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Gross hematuria after significant trauma requires imaging**. While microscopic hematuria in a stable patient might be observed, **gross hematuria** indicates significant injury that needs to be characterized. Observation alone could miss a serious injury requiring intervention.", "consequence": "Potentially serious injury goes undiagnosed.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Indications for imaging in pediatric blunt renal trauma**: Gross hematuria (always image), OR microscopic hematuria with hemodynamic instability (SBP <90 or signs of shock). Children's kidneys are more vulnerable due to **less perirenal fat**, weaker abdominal muscles, and relatively larger kidney size."}, "node-2": {"id": "node-2", "type": "decision", "content": "CT urogram results:\n- **Left kidney**: 2.5 cm laceration through cortex and medulla, NOT extending to collecting system\n- Small perinephric hematoma (contained)\n- No active contrast extravasation\n- No urine leak on delayed images\n- Good perfusion to entire kidney\n- Right kidney: Normal\n- No other intra-abdominal injuries\n\nPatient remains hemodynamically stable.", "question": "Based on the CT findings, what is the grade of this renal injury and how should it be managed?", "choices": [{"id": "node-2-choice-a", "text": "Grade III injury - conservative management with bedrest, serial hematocrits, and observation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **Grade III** renal injury (laceration >1 cm into parenchyma without collecting system involvement or urinary extravasation). **>90% of blunt renal injuries are managed non-operatively**. Management includes: bedrest, serial hematocrits (q6-8h initially), IV fluids, pain control, and close monitoring. Activity restriction for 2-4 weeks. Repeat imaging only if clinical deterioration.", "consequence": "Conservative management initiated. Patient admitted for observation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Grade II injury - discharge home with urology follow-up in 1 week", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect grading and disposition. **Grade II** is a superficial laceration <1 cm or small subcapsular hematoma. This patient has a **2.5 cm laceration through cortex AND medulla = Grade III**. Grade III injuries typically require **inpatient observation** with serial hematocrits, not outpatient management.", "consequence": "Underestimation of injury severity. Risk of delayed complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Grade IV injury - emergent surgical exploration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Grade IV** involves laceration extending to the collecting system with urinary extravasation OR segmental vascular injury with devascularization. This patient has **no collecting system involvement and no urinary leak**. Emergent surgery is NOT indicated. Even Grade IV injuries can often be managed conservatively if the patient is stable.", "consequence": "Unnecessary surgery for injury that can be managed conservatively.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Grade V injury - immediate nephrectomy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Grade V** is a shattered kidney or renal pedicle avulsion with devascularized kidney. This patient has a contained Grade III laceration with good perfusion. Nephrectomy is reserved for **uncontrollable hemorrhage**, shattered kidney, or complete pedicle avulsion\u2014none of which are present here.", "consequence": "Grossly inappropriate. Loss of kidney for treatable injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Grade III injury - angioembolization to prevent delayed bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Angioembolization** is indicated for **active arterial bleeding** seen on CT (contrast blush or extravasation) or persistent hemodynamic instability. This patient has a **contained hematoma with no active extravasation** and is **stable**. Prophylactic embolization is not indicated and could cause unnecessary renal parenchymal loss.", "consequence": "Unnecessary intervention with potential complications.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**AAST Renal Injury Grading**: I = contusion/subcapsular hematoma; II = <1cm laceration, no extravasation; III = >1cm laceration, no collecting system injury; IV = laceration into collecting system OR segmental vascular injury; V = shattered kidney OR pedicle avulsion. **>90% managed non-operatively!**"}, "node-3": {"id": "node-3", "type": "decision", "content": "The patient is admitted for observation. After 24 hours:\n- Hemoglobin stable: 11.2 \u2192 10.8 g/dL\n- Vital signs remain stable\n- Urine clearing (light pink now, was gross hematuria)\n- Tolerating diet\n- Pain controlled with oral analgesics\n\nThe family asks about recovery and follow-up.", "question": "What are the appropriate discharge instructions and follow-up plan?", "choices": [{"id": "node-3-choice-a", "text": "Activity restriction for 2-4 weeks, no contact sports for 6 weeks, urology follow-up with repeat imaging in 2-3 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! After renal trauma: **Bedrest until gross hematuria resolves**, then gradual activity. **No contact sports or strenuous activity for 4-6 weeks** to allow healing and reduce risk of delayed bleeding. **Follow-up imaging** (usually ultrasound or CT) in 2-3 months to assess healing and rule for complications (urinoma, pseudoaneurysm, hypertension). Blood pressure monitoring is important as renal trauma can cause renovascular hypertension.", "consequence": "Appropriate plan established. Patient discharged.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "No restrictions needed - can return to full activity immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activity restriction is essential** after renal trauma. The healing kidney is vulnerable to **re-injury and delayed hemorrhage** for several weeks. Return to contact sports too early could cause a minor re-injury to become life-threatening. Standard restriction is 4-6 weeks minimum.", "consequence": "Risk of re-injury and delayed bleeding.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Surgical repair before discharge to prevent complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is not indicated** for stable, healing Grade III injuries. The patient is improving clinically with stable hemoglobin and clearing hematuria. Non-operative management has excellent outcomes for Grade I-III injuries. Surgery would introduce unnecessary risks.", "consequence": "Unnecessary surgery for healing injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Lifelong activity restriction due to kidney injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Once the kidney has healed (typically confirmed by imaging at 2-3 months), the child can return to **full activity including contact sports**. Grade III injuries heal well with conservative management and do not require permanent restrictions. Overly restrictive recommendations are not evidence-based.", "consequence": "Unnecessarily restricts child's quality of life.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "No follow-up imaging needed if asymptomatic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Follow-up imaging is recommended** after significant renal trauma to confirm healing and identify delayed complications such as **urinoma, pseudoaneurysm, arteriovenous fistula, or scarring**. Additionally, blood pressure should be monitored as renal trauma can cause **renovascular hypertension**.", "consequence": "Delayed complications may go undetected.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Follow-up after renal trauma**: Repeat imaging (US or CT) in 2-3 months, blood pressure monitoring (risk of renovascular HTN from scarring), activity restriction 4-6 weeks. **Delayed complications** to watch for: urinoma, pseudoaneurysm, AV fistula, hypertension, Page kidney (subcapsular hematoma causing ischemia)."}, "node-4": {"id": "node-4", "type": "decision", "content": "At the 3-month follow-up:\n- Ultrasound shows complete healing of the left kidney laceration with minimal scarring\n- No hydronephrosis or fluid collections\n- Blood pressure: 108/68 mmHg (normal for age)\n- Urinalysis: No blood\n\nThe child and family are eager to know about return to sports.", "question": "What is the appropriate guidance regarding return to contact sports?", "choices": [{"id": "node-4-choice-a", "text": "Cleared for full activity including contact sports with normal protective equipment", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! With **confirmed healing on imaging**, normal blood pressure, and resolution of hematuria, the child can return to **full activity including contact sports**. There is no evidence that a healed kidney is at higher risk of injury than a normal kidney. Standard protective equipment (appropriate for the sport) is sufficient. No special restrictions are needed.", "consequence": "Child cleared for full activity. Family reassured.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "No contact sports ever again - solitary functioning kidney equivalent", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child has **two functioning kidneys**. A healed kidney injury does not make it a \"solitary kidney.\" The AAP recommends restricting contact sports only for true **solitary kidney** situations. With complete healing documented, this child can participate normally.", "consequence": "Unnecessarily restricts activities for healthy child.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Wait 6 more months before any sports clearance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Healing is documented at 3 months** with normal imaging and clinical status. Waiting an additional 6 months is not evidence-based and unnecessarily restricts the child. Standard recommendation is return to full activity once healing is confirmed, typically by 3 months.", "consequence": "Unnecessary prolonged restriction.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Return to sports only with special kidney protective gear (flak jacket)", "isOptimal": false, "isAcceptable": true, "feedback": "Additional kidney protection is sometimes used but is **not routinely required** for healed renal injuries. Some families and physicians prefer this for peace of mind, which is reasonable. However, evidence does not show that healed kidneys are at increased risk, so standard sport-appropriate equipment is sufficient.", "consequence": "Acceptable but not required. May provide peace of mind.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-e", "text": "Repeat CT scan before allowing sports", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ultrasound is sufficient** for follow-up of healed renal trauma. Repeat CT adds unnecessary radiation exposure without providing additional clinically useful information when ultrasound shows complete healing. CT should be reserved for suspected complications or inadequate US visualization.", "consequence": "Unnecessary radiation exposure.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Return to sports after renal trauma**: Once healing is confirmed on imaging (2-3 months), full activity is allowed. No increased risk of injury to healed kidney. **True solitary kidney** (one kidney total) does require counseling about contact sports risks, but normal protective equipment is still usually adequate."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "**Excellent management!** You appropriately evaluated this child with renal trauma using CT urogram, correctly graded the injury (Grade III), initiated conservative management, provided appropriate activity restrictions, and cleared the child for return to full activity after documented healing.\n\n**Key Learning Points:**\n- CT with IV contrast is gold standard for renal trauma staging\n- Pediatric kidneys are vulnerable: less perirenal fat, larger relative size\n- **>90%** of blunt renal injuries managed non-operatively\n- Grade I-III: conservative; Grade IV-V: may need intervention if unstable\n- Activity restriction 4-6 weeks, follow-up imaging in 2-3 months\n- Once healed, full activity including contact sports is allowed"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "**Suboptimal approach.** While you managed some aspects correctly, there were errors in imaging choice, injury grading, or follow-up planning.\n\n**Review:**\n- **CT with IV contrast** is essential for trauma evaluation\n- AAST grading: I-V based on laceration depth, collecting system involvement, vascular injury\n- Most injuries (>90%) managed conservatively\n- Activity restriction for 4-6 weeks after renal trauma\n- Follow-up imaging to confirm healing before return to sports"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "**Critical errors in management.** Renal trauma requires systematic evaluation, appropriate imaging, and evidence-based management. Failure to image gross hematuria, incorrect grading, or unnecessary surgery can lead to poor outcomes.\n\n**Key Pearl:** CT with IV contrast is essential for renal trauma - it shows parenchymal injury, extravasation, and vascular pedicle integrity. >90% of blunt renal injuries are managed non-operatively. Surgery is reserved for hemodynamic instability, shattered kidney, or pedicle avulsion."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-099", "title": "Urethral Injury Workup", "domain": "renal", "difficulty": "intermediate", "tags": ["blood at meatus", "cannot void", "high-riding prostate", "do NOT catheterize", "urethral injury workup"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male is brought to the emergency department after straddle injury or pelvic fracture with blood at urethral meatus, inability to void, perineal hematoma, or high-riding prostate on rectal exam.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the child carefully. The trauma occurred when he fell off his bicycle and landed straddling the crossbar.\n\n**Key examination findings:**\n- **Blood at the urethral meatus** (actively dripping)\n- **Unable to void** despite urge and full bladder\n- **Perineal ecchymosis** ('butterfly' pattern)\n- Rectal exam: prostate palpable in normal position\n- Scrotal exam: no hematoma\n- No pelvic instability on compression", "question": "Based on the mechanism and examination findings, what type of urethral injury is most likely?", "choices": [{"id": "node-1-choice-a", "text": "Anterior urethral injury (bulbar urethra) from straddle mechanism", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Straddle injuries** typically cause **anterior (bulbar) urethral injuries**. The bulbar urethra is compressed between the object (bike crossbar) and the pubic symphysis. Key features: **blood at meatus**, **perineal 'butterfly' hematoma** (blood tracks through Buck's fascia), ability to void may be impaired but prostate is **normal position**. Contrast with posterior urethral injury which involves the membranous urethra at the urogenital diaphragm.", "consequence": "Correct injury type identified. Now determine workup approach.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Posterior urethral injury from pelvic fracture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Posterior urethral injuries** occur with **pelvic fractures** (especially pubic rami fractures) - the membranous urethra is sheared at the urogenital diaphragm. Key signs: **high-riding or non-palpable prostate** on rectal exam (the bladder/prostate are displaced upward), pelvic instability, scrotal hematoma. This child has NO pelvic fracture and a **normally positioned prostate** - pointing to anterior injury.", "consequence": "Posterior injury requires pelvic fracture and high-riding prostate.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bladder rupture without urethral involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bladder rupture** presents with **suprapubic pain/tenderness**, **gross hematuria** (blood in urine, not just at meatus), and often inability to void. The key distinguishing feature is **blood AT the urethral meatus** (dripping before voiding) which indicates urethral injury, not bladder rupture. Bladder injury would show hematuria if catheterized, but blood doesn't drip from the meatus spontaneously.", "consequence": "Blood at meatus = urethral injury, not bladder rupture.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Penile fracture with urethral injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Penile fracture** is rupture of the tunica albuginea of the corpus cavernosum - it occurs during erection (sexual activity, rolling onto erect penis). Presents with sudden 'pop' or 'crack,' immediate detumescence, **penile deviation** ('eggplant deformity'), swelling. It can involve the urethra but mechanism is completely different from straddle injury. This 5-year-old's straddle injury involves the fixed bulbar urethra, not the mobile penile shaft.", "consequence": "Penile fracture has different mechanism and presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Testicular torsion with referred urethral symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Testicular torsion** causes severe **testicular pain** with a **high-riding testicle** and **absent cremasteric reflex** - it does NOT cause blood at the urethral meatus. The mechanism (straddle injury), blood at meatus, and perineal hematoma all point specifically to urethral trauma. Torsion is ischemia of the testicle, not a urethral injury.", "consequence": "Torsion doesn't cause blood at meatus or perineal hematoma.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Urethral injury types**: **ANTERIOR** (bulbar/penile) - caused by **straddle injury**, prostate normal position, 'butterfly' perineal hematoma. **POSTERIOR** (membranous) - caused by **pelvic fracture**, **HIGH-RIDING prostate**, scrotal hematoma. Both present with blood at meatus and inability to void!"}, "node-2": {"id": "node-2", "type": "decision", "content": "The emergency medicine resident wants to place a Foley catheter to relieve the child's distended bladder and obtain urine output for monitoring.\n\nThe child is hemodynamically stable with normal vital signs. The bladder is palpable at the umbilicus.", "question": "What is the critical next step BEFORE attempting bladder catheterization?", "choices": [{"id": "node-2-choice-a", "text": "Retrograde urethrogram (RUG) to evaluate urethral integrity", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Retrograde urethrogram (RUG)** is MANDATORY before any catheterization attempt when urethral injury is suspected. The classic teaching: **'Blood at the meatus = RUG before catheter!'** The RUG involves injecting contrast into the urethral meatus under fluoroscopy to visualize the urethra and identify the site/extent of injury. Blindly placing a catheter risks converting a partial tear to a complete disruption and creating a false passage.", "consequence": "Correct - RUG before any catheterization attempt.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Attempt gentle Foley catheter insertion with lidocaine gel", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **NEVER blindly catheterize** a patient with suspected urethral injury. Even 'gentle' catheterization can: (1) Convert a **partial tear to complete disruption**; (2) Create a **false passage** through the injured area; (3) Introduce **infection** into the periurethral tissues; (4) Cause additional **bleeding**. The presence of blood at meatus is an absolute indication for RUG BEFORE any instrumentation.", "consequence": "Blind catheterization can worsen injury and create false passage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "CT scan of pelvis to assess for associated injuries", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. CT is useful for evaluating **pelvic fractures and associated injuries**, but it does NOT adequately visualize the urethra. For suspected urethral injury, **retrograde urethrogram** is the diagnostic test of choice - it's a dynamic study that shows contrast extravasation at the injury site. CT can be done afterward if pelvic fracture is suspected, but RUG takes priority for the urethral injury.", "consequence": "CT useful for pelvic trauma but RUG needed for urethral evaluation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Place suprapubic catheter immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Suprapubic catheter** is the correct bladder drainage method IF urethral injury is confirmed, but you must first perform a **retrograde urethrogram** to document the injury. Placing a suprapubic catheter without imaging is premature - the RUG may show a partial injury that can be managed with gentle catheter placement under direct visualization, or it may confirm complete disruption requiring suprapubic diversion.", "consequence": "Must confirm injury with RUG before deciding on drainage method.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Obtain urinalysis to check for hematuria", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child has obvious **blood at the urethral meatus** - gross hematuria is already confirmed by inspection! The urgent question is whether the urethra is intact, not whether there's blood in the urine. Attempting to obtain urine (whether by catheter or voiding) could worsen the injury. **RUG first** to evaluate urethral integrity before any manipulation.", "consequence": "Blood at meatus already confirms bleeding - don't delay RUG.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **'Blood at the meatus = NO FOLEY until RUG!'** Signs requiring RUG before catheterization: (1) **Blood at urethral meatus**; (2) **High-riding prostate**; (3) **Perineal/scrotal hematoma**; (4) **Pelvic fracture**; (5) **Inability to void after trauma**. Blind catheterization can convert partial to complete disruption!"}, "node-3": {"id": "node-3", "type": "decision", "content": "**Retrograde urethrogram** is performed. Results show:\n- Contrast extravasation at the **bulbar urethra**\n- **Partial disruption** - some contrast enters the bladder\n- No contrast in the peritoneum\n\nThe child remains stable but uncomfortable with a distended bladder.", "question": "Based on these RUG findings showing partial anterior urethral disruption, what is the most appropriate management?", "choices": [{"id": "node-3-choice-a", "text": "Gentle urethral catheter placement over a guidewire under fluoroscopic guidance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For **partial urethral injuries** where the RUG shows some contrast reaching the bladder (indicating urethral continuity), **careful catheter placement under fluoroscopic guidance** is often successful. This allows bladder drainage while the injury heals. The catheter acts as a **stent** to maintain urethral alignment during healing. If catheter placement fails, suprapubic cystostomy is the backup option.", "consequence": "Appropriate management for partial anterior urethral injury.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Immediate open surgical repair (urethroplasty)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Immediate surgical repair is NOT recommended** for most urethral injuries in the acute setting. For partial injuries, catheter drainage allows healing. For complete disruptions, **delayed repair (3-6 months)** has better outcomes than immediate repair because acute inflammation, hematoma, and edema make surgical planes difficult. Acute surgery is reserved for specific indications (rectal injury, bladder neck involvement).", "consequence": "Delayed repair preferred over immediate surgery for most urethral injuries.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Suprapubic cystostomy and no urethral manipulation", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. **Suprapubic cystostomy** is the preferred bladder drainage method for **complete urethral disruptions** where the RUG shows no contrast reaching the bladder. For **partial injuries** (like this case where some contrast reaches the bladder), attempting gentle catheter placement under guidance is preferred because it maintains urethral continuity and may prevent stricture formation.", "consequence": "Suprapubic preferred for complete disruption; catheter attempt OK for partial.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Observation only - the injury will heal spontaneously without drainage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child has a **distended bladder** and cannot void - he needs bladder drainage! Urethral injuries can heal, but the patient needs urinary diversion while healing occurs. Without drainage, urinary extravasation can cause **urinoma formation**, **infection**, and **sepsis**. Additionally, without a stent/catheter, healing may result in **stricture formation**.", "consequence": "Bladder must be drained to prevent complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Emergent cystoscopy to assess injury from above", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cystoscopy** (looking from the bladder down) is not the initial approach for urethral trauma. The RUG has already defined the injury. Cystoscopy may be useful adjunctively for some injuries, but passing a scope through an injured urethra risks worsening the disruption. The appropriate next step is controlled catheter placement or suprapubic drainage, not endoscopy.", "consequence": "RUG already defined the injury; cystoscopy could worsen it.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Urethral injury management by type**: **Partial injury** (contrast reaches bladder) - attempt gentle catheter placement over guidewire under guidance. **Complete disruption** (no contrast in bladder) - suprapubic cystostomy + delayed repair (3-6 months). **Immediate surgery** only for: rectal injury, bladder neck involvement, open pelvic fracture."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **anterior (bulbar) urethral injury** from straddle mechanism based on the characteristic findings: blood at meatus, perineal 'butterfly' hematoma, inability to void, but normal prostate position. You appropriately insisted on **retrograde urethrogram BEFORE any catheterization** - the cardinal rule of urethral trauma. For this partial injury, gentle catheter placement under fluoroscopic guidance provides bladder drainage and urethral stenting for optimal healing."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key urethral injury concepts: (1) **Anterior** (straddle) vs **Posterior** (pelvic fracture) - differentiated by prostate position; (2) **NEVER catheterize** with blood at meatus until RUG performed; (3) **Partial injury** (contrast reaches bladder) - attempt gentle catheterization; (4) **Complete disruption** (no contrast in bladder) - suprapubic drainage + delayed repair; (5) Immediate surgery rarely indicated."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical urethral trauma teaching points: (1) **Blood at meatus = RUG BEFORE any catheterization** - blind catheter can convert partial to complete disruption; (2) **Anterior injury** (straddle): bulbar urethra, prostate normal; **Posterior injury** (pelvic fracture): membranous urethra, HIGH-RIDING prostate; (3) Management: partial \u2192 catheter with guidance; complete \u2192 suprapubic + delayed repair (3-6 months); (4) Complications of untreated injury: stricture, incontinence, impotence."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-100", "title": "VUR-Related Renal Scarring Recognition", "domain": "renal", "difficulty": "intermediate", "tags": ["recurrent febrile UTIs", "photopenic areas on DMSA", "hypertension in child", "vur-related renal scarring recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old female with history of recurrent UTIs is being evaluated for renal scarring.\n\nPhysical Examination:\n- Labs: BMP: Cr elevated.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 5-year-old female is referred to you for evaluation after her third febrile UTI this year. Her history reveals:\n\n**UTI History:**\n- Age 2: febrile UTI (E. coli), treated with oral antibiotics\n- Age 4: febrile UTI (E. coli), required IV antibiotics for poor oral intake\n- Current: presenting with fever 103\u00b0F, dysuria, and flank pain\n\n**Current Evaluation:**\n- **BP: 118/78 mmHg** (>95th percentile for age/height - HYPERTENSIVE)\n- **Urinalysis**: pyuria, bacteriuria, positive leukocyte esterase and nitrites\n- **BMP**: Creatinine 0.9 mg/dL (elevated for age; normal ~0.3-0.5 mg/dL)\n- **CBC**: WBC 16,000 with left shift\n\n**Previous Imaging (after 2nd UTI):**\n- **VCUG**: Grade IV vesicoureteral reflux (VUR) on left\n- **Renal ultrasound**: Left kidney smaller than right, cortical thinning\n\n**Vesicoureteral Reflux (VUR) Background:**\n- **Primary VUR**: congenital short intramural ureter \u2192 incompetent valve mechanism\n- Urine refluxes from bladder UP to kidney during voiding/filling\n- Grades I-V (I = reflux into ureter only; V = severe dilation with intrarenal reflux)\n- **Sterile reflux** rarely causes scarring; **infected reflux** causes pyelonephritis and scarring", "question": "Given this child's history of recurrent febrile UTIs, known VUR, hypertension, and elevated creatinine, what is the most likely underlying diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Reflux nephropathy - chronic kidney disease from recurrent pyelonephritis secondary to VUR", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Reflux nephropathy** is the diagnosis when VUR leads to recurrent pyelonephritis, causing renal scarring and progressive kidney damage. Key evidence in this case: (1) **History of recurrent FEBRILE UTIs** - febrile UTIs indicate upper tract (pyelonephritis), not just cystitis, (2) **Known high-grade VUR** (grade IV), (3) **Hypertension** - renal scarring is the #1 cause of secondary hypertension in children, (4) **Elevated creatinine** - indicates reduced renal function, (5) **Renal asymmetry and cortical thinning** on ultrasound. The infected urine refluxing to the kidney causes inflammation, scarring, and progressive nephron loss.", "consequence": "You correctly identify reflux nephropathy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Simple recurrent cystitis without upper tract involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cystitis** (lower UTI) does NOT cause: (1) Fever - cystitis is typically afebrile, (2) Flank pain, (3) Hypertension, (4) Elevated creatinine, (5) Renal scarring. This child has **febrile UTIs** with systemic symptoms, indicating **pyelonephritis** (upper tract infection). The presence of hypertension and elevated creatinine indicates established renal damage, not simple bladder infections.", "consequence": "Misdiagnosis as cystitis misses the severity of renal involvement.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Posterior urethral valves causing obstructive uropathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Posterior urethral valves (PUV)**: (1) Occur only in **males**, (2) Cause bilateral hydronephrosis, (3) Present with weak urinary stream, dribbling, (4) Often diagnosed prenatally or in infancy. This is a **female** patient with documented VUR, not obstruction. PUV is the most common cause of obstructive uropathy in boys, but is not the diagnosis here.", "consequence": "PUV only occurs in males.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Acute post-streptococcal glomerulonephritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **APSGN** presents with: (1) Gross hematuria (\"cola-colored\" urine), (2) Edema, (3) Hypertension, (4) Low complement (C3), (5) History of recent strep infection (pharyngitis or impetigo). This child has pyuria and bacteriuria (UTI), not hematuria and RBC casts. The history of recurrent febrile UTIs with known VUR points to reflux nephropathy, not glomerulonephritis.", "consequence": "APSGN has different clinical features (hematuria, edema, low C3).", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Congenital renal dysplasia unrelated to UTIs", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **renal dysplasia** can cause small kidneys and CKD, this child's presentation strongly points to **acquired** damage from recurrent pyelonephritis: (1) The kidney damage correlates with UTI history, (2) The affected kidney matches the side with VUR, (3) She was presumably healthy before recurrent UTIs began. Dysplasia is a congenital malformation present from birth, not acquired through infection.", "consequence": "The clinical history points to acquired damage from infection, not congenital dysplasia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Reflux nephropathy** = renal scarring from recurrent pyelonephritis in the setting of VUR. It is the #1 cause of **secondary hypertension in children** and a major cause of **pediatric CKD/ESRD**. Febrile UTIs (not afebrile cystitis) cause the damage."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose reflux nephropathy with chronic kidney disease. The current acute pyelonephritis is treated with IV antibiotics, and she improves.\n\nNow you need to assess the extent of renal scarring and plan long-term management.\n\n**Imaging for Reflux Nephropathy:**\n\n**DMSA Scan (Dimercaptosuccinic Acid):**\n- **Gold standard** for detecting renal scarring\n- Radionuclide taken up by functioning renal tubular cells\n- **Photopenic areas** (cold spots) = scarring/non-functioning tissue\n- Can distinguish acute pyelonephritis (diffuse decreased uptake) from chronic scarring (focal defects)\n\n**Renal Ultrasound:**\n- Shows kidney size, cortical thickness\n- Less sensitive for scarring than DMSA\n- Useful for follow-up monitoring\n\n**VCUG (Voiding Cystourethrogram):**\n- Already done - confirmed Grade IV VUR\n- Grades reflux severity (I-V)\n- Grade IV-V associated with highest scarring risk\n\n**Her DMSA scan shows:**\n- Left kidney: multiple photopenic areas (scarring), contributes only 35% of total function\n- Right kidney: normal uptake, compensatory hypertrophy, contributes 65% of function", "question": "What is the most important long-term monitoring priority for this child with established reflux nephropathy?", "choices": [{"id": "node-2-choice-a", "text": "Regular blood pressure monitoring, renal function tests, and urinalysis for proteinuria - proteinuria indicates progressive nephron loss", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Long-term monitoring** is critical because reflux nephropathy can progress even after VUR resolves. Key monitoring: (1) **Blood pressure** - hypertension is common and requires treatment (often ACE inhibitors), (2) **Renal function** (creatinine, GFR) - track for CKD progression, (3) **Urinalysis for PROTEINURIA** - this is the KEY marker of progressive nephron loss and hyperfiltration injury. Proteinuria indicates ongoing damage and predicts progression to ESRD. ACE inhibitors are used not just for BP control but also for renoprotection (reduce proteinuria).", "consequence": "You establish appropriate long-term monitoring.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Repeat DMSA scans every 6 months to track scarring progression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Frequent DMSA scans are not recommended**. Rationale: (1) DMSA involves radiation exposure, (2) Scarring, once established, doesn't \"progress\" on imaging - it's the functional consequences (BP, GFR, proteinuria) that matter, (3) DMSA is useful for initial assessment but not for routine follow-up. Clinical markers (BP, creatinine, proteinuria) are more useful for monitoring disease progression.", "consequence": "Frequent DMSA scans provide radiation without useful clinical information.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Monthly urine cultures even when asymptomatic to detect subclinical infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine screening urine cultures are NOT recommended** in asymptomatic children. Rationale: (1) Treatment of asymptomatic bacteriuria doesn't prevent pyelonephritis, (2) Leads to unnecessary antibiotic courses, (3) Promotes antibiotic resistance. Monitor for SYMPTOMATIC UTIs and treat promptly, but don't screen asymptomatic patients.", "consequence": "Screening asymptomatic patients leads to unnecessary antibiotic use.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "No monitoring needed if VUR resolves spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Monitoring is still needed even after VUR resolves**. Critical point: The damage is already done. Renal scars don't heal. Even after VUR resolves (spontaneously or surgically), the scarred kidney can: (1) Cause hypertension, (2) Progress to CKD through hyperfiltration injury, (3) Develop proteinuria. Lifelong monitoring is required for patients with established reflux nephropathy.", "consequence": "Damage persists after VUR resolves - monitoring is still required.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Annual kidney biopsies to assess histologic progression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Kidney biopsy is NOT indicated** for reflux nephropathy monitoring. The diagnosis is made clinically and radiographically. Biopsy: (1) Is invasive with bleeding risk, (2) Wouldn't change management, (3) Is reserved for unclear diagnoses (e.g., suspected glomerulonephritis). Non-invasive monitoring (BP, labs, urinalysis) is appropriate.", "consequence": "Biopsy is invasive and unnecessary for monitoring reflux nephropathy.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Proteinuria is the key prognostic marker** in reflux nephropathy. It indicates hyperfiltration injury to remaining nephrons and predicts progression to ESRD. ACE inhibitors reduce proteinuria and slow CKD progression (renoprotection)."}, "node-3": {"id": "node-3", "type": "decision", "content": "You establish a monitoring plan: BP checks at every visit, annual BMP, and urinalysis every 6 months.\n\nThe parents ask: \"Her VUR is grade IV. Should she have surgery to fix the reflux and prevent more kidney damage?\"\n\n**VUR Management Options:**\n\n**1. Observation/Spontaneous Resolution:**\n- Lower grades (I-III) often resolve spontaneously with bladder maturation\n- Higher grades (IV-V) less likely to resolve\n- Resolution rates: ~80% for grade I-II, ~50% for grade III, ~30% for grade IV-V\n\n**2. Antibiotic Prophylaxis:**\n- Controversial - RIVUR trial showed modest benefit in preventing recurrent febrile UTIs\n- May be considered in young children with high-grade VUR\n- Concerns: compliance, antibiotic resistance, limited long-term benefit for scarring\n\n**3. Surgical Correction:**\n- **Open ureteral reimplantation**: high success rate (95-98%)\n- **Endoscopic injection** (Deflux): less invasive but lower success rate\n- Surgery prevents reflux but does NOT reverse existing scarring\n\n**Key Evidence:**\n- Studies show surgical correction prevents UTIs but does NOT reduce scarring or CKD progression compared to medical management in children with EXISTING scarring", "question": "How do you counsel this family about surgical correction of VUR in a child with established reflux nephropathy?", "choices": [{"id": "node-3-choice-a", "text": "Surgery can prevent future UTIs but will NOT reverse existing kidney damage - the scars are permanent; decision should weigh UTI burden against surgical risks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Honest counseling about surgery limitations** is essential. Key points: (1) **Surgery prevents reflux** and may reduce febrile UTI frequency, (2) **Surgery does NOT reverse scarring** - the damage is permanent, (3) **Surgery does NOT prevent CKD progression** in children with established nephropathy - studies show no difference in renal outcomes, (4) Decision should consider: frequency/severity of breakthrough UTIs, family preference, surgical risks, compliance with medical management. For this child with significant existing damage, the kidney won't improve with surgery - the goal shifts to preventing further infections and monitoring for CKD progression.", "consequence": "You provide accurate counseling about surgical benefits and limitations.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Immediate surgery is mandatory to prevent any further kidney damage - delaying surgery will cause ESRD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is NOT mandatory** and this overstates the urgency. Key points: (1) Surgery prevents reflux but doesn't reverse existing damage, (2) Studies show similar long-term renal outcomes with medical vs surgical management, (3) ESRD risk depends on existing scarring severity, not VUR correction, (4) Many children with VUR are managed medically. This alarmist message would cause unnecessary anxiety and isn't evidence-based.", "consequence": "Overstating surgical urgency causes unnecessary anxiety and isn't evidence-based.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Surgery will restore her kidney function to normal and she won't need any further monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is FALSE and dangerous misinformation**. Surgery: (1) Does NOT reverse scarring - scars are permanent, (2) Does NOT restore kidney function, (3) Does NOT eliminate need for monitoring. The child will still need lifelong BP and renal function monitoring regardless of VUR correction. Telling families surgery will \"fix\" the kidney sets false expectations.", "consequence": "False promises about surgical outcomes lead to inappropriate expectations and potentially missed monitoring.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Refuse to discuss surgery and insist on antibiotic prophylaxis until age 10 regardless of parent preference", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Shared decision-making** is appropriate for VUR management. There's no single \"correct\" answer - both medical and surgical management are reasonable options with different trade-offs. Refusing to discuss surgery: (1) Is paternalistic and ignores family values, (2) Doesn't acknowledge legitimate surgical indications (recurrent breakthrough UTIs, antibiotic intolerance), (3) May not be appropriate for high-grade VUR with poor resolution likelihood. Present options and let the family participate in decision-making.", "consequence": "Refusing to discuss options violates shared decision-making principles.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Since she already has kidney damage, there's no point in doing anything - just wait for dialysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This nihilistic approach is inappropriate**. While existing damage can't be reversed, management goals include: (1) **Preventing further scarring** (treating UTIs promptly, possibly preventing with prophylaxis or surgery), (2) **Controlling hypertension** (prevents cardiovascular disease and slows CKD), (3) **Reducing proteinuria** with ACE inhibitors (slows progression), (4) **Monitoring** for timely intervention. Many children with reflux nephropathy maintain stable renal function for years with appropriate management.", "consequence": "Nihilistic approach ignores opportunities to slow progression and manage complications.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Surgery for VUR prevents reflux but does NOT reverse existing renal scars or prevent CKD progression**. For children with established reflux nephropathy, the decision to operate should be based on UTI frequency and severity, not expectation of renal recovery. Lifelong monitoring is required regardless of surgical intervention."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed reflux nephropathy and provided appropriate counseling about long-term management.\n\n**Key teaching points:**\n\n**Reflux Nephropathy:**\n- Renal scarring from recurrent pyelonephritis in setting of VUR\n- #1 cause of secondary hypertension in children\n- Major cause of pediatric CKD/ESRD\n- **Febrile UTIs** (not afebrile cystitis) cause the damage\n\n**Diagnosis:**\n- History of recurrent febrile UTIs + known VUR\n- Hypertension, elevated creatinine\n- **DMSA scan**: gold standard for scarring (photopenic areas)\n- Renal ultrasound: asymmetry, cortical thinning\n\n**Long-term Monitoring:**\n- Blood pressure (hypertension common)\n- Renal function (creatinine, GFR)\n- **Proteinuria** - KEY prognostic marker, indicates hyperfiltration injury\n- ACE inhibitors for BP control AND renoprotection\n\n**Surgery Counseling:**\n- Prevents reflux and may reduce UTI frequency\n- Does NOT reverse existing scarring\n- Does NOT prevent CKD progression in established nephropathy\n- Shared decision-making based on UTI burden, family preference\n\n**Prognosis**: Variable - depends on severity of scarring, blood pressure control, proteinuria management."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of reflux nephropathy:\n\n**Diagnosis:**\n- Recurrent FEBRILE UTIs (not cystitis) + VUR \u2192 pyelonephritis \u2192 scarring\n- Hypertension and elevated creatinine indicate established damage\n- DMSA scan shows photopenic areas (scarring)\n\n**Monitoring priorities:**\n- Blood pressure (hypertension common)\n- Renal function (creatinine, GFR)\n- PROTEINURIA - key prognostic marker\n- NOT frequent imaging or asymptomatic urine cultures\n\n**Surgery limitations:**\n- Prevents reflux, may reduce UTIs\n- Does NOT reverse scarring\n- Does NOT prevent CKD progression\n- Shared decision-making is appropriate"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Review the critical concepts of reflux nephropathy:\n\n**What reflux nephropathy IS:**\n- Renal scarring from infected urine refluxing to kidneys\n- Causes: hypertension (#1 cause in children), CKD, proteinuria\n- Damage is PERMANENT - scars don't heal\n\n**What reflux nephropathy is NOT:**\n- Simple cystitis (that's lower tract, no fever, no scarring)\n- Reversible with VUR surgery\n- Benign after VUR resolves\n\n**Key monitoring:**\n- BP, renal function, and PROTEINURIA (not DMSA scans or routine urine cultures)\n- Monitoring continues LIFELONG, even after VUR resolves\n\n**Surgery facts:**\n- Prevents reflux, doesn't reverse scarring\n- No proven benefit for CKD progression in established nephropathy\n- Decision based on UTI burden, not expectation of renal recovery"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-101", "title": "VUR Monitoring Protocol", "domain": "renal", "difficulty": "intermediate", "tags": ["antibiotic prophylaxis", "serial imaging", "grades of reflux", "vur monitoring protocol"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old female is being evaluated for vesicoureteral reflux diagnosed after her first febrile UTI.\n\nPhysical Examination:\n- Vitals: febrile.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 2-year-old female presents with her first febrile UTI. She has fever of 103\u00b0F, irritability, and foul-smelling urine. Urinalysis confirms pyuria and bacteriuria; culture grows E. coli.\n\nPer AAP guidelines, you obtain imaging after this first febrile UTI:\n- **Renal/bladder ultrasound**: Normal kidney size bilaterally, no hydronephrosis\n- **VCUG (voiding cystourethrogram)**: Grade II vesicoureteral reflux on the RIGHT\n\n**VUR Grading System (I-V):**\n- **Grade I**: Reflux into ureter only (no dilation)\n- **Grade II**: Reflux into renal pelvis, no dilation\n- **Grade III**: Mild dilation of ureter and collecting system\n- **Grade IV**: Moderate dilation, blunting of fornices\n- **Grade V**: Severe dilation with ureteral tortuosity, loss of papillary impressions\n\n**VUR Natural History:**\n- **Lower grades (I-III)** have HIGH spontaneous resolution rates (~80% for I-II, ~50% for III)\n- **Higher grades (IV-V)** are less likely to resolve spontaneously (~30%)\n- Resolution occurs due to bladder maturation and lengthening of intramural ureter\n- Resolution typically occurs by age 5-8 years", "question": "What is the most appropriate initial management approach for this child with Grade II VUR after her first febrile UTI?", "choices": [{"id": "node-1-choice-a", "text": "Observation with prompt treatment of any future UTIs - antibiotic prophylaxis is optional for low-grade VUR", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Observation with prompt UTI treatment** is appropriate for low-grade VUR (I-II). Key evidence: (1) **RIVUR trial** showed antibiotic prophylaxis reduces recurrent febrile UTI rate but does NOT reduce renal scarring, (2) Low-grade VUR has **high spontaneous resolution** rates (~80%), (3) Current guidelines (AAP, AUA) support observation WITHOUT prophylaxis as a reasonable option for low-grade VUR, especially after first UTI, (4) Key to observation: parents must understand importance of PROMPT evaluation and treatment of any febrile illness. Prophylaxis is optional, not mandatory, for low-grade VUR.", "consequence": "You choose appropriate conservative management for low-grade VUR.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Immediate surgical correction - all VUR requires surgery to prevent kidney damage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is NOT indicated for low-grade VUR**, especially after a single UTI. Key points: (1) Grade II VUR has ~80% chance of spontaneous resolution, (2) Surgery has risks (anesthesia, complications) that outweigh benefits for low-grade disease, (3) Studies show NO difference in renal outcomes between surgical and medical management for low-grade VUR, (4) Surgery is considered for: high-grade VUR (IV-V) unlikely to resolve, breakthrough febrile UTIs despite prophylaxis, or parental preference after informed discussion.", "consequence": "Surgery for low-grade VUR exposes the child to unnecessary procedural risks.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Lifelong daily antibiotic prophylaxis until adulthood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lifelong prophylaxis is not recommended**. Rationale: (1) Low-grade VUR typically resolves by age 5-8, (2) Long-term antibiotics promote resistance and have side effects, (3) Even if prophylaxis is chosen, it should be time-limited (until VUR resolves or child toilet trains), (4) There's no evidence supporting lifelong prophylaxis. If prophylaxis is used, it's typically re-evaluated with repeat VCUG after 1-2 years.", "consequence": "Lifelong prophylaxis is excessive and promotes antibiotic resistance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "No follow-up needed since the ultrasound was normal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Follow-up IS required** even with normal ultrasound and low-grade VUR. Key points: (1) The child still has VUR - there's risk of future febrile UTIs, (2) Parents need education about UTI symptoms and when to seek care, (3) Renal ultrasound can miss early scarring (DMSA is more sensitive), (4) VUR status should be reassessed periodically. Dismissing the diagnosis without a follow-up plan is inappropriate.", "consequence": "Lack of follow-up plan leaves the family without guidance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Repeat VCUG in one month to see if VUR resolved", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Monthly VCUG is inappropriate**. Rationale: (1) VUR resolution takes months to years, not weeks, (2) VCUG involves radiation exposure and catheterization - should be done sparingly, (3) Typical repeat VCUG timing is every 12-24 months if monitoring for resolution, (4) One month is far too soon to expect any change. The interval should balance desire to document resolution against procedural burden.", "consequence": "Monthly VCUG provides excessive radiation without clinical benefit.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Low-grade VUR (I-II)** has ~80% spontaneous resolution rate. Management options include observation with prompt UTI treatment OR antibiotic prophylaxis - both are acceptable. The RIVUR trial showed prophylaxis reduces UTI recurrence but NOT renal scarring."}, "node-2": {"id": "node-2", "type": "decision", "content": "You choose observation with education about prompt UTI recognition. The parents ask: \"What symptoms should we watch for, and when should we repeat testing?\"\n\n**UTI Symptoms in Young Children (often non-specific):**\n- Fever without obvious source\n- Irritability, poor feeding\n- Vomiting\n- Foul-smelling urine\n- New urinary incontinence (in toilet-trained child)\n- Abdominal or flank pain\n\n**Monitoring Protocol for VUR:**\n- **Clinical surveillance**: Watch for UTI symptoms; obtain urinalysis/culture with any fever\n- **Repeat imaging**: Options vary by practice\n  - Renal ultrasound: periodically to monitor kidney growth\n  - VCUG: may repeat every 12-24 months to assess for resolution (controversial - some avoid repeat VCUG due to radiation/invasiveness)\n  - DMSA scan: if new febrile UTI to assess for scarring\n\n**Factors Affecting Management Intensity:**\n- Age (younger = higher risk of scarring)\n- Sex (females have higher recurrence rates)\n- VUR grade (higher grade = lower resolution rate)\n- Bladder/bowel dysfunction (increases UTI risk)", "question": "What is the most appropriate monitoring plan for this 2-year-old with Grade II VUR managed with observation?", "choices": [{"id": "node-2-choice-a", "text": "Obtain urinalysis and culture with any fever; consider repeat VCUG in 12-18 months to assess for resolution; annual renal ultrasound to monitor kidney growth", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **balanced monitoring approach**. Key components: (1) **Urinalysis/culture with ANY fever** - critical for early UTI detection and treatment, (2) **Repeat VCUG in 12-18 months** - allows time for potential resolution while monitoring VUR status (some centers use radionuclide cystography for follow-up to reduce radiation), (3) **Annual renal ultrasound** - monitors kidney size and growth (scarred kidneys may show reduced growth). This plan balances vigilance against procedural burden.", "consequence": "You establish an appropriate monitoring protocol.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "No monitoring needed - schedule regular well-child visits only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Active monitoring is required** for children with VUR. Without a specific plan: (1) UTIs may be missed or diagnosed late, increasing scarring risk, (2) VUR resolution won't be documented, (3) New scarring won't be detected. VUR requires more than routine well-child care - it needs targeted surveillance. Parents must understand what symptoms to watch for.", "consequence": "Lack of monitoring plan increases risk of missed UTIs and delayed treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "VCUG and DMSA scan every 3 months until VUR resolves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Quarterly imaging is excessive**. This approach: (1) Exposes the child to unnecessary radiation, (2) Requires repeated catheterization (VCUG), (3) Is not supported by evidence - VUR resolution takes months to years, (4) Creates unnecessary anxiety and healthcare burden. Standard practice is repeat VCUG every 12-24 months, and DMSA only if new febrile UTI suggests possible scarring.", "consequence": "Excessive imaging provides radiation without clinical benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Only obtain urine culture if the child has dysuria - fever alone doesn't require testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ANY unexplained fever in a child with VUR warrants urine testing**. Key point: Young children with pyelonephritis often present with fever ONLY - no dysuria or localized symptoms. Waiting for dysuria in a toddler: (1) Misses most febrile UTIs, (2) Delays treatment and increases scarring risk, (3) Is not appropriate for a child with known VUR. Fever is a sensitive (not specific) marker for UTI in this population.", "consequence": "Waiting for dysuria misses UTIs presenting as fever alone.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start antibiotic prophylaxis now since observation requires too much vigilance", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. **Antibiotic prophylaxis IS a valid option** for low-grade VUR, and some families prefer this approach. However: (1) Prophylaxis was just explained as optional, (2) The question asks about monitoring for observation - if you switch to prophylaxis, monitoring is still needed, (3) Prophylaxis doesn't eliminate need for UTI surveillance (breakthrough infections occur), (4) The choice between observation and prophylaxis should be made jointly with family. Prophylaxis is acceptable, but not required.", "consequence": "Prophylaxis is valid but the question focused on observation monitoring.", "nextNodeId": "node-3"}], "clinicalPearl": "**ANY fever in a child with VUR warrants urinalysis and culture**. Young children with pyelonephritis often present with fever alone - no dysuria or localizing symptoms. Early UTI detection and treatment is critical for preventing renal scarring."}, "node-3": {"id": "node-3", "type": "decision", "content": "At her 4-year follow-up visit (now age 6), the child has had NO febrile UTIs on observation alone. She is toilet-trained with no daytime accidents.\n\nRepeat VCUG shows: **VUR has resolved** (no reflux visualized)\nRenal ultrasound: Both kidneys normal size and appearance\n\n**VUR Resolution:**\n- Occurs due to bladder maturation and lengthening of intramural ureter\n- Higher resolution rates: lower grades, younger age, unilateral VUR\n- Resolution doesn't guarantee no future UTIs - just no reflux mechanism\n- Once resolved, routine VCUG follow-up is no longer needed\n\n**Considerations After VUR Resolution:**\n- If no scarring occurred \u2192 excellent prognosis, minimal follow-up\n- If scarring present \u2192 lifelong monitoring for hypertension, proteinuria, CKD\n- Toilet training and treating constipation/dysfunctional voiding helps maintain low UTI risk\n- Future pregnancies: women with VUR history have increased UTI risk during pregnancy", "question": "Given that VUR has resolved and there is no evidence of renal scarring, what follow-up do you recommend?", "choices": [{"id": "node-3-choice-a", "text": "Discharge from intensive monitoring - routine well-child care with attention to UTI symptoms; no further routine imaging needed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Resolved VUR with no scarring has excellent prognosis**. Appropriate follow-up: (1) **No further routine VCUG** - VUR has resolved, (2) **No scheduled renal ultrasounds** - kidneys are normal, (3) **Return to routine well-child care** - with awareness that UTI symptoms warrant evaluation, (4) **Parent education**: UTIs can still occur (no longer reflux-related), healthy voiding habits matter, (5) **Future consideration**: if female, mention increased UTI risk during pregnancy (prenatal providers should be aware of VUR history). This child has the best possible outcome - resolved VUR without scarring.", "consequence": "You appropriately de-escalate care for resolved VUR without scarring.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Continue annual VCUG indefinitely to ensure VUR doesn't recur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **VUR that resolves does NOT typically recur**. Once the intramural ureter has matured, the valve mechanism is competent. Continuing annual VCUG: (1) Is unnecessary - there's no indication for ongoing testing, (2) Subjects the child to unnecessary radiation and catheterization, (3) Is not supported by evidence. Primary VUR that resolves spontaneously is considered \"cured.\" Annual VCUGs are not indicated.", "consequence": "Unnecessary ongoing VCUG provides no clinical benefit.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Start antibiotic prophylaxis now to prevent UTI recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylaxis is NOT indicated after VUR resolution**. The rationale for prophylaxis was to prevent infected urine from reaching the kidneys via reflux. Without VUR: (1) There's no reflux mechanism - regular UTIs don't cause pyelonephritis as easily, (2) Prophylaxis provides no benefit over observation in normal children, (3) Antibiotic resistance and side effects become the only outcomes. Prophylaxis is not indicated for children without VUR.", "consequence": "Prophylaxis provides no benefit after VUR resolution.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Schedule surgical consultation to prevent future problems", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is contraindicated when VUR has resolved**. There is nothing to fix - the reflux is gone. Surgical consultation: (1) Is unnecessary, (2) Would cause family anxiety, (3) Has no indication. This child has the ideal outcome - spontaneous resolution without intervention. Surgery was never needed.", "consequence": "Surgical consultation is inappropriate when VUR has resolved.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Refer to nephrology for lifelong CKD monitoring due to VUR history", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Nephrology referral is NOT needed for resolved VUR without scarring**. CKD monitoring is required when there IS renal scarring (reflux nephropathy). This child has: (1) Normal kidney ultrasound, (2) No scarring, (3) Normal renal function (presumably). Without scarring, there is no CKD to monitor. Nephrology follow-up would be indicated if she had developed reflux nephropathy with hypertension, proteinuria, or elevated creatinine.", "consequence": "Nephrology referral is unnecessary without renal scarring.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Resolved VUR without renal scarring = excellent prognosis**. No further routine imaging or prophylaxis is needed. The child returns to routine well-child care. Nephrology follow-up is only indicated if scarring (reflux nephropathy) developed."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed this child with low-grade VUR through spontaneous resolution.\n\n**Key teaching points:**\n\n**VUR Natural History:**\n- Low-grade (I-II): ~80% spontaneous resolution\n- Moderate (III): ~50% resolution\n- High-grade (IV-V): ~30% resolution\n- Resolution typically by age 5-8 years\n\n**Management Options:**\n- **Observation with prompt UTI treatment**: Valid for low-grade VUR\n- **Antibiotic prophylaxis**: Reduces UTI recurrence but NOT scarring (RIVUR trial)\n- **Surgery**: Reserved for high-grade VUR, breakthrough UTIs, or family preference\n\n**Monitoring Protocol:**\n- UA/culture with ANY fever (young children present with fever alone)\n- Consider repeat VCUG every 12-24 months to document resolution\n- Annual renal ultrasound to monitor kidney growth\n- DMSA scan if new febrile UTI (assess for scarring)\n\n**After Resolution:**\n- No further routine imaging needed\n- No prophylaxis needed\n- Return to routine well-child care\n- Nephrology follow-up ONLY if scarring developed\n\n**Best outcome**: Spontaneous resolution without renal scarring - this child achieved that."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review VUR monitoring principles:\n\n**Low-grade VUR (I-II):**\n- ~80% spontaneous resolution\n- Observation OR prophylaxis are both acceptable\n- Surgery NOT indicated initially\n\n**Monitoring:**\n- ANY fever \u2192 UA and culture\n- Repeat VCUG every 12-24 months (not monthly)\n- Annual ultrasound for kidney growth\n- DMSA only if new febrile UTI\n\n**After resolution:**\n- No further routine VCUG\n- No prophylaxis needed\n- Nephrology only if scarring present"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Review key VUR management principles:\n\n**NOT indicated for low-grade VUR:**\n- Immediate surgery (high resolution rate without intervention)\n- Lifelong antibiotic prophylaxis\n- Monthly/quarterly imaging\n\n**Required for VUR monitoring:**\n- UA/culture with ANY fever (not just dysuria)\n- Parent education about UTI symptoms\n- Follow-up plan for VUR reassessment\n\n**After VUR resolution without scarring:**\n- No further VCUG needed (doesn't recur)\n- No prophylaxis needed (no reflux)\n- No surgery consultation (nothing to fix)\n- No nephrology if no scarring (no CKD)\n- Return to routine well-child care"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-121", "title": "Atopic Dermatitis Management", "domain": "renal", "difficulty": "intermediate", "tags": ["itch that rashes", "flexural distribution", "atopic triad", "emollients first-line", "topical corticosteroids", "soak and seal", "atopic march", "atopic dermatitis management"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 6-month-old boy is brought to clinic by his mother for evaluation of a persistent rash that has been present for 3 months.\n\nHistory of Present Illness:\n- Rash first appeared on his cheeks and forehead around age 3 months\n- Now involves the scalp and extensor surfaces of arms and legs\n- The rash is intensely pruritic - the baby scratches constantly, especially at night\n- Sleep is significantly disrupted for both baby and parents\n- Symptoms worsen after baths (especially with soap), when overheated, and in dry weather\n- No fever, vomiting, or diarrhea\n\nFamily History:\n- Mother has **asthma** (uses inhaler daily)\n- Father has **seasonal allergic rhinitis** (hay fever)\n- Older sister (age 4) has **food allergies** (peanut, tree nuts)\n\nPhysical Examination:\n- General: Well-nourished, fussy infant who repeatedly scratches his face\n- Skin:\n  - **Cheeks**: Erythematous, scaly, weeping patches with areas of crusting\n  - **Scalp**: Dry, scaly patches with some yellow crusting\n  - **Extensor arms/legs**: Erythematous papules with excoriations\n  - **Diaper area**: Spared\n- HEENT: Mild conjunctival injection bilaterally, clear nasal discharge\n- No lymphadenopathy, lungs clear", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-month-old presents with a classic picture of infantile eczema:\n\n- **Chronic, relapsing, pruritic rash** beginning in early infancy\n- **Distribution**: Face (cheeks), scalp, extensor surfaces (infant pattern)\n- **'The itch that rashes'** - pruritus is the primary symptom, scratching causes the rash\n- **Family history of atopy** (asthma, allergic rhinitis, food allergies)\n- **Diaper area sparing** (moisture protects this area)\n- **Triggers**: Irritants (soap), heat, dry weather\n\nThe **atopic triad** = eczema + asthma + allergic rhinitis (often progressing in this order - the 'atopic march').", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Atopic dermatitis (eczema)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Atopic dermatitis (AD)** is a chronic, relapsing, inflammatory skin condition characterized by **intense pruritus** and typical distribution patterns that vary by age. This infant demonstrates classic features:\n\n**Key diagnostic features:**\n- **'The itch that rashes'** - pruritus is the hallmark\n- **Age-appropriate distribution**: Infants = face, scalp, extensor surfaces; Children = flexural surfaces\n- **Chronic/relapsing course**\n- **Personal/family history of atopy** (eczema, asthma, allergic rhinitis)\n- **Diaper area sparing** (moisture-protected)\n\n**Epidemiology:**\n- Affects **10-20% of children**\n- **60%** develop by age 1, **90%** by age 5\n- Majority improve by adolescence", "consequence": "You recognize classic atopic dermatitis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Seborrheic dermatitis (cradle cap)", "isOptimal": false, "isAcceptable": true, "feedback": "Seborrheic dermatitis is in the differential, and this patient does have some scalp involvement with yellow crusting. However, key differences favor atopic dermatitis: (1) **Intense pruritus** - seborrheic dermatitis is typically **not itchy**, (2) **Distribution** - seborrheic dermatitis favors scalp, eyebrows, nasolabial folds, not extensors, (3) **Family history of atopy** - strongly supports AD, (4) **Age** - seborrheic dermatitis usually appears in first weeks of life and resolves by 3-4 months. This 6-month-old with itchy rash and atopic family history has AD.", "consequence": "Seborrheic dermatitis is possible but less likely given the intense pruritus.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Scabies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Scabies** is caused by the mite *Sarcoptes scabiei* and can cause intense pruritus, but key differences: (1) Scabies favors **interdigital web spaces, wrists, axillae, genitals** - not typically cheeks/extensors in infants, (2) Scabies causes **burrows** (linear, serpiginous tracks), (3) In infants, scabies often affects **palms, soles, and head** (different from AD), (4) Family history of **atopy** (not scabies exposure) is the clue here. Look for **other affected family members** to suspect scabies.", "consequence": "Scabies has different distribution and doesn't explain the atopic family history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Contact dermatitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Contact dermatitis** (allergic or irritant) occurs at sites of **direct contact** with the offending substance. Key differences: (1) Contact dermatitis has a **geographic distribution** matching the contactant (e.g., nickel from jewelry, poison ivy), (2) It is **not typically bilateral and symmetric** on cheeks/extensors in an infant, (3) The **family history of atopy** supports AD, not contact dermatitis. While irritants can trigger AD flares, the primary diagnosis here is atopic dermatitis.", "consequence": "Contact dermatitis doesn't explain the symmetric distribution or atopic family history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Psoriasis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Psoriasis** can occur in infants but is rare. Key differences: (1) Psoriasis causes **well-demarcated, thick, silvery-white scales** on erythematous plaques, (2) Psoriasis is typically **less pruritic** than AD, (3) Infantile psoriasis often presents in the **diaper area** (psoriatic diaper rash), which is spared in this patient, (4) Psoriasis is associated with **nail pitting** and family history of psoriasis, not atopy. This presentation is classic for AD.", "consequence": "Psoriasis has different morphology and distribution.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Age-specific distribution of atopic dermatitis**: Infants = face (cheeks), scalp, extensors; Children/adolescents = **flexural** surfaces (antecubital/popliteal fossae, neck, wrists). The distribution 'flexes' as the child grows!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose atopic dermatitis. The mother is frustrated and exhausted from sleepless nights and asks what she should do.\n\n**Pathophysiology review:**\n- **Skin barrier dysfunction** (often due to **filaggrin gene mutations**) allows allergen penetration\n- **Th2-predominant inflammation** leads to pruritus and eczematous changes\n- Scratching causes further barrier damage \u2192 **itch-scratch cycle**\n- Triggers include irritants, allergens, infection, stress, and environmental factors", "question": "What is the FIRST-LINE treatment for atopic dermatitis?", "choices": [{"id": "node-2-choice-a", "text": "Liberal and frequent application of emollients (moisturizers)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Emollients (moisturizers) are the cornerstone of AD treatment** - they should be used **liberally and frequently**, not just during flares.\n\n**Why emollients work:**\n- **Restore the skin barrier** (replace deficient lipids)\n- **Reduce water loss** from the skin\n- **Decrease need for topical steroids**\n- **Prevent flares** when used consistently\n\n**Application guidelines:**\n- Apply **within 3 minutes of bathing** ('soak and seal')\n- Use **thick, fragrance-free ointments or creams** (ointments > creams > lotions)\n- Apply **at least twice daily**, more often if needed\n- Use **250-500g per week** for full-body coverage in a child\n\n**'Moisturize, moisturize, moisturize'** is the mantra of eczema management!", "consequence": "You initiate first-line therapy correctly.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "High-potency topical corticosteroids applied to all affected areas", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **topical corticosteroids (TCS) are effective for flares**, they are **not first-line for maintenance**. More importantly, **high-potency TCS should NEVER be used on the face** (causes skin atrophy, telangiectasia, perioral dermatitis). For facial eczema in infants, use **low-potency TCS** (hydrocortisone 1%) or **non-steroidal alternatives** (tacrolimus, pimecrolimus). The foundation of treatment is always **emollients** - steroids are added for flares.", "consequence": "High-potency steroids are inappropriate for the face and shouldn't be first-line.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Oral antihistamines (diphenhydramine) around the clock", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oral antihistamines have limited efficacy in AD** because the pruritus is not primarily histamine-mediated. First-generation antihistamines (diphenhydramine) may help with sleep due to **sedation**, but they don't significantly reduce eczema-related itch. Non-sedating antihistamines (cetirizine, loratadine) have **no proven benefit** for AD pruritus. The primary treatment is **emollients + topical anti-inflammatories**, not oral antihistamines.", "consequence": "Antihistamines don't significantly reduce eczema itch.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Systemic oral corticosteroids (prednisone)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Systemic steroids should be avoided** in atopic dermatitis due to: (1) **Rebound flaring** - eczema often worsens when steroids are discontinued, (2) **Side effects** - growth suppression, adrenal suppression, immunosuppression, (3) **AD is a chronic condition** - steroids are not sustainable long-term. Systemic steroids are reserved only for **severe, refractory cases** and even then are used cautiously. Start with emollients and topical therapies.", "consequence": "Systemic steroids cause rebound flares and are not first-line.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Strict elimination diet removing all potential allergens", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine elimination diets are NOT recommended** for AD. While some children with AD have food allergies, these should be evaluated with **specific testing** (IgE, skin prick testing) before eliminating foods. Unnecessary dietary restrictions can lead to: (1) **Nutritional deficiencies**, (2) **Feeding difficulties**, (3) **Increased food allergy risk** (early introduction may prevent allergies). Food allergy evaluation should only be done if there is **clear temporal relationship** between food and flares or if AD is **severe and refractory** to treatment.", "consequence": "Elimination diets without testing can be harmful.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**'Soak and seal'**: Bathe in lukewarm water for 10-15 minutes, pat dry gently, then immediately apply thick emollient within 3 minutes to 'seal in' moisture. This is more effective than applying emollient to dry skin."}, "node-3": {"id": "node-3", "type": "decision", "content": "You recommend liberal emollient use with the 'soak and seal' technique and advise avoiding triggers (harsh soaps, fragrances, overheating).\n\nTwo weeks later, the mother returns. The skin is improved in some areas but there are still **active, inflamed patches** on the cheeks and arms with new areas of weeping and crusting.\n\n**Current status:**\n- Using emollients faithfully twice daily\n- Still significant redness and oozing on cheeks\n- Baby still scratching, especially at night\n- Some excoriated areas look slightly pustular", "question": "What is the MOST appropriate next step for the active, inflamed areas?", "choices": [{"id": "node-3-choice-a", "text": "Low-potency topical corticosteroid (hydrocortisone 1%) for the face, medium-potency for the body", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Topical corticosteroids (TCS) are the first-line anti-inflammatory treatment for AD flares**.\n\n**Potency selection by location:**\n- **Face, eyelids, intertriginous areas**: Low-potency (hydrocortisone 1-2.5%)\n- **Body, extremities**: Medium-potency (triamcinolone 0.1%)\n- **Thick skin (palms, soles)**: May need high-potency\n\n**Usage guidelines:**\n- Apply **thin layer once or twice daily** to inflamed areas\n- Continue **emollients** on all areas, including over steroids\n- Use for **1-2 weeks** to control flare, then taper\n- **'Proactive therapy'**: Twice-weekly TCS to previously affected areas can prevent flares\n\n**Side effects of inappropriate use:**\n- Skin atrophy, striae, telangiectasia\n- Perioral dermatitis (face)\n- Hypothalamic-pituitary-adrenal axis suppression (rare with topical)", "consequence": "You add appropriate topical steroids for the flare.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Increase emollient frequency to 4 times daily without adding other treatments", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While more frequent emollient use is helpful, **active inflamed eczema requires anti-inflammatory treatment** in addition to moisturizers. Emollients alone cannot control significant flares - they are for maintenance and prevention. This infant has **active, weeping patches** that need topical corticosteroids or calcineurin inhibitors. Continuing emollients alone will prolong the baby's discomfort and the itch-scratch cycle.", "consequence": "Active flares need anti-inflammatory treatment, not just emollients.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Topical calcineurin inhibitor (tacrolimus) for all areas including the face", "isOptimal": false, "isAcceptable": true, "feedback": "Topical calcineurin inhibitors (TCIs) like tacrolimus and pimecrolimus are effective for AD and are **steroid-sparing** options, especially useful for the face and intertriginous areas. However, tacrolimus is only FDA-approved for **children \u22652 years old** (pimecrolimus for \u22652 years as well). For this 6-month-old, **low-potency topical corticosteroids** are more appropriate for facial eczema. TCIs can be used off-label in severe cases under specialist supervision, but are not first-line in infants.", "consequence": "TCIs are not first-line in infants <2 years old.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Oral antibiotics (cephalexin) for 10 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as the primary treatment. While the mention of **pustular areas** raises concern for **secondary bacterial infection** (usually *S. aureus*), the primary treatment for this flare is still **topical corticosteroids**. Antibiotics should be added if there are clear signs of infection: honey-crusted lesions (impetigo), pustules, increased pain, fever, or spreading cellulitis. Mild impetiginization can sometimes be managed with **dilute bleach baths** rather than oral antibiotics.", "consequence": "Antibiotics are only needed if clearly infected, not for all flares.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Wet wrap therapy with high-potency steroids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Wet wrap therapy** involves applying moisturizer or dilute topical steroid under wet bandages, and it can be very effective for severe, refractory eczema. However, it should be done with **low-to-medium potency steroids**, NOT high-potency, due to increased absorption through occluded, inflamed skin. Additionally, wet wraps are typically reserved for **severe, hospitalized cases** or done under close supervision, not as initial outpatient management for a moderate flare.", "consequence": "Wet wraps with high-potency steroids risk significant steroid absorption.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**TCS potency by location**: 'Face gets the weak stuff, body gets the medium stuff.' Never use high-potency steroids on the face - this causes irreversible skin atrophy and telangiectasia."}, "node-4": {"id": "node-4", "type": "decision", "content": "You prescribe hydrocortisone 1% ointment for the face (twice daily) and triamcinolone 0.1% ointment for the body (twice daily), to be used for 1-2 weeks during flares, with continued liberal emollient use.\n\nThe mother asks about the prognosis and what to expect long-term. She's also worried about her son developing asthma like she has.\n\n**Atopic march:**\nEczema \u2192 Food allergies \u2192 Asthma \u2192 Allergic rhinitis\n(This progression occurs in ~50% of children with moderate-severe AD)", "question": "What should you counsel the family about the LONG-TERM prognosis of atopic dermatitis?", "choices": [{"id": "node-4-choice-a", "text": "Most children improve significantly by adolescence, but there is increased risk of developing other atopic conditions", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prognosis of atopic dermatitis:**\n\n**Good news:**\n- **Majority of children improve significantly** by adolescence\n- ~60% of infantile eczema resolves by age 6\n- ~90% experience significant improvement by adulthood\n- Earlier onset and milder disease = better prognosis\n\n**Concerning aspects:**\n- **Atopic march**: ~50% of children with moderate-severe AD develop asthma and/or allergic rhinitis\n- Severe, widespread, or persistent AD has higher atopic march risk\n- **Filaggrin mutations** increase risk of persistent AD and asthma development\n\n**Counseling points:**\n- Continue skin barrier protection even when clear (prevents flares)\n- Watch for signs of asthma (wheezing, cough, exercise intolerance)\n- Early introduction of allergenic foods may reduce food allergy risk\n- AD is chronic but **controllable** with consistent skin care", "consequence": "You provide appropriate prognostic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Atopic dermatitis is a lifelong condition that never improves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **unnecessarily pessimistic**! While some individuals have persistent AD into adulthood, the **majority of children improve significantly** by adolescence. Telling parents their child will never get better is inaccurate and can lead to hopelessness and poor adherence to treatment. Emphasize that with proper skin care, most children achieve good control and many will outgrow their eczema.", "consequence": "This is inaccurate - most children improve significantly.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Atopic dermatitis will definitely progress to asthma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While there is an **increased risk** of asthma in children with AD (the 'atopic march'), it is **not inevitable**. Approximately **50% of children with moderate-severe AD** develop asthma, meaning **50% do not**. Children with mild eczema have lower risk. It would be inaccurate to tell parents their child will definitely develop asthma - instead, counsel about the **increased risk** and signs to watch for.", "consequence": "Asthma is more likely but not guaranteed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "There is no connection between atopic dermatitis and other allergic conditions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is a **well-established connection** between AD and other atopic conditions - the **atopic march**. Children with AD have increased risk of: (1) Food allergies (~30%), (2) Asthma (~50%), (3) Allergic rhinitis (~75%). This occurs because AD involves the same Th2-skewed immune response and often similar genetic predisposition (filaggrin mutations). The family history of maternal asthma and paternal allergic rhinitis reinforces this connection.", "consequence": "The atopic march is well-established.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "The child should be kept away from all other children to prevent spreading eczema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **harmful advice**! **Atopic dermatitis is NOT contagious**. It cannot be spread to other children through contact. AD is an inflammatory condition related to genetics and immune dysfunction, not an infection. Isolating a child with eczema is unnecessary, stigmatizing, and potentially harmful to their social development. Normal interactions with other children should be encouraged.", "consequence": "Eczema is not contagious - isolation is harmful and unnecessary.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**'The atopic march'**: Eczema \u2192 Food allergies \u2192 Asthma \u2192 Allergic rhinitis. This progression occurs in ~50% of children with moderate-severe AD. The good news: skin barrier restoration through aggressive moisturization may help interrupt this march."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **atopic dermatitis (eczema)**.\n\n**Key takeaways:**\n- **'The itch that rashes'** - pruritus is the hallmark\n- **Age-specific distribution**: Infants = face/extensors; Children = flexural surfaces\n- **Family history of atopy** (asthma, allergic rhinitis, food allergies) supports diagnosis\n- **Treatment hierarchy**:\n  1. **Emollients** - foundation of treatment, use liberally and frequently\n  2. **Topical corticosteroids** - for flares (low-potency for face, medium for body)\n  3. **Topical calcineurin inhibitors** - steroid-sparing, ages \u22652 years\n  4. **Systemic therapy** - reserved for severe, refractory cases\n- **'Soak and seal'** technique maximizes moisturizer effectiveness\n- **Prognosis**: Most improve by adolescence; watch for atopic march\n\n**Pearls:**\n- Emollients prevent flares when used consistently, not just during flares\n- Avoid high-potency steroids on the face\n- Antihistamines don't significantly help eczema itch"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **atopic dermatitis**:\n\n- **'The itch that rashes'** - pruritus is the defining symptom\n- **Distribution varies by age**: Infants = face, scalp, extensors; Older children = flexures\n- **Atopic triad**: Eczema + asthma + allergic rhinitis\n- **Treatment ladder**:\n  1. Emollients (ALWAYS - foundation of therapy)\n  2. Low-potency TCS for face, medium for body\n  3. TCIs for steroid-sparing (ages \u22652)\n- **Avoid**: High-potency steroids on face, systemic steroids, unnecessary elimination diets\n- **Prognosis**: Most improve; ~50% with moderate-severe AD develop asthma"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in atopic dermatitis management!\n\n**Never do:**\n- **Systemic steroids** for routine AD - causes rebound flares\n- **High-potency topical steroids on the face** - causes skin atrophy\n- **Isolate children with eczema** - it's NOT contagious!\n\n**Always do:**\n- Start with **emollients** as the foundation\n- Use **appropriate-potency steroids for the location**\n- Counsel families that **most children improve** with time\n- Monitor for the **atopic march** (asthma, allergies)\n\n**Remember:** 'Moisturize, moisturize, moisturize' - emollients are the cornerstone of eczema management and should be used liberally and frequently."}}, "rootNodeId": "node-1"}], "rheum_immunology": [{"id": "vignette-lens-peds-011", "title": "Anaphylaxis", "domain": "rheum_immunology", "difficulty": "intermediate", "tags": ["urticaria", "stridor", "wheezing", "hypotension after exposure", "anaphylaxis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents to the clinic with difficulty breathing and rash after eating peanuts of 20 minutes duration.\n\nPer the parents, he ate a cookie at a birthday party and within minutes developed hives all over his body. His lips swelled and he started wheezing and having trouble breathing.\n\nfacial swelling, wheezing, and nausea. No loss of consciousness.\n\nMedical history is notable for He has a known peanut allergy diagnosed at age 2. He carries an epinephrine auto-injector. Family history of atopy.\n\nPhysical Examination:\n- General: anxious child in respiratory distress with diffuse urticaria.\n- Vitals: HR 140, BP 80/50, RR 36, SpO2 91%\n- Respiratory: stridor, wheezing, accessory muscle use.\n- Skin: diffuse urticaria, angioedema of lips and periorbital area.\n- Cardiovascular: tachycardia, weak pulses, capillary refill 4 seconds.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This child has acute onset of respiratory distress, urticaria, and hypotension after allergen exposure. You need to rapidly assess and act.", "question": "What clinical criteria confirm the diagnosis of anaphylaxis?", "choices": [{"id": "node-1-choice-a", "text": "Acute onset of skin involvement (urticaria) PLUS respiratory compromise OR hypotension", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Anaphylaxis criteria** (any ONE of these): 1) Acute skin involvement + respiratory OR hypotension, 2) Two or more body systems affected after likely allergen exposure (skin, respiratory, cardiovascular, GI), 3) Hypotension after known allergen exposure. This child has skin (urticaria), respiratory (stridor, wheezing), AND cardiovascular (hypotension) involvement.", "consequence": "You confirm anaphylaxis and prepare for immediate treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Urticaria alone is sufficient for anaphylaxis diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Urticaria alone is NOT anaphylaxis** - it's an allergic reaction. Anaphylaxis requires involvement of **multiple organ systems** (skin + respiratory, skin + cardiovascular, etc.) or hypotension alone after known allergen exposure.", "consequence": "You may underestimate severity of isolated urticaria cases.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Positive skin prick test is required for diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Anaphylaxis is a clinical diagnosis** - you do NOT wait for any testing. Skin prick tests and allergen-specific IgE are done AFTER recovery to identify triggers, not during the acute episode.", "consequence": "You delay treatment waiting for testing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Elevated serum tryptase is required for diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Tryptase** can support the diagnosis (peaks 1-2 hours after onset) but is NOT required. Treatment should never be delayed for tryptase results. Tryptase is most useful when the diagnosis is uncertain or for medicolegal documentation.", "consequence": "You delay treatment for lab results.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Loss of consciousness is required for anaphylaxis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Loss of consciousness is NOT required** for anaphylaxis diagnosis - it indicates very severe anaphylaxis. This child is conscious but has multiple organ system involvement qualifying for anaphylaxis. Don't wait for unconsciousness!", "consequence": "You may miss anaphylaxis in alert patients.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Anaphylaxis can occur WITHOUT skin findings** in up to 20% of cases! Don't rule out anaphylaxis just because there's no urticaria. Cardiovascular (hypotension) or respiratory symptoms after allergen exposure can be anaphylaxis."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have confirmed anaphylaxis. The child is in respiratory distress with stridor and hypotension. His EpiPen was not used at the party.", "question": "What is the FIRST and MOST important treatment for anaphylaxis?", "choices": [{"id": "node-2-choice-a", "text": "Epinephrine IM in the anterolateral thigh (0.01 mg/kg, max 0.5 mg)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Epinephrine IM** is the FIRST and MOST critical treatment. Give **0.01 mg/kg** (max 0.5 mg adults, 0.3 mg children <30 kg) in the **anterolateral thigh** (vastus lateralis) - best absorption site. Do NOT delay for IV access. Epinephrine reverses bronchospasm, vasoconstriction, and reduces mediator release.", "consequence": "You administer IM epinephrine immediately.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Diphenhydramine (Benadryl) IV/IM for urticaria", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Antihistamines are NOT first-line** for anaphylaxis - they do NOT reverse bronchospasm or hypotension. They only help with urticaria/pruritus and are adjunctive therapy AFTER epinephrine. Delaying epinephrine for antihistamines can be fatal.", "consequence": "You delay life-saving epinephrine.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Methylprednisolone IV for inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Steroids are NOT first-line** and take hours to work. They may help prevent biphasic reactions but do NOTHING for acute symptoms. Give steroids AFTER epinephrine and stabilization, never instead of it.", "consequence": "You delay life-saving epinephrine.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Albuterol nebulizer for wheezing", "isOptimal": false, "isAcceptable": true, "feedback": "Albuterol is helpful for **bronchospasm** but is adjunctive, NOT first-line. **Epinephrine** is the first treatment - it also bronchodilates AND addresses the hypotension that albuterol cannot. Give albuterol after epinephrine if wheezing persists.", "consequence": "You consider albuterol but epinephrine comes first.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "IV normal saline bolus for hypotension first", "isOptimal": false, "isAcceptable": true, "feedback": "Fluids are important for anaphylactic shock but **epinephrine comes first**. Epinephrine causes vasoconstriction that helps restore blood pressure. Fluids support this but don't reverse the underlying vasodilation. Give epinephrine, THEN bolus fluids.", "consequence": "You start fluids but epinephrine is most critical.", "nextNodeId": "node-3"}], "clinicalPearl": "**There are NO contraindications to epinephrine in anaphylaxis** - not pregnancy, not heart disease, not age. The only contraindication to epinephrine in anaphylaxis is a **dead patient**. Give it IM in the thigh, NOT subcutaneous or deltoid!"}, "node-3": {"id": "node-3", "type": "decision", "content": "You administered IM epinephrine (0.15 mg via EpiPen Jr). After 5 minutes, the stridor has improved slightly but the patient remains hypotensive (BP 75/45) with ongoing urticaria and wheezing.", "question": "What is the most appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Repeat IM epinephrine (can give every 5-15 minutes)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Epinephrine can be repeated every 5-15 minutes** if symptoms persist or recur. Up to **30%** of patients require more than one dose. Continue repeat dosing while establishing IV access and starting adjunctive therapies (fluids, antihistamines, steroids).", "consequence": "You give a second dose of epinephrine.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Wait 30 minutes to see if first dose works", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Do not wait** - epinephrine's effects are rapid but short-lived (duration ~5-15 minutes). If symptoms persist after 5 minutes, give another dose. Waiting allows continued deterioration.", "consequence": "Patient deteriorates while waiting.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Switch to IV epinephrine drip", "isOptimal": false, "isAcceptable": true, "feedback": "**IV epinephrine** (infusion) is reserved for **refractory anaphylaxis** not responding to repeated IM doses, or for patients in cardiac arrest. It requires close monitoring due to arrhythmia risk. Try additional IM doses first before IV infusion.", "consequence": "You consider IV epinephrine for refractory cases.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Give high-dose diphenhydramine instead", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Antihistamines cannot substitute for epinephrine**. No amount of diphenhydramine will reverse hypotension or bronchospasm. Continue epinephrine; add antihistamines as adjunct.", "consequence": "You rely on ineffective therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Glucagon for beta-blocker patients", "isOptimal": false, "isAcceptable": false, "feedback": "**Glucagon** is specifically for patients on **beta-blockers** who may not respond to epinephrine. This child is not on beta-blockers, so glucagon is not indicated. First-line remains epinephrine.", "consequence": "You consider glucagon for wrong indication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Most deaths from anaphylaxis are due to delayed or withheld epinephrine.** Give it early, give it IM in the thigh, and repeat it if needed. Epinephrine autoinjectors (EpiPen) deliver fixed doses - may need repeat dosing."}, "node-4": {"id": "node-4", "type": "decision", "content": "After the second epinephrine dose, the patient improves significantly. BP is 95/60, stridor has resolved, wheezing is mild. You've given diphenhydramine, methylprednisolone, and IV fluids.", "question": "What is the minimum observation period after anaphylaxis treatment?", "choices": [{"id": "node-4-choice-a", "text": "4-6 hours minimum, longer (24 hours) for severe or biphasic risk", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Patients must be observed for **at least 4-6 hours** after symptom resolution because of **biphasic anaphylaxis** - a recurrence of symptoms without re-exposure occurring in **5-20%** of patients. Higher-risk patients (severe initial presentation, required multiple epinephrine doses, history of biphasic reaction) should be observed longer or admitted.", "consequence": "You plan appropriate observation.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "1 hour is sufficient if symptoms resolve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! One hour is insufficient. **Biphasic reactions** typically occur **4-12 hours** after initial reaction (but can occur up to 72 hours later). Discharging too early risks life-threatening recurrence at home.", "consequence": "Patient has biphasic reaction at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "No observation needed if epinephrine was effective", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Even with excellent response to epinephrine, **biphasic reactions can occur**. Observation is required regardless of initial response quality. The epinephrine treats the first phase; you're watching for the second.", "consequence": "Patient has biphasic reaction at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Discharge immediately with EpiPen prescription", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While an **EpiPen prescription is essential** for discharge, immediate discharge is dangerous. The patient needs observation for biphasic reaction first. EpiPen is for future emergencies, not to replace current observation.", "consequence": "Patient may have biphasic reaction unsupervised.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Only observe if steroids were not given", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Steroids do NOT prevent biphasic reactions** - this is a common misconception. We give steroids hoping they help, but they haven't been proven to prevent biphasic reactions. Observation is still required.", "consequence": "False security from steroids.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Biphasic anaphylaxis**: Recurrence of symptoms 4-12 hours after initial reaction without re-exposure. Occurs in **5-20%** of patients. Risk factors: severe initial reaction, required multiple epinephrine doses, delayed epinephrine administration."}, "node-5": {"id": "node-5", "type": "decision", "content": "After 6 hours of observation, the patient is stable and ready for discharge. You need to provide comprehensive discharge planning.", "question": "What is the MOST critical component of discharge planning?", "choices": [{"id": "node-5-choice-a", "text": "Prescribe epinephrine autoinjector with training, allergist referral, and action plan", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Every anaphylaxis patient needs: 1) **Epinephrine autoinjector prescription** (2 devices recommended), 2) **Training** on when and how to use it, 3) **Allergist/immunologist referral** for trigger identification and possible desensitization, 4) **Written anaphylaxis action plan** for school/caregivers, 5) **Medical alert identification**.", "consequence": "Complete discharge planning ensures patient safety.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Antihistamine prescription only with advice to avoid allergen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Antihistamines do NOT treat anaphylaxis** - they only help with hives. The patient MUST have an **epinephrine autoinjector** for future reactions. Allergen avoidance is important but accidental exposures happen.", "consequence": "Patient is unprotected for future anaphylaxis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Oral prednisone taper is sufficient protection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Steroids cannot prevent or treat anaphylaxis**. They may be given as adjunctive therapy but provide no protection against future reactions. Epinephrine is the only life-saving treatment.", "consequence": "Patient has false sense of security.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Allergy testing before prescribing epinephrine", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Do not wait for allergy testing** to prescribe epinephrine. The patient had clear anaphylaxis - they need an EpiPen NOW. Allergy testing is done as an outpatient for trigger confirmation and possible immunotherapy.", "consequence": "Patient is unprotected during testing period.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Follow-up with primary care only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While PCP follow-up is important, **allergist/immunologist referral** is essential for: identifying specific triggers (skin/blood testing), considering immunotherapy (desensitization), comprehensive allergy education, and ongoing management.", "consequence": "Patient misses specialist evaluation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Discharge essentials**: 1) Prescribe **2 EpiPens** (reactions can require multiple doses), 2) Train patient/family on proper use, 3) **Allergist referral**, 4) Written action plan, 5) Medical alert jewelry, 6) School/daycare notification, 7) Food allergy education."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of anaphylaxis! You correctly identified the diagnosis by clinical criteria, gave IM epinephrine immediately as first-line treatment, repeated the dose appropriately, observed for biphasic reaction, and provided comprehensive discharge planning with epinephrine autoinjector prescription and allergist referral. The patient had no biphasic reaction and was discharged safely with appropriate follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key anaphylaxis pearls: **Epinephrine IM** is ALWAYS first-line - no contraindications in anaphylaxis. Give in **anterolateral thigh** (best absorption). Can repeat every **5-15 minutes**. Observe minimum **4-6 hours** for biphasic reactions. Discharge with **EpiPen prescription**, training, and **allergist referral**."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. **Anaphylaxis deaths are usually from delayed or withheld epinephrine.** Antihistamines and steroids are NOT substitutes for epinephrine. Never delay epinephrine for testing, IV access, or other treatments. Never discharge without observation (biphasic risk) or epinephrine prescription."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-035", "title": "Henoch-Schonlein Purpura", "domain": "rheum_immunology", "difficulty": "advanced", "tags": ["henoch-schonlein purpura", "HSP", "IgA vasculitis", "palpable purpura", "normal platelets", "abdominal pain", "arthritis", "nephritis", "renal monitoring", "NSAIDs"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 6-year-old male presents to the clinic with a rash on his legs and abdominal pain of 4 days duration.\n\nPer the parents, he developed a purple, bruise-like rash on his legs and buttocks 4 days ago. Over the past 2 days, he has complained of crampy belly pain and his knees and ankles are swollen.\n\njoint swelling and blood in urine noticed yesterday. No fever, weight loss, or easy bruising elsewhere.\n\nPertinent history includes He had a cold about 2 weeks ago. No history of bleeding disorders.\n\nPhysical Examination:\n- Skin: palpable purpuric lesions on buttocks and lower extremities.\n- Joints: bilateral ankle and knee swelling.\n- Abdomen: diffuse tenderness without peritoneal signs.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-year-old presents with the classic tetrad of HSP (IgA vasculitis): palpable purpura on dependent areas (buttocks, legs), arthritis (ankles, knees), abdominal pain, and recent URI. The rash is palpable and concentrated in dependent/pressure areas - a key distinguishing feature.", "question": "What is the MOST IMPORTANT initial laboratory finding to distinguish HSP from other causes of purpura?", "choices": [{"id": "node-1-choice-a", "text": "Normal platelet count", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Normal platelet count** is the key distinguishing feature. HSP causes purpura through **IgA-mediated vasculitis**, NOT platelet consumption. In contrast, **ITP** (immune thrombocytopenic purpura) presents with low platelets. Meningococcemia also has normal-to-low platelets but presents with fever and rapid deterioration. The presence of **palpable purpura with NORMAL platelets** strongly suggests HSP.", "consequence": "You correctly identify the critical lab finding for diagnosis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Elevated ESR/CRP", "isOptimal": false, "isAcceptable": true, "feedback": "Inflammatory markers may be elevated in HSP but are **non-specific**. They can be elevated in many conditions including infections, other vasculitides, and malignancies. The **platelet count** is more helpful in distinguishing HSP from ITP, which is a key differential.", "consequence": "Non-specific finding, but you proceed with evaluation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Low platelet count", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Low platelet count suggests ITP, NOT HSP**. In HSP, platelets are NORMAL because the purpura is caused by **small vessel vasculitis** (IgA deposition), not platelet consumption. This is a critical distinction for the differential diagnosis of purpuric rashes in children.", "consequence": "Wrong diagnosis suspected; may lead to inappropriate workup.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Positive blood culture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Blood cultures would be indicated if **meningococcemia** or sepsis were suspected (fever, toxic appearance, rapid progression). This child is **afebrile** with a subacute 4-day course and classic HSP features. Blood cultures are not routinely needed in typical HSP.", "consequence": "Unnecessary workup for infection in classic HSP presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Elevated IgA levels", "isOptimal": false, "isAcceptable": true, "feedback": "Serum **IgA levels may be elevated** in about 50% of HSP cases, but this is **not sensitive or specific** enough to be diagnostic. The diagnosis is **clinical** based on the classic tetrad. Normal IgA levels do not rule out HSP.", "consequence": "You proceed with clinical diagnosis.", "nextNodeId": "node-2"}], "clinicalPearl": "**HSP (IgA vasculitis)** presents with the classic tetrad: **Palpable purpura** (dependent areas), **Arthritis/arthralgia** (knees, ankles), **Abdominal pain** (colicky, may have bloody stools), and **Renal involvement** (hematuria, proteinuria). **Normal platelets** distinguish it from ITP. Peak age is **4-6 years**, often following URI."}, "node-2": {"id": "node-2", "type": "decision", "content": "HSP (IgA vasculitis) is diagnosed based on clinical findings. Initial labs show: CBC with normal platelets (215K), urinalysis with 2+ blood and 1+ protein, BUN/Cr normal. The child has joint pain and abdominal discomfort but is tolerating oral intake.", "question": "What is the MOST IMPORTANT complication to monitor for that determines long-term prognosis in HSP?", "choices": [{"id": "node-2-choice-a", "text": "Renal involvement (nephritis)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Renal involvement** is the most important prognostic factor. **HSP nephritis** occurs in 20-50% of cases and can progress to chronic kidney disease in severe cases. Findings include **hematuria, proteinuria, hypertension, and elevated creatinine**. This child already shows hematuria and proteinuria - concerning signs requiring close monitoring.", "consequence": "You correctly prioritize renal monitoring.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Intussusception", "isOptimal": false, "isAcceptable": true, "feedback": "**Intussusception** is an important GI complication (2-3% of cases), typically **ileoileal** (unlike idiopathic ileocolic). Signs include worsening abdominal pain, vomiting, bloody stools, and palpable mass. However, **renal involvement** determines LONG-TERM prognosis, while intussusception is an acute complication requiring immediate intervention.", "consequence": "Important acute complication, but renal disease determines prognosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Joint destruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Unlike rheumatoid arthritis, **HSP arthritis is NON-EROSIVE and self-limiting**. It causes significant pain and swelling but resolves completely without joint damage. Renal involvement is the complication that affects long-term outcomes.", "consequence": "Reassurance given but missing the key prognostic factor.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Skin scarring from purpura", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **purpuric rash of HSP resolves completely** without scarring. The lesions may go through color changes (red \u2192 purple \u2192 brown) over 1-2 weeks but leave no permanent marks. Renal involvement is the key determinant of long-term outcomes.", "consequence": "Missing the most important prognostic factor.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Cardiac involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cardiac involvement is NOT a feature of HSP**. You may be thinking of Kawasaki disease (coronary aneurysms) or acute rheumatic fever (carditis). HSP primarily affects skin, joints, GI tract, and kidneys.", "consequence": "Wrong complication considered.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**HSP nephritis** occurs in 20-50% of patients, usually within 4-6 weeks of onset. Risk factors for severe nephritis: **age >8 years, persistent purpura, severe abdominal symptoms, low factor XIII**. **Nephrotic-range proteinuria** (>3.5 g/day) or **nephritic features** (hypertension, elevated creatinine) indicate severe disease requiring nephrology referral."}, "node-3": {"id": "node-3", "type": "decision", "content": "You appropriately prioritize renal monitoring. The child's current urinalysis shows microscopic hematuria and mild proteinuria. He is uncomfortable from joint pain and mild abdominal cramping but is otherwise stable.", "question": "What is the MOST appropriate initial management for this child's symptoms?", "choices": [{"id": "node-3-choice-a", "text": "Supportive care with NSAIDs for joint/abdominal pain", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **HSP is usually self-limited** and treatment is primarily **supportive**. **NSAIDs** (ibuprofen, naproxen) effectively manage joint pain and may help with abdominal discomfort. Adequate hydration and rest are also important. Most cases resolve within **4-6 weeks** without specific therapy.", "consequence": "Appropriate symptom management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "High-dose systemic corticosteroids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this presentation. **Corticosteroids are NOT routinely indicated** for uncomplicated HSP. They may be considered for: **severe abdominal pain** not responding to NSAIDs, **scrotal involvement**, or **severe nephritis** (nephrotic-range proteinuria, elevated creatinine). This child has mild symptoms manageable with NSAIDs.", "consequence": "Unnecessary steroid exposure with potential side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Empiric antibiotics for presumed infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HSP is an immune-mediated vasculitis, NOT an infection**. Although it often follows a URI (likely post-infectious trigger), the disease itself is not infectious and does not respond to antibiotics. Unnecessary antibiotics cause harm without benefit.", "consequence": "Inappropriate treatment with no benefit.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Immediate nephrology consultation for renal biopsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this presentation. **Renal biopsy is NOT indicated** for mild HSP nephritis (microscopic hematuria, mild proteinuria). Biopsy is reserved for: **nephrotic-range proteinuria, rapidly declining renal function, or unclear diagnosis**. Most children with mild nephritis recover without intervention.", "consequence": "Unnecessary invasive procedure for mild nephritis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Platelet transfusion to prevent bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Platelets are NORMAL in HSP**! The purpura is caused by **IgA-mediated small vessel vasculitis**, not thrombocytopenia. Platelet transfusion would be indicated in ITP with severe bleeding, but this child has HSP with normal platelet count.", "consequence": "Inappropriate intervention based on wrong diagnosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**HSP treatment is primarily supportive**: NSAIDs for joint/abdominal pain, adequate hydration, and rest. **Corticosteroids** may be considered for: severe GI symptoms (hemorrhage, intussusception), scrotal involvement, or severe nephritis. **Avoid aspirin** due to bleeding risk. Most cases resolve in **4-6 weeks** with no long-term sequelae."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child improves over 2 weeks with supportive care. The rash is fading and joint pain has resolved. You are planning follow-up care.", "question": "What is the MOST appropriate follow-up monitoring strategy for this child?", "choices": [{"id": "node-4-choice-a", "text": "Weekly urinalysis for 4-6 weeks, then monthly for 6 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Serial urinalysis monitoring** is essential because **HSP nephritis can develop up to 6 months after initial presentation**. Recommended schedule: **weekly for first 4-6 weeks**, then **monthly for 6 months**, then **yearly for several years** if any renal involvement was noted. This child had initial hematuria/proteinuria, so close monitoring is especially important.", "consequence": "Appropriate long-term renal monitoring plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Single follow-up visit in 1 week, no further monitoring needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HSP nephritis can develop or worsen up to 6 months after initial presentation**. Even children with initially normal urine findings need serial monitoring. This child already has hematuria/proteinuria, requiring extended follow-up to ensure resolution and detect progression.", "consequence": "Risk of missing progressive renal disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Immediate referral for renal biopsy before discharge", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Renal biopsy is NOT indicated** for mild, improving HSP nephritis. This child's symptoms are resolving with supportive care. Biopsy is reserved for persistent nephrotic-range proteinuria, declining renal function, or unclear diagnosis. Most children with mild nephritis recover completely.", "consequence": "Unnecessary invasive procedure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "CT scan of abdomen to rule out occult intussusception", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The child's **abdominal symptoms have resolved**. Routine imaging for intussusception is not indicated in a child who is improving. Imaging would only be needed if there were worsening abdominal pain, vomiting, bloody stools, or palpable mass suggesting acute intussusception.", "consequence": "Unnecessary radiation exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Prophylactic steroids to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic steroids do NOT prevent HSP recurrence** and are not indicated. Recurrence occurs in about **33% of cases**, typically within 4 months and usually milder than the initial episode. There is no proven prophylactic therapy - reassurance and monitoring are appropriate.", "consequence": "Unnecessary steroid exposure without benefit.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Long-term prognosis** in HSP is excellent for most children. However, **5-20% with renal involvement** may develop chronic kidney disease. Risk factors for poor renal outcome: **nephrotic-range proteinuria, hypertension, elevated creatinine, older age**. **Recurrence** occurs in ~33% of cases, usually milder. All children need **urinalysis monitoring for at least 6 months**."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed HSP (IgA vasculitis) in this 6-year-old with the classic tetrad of palpable purpura, arthritis, abdominal pain, and renal involvement following a URI. You recognized that NORMAL platelets distinguish HSP from ITP, appropriately prioritized renal monitoring as the key prognostic factor, initiated supportive care with NSAIDs, and established an appropriate long-term urinalysis monitoring plan. This child has a favorable prognosis with proper follow-up. Key teaching points: (1) HSP is diagnosed clinically - no specific test needed, (2) Renal involvement determines long-term outcome, (3) Most cases are self-limited with supportive care, (4) Serial urinalysis for 6+ months is essential."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of HSP: (1) Palpable purpura on buttocks/legs with NORMAL platelets, (2) Arthritis that is non-erosive and self-limiting, (3) Abdominal pain with possible intussusception (ileoileal), (4) Renal involvement is the key prognostic factor - monitor urinalysis for 6+ months. Treatment is primarily supportive with NSAIDs; steroids reserved for severe complications."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors were made in the management of HSP. Remember: (1) HSP has NORMAL platelets - it's a vasculitis, not thrombocytopenia, (2) HSP is immune-mediated, not infectious - antibiotics have no role, (3) Long-term renal monitoring is ESSENTIAL - nephritis can develop up to 6 months later. Key pearl: The diagnosis is clinical; treatment is supportive; prognosis depends on renal involvement."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-056", "title": "Acute Rheumatic Fever", "domain": "rheum_immunology", "difficulty": "intermediate", "tags": ["JONES criteria", "migratory polyarthritis", "erythema marginatum", "Sydenham chorea", "carditis"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 9-year-old male is brought to the emergency department for joint pain and rash that began 1 week ago.\n\nSubjectively, he had a sore throat 3 weeks ago that was not treated. Now he has painful, swollen joints that seem to move from one joint to another. He also developed a pink rash on his trunk.\n\nAssociated symptoms include fever and a new heart murmur. Denies shortness of breath or chest pain.\n\nPast medical history includes He had strep throat confirmed by rapid test 3 weeks ago but did not complete antibiotics.\n\nPhysical Examination:\n- Vitals: febrile.\n- Labs: ESR 60.\n- Joints: swollen, warm, tender left knee (yesterday was right ankle) - migratory arthritis.\n- Skin: erythema marginatum (pink rings with central clearing on trunk).\n- Cardiac: new grade III/VI holosystolic murmur at apex (mitral regurgitation).", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 9-year-old has migratory polyarthritis, erythema marginatum, and a new cardiac murmur. He had untreated strep pharyngitis 3 weeks ago. Labs show ESR 60 mm/hr and elevated ASO titer.", "question": "Using the MODIFIED JONES CRITERIA, how many MAJOR criteria does this patient have?", "choices": [{"id": "node-1-choice-a", "text": "3 major criteria: Carditis, Migratory polyarthritis, Erythema marginatum", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This patient has **3 MAJOR Jones criteria**: (1) **Carditis** (new MR murmur), (2) **Migratory polyarthritis** (joints alternating), (3) **Erythema marginatum** (pink rings with central clearing). The 5 major criteria are: **J**oints (migratory polyarthritis), **\u2661** (carditis), **N**odules (subcutaneous), **E**rythema marginatum, **S**ydenham chorea.", "consequence": "You correctly apply diagnostic criteria.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "2 major criteria: Arthritis and Erythema marginatum", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - you missed the **carditis**. The new holosystolic murmur at the apex indicates **mitral regurgitation** from valvulitis, which is a MAJOR criterion. Carditis is the most important manifestation as it causes permanent damage.", "consequence": "Underestimating disease severity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "1 major criterion: Only arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - you missed multiple major criteria. This patient has **carditis** (new MR murmur), **migratory polyarthritis**, AND **erythema marginatum**. All three are major Jones criteria.", "consequence": "Significant underdiagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "4 major criteria including fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fever is a MINOR criterion**, not major. The 5 major criteria are: Joints (migratory), O=carditis, Nodules, Erythema marginatum, Sydenham chorea. Minor criteria include fever, arthralgia, elevated ESR/CRP, and prolonged PR interval.", "consequence": "Confusing major and minor criteria.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "0 major criteria - this is reactive arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is NOT reactive arthritis. The **migratory** pattern of joint involvement, **erythema marginatum** rash, and **new cardiac murmur** are classic for ARF. Reactive arthritis typically has asymmetric oligoarthritis without carditis.", "consequence": "Wrong diagnosis entirely.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**JONES criteria** (5 major): **J**oints (migratory polyarthritis), **\u2661**=Carditis, **N**odules (subcutaneous), **E**rythema marginatum, **S**ydenham chorea. Diagnosis requires 2 major OR 1 major + 2 minor criteria PLUS evidence of preceding GAS infection."}, "node-2": {"id": "node-2", "type": "decision", "content": "ARF is diagnosed based on Jones criteria (3 major criteria + evidence of prior strep infection). The echocardiogram confirms mitral regurgitation from valvulitis.", "question": "Which component of ARF causes PERMANENT damage if not treated appropriately?", "choices": [{"id": "node-2-choice-a", "text": "Carditis - can lead to chronic rheumatic heart disease", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Carditis is the ONLY manifestation that causes permanent damage**. Untreated or recurrent ARF leads to **chronic rheumatic heart disease** with valvular scarring, most commonly **mitral stenosis**. All other manifestations (arthritis, chorea, rash, nodules) resolve completely without sequelae.", "consequence": "You understand the critical importance of cardiac involvement.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Polyarthritis - causes chronic joint destruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Unlike rheumatoid arthritis, the arthritis of ARF is **completely reversible** and does NOT cause joint destruction. It is dramatically responsive to **aspirin** and resolves within weeks without permanent sequelae.", "consequence": "Misunderstanding disease course.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Sydenham chorea - causes permanent neurologic damage", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sydenham chorea **resolves completely** over weeks to months without permanent neurologic sequelae. It may be the only manifestation of ARF (presenting months after strep infection) but does not cause lasting damage.", "consequence": "Chorea is self-limited.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Erythema marginatum - causes permanent scarring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Erythema marginatum is **evanescent** (comes and goes) and resolves completely without scarring. It is a useful diagnostic finding but has no long-term consequences.", "consequence": "Rash has no permanent sequelae.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Subcutaneous nodules - become permanent masses", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Subcutaneous nodules (firm, painless nodules over bony prominences) **resolve completely** without permanent changes. They are associated with more severe carditis but themselves cause no lasting damage.", "consequence": "Nodules resolve completely.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Carditis is the ONLY permanent sequela** of ARF. Recurrent episodes cause cumulative valve damage \u2192 **chronic rheumatic heart disease** (most common cause of acquired heart disease in developing world). **Mitral stenosis** is the classic long-term valve lesion."}, "node-3": {"id": "node-3", "type": "decision", "content": "You need to initiate treatment for this patient with ARF and active carditis.", "question": "What is the FIRST priority in management of acute rheumatic fever?", "choices": [{"id": "node-3-choice-a", "text": "Penicillin to eradicate GAS (even if current throat culture is negative)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **first priority** is to eradicate any remaining Group A Strep with **Penicillin** (IM Bicillin or oral Pen VK for 10 days). This is given even if the current throat culture is negative because the immune reaction causing ARF continues. This also serves as the start of secondary prophylaxis.", "consequence": "Appropriate first-line treatment initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "High-dose aspirin for anti-inflammatory effect", "isOptimal": false, "isAcceptable": true, "feedback": "Aspirin (80-100 mg/kg/day) is important for **arthritis** (dramatic response) but **Penicillin comes FIRST** to eradicate GAS. Anti-inflammatory therapy addresses symptoms but does not prevent ongoing immune-mediated damage from persistent strep antigens.", "consequence": "Symptom control but missing primary treatment.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "High-dose corticosteroids for carditis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect sequence. Steroids may be used for **severe carditis with heart failure**, but **Penicillin is FIRST** to eradicate GAS. Steroids do NOT prevent chronic rheumatic heart disease - only prophylaxis (preventing recurrent infections) does that.", "consequence": "Steroids don't prevent valve damage - prophylaxis does.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Valve surgery for mitral regurgitation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Surgery is reserved for **chronic rheumatic heart disease** with severe valve dysfunction, not acute ARF. Acute valvulitis often improves with medical management. The priority is antibiotic therapy and anti-inflammatory treatment.", "consequence": "Surgery not indicated in acute setting.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Wait for positive throat culture before treating", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do NOT wait for culture** - the throat may be negative by the time ARF manifests (2-4 weeks after pharyngitis). Treat empirically based on clinical diagnosis. The ASO titer confirms recent strep infection.", "consequence": "Dangerous delay in treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ARF treatment sequence**: (1) **Penicillin** to eradicate GAS (even if culture negative), (2) **Aspirin** for arthritis/fever (80-100 mg/kg/day), (3) **Steroids** only for severe carditis with HF, (4) **Bed rest** during active inflammation."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient improves with Penicillin treatment and aspirin. Before discharge, you need to discuss long-term management.", "question": "What is the CRITICAL long-term management requirement for this patient?", "choices": [{"id": "node-4-choice-a", "text": "Secondary prophylaxis with monthly IM Penicillin G Benzathine", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Secondary prophylaxis** with **IM Bicillin (Penicillin G Benzathine) every 3-4 weeks** is CRITICAL to prevent recurrent GAS infections, which cause cumulative cardiac damage. Duration depends on cardiac involvement: **10 years or until age 40** (whichever is longer) if carditis was present.", "consequence": "Long-term cardiac protection initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Treat each sore throat individually when symptoms occur", "isOptimal": false, "isAcceptable": false, "feedback": "DANGEROUS. **Waiting for symptoms is inadequate** - many strep infections are asymptomatic but still trigger ARF recurrence. **Continuous prophylaxis** is required because each recurrence causes MORE cardiac damage. This patient has proven susceptibility to ARF.", "consequence": "Recurrent ARF causes cumulative valve damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Daily aspirin indefinitely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Aspirin is used for acute symptom control during active ARF but is **not used for long-term prophylaxis**. **Penicillin prophylaxis** is what prevents recurrent infections and cumulative cardiac damage.", "consequence": "Aspirin does not prevent recurrence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Prophylaxis for 1 year only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect duration. For ARF **WITH carditis** (like this patient), prophylaxis should continue for **10 years or until age 40** (whichever is longer). If permanent valve damage exists, prophylaxis may be lifelong.", "consequence": "Insufficient prophylaxis duration.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "No prophylaxis needed if echo normalizes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Even if the echo normalizes, the patient remains at **high risk for recurrent ARF** because they've demonstrated susceptibility. **Prophylaxis duration is based on having HAD carditis**, not current echo findings.", "consequence": "Normal echo does not eliminate need for prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Secondary prophylaxis duration**: ARF with carditis = **10 years or until age 40** (longer duration). ARF without carditis = 5 years or until age 21. Persistent valve disease = **lifelong**. **IM Bicillin q3-4 weeks** is most reliable (compliance issues with daily oral)."}, "node-5": {"id": "node-5", "type": "decision", "content": "One year later, the patient needs a dental procedure. The parents ask about antibiotic prophylaxis for dental work.", "question": "Does this patient with a history of rheumatic carditis need antibiotic prophylaxis for dental procedures?", "choices": [{"id": "node-5-choice-a", "text": "Yes, if there is residual valvular dysfunction - prophylaxis for infective endocarditis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Patients with **rheumatic heart disease and residual valve dysfunction** require **infective endocarditis (IE) prophylaxis** for dental procedures involving gingival manipulation. Note: This is SEPARATE from GAS prophylaxis - they need BOTH. IE prophylaxis = amoxicillin 2g PO 30-60 min before procedure.", "consequence": "Appropriate dual prophylaxis understanding.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "No, the monthly Penicillin shots cover dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **GAS prophylaxis and IE prophylaxis are DIFFERENT**. Monthly Bicillin prevents strep throat/ARF recurrence but does NOT provide adequate coverage for oral flora (viridans strep) that cause endocarditis. A separate dose of amoxicillin is needed before dental work.", "consequence": "Inadequate IE prophylaxis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "No, endocarditis prophylaxis is never needed for rheumatic heart disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Rheumatic heart disease with valve dysfunction IS an indication for IE prophylaxis** per AHA guidelines. Damaged valves are susceptible to bacterial seeding during dental procedures.", "consequence": "Missing important prophylaxis indication.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Yes, but only if the patient has a prosthetic valve", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While prosthetic valves are the highest-risk category, **native valve disease from rheumatic fever also qualifies** for IE prophylaxis if there is regurgitation or stenosis. The threshold is valve dysfunction, not prosthetic valve only.", "consequence": "Too restrictive interpretation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Give IV vancomycin for all dental procedures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oral amoxicillin** is first-line for IE prophylaxis before dental procedures. IV vancomycin is reserved for patients who cannot take oral medications or have severe penicillin allergy (use clindamycin or azithromycin instead in penicillin allergy).", "consequence": "Unnecessarily aggressive approach.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Dual prophylaxis in rheumatic heart disease**: (1) **GAS prophylaxis** (monthly Bicillin) to prevent ARF recurrence, AND (2) **IE prophylaxis** (amoxicillin before dental work) if residual valve disease. These are SEPARATE requirements with different purposes."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You correctly applied Jones criteria, identified carditis as the only permanent sequela, initiated appropriate Penicillin treatment, prescribed secondary prophylaxis, and understood the dual prophylaxis requirements (GAS + IE). Key teaching points: (1) Jones criteria: 2 major OR 1 major + 2 minor + strep evidence, (2) ONLY carditis causes permanent damage, (3) Penicillin first even if culture negative, (4) Secondary prophylaxis: 10 years/age 40 for carditis, (5) IE prophylaxis ALSO needed for dental work."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key ARF concepts: (1) JONES = Joints, \u2661, Nodules, Erythema marginatum, Sydenham chorea, (2) Only carditis causes permanent damage (chronic RHD), (3) Penicillin first to eradicate GAS, (4) Secondary prophylaxis is CRITICAL - prevents recurrence and cumulative damage, (5) Dual prophylaxis needed if valve disease (GAS + IE)."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management error. Key ARF principles: (1) Treat with Penicillin even if throat culture negative - ARF is immune-mediated, (2) Secondary prophylaxis is MANDATORY - recurrent episodes cause cumulative cardiac damage, (3) Duration with carditis = 10 years/age 40 minimum, (4) Chronic rheumatic heart disease (mitral stenosis) results from untreated/recurrent ARF."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-062", "title": "Septic Arthritis Recognition", "domain": "rheum_immunology", "difficulty": "advanced", "tags": ["septic arthritis", "joint infection", "Kocher criteria", "arthrocentesis", "synovial fluid analysis", "Staphylococcus aureus", "Kingella kingae", "surgical emergency", "joint drainage", "avascular necrosis"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 3-year-old male presents to the clinic with fever and refusal to walk of 1 day duration.\n\nSubjectively, he developed high fever yesterday and suddenly stopped walking. He cries when anyone touches his right leg. He was well until yesterday.\n\nReview of systems is positive for irritability and poor appetite and negative for rash or cough.\n\nMedical history is notable for He is otherwise healthy. He scraped his knee at the playground 5 days ago.\n\nPhysical Examination:\n- Joints: right knee is swollen, warm, erythematous, with severe tenderness.\n- General: toxic-appearing, febrile (39.5\u00b0C), irritable.\n- Vitals: high fever.\n- Gait: refuses to bear weight.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 3-year-old with acute-onset fever, refusal to bear weight, and a swollen, warm, erythematous joint. The child is toxic-appearing.\n\nKey clinical features:\n- **Monoarticular** joint involvement (single joint)\n- **Refusal to bear weight** or move the joint\n- **Joint held in position of comfort** (flexion - maximizes joint capsule volume)\n- **Systemic toxicity** with high fever\n- Possible recent minor trauma (skin break)\n\nThe differential includes septic arthritis, transient synovitis, osteomyelitis, and reactive arthritis.", "question": "Based on this presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Septic arthritis - toxic appearance with monoarticular involvement", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This presentation is classic for **septic arthritis**: acute onset, **monoarticular** involvement, **refusal to bear weight**, joint held in flexion, high fever, and **toxic appearance**. Septic arthritis is a **joint emergency** - bacterial infection within the joint space causes rapid **cartilage destruction within 24-48 hours** if untreated due to inflammatory enzymes and pus under pressure.", "consequence": "Emergency recognized. Proceed with urgent workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Transient synovitis - post-viral hip pain is common", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Transient synovitis (toxic synovitis) is the most common cause of acute hip pain in children, but patients are typically **well-appearing, afebrile or low-grade fever**, and can often bear some weight. This patient is **toxic-appearing with high fever (39.5\u00b0C)** and refuses to bear any weight - these features strongly favor septic arthritis over transient synovitis.", "consequence": "Missed septic arthritis leads to joint destruction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Osteomyelitis - bone infection with overlying cellulitis", "isOptimal": false, "isAcceptable": true, "feedback": "Close but not the best answer. Osteomyelitis causes **focal bone tenderness** (typically at the metaphysis) with fever, but the **joint itself is usually uninvolved** unless infection spreads from adjacent bone. This patient has **joint swelling and effusion** as the primary finding, with the joint being warm and erythematous - this pattern indicates septic arthritis. Osteomyelitis and septic arthritis can coexist, especially in infants where the metaphysis is intracapsular.", "consequence": "Consider both diagnoses but treat as septic arthritis urgently.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Juvenile idiopathic arthritis (JIA) - chronic inflammatory arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. JIA presents with **chronic** joint symptoms (\u22656 weeks by definition), morning stiffness, and patients are typically **NOT toxic-appearing**. This patient has **acute onset** (1 day), high fever, and systemic toxicity. JIA is a diagnosis of exclusion after ruling out infectious and other causes.", "consequence": "Missed acute infection. JIA is not an acute presentation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Reactive arthritis - post-infectious joint inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Reactive arthritis is a **sterile inflammatory arthritis** occurring 1-4 weeks after an infection (usually GI or GU). Patients are **not typically toxic-appearing** and synovial fluid is inflammatory but **sterile**. This patient is toxic with acute onset - infectious arthritis must be ruled out first.", "consequence": "Missed septic arthritis. Reactive arthritis is not toxic.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Kocher criteria** help differentiate septic arthritis from transient synovitis (for hip): (1) **Non-weight-bearing**, (2) **Fever >38.5\u00b0C**, (3) **ESR >40**, (4) **WBC >12,000**. With 4/4 criteria, probability of septic arthritis is **>99%**. With 0/4, probability is <0.2%. This child has multiple criteria positive."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect septic arthritis in this toxic-appearing 3-year-old with a swollen, warm knee.\n\n**Septic arthritis is a surgical emergency** - delays in treatment lead to irreversible cartilage damage.\n\nDiagnostic steps include:\n- Joint aspiration (arthrocentesis) for synovial fluid analysis\n- Blood cultures\n- Inflammatory markers (CRP, ESR)\n- X-ray (to rule out other pathology)\n- Ultrasound (to confirm effusion and guide aspiration)", "question": "What is the most important next step in management?", "choices": [{"id": "node-2-choice-a", "text": "Emergent arthrocentesis for synovial fluid analysis", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Arthrocentesis** is the key diagnostic procedure. Synovial fluid analysis reveals: **WBC >50,000/\u03bcL** (often >100,000 in septic arthritis), **>90% PMNs**, **low glucose**, **positive Gram stain** (40-50% sensitivity), and **culture** (gold standard). Aspiration also provides immediate pain relief by decompressing the joint and should be performed BEFORE antibiotics if possible (to maximize culture yield).", "consequence": "Arthrocentesis performed. Proceed with analysis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start empiric IV antibiotics immediately", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. While antibiotics should not be delayed significantly, **obtaining synovial fluid BEFORE antibiotics** maximizes culture yield. If arthrocentesis can be performed within 30-60 minutes, it should be done first. However, in a septic or unstable patient, empiric antibiotics should not be delayed for aspiration. Blood cultures should be drawn before antibiotics in either case.", "consequence": "Antibiotics may reduce culture yield. Still acceptable in sick patient.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Obtain MRI of the knee", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While MRI provides excellent soft tissue detail and can identify adjacent osteomyelitis, it is **time-consuming, requires sedation in young children**, and is not necessary for initial diagnosis of septic arthritis. **Arthrocentesis is the diagnostic gold standard** and should not be delayed for imaging. MRI may be useful later if osteomyelitis is suspected.", "consequence": "Delayed diagnosis while waiting for MRI.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Observe and reassess in 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect and dangerous.** Septic arthritis causes **irreversible cartilage destruction within 24-48 hours**. Observation in a toxic child with suspected joint infection is inappropriate. Urgent arthrocentesis and antibiotics are required.", "consequence": "Delayed treatment causes permanent joint damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Oral antibiotics and outpatient follow-up", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Septic arthritis requires **IV antibiotics AND joint drainage** (surgical emergency). Oral antibiotics are completely inadequate, and outpatient management is inappropriate for a toxic child with suspected joint infection. This patient needs admission, IV antibiotics, and surgical consultation.", "consequence": "Grossly inadequate treatment. Joint destruction inevitable.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Synovial fluid in septic arthritis**: WBC **>50,000/\u03bcL** (usually >100,000), **>90% PMNs**, **low glucose** (<40 mg/dL or <50% serum), **positive Gram stain** (40-50% sensitivity), **positive culture** (70-90% if no prior antibiotics). Normal synovial fluid: <200 WBC/\u03bcL, clear, viscous."}, "node-3": {"id": "node-3", "type": "decision", "content": "Arthrocentesis of the right knee is performed under ultrasound guidance. Results:\n\n**Synovial fluid analysis:**\n- Appearance: **turbid/purulent**\n- WBC: **85,000/\u03bcL with 95% PMNs**\n- Glucose: 25 mg/dL (serum glucose 100 mg/dL)\n- Gram stain: **Gram-positive cocci in clusters**\n- Culture: pending\n\n**Additional labs:**\n- Blood WBC: 18,000/\u03bcL\n- CRP: 12 mg/dL (normal <0.5)\n- ESR: 65 mm/hr\n- Blood culture: pending\n\nThe synovial fluid findings confirm bacterial septic arthritis.", "question": "What is the most appropriate empiric antibiotic regimen for this 3-year-old?", "choices": [{"id": "node-3-choice-a", "text": "Nafcillin or oxacillin (or vancomycin if MRSA risk)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** The most common cause of septic arthritis in children >3 months is **Staphylococcus aureus**. With Gram-positive cocci in clusters on Gram stain, Staph aureus is highly likely. **Anti-staphylococcal penicillins** (nafcillin, oxacillin) are first-line for MSSA. In areas with high **MRSA prevalence** (>10%) or if the child has MRSA risk factors, **vancomycin** should be used empirically until cultures return.", "consequence": "Appropriate empiric coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ceftriaxone alone", "isOptimal": false, "isAcceptable": true, "feedback": "Ceftriaxone provides good coverage for many pathogens including **Kingella kingae** (common in children <5), Streptococci, and some Staph species, but it does **NOT cover MRSA**. In areas with significant MRSA prevalence, ceftriaxone alone may be inadequate. It's acceptable if MRSA is rare in your area, but adding vancomycin is safer empirically.", "consequence": "MRSA not covered. May be acceptable in low-prevalence areas.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Oral amoxicillin-clavulanate", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Septic arthritis requires **IV antibiotics** to achieve adequate joint penetration and bactericidal levels. Oral antibiotics are not appropriate for initial treatment of septic arthritis, regardless of the agent chosen.", "consequence": "Inadequate antibiotic levels in joint. Treatment failure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Vancomycin plus ceftazidime", "isOptimal": false, "isAcceptable": false, "feedback": "This combination is **broader than necessary**. Ceftazidime is an anti-pseudomonal cephalosporin used for suspected Pseudomonas (immunocompromised, puncture wounds through shoes). This healthy child with community-acquired septic arthritis does not need Pseudomonas coverage. Vancomycin alone (or with ceftriaxone for Kingella coverage) is appropriate.", "consequence": "Unnecessarily broad spectrum. Use appropriate empiric therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Clindamycin alone", "isOptimal": false, "isAcceptable": true, "feedback": "Clindamycin covers most Staph (including many MRSA) and Strep, and has good bone/joint penetration. However, it is **bacteriostatic** rather than bactericidal and resistance is increasing. It's an acceptable alternative but not first-line for serious infections. Also doesn't cover Kingella well (important in children <5).", "consequence": "Acceptable alternative but not preferred for severe infection.", "nextNodeId": "node-4"}], "clinicalPearl": "**Common organisms by age**: Neonates: **GBS, S. aureus, gram-negatives**. Infants 3mo-5yr: **S. aureus, Kingella kingae** (fastidious, may need special culture), Strep pyogenes. >5 years: **S. aureus**. Sexually active teens: consider **N. gonorrhoeae**. Sickle cell: **Salmonella** (in addition to Staph)."}, "node-4": {"id": "node-4", "type": "decision", "content": "IV antibiotics have been started. The orthopedic surgery team has evaluated the patient.\n\n**Septic arthritis treatment requires:**\n1. **Antibiotics** (IV initially)\n2. **Joint drainage** - to remove purulent material and reduce pressure\n\n**Joint drainage options:**\n- Repeated needle aspirations\n- Arthroscopic lavage\n- Open arthrotomy (surgical drainage)\n\nThe knee is the most commonly affected joint in older children. The hip is most common in infants.", "question": "What is the most appropriate approach for joint drainage in this patient with septic knee arthritis?", "choices": [{"id": "node-4-choice-a", "text": "Surgical drainage (arthroscopy or arthrotomy) is preferred for the knee", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** While management varies by institution, **surgical drainage** (arthroscopic or open arthrotomy) is generally preferred for the **knee** because it allows complete visualization, thorough washout, and removal of fibrinous debris. The knee's complex anatomy makes serial needle aspirations less effective. **The hip ALWAYS requires surgical drainage** due to risk of avascular necrosis (increased intracapsular pressure compromises femoral head blood supply).", "consequence": "Surgical consultation and drainage arranged.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Serial needle aspirations are adequate for knee septic arthritis", "isOptimal": false, "isAcceptable": true, "feedback": "This approach can be acceptable for the knee in select cases (early presentation, good response to initial aspiration, improving rapidly). However, surgical drainage is generally preferred because it provides more complete evacuation of purulent material and allows inspection of the joint. Serial aspiration requires repeated procedures and close monitoring.", "consequence": "May be acceptable but surgical drainage is more definitive.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Antibiotics alone without drainage", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Antibiotics alone are **NOT sufficient** for septic arthritis. The purulent material in the joint contains inflammatory enzymes that destroy cartilage. **Drainage is essential** to remove pus, reduce pressure, and allow antibiotics to work effectively. Antibiotics cannot penetrate well into collections of pus.", "consequence": "Ongoing cartilage destruction despite antibiotics.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Wait 48-72 hours to see if antibiotics work before considering drainage", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Septic arthritis is a surgical emergency. **Cartilage damage begins within 24-48 hours** and becomes irreversible. Waiting to see if antibiotics alone work delays definitive treatment and increases the risk of permanent joint damage.", "consequence": "Delay causes irreversible cartilage destruction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Intra-articular antibiotic injection", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Intra-articular antibiotics are **NOT recommended** and may cause chemical synovitis. **IV antibiotics achieve adequate joint levels** and are the standard of care. The joint needs drainage of purulent material, not more medication injected into it.", "consequence": "Not standard of care. May cause additional joint inflammation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hip septic arthritis ALWAYS requires surgical drainage** - increased intracapsular pressure can compromise blood supply to the femoral head, causing **avascular necrosis (AVN)**. The hip joint capsule encloses the femoral neck, so pressure directly affects the vessels. **Knee and other joints**: surgical drainage preferred but serial aspiration may be acceptable in select cases."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient undergoes arthroscopic washout of the right knee. Intraoperatively, there is significant purulent material evacuated. The joint is thoroughly irrigated.\n\nPost-operative course:\n- Fever resolves within 48 hours\n- Pain and swelling improving\n- Beginning to bear weight on day 3\n- CRP trending down (12 \u2192 5 \u2192 2)\n\n**Cultures return:**\n- Synovial fluid: **Methicillin-sensitive Staphylococcus aureus (MSSA)**\n- Blood culture: Negative\n\nThe patient has been on IV vancomycin for 4 days.", "question": "How should antibiotic therapy be managed now that cultures have resulted?", "choices": [{"id": "node-5-choice-a", "text": "Switch from vancomycin to nafcillin/oxacillin; continue IV for 3-4 weeks total", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** With MSSA confirmed, **narrow from vancomycin to anti-staphylococcal penicillin** (nafcillin or oxacillin) - these are more effective against MSSA than vancomycin. Total antibiotic duration for uncomplicated septic arthritis is **3-4 weeks** (typically 2 weeks IV followed by 2 weeks oral once improving). Some centers use shorter IV courses with early oral transition if CRP normalizes.", "consequence": "Appropriate antibiotic stewardship and duration.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Continue vancomycin for simplicity; total 3-4 weeks", "isOptimal": false, "isAcceptable": true, "feedback": "This is acceptable but not optimal. Continuing vancomycin when MSSA is confirmed is **inferior to beta-lactams** for Staph aureus and contributes to vancomycin resistance. Narrowing to nafcillin/oxacillin provides better killing and is standard practice. However, outcomes are still generally good with vancomycin.", "consequence": "Suboptimal drug choice for MSSA but may still cure infection.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-c", "text": "Stop antibiotics now - surgery was definitive treatment", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** While surgical drainage is essential, **antibiotics are also required** to clear the infection. Stopping after only 4 days risks incomplete treatment and relapse. Total duration should be 3-4 weeks for uncomplicated septic arthritis.", "consequence": "Incomplete treatment leads to relapse.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Add rifampin to vancomycin for enhanced penetration", "isOptimal": false, "isAcceptable": false, "feedback": "Rifampin is sometimes added for **biofilm-associated infections** (prosthetic joints, osteomyelitis) but is **not routinely recommended for native joint septic arthritis**. It has significant drug interactions and side effects. The better approach is to narrow to an anti-staphylococcal penicillin.", "consequence": "Not indicated for native joint septic arthritis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Switch immediately to oral cephalexin to complete 2 weeks total", "isOptimal": false, "isAcceptable": false, "feedback": "Transitioning to oral antibiotics too early (at 4 days) is premature. Traditional approach is **2 weeks IV followed by 2 weeks oral** (total 4 weeks). Some newer evidence supports shorter IV courses (3-7 days) with early oral transition IF the patient is afebrile, clinically improved, and CRP is normalizing. At day 4 with CRP still 5, this is too early.", "consequence": "Premature oral transition risks treatment failure.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Antibiotic duration for septic arthritis**: Traditional: **3-4 weeks total** (2 weeks IV + 2 weeks oral). Recent evidence supports shorter IV courses with early oral transition if: afebrile \u226548h, clinically improving, CRP normalizing, reliable family for oral compliance. **Narrow antibiotics** based on culture - beta-lactams are superior to vancomycin for MSSA."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of pediatric septic arthritis!\n\n**Key Learning Points:**\n1. **Septic arthritis is a joint emergency** - cartilage destruction within 24-48 hours\n2. **Kocher criteria** help differentiate from transient synovitis (for hip)\n3. **Arthrocentesis** is the diagnostic gold standard\n4. **Treatment = IV antibiotics + joint drainage**\n5. **S. aureus** is the most common pathogen; **Kingella** in children <5\n6. **Hip ALWAYS requires surgical drainage** (AVN risk)\n7. **Antibiotic duration**: 3-4 weeks total; narrow based on cultures\n\nThe patient completed 3 weeks of antibiotics (IV then oral transition), regained full range of motion, and had no long-term sequelae at 6-month follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review these key concepts:\n\n**Recognition:**\n- Monoarticular, refusal to bear weight, joint held in flexion, toxic appearance, high fever\n- Kocher criteria help differentiate from transient synovitis\n\n**Diagnosis:**\n- **Arthrocentesis** is essential: WBC >50,000, >90% PMNs, low glucose, Gram stain, culture\n\n**Treatment:**\n- **IV antibiotics** (cover S. aureus, consider MRSA, Kingella in young children)\n- **Joint drainage** is mandatory (surgical for hip; surgical or aspiration for knee)\n- Duration: 3-4 weeks total"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in management. Septic arthritis is a **joint emergency**.\n\n**Consequences of delayed/inadequate treatment:**\n- **Irreversible cartilage destruction** (within 24-48 hours)\n- **Chronic arthritis and joint stiffness**\n- **Avascular necrosis** (especially hip)\n- **Growth plate damage** and limb length discrepancy\n- **Sepsis and systemic spread**\n\n**Key Pearl:** When septic arthritis is suspected, act urgently. The joint needs: (1) aspiration for diagnosis, (2) drainage for source control, (3) IV antibiotics for 3-4 weeks. Delays are measured in hours, not days."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-063", "title": "Septic Hip Arthritis - Urgent Management", "domain": "rheum_immunology", "difficulty": "advanced", "tags": ["septic arthritis", "hip arthritis", "Kocher criteria", "avascular necrosis", "AVN", "surgical emergency", "joint drainage", "arthrotomy", "Staphylococcus aureus", "antibiotic stewardship"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "An 18-month-old male is brought to the emergency department with irritability and refusal to move his right leg for 2 days.\n\nHistory: The parents noticed he has been crying more than usual and doesn't want to stand or walk. He has had a fever at home (up to 39.2\u00b0C). He had a mild upper respiratory infection 1 week ago that has resolved.\n\nAdditional concerns: Poor appetite, difficulty sleeping due to pain. He cries when his diaper is changed.\n\nMedical history: Term infant, up-to-date on immunizations, no prior surgeries or hospitalizations.\n\nPhysical Examination:\n- General: Irritable, febrile (39.0\u00b0C), appears uncomfortable\n- Right hip: Held in flexion, abduction, and external rotation (position of comfort). Refuses to bear weight. Extremely irritable with any passive range of motion.\n- Left hip: Normal range of motion, non-tender\n- Knees/ankles: Normal\n- Skin: No rash, no warmth or erythema over the hip (deep joint)", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating an 18-month-old with fever and refusal to move the right leg. The hip is held in the classic position of comfort (flexion, abduction, external rotation) - this maximizes joint capsule volume and reduces pain.\n\nKey features:\n- Fever with **refusal to bear weight**\n- Hip held in **flexion/abduction/external rotation**\n- **Extreme irritability** with passive ROM\n- Recent viral illness (common preceding event)\n\n**Kocher criteria** for septic hip (vs transient synovitis):\n1. Non-weight-bearing\n2. Fever >38.5\u00b0C\n3. ESR >40 mm/hr\n4. WBC >12,000/\u03bcL", "question": "Labs return: WBC 15,000/\u03bcL, ESR 55 mm/hr, CRP 8.5 mg/dL. How many Kocher criteria are met, and what is the probability of septic arthritis?", "choices": [{"id": "node-1-choice-a", "text": "4/4 criteria met (non-weight-bearing, fever, ESR >40, WBC >12k) - >99% probability", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This patient meets **all 4 Kocher criteria**: (1) Non-weight-bearing \u2713, (2) Fever >38.5\u00b0C \u2713 (39.0\u00b0C), (3) ESR >40 \u2713 (55), (4) WBC >12,000 \u2713 (15,000). With 4/4 criteria, the predicted probability of septic arthritis is **>99.6%**. This child needs urgent evaluation and treatment for presumed septic hip arthritis.", "consequence": "High probability septic arthritis identified. Proceed urgently.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "2/4 criteria met - 40% probability, consider observation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Count the criteria again: Non-weight-bearing \u2713, Fever 39\u00b0C (>38.5) \u2713, ESR 55 (>40) \u2713, WBC 15,000 (>12,000) \u2713. This patient has **4/4 criteria** met, not 2/4. With 2/4 criteria, probability is ~40%, but this patient has much higher risk.", "consequence": "Underestimated risk. Septic arthritis likely.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "0/4 criteria met - <0.2% probability, transient synovitis likely", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** This patient clearly meets multiple criteria. With 0/4 Kocher criteria, probability of septic arthritis is indeed <0.2%, but this patient has fever >38.5\u00b0C, ESR >40, WBC >12,000, and is non-weight-bearing - all criteria are positive.", "consequence": "Grossly underestimated risk. Septic hip will be missed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "3/4 criteria met - 93% probability", "isOptimal": false, "isAcceptable": true, "feedback": "Close but incorrect count. Review: Non-weight-bearing \u2713, Fever 39\u00b0C (>38.5\u00b0C threshold) \u2713, ESR 55 (>40) \u2713, WBC 15,000 (>12,000) \u2713. All 4 criteria are met. With 3/4, probability is ~93%, which would still warrant urgent treatment, so the clinical approach is similar.", "consequence": "Slightly underestimated but still recognized as high-risk.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Kocher criteria don't apply to hip - need different assessment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **Kocher criteria were developed specifically for the pediatric hip** to differentiate septic arthritis from transient synovitis. They are most validated for the hip joint. Some centers have added CRP as a 5th predictor to improve accuracy.", "consequence": "Kocher criteria are essential for hip evaluation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Kocher criteria probabilities**: 0 criteria = <0.2%, 1 = 3%, 2 = 40%, 3 = 93%, **4 = 99.6%**. Some add **CRP >2 mg/dL** as 5th predictor. Even with 1 criterion, septic arthritis cannot be excluded - **arthrocentesis is definitive**. Hip held in **flexion, abduction, external rotation** = classic position of comfort."}, "node-2": {"id": "node-2", "type": "decision", "content": "With 4/4 Kocher criteria and >99% probability of septic arthritis, you must act urgently.\n\n**Why hip septic arthritis is especially dangerous:**\n- The hip joint capsule **encloses the femoral neck**\n- Increased intracapsular pressure can **compress the blood supply** to the femoral head\n- **Avascular necrosis (AVN)** can develop within hours\n- The hip is a deep joint - external signs (warmth, erythema) are often absent\n\nUltrasound of the right hip shows a **moderate joint effusion**.", "question": "What is the most appropriate next step?", "choices": [{"id": "node-2-choice-a", "text": "Urgent hip aspiration (arthrocentesis) - diagnostic and therapeutic", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Urgent **arthrocentesis** is essential. For the hip, this is typically done under **ultrasound or fluoroscopic guidance** due to the deep location. Aspiration is both **diagnostic** (synovial fluid analysis confirms infection) and **therapeutic** (decompresses the joint, reducing AVN risk). This should be done immediately, ideally before antibiotics to maximize culture yield.", "consequence": "Arthrocentesis performed. Purulent fluid obtained.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start IV antibiotics and observe for 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Observation is inappropriate for suspected septic hip. The hip is at **immediate risk for avascular necrosis** due to the anatomy (blood supply compressed by increased intracapsular pressure). Additionally, starting antibiotics without aspirating the joint first reduces culture yield and delays definitive diagnosis.", "consequence": "Delay risks AVN and permanent hip damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Obtain MRI before any intervention", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** MRI provides excellent detail but takes time, requires sedation in an 18-month-old, and should not delay treatment of suspected septic hip. The ultrasound already shows an effusion. **Time to drainage** is critical for the hip - every hour of delay increases the risk of permanent damage.", "consequence": "MRI delays urgent treatment. AVN risk increases.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Trial of NSAIDs to see if it's transient synovitis", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect and dangerous.** With 4/4 Kocher criteria, the probability of septic arthritis is >99%. A trial of NSAIDs is inappropriate - you cannot safely \"watch and wait\" when septic hip is this likely. Transient synovitis is a diagnosis of exclusion, made after ruling out infection.", "consequence": "Septic hip will progress to permanent joint destruction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Repeat labs in 12 hours to confirm trend", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** The diagnosis is already clear based on clinical presentation and labs. Repeating labs delays treatment and provides no additional useful information. The child needs joint aspiration NOW, not more lab work.", "consequence": "Unnecessary delay. Joint destruction progressing.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hip anatomy makes septic arthritis dangerous**: The joint capsule attaches to the intertrochanteric line, enclosing the **femoral neck and its blood supply**. Increased intracapsular pressure compresses the **lateral epiphyseal vessels** \u2192 **avascular necrosis (AVN)** of the femoral head. This can occur within **hours**. Hip septic arthritis is a true orthopedic emergency."}, "node-3": {"id": "node-3", "type": "decision", "content": "Ultrasound-guided arthrocentesis of the right hip yields **8 mL of purulent fluid**.\n\n**Synovial fluid analysis:**\n- Appearance: Turbid, yellow-green\n- WBC: **120,000/\u03bcL with 98% PMNs**\n- Glucose: 15 mg/dL (serum 90 mg/dL)\n- Gram stain: Gram-positive cocci in clusters\n- Culture: Pending\n\nThe fluid analysis confirms bacterial septic arthritis. The orthopedic surgery team has been notified.", "question": "What is the definitive treatment for septic hip arthritis in this child?", "choices": [{"id": "node-3-choice-a", "text": "Urgent surgical drainage (arthrotomy) - the hip MUST be surgically drained", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **The hip ALWAYS requires surgical drainage** - this is one of the most important principles in pediatric orthopedics. Unlike other joints where serial aspirations may be considered, the hip's anatomy and AVN risk mandate surgical washout. Open **arthrotomy** or arthroscopic drainage allows complete evacuation of purulent material, irrigation, and inspection of the joint.", "consequence": "Surgical drainage arranged emergently.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Serial needle aspirations can be used for the hip", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** While serial aspirations may be acceptable for some joints (knee, ankle) in select cases, **the hip is an exception**. Due to (1) the deep location making repeat aspirations difficult, (2) the anatomical risk of AVN from persistent effusion, and (3) inability to fully evacuate loculated pus, **surgical drainage is mandatory for the hip**.", "consequence": "Inadequate drainage. AVN and permanent damage likely.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "IV antibiotics alone now that the joint has been decompressed", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** While the initial aspiration provides some decompression, **a single needle aspiration is not adequate surgical drainage**. Purulent material reaccumulates, fibrin and debris remain, and the infection will persist. The hip requires formal surgical washout for definitive source control.", "consequence": "Infection will persist and worsen without surgical drainage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Place a drain and monitor output", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Percutaneous drain placement without surgical visualization is inadequate. Septic arthritis requires **direct visualization and irrigation** of the joint to remove purulent material, fibrin, and debris. This can only be accomplished through formal surgical drainage (arthrotomy or arthroscopy).", "consequence": "Inadequate source control.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Intra-articular antibiotic injection during aspiration", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Intra-articular antibiotics are **not recommended** and may cause chemical synovitis. Systemic IV antibiotics achieve adequate joint concentrations. The joint needs mechanical drainage, not more medication injected into it.", "consequence": "Not standard of care. May cause additional harm.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"The hip MUST be surgically drained\"** - memorize this. Hip septic arthritis mandates surgical washout (arthrotomy or arthroscopy) due to: (1) Deep location - hard to completely drain percutaneously, (2) **AVN risk** from persistent effusion/pressure, (3) Severe consequences of inadequate treatment. No exceptions."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient undergoes emergent surgical irrigation and debridement (I&D) of the right hip via anterior approach. Intraoperatively, significant purulent material is evacuated, and the joint is thoroughly irrigated.\n\nPost-operative day 1:\n- Fever resolved (36.8\u00b0C)\n- Less irritable, taking oral fluids\n- Hip still painful but improved\n- CRP: 6.2 mg/dL (down from 8.5)\n\n**Culture results:**\n- Synovial fluid: **Staphylococcus aureus (MSSA)**\n- Blood culture: Negative\n\nThe patient is on IV vancomycin (started empirically pre-op).", "question": "How should antibiotic therapy be optimized now?", "choices": [{"id": "node-4-choice-a", "text": "Switch from vancomycin to nafcillin/oxacillin for MSSA", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** With **MSSA** confirmed, therapy should be narrowed from vancomycin to an **anti-staphylococcal penicillin** (nafcillin, oxacillin) or first-generation cephalosporin (cefazolin). Beta-lactams are **more effective than vancomycin for MSSA** and should be preferred when susceptibility allows. This is appropriate antibiotic stewardship.", "consequence": "Appropriate de-escalation to optimal agent.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue vancomycin - it's working", "isOptimal": false, "isAcceptable": true, "feedback": "While the patient is improving on vancomycin, this is suboptimal. **Beta-lactams are superior to vancomycin for MSSA** - vancomycin has slower bacterial killing and higher failure rates for MSSA infections. When sensitivities show MSSA, narrowing to nafcillin/oxacillin is strongly recommended.", "consequence": "Acceptable but not optimal for MSSA.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Add rifampin for better bone/joint penetration", "isOptimal": false, "isAcceptable": false, "feedback": "Rifampin is used as adjunctive therapy for **biofilm-associated infections** (prosthetic joints, chronic osteomyelitis) but is **not routinely indicated for native joint septic arthritis**. It has significant drug interactions (CYP450 inducer) and should not be added without specific indication.", "consequence": "Not indicated for native joint infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Broaden to vancomycin plus piperacillin-tazobactam", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** The organism has been identified as MSSA - there is no indication to broaden coverage. Adding piperacillin-tazobactam adds unnecessary gram-negative and anaerobic coverage for an infection known to be caused by a susceptible Staph aureus. This violates antibiotic stewardship principles.", "consequence": "Unnecessarily broad. Promotes resistance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Switch to oral antibiotics now that surgery is complete", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** It is post-operative day 1 - far too early for oral transition. Standard practice is to continue **IV antibiotics until the patient is afebrile, clinically improving, and inflammatory markers are trending down** (typically 5-7+ days of IV therapy). Premature switch to oral risks treatment failure.", "consequence": "Premature oral transition. Treatment failure risk.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Antibiotic de-escalation** is important: Once cultures show **MSSA**, switch from vancomycin to **nafcillin/oxacillin** (or cefazolin). Beta-lactams have faster bactericidal activity against MSSA than vancomycin. For **MRSA**, continue vancomycin (or use daptomycin/linezolid based on local patterns)."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient continues to improve on IV nafcillin:\n\nPost-operative day 5:\n- Afebrile for 3 days\n- Moving right leg more freely, less irritable\n- Tolerating oral intake well\n- CRP: 1.8 mg/dL (down from 8.5 pre-op)\n- Hip exam: Reduced swelling, improved ROM\n\nThe family is asking about discharge planning and total treatment duration.", "question": "What is the recommended total antibiotic duration and when can this patient transition to oral therapy?", "choices": [{"id": "node-5-choice-a", "text": "3-4 weeks total; can transition to oral after 5-7 days IV if stable", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** For uncomplicated septic arthritis: **3-4 weeks total antibiotic duration**. Traditional approach is 2 weeks IV + 2 weeks oral. **Recent evidence supports earlier oral transition** (after 5-7 days IV) if: (1) Afebrile \u226548h, (2) Clinically improving, (3) CRP trending down, (4) Able to tolerate oral, (5) Reliable family for adherence. This patient meets criteria for oral transition.", "consequence": "Appropriate transition to oral therapy.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "6 weeks total IV antibiotics required for septic arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **6 weeks** is the duration for **osteomyelitis**, not uncomplicated septic arthritis. Septic arthritis (without adjacent osteomyelitis) requires **3-4 weeks total**. If there is concomitant osteomyelitis, then longer duration (4-6 weeks) may be needed.", "consequence": "Unnecessarily prolonged treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "10-14 days total is sufficient for septic arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **10-14 days is too short** for septic arthritis. Inadequate treatment duration risks relapse and chronic joint damage. Standard duration is **3-4 weeks** minimum for uncomplicated cases.", "consequence": "Inadequate duration. Relapse risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Must complete full 4 weeks IV - no oral transition", "isOptimal": false, "isAcceptable": false, "feedback": "This is unnecessarily conservative. **Modern evidence supports oral transition** when patients meet criteria (afebrile, improving, CRP down, able to take oral, reliable adherence). Oral antibiotics achieve adequate joint levels. Keeping a well child hospitalized for 4 weeks of IV therapy is not necessary.", "consequence": "Unnecessary prolonged hospitalization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Duration depends on CRP - continue until CRP normalizes", "isOptimal": false, "isAcceptable": true, "feedback": "CRP trending is helpful for monitoring response, but treatment duration should not be solely based on CRP normalization. CRP may take weeks to fully normalize even after infection is controlled. Standard duration is **3-4 weeks** with clinical improvement, regardless of whether CRP has completely normalized.", "consequence": "CRP is a guide but not sole determinant of duration.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**Antibiotic duration for septic arthritis: 3-4 weeks**. **Oral transition criteria**: (1) Afebrile \u226548h, (2) Clinical improvement, (3) CRP trending down (doesn't need to normalize), (4) Tolerating oral intake, (5) Reliable family. **Oral options** for MSSA: cephalexin, dicloxacillin, or amoxicillin-clavulanate (high dose for adequate coverage)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of septic hip arthritis!\n\n**Key Learning Points:**\n1. **Kocher criteria** predict septic arthritis probability (4/4 = >99%)\n2. **Hip is a surgical emergency** - AVN risk from increased intracapsular pressure\n3. **The hip MUST be surgically drained** - no exceptions\n4. **S. aureus** is the most common pathogen in children >3 months\n5. **De-escalate antibiotics** based on culture (beta-lactams > vancomycin for MSSA)\n6. **Duration: 3-4 weeks total** with early oral transition when stable\n\nThis patient transitioned to oral cephalexin on day 7, completed 4 weeks total antibiotics, and had normal hip function at 6-month follow-up with no evidence of AVN."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key principles:\n\n**Hip Septic Arthritis Pearls:**\n- **Kocher criteria** help risk-stratify (0-4 criteria \u2192 0.2% to 99.6% probability)\n- Hip position of comfort: **flexion, abduction, external rotation**\n- **Hip ALWAYS requires surgical drainage** (AVN risk)\n- **Antibiotics**: Cover S. aureus (MRSA if high prevalence); de-escalate based on culture\n- **Duration**: 3-4 weeks total; oral transition when afebrile, improving, CRP down"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in hip septic arthritis management.\n\n**Consequences:**\n- **Avascular necrosis (AVN)** of femoral head - permanent hip damage\n- **Growth plate injury** - limb length discrepancy\n- **Chronic arthritis** and decreased range of motion\n- **Sepsis** from uncontrolled infection\n\n**Key Pearl:** Hip septic arthritis is one of the few true orthopedic emergencies. The phrase **\"The hip MUST be surgically drained\"** should be memorized. Time to surgical drainage directly correlates with outcomes - delays are measured in hours, not days."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-077", "title": "Selective IgA Deficiency", "domain": "rheum_immunology", "difficulty": "intermediate", "tags": ["recurrent sinopulmonary infections", "anaphylaxis after transfusion", "most common immunodeficiency", "selective iga deficiency"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with recurrent sinopulmonary infections since infancy.\n\nParents report he had a severe reaction during a prior blood transfusion.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory workup reveals:\n- **IgA: <7 mg/dL** (undetectable; normal 70-400 mg/dL)\n- **IgG: 950 mg/dL** (normal for age)\n- **IgM: 120 mg/dL** (normal for age)\n- Lymphocyte subsets: Normal T and B cell numbers\n- Vaccine responses: Normal IgG antibody responses to tetanus and pneumococcus\n\nThe history of severe transfusion reaction and recurrent sinopulmonary infections is highly suggestive.", "question": "What is the most likely diagnosis and why did the transfusion reaction occur?", "choices": [{"id": "node-1-choice-a", "text": "Selective IgA deficiency; anti-IgA antibodies caused anaphylaxis to IgA in donor blood", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Selective IgA deficiency** is the **most common primary immunodeficiency** (prevalence ~1:500). It is defined as **IgA <7 mg/dL with normal IgG and IgM** in a patient >4 years old. Patients can develop **anti-IgA antibodies** (IgE or IgG class) because their immune system has never seen IgA and treats it as foreign. When exposed to IgA in **blood products**, these antibodies trigger **anaphylaxis**. This is a classic board question!", "consequence": "You correctly identify the diagnosis and mechanism.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Common variable immunodeficiency (CVID)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CVID** presents with low IgG AND low IgA (\u00b1low IgM), plus impaired vaccine responses. This patient has **normal IgG** and **normal vaccine responses** with isolated IgA deficiency. CVID patients typically have more severe infections (pneumonia, bronchiectasis) and may develop autoimmune complications.", "consequence": "IgG is normal, ruling out CVID.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "X-linked agammaglobulinemia (Bruton's)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **X-linked agammaglobulinemia** presents with **absent B cells** and very low levels of ALL immunoglobulin classes (IgG, IgA, IgM). This patient has isolated IgA deficiency with normal IgG, IgM, and normal lymphocyte counts. XLA also presents earlier (after maternal antibodies wane ~6 months) with severe bacterial infections.", "consequence": "All immunoglobulins would be low in XLA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Transient hypogammaglobulinemia of infancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Transient hypogammaglobulinemia** is physiologic and involves low IgG (not IgA) in infants that resolves by age 2-4 years. This 5-year-old has persistent isolated IgA deficiency with normal IgG. Additionally, transient hypogammaglobulinemia doesn't cause transfusion reactions.", "consequence": "Wrong age and wrong immunoglobulin pattern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "ABO incompatibility causing hemolytic transfusion reaction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ABO incompatibility** causes **acute hemolytic transfusion reaction** with fever, chills, back pain, hemoglobinuria, and DIC - not anaphylaxis. The anaphylactic reaction (rapid onset, hypotension, urticaria, bronchospasm) specifically suggests **anti-IgA antibodies** in an IgA-deficient patient.", "consequence": "Different type of transfusion reaction.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Selective IgA deficiency** = most common primary immunodeficiency (~1:500). Defined as **IgA <7 mg/dL with normal IgG/IgM** after age 4. Most patients are **asymptomatic**! Symptomatic patients have recurrent **sinopulmonary infections** and/or **GI problems**. Critical point: patients can develop **anti-IgA antibodies** \u2192 anaphylaxis to blood products containing IgA."}, "node-2": {"id": "node-2", "type": "decision", "content": "The diagnosis of selective IgA deficiency is confirmed. You discuss management with the family.\n\nThe parents ask what conditions they should watch for, as they've read that IgA deficiency is associated with other problems.", "question": "Which condition is MOST commonly associated with selective IgA deficiency?", "choices": [{"id": "node-2-choice-a", "text": "Celiac disease (10-15 fold increased risk)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Celiac disease** has a **10-15 fold increased prevalence** in patients with IgA deficiency (2-3% vs 0.5-1% in general population). Importantly, because IgA-deficient patients cannot make **IgA anti-tissue transglutaminase (tTG-IgA)** antibodies, **celiac screening must use IgG-based tests** (IgG-tTG or IgG-DGP). Using standard IgA-based screening will give false-negative results!", "consequence": "You identify the most important association.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Type 1 diabetes mellitus", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. IgA deficiency is associated with increased risk of **autoimmune diseases** including type 1 diabetes, but the association with **celiac disease** is stronger and more clinically important. Interestingly, celiac disease itself is associated with type 1 diabetes, creating overlapping risk.", "consequence": "True association but not the strongest.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Severe combined immunodeficiency (SCID)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SCID** is a separate, much more severe primary immunodeficiency with absent T cells (\u00b1B/NK cells). IgA deficiency does not progress to SCID. However, some IgA-deficient patients may later develop **CVID** (common variable immunodeficiency), so follow IgG levels.", "consequence": "Different disease entity entirely.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Cystic fibrosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cystic fibrosis** causes recurrent sinopulmonary infections but is a **chloride channel defect (CFTR mutation)**, not an immunodeficiency. There is no association between IgA deficiency and CF. CF would show elevated sweat chloride and characteristic GI/pulmonary features.", "consequence": "No association between these conditions.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Hepatitis B infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is no specific association between IgA deficiency and hepatitis B. IgA-deficient patients may have slightly increased susceptibility to mucosal infections but are not specifically predisposed to hepatitis B.", "consequence": "No known association.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **IgA deficiency associations**: (1) **Celiac disease** (10-15x increased risk - screen with IgG-based tests!); (2) **Autoimmune diseases** (SLE, RA, thyroiditis, T1DM); (3) **Allergic diseases** (asthma, allergic rhinitis); (4) **GI infections** (Giardia). Up to **20% may progress to CVID** - follow IgG levels annually."}, "node-3": {"id": "node-3", "type": "decision", "content": "You counsel the family about management and precautions for selective IgA deficiency.\n\nThe child is scheduled for an elective surgery in 3 months, and the surgeon asks about any special blood product considerations.", "question": "What is the appropriate blood product management for this patient?", "choices": [{"id": "node-3-choice-a", "text": "Use washed cellular blood products or products from IgA-deficient donors; alert blood bank and update medical records", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Patients with **IgA deficiency who have had transfusion reactions** should receive **washed RBCs/platelets** (washing removes plasma containing IgA) or blood from **IgA-deficient donors**. The blood bank should be notified, and the patient should have a **medical alert bracelet**. Note: not all IgA-deficient patients have anti-IgA antibodies, but this child's prior reaction indicates he does. **IVIG is contraindicated** as it contains IgA.", "consequence": "Appropriate blood product precautions established.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Administer IVIG before surgery to boost immunity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and potentially dangerous! **IVIG contains IgA** and can trigger anaphylaxis in patients with anti-IgA antibodies. IVIG is generally not indicated for selective IgA deficiency anyway (IgG is normal). If immunoglobulin replacement is ever needed, special **IgA-depleted preparations** must be used.", "consequence": "Risk of severe anaphylaxis from IgA in IVIG.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Standard blood products are fine; the prior reaction was likely coincidental", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The combination of **IgA deficiency + prior severe transfusion reaction** strongly suggests **anti-IgA antibodies**. Ignoring this puts the patient at risk for **potentially fatal anaphylaxis** with future transfusions. This is a well-documented, predictable complication that must be addressed proactively.", "consequence": "Ignoring documented risk could be fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Premedicate with diphenhydramine and steroids before standard blood products", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Premedication does not prevent IgE-mediated anaphylaxis** to IgA. While antihistamines may reduce minor allergic reactions, they cannot prevent severe anaphylaxis from anti-IgA antibodies. The correct approach is to **avoid the antigen** (IgA) entirely by using washed or IgA-deficient products.", "consequence": "Premedication cannot prevent this type of anaphylaxis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Irradiate all blood products to prevent reactions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Irradiation** prevents transfusion-associated graft-versus-host disease (TA-GVHD) by inactivating donor lymphocytes - it has nothing to do with IgA content. Irradiation is used for immunocompromised patients at risk for TA-GVHD, not for preventing anti-IgA reactions. **Washing** removes plasma proteins including IgA.", "consequence": "Wrong intervention for this problem.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Blood products in IgA deficiency**: (1) **Washed RBCs/platelets** - washing removes plasma (and IgA); (2) **IgA-deficient donor products** - from rare donor registries; (3) **NO standard IVIG** - contains IgA, use IgA-depleted preparations if needed; (4) **Medical alert bracelet** - critical for emergencies. Test for anti-IgA antibodies if planning elective transfusion."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly diagnosed **selective IgA deficiency** (most common primary immunodeficiency), understood that **anti-IgA antibodies** caused the prior transfusion reaction, identified **celiac disease** as the most important associated condition (remember to use IgG-based screening!), and established appropriate **blood product precautions** (washed products or IgA-deficient donors). This comprehensive approach prevents potentially fatal anaphylaxis and monitors for associated conditions."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key IgA deficiency concepts: (1) **Most common primary immunodeficiency** (~1:500); (2) Defined as **IgA <7 mg/dL with normal IgG/IgM** after age 4; (3) **Anti-IgA antibodies** can cause anaphylaxis to blood products; (4) Associated with **celiac disease** (screen with IgG-tTG), autoimmune diseases, allergies; (5) Use **washed or IgA-deficient blood products**."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Dangerous approach. Selective IgA deficiency with prior transfusion reaction indicates **anti-IgA antibodies** - this patient is at high risk for **fatal anaphylaxis** with standard blood products or IVIG. Critical management: (1) Document allergy prominently; (2) Use washed or IgA-deficient products; (3) Medical alert bracelet; (4) NO standard IVIG; (5) Screen for celiac with IgG-based tests. Ignoring these precautions can be lethal."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-115", "title": "X-linked Agammaglobulinemia Management", "domain": "rheum_immunology", "difficulty": "intermediate", "tags": ["male with recurrent infections after 6 months", "absent tonsils", "no B cells", "BTK mutation", "Bruton disease", "IVIG therapy", "live vaccine contraindication", "enteroviral meningoencephalitis", "x-linked agammaglobulinemia management"], "estimatedMinutes": 5, "source": ["NBME", "Amboss"], "stem": "A 9-month-old boy is brought to clinic by his mother with concerns about recurrent infections. Over the past 3 months, he has had 2 episodes of acute otitis media, 1 episode of pneumonia requiring hospitalization, and currently presents with purulent rhinorrhea and cough productive of green sputum.\n\nBirth and Early History:\n- Born full-term via uncomplicated vaginal delivery\n- Well until approximately 6 months of age\n- Mother notes he was 'never sick' before age 6 months\n- Fully breastfed until 4 months, then formula\n\nFamily History:\n- Maternal uncle died in childhood from 'lung problems'\n- No other significant family history\n\nPhysical Examination:\n- General: Alert, interactive, but appears chronically ill\n- Vitals: T 38.5\u00b0C, RR 32, HR 120, SpO2 95% on room air\n- HEENT: Purulent discharge from both nares; tympanic membranes erythematous with effusion bilaterally; **NO visible tonsils** despite good visualization\n- Neck: **NO palpable lymph nodes** (cervical, axillary, or inguinal)\n- Lungs: Coarse breath sounds bilaterally, scattered rhonchi\n- Abdomen: Soft, **no hepatosplenomegaly**, no palpable spleen", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 9-month-old male presents with **recurrent sinopulmonary infections starting after 6 months of age**. Key physical findings include:\n\n- **Absent tonsils and lymph nodes** - suggests deficient lymphoid tissue\n- Infections by **encapsulated bacteria** (S. pneumoniae, H. influenzae) - typical of antibody deficiency\n- **Male patient with maternal uncle who died from lung problems** - suggests X-linked inheritance\n\nThe timing is critical: the child was well until 6 months when **maternal IgG (transferred transplacentally) wanes**.", "question": "What is the MOST likely diagnosis explaining this presentation?", "choices": [{"id": "node-1-choice-a", "text": "X-linked agammaglobulinemia (Bruton's disease)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **X-linked agammaglobulinemia (XLA)** is the most likely diagnosis. The classic triad is: (1) **Male patient**, (2) **Recurrent sinopulmonary infections beginning after 6 months**, and (3) **Absent/hypoplastic lymphoid tissue** (no tonsils, no palpable lymph nodes). The maternal uncle's death suggests X-linked inheritance. XLA is caused by mutations in **Bruton tyrosine kinase (BTK)**, which arrests B-cell development at the **pre-B cell stage**.", "consequence": "You recognize the classic presentation of XLA.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Common variable immunodeficiency (CVID)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CVID** also presents with recurrent sinopulmonary infections and hypogammaglobulinemia, but it has key differences: (1) CVID typically presents **later** (late childhood to adulthood, usually >2 years), (2) CVID affects **both males and females** equally, (3) Patients with CVID usually **have lymphoid tissue** (tonsils and lymph nodes are present, sometimes enlarged). This 9-month-old male with absent lymphoid tissue is more consistent with XLA.", "consequence": "CVID doesn't fit the age or physical findings.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Transient hypogammaglobulinemia of infancy (THI)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **THI** is a benign, self-limited condition where IgG production is delayed but eventually normalizes (usually by age 2-4 years). Key differences: (1) THI does **not** cause absent lymphoid tissue - tonsils and lymph nodes are **present**, (2) Infections in THI are typically **milder** and less frequent, (3) There is no X-linked inheritance pattern. The absent tonsils and family history of X-linked disease exclude THI.", "consequence": "THI doesn't cause absent lymphoid tissue.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Severe combined immunodeficiency (SCID)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **SCID** is a more severe immunodeficiency affecting both T and B cells. Key differences: (1) SCID presents **earlier**, typically by **1-3 months of age** (doesn't wait for maternal antibodies to wane because T-cell defects manifest immediately), (2) SCID causes **opportunistic infections** (PCP, CMV, Candida) in addition to bacterial infections, (3) SCID patients have **failure to thrive** and often **chronic diarrhea**. This patient's later onset and lack of opportunistic infections favor XLA.", "consequence": "SCID presents earlier with opportunistic infections.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Selective IgA deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Selective IgA deficiency** is the most common primary immunodeficiency (~1:500), but it is usually **asymptomatic** or causes only **mild recurrent respiratory infections**. Key differences: (1) IgA deficiency does **not** cause absent lymphoid tissue, (2) IgG and IgM levels are **normal**, (3) Most patients are **asymptomatic**. This patient's severe presentation with absent tonsils/nodes indicates a more profound B-cell defect.", "consequence": "IgA deficiency causes milder disease and normal lymphoid tissue.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**XLA timing mnemonic**: 'Six months to sicken' - infections begin at 6 months when maternal IgG wanes. The absence of ALL lymphoid tissue (tonsils, lymph nodes) distinguishes XLA from other antibody deficiencies."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect X-linked agammaglobulinemia and order laboratory studies.\n\n**Laboratory Results:**\n- CBC: WBC 9,500 with normal differential, Hgb 11.2, Plt 285,000\n- **Quantitative immunoglobulins:**\n  - IgG: **<20 mg/dL** (normal 300-1000 mg/dL)\n  - IgA: **<5 mg/dL** (normal 20-100 mg/dL)\n  - IgM: **<10 mg/dL** (normal 40-120 mg/dL)\n- **Flow cytometry:**\n  - CD3+ T cells: 75% (normal)\n  - **CD19+ B cells: <1%** (normal 15-25%)\n  - CD4:CD8 ratio: Normal", "question": "Which additional test would CONFIRM the diagnosis of X-linked agammaglobulinemia?", "choices": [{"id": "node-2-choice-a", "text": "Genetic testing for BTK gene mutation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **BTK gene mutation analysis** is the confirmatory test for XLA. The BTK gene is located on the **X chromosome (Xq21.3-22)** and encodes Bruton tyrosine kinase, essential for B-cell development. >90% of clinically diagnosed XLA patients have identifiable BTK mutations. Genetic testing also allows for **carrier detection in female relatives** and **prenatal diagnosis** in future pregnancies. Flow cytometry showing **absent BTK protein in monocytes** is an alternative confirmatory test.", "consequence": "Genetic testing confirms the molecular defect.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Bone marrow biopsy", "isOptimal": false, "isAcceptable": true, "feedback": "A bone marrow biopsy would show **arrested B-cell maturation at the pre-B cell stage** with absence of mature B cells, which supports the diagnosis. However, this is an **invasive procedure** that is no longer first-line for diagnosis. **Genetic testing for BTK mutations** is preferred because it is non-invasive, definitive, and allows for family counseling. Bone marrow biopsy may be considered if genetic testing is inconclusive or unavailable.", "consequence": "Bone marrow biopsy is informative but more invasive than genetic testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Lymph node biopsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lymph node biopsy is not helpful** in XLA because the patient has **no palpable lymph nodes to biopsy**! The absence of lymphoid tissue is itself a diagnostic clue. Even if lymphoid tissue could be found, the histologic findings (absent germinal centers) would be nonspecific and wouldn't confirm the genetic defect.", "consequence": "Cannot biopsy lymph nodes that don't exist.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Complement levels (CH50, C3, C4)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Complement levels are normal in XLA**. Complement deficiencies cause susceptibility to **Neisseria infections** (meningococcemia, disseminated gonococcal infection), not the recurrent sinopulmonary infections seen here. Complement testing would not help confirm or rule out XLA. The combination of absent B cells + agammaglobulinemia + male patient is diagnostic of XLA.", "consequence": "Complement is normal in XLA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "HIV antibody testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While HIV can cause hypogammaglobulinemia, **HIV antibody testing would be falsely negative** in this patient because he has **no B cells to produce antibodies**! If HIV were suspected, **HIV DNA PCR** would be needed. However, HIV doesn't explain the absent lymphoid tissue (HIV usually causes lymphadenopathy) or the X-linked family history. The clinical picture is classic for XLA.", "consequence": "HIV testing is not indicated and antibody tests would be unreliable.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**XLA laboratory triad**: (1) Absent/very low ALL immunoglobulin classes (IgG, IgA, IgM), (2) Absent B cells (<1-2% CD19+), (3) Normal T cells. Genetic confirmation via **BTK mutation analysis** is the gold standard."}, "node-3": {"id": "node-3", "type": "decision", "content": "Genetic testing confirms a pathogenic mutation in the BTK gene. You diagnose X-linked agammaglobulinemia.\n\nThe patient is currently stable but has signs of acute sinusitis and possible early pneumonia. You need to initiate long-term management.\n\n**Management considerations:**\n- Treat current infection\n- Prevent future infections\n- Avoid treatments that could be harmful in this condition", "question": "What is the MOST important component of long-term management for this patient?", "choices": [{"id": "node-3-choice-a", "text": "Lifelong intravenous or subcutaneous immunoglobulin (IVIG/SCIG) replacement", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Lifelong immunoglobulin replacement therapy** is the cornerstone of XLA management. Since patients cannot produce their own antibodies, they require regular infusions of pooled IgG from donors. **Key points:**\n- **Dosing**: 400-600 mg/kg every 3-4 weeks (IVIG) or weekly (SCIG)\n- **Goal**: Maintain **trough IgG >500-800 mg/dL** (some target >800 for patients with lung disease)\n- **Reduces infections** by 70-90% and prevents progression to bronchiectasis\n- **SCIG** (subcutaneous) can be administered at home, improving quality of life\n- Treatment is **lifelong** - there is no cure for XLA", "consequence": "You initiate the cornerstone therapy for XLA.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Prophylactic daily antibiotics (TMP-SMX or azithromycin)", "isOptimal": false, "isAcceptable": true, "feedback": "Prophylactic antibiotics are used **adjunctively** in some XLA patients but are **not the primary treatment**. They may be considered for patients who continue to have frequent infections despite adequate IVIG, or to prevent specific organisms. However, **IVIG replacement is essential** and cannot be replaced by antibiotics alone. Antibiotics prevent some bacterial infections but don't address the fundamental lack of humoral immunity.", "consequence": "Prophylactic antibiotics are adjunctive but not the primary therapy.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Hematopoietic stem cell transplant (HSCT)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HSCT is not indicated for XLA**. Unlike SCID (where HSCT is life-saving), XLA patients have **normal T-cell function** and can live near-normal lives with IVIG replacement. HSCT carries significant morbidity and mortality risks that outweigh the benefits in XLA. HSCT might be considered only in exceptional cases (e.g., associated lymphoma, uncontrolled infections), but it is not standard management.", "consequence": "HSCT risks outweigh benefits in XLA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Update vaccinations including live vaccines to boost immunity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and **DANGEROUS**! **Live vaccines are CONTRAINDICATED in XLA**. Patients cannot mount an antibody response to any vaccine (so vaccines are ineffective), and live vaccines can cause **disseminated infection** in immunocompromised patients. Specifically contraindicated: **OPV** (can cause vaccine-associated paralytic polio), **MMR**, **varicella**, **rotavirus**, **live intranasal influenza**. Family members should also avoid OPV (can shed virus to patient).", "consequence": "Live vaccines are contraindicated and dangerous in XLA!", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Gene therapy to correct the BTK defect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Gene therapy for XLA is still experimental** and not available as standard treatment. While research is ongoing and promising results have been seen in preclinical studies and early trials, gene therapy is not yet FDA-approved for XLA. The current standard of care remains **lifelong IVIG/SCIG replacement**, which is highly effective at preventing infections and improving quality of life.", "consequence": "Gene therapy is experimental, not standard care.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**IVIG dosing goal**: Maintain trough IgG >500 mg/dL (some target >800 mg/dL). Patients need higher trough levels if they have chronic lung disease or continue to have breakthrough infections."}, "node-4": {"id": "node-4", "type": "decision", "content": "You initiate IVIG therapy, targeting a trough IgG level of 800 mg/dL given his history of pneumonia. You also treat his current infection with amoxicillin-clavulanate.\n\nThe mother asks about the prognosis and what infections to watch for. She also has a 2-year-old daughter and is currently 12 weeks pregnant with a male fetus.\n\n**Prognostic considerations:**\n- With modern IVIG therapy, life expectancy is near-normal\n- Main morbidity is **chronic lung disease** from recurrent/undertreated infections\n- Certain pathogens remain problematic despite IVIG", "question": "Which infection remains a significant risk in XLA patients EVEN with adequate IVIG replacement?", "choices": [{"id": "node-4-choice-a", "text": "Enteroviral meningoencephalitis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Enteroviral infections**, particularly **chronic enteroviral meningoencephalitis**, remain a serious threat in XLA patients despite IVIG. **Why IVIG doesn't fully protect:**\n- Enteroviruses mutate rapidly, and **IVIG may not contain antibodies to all circulating strains**\n- Enteroviruses can cause **persistent CNS infection** that is difficult to eradicate\n- **Vaccine-derived poliovirus** from OPV is a particular concern (hence live vaccine contraindication)\n\nOther problematic organisms: **Giardia lamblia** (chronic diarrhea despite IVIG), **Mycoplasma** (can cause destructive arthritis), and **Campylobacter** (persistent GI infection).", "consequence": "You counsel the family about enteroviral precautions.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Streptococcus pneumoniae pneumonia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **S. pneumoniae** and other encapsulated bacteria (H. influenzae, S. aureus) are the classic pathogens in untreated XLA, but **IVIG is highly effective** at preventing these infections. The pooled immunoglobulin contains antibodies against common pneumococcal serotypes and other encapsulated organisms. Breakthrough pneumococcal infections suggest inadequate IVIG dosing or poor compliance.", "consequence": "IVIG effectively prevents pneumococcal infections.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Pneumocystis jirovecii pneumonia (PCP)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PCP** is an **opportunistic fungal infection** that primarily affects patients with **T-cell defects** (HIV, SCID). XLA patients have **normal T-cell function** and are therefore **not at increased risk for PCP**. If an XLA patient develops PCP, you should suspect a coexisting T-cell defect or misdiagnosis.", "consequence": "PCP affects T-cell immunodeficiencies, not XLA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Invasive aspergillosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Invasive aspergillosis** primarily affects patients with **neutrophil defects** (chronic granulomatous disease, neutropenia) or severe T-cell deficiency. XLA patients have **normal neutrophils and normal T cells**, so they are not at increased risk for Aspergillus infections. Antibody deficiency primarily increases susceptibility to encapsulated bacteria, enteroviruses, and Giardia.", "consequence": "Aspergillosis affects neutrophil/T-cell defects, not XLA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Cytomegalovirus (CMV) disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CMV** is a herpesvirus that is primarily controlled by **T-cell immunity**. XLA patients have **normal T cells** and therefore handle CMV infections normally. CMV disease is a concern in SCID, HIV, and post-transplant patients. While IVIG preparations contain some anti-CMV antibodies, T-cell function is the key defense against CMV.", "consequence": "CMV is controlled by T cells, which are normal in XLA.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**XLA infection pearls**: (1) **Enteroviruses** can cause devastating chronic meningoencephalitis despite IVIG, (2) **Giardia** causes chronic diarrhea, (3) **Mycoplasma** causes destructive arthritis. These organisms are small, rapidly mutating, or intracellular - limiting IVIG effectiveness."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **X-linked agammaglobulinemia (Bruton's disease)** and initiated appropriate management.\n\n**Key takeaways:**\n- **Classic triad**: Male patient + recurrent infections after 6 months + absent lymphoid tissue\n- **Labs**: Absent B cells (<1%), absent/very low ALL Ig classes, normal T cells\n- **Genetics**: BTK gene mutation (X-linked recessive) - confirm with genetic testing\n- **Treatment**: Lifelong IVIG/SCIG replacement (goal trough IgG >500-800 mg/dL)\n- **Contraindicated**: ALL live vaccines (risk of disseminated infection)\n- **Ongoing risks despite IVIG**: Enteroviral meningoencephalitis, Giardia, Mycoplasma arthritis\n\n**Prognosis**: With early diagnosis and consistent IVIG therapy, patients can have near-normal life expectancy. Main long-term concern is **bronchiectasis** from cumulative lung damage.\n\n**Family counseling**: Mother is an obligate carrier. The 2-year-old daughter has 50% chance of being a carrier. The male fetus has 50% chance of having XLA - offer prenatal testing."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key features of **X-linked agammaglobulinemia**:\n\n- **'Six months to sicken'** - infections begin when maternal IgG wanes\n- **Absent tonsils and lymph nodes** - no B cells means no lymphoid tissue\n- **Male patients only** (X-linked recessive)\n- **Labs**: Absent B cells, agammaglobulinemia, NORMAL T cells\n- **Confirm with BTK genetic testing**, not invasive procedures\n- **Treatment**: Lifelong IVIG (not HSCT, not just antibiotics)\n- **NO live vaccines ever**\n\nRemember: T cells are NORMAL in XLA, so opportunistic infections (PCP, CMV, Aspergillus) are NOT features of this disease."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error! **Live vaccines are absolutely CONTRAINDICATED in X-linked agammaglobulinemia** and can cause fatal disseminated infection.\n\nPatients with XLA:\n- Cannot respond to ANY vaccine (no B cells = no antibody production)\n- Are at risk for **vaccine-associated paralytic polio** from OPV\n- Can develop disseminated infection from live attenuated viruses\n\n**Contraindicated vaccines**: OPV, MMR, varicella, rotavirus, live intranasal influenza, BCG, yellow fever, oral typhoid.\n\n**Family members** should also avoid OPV (use IPV instead) as they can shed virus to the patient.\n\nRemember: The fundamental defect in XLA is **absent B cells** - vaccines require B cells to produce protective antibodies!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-117", "title": "Terminal Complement Deficiency Recognition", "domain": "rheum_immunology", "difficulty": "intermediate", "tags": ["complement deficiency", "CH50", "membrane attack complex", "Neisseria meningitidis", "meningococcal disease", "immunodeficiency", "C5-C9"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 5-year-old male is admitted to the PICU with his THIRD episode of bacterial meningitis in 2 years. All three episodes have been caused by Neisseria meningitidis (meningococcus).\n\nPrevious episodes:\n- Age 3: Meningococcal meningitis (serogroup B), treated with ceftriaxone, full recovery\n- Age 4: Meningococcal meningitis (serogroup Y), treated with ceftriaxone, full recovery\n- Current: Meningococcal meningitis (serogroup W), currently on ceftriaxone\n\nFamily history: Maternal uncle died of \"brain infection\" at age 8. A cousin had \"serious blood infection\" requiring ICU.\n\nThe infectious disease team is consulted and asks: \"Why does this child keep getting meningococcal infections?\"", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 5-year-old with THREE episodes of meningococcal meningitis.\n\n**Recurrent Neisseria Infections - The Differential:**\n\n**Why is this pattern so unusual?**\n- Meningococcal meningitis is typically a **once-in-a-lifetime** event in immunocompetent individuals\n- RECURRENT meningococcal disease strongly suggests **immune deficiency**\n\n**Causes of Susceptibility to Neisseria:**\n\n**1. Terminal Complement Deficiency (C5-C9):**\n- **The classic association** with recurrent Neisseria infections\n- Deficiency of any component of the **membrane attack complex (MAC)**\n- MAC is essential for killing **encapsulated organisms**, especially Neisseria\n- **1000-10,000x increased risk** of meningococcal disease\n- Infections may be LESS severe (paradoxically) but RECURRENT\n\n**2. Properdin Deficiency:**\n- X-linked complement deficiency (alternative pathway)\n- Also causes recurrent Neisseria infections\n- More fulminant infections than terminal complement deficiency\n\n**3. Asplenia (Functional or Anatomic):**\n- Sickle cell disease (functional asplenia)\n- Surgical splenectomy\n- Congenital asplenia\n- Susceptible to encapsulated organisms (Strep pneumo, H. flu, Neisseria)\n\n**4. Antibody Deficiencies:**\n- X-linked agammaglobulinemia, CVID\n- Usually present with recurrent sinopulmonary infections more than meningitis\n\n**Key Clue:** Family history of early deaths from \"brain infection\" suggests **inherited** complement deficiency (autosomal recessive for most terminal components, X-linked for properdin).", "question": "Given the pattern of THREE meningococcal infections from different serogroups with a suspicious family history, what underlying condition should be strongly suspected?", "choices": [{"id": "node-1-choice-a", "text": "Terminal complement deficiency (C5-C9) - defective membrane attack complex", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Recurrent Neisseria meningitidis infections = Terminal complement deficiency until proven otherwise.** Key features pointing to this diagnosis:\n\n1. **THREE episodes** of meningococcal meningitis (virtually never happens in immunocompetent hosts)\n2. **Different serogroups** (B, Y, W) - not vaccine failure, true susceptibility\n3. **Family history** of early deaths from \"brain infection\" (autosomal recessive inheritance)\n4. **Full recovery** between episodes (MAC-deficient patients often have LESS fulminant but RECURRENT disease)\n\nThe **membrane attack complex (C5-C9)** forms pores in bacterial membranes and is the ONLY mechanism the immune system has to kill Neisseria species. Without it, these patients cannot clear Neisseria even with antibodies and functioning phagocytes.", "consequence": "You suspect terminal complement deficiency and order appropriate testing.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Functional asplenia from undiagnosed sickle cell disease", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. **Asplenia** (functional or anatomic) does increase susceptibility to encapsulated organisms including Neisseria. However, several features make sickle cell less likely:\n\n1. **No history** of pain crises, anemia, or other sickle cell manifestations\n2. Sickle cell patients are more susceptible to **Streptococcus pneumoniae** (most common) than Neisseria\n3. **Family history** pattern suggests X-linked or autosomal recessive inheritance, fitting complement deficiency better\n\nAsplenia should be considered, but the specific pattern of RECURRENT NEISSERIA with family history is most classic for terminal complement deficiency.", "consequence": "Consider asplenia, but complement deficiency is more likely.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "X-linked agammaglobulinemia (Bruton's disease)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **X-linked agammaglobulinemia (XLA)** presents with:\n- **Recurrent SINOPULMONARY infections** (pneumonia, sinusitis, otitis media)\n- **Absent B cells and immunoglobulins**\n- **Absent/small tonsils and lymph nodes** (no B cell follicles)\n- Susceptibility to **encapsulated bacteria** but not specifically Neisseria pattern\n\nXLA patients CAN get meningitis, but the classic XLA presentation is recurrent respiratory infections, not recurrent meningococcal meningitis specifically. The NEISSERIA-specific pattern strongly suggests complement deficiency.", "consequence": "XLA has different infection pattern; complement deficiency more likely.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Bad luck - some children just get more infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Three episodes of meningococcal meningitis is NOT bad luck - it's pathognomonic for immunodeficiency.** The odds of having THREE meningococcal infections by chance are astronomically low:\n\n- Meningococcal disease incidence: ~1 per 100,000 per year\n- Probability of 3 episodes by chance: essentially zero\n\nAdditionally, the **family history** of early deaths from \"brain infection\" confirms this is an inherited susceptibility, not random misfortune. Dismissing this pattern as \"bad luck\" would miss a critical diagnosis.", "consequence": "Dangerous assumption - misses life-threatening immunodeficiency.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Vaccine failure - needs repeat meningococcal vaccination", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While vaccine failure can occur, this doesn't explain:\n\n1. **THREE different serogroups** (B, Y, W) - would need to fail multiple different vaccines\n2. **Family history** of meningitis deaths (vaccines don't fail in families)\n3. The **fundamental immunologic problem** (complement-deficient patients may have REDUCED vaccine efficacy because they cannot form MAC even with antibodies)\n\nVaccination IS important for this patient, but it won't be fully protective without first identifying and addressing the underlying immunodeficiency. The child needs complement testing, not just repeat vaccination.", "consequence": "Misses underlying diagnosis; vaccines alone won't protect this child.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Recurrent Neisseria infections (meningococcal meningitis, disseminated gonococcal infection) = Check CH50 for terminal complement deficiency.** This is one of the highest-yield associations in immunology."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order complement studies. Results return:\n\n- **CH50 (Total Hemolytic Complement): <10 U/mL** (normal >41 U/mL) - **UNDETECTABLE**\n- **AH50 (Alternative Pathway): Normal**\n- **C3: Normal**\n- **C4: Normal**\n\nThe CH50 is completely undetectable with normal C3 and C4.\n\n**Interpreting Complement Studies:**\n\n**CH50 (Total Hemolytic Complement):**\n- Functional assay that tests the **ENTIRE classical pathway + MAC**\n- Requires ALL components (C1-C9) to be present for normal result\n- **Absent CH50 with normal C3/C4** = Terminal complement deficiency (C5-C9)\n- Also absent in: early classical pathway defects (C1, C2), but C4 would be low\n\n**AH50 (Alternative Pathway Hemolytic):**\n- Tests alternative pathway + MAC\n- Normal AH50 with absent CH50 suggests **classical pathway specific** defect\n- But since C3/C4 are normal, the defect must be in MAC (C5-C9)\n\n**Individual Component Testing:**\n- Can measure C5, C6, C7, C8, C9 individually to identify specific deficiency\n- Most common: **C6 deficiency** (especially in African Americans)\n- All terminal deficiencies have similar clinical presentation", "question": "CH50 is undetectable with normal C3, C4, and AH50. What is the diagnosis and most important next step?", "choices": [{"id": "node-2-choice-a", "text": "Terminal complement (C5-C9) deficiency confirmed; order individual component levels and immunology referral", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **undetectable CH50 with normal C3/C4** confirms terminal complement deficiency. Next steps:\n\n**1. Identify the specific component:**\n- Order C5, C6, C7, C8, C9 levels individually\n- Most common deficiencies: C6, C7, C8\n- Identifies the exact defect for genetic counseling\n\n**2. Immunology/Infectious Disease referral:**\n- Specialist management of primary immunodeficiency\n- Coordinate vaccination strategy\n- Family screening\n\n**3. Genetic testing:**\n- Confirm specific mutation\n- Enable family counseling and prenatal diagnosis\n- Most are autosomal recessive\n\n**4. Screen family members:**\n- Siblings at 25% risk if parents are carriers\n- Asymptomatic affected relatives need identification and vaccination", "consequence": "You confirm the diagnosis and arrange appropriate follow-up.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Results are likely lab error; repeat CH50 before pursuing further workup", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While lab error is always possible, **an undetectable CH50 in a child with THREE meningococcal infections is the expected finding, not an error**. This result:\n\n1. **Perfectly explains** the clinical presentation\n2. Is **consistent with family history** of meningitis deaths\n3. Has **normal C3/C4** ruling out specimen degradation (which would affect all components)\n\nDelaying workup to repeat a test that fits perfectly with the clinical picture wastes time. Proceed with individual component testing and subspecialty referral.", "consequence": "Delay in diagnosis and management of confirmed immunodeficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Start IVIG replacement therapy immediately for presumed antibody deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **IVIG does NOT treat complement deficiency.** Key points:\n\n1. This patient has a **COMPLEMENT deficiency**, not antibody deficiency\n2. IVIG provides **immunoglobulins (antibodies)**, which this patient likely makes normally\n3. The problem is that even WITH antibodies, the patient **cannot form the membrane attack complex** to kill Neisseria\n4. IVIG would not provide functional complement proteins\n\nThe correct management is vaccination (to maximize antibody-mediated protection) and antibiotic prophylaxis, NOT IVIG replacement.", "consequence": "Inappropriate and expensive therapy that doesn't address the defect.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Diagnose lupus based on low complement and start immunosuppression", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is a dangerous misinterpretation. **Low complement in lupus** shows:\n\n- Low **C3 and C4** (consumed by immune complexes)\n- Often reduced but NOT absent CH50\n- Associated with lupus clinical features (rash, nephritis, arthritis)\n\nThis patient has:\n- **ABSENT** CH50 (not just low)\n- **NORMAL** C3 and C4 (not consumed)\n- **No lupus features**\n- **Recurrent infections** (opposite of autoimmune pattern)\n\nThis is a PRIMARY complement deficiency causing infections, NOT secondary consumption from autoimmune disease. Starting immunosuppression would be catastrophic.", "consequence": "Catastrophic misdiagnosis - immunosuppression would worsen infections.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Order bone marrow biopsy to evaluate for malignancy causing immunodeficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Complement proteins are made in the LIVER, not bone marrow.** This is a hereditary deficiency of complement protein production, not a hematologic malignancy.\n\n- Primary complement deficiencies are genetic (autosomal recessive usually)\n- They are NOT caused by malignancy or bone marrow failure\n- The patient has normal blood counts and no features of malignancy\n\nBone marrow biopsy is invasive and not indicated. The diagnosis is already clear from complement studies.", "consequence": "Invasive procedure with no diagnostic value for this condition.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CH50 = 0 (undetectable) with normal C3/C4** indicates terminal complement deficiency (C5-C9). These patients can make antibodies but cannot form the membrane attack complex needed to kill Neisseria."}, "node-3": {"id": "node-3", "type": "decision", "content": "Individual component testing reveals **C6 deficiency** (C6 level undetectable, C5/C7/C8/C9 normal). The diagnosis is confirmed as **C6 deficiency causing terminal complement deficiency**.\n\nThe patient recovers from his current meningitis episode. His parents ask: \"How do we prevent this from happening again? Can he live a normal life?\"\n\n**Management of Terminal Complement Deficiency:**\n\n**1. Vaccination (CRITICAL):**\n- **Meningococcal vaccines**: ALL serogroups (ACWY + B)\n- Must cover serogroups not in standard vaccines (especially B)\n- May need **booster doses more frequently** than normal population\n- Vaccines are NOT fully protective (still lack MAC) but provide SOME protection via opsonization\n\n**2. Antibiotic Prophylaxis:**\n- Consider **daily penicillin or amoxicillin** prophylaxis\n- Similar to asplenia prophylaxis protocols\n- Controversial but often recommended especially in children\n\n**3. Education:**\n- **Fever = Emergency** - seek immediate medical attention\n- Wear medical alert identification\n- Inform all healthcare providers of diagnosis\n\n**4. Family Screening:**\n- Test siblings and parents\n- Autosomal recessive - 25% sibling risk\n- Asymptomatic affected individuals need vaccination", "question": "What is the most important preventive strategy for this patient with confirmed C6 deficiency?", "choices": [{"id": "node-3-choice-a", "text": "Comprehensive meningococcal vaccination (both MenACWY and MenB), antibiotic prophylaxis, medical alert ID, and family screening", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Comprehensive prevention includes:\n\n**1. Meningococcal Vaccination:**\n- **MenACWY vaccine** (covers serogroups A, C, W, Y)\n- **MenB vaccine** (covers serogroup B - often missed!)\n- More frequent boosters than general population (every 3-5 years)\n- Note: Vaccines provide PARTIAL protection only (opsonization works, but MAC still defective)\n\n**2. Antibiotic Prophylaxis:**\n- **Daily penicillin VK or amoxicillin**\n- Continue through childhood at minimum\n- Some experts recommend lifelong prophylaxis\n\n**3. Emergency Preparedness:**\n- **Medical alert bracelet/necklace**\n- **Fever = immediate medical evaluation** and empiric antibiotics\n- Written emergency plan for schools, caregivers\n\n**4. Family Screening:**\n- Test all siblings (25% risk)\n- Identify asymptomatic affected relatives for vaccination\n- Genetic counseling for parents", "consequence": "Comprehensive prevention plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Standard childhood vaccination schedule only; complement deficiency doesn't affect vaccine response", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Standard vaccination is INSUFFICIENT** for complement-deficient patients:\n\n1. **Need BOTH MenACWY AND MenB** - standard schedules may miss MenB\n2. **Need more frequent boosters** - protection wanes faster\n3. **Vaccines are only PARTIALLY effective** - antibodies work for opsonization but cannot kill via MAC\n4. **Need additional protection** (prophylactic antibiotics)\n\nComplement deficiency DOES affect the ultimate effectiveness of vaccines because even perfect antibody response cannot compensate for absent MAC. These patients need an enhanced, not standard, approach.", "consequence": "Inadequate protection leaves child at continued high risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Prophylactic antibiotics only; vaccines don't work without functional complement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While it's true that vaccines are **less effective** without MAC function, they are **NOT useless**:\n\n1. **Antibodies enable OPSONIZATION** - phagocytes can still engulf antibody-coated bacteria\n2. Vaccines **reduce disease severity** even if they don't fully prevent infection\n3. **Some protection is better than none**\n\nThe correct approach is **BOTH vaccination AND prophylactic antibiotics** - a layered defense. Relying on antibiotics alone risks breakthrough infection and antibiotic resistance.", "consequence": "Missed opportunity for additional protection from vaccination.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Bone marrow transplant to cure the complement deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bone marrow transplant does NOT cure complement deficiency.** Key point:\n\n- Complement proteins (including C6) are made in the **LIVER**, not bone marrow\n- Bone marrow transplant changes hematopoietic cells (blood cells), not hepatocytes\n- The C6 gene defect is in the patient's hepatocytes, which would not be replaced by BMT\n\n**Liver transplant** could theoretically cure complement deficiency (new hepatocytes with working gene), but this is NOT done given the risks vs. benefits of vaccination/prophylaxis. Gene therapy may be future option.", "consequence": "BMT would not help and carries significant morbidity/mortality.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Eculizumab (complement inhibitor) to treat the complement deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This shows a fundamental misunderstanding. **Eculizumab INHIBITS complement** (specifically blocks C5 cleavage) - it is used to SUPPRESS complement in diseases of complement OVERactivity (PNH, aHUS).\n\nThis patient has complement DEFICIENCY - giving a complement INHIBITOR would:\n1. Make the problem **WORSE**\n2. Further increase susceptibility to Neisseria\n3. In fact, eculizumab patients must be vaccinated against meningococcus because the drug CAUSES susceptibility similar to genetic deficiency!\n\nThe patient needs complement SUPPORT (vaccination, prophylaxis), not complement suppression.", "consequence": "Would worsen the underlying problem, not treat it.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Terminal complement deficiency requires LAYERED protection:** (1) Meningococcal vaccines (ALL serogroups including B), (2) Antibiotic prophylaxis (daily penicillin), (3) Emergency fever protocol, (4) Medical alert ID. Vaccines help but are NOT fully protective without MAC."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully diagnosed and managed terminal complement deficiency.\n\n**Key Learning Points:**\n\n1. **Recognition Pattern:**\n   - Recurrent Neisseria infections (meningococcal meningitis, disseminated gonococcal infection) = CHECK CH50\n   - This is a HIGH-YIELD board association\n   - 1000-10,000x increased risk of meningococcal disease\n   - Paradoxically LESS severe but MORE RECURRENT infections\n\n2. **Diagnosis:**\n   - **CH50 = 0 (undetectable)** with normal C3/C4 = Terminal complement deficiency\n   - Order individual C5, C6, C7, C8, C9 levels to identify specific defect\n   - Most common: C6 deficiency (especially in African Americans)\n\n3. **Pathophysiology:**\n   - Membrane Attack Complex (C5-C9) creates pores in bacterial membranes\n   - **Only mechanism to kill Neisseria** - no MAC = cannot clear Neisseria\n   - Antibodies and phagocytes alone are insufficient\n\n4. **Management:**\n   - **Meningococcal vaccines ALL serogroups** (ACWY + B) with frequent boosters\n   - **Daily antibiotic prophylaxis** (penicillin)\n   - **Medical alert identification**\n   - **Fever = Emergency**\n   - **Family screening** (autosomal recessive, 25% sibling risk)\n\n5. **NOT Helpful:**\n   - IVIG (doesn't provide complement)\n   - Bone marrow transplant (complement made in liver)\n   - Eculizumab (complement INHIBITOR - would make worse)\n\n**Remember:** Recurrent Neisseria = CH50. This is one of the most testable associations in immunology."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Recognition:**\n- Recurrent Neisseria infections = CHECK CH50 for complement deficiency\n- THREE meningococcal infections is NOT \"bad luck\" - it's pathognomonic for immunodeficiency\n- Family history of early deaths from meningitis supports inherited deficiency\n\n**Diagnosis:**\n- CH50 = 0 with normal C3/C4 = Terminal complement deficiency (C5-C9)\n- Not lab error when it perfectly fits clinical presentation\n- Individual component levels identify specific defect\n\n**Management:**\n- Need comprehensive vaccination (MenACWY + MenB), not just standard schedule\n- Antibiotic prophylaxis is recommended\n- Family screening is essential (25% sibling risk)\n- BMT doesn't help (complement made in liver)\n- IVIG doesn't help (provides antibodies, not complement)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors:**\n\n1. **Dismissing Pattern as \"Bad Luck\":**\n   - THREE meningococcal infections is virtually impossible by chance\n   - This is classic terminal complement deficiency\n   - Failure to diagnose = future preventable deaths\n\n2. **IVIG for Complement Deficiency:**\n   - Complement deficiency \u2260 antibody deficiency\n   - IVIG provides antibodies, which this patient makes normally\n   - The problem is COMPLEMENT, not immunoglobulin\n\n3. **Misdiagnosing as Lupus:**\n   - Lupus has LOW C3/C4 (consumed), not ABSENT CH50 with NORMAL C3/C4\n   - Immunosuppression would be catastrophic for this patient\n\n4. **Eculizumab:**\n   - This INHIBITS complement - would make the deficiency WORSE\n   - Eculizumab is for complement OVERACTIVITY (PNH, aHUS)\n\n5. **Standard Vaccination Only:**\n   - These patients need ENHANCED vaccination (all serogroups, frequent boosters)\n   - Plus antibiotic prophylaxis\n   - Vaccines are NOT fully protective without functional MAC\n\n**Remember:** Recurrent Neisseria = CH50. Treatment is vaccination + prophylaxis, NOT IVIG or complement inhibitors."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-154", "title": "DiGeorge Syndrome (22q11.2 Deletion)", "domain": "rheum_immunology", "difficulty": "advanced", "tags": ["CATCH-22", "absent thymus", "hypocalcemia", "conotruncal defects", "22q11.2 deletion", "T-cell deficiency", "live vaccines", "schizophrenia risk"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 1-week-old male is brought to the emergency department for new-onset seizures.\n\nThe parents report he was born full-term with a heart murmur detected at birth. Today he became increasingly jittery and then had a generalized tonic-clonic seizure lasting 2 minutes. He has been feeding poorly since birth.\n\nPrenatal history reveals a fetal echocardiogram showing interrupted aortic arch.\n\nPhysical Examination:\n- General: newborn with characteristic facies - hypertelorism (widely spaced eyes), short philtrum, low-set posteriorly rotated ears, micrognathia (small jaw)\n- Vitals: HR 150, RR 45, SpO2 85% on room air\n- Cardiovascular: harsh systolic ejection murmur, weak femoral pulses\n- Neurologic: jittery at rest, positive Chvostek sign (facial muscle twitch when tapping facial nerve), positive Trousseau sign\n- CXR: narrow mediastinum with absent thymic shadow", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 1-week-old has: seizures with positive Chvostek and Trousseau signs (suggesting hypocalcemia), a congenital heart defect (interrupted aortic arch), characteristic facial features, and absent thymic shadow on CXR. This constellation should trigger recognition of a specific syndrome.", "question": "What syndrome does this constellation of findings - Cardiac defect, Abnormal facies, Thymic aplasia, Cleft palate (not present here), Hypocalcemia - suggest?", "choices": [{"id": "node-1-choice-a", "text": "DiGeorge Syndrome (22q11.2 deletion) - the 'CATCH-22' mnemonic fits this presentation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is classic **DiGeorge syndrome (22q11.2 deletion syndrome)**. The mnemonic **CATCH-22** captures the key features: **C**ardiac anomalies (conotruncal defects), **A**bnormal facies, **T**hymic aplasia/hypoplasia, **C**left palate, **H**ypocalcemia - chromosome **22**. It's the **most common microdeletion syndrome** (1:4000-6000 births).", "consequence": "You recognize the classic DiGeorge presentation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "CHARGE syndrome", "isOptimal": false, "isAcceptable": true, "feedback": "Good differential, but incorrect. CHARGE syndrome (CHD7 gene) includes: **C**oloboma, **H**eart defects, **A**tresia choanae, **R**etardation of growth, **G**enital hypoplasia, **E**ar anomalies. The **absence of coloboma and choanal atresia** makes CHARGE less likely. Also, CHARGE doesn't cause hypocalcemia from hypoparathyroidism.", "consequence": "CHARGE features compared to presentation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Isolated congenital heart disease with incidental hypocalcemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **combination** of conotruncal heart defect + hypocalcemia + absent thymus + characteristic facies is NOT coincidental - it indicates a **unifying diagnosis**. Isolated CHD doesn't cause hypocalcemia or thymic aplasia. Missing the syndrome diagnosis means missing important immunologic management.", "consequence": "Syndromic features missed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Neonatal sepsis with secondary hypocalcemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sepsis can cause hypocalcemia, but it does NOT explain: the **congenital heart defect**, **characteristic facies**, or **absent thymic shadow**. The constellation of findings is too specific for DiGeorge to attribute to infection. The infant is also afebrile.", "consequence": "Syndromic diagnosis missed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Maternal diabetes embryopathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While maternal diabetes increases cardiac defect risk, it causes **different patterns** (TGA, VSD, cardiomyopathy) and does NOT cause: hypoparathyroidism, thymic aplasia, or the specific DiGeorge facial features. This presentation is too specific for DiGeorge to attribute to diabetic embryopathy.", "consequence": "Syndromic diagnosis missed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CATCH-22 mnemonic**: **C**ardiac anomalies (conotruncal: interrupted aortic arch, TOF, truncus arteriosus), **A**bnormal facies (hypertelorism, short philtrum, low ears), **T**hymic aplasia/hypoplasia, **C**left palate/velopharyngeal insufficiency, **H**ypocalcemia (from hypoparathyroidism) - chromosome **22** (22q11.2 deletion)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect DiGeorge syndrome. Initial labs show:\n- Calcium: 5.8 mg/dL (critically low; normal 8.5-10.5)\n- Ionized calcium: 0.8 mmol/L (low)\n- PTH: 8 pg/mL (inappropriately low/normal for severe hypocalcemia)\n- Phosphorus: elevated\n\nThe hypocalcemia with low PTH confirms hypoparathyroidism.", "question": "What is the embryologic basis for the features of DiGeorge syndrome, and why do parathyroid and thymus problems occur together?", "choices": [{"id": "node-2-choice-a", "text": "22q11.2 deletion disrupts neural crest cell development, affecting 3rd/4th pharyngeal pouches which form thymus and parathyroids", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **22q11.2 deletion** affects genes critical for **neural crest cell** development (especially TBX1). Neural crest cells contribute to: **3rd pharyngeal pouch** (thymus, inferior parathyroids), **4th pharyngeal pouch** (superior parathyroids), and **conotruncal cardiac structures** (outflow tract). This explains why thymus, parathyroids, and heart are all affected together.", "consequence": "You understand the developmental basis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "The deletion directly destroys already-formed thymus and parathyroid tissue", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The deletion doesn't 'destroy' formed organs - it disrupts their **embryonic development**. The organs never form properly because neural crest cells fail to migrate and differentiate correctly. This is a **developmental/organogenesis defect**, not destruction of existing tissue.", "consequence": "Embryologic mechanism misunderstood.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Thymic aplasia causes secondary parathyroid failure through immune mechanisms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The thymic and parathyroid problems are **independent consequences** of the same developmental defect, not causally related to each other. Both organs derive from pharyngeal pouches, and the 22q11.2 deletion affects neural crest cells needed for both. There's no immune-mediated parathyroid destruction.", "consequence": "Causal relationship misunderstood.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Parathyroid hormone gene is located on chromosome 22q11.2", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **PTH gene is on chromosome 11**, not 22. The 22q11.2 deletion causes hypoparathyroidism because it affects **development of the parathyroid glands** (from pharyngeal pouches), not because PTH gene is deleted. The key deleted gene is **TBX1**, which regulates pharyngeal development.", "consequence": "Gene location incorrect.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "The syndrome is caused by maternal infection during pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DiGeorge syndrome is a **genetic disorder** caused by deletion of chromosome 22q11.2, not by infection. **90% of cases are de novo** (new mutations), while **10% are inherited** in an autosomal dominant pattern. Maternal infection can cause other congenital problems (TORCH) but not DiGeorge.", "consequence": "Etiology misunderstood.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Embryology of DiGeorge**: Neural crest cells + pharyngeal pouches. **3rd pouch** \u2192 thymus + inferior parathyroids. **4th pouch** \u2192 superior parathyroids. **Neural crest** \u2192 conotruncal heart structures. **TBX1** gene on 22q11.2 is critical for pharyngeal development. This explains why thymus, parathyroids, AND heart are affected together!"}, "node-3": {"id": "node-3", "type": "decision", "content": "You need to manage the acute hypocalcemia while also addressing the cardiac defect and planning for confirmation of the diagnosis.\n\nThe infant's seizures have stopped after initial stabilization but he remains jittery.", "question": "What is the immediate priority and how should hypocalcemia be managed in DiGeorge syndrome?", "choices": [{"id": "node-3-choice-a", "text": "Treat symptomatic hypocalcemia with IV calcium gluconate, then maintain with oral calcium and calcitriol (active vitamin D)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Acute symptomatic hypocalcemia** (seizures, tetany) requires **IV calcium gluconate** (100-200 mg/kg slow IV push with cardiac monitoring). Maintenance: **oral calcium supplements** + **calcitriol** (1,25-dihydroxyvitamin D) - NOT regular vitamin D, because these patients lack PTH needed to convert 25-OH to active 1,25-OH vitamin D. Lifelong supplementation usually required.", "consequence": "Hypocalcemia appropriately treated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Give regular vitamin D (cholecalciferol) - it will eventually correct the calcium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Regular vitamin D is **ineffective** in DiGeorge-associated hypoparathyroidism because these patients **lack PTH**. PTH is required to activate the 1-alpha-hydroxylase enzyme that converts 25-OH vitamin D to active **1,25-OH vitamin D (calcitriol)**. Must give **calcitriol directly** to bypass this block.", "consequence": "Ineffective vitamin D form given.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Oral calcium supplements alone are sufficient for acute management", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Symptomatic hypocalcemia** (seizures, tetany, cardiac arrhythmias) requires **IV calcium** for rapid correction. Oral absorption is too slow for acute management. Once stabilized, transition to oral calcium + calcitriol for maintenance, but acute treatment must be IV.", "consequence": "Inadequate acute treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "PTH replacement therapy", "isOptimal": false, "isAcceptable": true, "feedback": "Recombinant PTH (teriparatide) exists but is **not first-line** for DiGeorge-associated hypoparathyroidism. Standard management is **calcium + calcitriol** supplementation. PTH therapy may be considered in refractory cases but is expensive, requires injections, and long-term pediatric data is limited.", "consequence": "PTH therapy is not first-line.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Magnesium supplementation will correct the hypocalcemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While hypomagnesemia can cause **functional hypoparathyroidism** (and should be checked), DiGeorge syndrome causes **primary hypoparathyroidism** due to parathyroid gland aplasia/hypoplasia. Magnesium repletion won't fix missing parathyroid glands. The problem is structural, not functional.", "consequence": "Underlying cause not addressed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hypocalcemia management in DiGeorge**: **Acute**: IV calcium gluconate (cardiac monitoring!). **Maintenance**: Oral calcium + **CALCITRIOL** (NOT regular vitamin D - no PTH means can't activate vitamin D!). Monitor for hypercalcemia/hypercalciuria. Some patients' hypoparathyroidism **improves with age** (partial parathyroid development)."}, "node-4": {"id": "node-4", "type": "decision", "content": "Hypocalcemia is corrected. The cardiology team is managing the interrupted aortic arch with prostaglandin E1 to maintain ductal patency pending surgical repair.\n\nYou now need to address the immunologic implications of thymic aplasia.", "question": "What is the immunologic defect in DiGeorge syndrome, and what are the critical vaccination considerations?", "choices": [{"id": "node-4-choice-a", "text": "T-cell deficiency from thymic aplasia; AVOID live vaccines until T-cell function is assessed", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Thymic aplasia/hypoplasia causes **T-cell lymphopenia** (variable severity). The immunodeficiency is primarily **cellular (T-cell)**, not humoral (B-cells are present but may not function optimally without T-cell help). **CRITICAL**: Avoid **live vaccines** (MMR, varicella, rotavirus, BCG, live influenza) until T-cell counts and function are assessed. Some patients need **PCP prophylaxis** if severely T-cell depleted.", "consequence": "Appropriate immunologic precautions taken.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "B-cell deficiency requiring IVIG replacement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DiGeorge syndrome primarily causes **T-cell deficiency** from thymic aplasia, not B-cell deficiency. B-cells are typically present, though they may not function optimally without T-cell help. IVIG is NOT routinely indicated unless there's documented severe antibody deficiency (rare in typical DiGeorge).", "consequence": "Immune defect type misidentified.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "No immunodeficiency - thymic aplasia has no immune consequences", "isOptimal": false, "isAcceptable": false, "feedback": "**Dangerously incorrect!** The thymus is essential for T-cell maturation. Thymic aplasia/hypoplasia causes **variable T-cell lymphopenia** - from mild (most patients) to severe (rare 'complete DiGeorge' with <50 T-cells/\u03bcL requiring thymic transplant). Ignoring immunodeficiency risks severe infections from live vaccines or opportunistic pathogens.", "consequence": "Life-threatening immune deficiency ignored.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "All vaccines should be given on normal schedule regardless of immune status", "isOptimal": false, "isAcceptable": false, "feedback": "**Dangerous!** **Live vaccines are contraindicated** until T-cell function is assessed. Giving live vaccines (MMR, varicella, rotavirus) to a T-cell deficient patient can cause **disseminated, potentially fatal infections** from the vaccine strains. Inactivated vaccines are safe but may be less effective.", "consequence": "Risk of vaccine-strain infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Neutrophil deficiency requiring G-CSF", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DiGeorge syndrome does NOT cause neutrophil deficiency - neutrophils develop in the bone marrow, not thymus. The immune defect is **T-cell (lymphocyte)** based from thymic problems. G-CSF is not indicated.", "consequence": "Wrong cell lineage identified.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**DiGeorge immunology**: **T-cell deficiency** (variable severity). **AVOID LIVE VACCINES** until T-cells assessed: MMR, varicella, rotavirus, oral polio, BCG. **Complete DiGeorge** (<50 T-cells/\u03bcL, <1% of patients) may need **thymic transplant**. Most patients have 'partial DiGeorge' with mild-moderate deficiency that improves with age. PCP prophylaxis if CD4 <200."}, "node-5": {"id": "node-5", "type": "decision", "content": "T-cell studies show CD3+ count of 800/\u03bcL (low normal range), indicating partial DiGeorge syndrome. Genetic testing confirms 22q11.2 deletion. The cardiac surgery was successful.\n\nThe family asks about long-term prognosis and what to expect.", "question": "What are the key long-term considerations for patients with DiGeorge syndrome?", "choices": [{"id": "node-5-choice-a", "text": "Multidisciplinary follow-up for cardiac, immune, endocrine, developmental, and psychiatric issues - 25-30% develop schizophrenia by adulthood", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! DiGeorge syndrome requires **lifelong multidisciplinary care**: (1) **Cardiology** - surgical outcomes, residual defects; (2) **Immunology** - T-cell monitoring, infection prevention; (3) **Endocrinology** - calcium/PTH monitoring; (4) **Development** - learning disabilities common, speech therapy for VPI; (5) **PSYCHIATRY** - **25-30% develop schizophrenia/psychosis** by adulthood - highest psychiatric risk of any genetic syndrome!", "consequence": "Comprehensive long-term plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Once the heart is repaired, no further follow-up is needed", "isOptimal": false, "isAcceptable": false, "feedback": "**Dangerously incomplete!** Cardiac repair is just one aspect. These patients need **lifelong monitoring** for: immune function, calcium levels (may change with age), developmental delays, speech problems (velopharyngeal insufficiency), and critically - **psychiatric disorders** (25-30% schizophrenia risk). DiGeorge is a multisystem syndrome requiring multidisciplinary care.", "consequence": "Multiple complications missed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Prognosis is universally poor with most patients dying in childhood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Prognosis is **variable but generally good** with modern management. Most patients with **partial DiGeorge** (majority) have **normal or near-normal life expectancy**. Mortality is mainly from severe cardiac defects (if present) or rare complete DiGeorge. Most patients live into adulthood with appropriate multidisciplinary care.", "consequence": "Unnecessarily pessimistic prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Immune function will definitely worsen over time requiring eventual transplant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Actually, T-cell function often **IMPROVES with age** in partial DiGeorge, as extrathymic T-cell development and residual thymic tissue compensate. Only **complete DiGeorge** (<1% of patients) may require thymic transplant. The trend is usually toward improvement, not worsening.", "consequence": "Immune trajectory misunderstood.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Psychiatric problems are rare and not a significant concern", "isOptimal": false, "isAcceptable": false, "feedback": "**Critically incorrect!** DiGeorge syndrome has the **highest schizophrenia risk of any genetic condition** - **25-30% develop schizophrenia or psychosis** by adulthood. This is 25x the general population risk! Psychiatric monitoring and early intervention are essential parts of long-term care.", "consequence": "Major psychiatric risk ignored.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**DiGeorge long-term**: Multidisciplinary care essential! (1) **Cardiac** - 75-80% have defects; (2) **Immune** - often improves with age; (3) **Calcium** - lifelong monitoring, may improve; (4) **Development** - learning disabilities, speech therapy for VPI; (5) **PSYCHIATRY** - **25-30% schizophrenia** by adulthood (highest of any genetic syndrome!). Most patients have good outcomes with comprehensive care."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You recognized the CATCH-22 features, understood the embryologic basis, appropriately managed hypocalcemia, took proper immunologic precautions, and established comprehensive long-term follow-up.\n\n**Key teaching points:**\n\u2022 **CATCH-22**: Cardiac, Abnormal facies, Thymic aplasia, Cleft palate, Hypocalcemia - chromosome 22\n\u2022 **Embryology**: 22q11.2 deletion affects neural crest \u2192 pharyngeal pouch derivatives (thymus, parathyroids, conotruncal heart)\n\u2022 **Hypocalcemia**: Treat with calcium + CALCITRIOL (not regular vitamin D - no PTH to activate it!)\n\u2022 **Immunology**: T-cell deficiency - AVOID LIVE VACCINES until assessed\n\u2022 **Psychiatric risk**: 25-30% develop schizophrenia - highest of any genetic syndrome\n\u2022 **Prognosis**: Good with multidisciplinary care; most have partial DiGeorge with near-normal life expectancy"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review DiGeorge syndrome key principles:\n\n\u2022 **CATCH-22**: Cardiac, Abnormal facies, Thymic aplasia, Cleft palate, Hypocalcemia\n\u2022 **Cause**: 22q11.2 deletion affecting neural crest development\n\u2022 **Hypocalcemia**: Use CALCITRIOL (active vitamin D) - not regular vitamin D\n\u2022 **Immunology**: T-cell deficiency - avoid live vaccines!\n\u2022 **Long-term**: Cardiac, immune, endocrine, developmental, PSYCHIATRIC (25-30% schizophrenia)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management errors occurred. Review dangerous pitfalls:\n\n\u2022 **NEVER give live vaccines** without T-cell assessment - risk of disseminated vaccine-strain infection\n\u2022 **Thymic aplasia = T-cell deficiency** - this IS an immunodeficiency\n\u2022 **Oral calcium alone is inadequate** for acute symptomatic hypocalcemia - need IV calcium\n\u2022 **DiGeorge is a MULTISYSTEM syndrome** - cardiac repair alone is insufficient\n\u2022 **25-30% develop SCHIZOPHRENIA** - psychiatric monitoring is essential\n\nKey pearl: DiGeorge requires lifelong multidisciplinary care. Missing any component (immune, endocrine, cardiac, psychiatric) puts the patient at risk."}}, "rootNodeId": "node-1"}], "endocrine": [{"id": "vignette-lens-peds-012", "title": "DKA Initial Management", "domain": "endocrine", "difficulty": "intermediate", "tags": ["Kussmaul breathing", "fruity breath", "polyuria/polydipsia", "dka initial management", "cerebral edema", "potassium paradox"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 12-year-old male presents to the ED with vomiting and confusion of 1 day duration.\n\nPer the mother, he has known type 1 diabetes and has been sick with a stomach bug for 2 days. He has been vomiting and unable to keep down fluids. This morning he became increasingly confused and lethargic.\n\nAssociated symptoms include abdominal pain, rapid breathing, and fruity breath odor. Denies fever or diarrhea.\n\nMedical history: Diagnosed with type 1 diabetes 2 years ago. Last HbA1c was 9.5%.\n\nPhysical Examination:\n- General: Lethargic, dehydrated adolescent with fruity breath odor.\n- Vitals: HR 120, RR 32 (deep, rapid), BP 95/60.\n- Respiratory: Kussmaul respirations.\n- Neurologic: Confused, responds to verbal stimuli, GCS 13.\n- Skin: Poor turgor, dry mucous membranes, delayed capillary refill.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Initial labs return:\n- Glucose: 450 mg/dL\n- pH: 7.18 (venous)\n- HCO3: 10 mEq/L\n- Anion gap: 24\n- Serum K+: 5.8 mEq/L\n- BUN/Cr: 28/1.2\n- Serum ketones: Large positive", "question": "Based on the clinical presentation and labs, what is the diagnosis and severity?", "choices": [{"id": "node-1-choice-a", "text": "Moderate DKA (pH 7.1-7.24, HCO3 10-15)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is moderate DKA: glucose >250, pH 7.18 (7.1-7.24 = moderate), HCO3 10 (10-15 = moderate), elevated anion gap with ketosis. The DKA triad: hyperglycemia + acidosis + ketosis.", "consequence": "Proceed to initial management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Mild DKA (pH 7.25-7.30)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Mild DKA has pH 7.25-7.30 and HCO3 15-18. This patient has pH 7.18 and HCO3 10, which is moderate severity.", "consequence": "Underestimating severity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Severe DKA (pH <7.1)", "isOptimal": false, "isAcceptable": true, "feedback": "Close but not quite. Severe DKA has pH <7.1 and/or HCO3 <10. This patient has pH 7.18, which falls in the moderate category. However, aggressive treatment is still appropriate.", "consequence": "Slightly overestimating severity, but appropriate caution.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Hyperosmolar Hyperglycemic State (HHS)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HHS has: glucose often >600, minimal ketosis, serum osm >320, and mild acidosis. This patient has significant ketosis and metabolic acidosis, consistent with DKA.", "consequence": "Wrong diagnosis affects treatment approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Sepsis with lactic acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sepsis can trigger DKA, this patient has the classic DKA presentation: known T1DM, hyperglycemia, Kussmaul breathing, fruity breath, and significant ketosis. The elevated anion gap is from ketoacids, not lactate.", "consequence": "Missed diagnosis of DKA.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "DKA severity by pH: Mild 7.25-7.30, Moderate 7.1-7.24, Severe <7.1. DKA criteria: glucose >250, pH <7.3, HCO3 <18, anion gap >12, ketosis."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have confirmed moderate DKA. The patient is dehydrated and confused. His initial K+ is 5.8 mEq/L.", "question": "What is the most appropriate FIRST step in management?", "choices": [{"id": "node-2-choice-a", "text": "IV normal saline bolus (10-20 mL/kg) for fluid resuscitation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! FLUIDS BEFORE INSULIN. Initial fluid resuscitation with 10-20 mL/kg NS bolus restores intravascular volume and improves perfusion. This is critical before starting insulin to prevent cardiovascular collapse and cerebral edema.", "consequence": "Volume resuscitation initiated. Patient's perfusion improves.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "IV insulin bolus followed by insulin drip", "isOptimal": false, "isAcceptable": false, "feedback": "CRITICAL ERROR. In pediatric DKA, insulin bolus is NEVER given - it increases cerebral edema risk. Also, insulin before adequate fluid resuscitation can cause cardiovascular collapse and precipitous K+ drop. FLUIDS FIRST.", "consequence": "Increased risk of cerebral edema and arrhythmia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "IV potassium replacement immediately (K+ is only 5.8)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Although total body K+ is depleted in DKA, the serum K+ of 5.8 is elevated due to transcellular shift from acidosis. Giving K+ now risks hyperkalemic arrhythmia. Start K+ replacement when K+ <5.2 and urine output is adequate.", "consequence": "Risk of hyperkalemic cardiac arrest.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "IV bicarbonate to correct acidosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Bicarbonate is NOT routinely recommended in pediatric DKA (increases cerebral edema risk, causes paradoxical CNS acidosis, and shifts K+ into cells). Reserve for pH <6.9 with hemodynamic instability.", "consequence": "Increased cerebral edema risk without benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Intubation for airway protection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. GCS is 13 and he responds to verbal stimuli - airway is protected. Kussmaul respirations are compensatory for acidosis. Intubation in DKA is dangerous: eliminating respiratory compensation can worsen acidosis rapidly.", "consequence": "Unnecessary intubation with significant risks.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "FLUIDS BEFORE INSULIN. Always. Give 10-20 mL/kg NS bolus first. NO insulin bolus in pediatric DKA. NO bicarbonate unless pH <6.9 with shock."}, "node-3": {"id": "node-3", "type": "decision", "content": "After fluid bolus, the patient's BP is 105/65 and perfusion has improved. You are ready to start insulin.\n\nCurrent labs (1 hour after admission):\n- Glucose: 420 mg/dL\n- K+: 5.2 mEq/L (trending down)\n- pH: 7.15 (still acidotic)\n- Anion gap: 22", "question": "What is the appropriate approach to insulin therapy and potassium management?", "choices": [{"id": "node-3-choice-a", "text": "Start insulin drip at 0.05-0.1 U/kg/hr; add K+ to IV fluids since K+ is 5.2", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Start insulin infusion (NO bolus) at 0.05-0.1 U/kg/hr after fluid resuscitation. Since K+ is now 5.2 and trending down, add 20-40 mEq/L K+ to maintenance fluids (insulin drives K+ into cells, causing levels to drop rapidly).", "consequence": "Appropriate insulin and K+ management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Give insulin bolus 0.1 U/kg, then start drip at 0.1 U/kg/hr", "isOptimal": false, "isAcceptable": false, "feedback": "CRITICAL ERROR. Insulin bolus is NEVER given in pediatric DKA - it significantly increases cerebral edema risk. Start with infusion only at 0.05-0.1 U/kg/hr.", "consequence": "Increased cerebral edema risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Hold insulin until K+ drops below 4.0 mEq/L", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Delaying insulin prolongs ketoacidosis. K+ 5.2 is safe to start insulin - just add K+ to maintenance fluids. The key is to add K+ when level is <5.2 (or even prophylactically if trending down).", "consequence": "Prolonged acidosis and ketosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Start insulin at 0.1 U/kg/hr; hold K+ since level is still >5.0", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. The insulin rate is appropriate, but you should start K+ replacement when K+ <5.2 (which it is now). Insulin causes rapid intracellular K+ shift - waiting too long risks dangerous hypokalemia.", "consequence": "Risk of hypokalemia if K+ not added promptly.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Give subcutaneous insulin and transition to oral fluids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DKA requires IV insulin drip for precise control. Subcutaneous absorption is unpredictable in dehydrated patients. IV fluids are necessary until acidosis resolves and patient tolerates PO.", "consequence": "Inadequate treatment and unpredictable glucose control.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The K+ paradox: Serum K+ appears normal/high in DKA but total body K+ is severely depleted. Insulin drives K+ into cells rapidly. Start K+ replacement when serum K+ <5.2 mEq/L to prevent dangerous hypokalemia."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 6 hours of treatment:\n- Glucose: 180 mg/dL (was 450)\n- pH: 7.32 (normalizing)\n- HCO3: 18 mEq/L\n- Anion gap: 12 (closed)\n- K+: 4.2 mEq/L\n- Mental status: Alert, oriented\n- Tolerating sips of water\n\nSuddenly, the patient complains of a new headache, becomes irritable, and you notice subtle bradycardia (HR 58).", "question": "What is the most concerning complication, and what is the immediate management?", "choices": [{"id": "node-4-choice-a", "text": "Cerebral edema - Give hypertonic saline (3%) or mannitol, elevate HOB, reduce IV fluids", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The most feared complication of pediatric DKA: cerebral edema. Signs include headache, irritability, altered mental status, bradycardia, hypertension (Cushing response), and pupillary changes. Treatment: 3% saline 2-5 mL/kg OR mannitol 0.5-1 g/kg, elevate head of bed, reduce IV rate, consider intubation if deteriorating.", "consequence": "Cerebral edema treated promptly. Order STAT head CT.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Hypoglycemia - Give D50W bolus and stop insulin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Glucose is 180 mg/dL - this is not hypoglycemia. The constellation of headache, irritability, and bradycardia in resolving DKA is classic for cerebral edema, not hypoglycemia.", "consequence": "Missed cerebral edema - life-threatening.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Resolution of DKA - Transition to subcutaneous insulin", "isOptimal": false, "isAcceptable": false, "feedback": "CRITICAL ERROR. While the metabolic parameters are improving, the NEW symptoms (headache, irritability, bradycardia) are red flags for cerebral edema. Never ignore these warning signs - cerebral edema can be rapidly fatal.", "consequence": "Missed cerebral edema - high mortality risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Hypokalemia - Give IV potassium bolus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. K+ is 4.2 mEq/L - this is normal. The symptoms described (headache, bradycardia) are NOT consistent with hypokalemia. This is cerebral edema presentation.", "consequence": "Missed cerebral edema.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Anxiety/headache - Give acetaminophen and reassure", "isOptimal": false, "isAcceptable": false, "feedback": "CRITICAL ERROR. In a child recovering from DKA, new headache + neurologic changes = cerebral edema until proven otherwise. This is a medical emergency with mortality up to 25%. Never dismiss these symptoms.", "consequence": "Potentially fatal delay in treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Cerebral edema is the most feared complication of pediatric DKA (mortality 20-25%). Risk factors: young age, new-onset DM, severe acidosis, rapid fluid/glucose correction. Warning signs: headache, confusion, bradycardia, hypertension, pupil changes. Treat immediately with hypertonic saline or mannitol."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully managed this DKA case and recognized the life-threatening complication of cerebral edema.\n\nKey Learning Points:\n1. FLUIDS BEFORE INSULIN - Always (10-20 mL/kg NS bolus first)\n2. NO insulin bolus in pediatric DKA (increases cerebral edema risk)\n3. K+ paradox: Serum K+ appears normal but total body K+ is depleted\n4. Add K+ to fluids when serum K+ <5.2 mEq/L\n5. Cerebral edema: headache + altered mental status + bradycardia = emergency\n6. Treat cerebral edema with hypertonic saline (3%) or mannitol\n\nOutcome: With prompt recognition and treatment of cerebral edema, the patient stabilizes. Head CT shows mild diffuse cerebral edema without herniation. He makes a full recovery and is transitioned to subcutaneous insulin the following day."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points in pediatric DKA management:\n\n- Fluids FIRST, then insulin (prevents cardiovascular collapse)\n- NO insulin bolus in children (increases cerebral edema risk)\n- K+ management is critical: appears high but total body depleted\n- Start K+ replacement when serum K+ <5.2 mEq/L\n- Avoid bicarbonate (increases cerebral edema risk)\n- Monitor closely for cerebral edema (headache, altered MS, bradycardia)\n\nKey pearl: Fluids before insulin. Always."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in DKA management.\n\nRemember the key principles:\n1. FLUIDS BEFORE INSULIN - Always\n2. NO insulin bolus in pediatric DKA\n3. Cerebral edema is the FEARED complication (20-25% mortality)\n4. Warning signs: new headache, irritability, bradycardia, obtundation, pupil changes\n5. Treat cerebral edema immediately: 3% saline or mannitol\n\nRisk factors for cerebral edema:\n- Young age (<5 years)\n- New-onset diabetes\n- Severe acidosis (pH <7.1)\n- High BUN\n- Rapid fluid administration\n- Failure of Na to rise with treatment\n\nKey pearl: Any neurologic change during DKA treatment = cerebral edema until proven otherwise."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-046", "title": "Congenital Hypothyroidism", "domain": "endocrine", "difficulty": "intermediate", "tags": ["prolonged neonatal jaundice", "macroglossia", "umbilical hernia", "large anterior fontanelle", "congenital hypothyroidism"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 2-week-old female presents with abnormal newborn screening.\n\nHistory reveals, she is feeding slowly and seems sleepy most of the time. She has constipation and her cry is hoarse. The newborn screening showed elevated TSH.\n\nAssociated symptoms include prolonged jaundice and constipation. Denies fever or respiratory distress.\n\nPast medical history includes She was born at 41 weeks weighing 4.2 kg. No family history of thyroid disease.\n\nPhysical Examination:\n- General: large, quiet infant with coarse facial features, macroglossia, and hypotonia.\n- Abdomen: distended with umbilical hernia.\n- Skin: jaundiced, cool, mottled, with delayed capillary refill.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-week-old has classic features of congenital hypothyroidism: **prolonged jaundice**, **macroglossia**, **umbilical hernia**, **constipation**, **hypotonia**, and **coarse facial features**. The newborn screen showed elevated TSH.", "question": "What is the MOST COMMON cause of congenital hypothyroidism?", "choices": [{"id": "node-1-choice-a", "text": "Thyroid dysgenesis (aplasia, hypoplasia, or ectopic thyroid) - accounts for 85% of cases", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Thyroid dysgenesis** (failure of normal thyroid development) accounts for **85% of congenital hypothyroidism**. Types include: **aplasia** (absent thyroid), **hypoplasia** (small thyroid), and **ectopic thyroid** (usually lingual or sublingual). This is typically **sporadic** (not inherited).", "consequence": "You understand the most common etiology.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Dyshormonogenesis (enzyme defects in thyroid hormone synthesis)", "isOptimal": false, "isAcceptable": true, "feedback": "This accounts for only **10-15%** of cases. Dyshormonogenesis includes enzyme defects like **thyroid peroxidase deficiency** or **thyroglobulin defects**. Unlike dysgenesis, these are **autosomal recessive** and the thyroid gland is present (often enlarged as goiter).", "consequence": "Less common cause but important to know.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Maternal antithyroid antibodies crossing placenta", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While maternal **TSH receptor-blocking antibodies** can cause **transient** neonatal hypothyroidism, this is rare and resolves as maternal antibodies clear (weeks to months). This infant has classic permanent congenital hypothyroidism features.", "consequence": "This causes transient, not permanent hypothyroidism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Central (pituitary) hypothyroidism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Central hypothyroidism (pituitary TSH deficiency) is rare (<5%) and would show **LOW TSH** with low T4. This infant has **elevated TSH** on newborn screen, indicating **primary** thyroid failure (the pituitary is trying to stimulate a failing thyroid).", "consequence": "TSH would be low in central hypothyroidism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Iodine deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Iodine deficiency is the **most common worldwide cause** of preventable hypothyroidism but is **rare in developed countries** due to iodized salt. In the US, thyroid dysgenesis is the most common cause.", "consequence": "Rare in developed countries with iodized salt.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Congenital hypothyroidism etiologies**: **Dysgenesis 85%** (aplasia, hypoplasia, ectopic - sporadic), **Dyshormonogenesis 10-15%** (enzyme defects - autosomal recessive, may have goiter), **Central <5%** (low TSH), **Transient** (maternal antibodies, iodine excess/deficiency)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Confirmatory labs show: **TSH 85 mU/L** (normal <10), **free T4 0.3 ng/dL** (normal 0.9-2.3). The diagnosis of primary congenital hypothyroidism is confirmed. Treatment must begin **urgently** to prevent irreversible neurological damage.", "question": "What is the FIRST step in management of confirmed congenital hypothyroidism?", "choices": [{"id": "node-2-choice-a", "text": "Start levothyroxine 10-15 mcg/kg/day IMMEDIATELY - do NOT wait for imaging", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Levothyroxine 10-15 mcg/kg/day** must be started **immediately** upon diagnosis. The goal is to normalize T4 within **2 weeks** and TSH within **1 month**. **DO NOT delay treatment** for thyroid imaging or other workup - every day of delay increases risk of **permanent intellectual disability**.", "consequence": "Treatment started promptly to protect neurodevelopment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Order thyroid ultrasound and nuclear scan before starting treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **NEVER delay treatment** for imaging. Thyroid imaging (ultrasound, Tc-99m scan) can help determine etiology but is **NOT required** before treatment. The critical window for brain development cannot be recovered - start levothyroxine immediately.", "consequence": "Dangerous delay - brain development is time-sensitive.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Start low-dose levothyroxine 2-3 mcg/kg/day and titrate slowly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Low-dose replacement is **inadequate** for congenital hypothyroidism. Infants need **10-15 mcg/kg/day** (much higher than adult dosing per kg) because rapid brain myelination requires high thyroid hormone levels. Under-treatment leads to **cognitive deficits**.", "consequence": "Inadequate dosing fails to protect neurodevelopment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Repeat thyroid function tests in 1-2 weeks to confirm diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! With classic clinical features AND abnormal newborn screen AND confirmatory labs showing elevated TSH with low T4, the diagnosis is confirmed. **Repeat testing wastes critical time**. Treatment should begin within the **first 2 weeks of life** ideally.", "consequence": "Dangerous delay - irreversible brain damage may occur.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start liothyronine (T3) instead of levothyroxine (T4)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Levothyroxine (T4)** is the treatment of choice, not liothyronine (T3). T4 is converted to T3 in tissues including the brain. T4 has a longer half-life providing stable levels, while T3 causes fluctuating levels and is harder to monitor.", "consequence": "Wrong medication - T4 is standard of care.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Congenital hypothyroidism treatment urgency**: Start **levothyroxine 10-15 mcg/kg/day immediately** - do NOT delay for imaging. Goal: normalize **T4 in 2 weeks**, **TSH in 1 month**. Treatment started **<2 weeks of life** = **normal IQ**. Each week of delay = **~4 IQ point loss**."}, "node-3": {"id": "node-3", "type": "decision", "content": "Levothyroxine 15 mcg/kg/day is started. The infant is feeding levothyroxine **crushed and mixed with breast milk** (NOT soy formula). At **2 weeks of treatment**, labs show: T4 1.8 ng/dL (normal), TSH 25 mU/L (still elevated).", "question": "What is the appropriate next step in monitoring and management?", "choices": [{"id": "node-3-choice-a", "text": "Continue current dose - TSH lags behind T4 normalization and will decrease over 1-2 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **TSH normalization lags behind T4** - this is expected. The T4 has normalized (goal achieved at 2 weeks), and TSH will gradually decrease over **1-4 months**. Continue the current dose and recheck in **2-4 weeks**. Monitoring schedule: every **1-2 weeks** until T4 normal, then every **1-2 months** in first year.", "consequence": "Appropriate monitoring approach.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Increase levothyroxine dose to normalize TSH faster", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The T4 is already normalized, which is the primary treatment goal. Increasing the dose would cause **hyperthyroidism** (tachycardia, irritability, poor weight gain, craniosynostosis with chronic overtreatment). TSH suppression follows T4 normalization over weeks.", "consequence": "Over-treatment causes iatrogenic hyperthyroidism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Decrease dose since T4 is normalized", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The current dose is achieving the target T4. Decreasing would cause **under-treatment** and risk neurodevelopmental harm. The elevated TSH will normalize over time with the current adequate T4 levels.", "consequence": "Under-treatment risks cognitive outcomes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Add liothyronine (T3) to help suppress TSH", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Combination T4/T3 therapy is NOT recommended** in congenital hypothyroidism. T4 monotherapy is standard of care. The brain converts T4 to T3 locally. Adding T3 causes unstable levels and complicates monitoring.", "consequence": "Not standard of care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Switch to IV levothyroxine for better absorption", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Oral levothyroxine is well-absorbed when given correctly (crushed, with breast milk or water, **NOT with soy or iron**). IV formulation is reserved for patients who cannot take oral medications. The T4 level shows the current oral dosing is effective.", "consequence": "Unnecessary - oral absorption is adequate.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Monitoring congenital hypothyroidism**: Check **T4 and TSH** every **1-2 weeks** until T4 normalized, then every **1-2 months** in first year, every **2-3 months** ages 1-3, then every **3-12 months**. **T4 normalizes in ~2 weeks**, **TSH may take 1-4 months**. Avoid giving levothyroxine with **soy formula** or **iron** (impair absorption)."}, "node-4": {"id": "node-4", "type": "decision", "content": "At **12 months of age**, the infant has been on levothyroxine with excellent adherence. Growth and development are normal. T4 and TSH are stable in normal range. The mother asks about long-term prognosis and whether treatment can ever be stopped.", "question": "What do you tell the parents about prognosis and treatment duration?", "choices": [{"id": "node-4-choice-a", "text": "Treatment is lifelong for permanent hypothyroidism; prognosis excellent if treated early", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Permanent congenital hypothyroidism requires lifelong levothyroxine**. The excellent news: children treated within **2 weeks of life** achieve **normal IQ and development**. This infant was diagnosed via newborn screen and treated promptly - prognosis is excellent. The dose will need adjustment as the child grows.", "consequence": "Family understands the excellent prognosis with continued treatment.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Can trial off medication at age 3 to reassess if hypothyroidism is transient", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. A **medication trial-off at age 3** is appropriate ONLY if there is suspicion of **transient hypothyroidism** (e.g., borderline labs, eutopic thyroid on imaging, maternal thyroid disease). For this infant with classic dysgenesis, permanent hypothyroidism is presumed and treatment is lifelong.", "consequence": "Trial-off only appropriate for suspected transient cases.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Treatment only needed until brain development is complete around age 3", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While brain development is most critical in the first 3 years, **thyroid hormone is essential for life**. It regulates metabolism, growth, cardiac function, and many other processes. Stopping treatment would cause hypothyroidism symptoms and complications at any age.", "consequence": "Dangerous misconception - treatment is lifelong.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Prognosis is guarded - most children have some developmental delay despite treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! With **newborn screening and early treatment**, prognosis is **excellent**. Studies show children treated within the first 2 weeks of life have **normal IQ** and development. Developmental concerns only arise with **delayed diagnosis** or **inadequate treatment**.", "consequence": "Unnecessarily pessimistic - outcomes are excellent with early treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Monitor for thyroid cancer since the thyroid gland is abnormal", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Thyroid dysgenesis (aplasia, hypoplasia, ectopy) is NOT a risk factor for thyroid cancer. Thyroid cancer screening is indicated in conditions like **familial syndromes** (MEN2, Cowden) or **radiation exposure**, not congenital hypothyroidism.", "consequence": "Thyroid cancer risk is not elevated in dysgenesis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Congenital hypothyroidism prognosis**: Treatment **<2 weeks of life** = **normal IQ and development**. Delay in treatment: each week = ~4 IQ point loss. **Permanent hypothyroidism** (dysgenesis, dyshormonogenesis) = **lifelong levothyroxine**. **Transient hypothyroidism** (maternal antibodies) = may trial off at age 3. Dose increases needed as child grows."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **congenital hypothyroidism**. Key learning points: 1) **Dysgenesis accounts for 85%** of cases (aplasia, hypoplasia, ectopy - sporadic). 2) Start **levothyroxine 10-15 mcg/kg/day IMMEDIATELY** - do NOT delay for imaging. 3) Goal: **T4 normal in 2 weeks**, TSH normal in 1-4 months. 4) **Treatment <2 weeks of life** = normal IQ and development. 5) Most cases require **lifelong treatment**. Newborn screening has revolutionized outcomes - early treatment prevents intellectual disability."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key features of congenital hypothyroidism: **prolonged jaundice**, **macroglossia**, **umbilical hernia**, **hypotonia**, **constipation**, **coarse facies**, large fontanelles. Remember: **NEVER delay treatment for imaging** - start levothyroxine immediately. Each week of delay = ~4 IQ points lost. Dose: **10-15 mcg/kg/day** (higher than adults per kg)."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. **Congenital hypothyroidism** is a MEDICAL EMERGENCY for neurodevelopment. Newborn screening catches most cases before clinical signs appear. Critical points: Start **levothyroxine 10-15 mcg/kg/day within 2 weeks of life** for optimal outcomes. **T4 is the treatment** (not T3). Avoid soy formula and iron with levothyroxine (impair absorption)."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-047", "title": "Congenital Adrenal Hyperplasia - 21-Hydroxylase Deficiency", "domain": "endocrine", "difficulty": "advanced", "tags": ["congenital adrenal hyperplasia", "21-hydroxylase deficiency", "salt-wasting crisis", "adrenal insufficiency", "ambiguous genitalia", "17-OHP", "stress dosing"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 12-day-old infant is brought to the emergency department by parents for poor feeding, vomiting, and lethargy.\n\nHistory: The baby was born full-term after an uncomplicated pregnancy and delivery. She seemed healthy at birth and was discharged at 48 hours. Newborn screening was sent. Over the past 4 days, she has been feeding poorly, vomiting after feeds, and becoming increasingly sleepy. Today she barely woke up to feed.\n\nFamily history: The parents mention that a male cousin died suddenly at 2 weeks of age - \"they said it was some kind of salt problem.\"\n\nPhysical Examination:\n- General: Lethargic infant, poor responsiveness to stimulation, appears dehydrated\n- Vitals: T 36.5\u00b0C, HR 180, RR 50, BP 55/30 (hypotensive)\n- Skin: Diffuse hyperpigmentation, especially of labial folds, nipples, and midline\n- Genitourinary: Appears female with enlarged clitoris (clitoromegaly), rugated and partially fused labia resembling a scrotum, single urogenital opening\n- Mucous membranes: Dry, sunken fontanelle\n- Extremities: Weak pulses, delayed capillary refill (4 seconds)\n\nInitial labs:\n- Na: 118 mEq/L (low)\n- K: 7.8 mEq/L (high)\n- Glucose: 45 mg/dL (low)\n- BUN/Cr: 35/0.8 mg/dL", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this critically ill 12-day-old infant with shock, hyponatremia, hyperkalemia, and hypoglycemia.\n\nKey findings include:\n- Virilized external genitalia in an apparent female infant\n- Hyperpigmentation\n- Salt-wasting crisis with cardiovascular collapse\n- Family history of sudden infant death with \"salt problem\"\n- Electrolyte pattern: low sodium, high potassium", "question": "What is the most likely diagnosis based on this clinical presentation?", "choices": [{"id": "node-1-choice-a", "text": "Congenital adrenal hyperplasia (21-hydroxylase deficiency) with salt-wasting crisis", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** This is the classic presentation of **salt-wasting congenital adrenal hyperplasia (CAH)** due to **21-hydroxylase deficiency**. Key features include: **Virilized female** (clitoromegaly, labial fusion) due to excess androgens in utero, **salt-wasting crisis** (hyponatremia, hyperkalemia) from mineralocorticoid deficiency presenting at 1-2 weeks of life, **hypoglycemia** from cortisol deficiency, **hyperpigmentation** from ACTH excess, and **family history** (autosomal recessive). 21-hydroxylase deficiency accounts for ~95% of CAH cases.", "consequence": "Correct diagnosis. Proceed with emergency management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Pyloric stenosis - projectile vomiting with electrolyte abnormalities", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pyloric stenosis presents with **projectile non-bilious vomiting** at 3-6 weeks of age, but causes **hypochloremic, hypokalemic metabolic alkalosis** (from loss of gastric HCl). This infant has **hyperkalemia**, which is opposite to pyloric stenosis. Additionally, pyloric stenosis does not cause virilization or hyperpigmentation.", "consequence": "Wrong diagnosis leads to inappropriate management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Sepsis - ill-appearing neonate with shock", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sepsis should be considered in any ill neonate and can cause hypotension, it typically presents with **fever** (or hypothermia), and electrolyte abnormalities are usually different. Sepsis does not explain the **virilized genitalia**, **hyperpigmentation**, or the specific **low Na + high K** pattern. These findings are pathognomonic for adrenal insufficiency.", "consequence": "Antibiotics alone won't address the underlying crisis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Gastroenteritis - vomiting and dehydration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Gastroenteritis causes dehydration but typically with **diarrhea** (not present here) and does not cause **hyperkalemia** - usually you see hypokalemia from GI losses. Additionally, gastroenteritis cannot explain the virilized genitalia or hyperpigmentation. The electrolyte pattern here is specific for mineralocorticoid deficiency.", "consequence": "Treating for gastroenteritis misses the life-threatening diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Androgen-secreting tumor - causing virilization", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Androgen-secreting tumors are extremely rare in neonates and would not cause **salt-wasting** with the typical electrolyte pattern (low Na, high K). Maternal androgen-secreting tumors during pregnancy can cause fetal virilization but would not cause the infant to have adrenal crisis. CAH is the most common cause of virilization in XX infants.", "consequence": "Rare diagnosis considered when common one fits perfectly.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**21-hydroxylase deficiency** blocks cortisol and aldosterone synthesis, causing: buildup of precursors (17-OHP, androstenedione) that shunt to **androgen production** \u2192 virilization, plus **cortisol deficiency** \u2192 hypoglycemia, ACTH elevation \u2192 hyperpigmentation, plus **aldosterone deficiency** \u2192 salt-wasting (low Na, high K)."}, "node-2": {"id": "node-2", "type": "decision", "content": "This infant is critically ill with cardiovascular collapse from salt-wasting CAH crisis.\n\nVital signs show hypotension (BP 55/30), tachycardia, and signs of shock with poor perfusion.\n\nLabs confirm severe hyponatremia (118), dangerous hyperkalemia (7.8), and hypoglycemia (45).\n\nYou need to initiate emergency treatment immediately.", "question": "What is the most appropriate immediate management for this infant in adrenal crisis?", "choices": [{"id": "node-2-choice-a", "text": "IV fluid resuscitation with normal saline bolus, IV dextrose for hypoglycemia, IV stress-dose hydrocortisone", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Emergency management of adrenal crisis includes: **IV fluid resuscitation** with isotonic saline (20 mL/kg boluses) to restore intravascular volume and begin correcting hyponatremia, **IV dextrose** (D10 bolus or D10 maintenance) to correct hypoglycemia, and **IV hydrocortisone** at stress doses (50-100 mg/m\u00b2 initial bolus, then divided doses). Hydrocortisone at high doses has mineralocorticoid activity, helping address both cortisol and aldosterone deficiency. Also monitor for hyperkalemia complications (ECG).", "consequence": "Appropriate emergency stabilization initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Oral hydrocortisone and fludrocortisone - standard CAH replacement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Oral medications are **not appropriate for acute adrenal crisis** - the infant is in shock with impaired absorption. **IV hydrocortisone** must be given emergently. Additionally, in acute crisis, high-dose hydrocortisone provides sufficient mineralocorticoid effect; oral fludrocortisone is for chronic maintenance, not acute management.", "consequence": "Oral medications inadequate for shock state.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Wait for 17-OHP level to confirm diagnosis before starting treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never delay treatment** in suspected adrenal crisis to await confirmatory testing - this infant could die. Draw 17-OHP (the diagnostic marker) and cortisol levels **while initiating treatment**. The clinical picture (virilization + salt-wasting in neonate) is essentially diagnostic. Results will return later to confirm, but treatment must start now.", "consequence": "Dangerous delay leads to cardiovascular collapse.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Hypertonic saline (3%) to rapidly correct sodium", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hypertonic saline is not indicated** for this type of hyponatremia. This is **hypovolemic hyponatremia** from salt-wasting, not SIADH. Treatment with isotonic saline (normal saline) and glucocorticoids will gradually correct sodium. Rapid correction with hypertonic saline risks **osmotic demyelination syndrome** (central pontine myelinolysis). Correct sodium no faster than 8-10 mEq/L per 24 hours.", "consequence": "Risk of osmotic demyelination with rapid correction.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Insulin and glucose for hyperkalemia, then address other issues", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct - hyperkalemia is dangerous and may need treatment, but the **underlying cause is mineralocorticoid deficiency**. Giving hydrocortisone (which has mineralocorticoid activity at high doses) will address the underlying problem. For severe hyperkalemia (7.8 with ECG changes), calcium gluconate for cardiac protection and insulin/glucose may be needed, but the definitive treatment is steroid replacement.", "consequence": "Treating symptom without addressing underlying cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hydrocortisone** at high stress doses (~100 mg/m\u00b2/day) has significant **mineralocorticoid activity** and is sufficient for acute crisis. In maintenance therapy, lower hydrocortisone doses are used with separate **fludrocortisone** for mineralocorticoid replacement since lower cortisol doses have inadequate mineralocorticoid effect."}, "node-3": {"id": "node-3", "type": "decision", "content": "The infant receives 20 mL/kg normal saline bolus (repeated x2), D10 bolus followed by D10-containing maintenance fluids, and IV hydrocortisone 25 mg (stress dose).\n\nOver the next several hours:\n- Blood pressure improves to 70/45\n- Heart rate decreases to 140\n- Na rises to 125 mEq/L\n- K decreases to 6.2 mEq/L\n- Glucose normalizes to 85 mg/dL\n\nLaboratory confirmation returns:\n- 17-OHP (17-hydroxyprogesterone): 15,000 ng/dL (markedly elevated; normal <100)\n- Cortisol: 2 \u03bcg/dL (inappropriately low given stress)\n- ACTH: 800 pg/mL (markedly elevated)\n\nPelvic ultrasound shows: Normal uterus and bilateral ovaries (confirming 46,XX karyotype)", "question": "The labs confirm 21-hydroxylase deficiency CAH in a 46,XX infant. What explains the virilized genitalia in this genetic female?", "choices": [{"id": "node-3-choice-a", "text": "Excess androgen production from accumulated steroid precursors that shunt to androgen pathway", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** In 21-hydroxylase deficiency, the enzyme block prevents cortisol and aldosterone synthesis. Precursors (especially **17-OHP and androstenedione**) accumulate and are shunted into the **androgen synthesis pathway**, producing excess **testosterone and androstenedione**. In the female fetus (46,XX), this causes virilization: clitoromegaly, labial fusion, and variable urogenital abnormalities (**Prader staging**). Internal female organs (uterus, ovaries) develop normally since they're M\u00fcllerian structures unaffected by androgens.", "consequence": "Understanding the pathophysiology guides treatment monitoring.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "The infant is actually 46,XY male with undescended testes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The pelvic ultrasound clearly shows a **uterus and ovaries**, confirming this is a **46,XX female**. Males with CAH may have subtle findings (mild penile enlargement, hyperpigmented scrotum) but would not have a uterus. Proper sex assignment is critical - this infant should be raised female as she has ovaries and a uterus.", "consequence": "Misunderstanding of sex determination.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Maternal testosterone exposure during pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While maternal androgen exposure can cause fetal virilization, it would not explain the **salt-wasting crisis** and **elevated 17-OHP**. The markedly elevated 17-OHP (>15,000) is diagnostic for 21-hydroxylase deficiency CAH. External androgen exposure does not block cortisol or aldosterone synthesis.", "consequence": "External source doesn't explain the metabolic crisis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "True hermaphroditism with both testicular and ovarian tissue", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. True hermaphroditism (ovotesticular DSD) is rare and would show both ovarian and testicular tissue. Ultrasound shows **normal ovaries bilaterally** and the elevated 17-OHP confirms CAH. The virilization is from excess adrenal androgens, not gonadal tissue.", "consequence": "Rare condition when common CAH is confirmed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "5-alpha reductase deficiency causing incomplete masculinization", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **5-alpha reductase deficiency** causes **undervirilization of XY males** (ambiguous genitalia in genetic males due to inability to convert testosterone to DHT). This infant is XX female being **virilized by excess androgens** - the opposite scenario. CAH is the most common cause of virilization in XX females.", "consequence": "Confusion about virilization vs undervirilization.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**17-OHP** (17-hydroxyprogesterone) is the diagnostic marker for 21-hydroxylase deficiency - it accumulates proximal to the enzyme block. Levels are **markedly elevated** (often >10,000 ng/dL) compared to normal (<100 ng/dL). 17-OHP is included on **newborn screening** in most states, allowing detection before salt-wasting crisis in males (who lack obvious genital ambiguity)."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 48 hours of IV hydrocortisone and fluid resuscitation, the infant is stabilized:\n- Feeding well\n- Electrolytes normalized (Na 138, K 4.8)\n- Hemodynamically stable\n\nThe team is planning transition to maintenance therapy and discussing long-term management with the family.\n\nThe parents ask about sex assignment and whether their daughter will need surgery for her genitalia.", "question": "What is the appropriate approach to sex assignment and surgical decision-making in this 46,XX infant with CAH?", "choices": [{"id": "node-4-choice-a", "text": "Sex assignment as female (consistent with XX karyotype and gonads); surgical decisions deferred for multidisciplinary discussion and family counseling", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This infant is a **46,XX female** with normal internal female organs (uterus, ovaries) and should be raised female. The virilized external genitalia are from prenatal androgen exposure, not chromosomal/gonadal abnormality. Regarding surgery: current guidelines recommend **deferring cosmetic genital surgery** when possible, involving a **multidisciplinary DSD team** (endocrinology, urology, psychology, genetics), and **family-centered decision-making** with full informed consent. Some advocate waiting until the child can participate in decisions. Medical treatment (hormones) will prevent further virilization.", "consequence": "Appropriate sex assignment with thoughtful surgical planning.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Assign male sex since the genitalia appear masculinized", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sex assignment should be based on **karyotype, gonadal function, and fertility potential** - not external genital appearance alone. This infant is **46,XX with functional ovaries and a uterus** - she has potential for fertility as a female. With hormone treatment, she will develop female secondary sex characteristics at puberty. The virilized external genitalia are a consequence of excess androgens, not an indication to raise as male.", "consequence": "Inappropriate sex assignment causes long-term psychological harm.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Immediate feminizing genitoplasty before discharge to 'normalize' appearance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Current guidelines recommend **against** immediate cosmetic surgery in most cases. There is ongoing debate about early genital surgery, with increasing recognition that early operations may cause harm (scarring, sensation loss, need for revision) and the individual should participate in decisions affecting their body when possible. Some procedures (like clitoral recession for severe clitoromegaly causing urinary problems) may be needed, but routine cosmetic surgery is being reconsidered.", "consequence": "Rushed surgery without proper counseling and consent process.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Remove the ovaries since they will be non-functional due to hyperandrogenism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ovaries should be preserved** - they are functional and will provide fertility potential. With appropriate hormone management (suppressing excess androgens with glucocorticoid therapy), XX females with CAH can have normal pubertal development and fertility. Some may need reproductive assistance, but ovarian function should be preserved.", "consequence": "Unnecessary removal of functional gonads.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Delay all decisions until puberty when the child can decide their gender", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct in spirit (respect for patient autonomy) but incomplete. **Sex assignment** should be made in infancy based on medical information - it's important for the child's psychosocial development and medical care. What should be deferred is **irreversible cosmetic surgery** when possible. The child will be raised female (consistent with her biology), with surgical decisions involving appropriate counseling and consideration of the child's future input.", "consequence": "Delaying sex assignment causes confusion and potential harm.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prader staging** classifies the degree of virilization in 46,XX CAH from stage I (mild clitoromegaly) to stage V (complete male-appearing genitalia with penile urethra). Higher stages may need surgical intervention for urinary function, but cosmetic-only surgery is increasingly deferred pending fuller understanding of long-term outcomes and patient preferences."}, "node-5": {"id": "node-5", "type": "decision", "content": "The infant is transitioned to maintenance therapy:\n- Hydrocortisone 12-15 mg/m\u00b2/day divided TID (glucocorticoid replacement)\n- Fludrocortisone 0.1 mg daily (mineralocorticoid replacement)\n- Sodium chloride supplementation (infants have high sodium requirements)\n\nThe family is counseled about sex assignment (female), and surgical decisions will be discussed with the multidisciplinary team over time.\n\nBefore discharge, you discuss the critical importance of stress dosing with the family.", "question": "What essential education must the family receive about stress dosing for this infant with CAH?", "choices": [{"id": "node-5-choice-a", "text": "Triple hydrocortisone dose during illness/fever, give IM hydrocortisone injection if unable to take orally or vomiting, wear medical alert bracelet", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Stress dosing education is **life-saving** for CAH patients. Key points: **Triple the hydrocortisone dose** during illness (fever, vomiting, injury) to mimic normal cortisol stress response. If the child **cannot take oral medication** (vomiting, unconscious), give **IM hydrocortisone injection** (Solu-Cortef) immediately - parents must have this at home and know how to use it. **Medical alert identification** is essential so emergency responders know to give steroids. **Surgery, anesthesia, and severe illness** require IV stress-dose steroids. **Never abruptly stop steroids** - can cause adrenal crisis.", "consequence": "Family prepared for emergencies with potentially life-saving knowledge.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Stop all medications when the child is ill to avoid drug interactions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This would be **fatal**. Patients with CAH cannot produce cortisol and **must INCREASE** (not stop) steroid doses during stress. Stopping steroids during illness would cause acute adrenal crisis - exactly what we're trying to prevent. The normal stress response involves dramatically increased cortisol; CAH patients need exogenous replacement to compensate.", "consequence": "Potentially fatal advice - adrenal crisis during illness.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Only change doses after consulting endocrinology - never adjust at home", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While endocrinology should be involved in long-term dosing adjustments, **parents must be empowered to increase doses during acute illness** without waiting for physician consultation. An adrenal crisis can develop within hours. Parents should be trained to recognize stress situations and initiate stress dosing immediately, then contact their physician afterward.", "consequence": "Delayed stress dosing leads to preventable crisis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Extra doses are only needed for major surgery, not minor illnesses", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Even **minor illnesses** like fever or gastroenteritis can trigger adrenal crisis in CAH. The normal body increases cortisol production 5-10x during stress. CAH patients cannot do this and need increased exogenous steroids for any physiologic stress - not just major events. Underestimating stress dose needs is a common cause of preventable adrenal crisis.", "consequence": "Undertreatment of minor illness leads to crisis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Fludrocortisone dose should also be tripled during stress", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. During acute stress, **only hydrocortisone is increased** (tripled or given IV stress doses). Fludrocortisone (mineralocorticoid) does not need stress dosing - the high-dose hydrocortisone has sufficient mineralocorticoid activity. In fact, excessive fludrocortisone can cause hypertension and hypokalemia. The stress dosing protocols focus on glucocorticoid replacement.", "consequence": "Incorrect information about mineralocorticoid dosing.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Adrenal crisis** kills patients with CAH. Every patient/family must have: **Written stress dosing instructions** (double or triple oral dose for mild illness, IM injection instructions for vomiting/severe illness), **IM hydrocortisone kit** at home with proper training, **Medical alert bracelet/necklace**, and **Emergency letter** explaining the condition for emergency personnel."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of salt-wasting congenital adrenal hyperplasia:\n\n\u2713 Recognized classic presentation: virilized female + salt-wasting crisis + family history\n\u2713 Initiated appropriate emergency treatment: fluids, glucose, stress-dose hydrocortisone\n\u2713 Understood the pathophysiology: 21-hydroxylase block \u2192 precursors shunt to androgens\n\u2713 Confirmed diagnosis with 17-OHP (markedly elevated)\n\u2713 Addressed sex assignment appropriately (female, matching karyotype and gonads)\n\u2713 Provided critical stress dosing education to family\n\nKey learning points:\n- 21-hydroxylase deficiency = ~95% of CAH\n- Classic triad: virilization (XX females), salt-wasting, elevated 17-OHP\n- Salt-wasting crisis: hyponatremia + hyperkalemia + hypoglycemia + shock\n- Males present later (no obvious genital ambiguity) - newborn screening saves lives\n- Emergency treatment: IV saline, glucose, stress-dose hydrocortisone\n- Maintenance: hydrocortisone + fludrocortisone + salt supplementation (infants)\n- Stress dosing education is LIFE-SAVING"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of CAH management:\n\n- Diagnosis: virilized XX female + salt-wasting (low Na, high K) + markedly elevated 17-OHP\n- Don't delay treatment for confirmatory tests - draw labs while treating\n- Emergency treatment: IV NS boluses + D10 for hypoglycemia + IV hydrocortisone (stress dose)\n- Pathophysiology: 21-hydroxylase block causes precursor accumulation \u2192 shunts to androgen pathway\n- Sex assignment based on karyotype and gonadal function, not external appearance\n- Surgical decisions require multidisciplinary team and family-centered approach\n- Stress dosing education is critical - triple oral dose or IM injection during illness"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in CAH management can be fatal:\n\n- Salt-wasting CAH crisis kills infants within days if untreated\n- Never wait for confirmatory tests when clinical picture is clear\n- Oral medications are inadequate for acute crisis - IV hydrocortisone is mandatory\n- Do not rapidly correct sodium with hypertonic saline - use isotonic NS\n- Sex assignment should match karyotype and gonadal function (46,XX = female)\n- Never stop or reduce steroids during illness - INCREASE them\n- Parents must have IM hydrocortisone at home for emergencies\n\nKey pearl: Male infants with salt-wasting CAH can present as sudden death at 1-2 weeks of age because they lack obvious genital abnormality. Newborn screening saves lives."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-105", "title": "Thyroid Dysgenesis Etiology", "domain": "endocrine", "difficulty": "intermediate", "tags": ["absent or ectopic thyroid on scan", "lingual thyroid", "permanent hypothyroidism", "thyroid dysgenesis etiology"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-week-old female presents with confirmed congenital hypothyroidism on follow-up testing.\n\nThyroid ultrasound or radionuclide scan performed to determine etiology.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 2-week-old female was recalled after abnormal newborn screen showing elevated TSH. Confirmatory testing reveals:\n\n**Laboratory Results:**\n- **TSH: 85 mIU/L** (very elevated; normal <10 mIU/L in newborns)\n- **Free T4: 0.4 ng/dL** (low; normal 0.9-2.3 ng/dL)\n- Diagnosis: **Congenital Hypothyroidism (CH)** confirmed\n\nThe endocrinologist wants to determine the etiology before the family leaves.\n\n**Causes of Congenital Hypothyroidism:**\n\n**1. Thyroid Dysgenesis (~85% of permanent CH):**\n- **Agenesis** (35-40%): complete absence of thyroid tissue\n- **Ectopy** (30-45%): thyroid tissue in wrong location (lingual, sublingual)\n- **Hypoplasia** (5%): small but normally located gland\n- **SPORADIC** (not hereditary) - caused by defects in thyroid migration/development\n\n**2. Dyshormonogenesis (~10-15% of permanent CH):**\n- Normally located, normal or enlarged gland\n- Enzyme defects in thyroid hormone synthesis\n- **AUTOSOMAL RECESSIVE** (hereditary)\n- Examples: TPO deficiency, thyroglobulin defects, iodide transport defects\n\n**3. Transient Hypothyroidism:**\n- Maternal antithyroid antibodies, iodine deficiency/excess, prematurity\n- Resolves within weeks to months", "question": "Thyroid ultrasound shows NO thyroid tissue in the normal cervical location. Thyroid scan (I-123) shows uptake at the base of the tongue. What is the underlying etiology?", "choices": [{"id": "node-1-choice-a", "text": "Thyroid dysgenesis - specifically ectopic lingual thyroid, the most common cause of congenital hypothyroidism", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Thyroid ectopy** (a form of thyroid dysgenesis) is the diagnosis. Embryology: (1) Thyroid develops at base of tongue (foramen cecum) at 3-4 weeks gestation, (2) Migrates DOWN through thyroglossal duct to final position in anterior neck, (3) **Ectopic thyroid** = migration arrested at some point along this path. **Lingual thyroid** = tissue remains at base of tongue (most common ectopic location). This tissue is often **insufficient** to provide adequate thyroid hormone, causing hypothyroidism. The ectopic tissue IS functional (shown by radionuclide uptake) but inadequate.", "consequence": "You correctly identify ectopic thyroid (thyroid dysgenesis).", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Dyshormonogenesis - defect in thyroid hormone synthesis enzymes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dyshormonogenesis** would show: (1) **Normal or enlarged thyroid** in the normal cervical location, (2) Uptake in the normal position on scan (gland is present, just can't make hormone efficiently), (3) Often goiter due to TSH stimulation. This patient has NO thyroid in the normal location - the tissue is ectopic (at base of tongue). The imaging findings clearly point to dysgenesis (ectopy), not dyshormonogenesis.", "consequence": "Dyshormonogenesis shows normal-position gland, not ectopic tissue.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Thyroid agenesis - complete absence of all thyroid tissue", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The thyroid scan shows **uptake at the base of the tongue** - meaning thyroid tissue IS present, just in the wrong location. **Agenesis** = complete absence of thyroid tissue. With agenesis: (1) NO uptake anywhere on radionuclide scan, (2) Severely elevated TSH, (3) Undetectable thyroglobulin. This patient has ectopic functional tissue, not agenesis.", "consequence": "Agenesis would show NO uptake on thyroid scan.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Transient hypothyroidism from maternal antithyroid antibodies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Transient hypothyroidism** from maternal antibodies: (1) Would show **normal thyroid anatomy** on imaging (gland is present and structurally normal), (2) Resolves as maternal antibodies clear (weeks to months), (3) Mother usually has Graves' disease or Hashimoto's. This patient has clear anatomic abnormality (no thyroid in neck, tissue at tongue base) - this is a permanent structural problem, not transient antibody-mediated.", "consequence": "Transient causes show normal thyroid anatomy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Central hypothyroidism - pituitary TSH deficiency", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Central (secondary) hypothyroidism** shows: (1) Low T4 with **LOW or inappropriately normal TSH**, (2) Normal thyroid anatomy (gland is present but not stimulated), (3) Often associated with other pituitary hormone deficiencies. This patient has **very HIGH TSH** (85 mIU/L) - the pituitary is working hard to stimulate a failing thyroid. The anatomy confirms the problem is in the thyroid itself (ectopy), not the pituitary.", "consequence": "Central hypothyroidism has low/normal TSH, not elevated TSH.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Thyroid dysgenesis** (agenesis, ectopy, hypoplasia) causes ~85% of permanent congenital hypothyroidism and is **SPORADIC** (not hereditary). **Dyshormonogenesis** (enzyme defects) causes ~15% and is **AUTOSOMAL RECESSIVE**. Imaging distinguishes: dysgenesis = absent/ectopic gland; dyshormonogenesis = normal/enlarged gland in normal location."}, "node-2": {"id": "node-2", "type": "decision", "content": "You confirm ectopic lingual thyroid as the cause of congenital hypothyroidism.\n\nThe parents ask: \"When should treatment start? Should we wait to see if her thyroid function improves?\"\n\n**URGENCY of Treatment in Congenital Hypothyroidism:**\n\n**Thyroid hormone is CRITICAL for brain development:**\n- Most rapid brain growth occurs in first 2-3 years of life\n- Myelination, synaptogenesis, and neuronal migration depend on T4/T3\n- **Untreated CH \u2192 irreversible intellectual disability** (formerly called cretinism)\n\n**Treatment Timing Goals:**\n- Start levothyroxine **within first 2 weeks of life** (ideally by day 14)\n- Earlier treatment = better neurodevelopmental outcomes\n- **Do NOT delay treatment** to obtain imaging or determine etiology\n- Imaging can be done after treatment is started (or deferred entirely)\n\n**Levothyroxine Dosing:**\n- Newborn dose: **10-15 mcg/kg/day** (much higher per-kg than adults)\n- Adjust based on TSH and free T4 levels\n- Goal: normalize TSH and maintain free T4 in upper half of normal range", "question": "What is the most appropriate management for this 2-week-old with confirmed congenital hypothyroidism?", "choices": [{"id": "node-2-choice-a", "text": "Start levothyroxine immediately - do NOT delay treatment for additional testing; the brain needs thyroid hormone NOW", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Immediate levothyroxine** is critical. Key points: (1) **Brain development is time-sensitive** - every day of delay matters, (2) Goal: start treatment by day 14 of life (ideally earlier), (3) This infant is already 2 weeks old - no time to waste, (4) **Imaging was already done** (to determine etiology), but even if it hadn't been, treatment should NOT be delayed for imaging, (5) Dose: 10-15 mcg/kg/day, (6) Monitor TSH and free T4, adjust to normalize. The prognosis is excellent IF treatment starts early; devastating IF delayed.", "consequence": "You initiate appropriate urgent treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Wait 2-4 weeks and recheck thyroid function - some cases resolve spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **this is dangerous**. While SOME congenital hypothyroidism is transient, this patient has **structural thyroid dysgenesis** (ectopic thyroid) - this will NOT resolve spontaneously. Even if it might be transient, waiting 2-4 weeks: (1) Risks irreversible brain damage, (2) Is NOT the standard of care, (3) Can always stop treatment later if it proves unnecessary. The mantra is: **treat first, ask questions later**. Permanent CH is more common than transient, and the stakes are too high.", "consequence": "Delay risks irreversible neurodevelopmental damage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start treatment only if the infant develops clinical symptoms of hypothyroidism", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **waiting for symptoms causes irreversible harm**. Clinical symptoms of neonatal hypothyroidism (lethargy, poor feeding, constipation, prolonged jaundice, macroglossia) are: (1) **Late findings** - damage is already occurring, (2) Often subtle in first weeks, (3) NOT required to diagnose or treat. The whole point of newborn screening is to detect and treat BEFORE symptoms develop. Waiting for symptoms defeats this purpose and risks permanent intellectual disability.", "consequence": "Waiting for symptoms allows brain damage to occur.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Refer to endocrinology and wait for their appointment before starting treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **endocrinology referral should NOT delay treatment**. If an endocrinology appointment is weeks away: (1) The pediatrician should start levothyroxine TODAY, (2) Endocrinology can adjust dosing later, (3) The specialist can be consulted by phone if needed. The primary care provider CAN and SHOULD initiate treatment. \"Wait for the specialist\" is NOT acceptable when brain development is at stake.", "consequence": "Waiting for specialist delays critical treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start a low dose of levothyroxine and gradually increase over several months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **full replacement dosing is needed immediately**. Unlike in adults (where \"start low, go slow\" may be appropriate), newborns with CH need: (1) **Full replacement dose** (10-15 mcg/kg/day) from the start, (2) Rapid normalization of thyroid levels, (3) No gradual titration - the brain needs hormone NOW. Starting low and going slow wastes precious time during critical neurodevelopment.", "consequence": "Subtherapeutic dosing delays normalization of thyroid levels.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Treatment urgency in CH**: Start levothyroxine by day 14 of life (earlier = better). Do NOT delay for imaging or specialist referral. Full replacement dose (10-15 mcg/kg/day) - no \"start low, go slow.\" The brain NEEDS thyroid hormone for development."}, "node-3": {"id": "node-3", "type": "decision", "content": "You start levothyroxine 12 mcg/kg/day. The parents have more questions:\n\n\"Is this hereditary? Our next child could have this too?\"\n\"Will she need thyroid medication forever?\"\n\n**Genetics of Congenital Hypothyroidism:**\n\n**Thyroid Dysgenesis (this patient's diagnosis):**\n- **85% of cases are SPORADIC** (not hereditary)\n- Recurrence risk in siblings: ~2% (slightly higher than general population)\n- Exact cause unknown in most cases (transcription factor mutations in rare cases)\n- Parents can be reassured that risk to future children is LOW\n\n**Dyshormonogenesis:**\n- **AUTOSOMAL RECESSIVE** inheritance\n- 25% recurrence risk in siblings\n- Genetic testing may identify specific mutation\n\n**Permanence of Hypothyroidism:**\n- Thyroid dysgenesis (agenesis, ectopy) = **PERMANENT** - lifelong treatment needed\n- Dyshormonogenesis = **PERMANENT** - lifelong treatment\n- Transient causes = may resolve; can trial off medication at age 3\n\n**Follow-up:**\n- Frequent monitoring in first year (every 1-2 months initially)\n- Dose increases needed as child grows\n- Goal: TSH normal, free T4 upper half of normal", "question": "How do you counsel this family about genetics and prognosis?", "choices": [{"id": "node-3-choice-a", "text": "Thyroid dysgenesis is usually sporadic, so sibling recurrence risk is low (~2%); she will need lifelong thyroid replacement since the ectopic thyroid cannot provide adequate hormone", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Accurate genetic counseling** for thyroid dysgenesis: (1) **Sporadic** in ~85% of cases - NOT inherited from parents, (2) **Sibling recurrence risk ~2%** - slightly above general population (~1:2000-4000) but much lower than Mendelian inheritance, (3) Parents did NOT cause this, (4) Future pregnancies: routine prenatal care, newborn screening will detect CH. **Prognosis**: (1) Ectopic thyroid is **permanent** - will never provide adequate hormone, (2) **Lifelong levothyroxine** required, (3) With early treatment, **normal neurodevelopment expected**, (4) Normal life expectancy, fertility, etc.", "consequence": "You provide accurate and reassuring genetic counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "This is autosomal recessive, so there's a 25% chance each future child will be affected; genetic testing is mandatory", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Thyroid dysgenesis is NOT autosomal recessive** - it's sporadic. You're confusing it with **dyshormonogenesis**, which IS autosomal recessive. The imaging clearly showed ectopic thyroid (dysgenesis), not dyshormonogenesis. Telling these parents they have 25% recurrence risk would cause unnecessary anxiety and is factually wrong. The recurrence risk for thyroid dysgenesis is only ~2%.", "consequence": "Incorrect recurrence risk causes unnecessary parental anxiety.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "She will likely outgrow this condition and won't need medication after age 3", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Thyroid dysgenesis is PERMANENT**. The ectopic lingual thyroid: (1) Is structurally abnormal and inadequate, (2) Will NOT grow into a normal thyroid, (3) Will never produce adequate hormone. This is fundamentally different from **transient hypothyroidism** (which can be trialed off medication at age 3). Telling parents she'll \"outgrow it\" sets false expectations and may lead to treatment discontinuation.", "consequence": "False expectations about outgrowing permanent condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "The prognosis is poor even with treatment - most children with congenital hypothyroidism have intellectual disability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - **this is outdated information**. Before newborn screening, untreated CH did cause severe intellectual disability. However, with EARLY treatment (within first 2 weeks): (1) **Normal IQ** is expected, (2) Normal development, schooling, career, (3) Normal life expectancy and fertility. This is a success story of newborn screening! Don't give families unnecessarily pessimistic prognosis when early treatment yields excellent outcomes.", "consequence": "Unnecessarily pessimistic prognosis is inaccurate for early-treated CH.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "We should surgically remove the lingual thyroid tissue to prevent complications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgical removal is NOT indicated**. The ectopic lingual thyroid: (1) May be the patient's ONLY thyroid tissue - removal would guarantee complete hormone deficiency, (2) Is usually asymptomatic (unless very large causing dysphagia/airway obstruction), (3) Removing it doesn't change the need for lifelong levothyroxine. Surgery is only considered if the ectopic tissue causes mechanical symptoms (very rare in infancy).", "consequence": "Unnecessary surgery removes the patient's only thyroid tissue.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Thyroid dysgenesis genetics**: ~85% sporadic (not inherited), sibling recurrence ~2%. **Dyshormonogenesis**: autosomal recessive, 25% sibling risk. Dysgenesis is PERMANENT (lifelong treatment), but prognosis is EXCELLENT with early treatment - normal IQ expected."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified thyroid dysgenesis, initiated prompt treatment, and provided accurate genetic counseling.\n\n**Key teaching points:**\n\n**Causes of Congenital Hypothyroidism:**\n- **Thyroid dysgenesis** (~85%): agenesis, ectopy, hypoplasia - SPORADIC\n- **Dyshormonogenesis** (~15%): enzyme defects - AUTOSOMAL RECESSIVE\n- **Transient**: maternal antibodies, iodine, prematurity - RESOLVES\n\n**Imaging to Distinguish:**\n- Dysgenesis: absent, ectopic, or hypoplastic thyroid\n- Dyshormonogenesis: normal or enlarged gland in normal location\n- Scan (I-123) localizes ectopic tissue and shows uptake\n\n**Treatment Urgency:**\n- Start levothyroxine by day 14 of life\n- Full dose: 10-15 mcg/kg/day (no \"start low, go slow\")\n- Do NOT delay for imaging or specialist referral\n- Brain development depends on early treatment\n\n**Genetic Counseling for Dysgenesis:**\n- Sporadic (not hereditary in most cases)\n- Sibling recurrence: ~2%\n- PERMANENT - lifelong treatment\n- Prognosis: EXCELLENT with early treatment - normal IQ expected\n\n**Follow-up:**\n- Monitor TSH and free T4 frequently (every 1-2 months initially)\n- Adjust dose as child grows\n- Goal: TSH normal, free T4 upper half of normal"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts:\n\n**Etiology of CH:**\n- Dysgenesis (absent/ectopic/hypoplastic): sporadic, ~85%\n- Dyshormonogenesis (normal gland, enzyme defect): autosomal recessive, ~15%\n- Imaging distinguishes: scan shows ectopic uptake in dysgenesis\n\n**Treatment:**\n- URGENT - start by day 14 of life\n- Full dose immediately (10-15 mcg/kg/day)\n- Do NOT delay for any reason\n\n**Prognosis:**\n- Dysgenesis is PERMANENT (not transient)\n- Lifelong treatment required\n- NORMAL IQ with early treatment"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Review critical concepts:\n\n**Imaging interpretation:**\n- No thyroid in neck + uptake at tongue base = ECTOPIC thyroid (dysgenesis)\n- NOT dyshormonogenesis (would have normal-position gland)\n- NOT agenesis (would have NO uptake anywhere)\n- NOT central hypothyroidism (TSH is HIGH, not low)\n\n**Treatment urgency:**\n- Brain development is TIME-SENSITIVE\n- Do NOT wait for symptoms (late finding = damage already done)\n- Do NOT wait for specialist (PCP can start treatment)\n- Do NOT \"start low, go slow\" (full dose needed immediately)\n\n**Genetics:**\n- Thyroid DYSGENESIS is SPORADIC (~2% sibling risk)\n- Dyshormonogenesis is autosomal recessive (25% sibling risk)\n- Don't confuse them!\n\n**Prognosis:**\n- Dysgenesis is PERMANENT (won't \"outgrow\")\n- BUT prognosis is EXCELLENT with early treatment\n- Normal IQ expected if treated by day 14"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-127", "title": "Primary Dysmenorrhea Recognition", "domain": "endocrine", "difficulty": "intermediate", "tags": ["pain with menses", "normal pelvic exam", "shortly after menarche", "responds to NSAIDs", "primary dysmenorrhea recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old female presents with crampy lower abdominal pain that occurs monthly with her menstrual periods. She has had regular periods for 18 months since menarche at age 12.5.\n\nHistory:\n- Pain begins within hours of menstrual flow onset\n- Lasts 1-2 days, most severe on day 1\n- Crampy, suprapubic pain that sometimes radiates to back and thighs\n- Associated with nausea (no vomiting), fatigue, and headache\n- Pain causes her to miss school 1-2 days per month\n- No intermenstrual bleeding, no pain outside of menses\n- Not sexually active\n\nPhysical Examination:\n- Abdomen: soft, mild suprapubic tenderness, no masses, no rebound\n- External genitalia: normal (internal pelvic exam deferred)\n- Vital signs: normal", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You take a detailed menstrual history. Key characteristics:\n\n**Features suggesting PRIMARY dysmenorrhea:**\n- Onset **within 1-2 years of menarche** (ovulatory cycles established)\n- Pain begins **at or shortly after menstrual flow starts**\n- Lasts **1-3 days** (correlates with prostaglandin release)\n- **Crampy, suprapubic** pain, may radiate to back/thighs\n- **Associated symptoms**: nausea, diarrhea, headache, fatigue (prostaglandin-mediated)\n- **Normal pelvic exam** (no pelvic pathology)\n\n**Red flags for SECONDARY dysmenorrhea:**\n- Pain starting years after menarche (new pattern)\n- Pain throughout the cycle or worsening over time\n- Abnormal bleeding or vaginal discharge\n- Failure to respond to NSAIDs and hormonal therapy\n- Pelvic mass or tenderness on exam", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Primary dysmenorrhea", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **primary dysmenorrhea** - painful menstruation WITHOUT underlying pelvic pathology. Key supporting features: (1) Onset within 2 years of menarche (ovulatory cycles), (2) Pain begins with menstrual flow, (3) Duration 1-2 days with decreasing severity, (4) Crampy suprapubic pain with prostaglandin-mediated symptoms (nausea, headache), (5) Normal physical exam, (6) No intermenstrual symptoms. Primary dysmenorrhea affects 50-90% of adolescent females and is the most common cause of menstrual pain. **Pelvic exam is NOT required** for initial diagnosis in non-sexually active adolescents with typical presentation.", "consequence": "You correctly identify primary dysmenorrhea as a clinical diagnosis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Endometriosis", "isOptimal": false, "isAcceptable": true, "feedback": "This is a reasonable consideration as endometriosis CAN occur in adolescents and is often underdiagnosed. However, this patient's presentation is more consistent with primary dysmenorrhea: (1) Symptoms began within 2 years of menarche (typical for primary), (2) Pain is limited to menses (endometriosis often causes chronic pelvic pain), (3) No intermenstrual symptoms. **Endometriosis red flags**: pain not responding to NSAIDs/hormones, progressively worsening, pain with defecation/urination, chronic pelvic pain. Consider if she fails first-line treatment.", "consequence": "Endometriosis should be considered if treatment fails, but primary dysmenorrhea is more likely.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Pelvic inflammatory disease (PID)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **PID** has different features: (1) Usually occurs in sexually active individuals (this patient is not), (2) Causes **constant** pelvic pain, not cyclical with menses, (3) Associated with fever, vaginal discharge, cervical motion tenderness, (4) May cause intermenstrual bleeding. This patient's pain is exclusively menstrual with normal exam and no risk factors for STIs. PID should not be the leading diagnosis here.", "consequence": "PID is unlikely in non-sexually active patient with cyclical symptoms.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Ovarian cyst", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Functional ovarian cysts** (follicular, corpus luteum) are common in adolescents but typically cause: (1) **Unilateral** lower quadrant pain (not suprapubic/midline), (2) Pain that may occur at ovulation (mittelschmerz) or throughout the cycle, (3) Sudden severe pain if cyst ruptures or torts. This patient has strictly menstrual, midline, crampy pain - characteristic of primary dysmenorrhea, not ovarian pathology. Cyst rupture would present acutely, not chronically over 18 months.", "consequence": "Ovarian cyst pain is typically unilateral and not strictly menstrual.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "M\u00fcllerian anomaly with obstructed outflow", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Obstructed M\u00fcllerian anomalies** (imperforate hymen, transverse vaginal septum, uterine horn obstruction) cause: (1) **Cyclic pain WITHOUT visible menstrual flow** (cryptomenorrhea), (2) **Primary amenorrhea** or delayed menarche, (3) Abdominal/pelvic mass from hematocolpos. This patient has **regular menstrual periods with normal flow** - ruling out outflow obstruction. Her menarche was at normal age and she has had regular cycles for 18 months.", "consequence": "Normal menstrual flow rules out outflow obstruction.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Primary dysmenorrhea is a CLINICAL diagnosis** - pelvic exam is NOT required initially in non-sexually active adolescents with typical presentation. Key features: onset within 1-2 years of menarche, pain begins WITH menses, lasts 1-3 days, responds to NSAIDs. Reserve imaging/exam for treatment failure or red flags."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose primary dysmenorrhea based on the classic clinical presentation.\n\n**Understanding the pathophysiology:**\n- During menstruation, the endometrium releases **prostaglandins** (PGF2\u03b1, PGE2)\n- Prostaglandins cause **uterine smooth muscle contraction** and vasoconstriction\n- This leads to **uterine ischemia** \u2192 pain\n- Systemic prostaglandin effects explain associated symptoms: nausea, diarrhea, headache\n- Women with dysmenorrhea have **higher prostaglandin levels** in menstrual fluid\n\n**Treatment targets prostaglandin synthesis and effects:**", "question": "What is the most appropriate first-line treatment?", "choices": [{"id": "node-2-choice-a", "text": "NSAIDs (ibuprofen or naproxen) starting at onset of menses or 1-2 days before", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **NSAIDs are first-line treatment** for primary dysmenorrhea. They work by inhibiting **cyclooxygenase (COX)** \u2192 reduced prostaglandin synthesis. Key prescribing points: (1) **Start at symptom onset** or 1-2 days before expected menses (preemptive), (2) **Ibuprofen** 400-600 mg q6h or **naproxen** 250-500 mg q12h, (3) Continue for 2-3 days (first days of menses), (4) Take with food to reduce GI side effects. NSAIDs are effective in 80% of patients. If one NSAID fails, try a different one before concluding NSAID failure.", "consequence": "You prescribe appropriate first-line therapy targeting the underlying mechanism.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Combined oral contraceptive pills", "isOptimal": false, "isAcceptable": true, "feedback": "This is an acceptable alternative but NOT first-line. **Hormonal contraceptives** reduce dysmenorrhea by: (1) Suppressing ovulation, (2) Thinning the endometrial lining \u2192 less prostaglandin production, (3) Reducing menstrual flow volume. They are excellent for patients who also desire contraception, have contraindications to NSAIDs, or fail NSAID therapy. However, **NSAIDs should be tried first** as they are simpler, have fewer systemic effects, and don't require daily dosing.", "consequence": "OCPs are effective but NSAIDs are preferred first-line for uncomplicated cases.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Acetaminophen (Tylenol)", "isOptimal": false, "isAcceptable": true, "feedback": "Acetaminophen can be used but is **less effective** than NSAIDs for dysmenorrhea. Acetaminophen does NOT inhibit peripheral prostaglandin synthesis - it has primarily central analgesic effects. Studies show NSAIDs are significantly more effective for menstrual pain. Acetaminophen may be considered when NSAIDs are contraindicated (peptic ulcer disease, NSAID allergy, renal disease), but expect less relief.", "consequence": "Acetaminophen works but is less effective than NSAIDs.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Opioid analgesics (codeine or hydrocodone)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Opioids are NOT appropriate** for primary dysmenorrhea. Reasons: (1) Primary dysmenorrhea is a chronic, recurring condition - opioids risk dependence, (2) NSAIDs address the underlying mechanism (prostaglandins), while opioids only mask pain, (3) Opioid side effects (constipation, sedation, respiratory depression) are problematic, (4) Adolescents are particularly vulnerable to opioid misuse. Reserve opioids for severe acute pain situations, not monthly menstrual pain.", "consequence": "Opioids are inappropriate for this chronic, recurring condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Pelvic ultrasound before initiating treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Imaging is NOT required** for typical primary dysmenorrhea in adolescents. Ultrasound is indicated for: (1) Failure to respond to NSAIDs AND hormonal therapy (suggests secondary cause), (2) Abnormal pelvic exam findings, (3) Red flags for secondary dysmenorrhea, (4) Concern for pregnancy. This patient has a classic presentation - proceeding directly to empiric treatment is appropriate. Unnecessary imaging adds cost and anxiety without changing management.", "consequence": "Imaging not needed for typical presentation; trial of NSAIDs is appropriate.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NSAIDs are first-line** because they target the underlying pathophysiology (prostaglandin synthesis). Start at menses onset or 1-2 days before for best effect. If one NSAID fails, try another before declaring NSAID failure. Hormonal contraceptives are second-line or for those desiring contraception."}, "node-3": {"id": "node-3", "type": "decision", "content": "You prescribe ibuprofen 400 mg every 6 hours starting at onset of menstrual flow, to be taken with food for the first 2-3 days of her period.\n\n**She returns 3 months later:**\n- Tried ibuprofen as prescribed\n- Reports 50% improvement in pain (better but not adequate)\n- Still missing some school due to residual symptoms\n- Continues to have associated nausea and headache\n- No new symptoms, no intermenstrual pain\n\n**She asks if there is something else that can help.**", "question": "What is the most appropriate next step for this patient who has partial response to NSAIDs?", "choices": [{"id": "node-3-choice-a", "text": "Add or switch to hormonal contraception (combined OCPs, patch, or ring) for suppression of ovulation and endometrial growth", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! For patients with **inadequate response to NSAIDs**, adding **hormonal contraception** is appropriate. Options include: (1) **Combined OCPs** - most commonly used; can be taken cyclically or continuously, (2) **Contraceptive patch or ring** - same hormonal effect, different delivery, (3) **Progestin-only methods** (pills, implant, IUD) - also effective. Hormonal therapy works by: suppressing ovulation, thinning the endometrium (less prostaglandin production), and reducing menstrual flow. Can be used WITH NSAIDs for additive effect. Continuous cycling (skipping placebo pills) provides even more relief.", "consequence": "You appropriately escalate therapy with hormonal contraception.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Order pelvic ultrasound to evaluate for secondary causes", "isOptimal": false, "isAcceptable": true, "feedback": "This is reasonable but may be premature. Guidelines recommend imaging when patients fail **BOTH NSAIDs AND hormonal therapy**. This patient has only tried NSAIDs with partial response - she hasn't yet tried hormonal contraception. The absence of red flags (normal exam, pain only with menses, no progression) makes secondary pathology less likely. Proceed with hormonal therapy trial first; if that fails, then pursue imaging.", "consequence": "Imaging may be indicated later but hormonal therapy should be tried first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Increase ibuprofen dose and add acetaminophen", "isOptimal": false, "isAcceptable": true, "feedback": "This could provide modest additional benefit but is not optimal. Increasing ibuprofen dose has ceiling effects (beyond 600-800 mg, additional benefit is minimal with more side effects). Adding acetaminophen provides only mild additive analgesia. **Hormonal contraception** offers a different mechanism of action (suppresses prostaglandin production at the source by thinning endometrium) and is more effective for patients with inadequate NSAID response.", "consequence": "May help marginally but hormonal therapy is more effective.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Refer to gynecology for diagnostic laparoscopy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is premature. **Laparoscopy** is reserved for patients who fail **medical management** (NSAIDs AND hormonal therapy) and have suspected endometriosis or other pathology. This patient has only tried NSAIDs; she hasn't yet tried hormonal contraception. Laparoscopy is invasive with surgical risks - it should not be performed before completing medical therapy trials. If she fails hormonal therapy AND imaging is concerning, then laparoscopy may be considered.", "consequence": "Laparoscopy is premature before completing medical therapy trials.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Recommend she \"push through\" the pain as it's a normal part of menstruation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dismissing menstrual pain is inappropriate**. While dysmenorrhea is common, pain severe enough to cause school absence significantly impacts quality of life and is NOT something to simply tolerate. Effective treatments exist and should be offered. This attitude contributes to undertreatment of women's pain and delays in diagnosing conditions like endometriosis. Take her symptoms seriously and escalate therapy appropriately.", "consequence": "Dismissing pain is inappropriate - effective treatments should be offered.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Treatment ladder for primary dysmenorrhea**: (1) NSAIDs first-line, (2) Add/switch to hormonal contraception if inadequate response, (3) Consider continuous cycling (skip placebo pills) for more relief, (4) Investigate for secondary causes (imaging, laparoscopy) only after failing medical management."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed primary dysmenorrhea based on classic clinical features, initiated appropriate first-line NSAID therapy, and appropriately escalated to hormonal contraception when NSAIDs provided inadequate relief.\n\n**Key teaching points:**\n- **Primary dysmenorrhea** is a clinical diagnosis - pelvic exam NOT required initially in non-sexually active adolescents\n- **Pathophysiology**: prostaglandin release \u2192 uterine contraction and ischemia \u2192 pain\n- **First-line**: NSAIDs (inhibit prostaglandin synthesis); start at menses onset or 1-2 days before\n- **Second-line**: Hormonal contraception (suppress ovulation, thin endometrium, reduce prostaglandins)\n- **Imaging** only if failing BOTH NSAIDs and hormonal therapy or red flags present\n- **Red flags** for secondary dysmenorrhea: pain not with menses, progressive symptoms, treatment failure, abnormal exam\n\n**Prognosis**: 80-90% of patients with primary dysmenorrhea achieve adequate relief with NSAIDs and/or hormonal therapy. If treatment fails, consider endometriosis or other secondary causes."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of primary dysmenorrhea management:\n\n**Diagnosis:**\n- Clinical diagnosis in adolescents with typical features\n- Pelvic exam NOT required initially if non-sexually active with classic symptoms\n- Red flags: pain outside menses, treatment failure, abnormal exam\n\n**Treatment ladder:**\n1. NSAIDs first-line (ibuprofen, naproxen)\n2. Hormonal contraception if NSAID response inadequate\n3. Imaging if failing BOTH medical therapies\n4. Laparoscopy reserved for treatment failures with suspected endometriosis\n\n**Key concept:**\n- Prostaglandins cause the pain \u2192 NSAIDs inhibit prostaglandin synthesis"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates management of primary dysmenorrhea:\n\n**Recognizing primary dysmenorrhea:**\n- Onset within 1-2 years of menarche\n- Pain begins WITH menstrual flow\n- Lasts 1-3 days\n- Associated symptoms: nausea, headache, diarrhea (prostaglandin-mediated)\n- Normal exam, no intermenstrual symptoms\n\n**Treatment principles:**\n- NSAIDs are first-line (target prostaglandins)\n- Hormonal contraception is second-line\n- Opioids are NOT appropriate for this chronic condition\n- Don't dismiss pain - effective treatments exist\n\n**When to investigate:**\n- Failure of BOTH NSAIDs and hormonal therapy\n- Red flags for secondary causes\n- Abnormal exam findings"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-128", "title": "Primary Dysmenorrhea Mechanism", "domain": "endocrine", "difficulty": "intermediate", "tags": ["prostaglandin-mediated", "myometrial contractions", "uterine ischemia", "NSAIDs target mechanism", "primary dysmenorrhea mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old female and her mother are in the office after the teen was diagnosed with primary dysmenorrhea at a previous visit. She has been started on ibuprofen with good results.\n\nThe mother asks: \"I want to understand why this happens. What causes the pain, and why does ibuprofen help? Is there anything wrong with her uterus?\"\n\nThe teen also wants to understand her body better and asks if there's anything she can do to prevent the pain from happening in the first place.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You take this opportunity to explain the pathophysiology of primary dysmenorrhea.\n\n**The Prostaglandin Pathway:**\n\n1. **Progesterone withdrawal** at the end of the menstrual cycle triggers endometrial breakdown\n\n2. **Phospholipase A2** is released, liberating arachidonic acid from cell membranes\n\n3. **Cyclooxygenase (COX)** enzymes convert arachidonic acid to prostaglandins\n\n4. **Key prostaglandins in dysmenorrhea:**\n   - **PGF2\u03b1** (prostaglandin F2-alpha): causes intense uterine contractions\n   - **PGE2** (prostaglandin E2): sensitizes nerve endings to pain\n\n5. The **uterine contractions** compress blood vessels \u2192 **uterine ischemia** \u2192 PAIN", "question": "Based on this pathway, which step do NSAIDs (ibuprofen) target?", "choices": [{"id": "node-1-choice-a", "text": "NSAIDs inhibit cyclooxygenase (COX), preventing prostaglandin synthesis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **NSAIDs work by inhibiting COX enzymes**, which prevents the conversion of arachidonic acid to prostaglandins. By blocking prostaglandin synthesis at the source, NSAIDs reduce: (1) **Uterine contractions** (less PGF2\u03b1), (2) **Pain sensitization** (less PGE2), (3) **Uterine ischemia** (fewer contractions = better blood flow). This is why NSAIDs are so effective for dysmenorrhea - they target the exact mechanism causing the pain.", "consequence": "You correctly explain the mechanism of NSAID action.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "NSAIDs block progesterone receptors to prevent the cycle from triggering", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NSAIDs do NOT affect progesterone receptors. **Progesterone withdrawal** is a normal part of the menstrual cycle that signals the endometrium to shed. Blocking progesterone receptors would not prevent dysmenorrhea and could disrupt the normal menstrual cycle. NSAIDs work downstream in the pathway by inhibiting COX enzymes and preventing prostaglandin synthesis.", "consequence": "Incorrect understanding of NSAID mechanism.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "NSAIDs directly relax uterine smooth muscle like a muscle relaxant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NSAIDs are NOT direct smooth muscle relaxants. They work **upstream** by preventing prostaglandin synthesis. Less prostaglandin = fewer signals for the uterus to contract. This is an indirect effect on uterine contractions, not direct muscle relaxation. True smooth muscle relaxants (like terbutaline) act directly on muscle cells, but these are not used for dysmenorrhea.", "consequence": "Incorrect mechanism - NSAIDs don't directly relax muscle.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "NSAIDs block nerve conduction to prevent pain signal transmission", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NSAIDs do NOT block nerve conduction (that's what local anesthetics do). While NSAIDs do reduce pain sensitization by decreasing PGE2 (which sensitizes pain receptors), their primary mechanism is **inhibiting COX enzymes** to prevent prostaglandin synthesis. The pain relief comes from reducing the stimulus (uterine ischemia) rather than blocking the pain signals.", "consequence": "Incorrect mechanism - NSAIDs don't block nerves.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "NSAIDs increase blood flow to the uterus by dilating vessels", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NSAIDs do NOT directly dilate blood vessels (some prostaglandins are actually vasodilators, so blocking them could theoretically cause vasoconstriction). The improved blood flow during NSAID treatment is an **indirect effect**: by reducing prostaglandin-mediated uterine contractions, the blood vessels are no longer being compressed, allowing better perfusion and reducing ischemic pain.", "consequence": "Improved blood flow is indirect, not the primary mechanism.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**NSAIDs inhibit COX \u2192 less prostaglandin synthesis \u2192 fewer uterine contractions \u2192 less ischemia \u2192 less pain**. This is why NSAIDs are first-line for dysmenorrhea - they target the exact pathophysiology. Acetaminophen (which doesn't significantly inhibit peripheral COX) is less effective."}, "node-2": {"id": "node-2", "type": "decision", "content": "You've explained that NSAIDs block prostaglandin synthesis. The mother and teen understand the mechanism now.\n\n**The teen asks: \"Why does my doctor tell me to start taking ibuprofen BEFORE my pain starts? Shouldn't I wait until I have pain?\"**\n\n**Understanding NSAID timing:**\n- Prostaglandins are synthesized and released at the START of menstruation\n- Once prostaglandins are already produced and bound to receptors, NSAIDs are less effective\n- **Preemptive dosing** prevents prostaglandin buildup", "question": "How do you explain the importance of NSAID timing?", "choices": [{"id": "node-2-choice-a", "text": "NSAIDs PREVENT prostaglandin formation but cannot reverse prostaglandins already made; starting early blocks production before it begins", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **NSAIDs work best when started BEFORE prostaglandins are synthesized**. Key teaching points: (1) NSAIDs **inhibit COX** - they prevent NEW prostaglandin production, (2) They do NOT neutralize prostaglandins already made and bound to receptors, (3) Once the cascade starts, catching up is harder, (4) **Optimal timing**: Start 1-2 days before expected menses OR at first sign of bleeding/cramping, (5) Continue for 2-3 days (duration of prostaglandin release). This \"preemptive analgesia\" approach is more effective than reactive dosing.", "consequence": "You correctly explain why timing matters.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Starting early allows the medication to build up in your system to higher levels", "isOptimal": false, "isAcceptable": true, "feedback": "This is partially true but not the main reason. NSAIDs do reach steady-state with regular dosing, but the **key point** is that they prevent NEW prostaglandin synthesis rather than neutralizing existing prostaglandins. Even with high blood levels, if prostaglandins are already produced, NSAIDs are less effective. The critical concept is blocking the COX enzyme BEFORE the prostaglandin cascade begins.", "consequence": "Partially correct but misses the key mechanism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "It doesn't really matter when you start - NSAIDs work the same whether taken early or late", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Timing significantly affects NSAID efficacy** in dysmenorrhea. Studies show preemptive dosing (starting before or at the very onset of menses) is more effective than waiting until pain is established. Once prostaglandins are produced and causing contractions, NSAIDs must \"catch up\" rather than prevent the problem. Early dosing = better pain control.", "consequence": "Timing does matter - early dosing is more effective.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Starting early prevents addiction to pain medications by using less overall", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect framing. **NSAIDs are not addictive** - this is a common misconception that conflates NSAIDs with opioids. There is no addiction concern with ibuprofen or naproxen. The reason for early dosing is mechanistic: NSAIDs block prostaglandin SYNTHESIS, so they work best when started before the prostaglandin cascade is in full swing. The addiction concern is not relevant here.", "consequence": "NSAIDs are not addictive; this misses the real reason for early dosing.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Taking medication early conditions your body to feel less pain over time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NSAIDs do NOT \"condition\" the body or have lasting effects after they're metabolized. Each menstrual cycle, the prostaglandin cascade restarts, and NSAIDs must be taken again. The benefit of early dosing is **pharmacological** (blocking prostaglandin synthesis before it begins), not a conditioning or training effect on pain pathways.", "consequence": "No conditioning effect - benefit is pharmacological.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Start NSAIDs 1-2 days before expected menses or at the first sign of bleeding/cramping**. NSAIDs prevent prostaglandin SYNTHESIS - they can't reverse prostaglandins already made. Preemptive dosing is more effective than waiting until pain is severe."}, "node-3": {"id": "node-3", "type": "decision", "content": "The teen now understands why early NSAID dosing helps. She has one more question:\n\n**\"My friend takes birth control pills for her cramps, but she doesn't have a boyfriend. How do those help with pain?\"**\n\n**Mechanism of hormonal contraceptives in dysmenorrhea:**\n- OCPs suppress ovulation\n- They thin the endometrial lining\n- A thinner endometrium produces LESS prostaglandin\n- Less prostaglandin = less pain\n- Can be taken continuously (skip placebo pills) to further reduce or eliminate menses", "question": "How do you explain the mechanism by which hormonal contraceptives reduce dysmenorrhea?", "choices": [{"id": "node-3-choice-a", "text": "Hormonal contraceptives thin the endometrial lining, which produces less prostaglandin, and suppress ovulation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Hormonal contraceptives reduce dysmenorrhea through multiple mechanisms**: (1) **Thinner endometrium** - less tissue to break down means less prostaglandin release, (2) **Suppressed ovulation** - anovulatory cycles tend to have less prostaglandin production, (3) **Reduced menstrual flow** - less volume = less prostaglandin, (4) **Continuous use** (skipping placebo pills) can eliminate menses entirely, providing complete relief. This explains why OCPs are used for dysmenorrhea even when contraception isn't needed.", "consequence": "You correctly explain the mechanism of hormonal therapy.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Birth control pills directly block pain receptors in the uterus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hormonal contraceptives do NOT directly affect pain receptors**. Their mechanism involves hormonal regulation of the endometrium: (1) Estrogen and progestin suppress endometrial growth, (2) A thinner lining produces less prostaglandin when shed, (3) Less prostaglandin = fewer contractions = less pain. The effect is upstream in the pathway, not at the level of pain perception.", "consequence": "Hormones don't directly block pain receptors.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Birth control pills contain pain medication as an added ingredient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Birth control pills contain only hormones** (estrogen and/or progestin), not pain medications. The pain relief comes from the hormonal effect on the endometrium - thinning the lining so less prostaglandin is produced during menstruation. Some women take NSAIDs in addition to OCPs for enhanced relief, but the OCP itself doesn't contain analgesics.", "consequence": "OCPs don't contain pain medication.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Birth control pills work by increasing blood flow to the uterus", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **OCPs do not increase uterine blood flow** as their mechanism for reducing dysmenorrhea. In fact, OCPs may slightly reduce uterine blood flow. The mechanism is hormonal suppression of the endometrium: thinner lining \u2192 less prostaglandin production \u2192 fewer contractions \u2192 less ischemic pain. The benefit is from reduced prostaglandin synthesis, not increased perfusion.", "consequence": "Mechanism is not related to blood flow.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Birth control pills only work for dysmenorrhea if you're sexually active", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sexual activity is irrelevant to the mechanism** of OCPs in treating dysmenorrhea. The hormonal effects on the endometrium work regardless of sexual activity. OCPs are commonly prescribed to adolescents specifically FOR dysmenorrhea management, even when contraception is not needed. This is an important point to communicate to patients and families to reduce stigma around OCP use for medical indications.", "consequence": "Sexual activity is irrelevant to the dysmenorrhea benefit.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hormonal contraceptives reduce dysmenorrhea by thinning the endometrium** \u2192 less tissue to shed \u2192 less prostaglandin production. This mechanism is independent of contraceptive need. Continuous cycling (skipping placebo pills) provides even more relief by eliminating menses."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You effectively explained the pathophysiology of primary dysmenorrhea and connected mechanism to treatment.\n\n**Key Teaching Points:**\n\n**The Prostaglandin Pathway:**\n1. Progesterone withdrawal \u2192 endometrial breakdown\n2. Arachidonic acid released \u2192 COX converts to prostaglandins\n3. PGF2\u03b1 causes uterine contractions \u2192 vessel compression \u2192 ischemia \u2192 PAIN\n4. PGE2 sensitizes pain receptors\n\n**Why NSAIDs Work:**\n- Inhibit COX \u2192 prevent prostaglandin synthesis\n- Start BEFORE menses for best effect (prevent, don't chase)\n\n**Why Hormonal Contraceptives Work:**\n- Thin endometrium \u2192 less prostaglandin produced\n- Suppress ovulation\n- Can be used continuously to eliminate menses\n- Work regardless of sexual activity\n\n**Clinical Application:**\nUnderstanding mechanism helps patients adhere to treatment (especially early NSAID dosing) and reduces stigma around OCP use for non-contraceptive indications."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key pathophysiology:\n\n**Prostaglandin Pathway:**\n- Progesterone withdrawal \u2192 endometrial breakdown\n- COX enzymes convert arachidonic acid \u2192 prostaglandins\n- PGF2\u03b1 \u2192 uterine contractions \u2192 ischemia \u2192 pain\n\n**NSAIDs:**\n- Inhibit COX \u2192 prevent prostaglandin SYNTHESIS\n- Cannot neutralize prostaglandins already made\n- Must start EARLY (before or at menses onset) for best effect\n\n**Hormonal Contraceptives:**\n- Thin endometrium \u2192 less prostaglandin production\n- Suppress ovulation\n- Work for dysmenorrhea regardless of sexual activity"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Understanding the mechanism is crucial for patient education:\n\n**Primary Dysmenorrhea = Prostaglandin-Mediated Pain**\n\n**The Cascade:**\nProgesterone withdrawal \u2192 Phospholipase \u2192 Arachidonic acid \u2192 **COX** \u2192 Prostaglandins \u2192 Uterine contractions \u2192 Ischemia \u2192 PAIN\n\n**NSAIDs Target COX:**\n- Block prostaglandin SYNTHESIS\n- Cannot reverse existing prostaglandins\n- Start BEFORE menses for best effect\n\n**Hormonal Contraceptives:**\n- Thin endometrium \u2192 less prostaglandin production\n- NOT direct pain blockers\n- NOT dependent on sexual activity\n- Can be used continuously to eliminate menses"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-136", "title": "Pediatric Lipid Screening", "domain": "endocrine", "difficulty": "intermediate", "tags": ["universal screening 9-11 years", "familial hypercholesterolemia", "FH", "LDL cholesterol", "statin therapy in children", "cascade screening", "pediatric lipid screening"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 10-year-old male is at his well-child visit. He has no significant medical history and takes no medications. His BMI is at the 65th percentile (healthy weight). He is active in soccer and his diet is generally balanced.\n\nHis parents mention: \"We read online that children should be screened for cholesterol. His grandfather had a heart attack at age 52. Should we test him?\"\n\nYou need to counsel them on pediatric lipid screening guidelines.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You review the current pediatric lipid screening guidelines with the family.\n\n**NHLBI/AAP Pediatric Lipid Screening Guidelines:**\n\n**Universal Screening (regardless of family history or risk factors):**\n- **Ages 9-11 years** - first universal screening\n- **Ages 17-21 years** - second universal screening\n- Rationale: Detects **familial hypercholesterolemia (FH)**, which affects **1 in 250** people and causes premature cardiovascular disease if untreated\n\n**Selective/Targeted Screening (earlier, based on risk factors):**\n- **Ages 2-8 years** AND **12-16 years**: Screen if risk factors present:\n  - Family history of premature CVD (MI, stroke, sudden death <55 years in males, <65 years in females)\n  - Family history of dyslipidemia (total cholesterol >240 mg/dL)\n  - Unknown family history\n  - Child has cardiovascular risk factors (obesity, hypertension, diabetes, smoking)\n\n**Why Universal Screening at 9-11?**\n- Lipid levels are most stable before puberty\n- Allows detection of FH before atherosclerosis progresses\n- Many children with FH have no known family history (missed if only selective screening)\n- Early intervention with lifestyle \u00b1 medication prevents premature CVD", "question": "Based on the screening guidelines, what do you recommend for this 10-year-old?", "choices": [{"id": "node-1-choice-a", "text": "Order a lipid panel - he is within the universal screening age range (9-11 years) and screening is recommended regardless of family history", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Universal lipid screening is recommended for all children ages 9-11**, regardless of family history or risk factors. This child is 10 years old - right in the target range. Key points: (1) **Universal screening** catches FH even without known family history, (2) **FH affects 1 in 250** - more common than many conditions we routinely screen for, (3) **9-11 years** is optimal because lipid levels are stable before puberty, (4) The grandfather's early MI (age 52) is an additional risk factor, but screening would be indicated even without this history.", "consequence": "You appropriately apply universal screening guidelines.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Defer screening - he is healthy with normal BMI and only needs testing if he has risk factors like obesity or diabetes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Universal screening at 9-11 years is recommended for ALL children**, not just those with risk factors. This is a common misconception. The rationale: (1) **FH is genetically determined** - a child can have severe hypercholesterolemia regardless of weight or lifestyle, (2) **50% of people with FH don't know a family member had it** - selective screening misses many cases, (3) **Obesity is an indication for EARLIER screening** (ages 2-8), not a prerequisite for screening at 9-11. Healthy-appearing children can still have FH.", "consequence": "Missing opportunity for guideline-recommended universal screening.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Recommend screening only because of the family history of early MI - otherwise it wouldn't be needed at his age", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct but incomplete reasoning. Yes, the grandfather's MI at 52 is a risk factor (premature CVD in first-degree relative <55 for males). BUT **universal screening at 9-11 is recommended regardless of family history**. Your reasoning would apply if he were 8 years old (selective screening based on risk factors) or 13 years old (between universal screening windows). At age 10, he should be screened whether or not there's family history. Understanding the difference between universal (9-11, 17-21) and selective (2-8, 12-16 with risk factors) screening is important.", "consequence": "Correct action but incomplete understanding of guidelines.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Wait until he's older - cholesterol screening should be done after puberty when levels stabilize", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lipid levels are MOST stable BEFORE puberty**, which is why 9-11 years is the recommended window. During puberty: (1) **HDL decreases** (especially in males), (2) **LDL fluctuates**, (3) Values may not reflect true baseline. Screening at 9-11 captures the pre-pubertal baseline. The second universal screening window (17-21 years) occurs AFTER puberty is complete. Waiting until 'after puberty' would miss the optimal screening window and delay detection of FH.", "consequence": "Delaying screening misses the optimal pre-pubertal window.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Order screening but only if the family pays out of pocket since preventive lipid screening isn't covered by insurance for children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Universal lipid screening at 9-11 years IS covered by insurance** under the Affordable Care Act as a preventive service with a Grade B recommendation from the USPSTF. Preventive services with A or B ratings must be covered without cost-sharing. This is standard preventive care, not an optional extra service. Insurance coverage should not be a barrier to guideline-recommended screening.", "consequence": "Incorrect information about insurance coverage creates unnecessary barriers.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Universal lipid screening at 9-11 years** catches familial hypercholesterolemia (FH) before atherosclerosis progresses. FH affects **1 in 250** people - more common than many conditions we screen for. Pre-pubertal screening (9-11) is ideal because lipid levels are most stable before puberty."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order a lipid panel. The results return:\n\n**Lipid Panel Results:**\n- **Total cholesterol: 285 mg/dL** (normal <170, borderline 170-199, high \u2265200)\n- **LDL cholesterol: 210 mg/dL** (normal <110, borderline 110-129, high \u2265130)\n- **HDL cholesterol: 55 mg/dL** (normal \u226545)\n- **Triglycerides: 100 mg/dL** (normal <90, borderline 90-129)\n\nThe parents are shocked: \"He eats healthy and exercises! How can his cholesterol be so high?\"\n\n**Interpreting Pediatric Lipid Levels:**\n\n**LDL Cholesterol:**\n- **\u2265190 mg/dL** = Likely FH (heterozygous) - consider genetic cause\n- **\u2265130 mg/dL** = High - warrants intervention\n- **110-129 mg/dL** = Borderline - lifestyle modifications, recheck\n\n**This child's LDL of 210 mg/dL is HIGHLY suggestive of Familial Hypercholesterolemia:**\n- **Heterozygous FH**: LDL typically 190-350 mg/dL\n- **Homozygous FH**: LDL >400 mg/dL (extremely rare, ~1 in 1 million)\n- FH is **autosomal dominant** - 50% of first-degree relatives affected\n- **LDL receptor mutations** cause impaired clearance of LDL from blood", "question": "How do you interpret these results and counsel the family?", "choices": [{"id": "node-2-choice-a", "text": "Explain this strongly suggests familial hypercholesterolemia - a genetic condition causing high LDL regardless of diet. Confirm with fasting lipid panel and consider genetic testing and cascade family screening.", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **LDL \u2265190 mg/dL in a child strongly suggests familial hypercholesterolemia (FH)**. Key counseling points: (1) **FH is genetic** - the LDL receptor doesn't work properly regardless of diet/exercise, (2) **Autosomal dominant** - 50% of first-degree relatives are affected, (3) **Cascade screening** - parents, siblings, and eventually the child's own children should be tested, (4) **Confirmatory fasting lipid panel** is appropriate, (5) **Genetic testing** can confirm the diagnosis and identify the specific mutation, (6) **The grandfather's MI at 52 is now explained** - he likely had undiagnosed FH. Early treatment prevents premature cardiovascular disease.", "consequence": "You correctly identify likely FH and initiate appropriate workup.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Reassure them this is likely a lab error since he's healthy and active - repeat the test in a few months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **An LDL of 210 mg/dL is NOT a lab error** - it's a highly abnormal value that demands investigation. This is a dangerous misconception: (1) **FH causes severe hypercholesterolemia in otherwise healthy children**, (2) The fact that he's active and eats well is EXACTLY why FH should be suspected - his LDL is high despite healthy habits, (3) **Delaying evaluation** allows atherosclerosis to progress. The results should be confirmed with a fasting lipid panel (for accuracy), but dismissing them as an error is inappropriate.", "consequence": "Dismissing significantly abnormal results delays critical diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Recommend strict dietary changes - eliminate all saturated fat and cholesterol from his diet and recheck in 6 months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While lifestyle modifications are part of FH management, **diet alone cannot normalize LDL in familial hypercholesterolemia**. Key points: (1) **FH is a genetic defect in LDL receptor function** - dietary cholesterol has minimal impact, (2) Dietary changes typically lower LDL by only 10-15% in FH, (3) **An LDL of 210 would remain severely elevated** even with perfect diet, (4) **Medication (statins) is typically needed** for children with FH, (5) Strict dietary restriction without proper diagnosis and treatment is inadequate and may create food anxiety. The diagnosis of FH must be established and appropriate treatment initiated.", "consequence": "Diet alone is insufficient for FH and delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Start a statin medication immediately - his LDL is dangerously high and needs urgent treatment", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable but premature. While this child likely needs statin therapy, **starting medication before confirming the diagnosis is not optimal practice**. The appropriate sequence: (1) **Confirm with fasting lipid panel** (non-fasting screens can overestimate triglycerides), (2) **Rule out secondary causes** (hypothyroidism, nephrotic syndrome, diabetes, liver disease), (3) **Establish FH diagnosis** (clinical criteria \u00b1 genetic testing), (4) **Initiate lifestyle modifications**, (5) **THEN start statin therapy** with informed consent and proper monitoring. Statins are safe and effective in children with FH, but the diagnosis should be established first.", "consequence": "Starting treatment before confirming diagnosis is premature.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Explain that high cholesterol in children isn't concerning - atherosclerosis doesn't start until adulthood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Atherosclerosis begins in childhood**, particularly in children with FH. Key evidence: (1) **Fatty streaks** (earliest atherosclerotic lesions) are found in children as young as 3 years, (2) **Autopsy studies** show advanced atherosclerosis in young adults who died from other causes, (3) **Children with untreated FH** have significantly increased carotid intima-media thickness, (4) **Untreated heterozygous FH** leads to MI in 50% of men by age 50 and 30% of women by age 60. Early treatment prevents decades of LDL-mediated arterial damage.", "consequence": "False reassurance ignores the reality of childhood atherosclerosis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**LDL \u2265190 mg/dL in a child = suspect familial hypercholesterolemia (FH)** until proven otherwise. FH is genetic (autosomal dominant) - diet and exercise alone cannot normalize LDL. Confirm diagnosis, screen family members (cascade screening), and plan for likely statin therapy."}, "node-3": {"id": "node-3", "type": "decision", "content": "Confirmatory fasting lipid panel shows LDL 205 mg/dL (confirming the initial finding). Secondary causes are ruled out (normal TSH, urinalysis, glucose, liver enzymes).\n\nYou explain to the family that their son has **familial hypercholesterolemia (FH)** based on:\n- LDL >190 mg/dL in a child\n- Family history of premature CVD (grandfather's MI at 52)\n- No secondary causes identified\n\nThe parents ask: \"What does this mean for his treatment? Will he need to take medication? He's only 10!\"\n\n**Treatment of Pediatric FH:**\n\n**Lifestyle Modifications (for ALL patients):**\n- Heart-healthy diet (limit saturated fat, increase fiber)\n- Regular physical activity\n- Maintain healthy weight\n- Avoid tobacco exposure\n\n**Statin Therapy:**\n- **Recommended for children \u226510 years with FH** if LDL remains \u2265190 mg/dL (or \u2265160 with additional risk factors)\n- **Goal**: Reduce LDL by \u226550% OR achieve LDL <130 mg/dL\n- Statins are safe and effective in children; extensive pediatric safety data\n- Start low dose, titrate as needed\n- Monitor liver enzymes and CK periodically", "question": "How do you counsel the family about treatment?", "choices": [{"id": "node-3-choice-a", "text": "Recommend lifestyle modifications AND statin therapy - at age 10 with LDL >190 and family history, medication is indicated alongside diet and exercise", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Statin therapy is indicated for children \u226510 years with FH and LDL \u2265190 mg/dL**. Key counseling points: (1) **Statins are safe in children** - decades of pediatric data support their use, (2) **Lifestyle PLUS medication** - both are essential; neither alone is sufficient, (3) **Goal is LDL reduction \u226550%** or achieving LDL <130 mg/dL, (4) **Early treatment prevents atherosclerosis** - each year of elevated LDL causes cumulative arterial damage, (5) **The grandfather's early MI demonstrates the consequence of untreated FH** - treatment can prevent this outcome in their son. Monitoring includes periodic liver enzymes and CK.", "consequence": "Appropriate treatment initiated for pediatric FH.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Recommend lifestyle modifications only and defer statins until adulthood - medications have too many side effects for children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Statins are safe and effective in children with FH**, and deferring treatment until adulthood allows decades of atherosclerosis progression. Key evidence: (1) **Pediatric statin studies** show excellent safety profiles with minimal side effects, (2) **Myopathy and liver toxicity** are rare and reversible, (3) **The REAL risk is untreated FH** - 50% of men with untreated heterozygous FH have MI by age 50, (4) **Lifestyle alone reduces LDL by only 10-15%** in FH - nowhere near sufficient. The benefit of preventing cardiovascular disease far outweighs the minimal risks of statin therapy.", "consequence": "Withholding indicated treatment allows preventable atherosclerosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Refer to cardiology before making any treatment recommendations - this is too specialized for primary care", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. While **lipid specialist or pediatric cardiologist referral can be helpful** for FH management, **primary care providers can initiate statin therapy** for straightforward pediatric FH. Referral is particularly appropriate for: (1) Homozygous FH (extremely high LDL >400), (2) Inadequate response to initial statin therapy, (3) Complex cases with multiple comorbidities, (4) Provider discomfort with pediatric statin management. However, delaying treatment pending specialty referral is not ideal - lifestyle modifications and initial statin therapy can begin in primary care.", "consequence": "Referral is acceptable but may delay treatment initiation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Recommend aggressive treatment with the highest statin dose plus additional lipid-lowering medications immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While treatment is indicated, **starting with maximum doses and multiple medications is not recommended**. The appropriate approach: (1) **Start with lifestyle modifications**, (2) **Begin low-to-moderate dose statin**, (3) **Titrate based on response and tolerability**, (4) **Add second agent only if target not achieved** with maximally tolerated statin. Starting aggressively increases side effect risk without proven benefit. The goal is sustainable, well-tolerated treatment that the child will continue for life.", "consequence": "Overly aggressive initial treatment increases side effects without benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Wait until he's 18 to discuss treatment since he can make his own medical decisions as an adult", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Waiting until age 18 allows 8 more years of atherosclerosis progression**. This approach is medically inappropriate because: (1) **Parents provide informed consent for minors** - waiting for autonomous decision-making is not a valid reason to defer treatment, (2) **Each year of elevated LDL causes cumulative damage** - atherosclerosis is progressive, (3) **Treatment at age 10 prevents disease; treatment at 18 treats established disease**, (4) **The child can be involved in age-appropriate shared decision-making** without deferring medically necessary treatment. Early intervention is the standard of care for pediatric FH.", "consequence": "Delaying treatment causes preventable cardiovascular damage.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Statins are safe and indicated for children \u226510 years with FH** and LDL \u2265190 mg/dL. The goal is LDL reduction \u226550% or achieving LDL <130 mg/dL. Early treatment prevents the premature cardiovascular disease that affected this child's grandfather. Both lifestyle AND medication are essential components of FH management."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly applied pediatric lipid screening guidelines, recognized familial hypercholesterolemia, and initiated appropriate treatment.\n\n**Key Teaching Points:**\n\n**Universal Lipid Screening:**\n- **Ages 9-11 years** and **17-21 years** - screen ALL children regardless of risk factors\n- **Ages 2-8** and **12-16** - selective screening if risk factors present\n- Pre-pubertal screening (9-11) is ideal because lipid levels are most stable\n\n**Familial Hypercholesterolemia (FH):**\n- Affects **1 in 250** people - very common genetic condition\n- **LDL \u2265190 mg/dL in a child** = suspect FH until proven otherwise\n- **Autosomal dominant** - 50% of first-degree relatives affected\n- **Cascade screening** of family members is essential\n- Diet and exercise alone CANNOT normalize LDL in FH\n\n**Treatment of Pediatric FH:**\n- Lifestyle modifications (diet, exercise, avoid tobacco) for ALL\n- **Statins indicated for children \u226510 years** with LDL \u2265190 mg/dL\n- Statins are safe in children - extensive pediatric safety data\n- **Goal: LDL reduction \u226550%** or LDL <130 mg/dL\n- Early treatment prevents premature cardiovascular disease\n\n**Clinical Impact:**\n- Untreated heterozygous FH: 50% of men have MI by age 50\n- Treated FH: near-normal life expectancy\n- This child's diagnosis may save his life AND identify affected family members"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in pediatric lipid screening and FH management:\n\n**Universal Screening Guidelines:**\n- Screen ALL children at 9-11 years regardless of risk factors\n- Don't require family history or obesity to justify screening\n- Pre-pubertal window captures stable lipid values\n\n**Recognizing FH:**\n- LDL \u2265190 mg/dL in a child = likely FH\n- Genetic condition - diet alone is insufficient\n- Confirm with fasting panel, rule out secondary causes\n\n**Treatment Principles:**\n- Lifestyle + medication for children \u226510 with FH\n- Statins are safe in children\n- Start low dose, titrate to goal\n- Don't delay treatment pending specialty referral for straightforward cases\n\n**Common Mistakes:**\n- Assuming healthy lifestyle rules out hyperlipidemia\n- Relying on diet alone for FH\n- Deferring statins due to unfounded safety concerns\n- Waiting for adulthood to treat"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical concepts in pediatric cardiovascular prevention:\n\n**Universal Screening is Essential:**\n- **FH affects 1 in 250** - too common to miss\n- **50% of FH patients have no known family history** - selective screening misses many cases\n- **9-11 years is the optimal window** - stable pre-pubertal lipid levels\n\n**FH is a Genetic Emergency:**\n- **LDL \u2265190 mg/dL in a child is NOT normal** - investigate immediately\n- **Diet cannot overcome defective LDL receptors**\n- **Atherosclerosis begins in childhood** and progresses with each year of elevated LDL\n\n**Treatment Saves Lives:**\n- **Untreated FH**: 50% of men have MI by age 50, 30% of women by age 60\n- **Treated FH**: near-normal cardiovascular outcomes\n- **Statins are safe in children** - pediatric data spans decades\n- **Early treatment prevents disease** rather than treating established atherosclerosis\n\n**The Grandfather's Story:**\n- His MI at 52 was likely due to undiagnosed FH\n- Identifying FH in this child may prevent the same outcome\n- Cascade screening can identify other affected family members"}}, "rootNodeId": "node-1"}], "heme_onc": [{"id": "vignette-lens-peds-016", "title": "Methemoglobinemia", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["cyanosis unresponsive to oxygen", "chocolate-colored blood", "methemoglobinemia"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 4-month-old male is brought to the ED with bluish skin color that developed after the mother gave him well water mixed with formula.\n\nSubjectively, he has been looking increasingly 'blue' over the past 6 hours. The family recently moved to a rural area with well water. He is fussy but feeding adequately.\n\nPhysical Examination:\n- General: cyanotic infant who appears well-perfused, irritable but consolable.\n- Vitals: HR 150, RR 40, BP 75/45, SpO2 reading 85% on room air (not improving with oxygen).\n- Skin: generalized grayish-blue discoloration (cyanosis), lips and nail beds dusky.\n- Lungs: clear, no distress.\n- Cardiovascular: regular rhythm, no murmur, strong pulses.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This infant has cyanosis that does NOT improve with supplemental 100% oxygen. The pulse oximeter reads 85% consistently and does not change. The infant appears well-perfused with strong pulses despite the cyanosis.", "question": "What is the MOST important diagnostic clue that points AWAY from cardiac or pulmonary causes of cyanosis?", "choices": [{"id": "node-1-choice-a", "text": "Cyanosis does not improve with 100% oxygen administration", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Cyanosis unresponsive to oxygen** is the hallmark of methemoglobinemia. In cardiac shunts or pulmonary disease, supplemental oxygen typically produces SOME improvement. In methemoglobinemia, the problem is that hemoglobin cannot carry oxygen regardless of how much is available - the iron is oxidized (Fe\u00b3\u207a instead of Fe\u00b2\u207a).", "consequence": "You suspect a hemoglobinopathy or dyshemoglobin state.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Strong peripheral pulses suggest adequate cardiac output", "isOptimal": false, "isAcceptable": true, "feedback": "Strong pulses indicate adequate perfusion, which is helpful, but cyanotic heart defects (like Tetralogy of Fallot) can have normal perfusion. The key clue is the **lack of response to oxygen**, which is unique to dyshemoglobinemias (methemoglobin, carboxyhemoglobin, sulfhemoglobin).", "consequence": "Helpful finding but not the most specific clue.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Clear lung sounds rule out pulmonary disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Clear lungs help exclude pneumonia or pulmonary edema, but don't explain the **oxygen-unresponsive cyanosis**. Cyanotic heart defects also have clear lungs. The failure to improve with O2 is more diagnostic.", "consequence": "Missing the key diagnostic feature.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Absence of murmur excludes cardiac disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Some cyanotic heart defects (like TGA) may have no murmur initially. The absence of murmur does NOT rule out cardiac disease. The **failure to respond to oxygen** is the key finding pointing toward methemoglobinemia.", "consequence": "False reassurance from absence of murmur.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Age of 4 months makes congenital heart disease unlikely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Many congenital heart defects present at 4 months or later as ductal-dependent lesions manifest or shunts become apparent. Age does NOT rule out cardiac disease.", "consequence": "False reassurance about cardiac disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**'Blue baby + doesn't get pink with O2'** = think methemoglobinemia. The pulse ox reads ~85% and **won't budge** because standard pulse oximetry cannot distinguish methemoglobin from deoxyhemoglobin. It averages the two absorption spectra."}, "node-2": {"id": "node-2", "type": "decision", "content": "You draw an arterial blood gas. When you hold the syringe up to the light, the blood appears **chocolate brown** rather than the expected dark red of venous blood or bright red of arterial blood. ABG: pH 7.35, PaO2 150 mmHg (on supplemental O2), SaO2 reported as 99%.", "question": "What explains the discrepancy between the PaO2 (high), calculated SaO2 (99%), and the clinical cyanosis with SpO2 of 85%?", "choices": [{"id": "node-2-choice-a", "text": "Methemoglobin is present; ABG calculates SaO2 from PaO2 and misses methemoglobin; need co-oximetry", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Standard ABG analyzers **calculate** oxygen saturation from PaO2 using the normal oxyhemoglobin dissociation curve. This **misses dyshemoglobins** like methemoglobin. **Co-oximetry** directly measures multiple hemoglobin species (oxyhemoglobin, deoxyhemoglobin, methemoglobin, carboxyhemoglobin) and is required for diagnosis.", "consequence": "You order co-oximetry which shows methemoglobin level of 35%.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "The ABG machine is malfunctioning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The ABG is functioning correctly - it's measuring PaO2 accurately. The problem is that **calculated SaO2** assumes normal hemoglobin. When methemoglobin is present, calculated SaO2 overestimates true oxygen-carrying capacity.", "consequence": "You miss the diagnosis by assuming equipment error.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "The pulse oximeter is malfunctioning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The pulse oximeter is working correctly - it reads ~85% because that's the **average of oxyhemoglobin and methemoglobin absorption**. The pulse ox doesn't distinguish between them and reports a value between the two.", "consequence": "You miss the diagnosis by assuming equipment error.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Patient has polycythemia causing dark blood", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Polycythemia causes dark red blood from increased hemoglobin concentration, but would NOT cause oxygen-unresponsive cyanosis or the characteristic **chocolate-brown** color. Methemoglobin specifically appears chocolate-brown due to the oxidized iron.", "consequence": "Incorrect diagnosis misses methemoglobinemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Laboratory error - repeat the ABG", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The ABG is accurate. The **saturation gap** (high calculated SaO2 but low SpO2) is diagnostic of dyshemoglobinemia. Repeating the ABG wastes time - you need **co-oximetry**.", "consequence": "Unnecessary delay in diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Saturation gap**: Calculated SaO2 (from ABG) much higher than measured SpO2 (pulse ox) = dyshemoglobinemia. **Chocolate-brown blood** is pathognomonic for methemoglobinemia. Normal MetHb is <1%."}, "node-3": {"id": "node-3", "type": "decision", "content": "Co-oximetry confirms: Methemoglobin 35% (normal <1%), Carboxyhemoglobin 1% (normal). Given the history of well water exposure in an infant, you suspect nitrate-contaminated well water ('blue baby syndrome').", "question": "What is the first-line treatment for symptomatic methemoglobinemia with MetHb level >20%?", "choices": [{"id": "node-3-choice-a", "text": "Methylene blue 1-2 mg/kg IV over 5 minutes", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Methylene blue** is the antidote for methemoglobinemia. It acts as a cofactor for NADPH-methemoglobin reductase (an alternative reduction pathway) to convert methemoglobin back to functional hemoglobin. Dose: **1-2 mg/kg IV over 5 minutes**; can repeat in 1 hour if no response.", "consequence": "Methylene blue administered. Cyanosis improves within minutes.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Exchange transfusion", "isOptimal": false, "isAcceptable": true, "feedback": "Exchange transfusion is a **second-line treatment** for methemoglobinemia refractory to methylene blue or in patients with **G6PD deficiency** (where methylene blue is contraindicated). First-line is always methylene blue.", "consequence": "More invasive than necessary as first-line.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "High-flow oxygen therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oxygen does NOT treat methemoglobinemia** - the problem is that methemoglobin cannot carry oxygen regardless of how much is available. The iron must be reduced from Fe\u00b3\u207a back to Fe\u00b2\u207a using methylene blue.", "consequence": "Oxygen alone fails to improve the condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Ascorbic acid (vitamin C) IV", "isOptimal": false, "isAcceptable": true, "feedback": "Ascorbic acid can reduce methemoglobin but works much **slower than methylene blue** (hours vs minutes). It's used for chronic/mild methemoglobinemia or when methylene blue is contraindicated. Not first-line for acute symptomatic cases.", "consequence": "Suboptimal - too slow for acute symptomatic case.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Hyperbaric oxygen therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hyperbaric oxygen is used for **carbon monoxide poisoning**, NOT methemoglobinemia. HBO increases dissolved O2 in plasma but doesn't address the dysfunctional hemoglobin. Methylene blue is the treatment.", "consequence": "Wrong treatment modality.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Treatment thresholds**: MetHb <20% asymptomatic = observation; MetHb >20% OR symptomatic = **methylene blue**. **Caution**: Methylene blue is CONTRAINDICATED in **G6PD deficiency** (causes hemolysis) - use exchange transfusion instead."}, "node-4": {"id": "node-4", "type": "decision", "content": "After methylene blue administration, the infant's color improves dramatically within 15 minutes. SpO2 rises to 98%. Repeat MetHb level is 5%. The mother asks what caused this and how to prevent recurrence.", "question": "What is the most likely cause of methemoglobinemia in this infant, and what counseling is needed?", "choices": [{"id": "node-4-choice-a", "text": "Nitrates in well water converted to nitrites by gut bacteria; infants <6 months are especially susceptible; use bottled water or test well", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **'Blue baby syndrome'** from nitrate-contaminated well water is classic. Nitrates are converted to nitrites by gut bacteria (especially in infants with higher gastric pH). Nitrites oxidize hemoglobin to methemoglobin. **Infants <6 months are highly susceptible** due to fetal hemoglobin (more easily oxidized) and immature methemoglobin reductase system.", "consequence": "Family counseled to use bottled water and test their well.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Congenital methemoglobinemia from enzyme deficiency; genetic testing needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Congenital methemoglobinemia (cytochrome b5 reductase deficiency) presents from birth with persistent cyanosis, not acute onset after well water exposure. This case has a clear environmental trigger.", "consequence": "Missing the environmental cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Hemoglobin M disease; this is an inherited condition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hemoglobin M is a rare inherited variant that causes lifelong cyanosis from birth. It does NOT respond to methylene blue (the abnormal hemoglobin structure is the problem). This infant responded to methylene blue, indicating acquired methemoglobinemia.", "consequence": "Incorrect diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Dapsone toxicity from medication exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Dapsone is a common cause of acquired methemoglobinemia in older patients, but this infant has no medication exposure. The well water history points to nitrate exposure.", "consequence": "Missing the actual cause.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Benzocaine exposure from teething gel", "isOptimal": false, "isAcceptable": false, "feedback": "Benzocaine (in teething gels) is a well-known cause of methemoglobinemia in infants, but there's no history of topical anesthetic use. The well water exposure is the clear culprit here.", "consequence": "Missing the actual cause.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Common causes of acquired methemoglobinemia**: Nitrates (well water, vegetables), **Dapsone**, topical anesthetics (**benzocaine**, lidocaine), **nitrites** (poppers), sulfonamides, antimalarials. **Infants are high-risk** due to fetal Hb and immature enzyme systems."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of methemoglobinemia!\n\n**Key Learning Points:**\n1. **Recognition**: Cyanosis that does NOT improve with oxygen + chocolate-brown blood\n2. **Diagnosis**: Co-oximetry (NOT standard ABG) measures methemoglobin directly\n3. **Saturation gap**: High calculated SaO2 + low SpO2 = dyshemoglobinemia\n4. **Treatment**: Methylene blue 1-2 mg/kg IV (contraindicated in G6PD deficiency)\n5. **Causes**: Nitrates (well water), dapsone, benzocaine, nitrites\n6. **Infants at risk**: <6 months, fetal Hb, immature reductase, higher gastric pH\n7. **Response**: Improvement within minutes of methylene blue\n\n**Pulse ox reads ~85%** because it can't distinguish methemoglobin from deoxyhemoglobin."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review methemoglobinemia pearls:\n\n1. **Cyanosis + no O2 response** = think methemoglobin\n2. **Chocolate-brown blood** is pathognomonic\n3. **Co-oximetry** is required - standard ABG misses it\n4. **Pulse ox reads ~85%** and doesn't budge\n5. **Methylene blue** is first-line treatment\n6. **Well water + infant** = nitrate-induced 'blue baby syndrome'"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in methemoglobinemia management.\n\n**Oxygen alone does NOT work** - the hemoglobin cannot carry oxygen regardless of how much is available. The Fe\u00b3\u207a must be reduced to Fe\u00b2\u207a.\n\n**Methylene blue** is the antidote - do not delay or substitute.\n\n**Hyperbaric oxygen** is for CO poisoning, not methemoglobinemia.\n\n**G6PD deficiency** is a contraindication to methylene blue - use exchange transfusion."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-038", "title": "Immune Thrombocytopenic Purpura", "domain": "heme_onc", "difficulty": "advanced", "tags": ["immune thrombocytopenic purpura", "ITP", "isolated thrombocytopenia", "petechiae", "IVIG", "corticosteroids", "post-viral", "well-appearing child", "activity restrictions", "intracranial hemorrhage"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 4-year-old female presents to the clinic with bruising and a rash of 3 days duration.\n\nSubjectively, she has developed multiple bruises on her arms and legs without any known trauma. Her parents also noticed small red dots on her skin. She had a viral illness 2 weeks ago.\n\nReview of systems is positive for occasional nosebleeds and negative for fever, bone pain, weight loss, or fatigue.\n\nMedical history is notable for She was previously healthy with no bleeding history. No family history of bleeding disorders.\n\nPhysical Examination:\n- Skin: scattered petechiae and ecchymoses on trunk and extremities, no palpable purpura.\n- General: well-appearing, playful child, afebrile.\n- Lymph nodes: no lymphadenopathy. Spleen: not palpable.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 4-year-old with sudden onset of bruising and petechiae 2 weeks after a viral illness.\n\n**Key features suggesting ITP:**\n- **Well-appearing child** (not sick)\n- **Isolated petechiae and bruising** (bleeding symptoms only)\n- **No lymphadenopathy or hepatosplenomegaly**\n- **No fever, bone pain, or systemic symptoms**\n- **Recent viral illness** (1-4 weeks prior)\n- No concerning features for malignancy\n\nCBC returns: Platelets **8,000/\u03bcL**, WBC 7,500/\u03bcL (normal differential), Hemoglobin 12.5 g/dL", "question": "Based on these findings, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Immune thrombocytopenic purpura (ITP) - isolated thrombocytopenia in well-appearing child", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is classic **ITP**: **isolated thrombocytopenia** (only platelets are low), **well-appearing child** without systemic symptoms, **recent viral illness**, and **no lymphadenopathy or hepatosplenomegaly**. ITP is caused by **antiplatelet antibodies** (usually IgG) that lead to platelet destruction in the spleen. It's the most common cause of isolated thrombocytopenia in children.", "consequence": "Correct diagnosis. Proceed with management decisions.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Acute lymphoblastic leukemia - petechiae suggest bone marrow failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Leukemia causes **pancytopenia** (low WBC, anemia, AND thrombocytopenia) from bone marrow infiltration. This child has **isolated thrombocytopenia** with normal WBC and hemoglobin. Leukemia also typically presents with **bone pain, lymphadenopathy, hepatosplenomegaly**, and the child appears **ill** - all absent here.", "consequence": "Leukemia causes pancytopenia. This is isolated thrombocytopenia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Aplastic anemia - low platelets indicate bone marrow failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Aplastic anemia causes **pancytopenia** (failure of all cell lines) from bone marrow aplasia. This child has **isolated thrombocytopenia** with normal WBC and hemoglobin. Aplastic anemia would also cause anemia symptoms (fatigue, pallor) and increased infections from neutropenia.", "consequence": "Aplastic anemia causes pancytopenia, not isolated thrombocytopenia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Henoch-Sch\u00f6nlein purpura (HSP) - purpura after viral illness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HSP causes **palpable purpura** on lower extremities and buttocks (vasculitic, raised lesions) along with **abdominal pain, arthritis, and nephritis**. HSP has **NORMAL platelet counts** because it's a vasculitis, not a platelet disorder. This child has flat petechiae with thrombocytopenia.", "consequence": "HSP has normal platelets. This child is thrombocytopenic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Meningococcemia - petechiae indicate serious infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Meningococcemia presents with **toxic appearance, high fever, rapid deterioration**, and petechiae that quickly progress to purpura fulminans. This child is **well-appearing, afebrile, and playful** - completely inconsistent with sepsis. DIC from sepsis would also affect other cell lines.", "consequence": "Meningococcemia: sick child with rapid deterioration. This child is well.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**ITP is a diagnosis of EXCLUSION**: Before diagnosing ITP, ensure the child is **well-appearing** with **isolated thrombocytopenia** (normal WBC and hemoglobin). **Red flags** that suggest another diagnosis: sick appearance, hepatosplenomegaly, lymphadenopathy, bone pain, abnormal WBC, anemia \u2192 consider leukemia, aplastic anemia, or sepsis."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed ITP in this well-appearing 4-year-old with platelets of 8,000/\u03bcL.\n\n**ITP Management Principles:**\n- Treatment decisions based on **bleeding symptoms**, NOT just platelet count\n- Children rarely have serious bleeding even with very low platelets\n- Most children (80%) resolve spontaneously within 6 months\n- Intracranial hemorrhage is rare (<1%) but is the major concern\n\n**Current symptoms:** Petechiae, ecchymoses, occasional nosebleeds (minor mucosal bleeding)", "question": "What is the most appropriate initial management?", "choices": [{"id": "node-2-choice-a", "text": "IVIG or corticosteroids - treatment indicated for platelets <20,000 with bleeding symptoms", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** With platelets **<20,000** AND **mucosal bleeding** (nosebleeds), treatment is indicated. Options include: **IVIG** (1 g/kg, fastest response in 24-48h), **corticosteroids** (prednisone 1-2 mg/kg/day x 2-4 weeks), or **anti-D immunoglobulin** (in Rh+ patients). Treatment aims to raise platelets quickly to reduce bleeding risk.", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Observation only - ITP resolves spontaneously", "isOptimal": false, "isAcceptable": false, "feedback": "Observation alone is appropriate for **asymptomatic** children or those with **only skin bleeding (petechiae/bruising)** and platelets **>20,000**. This child has platelets of 8,000 AND mucosal bleeding (nosebleeds), which increases risk and warrants treatment to raise platelets.", "consequence": "With platelets <20,000 and mucosal bleeding, treatment is indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Platelet transfusion to stop bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Platelet transfusion is generally **NOT indicated** for ITP because transfused platelets are **rapidly destroyed** by the same autoantibodies causing the disease. Transfusion is reserved for **life-threatening bleeding** only (intracranial hemorrhage, severe GI bleed). First-line treatment is IVIG or steroids.", "consequence": "Transfused platelets are rapidly destroyed in ITP.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Emergency splenectomy - remove the site of platelet destruction", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Splenectomy is reserved for **chronic ITP** (>12 months) that fails medical therapy. It is **never first-line treatment** for acute ITP. Most children recover spontaneously within 6 months. Splenectomy also increases lifelong infection risk.", "consequence": "Splenectomy is last resort for chronic refractory ITP only.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Bone marrow biopsy before any treatment", "isOptimal": false, "isAcceptable": true, "feedback": "Bone marrow biopsy is **not required** for typical ITP presentation (well-appearing child, isolated thrombocytopenia, no red flags). Biopsy is indicated if: atypical features (hepatosplenomegaly, lymphadenopathy, other cytopenias), age <1 or >10 years, treatment failure, or before starting steroids if diagnosis uncertain (steroids can mask leukemia).", "consequence": "Biopsy not routinely needed for classic ITP presentation.", "nextNodeId": "node-3"}], "clinicalPearl": "**ITP treatment indications**: (1) Platelets **<20,000** with any bleeding, (2) **Mucosal bleeding** regardless of count (epistaxis, gum bleeding, GI bleeding), (3) Platelets <10,000 even if asymptomatic (some experts). **First-line options**: IVIG (fastest), corticosteroids (cheapest), anti-D (Rh+ only). Most cases resolve in weeks to months."}, "node-3": {"id": "node-3", "type": "decision", "content": "IVIG (1 g/kg) is administered. The next morning, repeat CBC shows platelets have increased to 45,000/\u03bcL. The child has no new bleeding.\n\nThe family asks about activity restrictions and when their child can return to normal activities.", "question": "What activity restrictions are appropriate for this child recovering from ITP?", "choices": [{"id": "node-3-choice-a", "text": "Avoid contact sports and head injury risk activities until platelets >50,000", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** The main concern in ITP is **intracranial hemorrhage** from head trauma. **Activity restrictions** should focus on avoiding **contact sports** (football, hockey, wrestling) and **high head-injury risk activities** (diving, trampolines) until platelets are **>50,000-100,000** (varies by source). Normal play and school can usually resume with minor restrictions.", "consequence": "Appropriate activity guidance provided.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Complete bed rest until platelets normalize completely", "isOptimal": false, "isAcceptable": false, "feedback": "**Overly restrictive.** Complete bed rest is not necessary and negatively impacts quality of life. The risk of serious spontaneous bleeding is low even with low platelets. Restrictions should focus on **preventing head trauma** specifically, not all activity.", "consequence": "Unnecessary restriction. Focus on head trauma prevention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "No restrictions - children rarely have serious bleeding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While spontaneous serious bleeding is rare, **trauma-induced intracranial hemorrhage** is the major concern in ITP. Some activity restrictions (avoiding contact sports and high head-injury risk activities) are appropriate while platelets are low.", "consequence": "Head trauma with low platelets can cause ICH.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Wear a protective helmet at all times", "isOptimal": false, "isAcceptable": false, "feedback": "This is impractical and unnecessary for most children with ITP. While helmets can be recommended for certain high-risk activities (biking, skating), requiring constant helmet use is excessive. Activity modification (avoiding contact sports) is more practical.", "consequence": "Impractical recommendation. Activity modification is better approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "No physical education class for 6 months", "isOptimal": false, "isAcceptable": false, "feedback": "Overly restrictive. Most PE activities are safe. Restrictions should be **specific to high-risk activities** (contact sports, activities with fall/head injury risk), not a blanket exclusion from all PE. Most children can participate with modifications.", "consequence": "Too restrictive. Modify specific activities only.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Activity restrictions in ITP**: Avoid **contact sports** (football, hockey, soccer) and **head injury risk activities** (diving, trampolines, gymnastics) while platelets <50,000-100,000. Normal school, gentle play, and swimming (no diving) are usually OK. **Aspirin and NSAIDs should be avoided** (impair platelet function). Most restrictions can be lifted once platelets recover."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is discharged with activity restrictions. At 2-week follow-up, platelets are 85,000/\u03bcL and she has no bleeding symptoms.\n\nHowever, at 4-month follow-up, the platelets have dropped again to 12,000/\u03bcL and she has new petechiae. She is still well-appearing with no other symptoms.\n\nITP that persists **>3 months** but **<12 months** is termed **persistent ITP**.", "question": "How should you approach this child with persistent ITP and recurrent symptoms at 4 months?", "choices": [{"id": "node-4-choice-a", "text": "Treat acute episode; discuss that most children still resolve within 12 months", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Even with persistent ITP (3-12 months), the majority of children **still resolve spontaneously** - just takes longer. Treat the acute exacerbation (IVIG or steroids) and reassure that chronic ITP (<12 months with ongoing symptoms) occurs in only **~20%** of children. Continue observation with treatment as needed for bleeding episodes.", "consequence": "Appropriate management and realistic expectations.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Recommend splenectomy now since the ITP has persisted", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Splenectomy is reserved for **chronic ITP** (>12 months) that has **failed medical therapy** and significantly impacts quality of life. At 4 months, this is still \"persistent\" ITP, and the majority will still resolve. Splenectomy should not be considered this early.", "consequence": "Too early for splenectomy. Most persistent ITP still resolves.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Start chronic immunosuppression with rituximab", "isOptimal": false, "isAcceptable": false, "feedback": "Rituximab (anti-CD20) is reserved for **chronic, refractory ITP** that has failed first-line therapies. At 4 months with a first recurrence, this is premature. Continue managing acute episodes with IVIG/steroids and observe for spontaneous resolution.", "consequence": "Rituximab reserved for chronic refractory cases.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "This confirms leukemia - bone marrow biopsy urgently needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Recurrence of thrombocytopenia in ITP is **common** and does NOT indicate leukemia. The child remains well-appearing with isolated thrombocytopenia and no new red flags. Bone marrow biopsy would be indicated if atypical features develop (other cytopenias, hepatosplenomegaly, bone pain) or if treatment fails repeatedly.", "consequence": "ITP relapses are common. No indication for biopsy here.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "No treatment needed - persistent ITP is benign and doesn't require intervention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While persistent ITP often resolves, treatment IS indicated when platelets drop low (<20,000) with bleeding symptoms. This child has platelets of 12,000 with petechiae - treatment of this acute episode is appropriate to reduce bleeding risk.", "consequence": "Acute episodes still require treatment even in persistent ITP.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ITP classification by duration**: **Acute** (<3 months, most common), **Persistent** (3-12 months), **Chronic** (>12 months). Even with persistent ITP, **~80% of children eventually resolve**. **Splenectomy** is only considered for chronic ITP (>12 months) failing medical therapy. **TPO-receptor agonists** (romiplostim, eltrombopag) are newer options for chronic ITP."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of ITP!\n\n**Key Learning Points:**\n1. **ITP = Isolated Thrombocytopenia** in a **well-appearing child** (diagnosis of exclusion)\n2. **Red flags** to rule out: sick appearance, hepatosplenomegaly, lymphadenopathy, other cytopenias, bone pain\n3. **Treatment indications**: Platelets <20,000 + bleeding, mucosal bleeding, very low counts\n4. **First-line treatment**: IVIG (fastest), steroids, or anti-D (Rh+ only)\n5. **Platelet transfusion rarely helps** - platelets are rapidly destroyed\n6. **Activity restrictions**: Avoid contact sports and head injury risk until platelets >50,000\n7. **Most children resolve** spontaneously within 6-12 months\n\nThis child was treated successfully with IVIG, given appropriate activity guidance, and managed through a recurrence. Most children with ITP have an excellent prognosis."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key ITP concepts:\n\n**Diagnosis:**\n- **Isolated thrombocytopenia** in well-appearing child\n- Normal WBC and hemoglobin (NOT pancytopenia)\n- No hepatosplenomegaly or lymphadenopathy\n- Recent viral illness common\n\n**Treatment:**\n- Indicated if: platelets <20,000 + bleeding, mucosal bleeding\n- Options: **IVIG** (fastest), **steroids**, anti-D (Rh+ only)\n- Platelet transfusion usually NOT effective\n\n**Prognosis:**\n- 80% resolve within 6 months\n- Splenectomy only for chronic (>12 months) refractory ITP"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in ITP management.\n\n**Key Principles:**\n1. **ITP is a diagnosis of EXCLUSION** - rule out leukemia, aplastic anemia, sepsis first\n2. **Don't transfuse platelets** in ITP - they are rapidly destroyed by autoantibodies\n3. **Don't rush to splenectomy** - reserve for chronic refractory cases (>12 months)\n4. **Treat based on bleeding, not just platelet count**\n\n**Remember:** A well-appearing child with isolated thrombocytopenia after viral illness = ITP until proven otherwise. An ill-appearing child with thrombocytopenia = NOT ITP until proven otherwise (consider leukemia, sepsis, DIC)."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-039", "title": "Sickle Cell Vasoocclusive Crisis", "domain": "heme_onc", "difficulty": "advanced", "tags": ["sickle cell disease", "vasoocclusive crisis", "acute chest syndrome", "pain management", "hydroxyurea", "transfusion"], "estimatedMinutes": 8, "source": ["NBME"], "stem": "An 8-year-old girl with known sickle cell disease (HbSS) presents to the emergency department with severe pain in her arms and legs for the past 6 hours.\n\nHer mother reports progressively worsening pain in both arms and legs since this morning. The pain is severe and throbbing, rated 9/10. She had a cold last week with runny nose and cough. Yesterday she was at a birthday pool party and may have gotten dehydrated.\n\nAssociated symptoms include mild fever and fatigue. She denies shortness of breath, chest pain, or abdominal pain.\n\nMedical history: Sickle cell disease (HbSS) diagnosed at birth on newborn screen. She takes hydroxyurea daily with good compliance. She has had 3 prior pain crises requiring hospitalization.\n\nPhysical Examination:\n- General: Distressed child in obvious pain, crying\n- Vitals: T 38.1\u00b0C, HR 110, RR 22, BP 100/65, SpO2 98% on room air\n- HEENT: Mild scleral icterus\n- Lungs: Clear to auscultation bilaterally\n- Extremities: Tenderness to palpation over bilateral femurs and humeri, no swelling or erythema\n- Abdomen: Soft, non-tender, spleen not palpable", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this child with known sickle cell disease presenting with acute extremity pain and low-grade fever.\n\nHer vital signs show mild tachycardia and low-grade fever. She appears in significant distress from pain. Her lungs are clear and she has no respiratory symptoms.", "question": "What is the most likely diagnosis, and what clinical features help distinguish it from other serious complications in sickle cell disease?", "choices": [{"id": "node-1-choice-a", "text": "Vasoocclusive crisis - bilateral extremity bone pain without focal signs or respiratory symptoms", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Vasoocclusive crisis (VOC) is the most common acute complication of sickle cell disease. Key features supporting VOC include: **bilateral extremity pain** over long bones (typical sites), **precipitating factors** (recent viral illness, possible dehydration from pool party), and **absence of focal findings** suggesting osteomyelitis (no point tenderness, swelling, or erythema). The low-grade fever can occur with VOC alone. Clear lungs and normal oxygen saturation make acute chest syndrome less likely.", "consequence": "Correct diagnosis. Proceed with acute management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Acute chest syndrome - new pulmonary infiltrate with fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acute chest syndrome** requires a new pulmonary infiltrate on chest X-ray plus respiratory symptoms (chest pain, cough, hypoxia, tachypnea). This patient has **clear lungs on exam** and **normal oxygen saturation**. Her symptoms are isolated to extremity pain without respiratory complaints. However, remember that VOC can progress to acute chest syndrome, so continued monitoring is essential.", "consequence": "Misdiagnosis delays appropriate pain management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Osteomyelitis - fever with bone pain requires antibiotic treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While osteomyelitis is a concern in sickle cell patients (especially **Salmonella** osteomyelitis), this presentation is more consistent with VOC. Osteomyelitis typically causes **focal point tenderness** with overlying erythema and swelling at a single site, not diffuse bilateral pain. Additionally, osteomyelitis develops over days with progressive symptoms, not the acute 6-hour presentation seen here.", "consequence": "Unnecessary antibiotics and delayed pain management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Septic arthritis - must rule out joint infection before treating pain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Septic arthritis causes **monoarticular** joint swelling with severe pain on passive range of motion and refusal to bear weight. This patient has pain over **long bones bilaterally** without joint effusion or limited range of motion. Her pain distribution is typical of vasoocclusive crisis affecting bone marrow, not septic arthritis.", "consequence": "Unnecessary joint workup delays pain control.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Splenic sequestration - spleen trapping blood with acute anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Splenic sequestration** presents with acute **left upper quadrant pain**, rapidly enlarging spleen, and signs of hypovolemic shock due to blood pooling in the spleen. This patient's spleen is **not palpable** (likely auto-infarcted given her age and HbSS genotype), and her symptoms are extremity pain without abdominal findings.", "consequence": "Misdiagnosis of a different sickle cell complication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "In sickle cell disease, the **most common organisms** causing osteomyelitis are **Salmonella** (most common overall) and **Staphylococcus aureus** (most common in general population). Sickle cell patients have **functional asplenia** increasing susceptibility to encapsulated organisms."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have correctly identified vasoocclusive crisis. The patient is in severe pain (9/10) and crying.\n\nHer mother states that ibuprofen at home did not help. The patient is clearly distressed and rates her pain as the worst she has experienced.\n\nYou need to initiate pain management urgently.", "question": "What is the most appropriate initial pain management strategy for this patient with severe vasoocclusive crisis?", "choices": [{"id": "node-2-choice-a", "text": "IV morphine 0.1 mg/kg with reassessment every 15-20 minutes, plus IV fluids at 1.5x maintenance", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Severe VOC requires **aggressive opioid analgesia**. IV morphine (or hydromorphone) at 0.1 mg/kg should be given immediately with frequent reassessment (every 15-20 minutes) until pain is controlled. **Undertreatment of pain** in sickle cell crisis is common and harmful - these patients know their pain and should be believed. IV fluids at **1.5x maintenance** help reverse dehydration (a precipitating factor) without causing fluid overload. NSAIDs can be added as adjunctive therapy but are insufficient alone for severe pain.", "consequence": "Pain begins to improve with appropriate multimodal therapy.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Oral oxycodone and observe for 2 hours before considering IV medications", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. For **severe pain** (9/10), IV opioids should be used initially. Oral medications have slower onset and less predictable absorption, especially in a distressed, potentially dehydrated patient. The 2-hour observation period would subject this child to prolonged severe pain. Guidelines recommend IV opioids for severe VOC pain with reassessment every **15-30 minutes**.", "consequence": "Prolonged severe pain and distress.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "IV ketorolac alone - avoid opioids due to addiction concerns", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While IV ketorolac is a useful **adjunctive** therapy for VOC, it is insufficient alone for severe pain. **Addiction concerns should not limit appropriate opioid use** for acute pain crises. Sickle cell patients are often undertreated due to unfounded addiction fears. This contributes to inadequate pain control and poor outcomes. Studies show appropriate acute opioid use for VOC does not increase addiction risk.", "consequence": "Inadequate pain control due to inappropriate opioid avoidance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "IM meperidine (Demerol) for quick pain relief", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Meperidine (Demerol) is contraindicated** in sickle cell patients. Its metabolite **normeperidine** accumulates and causes **seizures**, especially with repeated dosing or renal impairment. The American Pain Society specifically recommends against meperidine for sickle cell pain. Additionally, IM injections are painful and have variable absorption - IV route is preferred.", "consequence": "Risk of seizures from normeperidine toxicity.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Hold pain medications until infection is ruled out with blood cultures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pain management should never be delayed** for diagnostic workup. Blood cultures can be drawn simultaneously with initiating analgesia. Untreated severe pain is harmful and causes physiologic stress that can worsen sickling. While infection workup is appropriate given the fever, it does not preclude immediate pain control.", "consequence": "Unnecessary suffering and potentially worsening crisis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Meperidine (Demerol) is contraindicated** in sickle cell disease due to accumulation of the neurotoxic metabolite **normeperidine**, which causes seizures. Use morphine or hydromorphone instead."}, "node-3": {"id": "node-3", "type": "decision", "content": "The patient has received two doses of IV morphine with some improvement in pain (now 6/10). IV fluids are infusing.\n\nLaboratory results return:\n- Hemoglobin: 6.8 g/dL (baseline 8.5 g/dL)\n- Reticulocyte count: 12%\n- WBC: 14,000/\u03bcL\n- Platelet count: 350,000/\u03bcL\n- LDH: 450 U/L (elevated)\n- Total bilirubin: 3.2 mg/dL (elevated)\n\nHer baseline hemoglobin on hydroxyurea is typically 8.5-9 g/dL.", "question": "Based on these laboratory findings, should this patient receive a blood transfusion?", "choices": [{"id": "node-3-choice-a", "text": "No transfusion indicated - hemoglobin drop is moderate with adequate reticulocyte response", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Transfusion is not routinely indicated for uncomplicated VOC. Her hemoglobin has dropped from baseline (8.5 to 6.8 g/dL), but she has a **robust reticulocyte response** (12%) indicating adequate bone marrow compensation. Transfusion in sickle cell disease carries risks including **alloimmunization** (forming antibodies to donor blood antigens), iron overload, and hyperviscosity if hemoglobin rises too high. **Transfusion is reserved for**: severe anemia (Hgb <5-6), acute chest syndrome, stroke, aplastic crisis, or symptomatic anemia with cardiopulmonary compromise.", "consequence": "Appropriate conservative management avoiding unnecessary transfusion risks.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Yes - transfuse to raise hemoglobin above 10 g/dL for faster crisis resolution", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Transfusing to hemoglobin >10 g/dL is **contraindicated** in sickle cell disease as it increases blood **viscosity** and can paradoxically worsen sickling. The target hemoglobin should generally not exceed 10 g/dL. Additionally, transfusion does not accelerate VOC resolution - pain management and hydration are the mainstays of treatment. Each transfusion increases **alloimmunization risk** (forming antibodies that complicate future transfusions).", "consequence": "Risk of hyperviscosity and unnecessary alloimmunization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Yes - low reticulocyte count indicates aplastic crisis requiring transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The reticulocyte count is actually **elevated at 12%**, indicating appropriate bone marrow response to hemolysis - not aplastic crisis. **Aplastic crisis** (usually from parvovirus B19 infection) presents with **reticulocyte count <1%** and severe anemia as the bone marrow fails to compensate for ongoing hemolysis. This patient's marrow is responding appropriately.", "consequence": "Misinterpretation of lab values leading to unnecessary transfusion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Exchange transfusion needed for this severe crisis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Exchange transfusion** (removing patient blood while transfusing donor blood) is reserved for severe complications: **acute chest syndrome** with respiratory failure, **stroke**, or **multiorgan failure**. It rapidly reduces HbS percentage while avoiding hyperviscosity. An uncomplicated VOC with stable vital signs and clear lungs does not warrant exchange transfusion.", "consequence": "Overly aggressive intervention for uncomplicated VOC.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Cannot determine - need hemoglobin electrophoresis first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hemoglobin electrophoresis is used for **diagnosis** of sickle cell disease, not for acute management decisions. This patient already has confirmed HbSS disease. The decision to transfuse is based on clinical status (symptoms, vital signs, organ function) and degree of anemia relative to baseline, not hemoglobin electrophoresis results.", "consequence": "Unnecessary delay in clinical decision-making.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Transfusion in sickle cell disease** should target hemoglobin **no higher than 10 g/dL** to avoid hyperviscosity. Each transfusion carries **alloimmunization risk** - about 30% of chronically transfused sickle cell patients develop red cell antibodies."}, "node-4": {"id": "node-4", "type": "decision", "content": "You continue pain management with IV morphine PCA (patient-controlled analgesia) and IV fluids. By hour 18 of admission, the patient's extremity pain has improved significantly (now 3/10).\n\nHowever, overnight the nurse pages you because the patient has developed:\n- New cough and chest tightness\n- Temperature spike to 39.2\u00b0C\n- Oxygen saturation dropped from 98% to 91% on room air\n- Respiratory rate increased to 28/min\n\nA chest X-ray shows a new right lower lobe infiltrate.", "question": "What complication has developed, and what is the most appropriate management?", "choices": [{"id": "node-4-choice-a", "text": "Acute chest syndrome - supplemental oxygen, empiric antibiotics (ceftriaxone + azithromycin), consider transfusion", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** This patient has developed **acute chest syndrome (ACS)**, the leading cause of death in sickle cell disease. ACS is defined by: **new pulmonary infiltrate** plus respiratory symptoms (chest pain, cough, hypoxia, fever, tachypnea). It often develops **24-72 hours after admission** for VOC (as in this case). Management includes: **supplemental oxygen** to maintain SpO2 >92%, **empiric antibiotics** covering typical and atypical pathogens (ceftriaxone + azithromycin), **incentive spirometry**, and **transfusion** (simple or exchange) if severe or worsening.", "consequence": "Appropriate recognition and treatment of life-threatening complication.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Hospital-acquired pneumonia - broader antibiotic coverage with vancomycin and piperacillin-tazobactam", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this could be pneumonia, in a sickle cell patient with VOC who develops respiratory symptoms with new infiltrate, the diagnosis is **acute chest syndrome** regardless of etiology. ACS can be caused by infection, fat embolism from bone marrow infarction, or pulmonary infarction. Broad-spectrum antibiotics for HAP (vancomycin + pip-tazo) are not indicated - community-acquired coverage with a cephalosporin and macrolide is appropriate.", "consequence": "Overly broad antibiotics without addressing ACS-specific management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Opioid-induced respiratory depression - hold morphine and give naloxone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Opioid-induced respiratory depression causes **hypoventilation** (low respiratory rate) and **somnolence**, not tachypnea, cough, fever, and new infiltrates. This patient has **increased** respiratory rate (28/min) and new pulmonary infiltrate - classic signs of acute chest syndrome, not opioid toxicity. Withholding opioids would leave her in severe pain and potentially worsen the crisis.", "consequence": "Missed ACS diagnosis and inappropriate pain medication withholding.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Pulmonary embolism - order CT angiogram before any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While pulmonary embolism can occur in sickle cell patients, the combination of new infiltrate with fever in a hospitalized VOC patient is **acute chest syndrome** until proven otherwise. CT angiogram may be considered if PE is strongly suspected, but should not delay treatment. The **etiology of ACS** (infection vs fat embolism vs infarction) is often unclear, but management is the same regardless: oxygen, antibiotics, and transfusion if severe.", "consequence": "Delay in ACS treatment for unnecessary imaging.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Fluid overload from IV hydration - give furosemide and restrict fluids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While fluid overload can cause respiratory symptoms, the **new pulmonary infiltrate** (focal, right lower lobe) and **fever** point to acute chest syndrome, not pulmonary edema. Pulmonary edema would show bilateral infiltrates, typically in a perihilar or diffuse pattern. Diuresis without addressing ACS would be harmful. Fluid management should be balanced - not aggressive hydration (which can worsen ACS) but not restriction either.", "consequence": "Inappropriate diuresis without treating underlying ACS.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Acute chest syndrome** is the **leading cause of death** in sickle cell disease. It often develops **24-72 hours after VOC admission** due to hypoventilation from rib/spine pain, fat embolism from bone marrow infarction, or superimposed infection. Always monitor for respiratory decline during VOC hospitalization."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient receives supplemental oxygen (now SpO2 95% on 2L NC), ceftriaxone + azithromycin, and a simple blood transfusion.\n\nOver the next 48 hours, she improves significantly. Her respiratory symptoms resolve, oxygen is weaned off, and her pain is well-controlled on oral opioids.\n\nShe is ready for discharge. Her hemoglobin is 9.2 g/dL. She is back on her home hydroxyurea.", "question": "What is the most important discharge planning consideration for preventing future crises?", "choices": [{"id": "node-5-choice-a", "text": "Emphasize hydroxyurea compliance, adequate hydration, avoiding triggers, and establish hematology follow-up", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Comprehensive discharge planning is crucial for sickle cell patients. **Hydroxyurea** is the mainstay of disease-modifying therapy - it increases **fetal hemoglobin (HbF)** which interferes with HbS polymerization, reducing VOC frequency by 50%. Ensure compliance and regular monitoring (CBC every 4-8 weeks). **Trigger avoidance** includes adequate hydration, avoiding temperature extremes, treating infections promptly, and avoiding high altitude. **Hematology follow-up** ensures ongoing disease management and screening for complications (transcranial Doppler for stroke risk).", "consequence": "Optimal prevention strategy established.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Prescribe prophylactic monthly blood transfusions to prevent future crises", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Chronic transfusion therapy** is reserved for specific high-risk patients: those with **prior stroke** (or abnormal transcranial Doppler indicating stroke risk), recurrent severe ACS, or severe recurrent VOC despite optimal hydroxyurea therapy. It requires extended phenotype matching and chelation therapy for iron overload. For this patient with typical VOC frequency on hydroxyurea, chronic transfusion is not indicated.", "consequence": "Unnecessary chronic transfusion with iron overload and alloimmunization risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Stop hydroxyurea since she had a crisis while taking it - it's not working", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hydroxyurea does not prevent all crises** - it reduces frequency by about 50%. Having a breakthrough crisis does not mean the medication has failed. Discontinuing hydroxyurea would increase her crisis frequency and worsen outcomes. If crises remain frequent despite good compliance and adequate dosing, dose escalation or alternative therapies can be considered with hematology guidance.", "consequence": "Discontinuing effective prophylactic therapy increases crisis risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Prescribe daily oral opioids for pain prevention", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Daily opioids are not appropriate for VOC prevention**. Pain management should be acute/episodic for active crises. Chronic daily opioids increase tolerance, complicate acute crisis management, and do not prevent sickling. Prevention focuses on disease-modifying therapy (hydroxyurea), trigger avoidance, and treating underlying factors. NSAIDs may be used for mild chronic pain if needed.", "consequence": "Inappropriate chronic opioid prescribing without addressing prevention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "No specific follow-up needed - only return if symptoms recur", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sickle cell disease requires **regular follow-up** even when asymptomatic. Patients need: CBC monitoring for hydroxyurea dosing, **annual transcranial Doppler** (ages 2-16) to screen for stroke risk, ophthalmology exams for proliferative retinopathy, cardiac screening, and renal function monitoring. Lack of routine care leads to preventable complications.", "consequence": "Missed opportunity for preventive care and screening.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hydroxyurea** increases **fetal hemoglobin (HbF)** production, which disrupts HbS polymerization and reduces VOC frequency by ~50%. It is indicated for patients with frequent pain crises, history of ACS, or severe anemia. Monitor CBC every 4-8 weeks and titrate to maximum tolerated dose."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this complex sickle cell vasoocclusive crisis case:\n\n\u2713 Correctly identified VOC based on bilateral bone pain with appropriate triggers\n\u2713 Initiated aggressive IV opioid analgesia without inappropriate delays\n\u2713 Made appropriate transfusion decision based on hemoglobin and reticulocyte count\n\u2713 Recognized acute chest syndrome when it developed and initiated proper treatment\n\u2713 Established comprehensive discharge planning for prevention\n\nKey learning points:\n- Believe sickle cell patients about their pain - undertreatment is common\n- Meperidine is contraindicated (normeperidine toxicity)\n- Transfuse conservatively - target Hgb \u226410 g/dL to avoid hyperviscosity\n- Monitor for ACS development 24-72 hours into VOC admission\n- Hydroxyurea is the mainstay of prevention - increases HbF and reduces crises by 50%"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key management principles for sickle cell vasoocclusive crisis:\n\n- Aggressive pain control with IV opioids (not meperidine)\n- IV fluids at 1.5x maintenance\n- Transfusion only for severe anemia, ACS, stroke, or aplastic crisis\n- Target hemoglobin \u226410 g/dL to avoid hyperviscosity\n- Monitor closely for ACS development (24-72 hours after admission)\n- Hydroxyurea compliance is essential for prevention"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in sickle cell management can lead to poor outcomes:\n\n- Never use meperidine (Demerol) - causes seizures from normeperidine\n- Never withhold opioids for addiction concerns in acute crisis\n- Never transfuse to Hgb >10 g/dL (causes hyperviscosity)\n- Never ignore new respiratory symptoms - may indicate acute chest syndrome\n- Acute chest syndrome is the leading cause of death in sickle cell disease\n\nKey pearl: These patients know their pain - believe them. Undertreatment is more harmful than appropriate opioid use."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-040", "title": "Acute Chest Syndrome", "domain": "heme_onc", "difficulty": "advanced", "tags": ["sickle cell disease", "acute chest syndrome", "exchange transfusion", "respiratory failure", "hematopoietic stem cell transplant"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 12-year-old boy with sickle cell disease (HbSS) presents with chest pain and difficulty breathing.\n\nHistory: He was admitted 2 days ago for a vasoocclusive crisis affecting his back and legs. He was receiving IV morphine and fluids and had been improving with pain decreasing from 8/10 to 3/10. However, over the past 8 hours, he has developed new chest pain (pleuritic, worse with deep breathing), shortness of breath, and a dry cough. His mother notes he feels warm.\n\nAssociated symptoms: Increasing oxygen requirement from room air to 2L nasal cannula, then to 4L without improvement. He denies leg swelling, calf pain, or hemoptysis.\n\nMedical history: Sickle cell disease (HbSS) diagnosed at birth. He had one prior episode of acute chest syndrome 2 years ago requiring ICU admission. Takes hydroxyurea and folic acid daily.\n\nPhysical Examination:\n- General: Ill-appearing, using accessory muscles, unable to speak full sentences\n- Vitals: T 38.9\u00b0C, HR 128, RR 32, BP 95/60, SpO2 88% on 4L NC\n- Respiratory: Tachypnea, decreased breath sounds at left lower lobe with crackles and dullness to percussion\n- Cardiovascular: Tachycardia, regular rhythm, no murmurs\n- Abdomen: Soft, mild splenomegaly\n- Extremities: No calf tenderness or swelling", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This sickle cell patient was admitted for VOC and has developed new respiratory symptoms with hypoxia despite supplemental oxygen.\n\nChest X-ray shows a new left lower lobe consolidation with small pleural effusion.\n\nLaboratory results:\n- Hemoglobin: 6.2 g/dL (baseline 9 g/dL on hydroxyurea)\n- WBC: 18,000/\u03bcL with left shift\n- Platelets: 280,000/\u03bcL\n- Reticulocyte count: 15%\n- LDH: 680 U/L (elevated)\n- ABG on 4L NC: pH 7.32, pCO2 32, pO2 58, HCO3 18", "question": "What is the diagnosis, and what criteria define this condition?", "choices": [{"id": "node-1-choice-a", "text": "Acute chest syndrome - new pulmonary infiltrate plus respiratory symptoms (fever, hypoxia, chest pain, cough) in sickle cell patient", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Acute chest syndrome (ACS) is defined by: **new pulmonary infiltrate** on chest X-ray involving at least one complete lung segment, plus **one or more** respiratory findings: chest pain, fever >38.5\u00b0C, tachypnea, wheezing, or cough. This patient has the infiltrate plus fever, hypoxia, chest pain, and cough - meeting criteria definitively. ACS is the **leading cause of death** in sickle cell disease and often develops **24-72 hours after VOC admission** due to hypoventilation, fat embolism from bone infarction, or infection.", "consequence": "Correct diagnosis identified. Proceed with urgent management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Community-acquired pneumonia - fever with productive cough and consolidation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While pneumonia can be an etiology of ACS, in a sickle cell patient with new infiltrate and respiratory symptoms, the diagnosis is **acute chest syndrome** regardless of etiology. ACS is a clinical syndrome that may be caused by infection (pneumonia), pulmonary infarction, or fat embolism. The management differs from simple CAP because transfusion is often required. Always diagnose ACS in this context.", "consequence": "Misclassification may lead to inadequate treatment without transfusion consideration.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Pulmonary embolism - acute hypoxia with pleuritic chest pain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While pulmonary embolism can occur in sickle cell patients (and pulmonary infarction from in-situ thrombosis is one etiology of ACS), the presence of **new infiltrate** and **fever** makes ACS the primary diagnosis. PE typically shows clear lung fields with hypoxia (V/Q mismatch), not consolidation. The clinical presentation with VOC progression to respiratory symptoms over 24-72 hours is classic for ACS.", "consequence": "CT angiogram delays treatment without changing management significantly.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Opioid-induced respiratory depression - morphine causing hypoventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Opioid toxicity causes **hypoventilation** (decreased respiratory rate, somnolence, pinpoint pupils), not **tachypnea** with respiratory rate of 32. This patient is working hard to breathe with accessory muscle use. The new infiltrate on CXR, fever, and clinical deterioration point to acute chest syndrome, not opioid effects. Never withhold analgesia based on this concern when the clinical picture clearly indicates ACS.", "consequence": "Withholding opioids causes severe pain without addressing the actual problem.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "ARDS - bilateral infiltrates with severe hypoxemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ARDS requires **bilateral** infiltrates and P/F ratio <300. This patient has **unilateral** (left lower lobe) involvement. While ACS can progress to ARDS if severe or untreated, the current presentation meets ACS criteria. ARDS would be considered if bilateral infiltrates develop despite treatment.", "consequence": "Incorrect classification may lead to overly aggressive respiratory support initially.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Acute chest syndrome** is the **leading cause of death** in sickle cell disease. It often develops **24-72 hours after admission for VOC** due to three mechanisms: **infection** (most common in children), **fat embolism** from bone marrow infarction, or **pulmonary infarction** from in-situ sickling."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed acute chest syndrome. The patient is hypoxic (SpO2 88% on 4L NC), tachypneic, and using accessory muscles.\n\nHis hemoglobin has dropped to 6.2 g/dL from baseline of 9 g/dL, and he has significant hypoxia with pO2 of 58 despite supplemental oxygen.\n\nYou need to initiate immediate management.", "question": "What is the most appropriate initial management for this patient with acute chest syndrome?", "choices": [{"id": "node-2-choice-a", "text": "High-flow oxygen, empiric antibiotics (ceftriaxone + azithromycin), incentive spirometry, simple transfusion", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** ACS management includes multiple components: **Supplemental oxygen** to maintain SpO2 >92% (use high-flow if needed). **Empiric antibiotics** covering typical and atypical pathogens (ceftriaxone + macrolide) since infection is often a trigger or complication. **Incentive spirometry** every 2 hours while awake to prevent atelectasis from splinting due to chest pain. **Simple transfusion** is indicated for this patient given significant anemia (Hgb 6.2) and moderate-severe ACS with hypoxia. Target post-transfusion Hgb \u226410 g/dL.", "consequence": "Comprehensive initial management initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Supplemental oxygen only - wait for culture results before starting antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Empiric antibiotics should not be delayed** for culture results in ACS. Infection is common (either as trigger or concurrent), and delayed antibiotics worsen outcomes. The combination of ceftriaxone (typical pathogens including encapsulated organisms) plus azithromycin (atypical coverage for Mycoplasma, Chlamydia) is standard. This patient also needs transfusion given significant hypoxia and anemia.", "consequence": "Delayed antibiotics and missing transfusion indication.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Immediate intubation and mechanical ventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this patient is sick, he does not yet meet criteria for immediate intubation. He is hypoxic on 4L NC but may respond to high-flow nasal cannula or non-invasive ventilation. Intubation should be considered for: respiratory failure despite maximal non-invasive support, altered mental status, or impending arrest. Initial management with oxygen, antibiotics, and transfusion may improve his status and avoid intubation.", "consequence": "Premature intubation with associated risks.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Bronchodilators and steroids for presumed asthma exacerbation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bronchodilators may be helpful if wheezing is present (many sickle cell patients have airway hyperreactivity), this is not an asthma exacerbation. The **new infiltrate**, fever, and hypoxia indicate ACS. Steroids are **not routinely recommended** for ACS - studies show mixed results and potential harm. Focus on the core ACS treatment: oxygen, antibiotics, incentive spirometry, and transfusion.", "consequence": "Missing the core ACS management while treating presumed asthma.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "CT angiogram to rule out PE before any treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT angiogram should not delay treatment for ACS. While PE can occur in sickle cell patients, the clinical picture of VOC progressing to respiratory symptoms with new infiltrate is classic for ACS. Management of ACS (oxygen, antibiotics, transfusion) addresses most underlying etiologies. CT can be considered later if PE remains high suspicion or patient doesn't respond to treatment.", "consequence": "Imaging delays life-saving treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Incentive spirometry** is critical in ACS management - patients splint from chest/rib pain leading to atelectasis, which worsens sickling. Order spirometry every 2 hours while awake and ensure adequate pain control to allow deep breathing."}, "node-3": {"id": "node-3", "type": "decision", "content": "The patient receives high-flow nasal cannula (SpO2 improves to 92%), ceftriaxone + azithromycin, and a simple blood transfusion of 10 mL/kg packed RBCs.\n\nHowever, 6 hours later, despite these interventions:\n- SpO2 drops to 86% on 15L high-flow\n- Respiratory rate increased to 40/min\n- Hemoglobin post-transfusion is 8.5 g/dL\n- He is becoming increasingly lethargic and confused\n- Repeat CXR shows bilateral infiltrates (previously only left lower lobe)\n- ABG: pH 7.25, pCO2 50, pO2 52 on 15L high-flow\n\nThe hematologist is at bedside.", "question": "What is the most appropriate next step for this patient with deteriorating acute chest syndrome?", "choices": [{"id": "node-3-choice-a", "text": "Exchange transfusion and prepare for possible intubation", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This patient has **severe/deteriorating ACS** despite initial simple transfusion and requires **exchange transfusion**. Exchange transfusion rapidly reduces **HbS percentage** (target <30%) while avoiding hyperviscosity that would occur with simple transfusion to high hemoglobin. Indications for exchange transfusion in ACS include: rapid clinical deterioration, severe hypoxemia (pO2 <70 despite O2), multilobar involvement, or neurologic symptoms. His altered mental status, bilateral infiltrates, and worsening hypoxia with hypercapnia indicate severe disease requiring escalation. Prepare for intubation if exchange transfusion doesn't rapidly improve status.", "consequence": "Appropriate escalation for severe ACS.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Repeat simple transfusion to raise hemoglobin to 12 g/dL", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never transfuse to Hgb >10 g/dL** in sickle cell disease - this causes **hyperviscosity** and can paradoxically worsen sickling and ACS. His current Hgb is 8.5 g/dL, which is adequate for oxygen carrying capacity. The problem is the high percentage of HbS causing ongoing sickling. **Exchange transfusion** (removing patient's HbS-containing blood while replacing with normal donor blood) is needed to rapidly reduce HbS% without increasing viscosity.", "consequence": "Hyperviscosity worsens sickling and respiratory status.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Continue current management and observe for 12 more hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient is **clinically deteriorating** with worsening hypoxemia, hypercapnia (pCO2 50 indicating respiratory failure), altered mental status, and bilateral infiltrates. Waiting is dangerous - ACS can progress rapidly to ARDS, respiratory failure, and death. The **leading cause of death** in sickle cell disease is ACS, and aggressive intervention with exchange transfusion is indicated for severe cases.", "consequence": "Delay allows progression to respiratory failure and death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Add high-dose steroids for presumed ARDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this patient may be developing ARDS (bilateral infiltrates, severe hypoxemia), steroids are **not routinely beneficial** in ACS and may cause harm (increased VOC, infection risk). The priority is reducing HbS percentage through exchange transfusion. Some studies suggest steroids may increase readmission rates in ACS. Focus on proven interventions: oxygen support, transfusion optimization, and respiratory support.", "consequence": "Unproven therapy with potential harm, delaying exchange transfusion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Start inhaled nitric oxide for pulmonary vasodilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Inhaled nitric oxide has been studied in ACS but **has not shown clear benefit** and is not standard of care. A large trial (DeNOVO) showed no improvement in outcomes with iNO in ACS. The priority intervention for severe, deteriorating ACS is **exchange transfusion** to reduce HbS percentage. iNO may be considered as adjunctive therapy in refractory cases but should not replace exchange transfusion.", "consequence": "Unproven therapy delays more effective exchange transfusion.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Exchange transfusion** is indicated for severe ACS: rapid deterioration, PaO2 <70 despite supplemental O2, multilobar/bilateral involvement, or neurologic changes. Target **HbS <30%** post-exchange. This rapidly reduces sickling without the hyperviscosity risk of simple transfusion to high hemoglobin."}, "node-4": {"id": "node-4", "type": "decision", "content": "Exchange transfusion is performed using automated erythrocytapheresis. The patient's HbS decreases from 85% to 25%.\n\nWithin 12 hours of exchange transfusion:\n- SpO2 improves to 94% on 6L NC\n- Mental status returns to baseline\n- Respiratory rate decreases to 24/min\n- Repeat ABG shows improved oxygenation (pO2 72 on 6L)\n\nHe continues to improve over the next 48 hours. His oxygen is weaned to room air, and he is afebrile.\n\nThe team is planning for discharge.", "question": "What secondary prevention measure should be discussed before discharge given his recurrent severe ACS episodes?", "choices": [{"id": "node-4-choice-a", "text": "Chronic transfusion therapy to maintain HbS <30% given recurrent severe ACS", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** For patients with **recurrent severe ACS** (this is his second episode, both requiring ICU-level care), **chronic transfusion therapy** should be strongly considered. Chronic transfusions maintain HbS <30%, dramatically reducing ACS recurrence. This requires: monthly transfusions, extended red cell antigen matching (to prevent alloimmunization), and **iron chelation** therapy (deferasirox or deferoxamine) to prevent transfusional iron overload. Alternative options include **stem cell transplant** (curative) if a matched donor is available, or newer therapies like crizanlizumab or voxelotor.", "consequence": "Appropriate secondary prevention initiated.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Increase hydroxyurea dose and reassess in 3 months", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Hydroxyurea optimization** is important and dose escalation to maximum tolerated dose (aiming for mild myelosuppression) can reduce ACS frequency. However, this patient has had **two severe ACS episodes** despite hydroxyurea therapy. While ensuring maximum dose hydroxyurea is reasonable, recurrent severe ACS typically warrants discussion of **chronic transfusion therapy** as more definitive secondary prevention.", "consequence": "Reasonable but may be insufficient for recurrent severe disease.", "nextNodeId": "node-5"}, {"id": "node-4-choice-c", "text": "Prophylactic antibiotics to prevent future respiratory infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While sickle cell patients should receive **penicillin prophylaxis until age 5** (for pneumococcal protection due to functional asplenia), prophylactic antibiotics are not the answer for preventing recurrent ACS in a 12-year-old. ACS has multiple etiologies beyond infection (fat embolism, pulmonary infarction). The focus should be on reducing HbS% through chronic transfusion or optimizing disease-modifying therapy.", "consequence": "Antibiotics don't address the underlying sickling pathophysiology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "No changes needed - current hydroxyurea regimen is adequate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This patient has had **two severe ACS episodes** requiring exchange transfusion - his current regimen is clearly **not adequately preventing** life-threatening complications. ACS is the leading cause of death in sickle cell disease, and recurrent episodes warrant escalation of therapy. Options include chronic transfusion, hematopoietic stem cell transplant, or newer agents (crizanlizumab, voxelotor).", "consequence": "Failure to escalate therapy for inadequately controlled disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Recommend avoiding all physical activity to prevent future crises", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activity restriction is not appropriate** for sickle cell patients. Moderate exercise is safe and beneficial. Triggers to avoid include: dehydration, extreme temperatures, high altitude (low oxygen), and untreated infections. Patients should stay well-hydrated, especially during exercise. Complete activity restriction leads to deconditioning and reduced quality of life without preventing crises.", "consequence": "Inappropriate restriction without addressing disease modification.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Chronic transfusion therapy** for sickle cell disease requires **extended red cell antigen matching** (beyond ABO/Rh) to reduce alloimmunization risk. Patients need **iron chelation** (deferasirox daily or deferoxamine infusions) to prevent transfusional hemosiderosis affecting liver, heart, and endocrine organs."}, "node-5": {"id": "node-5", "type": "decision", "content": "The hematology team discusses chronic transfusion therapy with the family. They are concerned about the burden of monthly transfusions and iron chelation.\n\nThe family asks about other options, including whether there is a cure for sickle cell disease.\n\nYou are counseling them on the full range of options for this patient with recurrent severe ACS.", "question": "What is the only curative therapy for sickle cell disease, and what are the key considerations?", "choices": [{"id": "node-5-choice-a", "text": "Hematopoietic stem cell transplant (HSCT) - curative but requires matched donor and has significant risks", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Allogeneic **hematopoietic stem cell transplant** is the only established **curative therapy** for sickle cell disease. Key considerations: **Donor match** - best outcomes with HLA-matched sibling donor (only ~15% of patients have one); matched unrelated donor and haploidentical transplants have higher complication rates. **Risks** include graft-versus-host disease, graft failure, infertility, and transplant-related mortality (5-10% even in best centers). **Timing** - best outcomes in children <16 before organ damage accumulates. For this patient with recurrent severe ACS, transplant should be discussed as a potentially curative option versus lifelong transfusion therapy.", "consequence": "Family receives comprehensive counseling on curative and disease-modifying options.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Gene therapy is now FDA-approved and cures all patients", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct but overstated. Gene therapy approaches (including lovotibeglogene autotemcel/Lyfgenia and exagamglogene autotemcel/Casgevy) have shown promising results and some are FDA-approved. However, they are **not universally curative**, have limited long-term data, require conditioning chemotherapy, are extremely expensive, and have limited availability. While gene therapy represents an exciting advance, HSCT with matched sibling donor remains the best-established curative option with the longest follow-up data.", "consequence": "Overstating gene therapy while underrepresenting established HSCT option.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Hydroxyurea at maximum dose will cure the disease over time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hydroxyurea does not cure** sickle cell disease - it is a disease-modifying therapy that increases fetal hemoglobin (HbF) and reduces sickling, decreasing crisis frequency by ~50%. Patients must take it lifelong, and it does not eliminate the underlying genetic defect. For severe disease like this patient's, hydroxyurea alone may be insufficient, hence the discussion of chronic transfusion or curative HSCT.", "consequence": "Incorrectly counseling about disease cure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Splenectomy will cure the disease by removing the site of red cell destruction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Most HbSS patients have **functional asplenia** by late childhood from repeated splenic infarctions (autosplenectomy). Even in patients with intact spleens, splenectomy does not cure sickle cell disease - sickling occurs throughout the vasculature, not just the spleen. Splenectomy is only indicated for specific complications like splenic sequestration or hypersplenism with transfusion-dependent anemia.", "consequence": "Incorrect understanding of disease pathophysiology.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-e", "text": "There is no cure - only supportive care is available", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HSCT is curative** for sickle cell disease and has been performed successfully for decades. Disease-free survival with matched sibling donor transplant exceeds 90% in experienced centers. Not discussing transplant as an option deprives families of potentially life-saving information. Gene therapy also offers potentially curative approaches. Families deserve to know all options, including curative ones.", "consequence": "Family not informed of curative options.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hematopoietic stem cell transplant** for sickle cell disease has **>90% disease-free survival** with matched sibling donor. Best outcomes occur in children **before significant organ damage** (stroke, chronic lung disease, renal failure). Indications include recurrent severe ACS, stroke, or frequent severe VOC despite optimal medical therapy."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this severe acute chest syndrome case:\n\n\u2713 Correctly identified ACS based on new infiltrate plus respiratory symptoms in sickle cell patient\n\u2713 Initiated comprehensive initial management: oxygen, antibiotics, incentive spirometry, transfusion\n\u2713 Recognized deterioration requiring escalation to exchange transfusion\n\u2713 Discussed appropriate secondary prevention for recurrent severe ACS\n\u2713 Counseled family on curative option (HSCT) versus chronic transfusion\n\nKey learning points:\n- ACS = new infiltrate + respiratory symptoms in sickle cell patient (leading cause of death)\n- Initial management: oxygen, empiric antibiotics (ceftriaxone + azithromycin), incentive spirometry, consider transfusion\n- Exchange transfusion for severe/deteriorating ACS (target HbS <30%)\n- Never transfuse to Hgb >10 g/dL (hyperviscosity)\n- HSCT is the only established cure - discuss for severe disease"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key management principles for acute chest syndrome:\n\n- ACS = new pulmonary infiltrate + respiratory symptoms (fever, chest pain, cough, hypoxia)\n- Initial treatment: oxygen, antibiotics (ceftriaxone + azithromycin), incentive spirometry\n- Simple transfusion for moderate ACS with anemia\n- Exchange transfusion for severe/deteriorating ACS (multilobar, pO2 <70, neurologic changes)\n- Target Hgb \u226410 g/dL and HbS <30% with exchange\n- Consider chronic transfusion or HSCT for recurrent severe episodes"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in acute chest syndrome can be fatal:\n\n- ACS is the LEADING CAUSE OF DEATH in sickle cell disease\n- Never delay treatment for imaging - diagnose clinically and treat immediately\n- Never transfuse to Hgb >10 g/dL (causes hyperviscosity)\n- Deteriorating ACS requires exchange transfusion, not more simple transfusion\n- Steroids and inhaled nitric oxide are NOT standard of care\n- HSCT is curative and should be discussed for severe disease\n\nKey pearl: ACS develops 24-72 hours after VOC admission - maintain high vigilance for respiratory decline in all hospitalized sickle cell patients."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-064", "title": "Acute Lymphoblastic Leukemia Recognition", "domain": "heme_onc", "difficulty": "advanced", "tags": ["acute lymphoblastic leukemia", "childhood cancer", "pancytopenia", "bone pain", "tumor lysis syndrome", "chemotherapy toxicity"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 5-year-old boy is brought to the pediatrician by his mother for fatigue, fever, and leg pain for the past 3 weeks.\n\nHistory: He has been increasingly tired and not wanting to play with his friends. For the past 3 weeks, he has had intermittent fevers (up to 38.5\u00b0C at home) and keeps complaining that his legs hurt, especially at night. His mother says he's been \"a different child\" - not eating well and more pale than usual.\n\nAdditional concerns: Easy bruising (noticed several bruises she can't explain), recurrent nosebleeds (2-3 times per week), and decreased appetite. No weight loss or drenching night sweats.\n\nMedical history: Previously healthy, meeting all developmental milestones. No family history of childhood cancers.\n\nPhysical Examination:\n- General: Pale, ill-appearing child with scattered petechiae on trunk\n- Vitals: T 38.2\u00b0C, HR 110, RR 22, BP 95/60\n- HEENT: Pale conjunctivae\n- Lymph nodes: Generalized non-tender lymphadenopathy (cervical, axillary, inguinal - largest 2 cm)\n- Abdomen: Hepatomegaly (liver 4 cm below costal margin), splenomegaly (spleen 3 cm below costal margin)\n- Musculoskeletal: Tenderness to palpation over bilateral tibias and femurs\n- Skin: Multiple ecchymoses of varying ages on extremities", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this 5-year-old with a 3-week history of fatigue, fever, and bone pain. Key findings include:\n- Pallor suggesting anemia\n- Petechiae and easy bruising suggesting thrombocytopenia\n- Generalized lymphadenopathy\n- Hepatosplenomegaly\n- Bone pain/tenderness\n\nYou order a CBC with differential which returns:\n- WBC: 45,000/\u03bcL with 65% lymphoblasts identified on smear\n- Hemoglobin: 6.8 g/dL\n- Platelets: 28,000/\u03bcL\n- Peripheral smear: numerous large cells with scant cytoplasm, fine chromatin, and visible nucleoli", "question": "What is the most likely diagnosis based on these findings?", "choices": [{"id": "node-1-choice-a", "text": "Acute lymphoblastic leukemia (ALL) - most common childhood malignancy", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This presentation is classic for **acute lymphoblastic leukemia (ALL)**, the most common childhood cancer (peak age 2-5 years). Key features include: **Bone pain** (from marrow expansion), **pancytopenia symptoms** (anemia \u2192 fatigue/pallor, thrombocytopenia \u2192 bleeding/bruising, neutropenia \u2192 infections/fever), **lymphadenopathy**, and **hepatosplenomegaly** from leukemic infiltration. The **peripheral blood showing >20% blasts** is highly suggestive of acute leukemia.", "consequence": "Correct diagnosis. Proceed with urgent workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Juvenile idiopathic arthritis (JIA) - fever with joint/bone pain", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While systemic JIA can cause fever and musculoskeletal pain, it does not cause **pancytopenia** or **circulating blasts**. JIA may cause elevated WBC (leukocytosis with neutrophilia), elevated inflammatory markers, and anemia of chronic disease, but not thrombocytopenia or blasts. The presence of **65% lymphoblasts** on peripheral smear rules out JIA.", "consequence": "Missing leukemia diagnosis is potentially fatal.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Infectious mononucleosis - lymphadenopathy and atypical lymphocytes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. EBV mononucleosis causes lymphadenopathy and hepatosplenomegaly, but the lymphocytes are **atypical** (reactive), not blasts. EBV does not typically cause severe anemia (Hgb 6.8) or profound thrombocytopenia (28,000). The **65% blasts** on smear clearly distinguish leukemia from infectious mononucleosis.", "consequence": "Treating as viral illness delays cancer diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Immune thrombocytopenic purpura (ITP) - low platelets causing bruising", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. ITP causes **isolated thrombocytopenia** in an otherwise well-appearing child. This patient has **pancytopenia** (all cell lines affected: anemia + thrombocytopenia + abnormal WBC with blasts), plus hepatosplenomegaly and lymphadenopathy. ITP does not cause blasts, organomegaly, or bone pain. Always obtain CBC with smear review before diagnosing ITP.", "consequence": "ITP is a diagnosis of exclusion - blasts rule it out.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Growing pains - common cause of leg pain in children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Growing pains** are benign and occur in healthy children without any systemic symptoms or laboratory abnormalities. This child has fever, pallor, bleeding symptoms, organomegaly, and profound CBC abnormalities including **circulating blasts**. Never dismiss bone pain in a child with abnormal labs or systemic symptoms as \"growing pains.\"", "consequence": "Dangerous dismissal of serious symptoms.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**\"Bone pain in a child with pancytopenia is leukemia until proven otherwise.\"** Never dismiss as growing pains. Classic ALL presentation: fever, fatigue, bone pain, bruising, pallor, lymphadenopathy, hepatosplenomegaly. Peak age is 2-5 years. ALL is the **most common childhood malignancy** (~25% of all childhood cancers)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You strongly suspect acute lymphoblastic leukemia based on the clinical presentation and CBC with blasts.\n\nThe family is anxious and asking what happens next.\n\nYou need to coordinate the diagnostic workup and initial management.", "question": "What is the most appropriate next step to confirm the diagnosis and guide treatment?", "choices": [{"id": "node-2-choice-a", "text": "Urgent bone marrow biopsy and aspirate for morphology, immunophenotyping, cytogenetics, and molecular studies", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Bone marrow biopsy/aspirate is essential for definitive diagnosis and risk stratification. Studies include: **Morphology** (>25% blasts confirms acute leukemia), **immunophenotyping** by flow cytometry (determines B-cell vs T-cell ALL), **cytogenetics** (identifies chromosomal abnormalities for prognosis), and **molecular studies** (detects specific translocations like TEL-AML1, BCR-ABL). Risk stratification determines treatment intensity. Also send lumbar puncture for CNS involvement staging.", "consequence": "Appropriate diagnostic workup initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Repeat CBC in 1 week to see if abnormalities persist", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never delay** diagnosis when blasts are present on peripheral smear. Leukemia is a medical emergency - delays can lead to tumor lysis syndrome, infection, or bleeding complications. The child needs immediate referral to pediatric oncology and bone marrow evaluation, not watchful waiting.", "consequence": "Dangerous delay in cancer diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Start chemotherapy empirically before biopsy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bone marrow biopsy must precede chemotherapy** (except in rare emergencies like hyperleukocytosis with symptoms). Starting treatment before diagnosis: loses diagnostic information needed for risk stratification, may select an inappropriate regimen, and makes it harder to confirm the diagnosis. Chemotherapy is tailored to immunophenotype and cytogenetics.", "consequence": "Treating without proper diagnosis and risk stratification.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Order CT scan of chest, abdomen, and pelvis first", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct - imaging may be needed (especially CXR to rule out mediastinal mass in T-ALL), but **bone marrow biopsy is the priority** for diagnosis. Imaging does not diagnose leukemia or provide the crucial information (immunophenotype, cytogenetics) needed for treatment planning. Don't delay bone marrow evaluation for extensive imaging.", "consequence": "Imaging delays the diagnostic biopsy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Lymph node biopsy since lymphadenopathy is prominent", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bone marrow biopsy is the diagnostic test of choice** for leukemia, not lymph node biopsy. The bone marrow provides tissue for all necessary studies and directly shows marrow involvement. Lymph node biopsy is used for lymphoma diagnosis, not leukemia. With blasts in peripheral blood, the diagnosis is clearly leukemia originating in bone marrow.", "consequence": "Wrong tissue for leukemia diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "The **bone marrow biopsy** provides: morphology (blast percentage), immunophenotyping (B-ALL vs T-ALL), cytogenetics (hyperdiploidy = good prognosis, t(9;22) Philadelphia chromosome = poor prognosis), and molecular studies. These determine **risk stratification** which guides treatment intensity - standard risk vs high risk protocols."}, "node-3": {"id": "node-3", "type": "decision", "content": "Bone marrow biopsy is performed and shows:\n- 85% lymphoblasts (confirming ALL)\n- Immunophenotyping: CD19+, CD10+, CD22+, TdT+ (B-cell precursor ALL)\n- Cytogenetics: Hyperdiploidy (>50 chromosomes) - favorable\n- No BCR-ABL1 fusion (Philadelphia chromosome negative)\n\nLumbar puncture shows:\n- No blasts in CSF (CNS negative)\n\nThe diagnosis is B-cell precursor ALL, standard risk.\n\nBefore starting chemotherapy, you need to address some urgent concerns.", "question": "What metabolic emergency must be anticipated and prevented when starting chemotherapy for leukemia?", "choices": [{"id": "node-3-choice-a", "text": "Tumor lysis syndrome - hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Tumor lysis syndrome (TLS)** occurs when rapid cell death releases intracellular contents: **purines** (metabolized to uric acid \u2192 hyperuricemia \u2192 urate nephropathy), **potassium** (hyperkalemia \u2192 arrhythmias), **phosphorus** (hyperphosphatemia \u2192 binds calcium \u2192 hypocalcemia \u2192 seizures, arrhythmias). Prevention includes: **aggressive IV hydration** (3L/m\u00b2/day), **allopurinol or rasburicase** (reduces uric acid), **monitoring** electrolytes and renal function frequently, and **avoiding potassium/phosphorus** in IV fluids.", "consequence": "TLS prevention initiated appropriately.", "nextNodeId": "node-4"}, {"id": "node-2-choice-b", "text": "Hypoglycemia from tumor glucose consumption", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While leukemia cells are metabolically active, **hypoglycemia is not a typical complication** of chemotherapy initiation. The main concern is tumor lysis syndrome from rapid cell death releasing intracellular contents. Glucose levels should be monitored but TLS prevention is the priority.", "consequence": "Missing the primary metabolic emergency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Syndrome of inappropriate ADH secretion (SIADH)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. SIADH can occur in various malignancies and with certain chemotherapy agents, but the **immediate concern** when starting chemotherapy for leukemia with high tumor burden is **tumor lysis syndrome**. TLS prevention with hydration and uric acid management must be in place before chemotherapy begins.", "consequence": "Focusing on wrong metabolic problem.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Adrenal insufficiency from steroid therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While ALL treatment includes high-dose steroids (which can suppress adrenal function with prolonged use), this is not the **immediate concern** when starting therapy. Tumor lysis syndrome can occur within hours of chemotherapy initiation and requires preventive measures before the first dose.", "consequence": "Long-term concern, not immediate priority.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Iron overload from transfusions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Iron overload develops after **multiple transfusions over time**, not acutely when starting treatment. The immediate concern is tumor lysis syndrome. This child may need transfusions for his anemia, but iron overload is a long-term consideration for chronically transfused patients.", "consequence": "Wrong timeline - this is a chronic, not acute concern.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Rasburicase** (recombinant urate oxidase) rapidly reduces uric acid and is preferred over allopurinol for high-risk TLS. However, rasburicase is **contraindicated in G6PD deficiency** (causes severe hemolysis). Screen for G6PD before giving rasburicase. Remember: TLS shows **HyperKalemia, HyperUricemia, HyperPhosphatemia, HypOcalcemia** (3 hypers, 1 hypo)."}, "node-4": {"id": "node-4", "type": "decision", "content": "TLS prophylaxis is initiated with IV hydration, allopurinol (G6PD status pending), and frequent electrolyte monitoring.\n\nChemotherapy begins with the induction phase. The family asks about prognosis and treatment duration.\n\nThis child has B-cell precursor ALL with favorable cytogenetics (hyperdiploidy), age 1-10 years, WBC <50,000 - classified as **standard risk**.", "question": "What is the expected prognosis and treatment duration for standard-risk childhood B-ALL?", "choices": [{"id": "node-4-choice-a", "text": "Excellent prognosis (~90% cure rate), but treatment lasts 2-3 years with multiple phases", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Standard-risk childhood B-ALL has an excellent prognosis with modern treatment - **event-free survival exceeds 90%**. However, treatment is **prolonged (2-3 years)** with multiple phases: **Induction** (~4 weeks) to achieve remission, **Consolidation** to eliminate residual disease, **CNS prophylaxis** (intrathecal chemotherapy), and **Maintenance** (1.5-2 years of lower-intensity therapy). Despite the lengthy treatment, most children are cured and can lead normal lives.", "consequence": "Family appropriately counseled about prognosis and timeline.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Poor prognosis - most children do not survive 5 years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is overly pessimistic. **Childhood ALL is one of the great success stories** of pediatric oncology. In the 1960s, ALL was nearly universally fatal; today, **>90% of standard-risk patients are cured**. While treatment is intensive and prolonged, the outlook for this child is excellent.", "consequence": "Unnecessarily devastating the family.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Good prognosis with only 2-3 months of chemotherapy needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While prognosis is excellent, **treatment duration is 2-3 years**, not months. Short-course therapy leads to relapse. The maintenance phase, lasting 1.5-2 years, is essential for sustained remission. Underestimating treatment duration sets unrealistic expectations for the family.", "consequence": "Underestimating treatment commitment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Prognosis depends entirely on whether bone marrow transplant is available", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Standard-risk B-ALL does not require bone marrow transplant** in first remission - chemotherapy alone is curative in >90% of cases. BMT is reserved for high-risk features (like Philadelphia chromosome), relapsed disease, or refractory disease. This child has favorable features and will receive chemotherapy without BMT.", "consequence": "Incorrect understanding of treatment approach.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Cannot determine prognosis until seeing response to treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct - treatment response (minimal residual disease) further refines prognosis. However, we can already provide good prognostic information based on **risk stratification**: age 1-10, WBC <50K, favorable cytogenetics (hyperdiploidy), and B-cell phenotype all indicate standard risk with excellent expected outcomes. Don't withhold reassuring information from worried families.", "consequence": "Withholding useful prognostic information.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prognostic factors in childhood ALL**: Favorable = age 1-10 years, WBC <50,000, B-cell phenotype, hyperdiploidy (>50 chromosomes), TEL-AML1 fusion. Unfavorable = age <1 or >10, WBC >50,000, T-cell ALL, hypodiploidy, Philadelphia chromosome t(9;22), MLL rearrangements, slow early response."}, "node-5": {"id": "node-5", "type": "decision", "content": "The family is relieved about the good prognosis but concerned about treatment side effects.\n\nInduction chemotherapy typically includes:\n- Vincristine (vinca alkaloid)\n- Corticosteroids (prednisone or dexamethasone)\n- Asparaginase (PEGylated or native)\n- \u00b1 Anthracycline (daunorubicin)\n\nThe parents ask about common side effects they should watch for during treatment.", "question": "Which side effect is specific to asparaginase therapy and requires immediate medical attention?", "choices": [{"id": "node-5-choice-a", "text": "Pancreatitis - abdominal pain, nausea, elevated amylase/lipase", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Asparaginase-induced pancreatitis** is a serious complication occurring in 5-10% of patients. Symptoms include: severe abdominal pain (often epigastric radiating to back), nausea, vomiting, and elevated amylase/lipase. Other asparaginase toxicities include: **allergic reactions** (anaphylaxis), **thrombosis** (decreased antithrombin III), **hepatotoxicity**, and **hyperglycemia**. Pancreatitis requires immediate asparaginase discontinuation and may preclude future use.", "consequence": "Family educated about specific warning signs.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Peripheral neuropathy - numbness and tingling in hands and feet", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Peripheral neuropathy** is a side effect of **vincristine**, not asparaginase. Vincristine causes dose-dependent neuropathy (numbness, weakness, constipation from autonomic neuropathy). While important to monitor, this is vincristine-specific. Asparaginase's unique toxicities include pancreatitis, thrombosis, and allergic reactions.", "consequence": "Attributing side effect to wrong drug.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "Cardiomyopathy - decreased heart function", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cardiomyopathy** is a side effect of **anthracyclines** (daunorubicin, doxorubicin), not asparaginase. Anthracycline cardiotoxicity is cumulative and dose-dependent. Patients receiving anthracyclines need echocardiogram monitoring. Asparaginase does not cause cardiac toxicity.", "consequence": "Wrong drug association.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Cushingoid features and mood changes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cushingoid features** (moon face, weight gain, mood changes, hyperglycemia, hypertension) are side effects of **corticosteroids** (prednisone, dexamethasone), not asparaginase. Steroids are a critical component of ALL therapy but have significant short-term and long-term side effects.", "consequence": "Steroid effects, not asparaginase.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Hair loss - alopecia from rapid cell turnover", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Alopecia** is a common side effect of many chemotherapy agents but is not specific to asparaginase. It occurs from agents affecting rapidly dividing cells (like doxorubicin). Asparaginase has unique toxicities (pancreatitis, thrombosis, allergic reactions) that distinguish it from other chemotherapy drugs.", "consequence": "Non-specific side effect.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Drug-specific toxicities to remember**: Vincristine \u2192 neuropathy (peripheral and autonomic), Steroids \u2192 Cushingoid features, hyperglycemia, avascular necrosis, Anthracyclines \u2192 cardiomyopathy, Asparaginase \u2192 pancreatitis, thrombosis, allergic reactions, Methotrexate \u2192 mucositis, hepatotoxicity, nephrotoxicity (high-dose)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully recognized and managed this case of childhood ALL:\n\n\u2713 Recognized classic presentation: bone pain + pancytopenia + organomegaly + lymphadenopathy\n\u2713 Identified blasts on peripheral smear as diagnostic clue\n\u2713 Ordered appropriate diagnostic workup (bone marrow biopsy with flow cytometry, cytogenetics)\n\u2713 Understood risk stratification factors\n\u2713 Anticipated and planned for tumor lysis syndrome prevention\n\u2713 Counseled family accurately about excellent prognosis and treatment duration\n\u2713 Educated about drug-specific toxicities\n\nKey learning points:\n- ALL is the most common childhood malignancy (peak age 2-5)\n- Never dismiss bone pain + abnormal CBC as \"growing pains\"\n- Diagnosis requires bone marrow biopsy with immunophenotyping and cytogenetics\n- Standard-risk B-ALL has >90% cure rate with 2-3 years of chemotherapy\n- Tumor lysis syndrome prevention is essential before starting chemotherapy\n- Know drug-specific toxicities: vincristine=neuropathy, steroids=Cushingoid, anthracyclines=cardiotoxicity, asparaginase=pancreatitis/thrombosis"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key ALL concepts:\n\n- Classic presentation: bone pain, fatigue, bleeding, fever, pallor, lymphadenopathy, hepatosplenomegaly\n- CBC shows pancytopenia + circulating blasts\n- Diagnosis: bone marrow biopsy with immunophenotyping and cytogenetics\n- Risk stratification: age, WBC, immunophenotype, cytogenetics\n- Standard-risk B-ALL: >90% cure rate, 2-3 years treatment\n- Tumor lysis syndrome: hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia\n- Prevent TLS with hydration, allopurinol/rasburicase\n- Drug toxicities: vincristine=neuropathy, anthracyclines=cardiotoxicity, asparaginase=pancreatitis"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical ALL concepts:\n\n- NEVER dismiss bone pain in a child with abnormal CBC as \"growing pains\"\n- Blasts on peripheral smear = acute leukemia until proven otherwise\n- Do not delay diagnosis - ALL is a medical emergency\n- ITP is a diagnosis of exclusion - always review peripheral smear\n- Bone marrow biopsy is diagnostic, not lymph node biopsy\n- Treatment must wait for proper diagnosis and risk stratification\n- Tumor lysis syndrome can be fatal - prevention is mandatory\n\nKey pearl: Bone pain + pancytopenia = leukemia until proven otherwise. ALL is the most common childhood malignancy but is highly curable with modern therapy."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-074", "title": "Carbon Monoxide Poisoning Recognition", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["carbon monoxide", "CO poisoning", "pulse oximetry", "CO-oximetry", "carboxyhemoglobin", "hyperbaric oxygen", "delayed neuropsychiatric sequelae"], "estimatedMinutes": 7, "source": ["NBME"], "stem": "A 5-year-old girl is brought to the ED in January with headache, dizziness, and nausea. Her 8-year-old brother and mother are also in the waiting room with similar symptoms. The family recently moved into an older home with a gas furnace.\n\nThe mother mentions that everyone's symptoms started this morning and seemed to improve briefly when they went outside to walk to the car.\n\nPhysical Examination:\n- General: Drowsy but arousable, mildly confused\n- Vitals: T 37.1\u00b0C, HR 110, RR 24, BP 100/65, SpO2 99% on room air\n- HEENT: No cherry-red discoloration (this finding is rare and unreliable)\n- Neuro: Oriented to person only, mild ataxia, no focal deficits\n- Lungs: Clear to auscultation", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This family presents with a classic pattern for carbon monoxide poisoning: **multiple household members** with nonspecific symptoms (headache, nausea, confusion) during **winter months** with gas heating. The symptoms improved when they went outside (away from the CO source).\n\nNotably, the **pulse oximetry reads 99%** despite the patient being symptomatic.", "question": "What clinical clue is MOST helpful in distinguishing CO poisoning from viral illness in this presentation?", "choices": [{"id": "node-1-choice-a", "text": "Multiple family members affected simultaneously with symptoms that improve outside the home", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **epidemiologic pattern** is the key clue. CO poisoning typically affects **everyone in the household simultaneously** (unlike viral illness which spreads over days) and symptoms **improve when leaving the contaminated environment**. Viral illness doesn't improve with location change, and family members typically get sick sequentially as the virus spreads. The **winter timing + gas heating** further supports CO exposure.", "consequence": "You recognize the classic epidemiologic pattern of CO poisoning.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Cherry-red skin discoloration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cherry-red skin is a classic but RARE and UNRELIABLE finding** - it is more often seen postmortem. Most living patients with CO poisoning have **normal-appearing skin** or may appear pale. Do NOT rely on cherry-red discoloration to make the diagnosis. The epidemiologic history is far more helpful.", "consequence": "Cherry-red skin is unreliable and usually absent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Low oxygen saturation on pulse oximetry", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is a critical teaching point: **Standard pulse oximetry is FALSELY NORMAL** in CO poisoning. Pulse oximeters measure light absorption and cannot distinguish oxyhemoglobin from carboxyhemoglobin - both absorb light similarly. The patient's SpO2 of 99% does NOT rule out CO poisoning. This is why CO poisoning is often missed!", "consequence": "Pulse ox is falsely normal - this is a major pitfall.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Presence of fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CO poisoning typically does NOT cause fever** (this patient is 37.1\u00b0C - normal). The presence of fever would actually make viral illness more likely. However, the absence of fever in this family is not specific enough to diagnose CO poisoning - the epidemiologic pattern is the key.", "consequence": "Absence of fever is nonspecific.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Headache and nausea", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Headache and nausea are **nonspecific symptoms** that occur in many conditions (viral illness, migraine, food poisoning, medication effects). These symptoms alone cannot distinguish CO poisoning from other causes. The pattern of **multiple simultaneous cases + improvement with location change** is what makes CO poisoning the leading diagnosis.", "consequence": "Headache and nausea are nonspecific.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CO Poisoning Clues**: (1) **Multiple household members sick simultaneously** (unlike viral spread over days), (2) **Winter months** with heating sources, (3) **Symptoms improve when leaving home**, (4) **Normal pulse oximetry** (pulse ox CANNOT detect CO!), (5) Sources: gas heaters, furnaces, car exhaust in garage, generators, house fires. **Cherry-red skin is unreliable** - more common in autopsy than living patients."}, "node-2": {"id": "node-2", "type": "decision", "content": "You strongly suspect CO poisoning. The triage nurse questions why you're concerned when the pulse oximetry shows 99%.", "question": "Why does standard pulse oximetry give FALSELY NORMAL readings in carbon monoxide poisoning?", "choices": [{"id": "node-2-choice-a", "text": "Pulse oximetry cannot distinguish carboxyhemoglobin (COHb) from oxyhemoglobin - both absorb light similarly", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Standard pulse oximeters use **two wavelengths of light** to distinguish oxyhemoglobin from deoxyhemoglobin. However, **carboxyhemoglobin (COHb) absorbs light at nearly the same wavelength as oxyhemoglobin**, so the device 'thinks' the hemoglobin is carrying oxygen when it's actually bound to CO. The SpO2 reading represents (OxyHb + COHb), which can be 99% even with dangerous COHb levels. **CO-oximetry** uses multiple wavelengths to separately measure COHb.", "consequence": "You understand why CO-oximetry is needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CO increases oxygen release from hemoglobin, improving peripheral oxygenation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is **opposite of the truth**. CO actually **LEFT-SHIFTS the oxyhemoglobin dissociation curve**, meaning hemoglobin holds onto oxygen MORE tightly and releases it LESS readily to tissues. This is part of why CO is so toxic - it not only blocks O2 binding but also impairs release of remaining O2 to tissues.", "consequence": "CO actually impairs oxygen release.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CO only affects venous blood, and pulse oximetry measures arterial saturation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CO binds to hemoglobin **240 times more avidly than oxygen** and affects both arterial and venous blood equally. Pulse oximetry measures arterial blood but still cannot detect CO because of the similar light absorption properties of COHb and OxyHb.", "consequence": "CO affects both arterial and venous blood.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Peripheral vasoconstriction from CO blocks pulse oximetry readings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While severe CO poisoning can cause cardiovascular effects, vasoconstriction is not the reason for falsely normal readings. The issue is that the **optical detection method cannot distinguish** between hemoglobin bound to oxygen versus hemoglobin bound to CO.", "consequence": "This is not the mechanism.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "CO stimulates erythropoietin, increasing hemoglobin concentration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While chronic CO exposure (like in smokers) can cause secondary polycythemia over time, this is not relevant to acute poisoning and does not explain the falsely normal pulse ox. The key issue is the **optical similarity** between COHb and OxyHb.", "consequence": "Chronic effect, not relevant to acute diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**CO-Oximetry vs Pulse Oximetry**: Standard pulse ox uses 2 wavelengths \u2192 detects OxyHb + DeoxyHb but CANNOT distinguish COHb or MetHb. **CO-oximetry** uses 4+ wavelengths \u2192 separately measures **OxyHb, DeoxyHb, COHb, and MetHb**. Always order CO-oximetry (venous or arterial blood gas) when suspecting CO poisoning. **COHb levels**: >3% (non-smokers) or >10% (smokers) is abnormal. Symptoms correlate loosely with levels."}, "node-3": {"id": "node-3", "type": "decision", "content": "CO-oximetry confirms the diagnosis: **COHb level is 25%** (severely elevated; normal <3% in non-smokers).\n\n**The child is now drowsy but arousable, with intermittent confusion.**\n\nYou need to decide on treatment. The nearest hyperbaric oxygen chamber is 90 minutes away by ambulance.", "question": "What is the INITIAL treatment, and when is hyperbaric oxygen (HBO) indicated?", "choices": [{"id": "node-3-choice-a", "text": "100% O2 via non-rebreather mask immediately; HBO indicated for LOC, neurologic symptoms, COHb >25%, or pregnancy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Immediate treatment** is **100% oxygen via non-rebreather mask** (or intubation if needed). This reduces COHb half-life from **4-6 hours (room air) to ~60-90 minutes (100% O2)**. **Hyperbaric oxygen (HBO)** further reduces half-life to **~20-30 minutes** and is indicated for: (1) **Loss of consciousness** at any point, (2) **Neurologic symptoms** (confusion, ataxia, seizures), (3) **COHb >25%**, (4) **Pregnancy** (fetal Hb has higher CO affinity), (5) **Cardiac ischemia/arrhythmia**. This child has neurologic symptoms (confusion, ataxia) and COHb 25%, qualifying for HBO.", "consequence": "You initiate appropriate treatment.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immediate transfer for HBO without starting oxygen - HBO is the definitive treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never delay 100% oxygen while arranging HBO**. High-flow oxygen should begin IMMEDIATELY upon suspicion of CO poisoning - every minute counts as CO continues damaging tissues. Start 100% O2 first, then arrange HBO transfer if indicated. The patient should receive oxygen during transport as well.", "consequence": "Do not delay oxygen while arranging HBO.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "100% O2 via non-rebreather; HBO only for COHb >50%", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The threshold for HBO is much lower. COHb **>25%** is an indication for HBO, not 50%. Waiting for COHb to reach 50% would result in severe neurologic injury or death. Additionally, **clinical symptoms** (LOC, confusion) are indications regardless of the level.", "consequence": "HBO threshold is 25%, not 50%.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Methylene blue infusion as the antidote for CO poisoning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Methylene blue is the antidote for METHEMOGLOBINEMIA, not CO poisoning**. Methylene blue works by reducing methemoglobin (Fe\u00b3\u207a) back to normal hemoglobin (Fe\u00b2\u207a). CO poisoning requires oxygen therapy to competitively displace CO from hemoglobin - there is no chemical antidote.", "consequence": "Methylene blue is for methemoglobinemia, not CO.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Exchange transfusion to remove carboxyhemoglobin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Exchange transfusion is NOT indicated for CO poisoning**. High-flow oxygen effectively displaces CO from hemoglobin through competitive binding (O2 has 200-250x lower affinity than CO, but providing 100% O2 shifts the equilibrium). Exchange transfusion is occasionally used for severe methemoglobinemia or sickle cell crisis.", "consequence": "Exchange transfusion is not used for CO poisoning.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**CO Poisoning Treatment**: (1) **Remove from exposure** + call fire department/gas company, (2) **100% O2 non-rebreather** immediately (reduces COHb half-life 4-6h \u2192 60-90min), (3) **HBO indications**: LOC, neurologic symptoms, COHb >25%, pregnancy, cardiac ischemia (reduces half-life to 20-30min and may reduce delayed neurologic sequelae). **COHb levels correlate poorly** with clinical severity - treat based on symptoms. Intubate if GCS <8."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is started on 100% oxygen and transferred for hyperbaric oxygen therapy. The family's home is inspected and a faulty furnace is identified.\n\nThree days later, the patient has recovered and is being discharged. The parents ask about long-term effects.", "question": "What is the MOST IMPORTANT long-term complication to counsel the family about after CO poisoning?", "choices": [{"id": "node-4-choice-a", "text": "Delayed neuropsychiatric sequelae (DNS) - cognitive problems, personality changes, movement disorders appearing 2-40 days later", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Delayed neuropsychiatric sequelae (DNS)** is the most important complication. It occurs in **10-30% of CO poisoning survivors** and appears **2-40 days after exposure** (typically within 2-3 weeks). Symptoms include: **cognitive impairment** (memory, concentration), **personality changes** (irritability, apathy), **movement disorders** (parkinsonism, chorea), and **mood disorders**. DNS may occur even after apparent full recovery. HBO therapy may reduce (but not eliminate) DNS risk.", "consequence": "You provide important anticipatory guidance.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Permanent carboxyhemoglobin that remains for life", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **COHb is reversible** - with oxygen therapy, CO is displaced from hemoglobin and exhaled through the lungs. COHb levels return to normal within hours to days with treatment. There is no permanent carboxyhemoglobin.", "consequence": "COHb is reversible with treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Chronic lung disease requiring lifelong oxygen supplementation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CO poisoning does NOT cause chronic lung disease. The lungs themselves are not damaged by CO - the toxicity is from **tissue hypoxia** due to hemoglobin being unable to carry oxygen. Smoke inhalation injury (often accompanying CO exposure in fires) can cause airway/lung damage, but this is from heat and particulates, not CO itself.", "consequence": "CO doesn't cause chronic lung disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Increased future cancer risk from CO exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **CO is not a carcinogen**. There is no increased cancer risk from CO poisoning. The long-term concerns are neurologic/neuropsychiatric, not oncologic.", "consequence": "CO is not carcinogenic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Immunity to future CO exposure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no immunity or tolerance** to CO. Prior exposure does not protect against future poisoning - if anything, prior neurologic injury may make patients more vulnerable to subsequent insults. The family must ensure their heating systems are properly maintained and install CO detectors.", "consequence": "There is no immunity to CO.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Delayed Neuropsychiatric Sequelae (DNS)**: (1) Occurs in **10-30%** of moderate-severe CO poisoning, (2) Appears **2-40 days** after exposure (even after initial recovery), (3) Symptoms: memory/concentration problems, personality changes, parkinsonism, depression, (4) Risk factors: LOC during exposure, age >36, longer exposure, (5) **MRI** may show bilateral **globus pallidus lesions** (classic) or white matter changes, (6) **Neuropsych follow-up** is recommended. **Prevention**: CO detectors in every home!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed carbon monoxide poisoning.\n\n**Key Learning Points:**\n\n1. **Recognition**: Multiple family members sick simultaneously + winter + gas heating + symptoms improve outside = CO until proven otherwise. Cherry-red skin is unreliable.\n\n2. **Pulse Ox Pitfall**: Standard pulse oximetry is FALSELY NORMAL because it cannot distinguish COHb from OxyHb. Order **CO-oximetry** (blood gas).\n\n3. **Treatment**: 100% O2 via non-rebreather IMMEDIATELY. HBO indicated for: LOC, neurologic symptoms, COHb >25%, pregnancy, cardiac ischemia.\n\n4. **Mechanism**: CO binds Hb 240x more avidly than O2 AND left-shifts the curve (impairs O2 release). 100% O2 competitively displaces CO.\n\n5. **Complications**: Delayed neuropsychiatric sequelae (DNS) in 10-30% - cognitive/personality changes appearing 2-40 days later. Arrange follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review CO poisoning essentials:\n\n**Diagnosis**: Multiple sick family members + winter + gas/furnace + symptoms improve outside. **Pulse ox is FALSELY NORMAL** - order CO-oximetry.\n\n**Pathophysiology**: COHb and OxyHb absorb light similarly, so pulse ox can't tell them apart. Need CO-oximeter (4+ wavelengths).\n\n**Treatment**: 100% O2 immediately (reduces COHb half-life from 4-6h to 60-90min). HBO if: LOC, neurologic symptoms, COHb >25%, pregnancy.\n\n**Complications**: Delayed neuropsychiatric sequelae (DNS) in 10-30% appearing 2-40 days later. Install CO detectors!"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical CO poisoning points:\n\n1. **Methylene blue is for METHEMOGLOBINEMIA, not CO** - there's no chemical antidote for CO. Treatment is oxygen (competitive displacement).\n\n2. **Exchange transfusion is NOT used** for CO poisoning - oxygen therapy is effective.\n\n3. **Pulse oximetry is FALSELY NORMAL** - must order CO-oximetry.\n\n4. **No immunity to CO** - prior exposure doesn't protect against future poisoning. Install CO detectors.\n\n5. **COHb is reversible** - returns to normal with treatment."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-079", "title": "Thalassemia Trait vs Iron Deficiency", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["microcytic anemia", "elevated RBC count", "target cells", "normal RDW", "Mentzer index", "hemoglobin electrophoresis", "genetic counseling"], "estimatedMinutes": 4, "source": ["NBME"], "stem": "A 2-year-old male of Mediterranean descent is brought for a routine well-child visit. His mother mentions he seems pale compared to his siblings and tires easily during play.\n\nDiet history reveals he drinks 32 oz of cow's milk daily and is a 'picky eater' who refuses most meats and vegetables.\n\nPhysical Examination:\n- General: pale but well-appearing toddler.\n- Vitals: HR 110 bpm, RR 24/min, normal BP.\n- HEENT: mild conjunctival pallor, no scleral icterus.\n- Cardiovascular: soft systolic flow murmur (2/6).\n- Abdomen: no hepatosplenomegaly.\n- Extremities: no clubbing or cyanosis.\n\nLaboratory Results:\n- Hgb: 9.5 g/dL (low)\n- MCV: 62 fL (low - microcytic)\n- RBC count: 5.8 million/\u03bcL (elevated)\n- RDW: 13.5% (normal)\n- Peripheral smear: microcytes, target cells, basophilic stippling", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You need to determine whether this microcytic anemia is due to iron deficiency (common in toddlers with high milk intake) or thalassemia trait (common in Mediterranean populations).", "question": "Based on the CBC indices provided, which diagnosis is MOST likely?", "choices": [{"id": "node-1-choice-a", "text": "Beta-thalassemia trait", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The CBC pattern strongly suggests **beta-thalassemia trait**: (1) **Elevated RBC count** (5.8 million - MORE red cells, not fewer), (2) **Low MCV** (small cells), (3) **Normal RDW** (uniform cell size), (4) **Target cells** on smear. The **Mentzer index** (MCV/RBC) = 62/5.8 = **10.7** (<13 favors thalassemia). Mediterranean ancestry is also a strong clue.", "consequence": "You suspect thalassemia trait and order confirmatory testing.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Iron deficiency anemia", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration given the dietary history (high milk intake, low iron foods), but the CBC pattern argues against it. In **iron deficiency**, you would expect: (1) **Low RBC count** (fewer cells), (2) **High RDW** (variable cell sizes - anisocytosis), (3) **Low MCV**. This patient has elevated RBC count and normal RDW, which favors thalassemia. However, both can coexist.", "consequence": "You order iron studies to evaluate further.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Lead poisoning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While lead poisoning can cause microcytic anemia with basophilic stippling, it would NOT cause an **elevated RBC count**. Lead poisoning typically shows: basophilic stippling, abdominal pain, developmental delay, and a history of pica or lead exposure. Screen for lead if clinical suspicion is high, but the RBC indices favor thalassemia.", "consequence": "Lead level may be checked but thalassemia workup is more appropriate here.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Sideroblastic anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Sideroblastic anemia is **rare in children** and presents with microcytosis but NOT an elevated RBC count. It is characterized by ringed sideroblasts on bone marrow (iron-laden mitochondria surrounding nucleus). The normal RDW and elevated RBC count in this patient strongly favor thalassemia trait.", "consequence": "Unlikely diagnosis leads to inappropriate workup.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Anemia of chronic disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Anemia of chronic disease (ACD) is typically **normocytic** (can be mildly microcytic in chronic cases) and associated with chronic inflammation. This well-appearing child has no evidence of chronic illness. ACD would show low iron, low TIBC, and normal/elevated ferritin - very different from iron deficiency or thalassemia.", "consequence": "Misdiagnosis delays appropriate management.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Mentzer Index** = MCV/RBC count. **<13 = thalassemia likely**, >13 = iron deficiency likely. Remember: thalassemia = MORE cells that are SMALLER (high RBC, low MCV, normal RDW). Iron deficiency = FEWER cells of VARIABLE size (low RBC, low MCV, HIGH RDW)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You order iron studies and hemoglobin electrophoresis.\n\nResults:\n- Ferritin: 45 ng/mL (normal)\n- Serum iron: 70 \u03bcg/dL (normal)\n- TIBC: 320 \u03bcg/dL (normal)\n- Transferrin saturation: 22% (normal)\n\n- Hemoglobin electrophoresis:\n  - HbA: 94% (normal 96-98%)\n  - HbA2: 5.2% (elevated - normal <3.5%)\n  - HbF: 0.8% (normal)", "question": "Based on these results, what is the definitive diagnosis?", "choices": [{"id": "node-2-choice-a", "text": "Beta-thalassemia trait (beta-thalassemia minor)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **elevated HbA2 (>3.5%)** is diagnostic for **beta-thalassemia trait**. This occurs because reduced beta-globin chain production leads to relative excess of delta chains, which combine with alpha chains to form HbA2 (\u03b12\u03b42). Normal iron studies confirm this is NOT iron deficiency. Beta-thalassemia trait is a **benign carrier state** - patients have mild anemia but are otherwise healthy.", "consequence": "Diagnosis confirmed. You counsel the family about this benign condition.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Alpha-thalassemia trait", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Alpha-thalassemia trait** has a **NORMAL hemoglobin electrophoresis** (because HbA, HbA2, and HbF all contain alpha chains). The elevated HbA2 (5.2%) is specific for **beta-thalassemia**, not alpha. Alpha-thalassemia requires genetic testing or demonstration of HbH inclusions.", "consequence": "Misidentifying the type of thalassemia leads to incorrect counseling.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Iron deficiency anemia coexisting with thalassemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **normal iron studies** (ferritin 45, normal transferrin saturation) rule out concurrent iron deficiency. If iron deficiency were present, you would see: low ferritin, low serum iron, high TIBC, and low transferrin saturation. This patient has isolated beta-thalassemia trait.", "consequence": "Unnecessary iron supplementation would be started.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Hemoglobin E trait", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hemoglobin E** (common in Southeast Asian populations) would show an **HbE band** on electrophoresis, not just elevated HbA2. HbE trait shows approximately 25-30% HbE on electrophoresis. This patient's electrophoresis shows only elevated HbA2, consistent with beta-thalassemia trait.", "consequence": "Misdiagnosis of hemoglobinopathy type.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Beta-thalassemia major (Cooley anemia)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Beta-thalassemia major** presents in infancy (6-12 months) with **severe anemia** (Hgb <7 g/dL), **hepatosplenomegaly**, failure to thrive, and transfusion dependence. This patient has mild anemia, no organomegaly, and is well-appearing. Thalassemia major shows **markedly elevated HbF** (>90%) and minimal/absent HbA.", "consequence": "Overdiagnosis leads to unnecessary alarm and inappropriate treatment planning.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Beta-thalassemia trait diagnosis**: Elevated **HbA2 >3.5%** is diagnostic. Normal HbF, slightly reduced HbA. **Alpha-thalassemia trait has NORMAL electrophoresis** - requires genetic testing. Iron deficiency can MASK elevated HbA2, so always check iron status first."}, "node-3": {"id": "node-3", "type": "decision", "content": "The diagnosis of beta-thalassemia trait is confirmed. The parents are concerned and ask 'What does this mean for our son? Does he need treatment?'", "question": "What is the most important counseling point for this family?", "choices": [{"id": "node-3-choice-a", "text": "Benign condition - no treatment needed; genetic counseling for future family planning", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Beta-thalassemia trait is benign** - patients have mild anemia that does NOT worsen and requires NO treatment. Key counseling: (1) **No iron supplementation** needed (and can cause iron overload), (2) Mild anemia is lifelong but harmless, (3) **Genetic counseling** is important - if both parents are carriers, 25% chance of offspring having thalassemia major, (4) Screen partner before pregnancy, (5) No activity restrictions.", "consequence": "Family understands the benign nature of the condition and importance of partner screening.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start iron supplementation to treat the anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never give iron for thalassemia trait** - it will NOT improve the anemia (which is due to ineffective erythropoiesis, not iron deficiency) and can cause **iron overload**. Iron supplementation is only appropriate if there is CONCURRENT iron deficiency (low ferritin), which this patient does not have.", "consequence": "Unnecessary iron causes potential iron overload without improving hemoglobin.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Refer to hematology for blood transfusions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Thalassemia TRAIT never requires transfusions**. Only thalassemia MAJOR (Cooley anemia) requires chronic transfusions. Patients with thalassemia trait have stable mild anemia (Hgb typically 9-11 g/dL) that does not worsen and does not cause symptoms requiring transfusion.", "consequence": "Unnecessary referral and family anxiety.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Restrict physical activity due to anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **No activity restrictions** are needed for thalassemia trait. The mild anemia is well-tolerated and children can participate in all normal activities including sports. Activity restriction would be inappropriate and harmful to the child's development and quality of life.", "consequence": "Unnecessary restrictions harm quality of life without medical benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Schedule monthly hemoglobin monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Frequent monitoring is not needed** for thalassemia trait. The anemia is stable and does not change over time. Routine well-child visits with periodic CBC (annually or as clinically indicated) are sufficient. Monthly monitoring adds cost and anxiety without clinical benefit.", "consequence": "Over-monitoring creates unnecessary burden and healthcare costs.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Thalassemia trait management**: (1) **No treatment needed** - benign carrier state, (2) **NO iron** unless concurrent deficiency proven, (3) **Genetic counseling** essential - screen partners, (4) **No activity restrictions**, (5) Reassure that anemia is stable and harmless. Two trait carriers have 25% chance of having a child with thalassemia major."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly differentiated thalassemia trait from iron deficiency anemia using CBC indices, confirmed with hemoglobin electrophoresis, and provided appropriate counseling.\n\n**Key Learning Points:**\n- **Mentzer Index** (MCV/RBC): <13 = thalassemia, >13 = iron deficiency\n- Thalassemia trait: **MORE cells, SMALLER cells, UNIFORM size** (high RBC, low MCV, normal RDW)\n- Iron deficiency: **FEWER cells, VARIABLE sizes** (low RBC, low MCV, HIGH RDW)\n- **Elevated HbA2 (>3.5%)** = beta-thalassemia trait\n- **Alpha-thalassemia has NORMAL electrophoresis** - requires genetic testing\n- Thalassemia trait is **benign** - NO iron, NO transfusions, NO restrictions\n- **Genetic counseling** is essential for family planning"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While the patient may be correctly diagnosed, important aspects of management or counseling were missed.\n\n**Review these key principles:**\n- Use Mentzer index and RDW to distinguish thalassemia from iron deficiency\n- Beta-thalassemia trait = elevated HbA2; alpha-thalassemia trait = normal electrophoresis\n- Iron deficiency can mask elevated HbA2 - check iron status first\n- Thalassemia trait requires NO treatment, NO restrictions, and NO frequent monitoring\n- Genetic counseling is essential - especially for partner screening"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in microcytic anemia evaluation. These mistakes can lead to inappropriate treatment or missed diagnoses.\n\n**Critical Teaching Points:**\n- NEVER give iron for thalassemia trait - causes iron overload without benefit\n- Thalassemia TRAIT is NOT thalassemia MAJOR - don't over-treat a benign condition\n- Know the difference: beta-thal trait (elevated HbA2) vs alpha-thal trait (normal electrophoresis)\n- Elevated RBC count with low MCV strongly suggests thalassemia, not iron deficiency\n- Genetic counseling prevents thalassemia major in future offspring"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-119", "title": "ALL Marrow Infiltration Mechanism", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["packed marrow with blasts", "normal cells crowded out", "pancytopenia despite hypercellular marrow", "all marrow infiltration mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old male presents with fatigue, pallor, and easy bruising for 2 weeks. His parents also note he has been refusing to walk and complains his legs hurt.\n\nPhysical Examination:\n- General: pale, fatigued-appearing child\n- Skin: petechiae on lower extremities, ecchymoses on shins and arms\n- Musculoskeletal: tenderness over long bones bilaterally, refuses to bear weight\n- Lymph: hepatosplenomegaly (liver 4 cm below costal margin, spleen palpable), cervical and axillary lymphadenopathy\n- Vital signs: T 38.2\u00b0C, HR 110, RR 22", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "Laboratory findings:\n- **CBC**: WBC 2,800/\u00b5L (neutrophils 15%, lymphocytes 80%), Hgb 7.2 g/dL, platelets 32,000/\u00b5L\n- **Peripheral smear**: circulating blasts noted\n- **LDH**: 1,450 U/L (elevated)\n- **Uric acid**: 8.2 mg/dL (elevated)\n\n**Understanding the mechanism of cytopenias in ALL:**\n- Leukemic blasts proliferate rapidly and **physically crowd out normal hematopoietic cells**\n- The marrow is **hypercellular** (packed with cells), NOT hypocellular\n- This is **marrow replacement**, not marrow failure\n- All three cell lines affected: anemia (fatigue, pallor), thrombocytopenia (bruising, petechiae), neutropenia (infection risk)", "question": "What is the underlying mechanism for this patient's pancytopenia?", "choices": [{"id": "node-1-choice-a", "text": "Bone marrow infiltration by leukemic blasts crowding out normal hematopoiesis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Acute lymphoblastic leukemia (ALL)** causes pancytopenia through **marrow infiltration and replacement**. The key concept is that the marrow is FULL of cells - just the wrong cells. Leukemic blasts proliferate uncontrollably and physically displace normal erythroid, myeloid, and megakaryocytic precursors. This explains why patients have **pancytopenia despite hypercellular marrow** - a critical distinction from aplastic anemia where the marrow is hypocellular/empty.", "consequence": "You correctly identify the pathophysiology and proceed to diagnostic workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Aplastic anemia with bone marrow failure", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Aplastic anemia** causes pancytopenia through **marrow failure** with a **hypocellular/empty marrow**. In contrast, ALL causes pancytopenia through **marrow replacement** with a **hypercellular marrow packed with blasts**. The presence of circulating blasts, lymphadenopathy, hepatosplenomegaly, and bone pain strongly suggest a proliferative malignancy, not marrow failure. In aplastic anemia, you would NOT see blasts, organomegaly, or elevated LDH.", "consequence": "Misunderstanding the mechanism could lead to inappropriate management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Immune-mediated peripheral destruction of blood cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Immune-mediated cytopenias** (like ITP or AIHA) cause destruction of mature cells in the peripheral blood, but the bone marrow shows **increased production** as compensation. In this case, the circulating blasts, organomegaly, elevated LDH, and bone pain indicate **marrow infiltration by malignancy**. ITP would show isolated thrombocytopenia with megakaryocytic hyperplasia in marrow, not pancytopenia with blasts.", "consequence": "Misdiagnosis delays appropriate oncologic referral.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Nutritional deficiency causing ineffective hematopoiesis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Nutritional deficiencies** (B12, folate, iron) cause specific patterns of anemia with characteristic morphologic changes. B12/folate deficiency causes **megaloblastic anemia** with hypersegmented neutrophils. This patient has **circulating blasts**, organomegaly, and bone pain - none of which occur with nutritional deficiencies. The elevated LDH suggests high cell turnover from malignancy, not ineffective erythropoiesis.", "consequence": "Pursuing nutritional workup delays critical cancer diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Splenic sequestration of blood cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While splenomegaly is present, **splenic sequestration** alone does not explain this presentation. Hypersplenism causes mild-moderate cytopenias but would NOT produce **circulating blasts**, bone pain, or markedly elevated LDH. The splenomegaly here is a consequence of leukemic infiltration, not the primary cause of cytopenias. The blasts on peripheral smear are the key finding pointing to ALL.", "consequence": "Focusing on splenomegaly misses the underlying malignancy.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Marrow replacement vs marrow failure**: In ALL, the pancytopenia is from marrow REPLACEMENT (hypercellular marrow packed with blasts) - the marrow is full, just full of the wrong cells. In aplastic anemia, pancytopenia is from marrow FAILURE (hypocellular/empty marrow). This distinction is critical for understanding pathophysiology and guides treatment."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect acute lymphoblastic leukemia. The patient needs urgent evaluation.\n\n**Radiographic findings on skeletal survey:**\n- **Metaphyseal lucent bands** (leukemic lines) - areas of bone destruction at growth plates\n- **Periosteal reaction** along long bones\n- **Diffuse osteopenia**\n\n**Why bone pain in ALL?**\n- Leukemic infiltration of bone marrow causes **expansion and periosteal stretching**\n- Bone pain/refusal to walk occurs in ~25% of ALL cases\n- Can mimic JIA, osteomyelitis, or growing pains\n- **\"Midnight bone pain\"** that wakes child from sleep is a red flag", "question": "What is the most appropriate next diagnostic step?", "choices": [{"id": "node-2-choice-a", "text": "Bone marrow aspirate and biopsy with flow cytometry", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bone marrow aspirate and biopsy** is the gold standard for diagnosing ALL. It provides: (1) **Morphology** - blast percentage (>25% defines leukemia), (2) **Flow cytometry** - immunophenotyping to classify B-ALL vs T-ALL, (3) **Cytogenetics** - chromosomal abnormalities for risk stratification (e.g., t(12;21) favorable, t(9;22) Philadelphia chromosome unfavorable), (4) **Molecular studies** - for minimal residual disease monitoring. This should be done **urgently** but in coordination with pediatric oncology.", "consequence": "You appropriately proceed with definitive diagnostic testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CT scan of chest, abdomen, and pelvis for staging", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct but not the immediate next step. Imaging may be part of the workup (especially to evaluate for **mediastinal mass** in T-ALL), but **bone marrow examination** must come first to establish the diagnosis. CT imaging is typically done after bone marrow confirms leukemia and helps assess disease burden and complications. Obtaining marrow first allows appropriate risk stratification and treatment planning.", "consequence": "Imaging is helpful but should follow bone marrow confirmation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Repeat CBC in 1 week to confirm findings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is a hematologic emergency** - do NOT delay diagnosis. The presence of circulating blasts, pancytopenia, organomegaly, and constitutional symptoms is highly concerning for acute leukemia. Waiting 1 week risks: (1) **Tumor lysis syndrome** from high cell turnover, (2) Life-threatening **infection** due to neutropenia, (3) **Severe bleeding** from thrombocytopenia, (4) Disease progression. Immediate bone marrow evaluation is indicated.", "consequence": "Dangerous delay in diagnosis of life-threatening malignancy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Empiric antibiotics for presumed osteomyelitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bone pain can mimic osteomyelitis, this patient has **systemic findings** that do not fit infection: pancytopenia (osteomyelitis causes leukocytosis), hepatosplenomegaly, lymphadenopathy, and **circulating blasts**. The metaphyseal lucent bands are characteristic of leukemia, not infection. Treating presumptively for osteomyelitis delays critical cancer diagnosis and appropriate oncologic care.", "consequence": "Misdiagnosis leads to inappropriate treatment and delayed cancer care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Rheumatology referral for suspected juvenile idiopathic arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While ALL can mimic JIA (both cause joint pain, fever, fatigue), this patient has **red flags for malignancy**: pancytopenia with circulating blasts, hepatosplenomegaly, elevated LDH, and metaphyseal lucent bands. JIA does NOT cause circulating blasts or pancytopenia. **Key teaching point**: Always check CBC before diagnosing JIA - missing leukemia has serious consequences. The saying is \"ALL is in the differential of JIA, but JIA is not in the differential of ALL.\"", "consequence": "Critical misdiagnosis delays life-saving treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Leukemia mimics JIA**: Up to 25% of ALL patients present with bone/joint pain, sometimes leading to initial rheumatology referral. ALWAYS check CBC before diagnosing JIA. Red flags for leukemia: night pain waking from sleep, pain out of proportion to swelling, pancytopenia, hepatosplenomegaly, lymphadenopathy."}, "node-3": {"id": "node-3", "type": "decision", "content": "Bone marrow biopsy confirms **B-cell ALL** with >90% blasts. Flow cytometry shows CD10+, CD19+, CD22+, TdT+. Cytogenetics reveal **t(12;21) ETV6-RUNX1 fusion** (favorable prognosis).\n\n**Pre-treatment considerations:**\n- WBC 2,800/\u00b5L with blasts (lower WBC = better prognosis)\n- No CNS involvement on lumbar puncture\n- No mediastinal mass on chest X-ray\n- LDH 1,450 U/L, uric acid 8.2 mg/dL (tumor lysis risk)\n\n**Risk of tumor lysis syndrome (TLS):**\n- Occurs when rapid cell death releases intracellular contents\n- Causes: hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia\n- Can lead to acute kidney injury, cardiac arrhythmias, seizures", "question": "Before initiating chemotherapy, what is the most critical supportive care measure?", "choices": [{"id": "node-3-choice-a", "text": "Aggressive IV hydration and tumor lysis syndrome prophylaxis with allopurinol or rasburicase", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Tumor lysis syndrome (TLS) prophylaxis** is critical before starting chemotherapy. Management includes: (1) **Aggressive IV hydration** (2-3 L/m\u00b2/day) to maintain high urine output and flush uric acid, (2) **Allopurinol** - xanthine oxidase inhibitor that prevents NEW uric acid formation (standard prophylaxis), (3) **Rasburicase** - recombinant urate oxidase that BREAKS DOWN existing uric acid (used for high-risk patients or elevated uric acid). Also monitor K+, phosphorus, calcium, creatinine Q6-8h. This patient has elevated uric acid already, indicating high tumor burden.", "consequence": "You appropriately prevent life-threatening metabolic complications.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Platelet transfusion to raise count above 100,000/\u00b5L", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct but not the MOST critical intervention. Platelet transfusion may be needed if there is **active bleeding** or before **invasive procedures** (LP, bone marrow biopsy). However, the threshold for prophylactic transfusion is typically **10,000-20,000/\u00b5L**, not 100,000/\u00b5L. At 32,000/\u00b5L without active bleeding, immediate transfusion is not the priority. **TLS prophylaxis** is more urgent as it prevents life-threatening metabolic derangements that can occur rapidly once treatment begins.", "consequence": "Platelet support is helpful but TLS prevention is more urgent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Immediate initiation of chemotherapy to reduce tumor burden", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While prompt treatment is important, **starting chemotherapy without TLS prophylaxis is dangerous**. Chemotherapy causes rapid tumor cell lysis, releasing massive amounts of potassium, phosphorus, and nucleic acids (converted to uric acid). Without adequate hydration and uric acid control, this leads to: acute kidney injury (uric acid crystals), fatal hyperkalemia (cardiac arrhythmias), hypocalcemia with tetany/seizures. Always establish TLS prophylaxis BEFORE starting chemotherapy.", "consequence": "Precipitating tumor lysis without prophylaxis causes life-threatening complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "G-CSF (filgrastim) to boost neutrophil count", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **G-CSF is contraindicated in untreated ALL**. Growth factors can stimulate leukemic blast proliferation and worsen the disease. G-CSF may be used AFTER chemotherapy during the recovery phase to shorten neutropenia duration, but NEVER before treatment to \"boost counts.\" The neutropenia will improve once chemotherapy eliminates the leukemic cells and normal hematopoiesis recovers.", "consequence": "G-CSF could stimulate leukemic cell growth and worsen disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Prophylactic lumbar puncture with intrathecal chemotherapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. While **CNS-directed therapy** is a critical component of ALL treatment (ALL has high CNS relapse risk without it), the LP should be done (1) diagnostically first to check for CNS involvement, and (2) after platelet count is adequate and coagulopathy corrected. More importantly, **TLS prophylaxis** must be established before any cytotoxic therapy to prevent life-threatening metabolic complications. CNS prophylaxis is part of the treatment protocol, not a pre-treatment priority.", "consequence": "Premature LP without addressing TLS risk and coagulopathy is dangerous.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Tumor lysis syndrome prophylaxis is MANDATORY before treating ALL**. Allopurinol prevents new uric acid formation; rasburicase breaks down existing uric acid (works faster, used for high-risk/elevated uric acid). Remember: hyperuricemia, hyperKalemia, hyperPhosphatemia, hypOcalcemia (\"High-High-High-Low\"). Monitor labs Q6-8h during induction."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly understood that pancytopenia in ALL results from **marrow infiltration/replacement** (hypercellular marrow packed with blasts), not marrow failure. You appropriately obtained bone marrow biopsy for definitive diagnosis and initiated **tumor lysis syndrome prophylaxis** before chemotherapy.\n\n**Key teaching points:**\n- ALL causes pancytopenia through marrow REPLACEMENT - the marrow is full of the wrong cells\n- Bone pain in children (especially night pain) + cytopenias = think leukemia before JIA\n- Metaphyseal lucent bands (\"leukemic lines\") on X-ray are characteristic\n- TLS prophylaxis (hydration + allopurinol/rasburicase) is mandatory before chemotherapy\n- This patient has favorable prognostic features: age 1-10, WBC <50k, B-ALL, t(12;21)\n\n**Prognosis**: With modern treatment protocols, childhood B-ALL has >90% cure rate, especially with favorable cytogenetics like t(12;21)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. While you recognized some aspects of the case, review the key concepts:\n\n**Marrow infiltration mechanism:**\n- Pancytopenia in ALL is from marrow REPLACEMENT, not failure\n- The marrow is HYPERcellular (packed with blasts), not hypocellular\n- Normal hematopoietic cells are physically crowded out\n\n**Diagnostic approach:**\n- Bone marrow aspirate/biopsy with flow cytometry is the gold standard\n- Must be done URGENTLY - this is a hematologic emergency\n\n**Pre-treatment essentials:**\n- TLS prophylaxis (hydration + allopurinol/rasburicase) BEFORE chemotherapy\n- Never give G-CSF to untreated leukemia"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical concepts in pediatric ALL:\n\n**The pancytopenia paradox:**\n- Marrow is FULL (hypercellular), not empty - it's full of the WRONG cells\n- Leukemic blasts crowd out normal erythroid, myeloid, and megakaryocytic precursors\n- This is marrow REPLACEMENT, not marrow FAILURE (like aplastic anemia)\n\n**Don't miss leukemia:**\n- Bone pain + cytopenias + organomegaly = leukemia until proven otherwise\n- Always check CBC before diagnosing JIA in a child with joint pain\n- Circulating blasts on smear are diagnostic - never ignore them\n\n**Treatment priorities:**\n- Bone marrow biopsy for definitive diagnosis\n- TLS prophylaxis BEFORE starting chemotherapy\n- Never give G-CSF to untreated leukemia (stimulates blast proliferation)"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-120", "title": "Anemia of Chronic Disease Mechanism", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["iron studies don't match iron deficiency", "high ferritin", "low TIBC", "hepcidin", "anemia of chronic disease mechanism"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 9-year-old female with known juvenile idiopathic arthritis (JIA) presents for routine follow-up. She has been on methotrexate for 18 months with good joint control. Her mother mentions she seems more tired lately and looks pale.\n\nPhysical Examination:\n- General: pale-appearing girl, no acute distress\n- Skin: pallor of conjunctivae and nail beds\n- Joints: no active synovitis, good range of motion\n- Abdomen: no hepatosplenomegaly\n- Vital signs: HR 95 (normal), RR 18, BP 100/65", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You order laboratory studies to evaluate her anemia.\n\n**CBC:**\n- Hemoglobin: 9.8 g/dL (low)\n- MCV: 78 fL (low-normal, mildly microcytic)\n- RDW: 14% (normal)\n- WBC: 7,200/\u00b5L (normal)\n- Platelets: 380,000/\u00b5L (normal-high)\n\n**Iron studies:**\n- Serum iron: 35 \u00b5g/dL (LOW)\n- TIBC: 220 \u00b5g/dL (LOW) - normally elevated in iron deficiency\n- Transferrin saturation: 16% (low-normal)\n- **Ferritin: 185 ng/mL (HIGH)** - normally low in iron deficiency\n\n**Inflammatory markers:**\n- ESR: 45 mm/hr (elevated)\n- CRP: 1.8 mg/dL (elevated)\n\n**The iron studies paradox:**\nThis patient has LOW serum iron but HIGH ferritin. How do you explain this?", "question": "What is the most likely diagnosis for this patient's anemia?", "choices": [{"id": "node-1-choice-a", "text": "Anemia of chronic disease (anemia of inflammation)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **anemia of chronic disease (ACD)**, also called anemia of inflammation. The key to diagnosis is the **iron studies pattern**: LOW serum iron + LOW TIBC + HIGH ferritin. This paradoxical pattern occurs because: (1) **Hepcidin** (the master iron regulator) is elevated in chronic inflammation, (2) Hepcidin blocks iron absorption from the gut AND traps iron in macrophages, (3) Iron is PRESENT in the body (high ferritin = adequate stores) but SEQUESTERED and unavailable for erythropoiesis, (4) TIBC is low because the liver decreases transferrin production during inflammation.", "consequence": "You correctly identify the mechanism and proceed to management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Iron deficiency anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Iron deficiency anemia** shows a DIFFERENT iron study pattern: LOW serum iron + HIGH TIBC + LOW ferritin. The body responds to true iron deficiency by increasing transferrin (TIBC) to capture more iron, and ferritin drops because stores are depleted. This patient has the OPPOSITE ferritin finding (HIGH ferritin = adequate iron stores). The iron is present but sequestered due to inflammation - this is anemia of chronic disease, not iron deficiency.", "consequence": "Misdiagnosis would lead to inappropriate iron supplementation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Methotrexate-induced bone marrow suppression", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct consideration, but not the best answer. Methotrexate CAN cause bone marrow suppression (typically affecting all cell lines - pancytopenia), but this patient has isolated anemia with normal WBC and platelets. More importantly, the **iron studies pattern** (low iron, low TIBC, high ferritin) is classic for anemia of chronic disease and directly explains the anemia. While methotrexate toxicity should always be considered, the lab pattern here points to ACD.", "consequence": "Important to consider but iron studies point to ACD.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Thalassemia trait", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Thalassemia trait** causes microcytic anemia but with a DIFFERENT pattern: (1) Very low MCV relative to mild anemia (MCV often <70 with Hgb ~10-11), (2) Elevated RBC count (not low), (3) **Normal iron studies** - serum iron, TIBC, and ferritin are all normal, (4) Elevated HbA2 on hemoglobin electrophoresis (beta-thal trait). This patient has abnormal iron studies (low iron, low TIBC, HIGH ferritin) which is inconsistent with thalassemia and classic for ACD.", "consequence": "Iron studies are inconsistent with thalassemia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Mixed iron deficiency and anemia of chronic disease", "isOptimal": false, "isAcceptable": true, "feedback": "This is a reasonable consideration since ACD and iron deficiency CAN coexist, making diagnosis challenging. In mixed states, ferritin may be \"falsely normal\" (elevated by inflammation but depleted stores). However, this patient's **ferritin of 185 ng/mL is clearly elevated**, making pure ACD more likely than a mixed picture. A ferritin <30-50 ng/mL in the setting of inflammation would suggest coexisting iron deficiency. Some use soluble transferrin receptor (sTfR) to distinguish: elevated in iron deficiency, normal in pure ACD.", "consequence": "Possible but ferritin level suggests pure ACD.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**The ferritin tells the story**: HIGH ferritin + LOW serum iron = ACD (iron is present but sequestered). LOW ferritin + LOW serum iron = true iron deficiency (stores depleted). TIBC is HIGH in iron deficiency (body trying to capture iron) but LOW in ACD (inflammation suppresses transferrin)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose anemia of chronic disease in the setting of JIA.\n\n**Understanding the pathophysiology (hepcidin-mediated):**\n\n**Hepcidin** is the master regulator of iron homeostasis:\n- Produced by the liver in response to **inflammation (IL-6)** and iron excess\n- Binds to **ferroportin** (iron exporter) on enterocytes and macrophages\n- Causes ferroportin degradation \u2192 iron TRAPPED inside cells\n\n**Result of elevated hepcidin:**\n1. **Decreased iron absorption** from the gut\n2. **Iron sequestration** in macrophages (iron can't get out)\n3. **Functional iron deficiency** - iron present but unavailable for RBC production\n4. This is actually a **host defense mechanism** - depriving pathogens of iron", "question": "What is the most appropriate treatment approach for this patient's anemia?", "choices": [{"id": "node-2-choice-a", "text": "Optimize treatment of underlying JIA to reduce inflammation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **primary treatment for ACD is treating the underlying inflammatory condition**. When inflammation decreases: (1) IL-6 levels drop, (2) Hepcidin production decreases, (3) Ferroportin is no longer degraded, (4) Iron is released from macrophages and becomes available for erythropoiesis, (5) Anemia improves. In this JIA patient, optimizing disease control (adjusting methotrexate, adding biologics if needed) will improve the anemia. Iron supplementation is NOT the answer since iron stores are adequate.", "consequence": "You correctly identify that controlling inflammation is the key treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start oral iron supplementation (ferrous sulfate)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oral iron will NOT work in ACD**. Here's why: (1) The problem is NOT lack of iron - stores are adequate (ferritin is HIGH), (2) Elevated hepcidin BLOCKS iron absorption from the gut by degrading ferroportin on enterocytes, (3) Even if some iron is absorbed, it will be sequestered in macrophages, (4) Oral iron may cause GI side effects without benefit. The body has iron; it just can't use it because of the inflammatory block. Treating the underlying inflammation is the solution.", "consequence": "Oral iron is ineffective when hepcidin is elevated - it won't be absorbed.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Administer IV iron infusion to bypass absorption issues", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While IV iron bypasses the gut absorption block, it does NOT solve the fundamental problem. The iron will still be **sequestered in macrophages** due to elevated hepcidin - it won't be available for erythropoiesis. IV iron is only helpful in ACD if there is **concomitant true iron deficiency** (low ferritin despite inflammation). This patient has high ferritin indicating adequate stores; adding more iron won't help and may cause iron overload.", "consequence": "IV iron adds to sequestered stores without improving erythropoiesis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Start erythropoiesis-stimulating agent (ESA) such as epoetin", "isOptimal": false, "isAcceptable": true, "feedback": "This can be considered but is NOT first-line for ACD in a child with JIA. **ESAs** (erythropoietin) may help in ACD by overcoming the relative EPO deficiency that occurs with inflammation. However: (1) ESAs are expensive and require injections, (2) They work best when combined with iron availability, (3) **First-line treatment is still controlling the underlying disease**. ESAs are typically reserved for severe symptomatic anemia unresponsive to disease control, particularly in chronic kidney disease-associated anemia.", "consequence": "ESAs can help but are not first-line - treat underlying inflammation first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Blood transfusion to correct the anemia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is over-treatment. Hemoglobin of 9.8 g/dL is mild anemia and does NOT warrant transfusion. Transfusion is reserved for **severe symptomatic anemia** (typically Hgb <7 g/dL, or higher threshold with cardiovascular symptoms). Transfusion has risks (infection, alloimmunization, iron overload) and does not address the underlying cause. The anemia will recur without treating the inflammation. Optimize JIA management first.", "consequence": "Transfusion is over-treatment for mild anemia and doesn't address the cause.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Oral iron doesn't work in ACD** - hepcidin blocks absorption. IV iron adds to sequestered stores without helping. The ONLY effective treatment is **reducing inflammation** (treat the underlying disease). ESAs are second-line for severe cases."}, "node-3": {"id": "node-3", "type": "decision", "content": "You decide to optimize JIA management. After discussion with rheumatology, the decision is made to add a biologic agent (adalimumab) to her regimen to better control inflammation.\n\n**Three months later:**\n- Patient reports improved energy\n- Joint symptoms well-controlled\n- Repeat labs: Hgb 11.5 g/dL (improved), ESR 12 mm/hr (normalized), ferritin 95 ng/mL (decreasing toward normal)\n\n**The parents ask about preventing anemia in the future and whether their daughter should take iron supplements.**", "question": "What is the most appropriate advice regarding iron supplementation and monitoring?", "choices": [{"id": "node-3-choice-a", "text": "No routine iron supplementation; monitor hemoglobin with disease flares; iron only if true deficiency develops", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Routine iron supplementation is NOT indicated** in ACD when iron stores are adequate. Key points: (1) Continue monitoring CBC periodically and during disease flares, (2) Anemia may recur if JIA flares - this indicates need for better disease control, not iron, (3) Iron supplementation is only needed if **true iron deficiency develops** (low ferritin, high TIBC) - which can occur from dietary insufficiency, blood loss, or growth demands, (4) In chronic inflammatory conditions, ferritin <50-100 ng/mL may indicate coexisting iron deficiency requiring supplementation.", "consequence": "You provide appropriate guidance on monitoring and avoiding unnecessary iron.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Start daily prophylactic iron to prevent anemia recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic iron is not indicated** when stores are adequate (ferritin normal/elevated). Unnecessary iron supplementation in ACD: (1) Won't prevent anemia recurrence (the issue is inflammation, not iron deficiency), (2) May cause GI side effects (constipation, nausea), (3) Could contribute to iron overload over time, (4) Excess iron may actually worsen inflammation in some settings. The key to preventing anemia is maintaining good disease control, not taking iron.", "consequence": "Unnecessary iron supplementation with no benefit and potential harm.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Check iron studies only if hemoglobin drops below 8 g/dL", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this threshold is too low. By the time hemoglobin reaches 8 g/dL, the anemia is moderate-severe and causing symptoms. **Proactive monitoring** is better: (1) Check CBC periodically (every 3-6 months) and during disease flares, (2) Check iron studies if anemia develops or worsens - BEFORE it becomes severe, (3) Early detection allows you to distinguish ACD (treat inflammation) from true iron deficiency (supplement iron). Waiting until Hgb <8 delays appropriate intervention.", "consequence": "Delayed evaluation misses opportunity for early intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Recommend routine hematology follow-up for chronic anemia management", "isOptimal": false, "isAcceptable": true, "feedback": "This is not wrong but is typically unnecessary for ACD in well-controlled JIA. **Hematology referral** should be considered for: (1) Severe anemia (Hgb <8 g/dL) not responding to disease control, (2) Diagnostic uncertainty (mixed ACD/iron deficiency, other causes), (3) Need for ESA therapy, (4) Suspected hemolysis or bone marrow pathology. For straightforward ACD that improves with disease control, the rheumatologist and pediatrician can manage monitoring without routine hematology involvement.", "consequence": "May be helpful but not routinely necessary for well-controlled ACD.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Advise high-iron diet (red meat, fortified cereals) to boost iron stores", "isOptimal": false, "isAcceptable": true, "feedback": "A balanced diet with adequate iron is always reasonable advice, but this patient does NOT have iron deficiency - her stores are adequate (ferritin was elevated). Dietary iron recommendations are more important for: (1) True iron deficiency, (2) Periods of rapid growth, (3) Adolescent females with menstrual losses. In ACD with adequate stores, dietary iron intake won't significantly impact the anemia - the problem is iron sequestration from inflammation, not dietary insufficiency.", "consequence": "Good general advice but won't address ACD mechanism.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ACD resolves when inflammation resolves**. Monitor for anemia during disease flares (indicates need for better disease control, not iron). Only supplement iron if TRUE deficiency develops (ferritin <50-100 in inflammatory states). In children with chronic illness, consider mixed ACD + iron deficiency if ferritin is not clearly elevated."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified anemia of chronic disease based on the classic iron study pattern (low iron, low TIBC, HIGH ferritin), understood the hepcidin-mediated pathophysiology, and appropriately treated by optimizing control of the underlying inflammatory condition.\n\n**Key teaching points:**\n- **ACD iron studies**: LOW serum iron + LOW TIBC + HIGH ferritin (iron present but sequestered)\n- **IDA iron studies**: LOW serum iron + HIGH TIBC + LOW ferritin (true iron depletion)\n- **Hepcidin** is the key mediator - elevated in inflammation, blocks iron release\n- **Treatment**: Control underlying inflammation - oral iron WON'T work (blocked absorption and sequestration)\n- **Monitor** for anemia during disease flares; iron only if true deficiency develops\n\n**Prognosis**: Anemia improves when inflammation is controlled. This patient's hemoglobin normalized with better JIA management."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key concepts of anemia of chronic disease:\n\n**Iron study patterns:**\n- ACD: LOW iron + LOW TIBC + HIGH ferritin\n- IDA: LOW iron + HIGH TIBC + LOW ferritin\n- Ferritin is the KEY differentiator\n\n**Pathophysiology:**\n- Inflammation \u2192 IL-6 \u2192 increased hepcidin\n- Hepcidin degrades ferroportin \u2192 iron trapped in macrophages\n- Functional iron deficiency despite adequate stores\n\n**Treatment:**\n- Primary: Treat underlying inflammatory condition\n- Oral iron is INEFFECTIVE (hepcidin blocks absorption)\n- ESAs are second-line for severe cases"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates anemia of chronic disease (ACD):\n\n**The ferritin paradox:**\n- LOW serum iron (looks like iron deficiency)\n- But HIGH ferritin (adequate iron stores!)\n- The problem is SEQUESTRATION, not deficiency\n\n**Why iron supplementation fails:**\n- Elevated hepcidin BLOCKS gut iron absorption\n- Even IV iron gets sequestered in macrophages\n- You can't out-supplement the inflammatory block\n\n**The only effective treatment:**\n- Control the underlying inflammatory disease\n- When inflammation decreases \u2192 hepcidin decreases \u2192 iron released \u2192 anemia improves\n\n**Remember**: High ferritin = adequate stores. Don't give iron to someone who has enough!"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-145", "title": "G6PD Deficiency", "domain": "heme_onc", "difficulty": "advanced", "tags": ["G6PD deficiency", "glucose-6-phosphate dehydrogenase", "hemolytic anemia", "bite cells", "Heinz bodies", "X-linked", "Mediterranean descent", "oxidative stress", "fava beans", "sulfonamides", "drug-induced hemolysis"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 4-year-old male presents with yellow eyes and dark urine for 2 days.\n\nThe patient's mother reports, his parents noticed his eyes turned yellow and his urine has been very dark. He was given an antibiotic 4 days ago for a urinary tract infection.\n\nfatigue and pallor. No abdominal pain or fever.\n\nPertinent history includes He is of Mediterranean descent. No prior episodes of jaundice.\n\nPhysical Examination:\n- General: pale, jaundiced child with icteric sclerae.\n- Vitals: tachycardia.\n- Labs: CBC: Hgb low (anemia).\n- Abdomen: mild splenomegaly.\n- Cardiovascular: tachycardia with flow murmur.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 4-year-old male of Mediterranean descent presents with acute jaundice, dark urine, and pallor 4 days after starting an antibiotic. Key findings: icteric sclerae, tachycardia (compensatory), mild splenomegaly, and flow murmur (from anemia). The antibiotic trigger and ethnic background are highly suggestive.", "question": "What is the MOST characteristic peripheral blood smear finding in G6PD deficiency during an acute hemolytic episode?", "choices": [{"id": "node-1-choice-a", "text": "Bite cells and Heinz bodies", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bite cells** (degmacytes) are RBCs that appear as if a 'bite' has been taken out - this occurs when splenic macrophages remove **Heinz bodies** (denatured hemoglobin precipitates). **Heinz bodies** require **supravital staining** (crystal violet or methylene blue) to visualize and represent oxidized, denatured hemoglobin. These findings are pathognomonic for oxidative hemolysis in G6PD deficiency.", "consequence": "You correctly identify the diagnostic smear findings.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Spherocytes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Spherocytes** are characteristic of **hereditary spherocytosis** or **autoimmune hemolytic anemia** (AIHA), not G6PD deficiency. In hereditary spherocytosis, RBCs lose membrane surface area and become spherical. In AIHA, antibody-coated cells are partially phagocytosed, also creating spherocytes. G6PD shows **bite cells and Heinz bodies** from oxidative damage.", "consequence": "Wrong smear finding - consider alternative diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Schistocytes (helmet cells)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Schistocytes** (fragmented RBCs) indicate **microangiopathic hemolytic anemia** (MAHA) - seen in HUS, TTP, DIC, or mechanical heart valve destruction. In G6PD, RBCs are damaged by **oxidative stress**, not mechanical shearing. Look for **bite cells and Heinz bodies**.", "consequence": "Wrong mechanism of hemolysis considered.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Sickle cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sickle cells** are pathognomonic for **sickle cell disease**, where abnormal hemoglobin S polymerizes under low oxygen tension, causing RBCs to assume a crescent shape. G6PD deficiency involves **oxidative damage** to normal hemoglobin, producing **bite cells and Heinz bodies**, not sickling.", "consequence": "Wrong hemoglobinopathy considered.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Target cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Target cells** (codocytes) have a 'bullseye' appearance and are seen in **thalassemia, liver disease, hemoglobin C disease**, and post-splenectomy. They result from excess membrane relative to hemoglobin content. G6PD deficiency shows **bite cells and Heinz bodies** from oxidative damage.", "consequence": "Wrong smear finding considered.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**G6PD deficiency** is the most common human enzyme deficiency (~400 million affected worldwide). It's **X-linked recessive**, so primarily affects **males**. The enzyme protects RBCs from oxidative stress by regenerating **NADPH** (needed for glutathione reduction). Without G6PD, oxidants cause hemoglobin to denature into **Heinz bodies**, which are 'bitten' out by the spleen, creating **bite cells**."}, "node-2": {"id": "node-2", "type": "decision", "content": "Labs confirm hemolysis: Hgb 6.8 g/dL (low), reticulocytes 8% (elevated), LDH elevated, haptoglobin low, indirect bilirubin elevated. Peripheral smear shows bite cells. Coombs test is negative. You suspect G6PD deficiency triggered by the antibiotic (likely TMP-SMX or nitrofurantoin).", "question": "What is the MOST important principle regarding G6PD enzyme level testing during an acute hemolytic episode?", "choices": [{"id": "node-2-choice-a", "text": "G6PD levels may be falsely NORMAL during acute hemolysis; test 2-3 months after crisis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! During acute hemolysis, the **oldest, most G6PD-deficient RBCs are preferentially destroyed**. The remaining young RBCs (reticulocytes) have **higher G6PD activity**, causing **falsely normal** enzyme levels. Wait **2-3 months** after the acute episode for accurate testing when the RBC population normalizes. This is a classic board question pitfall!", "consequence": "You understand the testing limitation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "G6PD levels should be tested immediately for accurate results", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Testing during acute hemolysis gives FALSELY NORMAL results**. The oldest RBCs with the lowest G6PD levels are destroyed first. The remaining young RBCs (reticulocytes) and newly produced cells have higher enzyme activity, masking the deficiency. Test **2-3 months after the crisis** for accurate diagnosis.", "consequence": "May miss the diagnosis due to false negative result.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "G6PD levels are always low regardless of timing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. G6PD levels **vary with RBC age** - young RBCs have higher enzyme activity. During acute hemolysis, preferential destruction of old, G6PD-deficient cells leaves a population of young cells with **near-normal enzyme levels**. Timing of testing is crucial - wait 2-3 months post-crisis.", "consequence": "Misunderstanding of enzyme kinetics.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Genetic testing replaces enzyme level testing entirely", "isOptimal": false, "isAcceptable": true, "feedback": "Genetic testing **can** confirm G6PD deficiency but is not routinely first-line in most settings. It's useful when enzyme testing is inconclusive, for carrier detection in females, or to identify specific variants. However, understanding that **enzyme levels are falsely normal during crisis** remains important for interpreting any testing.", "consequence": "Acceptable but doesn't address the acute testing issue.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "G6PD testing is unnecessary if peripheral smear shows Heinz bodies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **Heinz bodies strongly suggest G6PD deficiency**, confirmatory testing is important for: (1) Definitive diagnosis, (2) Family counseling (X-linked inheritance), (3) Identifying the specific G6PD variant (some are more severe). The smear finding supports the diagnosis but doesn't replace enzyme testing.", "consequence": "Incomplete diagnostic approach.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**G6PD enzyme activity decreases with RBC age**. During hemolysis, the oldest (most deficient) cells are destroyed first, leaving young cells with **near-normal G6PD levels**. This causes **false-negative testing** during crisis. Repeat testing **2-3 months later** when the RBC population equilibrates. In females (X-linked carriers), levels may be intermediate due to **random X-inactivation**."}, "node-3": {"id": "node-3", "type": "decision", "content": "You discontinue the offending antibiotic (TMP-SMX) and initiate supportive care. The child's hemoglobin is 6.8 g/dL with ongoing hemolysis signs. He is tachycardic but hemodynamically stable.", "question": "What is the MOST appropriate management for this child's acute hemolytic episode?", "choices": [{"id": "node-3-choice-a", "text": "Supportive care, IV fluids, monitor closely; transfuse if hemoglobin drops below 7 g/dL or symptomatic", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Management of G6PD hemolytic crisis is primarily **supportive**: (1) **Remove the oxidative trigger** (already done), (2) **IV hydration** to prevent renal damage from hemoglobinuria, (3) **Monitor hemoglobin closely** (hemolysis may continue 7-10 days), (4) **Transfuse** if Hgb <7 g/dL or symptomatic anemia (severe fatigue, dyspnea, chest pain, cardiovascular instability). This child is borderline - close monitoring is appropriate.", "consequence": "Appropriate supportive management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immediate exchange transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Exchange transfusion** is reserved for **severe, life-threatening hemolysis** with cardiovascular compromise or hemoglobin <5 g/dL. This child is stable with Hgb 6.8. Standard supportive care with possible simple transfusion is appropriate. Exchange transfusion is used in conditions like severe sickle cell crisis or severe AIHA.", "consequence": "Overly aggressive intervention for stable patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Start high-dose corticosteroids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Corticosteroids are NOT effective** in G6PD deficiency because it's an **intrinsic RBC enzyme defect**, not immune-mediated. Steroids are used in **autoimmune hemolytic anemia (AIHA)** where antibodies target RBCs. The negative Coombs test rules out AIHA in this case.", "consequence": "Inappropriate treatment for non-immune hemolysis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Splenectomy consultation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Splenectomy has NO role** in G6PD deficiency management. Unlike **hereditary spherocytosis** (where splenectomy is curative) or refractory AIHA, G6PD hemolysis is **episodic and self-limiting** once triggers are removed. The spleen is not the primary site of RBC destruction in G6PD crisis.", "consequence": "Inappropriate surgical consideration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Restart a different antibiotic class immediately", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **priority is stopping hemolysis**, not treating the original infection. If the UTI still requires treatment, choose a **G6PD-safe antibiotic** (cephalosporins, penicillins are generally safe) AFTER hemolysis stabilizes. Many G6PD patients can safely take most antibiotics - only specific oxidants are triggers.", "consequence": "Premature focus on infection before stabilizing hemolysis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**G6PD hemolytic crisis management**: (1) **Remove trigger** (drugs, fava beans, treat infection), (2) **IV hydration** (prevents pigment nephropathy from hemoglobinuria), (3) **Monitor Hgb** q6-12h initially, (4) **Transfuse PRBCs** if Hgb <7 or symptomatic. Hemolysis is **self-limited** (7-10 days) once trigger removed. **Folate supplementation** helps support increased RBC production."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child is stabilized with supportive care and ultimately receives one unit of PRBCs when his hemoglobin drops to 6.2 g/dL. Hemolysis resolves over the next week. You're now counseling the family about long-term management and prevention.", "question": "Which of the following is the MOST important counseling point for preventing future hemolytic episodes?", "choices": [{"id": "node-4-choice-a", "text": "Provide a list of medications and foods to avoid (oxidative triggers)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Trigger avoidance** is the cornerstone of G6PD management. Key triggers to avoid: **Medications** - Sulfonamides (TMP-SMX), Nitrofurantoin, Primaquine, Dapsone, Methylene blue, high-dose aspirin. **Foods** - Fava beans (favism). **Situations** - Certain infections can trigger hemolysis (viral, bacterial). Families should carry a **G6PD card** listing unsafe medications and inform all healthcare providers.", "consequence": "Comprehensive education for prevention.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Start prophylactic folic acid and iron supplementation", "isOptimal": false, "isAcceptable": true, "feedback": "**Folic acid** supplementation can help during recovery from hemolysis when RBC production is increased. However, **iron supplementation is NOT routinely needed** and may be harmful - G6PD patients often have adequate iron stores (iron is released during hemolysis). **Trigger avoidance** is more important than supplements for prevention.", "consequence": "Supportive measure but not the key preventive strategy.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Schedule prophylactic monthly blood transfusions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic transfusions are NOT indicated** in G6PD deficiency. Between episodes, patients have **normal hemoglobin** and normal RBC survival. This contrasts with **thalassemia major** or severe **sickle cell disease** where chronic transfusion programs prevent complications. G6PD only requires transfusion during acute crises.", "consequence": "Inappropriate chronic transfusion protocol.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Recommend splenectomy to prevent future episodes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Splenectomy has NO role** in G6PD deficiency. Hemolysis is **episodic and triggered by oxidative stress**, not chronic splenic sequestration. Between episodes, RBC survival is normal. Splenectomy is beneficial in **hereditary spherocytosis** (where the spleen destroys abnormal spherocytes) but not in G6PD.", "consequence": "Inappropriate surgical recommendation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Advise genetic testing for all family members before prescribing any antibiotics", "isOptimal": false, "isAcceptable": true, "feedback": "Testing **male relatives** (brothers, maternal uncles) is reasonable given X-linked inheritance. However, routine testing before ANY antibiotic is excessive - most antibiotics are safe in G6PD. **Selective avoidance** of known triggers (sulfonamides, nitrofurantoin) is sufficient. A list of unsafe medications is more practical than universal genetic screening.", "consequence": "Overly cautious approach; trigger list is more practical.", "nextNodeId": "node-outcome-good"}], "clinicalPearl": "**G6PD trigger avoidance list** (mnemonic: **'Fava Sulfa Nitro Prime'**): **Fava beans**, **Sulfonamides** (TMP-SMX), **Nitrofurantoin**, **Primaquine/Chloroquine**. Also: Dapsone, Methylene blue, Naphthalene (mothballs), high-dose vitamin C. Most common antibiotics (penicillins, cephalosporins, macrolides) are SAFE. Infections themselves can trigger hemolysis - treat promptly with G6PD-safe antibiotics."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed G6PD deficiency in this 4-year-old male of Mediterranean descent with acute hemolysis following antibiotic exposure. You recognized bite cells and Heinz bodies as pathognomonic findings, understood that G6PD levels may be falsely normal during crisis (test 2-3 months later), provided appropriate supportive care with transfusion threshold, and counseled the family on trigger avoidance. Key teaching points: (1) G6PD is X-linked - affects males, (2) Bite cells + Heinz bodies on smear, (3) Test enzyme levels AFTER crisis, (4) Treatment is supportive + trigger removal, (5) Prevention = medication/food avoidance list."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review G6PD deficiency key points: (1) X-linked recessive - primarily affects males, (2) Mediterranean, African, Asian descent at highest risk, (3) Triggers: Fava beans, Sulfa drugs, Nitrofurantoin, Primaquine, infections, (4) Smear: BITE CELLS + HEINZ BODIES (supravital stain), (5) G6PD levels falsely normal during crisis - test 2-3 months later, (6) Treatment: supportive care, remove trigger, transfuse if severe, (7) Prevention: medication/food avoidance list."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical errors in G6PD management: (1) Steroids do NOT work - this is intrinsic RBC defect, not immune-mediated, (2) Splenectomy has NO role - hemolysis is episodic from oxidative triggers, not chronic, (3) Prophylactic transfusions are NOT needed - patients are normal between episodes. Remember: G6PD deficiency is MANAGED, not cured. Trigger avoidance is the cornerstone of prevention. Most patients live normal lives with appropriate education."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-150", "title": "Hereditary Spherocytosis", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["spherocytes", "negative Coombs", "elevated MCHC", "splenomegaly", "family history of splenectomy"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 7-year-old male is brought in by his parents for jaundice and fatigue for 1 week.\n\nSubjectively, he has been more tired than usual and his parents noticed his eyes and skin look yellow. He had a cold last week. He has had similar episodes before.\n\ndark urine and pallor. No fever or abdominal pain.\n\nPast medical history includes He has a history of neonatal jaundice that required phototherapy. His father had his spleen removed as a teenager for \"blood problems\".\n\nPhysical Examination:\n- Skin: jaundice, pallor.\n- Abdomen: splenomegaly.\n- General: tired-appearing child but in no acute distress.\n- Labs: CBC: Hgb low (anemia).\n- Sclera: icteric.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 7-year-old has recurrent episodes of **jaundice + anemia + splenomegaly** triggered by viral illness. Family history reveals father had splenectomy for \"blood problems.\" Labs show **elevated MCHC** and reticulocytosis. He had **neonatal hyperbilirubinemia** requiring phototherapy.", "question": "What peripheral blood smear finding would CONFIRM the suspected diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Spherocytes - small, round RBCs lacking central pallor", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Spherocytes** (small, dense, round RBCs without central pallor) are pathognomonic for **hereditary spherocytosis**. The defective spectrin/ankyrin membrane proteins cause loss of membrane surface area, creating rigid spherical cells that are destroyed in the spleen. **MCHC is elevated >36 g/dL** because cells are smaller but hemoglobin concentration is preserved.", "consequence": "You identify the classic smear finding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bite cells and Heinz bodies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Bite cells** (from splenic macrophages removing Heinz bodies) and **Heinz bodies** (denatured hemoglobin on supravital stain) are seen in **G6PD deficiency**, an X-linked enzyme defect causing oxidative hemolysis. The family history and chronic pattern don't fit G6PD.", "consequence": "This suggests G6PD deficiency.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Sickle cells and target cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Sickle cells** (crescent-shaped) are seen in **sickle cell disease**. This child has no history of vaso-occlusive crises and his ethnicity isn't mentioned as African descent. The elevated MCHC and spherocytes point to hereditary spherocytosis.", "consequence": "This suggests sickle cell disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Schistocytes and helmet cells", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Schistocytes** (fragmented RBCs) indicate **microangiopathic hemolytic anemia** (MAHA) - seen in HUS, TTP, DIC. This child has a chronic, familial pattern of hemolysis without thrombocytopenia or renal failure.", "consequence": "Schistocytes indicate MAHA.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Target cells with microcytosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Target cells with microcytosis** suggest **thalassemia** or hemoglobin C disease. Hereditary spherocytosis causes **normocytic** (or slightly microcytic) anemia with elevated MCHC, not the low MCHC seen in thalassemia.", "consequence": "Target cells suggest thalassemia.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Hereditary spherocytosis labs**: **Spherocytes** on smear, **elevated MCHC >36** (concentrated cells), **elevated reticulocytes**, **negative direct Coombs** (distinguishes from autoimmune hemolysis). Confirmatory: **EMA binding test** (decreased fluorescence) has replaced osmotic fragility test."}, "node-2": {"id": "node-2", "type": "decision", "content": "Labs confirm hereditary spherocytosis: **spherocytes** on smear, **MCHC 38 g/dL** (elevated), **reticulocytes 12%** (elevated), **direct Coombs negative**. The child currently has **Hgb 7.5 g/dL** with jaundice during this viral illness-triggered crisis.", "question": "What type of crisis is this child experiencing, and what triggers it?", "choices": [{"id": "node-2-choice-a", "text": "Hemolytic crisis - triggered by viral illness accelerating baseline hemolysis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **hemolytic crisis** - viral infections (especially EBV, CMV) can accelerate the already-increased baseline hemolysis, causing acute drops in hemoglobin with increased jaundice and reticulocytosis. Treatment is supportive; transfusion if symptomatic.", "consequence": "You identify the crisis type.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Aplastic crisis - Parvovirus B19 destroying RBC precursors", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this case! **Aplastic crisis** (from **Parvovirus B19**) causes severe anemia with **LOW reticulocyte count** (the virus destroys erythroid precursors). This child has **elevated reticulocytes (12%)**, indicating bone marrow is responding - this is hemolytic crisis, not aplastic crisis.", "consequence": "Aplastic crisis has LOW reticulocytes.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Sequestration crisis - pooling of RBCs in enlarged spleen", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Splenic sequestration crisis** is primarily seen in **sickle cell disease** (NOT hereditary spherocytosis), where sickled cells pool in the spleen causing acute splenomegaly and hemodynamic instability. While HS patients have chronic splenomegaly, acute sequestration crisis is not typical.", "consequence": "Sequestration crisis is a sickle cell phenomenon.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Megaloblastic crisis - folate deficiency from chronic hemolysis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this acute presentation! **Megaloblastic crisis** occurs when chronic hemolysis depletes folate stores, causing macrocytic anemia with hypersegmented neutrophils. This child's acute illness-triggered hemolysis with elevated reticulocytes is more consistent with hemolytic crisis. However, HS patients should take prophylactic folic acid.", "consequence": "Megaloblastic crisis is from chronic folate depletion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Vaso-occlusive crisis - painful sickle cell crisis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Vaso-occlusive crises** occur in **sickle cell disease**, NOT hereditary spherocytosis. HS does not cause sickling or vaso-occlusion. This child has no bone pain or dactylitis. The spherocytes in HS are destroyed in the spleen, not causing vascular occlusion.", "consequence": "VOC is a sickle cell phenomenon.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Crises in hereditary spherocytosis**: (1) **Hemolytic crisis** - viral illness triggers \u2191hemolysis, \u2191reticulocytes, \u2191jaundice. (2) **Aplastic crisis** - **Parvovirus B19** destroys RBC precursors, \u2193\u2193reticulocytes, severe anemia (EMERGENCY). (3) **Megaloblastic crisis** - folate depletion from chronic hemolysis. Prevention: **folic acid 1 mg/day** prophylaxis."}, "node-3": {"id": "node-3", "type": "decision", "content": "This hemolytic crisis is managed supportively with monitoring. At **age 8**, after multiple hospitalizations for hemolytic crises and development of **pigment gallstones**, the family asks about **splenectomy**.", "question": "What are the indications and important considerations for splenectomy in hereditary spherocytosis?", "choices": [{"id": "node-3-choice-a", "text": "Indicated for severe HS or complications; delay until age 6+ and vaccinate first", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Splenectomy is curative** (stops hemolysis and anemia) because the spleen is where spherocytes are destroyed. **Indications**: severe anemia, growth failure, symptomatic gallstones, frequent transfusions. **Timing**: delay until **age 6+** (preferably >6) to reduce infection risk. **Pre-splenectomy vaccinations**: pneumococcal, meningococcal, H. influenzae type b (at least 2 weeks before).", "consequence": "You understand splenectomy indications and timing.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Splenectomy should be done in infancy for all HS patients", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Splenectomy is NOT indicated for all HS patients** and should NOT be done in infancy. Many patients have mild disease managed with folic acid and observation. Early splenectomy (<6 years) carries higher risk of **overwhelming post-splenectomy infection (OPSI)** - potentially fatal sepsis from encapsulated organisms.", "consequence": "Early splenectomy increases OPSI risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Partial splenectomy is preferred to avoid infection risk", "isOptimal": false, "isAcceptable": true, "feedback": "**Partial splenectomy** (or subtotal) is an option that preserves some splenic function while reducing hemolysis. It may be considered in **young children** or **mild-moderate HS** to balance hemolysis control with infection protection. However, hemolysis may recur if splenic remnant enlarges. Total splenectomy is more definitive.", "consequence": "Partial splenectomy is an alternative approach.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Bone marrow transplant is the only curative option", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Splenectomy is curative** for hereditary spherocytosis - it eliminates hemolysis because the spleen is where spherocytes are destroyed. Bone marrow transplant is NOT indicated for HS (unlike thalassemia major or sickle cell disease where the bone marrow produces abnormal hemoglobin).", "consequence": "BMT is not needed - splenectomy is curative.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Splenectomy is contraindicated due to infection risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While OPSI is a real risk, splenectomy is appropriate for **severe HS with significant complications**. The risk is mitigated by: **waiting until age 6+**, **pre-operative vaccinations**, **prophylactic penicillin** post-splenectomy, and **patient education** about fever protocols.", "consequence": "Splenectomy is appropriate with proper precautions.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Splenectomy in HS**: Wait until **age 6+**, give vaccines **2+ weeks before** (pneumococcal, meningococcal, Hib). Post-splenectomy: **prophylactic penicillin** (at least until adulthood), **fever protocol** education (any fever = immediate medical evaluation for OPSI). Consider **laparoscopic cholecystectomy** if gallstones present."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient undergoes laparoscopic splenectomy (with cholecystectomy for gallstones) at age 9 after completing vaccinations. Post-operatively, the parents ask about long-term care and what to watch for.", "question": "What is the MOST important complication to counsel the family about after splenectomy?", "choices": [{"id": "node-4-choice-a", "text": "Overwhelming post-splenectomy infection (OPSI) - any fever needs urgent evaluation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **OPSI** is a life-threatening fulminant sepsis (usually from **encapsulated organisms** - Strep pneumoniae, H. influenzae, N. meningitidis) that can progress from mild fever to death within hours. **Prevention**: prophylactic penicillin (recommended at least through adolescence), medical alert bracelet, urgent evaluation for ANY fever. Lifetime risk ~5%, higher in younger children.", "consequence": "Essential counseling for post-splenectomy patients.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Recurrence of hemolysis from accessory spleen", "isOptimal": false, "isAcceptable": true, "feedback": "**Accessory spleens** (present in ~15-30% of people) can hypertrophy after splenectomy and cause recurrent hemolysis. If hemolysis recurs post-splenectomy, evaluate for accessory spleen with nuclear medicine scan. However, **OPSI** is the most critical counseling point due to its life-threatening nature.", "consequence": "Accessory spleen is possible but OPSI is more critical.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Thrombocytosis - high platelets cause stroke risk", "isOptimal": false, "isAcceptable": true, "feedback": "**Post-splenectomy thrombocytosis** is common (platelets can exceed 1 million initially) but usually self-limited and rarely causes thrombotic complications in children. Anti-platelet therapy is not routinely indicated unless extremely elevated with symptoms. **OPSI** remains the primary concern.", "consequence": "Thrombocytosis usually resolves - OPSI is priority.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-d", "text": "Lifelong anemia requiring monthly transfusions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Splenectomy CURES the anemia** in HS because the spleen is where spherocytes are destroyed. Post-splenectomy, hemoglobin normalizes and patients no longer have chronic hemolysis. Spherocytes remain on smear but are no longer clinically significant.", "consequence": "Splenectomy cures anemia - no transfusions needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "No special precautions needed after complete recovery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Asplenic patients require lifelong precautions**: prophylactic penicillin, medical alert identification, urgent fever evaluation, and updated vaccinations (including yearly flu vaccine). OPSI can occur **decades** after splenectomy. Education is essential.", "consequence": "Asplenic patients need lifelong precautions.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Post-splenectomy care**: **Prophylactic penicillin** (penicillin V 250mg BID or amoxicillin) - at minimum through adolescence, many recommend lifelong. **Vaccinations** current (annual flu, pneumococcal booster q5 years). **Medical alert** bracelet/card. **Fever protocol**: ANY fever (\u2265101\u00b0F) = seek immediate medical attention for blood cultures and empiric IV antibiotics covering encapsulated organisms."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **hereditary spherocytosis**. Key learning points: 1) **Spherocytes + negative Coombs + elevated MCHC + family history** = HS. 2) **Crises**: hemolytic (viral trigger, high retics), aplastic (Parvo B19, LOW retics - emergency), megaloblastic (folate depletion). 3) **Splenectomy is curative** but delay until age 6+ and vaccinate 2+ weeks before. 4) **Post-splenectomy**: prophylactic penicillin, fever protocol (OPSI risk), medical alert."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key HS points: **Autosomal dominant** (usually family history). **Labs**: spherocytes, **elevated MCHC >36** (concentrated cells), negative Coombs, **EMA binding test** confirmatory. **Crises**: Hemolytic (viral trigger, HIGH retics), **Aplastic** (Parvo B19, LOW retics - emergency!). Prevention: **folic acid** prophylaxis. Splenectomy curative but requires pre-op vaccines and post-op penicillin."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in HS management. Key points: 1) **Aplastic crisis** (Parvovirus B19) is an emergency - severe anemia with **LOW reticulocytes**. 2) **Splenectomy should NOT be done in infancy** (high OPSI risk) - wait until age 6+. 3) **OPSI** (overwhelming post-splenectomy infection) can be fatal within hours - asplenic patients need lifelong precautions: prophylactic penicillin, vaccinations, urgent fever evaluation."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-157", "title": "Iron Deficiency Anemia", "domain": "heme_onc", "difficulty": "intermediate", "tags": ["microcytic hypochromic", "low ferritin", "high TIBC", "excessive cow's milk", "pica"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 18-month-old male is brought to the emergency department for pallor and decreased energy that began 2 months ago.\n\nThe patient's mother reports, he has seemed more tired lately and his parents noticed he looks pale. He drinks about 32 ounces of whole milk daily and is a picky eater who mainly eats crackers and cheese. He was never given iron-fortified formula.\n\nReview of systems is positive for pica (eating ice and dirt) and negative for blood in stool, fever, or weight loss.\n\nMedical history is notable for He was born full-term. He was exclusively breastfed until 6 months without iron supplementation.\n\nPhysical Examination:\n- General: pale toddler, appears well but tired.\n- Vitals: febrile, tachycardia.\n- Labs: CBC: Hgb low (anemia).\n- Cardiovascular: tachycardia, grade II/VI systolic flow murmur.\n- Conjunctivae: pale. Nails: mild koilonychia.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 18-month-old has classic features of **iron deficiency anemia**: pallor, fatigue, **pica** (eating ice = pagophagia, eating dirt = geophagia), **excessive cow's milk intake** (32 oz/day), and **koilonychia** (spoon-shaped nails). Labs show **microcytic, hypochromic anemia**.", "question": "Which iron study pattern confirms iron deficiency anemia?", "choices": [{"id": "node-1-choice-a", "text": "Low serum iron, LOW ferritin, HIGH TIBC, LOW transferrin saturation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is the classic pattern of **iron deficiency**: **Low ferritin** (most specific marker), **low serum iron**, **high TIBC** (the body upregulates iron carriers trying to find more iron), and **low transferrin saturation** (<16%). Also expect **elevated RDW** (anisocytosis).", "consequence": "You identify the classic iron studies pattern.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Low serum iron, HIGH ferritin, LOW TIBC, LOW transferrin saturation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This pattern indicates **anemia of chronic disease/inflammation**. In chronic disease, iron is trapped in macrophages (high ferritin = storage) but unavailable for RBC production. TIBC is low or normal because the body downregulates iron transport to starve pathogens.", "consequence": "This is anemia of chronic disease pattern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Normal serum iron, NORMAL ferritin, normal TIBC, normal Hgb electrophoresis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This child has documented **anemia** with microcytosis. Normal iron studies with microcytic anemia suggests **thalassemia trait** - would need Hgb electrophoresis showing elevated HbA2 (beta-thal) or HbH bodies (alpha-thal).", "consequence": "Normal iron studies suggest thalassemia.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "High serum iron, HIGH ferritin, HIGH transferrin saturation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This pattern suggests **iron overload** (hemochromatosis, multiple transfusions, sideroblastic anemia). In sideroblastic anemia, iron accumulates in mitochondria forming **ringed sideroblasts** but cannot be incorporated into heme.", "consequence": "This suggests iron overload.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Low serum iron, LOW ferritin, LOW TIBC, basophilic stippling on smear", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Basophilic stippling** with microcytic anemia suggests **lead poisoning**. Iron deficiency does NOT cause basophilic stippling. However, iron deficiency and lead poisoning can coexist - **iron deficiency increases lead absorption**.", "consequence": "Basophilic stippling points to lead poisoning.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Microcytic anemia differential**: Remember **TAILS** - **T**halassemia (normal RDW, high RBC count), **A**nemia of chronic disease (high ferritin, low TIBC), **I**ron deficiency (low ferritin, high TIBC, high RDW), **L**ead poisoning (basophilic stippling), **S**ideroblastic (ringed sideroblasts, high iron)."}, "node-2": {"id": "node-2", "type": "decision", "content": "Labs confirm iron deficiency: **Hgb 7.5 g/dL**, **MCV 62 fL** (low), **ferritin 5 ng/mL** (low), **TIBC 450** (high), **RDW 18%** (elevated). The child drinks **32 oz of cow's milk daily** and eats mainly crackers.", "question": "What is the MOST IMPORTANT initial intervention?", "choices": [{"id": "node-2-choice-a", "text": "Limit cow's milk to <16-24 oz/day AND start oral iron supplementation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Both interventions are essential**. Excessive cow's milk causes iron deficiency by: 1) **Displacing iron-rich foods**, 2) **Low iron content** in cow's milk, 3) **Calcium inhibits iron absorption**, 4) Can cause **occult GI blood loss**. Limit milk to **16-24 oz/day** and start **ferrous sulfate 3-6 mg/kg/day of elemental iron**.", "consequence": "Addresses the root cause and treats deficiency.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start oral iron supplementation only - no dietary changes needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Without limiting excessive milk intake, iron supplementation alone may be ineffective. **Cow's milk interferes with iron absorption** and continues to displace iron-rich foods. The underlying dietary cause MUST be addressed.", "consequence": "Treatment fails without dietary intervention.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Blood transfusion for Hgb 7.5 g/dL", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Transfusion is reserved for symptomatic severe anemia** (usually Hgb <5-6 g/dL) or hemodynamic instability. This child has chronic, compensated anemia - the body has adapted. Oral iron will raise Hgb effectively. Transfusion carries unnecessary risks.", "consequence": "Transfusion not indicated for compensated anemia.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Switch to iron-fortified formula and stop all cow's milk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect approach for an 18-month-old. Iron-fortified formula is for **infants <12 months**. Toddlers should transition to table foods and limited whole milk. This child needs **iron supplementation** and a **diet with iron-rich foods** (meat, beans, fortified cereals), not formula.", "consequence": "Age-inappropriate - toddlers don't need formula.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "GI workup for occult blood loss before treating", "isOptimal": false, "isAcceptable": true, "feedback": "The history clearly identifies **dietary etiology** (excessive milk, poor iron intake). In typical toddler IDA, GI workup is NOT routinely needed. However, if iron deficiency **fails to respond to treatment** or recurs, evaluate for blood loss (Meckel's, celiac, IBD, parasites).", "consequence": "GI workup indicated only if treatment fails.", "nextNodeId": "node-3"}], "clinicalPearl": "**Cow's milk and iron deficiency**: Limit to **16-24 oz/day** in toddlers. Cow's milk causes IDA by: 1) **Low iron content**, 2) **High calcium inhibits absorption**, 3) **Displaces iron-rich foods**, 4) Can cause **occult GI bleeding** (cow's milk protein-induced colitis). Give iron with **vitamin C** (enhances absorption), NOT with milk/dairy."}, "node-3": {"id": "node-3", "type": "decision", "content": "You start **ferrous sulfate 6 mg/kg/day of elemental iron** divided BID-TID, given with orange juice (vitamin C enhances absorption). You advise limiting milk to 16 oz/day. At the **2-week follow-up**, the mother reports the child is more energetic. Labs show Hgb 8.5 g/dL (was 7.5).", "question": "What is the FIRST laboratory evidence of response to iron therapy?", "choices": [{"id": "node-3-choice-a", "text": "Reticulocytosis within 3-5 days of starting iron", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Reticulocytosis** (increase in immature RBCs) is the **first sign of response** to iron therapy, occurring within **3-5 days** (peak at 7-10 days). Hemoglobin starts rising at **1-2 weeks** and normalizes by **6-8 weeks**. If no reticulocytosis, suspect non-compliance, ongoing blood loss, or wrong diagnosis.", "consequence": "You understand the expected treatment response.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Rising hemoglobin within 24-48 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Hemoglobin takes **1-2 weeks** to begin rising noticeably. RBC production takes time - the bone marrow first releases reticulocytes (3-5 days), which then mature into RBCs. Expecting Hgb rise in 24-48 hours is unrealistic.", "consequence": "Hgb rise takes longer.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Normalization of ferritin within 1 week", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Ferritin is the LAST parameter to normalize** - it takes **3-6 months** of continued iron therapy AFTER hemoglobin normalizes. This is why treatment continues for **3 months after Hgb normalization** - to replenish iron stores.", "consequence": "Ferritin normalizes last, not first.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "Increase in MCV within 3 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **MCV increases gradually** over weeks as new, properly hemoglobinized RBCs replace the old microcytic cells. It's NOT an early marker. The RDW may actually increase initially (more anisocytosis) as normal-sized RBCs mix with microcytic ones.", "consequence": "MCV changes slowly over weeks.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Resolution of pica within 24 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While pica does resolve with iron treatment, it takes **days to weeks**, not 24 hours. Pica (especially pagophagia - ice craving) is a strong indicator of iron deficiency but its resolution is variable and not used to monitor treatment response.", "consequence": "Pica resolves over days to weeks.", "nextNodeId": "node-4"}], "clinicalPearl": "**Iron therapy response timeline**: **3-5 days** = reticulocytosis (FIRST sign). **1-2 weeks** = Hgb starts rising (expect ~1 g/dL/week). **6-8 weeks** = Hgb normalizes. **3-6 months** = ferritin normalizes (LAST). Continue iron **3 months AFTER Hgb normalizes** to replenish stores."}, "node-4": {"id": "node-4", "type": "decision", "content": "At **2 months**, Hgb has normalized to 12 g/dL. The family asks how long to continue iron therapy and whether they should change the child's diet permanently.", "question": "What are the appropriate next steps?", "choices": [{"id": "node-4-choice-a", "text": "Continue iron for 3 months AFTER Hgb normalizes; permanent dietary changes to prevent recurrence", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Continue iron for **3 months after Hgb normalizes** to replenish body iron stores (reflected by ferritin). Permanent dietary changes: limit milk to **16-24 oz/day**, include **iron-rich foods** (meat, beans, fortified cereals), pair with **vitamin C** foods. Screen for recurrence at well-child visits.", "consequence": "Complete treatment and prevent recurrence.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Stop iron now that Hgb is normal - stores will replenish from diet alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Stopping iron when Hgb normalizes leads to **recurrence** because iron stores (ferritin) are NOT yet replenished. It takes **3 additional months** of supplementation to rebuild stores. Diet alone is insufficient to replenish depleted stores.", "consequence": "Iron deficiency will recur.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Switch to IV iron for faster store repletion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **IV iron is reserved for**: oral iron intolerance/failure, malabsorption (IBD, celiac), ongoing blood loss exceeding oral absorption capacity, or severe anemia needing rapid correction. This child is responding well to oral therapy - IV iron is unnecessary and has more risks.", "consequence": "IV iron not indicated - oral is working.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Continue iron indefinitely to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Long-term iron supplementation is not recommended** due to risk of **iron overload** and **constipation**. Once stores are replenished (3 months after Hgb normalizes), dietary prevention is the strategy. Check ferritin to confirm stores are adequate, then stop.", "consequence": "Prolonged iron has risks - stop after stores replenish.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "No follow-up needed - iron deficiency is cured", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Follow-up is important to: 1) **Confirm ferritin normalizes** (stores replenished), 2) **Screen for recurrence** at subsequent well-child visits, 3) **Reinforce dietary counseling**. Children with history of IDA remain at higher risk for recurrence.", "consequence": "Follow-up ensures complete treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Iron deficiency prevention**: Breastfed infants need **iron supplementation starting at 4 months** (1 mg/kg/day) until eating iron-rich foods. **Iron-fortified formula** for formula-fed infants. Toddlers: limit cow's milk to **16-24 oz/day**, include iron-rich foods (meat, beans, fortified cereals), pair with vitamin C. Screen at **9-12 months** and again at **15-18 months**."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **iron deficiency anemia**. Key learning points: 1) Classic iron studies: **low ferritin** (most specific), **high TIBC**, **elevated RDW**. 2) **Excessive cow's milk** is #1 cause in toddlers - limit to 16-24 oz/day. 3) **Reticulocytosis in 3-5 days** is first sign of response. 4) Continue iron **3 months AFTER Hgb normalizes** to replenish stores. 5) Give iron with vitamin C, NOT with milk/dairy."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points in iron deficiency anemia: **TAILS** differential (Thalassemia, Anemia of chronic disease, Iron deficiency, Lead, Sideroblastic). Iron deficiency = **low ferritin + high TIBC + high RDW**. Treat with ferrous sulfate **3-6 mg/kg/day**, continue **3 months after Hgb normalizes**. Limit cow's milk to **16-24 oz/day**."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. **Iron deficiency anemia** is the most common anemia in children. Key points: **Ferritin is most specific** marker (low in IDA). **Reticulocytosis in 3-5 days** = first response to treatment. Transfusion only for severe symptomatic anemia. Continue iron **3 months after Hgb normalizes**."}}, "rootNodeId": "node-1"}], "infectious_disease": [{"id": "vignette-lens-peds-028", "title": "Pertussis", "domain": "infectious_disease", "difficulty": "advanced", "tags": ["pertussis", "whooping cough", "Bordetella pertussis", "paroxysmal cough", "inspiratory whoop", "post-tussive vomiting", "lymphocytosis", "azithromycin", "post-exposure prophylaxis", "infant apnea"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 3-month-old female is brought in by her parents for prolonged coughing episodes with color change for 2 weeks.\n\nAccording to the caregiver, she has had worsening coughing spells that come in bursts. She turns red then blue during the episodes and sometimes vomits afterward. She makes a high-pitched sound when she catches her breath.\n\nReview of systems is positive for post-tussive vomiting and apnea episodes and negative for fever.\n\nPast medical history includes She has received only her first DTaP vaccine. Her older sibling has had a prolonged cough.\n\nPhysical Examination:\n- Respiratory: paroxysmal cough with inspiratory whoop and post-tussive emesis observed during examination. Subconjunctival hemorrhage.\n- General: infant appears well between coughing episodes.\n- Vitals: afebrile.\n- Lungs: clear between paroxysms.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 3-month-old with 2 weeks of worsening coughing episodes. Key features:\n\n**Classic pertussis presentation:**\n- **Paroxysmal cough** - bursts of rapid coughs in one exhalation\n- **Inspiratory whoop** - forceful inspiration against closed glottis\n- **Post-tussive vomiting** - vomiting after coughing paroxysm\n- **Cyanosis** during episodes (turning blue)\n- **Well-appearing between episodes**\n- **Afebrile** (pertussis typically doesn't cause fever)\n- **Subconjunctival hemorrhage** - from coughing pressure\n\nRisk factors: Incomplete vaccination (only 1 DTaP), sick contact (sibling with prolonged cough)", "question": "Based on this classic presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Pertussis (whooping cough) - Bordetella pertussis infection", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is classic **pertussis**: paroxysmal cough with **inspiratory whoop**, **post-tussive vomiting**, cyanosis during episodes but well-appearing between them, **afebrile**, subconjunctival hemorrhage from coughing pressure, incomplete vaccination, and sick contact. Pertussis is caused by **Bordetella pertussis**, a gram-negative coccobacillus.", "consequence": "Correct diagnosis. Proceed with testing and treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "RSV bronchiolitis - common cause of infant respiratory illness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. RSV bronchiolitis presents with **wheezing, crackles, and tachypnea** - findings of lower airway disease. This infant has **clear lungs between paroxysms** and the characteristic whooping cough pattern. RSV also typically causes **fever** and doesn't produce the classic paroxysmal cough with whoop.", "consequence": "Missed pertussis - a reportable disease requiring treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Chlamydia trachomatis pneumonia - afebrile pneumonia of infancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Chlamydia pneumonia causes **staccato cough** (short, choppy coughs) and is associated with **conjunctivitis** and **eosinophilia**. It does NOT cause the classic **inspiratory whoop** or paroxysmal cough pattern. Onset is typically at 4-12 weeks of age with a more insidious course.", "consequence": "Different cough pattern. Staccato \u2260 paroxysmal with whoop.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Foreign body aspiration - sudden onset coughing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Foreign body aspiration has **sudden onset** (not 2-week progressive course) and may cause **unilateral wheezing** or decreased breath sounds. This infant has a 2-week history with classic pertussis features and clear lungs. Foreign body should cause asymmetric findings.", "consequence": "Wrong mechanism. 2-week progressive course rules out sudden aspiration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Viral upper respiratory infection - common childhood illness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Viral URIs may cause cough but do NOT produce the **classic triad** of paroxysmal cough, inspiratory whoop, and post-tussive vomiting. Viral coughs are typically non-paroxysmal and don't cause cyanosis or subconjunctival hemorrhage from coughing pressure.", "consequence": "Underestimated severity. This is not a simple URI.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Pertussis stages**: (1) **Catarrhal** (1-2 weeks) - URI symptoms, most contagious, (2) **Paroxysmal** (2-8 weeks) - classic whooping cough, (3) **Convalescent** (weeks-months) - gradual resolution. **\"100-day cough\"** refers to total duration. Young infants may NOT whoop - they present with **apnea and cyanosis** instead."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect pertussis based on the classic clinical presentation. This 3-month-old has had symptoms for 2 weeks, placing her in the **paroxysmal phase**.\n\n**Diagnostic testing:**\n- **Nasopharyngeal PCR** - test of choice, rapid and sensitive\n- **Culture** - gold standard but takes 7-10 days, less sensitive\n- **Serology** - useful for late presentation when PCR/culture negative\n\n**CBC may show:**\n- **Lymphocytosis** (often striking, >20,000/\u03bcL) - classic finding\n- WBC can be >50,000 in severe cases", "question": "What is the most appropriate diagnostic test to confirm pertussis?", "choices": [{"id": "node-2-choice-a", "text": "Nasopharyngeal PCR for Bordetella pertussis", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Nasopharyngeal PCR** is the test of choice - it's rapid (results in hours) and more sensitive than culture, especially if antibiotics have been started. Proper specimen collection is critical: use a **Dacron or calcium alginate swab** (not cotton), insert deep into the nasopharynx, and hold for 10 seconds.", "consequence": "PCR ordered. Results positive for B. pertussis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Throat swab culture", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A **throat swab** will miss pertussis - the organism colonizes the **nasopharynx**, not the oropharynx. Additionally, culture takes 7-10 days, is less sensitive than PCR (especially after antibiotics), and requires special media (Regan-Lowe or Bordet-Gengou).", "consequence": "Wrong specimen site. Need nasopharyngeal sample.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Chest X-ray", "isOptimal": false, "isAcceptable": true, "feedback": "CXR may be helpful to evaluate for complications but is **not diagnostic** for pertussis. Classic finding is **perihilar infiltrates** with a **\"shaggy heart border\"** appearance from peribronchial thickening. CXR may be normal in uncomplicated pertussis. PCR confirms the diagnosis.", "consequence": "CXR doesn't confirm pertussis. PCR needed.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Complete blood count only", "isOptimal": false, "isAcceptable": true, "feedback": "CBC showing **lymphocytosis** (often >20,000/\u03bcL, can be >50,000) is suggestive but **not specific** for pertussis. Other infections and conditions can cause lymphocytosis. PCR provides definitive diagnosis. CBC is a supportive test.", "consequence": "Lymphocytosis supports diagnosis but PCR confirms it.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "No testing needed - treat empirically based on clinical diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "Empiric treatment can be started based on strong clinical suspicion, but **testing should still be performed**. Confirmed cases are **reportable to public health**, and diagnosis helps guide contact prophylaxis decisions. PCR can be positive even after antibiotics are started.", "consequence": "Treatment can start but testing still needed for public health.", "nextNodeId": "node-3"}], "clinicalPearl": "**Laboratory clue:** **Lymphocytosis** is classic for pertussis - WBC often 15,000-50,000/\u03bcL with **>60% lymphocytes**. The toxin inhibits lymphocyte migration from blood to lymph nodes. **Extreme leukocytosis** (>50,000) in young infants is associated with **pulmonary hypertension** and poor prognosis - consider exchange transfusion."}, "node-3": {"id": "node-3", "type": "decision", "content": "Nasopharyngeal PCR returns **positive for Bordetella pertussis**. CBC shows WBC 25,000/\u03bcL with 75% lymphocytes.\n\nThis is a 3-month-old infant with confirmed pertussis. The case must be **reported to public health authorities** (pertussis is a notifiable disease).\n\n**Treatment goals:**\n1. Reduce transmission (patient is contagious during catarrhal phase and first 3 weeks of cough)\n2. Provide supportive care\n3. Protect contacts through prophylaxis", "question": "What is the most appropriate antibiotic treatment for this infant with pertussis?", "choices": [{"id": "node-3-choice-a", "text": "Azithromycin 10 mg/kg/day x 5 days", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Azithromycin** is the first-line treatment for pertussis in infants <1 month and preferred in infants 1-5 months due to the risk of **infantile hypertrophic pyloric stenosis (IHPS)** with erythromycin. Dosing: **10 mg/kg/day x 5 days**. Azithromycin has the lowest IHPS risk among macrolides.", "consequence": "Appropriate antibiotic initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Erythromycin for 14 days", "isOptimal": false, "isAcceptable": true, "feedback": "Erythromycin is effective but is **second-line in infants <6 months** due to association with **infantile hypertrophic pyloric stenosis (IHPS)**. If erythromycin is used, it requires 14 days of treatment (longer than azithromycin). Azithromycin is preferred for its shorter course and lower IHPS risk.", "consequence": "Effective but higher IHPS risk in young infants.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Amoxicillin for 10 days", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Amoxicillin and other beta-lactams are **NOT effective** against Bordetella pertussis. The organism is susceptible to **macrolides** (azithromycin, erythromycin, clarithromycin) and **trimethoprim-sulfamethoxazole** (alternative for macrolide allergy).", "consequence": "Wrong antibiotic class. Beta-lactams don't treat pertussis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "No antibiotics - pertussis is viral", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Pertussis is caused by **Bordetella pertussis**, a **gram-negative bacterium**, not a virus. Antibiotics are indicated to reduce transmission (make patient non-contagious after 5 days of treatment) and may reduce severity if given early in the catarrhal phase.", "consequence": "Pertussis is bacterial - antibiotics are indicated.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Supportive care only - too late for antibiotics to help", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While antibiotics may not significantly reduce symptom duration if given late in the paroxysmal phase, they are still indicated to **reduce transmission**. The patient becomes non-contagious after **5 days of appropriate antibiotic treatment**. This is especially important for protecting vulnerable contacts.", "consequence": "Antibiotics still reduce transmission even late in disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Antibiotics for pertussis**: First-line = **Azithromycin** (5 days). Alternative = TMP-SMX (14 days, for macrolide allergy). **IHPS risk**: Erythromycin > clarithromycin > azithromycin. Monitor infants <1 month for **pyloric stenosis** symptoms (projectile vomiting) for 4 weeks after macrolide treatment."}, "node-4": {"id": "node-4", "type": "decision", "content": "Azithromycin is started. Given this is a young infant with pertussis, you must decide on disposition.\n\n**Pertussis in young infants is dangerous:**\n- **Apnea** - may occur without coughing paroxysm\n- **Respiratory failure** requiring mechanical ventilation\n- **Pulmonary hypertension** (from extreme leukocytosis)\n- **Seizures** from hypoxia or pertussis encephalopathy\n- **Death** - pertussis kills infants (mortality highest in <3 months)\n\n**Post-exposure prophylaxis** is needed for close contacts regardless of vaccination status.", "question": "What is the appropriate disposition and management for this 3-month-old with pertussis?", "choices": [{"id": "node-4-choice-a", "text": "Admit for monitoring; PEP with azithromycin for all household contacts", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Infants <6 months should be hospitalized** for pertussis due to risk of apnea (may occur without warning), respiratory failure, and death. Monitor continuously with **apnea monitors** and pulse oximetry. **Post-exposure prophylaxis (PEP)** with azithromycin should be given to **ALL close contacts** regardless of vaccination status - this includes household members, childcare contacts, and anyone with face-to-face exposure.", "consequence": "Appropriate admission and contact prophylaxis.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Discharge home with azithromycin; no prophylaxis needed for vaccinated contacts", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect on both counts.** (1) Infants <6 months with pertussis should be **hospitalized** for monitoring - apnea can occur suddenly and be fatal. (2) **PEP is recommended for ALL close contacts regardless of vaccination status** - vaccine protection wanes over time, and contacts may have incomplete immunity.", "consequence": "High-risk infant sent home. Contacts not protected.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Admit for monitoring; give azithromycin PEP only to unvaccinated contacts", "isOptimal": false, "isAcceptable": false, "feedback": "Admission is correct, but PEP should be given to **ALL close contacts, including vaccinated individuals**. Pertussis vaccine (DTaP/Tdap) protection **wanes over time** (estimated 4-12 years), and even vaccinated individuals can be infected and transmit disease. Universal PEP is the standard.", "consequence": "Vaccinated contacts may still acquire and spread pertussis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Admit to PICU; start exchange transfusion for leukocytosis", "isOptimal": false, "isAcceptable": false, "feedback": "This patient's WBC is 25,000/\u03bcL - elevated but not at the critical threshold. **Exchange transfusion/leukapheresis** is reserved for **extreme leukocytosis** (>50,000-100,000) associated with **pulmonary hypertension**. This patient doesn't have evidence of pulmonary hypertension and doesn't need exchange transfusion. Regular floor admission with monitoring is appropriate.", "consequence": "WBC not critically elevated. Exchange transfusion not indicated.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Discharge after 48 hours of antibiotics if afebrile", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** The 48-hour rule applies to some bacterial infections but NOT pertussis in young infants. Risk of apnea continues throughout the paroxysmal phase. Infants should remain hospitalized until they are past the highest-risk period (typically 1-2 weeks), are clinically stable, and can be safely monitored at home.", "consequence": "Premature discharge puts infant at risk for fatal apnea at home.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Post-exposure prophylaxis (PEP)** is recommended for **ALL close contacts** within 21 days of cough onset, regardless of vaccination status. **High-priority contacts** for PEP: (1) Infants <1 year, (2) Pregnant women in 3rd trimester, (3) Anyone with contact with infants/pregnant women. **Regimen**: Same as treatment (azithromycin 5 days)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of infant pertussis!\n\n**Key Learning Points:**\n1. **Classic triad**: Paroxysmal cough + inspiratory whoop + post-tussive vomiting\n2. **Young infants may NOT whoop** - present with **apnea and cyanosis**\n3. **Lymphocytosis** is a classic lab finding (WBC often >20,000)\n4. **Diagnosis**: Nasopharyngeal PCR (test of choice)\n5. **Treatment**: **Azithromycin** 5 days (preferred in infants due to lower IHPS risk)\n6. **Hospitalize infants <6 months** for apnea monitoring\n7. **PEP for ALL close contacts** regardless of vaccination status\n8. **Report to public health** - pertussis is notifiable\n\nThis infant was hospitalized, completed azithromycin, and recovered without complications. All household contacts received prophylaxis. The case was reported to the health department."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key concepts:\n\n**Pertussis Recognition:**\n- Classic triad: paroxysmal cough, inspiratory whoop, post-tussive vomiting\n- Young infants: **apnea and cyanosis** (may not whoop)\n- Lab: **Lymphocytosis** (often striking)\n- Diagnosis: **Nasopharyngeal PCR**\n\n**Treatment:**\n- **Azithromycin** 5 days (first-line)\n- **Hospitalize infants <6 months** for apnea monitoring\n- **PEP for ALL contacts** regardless of vaccination\n- Report to public health"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in pertussis management. **Pertussis kills infants.**\n\n**Mortality is highest in infants <3 months** due to:\n- Apnea (may be sudden and fatal)\n- Respiratory failure\n- Pulmonary hypertension from extreme leukocytosis\n- Pertussis encephalopathy\n\n**Key Pearl:** \"Young infants may NOT whoop - they present with apnea and cyanosis.\" Any infant <6 months with suspected pertussis should be hospitalized for monitoring. Apnea can occur without warning and be fatal if not immediately recognized and treated."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-041", "title": "Measles", "domain": "infectious_disease", "difficulty": "advanced", "tags": ["measles", "rubeola", "Koplik spots", "cephalocaudal rash", "3 Cs", "cough coryza conjunctivitis", "vitamin A", "MMR vaccine", "post-exposure prophylaxis", "airborne precautions", "measles pneumonia"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 4-year-old male presents with fever, cough, and rash for the past 5 days.\n\nAccording to the caregiver, he developed high fever, cough, runny nose, and red eyes 5 days ago. Yesterday he developed a red rash that started on his face and is spreading down his body.\n\nAssociated symptoms include Koplik spots were noted in his mouth 2 days ago. Denies difficulty breathing or seizures.\n\nPast medical history includes He is unvaccinated. His family recently traveled internationally to a country with measles outbreak.\n\nPhysical Examination:\n- Skin: erythematous maculopapular rash starting on face and spreading cephalocaudally.\n- Eyes: conjunctivitis.\n- Oropharynx: Koplik spots (white spots on buccal mucosa).\n- General: ill-appearing, febrile (39.5\u00b0C).\n- Vitals: high fever.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 4-year-old with fever, respiratory symptoms, and rash. Key features:\n\n**Classic measles presentation:**\n- **Prodrome** (3-5 days): High fever, the **\"3 C's\"** (Cough, Coryza, Conjunctivitis)\n- **Koplik spots**: Pathognomonic - white/blue-gray spots on erythematous base on buccal mucosa, appear 1-2 days BEFORE rash\n- **Exanthem**: Erythematous maculopapular rash starting on **face/hairline**, spreads **cephalocaudally** (head \u2192 trunk \u2192 extremities)\n\n**Risk factors:** Unvaccinated, recent international travel to outbreak area", "question": "Based on this classic presentation with Koplik spots, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Measles (rubeola) - pathognomonic Koplik spots", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is classic **measles (rubeola)**: prodrome with the **3 C's** (cough, coryza, conjunctivitis), **Koplik spots** (pathognomonic - no other disease has this finding), and **cephalocaudal maculopapular rash**. Measles is caused by a **paramyxovirus** and is one of the most contagious infections known (R0 ~15-18).", "consequence": "Correct diagnosis. Implement isolation and treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Rubella (German measles) - also causes fever and rash", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Rubella has a **milder course** with low-grade fever, **posterior auricular and suboccipital lymphadenopathy** (characteristic), and a fine pink rash. Rubella does **NOT cause Koplik spots** or the severe \"3 C's\" prodrome. The rash in rubella is less confluent and clears more quickly.", "consequence": "Rubella doesn't cause Koplik spots or severe prodrome.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Roseola infantum - fever with rash", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Roseola (HHV-6) has a distinctive pattern: **high fever for 3-5 days THEN rash appears AS fever breaks** (\"fever first, rash after defervescence\"). In measles, **rash appears while fever is still present** and often at its peak. Roseola also doesn't cause Koplik spots or the 3 C's.", "consequence": "Roseola: rash appears after fever breaks. This patient is still febrile.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Kawasaki disease - fever with mucosal changes", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Kawasaki disease causes **strawberry tongue** and cracked lips, not Koplik spots. KD also has **conjunctival injection without discharge** (limbic sparing), while measles has conjunctivitis WITH discharge. KD lacks the \"3 C's\" prodrome. The rash in KD is polymorphous, not the classic cephalocaudal maculopapular pattern.", "consequence": "Kawasaki has different mucosal findings and no Koplik spots.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Scarlet fever - streptococcal rash illness", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Scarlet fever follows streptococcal pharyngitis with **sandpaper-textured rash**, **strawberry tongue**, **pastia lines** (linear petechiae in skin folds), and **circumoral pallor**. It does not cause Koplik spots, conjunctivitis, or coryza. The rash spares the face (in contrast to measles which starts on the face).", "consequence": "Scarlet fever: sandpaper rash, no Koplik spots or conjunctivitis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Koplik spots** are **pathognomonic** for measles - they appear **1-2 days BEFORE the rash** and fade as the rash appears. Look for them on the buccal mucosa opposite the molars: white/blue-gray spots on an erythematous base (\"grains of salt on a red background\"). If you see Koplik spots, it's measles until proven otherwise."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed measles. This is a **public health emergency** - measles is extremely contagious.\n\n**Infection control priorities:**\n- **Airborne precautions** (negative pressure room, N95 respirator)\n- Patient should be isolated until **4 days after rash onset**\n- Report to public health immediately (notifiable disease)\n- Identify and notify exposed contacts\n\n**Measles R0 (basic reproduction number) = 15-18** - one of the most contagious diseases known. An infected person can transmit to ~15-18 susceptible individuals.", "question": "What is the most important treatment intervention for this child with measles?", "choices": [{"id": "node-2-choice-a", "text": "Vitamin A supplementation", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Vitamin A** is the key treatment for measles. The **WHO and AAP recommend vitamin A** for ALL children with measles. Vitamin A reduces mortality and prevents blindness (measles is a leading cause of preventable blindness in developing countries). **Dosing**: Age-based (100,000 IU for 6-11 months, 200,000 IU for \u226512 months), given on 2 consecutive days.", "consequence": "Vitamin A administered. Reduces mortality and complications.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Empiric antibiotics for bacterial superinfection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Antibiotics are **not routinely indicated** for uncomplicated measles. Measles is a viral infection (paramyxovirus). Antibiotics should only be given if there is evidence of **bacterial superinfection** (otitis media, pneumonia). Prophylactic antibiotics are not recommended.", "consequence": "Antibiotics not indicated for uncomplicated viral measles.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Antiviral therapy (acyclovir or ribavirin)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no proven effective antiviral** for routine measles treatment. Acyclovir is for herpesviruses (not paramyxoviruses). Ribavirin has been used in severe cases but is **not standard of care**. The mainstay of treatment is supportive care + vitamin A.", "consequence": "No proven antiviral for measles. Focus on vitamin A.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "IVIG (intravenous immunoglobulin)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IVIG is used for **post-exposure prophylaxis** in high-risk contacts (immunocompromised, infants <12 months), NOT for treatment of active measles. Once the patient has active disease with rash, IVIG does not change the course.", "consequence": "IVIG is for prophylaxis, not treatment of active measles.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Systemic corticosteroids to reduce inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Corticosteroids are **not routinely indicated** and may worsen outcome by suppressing immune response to the virus. Steroids may be considered only for specific complications (e.g., measles encephalitis with cerebral edema), but not for routine treatment.", "consequence": "Steroids may worsen viral infection. Not indicated routinely.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Vitamin A dosing for measles** (WHO/AAP): <6 months: 50,000 IU, 6-11 months: 100,000 IU, \u226512 months: **200,000 IU**. Give on **2 consecutive days**, with a third dose 2-4 weeks later if evidence of vitamin A deficiency. Vitamin A reduces measles mortality by up to **50%** in developing countries and prevents measles-related blindness."}, "node-3": {"id": "node-3", "type": "decision", "content": "Vitamin A has been administered. The patient is in airborne isolation and the case has been reported to public health.\n\n**Measles complications to monitor for:**\n- **Otitis media** - most common complication (7-9%)\n- **Pneumonia** - most common cause of death (1-6%)\n- **Encephalitis** - 1 in 1,000 cases (high mortality/morbidity)\n- **SSPE** - subacute sclerosing panencephalitis (delayed, fatal)\n\nYou are asked about **post-exposure prophylaxis** for contacts. The patient's 8-month-old sibling was exposed 3 days ago.", "question": "What is the appropriate post-exposure prophylaxis for this 8-month-old unvaccinated sibling exposed to measles 3 days ago?", "choices": [{"id": "node-3-choice-a", "text": "MMR vaccine - can be given to infants as young as 6 months for post-exposure prophylaxis", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **MMR vaccine** can be given for post-exposure prophylaxis if administered within **72 hours** of exposure. For infants 6-11 months, MMR can be given as an **off-label dose** for outbreak control or post-exposure prophylaxis (this dose doesn't count toward the routine series). At 3 days post-exposure, this infant is still within the 72-hour window.", "consequence": "MMR given within 72 hours. Likely to prevent or modify disease.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immune globulin (IG) - if >72 hours since exposure", "isOptimal": false, "isAcceptable": true, "feedback": "IG is appropriate for high-risk contacts when **>72 hours but \u22646 days** since exposure, OR for those who cannot receive MMR (immunocompromised, infants <6 months, pregnant women). Since this infant is within 72 hours of exposure, **MMR is preferred**. IG would be correct if >72 hours had passed.", "consequence": "IG is second-line when >72 hours. MMR preferred within 72 hours.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "No prophylaxis needed - wait to see if symptoms develop", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Post-exposure prophylaxis is indicated for susceptible contacts. Measles is highly contagious (attack rate >90% in susceptible household contacts). Waiting to see if symptoms develop means the opportunity for prophylaxis is lost - once symptoms appear, it's too late.", "consequence": "Missed opportunity for prophylaxis. High risk of measles.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Antibiotics to prevent secondary infections", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Antibiotics do not prevent measles (a viral infection) or provide post-exposure prophylaxis. Prophylaxis options are **MMR vaccine** (within 72 hours) or **immune globulin** (within 6 days for those who can't receive MMR).", "consequence": "Antibiotics don't prevent viral measles infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Wait until 12 months of age for routine MMR", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** In a post-exposure setting, MMR can be given as early as **6 months of age**. Waiting until 12 months (routine schedule) would mean the infant is unprotected for months after a known high-risk exposure. The infant will still need the routine 2-dose series starting at 12 months.", "consequence": "Waiting leaves infant unprotected after known exposure.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Measles post-exposure prophylaxis**: **MMR vaccine** within **72 hours** (can give to infants \u22656 months). **Immune globulin (IG)** within **6 days** if: >72 hours since exposure, infants <6 months, immunocompromised, or pregnant. IM dose: 0.5 mL/kg (max 15 mL); IV dose: 400 mg/kg. IG and MMR should NOT be given together (IG interferes with vaccine response)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The 8-month-old sibling received MMR vaccine within 72 hours of exposure.\n\nOn day 3 of hospitalization, the 4-year-old patient develops worsening respiratory symptoms:\n- Temperature 40.2\u00b0C (recurrent fever after initial defervescence)\n- Respiratory rate 40/min with subcostal retractions\n- Oxygen saturation 91% on room air\n- Crackles heard bilaterally on auscultation\n- Appears more ill", "question": "The patient has developed respiratory deterioration. What is the most likely complication and appropriate next step?", "choices": [{"id": "node-4-choice-a", "text": "Measles pneumonia - obtain CXR and start empiric antibiotics for secondary bacterial infection", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Pneumonia is the most common cause of death** from measles. This patient has signs of pneumonia (tachypnea, hypoxia, crackles, recurrent fever). Measles pneumonia can be: (1) **Primary viral** (giant cell/Hecht pneumonia), (2) **Secondary bacterial** (S. pneumoniae, S. aureus, H. influenzae). Given the clinical deterioration and recurrent fever, empiric antibiotics are appropriate while obtaining CXR.", "consequence": "CXR shows bilateral infiltrates. Antibiotics started.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Continue supportive care only - this is expected course of measles", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** While fever and respiratory symptoms are part of measles, **recurrent fever with hypoxia and respiratory distress** indicates a complication (likely pneumonia), not the expected course. Pneumonia is the leading cause of measles death and requires active treatment.", "consequence": "Pneumonia will progress without treatment. Risk of death.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Measles encephalitis - obtain CT head and lumbar puncture", "isOptimal": false, "isAcceptable": false, "feedback": "Encephalitis is a serious complication but presents with **neurological symptoms**: altered mental status, seizures, focal deficits, headache. This patient has **respiratory deterioration** without neurological findings. While encephalitis should be considered if CNS symptoms develop, the current presentation points to pneumonia.", "consequence": "Symptoms point to respiratory, not CNS complication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Allergic reaction to vitamin A - discontinue and give antihistamines", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This presentation (fever, hypoxia, crackles, respiratory distress) is **not consistent with allergic reaction**. Allergic reactions would cause urticaria, angioedema, or anaphylaxis - not progressive pneumonia with crackles. Vitamin A is not typically allergenic.", "consequence": "This is pneumonia, not allergic reaction.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Otitis media - examine ears and treat with amoxicillin", "isOptimal": false, "isAcceptable": false, "feedback": "Otitis media is the **most common** complication of measles but causes **ear pain, not respiratory distress**. This patient has bilateral crackles, hypoxia, and tachypnea - these are signs of **pneumonia**, which is the most common cause of measles-related death.", "consequence": "Respiratory distress indicates pneumonia, not otitis media.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Measles complications by frequency**: (1) **Otitis media** (7-9%), (2) **Pneumonia** (1-6%, but leading cause of death), (3) **Diarrhea**, (4) **Encephalitis** (1 in 1,000 - 15% mortality, 25% permanent neurological damage), (5) **SSPE** (subacute sclerosing panencephalitis, 1 in 10,000 - delayed onset 7-10 years later, always fatal)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Good management of measles and its complications!\n\n**Key Learning Points:**\n1. **Diagnosis**: 3 C's (cough, coryza, conjunctivitis) + **Koplik spots** (pathognomonic) + cephalocaudal rash\n2. **Infection control**: **Airborne precautions**, isolate until 4 days after rash onset\n3. **Treatment**: **Vitamin A** (reduces mortality 50%, prevents blindness)\n4. **PEP**: **MMR within 72 hours** or **IG within 6 days**\n5. **Complications**: Pneumonia (#1 cause of death), otitis media (#1 most common), encephalitis (rare but devastating)\n6. **Report to public health** - measles is notifiable\n\nThis patient was treated with antibiotics for secondary bacterial pneumonia, continued vitamin A, and recovered. The sibling who received MMR prophylaxis did not develop measles."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key concepts:\n\n**Measles Recognition:**\n- Prodrome: **3 C's** (Cough, Coryza, Conjunctivitis)\n- **Koplik spots** - pathognomonic (appear BEFORE rash)\n- Rash: maculopapular, **cephalocaudal spread** (face \u2192 trunk \u2192 extremities)\n\n**Management:**\n- **Vitamin A** for ALL patients (reduces mortality and blindness)\n- Airborne isolation until 4 days after rash onset\n- PEP: MMR within 72h, IG within 6 days\n- Monitor for complications (pneumonia = #1 cause of death)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in measles management.\n\n**Measles kills** - before vaccination, it caused millions of deaths annually. Even now:\n- **Mortality**: 1-2 per 1,000 in developed countries (higher in developing world)\n- **Pneumonia**: Leading cause of death\n- **Encephalitis**: 1 in 1,000 cases, high mortality/morbidity\n- **SSPE**: Fatal late complication (7-10 years post-infection)\n\n**Key Pearls:**\n1. **Koplik spots are pathognomonic** - if you see them, it's measles\n2. **Vitamin A saves lives** - give to ALL patients with measles\n3. **Measles is extremely contagious** (R0 = 15-18) - strict airborne isolation required\n4. **Post-exposure prophylaxis works** - MMR within 72h or IG within 6 days"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-042", "title": "Varicella", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["dewdrop on rose petal", "lesions in all stages", "centrifugal spread", "varicella"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 5-year-old female presents with itchy rash with blisters for the past 3 days.\n\nPer the parents, she developed an intensely itchy rash that started on her trunk and spread outward. The rash started as small red bumps and then became blisters. She had mild fever and malaise before the rash.\n\nReview of systems is positive for low-grade fever and malaise and negative for difficulty breathing or severe headache.\n\nPast medical history includes She is unvaccinated. A classmate was recently diagnosed with chickenpox.\n\nPhysical Examination:\n- Skin: vesicular rash in different stages (papules, vesicles, crusted lesions) - \"dew drops on rose petals.\"\n- Distribution: centripetal, concentrated on trunk.\n- General: mildly uncomfortable, low-grade fever.\n- Vitals: febrile.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 5-year-old has classic varicella (chickenpox): **centripetal rash** (trunk-predominant), lesions in **multiple stages simultaneously** (papules, vesicles, crusts - \"crops\"), **\"dewdrops on a rose petal\"** appearance, and prodrome of fever/malaise. She is unvaccinated with a known exposure.", "question": "Which feature BEST distinguishes varicella from smallpox?", "choices": [{"id": "node-1-choice-a", "text": "Lesions in different stages simultaneously (varicella) vs all same stage (smallpox)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Varicella** has lesions in **multiple stages simultaneously** (papules, vesicles, pustules, crusts appearing together). **Smallpox** lesions are all in the **same stage of development**. Other differences: smallpox is **centrifugal** (face/extremities > trunk), deeper lesions, and more severe systemic illness.", "consequence": "You identify the key distinguishing feature.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Varicella has dermatomal distribution like shingles", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Dermatomal distribution** is characteristic of **herpes zoster (shingles)**, which is VZV **reactivation**, not primary varicella. Primary varicella has a **generalized, centripetal distribution** (starts on trunk, spreads outward).", "consequence": "Dermatomal = zoster, not primary varicella.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Varicella only affects children", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Varicella can affect **any age** - primary infection in adults is actually more severe with higher complication rates (pneumonia, encephalitis). Adults without immunity (unvaccinated, no prior infection) are susceptible.", "consequence": "Adults can get varicella too.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Varicella always has high fever >104\u00b0F", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Varicella typically causes **low-grade fever** (100-102\u00b0F) in children. **High fever** may suggest bacterial superinfection or more severe disease. Smallpox typically has **higher fevers** with severe prodrome.", "consequence": "High fever suggests complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Varicella vesicles don't umbilicate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Varicella vesicles can show **central umbilication** (depression). Both varicella and smallpox can have umbilicated lesions. The key difference is **staging** (synchronous vs asynchronous) and **distribution** (centripetal vs centrifugal).", "consequence": "Umbilication occurs in both.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Varicella vs Smallpox**: Varicella = **centripetal** (trunk > extremities), **asynchronous** lesions (all stages at once), superficial. Smallpox = **centrifugal** (face/extremities > trunk), **synchronous** lesions (all same stage), deep. **Smallpox is eradicated** but important for bioterrorism awareness."}, "node-2": {"id": "node-2", "type": "decision", "content": "This is an otherwise healthy 5-year-old with uncomplicated varicella. She is uncomfortable with itching but has no signs of complications (no respiratory symptoms, neurologic changes, or skin superinfection).", "question": "What is the appropriate management for this HEALTHY child with uncomplicated varicella?", "choices": [{"id": "node-2-choice-a", "text": "Supportive care: antihistamines, acetaminophen (NOT aspirin), calamine lotion", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Healthy children** need supportive care only: antihistamines for pruritus, **acetaminophen** for fever (NOT aspirin - Reye syndrome!), calamine lotion. Keep nails trimmed. **Acyclovir is NOT routinely indicated** for healthy children <12 years.", "consequence": "Appropriate supportive management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Oral acyclovir for all children with varicella", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Acyclovir is NOT routinely recommended** for healthy children - it only modestly reduces duration (~1 day) if started within 24 hours. Reserve antivirals for **high-risk groups**: immunocompromised, >12 years old, chronic skin/lung disease, long-term salicylate therapy.", "consequence": "Unnecessary antiviral in healthy children.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Aspirin (ASA) for fever and discomfort", "isOptimal": false, "isAcceptable": false, "feedback": "NEVER give **aspirin** to children with varicella (or influenza)! This causes **Reye syndrome** - acute hepatic failure with encephalopathy with high mortality. Use **acetaminophen or ibuprofen** instead.", "consequence": "Risk of fatal Reye syndrome.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Prophylactic antibiotics to prevent superinfection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Prophylactic antibiotics are NOT indicated**. Bacterial superinfection (GAS, S. aureus) occurs in only ~5% of cases. Antibiotics are given only if superinfection develops (expanding erythema, purulent drainage).", "consequence": "Unnecessary antibiotic exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Varicella vaccine now to boost immunity", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Do NOT give vaccine during active infection**. Vaccine is for prevention (12-15 months and 4-6 years). Post-exposure prophylaxis can be given to susceptible contacts within **3-5 days of exposure**, not during active disease.", "consequence": "Vaccine not indicated during active disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Acyclovir indications in varicella**: NOT for healthy children <12. GIVE to: **>12 years old**, **immunocompromised**, **chronic skin disease** (eczema), **chronic pulmonary disease**, **long-term salicylate therapy**, **secondary household cases**. Must start within **24-48 hours** of rash."}, "node-3": {"id": "node-3", "type": "decision", "content": "Three days later, the mother calls. The child's fever has returned (102\u00b0F) and several lesions on her arm are now **red, swollen, warm, and have purulent drainage**. The surrounding skin is erythematous and spreading.", "question": "What complication has developed and what is the most appropriate management?", "choices": [{"id": "node-3-choice-a", "text": "Bacterial superinfection - start oral antibiotics covering GAS and S. aureus", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **bacterial superinfection** (cellulitis/impetigo), the most common complication of varicella. Usually caused by **Group A Strep (GAS)** or **S. aureus** (including MRSA). Start oral antibiotics covering both: cephalexin (if low MRSA risk) or TMP-SMX + cephalexin or clindamycin (if high MRSA risk).", "consequence": "Appropriate recognition and treatment of superinfection.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Normal varicella progression - continue supportive care only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Fever recurrence with purulent lesions and spreading erythema** indicates bacterial superinfection, NOT normal progression. Varicella lesions should be crusting and healing by now. This requires antibiotics.", "consequence": "Missed superinfection - risk of sepsis/necrotizing fasciitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Start IV acyclovir for severe varicella", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The symptoms (purulent drainage, spreading erythema, fever recurrence) indicate **bacterial superinfection**, not worsening viral disease. Acyclovir treats VZV but won't help with bacterial infection. This child needs antibiotics.", "consequence": "Wrong treatment - needs antibiotics, not antivirals.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "This is varicella pneumonia - obtain CXR urgently", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Varicella pneumonia** presents with **respiratory symptoms** (cough, dyspnea, tachypnea, hypoxia) days after rash onset - NOT skin changes with purulent drainage. The described findings (localized erythema, swelling, purulent discharge) are classic for **skin superinfection**.", "consequence": "Misidentifies the complication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Cerebellitis - this explains the fever return", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Varicella cerebellitis** presents with **ataxia** (unsteady gait, dysmetria) typically 1-3 weeks post-infection. It does NOT cause skin changes. The described findings clearly indicate bacterial skin superinfection, not CNS involvement.", "consequence": "Misidentifies the complication.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Varicella complications**: Most common = **bacterial superinfection** (GAS, S. aureus - can cause necrotizing fasciitis!). Others: **pneumonia** (more common in adults, immunocompromised), **cerebellitis** (ataxia 1-3 weeks post-infection, good prognosis), **encephalitis** (altered mental status, seizures - worse prognosis), **Reye syndrome** (if given aspirin)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The superinfection resolves with antibiotics. Before discharge, the mother asks when her daughter can return to school and whether her newborn sibling (2 weeks old) is at risk.", "question": "What do you advise about contagiousness and protecting the newborn?", "choices": [{"id": "node-4-choice-a", "text": "Return to school when ALL lesions are crusted; newborn needs VariZIG immediately", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Child is contagious from **1-2 days before rash until ALL lesions are crusted** (usually 5-7 days after rash onset). The **2-week-old newborn** is at HIGH RISK for severe/fatal varicella. Give **VariZIG (varicella zoster immune globulin)** within **10 days of exposure** (ideally within 96 hours) - passive immunization.", "consequence": "Appropriate infection control and protection of newborn.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Return to school after 24 hours of antibiotics; newborn protected by maternal antibodies", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect on both counts! Varicella contagiousness depends on **lesion crusting**, NOT antibiotic duration (antibiotics were for bacterial superinfection). The newborn is NOT protected - mother is susceptible (unvaccinated, never had chickenpox), so no transplacental antibody transfer. Newborn needs VariZIG.", "consequence": "Dangerous - exposes contacts and newborn.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Return when fever-free; give newborn varicella vaccine now", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Varicella **vaccine is NOT given to infants <12 months** - they cannot mount adequate immune response. Newborns exposed to varicella need **VariZIG** (passive antibodies), not vaccine. Return to school depends on lesion crusting, not fever.", "consequence": "Vaccine inappropriate for newborn.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Immediate return is fine once on antibiotics; newborn unlikely to catch it", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Varicella is **HIGHLY contagious** (~90% attack rate in susceptible contacts). Exposed susceptible newborns have **significant mortality risk**. Keep siblings separated if possible and give VariZIG to the newborn urgently.", "consequence": "Underestimates contagiousness and newborn risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Return when lesions heal completely; newborn only needs monitoring", "isOptimal": false, "isAcceptable": false, "feedback": "Partially incorrect. Return is appropriate when lesions are **crusted** (not fully healed). More importantly, **monitoring alone is insufficient** for an exposed newborn - neonatal varicella can be fatal. The newborn needs **VariZIG** for passive protection.", "consequence": "Newborn needs VariZIG, not just monitoring.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Varicella post-exposure prophylaxis**: **VariZIG** (passive immunization) for high-risk exposed individuals: **newborns** (especially if mother had varicella 5 days before to 2 days after delivery), **immunocompromised**, **pregnant women without immunity**, **premature infants**. Give within **10 days** of exposure (ideally <96 hours). Varicella **vaccine** can be given to healthy susceptible contacts within **3-5 days** of exposure."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **varicella**. Key learning points: 1) **Dewdrops on rose petals** with lesions in **all stages simultaneously** = varicella. 2) Healthy children need **supportive care only** (NO aspirin - Reye syndrome!). 3) **Acyclovir** reserved for high-risk groups: >12yo, immunocompromised, chronic disease. 4) Most common complication = **bacterial superinfection** (GAS, S. aureus). 5) **VariZIG** for exposed high-risk contacts (newborns, immunocompromised, pregnant)."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key varicella points: **Centripetal** distribution (trunk > extremities), lesions in **all stages** (unlike smallpox). **NO aspirin** (Reye syndrome). Complications: **superinfection** (GAS/S. aureus), **pneumonia**, **cerebellitis** (ataxia), **encephalitis**. Contagious until **ALL lesions crusted**. **VariZIG** for exposed newborns/immunocompromised."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical varicella points: **NEVER give aspirin** (Reye syndrome). Recognize **superinfection** (fever recurrence, purulent lesions, spreading erythema) - needs antibiotics. **Neonatal varicella can be fatal** - give VariZIG to exposed newborns. Contagious until ALL lesions crusted."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-044", "title": "Erythema Infectiosum", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["slapped cheek appearance", "lacy reticular rash", "no longer contagious once rash appears", "erythema infectiosum"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-year-old female is brought to the pediatric clinic by her mother who is concerned about a facial rash that appeared 2 days ago.\n\nHistory: The child developed bright red cheeks that \"look like she was slapped.\" A day later, a lacy, pink rash appeared on her arms and legs. She had mild cold symptoms (runny nose, low-grade fever) about 1 week before the rash appeared, which have now resolved.\n\nThe child complains of mild joint aches in her knees. She is otherwise well with no fever currently.\n\nEpidemiology: Several classmates have had similar rashes over the past 2 weeks.\n\nPhysical Examination:\n- Face: Bilateral bright red, confluent erythema on cheeks with circumoral pallor (\"slapped cheek\" appearance)\n- Extremities: Lacy, reticular (net-like) erythematous rash on arms and legs\n- Joints: No swelling or warmth\n- General: Well-appearing, playful, afebrile", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the characteristic rash pattern:\n\n**Stage 1** (days 1-4): **\"Slapped cheek\"** appearance - bright red, confluent erythema on both cheeks with **circumoral pallor**\n\n**Stage 2** (days 4-7): **Lacy, reticular rash** spreads to trunk and extremities\n\n**Stage 3** (weeks 1-3): Rash **fades and recurs** with triggers (heat, sunlight, bathing, exercise)\n\n**Key history:**\n- Prodromal viral symptoms **1 week before rash** (now resolved)\n- School outbreak of similar illness\n- Mild arthralgias", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Erythema infectiosum (Fifth Disease) - Parvovirus B19", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Erythema infectiosum** (Fifth Disease) caused by **Parvovirus B19** is the most likely diagnosis. The buzzwords are: **slapped cheek appearance**, **lacy reticular rash**, and importantly - the child is **no longer contagious once the rash appears**. The prodromal illness (fever, URI symptoms) occurred during the contagious period before the rash. School-age children (5-15 years) are most commonly affected.", "consequence": "You correctly diagnose Fifth Disease. Now you need to determine management and identify any high-risk situations.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Systemic Lupus Erythematosus (SLE)", "isOptimal": false, "isAcceptable": true, "feedback": "Good consideration - both can cause facial erythema. However, the **malar rash of SLE** is a **fixed, butterfly-shaped** rash that **does NOT cross the nasolabial folds**, whereas the slapped cheek of Fifth Disease involves the entire cheek. SLE would also have **systemic symptoms** (fatigue, weight loss, fever) and **other findings** (arthritis, nephritis, serositis). The **reticular pattern** of the extremity rash and school outbreak favor Parvovirus B19.", "consequence": "SLE should be considered in the differential, but clinical features strongly favor Fifth Disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Rubella (German Measles)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Rubella** presents with a **maculopapular rash** (not reticular/lacy) that starts on the face and spreads downward. Key features of rubella include **posterior cervical and suboccipital lymphadenopathy** and **Forchheimer spots** (palatal petechiae). The **lacy, reticular pattern** and **slapped cheek appearance** are characteristic of Parvovirus B19, not rubella. Rubella is also rare due to vaccination.", "consequence": "Misdiagnosis delays appropriate counseling about Fifth Disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Scarlet Fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Scarlet fever** (Group A Strep) presents with a **sandpaper-textured**, diffuse erythematous rash with **Pastia lines** (accentuation in skin folds) and a **strawberry tongue**. The face is flushed but shows **circumoral pallor** (similar to Fifth Disease), but the rash texture and distribution are different. Scarlet fever is associated with **pharyngitis** and requires **antibiotic treatment**.", "consequence": "Unnecessary antibiotic treatment and incorrect diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Drug eruption", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is **no recent medication exposure** mentioned. Drug eruptions typically occur **within days to weeks** of starting a new medication and resolve after discontinuation. The characteristic **slapped cheek** and **lacy reticular pattern** with preceding viral prodrome strongly suggest Parvovirus B19.", "consequence": "Incorrect diagnosis; no medication to discontinue.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Fifth Disease buzzwords: **slapped cheek appearance**, **lacy reticular rash**, **no longer contagious once rash appears**. The child was contagious during the prodromal phase BEFORE the rash appeared."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose Erythema infectiosum (Fifth Disease).\n\nThe mother asks several questions:\n1. Does my daughter need any treatment?\n2. Can she go back to school?\n3. Are there any special precautions needed?\n\nYou also notice in the chart that the child's teacher is pregnant (12 weeks gestation).", "question": "What is the most appropriate management and counseling?", "choices": [{"id": "node-2-choice-a", "text": "Supportive care; child can return to school (no longer contagious); advise pregnant teacher to consult her OB", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Supportive care** is all that's needed for healthy children - the illness is self-limited. Critically, the child is **no longer contagious once the rash appears** (contagious period was during the prodromal phase), so she **can return to school**. However, **pregnant women** exposed to Parvovirus B19 should be counseled to consult their OB for **IgG/IgM testing** due to the risk of **hydrops fetalis** (especially in first 20 weeks).", "consequence": "You provide appropriate counseling. The mother has one more question about a family situation.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Prescribe acyclovir for antiviral treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acyclovir** is effective against herpesviruses (HSV, VZV), not Parvovirus B19. **Parvovirus B19 is a single-stranded DNA virus** and there is no specific antiviral therapy. The illness is self-limited in healthy children. IVIG may be used in immunocompromised patients with chronic infection.", "consequence": "Unnecessary medication that won't help.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Keep child home from school until rash resolves completely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Isolation is NOT necessary** once the rash appears because the child is **no longer contagious**. The contagious period is during the **prodromal phase** (before the rash), when the diagnosis is typically not known. The rash may recur for weeks with triggers (heat, exercise, bathing), but this does not indicate ongoing contagiousness.", "consequence": "Unnecessary school absence; child is not contagious.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Order parvovirus IgG/IgM titers to confirm diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "Serologic testing is generally **not needed** for diagnosis in typical cases - the clinical presentation is distinctive. Testing may be helpful in **atypical presentations**, for **pregnant contacts**, or when evaluating **complications**. In this well-appearing child with classic presentation, clinical diagnosis is sufficient.", "consequence": "Unnecessary testing for classic clinical presentation; adds cost without changing management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Reassure mother; no need to inform the pregnant teacher", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While Fifth Disease is benign in healthy children, **pregnant women** should be informed of exposure so they can consult their OB. Parvovirus B19 can cause **hydrops fetalis** (severe fetal anemia and heart failure) in **~5% of infected pregnancies**, particularly in the **first 20 weeks**. The teacher should be tested for IgG/IgM.", "consequence": "Failure to counsel about pregnancy risk could lead to missed opportunity for monitoring.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**No longer contagious once rash appears** - child can return to school! Pregnant contacts should consult OB for testing (risk of **hydrops fetalis** in ~5% of infected pregnancies)."}, "node-3": {"id": "node-3", "type": "decision", "content": "The mother mentions that her 8-year-old nephew, who also attends the same school, has **sickle cell disease**. He visited their home last week when her daughter had the \"cold symptoms\" (before the rash appeared).\n\nShe asks if her nephew is at any special risk.", "question": "What is the most important concern regarding the nephew with sickle cell disease?", "choices": [{"id": "node-3-choice-a", "text": "Risk of aplastic crisis - advise his family to monitor for pallor/fatigue and contact hematologist", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **critical teaching point**. Parvovirus B19 infects **erythroid progenitor cells** via the P antigen receptor, causing **transient arrest of erythropoiesis**. In healthy individuals, this is subclinical. However, in patients with **chronic hemolytic anemias** (sickle cell disease, hereditary spherocytosis, thalassemia), who depend on high RBC production to compensate for destruction, this can cause **aplastic crisis** with severe, life-threatening anemia. The reticulocyte count drops to near zero. The family should be counseled to watch for **pallor, fatigue, dyspnea** and contact the hematologist immediately.", "consequence": "You provide appropriate counseling. The nephew's family is alerted and he is monitored closely by hematology.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "No special concern; Fifth Disease is always benign", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While Fifth Disease is benign in **healthy children**, it can cause **serious complications** in specific populations: **aplastic crisis** in patients with chronic hemolytic anemias (sickle cell, spherocytosis), **hydrops fetalis** in pregnant women, and **chronic anemia** in immunocompromised patients. The nephew with sickle cell disease is at **significant risk** for aplastic crisis.", "consequence": "Failure to recognize this critical complication could be life-threatening.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Risk of vasoocclusive crisis from the infection", "isOptimal": false, "isAcceptable": true, "feedback": "While any infection can potentially trigger a **vasoocclusive crisis** in sickle cell disease, the **specific and more serious concern** with Parvovirus B19 is **aplastic crisis**. The virus directly infects erythroid precursors, halting RBC production. In a patient who already has shortened RBC survival, this causes a **precipitous drop in hemoglobin** that can be life-threatening. Aplastic crisis is THE key association to remember.", "consequence": "Partially correct, but the more critical concern is aplastic crisis from erythroid suppression.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Recommend prophylactic blood transfusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic transfusion is not indicated**. The appropriate action is **close monitoring** and **education** about signs of anemia (pallor, fatigue, dyspnea, tachycardia). If aplastic crisis develops, the patient may need **transfusion support**, but this is done based on clinical/laboratory evidence of significant anemia, not prophylactically.", "consequence": "Unnecessary transfusion with associated risks.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Give IVIG prophylaxis to prevent infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **IVIG is not used prophylactically** for Parvovirus exposure. IVIG may be used to treat **chronic Parvovirus B19 infection in immunocompromised patients** who cannot clear the virus, but it is not indicated for exposure in sickle cell patients. The exposure has already occurred; appropriate management is **monitoring** for aplastic crisis.", "consequence": "Inappropriate use of IVIG; does not prevent aplastic crisis.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "Parvovirus B19 can cause **APLASTIC CRISIS** in patients with chronic hemolytic anemias (sickle cell, spherocytosis, thalassemia). The virus infects erythroid progenitors \u2192 transient arrest of RBC production \u2192 severe anemia in patients with shortened RBC survival."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **Erythema infectiosum (Fifth Disease)** and identified the critical complications.\n\n**Key Learning Points:**\n\n**Fifth Disease Recognition:**\n- Caused by **Parvovirus B19** (single-stranded DNA virus)\n- Buzzwords: **slapped cheek appearance**, **lacy reticular rash**\n- Three stages: slapped cheek \u2192 lacy rash on extremities \u2192 fading/recurrence with triggers\n- **No longer contagious once rash appears** - child can return to school\n\n**High-Risk Populations:**\n1. **Chronic hemolytic anemias** (sickle cell, spherocytosis) \u2192 **Aplastic crisis**\n2. **Pregnant women** (especially <20 weeks) \u2192 **Hydrops fetalis** (~5% risk)\n3. **Immunocompromised** \u2192 Chronic infection, pure red cell aplasia\n\n**Management:**\n- Healthy children: Supportive care (self-limited)\n- Pregnant contacts: IgG/IgM testing, OB consultation\n- Hemolytic anemia patients: Close monitoring for aplastic crisis"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key features:\n\n**Fifth Disease (Parvovirus B19):**\n- **Slapped cheek appearance** + **lacy reticular rash**\n- **No longer contagious once rash appears** (contagious during prodrome)\n- Self-limited in healthy children - supportive care only\n\n**Critical Complications:**\n- **Aplastic crisis** in patients with chronic hemolytic anemias (sickle cell, spherocytosis)\n- **Hydrops fetalis** in pregnant women (first 20 weeks highest risk)\n- **Chronic infection** in immunocompromised patients\n\nAlways ask about pregnant contacts and patients with hemolytic anemias!"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect.\n\n**Critical Points:**\n- Fifth Disease is caused by **Parvovirus B19**, NOT a herpesvirus (acyclovir won't help)\n- Child is **NO LONGER CONTAGIOUS** once rash appears - can return to school\n- **Pregnant women** must be counseled about **hydrops fetalis** risk\n- **Sickle cell patients** are at risk for **APLASTIC CRISIS** (life-threatening anemia)\n- The virus infects erythroid progenitors, causing transient arrest of RBC production\n- No specific antiviral treatment; supportive care only"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-045", "title": "Hand-Foot-Mouth Disease", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["oral ulcers", "vesicles on palms and soles", "refuses to eat due to mouth pain", "hand-foot-mouth disease"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-year-old male is brought to the pediatric clinic by his mother who is concerned about mouth sores and a rash.\n\nHistory: Three days ago, the child developed a low-grade fever (38.2\u00b0C) and became fussy. He then developed painful sores in his mouth and has been refusing to eat and drooling. Small blisters appeared on his hands, feet, and diaper area.\n\nHis 4-year-old sister had similar symptoms last week, and several children at his daycare have been sick.\n\nPhysical Examination:\n- Vitals: T 38.0\u00b0C, HR 110, well-hydrated\n- Oropharynx: Multiple small vesicles and shallow ulcers (2-3 mm) on tongue, buccal mucosa, and soft palate\n- Hands/Feet: Oval, gray vesicles with surrounding erythema on palms and soles\n- Buttocks: Scattered papulovesicles\n- General: Irritable but alert, tolerating small sips of water", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the characteristic lesion distribution:\n\n**Oral findings:**\n- Small vesicles and **shallow ulcers** on tongue, buccal mucosa, soft palate\n- Ulcers are **painful** \u2192 causing decreased oral intake\n\n**Skin findings:**\n- **Oval vesicles** with gray center and erythematous halo\n- Located on **palms, soles, and buttocks** (classic distribution)\n- Lesions may be tender but less painful than oral ulcers\n\n**Key epidemiology:**\n- Age <5 years (peak age)\n- Daycare outbreak\n- Summer/fall seasonality", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Hand-Foot-Mouth Disease (Coxsackievirus A16)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Hand-Foot-Mouth Disease (HFMD)** is caused most commonly by **Coxsackievirus A16** (also Enterovirus 71 and other Coxsackie strains). The classic triad is: **oral ulcers** + **vesicles on palms and soles** + **buttock involvement**. The oval vesicles with gray centers are characteristic. HFMD is highly contagious and spreads through fecal-oral route, respiratory droplets, and vesicle fluid contact.", "consequence": "You correctly diagnose HFMD. Now you need to manage symptoms and counsel the family.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Herpangina", "isOptimal": false, "isAcceptable": true, "feedback": "Good differential! **Herpangina** is also caused by Coxsackieviruses and presents with oral vesicles/ulcers. However, the key difference is that herpangina has lesions **only in the POSTERIOR oropharynx** (soft palate, uvula, tonsils) with **NO skin lesions**. This child has vesicles on the palms, soles, and buttocks - the full triad of HFMD.", "consequence": "Herpangina and HFMD are related but the skin involvement points to HFMD.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "HSV Gingivostomatitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Primary HSV gingivostomatitis** causes painful oral vesicles/ulcers but involves the **ANTERIOR mouth** (gingiva, lips, anterior tongue) and often causes **bleeding, swollen gums**. Lesions may extend to **perioral skin** (around lips). HSV does **NOT cause vesicles on palms/soles**. The distribution here (posterior oral + palms/soles) is classic for HFMD.", "consequence": "HSV gingivostomatitis has different distribution and would require antiviral consideration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Varicella (Chickenpox)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Varicella** presents with vesicles in **all stages of development** (papules, vesicles, pustules, crusts) and has a **centripetal distribution** (trunk > face > extremities). The classic description is **\"dewdrop on a rose petal\"**. Varicella does NOT specifically target palms/soles like HFMD. The oval vesicles on palms, soles, and buttocks with oral ulcers is pathognomonic for HFMD.", "consequence": "Varicella has different lesion morphology and distribution.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Erythema multiforme", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Erythema multiforme** presents with **target lesions** (three concentric color zones) that favor the **extensor surfaces** and may involve palms/soles. EM can have oral involvement but the lesions are typically larger erosions rather than discrete vesicles. There is usually a trigger (HSV, Mycoplasma, drugs). The vesicular morphology and daycare outbreak favor HFMD.", "consequence": "EM has different lesion morphology (target lesions).", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "HFMD triad: **Oral ulcers** + **vesicles on PALMS and SOLES** + **buttock involvement**. Caused by Coxsackievirus A16 (common) or Enterovirus 71 (associated with severe neurologic complications)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose Hand-Foot-Mouth Disease.\n\nThe mother is concerned because her son is barely eating and asks what she can do to help. She also wants to know if he needs any medications and when he can return to daycare.\n\nThe child appears well-hydrated with moist mucous membranes and good urine output per the mother.", "question": "What is the most appropriate management?", "choices": [{"id": "node-2-choice-a", "text": "Supportive care: pain control (acetaminophen/ibuprofen, cold fluids), monitor hydration; can return to daycare when afebrile", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! HFMD is **self-limited** (resolves in 7-10 days) and requires only **supportive care**: **Pain control** with acetaminophen or ibuprofen helps with oral discomfort. **Cold fluids**, popsicles, and soft foods are easier to tolerate. **Monitor hydration** closely since oral pain may limit intake. The child can return to daycare when **afebrile and able to participate** - isolation is not strictly required since the virus is shed in stool for weeks anyway.", "consequence": "You provide appropriate counseling. The mother then mentions a concerning symptom.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Prescribe acyclovir for antiviral treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acyclovir** is effective against **herpesviruses** (HSV, VZV), not **enteroviruses** (Coxsackievirus). There is **no specific antiviral treatment** for HFMD. The illness is self-limited and resolves with supportive care in 7-10 days.", "consequence": "Acyclovir is ineffective and unnecessary.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Prescribe oral antibiotics for the mouth ulcers", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HFMD is caused by a **virus**, not bacteria. **Antibiotics are not indicated**. The oral ulcers are viral in origin and will heal on their own. Unnecessary antibiotics contribute to resistance and may cause side effects.", "consequence": "Antibiotics are ineffective and inappropriate for viral illness.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Apply topical benzocaine to oral ulcers for pain relief", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical benzocaine is NOT recommended** in young children due to risk of **methemoglobinemia** (FDA warning). Oral pain can be managed with **systemic analgesics** (acetaminophen, ibuprofen) and **cold foods/fluids**. Viscous lidocaine may be used cautiously in older children under specific guidance but is generally avoided in toddlers.", "consequence": "Benzocaine poses risk of methemoglobinemia in young children.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Strict isolation until all lesions have crusted over", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Unlike **varicella** (where isolation until lesions crust is recommended), HFMD does **not require strict isolation** until lesions resolve. The virus is shed in **stool for weeks** after clinical recovery, making complete isolation impractical. The child can return to daycare when **afebrile** and able to participate. Good **hand hygiene** is the most important preventive measure.", "consequence": "Prolonged isolation is impractical and unnecessary.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "HFMD is **self-limited** (7-10 days). Treatment is **supportive**: pain control (acetaminophen/ibuprofen - NOT topical benzocaine), cold fluids, monitor hydration. No antiviral or antibiotic treatment."}, "node-3": {"id": "node-3", "type": "decision", "content": "As you finish counseling, the mother mentions that last night the child had one episode where he seemed to \"jerk\" for about 10 seconds while sleeping. He was not responsive during the episode but returned to normal afterward and seemed fine this morning.\n\nYou examine the child more carefully:\n- Alert and interactive, playing with toys\n- No focal neurological deficits\n- Normal gait and coordination\n- Pupils equal and reactive\n- No meningeal signs", "question": "What is the most appropriate response to this new information?", "choices": [{"id": "node-3-choice-a", "text": "Counsel about febrile seizures; provide strict return precautions for neurologic symptoms", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! A brief, self-limited seizure in the context of fever is likely a **simple febrile seizure**, which is common in children 6 months to 5 years. However, **Enterovirus 71 (EV-71)**, one of the causes of HFMD, is associated with rare but serious **neurologic complications** including **brainstem encephalitis**, **aseptic meningitis**, and **acute flaccid paralysis**. The child should have **strict return precautions** for: persistent vomiting, altered consciousness, weakness, ataxia, or recurrent seizures. Currently, the child has a normal neurological exam, so immediate hospitalization is not required.", "consequence": "You provide appropriate counseling and return precautions. The family is instructed to return immediately if concerning symptoms develop.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Immediate hospitalization and lumbar puncture", "isOptimal": false, "isAcceptable": true, "feedback": "While **lumbar puncture and hospitalization** would be appropriate if there were **persistent neurological abnormalities**, **prolonged seizures**, or **meningeal signs**, this child currently has a **normal neurological examination** after what appears to be a simple febrile seizure. Immediate LP is not mandatory but close monitoring with **strict return precautions** is essential given the risk of EV-71 neurologic complications.", "consequence": "LP may be considered but is not urgently required given normal current examination.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Reassure completely - seizures are not associated with HFMD", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While most cases of HFMD are benign, **Enterovirus 71** can cause **severe neurologic complications** including **brainstem encephalitis**, **aseptic meningitis**, **acute flaccid paralysis**, and **myocarditis**. EV-71 outbreaks in Asia have caused significant morbidity and mortality. Complete reassurance without return precautions is inappropriate.", "consequence": "Failure to warn about potential neurologic complications is dangerous.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Order brain MRI before discharge", "isOptimal": false, "isAcceptable": false, "feedback": "**Brain MRI** is not routinely indicated after a simple febrile seizure with normal neurological examination. MRI would be considered for **focal seizures**, **prolonged seizures**, **persistent neurological deficits**, or **concern for brainstem encephalitis**. Close outpatient follow-up with return precautions is more appropriate for this well-appearing child.", "consequence": "MRI is not indicated for simple febrile seizure with normal examination.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Start prophylactic antiepileptic medication", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prophylactic antiepileptic medications are NOT recommended** after simple febrile seizures. The recurrence risk is about 30%, but the seizures are benign and self-limited. Antiepileptic medications have side effects and do not prevent future febrile seizures or epilepsy development. Management is supportive with fever control and return precautions.", "consequence": "Antiepileptic prophylaxis is not indicated for febrile seizures.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Enterovirus 71** HFMD can cause serious neurologic complications: **brainstem encephalitis**, **aseptic meningitis**, **acute flaccid paralysis**. Strict return precautions for: persistent vomiting, altered consciousness, weakness, ataxia, or recurrent seizures."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **Hand-Foot-Mouth Disease** and provided appropriate management and counseling.\n\n**Key Learning Points:**\n\n**HFMD Recognition:**\n- Classic triad: **Oral ulcers** + **vesicles on palms/soles** + **buttock lesions**\n- Caused by **Coxsackievirus A16** (most common) or **Enterovirus 71** (neuro complications)\n- Peak age: <5 years; Summer/fall; Daycare outbreaks\n\n**HFMD vs Herpangina:**\n- HFMD: Oral ulcers + skin lesions (palms, soles, buttocks)\n- Herpangina: ONLY posterior oral lesions (no skin involvement)\n\n**Management:**\n- **Supportive care** (self-limited in 7-10 days)\n- Pain control: acetaminophen/ibuprofen (NOT topical benzocaine - methemoglobinemia risk)\n- Cold fluids, soft foods, monitor hydration\n- No antiviral or antibiotic treatment\n\n**Complications (EV-71):**\n- Brainstem encephalitis, aseptic meningitis, acute flaccid paralysis, myocarditis\n- Return precautions: vomiting, altered consciousness, weakness, ataxia"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key features:\n\n**HFMD:**\n- **Oral ulcers** + **vesicles on palms/soles** + buttock lesions\n- Coxsackievirus A16 (common) or Enterovirus 71 (neuro complications)\n- Self-limited (7-10 days), supportive care only\n\n**Herpangina** = ONLY posterior oral lesions (no skin involvement)\n\n**Management:**\n- Pain control (acetaminophen/ibuprofen)\n- Cold fluids, monitor hydration\n- NO topical benzocaine (methemoglobinemia risk in young children)\n- NO antibiotics or antivirals\n- Return when afebrile - strict isolation not required\n\n**EV-71 Complications:** Watch for neurologic signs (vomiting, weakness, ataxia, altered consciousness)"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect.\n\n**Critical Points:**\n- HFMD is **VIRAL** (Coxsackievirus) - antibiotics and acyclovir are NOT effective\n- **Topical benzocaine** is contraindicated in young children (methemoglobinemia risk)\n- HFMD is usually **self-limited and benign** but **Enterovirus 71** can cause:\n  - Brainstem encephalitis\n  - Aseptic meningitis\n  - Acute flaccid paralysis\n  - Myocarditis\n- Never completely reassure without warning about potential **neurologic complications**\n- Provide **strict return precautions** for: vomiting, weakness, ataxia, altered consciousness"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-070", "title": "Osteomyelitis Recognition", "domain": "infectious_disease", "difficulty": "advanced", "tags": ["osteomyelitis", "bone infection", "Staphylococcus aureus", "MRSA", "metaphyseal tenderness", "MRI diagnosis", "subperiosteal abscess", "surgical drainage", "IV antibiotics", "antibiotic duration"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 10-year-old male presents with leg pain and limp for 5 days.\n\nHistory reveals, he has had worsening pain in his right leg for 5 days. He is now limping and refuses to bear weight. He has had fevers. He scraped his leg while skateboarding 2 weeks ago.\n\nAssociated symptoms include fever and localized warmth. Denies joint swelling.\n\nPast medical history includes He is otherwise healthy. Sickle cell disease ruled out previously.\n\nPhysical Examination:\n- Musculoskeletal: point tenderness over right tibial metaphysis with warmth.\n- General: febrile (38.8\u00b0C), ill-appearing.\n- Vitals: febrile.\n- Labs: CRP 2 mg/dL.\n- Joints: no effusion, full range of motion of knee and ankle.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 10-year-old with 5 days of progressive leg pain, fever, and limp. Key examination finding: **point tenderness over the tibial metaphysis** with normal joint exam.\n\n**Key clinical features suggesting bone infection:**\n- **Focal bone tenderness** (especially over metaphysis)\n- Fever with localized warmth\n- Limp or refusal to bear weight\n- **Recent minor trauma/skin break** (portal of entry for bacteria)\n- Symptoms develop over **days** (not sudden like septic arthritis)\n\nLabs: WBC 14,000/\u03bcL, ESR 45 mm/hr, CRP 8.2 mg/dL", "question": "Based on this clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Acute hematogenous osteomyelitis - focal bone tenderness at metaphysis", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This presentation is classic for **acute hematogenous osteomyelitis**: **focal point tenderness over the metaphysis**, fever, elevated inflammatory markers, and progression over days. The **metaphysis** is the most common site because it has slow, turbulent blood flow in the sinusoidal vessels, allowing bacteria to settle. The history of a skin break 2 weeks prior suggests a portal of entry for bacteremia.", "consequence": "Correct diagnosis. Proceed with workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Septic arthritis - fever with limp indicates joint infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Septic arthritis presents with **joint involvement**: swelling, effusion, pain with range of motion, joint held in position of comfort. This patient has **normal joint exam** (no effusion, full ROM of knee and ankle) with point tenderness **over the bone**, not the joint. The metaphysis of the tibia is the site of pathology, not the knee joint.", "consequence": "Wrong anatomical localization. The joints are normal.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Cellulitis - skin infection from skateboard injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Cellulitis causes **superficial skin findings**: spreading erythema, warmth, induration. This patient's skin appears normal - the tenderness is **deep, over the bone**. Additionally, the injury was 2 weeks ago - cellulitis would have presented earlier and more superficially.", "consequence": "Missed deep bone infection. Cellulitis is superficial.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Stress fracture - overuse injury in active child", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Stress fractures cause focal bone pain but are **NOT associated with fever, elevated inflammatory markers, or systemic illness**. This patient has fever 38.8\u00b0C, WBC 14,000, and CRP 8.2 - these findings indicate infection, not mechanical injury.", "consequence": "Fever and elevated CRP rule out simple stress fracture.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Growing pains - common cause of leg pain in children", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Growing pains are **bilateral**, typically nocturnal, affect muscles (not bones), resolve by morning, and are **NOT associated with fever, limp, point tenderness, or elevated inflammatory markers**. This patient's presentation with unilateral bone tenderness, fever, and elevated labs is pathological.", "consequence": "Dangerous dismissal of serious infection.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Osteomyelitis vs Septic Arthritis**: Osteomyelitis = **focal bone tenderness** (especially metaphysis), joints uninvolved, symptoms over days. Septic arthritis = **joint swelling/effusion**, pain with ROM, rapid onset. Both cause fever and elevated inflammatory markers. In infants, metaphysis is intracapsular (especially hip/shoulder) \u2192 can have both simultaneously."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect acute hematogenous osteomyelitis based on focal metaphyseal tenderness with fever and elevated inflammatory markers.\n\n**Diagnostic approach:**\n- Blood cultures (positive in ~50%)\n- Inflammatory markers (CRP, ESR - both elevated)\n- Imaging to confirm diagnosis\n\n**Important:** X-rays are often **NORMAL in early osteomyelitis** because bone destruction takes 10-14 days to become visible radiographically.", "question": "What is the most appropriate imaging study to confirm suspected osteomyelitis?", "choices": [{"id": "node-2-choice-a", "text": "MRI of the affected extremity - most sensitive early test", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **MRI is the gold standard** for diagnosing osteomyelitis. It detects changes within **24-48 hours** of infection onset: **bone marrow edema**, periosteal reaction, soft tissue involvement, and abscess formation. Sensitivity is **>95%**. MRI also helps differentiate osteomyelitis from other bone pathology (tumor, infarct) and identifies adjacent joint involvement.", "consequence": "MRI ordered. Bone marrow edema and periosteal enhancement seen.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Plain X-ray of the tibia", "isOptimal": false, "isAcceptable": true, "feedback": "X-ray is reasonable as an initial study and may show soft tissue swelling, but **X-rays are often NORMAL in the first 10-14 days** of osteomyelitis. Lytic changes and periosteal reaction take time to develop. A negative X-ray does NOT rule out osteomyelitis. If suspicion is high, MRI should be performed regardless of X-ray findings.", "consequence": "X-ray may be normal early. MRI needed for definitive diagnosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "CT scan of the leg", "isOptimal": false, "isAcceptable": false, "feedback": "CT is less sensitive than MRI for early osteomyelitis and involves radiation. CT is better for **chronic osteomyelitis** (sequestrum, involucrum) or surgical planning, but **MRI is superior for acute osteomyelitis** due to better soft tissue contrast and ability to detect early bone marrow edema.", "consequence": "CT is inferior to MRI for early osteomyelitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Bone scan (technetium-99m)", "isOptimal": false, "isAcceptable": true, "feedback": "Bone scan has high sensitivity for osteomyelitis and can survey the entire skeleton, useful when the site is uncertain or multifocal disease is suspected. However, it has **lower specificity than MRI** (can't distinguish infection from other causes of increased bone turnover) and provides less anatomical detail. MRI is preferred when the site is known.", "consequence": "Acceptable but MRI provides more specific information.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "No imaging needed - treat empirically based on clinical diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** While treatment should not be delayed significantly, imaging is important to: (1) **Confirm the diagnosis**, (2) Identify **abscess formation** requiring surgical drainage, (3) Rule out adjacent joint involvement, (4) Evaluate extent of disease. Blood cultures should be drawn before antibiotics, and MRI obtained promptly.", "consequence": "Missed abscess could lead to treatment failure.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**X-rays are often NORMAL for 10-14 days** in osteomyelitis - don't be falsely reassured! **MRI is the imaging modality of choice**: detects bone marrow edema within 24-48 hours, sensitivity >95%, shows abscess formation and soft tissue extent. Order MRI even if X-ray is normal."}, "node-3": {"id": "node-3", "type": "decision", "content": "MRI of the right leg shows:\n- **T1 low signal, T2/STIR high signal** in the proximal tibial metaphysis consistent with **bone marrow edema**\n- **Periosteal enhancement**\n- Small **subperiosteal fluid collection** (2 cm)\n- No joint effusion\n- No soft tissue abscess\n\nBlood cultures have been drawn. The findings confirm acute osteomyelitis with a small subperiosteal collection.\n\n**Most common pathogen:** Staphylococcus aureus (>80% of cases)", "question": "What is the most appropriate empiric antibiotic regimen?", "choices": [{"id": "node-3-choice-a", "text": "Cefazolin (or nafcillin) - if low MRSA prevalence; add vancomycin if high MRSA risk", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **S. aureus** causes >80% of pediatric osteomyelitis. Empiric coverage depends on local **MRSA prevalence**: In low-prevalence areas (<10%), **anti-staphylococcal penicillins** (nafcillin, oxacillin) or **first-generation cephalosporins** (cefazolin) are appropriate. In high-prevalence areas or with MRSA risk factors, **add vancomycin** empirically until cultures return.", "consequence": "Appropriate empiric coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Ceftriaxone alone", "isOptimal": false, "isAcceptable": true, "feedback": "Ceftriaxone provides good coverage for many pathogens but does **NOT cover MRSA**. It may be acceptable in low MRSA-prevalence areas, but many experts prefer anti-staphylococcal penicillins or first-generation cephalosporins (better S. aureus coverage) \u00b1 vancomycin if MRSA is a concern.", "consequence": "Acceptable but may miss MRSA.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Oral amoxicillin - bone infections can be treated orally", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Initial treatment of osteomyelitis requires **IV antibiotics** to achieve adequate bone penetration and bactericidal levels. Oral therapy may be used later for **step-down** after clinical improvement. Additionally, amoxicillin has poor S. aureus coverage (most are penicillinase-producers).", "consequence": "Inadequate initial therapy. Treatment failure likely.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Piperacillin-tazobactam for broad coverage", "isOptimal": false, "isAcceptable": false, "feedback": "This is **unnecessarily broad**. Piperacillin-tazobactam is used for polymicrobial infections, hospital-acquired infections, or when Pseudomonas coverage is needed. Community-acquired pediatric osteomyelitis is almost always caused by S. aureus - targeted anti-staphylococcal therapy is preferred.", "consequence": "Unnecessarily broad spectrum. Not appropriate for routine osteomyelitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Vancomycin plus metronidazole", "isOptimal": false, "isAcceptable": false, "feedback": "Metronidazole covers **anaerobes**, which are not typical pathogens in acute hematogenous osteomyelitis. Anaerobic coverage is needed for **diabetic foot infections, penetrating trauma, or chronic osteomyelitis** - not routine pediatric acute osteomyelitis.", "consequence": "Metronidazole not indicated for typical pediatric osteomyelitis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Osteomyelitis pathogens by age**: Neonates: **GBS, S. aureus, gram-negatives**. Children >3 months: **S. aureus** (>80%), Group A Strep. **Sickle cell patients**: **Salmonella** is as common as Staph (unique population). **Puncture wound through shoe**: **Pseudomonas aeruginosa**."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient is started on IV cefazolin (local MRSA prevalence is low). Blood cultures are pending.\n\nAfter 48 hours:\n- Fever persists (38.5\u00b0C)\n- Pain not improved\n- CRP increased to 10.5 mg/dL (was 8.2)\n- Still refusing to bear weight\n\nThe subperiosteal collection on MRI measured 2 cm.\n\n**Blood cultures return:** Staphylococcus aureus (pending sensitivities)", "question": "Given the lack of clinical improvement at 48 hours with a subperiosteal collection, what is the most appropriate next step?", "choices": [{"id": "node-4-choice-a", "text": "Surgical drainage of the subperiosteal abscess", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **Indications for surgical drainage** in osteomyelitis include: (1) **Subperiosteal or intraosseous abscess**, (2) Failure to improve after 48-72 hours of IV antibiotics, (3) Sequestrum (dead bone), (4) Adjacent joint involvement. This patient has a 2 cm subperiosteal collection and is not improving - surgical debridement and drainage is indicated.", "consequence": "Surgical drainage arranged.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue antibiotics for 2 more weeks before considering surgery", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Waiting weeks is inappropriate when there is an abscess and no clinical improvement. Antibiotics cannot adequately penetrate **walled-off collections** (abscess). The patient needs surgical source control. Delayed drainage leads to chronic osteomyelitis and bone destruction.", "consequence": "Delayed surgery leads to chronic osteomyelitis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Switch antibiotics to vancomycin (assume MRSA)", "isOptimal": false, "isAcceptable": true, "feedback": "Switching to vancomycin may be reasonable if MRSA is suspected (pending sensitivities), but the **primary issue is the undrained abscess**. Antibiotics alone won't cure an abscess - it needs drainage. The cultures grew S. aureus, and sensitivities will guide antibiotic choice, but surgical drainage is still needed.", "consequence": "Antibiotic change alone won't resolve abscess.", "nextNodeId": "node-4"}, {"id": "node-4-choice-d", "text": "Add rifampin for improved bone penetration", "isOptimal": false, "isAcceptable": false, "feedback": "Rifampin is used adjunctively for **chronic osteomyelitis** or **biofilm-associated infections** (prosthetics), not as a substitute for surgical drainage of an acute abscess. The primary problem is the undrained collection, not inadequate antibiotic penetration.", "consequence": "Rifampin won't compensate for undrained abscess.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Repeat MRI to see if collection has resolved", "isOptimal": false, "isAcceptable": false, "feedback": "The clinical picture is clear: fever persisting, CRP rising, pain unchanged. A repeat MRI is unlikely to show resolution and will only delay necessary surgical intervention. Clinical deterioration with a known abscess mandates drainage, not more imaging.", "consequence": "Imaging won't change management. Surgery needed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Indications for surgical drainage** in osteomyelitis: (1) **Abscess** (subperiosteal, intraosseous, soft tissue), (2) **No improvement after 48-72h IV antibiotics**, (3) **Sequestrum** (dead bone that won't respond to antibiotics), (4) **Chronic osteomyelitis**, (5) **Joint involvement**. Surgery allows debridement, culture, and drainage."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient undergoes surgical irrigation and debridement (I&D) of the tibial metaphysis. Findings:\n- Purulent material in subperiosteal space evacuated\n- Cortical drill holes created for decompression\n- No dead bone (sequestrum) identified\n- Intraoperative cultures sent\n\nPost-operative day 3:\n- Afebrile for 48 hours\n- Pain significantly improved\n- CRP: 5.2 mg/dL (down from 10.5)\n- Weight-bearing with minimal discomfort\n\n**Final culture sensitivities:** MSSA (methicillin-sensitive S. aureus)\n\nThe patient has been on cefazolin for 6 days total.", "question": "What is the appropriate antibiotic duration for acute osteomyelitis in this child?", "choices": [{"id": "node-5-choice-a", "text": "4-6 weeks total; can transition to oral when stable (typically after 1-2 weeks IV)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Acute osteomyelitis requires **4-6 weeks of antibiotic therapy**. Traditional approach is 2 weeks IV + 4 weeks oral. **Recent evidence** supports shorter IV courses (as little as 3-7 days) with early oral transition if: (1) Afebrile \u226548h, (2) Clinical improvement, (3) CRP declining, (4) Surgically drained (if abscess), (5) Reliable family. High-dose oral antibiotics achieve adequate bone levels.", "consequence": "Appropriate duration and transition criteria.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "2 weeks total is sufficient for pediatric osteomyelitis", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** 2 weeks is **too short** for osteomyelitis. Bone is relatively avascular compared to other tissues, and inadequate treatment duration leads to relapse, chronic osteomyelitis, and bone destruction. **4-6 weeks** is the standard duration.", "consequence": "Inadequate duration. Relapse and chronic osteomyelitis risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "6 weeks IV only - no oral step-down for osteomyelitis", "isOptimal": false, "isAcceptable": false, "feedback": "This is **overly conservative**. Studies show that **oral antibiotics** achieve adequate bone concentrations when given at appropriate doses. Keeping a well child hospitalized for 6 weeks of IV therapy is unnecessary, costly, and carries risks (line infections, hospital-acquired infections). Early oral transition is safe and effective.", "consequence": "Unnecessarily prolonged IV therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Continue until CRP completely normalizes, regardless of duration", "isOptimal": false, "isAcceptable": false, "feedback": "CRP is useful for monitoring response but should not be the sole determinant of treatment duration. CRP may take weeks to fully normalize even after infection is controlled. Standard duration is **4-6 weeks** based on clinical trials, with CRP used to ensure response rather than determine endpoint.", "consequence": "CRP normalization not required to complete therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Lifelong suppressive antibiotics needed for osteomyelitis", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect.** Lifelong suppression is sometimes used for **chronic osteomyelitis with retained hardware** (prosthetics) or in immunocompromised patients. Acute pediatric osteomyelitis is **curable** with appropriate drainage and 4-6 weeks of antibiotics. This child should make a full recovery.", "consequence": "Acute osteomyelitis is curable, not chronic.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Osteomyelitis antibiotic duration: 4-6 weeks**. Oral transition criteria: afebrile \u226548h, improving clinically, CRP declining (doesn't need to normalize), tolerating oral, reliable family. **Oral options for MSSA**: high-dose cephalexin (100-150 mg/kg/day) or clindamycin. Monitor CRP weekly - should continue to trend down."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of acute osteomyelitis!\n\n**Key Learning Points:**\n1. **Focal metaphyseal tenderness + fever + elevated CRP** = osteomyelitis until proven otherwise\n2. **X-rays are NORMAL for 10-14 days** - MRI is the gold standard\n3. **S. aureus** causes >80% of cases; cover MRSA empirically if high prevalence\n4. **Surgical drainage indicated** for: abscess, no improvement at 48-72h, sequestrum\n5. **Duration: 4-6 weeks** with early oral transition when stable\n6. **Monitor CRP** - should decline; if rising, reassess for complications\n\nThis patient completed 5 weeks of antibiotics (1 week IV, 4 weeks oral cephalexin), had full return of function, and no evidence of chronic osteomyelitis at follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review key principles:\n\n**Osteomyelitis Recognition:**\n- **Focal bone tenderness** (especially metaphysis)\n- Fever, elevated CRP/ESR\n- X-rays normal early \u2192 **MRI is gold standard**\n\n**Treatment:**\n- IV antibiotics covering **S. aureus** (\u00b1 MRSA coverage)\n- **Surgery if**: abscess, no improvement at 48-72h, sequestrum\n- **Duration: 4-6 weeks** total\n- Oral transition when: afebrile, improving, CRP declining"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in osteomyelitis management.\n\n**Consequences of inadequate treatment:**\n- **Chronic osteomyelitis** - difficult to cure, requires prolonged therapy and surgery\n- **Sequestrum formation** - dead bone that harbors bacteria\n- **Pathologic fracture** through weakened bone\n- **Growth plate damage** \u2192 limb length discrepancy\n- **Sepsis** from uncontrolled infection\n\n**Key Pearl:** Don't be falsely reassured by normal X-rays - they take 10-14 days to show changes. MRI is the gold standard for early diagnosis. Treat for the full 4-6 weeks to prevent chronic osteomyelitis."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-080", "title": "HPV Vaccination Timing", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["cancer prevention", "age 11-12", "before sexual debut", "hpv vaccination timing"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 11-year-old female's parents ask about HPV vaccination for their child..", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The parents are concerned about HPV vaccination. The mother asks: 'My daughter is only 11 - isn't she too young for this? She's not sexually active.'\n\nYou explain that HPV vaccination is recommended for all children ages 11-12 as routine immunization, regardless of anticipated sexual activity.", "question": "What is the PRIMARY reason the CDC recommends HPV vaccination at ages 11-12 rather than later?", "choices": [{"id": "node-1-choice-a", "text": "The immune response is stronger in younger adolescents, allowing for a 2-dose schedule instead of 3 doses", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The primary reason for vaccinating at **11-12 years** is the **superior immune response** at this age. When HPV vaccine is started **before age 15**, only **2 doses** are needed (0 and 6-12 months apart). If started at **age 15 or older**, **3 doses** are required (0, 1-2, and 6 months). Additionally, vaccination is most effective before any HPV exposure, which is best achieved by vaccinating before sexual debut.", "consequence": "You explain the immunologic rationale for early vaccination.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "HPV infections only occur before age 15", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HPV infections can occur at **any age** after sexual activity begins. The reason for early vaccination is to ensure protection **before** any potential exposure, and to take advantage of the **stronger immune response** in younger adolescents.", "consequence": "HPV infections can occur throughout life after exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "The vaccine contains live virus that is dangerous in older adolescents", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The HPV vaccine is a **recombinant subunit vaccine** made from **virus-like particles (VLPs)** - it contains NO viral DNA and **cannot cause infection**. It is safe at any age. The timing recommendation is based on immune response and ensuring protection before exposure, not safety concerns.", "consequence": "The vaccine does not contain live virus.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "It is easier to administer to younger children who are more compliant", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Compliance is not the primary reason for the age recommendation. The scientific basis is the **enhanced immunogenicity** (stronger immune response) in younger adolescents. This actually allows for a simpler 2-dose schedule compared to the 3-dose schedule needed for older adolescents/adults.", "consequence": "The reason is immunologic, not practical.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Insurance only covers the vaccine until age 13", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HPV vaccination is covered by insurance and the **Vaccines for Children (VFC) program** through age **26** for most individuals. The age 11-12 recommendation is based on **immunologic evidence**, not insurance coverage. Catch-up vaccination is recommended through age 26 (and sometimes 27-45 after shared decision-making).", "consequence": "Coverage extends well beyond age 13.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **HPV vaccine dosing by age**: Started **<15 years** = **2 doses** (0 and 6-12 months). Started **\u226515 years** = **3 doses** (0, 1-2, and 6 months). The 2-dose schedule produces equivalent antibody levels due to superior immune response in younger adolescents. Start at 9 years for history of sexual abuse."}, "node-2": {"id": "node-2", "type": "decision", "content": "The parents seem more receptive but ask: 'What cancers does this vaccine actually prevent? I've only heard about cervical cancer.'\n\nYou explain that HPV causes multiple types of cancer in both males and females.", "question": "Which of the following is TRUE regarding HPV-related cancers and the vaccine?", "choices": [{"id": "node-2-choice-a", "text": "HPV causes cervical, oropharyngeal, anal, vulvar, vaginal, and penile cancers; vaccination is equally important for males and females", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! HPV causes **multiple cancers** beyond cervical cancer: **oropharyngeal** (now the most common HPV-related cancer in the US), **anal**, **vulvar**, **vaginal**, and **penile** cancers, plus **genital warts**. **Males** are equally at risk for oropharyngeal and anal cancers. The 9-valent vaccine (Gardasil 9) protects against HPV types 16, 18, 31, 33, 45, 52, 58 (cancer-causing) and 6, 11 (wart-causing), preventing ~90% of HPV-related cancers.", "consequence": "Parents understand the broad cancer prevention benefit.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "HPV only causes cervical cancer; males don't need vaccination", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HPV causes **multiple cancers in both sexes**. **Oropharyngeal cancer** (throat cancer) caused by HPV is now more common than cervical cancer in the US, and affects **males more than females**. Anal cancer also affects both sexes. Male vaccination is equally important for individual protection and herd immunity.", "consequence": "Misses important cancer prevention for males.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "The HPV vaccine treats existing HPV infections and precancerous lesions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The HPV vaccine is **preventive only** - it does NOT treat existing HPV infections or precancerous lesions. It works by generating antibodies that prevent future infections. Patients with existing HPV infections can still benefit from vaccination against other HPV types they haven't been exposed to.", "consequence": "The vaccine is preventive, not therapeutic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "HPV vaccination eliminates the need for cervical cancer screening (Pap smears)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Cervical cancer screening remains necessary** even after HPV vaccination because: (1) The vaccine doesn't cover all HPV types; (2) Some individuals may have been exposed before vaccination; (3) Screening guidelines are based on age, not vaccination status. Follow standard screening recommendations (starting at age 21 or 25 depending on guidelines).", "consequence": "Screening remains important regardless of vaccination.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "The vaccine only needs to be given to individuals with multiple sexual partners", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HPV vaccination is recommended for **ALL adolescents** regardless of anticipated sexual behavior. HPV is extremely common - nearly all sexually active individuals will be infected at some point. Even individuals with a single lifetime partner can acquire HPV. Universal vaccination provides the best protection.", "consequence": "Universal vaccination is recommended.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **HPV-related cancers**: Cervical (virtually 100% HPV-caused), oropharyngeal (70-80% HPV-caused - now most common HPV cancer in US), anal (90%), vulvar (70%), vaginal (75%), penile (60%). **Gardasil 9** covers 9 HPV types and prevents ~90% of these cancers. Both **males and females** benefit from vaccination."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents agree to vaccination. Before administering the vaccine, you review contraindications and the schedule.\n\nThe father mentions their older son (age 17) never received the HPV vaccine and asks if it's too late.", "question": "What is the appropriate recommendation for the 17-year-old brother?", "choices": [{"id": "node-3-choice-a", "text": "Recommend catch-up vaccination with 3-dose series; HPV vaccine is recommended through age 26", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Catch-up HPV vaccination** is recommended for everyone through **age 26** who wasn't adequately vaccinated earlier. Since the brother is **\u226515 years old**, he needs the **3-dose series** (0, 1-2, and 6 months). For adults **27-45 years**, shared clinical decision-making is recommended - vaccination may benefit some individuals but provides less population-level benefit since many have already been exposed.", "consequence": "The 17-year-old can still receive significant benefit from vaccination.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "It's too late; HPV vaccine is only effective before age 15", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While vaccination is **most effective** before any HPV exposure (and immune response is strongest before 15), it still provides significant benefit through age 26. The vaccine can protect against HPV types the person hasn't been exposed to yet. Don't miss the opportunity for catch-up vaccination!", "consequence": "Missing opportunity for cancer prevention.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Only recommend if he is sexually active", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. HPV vaccination is recommended for **all** adolescents and young adults through age 26, **regardless of sexual history**. Even if someone is already sexually active, they likely haven't been exposed to all HPV types in the vaccine. Universal recommendation avoids stigma and maximizes protection.", "consequence": "Sexual history should not determine vaccination recommendation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Males don't need HPV vaccination; only the sister should be vaccinated", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Males need HPV vaccination too!** HPV causes oropharyngeal cancer (more common in males), anal cancer, penile cancer, and genital warts in males. Male vaccination also contributes to herd immunity, protecting those who can't be vaccinated. ACIP recommends routine vaccination for all adolescents.", "consequence": "Missing important cancer prevention in males.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Test for HPV first; only vaccinate if negative", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **HPV testing is not recommended before vaccination**. There is no test to determine exposure to all vaccine-covered types, and prior infection with one type doesn't preclude protection against others. Additionally, HPV testing in males is not routinely available. Just vaccinate without pre-testing.", "consequence": "Pre-vaccination testing is not indicated.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **HPV vaccine catch-up**: Routine vaccination ages **11-12**; catch-up through **age 26** (3 doses if started \u226515 years). Ages **27-45**: shared decision-making (some benefit, less population impact). **No pre-vaccination HPV testing** - just vaccinate. Both **males and females** should receive the vaccine. **Contraindications**: severe allergic reaction to vaccine component (very rare)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent counseling! You effectively explained the HPV vaccination rationale: **earlier vaccination (11-12)** provides stronger immune response allowing a **2-dose schedule**, the vaccine prevents **multiple cancers in both sexes** (not just cervical), and **catch-up vaccination through age 26** is recommended. You addressed common parental concerns while providing evidence-based guidance. Both children can now receive appropriate HPV vaccination for cancer prevention."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key HPV vaccination concepts: (1) **Routine vaccination at 11-12 years**; (2) **2 doses if started <15**, 3 doses if \u226515; (3) Prevents **multiple cancers** (cervical, oropharyngeal, anal, vulvar, vaginal, penile); (4) **Both males and females** should be vaccinated; (5) **Catch-up through age 26**; (6) No pre-vaccination HPV testing needed."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. HPV vaccination is one of the most effective cancer prevention tools available. **Key facts**: Routine ages 11-12 (can start at 9); 2 doses if <15, 3 doses if \u226515; prevents 90% of HPV-related cancers; equally important for males AND females; catch-up through age 26. Missing vaccination opportunities allows preventable cancers to occur."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-118", "title": "Histoplasmosis Recognition", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["histoplasmosis", "Histoplasma capsulatum", "endemic mycosis", "Ohio River Valley", "fungal infection", "hilar lymphadenopathy", "itraconazole"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 10-year-old male from rural Indiana presents with 3 weeks of low-grade fever, cough, fatigue, and decreased appetite.\n\nHis symptoms began approximately 2 weeks after a family camping trip to Kentucky, where he helped his father clean out an old barn that had many birds roosting in it.\n\nPMH: Healthy, no chronic conditions\nVital signs: T 38.3\u00b0C, HR 95, RR 22, SpO2 96% on room air\n\nPhysical examination:\n- General: Tired-appearing but not toxic\n- HEENT: Normal\n- Lymph nodes: Mildly enlarged cervical nodes bilaterally\n- Lungs: Clear to auscultation, no wheezes or crackles\n- Heart: Regular, no murmurs\n- Abdomen: Mild hepatosplenomegaly on palpation\n- Skin: No rashes\n\nChest X-ray: Bilateral hilar lymphadenopathy with several small pulmonary nodules.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 10-year-old from Indiana with 3 weeks of respiratory symptoms and bilateral hilar lymphadenopathy after exposure to bird droppings in an old barn.\n\n**Histoplasmosis - The \"Great Mimicker\":**\n\n**Causative Organism:** *Histoplasma capsulatum* - a dimorphic fungus\n- **Mold form** in environment (soil contaminated with bird/bat droppings)\n- **Yeast form** at body temperature (inside macrophages)\n\n**Geographic Distribution (HIGH-YIELD!):**\n- **Ohio and Mississippi River Valleys** - CLASSIC endemic area\n- Includes: Ohio, Indiana, Kentucky, Tennessee, Arkansas, Missouri, Illinois\n- Also: Central America, parts of Africa/Asia\n\n**Exposure History (KEY CLUE):**\n- **Bird droppings** - chicken coops, old barns, pigeon roosts\n- **Bat droppings (guano)** - caves, old buildings\n- Activities: Spelunking (cave exploration), cleaning old structures, farming, construction\n\n**Clinical Presentation:**\n\n**1. Acute Pulmonary (most common):**\n- Flu-like illness 1-3 weeks after exposure\n- Fever, cough, fatigue, chest pain\n- Often self-limited in immunocompetent hosts\n\n**2. Chronic Pulmonary:**\n- Resembles TB - cavitary lesions, hemoptysis\n- Usually in patients with underlying lung disease\n\n**3. Disseminated:**\n- Occurs in immunocompromised (HIV, transplant, infants)\n- Hepatosplenomegaly, pancytopenia, adrenal involvement\n- Can be fatal without treatment", "question": "Based on the geographic location, exposure history, and clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Acute pulmonary histoplasmosis from Histoplasma capsulatum exposure in the barn", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **classic acute pulmonary histoplasmosis**. All the key elements are present:\n\n1. **Geography:** Indiana is in the endemic Ohio/Mississippi River Valley region\n2. **Exposure:** Cleaning old barn with bird droppings - classic source of Histoplasma spores\n3. **Timing:** Symptoms began 2 weeks after exposure (typical 1-3 week incubation)\n4. **Presentation:** Low-grade fever, cough, fatigue - flu-like illness\n5. **CXR:** Bilateral hilar lymphadenopathy with pulmonary nodules - classic radiographic finding\n6. **Hepatosplenomegaly:** Suggests possible early dissemination or immune response\n\nThe combination of endemic geography + bird/bat exposure + hilar lymphadenopathy is essentially pathognomonic.", "consequence": "You suspect histoplasmosis and order confirmatory testing.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Tuberculosis - needs PPD and sputum AFB testing", "isOptimal": false, "isAcceptable": true, "feedback": "TB is a reasonable differential - it can cause similar findings (hilar lymphadenopathy, pulmonary nodules, systemic symptoms). However, several features favor histoplasmosis:\n\n1. **No TB exposure history** mentioned (close contact with active TB)\n2. **Specific exposure to bird droppings** - classic for histoplasmosis\n3. **Endemic area for histoplasmosis** (Indiana)\n4. **Acute onset** after specific exposure (TB typically more insidious)\n\nTB testing is reasonable to include in the workup, but histoplasmosis is more likely given the exposure history. The key teaching point: **always ask about geographic history and specific exposures**.", "consequence": "TB should be considered but histoplasmosis is more likely given exposure.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Lymphoma - hilar adenopathy requires malignancy workup", "isOptimal": false, "isAcceptable": true, "feedback": "Lymphoma CAN cause hilar lymphadenopathy and systemic symptoms. Features that would support lymphoma:\n- Night sweats (\"B symptoms\")\n- Unexplained weight loss\n- Painless, rubbery lymph nodes\n- No clear infectious exposure\n\nHowever, this child has:\n- **Clear temporal relationship** to barn exposure (2 weeks ago)\n- **Endemic area** for histoplasmosis\n- **Pulmonary nodules** (more typical of infection than lymphoma)\n- **Self-limited course** typical of histoplasmosis\n\nHistoplasmosis is called the \"great mimicker\" precisely because it can look like lymphoma or other malignancies. Always consider infectious causes first when there's a suggestive exposure.", "consequence": "Malignancy possible but infectious cause more likely with this exposure.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Community-acquired pneumonia - treat empirically with azithromycin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While this child does have respiratory symptoms, typical bacterial CAP does NOT cause:\n- **Bilateral hilar lymphadenopathy** (hallmark of granulomatous disease or malignancy)\n- **Pulmonary nodules** (CAP causes consolidation, not nodules)\n- **Hepatosplenomegaly**\n\nAdditionally, azithromycin (a macrolide antibiotic) has **no activity against Histoplasma**, which is a fungus. Treating empirically for bacterial pneumonia would:\n1. Not address the actual infection\n2. Delay appropriate antifungal therapy if needed\n3. Miss the underlying diagnosis", "consequence": "Antibiotics ineffective against fungal infection; delays diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Sarcoidosis - needs tissue biopsy for non-caseating granulomas", "isOptimal": false, "isAcceptable": true, "feedback": "Sarcoidosis CAN cause bilateral hilar lymphadenopathy and systemic symptoms. However:\n\n1. **Sarcoidosis is rare in children** (more common in adults 20-40)\n2. **No clear trigger** for sarcoidosis (histoplasmosis has obvious exposure)\n3. **Geographic/exposure history** strongly suggests infectious etiology\n4. **Sarcoidosis is a diagnosis of exclusion** - must rule out infections first\n\nImportantly, histoplasmosis causes **caseating granulomas** while sarcoidosis causes **non-caseating granulomas**, but both can look similar on imaging. The exposure history is the key differentiator. Rule out histoplasmosis (and TB) before considering sarcoidosis.", "consequence": "Sarcoidosis is diagnosis of exclusion; must rule out infections first.", "nextNodeId": "node-2"}], "clinicalPearl": "**Histoplasmosis is the \"Great Mimicker\"** - can look like TB, sarcoidosis, or lymphoma. The KEY is **geographic history** (Ohio/Mississippi River Valley) and **exposure** (bird/bat droppings, caves, old barns)."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect histoplasmosis. The parents ask: \"How do you test for this? Does he need a lung biopsy?\"\n\n**Diagnostic Testing for Histoplasmosis:**\n\n**1. Histoplasma Antigen Testing (BEST initial test):**\n- **Urine Histoplasma antigen** - most sensitive (>90% in disseminated)\n- **Serum Histoplasma antigen** - also useful\n- Advantages: Rapid, non-invasive, high sensitivity\n- Limitations: Cross-reacts with other endemic fungi (Blastomyces)\n\n**2. Serology (Antibody Testing):**\n- Complement fixation, immunodiffusion\n- Takes 4-8 weeks to become positive\n- May be falsely negative in immunocompromised\n- Useful for exposure history but not acute diagnosis\n\n**3. Fungal Culture:**\n- Gold standard for definitive diagnosis\n- Takes 2-6 WEEKS to grow (slow!)\n- Requires respiratory specimens or tissue\n- Useful for species confirmation and susceptibility\n\n**4. Histopathology:**\n- Shows small intracellular yeast in macrophages\n- Requires invasive tissue sampling\n- Reserved for unclear cases or suspected malignancy\n\n**5. Imaging:**\n- CXR: Hilar adenopathy, nodules, miliary pattern\n- CT: Better defines extent of disease\n- Old calcified granulomas = prior exposure (common incidental finding in endemic areas)", "question": "What is the best INITIAL diagnostic test to confirm suspected histoplasmosis in this patient?", "choices": [{"id": "node-2-choice-a", "text": "Urine and serum Histoplasma antigen testing - rapid, non-invasive, highly sensitive", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Histoplasma antigen testing** is the best initial test:\n\n**Advantages:**\n- **Rapid results** (1-2 days vs. weeks for culture)\n- **Non-invasive** (no biopsy needed)\n- **High sensitivity** (>90% in disseminated disease, ~70% in acute pulmonary)\n- Both **urine and serum** should be sent (urine often more sensitive)\n\n**Clinical Application:**\n- Positive antigen confirms active infection\n- Can be used to monitor treatment response (levels should decline)\n- May cross-react with Blastomyces (consider geographic overlap)\n\n**When antigen may be negative:**\n- Mild, self-limited disease\n- Very early infection\n- Isolated pulmonary nodule\n\nIn this patient with classic exposure and moderate disease (hepatosplenomegaly), antigen testing is likely to be positive.", "consequence": "You order antigen testing. Results return positive, confirming histoplasmosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Bronchoscopy with bronchoalveolar lavage and fungal culture", "isOptimal": false, "isAcceptable": true, "feedback": "Bronchoscopy with BAL CAN diagnose histoplasmosis, but it's **more invasive than necessary** as an initial test. BAL is appropriate when:\n\n- Non-invasive testing is negative but suspicion remains high\n- Need to rule out other diagnoses (TB, malignancy)\n- Severe disease requiring rapid diagnosis\n- Immunocompromised host where multiple pathogens possible\n\n**Disadvantages:**\n- Invasive procedure requiring sedation in children\n- Fungal culture takes weeks\n- Antigen testing is faster and often sufficient\n\nStart with **antigen testing first** - if negative and suspicion persists, then consider bronchoscopy.", "consequence": "Invasive; should try non-invasive antigen testing first.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Histoplasma serology (antibody testing) only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as the SOLE test. **Serology has significant limitations** for acute diagnosis:\n\n**Problems:**\n- Takes **4-8 weeks** after infection to become positive\n- May be **falsely negative** in early disease (like this patient at 3 weeks)\n- May be **falsely negative** in immunocompromised patients\n- Cannot distinguish recent from remote infection (antibodies persist)\n\n**Serology IS useful for:**\n- Epidemiologic studies\n- Supporting diagnosis when antigen is negative but exposure was distant\n- Chronic pulmonary histoplasmosis (antigen may be low)\n\nFor **acute disease**, antigen testing is far superior.", "consequence": "Serology often negative early; antigen testing is better for acute disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "CT-guided lung biopsy for histopathology", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lung biopsy is NOT indicated** as initial testing when:\n\n1. Clinical presentation strongly suggests histoplasmosis\n2. Non-invasive testing (antigen) is available and highly sensitive\n3. Patient is immunocompetent with non-severe disease\n\n**Biopsy IS appropriate when:**\n- Concern for malignancy that cannot be excluded otherwise\n- Non-invasive testing is negative but diagnosis must be established\n- Severe/disseminated disease in immunocompromised requiring rapid tissue diagnosis\n\nThis child has classic exposure, endemic area, and typical presentation - biopsy would be unnecessarily invasive.", "consequence": "Unnecessarily invasive when non-invasive testing available.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "No testing needed - treat empirically based on clinical presentation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the clinical picture is suggestive, **diagnostic confirmation is important** because:\n\n1. **Treatment implications** - antifungal therapy has side effects; don't treat unnecessarily\n2. **Duration of therapy** - depends on severity and confirmed diagnosis\n3. **Alternative diagnoses** - TB, malignancy, sarcoidosis need different management\n4. **Monitoring** - antigen levels can track treatment response\n\nAdditionally, **mild acute pulmonary histoplasmosis often doesn't require treatment** in immunocompetent patients - symptoms resolve spontaneously. Diagnostic testing helps determine if treatment is even needed.", "consequence": "May lead to unnecessary treatment or miss alternative diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Histoplasma antigen (urine + serum)** is the best initial test for suspected histoplasmosis - rapid, non-invasive, and highly sensitive. Serology takes weeks to become positive and may be negative in acute disease."}, "node-3": {"id": "node-3", "type": "decision", "content": "Histoplasma urine antigen returns **POSITIVE**. Serum antigen is also positive. The diagnosis of acute pulmonary histoplasmosis is confirmed.\n\nThe parents ask: \"Does he need medication? Will he be okay?\"\n\n**Treatment of Histoplasmosis:**\n\n**1. Mild Acute Pulmonary (immunocompetent):**\n- Often **self-limited** - resolves without treatment in 2-4 weeks\n- Treatment reserved for **symptoms >4 weeks** or **moderate-severe disease**\n- If treating: **Itraconazole** x 6-12 weeks\n\n**2. Moderate-Severe Acute Pulmonary:**\n- **Itraconazole** for most patients\n- If severe (hypoxia, ARDS): **Amphotericin B** initially \u2192 step down to itraconazole\n\n**3. Disseminated Disease:**\n- **Amphotericin B** induction (liposomal preferred)\n- Step down to **itraconazole** for 12+ months\n- Lifelong suppression if AIDS with CD4 <150\n\n**4. CNS Involvement:**\n- **Amphotericin B** for 4-6 weeks minimum\n- Prolonged itraconazole maintenance\n\n**Key Points:**\n- **Itraconazole** has better CNS penetration than fluconazole\n- Monitor itraconazole levels (therapeutic drug monitoring)\n- Watch for drug interactions (CYP3A4 inhibitor)\n- Antigen levels can monitor treatment response", "question": "This patient has confirmed acute pulmonary histoplasmosis with mild hepatosplenomegaly. What is the most appropriate treatment approach?", "choices": [{"id": "node-3-choice-a", "text": "Itraconazole for 6-12 weeks given persistent symptoms (>3 weeks) and hepatosplenomegaly suggesting possible dissemination", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Treatment with **itraconazole** is indicated because:\n\n**Reasons to Treat (not just observe):**\n1. **Symptoms >3 weeks** - exceeds typical self-limited course\n2. **Hepatosplenomegaly** - suggests organism has spread beyond lungs\n3. **Positive serum antigen** - indicates fungemia/dissemination\n4. **Moderate symptom burden** - fever, fatigue, lymphadenopathy persisting\n\n**Treatment Plan:**\n- **Itraconazole 5-10 mg/kg/day** (max 200mg BID) for 6-12 weeks\n- Liquid formulation preferred in children (better absorption)\n- Check **itraconazole levels** at 2 weeks to ensure therapeutic\n- Monitor **antigen levels** - should decline with effective treatment\n- Follow up clinically and radiographically\n\n**Prognosis:** Excellent in immunocompetent children with treatment.", "consequence": "Appropriate treatment initiated. Patient improves over several weeks.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Observation only - acute pulmonary histoplasmosis always resolves without treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **many** cases of mild acute pulmonary histoplasmosis do self-resolve, **this patient warrants treatment** because:\n\n1. **Symptoms persisting >3 weeks** (beyond typical self-limited course)\n2. **Hepatosplenomegaly** (concerning for dissemination)\n3. **Positive serum antigen** (indicates systemic involvement)\n\n**When observation IS appropriate:**\n- Mild symptoms <4 weeks duration\n- No evidence of dissemination\n- Immunocompetent host with improving trajectory\n\nThis patient does not meet criteria for observation alone.", "consequence": "Undertreating disseminated disease risks prolonged illness or complications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Amphotericin B IV for all confirmed histoplasmosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Amphotericin B is OVER-treatment** for this case. Amphotericin B is reserved for:\n\n- **Severe** disease (hypoxia, respiratory failure)\n- **Disseminated** disease in immunocompromised hosts\n- **CNS involvement**\n- Initial \"induction\" before stepping down to itraconazole\n\n**This patient has:**\n- Moderate (not severe) disease\n- Immunocompetent\n- Stable vital signs, no hypoxia\n- Can take oral medication\n\n**Amphotericin B problems:**\n- IV administration (hospitalization)\n- Nephrotoxicity, infusion reactions\n- Much more expensive\n- Not needed when oral itraconazole will suffice", "consequence": "Over-treatment with toxic medication when oral therapy appropriate.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Fluconazole is the antifungal of choice for all fungal infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Itraconazole, NOT fluconazole**, is preferred for histoplasmosis:\n\n**Why Itraconazole > Fluconazole:**\n1. **Better activity** against Histoplasma capsulatum\n2. **Better tissue penetration** including CNS\n3. **Proven efficacy** in clinical trials\n4. IDSA guidelines recommend itraconazole as first-line\n\n**Fluconazole limitations:**\n- Less active against Histoplasma\n- Higher failure rates\n- May be used if itraconazole not tolerated, but not first choice\n\n**Remember the azole spectrum:**\n- **Fluconazole:** Candida, Cryptococcus (NOT Histoplasma, Blastomyces, Aspergillus)\n- **Itraconazole:** Histoplasma, Blastomyces, Coccidioides, plus Candida\n- **Voriconazole:** Aspergillus, plus broader coverage", "consequence": "Fluconazole is inferior to itraconazole for histoplasmosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Antibiotics plus corticosteroids for presumed bacterial infection with inflammatory component", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect on multiple levels:\n\n**1. This is a FUNGAL infection**, not bacterial:\n- Antibiotics have no activity against Histoplasma\n- Need ANTIFUNGAL therapy (itraconazole)\n\n**2. Corticosteroids are generally AVOIDED** in histoplasmosis:\n- Can worsen fungal infection by immunosuppression\n- Steroids are only considered in specific situations (severe ARDS, pericarditis)\n- Should NOT be given without concurrent antifungal therapy\n\nThis combination would likely worsen the patient's infection while providing no benefit.", "consequence": "Antibiotics ineffective; steroids without antifungals would worsen infection.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Itraconazole is first-line** for moderate histoplasmosis (not fluconazole!). Treat if symptoms >4 weeks, moderate-severe disease, or evidence of dissemination. Mild self-limited disease in immunocompetent patients may be observed."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent! You successfully diagnosed and treated pediatric histoplasmosis.\n\n**Key Learning Points:**\n\n1. **Recognition - The \"Great Mimicker\":**\n   - Histoplasmosis can look like TB, sarcoidosis, or lymphoma\n   - KEY CLUES: Geographic history (Ohio/Mississippi River Valley) + Exposure (bird/bat droppings, caves, old barns)\n   - Classic CXR: Bilateral hilar lymphadenopathy with pulmonary nodules\n\n2. **Diagnosis:**\n   - **Histoplasma antigen (urine + serum)** is the best initial test\n   - Rapid, non-invasive, highly sensitive (>90% in disseminated)\n   - Serology takes weeks to become positive - not ideal for acute disease\n   - Culture takes 2-6 weeks (gold standard but slow)\n\n3. **Treatment:**\n   - **Mild acute pulmonary:** Often self-limited, observe if <4 weeks symptoms\n   - **Moderate disease or >4 weeks:** Itraconazole 6-12 weeks\n   - **Severe/disseminated:** Amphotericin B \u2192 step down to itraconazole\n   - **Itraconazole is preferred over fluconazole** for histoplasmosis\n\n4. **Endemic Fungi - Geographic Associations:**\n   - **Histoplasmosis:** Ohio/Mississippi River Valley (bird/bat droppings)\n   - **Blastomycosis:** Great Lakes, Ohio/Mississippi Valley (soil)\n   - **Coccidioidomycosis:** Southwest US, California (\"Valley Fever\")\n\n**Remember:** Always ask about travel/geographic history and specific exposures in pulmonary infections!"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach had some issues. Key points to review:\n\n**Diagnosis:**\n- Histoplasma antigen (urine + serum) is best initial test - rapid and non-invasive\n- Serology takes 4-8 weeks to become positive - not ideal for acute diagnosis\n- Invasive testing (bronchoscopy, biopsy) reserved for unclear cases\n\n**Geographic Clues:**\n- Ohio/Mississippi River Valley = Histoplasmosis endemic area\n- Exposure to bird/bat droppings (barns, caves) = classic source\n\n**Treatment Decisions:**\n- Mild (<4 weeks symptoms, no dissemination): May observe\n- This patient has >3 weeks symptoms + hepatosplenomegaly: Needs treatment\n- Itraconazole is first-line (NOT fluconazole)\n- Amphotericin B only for severe/CNS disease"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "This approach could have serious consequences.\n\n**Critical Errors:**\n\n1. **Treating Fungal Infection with Antibiotics:**\n   - Histoplasma is a FUNGUS - antibiotics have no activity\n   - Delays appropriate antifungal therapy\n   - This is NOT bacterial pneumonia\n\n2. **Wrong Antifungal Choice:**\n   - ITRACONAZOLE is first-line for histoplasmosis\n   - Fluconazole has inferior activity against Histoplasma\n   - Know your azole spectrum!\n\n3. **Corticosteroids Without Antifungals:**\n   - Steroids suppress immunity and can worsen fungal infection\n   - Only use steroids for specific indications (severe ARDS) WITH concurrent antifungals\n\n4. **Unnecessary Invasive Testing:**\n   - Antigen testing is non-invasive and highly sensitive\n   - Save biopsy for cases where non-invasive testing fails or malignancy suspected\n\n**Remember:** Geographic history + exposure history are the KEY to diagnosing endemic mycoses like histoplasmosis."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-122", "title": "Guttate Psoriasis Recognition", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["drop-like papules", "post-strep", "fine silvery scale", "raindrop pattern", "guttate psoriasis recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "An 8-year-old female is brought to the pediatric clinic by her mother who is concerned about a widespread rash that appeared suddenly 1 week ago.\n\nHistory: The child developed numerous small, pink \"droplet-like\" spots on her trunk and arms over 2-3 days. The lesions are mildly itchy. She had a severe sore throat 2 weeks ago that was treated with amoxicillin.\n\nFamily history: Mother has plaque psoriasis.\n\nPhysical Examination:\n- Skin: Hundreds of 0.5-1 cm, salmon-pink, teardrop-shaped papules with fine silvery scale scattered across the trunk, back, and proximal extremities\n- Distribution follows a \"raindrop\" or centripetal pattern (denser on trunk)\n- No nail pitting or joint swelling\n- General: Well-appearing, afebrile", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the rash more closely:\n\n**Lesion characteristics:**\n- **Drop-like (guttate) papules** 0.5-1 cm in diameter\n- **Salmon-pink** color\n- **Fine silvery scale** when scraped (Auspitz sign - pinpoint bleeding under scale)\n- Scattered across trunk and proximal extremities\n- Spares palms, soles, and face\n\n**Key history:**\n- **Sore throat 2 weeks ago** (streptococcal pharyngitis trigger)\n- **Family history of psoriasis** (genetic predisposition)\n- Sudden onset over days", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Guttate psoriasis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Guttate psoriasis** is characterized by sudden eruption of **drop-like (guttate) papules** with **fine silvery scale**, typically **2-3 weeks after streptococcal pharyngitis**. The buzzwords are: **drop-like papules**, **post-strep**, **fine silvery scale**, and **raindrop pattern**. Family history of psoriasis increases risk. This is distinct from plaque psoriasis which has larger, well-demarcated plaques.", "consequence": "You correctly diagnose guttate psoriasis. Now you need to confirm the streptococcal trigger and determine treatment.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Pityriasis rosea", "isOptimal": false, "isAcceptable": true, "feedback": "Good differential consideration. **Pityriasis rosea** also presents with oval, salmon-pink papules in a \"Christmas tree\" pattern on the back. However, key differences: pityriasis rosea has a **herald patch** (single large lesion preceding the eruption by 1-2 weeks), lesions have a **collarette of scale** (scale at the edges), and there is **no association with streptococcal infection**. This patient has no herald patch and has recent strep pharyngitis - guttate psoriasis is more likely.", "consequence": "Consider pityriasis rosea in the differential, but the strep trigger and family history favor guttate psoriasis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Viral exanthem", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Viral exanthems** typically present with a more confluent, macular rash, often with **prodromal symptoms** (fever, malaise, URI symptoms). The **fine silvery scale** and **drop-like morphology** are characteristic of psoriasis, not viral exanthem. Additionally, viral exanthems typically resolve within 1-2 weeks, while this child's rash has persisted and has characteristic psoriatic features.", "consequence": "Misdiagnosis as viral exanthem delays appropriate treatment for guttate psoriasis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Tinea corporis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Tinea corporis** (ringworm) presents with **annular plaques** with **raised, scaly borders** and **central clearing**. The lesions in guttate psoriasis are **solid papules** with **central scale** (not annular with central clearing). Additionally, tinea typically has fewer, larger lesions rather than the \"raindrop\" pattern of hundreds of small papules seen in guttate psoriasis.", "consequence": "Antifungal treatment would be ineffective and delay appropriate psoriasis management.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Drug eruption from amoxicillin", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration given the recent antibiotic use. However, **drug eruptions** typically present within days of starting the medication and resolve after stopping it. This patient's rash appeared **after completing** the antibiotic course, and the **characteristic silvery scale** and **drop-like morphology** are specific for psoriasis. The strep infection (not the antibiotic) is the trigger.", "consequence": "Drug eruption is in the differential but clinical features point more strongly to guttate psoriasis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Guttate psoriasis** is triggered by **streptococcal infection** 2-3 weeks prior. Buzzwords: **drop-like papules**, **post-strep**, **fine silvery scale**, **raindrop pattern**. Unlike plaque psoriasis, guttate often resolves spontaneously in 2-3 months."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose guttate psoriasis based on the classic presentation.\n\nThe mother asks about the connection to the recent sore throat and whether testing is needed.\n\nYou consider whether to confirm streptococcal infection and determine initial management.", "question": "What is the most appropriate next step?", "choices": [{"id": "node-2-choice-a", "text": "Check ASO titer or anti-DNase B to document streptococcal trigger; treat strep if culture positive", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **ASO titer** (anti-streptolysin O) or **anti-DNase B** antibodies can confirm recent streptococcal infection. If the throat culture is **positive for Group A Strep** (active infection), treat with antibiotics - some studies suggest this may shorten the course of guttate psoriasis, though evidence is mixed. Documenting the strep trigger also helps predict future flares (advise prompt treatment of future strep infections).", "consequence": "ASO titer is elevated (450 IU/mL, normal <200). Throat culture is negative (infection has cleared). You proceed to discuss treatment options.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Skin biopsy to confirm diagnosis", "isOptimal": false, "isAcceptable": true, "feedback": "Skin biopsy can confirm psoriasis histologically (showing **parakeratosis**, **Munro microabscesses**, and **dilated capillaries in dermal papillae**), but is **rarely needed** when the clinical presentation is classic. Biopsy is reserved for **atypical presentations** or when the diagnosis is uncertain. The characteristic drop-like papules with silvery scale after strep infection is diagnostic.", "consequence": "Biopsy provides histological confirmation but delays treatment and is not necessary for classic presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Start oral antibiotics empirically without testing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Empiric antibiotics are not indicated**. The streptococcal infection has already been treated (she received amoxicillin 2 weeks ago), and the psoriasis is an **immune-mediated reaction** to the prior infection, not an active infection. Antibiotics don't treat psoriasis. Testing helps document the trigger but treatment should focus on the skin disease itself.", "consequence": "Unnecessary antibiotics with no benefit for the psoriatic skin lesions.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Order complete metabolic panel and CBC", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine bloodwork** (CMP, CBC) is not indicated for diagnosis of guttate psoriasis. The diagnosis is clinical based on the characteristic rash morphology and history of streptococcal infection. Labs may be needed later if systemic therapy is considered, but not for initial diagnosis and mild disease.", "consequence": "Unnecessary testing that does not contribute to diagnosis or management.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Refer to dermatology before any workup", "isOptimal": false, "isAcceptable": true, "feedback": "Dermatology referral may be helpful for **severe or refractory cases**, but **initial management** of guttate psoriasis can be handled by the primary care provider. The diagnosis is clinical, and first-line treatments (topical steroids, phototherapy) can be initiated without specialist input. Referral is appropriate if the rash doesn't respond to initial treatment or if systemic therapy is needed.", "consequence": "Delays treatment; initial management can proceed while awaiting dermatology appointment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Always check **ASO titer** or **anti-DNase B** to document streptococcal trigger. If active strep infection (positive culture), treat with antibiotics. Future strep infections should be treated promptly to prevent recurrence."}, "node-3": {"id": "node-3", "type": "decision", "content": "ASO titer confirms recent streptococcal infection. The mother asks about treatment options.\n\nThe patient has:\n- Moderate guttate psoriasis (covering ~15% body surface area)\n- Mild pruritus\n- No joint symptoms\n- No nail involvement\n\nYou discuss the expected course and treatment options.", "question": "What is the most appropriate treatment approach for this patient?", "choices": [{"id": "node-3-choice-a", "text": "Topical corticosteroids; phototherapy if needed; expect spontaneous resolution in 2-3 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! First-line treatment for guttate psoriasis includes **topical corticosteroids** (medium-potency for body, low-potency for face) and **topical vitamin D analogs** (calcipotriene). For more extensive disease, **narrowband UVB phototherapy** is very effective. Importantly, guttate psoriasis often **resolves spontaneously within 2-3 months** - this should be communicated to provide reassurance. About one-third of patients may develop chronic plaque psoriasis later.", "consequence": "You prescribe triamcinolone 0.1% cream for the body. The rash gradually improves and resolves completely over 8 weeks.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Oral methotrexate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Methotrexate** is a systemic immunosuppressant reserved for **severe, refractory, or widespread psoriasis** that has failed topical therapy and phototherapy. For moderate guttate psoriasis in a child, systemic therapy is not first-line due to potential side effects (hepatotoxicity, bone marrow suppression, teratogenicity). Start with topical treatments and phototherapy.", "consequence": "Systemic therapy carries unnecessary risks for this self-limiting condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Oral retinoids (acitretin)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Acitretin** is a systemic retinoid that can be effective for psoriasis but is **not first-line** for moderate guttate psoriasis. It has significant side effects including **mucocutaneous dryness**, **hyperlipidemia**, and is **teratogenic** (important consideration for future fertility in females). Reserve for severe cases refractory to first-line treatments.", "consequence": "Systemic retinoids are not appropriate first-line therapy for this presentation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Tonsillectomy to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **tonsillectomy** has been studied for patients with **recurrent guttate psoriasis** triggered by frequent streptococcal infections, it is **not indicated for a first episode**. Most cases of guttate psoriasis resolve spontaneously and do not recur. Tonsillectomy may be considered only in patients with **multiple recurrences** directly linked to strep infections despite prompt antibiotic treatment.", "consequence": "Unnecessary surgery for a first episode that is likely to resolve spontaneously.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "No treatment needed; observation only", "isOptimal": false, "isAcceptable": true, "feedback": "While guttate psoriasis often **resolves spontaneously**, treatment is typically offered to **reduce symptoms** (pruritus) and **shorten duration**. Topical corticosteroids and emollients improve patient comfort. Complete observation is acceptable if the patient declines treatment, but most patients prefer active management given the visible and sometimes itchy nature of the rash.", "consequence": "The rash will likely resolve but may take longer and cause more discomfort without treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "Guttate psoriasis typically **resolves spontaneously in 2-3 months**. First-line treatment: **topical corticosteroids** and **phototherapy** (narrowband UVB). About 1/3 of patients develop chronic plaque psoriasis. Advise prompt treatment of future strep infections."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed **guttate psoriasis** and provided appropriate management.\n\n**Key Learning Points:**\n\n**Guttate Psoriasis Recognition:**\n- **Buzzwords**: drop-like papules, post-strep, fine silvery scale, raindrop pattern\n- Triggered by **streptococcal infection** 2-3 weeks prior\n- Sudden onset of **hundreds of small (0.5-1 cm) salmon-pink papules** with **fine silvery scale**\n- Distribution: trunk and proximal extremities (raindrop/centripetal pattern)\n\n**Differentiation from Pityriasis Rosea:**\n- Pityriasis rosea has a **herald patch** and **collarette scale**\n- No strep association with pityriasis rosea\n\n**Management:**\n- Document strep trigger with **ASO titer** or **anti-DNase B**\n- First-line: **Topical corticosteroids**, emollients\n- Phototherapy (narrowband UVB) for extensive disease\n- **Resolves spontaneously in 2-3 months** (reassure patient)\n- ~1/3 develop chronic plaque psoriasis"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. Review the key features:\n\n**Guttate Psoriasis:**\n- **Drop-like (guttate) papules** with **fine silvery scale**\n- Triggered by **streptococcal pharyngitis** 2-3 weeks prior\n- **Raindrop pattern** on trunk and proximal extremities\n- Family history of psoriasis is common\n\n**Workup:**\n- **ASO titer** or **anti-DNase B** to confirm strep trigger\n- Skin biopsy rarely needed for classic presentation\n\n**Treatment:**\n- First-line: **Topical corticosteroids**, phototherapy\n- Usually **resolves spontaneously in 2-3 months**\n- Systemic therapy reserved for severe/refractory cases"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Your approach was incorrect.\n\n**Critical Points:**\n- Guttate psoriasis is an **immune reaction** to streptococcal infection - antibiotics don't treat the skin lesions\n- First-line treatment is **topical corticosteroids** and **phototherapy**, not systemic immunosuppressants\n- The condition typically **resolves spontaneously in 2-3 months**\n- Key pearl: **Drop-like papules + post-strep + fine silvery scale** = guttate psoriasis\n- Always check **ASO titer** to document the streptococcal trigger\n- Advise prompt treatment of future strep infections to prevent recurrence"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-123", "title": "Tinea Capitis with Kerion Recognition", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["boggy scalp mass", "alopecia", "misdiagnosed as abscess", "do NOT I&D", "tinea capitis with kerion recognition"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 6-year-old male presents with a painful, boggy scalp mass with hair loss for 2 weeks.\n\nPer the parents, he developed a swollen, tender area on his scalp that has been progressively enlarging. The area oozes purulent-appearing material. His friend at school had a similar scalp problem last month.\n\nReview of systems: positive for cervical lymphadenopathy; negative for fever, weight loss, or night sweats.\n\nPast medical history: plays regularly with stray cats in the neighborhood.\n\nPhysical Examination:\n- Scalp: 4 cm boggy, tender, erythematous plaque on the vertex with multiple pustules, crusting, and overlying alopecia\n- Lymph nodes: posterior cervical lymphadenopathy (2 cm, tender, mobile)\n- Hair: easily epilated hairs at the periphery of the lesion; \"black dot\" appearance in areas\n- General: well-appearing, afebrile", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the scalp lesion more closely. The mass is tender, boggy (fluctuant-feeling), and has multiple pustules draining purulent material. Hairs are broken off at the scalp surface with \"black dots\" visible.\n\n**Key clinical clues:**\n- **Boggy, inflammatory mass** on scalp with alopecia\n- **Pustules and purulent drainage** (looks like pus but is actually keratin debris)\n- **Cervical lymphadenopathy** (reactive to fungal infection)\n- **Epidemiologic risk**: contact with cats (zoophilic dermatophytes) and affected friend\n- **Black dot tinea**: broken hair shafts at scalp level appear as black dots\n\n**The critical recognition point:**\nThis looks like an abscess but the clinical history and distribution are wrong for bacterial infection.", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Kerion (severe inflammatory tinea capitis)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **kerion** - a severe inflammatory reaction to dermatophyte infection of the scalp. Key features: (1) **Boggy, tender scalp mass** with alopecia, (2) **Pustules draining purulent-appearing material** (actually keratin debris, not pus), (3) **Black dot appearance** from broken hair shafts, (4) **Cervical lymphadenopathy**, (5) Exposure to cats (zoophilic fungi like *Microsporum canis*) or infected contacts (*Trichophyton tonsurans* - anthropophilic). The inflammatory response is an **immune-mediated hypersensitivity reaction** to fungal antigens, NOT a bacterial abscess.", "consequence": "You correctly identify the fungal etiology and avoid the common misdiagnosis pitfall.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Bacterial scalp abscess requiring I&D", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is the **most common and dangerous misdiagnosis**. While a kerion looks like an abscess (boggy, pustular, draining), it is NOT a bacterial infection. Key differences: (1) Kerion has **alopecia** in the affected area - abscesses don't cause hair loss, (2) **Black dots** (broken hair shafts) are pathognomonic for tinea, (3) History of **cat contact or infected classmate** suggests dermatophyte transmission, (4) **I&D of a kerion causes permanent scarring alopecia** and is absolutely contraindicated. The purulent material is inflammatory debris and keratin, not bacterial pus.", "consequence": "I&D of a kerion causes permanent scarring alopecia - this is a critical error.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Alopecia areata with secondary infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Alopecia areata** is an autoimmune condition causing well-circumscribed, NON-inflammatory patches of hair loss. The scalp appears completely normal (\"smooth as a baby's bottom\") without redness, scaling, or pustules. This patient has a highly inflammatory, boggy, tender mass with pustules - the opposite of alopecia areata. Additionally, alopecia areata shows **exclamation point hairs** (narrowed at the base), not black dots from broken shafts.", "consequence": "Misdiagnosis leads to inappropriate treatment and delayed antifungal therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Seborrheic dermatitis with superinfection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Seborrheic dermatitis** causes greasy, yellow, scaling plaques on the scalp (\"cradle cap\" in infants) but does NOT cause a boggy inflammatory mass, significant alopecia, or pustular drainage. Seborrheic dermatitis is generally non-tender and does not produce regional lymphadenopathy. The black dot appearance and highly inflammatory boggy mass are characteristic of kerion, not seborrheic dermatitis.", "consequence": "Missing the diagnosis delays appropriate antifungal treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Dissecting cellulitis of the scalp", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dissecting cellulitis** (perifolliculitis capitis abscedens et suffodiens) is a chronic, scarring condition primarily affecting **post-pubertal African American males**. It features interconnected nodules and sinuses with purulent drainage. This 6-year-old with acute onset, cat exposure, and black dot appearance has a classic presentation for kerion. Dissecting cellulitis is chronic, occurs in older patients, and has connecting sinus tracts - none of which apply here.", "consequence": "Incorrect diagnosis leads to inappropriate management.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Kerion looks like an abscess but is NOT** - it's an intense inflammatory hypersensitivity reaction to dermatophyte infection. The purulent material is keratin debris, not bacterial pus. **I&D is absolutely contraindicated** and causes permanent scarring alopecia. Always look for black dots (broken hair shafts) and ask about cat/pet exposure or affected contacts."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose kerion (severe inflammatory tinea capitis). You need to confirm the diagnosis and initiate treatment.\n\n**Diagnostic confirmation:**\n- **KOH prep** of plucked hairs: look for **endothrix** (spores inside hair shaft - *T. tonsurans*) or **ectothrix** (spores surrounding shaft - *M. canis*)\n- **Fungal culture** on Sabouraud's or DTM agar (takes 2-4 weeks but identifies species)\n- **Wood's lamp**: *M. canis* fluoresces blue-green; *T. tonsurans* does NOT fluoresce\n\n**Understanding the organisms:**\n- ***Trichophyton tonsurans*** (most common in US): anthropophilic (human-to-human), endothrix, does NOT fluoresce\n- ***Microsporum canis***: zoophilic (cats/dogs), ectothrix, DOES fluoresce green", "question": "What is the most appropriate treatment for this patient's kerion?", "choices": [{"id": "node-2-choice-a", "text": "Oral griseofulvin or terbinafine for 6-8 weeks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Systemic antifungal therapy is MANDATORY** for tinea capitis - topical antifungals cannot penetrate the hair follicle adequately. Treatment options: (1) **Griseofulvin** 20-25 mg/kg/day (microsize) for 6-8 weeks - give with fatty food to enhance absorption; first-line for *Microsporum*, (2) **Terbinafine** 3-6 mg/kg/day for 4-6 weeks - may be more effective for *Trichophyton*. For kerion specifically, a **short course of oral prednisone** (1-2 mg/kg/day for 1-2 weeks) may reduce inflammation and minimize scarring. Adjunctive selenium sulfide or ketoconazole shampoo reduces spore shedding.", "consequence": "You initiate appropriate systemic antifungal therapy.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Topical antifungal cream (clotrimazole) alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical antifungals are INSUFFICIENT for tinea capitis**. The fungus invades the hair shaft and follicle, which topical agents cannot adequately penetrate. Topical-only treatment will fail and prolong infection, increasing risk of scarring alopecia. Topical antifungals (ketoconazole shampoo, selenium sulfide) are used as **adjuncts** to reduce surface spore counts and transmission, but NEVER as monotherapy for tinea capitis.", "consequence": "Treatment fails and scarring alopecia risk increases.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Incision and drainage of the boggy mass", "isOptimal": false, "isAcceptable": false, "feedback": "**ABSOLUTELY CONTRAINDICATED**. This is the most dangerous error in kerion management. I&D of a kerion causes: (1) **Permanent scarring alopecia**, (2) No therapeutic benefit (there's no true abscess to drain), (3) Potential spread of infection. The boggy mass will resolve with systemic antifungal therapy. Remember: **kerion LOOKS like an abscess but IS NOT one** - it's an inflammatory hypersensitivity response to fungal antigens.", "consequence": "I&D causes permanent scarring alopecia - this is never indicated for kerion.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Oral antibiotics (cephalexin) for presumed bacterial infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The purulent appearance is misleading - this is NOT a bacterial infection. Antibiotics will not treat the underlying dermatophyte and will delay appropriate antifungal therapy. **Secondary bacterial infection of kerion is rare**. If there is concern for true superinfection (spreading cellulitis, fever, systemic symptoms), antibiotics may be added, but **antifungals remain the primary treatment**. This well-appearing, afebrile child does not need antibiotics.", "consequence": "Antibiotics don't treat the fungal infection and delay appropriate therapy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Observation and topical steroids to reduce inflammation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical steroids alone are harmful** in tinea infections - they suppress the immune response, allowing fungal proliferation (\"tinea incognito\"). While systemic steroids may be beneficial as ADJUNCT therapy in kerion to reduce inflammation and scarring risk, they must ALWAYS be combined with systemic antifungals. Never use steroids (topical or systemic) without concurrent antifungal coverage for fungal infections.", "consequence": "Steroids without antifungals worsen fungal infection (tinea incognito).", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Tinea capitis ALWAYS requires ORAL antifungals** - topical agents cannot penetrate the hair follicle. Griseofulvin is first-line (give with fatty food); terbinafine is an alternative. For severe kerion, consider adding a short course of oral steroids to reduce scarring, but NEVER steroids without concurrent antifungals."}, "node-3": {"id": "node-3", "type": "decision", "content": "You start oral griseofulvin 20 mg/kg/day with fatty food and add a short course of oral prednisone to reduce inflammation. You also prescribe ketoconazole shampoo twice weekly to reduce spore shedding.\n\n**Family and school considerations:**\n- *T. tonsurans* is highly contagious (anthropophilic)\n- Spread through: shared combs, brushes, hats, pillowcases, direct contact\n- Asymptomatic carriers are common (up to 50% of household contacts)\n- Child can return to school once treatment is initiated (no exclusion required)\n\n**The parents ask about the child's friend with similar symptoms and whether their other children need treatment.**", "question": "What is the most appropriate advice regarding household contacts and the affected friend?", "choices": [{"id": "node-3-choice-a", "text": "Screen household contacts with fungal culture; treat asymptomatic carriers with antifungal shampoo; symptomatic contacts need oral antifungals", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Contact management is essential** to prevent reinfection and ongoing transmission. Recommendations: (1) **Screen all household members** with fungal culture of the scalp, (2) **Asymptomatic carriers** (positive culture, no symptoms) - treat with antifungal shampoo (ketoconazole or selenium sulfide) twice weekly, (3) **Symptomatic contacts** with scalp findings - need oral antifungal therapy, (4) **Environmental measures**: don't share combs, brushes, hats, towels, pillows; wash bedding/towels in hot water, (5) **The friend** should see a physician for evaluation and treatment. Advise parents their child can return to school once treatment is started.", "consequence": "You provide comprehensive guidance to prevent reinfection and transmission.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "No need to evaluate contacts; treat only symptomatic individuals", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Asymptomatic carriers are a major source of reinfection and community spread**. Studies show up to 50% of household contacts may be asymptomatic carriers of *T. tonsurans*. If carriers are not identified and treated (at minimum with antifungal shampoo), the patient is likely to be reinfected after completing treatment. Contact screening and treatment of carriers is essential for successful eradication.", "consequence": "Failure to address carriers leads to reinfection and ongoing community transmission.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Prescribe prophylactic oral antifungals for all household members", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is overtreatment. **Oral antifungals have side effects** (hepatotoxicity with griseofulvin/terbinafine, drug interactions) and should not be given prophylactically to asymptomatic individuals without evidence of infection. The appropriate approach is to **screen contacts** with fungal culture, then treat based on results: antifungal shampoo for asymptomatic carriers, oral antifungals only for those with clinical infection.", "consequence": "Unnecessary medication exposure with potential side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Child must be excluded from school until fully treated and culture-negative", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is overly restrictive. **AAP guidelines state children can return to school once treatment is initiated**. Extended exclusion is not necessary and causes unnecessary disruption to the child's education and social development. With proper treatment (oral antifungals + antifungal shampoo), the child's infectivity rapidly decreases. Sharing of combs, hats, and direct head-to-head contact should be avoided, but school attendance is permitted.", "consequence": "Unnecessary school exclusion; child can attend once treatment is started.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Recommend the family get rid of all cats to prevent reinfection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While zoophilic organisms like *M. canis* come from cats/dogs, this is not the only consideration, and removing pets is not always necessary. **The pet should be evaluated by a veterinarian** and treated if infected. Additionally, *T. tonsurans* (the most common cause in the US) is **anthropophilic** (human-to-human), so pets may not even be the source. The exposure history to an infected friend suggests *T. tonsurans*. Environmental measures and contact screening are more important than removing pets.", "consequence": "Removing pets may be unnecessary; proper evaluation and contact management is key.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Asymptomatic carriers are common** (up to 50% of household contacts with *T. tonsurans*). Screen contacts with fungal culture; treat carriers with antifungal shampoo to prevent reinfection. Children can return to school once treatment is initiated - no extended exclusion required."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified kerion (severe inflammatory tinea capitis), avoided the dangerous misdiagnosis of bacterial abscess, initiated appropriate oral antifungal therapy, and provided comprehensive contact management guidance.\n\n**Key teaching points:**\n- **Kerion looks like an abscess but is NOT** - it's an inflammatory reaction to dermatophytes\n- **I&D is absolutely contraindicated** and causes permanent scarring alopecia\n- **Oral antifungals are MANDATORY** - topicals cannot penetrate the hair follicle\n- Griseofulvin (give with fatty food) or terbinafine for 6-8 weeks\n- Consider short-course oral steroids for severe kerion to reduce scarring\n- **Screen household contacts** - asymptomatic carriers are common\n- Child can return to school once treatment is started\n\n**Prognosis**: With prompt treatment, hair regrowth is expected within 2-3 months. Delayed treatment increases risk of permanent scarring alopecia."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key concepts:\n\n**Kerion recognition:**\n- Boggy, inflammatory scalp mass with alopecia and pustules\n- Looks like abscess but is FUNGAL - I&D is contraindicated\n- Black dots = broken hair shafts (pathognomonic for tinea)\n\n**Treatment essentials:**\n- ORAL antifungals mandatory (griseofulvin or terbinafine)\n- Topicals alone NEVER sufficient for tinea capitis\n- Consider oral steroids for severe kerion (with antifungals)\n\n**Contact management:**\n- Screen household contacts with fungal culture\n- Treat asymptomatic carriers with antifungal shampoo\n- Child can attend school once treatment is started"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical concepts in kerion management:\n\n**The dangerous misdiagnosis:**\n- Kerion is commonly mistaken for bacterial abscess\n- **I&D causes PERMANENT SCARRING ALOPECIA** - never indicated\n- The \"pus\" is actually keratin debris, not bacterial infection\n\n**Remember the clinical clues:**\n- Boggy scalp mass with ALOPECIA (abscesses don't cause hair loss)\n- Black dots = broken hair shafts (tinea, not bacterial)\n- Cat exposure suggests *M. canis*; infected contact suggests *T. tonsurans*\n\n**Treatment principles:**\n- ORAL antifungals required - topicals cannot reach the follicle\n- Steroids only with concurrent antifungals (never alone)\n- Antibiotics only if true superinfection (rare)"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-124", "title": "Tinea Capitis Treatment", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["oral antifungal required", "topical insufficient", "griseofulvin or terbinafine", "tinea capitis treatment"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old female is brought in by her parents. She was diagnosed with tinea capitis 3 weeks ago after a positive fungal culture. The parents were prescribed topical antifungal cream by an urgent care provider, but the condition has not improved.\n\nHistory:\n- Scaly, itchy scalp patch first noticed 5 weeks ago\n- Tried ketoconazole cream 2% for 3 weeks with no improvement\n- Her cousin had similar scalp problems last month\n- No pets at home\n\nPhysical Examination:\n- Scalp: 3 cm scaly, erythematous patch on the vertex with \"black dots\" (broken hair shafts at scalp level)\n- Lymph nodes: posterior auricular lymphadenopathy (1 cm, mobile, non-tender)\n- No kerion formation (no boggy mass)\n- General: well-appearing child\n\nLaboratory confirmation: KOH prep and fungal culture positive for *Trichophyton tonsurans*", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The patient has culture-confirmed tinea capitis caused by *Trichophyton tonsurans*. Topical antifungal therapy has failed after 3 weeks.\n\n**Why did topical therapy fail?**\n- Dermatophytes invade the **hair shaft and follicle** in tinea capitis\n- **Topical antifungals cannot penetrate** the hair shaft adequately\n- Topical therapy can treat tinea corporis (skin) but NOT tinea capitis (scalp/hair)\n- This is a fundamental pharmacokinetic limitation, not resistance\n\n**Understanding the organism:**\n- ***Trichophyton tonsurans***: most common cause in the US\n- **Anthropophilic** (human-to-human transmission) - explains cousin's similar problem\n- **Endothrix** pattern - spores inside hair shaft\n- Does NOT fluoresce under Wood's lamp", "question": "What is the most appropriate treatment for this patient?", "choices": [{"id": "node-1-choice-a", "text": "Oral griseofulvin for 6-8 weeks", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Oral griseofulvin** is the first-line treatment for tinea capitis. Key prescribing points: (1) **Dose**: 20-25 mg/kg/day of microsize formulation (or 10-15 mg/kg/day ultramicrosize), (2) **Duration**: 6-8 weeks minimum (until clinical AND mycologic cure), (3) **Administration**: Give with **fatty food** (improves absorption significantly), (4) **Mechanism**: Griseofulvin concentrates in keratin and inhibits fungal mitosis. It is particularly effective against *Microsporum* species but works well for *Trichophyton* too.", "consequence": "You prescribe appropriate first-line oral antifungal therapy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Continue topical ketoconazole for another 4 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical antifungals CANNOT cure tinea capitis** regardless of duration. The fungus invades the hair shaft and follicle where topicals cannot reach therapeutic concentrations. Continuing topical-only therapy will: (1) Prolong infection and transmission risk, (2) Increase risk of scarring alopecia, (3) Not achieve mycologic cure. Topicals can be used as ADJUNCT (antifungal shampoo) to reduce surface spores, but NEVER as monotherapy.", "consequence": "Continued topical-only therapy will fail and prolong infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Oral terbinafine for 4-6 weeks", "isOptimal": false, "isAcceptable": true, "feedback": "This is an acceptable alternative. **Terbinafine** is also effective for tinea capitis, particularly against *Trichophyton* species. Dose: weight-based (3-6 mg/kg/day), duration 4-6 weeks. Terbinafine may be MORE effective than griseofulvin for *Trichophyton* but LESS effective for *Microsporum*. Since this patient has confirmed *T. tonsurans*, terbinafine would work. However, griseofulvin remains first-line in many guidelines due to longer safety track record in children.", "consequence": "Terbinafine is effective for T. tonsurans and is an acceptable alternative.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Switch to a different topical antifungal (ciclopirox shampoo)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Switching topical agents will not solve the fundamental problem - **no topical can penetrate the hair shaft** to eradicate tinea capitis. Ciclopirox shampoo may be used as an ADJUNCT to oral therapy (reduces surface spores and transmission), but it cannot achieve cure as monotherapy. The patient needs ORAL antifungal therapy.", "consequence": "Topical-only therapy will fail regardless of which topical agent is used.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Oral fluconazole for 3 weeks", "isOptimal": false, "isAcceptable": true, "feedback": "Fluconazole is a second-line option. While it can be used for tinea capitis, it is generally **less effective** than griseofulvin or terbinafine for dermatophyte infections. Fluconazole is primarily effective against yeasts (Candida). If used, it requires higher doses (6 mg/kg/day) and longer duration (6+ weeks). It may be considered when griseofulvin and terbinafine are contraindicated or unavailable, but it's not first-line.", "consequence": "Fluconazole is less effective than first-line agents for dermatophytes.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Tinea capitis ALWAYS requires ORAL antifungal therapy** - topicals cannot penetrate the hair shaft. Griseofulvin (give with fatty food) for 6-8 weeks is first-line. Terbinafine for 4-6 weeks is an alternative, especially for *Trichophyton* species."}, "node-2": {"id": "node-2", "type": "decision", "content": "You prescribe oral griseofulvin 20 mg/kg/day to be given with breakfast (fatty food improves absorption).\n\n**The parents ask about adjunctive measures and whether the other children in the household need treatment.**\n\n**Key transmission considerations:**\n- *T. tonsurans* is **highly contagious** (anthropophilic)\n- Spread through direct contact, shared combs, brushes, hats, pillows\n- **Asymptomatic carriers** are common (up to 50% of household contacts)\n- Spores can survive on fomites for months\n\n**The patient has two younger siblings (ages 2 and 4) who share a bedroom with her.**", "question": "What adjunctive measures and household recommendations should you provide?", "choices": [{"id": "node-2-choice-a", "text": "Add antifungal shampoo (selenium sulfide or ketoconazole) twice weekly; screen siblings with fungal culture; symptomatic contacts need oral treatment, asymptomatic carriers need shampoo", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Comprehensive management** includes: (1) **Antifungal shampoo** (selenium sulfide 2.5% or ketoconazole 2%) twice weekly for the patient - reduces surface spore counts and decreases transmission, (2) **Screen household contacts** with fungal culture of the scalp, (3) **Treat symptomatic contacts** with oral antifungals, (4) **Treat asymptomatic carriers** with antifungal shampoo to prevent reinfection of the treated patient, (5) **Environmental measures**: don't share combs, brushes, hats, pillows; wash bedding in hot water.", "consequence": "You provide comprehensive treatment and contact management.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Treat the patient only; no need to evaluate siblings if they're asymptomatic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Asymptomatic carriers are a major source of reinfection and ongoing transmission**. Studies show 30-50% of household contacts may be asymptomatic carriers. If siblings are carriers and not treated, the patient is likely to be reinfected after completing therapy. At minimum, screen contacts with fungal culture and treat carriers with antifungal shampoo.", "consequence": "Failure to address carriers leads to reinfection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Prescribe prophylactic oral griseofulvin for all household members", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is overtreatment. **Oral antifungals should be reserved for symptomatic infection**, not given prophylactically. Griseofulvin has potential side effects (GI upset, headache, photosensitivity, rare hepatotoxicity, drug interactions) that don't justify prophylactic use. The appropriate approach is to: (1) Screen contacts with culture, (2) Treat asymptomatic carriers with antifungal SHAMPOO, (3) Reserve oral antifungals for symptomatic individuals.", "consequence": "Unnecessary medication exposure with potential side effects.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Recommend the patient stay home from school until treatment is complete", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this is overly restrictive. **AAP guidelines state children can return to school once oral antifungal treatment is initiated**. Extended school exclusion is not necessary and causes unnecessary educational and social disruption. With treatment (oral antifungal + antifungal shampoo), infectivity rapidly decreases. Avoiding sharing of combs/hats and direct head-to-head contact is sufficient.", "consequence": "Unnecessary school exclusion; child can attend once treatment is started.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Add oral steroids to reduce inflammation and speed healing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oral steroids are NOT indicated for uncomplicated tinea capitis**. Steroids without adequate antifungal coverage can worsen fungal infections by suppressing the immune response (\"tinea incognito\"). Oral steroids may be considered ONLY for **kerion** (severe inflammatory tinea) to reduce scarring - but ALWAYS with concurrent oral antifungal therapy. This patient does not have a kerion.", "consequence": "Steroids without indication risk worsening fungal infection.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Adjunctive antifungal shampoo** (selenium sulfide or ketoconazole) reduces surface spore counts and transmission. **Screen household contacts** - asymptomatic carriers are common and cause reinfection. Child can return to school once treatment is started."}, "node-3": {"id": "node-3", "type": "decision", "content": "You add ketoconazole 2% shampoo twice weekly and recommend screening the siblings. The younger siblings are brought in 1 week later - both have negative fungal cultures and no scalp symptoms.\n\n**The parents ask how long treatment should continue and what signs indicate the infection is cured.**\n\n**Monitoring treatment response:**\n- Clinical improvement (less scaling, hair regrowth) typically begins within 2-4 weeks\n- **Treatment should continue for 2 weeks AFTER clinical cure** to ensure mycologic cure\n- Total duration: typically 6-8 weeks for griseofulvin\n- Some clinicians obtain **repeat fungal culture** to confirm cure before stopping", "question": "What are appropriate criteria for determining treatment success and when to stop therapy?", "choices": [{"id": "node-3-choice-a", "text": "Continue treatment until clinical cure (no scaling, hair regrowth) plus 2 additional weeks; confirm with repeat fungal culture if available", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Treatment should continue until clinical AND mycologic cure**. Guidelines recommend: (1) **Minimum 6-8 weeks** of griseofulvin (or 4-6 weeks terbinafine), (2) Continue for **2 weeks beyond clinical resolution** to ensure spore eradication, (3) **Repeat fungal culture** before stopping is ideal (confirms mycologic cure), (4) If culture unavailable, extend treatment 2 weeks past clinical cure. Stopping too early leads to relapse because residual spores in the hair shaft can cause recurrence.", "consequence": "You provide appropriate guidance on treatment duration and endpoints.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Stop treatment as soon as symptoms resolve (typically 2-3 weeks)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stopping at symptom resolution leads to relapse**. Clinical improvement (reduced scaling) occurs before mycologic cure (complete spore elimination). The hair shaft may still harbor viable spores that will cause recurrence. The full course (6-8 weeks minimum) is necessary to eradicate all fungal elements. Premature discontinuation is a common cause of treatment failure.", "consequence": "Premature discontinuation leads to relapse.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Continue treatment for exactly 6 weeks regardless of clinical response", "isOptimal": false, "isAcceptable": true, "feedback": "This is reasonable but not optimal. While 6 weeks is the minimum standard duration, treatment should be individualized: (1) If clinical improvement is slow, **extend treatment**, (2) Treatment should continue **2 weeks beyond clinical cure**, which may exceed 6 weeks, (3) Repeat culture confirmation is ideal. A rigid 6-week cutoff without assessing clinical response may result in stopping too early in some patients.", "consequence": "Fixed duration may be insufficient if clinical cure is slow.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Switch to a different oral antifungal if not cured after 4 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect timing. **Clinical improvement typically takes 4-6 weeks** - switching at 4 weeks is premature. Griseofulvin and terbinafine work slowly because they must accumulate in the growing hair shaft. Indications to consider switching: (1) No improvement after 8+ weeks of compliant therapy, (2) Confirmed resistance on culture (rare), (3) Intolerance to first-line agent. Continue the initial agent for the full course before concluding it has failed.", "consequence": "Premature switching; allow full treatment course before determining failure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Check liver function tests monthly throughout treatment", "isOptimal": false, "isAcceptable": false, "feedback": "**Routine LFT monitoring is NOT required** for standard-duration tinea capitis treatment with griseofulvin or terbinafine. Both drugs are generally well-tolerated in children for 6-8 week courses. LFT monitoring may be considered for: (1) Pre-existing liver disease, (2) Concomitant hepatotoxic medications, (3) Treatment courses >8 weeks, (4) Symptoms of hepatotoxicity (jaundice, abdominal pain). For routine cases, baseline and monthly LFTs are unnecessary and add cost.", "consequence": "Routine LFT monitoring not needed for standard treatment duration.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Continue treatment 2 weeks beyond clinical cure** to ensure mycologic cure. Don't stop at symptom resolution - residual spores cause relapse. Confirm cure with repeat fungal culture if available. Total duration: typically 6-8 weeks griseofulvin, 4-6 weeks terbinafine."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly recognized that tinea capitis requires oral antifungal therapy, prescribed appropriate first-line treatment with griseofulvin, provided comprehensive contact management recommendations, and gave proper guidance on treatment duration.\n\n**Key teaching points:**\n- **Topical antifungals CANNOT cure tinea capitis** - oral therapy is mandatory\n- **Griseofulvin** 20-25 mg/kg/day with fatty food for 6-8 weeks (first-line)\n- **Terbinafine** 4-6 weeks is an effective alternative, especially for *Trichophyton*\n- **Adjunctive shampoo** (selenium sulfide, ketoconazole) reduces spore shedding\n- **Screen household contacts** - asymptomatic carriers are common\n- **Continue treatment 2 weeks beyond clinical cure** to prevent relapse\n- Children can return to school once treatment is initiated\n\n**Prognosis**: With complete treatment, cure rate >90%. Hair regrowth expected within 2-3 months. Delayed or inadequate treatment increases scarring alopecia risk."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of tinea capitis treatment:\n\n**Treatment fundamentals:**\n- ORAL antifungals are MANDATORY - topicals cannot penetrate the hair shaft\n- Griseofulvin 6-8 weeks (with fatty food) or terbinafine 4-6 weeks\n- Continue 2 weeks beyond clinical cure\n\n**Contact management:**\n- Screen household contacts with fungal culture\n- Treat symptomatic contacts with oral antifungals\n- Treat asymptomatic carriers with antifungal shampoo\n\n**Adjunctive measures:**\n- Antifungal shampoo twice weekly reduces spore shedding\n- Child can return to school once treatment is started"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical principles of tinea capitis treatment:\n\n**Why topical therapy fails:**\n- Dermatophytes invade the HAIR SHAFT and follicle\n- Topical antifungals CANNOT penetrate the hair shaft\n- No topical agent, regardless of type or duration, can cure tinea capitis\n\n**Correct treatment:**\n- ORAL griseofulvin (6-8 weeks with fatty food) or terbinafine (4-6 weeks)\n- Complete the FULL course - stopping early causes relapse\n- Continue 2 weeks beyond clinical cure\n\n**Don't forget contacts:**\n- Asymptomatic carriers cause reinfection\n- Screen and treat household contacts appropriately"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-129", "title": "HPV Vaccination Recommendation", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["cancer prevention vaccine", "age 11-12", "both boys and girls", "before sexual debut", "hpv vaccination recommendation"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "An 11-year-old female presents for her well-child visit. You note she is due for the HPV vaccine according to the recommended immunization schedule.\n\nWhen you mention the HPV vaccine, the mother appears uncomfortable and says: \"I've heard things about that vaccine. She's too young to need it, isn't she? She's not sexually active and won't be for a long time. Can't we wait until she's older?\"\n\nThe father adds: \"We also read some things online about safety concerns. Is it really necessary?\"", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You need to counsel this family about HPV vaccination.\n\n**Key HPV Vaccine Facts:**\n- **HPV (Human Papillomavirus)** is the most common sexually transmitted infection\n- HPV causes **6 types of cancer**: cervical, oropharyngeal, anal, vulvar, vaginal, penile\n- ~80% of people will be infected with HPV in their lifetime\n- Most infections clear spontaneously, but persistent infection \u2192 cancer\n- The vaccine is **most effective before any HPV exposure** (before sexual debut)\n\n**Current CDC Recommendations:**\n- Routine vaccination at **age 11-12** (can start as early as age 9)\n- **Both boys and girls** should be vaccinated\n- If started before age 15: **2-dose series** (0, 6-12 months)\n- If started at age 15+: **3-dose series** (0, 1-2, 6 months)", "question": "How do you frame your recommendation to this hesitant family?", "choices": [{"id": "node-1-choice-a", "text": "Frame it as cancer prevention: 'This vaccine prevents cancer. We give it at this age because it works best before any exposure to the virus'", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Framing HPV vaccine as cancer prevention** is the most effective approach for hesitant parents. Key messaging: (1) \"This is a **cancer prevention vaccine**\" - this reframes from STI to cancer, (2) \"We vaccinate at 11-12 because the **immune response is strongest** at this age,\" (3) \"The vaccine works **best before any exposure** to the virus - that's why we give it before sexual debut,\" (4) \"We're **preventing cervical cancer, throat cancer, and other HPV-related cancers**.\" Studies show parents are more receptive when the vaccine is framed as cancer prevention rather than STI prevention.", "consequence": "You use evidence-based communication strategies to address hesitancy.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Tell them it's mandatory and they don't have a choice", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While some states have school mandates for HPV vaccine, **taking an authoritarian approach is counterproductive**. This: (1) Damages the therapeutic relationship, (2) Increases resistance and vaccine hesitancy, (3) May cause the family to seek care elsewhere. Shared decision-making and addressing concerns respectfully is more effective than mandates for building vaccine acceptance.", "consequence": "Authoritarian approach increases resistance and damages trust.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Agree to delay vaccination until the child is sexually active", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying defeats the purpose** of the vaccine. Key points: (1) The vaccine is MOST effective BEFORE HPV exposure, (2) Many adolescents are sexually active before parents realize, (3) The immune response is STRONGER at age 11-12 than at older ages, (4) Waiting means the child may be exposed before vaccination. While respecting parental autonomy is important, recommending delay contradicts the medical evidence.", "consequence": "Delaying vaccination reduces effectiveness and misses the optimal window.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Focus on explaining that the vaccine prevents STIs", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect approach. While HPV IS sexually transmitted, **framing it as STI prevention triggers parental concerns** about their child's sexual activity. This is exactly what's causing the hesitancy. Research shows parents respond better to **cancer prevention framing**: \"This vaccine prevents cancer\" is more acceptable than \"This vaccine prevents an STI.\" The STI aspect can be addressed if asked, but shouldn't lead the discussion.", "consequence": "STI framing increases hesitancy; cancer prevention framing is more effective.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Give them materials to read and don't push the issue today", "isOptimal": false, "isAcceptable": true, "feedback": "This is acceptable but represents a **missed opportunity**. While providing educational materials is helpful, the strongest predictor of vaccine acceptance is **a clear provider recommendation**. Studies show that when providers give a strong, confident recommendation (\"Your child is due for the HPV vaccine today\"), acceptance rates are much higher than when vaccination is presented as optional. Use this visit to recommend AND provide materials.", "consequence": "Provider recommendation is the strongest driver of vaccine acceptance - don't miss the opportunity.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Frame HPV vaccine as CANCER PREVENTION**, not STI prevention. A strong provider recommendation is the most important factor in vaccine acceptance. \"This vaccine prevents cervical cancer and other cancers\" is more effective than \"This protects against a sexually transmitted infection.\""}, "node-2": {"id": "node-2", "type": "decision", "content": "You've framed the vaccine as cancer prevention. The mother seems more receptive but says: \"I still don't understand why you'd vaccinate a boy for cervical cancer. That doesn't make sense.\"\n\n**Why vaccinate boys?**\n- HPV causes cancer in males too: oropharyngeal (throat), anal, penile\n- **Oropharyngeal cancer** (HPV-related) is now MORE common in males than cervical cancer in females\n- Vaccinating boys provides **herd immunity** - protects unvaccinated individuals\n- Boys can transmit HPV to partners, contributing to cervical cancer\n- Equal protection for all genders", "question": "How do you address the question about vaccinating boys?", "choices": [{"id": "node-2-choice-a", "text": "Explain that HPV causes throat cancer, anal cancer, and penile cancer in males - oropharyngeal cancer from HPV is now more common than cervical cancer", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Boys benefit directly from HPV vaccination**: (1) **Oropharyngeal cancer** (HPV-related throat cancer) is now more common than cervical cancer and primarily affects males, (2) **Anal cancer** - HPV causes 90% of anal cancers, (3) **Penile cancer** - though rare, HPV causes most cases, (4) **Genital warts** - preventable with the vaccine. Additionally, vaccinating boys contributes to **herd immunity**, protecting those who can't be vaccinated. This isn't just about protecting female partners - boys directly benefit.", "consequence": "You explain the direct benefits to males.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Say it's mainly to protect their future female partners from cervical cancer", "isOptimal": false, "isAcceptable": true, "feedback": "While protecting partners is a valid reason, this framing **understates the direct benefits to males**. HPV-related oropharyngeal cancer in males is now more common than cervical cancer in females. Saying vaccination is mainly to protect partners may: (1) Make it seem optional for boys, (2) Miss the opportunity to explain direct benefits, (3) Reduce motivation if the boy doesn't plan to have female partners. Emphasize direct protection PLUS partner protection.", "consequence": "Correct but incomplete - emphasize direct benefits to males first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Admit that boys don't really need the vaccine as much as girls", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Boys have equal need for vaccination**. The data: (1) HPV-related oropharyngeal cancer in males now **exceeds** cervical cancer in females, (2) 90% of anal cancers are HPV-related, (3) Most penile cancers are HPV-related. The CDC recommends vaccination for all children regardless of sex. Suggesting boys don't need it as much is medically inaccurate and could lead to preventable cancer.", "consequence": "This is medically incorrect - boys have significant direct benefit from vaccination.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Tell them you only need to vaccinate boys if they will be sexually active with women", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for multiple reasons: (1) HPV causes cancer in males regardless of partner gender (oropharyngeal, anal, penile), (2) Oral HPV infection can occur through multiple routes, (3) This framing is heteronormative and excludes LGBTQ+ youth, (4) Most parents don't know their child's future sexual orientation. The vaccine is recommended for ALL adolescents regardless of anticipated sexual behavior or orientation.", "consequence": "Recommendation should be universal, not based on assumed sexual behavior.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Recommend skipping the vaccine for boys and only vaccinating the daughter", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This contradicts CDC recommendations and denies boys the direct benefits of vaccination. HPV-related cancers in males are **increasing**, particularly oropharyngeal cancer. Recommending against vaccination for boys: (1) Puts them at preventable cancer risk, (2) Reduces herd immunity, (3) Is not consistent with evidence-based practice. The vaccine is equally recommended for both sexes.", "consequence": "This denies boys protection from preventable cancer.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**HPV-related oropharyngeal cancer in males now exceeds cervical cancer in females**. Boys have direct benefit from vaccination - it's not just about protecting partners. Vaccinate ALL adolescents regardless of sex or anticipated sexual behavior."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents are now convinced about the cancer prevention benefits for both sexes. The father then asks: \"What about the safety concerns we read about online? We saw stories about serious side effects.\"\n\n**HPV Vaccine Safety Data:**\n- **Over 135 million doses** administered in the US\n- One of the most extensively monitored vaccines\n- **Common side effects**: injection site pain (90%), redness, swelling; mild systemic symptoms (headache, fatigue)\n- **Syncope (fainting)**: can occur with any injection in adolescents; recommend 15-minute observation\n- **No causal link** to serious adverse events, autoimmune diseases, or infertility\n- Safety monitored by VAERS, VSD, CISA, and international systems", "question": "How do you address the parents' safety concerns?", "choices": [{"id": "node-3-choice-a", "text": "Acknowledge their concerns, explain the extensive safety monitoring, and note that common side effects are mild and temporary", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Address safety concerns empathetically and factually**: (1) **Acknowledge** their concerns - don't dismiss them, (2) Explain that over **135 million doses** have been given with extensive safety monitoring, (3) **Common side effects** are mild: sore arm, headache, fatigue - temporary, (4) **Syncope** (fainting) can occur with any adolescent vaccination - we observe for 15 minutes, (5) Large studies have found **no causal link** to autoimmune diseases, infertility, or other serious conditions, (6) The **risks of HPV-related cancer** far outweigh the vaccine risks.", "consequence": "You address concerns with empathy and evidence.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Dismiss their concerns by saying 'you can't believe everything you read online'", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dismissing concerns damages trust** and makes parents more likely to refuse vaccination. While misinformation is a problem, dismissive responses: (1) Make parents feel judged, (2) Don't address the underlying concern, (3) May push them toward vaccine refusal. Instead, acknowledge the concern, then provide accurate information from reliable sources. Meet them where they are.", "consequence": "Dismissive responses increase vaccine hesitancy.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Tell them there are no side effects from the vaccine", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Claiming no side effects is dishonest** and will backfire. When the child experiences injection site pain (90% do) or feels tired afterward, parents will lose trust. Honest communication includes: (1) Common side effects ARE expected (sore arm, headache, fatigue), (2) These are **mild and temporary**, (3) Serious adverse events are **extremely rare** and not causally linked to the vaccine. Transparency builds trust.", "consequence": "Dishonesty about side effects destroys trust when expected symptoms occur.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Recommend they do their own research before deciding", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. \"Do your own research\" often leads to **misinformation** and is not helpful medical advice. Parents searching online frequently encounter anti-vaccine content that appears credible. **Your role is to provide accurate information**, not to abdicate that responsibility. If they want to learn more, direct them to **reliable sources** (CDC, AAP) rather than leaving them to navigate misinformation alone.", "consequence": "This cedes your expertise to potentially unreliable sources.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Tell them if they're worried about safety they should probably wait", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Validating unfounded safety fears** by suggesting they wait: (1) Implies the concerns have merit when they don't, (2) Delays protection during the optimal immune response window, (3) Misses the opportunity to provide accurate information. Instead, address the concerns directly with evidence, then maintain your strong recommendation. Parents often need reassurance, not validation of fears.", "consequence": "This validates unfounded fears and delays needed protection.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Address safety concerns with empathy AND evidence**: \"I understand your concern. This vaccine has been given over 135 million times and is one of the most monitored vaccines we have. Common side effects like a sore arm are temporary. Studies have found no link to the serious conditions you may have read about.\""}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You effectively counseled a vaccine-hesitant family using evidence-based communication strategies.\n\n**Key Teaching Points:**\n\n**Framing:**\n- Frame as **CANCER PREVENTION**, not STI prevention\n- \"This vaccine prevents cervical cancer, throat cancer, and other cancers\"\n\n**Why age 11-12:**\n- Best immune response at this age\n- Most effective BEFORE any HPV exposure\n- Only 2 doses needed if started before age 15\n\n**Why boys too:**\n- HPV-related oropharyngeal cancer in males exceeds cervical cancer in females\n- Direct protection from throat, anal, and penile cancers\n- Herd immunity benefits all\n\n**Addressing safety:**\n- Acknowledge concerns without dismissing\n- 135+ million doses given with extensive monitoring\n- Common side effects are mild and temporary\n- No causal link to serious adverse events\n\n**Strong provider recommendation is the #1 factor in vaccine acceptance.**"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review effective HPV vaccine counseling:\n\n**Framing matters:**\n- CANCER prevention > STI prevention\n- Strong provider recommendation is crucial\n\n**Key messages:**\n- Prevents 6 types of cancer\n- Both boys and girls benefit directly\n- Best immune response at age 11-12\n- Works best before HPV exposure\n\n**Addressing hesitancy:**\n- Acknowledge concerns empathetically\n- Provide accurate safety information\n- Don't dismiss or be authoritarian\n- Don't suggest delaying or doing \"research\""}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Effective HPV vaccination counseling requires:\n\n**DO:**\n- Frame as cancer prevention\n- Give strong, confident recommendation\n- Acknowledge concerns empathetically\n- Provide accurate safety information\n- Emphasize direct benefits to both sexes\n\n**DON'T:**\n- Be authoritarian or dismissive\n- Agree to delay vaccination\n- Focus on STI prevention\n- Claim there are no side effects\n- Tell parents to \"do their own research\"\n- Suggest boys need it less than girls\n\n**Key facts:**\n- HPV vaccine prevents cancer, not just STI\n- Oropharyngeal cancer in males > cervical cancer in females\n- 135+ million doses given safely\n- Strong provider recommendation is #1 factor in acceptance"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-137", "title": "Gonorrhea Exposure Management", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["STI exposure", "empiric treatment", "ceftriaxone", "dual therapy", "chlamydia co-infection", "adolescent confidentiality", "gonorrhea resistance", "gonorrhea exposure management"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 14-year-old female presents alone to your adolescent clinic. She appears anxious and says: \"I need to talk to you about something private. My boyfriend was just diagnosed with gonorrhea at the health department yesterday. We had sex without a condom about 5 days ago. I don't have any symptoms, but I'm really worried.\"\n\nShe has no significant medical history and no known drug allergies. Her last menstrual period was 10 days ago. She has never been pregnant.\n\nYou need to manage this gonorrhea exposure appropriately.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You reassure her that she did the right thing by coming in, and that her confidentiality will be protected.\n\n**Key Principles for STI Exposure Management:**\n\n**Empiric Treatment for Known Exposure:**\n- When a patient has **confirmed exposure** to gonorrhea (partner diagnosed), **treat empirically**\n- Do NOT wait for test results - infection may be incubating\n- Transmission rate per episode of vaginal sex: ~20-50% for female partners\n\n**Why Treat Without Waiting?**\n- **Incubation period**: Gonorrhea may not be detectable for 1-14 days after exposure\n- **Prevents complications**: Untreated gonorrhea can ascend \u2192 **PID, tubo-ovarian abscess, infertility**\n- **Reduces transmission**: Treating promptly prevents spread to other partners\n- **Partner notification**: The confirmed partner exposure is diagnostic\n\n**Testing Still Important:**\n- Collect specimens for gonorrhea AND chlamydia testing (NAAT)\n- Test results guide follow-up and public health reporting\n- But don't delay treatment while waiting for results\n\n**Confidentiality in Adolescents:**\n- Most states allow minors to consent to STI testing and treatment without parental involvement\n- Confidentiality is essential to encourage adolescents to seek care", "question": "What is your initial management approach?", "choices": [{"id": "node-1-choice-a", "text": "Collect specimens for testing AND provide empiric treatment today - don't wait for results given confirmed exposure", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Known gonorrhea exposure requires empiric treatment without waiting for test results**. Key principles: (1) **Partner confirmation is sufficient indication** - you don't need positive results to treat, (2) **Test AND treat** - collect specimens for documentation and public health, but don't delay treatment, (3) **Incubation period** means she may test negative today but develop infection - treatment prevents this, (4) **Prevents PID** - the most serious complication of untreated gonorrhea in females, (5) **Reduces transmission** to future partners. This \"test and treat\" approach is standard of care for confirmed STI exposure.", "consequence": "You appropriately initiate empiric treatment for confirmed exposure.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Collect specimens for testing and ask her to return in 3-5 days for results before deciding on treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Waiting for test results with confirmed gonorrhea exposure is inappropriate**. Key issues: (1) **Testing may be falsely negative** during incubation period - she could test negative today and develop PID next week, (2) **Delays treatment** allowing infection to ascend \u2192 PID risk, (3) **Patient may not return** - treat the patient in front of you, (4) **Known exposure IS diagnostic** - her partner's positive test confirms she was exposed. The standard of care is empiric treatment at the exposure visit, not waiting for her own test results.", "consequence": "Delaying treatment risks complications and patient loss to follow-up.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Tell her she needs to bring a parent for consent since she's only 14 years old", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Minors can consent to STI evaluation and treatment without parental involvement** in most states. Key points: (1) **Minor consent laws** allow adolescents to receive confidential STI care, (2) **Requiring parental involvement** creates barriers and may prevent teens from seeking care, (3) **Confidentiality is essential** for adolescent reproductive health, (4) **Public health benefit** - reducing barriers to STI treatment prevents disease spread. Know your state's laws, but most states allow minors age 12+ to consent to STI care.", "consequence": "Creating unnecessary barriers prevents timely treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Reassure her that since she has no symptoms, she probably wasn't infected and doesn't need treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Asymptomatic infection is common** - especially in females. Key facts: (1) **Up to 80% of females with gonorrhea are asymptomatic** initially, (2) **Asymptomatic infection can still cause PID** - silent inflammation, (3) **\"Absence of symptoms\" does NOT equal \"absence of infection\"**, (4) **Partner exposure is the key factor** - symptoms are irrelevant for treatment decisions. Reassuring her without treatment is medically inappropriate and dangerous.", "consequence": "False reassurance allows preventable infection and complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Ask her to have her boyfriend bring documentation of his diagnosis before you can treat her", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Patient history is sufficient** - you don't need documentation of the partner's diagnosis. Key issues: (1) **Her report of partner's diagnosis is credible** - treat based on history, (2) **Creating barriers delays treatment**, (3) **Partner may not cooperate** or may not be reachable, (4) **Privacy concerns** - the partner has a right to medical confidentiality too. Take her history at face value and treat empirically. If you have concerns about history accuracy, you can still test her - but treatment should proceed regardless.", "consequence": "Unnecessary barriers delay treatment and may deter care-seeking.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Known STI exposure = empiric treatment**, don't wait for test results. Up to 80% of females with gonorrhea are asymptomatic initially, but can still develop PID. The partner's positive test is your diagnostic evidence - treat now, confirm with testing for documentation."}, "node-2": {"id": "node-2", "type": "decision", "content": "You collect specimens (vaginal swab for NAAT and urine sample) and prepare to provide treatment.\n\n**CDC Guidelines for Gonorrhea Treatment (Current):**\n\n**Uncomplicated Gonorrhea (urogenital, rectal, pharyngeal):**\n- **Ceftriaxone 500 mg IM x 1 dose** (if weight <150 kg; 1g if \u2265150 kg)\n- PLUS empiric treatment for chlamydia if chlamydia not ruled out:\n  - **Doxycycline 100 mg PO BID x 7 days** (preferred)\n  - OR Azithromycin 1g PO x 1 dose (alternative)\n\n**Why DUAL THERAPY (Gonorrhea + Chlamydia)?**\n- **Chlamydia co-infection rate is 10-40%** in patients with gonorrhea\n- Chlamydia causes same complications (PID, infertility)\n- Cost-effective to treat empirically vs. waiting for results\n\n**Why Ceftriaxone is Essential:**\n- **Gonorrhea resistance** is a major public health threat\n- Resistance to fluoroquinolones, penicillins, tetracyclines is common\n- Ceftriaxone remains highly effective (>99% susceptible)\n- **NO oral alternatives** are recommended for gonorrhea treatment currently\n\n**Important Notes:**\n- If cephalosporin allergy: consult ID, consider gentamicin + azithromycin\n- Test of cure NOT routinely needed unless symptoms persist\n- Retest in 3 months for reinfection (high reinfection rates in adolescents)", "question": "What treatment regimen do you prescribe?", "choices": [{"id": "node-2-choice-a", "text": "Ceftriaxone 500 mg IM x 1 dose PLUS doxycycline 100 mg PO BID x 7 days for empiric chlamydia coverage", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! This is the **current CDC-recommended regimen** for uncomplicated gonorrhea with empiric chlamydia coverage. Key points: (1) **Ceftriaxone 500 mg IM** is the only recommended first-line gonorrhea treatment - no oral alternatives, (2) **Doxycycline for 7 days** covers potential chlamydia co-infection (10-40% co-infection rate), (3) **Single-dose IM + oral course** ensures compliance and efficacy, (4) **Addresses both infections** without waiting for separate chlamydia results. This dual therapy approach prevents complications from either infection.", "consequence": "Appropriate CDC-recommended dual therapy provided.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Azithromycin 1g PO x 1 dose alone - it covers both gonorrhea and chlamydia", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Azithromycin alone is NO LONGER recommended for gonorrhea** due to rising resistance. Key issues: (1) **Gonorrhea resistance to azithromycin is increasing** - now >5% in many areas, (2) **Single-dose azithromycin fails** for gonorrhea in a significant percentage of cases, (3) **Ceftriaxone is required** as the backbone of gonorrhea therapy, (4) **Azithromycin CAN be used for chlamydia** as an alternative to doxycycline, but NOT as monotherapy for gonorrhea. The old \"azithromycin alone\" regimen is outdated and inappropriate.", "consequence": "Monotherapy with azithromycin risks treatment failure due to resistance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Ciprofloxacin 500 mg PO x 1 dose - oral treatment is more convenient than an injection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fluoroquinolones are NOT recommended for gonorrhea** due to widespread resistance. Key facts: (1) **Fluoroquinolone-resistant gonorrhea** emerged in the early 2000s, (2) **Resistance rates exceed 30%** in many populations, (3) **CDC removed fluoroquinolones** from recommended gonorrhea treatment in 2007, (4) **No oral alternatives** are currently recommended - IM ceftriaxone is required. Convenience doesn't justify using an ineffective antibiotic.", "consequence": "Fluoroquinolone resistance makes this treatment likely to fail.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Ceftriaxone 500 mg IM x 1 dose alone - treat only for gonorrhea since that's what she was exposed to", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable but not optimal. **Ceftriaxone alone treats gonorrhea but misses potential chlamydia**. Key issues: (1) **Chlamydia co-infection rate is 10-40%** in patients with gonorrhea, (2) **Chlamydia causes the same complications** (PID, infertility), (3) **Cost-effective to treat empirically** rather than wait for separate results, (4) **Partner may have had both infections** even if only gonorrhea was diagnosed. CDC recommends dual therapy unless chlamydia has been definitively ruled out by testing.", "consequence": "Gonorrhea treated, but potential chlamydia co-infection not addressed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Amoxicillin 3g PO x 1 dose with probenecid - this older regimen is still effective", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Penicillin-based regimens are NO LONGER effective** for gonorrhea. Key history: (1) **Penicillinase-producing N. gonorrhoeae (PPNG)** emerged in the 1970s, (2) **Penicillin resistance is now widespread**, (3) **This regimen was abandoned decades ago**, (4) **Only ceftriaxone** remains reliably effective against gonorrhea. Using outdated regimens risks treatment failure and allows resistant strains to persist and spread.", "consequence": "Outdated regimen will likely fail due to penicillin resistance.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Gonorrhea treatment = Ceftriaxone IM** - there are NO recommended oral alternatives due to resistance. Always add **doxycycline or azithromycin for presumed chlamydia co-infection** (10-40% co-infection rate). Fluoroquinolones and penicillins are ineffective due to widespread resistance."}, "node-3": {"id": "node-3", "type": "decision", "content": "You administer ceftriaxone 500 mg IM and provide a 7-day prescription for doxycycline 100 mg BID. The patient tolerates the injection well.\n\nBefore she leaves, you need to address several important aspects of comprehensive STI care.\n\n**Additional Evaluation and Counseling:**\n\n**Testing for Other STIs:**\n- **HIV testing** - all patients with STI exposure should be offered HIV testing\n- **Syphilis serology** (RPR or VDRL)\n- **Hepatitis B** status (offer vaccination if not immune)\n- **Pregnancy test** - affects management and counseling\n\n**Partner Management:**\n- **Expedited Partner Therapy (EPT)** - providing antibiotics for the partner without examining them\n- Legal in most states for chlamydia; variable for gonorrhea\n- Reduces reinfection rates\n\n**Follow-up:**\n- **Test of cure** NOT routinely needed if treated with ceftriaxone\n- **Retest in 3 months** - high reinfection rates in adolescents\n- Return if symptoms develop (dysuria, discharge, pelvic pain)\n\n**Risk Reduction Counseling:**\n- Abstinence until treatment completed and partner treated\n- Consistent condom use\n- Reducing number of partners\n- PrEP discussion if high-risk for HIV", "question": "What additional evaluation and counseling do you provide?", "choices": [{"id": "node-3-choice-a", "text": "Offer HIV testing, syphilis serology, pregnancy test, hepatitis B status check; counsel on abstinence until treated, condom use, and plan for 3-month retest", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Comprehensive STI care includes testing for co-infections and risk reduction counseling**. Key components: (1) **HIV testing** - all STI patients should be offered HIV screening, (2) **Syphilis serology** - STIs cluster together, (3) **Pregnancy test** - affects management and counseling, (4) **Hepatitis B** - vaccinate if not immune, (5) **Abstinence counseling** - until she and partner complete treatment (7 days), (6) **Condom counseling** - prevent reinfection and other STIs, (7) **3-month retest** - high adolescent reinfection rates. This comprehensive approach addresses the index infection AND reduces future risk.", "consequence": "Comprehensive STI care provided with appropriate testing and counseling.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Tell her to come back in a week for HIV and syphilis testing since the gonorrhea treatment is the priority right now", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable but suboptimal. **Testing for co-infections should be done at the same visit** when possible. Key issues: (1) **She's already here** - drawing labs today is more efficient and ensures it gets done, (2) **She may not return** - adolescents have high no-show rates, (3) **HIV and syphilis** can be tested today regardless of gonorrhea treatment, (4) **No medical reason to delay** - these tests don't interfere with treatment. While her gonorrhea treatment is appropriately prioritized, comprehensive STI screening should be done today.", "consequence": "Patient may not return for additional testing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Tell her she needs to return in 2 weeks for a test of cure to confirm the gonorrhea treatment worked", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Test of cure is NOT routinely recommended** after ceftriaxone treatment for uncomplicated gonorrhea. Key points: (1) **Ceftriaxone efficacy >99%** - treatment failure is rare, (2) **Test of cure can be falsely positive** due to detecting dead organisms (NAATs remain positive for weeks), (3) **Resources better spent on 3-month retest** for reinfection (much more common than treatment failure), (4) Test of cure IS indicated if: symptoms persist, pharyngeal gonorrhea, or concern for antibiotic-resistant strain. For routine uncomplicated cases, schedule 3-month retest instead.", "consequence": "Unnecessary test of cure wastes resources and may cause confusion.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Focus only on the gonorrhea - other STI testing can wait until her annual well-visit", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **STI exposure is an indication for comprehensive screening** - not just the index infection. Key issues: (1) **STIs cluster** - patients with one STI have increased risk of others, (2) **HIV testing is critical** - early detection changes management and prognosis, (3) **Syphilis can be asymptomatic** for years while causing damage, (4) **Waiting for annual visit** may be months away and patient may not return. The exposure event creates a window of engagement - use it for comprehensive screening.", "consequence": "Missing opportunity for comprehensive STI screening.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Contact her boyfriend directly to ensure he gets treated - partner notification is your responsibility", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Direct provider-to-partner contact raises confidentiality concerns**. Key points: (1) **Her boyfriend was already diagnosed** at the health department - he's presumably being treated, (2) **Patient-delivered partner notification** or health department notification are preferred, (3) **You should not contact the partner directly** without clear protocols, (4) **Expedited Partner Therapy (EPT)** - giving her antibiotics to deliver to her partner - is an option in some states, but he already has a diagnosis. Focus on counseling HER about abstinence until both are treated and about partner treatment verification.", "consequence": "Direct partner contact raises confidentiality and ethical concerns.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Comprehensive STI care** means testing for HIV, syphilis, and hepatitis B at the same visit - not just treating the index infection. **Retest in 3 months** for reinfection (more common than treatment failure). Test of cure is NOT routinely needed after ceftriaxone for uncomplicated gonorrhea."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You provided comprehensive, evidence-based care for this adolescent with gonorrhea exposure.\n\n**Key Teaching Points:**\n\n**Management of Known STI Exposure:**\n- **Empiric treatment without waiting for results** - partner's diagnosis IS diagnostic evidence\n- **Test AND treat** - collect specimens for documentation, but don't delay treatment\n- **Asymptomatic infection is common** - especially in females (up to 80%)\n\n**Current Gonorrhea Treatment (CDC Guidelines):**\n- **Ceftriaxone 500 mg IM x 1 dose** - ONLY recommended first-line treatment\n- **NO oral alternatives** - fluoroquinolones and penicillins ineffective due to resistance\n- **PLUS empiric chlamydia treatment** - doxycycline 100 mg BID x 7 days (or azithromycin 1g x 1)\n- **Co-infection rate 10-40%** - always treat for both\n\n**Comprehensive STI Care:**\n- Test for HIV, syphilis, hepatitis B at same visit\n- Pregnancy test in females of reproductive age\n- Abstinence counseling until treatment complete\n- Condom counseling for risk reduction\n- **Retest in 3 months** for reinfection (NOT test of cure)\n\n**Adolescent Confidentiality:**\n- Minors can consent to STI care in most states\n- Confidentiality essential to encourage care-seeking\n- Know your state's minor consent laws\n\n**Preventing Complications:**\n- Untreated gonorrhea \u2192 PID \u2192 tubo-ovarian abscess, infertility, ectopic pregnancy\n- Early treatment prevents ascending infection\n- Partner treatment prevents reinfection"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in gonorrhea exposure management:\n\n**Empiric Treatment Principles:**\n- Known exposure = treat empirically, don't wait for results\n- Partner's diagnosis is sufficient evidence\n- Asymptomatic patients still need treatment\n\n**Correct Treatment Regimen:**\n- Ceftriaxone 500 mg IM - no oral alternatives\n- PLUS doxycycline for chlamydia coverage\n- Dual therapy addresses high co-infection rate\n\n**Comprehensive Care:**\n- Test for HIV, syphilis, hepatitis B at same visit\n- Don't defer additional testing to future visits\n- Patient may not return\n\n**Follow-up:**\n- Retest in 3 months for reinfection\n- Test of cure NOT routinely needed after ceftriaxone\n- Return if symptoms develop\n\n**Common Mistakes:**\n- Treating gonorrhea alone without chlamydia coverage\n- Deferring additional STI testing\n- Scheduling unnecessary test of cure"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case highlights critical concepts in STI management:\n\n**Known Exposure Requires Empiric Treatment:**\n- **Do NOT wait for test results** with confirmed exposure\n- Partner's diagnosis IS diagnostic evidence\n- **Asymptomatic infection is common** - absence of symptoms doesn't rule out infection\n- Delaying treatment risks PID, infertility, and transmission\n\n**Current Treatment Guidelines:**\n- **Ceftriaxone 500 mg IM** is the ONLY recommended first-line gonorrhea treatment\n- **NO oral alternatives** - fluoroquinolones, penicillins, azithromycin alone are all inadequate\n- **Resistance is a major public health threat** - use only recommended regimens\n- **Always co-treat for chlamydia** - 10-40% co-infection rate\n\n**Adolescent Care:**\n- **Minors can consent to STI care** in most states without parental involvement\n- **Confidentiality is essential** - barriers to care prevent treatment\n- Take patient history at face value - don't require partner documentation\n\n**Complications of Untreated Gonorrhea:**\n- Pelvic inflammatory disease (PID)\n- Tubo-ovarian abscess\n- Infertility\n- Ectopic pregnancy\n- Disseminated gonococcal infection\n\nEarly, appropriate treatment prevents these devastating outcomes."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-142", "title": "TORCH Infections", "domain": "infectious_disease", "difficulty": "advanced", "tags": ["TORCH infections", "congenital toxoplasmosis", "congenital CMV", "blueberry muffin rash", "intracranial calcifications", "chorioretinitis"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 5-day-old male newborn is being evaluated in the NICU for multiple abnormalities noted at birth.\n\nBirth history: Born at 38 weeks to a 22-year-old G1P1 mother. Prenatal care was limited - she only had 2 visits in the third trimester. The mother recalls having a \"flu-like illness\" with fever, rash, and swollen lymph nodes in her first trimester. She lived on a farm and had cats.\n\nThe baby was noted at birth to be small for gestational age (birth weight 2.1 kg at 38 weeks, <3rd percentile). He failed his newborn hearing screen bilaterally.\n\nPhysical Examination:\n- General: Small for gestational age, microcephalic (head circumference 30 cm, <3rd percentile)\n- Vitals: T 37.2\u00b0C, HR 150, RR 45\n- Skin: Scattered petechiae and purpuric papules (\"blueberry muffin\" rash) on trunk\n- Eyes: Bilateral chorioretinitis on fundoscopy\n- Abdomen: Hepatomegaly 4 cm below costal margin, splenomegaly 3 cm below costal margin\n- Neurologic: Hypotonia, weak cry\n\nInitial labs:\n- CBC: Hgb 10.2 g/dL, WBC 6,500, Platelets 42,000\n- LFTs: AST 210, ALT 185, Direct bilirubin 4.8 mg/dL\n- Total bilirubin: 12.5 mg/dL", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating this newborn with multiple congenital abnormalities including:\n- Intrauterine growth restriction (SGA)\n- Microcephaly\n- Blueberry muffin rash (dermal erythropoiesis)\n- Hepatosplenomegaly\n- Chorioretinitis\n- Thrombocytopenia\n- Direct hyperbilirubinemia\n- Failed hearing screen\n\nMother had febrile illness with rash and lymphadenopathy in first trimester, and had cat exposure.", "question": "What category of infection is most likely responsible for this constellation of findings?", "choices": [{"id": "node-1-choice-a", "text": "TORCH infection - congenital infection acquired in utero causing characteristic multi-system disease", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** This is classic **TORCH infection** - a group of congenital infections acquired in utero that cause similar clinical syndromes. TORCH stands for: **T**oxoplasmosis, **O**ther (syphilis, varicella, parvovirus B19), **R**ubella, **C**MV, **H**SV. Common features include: **IUGR**, **microcephaly**, **intracranial calcifications**, **chorioretinitis**, **hepatosplenomegaly**, **jaundice**, **thrombocytopenia**, **petechiae/purpura**, and **sensorineural hearing loss**. The mother's first-trimester illness and cat exposure suggest toxoplasmosis or rubella.", "consequence": "Correct diagnostic category identified. Proceed with specific workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Neonatal sepsis - fever and multisystem involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While bacterial sepsis causes multisystem illness, it does not explain the **intrauterine findings**: IUGR, microcephaly, and congenital abnormalities that developed during gestation. The blueberry muffin rash (dermal erythropoiesis) and chorioretinitis are characteristic of **congenital** infection, not postnatal sepsis.", "consequence": "Missing the congenital nature of this infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Congenital leukemia - hepatosplenomegaly with blueberry muffin rash", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While congenital leukemia can cause blueberry muffin rash (leukemia cutis) and hepatosplenomegaly, it does not cause **microcephaly**, **chorioretinitis**, or the maternal history of febrile illness. The constellation of IUGR + microcephaly + chorioretinitis + maternal illness is diagnostic for congenital infection, not malignancy.", "consequence": "Rare diagnosis considered when TORCH is classic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Hemolytic disease of the newborn - jaundice and hepatosplenomegaly", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hemolytic disease (Rh or ABO incompatibility) causes **indirect** hyperbilirubinemia from hemolysis, not direct hyperbilirubinemia. It also does not cause microcephaly, IUGR, chorioretinitis, or blueberry muffin rash. The **direct hyperbilirubinemia** (4.8 mg/dL) points to hepatobiliary disease from infection, not hemolysis.", "consequence": "Type of hyperbilirubinemia doesn't match.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Inborn error of metabolism - hepatomegaly with neurologic findings", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Metabolic disorders can cause hepatomegaly and neurologic findings, but they do not explain the maternal illness, IUGR (metabolic diseases typically present postnatally), chorioretinitis, or blueberry muffin rash. The pattern of findings with maternal illness history is diagnostic for congenital infection.", "consequence": "Pattern doesn't fit metabolic disease.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "The **\"blueberry muffin\" rash** represents **dermal erythropoiesis** - extramedullary hematopoiesis in the skin creating blue-purple papules. It occurs when bone marrow is suppressed or replaced. Classic causes: **congenital TORCH infections** (CMV, rubella, toxoplasmosis), congenital leukemia, and twin-twin transfusion syndrome."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect a TORCH infection and need to determine the specific pathogen.\n\nYou order a head ultrasound which shows:\n- **Diffuse, scattered intracranial calcifications** throughout the brain parenchyma\n- Ventriculomegaly (hydrocephalus)\n\nKey historical clues:\n- Mother had first-trimester illness with fever, rash, lymphadenopathy\n- Mother had cat exposure on farm\n- Limited prenatal care (no screening tests)", "question": "Based on the calcification pattern and maternal history, which TORCH pathogen is most likely?", "choices": [{"id": "node-2-choice-a", "text": "Toxoplasmosis - diffuse/scattered calcifications, cat exposure, triad of chorioretinitis/hydrocephalus/calcifications", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** The findings strongly suggest **congenital toxoplasmosis**. Key features include: **Diffuse, scattered intracranial calcifications** (vs periventricular in CMV), the **classic triad** of chorioretinitis + hydrocephalus + intracranial calcifications, and maternal **cat exposure** (cats are the definitive host for Toxoplasma gondii, shedding oocysts in feces). The mother's first-trimester illness is consistent with primary toxoplasmosis infection. First-trimester infection causes more severe fetal disease.", "consequence": "Correct identification of likely pathogen.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "CMV - most common congenital infection, causes hearing loss", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct - CMV is indeed the **most common congenital infection** and causes hearing loss. However, CMV characteristically causes **periventricular calcifications** (surrounding the ventricles), not diffuse scattered calcifications. The maternal cat exposure and first-trimester symptomatic illness also point more toward toxoplasmosis. CMV maternal infection is often asymptomatic.", "consequence": "Reasonable consideration but calcification pattern suggests toxoplasmosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Rubella - first-trimester infection with rash", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Congenital rubella syndrome classically causes the triad of **sensorineural deafness**, **cataracts** (not chorioretinitis), and **cardiac defects** (PDA, pulmonary stenosis). While the maternal rash is consistent, rubella does **not typically cause intracranial calcifications**. Due to widespread vaccination, congenital rubella is now rare in developed countries.", "consequence": "Rubella doesn't cause calcifications.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "HSV - neonatal infection from delivery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Neonatal HSV** is typically acquired **during delivery** (not in utero), usually presenting in the first 2-4 weeks of life with skin vesicles, encephalitis, or disseminated disease. It does not cause IUGR or the chronic intrauterine changes seen here. True **congenital HSV** (intrauterine infection) is rare and would show skin scarring, limb abnormalities, and microphthalmia.", "consequence": "HSV is acquired at delivery, not causing this intrauterine pattern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Syphilis - VDRL testing needed first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Congenital syphilis causes a different pattern: **rhinitis** (\"snuffles\"), **osteochondritis** and **periostitis** (bone abnormalities on X-ray), hepatosplenomegaly, and later features like Hutchinson teeth and saddle nose. Intracranial calcifications are not typical of syphilis. The cat exposure specifically suggests toxoplasmosis.", "consequence": "Different clinical pattern than syphilis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Calcification patterns** help differentiate TORCH infections: **Toxoplasmosis** = diffuse/scattered throughout brain, **CMV** = periventricular (around ventricles), **Rubella and HSV** = typically no calcifications. Remember: **\"Toxo scatters, CMV peri-V\"**"}, "node-3": {"id": "node-3", "type": "decision", "content": "Confirmatory testing is sent:\n\n- **Toxoplasma IgM** (infant): Positive\n- **Toxoplasma IgG** (infant): Positive (high titer, higher than maternal)\n- **Toxoplasma PCR** (CSF): Positive\n- CMV urine PCR: Negative\n- Rubella IgM: Negative\n\nCSF analysis:\n- Protein: 280 mg/dL (elevated)\n- Glucose: 30 mg/dL (low)\n- WBC: 45/\u03bcL with lymphocyte predominance\n\nThe diagnosis of congenital toxoplasmosis is confirmed.", "question": "What is the appropriate treatment for congenital toxoplasmosis?", "choices": [{"id": "node-3-choice-a", "text": "Pyrimethamine + sulfadiazine + leucovorin (folinic acid) for 12 months", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Congenital toxoplasmosis is treated with: **Pyrimethamine** (antifolate that inhibits parasite dihydrofolate reductase), **sulfadiazine** (sulfonamide that synergizes with pyrimethamine), and **leucovorin** (folinic acid to prevent bone marrow suppression from pyrimethamine). Treatment continues for **12 months** regardless of symptom severity. Studies show treatment improves outcomes including reduced hearing loss, developmental delay, and new chorioretinitis lesions. **Corticosteroids** are added if CSF protein >1 g/dL or significant chorioretinitis threatens vision.", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "IV ganciclovir for 6 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IV ganciclovir is the treatment for **congenital CMV**, not toxoplasmosis. Ganciclovir inhibits viral DNA polymerase and is effective against herpesviruses. Toxoplasmosis is a **parasitic** infection requiring antiparasitic therapy with pyrimethamine and sulfadiazine.", "consequence": "Wrong treatment for wrong pathogen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Supportive care only - no effective treatment exists", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Effective treatment exists** and makes a significant difference in outcomes. The Chicago Collaborative Treatment Trial showed that treated infants with congenital toxoplasmosis had better neurodevelopmental outcomes and fewer new chorioretinitis lesions than historical untreated controls. All symptomatic and asymptomatic congenital toxoplasmosis cases should be treated.", "consequence": "Missing opportunity for treatment that improves outcomes.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "IM penicillin G benzathine weekly for 3 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. IM penicillin is the treatment for **congenital syphilis**, not toxoplasmosis. Penicillin is effective against the spirochete Treponema pallidum but has no activity against the protozoan parasite Toxoplasma gondii.", "consequence": "Wrong antibiotic for parasitic infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Trimethoprim-sulfamethoxazole for 6 months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While TMP-SMX has some anti-toxoplasma activity and is used for prophylaxis in immunocompromised patients, it is **not the preferred treatment** for congenital toxoplasmosis. The combination of **pyrimethamine + sulfadiazine** is more effective and is the standard of care. The 12-month duration is also important - shorter courses are inadequate.", "consequence": "Suboptimal regimen for congenital toxoplasmosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Pyrimethamine causes bone marrow suppression** (thrombocytopenia, neutropenia, anemia) by inhibiting folate metabolism. **Leucovorin (folinic acid)** must be given concurrently to protect mammalian cells while still allowing antiparasitic effect (toxoplasma cannot use folinic acid). Monitor CBC weekly initially."}, "node-4": {"id": "node-4", "type": "decision", "content": "Treatment with pyrimethamine, sulfadiazine, and leucovorin is initiated. Steroids are added for the elevated CSF protein.\n\nYou are now counseling the family about prognosis and required monitoring.\n\nThe parents ask: \"Will our baby be normal? What problems should we expect?\"", "question": "What is the expected prognosis and what long-term monitoring is needed for congenital toxoplasmosis?", "choices": [{"id": "node-4-choice-a", "text": "High risk of neurodevelopmental sequelae; requires ophthalmology, audiology, and neurodevelopmental follow-up", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Congenital toxoplasmosis has significant long-term sequelae despite treatment. Expected problems include: **Visual impairment** (chorioretinitis can reactivate, causing progressive vision loss - needs regular ophthalmology exams), **Sensorineural hearing loss** (may be progressive - needs serial audiology), **Intellectual disability and developmental delay** (especially with severe disease like this case), **Seizures**, and **Hydrocephalus** (may require VP shunt). Treatment improves outcomes but does not eliminate risk. This infant with symptomatic disease has a guarded prognosis.", "consequence": "Family appropriately counseled about realistic expectations.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Most infants fully recover with treatment - expect normal development", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is overly optimistic. While treatment improves outcomes, **symptomatic congenital toxoplasmosis** (like this case with microcephaly, hydrocephalus, and chorioretinitis) has significant long-term morbidity. Studies show ~70-80% of symptomatic infants have some neurodevelopmental sequelae. Asymptomatic infants do better, but even they need monitoring as problems can emerge later.", "consequence": "False reassurance that doesn't prepare family for challenges.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Prognosis is uniformly poor - most children die in infancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is overly pessimistic. With treatment, **mortality from congenital toxoplasmosis is relatively low** (most deaths are from untreated severe disease). Most affected children survive but with varying degrees of impairment. Providing such a pessimistic prognosis is not accurate and may cause unnecessary distress.", "consequence": "Unnecessarily dire prognosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "No specific follow-up needed after completing 12 months of treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Lifelong monitoring is required**. Chorioretinitis can **reactivate** even years later, causing progressive vision loss - ophthalmology exams are needed regularly. Hearing loss can be progressive. Developmental problems may not be apparent until school age. These children need ongoing multidisciplinary care.", "consequence": "Missing critical long-term monitoring needs.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Sequelae only depend on whether mother was treated during pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **maternal treatment during pregnancy** (spiramycin in first trimester, pyrimethamine-sulfadiazine if fetal infection confirmed) can reduce severity, it does not eliminate risk. Infant outcome depends on: timing of maternal infection (first trimester = more severe), whether fetal infection occurred, extent of organ damage at birth, and postnatal treatment. This infant has established disease that cannot be reversed.", "consequence": "Oversimplified view of factors affecting prognosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Chorioretinitis in congenital toxoplasmosis can reactivate** at any point in life, causing new lesions and progressive vision loss. Patients need **lifelong ophthalmologic surveillance**. Reactivations are more common during adolescence and can be treated with repeat courses of pyrimethamine/sulfadiazine."}, "node-5": {"id": "node-5", "type": "decision", "content": "The family is counseled about the guarded prognosis and need for long-term monitoring. Referrals are placed for ophthalmology, audiology, early intervention, and developmental pediatrics.\n\nThe mother is now pregnant again (unplanned) and asks if her new baby is at risk for toxoplasmosis.", "question": "What is the risk of congenital toxoplasmosis in a subsequent pregnancy after a mother has had primary toxoplasma infection?", "choices": [{"id": "node-5-choice-a", "text": "Very low risk - prior infection provides immunity; reactivation rarely causes fetal infection in immunocompetent mothers", "isOptimal": true, "isAcceptable": true, "feedback": "**Excellent!** Once a mother has had **primary toxoplasma infection**, she develops **protective immunity**. Future pregnancies are at **very low risk** for congenital toxoplasmosis because: maternal IgG antibodies prevent parasitemia, T-cell immunity controls tissue cysts, and **reactivation of chronic infection rarely causes fetal transmission** in immunocompetent women (unlike in HIV/AIDS). The new baby is at minimal risk. However, the infected sibling needs ongoing care and should not be a source of infection (toxoplasmosis is not transmitted person-to-person).", "consequence": "Accurate reassurance for subsequent pregnancy.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "50% recurrence risk - this is an autosomal recessive genetic condition", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Congenital toxoplasmosis is an **infectious disease**, not a genetic condition. Toxoplasma gondii is a parasite transmitted via cat feces or undercooked meat. Once the mother has immunity from prior infection, subsequent pregnancies are protected. There is no genetic inheritance pattern.", "consequence": "Confusing infectious with genetic disease.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "High risk - she should avoid pregnancy or terminate current pregnancy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The mother now has **protective immunity** and the risk to future pregnancies is very low. Termination is not warranted based on prior infection. If there were concern about current infection (which would be unusual given prior immunity), amniocentesis with PCR could evaluate fetal infection status.", "consequence": "Unnecessarily alarming advice.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Unknown risk - she needs to be retested for acute infection", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct - confirming immune status is reasonable, but the expected finding would be **positive IgG** (indicating past infection and immunity) and **negative IgM** (no acute infection). Given her documented prior primary infection, she should have protective immunity. Retesting would simply confirm this.", "consequence": "Testing would confirm expected immunity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Risk is the same as first pregnancy - each pregnancy is independent", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Risk is **not the same** - it is much lower because the mother now has immunity. Congenital toxoplasmosis occurs when a **seronegative** mother acquires **primary infection** during pregnancy. Once she is seropositive with established immunity, the risk of fetal transmission in subsequent pregnancies is minimal.", "consequence": "Failing to account for protective immunity.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Prevention of congenital toxoplasmosis** for seronegative pregnant women: avoid cat litter (or wear gloves and wash hands), cook meat thoroughly (no rare/medium-rare), wash fruits and vegetables, wear gloves when gardening. Some countries (France) screen all pregnant women; in the US, screening is not routine but high-risk women may be tested."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully diagnosed and managed this case of congenital toxoplasmosis:\n\n\u2713 Recognized TORCH infection pattern: IUGR, microcephaly, hepatosplenomegaly, chorioretinitis, blueberry muffin rash\n\u2713 Used calcification pattern to differentiate (diffuse/scattered = toxoplasmosis, periventricular = CMV)\n\u2713 Identified maternal risk factors (cat exposure, first-trimester illness)\n\u2713 Confirmed diagnosis with specific testing (Toxoplasma IgM, PCR)\n\u2713 Initiated appropriate treatment (pyrimethamine + sulfadiazine + leucovorin x 12 months)\n\u2713 Counseled family on realistic prognosis and monitoring needs\n\u2713 Correctly explained low risk for subsequent pregnancies\n\nKey TORCH Learning Points:\n- CMV = most common congenital infection, periventricular calcifications\n- Toxoplasmosis = scattered calcifications, cat exposure, triad of chorioretinitis/hydrocephalus/calcifications\n- Rubella = cardiac defects (PDA, PS), cataracts, deafness, NO calcifications\n- HSV = usually acquired at delivery, not intrauterine\n- Syphilis = snuffles, osteochondritis, NO calcifications\n- Blueberry muffin rash = dermal erythropoiesis from bone marrow suppression"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key TORCH infection principles:\n\n- Classic features: IUGR, microcephaly, hepatosplenomegaly, chorioretinitis, thrombocytopenia, direct hyperbilirubinemia\n- Calcification patterns: Toxo = scattered, CMV = periventricular, Rubella/HSV = none\n- Blueberry muffin rash = dermal erythropoiesis\n- Toxoplasmosis treatment: pyrimethamine + sulfadiazine + leucovorin x 12 months\n- CMV treatment: IV ganciclovir or oral valganciclovir\n- Rubella: supportive only (prevention via vaccination)\n- Long-term monitoring needed for vision, hearing, development\n- Prior maternal toxoplasma infection provides immunity for subsequent pregnancies"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical TORCH infection concepts:\n\n- TORCH = Toxoplasmosis, Other (syphilis), Rubella, CMV, HSV\n- CMV is the MOST COMMON congenital infection\n- Toxoplasmosis from cat feces/undercooked meat - NOT person-to-person\n- Specific treatments exist and improve outcomes - never just observe\n- Calcification patterns are high-yield: Toxo scatters, CMV peri-V\n- Chorioretinitis can reactivate - lifelong ophthalmologic surveillance needed\n- Prior maternal infection provides immunity - subsequent pregnancies low risk\n\nKey pearl: TORCH infections cause similar clinical syndromes, but calcification pattern, maternal history, and specific testing differentiate them."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-146", "title": "Scarlet Fever", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["sandpaper rash", "circumoral pallor", "strawberry tongue", "Pastia lines", "scarlet fever"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 6-year-old female presents with sore throat, fever, and rash for 2 days.\n\nHistory reveals, she developed sore throat and high fever 2 days ago. Yesterday she developed a rough, red rash that started on her neck and spread to her body. It feels like sandpaper.\n\nAssociated symptoms include strawberry tongue and flushed cheeks with circumoral pallor. Denies difficulty breathing or drooling.\n\nPast medical history includes Her brother was diagnosed with strep throat last week.\n\nPhysical Examination:\n- Vitals: high fever.\n- Skin: diffuse erythematous, sandpaper-textured rash with Pastia lines in skin folds.\n- Face: flushed cheeks with circumoral pallor.\n- Oropharynx: tonsillar erythema with exudates, strawberry tongue.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 6-year-old has classic **scarlet fever**: **sandpaper rash**, **strawberry tongue**, **circumoral pallor** (pale around the mouth with flushed cheeks), **Pastia lines** (accentuated rash in skin folds), and tonsillar exudates. Her brother had strep throat last week.", "question": "What feature BEST distinguishes scarlet fever from other childhood exanthems?", "choices": [{"id": "node-1-choice-a", "text": "Sandpaper-textured rash with circumoral pallor and strawberry tongue", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The triad of **sandpaper rash** (fine papular erythema that blanches), **circumoral pallor**, and **strawberry tongue** is pathognomonic for scarlet fever. The rash is caused by **erythrogenic toxin** produced by Group A Streptococcus. Pastia lines (linear petechiae in skin folds) are also characteristic.", "consequence": "You identify the classic triad.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Conjunctivitis with cracked lips and cervical lymphadenopathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This describes **Kawasaki disease** - bilateral conjunctivitis, cracked/red lips, cervical lymphadenopathy (>1.5cm), plus polymorphous rash, and extremity changes. Kawasaki requires \u22655 days of fever. This child has sore throat with exudates (not typical for Kawasaki).", "consequence": "This is Kawasaki disease presentation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "High fever then rash appears as fever resolves", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This pattern (high fever for 3-5 days, then rash appears as fever breaks) describes **roseola infantum** (HHV-6). In scarlet fever, the rash appears **during** the febrile illness (usually day 1-2), not after fever resolves.", "consequence": "This is roseola pattern.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Slapped cheek appearance with lacy reticular rash", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Slapped cheek** (erythema infectiosum/fifth disease) is caused by **Parvovirus B19**. It has bright red cheeks followed by lacy reticular rash on extremities. Scarlet fever has **circumoral pallor** (pale ring around mouth), NOT slapped cheeks.", "consequence": "This describes fifth disease.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Koplik spots with cough, coryza, and conjunctivitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Koplik spots** (blue-white spots on buccal mucosa) with the **3 C's** (cough, coryza, conjunctivitis) are pathognomonic for **measles**. Scarlet fever has **strawberry tongue** (not Koplik spots) and pharyngitis (not respiratory symptoms).", "consequence": "This describes measles.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Childhood exanthems quick differentiators**: **Scarlet fever** = sandpaper rash + circumoral pallor + strawberry tongue. **Kawasaki** = conjunctivitis + cracked lips + lymphadenopathy. **Roseola** = high fever THEN rash. **Fifth disease** = slapped cheeks + lacy rash. **Measles** = Koplik spots + 3 C's (cough, coryza, conjunctivitis)."}, "node-2": {"id": "node-2", "type": "decision", "content": "The rapid strep test is **positive**. You confirm **scarlet fever** (GAS pharyngitis + erythrogenic toxin-mediated rash). Treatment is required not only for symptom relief but to prevent serious complications.", "question": "What is the MOST important reason to treat GAS pharyngitis with antibiotics?", "choices": [{"id": "node-2-choice-a", "text": "Prevent acute rheumatic fever (ARF) - antibiotics effective if started within 9 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **primary reason** to treat GAS pharyngitis is to prevent **acute rheumatic fever (ARF)** - a serious complication causing carditis, arthritis, chorea, and valve damage. Antibiotics are effective if started within **9 days** of symptom onset. Note: antibiotics do NOT prevent **post-streptococcal glomerulonephritis (PSGN)**.", "consequence": "You understand the key reason for treatment.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Prevent post-streptococcal glomerulonephritis (PSGN)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Antibiotics do NOT prevent PSGN**. PSGN is an immune-complex mediated disease that occurs 1-3 weeks after strep infection regardless of treatment. The primary reason for antibiotics is to prevent **acute rheumatic fever**, which CAN be prevented with timely treatment.", "consequence": "Antibiotics don't prevent PSGN.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Make the rash resolve faster", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While antibiotics may modestly reduce symptom duration, this is NOT the primary reason for treatment. The rash is caused by **erythrogenic toxin** already released - it will resolve on its own. The critical reason is **preventing rheumatic fever**.", "consequence": "Symptom relief is secondary to prevention.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Prevent spread to contacts - only reason to treat", "isOptimal": false, "isAcceptable": false, "feedback": "While reducing transmission is a benefit (no longer contagious after 24 hours of antibiotics), the **primary reason** for treatment is preventing **acute rheumatic fever**. Even if the patient were isolated, treatment would still be indicated for ARF prevention.", "consequence": "Transmission reduction is important but not the primary reason.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Antibiotics are not necessary - viral pharyngitis is more common", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This child has a **positive rapid strep test** confirming GAS infection. GAS pharyngitis MUST be treated to prevent **acute rheumatic fever**. While viral pharyngitis is more common overall, this case is confirmed bacterial.", "consequence": "Confirmed GAS requires treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**GAS pharyngitis treatment rationale**: Antibiotics **prevent acute rheumatic fever** (if started within 9 days), reduce symptom duration (~1 day), decrease transmission (non-contagious after 24h of treatment), and prevent suppurative complications (peritonsillar abscess). Antibiotics do **NOT prevent PSGN**."}, "node-3": {"id": "node-3", "type": "decision", "content": "You prescribe **amoxicillin 50 mg/kg/day divided BID for 10 days** (equivalent efficacy to penicillin V, better taste). At day 7, the rash is fading and the mother notices the skin is starting to **peel on her fingertips and toes**.", "question": "What do you tell the mother about the desquamation?", "choices": [{"id": "node-3-choice-a", "text": "Normal scarlet fever course - desquamation occurs days 7-21 as rash resolves", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Desquamation** (skin peeling) is a NORMAL part of scarlet fever recovery, occurring **7-21 days** after rash onset, typically starting on fingertips and toes. It's similar to sunburn peeling. This does NOT indicate treatment failure or new complication - continue antibiotics for full 10-day course.", "consequence": "Appropriate reassurance.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Treatment failure - switch to broader spectrum antibiotic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Desquamation indicates the normal healing process, NOT treatment failure. GAS remains **100% sensitive to penicillin** - there is no resistance. If there were treatment failure, you would see persistent fever and worsening pharyngitis, not skin peeling.", "consequence": "Misinterprets normal healing.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Staphylococcal scalded skin syndrome - needs IV antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **SSSS** has diffuse, tender erythema with **Nikolsky sign** (skin sloughs with gentle pressure) and large sheets of skin sloughing. Scarlet fever desquamation is localized (fingertips, toes), fine peeling, and the child is clinically well. This is normal healing.", "consequence": "Wrong diagnosis - SSSS is different.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Kawasaki disease presenting late - need echocardiogram", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While Kawasaki also has desquamation (periungueal peeling), this child has **confirmed GAS pharyngitis** (positive rapid strep, tonsillar exudates) which is NOT seen in Kawasaki. The clinical course is classic for scarlet fever - no need for echo.", "consequence": "GAS pharyngitis confirms scarlet fever, not Kawasaki.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Allergic reaction to amoxicillin - stop antibiotic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Drug reaction desquamation** would occur with hypersensitivity signs (urticaria, angioedema, or severe bullous eruption). Fine peeling on fingertips/toes at day 7 is classic for scarlet fever healing. Continue the full 10-day course.", "consequence": "This is not drug reaction.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Scarlet fever timeline**: Day 1-2: fever, pharyngitis, rash appears. Day 3-4: strawberry tongue (initially white-coated, then red). Day 4-5: rash peaks. Day 7-21: **desquamation** (fingertips, toes, then generalized fine peeling). Rash blanches and feels like sandpaper throughout."}, "node-4": {"id": "node-4", "type": "decision", "content": "The child completes 10 days of amoxicillin with full recovery. Three weeks later, the mother calls concerned because the child's **urine looks like cola/tea** and she has mild **facial puffiness**. BP is 130/85 (elevated for age).", "question": "What complication should you suspect, and what is the key teaching point?", "choices": [{"id": "node-4-choice-a", "text": "Post-streptococcal glomerulonephritis (PSGN) - NOT preventable by antibiotics", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **PSGN** - cola-colored urine (hematuria), edema, and hypertension occurring **1-3 weeks** after GAS infection. Key teaching point: **Antibiotics do NOT prevent PSGN** (unlike rheumatic fever). PSGN is immune complex-mediated (Type III hypersensitivity). Treatment is supportive; prognosis is excellent in children (>95% full recovery).", "consequence": "You correctly identify PSGN.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Acute rheumatic fever - antibiotics failed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **ARF** presents with **Jones criteria**: carditis, migratory polyarthritis, chorea, erythema marginatum, subcutaneous nodules - NOT hematuria and hypertension. Also, she completed full antibiotic course, which should have prevented ARF. These symptoms suggest **PSGN**.", "consequence": "Wrong complication - this is renal, not cardiac.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Nephrotic syndrome from scarlet fever", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Nephrotic syndrome** presents with massive proteinuria, hypoalbuminemia, edema, and hyperlipidemia - NOT hematuria and hypertension. PSGN causes **nephritic syndrome** (hematuria, RBC casts, hypertension, mild proteinuria, decreased GFR).", "consequence": "This is nephritic, not nephrotic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "IgA nephropathy - unrelated to recent infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **IgA nephropathy** causes **synpharyngitic hematuria** (hematuria DURING infection, not 1-3 weeks later). PSGN has a **latent period** of 1-3 weeks between infection and nephritis. The timing strongly suggests PSGN.", "consequence": "PSGN has latent period; IgA nephropathy is synpharyngitic.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Amoxicillin-induced interstitial nephritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Drug-induced interstitial nephritis** typically presents with fever, rash, eosinophilia, and sterile pyuria - NOT hematuria with RBC casts. Also, she finished amoxicillin 2 weeks ago. This timing and presentation are classic for PSGN.", "consequence": "Drug reaction has different presentation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**PSGN vs IgA nephropathy**: **PSGN** = **latent period 1-3 weeks** after strep infection (pharyngitis 1-2 weeks, skin 3-6 weeks), low C3, self-limited, excellent prognosis. **IgA nephropathy** = **synpharyngitic** (hematuria DURING infection), normal complement, recurrent episodes, may progress. Both cause hematuria and can have HTN."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **scarlet fever** and recognized its complications. Key learning points: 1) Classic triad: **sandpaper rash + circumoral pallor + strawberry tongue**. 2) Treat with penicillin/amoxicillin x **10 days** to prevent **acute rheumatic fever** (effective if started within 9 days). 3) Antibiotics do **NOT prevent PSGN**. 4) **Desquamation** at days 7-21 is NORMAL healing. 5) PSGN presents **1-3 weeks** post-infection with cola urine, edema, HTN."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key scarlet fever points: **Sandpaper rash**, **circumoral pallor**, **strawberry tongue**, **Pastia lines**. Treat with penicillin/amoxicillin x 10 days. **Desquamation** at days 7-21 is NORMAL. Complications: **ARF** (prevented by antibiotics), **PSGN** (NOT prevented by antibiotics, 1-3 week latent period), suppurative (peritonsillar abscess)."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. Critical scarlet fever points: 1) **GAS is 100% sensitive to penicillin** - no resistance. 2) **Desquamation is NORMAL** healing, not treatment failure or drug reaction. 3) Treat for **10 full days** to prevent ARF. 4) Antibiotics prevent **ARF** but NOT **PSGN**. 5) PSGN = nephritic syndrome (hematuria, HTN, edema) 1-3 weeks post-infection."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-147", "title": "Impetigo", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["honey-crusted lesions", "non-bullous impetigo", "S. aureus", "Group A Streptococcus", "mupirocin", "PSGN", "school return", "impetigo"], "estimatedMinutes": 6, "source": ["NBME"], "stem": "A 5-year-old male is brought to your clinic by his mother for \"sores on his face\" that have been present for 5 days.\n\nThe mother reports that about 5 days ago, she noticed a few small red bumps around his nose. These quickly turned into small blisters that popped and formed \"crusty yellow scabs.\" The lesions have been spreading despite her attempts to keep them clean. He has been scratching at them constantly.\n\nShe mentions: \"Three other kids at his daycare have the same thing. The daycare won't let him come back until he's been treated.\"\n\nThe child denies pain but says the spots are \"itchy.\" No fever, sore throat, or joint pain. He is otherwise well and acting normally.\n\nPhysical Examination:\n- General: Well-appearing, afebrile, playful child\n- Skin: Multiple honey-colored crusted lesions clustered around nares and mouth, with several satellite lesions on both cheeks. Lesions appear superficial with erythematous bases. No bullae, no deeper ulcerations.\n- Lymph nodes: Small, mobile, non-tender submandibular lymphadenopathy bilaterally\n- Oropharynx: Clear, no tonsillar exudates\n- Remainder of exam: Normal", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You recognize the classic appearance of **non-bullous impetigo**.\n\n**Impetigo - Overview:**\n- **Most common bacterial skin infection in children** (ages 2-5 years)\n- **Highly contagious** - spread by direct contact, autoinoculation (scratching)\n- Daycare outbreaks are common\n\n**Two Forms of Impetigo:**\n\n**1. Non-Bullous Impetigo (70% of cases):**\n- Classic **\"honey-colored crusts\"** on erythematous base\n- Begins as papules \u2192 vesicles \u2192 pustules \u2192 rupture \u2192 characteristic crusts\n- Favors **perioral and perinasal** areas\n- Spreads by **autoinoculation** (scratching spreads to other sites)\n- Usually **S. aureus** (most common) or **Group A Streptococcus (GAS)**\n\n**2. Bullous Impetigo (30% of cases):**\n- Larger, fluid-filled **bullae** (>1 cm) that rupture leaving thin, varnish-like crust\n- **Always S. aureus** (toxin-mediated: exfoliative toxin A and B)\n- More common in infants/neonates\n- Less contagious than non-bullous form\n\n**Key Differential Diagnoses:**\n- Herpes simplex: Grouped vesicles on erythematous base, painful, recurrent in same location\n- Contact dermatitis: Pruritic, geometric pattern matching contactant, no honey crusts\n- Varicella: Different stages simultaneously (\"dew drops on rose petal\"), systemic symptoms\n- Tinea faciei: Annular scaly plaques with central clearing", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Non-bullous impetigo - classic honey-colored crusted lesions in perioral distribution", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **classic non-bullous impetigo**. Key diagnostic features: (1) **Honey-colored crusts** - the pathognomonic finding, (2) **Perioral and perinasal distribution** - typical location, (3) **Spread by autoinoculation** - scratching \u2192 satellite lesions, (4) **Daycare outbreak** - highly contagious, (5) **Well-appearing child** - localized infection without systemic symptoms, (6) **Regional lymphadenopathy** - reactive nodes common. This clinical picture is diagnostic - no cultures needed for typical presentation.", "consequence": "You correctly identify non-bullous impetigo.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Herpes simplex virus (cold sores) - vesicular lesions around the mouth", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Herpes simplex differs in several ways**: (1) **Grouped vesicles on erythematous base** - not honey crusts, (2) **Painful, burning, tingling prodrome**, (3) **Recurs in the SAME location**, (4) **Not highly contagious in outbreak pattern** at daycares. Impetigo has honey crusts, is itchy (not painful), spreads to new sites, and causes daycare outbreaks. The appearance and epidemiology here clearly favor impetigo.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Bullous impetigo - this must be the bullous form given multiple lesions", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bullous impetigo has a different appearance**: (1) **Large bullae (>1 cm)** filled with clear to yellow fluid, (2) **Bullae rupture leaving thin, varnish-like crust** (not thick honey crust), (3) **More common in infants/neonates**, (4) **Caused by S. aureus exfoliative toxins**. This child has the classic **honey-colored crusts** of non-bullous impetigo. The number of lesions doesn't determine bullous vs non-bullous - it's the morphology.", "consequence": "Incorrect form identification, though treatment is similar.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Varicella (chickenpox) - spreading vesicular lesions in a child", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Varicella has distinct features**: (1) **\"Dew drops on rose petals\"** - clear vesicles on erythematous base, (2) **Lesions in ALL stages simultaneously** (papules, vesicles, crusts), (3) **Generalized distribution** (starts on trunk, spreads centrifugally), (4) **Systemic symptoms** (fever, malaise, pruritus), (5) **Individual vesicles on erythematous base** - not honey crusts. This child has localized perioral honey-crusted lesions without systemic symptoms - classic impetigo.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Contact dermatitis - allergic reaction to something he touched", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Contact dermatitis differs significantly**: (1) **Geometric pattern** matching the contactant shape, (2) **Vesicles, papules, or eczematous changes** - not honey crusts, (3) **Intensely pruritic**, (4) **History of exposure** to allergen/irritant. This child has honey-colored crusted lesions that spread by scratching, in a classic perioral distribution, with daycare outbreak - all pointing to impetigo, not contact dermatitis.", "consequence": "Incorrect diagnosis leads to wrong treatment.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Honey-colored crusts = impetigo** until proven otherwise. This is the pathognomonic finding. Non-bullous impetigo (70% of cases) favors the perioral/perinasal area and spreads by autoinoculation. Bullous impetigo has large fluid-filled blisters that leave thin crusts."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose non-bullous impetigo. Now you need to determine appropriate treatment.\n\n**Treatment of Impetigo:**\n\n**Localized Disease (\u22643 lesions, limited area):**\n- **Topical antibiotics** are first-line:\n  - **Mupirocin 2% ointment** TID x 5 days (most common)\n  - **Retapamulin 1% ointment** BID x 5 days (alternative)\n- Equally effective as oral antibiotics for limited disease\n- Advantage: Less systemic side effects, less resistance selection\n\n**Extensive Disease (numerous lesions, multiple body areas) or Treatment Failure:**\n- **Oral antibiotics** are indicated:\n  - **Cephalexin** 25-50 mg/kg/day divided TID-QID x 7 days (covers S. aureus + GAS)\n  - **Dicloxacillin** - alternative\n  - **Clindamycin** or **TMP-SMX** if MRSA suspected\n- Also consider oral antibiotics if: immunocompromised, systemic symptoms, or outbreaks in close contacts\n\n**Adjunctive Measures:**\n- Gentle cleansing to remove crusts (warm water, mild soap)\n- Good hand hygiene to prevent spread\n- Keep lesions covered\n- Avoid sharing towels, clothing\n- **Can return to school/daycare 24 hours after starting treatment**\n\n**When to Culture:**\n- Treatment failure\n- Recurrent impetigo\n- Suspected MRSA (history of MRSA, no response to first-line)", "question": "What treatment do you prescribe for this child with localized impetigo?", "choices": [{"id": "node-2-choice-a", "text": "Topical mupirocin 2% ointment TID for 5 days - first-line for localized disease", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Topical mupirocin is first-line treatment for localized impetigo**. Key advantages: (1) **Equally effective as oral antibiotics** for limited disease, (2) **Directly targets the infection site**, (3) **Fewer systemic side effects**, (4) **Preserves systemic antibiotic efficacy** by avoiding unnecessary oral antibiotics, (5) **Well-tolerated** - rare local irritation. Apply TID after gently removing crusts with warm water. This child has localized perioral disease - perfect candidate for topical therapy.", "consequence": "Appropriate first-line treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Oral cephalexin for 7 days - oral antibiotics work better than topical", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. **Oral cephalexin is effective** but not first-line for localized disease. Key considerations: (1) **Studies show topical and oral are equally effective** for limited impetigo, (2) **Oral antibiotics indicated for**: extensive disease, systemic symptoms, or treatment failure, (3) **Oral cephalexin has more side effects** (GI upset, allergic reactions) than topical therapy, (4) **Contributes more to antibiotic resistance**. For this child with localized disease, topical therapy is preferred. Oral antibiotics would be appropriate if lesions were extensive.", "consequence": "Effective but more aggressive than needed for localized disease.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Oral amoxicillin for 10 days - standard antibiotic for skin infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Amoxicillin is NOT appropriate for impetigo**. Key issue: (1) **Most S. aureus strains are resistant to amoxicillin** (produce beta-lactamase), (2) **Cephalexin or dicloxacillin** are beta-lactamase stable and appropriate for staph coverage, (3) Amoxicillin would only cover GAS, missing the most common pathogen (S. aureus), (4) **10 days is also too long** - 7 days is standard for oral impetigo treatment. If oral therapy is needed, use a beta-lactamase stable antibiotic.", "consequence": "Inadequate antibiotic choice with high failure risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Topical triple antibiotic ointment (Neosporin) - available over the counter", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Triple antibiotic ointment is NOT recommended for impetigo**. Key issues: (1) **Neosporin (bacitracin/neomycin/polymyxin)** has limited efficacy against S. aureus, (2) **High rates of resistance** to these older topical antibiotics, (3) **Contact dermatitis is common** with neomycin, (4) **Mupirocin is specifically effective** against S. aureus and GAS - the impetigo pathogens. Don't substitute OTC products for appropriate prescription treatment.", "consequence": "Ineffective treatment leads to treatment failure and spread.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "No antibiotics - impetigo is self-limited and will resolve on its own", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Impetigo requires treatment**. While it may eventually self-resolve, untreated impetigo: (1) **Spreads to other sites** via autoinoculation, (2) **Is highly contagious** - spreads to family and classmates, (3) **Can progress to deeper infection** (ecthyma, cellulitis), (4) **GAS impetigo can cause PSGN** - treating reduces spread but doesn't prevent PSGN, (5) **Prolongs school exclusion** - he can't return to daycare without treatment. Treatment is indicated for all cases of impetigo.", "consequence": "Untreated impetigo spreads and causes complications.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Topical mupirocin is first-line** for localized impetigo (<3-5 lesions). It's equally effective as oral antibiotics with fewer side effects. **Oral cephalexin** is reserved for extensive disease, systemic symptoms, or treatment failure. Avoid amoxicillin - most S. aureus are resistant."}, "node-3": {"id": "node-3", "type": "decision", "content": "You prescribe mupirocin 2% ointment TID for 5 days and provide instructions on gently removing crusts before application.\n\nThe mother asks: \"The daycare said something about a kidney problem that can happen with skin infections. Should I be worried about that?\"\n\n**Post-Streptococcal Glomerulonephritis (PSGN):**\n\nPSGN is a non-suppurative complication of Group A Streptococcus infection.\n\n**Key Points:**\n\n**When it occurs:**\n- **1-3 weeks after skin infection (impetigo)** - vs 10-14 days after pharyngitis\n- Only certain **nephritogenic strains** of GAS cause PSGN\n- More common with skin infections than pharyngitis in some regions\n\n**Clinical Features:**\n- **Hematuria** (tea/cola-colored urine)\n- **Edema** (periorbital, peripheral)\n- **Hypertension**\n- **Decreased urine output** (oliguria)\n\n**Critical Point:**\n- **Antibiotics do NOT prevent PSGN** - the immune-mediated damage is already triggered by the time infection is recognized\n- Antibiotics are given to: eradicate infection, prevent spread, prevent suppurative complications\n- This differs from **rheumatic fever**, which CAN be prevented by treating GAS pharyngitis\n\n**Prognosis:**\n- **Excellent in children** - 95%+ full recovery\n- Acute illness lasts 1-2 weeks\n- Microscopic hematuria may persist for months", "question": "How do you counsel the mother about the risk of post-streptococcal glomerulonephritis?", "choices": [{"id": "node-3-choice-a", "text": "Explain that PSGN can occur 1-3 weeks after strep skin infections, but antibiotics do not prevent it - she should watch for dark urine, swelling, or decreased urination", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent counseling! Key points delivered: (1) **PSGN is a possible complication** of GAS impetigo - honest disclosure, (2) **Occurs 1-3 weeks after skin infection** - she knows when to be vigilant, (3) **Antibiotics do NOT prevent PSGN** - important to understand treatment doesn't eliminate this risk, (4) **Symptoms to watch for** - dark urine, swelling, decreased urination - actionable guidance. This provides accurate information without causing undue alarm, and empowers her to seek care if PSGN develops.", "consequence": "Appropriate anticipatory guidance provided.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Reassure her that the antibiotics will prevent any kidney problems from developing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is false reassurance** - antibiotics do NOT prevent PSGN. Key points: (1) **PSGN is immune-mediated**, triggered before treatment begins, (2) **Treatment prevents spread and suppurative complications**, not PSGN, (3) **Parents should know the warning signs** of PSGN, (4) **Giving inaccurate information** could delay recognition of PSGN if it occurs. It's important to be honest about what antibiotics can and cannot prevent.", "consequence": "False reassurance may delay recognition of PSGN.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Order urinalysis now to check for kidney involvement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **UA at diagnosis is not indicated** because: (1) **PSGN develops 1-3 weeks AFTER the infection**, not during, (2) **Checking now would be too early** to detect PSGN, (3) **Routine UA is not recommended** for uncomplicated impetigo, (4) **If concerned**, check UA in 2-3 weeks if symptoms develop. The appropriate approach is anticipatory guidance about symptoms, not early screening.", "consequence": "Unnecessary testing at the wrong time.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Tell her PSGN only happens with strep throat, not skin infections", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is factually wrong** - PSGN occurs after BOTH pharyngitis AND skin infections. Key facts: (1) **Skin infections (impetigo) are actually the MORE common cause** of PSGN in some regions, (2) **Nephritogenic strains** differ between skin and throat, (3) **PSGN after impetigo** occurs 1-3 weeks later (vs 10-14 days after pharyngitis). Providing inaccurate information could lead to missed diagnosis.", "consequence": "Incorrect information may delay recognition of PSGN.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Switch to oral cephalexin since it's more likely to prevent kidney complications than topical therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Neither oral nor topical antibiotics prevent PSGN** - the route of administration doesn't matter for this complication. Key points: (1) **PSGN is immune-mediated** and develops regardless of antibiotic route, (2) **Oral antibiotics are not superior** to topical for preventing PSGN, (3) **Treatment choice should be based on disease extent**, not PSGN prevention, (4) **Topical is appropriate for localized disease** and shouldn't be changed based on this misconception.", "consequence": "Changing treatment based on false premise.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Antibiotics do NOT prevent PSGN** - the immune-mediated kidney damage is already triggered before treatment begins. However, antibiotics DO eradicate the infection, prevent spread, and prevent suppurative complications. PSGN after impetigo occurs **1-3 weeks later** - counsel parents on warning signs (dark urine, swelling, hypertension)."}, "node-4": {"id": "node-4", "type": "decision", "content": "The mother thanks you for the explanation. Before they leave, she asks: \"When can he go back to daycare? They said he's been excluded until a doctor clears him.\"\n\n**Return to School/Daycare Guidelines:**\n\n**For Impetigo:**\n- Child can return to school/daycare **24 hours after starting effective antibiotic treatment**\n- This applies to both topical and oral antibiotics\n- Lesions should be covered if possible (not always practical on face)\n\n**Hygiene Measures to Reduce Spread:**\n- Frequent handwashing\n- Avoid touching lesions\n- Keep fingernails short (reduces trauma from scratching)\n- Don't share towels, washcloths, or personal items\n- Wash clothing and linens in hot water\n\n**Infection Control in Daycare:**\n- Contact precautions\n- Clean and disinfect shared surfaces\n- Reinforce hand hygiene for all children\n- Notify parents of outbreak (they've likely already done this)\n\n**Treatment Failure:**\n- If no improvement after 3-5 days of topical therapy\n- Consider: MRSA, non-compliance, incorrect diagnosis\n- Options: Culture lesion, switch to oral antibiotics", "question": "What do you tell the mother about returning to daycare?", "choices": [{"id": "node-4-choice-a", "text": "He can return 24 hours after starting the mupirocin treatment, with good hygiene measures and keeping lesions covered when possible", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **24 hours after starting antibiotic treatment** is the standard return-to-care guideline for impetigo. Key points: (1) **Both topical and oral antibiotics count** - mupirocin qualifies, (2) **Lesions should be covered if practical** (may be difficult on face), (3) **Good hand hygiene** is essential, (4) **Remind daycare staff** about hygiene measures to prevent spread. He can return tomorrow if treatment starts today.", "consequence": "Appropriate guidance for school return.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "He must stay home until all lesions are completely healed, which could take 1-2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is overly restrictive** and not evidence-based. Key points: (1) **24 hours after starting treatment** is the standard guideline, (2) **Lesions may take 7-10 days to fully heal** - can't exclude that long, (3) **After 24 hours of treatment**, contagiousness is significantly reduced, (4) **Prolonged exclusion** is not necessary, causes hardship, and isn't supported by guidelines. The crusts don't need to completely resolve before return.", "consequence": "Unnecessary prolonged exclusion from daycare.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "He needs to complete the full 5-day course before returning to daycare", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Completing the entire course is NOT required before return**. Key points: (1) **24 hours of treatment** is sufficient to significantly reduce contagiousness, (2) **5 days of exclusion** is excessive and unnecessary, (3) **He should complete the full course** regardless of when he returns to daycare, (4) **Standard guidelines clearly state 24 hours**. Requiring course completion would cause unnecessary missed daycare.", "consequence": "Overly restrictive recommendation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "He can return immediately since we've started treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **24 hours of treatment is required before return**, not immediate return. Key reasoning: (1) **Treatment takes time to reduce bacterial load** and contagiousness, (2) **Standard guidelines specify 24 hours**, (3) **Returning immediately** while still highly contagious could spread infection to other children, (4) **The daycare's policy requiring clearance is reasonable** - they want to prevent outbreaks. He can return tomorrow, not today.", "consequence": "Too permissive - risks spreading infection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "He needs to switch to oral antibiotics before he can return - topical isn't strong enough for daycare clearance", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Topical antibiotics are adequate for school return**. Key points: (1) **Both topical and oral antibiotics** are effective and acceptable for the 24-hour rule, (2) **Topical mupirocin is first-line therapy** - it's not a lesser treatment, (3) **No need to switch to oral** antibiotics just for daycare return, (4) **The route of administration doesn't affect return timing**. He can return 24 hours after starting mupirocin.", "consequence": "Unnecessary escalation of therapy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Children with impetigo can return to school/daycare 24 hours after starting antibiotic treatment** (topical or oral). Lesions should be covered when practical, and good hand hygiene is essential. They do NOT need to wait for complete healing, which can take 7-10 days."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed non-bullous impetigo with appropriate treatment, patient education, and school return guidance.\n\n**Key Teaching Points:**\n\n**Recognition of Impetigo:**\n- **Honey-colored crusts** = pathognomonic for non-bullous impetigo\n- Favors perioral/perinasal area\n- Highly contagious - spreads by autoinoculation and direct contact\n- Most common pathogens: S. aureus > GAS\n\n**Treatment:**\n- **Topical mupirocin TID x 5 days** - first-line for localized disease\n- **Oral cephalexin x 7 days** - for extensive disease or treatment failure\n- **Avoid amoxicillin** - most S. aureus are resistant\n- Gently remove crusts before applying topical treatment\n\n**Post-Streptococcal Glomerulonephritis:**\n- Can occur 1-3 weeks after GAS impetigo\n- **Antibiotics do NOT prevent PSGN** (unlike rheumatic fever)\n- Watch for: dark urine, edema, hypertension, oliguria\n- Excellent prognosis in children (>95% full recovery)\n\n**Return to School/Daycare:**\n- **24 hours after starting antibiotic treatment** (topical or oral)\n- Cover lesions when practical\n- Good hand hygiene\n- Don't share towels or personal items\n\n**Treatment Failure:**\n- No improvement after 3-5 days \u2192 culture, consider MRSA, switch to oral therapy\n- Clindamycin or TMP-SMX for MRSA coverage"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in impetigo management:\n\n**Diagnosis:**\n- Honey-colored crusts = non-bullous impetigo\n- Bullous form has large fluid-filled blisters\n- Clinical diagnosis - cultures rarely needed\n\n**Treatment:**\n- Topical mupirocin - first-line for localized disease\n- Oral cephalexin - for extensive or refractory cases\n- NOT amoxicillin (staph resistance)\n- NOT OTC triple antibiotic ointment (ineffective)\n\n**PSGN:**\n- Occurs 1-3 weeks after GAS skin infection\n- Antibiotics do NOT prevent it\n- Watch for dark urine, edema, hypertension\n\n**School Return:**\n- 24 hours after starting treatment\n- Don't require complete healing (7-10 days)\n- Both topical and oral antibiotics qualify\n\n**Common Errors:**\n- Using amoxicillin (staph resistance)\n- False reassurance about PSGN prevention\n- Overly restrictive school exclusion"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates key principles in impetigo management:\n\n**Don't Miss the Classic Presentation:**\n- **Honey-colored crusts** = impetigo (non-bullous type)\n- Perioral/perinasal location is typical\n- Spreads by autoinoculation (scratching)\n- Daycare outbreaks are common\n\n**Treatment Must Be Appropriate:**\n- **Topical mupirocin** - first-line for localized disease\n- **Oral cephalexin** - for extensive disease\n- **Amoxicillin is WRONG** - most S. aureus are resistant\n- **OTC triple antibiotic is WRONG** - ineffective against impetigo pathogens\n- **Treatment IS required** - impetigo is contagious and spreads\n\n**PSGN Facts:**\n- Can occur after GAS skin infections (not just pharyngitis)\n- Occurs 1-3 weeks after infection\n- **Antibiotics do NOT prevent PSGN**\n- Watch for: dark urine, edema, hypertension\n\n**School Return:**\n- 24 hours after starting treatment (topical or oral)\n- Don't require complete lesion healing\n- Don't return immediately (still contagious)\n\n**Consequences of Mismanagement:**\n- Treatment failure \u2192 spread to contacts\n- Wrong antibiotic \u2192 prolonged infection, resistance\n- Wrong information about PSGN \u2192 delayed recognition"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-148", "title": "Periorbital vs Orbital Cellulitis", "domain": "infectious_disease", "difficulty": "advanced", "tags": ["orbital cellulitis", "periorbital cellulitis", "preseptal cellulitis", "postseptal cellulitis", "proptosis", "ophthalmoplegia", "subperiosteal abscess", "orbital septum", "vision emergency", "ethmoid sinusitis"], "estimatedMinutes": 12, "source": ["NBME"], "stem": "A 4-year-old female presents with swelling and redness around her eye for 2 days.\n\nPer the parents, she had an insect bite near her left eye 3 days ago. Yesterday the area became red and swollen. Today she has fever and the swelling is worse. She says it hurts to move her eye.\n\nReview of systems is positive for pain with eye movement, proptosis, and decreased vision and negative for recent sinus infection.\n\nMedical history is notable for She was previously healthy.\n\nPhysical Examination:\n- Left eye: erythema and edema of eyelid extending to cheek. Proptosis. Painful and limited extraocular movements. Decreased visual acuity.\n- General: febrile (39.2\u00b0C), ill-appearing.\n- Vitals: febrile.\n- Labs: CBC: WBC elevated.\n- Right eye: normal.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are evaluating a 4-year-old with periorbital swelling and fever. The critical first step is distinguishing periorbital (preseptal) cellulitis from orbital (postseptal) cellulitis - a vision-threatening emergency.\n\nKey examination findings to assess:\n- **Proptosis** (eye bulging forward)\n- **Ophthalmoplegia** (painful/limited eye movement)\n- **Vision changes** (decreased visual acuity)\n- **Pupil abnormalities**\n\nThis patient has proptosis, painful extraocular movements, and decreased vision.", "question": "Based on the physical examination findings, which diagnosis is most likely?", "choices": [{"id": "node-1-choice-a", "text": "Orbital (postseptal) cellulitis - presence of proptosis and ophthalmoplegia", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** The triad of **proptosis, painful/limited extraocular movements, and vision changes** indicates infection has spread **posterior to the orbital septum** - this is **orbital cellulitis**, a true emergency. The orbital septum is a fibrous membrane that normally contains infections anteriorly (periorbital). Once bacteria breach this barrier, they spread into the orbital fat and can compress the optic nerve, cause blindness, or spread intracranially.", "consequence": "Emergency recognized. Proceed with urgent workup.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Periorbital (preseptal) cellulitis - eyelid swelling and erythema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Periorbital cellulitis causes eyelid swelling but does **NOT** cause proptosis, ophthalmoplegia, or vision changes because infection stays **anterior to the orbital septum**. The eye itself is uninvolved. This patient has all three danger signs (proptosis, painful EOM, vision changes), indicating the infection has spread posteriorly - this is orbital cellulitis.", "consequence": "Missed orbital cellulitis - risk of blindness and intracranial spread.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Allergic angioedema - swelling from insect bite", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Allergic reactions cause **bilateral, non-tender, non-erythematous swelling** without fever. This patient has unilateral erythematous swelling WITH fever AND eye involvement (proptosis, ophthalmoplegia). Allergic reactions do not cause extraocular movement abnormalities or vision changes.", "consequence": "Missed infectious process. Patient at risk for complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Hordeolum (stye) or chalazion - localized lid infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Hordeolum and chalazion are **localized** lid lesions that do not cause diffuse cellulitis, fever, or any orbital signs. They present as discrete, tender nodules on the eyelid margin (hordeolum) or a painless nodule within the lid (chalazion). This patient's diffuse cellulitis with systemic symptoms and orbital signs indicates a much more serious infection.", "consequence": "Grossly underestimated severity of infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Dacryocystitis - lacrimal sac infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Dacryocystitis causes swelling specifically **over the medial canthus/lacrimal sac area** with tenderness over the lacrimal sac and often purulent discharge from the punctum when pressure is applied. It does not cause diffuse periorbital cellulitis, proptosis, or ophthalmoplegia.", "consequence": "Wrong anatomical localization of infection.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Orbital septum** is the key anatomical landmark. **Periorbital** (preseptal) = anterior to septum, NO eye signs. **Orbital** (postseptal) = posterior to septum, causes **proptosis + ophthalmoplegia + vision changes**. Any of these three findings = orbital cellulitis until proven otherwise."}, "node-2": {"id": "node-2", "type": "decision", "content": "You have diagnosed orbital cellulitis based on the presence of proptosis, painful extraocular movements, and vision changes.\n\nOrbital cellulitis is a **medical emergency** requiring:\n1. Immediate hospitalization\n2. Urgent imaging to assess extent and complications\n3. IV antibiotics\n4. Possible surgical intervention\n\nThe most common etiology in children is **extension from acute bacterial sinusitis** (especially ethmoid sinusitis due to the thin lamina papyracea).", "question": "What is the most appropriate imaging modality?", "choices": [{"id": "node-2-choice-a", "text": "CT orbits with IV contrast", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** **CT orbits with contrast** is the gold standard for suspected orbital cellulitis. It can identify: **subperiosteal abscess** (most common complication), **orbital abscess**, **extent of infection**, **sinus involvement**, and **intracranial extension** (cavernous sinus thrombosis, epidural abscess, subdural empyema). Contrast enhancement helps distinguish abscess (rim-enhancing) from phlegmon.", "consequence": "Appropriate imaging ordered. CT reveals subperiosteal abscess.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "MRI orbits with gadolinium", "isOptimal": false, "isAcceptable": true, "feedback": "MRI provides superior soft tissue detail and is better for evaluating intracranial complications, but it takes longer, requires sedation in young children, and may not be immediately available. **CT with contrast is preferred initially** for speed and availability. MRI may be added if intracranial extension is suspected or to better characterize soft tissue involvement.", "consequence": "Acceptable but delay in imaging may allow progression.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Plain X-ray of orbits", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Plain X-rays are **inadequate** for evaluating orbital cellulitis. They cannot visualize soft tissue inflammation, abscess formation, or assess for intracranial extension. They may show sinus opacification but provide no information about orbital involvement.", "consequence": "Inadequate imaging delays diagnosis of abscess.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Ultrasound of orbit", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While orbital ultrasound can identify some abnormalities, it cannot adequately assess the posterior orbit, sinuses, or intracranial structures. It is operator-dependent and not the standard of care for orbital cellulitis. **CT with contrast** is required.", "consequence": "Incomplete evaluation of orbital structures.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "No imaging needed - start antibiotics empirically", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect and dangerous.** Orbital cellulitis REQUIRES imaging to assess for **abscess formation** (subperiosteal or orbital abscess), which may need surgical drainage. Treating blindly with antibiotics alone risks missing an abscess that won't resolve without surgery, leading to vision loss or intracranial spread.", "consequence": "Missed abscess requiring surgical drainage.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**CT orbits with contrast** is the imaging modality of choice. Look for: **subperiosteal abscess** (collection between periorbita and orbital wall, usually medial from ethmoid sinus), **proptosis**, **fat stranding**, and **sinus opacification**. The **lamina papyracea** (paper-thin medial orbital wall) is the usual route of spread from ethmoid sinusitis."}, "node-3": {"id": "node-3", "type": "decision", "content": "CT orbits with contrast reveals:\n- **Subperiosteal abscess** measuring 1.5 cm along the medial orbital wall\n- Proptosis of the left globe\n- Opacification of left ethmoid and maxillary sinuses\n- No intracranial extension seen\n\nThe patient is admitted and started on IV antibiotics. The ophthalmology and ENT services have been consulted.\n\nFor orbital cellulitis with subperiosteal abscess, treatment includes:\n- **IV antibiotics** covering S. aureus, Streptococcus, and anaerobes\n- **Surgical drainage** may be needed", "question": "What is the most appropriate initial antibiotic regimen?", "choices": [{"id": "node-3-choice-a", "text": "Vancomycin plus ampicillin-sulbactam (or piperacillin-tazobactam)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Empiric coverage should include: **MRSA** (vancomycin), **Streptococcus species**, **H. influenzae**, and **anaerobes** (from sinuses). **Vancomycin + ampicillin-sulbactam** or **vancomycin + piperacillin-tazobactam** provides this broad coverage. Once cultures return, antibiotics can be narrowed. Duration is typically **2-3 weeks IV** followed by oral transition.", "consequence": "Appropriate broad-spectrum coverage initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Amoxicillin-clavulanate orally", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Oral antibiotics are insufficient** for orbital cellulitis. This is a serious, vision-threatening infection requiring **IV antibiotics**. Additionally, amoxicillin-clavulanate does not cover MRSA, which is an important pathogen in orbital cellulitis. IV therapy is needed initially with transition to oral only after significant improvement.", "consequence": "Inadequate treatment intensity. Disease progression likely.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Ceftriaxone alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While ceftriaxone covers many pathogens, it does **NOT cover MRSA** (a common cause of orbital cellulitis) and has **limited anaerobic coverage**. Given the sinus source of infection, anaerobic coverage is important. Empiric therapy must include MRSA and anaerobic coverage.", "consequence": "Gaps in coverage - MRSA and anaerobes not covered.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Vancomycin alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While vancomycin covers MRSA and most gram-positive organisms, it does **NOT cover gram-negative organisms** (H. influenzae) or **anaerobes** adequately. Given the polymicrobial nature of sinus-origin infections, broader coverage is needed initially.", "consequence": "Gram-negative and anaerobic organisms not covered.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Topical antibiotic eye drops", "isOptimal": false, "isAcceptable": false, "feedback": "**Incorrect and dangerous.** Topical antibiotics do NOT penetrate into the orbit and are completely ineffective for orbital cellulitis. This is a deep tissue/space infection requiring systemic IV antibiotics. Topical drops may be added for ocular surface protection but are not therapeutic for the cellulitis itself.", "consequence": "Completely inadequate treatment. Vision loss imminent.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Empiric IV antibiotics** for orbital cellulitis must cover: **MRSA** (vancomycin), **Streptococci**, **H. influenzae**, and **anaerobes** (from sinuses). Common regimens: **Vancomycin + ampicillin-sulbactam** or **Vancomycin + ceftriaxone + metronidazole**. Adjust based on cultures. Duration: 2-3 weeks IV initially."}, "node-4": {"id": "node-4", "type": "decision", "content": "After 48 hours of IV antibiotics, the patient is reassessed:\n- Fever persists (38.5\u00b0C)\n- Proptosis unchanged\n- Still has pain with eye movement\n- Vision has not improved (still 20/80 OS)\n- Repeat examination shows no interval improvement\n\nThe ENT and ophthalmology teams are following the patient. The subperiosteal abscess was 1.5 cm on initial CT.", "question": "Given the lack of improvement after 48 hours of IV antibiotics, what is the next best step?", "choices": [{"id": "node-4-choice-a", "text": "Surgical drainage of the subperiosteal abscess", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** Indications for **surgical drainage** include: **lack of improvement after 24-48 hours of IV antibiotics**, **large abscess (>1 cm)**, **vision changes**, **complete ophthalmoplegia**, or **intracranial involvement**. This patient meets multiple criteria: no improvement at 48 hours, 1.5 cm abscess, and persistent vision changes. Surgery involves external or endoscopic drainage of the abscess.", "consequence": "Surgical drainage performed successfully.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Continue current antibiotics for 2 more days before reassessing", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delayed surgical intervention** in orbital cellulitis with abscess can lead to **permanent vision loss** and **intracranial spread**. With no improvement at 48 hours, a 1.5 cm abscess, and ongoing vision changes, continuing antibiotics alone is inappropriate. The abscess requires drainage.", "consequence": "Delayed surgery risks permanent vision loss.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Switch to different antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While antibiotic failure is possible, the more likely issue is that **antibiotics cannot adequately penetrate an abscess**. Abscesses are walled-off collections where antibiotic penetration is poor. The treatment for an abscess that doesn't respond to antibiotics is **drainage**, not antibiotic changes.", "consequence": "Abscess will not resolve without drainage.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Add systemic corticosteroids", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Steroids are controversial** in orbital cellulitis and should NOT be added before source control (drainage) is achieved. Some evidence suggests steroids may reduce inflammation AFTER drainage, but they should never replace or delay surgical intervention. Adding steroids without draining the abscess could worsen infection.", "consequence": "Immunosuppression without source control is dangerous.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Repeat CT scan before deciding on surgery", "isOptimal": false, "isAcceptable": true, "feedback": "Repeat imaging may be reasonable to assess for progression or new complications, but clinical findings already indicate surgical drainage is needed. A repeat CT should not delay surgical consultation and intervention. The clinical picture (no improvement, large abscess, vision changes) is sufficient to proceed with surgery.", "consequence": "Imaging should not delay necessary surgery.", "nextNodeId": "node-4"}], "clinicalPearl": "**Indications for surgical drainage** in orbital cellulitis: (1) **No improvement after 24-48h IV antibiotics**, (2) **Abscess >1 cm**, (3) **Vision changes/loss**, (4) **Complete ophthalmoplegia**, (5) **Intracranial extension**, (6) **Dental source**. Children under 9 with small abscesses (<1cm) and no vision changes may be managed medically with close monitoring."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient undergoes endoscopic surgical drainage of the subperiosteal abscess through the ethmoid sinus (which is also debrided). Cultures grow **methicillin-sensitive Staphylococcus aureus (MSSA)** and **Streptococcus anginosus**.\n\nPost-operatively:\n- Fever resolves within 24 hours\n- Proptosis improving\n- Eye movements less painful\n- Vision improving (now 20/40)\n\nThe patient has been on IV antibiotics for 5 days total (3 days pre-op, 2 days post-op).", "question": "How should antibiotic therapy be managed going forward?", "choices": [{"id": "node-5-choice-a", "text": "Narrow antibiotics based on cultures; complete 2-3 weeks total (IV then oral transition)", "isOptimal": true, "isAcceptable": true, "feedback": "**Correct!** With culture results showing MSSA and Streptococcus, antibiotics should be **narrowed** (vancomycin can be discontinued, continue beta-lactam for MSSA). Total antibiotic duration for orbital cellulitis with abscess is typically **3-4 weeks** (2-3 weeks IV followed by oral transition once clinically improved). The patient can transition to oral antibiotics (e.g., amoxicillin-clavulanate or clindamycin) once afebrile and improving.", "consequence": "Appropriate antibiotic stewardship and treatment duration.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Stop antibiotics now that abscess is drained", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While drainage is essential, **antibiotics must continue** to treat the surrounding cellulitis and prevent recurrence. Stopping antibiotics prematurely after only 5 days risks treatment failure and recurrent infection. A full course of 3-4 weeks is standard.", "consequence": "Premature discontinuation risks recurrence.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-c", "text": "Continue broad-spectrum IV antibiotics for 4 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With **culture results available**, antibiotics should be **narrowed** (antibiotic stewardship). Continuing unnecessarily broad coverage increases side effects, promotes resistance, and is not better than targeted therapy. Also, completing the entire course as IV is unnecessary - oral transition is appropriate once improving.", "consequence": "Unnecessarily broad spectrum promotes resistance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-d", "text": "Switch immediately to oral antibiotics", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While oral transition is appropriate, it's too early at only 2 days post-surgery. The standard approach is to continue **IV antibiotics until afebrile for 24-48 hours AND showing clear clinical improvement** (typically 7-10 days total IV), then transition to oral to complete 3-4 weeks total.", "consequence": "Premature oral transition may lead to treatment failure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Add antifungal coverage empirically", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. There is no indication for antifungal therapy. Fungal orbital infections (mucormycosis, aspergillosis) occur in **immunocompromised patients** or those with **poorly controlled diabetes**. This immunocompetent child with bacterial cultures growing typical pathogens does not need antifungal coverage.", "consequence": "Unnecessary medication with potential toxicity.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Antibiotic duration** for orbital cellulitis: **3-4 weeks total** (longer if abscess present). Start IV, transition to oral when: afebrile 24-48h, clinically improving, tolerating oral intake. **Narrow antibiotics** once culture results available - antibiotic stewardship is important even in serious infections."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of orbital cellulitis with subperiosteal abscess.\n\n**Key Learning Points:**\n1. **Orbital septum** distinguishes periorbital (preseptal) from orbital (postseptal) cellulitis\n2. **Danger signs** = proptosis + ophthalmoplegia + vision changes \u2192 orbital cellulitis\n3. **CT orbits with contrast** is the imaging modality of choice\n4. **Empiric antibiotics** must cover MRSA, Strep, and anaerobes\n5. **Surgical drainage** indicated for: no improvement at 24-48h, large abscess, vision changes\n6. **Total antibiotic duration**: 3-4 weeks with appropriate narrowing\n\nThe patient completed 3 weeks of antibiotics, vision returned to 20/20, and she had no long-term complications. Follow-up with ophthalmology showed full recovery of extraocular movements."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal management. Review these key concepts:\n\n**Periorbital vs Orbital Cellulitis:**\n- **Periorbital**: anterior to septum, lid swelling only, NO eye involvement, can treat outpatient with oral antibiotics\n- **Orbital**: posterior to septum, **proptosis + ophthalmoplegia + vision changes**, EMERGENCY requiring admission, IV antibiotics, and CT imaging\n\n**Management principles:**\n- CT with contrast is gold standard imaging\n- IV antibiotics covering MRSA, Strep, anaerobes\n- Surgery if: no improvement 24-48h, abscess >1cm, vision changes, intracranial involvement"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in management. Orbital cellulitis is a **vision-threatening and potentially life-threatening emergency**.\n\n**Complications of delayed/inadequate treatment:**\n- **Permanent vision loss** (optic nerve compression, central retinal artery occlusion)\n- **Cavernous sinus thrombosis** (spreads via ophthalmic veins)\n- **Intracranial abscess** (subdural empyema, brain abscess)\n- **Meningitis**\n- **Death**\n\n**Key Pearl:** When in doubt, treat as orbital cellulitis. The consequence of under-treatment (blindness, death) far exceeds the consequence of over-treatment."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-160", "title": "Epididymitis in Adolescent", "domain": "infectious_disease", "difficulty": "intermediate", "tags": ["epididymitis", "sexually transmitted infection", "Chlamydia", "Gonorrhea", "NAAT testing", "positive Prehn sign", "ceftriaxone", "doxycycline"], "estimatedMinutes": 5, "source": ["Amboss"], "stem": "A 17-year-old sexually active male presents to the clinic with a 3-day history of progressive left scrotal pain and swelling. He denies trauma. He reports dysuria and urethral discharge for the past week but was embarrassed to tell anyone.\n\nHe is sexually active with one female partner and inconsistently uses condoms. He denies fever, nausea, or vomiting.\n\nPhysical Examination:\n- General: Well-appearing adolescent in mild discomfort\n- Vitals: T 37.8\u00b0C, HR 82, BP 118/72\n- GU exam: Left hemiscrotum swollen and erythematous. Left epididymis is tender, enlarged, and indurated. Left testicle is in normal position with intact cremasteric reflex. Urethral discharge is present (mucopurulent).\n- Prehn sign: Pain improves with scrotal elevation\n- No abdominal tenderness", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 17-year-old sexually active male presents with unilateral scrotal pain, swelling, and urethral discharge. Key findings:\n\n- **Gradual onset** (3 days) - not sudden\n- **Urethral discharge** - suggests STI\n- **Tender, swollen epididymis** with normal testicular position\n- **Positive Prehn sign** (pain relief with elevation)\n- **Intact cremasteric reflex**", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Epididymitis secondary to sexually transmitted infection", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! In **sexually active adolescents and young adults (<35 years)**, epididymitis is most commonly caused by **Chlamydia trachomatis** and **Neisseria gonorrhoeae**. Classic features: (1) **Gradual onset** of scrotal pain, (2) **Urethral discharge/dysuria**, (3) **Tender, swollen epididymis**, (4) **Positive Prehn sign**, (5) **Intact cremasteric reflex**. This distinguishes it from testicular torsion.", "consequence": "You recognize STI-related epididymitis in a sexually active teen.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Testicular torsion requiring emergent surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Testicular torsion** presents with **sudden onset** severe pain, **high-riding testicle** with abnormal lie, **absent cremasteric reflex**, and **negative Prehn sign** (no relief with elevation). This patient has gradual onset, positive Prehn sign, intact cremasteric reflex, and urethral discharge - all pointing to epididymitis, not torsion.", "consequence": "Features do not support torsion diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Testicular cancer presenting as scrotal mass", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Testicular cancer** presents as a **painless, firm testicular mass** - not epididymal swelling with urethral discharge. Testicular tumors are typically non-tender. This patient's painful, swollen epididymis with mucopurulent discharge is classic for infectious epididymitis.", "consequence": "Presentation inconsistent with malignancy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Orchitis from mumps infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Mumps orchitis** presents with **testicular** (not epididymal) swelling, typically occurs **5-7 days after parotitis**, and is rare in vaccinated individuals. This patient has **epididymal** tenderness with urethral discharge - urethritis is not a feature of mumps. His presentation is classic for STI-related epididymitis.", "consequence": "No history of parotitis; pattern suggests bacterial STI.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Inguinal hernia with incarceration", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Incarcerated inguinal hernia** presents with a **tender, irreducible groin mass**, often with **bowel obstruction symptoms** (nausea, vomiting, abdominal distension). This patient has isolated epididymal tenderness with urethral discharge - not consistent with hernia.", "consequence": "No groin mass or obstruction symptoms.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Epididymitis vs Torsion**: Epididymitis = gradual onset, positive Prehn sign, intact cremasteric reflex, often with urethral discharge. Torsion = sudden onset, negative Prehn sign, absent cremasteric reflex, high-riding testicle. When in doubt, get ultrasound - but don't delay surgery if torsion is suspected!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect epididymitis due to sexually transmitted infection. The patient is hemodynamically stable and the presentation is consistent with infectious epididymitis rather than torsion.\n\nHowever, you want to confirm the diagnosis and identify the causative organism.", "question": "What is the MOST appropriate diagnostic test to confirm the etiology?", "choices": [{"id": "node-2-choice-a", "text": "Nucleic acid amplification test (NAAT) for Chlamydia and Gonorrhea from urethral swab or first-void urine", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **NAAT testing** is the gold standard for diagnosing **Chlamydia trachomatis** and **Neisseria gonorrhoeae**. It has superior sensitivity and specificity compared to culture. Can be performed on **urethral swab** or **first-void urine** (first 20-30 mL). In sexually active young males with epididymitis, NAAT should always be obtained to guide treatment and partner notification.", "consequence": "NAAT ordered - results pending.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Testicular ultrasound with Doppler to rule out torsion", "isOptimal": false, "isAcceptable": true, "feedback": "Ultrasound is reasonable if there's any doubt about the diagnosis. In epididymitis, ultrasound shows **enlarged, hyperemic epididymis** with **increased blood flow** on Doppler. In torsion, there would be **decreased or absent flow**. However, in this classic presentation with urethral discharge and positive Prehn sign, the clinical diagnosis is clear and NAAT testing is the priority to identify the pathogen.", "consequence": "Ultrasound would confirm epididymitis but delays definitive STI testing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Urinalysis and urine culture only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Urine culture will miss Chlamydia and often Gonorrhea**. These organisms require specialized testing (NAAT). Urinalysis may show pyuria, but this is nonspecific. In sexually active young males, NAAT testing is essential - urine culture alone would miss the most common causative organisms.", "consequence": "Fails to identify the likely STI pathogens.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Gram stain of urethral discharge only", "isOptimal": false, "isAcceptable": true, "feedback": "Gram stain can provide rapid presumptive diagnosis: **gram-negative intracellular diplococci** suggest gonorrhea. However, Gram stain **misses Chlamydia** (which doesn't stain well) and has lower sensitivity than NAAT. While it can guide immediate treatment, NAAT should still be performed for definitive diagnosis and to detect Chlamydia co-infection.", "consequence": "Provides quick info but misses Chlamydia.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "Serum tumor markers (AFP, beta-hCG, LDH)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Tumor markers are used to evaluate **testicular cancer**, not epididymitis. This patient's presentation (painful, tender epididymis with urethral discharge) is clearly infectious, not neoplastic. Testicular cancer presents as a painless, firm testicular mass.", "consequence": "Inappropriate test for this presentation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**NAAT is gold standard** for Chlamydia and Gonorrhea - superior to culture. Can use urethral swab or first-void urine. Always test for BOTH organisms as co-infection is common (up to 50%). Gram stain can provide rapid presumptive diagnosis of GC but misses Chlamydia."}, "node-3": {"id": "node-3", "type": "decision", "content": "NAAT results come back positive:\n- **Chlamydia trachomatis: POSITIVE**\n- **Neisseria gonorrhoeae: POSITIVE**\n\nThe patient has co-infection with both organisms, which is common (occurs in up to 50% of cases).\n\nYou need to initiate treatment.", "question": "What is the MOST appropriate treatment regimen?", "choices": [{"id": "node-3-choice-a", "text": "Ceftriaxone 500 mg IM x1 PLUS Doxycycline 100 mg PO BID x 10 days", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Dual therapy** is required for STI-related epididymitis. Per CDC guidelines: **Ceftriaxone 500 mg IM single dose** (covers gonorrhea) PLUS **Doxycycline 100 mg PO twice daily for 10 days** (covers Chlamydia and provides extended coverage for epididymitis). The extended doxycycline course (10 days vs 7 days for uncomplicated urethritis) is needed because epididymal tissue penetration requires longer treatment.", "consequence": "Appropriate dual therapy initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Azithromycin 1 g PO x1 only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Single-dose azithromycin **does not adequately treat epididymitis** (tissue penetration requires longer therapy) and **does not cover gonorrhea** (resistance to azithromycin monotherapy is high). This patient has documented co-infection and requires dual therapy with ceftriaxone for GC and extended doxycycline for epididymitis.", "consequence": "Treatment failure likely; does not cover both organisms.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Ciprofloxacin 500 mg PO BID x 10 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fluoroquinolones are no longer recommended** for gonorrhea due to widespread resistance. Additionally, ciprofloxacin would not adequately cover Chlamydia. Fluoroquinolone-based regimens are only appropriate for epididymitis in men >35 or MSM where enteric organisms are more likely.", "consequence": "High likelihood of treatment failure due to resistance.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Ceftriaxone 500 mg IM x1 only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Ceftriaxone alone **does not cover Chlamydia**, which is also positive in this patient. Even if only gonorrhea were detected, CDC recommends presumptive treatment for both since co-infection is common. Always use dual therapy for STI-related epididymitis.", "consequence": "Fails to treat Chlamydia co-infection.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "TMP-SMX DS PO BID x 14 days", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. TMP-SMX **does not cover Chlamydia or Gonorrhea**. It may be used for epididymitis caused by enteric organisms (E. coli) in older men or those with urinary tract abnormalities, but it is inappropriate for STI-related epididymitis in a sexually active young male.", "consequence": "Wrong antibiotic spectrum for STI pathogens.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**STI-related epididymitis treatment**: Ceftriaxone 500 mg IM x1 + Doxycycline 100 mg BID x **10 days** (longer than 7-day course for uncomplicated urethritis). For patients with severe penicillin allergy: Gentamicin 240 mg IM + Azithromycin 2 g PO. Always treat for BOTH GC and CT even if only one is detected."}, "node-4": {"id": "node-4", "type": "decision", "content": "You administer ceftriaxone 500 mg IM and prescribe doxycycline 100 mg BID for 10 days. The patient asks about his girlfriend and whether he can have sex during treatment.\n\nYou need to provide appropriate counseling on partner management and prevention.", "question": "What is the MOST appropriate counseling regarding partner notification and sexual activity?", "choices": [{"id": "node-4-choice-a", "text": "Partner must be tested and treated; abstain from sex until both have completed treatment and are asymptomatic", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Partner management is essential**: (1) **All sexual partners within 60 days** should be notified, tested, and treated presumptively (don't wait for results), (2) **Abstain from sexual activity** until BOTH patient and partner have completed treatment AND are asymptomatic (typically 7 days after single-dose therapy or completion of multi-day regimen), (3) **Expedited partner therapy (EPT)** is legal in most states - can provide prescription for partner without examination.", "consequence": "Appropriate counseling on partner notification and abstinence.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "No need to notify partner if she is asymptomatic", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Asymptomatic infection is common**, especially in women (up to 80% of Chlamydia infections in women are asymptomatic). Untreated infection leads to **PID, infertility, ectopic pregnancy, and chronic pelvic pain**. Partner notification and treatment is mandatory regardless of symptoms to prevent complications and ongoing transmission.", "consequence": "Partner remains infected; risk of reinfection and complications.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Can resume sex after 24 hours of treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Patients should abstain from sex until **both patient and partner have completed treatment** (7 days after single-dose regimen or completion of multi-day regimen) **AND symptoms have resolved**. Having sex too early risks reinfection from untreated partner or treatment failure.", "consequence": "Premature resumption risks reinfection.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Condom use alone is sufficient; no need for abstinence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While condoms reduce transmission, they are not 100% effective and should not replace abstinence during treatment. The recommendation is to **abstain completely** until both partners are treated and asymptomatic. Condoms are important for **future prevention** but not a substitute for proper treatment completion.", "consequence": "Condoms alone insufficient during active treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Partner notification is the health department's responsibility only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While health departments can assist with partner notification, **physicians should counsel patients directly** and offer options: (1) Patient notifies partner, (2) Provider-assisted notification, (3) Health department assistance, (4) **Expedited partner therapy** (EPT) - providing prescription for partner. Multiple approaches improve notification rates.", "consequence": "Passive approach reduces partner notification rates.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Partner management**: Notify all partners within 60 days. Treat presumptively (don't wait for results). **EPT** allows prescribing for partners without exam (check state laws). Abstain until BOTH complete treatment + symptoms resolved. **Test of cure** not routinely needed but retest in 3 months (high reinfection rate)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly managed **STI-related epididymitis** in a sexually active adolescent.\n\n**Key learning points**:\n\n**Diagnosis**: Gradual onset scrotal pain, urethral discharge, positive Prehn sign, intact cremasteric reflex. NAAT testing confirms Chlamydia/Gonorrhea.\n\n**Treatment**: Ceftriaxone 500 mg IM x1 + Doxycycline 100 mg BID x 10 days (dual therapy essential).\n\n**Partner management**: Notify and treat all partners within 60 days. Abstain until both treated and asymptomatic.\n\n**Follow-up**: Symptoms should improve in 48-72 hours. Retest in 3 months for reinfection. Test of cure not routinely needed."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **epididymitis in sexually active males**:\n\n**Etiology**: Chlamydia trachomatis and Neisseria gonorrhoeae (most common in <35 years).\n\n**Diagnosis**: NAAT testing is gold standard. Ultrasound shows hyperemic epididymis with increased flow (vs torsion with decreased flow).\n\n**Treatment**: Ceftriaxone 500 mg IM + Doxycycline 100 mg BID x 10 days. DO NOT use fluoroquinolones (GC resistance).\n\n**Partner management**: ALL partners within 60 days must be notified and treated. Abstain until BOTH complete treatment."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in management.\n\n**Treatment failures**:\n- Azithromycin alone: Doesn't cover epididymitis adequately or GC resistance\n- Fluoroquinolones: High GC resistance - no longer recommended\n- Single agent: Must treat BOTH GC and CT with dual therapy\n\n**Partner notification failures**:\n- Asymptomatic partners still need treatment (80% of CT in women is asymptomatic)\n- Failure to treat partners \u2192 reinfection and ongoing transmission\n- Untreated Chlamydia \u2192 PID, infertility, ectopic pregnancy\n\n**Remember**: STI-related epididymitis requires DUAL therapy and PARTNER treatment."}}, "rootNodeId": "node-1"}], "adolescent": [{"id": "vignette-lens-peds-051", "title": "SIDS Prevention", "domain": "adolescent", "difficulty": "intermediate", "tags": ["sids prevention"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 1-month-old male is brought in by his parents for well-child visit.\n\nThe patient's mother reports, parents are here for routine visit and have questions about safe sleep. They mention the baby sleeps in their bed because it is easier for breastfeeding.\n\nAssociated symptoms include identified risk factors during visit. Denies any prior events or illness.\n\nPast medical history includes He was born at 37 weeks. He is breastfed. Mother smoked during pregnancy.\n\nPhysical Examination:\n- General: well-appearing infant.\n- Growth: appropriate weight gain.\n- Development: normal for age.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You review the infant's sleep environment and identify multiple SIDS risk factors:\n- **Bed-sharing** with parents\n- Mother **smoked during pregnancy**\n- **Late preterm** birth (37 weeks)\n- Soft bedding visible in photos parents show you\n\nSIDS remains the leading cause of death in infants aged 1-12 months in developed countries.", "question": "Which of the following is the SINGLE most important modifiable risk factor for SIDS?", "choices": [{"id": "node-1-choice-a", "text": "Prone (stomach) sleeping position", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prone sleeping** is the most significant modifiable risk factor for SIDS. The **Back to Sleep campaign** (now **Safe to Sleep**) reduced SIDS deaths by >50% simply by recommending supine positioning. Prone sleeping increases risk **10-fold** compared to supine. The mechanism involves rebreathing of exhaled CO\u2082, airway obstruction, and impaired arousal from sleep.", "consequence": "You identify the key modifiable risk factor.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Maternal smoking during pregnancy", "isOptimal": false, "isAcceptable": true, "feedback": "Important but not the single most important. **Maternal smoking** increases SIDS risk **2-4 fold** and is a significant modifiable factor. However, sleep position is more impactful - the Back to Sleep campaign alone reduced SIDS by >50%. Smoking cessation should still be strongly encouraged, especially for future pregnancies.", "consequence": "Correct risk factor but not the most impactful.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Prematurity (37 weeks gestation)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Prematurity** is a risk factor for SIDS, but it is **not modifiable**. Late preterm infants (34-36 weeks) have higher SIDS rates than term infants. While important to know for risk stratification, the question asks for modifiable factors. Sleep position and smoking are the key modifiable risks.", "consequence": "This risk factor cannot be changed after birth.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Male sex", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Male sex** is associated with higher SIDS risk (males have ~1.5x higher rates than females), but it is **not modifiable**. Focus prevention counseling on factors that can be changed: sleep position, sleep environment, smoking exposure, and breastfeeding.", "consequence": "Non-modifiable risk factor.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Family history of SIDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While there may be a slight increased risk with **family history**, it is not modifiable and the increased risk is modest. Some familial cases may be due to shared environmental factors (sleep practices, smoking) rather than genetics. Focus counseling on modifiable risks.", "consequence": "Non-modifiable risk factor with modest impact.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: The **ABCs of Safe Sleep**: **A**lone (no bed-sharing, no soft objects), on their **B**ack (supine position), in a **C**rib (firm, flat surface). The Back to Sleep campaign reduced SIDS deaths by **>50%** in the US."}, "node-2": {"id": "node-2", "type": "decision", "content": "You counsel the parents about safe sleep practices. They express concern about bed-sharing because it makes breastfeeding easier and they've heard it promotes bonding.\n\nThe mother asks: 'Isn't bed-sharing safer because I can monitor the baby better?'", "question": "What is the most appropriate response regarding bed-sharing?", "choices": [{"id": "node-2-choice-a", "text": "Bed-sharing increases SIDS risk; recommend room-sharing without bed-sharing for the first 6-12 months", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bed-sharing increases SIDS risk** approximately **2-3 fold** overall, and **10-fold** when combined with parental smoking or alcohol use. However, **room-sharing** (baby in crib/bassinet in parents' room) **decreases** SIDS risk by ~50% and facilitates breastfeeding. The AAP recommends **room-sharing without bed-sharing** for at least the first **6 months**, ideally **12 months**.", "consequence": "Parents understand the distinction between room-sharing and bed-sharing.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Bed-sharing is safe as long as parents don't smoke or drink alcohol", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While smoking and alcohol **dramatically increase** bed-sharing risk (10-fold), bed-sharing carries **some risk even without these factors** (2-3 fold increased SIDS risk). Soft bedding, parental fatigue, and the risk of overlay/suffocation remain concerns. The AAP recommends against bed-sharing regardless of other factors.", "consequence": "May falsely reassure parents about a risky practice.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Bed-sharing is fine because it promotes breastfeeding, which protects against SIDS", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **breastfeeding is protective** against SIDS (reduces risk by ~50%), this benefit does **not outweigh the risks of bed-sharing**. The protective benefits of breastfeeding can be achieved with room-sharing (bassinet next to bed), which facilitates nighttime feeding while maintaining a separate, safe sleep surface.", "consequence": "Risk-benefit analysis is incorrect; bed-sharing risk exceeds breastfeeding benefit.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "The baby should sleep in a separate room to promote independence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Room-sharing** (not same-bed, but same room) actually **reduces** SIDS risk by ~50%. The AAP recommends keeping the baby's sleep space in the parents' room for at least 6 months. Separate-room sleeping is associated with **higher** SIDS rates than room-sharing.", "consequence": "Separating rooms may increase SIDS risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Bed-sharing is cultural and should not be discouraged", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While cultural sensitivity is important, **SIDS risk is real regardless of cultural practices**. The physician's role is to provide evidence-based counseling while respecting the family. Harm reduction strategies can be discussed, but the clear recommendation should be against bed-sharing due to documented increased mortality risk.", "consequence": "Fails to provide evidence-based guidance.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "KEY CONCEPT: **Room-sharing \u2260 Bed-sharing**. Room-sharing (baby in separate sleep surface in parents' room) **reduces** SIDS risk by 50%. Bed-sharing (same surface) **increases** risk 2-3 fold (10-fold with smoking/alcohol). Recommend: bassinet or crib next to the bed for easy breastfeeding access."}, "node-3": {"id": "node-3", "type": "decision", "content": "The parents are receptive to your counseling. Before finishing the visit, you want to ensure they understand all components of safe sleep.\n\nThey ask about pacifiers, swaddling, and home monitors they've seen advertised.", "question": "Which of the following is a correct safe sleep recommendation?", "choices": [{"id": "node-3-choice-a", "text": "Pacifier use at sleep time is recommended after breastfeeding is established; home cardiorespiratory monitors are NOT recommended for SIDS prevention", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Pacifier use** at nap and bedtime is associated with **reduced SIDS risk** (mechanism unclear - may improve arousal or prevent airway obstruction). Offer after **breastfeeding is established** (~3-4 weeks) to avoid nipple confusion. **Home cardiorespiratory monitors** have **NOT been shown to prevent SIDS** and are not recommended - they may provide false reassurance while not addressing actual risk factors.", "consequence": "Parents receive complete, evidence-based safe sleep guidance.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Home apnea monitors are highly effective at preventing SIDS and should be recommended", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Home cardiorespiratory monitors have NOT been shown to prevent SIDS deaths**. Studies have failed to demonstrate any mortality benefit. They detect apnea events but SIDS is not simply apnea - many SIDS victims never trigger alarms. Monitors may cause **parental anxiety** and **false reassurance** that detracts from proven prevention measures.", "consequence": "Promotes ineffective intervention over evidence-based practices.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Swaddling should be continued until 12 months to help the baby sleep", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Swaddling** should be **discontinued when the baby shows signs of rolling** (typically around 2-4 months). A swaddled baby who rolls to prone cannot use arms to lift their face, dramatically increasing suffocation risk. Once rolling begins, transition to a wearable blanket (sleep sack) that leaves arms free.", "consequence": "Dangerous advice that could lead to suffocation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Bumper pads should be used to prevent the baby from hitting the crib slats", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Crib bumper pads are dangerous** and have been associated with suffocation, strangulation, and entrapment deaths. The AAP recommends **nothing in the crib** except the baby and a fitted sheet. Babies cannot generate enough force to injure themselves on crib slats, but they can suffocate against soft bumpers.", "consequence": "Recommends a known hazard.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Inclined sleepers and positioners are safer than flat surfaces", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Inclined sleepers** (like the recalled Fisher-Price Rock 'n Play) and **sleep positioners** have caused multiple infant deaths from positional asphyxia and rolling. The FDA and AAP recommend **only flat, firm surfaces** for infant sleep. These products have been recalled due to documented fatalities.", "consequence": "Recommends recalled, dangerous products.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "KEY CONCEPT: **Safe sleep environment** = firm, flat surface with fitted sheet only. **NO**: soft bedding, pillows, bumpers, toys, positioners, inclined surfaces. **YES**: pacifier at sleep time (after breastfeeding established), room-sharing for 6-12 months, fan use (may reduce SIDS risk). **NOT effective**: home monitors, sleep positioners."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent counseling! You effectively educated this family about **SIDS prevention** using evidence-based AAP guidelines. Key points covered: (1) **Supine positioning** is the single most important modifiable factor; (2) **Room-sharing without bed-sharing** for 6-12 months; (3) **Firm, flat sleep surface** with nothing in the crib; (4) **Pacifier use** after breastfeeding established; (5) **Home monitors do NOT prevent SIDS**. With proper safe sleep practices, SIDS risk is dramatically reduced."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key SIDS prevention concepts: (1) **ABCs**: Alone, on Back, in Crib; (2) **Prone sleeping** increases risk 10-fold; (3) **Bed-sharing** increases risk 2-3 fold (10-fold with smoking/alcohol); (4) **Room-sharing** (separate surface) decreases risk 50%; (5) **Modifiable risks**: sleep position, smoking, soft bedding, overheating."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. SIDS prevention requires evidence-based counseling. **Key facts**: Back to Sleep campaign reduced SIDS >50%; bed-sharing increases risk; room-sharing decreases risk; firm/flat surface only; no bumpers, positioners, or soft bedding; pacifiers are protective; home monitors do NOT prevent SIDS. Failing to provide correct guidance puts infants at unnecessary risk."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-061", "title": "Testicular Torsion", "domain": "adolescent", "difficulty": "intermediate", "tags": ["sudden severe scrotal pain", "high-riding testicle", "absent cremasteric reflex", "horizontal lie", "testicular torsion"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old male presents to the clinic with sudden severe testicular pain of 4 hours duration.\n\nPer the mother, he woke up with severe left testicular pain that came on suddenly. He has vomited twice from the pain. He denies any trauma or recent physical activity.\n\nAssociated symptoms include nausea and lower abdominal pain. Denies fever, dysuria, urethral discharge, or recent sexual activity.\n\nMedical history is notable for He had a similar but milder episode 6 months ago that resolved on its own.\n\nPhysical Examination:\n- GU: left testis is high-riding, horizontally oriented (bell-clapper deformity), and exquisitely tender. Absent cremasteric reflex on left. Right testis normal.\n- Abdomen: mild lower abdominal tenderness.\n- General: pale, diaphoretic adolescent in severe distress.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This adolescent presents with sudden onset severe testicular pain with nausea and vomiting. On exam, the testis is high-riding with a horizontal lie and absent cremasteric reflex. TIME IS CRITICAL.", "question": "Which physical examination finding is MOST specific for testicular torsion?", "choices": [{"id": "node-1-choice-a", "text": "Absent cremasteric reflex on the affected side", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **absent cremasteric reflex** is the most sensitive and specific physical exam finding for testicular torsion (sensitivity 99%, specificity 97%). Stroke the inner thigh - normally the cremasteric muscle contracts and elevates the testis. In torsion, this reflex is abolished due to ischemia and twisting of the cord.", "consequence": "You recognize the key finding confirming torsion.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Positive Prehn sign (pain relief with testicular elevation)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Positive Prehn sign** (pain relief with elevation) suggests **epididymitis**, NOT torsion. In torsion, elevation does NOT relieve pain (negative Prehn sign). However, this sign is unreliable and should not be used to rule out torsion.", "consequence": "You may mistakenly consider epididymitis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Blue dot sign at upper pole of testis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The **blue dot sign** is pathognomonic for **torsion of the appendix testis** (or appendix epididymis), NOT testicular torsion. It represents the infarcted appendage visible through scrotal skin at the upper pole.", "consequence": "You consider appendix testis torsion instead.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Fever with scrotal erythema", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Fever** and **scrotal erythema** suggest infection (epididymitis/orchitis), NOT torsion. Torsion is typically **afebrile** early, though late presentations may have reactive inflammation. This patient is afebrile.", "consequence": "You consider infectious causes.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Inguinal mass that increases with Valsalva", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. An **inguinal mass that increases with Valsalva** suggests **inguinal hernia**, not testicular torsion. While incarcerated hernia can cause scrotal pain, the testis itself would be normal on exam.", "consequence": "You consider hernia but the exam shows abnormal testis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**4 classic signs of torsion**: 1) **Sudden severe pain** (often wakes from sleep), 2) **High-riding testis** with horizontal lie, 3) **Absent cremasteric reflex** (most sensitive), 4) **Negative Prehn sign** (elevation doesn't help). Nausea/vomiting in 50%."}, "node-2": {"id": "node-2", "type": "decision", "content": "The clinical picture is classic for testicular torsion. Symptom onset was 4 hours ago. The urologist is not yet available. You need to make an immediate decision.", "question": "What is the MOST appropriate immediate next step?", "choices": [{"id": "node-2-choice-a", "text": "Immediate surgical exploration - do NOT delay for imaging", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! When clinical suspicion is high (as in this case), **do NOT delay for imaging**. Testicular salvage rates are **>90% if detorsed within 6 hours**, drop to **50% at 12 hours**, and approach **0% after 24 hours**. Call urology emergently and go straight to OR. Imaging may be falsely negative and wastes precious time.", "consequence": "You call for emergent surgical exploration.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Scrotal ultrasound with Doppler to confirm before surgery", "isOptimal": false, "isAcceptable": true, "feedback": "Ultrasound CAN be obtained **if immediately available AND will not delay surgery** in cases of intermediate clinical suspicion. However, in this classic presentation, imaging wastes time. Doppler can be **falsely negative** (especially early or with incomplete torsion), and a negative US does NOT rule out torsion.", "consequence": "You order US but this may delay surgery.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Empiric antibiotics for possible epididymitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This is NOT epididymitis - the presentation is classic for torsion. Starting antibiotics delays definitive treatment and could result in **loss of the testis**. Epididymitis has gradual onset, fever, and pyuria - none present here.", "consequence": "You treat the wrong diagnosis while the testis dies.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Pain control and observation for 4-6 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Absolutely incorrect! Observation is contraindicated - **every minute matters**. With 4 hours already elapsed, adding 4-6 more hours of observation would put this patient at 8-10 hours, with <50% salvage rate. This is a **surgical emergency**.", "consequence": "Testis becomes non-viable during observation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Manual detorsion as temporizing measure", "isOptimal": false, "isAcceptable": true, "feedback": "**Manual detorsion** can be attempted as a temporizing measure if surgery will be delayed, but it does NOT replace surgical exploration. Technique: rotate testis **'open the book'** (lateral rotation, like opening a book). Success is indicated by pain relief. Still needs OR for fixation.", "consequence": "You attempt manual detorsion while arranging surgery.", "nextNodeId": "node-3"}], "clinicalPearl": "**Salvage rates by time**: <6 hours = **90-100%**, 6-12 hours = **50%**, 12-24 hours = **20%**, >24 hours = **near 0%**. 'Time is testicle' - treat like you would a STEMI. Clinical diagnosis trumps imaging."}, "node-3": {"id": "node-3", "type": "decision", "content": "The patient is taken urgently to the OR. The surgeon finds the left testis torsed 720 degrees (two full rotations). After detorsion, the testis appears dusky but shows some color return with warm saline wraps.", "question": "What intraoperative procedure must be performed?", "choices": [{"id": "node-3-choice-a", "text": "Bilateral orchiopexy (fixation of BOTH testes)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Bilateral orchiopexy** is mandatory. The **bell-clapper deformity** (horizontal lie due to high tunica vaginalis attachment) that predisposes to torsion is almost always **bilateral**. The contralateral testis has approximately **40% risk of torsion** if not fixed. Always fix both testes with non-absorbable sutures.", "consequence": "Both testes are surgically fixed to prevent recurrence.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Unilateral orchiopexy of affected testis only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Fixing only the affected testis leaves the patient at **high risk for contralateral torsion**. The bell-clapper deformity is bilateral, and the contralateral testis MUST be fixed prophylactically. This is standard of care.", "consequence": "Patient returns later with torsion of the other testis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Orchiectomy (removal of affected testis)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect for this case. **Orchiectomy** is only indicated if the testis is clearly **non-viable** (no color return after 15-20 minutes of warm saline wraps, or obviously necrotic). This testis shows color return and should be salvaged. Even questionable testes should be preserved if possible.", "consequence": "You consider orchiectomy but the testis appears viable.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Detorsion only without fixation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Detorsion without orchiopexy results in **high recurrence rate** (torsion can recur). The testis must be surgically fixed to the scrotum with **non-absorbable sutures in 3 points** to prevent future torsion.", "consequence": "Patient has recurrent torsion after discharge.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Biopsy of testis to assess viability", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Biopsy is NOT performed intraoperatively - it would damage the testis and is unnecessary. Viability is assessed by **visual inspection** (color return with warm saline) and possibly **intraoperative Doppler**. Preserve the testis if there's any chance of viability.", "consequence": "Unnecessary biopsy damages the testis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Bell-clapper deformity**: High attachment of tunica vaginalis allows testis to hang horizontally and rotate freely. Present in **12% of males** and almost always **bilateral**. This is why contralateral fixation is mandatory."}, "node-4": {"id": "node-4", "type": "decision", "content": "Surgery is complete. Bilateral orchiopexy was performed. The affected testis appears viable. The patient is recovering well.", "question": "What is the most important post-operative counseling?", "choices": [{"id": "node-4-choice-a", "text": "Report any future scrotal pain immediately - recurrence is possible though rare", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Despite orchiopexy, **recurrence** is possible (1-2%) if sutures loosen or fail. Patients and families must understand that **any future scrotal pain requires immediate evaluation**. Also counsel about: possibility of testicular atrophy despite salvage, and normal fertility expected with one functional testis.", "consequence": "Family understands warning signs and follow-up needs.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "No further follow-up needed after surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Follow-up IS needed to monitor for: **testicular atrophy** (may occur despite successful detorsion due to prior ischemia), **suture complications**, and to reinforce warning signs. A post-op urology visit is standard.", "consequence": "Patient misses signs of atrophy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Fertility will definitely be impaired", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. With one functional testis, **fertility is typically normal**. Even if the affected testis atrophies, the contralateral testis compensates. Only bilateral torsion or loss affects fertility significantly. Provide realistic counseling, not overly pessimistic.", "consequence": "Unnecessary anxiety about fertility.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Avoid all physical activity permanently", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. After orchiopexy, patients can return to **normal activity** (including sports) typically within **4-6 weeks**. There's no permanent activity restriction. Torsion is due to anatomy (bell-clapper), not activity.", "consequence": "Unnecessary activity restrictions.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Hormone replacement therapy will be required", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Testosterone replacement** is only needed if **both testes** are lost. One functional testis provides adequate hormone production. This patient has bilateral orchiopexy with preserved testes - no hormone replacement needed.", "consequence": "Incorrect expectation about hormone needs.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Post-torsion outcomes**: Up to **50% of salvaged testes** may show some degree of atrophy over time. **Sperm quality** may be affected even in the contralateral testis (unclear mechanism). Still, most patients have **normal fertility**."}, "node-5": {"id": "node-5", "type": "decision", "content": "The patient mentions he had a similar episode 6 months ago that 'resolved on its own.' You realize this was likely intermittent torsion/detorsion.", "question": "What does the history of prior resolved episodes indicate?", "choices": [{"id": "node-5-choice-a", "text": "Intermittent torsion-detorsion, which indicates high risk and should have prompted earlier intervention", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Intermittent torsion-detorsion** is a recognized entity where the testis torsions but spontaneously untwists. These patients have the **bell-clapper deformity** and are at **very high risk** for complete torsion. This history should prompt **elective bilateral orchiopexy** to prevent future complete torsion.", "consequence": "You recognize this was a missed opportunity for prevention.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "Previous episodes mean future torsion is less likely", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! The opposite is true. Prior episodes indicate **underlying anatomic predisposition** (bell-clapper) and mean future torsion is **more likely**. Each episode of intermittent torsion is a warning sign.", "consequence": "You underestimate future risk.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "The previous episode was likely unrelated growing pains", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Sudden severe testicular pain that resolves spontaneously** is NOT growing pains - it's likely **intermittent torsion**. 'Growing pains' don't involve sudden onset or scrotal pain. Always take testicular pain seriously.", "consequence": "You dismiss an important warning sign.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "This pattern suggests epididymitis, not torsion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Epididymitis doesn't typically resolve suddenly and recur. The pattern of **sudden severe pain that spontaneously resolves** is classic for **intermittent torsion-detorsion**, not infection.", "consequence": "You misinterpret the history.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Psychological component should be investigated", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and dangerous thinking. Testicular pain in an adolescent should NEVER be dismissed as psychological without thorough evaluation. This patient clearly had a surgical emergency - any suggestion of psychological origin could delay life-saving treatment.", "consequence": "Dangerous dismissal of real symptoms.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Intermittent torsion-detorsion**: Recurrent episodes of sudden testicular pain lasting minutes to hours that resolve spontaneously. These patients should be offered **elective bilateral orchiopexy** to prevent complete torsion. Don't wait for the inevitable complete torsion!"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management of this surgical emergency! You recognized the classic signs (sudden pain, high-riding testis, absent cremasteric reflex), proceeded immediately to surgery without delay, performed bilateral orchiopexy, and understood the significance of prior intermittent torsion. The testis was salvaged, and the patient recovered well with appropriate counseling for follow-up."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key torsion pearls: **Absent cremasteric reflex** is most sensitive sign. **Don't delay for imaging** if clinical suspicion is high - 'time is testicle.' **Bilateral orchiopexy** is mandatory (bell-clapper is bilateral). **Intermittent torsion** is a warning sign requiring elective fixation."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors. Testicular torsion is a **surgical emergency** - delays cost testes. Never give antibiotics for classic torsion, never observe and wait, always fix BOTH testes. Salvage drops from >90% at 6 hours to near 0% at 24 hours. Prior resolved episodes indicate intermittent torsion requiring fixation."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-132", "title": "Adolescent Confidentiality Principles", "domain": "adolescent", "difficulty": "intermediate", "tags": ["confidential care", "minor consent", "reproductive health", "limits to confidentiality", "adolescent confidentiality principles"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old female asks to speak privately about her questions regarding sexual activity.\n\nParents are in the waiting room.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are seeing a 14-year-old female for a routine well visit. After completing the physical exam with her mother present, you inform the family that you'd like to speak with the teen privately for a few minutes - a standard part of the adolescent visit.\n\nThe mother hesitates: \"I don't understand why you need to talk to her alone. We have no secrets in our family.\"\n\n**Adolescent Confidentiality Framework:**\n- **Confidential time** with adolescents is a standard and essential component of well visits\n- This practice is recommended by AAP, AAFP, and ACOG starting at age 11-12\n- **Purpose**: allows teens to discuss sensitive topics (substance use, sexual activity, mental health) without fear of parental discovery\n- Without confidentiality, teens may avoid disclosing risky behaviors or seeking care\n\n**Legal framework for adolescent consent (varies by state):**\n- **Minor consent laws** allow teens to consent for specific services WITHOUT parental permission\n- Commonly covered: STI testing/treatment, contraception, mental health services, substance abuse treatment\n- Some states have specific age thresholds; others allow consent at any age for these services", "question": "How do you respond to this mother's concern about confidential time?", "choices": [{"id": "node-1-choice-a", "text": "Explain that confidential time is a routine part of adolescent care to help teens develop healthcare autonomy, and that you will share any safety concerns", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Framing confidential time as routine and developmental** is the most effective approach. Key communication points: (1) This is a **standard practice** for all adolescent visits, not singling out this family, (2) Purpose is to help teens develop **healthcare autonomy** and practice communicating with providers, (3) You maintain **open communication** with parents about general health, (4) You WILL share concerns about **safety** (suicidal ideation, abuse, danger to others), (5) Research shows teens are more likely to disclose risky behaviors and seek help when confidentiality is assured. This normalizes the practice while addressing parental concerns.", "consequence": "You set appropriate expectations for confidential care.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Tell the mother that confidential time is legally required and she has no choice but to leave", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **minor consent laws** exist, confidential time during routine visits is not legally mandated - it's a **recommended practice**. This adversarial approach will: (1) Damage the therapeutic relationship with the mother, (2) Create conflict that may affect future care, (3) Not explain the PURPOSE of confidential time, (4) Make the mother more suspicious. Parents are partners in adolescent care, and the goal is to help them understand the benefits, not force compliance through legal claims.", "consequence": "The adversarial approach damages trust with the family.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Skip the confidential time since the mother seems uncomfortable, and see if the teen has questions with mom present", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Skipping confidential time undermines adolescent care**. Consider: (1) The teen may have questions she can't ask with mom present (sexual health, substance use, mental health), (2) You're signaling to the teen that her privacy doesn't matter, (3) This sets a precedent that parental discomfort overrides standard care, (4) The mother's hesitation is COMMON - most parents initially resist, but accept when benefits are explained. Your job is to advocate for the teen's confidential care while addressing parental concerns.", "consequence": "The teen loses an essential component of adolescent-centered care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Reassure the mother that you'll tell her everything the teen says during the private conversation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This defeats the entire purpose of confidential time**. If the teen knows everything will be shared: (1) She won't disclose risky behaviors, (2) She may avoid seeking care for sensitive issues, (3) You've essentially made the private time meaningless, (4) This also **misrepresents confidentiality** to the mother - when the teen later learns about confidentiality rights, trust will be damaged. The correct approach is honesty about what IS and IS NOT shared.", "consequence": "False promises undermine the purpose of confidential care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Defer confidential time until the teen is 16, as younger adolescents don't really need privacy from parents", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Confidential care should begin in early adolescence (11-12 years)**. Rationale: (1) Sexual debut, substance experimentation, and mental health issues often begin in **early adolescence**, (2) Building trust and normalizing confidential conversations should start BEFORE sensitive issues arise, (3) A 14-year-old may already be sexually active, using substances, or experiencing depression, (4) AAP recommends confidential screening starting at age 11-12. Waiting until 16 misses critical opportunities for intervention.", "consequence": "Deferring confidential care misses critical early adolescent issues.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Introducing confidential time**: Frame it as routine, not suspicious. Say 'I do this with all my teenage patients' to normalize it. Explain that safety concerns (suicidality, abuse, danger to others) WILL be shared with parents. Most parents accept confidential time when benefits are explained."}, "node-2": {"id": "node-2", "type": "decision", "content": "The mother agrees to wait in the waiting room after you explain the purpose of confidential time. Now alone with the teen, you begin the confidential portion of the visit.\n\n**HEEADSSS Assessment** - structured psychosocial screening for adolescents:\n- **H**ome: living situation, family relationships\n- **E**ducation/Employment: school performance, plans\n- **E**ating: body image, disordered eating\n- **A**ctivities: peers, extracurriculars, screen time\n- **D**rugs: tobacco, alcohol, marijuana, other substances\n- **S**exuality: sexual activity, orientation, contraception, STI risk\n- **S**uicide/depression: mood, self-harm, suicidal thoughts\n- **S**afety: violence, bullying, abuse, seatbelts, guns\n\nDuring your assessment, the teen discloses that she has been sexually active with her 15-year-old boyfriend and wants to know about contraception. She says: \"Please don't tell my mom - she would kill me.\"\n\n**She is not pregnant (LMP 1 week ago), denies coercion, and the relationship sounds age-appropriate.**", "question": "What is the most appropriate response to her request for confidentiality?", "choices": [{"id": "node-2-choice-a", "text": "Reassure her that sexual health information is confidential, provide contraceptive counseling, and encourage her to consider discussing it with her mother when ready", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Reproductive health services are confidential** for adolescents in virtually all states. Key points: (1) **Minor consent laws** specifically protect contraceptive services - parental consent is NOT required, (2) This is a consensual, age-appropriate relationship (14 and 15 years old), so there's no mandatory reporting concern, (3) Providing contraception **without parental knowledge** is both legal and appropriate, (4) **Encouraging** (not requiring) discussion with parents supports family communication, (5) Your role is to provide confidential care while supporting the teen's relationship with her parents. This protects her health AND respects her developing autonomy.", "consequence": "You provide appropriate confidential care while supporting family communication.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Tell her you cannot provide contraception without her mother's permission since she is a minor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is factually wrong** in virtually all US states. Minor consent laws specifically allow adolescents to consent for reproductive health services (contraception, STI testing/treatment, pregnancy care) WITHOUT parental permission. Refusing to provide contraception: (1) Violates her legal rights, (2) Increases risk of unintended pregnancy, (3) May drive her away from healthcare, (4) Is NOT the standard of care. Know your state's minor consent laws.", "consequence": "Refusing confidential contraception violates her rights and increases pregnancy risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Provide contraception but insist she must tell her mother today, or you will tell the mother yourself", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **You cannot compel disclosure** for confidential services. Reproductive health care is protected by minor consent laws. Threatening to tell her mother: (1) Violates confidentiality protections, (2) Is coercive and inappropriate, (3) May prevent her from seeking care in the future, (4) Is NOT required by any safety concern (this is a consensual, age-appropriate relationship). You can ENCOURAGE discussion with parents, but CANNOT mandate it for confidential services.", "consequence": "Threatening to break confidentiality is inappropriate and may deter future care-seeking.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Tell her sexual activity at 14 is illegal and you must report this to child protective services", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Age-of-consent laws vary by state**, and most have **Romeo and Juliet provisions** that exempt consensual activity between similarly-aged teens. A 14-year-old and 15-year-old having consensual sex typically does NOT trigger mandatory reporting. Key considerations: (1) Both are minors of similar age, (2) There's no coercion or power differential, (3) Mandatory reporting is for ABUSE, not consensual peer relationships. Incorrectly threatening legal consequences will destroy trust and deter the teen from seeking care.", "consequence": "Misrepresenting the law destroys trust and deters future care.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Tell her you need to think about whether this can be kept confidential and will let her know at the next visit", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Delaying care is inappropriate** when there's a clear answer. This is straightforward: reproductive health services ARE confidential for adolescents. Delaying: (1) Leaves her without contraception during ongoing sexual activity, (2) Increases unintended pregnancy risk, (3) Suggests you're uncertain about basic confidentiality principles, (4) Creates unnecessary anxiety. If you're genuinely unsure about a confidentiality question, consult resources (AAP, your state medical board) - but this case is clear.", "consequence": "Delay increases pregnancy risk and suggests uncertainty about confidentiality.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Minor consent for reproductive health**: In virtually ALL US states, adolescents can consent for contraception, STI testing/treatment, and pregnancy care WITHOUT parental permission. This is not optional or provider-dependent - it's the law. Know your state's specific regulations."}, "node-3": {"id": "node-3", "type": "decision", "content": "You provide comprehensive contraceptive counseling and the teen chooses to start oral contraceptive pills. She's relieved that this can remain confidential.\n\nAs you're wrapping up the visit, she mentions: \"Sometimes I feel really sad and I've thought about hurting myself. But it's not a big deal.\"\n\n**She describes:**\n- Feeling sad \"most days\" for the past 2 months\n- Occasional passive suicidal ideation: \"Sometimes I think everyone would be better off without me\"\n- No specific plan, no intent to act, no access to lethal means\n- No history of self-harm or suicide attempts\n- Sleep and appetite changes consistent with depression\n\n**This disclosure changes the confidentiality equation.**", "question": "How do you handle this disclosure regarding suicidal ideation?", "choices": [{"id": "node-3-choice-a", "text": "Explain that this is a safety concern that requires involving her parents, but offer to help her tell them together and frame it supportively", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Suicidal ideation requires breaking confidentiality**, but HOW you do it matters enormously. Best approach: (1) **Acknowledge her trust** in sharing this with you, (2) Explain that safety concerns REQUIRE involving parents - you discussed this limit at the start, (3) **Offer to help** facilitate the conversation with parents, (4) Frame it as getting her SUPPORT, not getting in trouble, (5) Involve parents in safety planning and mental health follow-up. Breaking confidentiality for safety should be **transparent, supportive, and collaborative** - not punitive. The goal is to get the teen help while preserving as much trust as possible.", "consequence": "You appropriately break confidentiality while supporting the teen and family.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Keep this confidential since she says it's 'not a big deal' and doesn't have a specific plan", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Suicidal ideation ALWAYS requires action**, even without a specific plan. Key points: (1) Adolescents often minimize symptoms (\"not a big deal\"), (2) Passive SI (\"everyone would be better off\") is still a significant risk factor, (3) Adolescent suicide can be impulsive - lack of plan today doesn't mean safety tomorrow, (4) Depression symptoms (2 months of sadness, sleep/appetite changes) require intervention, (5) **Parents need to know** for safety monitoring and treatment engagement. Keeping this confidential could be fatal.", "consequence": "Failing to act on suicidal ideation puts the teen at risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Immediately call the mother into the room and tell her everything the teen disclosed during the confidential portion", "isOptimal": false, "isAcceptable": false, "feedback": "Partially correct but poorly executed. **Yes, parents need to be informed about suicidal ideation**. However, this approach: (1) **Breaches trust about sexual activity** which IS confidential, (2) May include contraceptive discussion that should remain private, (3) Doesn't give the teen any agency in how disclosure happens, (4) Feels like a betrayal rather than support. The CORRECT approach: involve parents specifically about the SAFETY concern (suicidal ideation/depression), while maintaining confidentiality about reproductive health. Break confidentiality narrowly for the specific safety issue.", "consequence": "Breaking confidentiality too broadly damages trust and inappropriately discloses reproductive health information.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Tell her she must promise not to hurt herself before you can let her leave, then schedule a follow-up in 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **'No-suicide contracts' are NOT evidence-based** and do not prevent suicide. This approach is inadequate: (1) No evidence that verbal contracts reduce suicide risk, (2) 2-week follow-up is too delayed for active suicidal ideation, (3) Parents are NOT informed for safety monitoring, (4) No mental health referral or safety planning, (5) Teen goes home with depression and SI without intervention. She needs SAME-DAY safety planning with parental involvement and urgent mental health follow-up.", "consequence": "Inadequate response to suicidal ideation leaves the teen at risk.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Call 911 to have her transported to the emergency department for psychiatric evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is an overreaction** to the current presentation. While suicidal ideation requires action, consider: (1) She has passive SI without plan, intent, or access to means, (2) No history of attempts or self-harm, (3) She's communicating openly and help-seeking, (4) This is **low-to-moderate risk**, not imminent danger. Appropriate response: same-day safety planning with parents, means restriction counseling, urgent (not emergent) mental health referral. Calling 911 may traumatize the teen, damage trust, and isn't indicated for this risk level.", "consequence": "Overreaction to low-to-moderate risk may traumatize the teen and damage trust.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Confidentiality limits**: Always break confidentiality for danger to self (suicidal ideation, self-harm), danger to others (homicidal ideation), and suspected abuse. When breaking confidentiality, be TRANSPARENT ('I have to tell your parents because this is a safety concern'), SUPPORTIVE ('Let me help you tell them'), and NARROW (share only the safety concern, not all confidential information)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You navigated the complex landscape of adolescent confidentiality appropriately, protecting confidential services while recognizing when safety concerns require parental involvement.\n\n**Key teaching points:**\n\n**Confidential time:**\n- Standard part of adolescent visits starting at age 11-12\n- Frame as routine and developmental, not suspicious\n- Explain both the protections AND the limits upfront\n\n**Minor consent laws:**\n- Allow adolescents to consent for reproductive health (contraception, STI care), mental health, and substance treatment without parental permission\n- Varies by state - know your regulations\n- This is LAW, not optional provider discretion\n\n**Limits to confidentiality (must break):**\n- Danger to self (suicidal ideation, self-harm)\n- Danger to others (homicidal ideation)\n- Suspected abuse or neglect\n- Court orders\n\n**Breaking confidentiality well:**\n- Be transparent: explain WHY you must involve parents\n- Be supportive: offer to facilitate the conversation\n- Be narrow: share only the safety concern, not all confidential information\n- Frame as getting help, not punishment\n\n**HEEADSSS assessment**: Use this structured tool for comprehensive adolescent psychosocial screening at every visit."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of adolescent confidentiality:\n\n**What IS confidential:**\n- Reproductive health services (contraception, STI testing/treatment)\n- Mental health services (in most states)\n- Substance abuse treatment\n- General health discussions\n\n**What is NOT confidential (must break):**\n- Danger to self (suicidal ideation, self-harm)\n- Danger to others (homicidal ideation)\n- Suspected abuse or neglect\n\n**Breaking confidentiality appropriately:**\n- Be transparent about why\n- Share only what's needed for safety\n- Support the teen through the disclosure\n- Don't break confidentiality more broadly than necessary\n\n**Common mistakes:**\n- Skipping confidential time due to parental resistance\n- Refusing confidential services due to age\n- Keeping suicidal ideation confidential\n- Breaking confidentiality too broadly"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical principles of adolescent confidentiality:\n\n**Legal protections for adolescent confidentiality:**\n- Minor consent laws allow teens to consent for reproductive health, mental health, and substance treatment WITHOUT parental permission\n- This is the LAW, not optional\n- Refusing confidential services violates the teen's rights and may cause harm\n\n**Confidentiality builds trust:**\n- Without confidentiality, teens won't disclose risky behaviors\n- They may avoid seeking care for sensitive issues\n- This leads to worse health outcomes\n\n**Safety exceptions require action:**\n- Suicidal ideation ALWAYS requires parental involvement and safety planning\n- 'No-suicide contracts' are NOT effective\n- Passive SI (without plan) still requires intervention\n\n**Key errors to avoid:**\n- Telling teens everything will be shared with parents (false)\n- Refusing contraception to minors (violates law)\n- Keeping suicidal ideation confidential (dangerous)\n- Breaking confidentiality punitively rather than supportively"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-133", "title": "Complementary/Alternative Medicine Counseling", "domain": "adolescent", "difficulty": "intermediate", "tags": ["non-judgmental approach", "assess for harm", "do not delay conventional treatment", "find common ground", "complementary/alternative medicine counseling"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 14-year-old male is brought for a checkup, and his parents mention they are using herbal supplements for his chronic condition.\n\nChild is also receiving conventional treatment but parents are questioning its necessity.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You are seeing a 14-year-old male with moderate persistent asthma for a routine follow-up. He's been on an inhaled corticosteroid (ICS) controller and albuterol rescue inhaler with good control - no ED visits or hospitalizations in 18 months.\n\nHis mother mentions: \"We've been reading about the long-term effects of steroids. We started him on an herbal supplement called 'Lung Clear' that we found online. It's all-natural, so it should be safer. We're thinking of stopping the steroid inhaler.\"\n\n**Complementary and Alternative Medicine (CAM) Statistics:**\n- **~12% of children** in the US use some form of CAM\n- **Higher rates** in children with chronic conditions (asthma, ADHD, autism)\n- Common CAM modalities: herbal supplements, vitamins, chiropractic, acupuncture, homeopathy\n- **Families often don't disclose** CAM use unless specifically asked\n\n**Key Regulatory Concerns:**\n- Herbal supplements are **NOT regulated by FDA** like prescription medications\n- No requirement for **safety testing** or **efficacy data** before sale\n- **Contamination** with heavy metals, pesticides, or undisclosed pharmaceuticals is documented\n- **'Natural' does NOT mean safe** - many toxic substances are natural (arsenic, hemlock, etc.)", "question": "What is the most appropriate initial response to this family's disclosure about CAM use?", "choices": [{"id": "node-1-choice-a", "text": "Thank them for sharing, ask what they hope the supplement will do, and express interest in understanding their concerns about the steroid inhaler", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **A non-judgmental, curious approach** is essential for productive CAM counseling. Key communication principles: (1) **Thank them for disclosure** - many families hide CAM use, fearing judgment, (2) **Explore their goals and concerns** - understanding their perspective helps you address specific worries, (3) **Don't immediately dismiss** - this shuts down dialogue, (4) **Find common ground** - you both want the child to be healthy. This approach maintains therapeutic alliance while opening the door for education and safety discussions.", "consequence": "You establish rapport and open productive dialogue about CAM use.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Tell them that herbal supplements are unproven and they should stop the 'Lung Clear' immediately and continue the prescribed treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While your concerns about the supplement may be valid, **this dismissive approach damages trust**. Likely outcomes: (1) Parents feel judged and defensive, (2) They may stop disclosing CAM use in the future, (3) They may stop the ICS anyway but not tell you, (4) You lose the opportunity to educate them. The goal is therapeutic alliance, not \"winning.\" A confrontational approach rarely changes minds and often backfires.", "consequence": "The dismissive approach damages trust and may lead to non-disclosure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Warn them that stopping the inhaled steroid could lead to severe asthma attacks, hospitalization, or death", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the risks are real, **leading with fear tactics** is counterproductive. This approach: (1) May be perceived as dismissive of their concerns, (2) Can trigger reactance (doubling down on their position), (3) Doesn't address WHY they want to try alternatives, (4) Doesn't explore the supplement's potential risks or benefits. Fear-based messaging works poorly for behavior change. Start with understanding, then provide balanced information.", "consequence": "Fear-based messaging triggers defensiveness and damages rapport.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Say you don't know enough about herbal supplements to comment and suggest they ask a naturopath instead", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Pediatricians should engage with CAM questions**, not deflect them. Problems with this approach: (1) You're the medical home - these conversations belong here, (2) Naturopaths may encourage discontinuing evidence-based treatment, (3) You miss opportunity for safety counseling, (4) It signals you're not interested in the family's concerns. You don't need to be a CAM expert to discuss safety principles and help families make informed decisions.", "consequence": "Deflecting the question abdicates your role and may lead to unsafe decisions.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Document 'parental non-compliance' and discuss involving child protective services due to medical neglect", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is a massive overreaction**. The family: (1) Is CONTINUING conventional treatment (has not stopped ICS), (2) Is openly discussing their thinking with you, (3) Has not harmed the child, (4) Is acting out of concern for the child's welfare. Exploring CAM is NOT medical neglect. CPS involvement would destroy the therapeutic relationship and is completely inappropriate here. Medical neglect applies to refusing essential treatment when a child is in danger - this situation is nowhere near that threshold.", "consequence": "Threatening CPS for CAM interest is inappropriate and destroys the therapeutic relationship.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Non-judgmental CAM counseling**: Thank families for disclosing CAM use. Ask open-ended questions: 'What are you hoping this will do?' 'What concerns do you have about the current treatment?' Understanding their perspective allows you to address specific concerns and find common ground."}, "node-2": {"id": "node-2", "type": "decision", "content": "You thank the family for sharing and ask about their concerns with the inhaled steroid. The mother explains:\n\n\"We've read that long-term steroids can affect his growth and cause adrenal problems. The 'Lung Clear' supplement has natural anti-inflammatory herbs, and the website has testimonials from other asthma patients who stopped their inhalers.\"\n\n**You need to address their specific concerns while providing accurate information.**\n\n**Facts about ICS and growth:**\n- ICS can cause **small reduction in growth velocity** (0.5-1 cm in first year)\n- Effect is **dose-dependent** and diminishes over time\n- **Final adult height** is minimally affected (~1 cm reduction)\n- **Uncontrolled asthma ALSO impairs growth** - often more than ICS\n\n**Facts about ICS and adrenal function:**\n- At standard doses, **clinically significant adrenal suppression is rare**\n- Risk increases with high doses, oral steroids, or multiple steroid sources\n- Benefits of asthma control typically outweigh these small risks\n\n**Supplement concerns:**\n- Testimonials are **not evidence** - placebo effect, natural disease fluctuation, selection bias\n- 'Natural anti-inflammatory herbs' may not have any proven effect on airway inflammation\n- **Contamination** is a real risk with unregulated supplements", "question": "How do you address their concerns about the inhaled steroid and the supplement?", "choices": [{"id": "node-2-choice-a", "text": "Acknowledge their concerns are understandable, explain the actual data on ICS and growth (minimal impact), and discuss the lack of regulation and evidence for the supplement", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Balanced, evidence-based counseling** addresses concerns without dismissing them. Key approach: (1) **Validate the concern** - 'It makes sense to worry about medications your child takes long-term,' (2) **Provide accurate data** - growth effect is small (~1 cm), dose-dependent, and uncontrolled asthma also impairs growth, (3) **Explain supplement concerns** - no FDA regulation, no required safety testing, contamination risks, testimonials \u2260 evidence, (4) **Don't demand they stop** - provide information and let them decide, (5) **Emphasize shared goal** - you both want him healthy with minimal medication burden.", "consequence": "You provide balanced information that respects their autonomy while ensuring safety.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Dismiss their growth concerns as internet misinformation and tell them the supplement is probably just an expensive placebo", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Their growth concerns are **actually based on real data** - ICS CAN affect growth velocity. Dismissing this as \"misinformation\" is: (1) Factually incorrect, (2) Condescending, (3) Likely to erode trust when they learn the data exists. A better approach acknowledges the real (but small) growth effect while putting it in context. Similarly, while the supplement may be ineffective, calling it a \"placebo\" dismisses their perspective without educating them.", "consequence": "Dismissing valid concerns as misinformation damages credibility and trust.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "Suggest they try stopping the inhaled steroid and using only the supplement for a month to see if it works", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This puts the child at significant risk**. Stopping ICS in a patient with moderate persistent asthma: (1) Increases risk of exacerbation within 1-4 weeks, (2) Could lead to hospitalization or life-threatening attack, (3) Is NOT a safe 'experiment,' (4) Contradicts evidence-based asthma guidelines. You cannot ethically suggest discontinuing proven treatment to trial an unproven supplement. Patient safety must be maintained even while respecting family preferences.", "consequence": "Stopping evidence-based treatment puts the child at risk of severe exacerbation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Tell them you refuse to see him as a patient if they stop the inhaled steroid", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Threatening to discharge the patient is inappropriate** and counterproductive. This approach: (1) Abandons the patient when they most need guidance, (2) Is coercive and damages trust, (3) Won't change their minds - they'll just find another provider, (4) Removes your ability to monitor for harm. The therapeutic relationship should be preserved even when families make decisions you disagree with. Continue to provide care, monitor closely, and keep the door open for ongoing dialogue.", "consequence": "Threatening discharge abandons the patient and destroys the therapeutic relationship.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Agree that steroids are harmful and suggest they switch to only using albuterol as needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is medically inappropriate** for moderate persistent asthma. Albuterol-only treatment: (1) Provides no anti-inflammatory control, (2) Leads to airway remodeling over time, (3) Increases risk of exacerbations, (4) Is below standard of care for this severity. You should not sacrifice evidence-based medicine to please families. The goal is to find common ground within safe parameters, not to abandon medical standards.", "consequence": "Albuterol-only treatment is inappropriate for moderate persistent asthma.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Addressing steroid fears**: ICS growth effects are real but SMALL (~1 cm final height reduction). Put this in context: uncontrolled asthma ALSO impairs growth, and severe exacerbations requiring oral steroids are more problematic. Help families understand the risk-benefit ratio rather than dismissing their concerns."}, "node-3": {"id": "node-3", "type": "decision", "content": "The family appreciates your balanced explanation. They understand that the growth effect is smaller than they thought and that the supplement isn't regulated.\n\nHowever, they're still interested in reducing his medication burden. The mother asks: \"Is there ANY way we could try lowering his dose or using fewer medications? He's been stable for over a year.\"\n\n**This is a reasonable question for a patient with well-controlled asthma.**\n\n**Step-down therapy in asthma:**\n- Guideline-recommended for patients with **well-controlled asthma for \u22653 months**\n- Goal: find the **minimum effective dose** to maintain control\n- Options: reduce ICS dose, reduce frequency, or trial discontinuation in mild persistent asthma\n- Should be done with **close monitoring** for loss of control\n\n**Key principles for finding common ground:**\n- **Don't make CAM an either/or** - families can use CAM alongside (not instead of) proven treatment\n- **Support informed decision-making** - provide information, respect autonomy\n- **Keep the door open** - if they do make choices you disagree with, continue to provide care and monitor", "question": "How do you respond to their request to reduce medications?", "choices": [{"id": "node-3-choice-a", "text": "Agree that step-down therapy is reasonable for well-controlled asthma, offer to try a lower ICS dose with close monitoring, and suggest they can continue the supplement if they wish", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Finding common ground** preserves the therapeutic alliance while maintaining safety. This approach: (1) **Validates their goal** - wanting to minimize medication is reasonable, (2) **Offers guideline-based step-down** - appropriate for well-controlled asthma, (3) **Maintains essential treatment** - ICS continues at a lower dose, not stopped, (4) **Allows supplement continuation** - if they want to use it alongside (not instead of) proven treatment, that's acceptable, (5) **Includes monitoring** - close follow-up ensures safety. You've achieved adherence to evidence-based treatment while respecting family preferences.", "consequence": "You achieve the ideal outcome: continued ICS therapy with a plan families accept.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Tell them the current regimen is non-negotiable since asthma is a serious disease", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Step-down therapy IS guideline-recommended** for well-controlled asthma. Refusing to consider it: (1) Ignores asthma guidelines that support step-down, (2) Doesn't align with \"minimum effective dose\" principles, (3) May lead to treatment fatigue and non-adherence, (4) Misses an opportunity to find common ground. Being inflexible about a regimen when adjustment is medically appropriate is not good practice.", "consequence": "Refusing guideline-supported step-down is inflexible and may lead to non-adherence.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Suggest they try stopping all asthma medications and using the herbal supplement exclusively since he's been stable", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Stability ON medication doesn't mean medication isn't needed**. This is a common misconception. Asthma requires ongoing controller therapy - stopping ICS in moderate persistent asthma will likely lead to: (1) Increased symptoms within weeks, (2) Risk of exacerbation, (3) Airway remodeling. Herbal supplements have NO proven efficacy for asthma control. You cannot recommend substituting unproven treatment for proven treatment.", "consequence": "Stopping ICS puts the child at risk, regardless of current stability.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Tell them you'll only consider medication changes if they agree to stop the herbal supplement first", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Making step-down contingent on stopping the supplement** is unnecessary and adversarial. The supplement: (1) Is unlikely to be harmful if it's truly just herbs (though you should research the specific product), (2) Can coexist with evidence-based treatment, (3) Is the family's choice. Using medication adjustments as leverage to control CAM use damages trust. If the supplement is genuinely dangerous, address that directly. Otherwise, allow them to use it alongside proven treatment.", "consequence": "Using medication adjustments as leverage against CAM use damages trust.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Recommend they see a pulmonologist for any medication changes since you're not comfortable managing this", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. **Pulmonology referral is appropriate for complex cases**, but routine step-down in well-controlled asthma can typically be managed by the primary care provider. This referral: (1) May delay appropriate care, (2) Suggests discomfort with standard asthma management, (3) Is reasonable if the asthma is truly complex or if you want specialist input on the medication reduction plan. However, for straightforward step-down therapy, primary care management is appropriate.", "consequence": "Referral is acceptable but may delay straightforward step-down therapy.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Finding common ground with CAM**: The goal is NOT to 'win' or eliminate CAM use. If families want to use supplements ALONGSIDE evidence-based treatment, that's often acceptable. Focus on: (1) Maintaining essential treatment, (2) Ensuring safety, (3) Respecting autonomy, (4) Keeping communication open. A family who feels heard is more likely to follow your recommendations."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You navigated CAM counseling using a non-judgmental, evidence-based approach that maintained the therapeutic alliance while ensuring patient safety.\n\n**Key teaching points:**\n\n**Initial approach:**\n- Thank families for disclosing CAM use (many hide it fearing judgment)\n- Ask open-ended questions: 'What are you hoping this will do?'\n- Understand their concerns before providing information\n\n**Key CAM facts to share:**\n- Supplements are NOT regulated by FDA like prescription drugs\n- No required safety testing or efficacy data before sale\n- 'Natural' does NOT mean safe\n- Testimonials are not evidence\n\n**Addressing medication concerns:**\n- Validate concerns rather than dismissing them\n- Provide accurate data (ICS growth effects are real but small)\n- Put risks in context (uncontrolled asthma also impairs growth)\n\n**Finding common ground:**\n- Offer guideline-supported adjustments (step-down therapy for well-controlled asthma)\n- Allow CAM use alongside (not instead of) proven treatment when safe\n- Maintain essential treatment while respecting family preferences\n- Keep communication open for ongoing dialogue\n\n**The goal is therapeutic alliance, not winning an argument.**"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key principles of CAM counseling:\n\n**Non-judgmental communication:**\n- Thank families for disclosing CAM use\n- Ask about their goals and concerns\n- Avoid dismissive or condescending responses\n\n**Evidence-based information:**\n- Explain supplement regulation (no FDA oversight)\n- Provide accurate data on conventional treatment risks\n- Put risks in context\n\n**Finding common ground:**\n- Don't make it CAM vs. conventional medicine\n- Offer acceptable alternatives within safe parameters\n- Allow CAM alongside (not instead of) proven treatment\n\n**Common mistakes:**\n- Dismissing concerns as 'misinformation'\n- Using fear tactics as primary approach\n- Refusing any medication adjustments\n- Making evidence-based treatment contingent on stopping CAM"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates critical principles of CAM counseling:\n\n**Therapeutic alliance is essential:**\n- Dismissive, judgmental, or confrontational approaches damage trust\n- Families who feel judged stop disclosing CAM use\n- You lose the opportunity to ensure safety\n\n**What NOT to do:**\n- Dismiss concerns without providing information\n- Use fear tactics as the primary approach\n- Threaten to discharge the patient\n- Suggest stopping evidence-based treatment to trial CAM\n- Agree that proven medications are harmful to appease families\n\n**Patient safety must be maintained:**\n- Cannot recommend stopping ICS for unproven supplement\n- Must address genuinely dangerous CAM practices directly\n- Stability on medication doesn't mean medication isn't needed\n\n**The goal is finding common ground within safe parameters, not winning an argument or completely controlling family choices.**"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-139", "title": "Slipped Capital Femoral Epiphysis (SCFE)", "domain": "adolescent", "difficulty": "advanced", "tags": ["obese adolescent", "hip pain", "externally rotated leg", "ice cream cone falling off the cone", "slipped capital femoral epiphysis (scfe)", "Klein's line", "in situ pinning", "avascular necrosis"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 13-year-old male is brought to the clinic by his mother for left hip pain and limping for the past 3 weeks.\n\nThe pain started gradually and has been getting worse. He now limps noticeably. He reports that his left knee also hurts, though he never injured it. The pain is worse with activity and improves with rest.\n\nPast medical history reveals he has gained 25 pounds over the past year. He denies fever, night sweats, recent illness, or trauma.\n\nPhysical Examination:\n- General: obese adolescent male, BMI 32 (>99th percentile)\n- Gait: antalgic gait favoring left leg\n- Left hip: limited internal rotation (10\u00b0 vs normal 35\u00b0), when hip is flexed the leg obligatorily externally rotates\n- Right hip: full range of motion\n- Left knee: non-tender, full ROM, no effusion\n- Vitals: afebrile, HR 76, BP 118/72", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This obese 13-year-old male has insidious hip pain with referred knee pain, antalgic gait, and the pathognomonic finding of **obligate external rotation when the hip is flexed** (Drehmann sign). Internal rotation is markedly limited.", "question": "What is the MOST likely diagnosis based on this classic presentation?", "choices": [{"id": "node-1-choice-a", "text": "Slipped Capital Femoral Epiphysis (SCFE) - the classic triad is present", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is textbook **SCFE**: (1) **Obese adolescent** (strongest risk factor), (2) **Hip/groin pain with referred knee pain** (knee pain can be the only symptom!), (3) **Obligate external rotation** when hip is flexed (pathognomonic). The femoral head slips posteriorly and inferiorly off the femoral neck through the weakened physis.", "consequence": "You recognize the classic SCFE presentation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Legg-Calv\u00e9-Perthes disease (avascular necrosis of femoral head)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Legg-Calv\u00e9-Perthes typically affects **younger children (4-8 years)**, who are usually **thin/small for age**, not obese adolescents. Perthes also has insidious onset but lacks the characteristic obligate external rotation. Age and body habitus are key differentiators.", "consequence": "Age group mismatch recognized.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Septic arthritis of the hip", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Septic arthritis presents with: **fever, acute onset, severe pain, inability to bear weight**, and the hip held in flexion/external rotation/abduction (not obligate external rotation with flexion). This patient is **afebrile** with **3-week gradual onset** - septic arthritis would not smolder this long.", "consequence": "Septic arthritis features absent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Transient synovitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Transient synovitis typically follows a **viral illness**, affects **younger children (3-8 years)**, and resolves within **1-2 weeks**. This patient has no recent illness, is an adolescent, and has had symptoms for 3 weeks without improvement. The obligate external rotation is not a feature of synovitis.", "consequence": "Transient synovitis features absent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Primary knee pathology with referred hip symptoms", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - it's actually the **opposite**! Hip pathology commonly refers pain to the **knee** (via obturator nerve), not the reverse. This patient's knee exam is normal while hip exam is markedly abnormal. **Always examine the hip when a child presents with knee pain!**", "consequence": "Referral pattern misunderstood.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SCFE classic presentation**: **Obese adolescent** + hip/groin pain (often with **referred knee pain**) + **obligate external rotation** when hip flexed (Drehmann sign). **Critical teaching**: When a child has knee pain, ALWAYS examine the hip - hip pathology commonly refers to the knee!"}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect SCFE and need to confirm the diagnosis with imaging. You order hip X-rays.", "question": "Which X-ray view is MOST sensitive for detecting SCFE, and what is the classic radiographic finding?", "choices": [{"id": "node-2-choice-a", "text": "Frog-leg lateral view - shows posterior slippage; Klein's line fails to intersect the epiphysis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **frog-leg lateral view** is MORE SENSITIVE than AP for detecting SCFE because the slip is **posterior**. Key findings: (1) **Klein's line** (drawn along superior femoral neck) normally intersects the epiphysis; in SCFE it doesn't. (2) **Widening/irregularity of physis**. (3) **'Ice cream falling off the cone'** appearance. Always get BILATERAL views - 20-40% are bilateral!", "consequence": "X-rays ordered with correct views.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "AP pelvis view alone is sufficient for diagnosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. AP view can **miss early or mild SCFE** because the slip is **posterior** (out of the AP plane). Up to **40% of SCFE cases are missed** on AP alone. **Frog-leg lateral is essential** for adequate sensitivity. Always obtain both views, plus image the contralateral hip.", "consequence": "Early SCFE potentially missed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "MRI is required for diagnosis - X-rays are not reliable", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Plain X-rays (AP + frog-leg lateral) are the gold standard** for diagnosing SCFE and are highly reliable. MRI is rarely needed except in: (1) very early/pre-slip SCFE (widened physis only), (2) evaluating for avascular necrosis complications. Don't delay diagnosis waiting for MRI when X-rays are diagnostic.", "consequence": "Unnecessary MRI delays diagnosis.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "CT scan is the imaging modality of choice", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. CT is NOT first-line for SCFE diagnosis due to **radiation exposure** and lack of additional benefit over plain films in typical cases. X-rays are diagnostic in most cases. CT may have a limited role in surgical planning or complex cases but is not the primary diagnostic modality.", "consequence": "Unnecessary radiation exposure.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Only the symptomatic hip needs imaging", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **ALWAYS image BOTH hips!** SCFE is **bilateral in 20-40% of cases**, and the contralateral side may be asymptomatic initially. Missing a contralateral slip can lead to delayed diagnosis and worse outcomes. Bilateral imaging is standard of care.", "consequence": "Contralateral SCFE potentially missed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SCFE imaging**: **Frog-leg lateral > AP** (slip is posterior). **Klein's line**: draw along superior femoral neck - should intersect epiphysis (doesn't in SCFE). **'Ice cream falling off the cone'** appearance. **ALWAYS image BOTH hips** - 20-40% bilateral. Metaphyseal blanch sign = early SCFE on AP."}, "node-3": {"id": "node-3", "type": "decision", "content": "X-rays show:\n- Left hip: Klein's line does not intersect the epiphysis, posterior/inferior displacement of femoral head, widened physis\n- Right hip: Klein's line normal, no slippage\n\nThe patient is able to bear weight with crutches (though painful).\n\nYou need to classify the SCFE to guide urgency of treatment.", "question": "How is SCFE classified, and what determines urgency of surgical intervention?", "choices": [{"id": "node-3-choice-a", "text": "Stable vs Unstable - based on ability to bear weight; unstable SCFE requires emergent surgery due to high AVN risk", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Stable SCFE**: patient CAN bear weight (with or without crutches) - urgent surgery within 24-48h. **Unstable SCFE**: patient CANNOT bear weight at all - **EMERGENT surgery** because **avascular necrosis (AVN) risk is 50%** (vs <10% in stable). This patient has **stable SCFE** since he can bear weight with crutches.", "consequence": "SCFE correctly classified as stable.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Mild, moderate, severe - based on degree of slippage angle; all require same urgency", "isOptimal": false, "isAcceptable": true, "feedback": "Slippage angle grading (mild <30\u00b0, moderate 30-50\u00b0, severe >50\u00b0) exists but is **less clinically useful** than the stable/unstable classification for determining urgency. The **ability to bear weight** is the critical factor that determines AVN risk and surgical urgency, not the angle alone.", "consequence": "Classification understood but urgency determination incomplete.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "Acute vs chronic - based on symptom duration; acute requires emergent surgery", "isOptimal": false, "isAcceptable": true, "feedback": "Acute (<3 weeks) vs chronic (>3 weeks) vs acute-on-chronic classifications exist, but the **stable vs unstable** classification is MORE important for determining surgical urgency and predicting AVN risk. A chronic SCFE can be unstable (acute worsening), and that unstable status drives emergent treatment.", "consequence": "Classification terminology correct but incomplete.", "nextNodeId": "node-4"}, {"id": "node-3-choice-d", "text": "All SCFE is emergent regardless of classification", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While all SCFE requires **urgent** treatment, the timing differs significantly. **Stable SCFE**: urgent (24-48h). **Unstable SCFE**: **emergent (same day)** due to 50% AVN risk. Treating all cases as equally emergent would waste OR resources and isn't supported by evidence.", "consequence": "Resource allocation not optimized.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Classification is based on patient age - younger patients need emergent surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Age affects SCFE risk (peak 10-16 years) but does NOT determine surgical urgency. The **ability to bear weight** (stable vs unstable) is the critical factor. A 12-year-old with stable SCFE and a 14-year-old with stable SCFE have the same urgency.", "consequence": "Incorrect urgency determination.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SCFE classification**: **Stable** = can bear weight \u2192 urgent surgery (24-48h), AVN risk <10%. **Unstable** = CANNOT bear weight \u2192 **EMERGENT surgery (same day)**, AVN risk **~50%**. This is the MOST important classification! Also classify: mild/moderate/severe (angle), acute/chronic/acute-on-chronic (duration)."}, "node-4": {"id": "node-4", "type": "decision", "content": "You diagnose stable SCFE. The patient is made non-weight bearing on the affected leg and orthopedic surgery is consulted urgently.\n\nThe orthopedic surgeon discusses the surgical plan with the family.", "question": "What is the surgical treatment for STABLE SCFE?", "choices": [{"id": "node-4-choice-a", "text": "In situ percutaneous screw fixation - pin the femoral head in its current position without attempting reduction", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **In situ pinning** (single cannulated screw across the physis into the epiphysis) is the standard treatment for **stable SCFE**. The key principle is **NO manipulation/reduction** - attempting to reduce the slip damages the blood supply and dramatically increases AVN risk. The screw prevents further slippage while the physis fuses.", "consequence": "Appropriate surgical plan made.", "nextNodeId": "node-5"}, {"id": "node-4-choice-b", "text": "Closed reduction followed by screw fixation", "isOptimal": false, "isAcceptable": false, "feedback": "**DANGEROUS!** Closed reduction is **contraindicated** in stable SCFE because manipulating the femoral head disrupts the **precarious blood supply** (retinacular vessels), dramatically increasing **AVN risk** from <10% to potentially 50%+. The mantra is: **'Pin it where it lies'** - no reduction attempts.", "consequence": "Avascular necrosis from reduction attempt.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "Hip spica cast immobilization without surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Casting alone is inadequate** treatment for SCFE. Without surgical fixation, the slip can progress, and prolonged immobilization leads to muscle atrophy, joint stiffness, and doesn't address the underlying mechanical instability. **Surgical pinning is the standard of care**.", "consequence": "Slip progresses despite casting.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-d", "text": "Total hip replacement", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Total hip replacement is **not appropriate** for adolescents with SCFE. Hip replacement is reserved for end-stage arthritis in adults, not acute SCFE in children. The goal is to preserve the native hip with pinning. Hip replacement would only be considered decades later if severe arthritis develops.", "consequence": "Inappropriate surgical procedure.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Open reduction and femoral osteotomy for all cases", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Open reduction and osteotomy are reserved for **severe, chronic SCFE** with significant deformity or for correcting residual deformity AFTER physeal closure. For typical stable SCFE, these aggressive procedures carry higher complication rates than in situ pinning. The principle is: **least intervention that prevents further slip**.", "consequence": "Unnecessarily aggressive surgery.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SCFE surgical principle**: **'Pin it where it lies!'** - NO reduction attempts (damages blood supply \u2192 AVN). **In situ percutaneous screw fixation** is standard for stable SCFE. Single screw across physis prevents further slip while allowing physeal fusion. More aggressive procedures (osteotomy) reserved for severe/chronic cases."}, "node-5": {"id": "node-5", "type": "decision", "content": "Surgery is performed successfully. The family asks about the prognosis and what to watch for going forward.\n\nYou discuss long-term considerations.", "question": "What are the key long-term considerations and complications to monitor after SCFE treatment?", "choices": [{"id": "node-5-choice-a", "text": "Monitor contralateral hip (20-40% bilateral risk), watch for AVN and chondrolysis, consider endocrine workup in atypical patients", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! Key follow-up: (1) **Contralateral hip**: 20-40% develop bilateral SCFE (prophylactic pinning controversial). (2) **AVN** (avascular necrosis): may occur months after treatment - presents with increased pain; MRI confirms. (3) **Chondrolysis**: cartilage destruction, presents with stiffness. (4) **Endocrine screening** if atypical (young, thin, short) - hypothyroidism, GH deficiency, hypogonadism.", "consequence": "Comprehensive follow-up plan established.", "nextNodeId": "node-outcome-good"}, {"id": "node-5-choice-b", "text": "No follow-up needed after successful surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Long-term follow-up is essential**. Complications (AVN, chondrolysis) may develop **months after surgery**. The **contralateral hip** must be monitored (20-40% bilateral risk). Weight management and activity guidance are ongoing needs. Premature discharge from care risks missing serious complications.", "consequence": "Complications missed without follow-up.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-c", "text": "The opposite hip is not at risk once one side is treated", "isOptimal": false, "isAcceptable": false, "feedback": "**Dangerously incorrect!** The contralateral hip has **20-40% risk of SCFE**, especially in patients with: endocrine disorders, younger age, open physis. Some surgeons advocate **prophylactic pinning** of the contralateral hip, especially in high-risk patients. At minimum, close monitoring with repeat imaging is essential.", "consequence": "Contralateral SCFE develops unmonitored.", "nextNodeId": "node-outcome-bad"}, {"id": "node-5-choice-d", "text": "Full unrestricted activity immediately after surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Post-operative activity restrictions are essential: (1) **Protected weight bearing** initially, (2) **Avoid high-impact activities** until physeal closure, (3) Physical therapy for ROM and strengthening. Premature return to full activity risks hardware failure, further slippage, or falls.", "consequence": "Complications from premature activity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-5-choice-e", "text": "Weight loss has no impact on outcomes after treatment", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Weight management is important** after SCFE treatment: (1) Reduces stress on the treated hip, (2) May reduce contralateral SCFE risk, (3) Decreases long-term osteoarthritis risk, (4) Addresses underlying metabolic health. Lifestyle counseling should be part of comprehensive SCFE care.", "consequence": "Missed opportunity for prevention.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**SCFE long-term**: (1) **Contralateral hip** - 20-40% bilateral risk, prophylactic pinning controversial (consider if endocrine disorder, young age). (2) **AVN** - <10% stable, ~50% unstable; presents months later with pain. (3) **Chondrolysis** - rare, causes stiffness. (4) **Endocrine workup** if atypical (thin, short, <10y or >16y) - check TSH, IGF-1, gonadotropins. (5) Long-term: increased **osteoarthritis** risk."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You recognized the classic SCFE presentation, ordered appropriate imaging, correctly classified the stability, understood the surgical principles, and established comprehensive follow-up.\n\n**Key teaching points:**\n\u2022 **Classic presentation**: obese adolescent + hip pain (often referred to knee) + obligate external rotation\n\u2022 **Imaging**: frog-leg lateral > AP; always image BOTH hips (20-40% bilateral)\n\u2022 **Klein's line**: fails to intersect epiphysis in SCFE\n\u2022 **Classification**: Stable (can bear weight) vs Unstable (cannot) - determines urgency and AVN risk\n\u2022 **Treatment**: In situ pinning - 'Pin it where it lies!' NO reduction attempts\n\u2022 **Follow-up**: monitor contralateral hip, watch for AVN/chondrolysis, endocrine workup if atypical"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review SCFE key principles:\n\n\u2022 **Presentation**: obese adolescent + hip/knee pain + obligate external rotation when hip flexed\n\u2022 **Imaging**: FROG-LEG LATERAL most sensitive; always image BOTH hips\n\u2022 **Klein's line**: normally intersects epiphysis; fails to in SCFE\n\u2022 **Stable vs Unstable**: based on ability to bear weight - determines urgency\n\u2022 **Treatment**: IN SITU PINNING - no reduction attempts (AVN risk)\n\u2022 **Follow-up**: contralateral hip (20-40% bilateral), AVN, chondrolysis, endocrine screening"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical management errors occurred. Review dangerous pitfalls:\n\n\u2022 **NEVER attempt closed reduction** in stable SCFE - disrupts blood supply \u2192 AVN\n\u2022 **'Pin it where it lies'** - no manipulation of the femoral head\n\u2022 **Casting alone is inadequate** - surgical fixation is standard of care\n\u2022 **Contralateral hip is at HIGH RISK (20-40%)** - must be monitored\n\u2022 **Unstable SCFE = EMERGENT surgery** due to 50% AVN risk\n\nKey pearl: When a child presents with knee pain, ALWAYS examine the hip - hip pathology commonly refers to the knee. SCFE is an orthopedic emergency that requires prompt recognition and appropriate surgical management."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-141", "title": "Nursemaid's Elbow (Radial Head Subluxation)", "domain": "adolescent", "difficulty": "intermediate", "tags": ["radial head subluxation", "annular ligament", "hyperpronation technique", "supination-flexion", "traction injury", "toddler", "nursemaid's elbow (radial head subluxation)"], "estimatedMinutes": 6, "source": ["NBME"], "stem": "A 2-year-old female is brought to the pediatric urgent care by her father. He reports that about 2 hours ago, his daughter was walking beside him in the parking lot when she suddenly darted toward the street. He instinctively grabbed her right hand and pulled upward to stop her.\n\nSince then, she has been holding her right arm at her side and refuses to use it. She cries when anyone tries to touch or move the arm. She is otherwise well - no fever, no recent illness, no other injuries.\n\nHer father mentions: \"This actually happened once before, about 6 months ago. They did something to her arm in the ER and she was fine right away.\"\n\nPhysical Examination:\n- General: Well-appearing toddler, holding right arm close to body\n- Right arm: Held in slight flexion at elbow with forearm pronated. No swelling, no ecchymosis, no deformity\n- Refuses to reach for toys or use right hand\n- No tenderness over clavicle, shoulder, or wrist\n- Neurovascular exam: Intact radial pulse, brisk capillary refill, moves fingers when distracted", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You recognize the classic presentation of **radial head subluxation** (nursemaid's elbow).\n\n**Radial Head Subluxation - Pathophysiology:**\n- The **annular ligament** normally encircles the radial head, holding it against the ulna\n- In young children, this ligament is loose and weak\n- **Longitudinal traction** on the extended arm causes the radial head to slip partially out from under the annular ligament\n- A portion of the annular ligament becomes **interposed** between the radial head and capitellum\n- This causes pain and the child refuses to use the arm\n\n**Classic Presentation:**\n- **Age**: 1-4 years (peak 2-3 years); rare after age 5 as ligament strengthens\n- **Mechanism**: Sudden pull or jerk on extended arm (swinging child by arms, pulling child up stairs, catching falling child)\n- **Position**: Arm held in **pronation and slight flexion** at the side (\"dead arm\")\n- **No swelling, deformity, or ecchymosis**\n- **Point tenderness absent** or minimal over radial head\n- **Refuses to use arm** but moves fingers normally\n\n**Key Differential Diagnoses:**\n- Supracondylar fracture (swelling, deformity, concerning for vascular injury)\n- Clavicle fracture (tenderness over clavicle, swelling)\n- Buckle fracture of distal radius (fall on outstretched hand, wrist tenderness/swelling)\n- Septic arthritis (fever, joint swelling, ill-appearing)", "question": "Based on the classic history and examination, what is your diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Radial head subluxation (nursemaid's elbow) - classic mechanism and presentation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **textbook radial head subluxation**. Key diagnostic features: (1) **Classic mechanism** - sudden longitudinal traction on extended arm, (2) **Age 2 years** - peak incidence, (3) **Arm held pronated and slightly flexed**, (4) **No swelling, ecchymosis, or deformity**, (5) **Prior episode** - recurrence is common (up to 25%), (6) **Well-appearing** child who simply refuses to use the arm. This clinical picture is so characteristic that **X-rays are NOT needed** before attempting reduction.", "consequence": "You correctly recognize the classic presentation.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Supracondylar fracture - need X-ray before any manipulation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Supracondylar fracture has a different presentation**: (1) **Fall onto outstretched hand (FOOSH)** - not traction injury, (2) **Swelling and ecchymosis** around elbow, (3) **Possible deformity**, (4) **Neurovascular compromise** is a major concern (brachial artery, median/radial nerves). This child has NO swelling, NO deformity, and the mechanism was a pulling injury, not a fall. The clinical picture is classic for nursemaid's elbow, not fracture.", "consequence": "Misdiagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Possible child abuse - the mechanism seems implausible", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This mechanism is completely consistent with accidental injury**. Key points: (1) **Grabbing a child's arm to prevent them from running into traffic** is a normal protective action, (2) **Nursemaid's elbow is one of the most common orthopedic injuries** in toddlers, (3) **The history is consistent** - traction injury \u2192 arm held at side, (4) **No concerning findings** for abuse (no bruises in concerning locations, no pattern injuries, consistent story). While abuse should always be considered, this presentation is classic accidental nursemaid's elbow.", "consequence": "Inappropriate suspicion delays treatment and causes family distress.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Septic arthritis of the elbow - need to rule out infection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Septic arthritis presents very differently**: (1) **Fever and systemic illness**, (2) **Joint swelling, warmth, and erythema**, (3) **Severe pain with ANY movement** of the joint, (4) **Ill-appearing child**, (5) **No history of traction mechanism**. This child is afebrile, well-appearing, has no joint swelling, and has a clear mechanical precipitant. Septic arthritis is not the diagnosis.", "consequence": "Pursuing wrong diagnosis delays appropriate treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Cannot diagnose without X-ray - imaging is required for all arm injuries", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Classic nursemaid's elbow does NOT require X-ray** before reduction. Key principles: (1) **X-rays are NORMAL** in radial head subluxation - there's nothing to see, (2) **Clinical diagnosis is sufficient** with classic history and exam, (3) **Diagnostic reduction** can be both therapeutic and confirmatory, (4) **X-rays indicated only if**: atypical mechanism, significant swelling, point bony tenderness, or failed reduction. Routine X-rays delay treatment and add unnecessary cost/radiation.", "consequence": "Unnecessary imaging delays appropriate treatment.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Classic nursemaid's elbow = clinical diagnosis**. The triad of (1) longitudinal traction mechanism, (2) arm held pronated and flexed, and (3) no swelling/deformity is diagnostic. X-rays are NOT needed before attempting reduction - they will be normal anyway."}, "node-2": {"id": "node-2", "type": "decision", "content": "You explain to the father that this is nursemaid's elbow (radial head subluxation) and that you can reduce it right now without X-rays.\n\n**Reduction Techniques:**\n\nThere are two main techniques, both highly effective:\n\n**1. Hyperpronation Technique (Preferred):**\n- Support the elbow with one hand, thumb over radial head\n- Hold the child's hand as if shaking hands\n- Firmly **hyperpronating** (rotating palm DOWN) in one smooth motion\n- Feel for a \"click\" over the radial head as it reduces\n- **Success rate: 80-95%** on first attempt\n- **Less painful** than supination-flexion\n\n**2. Supination-Flexion Technique:**\n- Support the elbow with one hand, thumb over radial head\n- Hold the child's wrist/hand\n- **Supinate** (rotate palm UP) while simultaneously **flexing** the elbow\n- Feel for a \"click\" over the radial head\n- **Success rate: 70-85%** on first attempt\n- Traditional technique, slightly more painful\n\n**Key Points:**\n- A palpable **\"click\"** is felt in ~70% of successful reductions\n- If no click, may still be reduced - observe for arm use\n- Child should **use arm normally within 15-30 minutes** after successful reduction\n- If still not using arm after 30 minutes, consider repeat attempt or X-ray\n- **Analgesia is NOT typically needed** - reduction is brief", "question": "Which reduction technique do you choose?", "choices": [{"id": "node-2-choice-a", "text": "Hyperpronation technique - higher success rate and less painful", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent choice! **Hyperpronation is the preferred technique** based on evidence. Key advantages: (1) **Higher first-attempt success rate** (80-95% vs 70-85%), (2) **Less painful** for the child, (3) **Simpler motion** - just rotate the forearm, (4) **Equally effective** regardless of provider experience. The technique is straightforward: support the elbow, grasp the hand, and firmly pronate (turn palm down) in one smooth motion. Feel for the click over the radial head.", "consequence": "You choose the most effective technique.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Supination-flexion technique - the traditional approach", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not optimal. **Supination-flexion is effective** and was the traditional technique for decades. However, studies show: (1) **Lower first-attempt success rate** (70-85%) compared to hyperpronation, (2) **More painful** for the child, (3) **Equally effective overall** if multiple attempts allowed. If this technique is more familiar to you, it's reasonable to use - but hyperpronation has become the preferred first-line approach.", "consequence": "Traditional technique, slightly lower success rate.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Wait for X-ray results before attempting any manipulation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **X-rays are not indicated** for classic nursemaid's elbow. Reasons to proceed without imaging: (1) **X-rays will be normal** - subluxation isn't visible radiographically, (2) **Delays treatment** unnecessarily, (3) **Unnecessary radiation and cost**, (4) **The history and exam are diagnostic**. Attempt reduction first; X-ray only if reduction fails or there are atypical features suggesting fracture.", "consequence": "Unnecessary delay in treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Give IV morphine for pain control before attempting reduction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **IV analgesia is NOT typically needed** for nursemaid's elbow reduction. Key points: (1) **Reduction takes 1-2 seconds** - faster than the onset of any analgesic, (2) **Momentary discomfort** followed by immediate relief, (3) **IV access causes more distress** than the reduction itself, (4) **Oral ibuprofen** can be given afterward if needed. Some providers use distraction techniques (bubbles, videos) but pharmacologic sedation is not indicated for this quick procedure.", "consequence": "Unnecessary intervention that delays treatment.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Refer to orthopedics for closed reduction under sedation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Nursemaid's elbow reduction is a primary care/ED procedure** that does not require orthopedic consultation. Key points: (1) **Any trained provider can perform reduction**, (2) **Sedation is not needed** for this quick maneuver, (3) **Orthopedic referral delays treatment** unnecessarily, (4) **Consultation appropriate only if**: multiple failed reduction attempts, concern for fracture, or very late presentation. This is a \"see it, reduce it\" diagnosis that shouldn't require specialty backup.", "consequence": "Unnecessary delay and resource utilization.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Hyperpronation is the preferred technique** - higher success rate (80-95%) and less painful than supination-flexion. No analgesia or sedation is needed. Feel for the \"click\" over the radial head. The child should use the arm normally within 15-30 minutes after successful reduction."}, "node-3": {"id": "node-3", "type": "decision", "content": "You perform the hyperpronation technique:\n\n1. You support her elbow with your left hand, placing your thumb over the radial head\n2. You hold her right hand with your right hand (as if shaking hands)\n3. You firmly hyperpronating her forearm in one smooth motion\n4. You feel a distinct **\"click\"** under your thumb\n\nThe child initially cries briefly but then stops. You offer her a toy.\n\n**After reduction, you observe:**\n- She reaches for the toy with her RIGHT hand\n- She is now using both arms normally\n- No more guarding or crying when the arm is touched\n- Full range of motion at the elbow\n\n**Post-Reduction Assessment:**\n\n**Signs of Successful Reduction:**\n- Palpable \"click\" during maneuver (present in ~70%)\n- Child uses arm normally within 15-30 minutes\n- No guarding or pain with passive movement\n- Able to reach overhead and grasp objects\n\n**If Reduction Appears to Fail:**\n- May retry with same or alternate technique\n- If still not using arm after 2-3 attempts, obtain X-ray\n- Consider alternative diagnosis (occult fracture)\n- May need longer observation - some children take up to 60 minutes\n\n**This reduction was clearly successful** - immediate return to function.", "question": "What do you do now that the reduction is successful?", "choices": [{"id": "node-3-choice-a", "text": "Observe for 15-20 minutes to confirm she continues using the arm, then discharge with anticipatory guidance", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Brief observation followed by discharge** is appropriate after successful reduction. Key components: (1) **Observe 15-20 minutes** - confirm sustained arm use, (2) **No X-ray needed** - reduction was successful, (3) **No immobilization needed** - the arm is functionally normal, (4) **Discharge with education** about recurrence risk and prevention. The immediate return to normal function confirms the diagnosis was correct and reduction was successful.", "consequence": "Appropriate post-reduction care.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Obtain X-ray now to confirm the reduction and rule out any missed injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **X-ray is NOT indicated after successful reduction**. Reasons: (1) **X-rays are normal** in nursemaid's elbow - nothing to confirm, (2) **Clinical success is the only confirmation needed** - she's using the arm, (3) **Unnecessary radiation and cost**, (4) X-ray is only indicated if: reduction fails, atypical features, or concern for occult fracture. The child using her arm normally IS the confirmation that reduction worked.", "consequence": "Unnecessary imaging after clinical success.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Place the arm in a sling for 1-2 weeks to prevent re-injury", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Immobilization is NOT recommended** after nursemaid's elbow reduction. Key points: (1) **The arm is functionally normal** after reduction, (2) **Immobilization serves no purpose** and may delay return to normal activity, (3) **Slings are uncomfortable** for toddlers and rarely stay on, (4) **Normal use is encouraged** immediately. The only intervention is education about avoiding traction mechanisms.", "consequence": "Unnecessary immobilization.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Refer to orthopedics for follow-up in 1-2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Orthopedic follow-up is not needed** after uncomplicated nursemaid's elbow. Key points: (1) **Reduction was successful** - no ongoing issue to follow, (2) **No structural damage occurred** - the ligament is intact, (3) **Routine follow-up wastes resources**, (4) Orthopedic referral only needed if: multiple recurrences raising concern for ligamentous laxity, or reduction repeatedly fails. This was a straightforward case.", "consequence": "Unnecessary specialty referral.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Admit for overnight observation given the history of prior episode", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Hospital admission is never indicated** for uncomplicated nursemaid's elbow. Key points: (1) **Recurrence is common** (up to 25%) but not dangerous, (2) **Reduction can be performed again** if it happens at home, (3) **No complications require monitoring**, (4) **Observation provides no benefit** - once reduced, she's fine. Admission would be inappropriate resource utilization for a benign condition.", "consequence": "Completely unnecessary admission.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Post-reduction care is minimal**: observe 15-20 minutes to confirm arm use, then discharge. No X-ray, no immobilization, no orthopedic follow-up needed for uncomplicated cases. The child using the arm IS the confirmation that reduction was successful."}, "node-4": {"id": "node-4", "type": "decision", "content": "You observe her for 20 minutes. She continues to use both arms normally, reaching for toys, clapping, and allowing you to examine the elbow without distress.\n\nBefore discharge, you need to counsel the family.\n\n**Discharge Education for Nursemaid's Elbow:**\n\n**Recurrence Risk:**\n- **20-25% recurrence rate** in children who have had it once\n- Risk decreases after age 5 as the annular ligament strengthens\n- Having had it twice already, she's at higher risk\n\n**Prevention Strategies:**\n- **Avoid pulling on the hand or wrist** when the arm is extended\n- **Lift under the armpits** instead of by the hands\n- **Be careful with \"swinging\" games** (swinging child by the arms)\n- Warn all caregivers (grandparents, daycare, babysitters)\n\n**What to Do if it Happens Again:**\n- Some parents can be taught to reduce it themselves (controversial)\n- Otherwise, return for repeat reduction\n- It's not dangerous, just uncomfortable for the child\n\n**When to Return:**\n- If child stops using arm again\n- Any swelling, bruising, or deformity\n- Fever or signs of illness", "question": "What key discharge education do you provide?", "choices": [{"id": "node-4-choice-a", "text": "Counsel on prevention (lift under armpits, avoid pulling hands), warn about recurrence risk, advise return if symptoms recur", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Comprehensive discharge education** is essential. Key points to cover: (1) **Prevention strategies** - lift under armpits, don't pull hands/wrists, avoid arm-swinging games, (2) **Recurrence risk** - 20-25%, higher with prior episodes, (3) **Educate ALL caregivers** - dad should tell mom, grandparents, daycare, (4) **Return if symptoms recur** - can be reduced again, (5) **Reassurance** - this is benign, not dangerous, won't cause lasting damage. Written instructions are helpful for reinforcing verbal counseling.", "consequence": "Family educated and prepared for potential recurrence.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Teach the father how to perform the reduction himself for future episodes", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but **controversial**. Some providers teach parents to reduce nursemaid's elbow at home. Arguments for: (1) It's a simple technique, (2) Saves ER visits, (3) Immediate relief for the child. Arguments against: (1) Parents may miss a fracture that mimics nursemaid's elbow, (2) May cause harm with improper technique, (3) Medico-legal concerns. If you choose to teach this, emphasize that they should seek care if: mechanism was a fall (not pulling), any swelling, or reduction doesn't work immediately.", "consequence": "Acceptable approach but requires careful patient selection.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-c", "text": "Tell them to restrict her activity to prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Activity restriction is NOT indicated** for nursemaid's elbow. Key points: (1) **Normal toddler activity doesn't cause nursemaid's elbow** - only traction mechanisms do, (2) **Restricting activity impairs development**, (3) **Prevention focuses on caregiver behavior** (how they hold the child), not child behavior, (4) **She should return to normal activity immediately**. The prevention message is about how adults handle her, not about limiting her play.", "consequence": "Inappropriate and developmentally harmful advice.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Tell them the condition will resolve permanently after this reduction", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is not true** - recurrence is common. Key facts: (1) **20-25% recurrence rate** overall, (2) **Higher with prior episodes** - she's already had it twice, (3) **Risk continues until age ~5** when the ligament strengthens, (4) **Families need realistic expectations**. Telling them it won't happen again sets them up for disappointment and may delay care-seeking when it recurs.", "consequence": "Providing false reassurance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Recommend physical therapy to strengthen the elbow and prevent recurrence", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Physical therapy has no role** in preventing nursemaid's elbow. Key points: (1) **The issue is ligamentous laxity** due to developmental stage, not weakness, (2) **PT cannot accelerate ligament maturation**, (3) **The ligament strengthens naturally** with age, (4) **Prevention is behavioral** (caregiver technique), not therapeutic. Physical therapy would be an inappropriate and wasteful recommendation.", "consequence": "Unnecessary and ineffective recommendation.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Key prevention message**: Lift toddlers under the armpits, not by the hands/wrists. Avoid arm-swinging games. Educate ALL caregivers. Recurrence rate is 20-25% - families should know to return if symptoms recur. The condition resolves naturally after age 5 as the annular ligament strengthens."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed nursemaid's elbow (radial head subluxation) with appropriate technique, observation, and family education.\n\n**Key Teaching Points:**\n\n**Recognition:**\n- **Classic mechanism**: Longitudinal traction on extended arm (pulling, swinging, catching a fall)\n- **Age**: 1-4 years (peak 2-3); rare after 5\n- **Position**: Arm held pronated and slightly flexed\n- **NO swelling, deformity, or ecchymosis**\n- **Clinical diagnosis** - X-rays NOT needed for classic presentation\n\n**Reduction Techniques:**\n- **Hyperpronation (preferred)**: Higher success rate (80-95%), less painful\n- **Supination-flexion**: Traditional technique, still effective (70-85%)\n- Feel for the **\"click\"** over the radial head\n- Child should **use arm within 15-30 minutes**\n\n**Post-Reduction:**\n- **Brief observation** (15-20 min) to confirm arm use\n- **No X-ray, immobilization, or specialty referral** needed\n- **Discharge with anticipatory guidance**\n\n**Prevention Education:**\n- Lift under armpits, not by hands/wrists\n- Avoid arm-swinging games\n- Educate all caregivers\n- **Recurrence rate 20-25%**\n- Resolves naturally after age 5\n\n**When to Consider Alternatives:**\n- Significant swelling or deformity \u2192 X-ray for fracture\n- Fall mechanism (FOOSH) \u2192 consider supracondylar fracture\n- Fever + swelling \u2192 consider septic arthritis\n- Failed reduction \u2192 X-ray, repeat attempt, or orthopedic consultation"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in nursemaid's elbow management:\n\n**Diagnosis is Clinical:**\n- Classic history + no swelling = nursemaid's elbow\n- X-rays are NOT needed before reduction attempt\n- X-rays are NORMAL in radial head subluxation\n\n**Reduction Technique:**\n- Hyperpronation preferred (higher success, less painful)\n- Supination-flexion is acceptable alternative\n- Analgesia/sedation NOT typically needed\n- Feel for the \"click\"\n\n**Post-Reduction Care:**\n- Observe 15-20 minutes for arm use\n- NO X-ray after successful reduction\n- NO immobilization (sling)\n- NO orthopedic referral for uncomplicated cases\n\n**Discharge Education:**\n- Prevention: lift under armpits, avoid pulling hands\n- Recurrence: 20-25% risk, higher with prior episodes\n- Return if: symptoms recur, swelling develops, fever\n\n**Common Errors:**\n- Ordering unnecessary X-rays\n- Delaying reduction for imaging or specialist\n- Immobilizing the arm after reduction\n- Not counseling on prevention"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates key principles in nursemaid's elbow management:\n\n**Don't Miss the Classic Presentation:**\n- **Traction mechanism** (pulling arm) + **pronated/flexed position** + **no swelling** = nursemaid's elbow\n- This is a CLINICAL diagnosis - X-rays are NOT needed\n- Fractures have different mechanisms (falls) and findings (swelling, deformity)\n\n**Reduction is Simple:**\n- Any trained provider can perform reduction\n- Hyperpronation or supination-flexion\n- Takes seconds, no sedation needed\n- Orthopedic consultation NOT required\n\n**Don't Over-Medicalize:**\n- No X-ray before or after reduction for classic cases\n- No immobilization\n- No hospital admission\n- No physical therapy\n- No specialty referral for uncomplicated cases\n\n**Key Prevention Message:**\n- Lift under armpits, not by hands\n- Educate ALL caregivers\n- Recurrence is common (20-25%)\n- Resolves after age 5\n\n**When to Investigate Further:**\n- Swelling or deformity suggests fracture\n- Fall mechanism (not pulling) suggests different injury\n- Failed reduction after 2-3 attempts\n- Fever or systemic symptoms"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-155", "title": "Osgood-Schlatter Disease", "domain": "adolescent", "difficulty": "intermediate", "tags": ["tibial tubercle apophysitis", "adolescent athlete", "activity-related knee pain", "growth spurt", "traction apophysitis", "activity modification", "osgood-schlatter disease"], "estimatedMinutes": 6, "source": ["NBME"], "stem": "A 12-year-old male presents to your sports medicine clinic with his mother for evaluation of right knee pain that has been bothering him for about 2 months.\n\nHe is an active athlete who plays basketball year-round and soccer in the spring. The pain started gradually and is located \"just below the kneecap.\" It gets worse when he runs, jumps, goes up stairs, or kneels. The pain improves when he rests. He has noticed a \"bump\" forming below his knee that wasn't there before.\n\nHe denies any specific injury, trauma, or fall. No locking, giving way, or instability. No fever, night pain, or pain at rest. His mother mentions he has grown about 3 inches in the past year.\n\nPhysical Examination:\n- General: Tall, thin adolescent male. Tanner stage 3.\n- Right knee: Prominent, tender bony bump at the tibial tubercle with mild overlying soft tissue swelling. No joint effusion. Full range of motion. Ligaments stable (negative Lachman, negative varus/valgus stress). Negative patellar apprehension.\n- Pain reproduced with resisted knee extension and when kneeling.\n- Left knee: Mild tibial tubercle prominence, non-tender.\n- Gait: Normal, no limp.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You recognize the classic presentation of **Osgood-Schlatter disease** (tibial tubercle apophysitis).\n\n**Osgood-Schlatter Disease - Pathophysiology:**\n- **Traction apophysitis** of the tibial tubercle\n- The **patellar tendon inserts** on the tibial tubercle (an apophysis - secondary ossification center)\n- During growth spurts, the apophysis is vulnerable to repetitive traction stress\n- **Repeated quadriceps contraction** (running, jumping, kneeling) causes microtrauma\n- Results in **inflammation, pain, and bony prominence** at the tibial tubercle\n\n**Classic Presentation:**\n- **Age**: 10-15 years (girls earlier due to earlier puberty)\n- **Sex**: More common in males (historically; now equal as girls increase sports participation)\n- **Activity**: Athletes in running/jumping sports (basketball, soccer, volleyball, gymnastics)\n- **Growth spurt**: Typically occurs during rapid skeletal growth\n- **Pain location**: Directly over the **tibial tubercle** (below the patella)\n- **Aggravating factors**: Running, jumping, kneeling, stairs, squatting\n- **Relieving factors**: Rest\n- **Physical finding**: **Tender, prominent tibial tubercle**\n\n**Key Differential Diagnoses:**\n- **Sinding-Larsen-Johansson syndrome**: Similar mechanism but at the **inferior pole of the patella**\n- **Patellar tendinitis**: Tenderness at the **mid-tendon**, not the tibial tubercle\n- **Patellofemoral pain syndrome**: Anterior knee pain, worse with stairs and prolonged sitting\n- **Tibial stress fracture**: More diffuse tenderness, rest pain, risk factors", "question": "Based on the history and examination, what is your diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Osgood-Schlatter disease - classic presentation with tibial tubercle tenderness in an adolescent athlete during growth spurt", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **textbook Osgood-Schlatter disease**. Key features: (1) **Age 12 years** - peak incidence, (2) **Active in running/jumping sports** (basketball, soccer), (3) **Recent growth spurt** (3 inches in past year), (4) **Pain over tibial tubercle** that worsens with activity and improves with rest, (5) **Prominent, tender bony bump** at tibial tubercle, (6) **Bilateral tibial tubercle prominence** (left non-tender - often bilateral but one side more symptomatic), (7) **No red flags** (no fever, night pain, rest pain, instability). This is a clinical diagnosis - no imaging needed.", "consequence": "You correctly identify Osgood-Schlatter disease.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Patellar tendinitis (jumper's knee) - common in basketball players", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Patellar tendinitis has different exam findings**. Key distinction: (1) **Patellar tendinitis**: Tenderness at the **mid-patellar tendon** or at the tendon origin (inferior patella), (2) **Osgood-Schlatter**: Tenderness at the **tibial tubercle** (tendon insertion), (3) This patient has **point tenderness at the tibial tubercle** with a prominent bony bump - classic for Osgood-Schlatter, (4) The anatomic location of tenderness distinguishes these conditions. Always localize the point of maximum tenderness.", "consequence": "Incorrect localization of pathology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Meniscal tear - need MRI to evaluate", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Meniscal tear has a different presentation**. Key differences: (1) **Meniscal tears** cause joint line tenderness, not tibial tubercle tenderness, (2) **Locking and catching** are common with meniscal tears - absent here, (3) **Joint effusion** is common - absent here, (4) **McMurray test and joint line tenderness** would be positive, (5) **No trauma** was reported to cause a meniscal tear. This patient has classic Osgood-Schlatter findings - MRI is not indicated.", "consequence": "Ordering unnecessary MRI for a clinical diagnosis.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "ACL tear - his knee instability needs evaluation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This patient has NO instability**. Key findings: (1) **Lachman test is NEGATIVE** - rules out ACL tear, (2) **No giving way or buckling reported**, (3) **No acute injury or trauma**, (4) **ACL tears** present with instability, effusion, and positive ligament testing - none present here, (5) **Tenderness is at the tibial tubercle**, not in the joint. This is Osgood-Schlatter, not ligamentous injury.", "consequence": "Misinterpreting a stable knee as ACL injury.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Bone tumor - the bony prominence is concerning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is NOT concerning for tumor**. Key reassuring features: (1) **Pain is activity-related and improves with rest** - tumors typically cause night pain and rest pain, (2) **Classic Osgood-Schlatter history and exam**, (3) **Bilateral tibial tubercle prominence** - tumors are unilateral, (4) **No systemic symptoms** (fever, weight loss, fatigue), (5) **The \"bump\" IS the tibial tubercle** - normal anatomic prominence that becomes more visible with Osgood-Schlatter. Red flags for tumor: night pain, rest pain, systemic symptoms, rapidly enlarging mass.", "consequence": "Unnecessary concern and testing for a benign condition.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Osgood-Schlatter disease = tibial tubercle apophysitis** in adolescent athletes during growth spurts. The key exam finding is **point tenderness at the tibial tubercle** with a prominent bony bump. This is a clinical diagnosis - imaging is NOT needed for typical presentations."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose Osgood-Schlatter disease. The mother asks: \"Does he need an X-ray? His coach said he should get imaging to make sure nothing is broken.\"\n\n**Imaging in Osgood-Schlatter Disease:**\n\n**X-ray Findings (if obtained):**\n- **Soft tissue swelling** anterior to tibial tubercle\n- **Fragmentation** of the tibial tubercle apophysis (irregular ossification)\n- **Prominence** of the tibial tubercle\n- **Normal knee joint**\n\n**When is Imaging Indicated?**\n\n**X-ray NOT routinely needed if:**\n- Classic history (adolescent athlete, activity-related pain, growth spurt)\n- Classic exam (point tenderness at tibial tubercle, no effusion, stable knee)\n- No red flags\n\n**Consider X-ray if:**\n- Atypical presentation\n- Trauma/injury history\n- Concern for other pathology (fracture, tumor)\n- Persistent symptoms despite treatment\n- Medico-legal or patient/parent reassurance needs\n\n**MRI indicated only if:**\n- Suspected alternative diagnosis (meniscus, ligament, tumor)\n- Atypical features (night pain, rest pain, effusion)\n- Failed conservative treatment (consider other pathology)\n\n**Important Note:**\n- X-ray findings do NOT correlate with symptom severity\n- Imaging does NOT change management for typical Osgood-Schlatter\n- Over-imaging adds cost, radiation, and potential for incidental findings", "question": "Do you order imaging for this patient?", "choices": [{"id": "node-2-choice-a", "text": "No imaging needed - this is a clinical diagnosis with a classic presentation and no red flags", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Imaging is NOT necessary for typical Osgood-Schlatter disease**. Key reasoning: (1) **Classic history and exam** make the diagnosis certain, (2) **X-ray findings don't change management** - treatment is the same regardless, (3) **X-ray findings don't correlate with symptoms** - severe-looking X-rays may be asymptomatic, (4) **No red flags** that warrant imaging (no trauma, no night pain, no effusion, no instability), (5) **Avoid unnecessary radiation and cost**. You can reassure the mother that the diagnosis is clear and imaging won't change the plan.", "consequence": "Appropriate use of clinical diagnosis.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Order X-ray to confirm the diagnosis and rule out fracture", "isOptimal": false, "isAcceptable": true, "feedback": "Acceptable but not necessary. **X-ray can be obtained but won't change management**. Key considerations: (1) **X-ray may show** fragmentation of tibial tubercle ossification center - this is expected with Osgood-Schlatter, (2) **No trauma history** to suggest fracture, (3) **Findings don't correlate with symptoms** or guide treatment, (4) **May be reasonable** for parental reassurance or documentation. If you do order X-ray, be prepared to explain that the findings are consistent with Osgood-Schlatter and don't indicate fracture or severity.", "consequence": "Unnecessary but not harmful imaging.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Order MRI to evaluate for cartilage damage and ligament injuries", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **MRI is NOT indicated for typical Osgood-Schlatter disease**. Key issues: (1) **No findings suggest internal derangement** - ligaments stable, no effusion, no locking, (2) **MRI would show** tibial tubercle edema and fragmentation - already expected with Osgood-Schlatter, (3) **High cost** without clinical benefit, (4) **May find incidental findings** that cause unnecessary concern. MRI is reserved for atypical presentations or failed conservative treatment when alternative diagnoses are considered.", "consequence": "Excessive and expensive imaging without indication.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-d", "text": "Order bone scan to rule out stress fracture or tumor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bone scan is NOT indicated**. Key issues: (1) **No features suggest stress fracture** - pain is localized to tibial tubercle, not diffuse tibial pain, (2) **No features suggest tumor** - activity-related pain without night pain, rest pain, or systemic symptoms, (3) **Osgood-Schlatter WOULD show uptake** on bone scan due to inflammation - this would be a false positive for other pathology, (4) **Unnecessary radiation exposure**. The clinical picture is classic for Osgood-Schlatter.", "consequence": "Inappropriate and potentially confusing imaging.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Defer imaging decision to orthopedic consultation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Orthopedic referral is not needed for typical Osgood-Schlatter disease**. Key points: (1) **This is a primary care diagnosis** that doesn't require specialty evaluation, (2) **Management is conservative** and can be initiated immediately, (3) **Orthopedic referral** is reserved for: failed conservative treatment, atypical features, or consideration of surgery (rare). Referring for imaging decision unnecessarily delays care and uses specialty resources inappropriately.", "consequence": "Unnecessary referral for a primary care diagnosis.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Imaging is NOT routinely needed for Osgood-Schlatter disease**. The diagnosis is clinical. X-ray may show tibial tubercle fragmentation and soft tissue swelling, but findings don't correlate with symptoms or change management. Save imaging for atypical presentations or failed conservative treatment."}, "node-3": {"id": "node-3", "type": "decision", "content": "You explain that imaging isn't necessary and the diagnosis is clear. Now you need to discuss treatment and return to sports.\n\nThe patient asks anxiously: \"Do I have to stop playing basketball? We have playoffs coming up!\"\n\n**Treatment of Osgood-Schlatter Disease:**\n\n**Conservative Management (first-line for all patients):**\n\n**1. Activity Modification:**\n- **NOT complete rest** - activity modification to pain tolerance\n- **Reduce high-impact activities** that aggravate symptoms (jumping, running, kneeling)\n- **Maintain fitness** with low-impact activities (swimming, cycling)\n- **Play through mild pain** if tolerable; rest if severe\n\n**2. Pain Management:**\n- **NSAIDs** (ibuprofen, naproxen) for acute flares\n- **Ice** after activity (15-20 minutes)\n- **Patellar tendon strap** may reduce traction on tibial tubercle\n\n**3. Rehabilitation:**\n- **Quadriceps and hamstring stretching** (tight muscles increase traction)\n- **Hip and core strengthening**\n- **Gradual return to full activity** as symptoms allow\n\n**Prognosis:**\n- **Self-limited condition** - resolves when growth plate closes (skeletal maturity)\n- **12-24 months typical duration** of symptoms\n- **May leave permanent bump** at tibial tubercle (cosmetic only, not functional)\n- **No long-term sequelae** in vast majority\n\n**Surgical Referral (rare):**\n- Reserved for **failed conservative treatment** after skeletal maturity\n- Excision of ossicles if symptomatic\n- <5% of patients require surgery", "question": "What do you tell him about continuing to play basketball?", "choices": [{"id": "node-3-choice-a", "text": "You can continue playing but modify activity based on pain - use ice and NSAIDs as needed, and focus on stretching. Complete rest isn't necessary.", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Activity modification to pain tolerance is the recommended approach**. Key counseling points: (1) **Complete rest is NOT required** - and may be counterproductive (deconditioning), (2) **Continue sports** with modifications as tolerable, (3) **\"Let pain be the guide\"** - if it hurts too much, reduce activity; mild pain is okay, (4) **Use NSAIDs and ice** around activity to manage symptoms, (5) **Stretching is important** - tight quads/hamstrings worsen symptoms, (6) **Condition will improve with time** as growth slows. This empowers the athlete to remain active while managing symptoms.", "consequence": "Appropriate activity guidance provided.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "You must stop all sports immediately and rest completely until the pain is gone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Complete activity cessation is NOT recommended** for Osgood-Schlatter disease. Key issues: (1) **Symptoms may persist for 12-24 months** - can't rest that long, (2) **Complete rest leads to deconditioning** and muscle weakness, (3) **Activity modification** (not elimination) is the standard approach, (4) **Playing through mild pain is acceptable**, (5) **Condition resolves with skeletal maturity** regardless of activity level. This overly restrictive advice would unnecessarily sideline an adolescent athlete.", "consequence": "Overly restrictive advice that's not evidence-based.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "You need surgery to fix this before you can return to basketball", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is almost NEVER indicated for Osgood-Schlatter disease**. Key facts: (1) **<5% of patients ever need surgery**, (2) **Surgery is reserved for failed conservative treatment** in skeletally mature patients, (3) **This patient hasn't tried ANY conservative treatment yet**, (4) **Condition is self-limited** and resolves with growth plate closure, (5) **Jumping to surgery** for a benign overuse condition would be inappropriate. Conservative management is always first-line.", "consequence": "Inappropriate surgical recommendation for benign condition.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "You can play but need a knee brace and should avoid any contact", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bracing is NOT the primary treatment** and contact isn't the issue. Key points: (1) **Contact doesn't cause or worsen Osgood-Schlatter** - it's a traction injury from repetitive quadriceps contraction, (2) **Knee braces don't address the pathophysiology**, (3) **A patellar tendon strap** may help some patients by changing the vector of pull, but isn't required, (4) **The primary treatment** is activity modification, stretching, and NSAIDs. Focusing on bracing and contact avoidance misses the actual management approach.", "consequence": "Incorrect focus on bracing rather than activity modification.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "I need to see the orthopedic surgeon before I can clear you for sports", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Orthopedic referral is not needed to clear for sports**. Key points: (1) **Osgood-Schlatter is managed in primary care** - you can provide guidance now, (2) **No activity restrictions require specialist input**, (3) **Delaying return to activity** waiting for orthopedic appointment is unnecessary, (4) **Orthopedic referral** is only needed for: failed conservative treatment, atypical presentation, or surgical consideration (rare). The patient can continue sports with appropriate modifications - no referral needed.", "consequence": "Unnecessary delay and specialist referral.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Activity modification, not complete rest** is the key message for Osgood-Schlatter disease. Athletes can continue sports with modifications based on pain tolerance. **\"Let pain be the guide\"** - reduce activity if severe, but mild discomfort is acceptable. The condition is self-limited and resolves with skeletal maturity."}, "node-4": {"id": "node-4", "type": "decision", "content": "You counsel him on activity modification and provide a stretching program. Before they leave, the mother asks: \"When will this go away? And will he have any long-term problems?\"\n\n**Prognosis and Long-Term Outcomes:**\n\n**Natural History:**\n- **Symptoms resolve with skeletal maturity** (closure of tibial tubercle apophysis)\n- **Girls**: Typically resolve by age 14-16\n- **Boys**: Typically resolve by age 16-18\n- **Duration**: Usually 12-24 months of symptoms\n\n**Long-Term Outcomes:**\n- **Excellent prognosis** - no functional limitations in >95%\n- **Residual tibial tubercle prominence** is common (cosmetic only)\n- **Rare complications**:\n  - Persistent ossicle (unfused bone fragment) - may be symptomatic\n  - Tibial tubercle avulsion fracture (rare, with forceful contraction)\n  - Kneeling discomfort due to prominent tubercle\n\n**Follow-Up:**\n- **Routine follow-up not needed** if improving\n- **Return if**: symptoms worsen, new symptoms develop, or no improvement with conservative management\n\n**When to Refer to Orthopedics:**\n- Failed conservative management after 6-12 months\n- Suspicion of tibial tubercle avulsion fracture (acute severe pain, inability to extend knee)\n- Persistent symptoms after skeletal maturity\n- Patient/family request for surgical consultation", "question": "How do you counsel the mother about the prognosis?", "choices": [{"id": "node-4-choice-a", "text": "This will resolve on its own when he stops growing, usually by age 16-18. He may have a permanent bump but no long-term functional problems. Excellent prognosis.", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! **Accurate and reassuring prognostic counseling**. Key points delivered: (1) **Self-limited condition** - resolves with skeletal maturity, (2) **Timeline**: By age 16-18 in boys (slightly earlier in girls), (3) **Residual bump is common** but purely cosmetic, (4) **No long-term functional limitations** in vast majority, (5) **Excellent prognosis** - this is important for anxious parents and athletes to hear. This realistic counseling helps set appropriate expectations while providing reassurance.", "consequence": "Appropriate prognostic counseling provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "This is a chronic condition that may cause lifelong knee problems and early arthritis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **This is NOT a chronic condition and does NOT cause arthritis**. Key facts: (1) **Osgood-Schlatter is SELF-LIMITED** - it resolves with growth plate closure, (2) **No increased risk of knee arthritis**, (3) **>95% have excellent long-term outcomes** with no functional limitations, (4) **Providing false negative prognosis** causes unnecessary anxiety and may lead to inappropriate activity restriction. Always provide accurate prognostic information based on evidence.", "consequence": "False negative prognosis causing unnecessary anxiety.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "We won't know the prognosis until we see how he responds to treatment over the next few years", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **The prognosis is well-established and predictable**. Key points: (1) **Osgood-Schlatter has an excellent, well-known prognosis**, (2) **We CAN confidently predict** it will resolve with skeletal maturity, (3) **Uncertainty about prognosis** is unnecessary and anxiety-provoking, (4) **Parents deserve accurate information** to make informed decisions about activity and expectations. Being vague when the prognosis is actually excellent doesn't serve the patient.", "consequence": "Unnecessary uncertainty when prognosis is well-established.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "The symptoms will go away in a few weeks with rest and ice", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Symptoms typically last 12-24 months**, not weeks. Key issues: (1) **This is an overuse condition during growth** - it doesn't resolve until growth slows, (2) **Promising quick resolution** sets unrealistic expectations, (3) **When symptoms persist** (as they will), the family may think treatment failed or seek unnecessary second opinions, (4) **Honest timeline** (12-24 months, resolving by skeletal maturity) is important. Set realistic expectations from the start.", "consequence": "Unrealistic timeline creates false expectations.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "He'll need to stop all sports permanently to prevent long-term damage to his knee", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Permanent activity restriction is NEVER indicated** for Osgood-Schlatter. Key facts: (1) **The condition is benign** and self-limited, (2) **Activity modification** (not elimination) is appropriate during symptoms, (3) **Full return to all activities** is expected after skeletal maturity, (4) **No \"damage\"** occurs from continued activity - pain is from inflammation, not structural injury, (5) **This advice would unnecessarily limit** an adolescent athlete's development and quality of life.", "consequence": "Completely inappropriate permanent activity restriction.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Osgood-Schlatter disease has an EXCELLENT prognosis** - it resolves when growth stops (age 16-18 in boys, 14-16 in girls). Symptoms typically last 12-24 months. A residual bump is common but purely cosmetic. No long-term functional limitations in >95% of patients. Reassure families that this is a benign, self-limited condition."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed Osgood-Schlatter disease with appropriate clinical reasoning, no unnecessary imaging, and excellent patient education.\n\n**Key Teaching Points:**\n\n**Diagnosis:**\n- **Clinical diagnosis** - imaging NOT routinely needed\n- **Key finding**: Point tenderness at the tibial tubercle with bony prominence\n- **Classic patient**: Adolescent athlete during growth spurt\n- **Aggravating factors**: Running, jumping, kneeling, stairs\n- **No red flags**: No fever, night pain, rest pain, effusion, instability\n\n**Differential Diagnosis (know the locations):**\n- **Osgood-Schlatter**: Tibial tubercle (tendon insertion)\n- **Sinding-Larsen-Johansson**: Inferior pole of patella (tendon origin)\n- **Patellar tendinitis**: Mid-tendon\n- **Patellofemoral syndrome**: Retropatellar pain\n\n**Management:**\n- **Activity modification** (not complete rest) to pain tolerance\n- **NSAIDs and ice** for symptom control\n- **Stretching** (quadriceps, hamstrings) - essential\n- **Continue sports** with modifications\n- **No surgery needed** in >95% of patients\n\n**Prognosis:**\n- **Self-limited** - resolves with skeletal maturity\n- **Duration**: 12-24 months typical\n- **Excellent outcomes** - no long-term functional limitations\n- **Residual bump** is common but cosmetic only\n\n**When to Image:**\n- Atypical presentation, trauma, or red flags\n- NOT for typical Osgood-Schlatter\n\n**When to Refer:**\n- Failed conservative treatment\n- Persistent symptoms after skeletal maturity\n- Concern for alternative diagnosis"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in Osgood-Schlatter disease:\n\n**Diagnosis:**\n- Clinical diagnosis based on history and exam\n- Point tenderness at tibial tubercle is the key finding\n- Imaging NOT routinely needed for typical presentation\n\n**Imaging:**\n- X-ray shows fragmentation but doesn't change management\n- MRI NOT indicated for typical Osgood-Schlatter\n- Reserve imaging for atypical features or failed treatment\n\n**Management:**\n- Activity modification, NOT complete rest\n- Continue sports with modifications to pain tolerance\n- NSAIDs, ice, stretching\n- No bracing required\n- No orthopedic referral needed for typical cases\n\n**Prognosis:**\n- Self-limited condition\n- Resolves with skeletal maturity (16-18 years in boys)\n- Duration 12-24 months\n- Excellent long-term outcomes\n- Residual bump is common but cosmetic\n\n**Common Errors:**\n- Ordering unnecessary imaging\n- Recommending complete rest\n- Unnecessary orthopedic referral\n- Overly restrictive activity limitations"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates key principles in Osgood-Schlatter disease management:\n\n**Don't Over-Test:**\n- Clinical diagnosis - imaging NOT needed for typical presentation\n- X-ray doesn't change management\n- MRI is excessive for this benign condition\n- Bone scan is inappropriate\n\n**Don't Over-Diagnose:**\n- Osgood-Schlatter is NOT a tumor, fracture, or ACL tear\n- Point tenderness at tibial tubercle is the key finding\n- Stable knee with no effusion rules out internal derangement\n- Red flags for concerning diagnoses are ABSENT\n\n**Don't Over-Treat:**\n- Complete rest is NOT indicated\n- Surgery is almost NEVER needed\n- Activity modification (not elimination) is appropriate\n- This is a benign, self-limited condition\n\n**Don't Over-Worry:**\n- Excellent prognosis - resolves with skeletal maturity\n- No long-term functional limitations\n- No increased arthritis risk\n- Residual bump is cosmetic only\n\n**Appropriate Approach:**\n- Clinical diagnosis\n- Activity modification to pain tolerance\n- NSAIDs, ice, stretching\n- Reassurance about excellent prognosis\n- Return to full activity expected"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-161", "title": "Spondylolisthesis in Adolescent Athlete", "domain": "adolescent", "difficulty": "intermediate", "tags": ["spondylolisthesis", "spondylolysis", "pars interarticularis defect", "step-off sign", "adolescent athlete", "back pain", "Scottie dog sign", "hyperextension sport"], "estimatedMinutes": 5, "source": ["Amboss"], "stem": "A 15-year-old female gymnast presents with a 6-week history of low back pain. The pain is worse with extension and twisting movements during practice. She denies radicular symptoms, numbness, weakness, or bowel/bladder changes. No history of trauma.\n\nShe has been doing gymnastics competitively since age 8 and practices 20 hours per week. The pain has been progressively limiting her ability to perform back walkovers and dismounts.\n\nPhysical Examination:\n- General: Well-developed athletic female in no acute distress\n- Spine: Mild lumbar lordosis. Tenderness to palpation at L5-S1. **Palpable step-off** at the lumbosacral junction.\n- Neurologic: 5/5 strength in bilateral lower extremities. Sensation intact. Reflexes 2+ and symmetric. Negative straight leg raise.\n- Gait: Normal\n- Single-leg hyperextension test (stork test): Reproduces pain on the left side", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 15-year-old gymnast presents with chronic low back pain worsened by extension. Key findings:\n\n- **Adolescent athlete** in hyperextension sport (gymnastics)\n- **Pain with extension** and twisting\n- **Palpable step-off** at lumbosacral junction\n- **Positive stork test** (single-leg hyperextension)\n- **Normal neurologic exam**", "question": "What is the MOST likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Spondylolisthesis (likely secondary to bilateral spondylolysis)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Spondylolisthesis** is the forward slippage of one vertebra over another, most commonly at L5-S1. In adolescent athletes (especially gymnasts, football linemen, divers), it's typically caused by bilateral **spondylolysis** (pars interarticularis stress fractures). Classic features: (1) **Hyperextension sport**, (2) **Extension-related pain**, (3) **Palpable step-off**, (4) **Positive stork test**. The palpable step-off indicates vertebral slippage.", "consequence": "You recognize the classic presentation of spondylolisthesis.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Lumbar disc herniation with radiculopathy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Disc herniation** typically causes **flexion-related pain** (worse with sitting, bending forward) and presents with **radicular symptoms** (leg pain following dermatomal pattern, positive straight leg raise). This patient has extension-related pain, negative straight leg raise, and no radiculopathy. The palpable step-off is not a feature of disc herniation.", "consequence": "Features don't match disc herniation.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Muscle strain from overuse", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While muscle strain is common in athletes, it **does not cause a palpable step-off**. The step-off indicates **vertebral slippage** (spondylolisthesis). Additionally, the 6-week duration and progressive nature with specific extension-related pain pattern suggest a structural problem rather than simple muscle strain.", "consequence": "Step-off indicates bony pathology, not muscular.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Ankylosing spondylitis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Ankylosing spondylitis** presents with **inflammatory back pain** (worse in morning, improves with activity, night pain). It typically affects young adult males with **sacroiliitis** and **limited spinal mobility**. This patient has mechanical pain worse with activity (extension) and a palpable step-off - features of spondylolisthesis, not inflammatory spondyloarthropathy.", "consequence": "Features suggest mechanical, not inflammatory etiology.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Spinal tumor", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While tumors should be considered in persistent back pain, this presentation lacks red flags: no **night pain**, no **constitutional symptoms**, no **neurologic deficits**, and the **mechanical pattern** (worse with extension) is classic for spondylolisthesis. A tumor would not cause a palpable step-off at the lumbosacral junction.", "consequence": "No red flags for malignancy present.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Spondylolisthesis clues**: (1) Adolescent in hyperextension sport, (2) Extension-related pain, (3) **Palpable step-off** (pathognomonic), (4) Positive **stork test** (single-leg hyperextension reproduces pain). Most common at **L5-S1**. Usually caused by bilateral **pars defects (spondylolysis)**."}, "node-2": {"id": "node-2", "type": "decision", "content": "You suspect spondylolisthesis based on the classic presentation. You need imaging to confirm the diagnosis and assess the degree of slippage.", "question": "What is the MOST appropriate initial imaging study?", "choices": [{"id": "node-2-choice-a", "text": "Lumbar spine X-rays (AP, lateral, and oblique views)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Plain radiographs** are the appropriate initial imaging. **Lateral view** shows the forward slippage and allows grading (Meyerding classification). **Oblique views** may show the **'Scottie dog' sign** with a 'collar' (lucency at the pars = spondylolysis). Standing/flexion-extension views can assess stability. X-rays are sufficient for initial diagnosis and treatment planning in most cases.", "consequence": "X-rays ordered - appropriate first-line imaging.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "MRI lumbar spine as first-line imaging", "isOptimal": false, "isAcceptable": true, "feedback": "MRI is useful for evaluating **soft tissue**, **disc abnormalities**, and **nerve compression**, but it is not the best initial test for bony pathology like spondylolisthesis. MRI may be added if there are neurologic symptoms or if X-rays are inconclusive. For classic spondylolisthesis presentation, start with X-rays.", "consequence": "MRI useful but not first-line for bony pathology.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "CT scan without contrast", "isOptimal": false, "isAcceptable": true, "feedback": "CT provides excellent **bony detail** and can identify pars defects. However, it involves **significant radiation** and is typically reserved for surgical planning or when X-rays are inconclusive. SPECT-CT may be used to assess healing potential of acute pars fractures. For initial evaluation, start with plain X-rays.", "consequence": "CT provides detail but involves more radiation than needed initially.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Bone scan (scintigraphy)", "isOptimal": false, "isAcceptable": true, "feedback": "Bone scan can detect **active stress reactions** and may help distinguish acute from chronic pars defects (acute lesions show increased uptake). However, it has lower anatomic resolution than other modalities. **SPECT** (single-photon emission CT) is more useful. Plain X-rays remain the appropriate first step.", "consequence": "Bone scan has role but not first-line.", "nextNodeId": "node-3"}, {"id": "node-2-choice-e", "text": "No imaging needed - clinical diagnosis is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While the clinical presentation is suggestive, **imaging is necessary** to: (1) **Confirm the diagnosis**, (2) **Grade the slippage** (affects treatment), (3) **Rule out other pathology**, (4) **Establish baseline** for monitoring progression. The degree of slippage (Meyerding grade) directly influences management decisions.", "consequence": "Imaging required for proper management.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Imaging approach**: (1) **X-rays first** - lateral shows slippage, oblique shows 'Scottie dog'; (2) **SPECT or MRI** - if X-rays negative but clinical suspicion high; (3) **CT** - for surgical planning or detailed bony anatomy. **Meyerding grading**: I (<25%), II (25-50%), III (50-75%), IV (75-100%), V (spondyloptosis >100%)."}, "node-3": {"id": "node-3", "type": "decision", "content": "Lumbar X-rays are obtained:\n\n**Lateral view**: Forward slippage of L5 on S1, approximately **30% displacement** (Meyerding Grade II).\n\n**Oblique view**: Bilateral pars interarticularis defects visible ('Scottie dog with collar').\n\n**Diagnosis**: **Grade II isthmic spondylolisthesis** at L5-S1 secondary to bilateral spondylolysis.", "question": "What is the MOST appropriate initial management for this patient?", "choices": [{"id": "node-3-choice-a", "text": "Activity modification, physical therapy focusing on core strengthening and flexion-based exercises, and NSAIDs; restrict from gymnastics temporarily", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Conservative management** is first-line for **Grade I-II spondylolisthesis** without neurologic deficits. Key components: (1) **Activity modification** - avoid hyperextension activities temporarily, (2) **Physical therapy** - core strengthening, hamstring stretching, flexion-based exercises (Williams flexion exercises), (3) **NSAIDs** for pain, (4) **Bracing** may be considered for acute pars fractures. Most patients improve with 3-6 months of conservative treatment.", "consequence": "Appropriate conservative management initiated.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Immediate surgical referral for spinal fusion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Surgery is NOT first-line** for Grade I-II spondylolisthesis without neurologic deficits. Surgical indications include: (1) **Grade III-IV slippage**, (2) **Progressive slippage** despite conservative treatment, (3) **Neurologic deficits**, (4) **Intractable pain** failing conservative management (3-6 months). This patient should try conservative treatment first.", "consequence": "Surgery premature; conservative management indicated first.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-c", "text": "Continue gymnastics at full intensity with a back brace", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Continuing high-intensity hyperextension activities** (gymnastics) risks **progression of slippage** and delayed healing of pars defects. Activity modification is essential - the patient should temporarily avoid gymnastics and other extension-loading activities. A gradual return to sport can be considered once pain-free and after completing rehabilitation.", "consequence": "Continued stress may worsen slippage.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Strict bed rest for 6 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Bed rest is not recommended** for spondylolisthesis. It leads to deconditioning and does not improve outcomes. The treatment involves **activity modification** (avoiding aggravating activities) combined with **active physical therapy** to strengthen core muscles and improve flexibility. The goal is controlled activity, not immobilization.", "consequence": "Bed rest leads to deconditioning without benefit.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Epidural steroid injection", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Epidural injections** are considered for **radicular pain** from nerve compression, not for mechanical back pain from spondylolisthesis without radiculopathy. This patient has no neurologic symptoms or radiculopathy - her pain is mechanical. Physical therapy and activity modification are more appropriate.", "consequence": "Not indicated without radicular symptoms.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Conservative management success**: ~85% of patients with Grade I-II spondylolisthesis improve with conservative treatment. **Key components**: Activity modification (avoid extension), PT (core strengthening, hamstring flexibility), NSAIDs. **Surgical indications**: Grade III+, neurologic deficits, progressive slippage, failed conservative treatment (3-6 months)."}, "node-4": {"id": "node-4", "type": "decision", "content": "You initiate conservative management with activity restriction from gymnastics, physical therapy referral, and naproxen for pain. The patient asks about her prognosis and return to sport.\n\n**Key questions to address**:\n- Will the slippage get worse?\n- Can she ever return to gymnastics?\n- What should she watch for?", "question": "Which statement is MOST accurate regarding prognosis and follow-up?", "choices": [{"id": "node-4-choice-a", "text": "Most adolescents with Grade I-II spondylolisthesis do well with conservative treatment; progression is unlikely after skeletal maturity; gradual return to sport is possible", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Prognosis is generally good** for Grade I-II spondylolisthesis. Key points: (1) **~85% improve** with conservative management, (2) **Progression is most common during growth spurts** (before skeletal maturity), (3) **After skeletal maturity, further slippage is rare**, (4) **Return to sport** is possible after completing rehab and being pain-free - typically 3-6 months, (5) **Monitor with periodic X-rays** during growth to detect progression.", "consequence": "Accurate prognostic counseling provided.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "She will never be able to participate in gymnastics again", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While she needs to modify activities temporarily, **many athletes with spondylolisthesis return to sport** successfully. Some even continue at elite levels with proper management. The decision to return depends on: symptom resolution, completed rehabilitation, stable imaging, and individual risk tolerance. A blanket prohibition is not appropriate.", "consequence": "Overly restrictive; return to sport is often possible.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "The slippage will definitely progress and she will need surgery", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Progression is NOT inevitable**. Most Grade I-II slips remain stable, especially after skeletal maturity. Risk factors for progression include: younger age, higher grade, female sex, and dome-shaped sacrum. However, most patients do well with conservative treatment and never require surgery.", "consequence": "Progression is not inevitable; surgery often not needed.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "No follow-up imaging is needed once the diagnosis is made", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Periodic monitoring is important** during growth, as slippage can progress during growth spurts. Recommended follow-up: X-rays every 6-12 months until skeletal maturity (or sooner if symptoms worsen). After skeletal maturity, if stable and asymptomatic, imaging frequency can decrease.", "consequence": "Monitoring needed during growth to detect progression.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Physical therapy has no role; activity restriction alone is sufficient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Physical therapy is a cornerstone** of spondylolisthesis management. Goals: (1) Core stabilization (abdominal and paraspinal muscles), (2) Hamstring flexibility (tight hamstrings increase pelvic tilt and lumbar stress), (3) Postural training, (4) Sport-specific rehabilitation before return to activity. PT significantly improves outcomes.", "consequence": "PT is essential for optimal outcomes.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Follow-up monitoring**: X-rays every 6-12 months during growth. **Risk factors for progression**: Young age, female sex, higher grade, dome-shaped sacrum, ligamentous laxity. **Return to sport criteria**: Pain-free, completed PT program, stable imaging. Some modifications may be permanent (avoid extreme hyperextension)."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly diagnosed and managed **spondylolisthesis** in an adolescent athlete.\n\n**Key learning points**:\n\n**Diagnosis**: Extension-related back pain + palpable step-off + positive stork test in young athlete = spondylolisthesis until proven otherwise.\n\n**Imaging**: X-rays first (lateral for grading, oblique for pars defects).\n\n**Management**: Conservative for Grade I-II (activity modification, PT, NSAIDs). Surgery for Grade III+, neurologic deficits, or failed conservative treatment.\n\n**Prognosis**: Good with conservative management; most return to activity; monitor during growth for progression."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **adolescent spondylolisthesis**:\n\n**Clinical features**: Extension-related pain, **palpable step-off** (key finding), positive stork test, common in hyperextension sports.\n\n**Imaging**: X-rays first (lateral + oblique). Meyerding grading: I (<25%), II (25-50%), III (50-75%), IV (75-100%).\n\n**Treatment**: Conservative for Grade I-II: activity modification, PT (core strengthening, hamstring stretching), NSAIDs. Surgery rarely needed.\n\n**Prognosis**: ~85% improve with conservative treatment. Monitor during growth. Return to sport usually possible."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error. **Continuing hyperextension activities** with known spondylolisthesis risks:\n\n- **Progressive slippage** (vertebral body slides further forward)\n- **Neurologic compromise** (nerve root compression)\n- **Chronic pain** and disability\n- **Need for surgical intervention**\n\n**Correct approach**: Activity modification is essential. Restrict from gymnastics temporarily. Physical therapy for core strengthening. Gradual return to sport only after completing rehabilitation and being pain-free."}}, "rootNodeId": "node-1"}], "general": [{"id": "vignette-lens-peds-052", "title": "Lead Poisoning", "domain": "general", "difficulty": "intermediate", "tags": ["old house with peeling paint", "pica", "basophilic stippling", "lead lines on X-ray", "lead poisoning"], "estimatedMinutes": 10, "source": ["NBME"], "stem": "A 2-year-old male is brought in by his parents for developmental regression and irritability for 2 months.\n\nHistory reveals, he has become more irritable and is losing skills he previously had. He stopped saying words he used to say. He has been eating paint chips from the windowsill.\n\nReview of systems is positive for pica, constipation, and abdominal pain and negative for seizures.\n\nMedical history is notable for He lives in a house built in 1950 with peeling paint. Routine lead screening was elevated.\n\nPhysical Examination:\n- General: irritable, pale toddler.\n- Abdomen: mild tenderness.\n- Neurologic: decreased activity level.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "This 2-year-old presents with classic lead poisoning features: **developmental regression**, **irritability**, **pica** (eating paint chips), and lives in a **pre-1978 house** with peeling paint. Lead-based paint was banned in 1978 - older homes are high-risk. Initial labs show **microcytic anemia**.", "question": "What laboratory finding is MOST SPECIFIC for lead poisoning?", "choices": [{"id": "node-1-choice-a", "text": "Basophilic stippling on peripheral blood smear", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Basophilic stippling** (coarse blue granules in RBCs) is highly suggestive of lead poisoning, though not always present. It represents aggregated ribosomal RNA due to lead inhibiting pyrimidine 5'-nucleotidase. Other causes include thalassemia and arsenic poisoning.", "consequence": "You identify a pathognomonic finding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Microcytic anemia with low MCV", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. Lead does cause **microcytic anemia** by inhibiting heme synthesis (ALA dehydratase and ferrochelatase). However, microcytic anemia has a broad differential (iron deficiency, thalassemia). Lead poisoning and iron deficiency often coexist - **iron deficiency increases lead absorption**.", "consequence": "Common but not specific finding.", "nextNodeId": "node-2"}, {"id": "node-1-choice-c", "text": "Elevated free erythrocyte protoporphyrin (FEP)", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **FEP/ZPP is elevated** in lead poisoning because lead inhibits ferrochelatase, causing protoporphyrin accumulation. However, FEP is also elevated in iron deficiency and is not routinely used for screening anymore - **blood lead level (BLL)** is the standard test.", "consequence": "Historically used but not primary test today.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Lead lines on X-ray of long bones", "isOptimal": false, "isAcceptable": true, "feedback": "Partially correct. **Lead lines** (dense bands at metaphyses) indicate chronic lead exposure but are not always present and are NOT used for diagnosis. They form because lead inhibits osteoclast resorption of calcified cartilage. The diagnosis is made by **blood lead level**, not imaging.", "consequence": "Radiographic finding, not diagnostic.", "nextNodeId": "node-2"}, {"id": "node-1-choice-e", "text": "Elevated serum iron with high ferritin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Lead poisoning causes **sideroblastic anemia** pattern - iron studies may show normal or elevated serum iron with **ringed sideroblasts** on bone marrow (not routinely done). However, many lead-poisoned children have **concurrent iron deficiency** (low ferritin), which actually worsens lead absorption.", "consequence": "Iron deficiency is often concurrent.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Lead poisoning mnemonic - LEAD**: **L**ines on gingiva (Burton lines) and long bones, **E**ncephalopathy, **A**nemia (sideroblastic, with basophilic stippling), **D**rops (wrist/foot drop). Lead inhibits **ALA dehydratase** and **ferrochelatase** in heme synthesis."}, "node-2": {"id": "node-2", "type": "decision", "content": "The **blood lead level (BLL) returns at 55 mcg/dL**. This child is symptomatic with developmental regression. Reference: CDC action level is \u22653.5 mcg/dL (lowered from 5 in 2021), chelation threshold is **\u226545 mcg/dL**.", "question": "What is the MOST IMPORTANT initial step in management?", "choices": [{"id": "node-2-choice-a", "text": "Identify and eliminate the lead source IMMEDIATELY", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Source identification and removal** is the MOST CRITICAL step for ALL lead levels. Without removing ongoing exposure, chelation is ineffective and lead continues to accumulate. For this child: relocate from the home, professional lead paint remediation, evaluate all family members.", "consequence": "Addressing the root cause of exposure.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Start oral chelation therapy with succimer (DMSA)", "isOptimal": false, "isAcceptable": true, "feedback": "Chelation is indicated for BLL \u226545 mcg/dL, but **source removal comes first**. Chelation without removing exposure is futile - lead reaccumulates. **Succimer (DMSA)** is oral and used for BLL 45-69 mcg/dL without encephalopathy. However, this child needs both source removal AND chelation.", "consequence": "Chelation is needed but source removal is priority.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Obtain abdominal X-ray to check for lead paint chips", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Abdominal X-ray can show **radio-opaque foreign bodies** if lead was recently ingested. If positive, **whole bowel irrigation** may be indicated to prevent continued absorption. However, the history already confirms ingestion and source removal remains the priority.", "consequence": "May guide additional decontamination.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Recheck blood lead level in 1-3 months", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This child has **symptomatic lead poisoning with BLL 55 mcg/dL** - this requires urgent intervention, not watchful waiting. Waiting would allow continued neurological damage. Action is needed NOW.", "consequence": "Dangerous delay in symptomatic poisoning.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Start iron supplementation only", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! While iron deficiency increases lead absorption and should be corrected, **iron supplementation alone is insufficient** for BLL 55 mcg/dL with symptoms. This level requires source removal AND chelation therapy.", "consequence": "Insufficient for this level of toxicity.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Lead level management**: **<3.5 mcg/dL** = reference value (2021 CDC). **3.5-44 mcg/dL** = source removal, nutritional counseling, follow-up. **45-69 mcg/dL** = oral chelation (succimer/DMSA). **\u226570 mcg/dL OR encephalopathy** = hospitalize for IV chelation (EDTA \u00b1 BAL/dimercaprol)."}, "node-3": {"id": "node-3", "type": "decision", "content": "The family is relocated to a lead-free home. The child has **BLL 55 mcg/dL with neurological symptoms** (developmental regression, irritability). Chelation therapy is indicated.", "question": "What is the MOST appropriate chelation regimen for this child?", "choices": [{"id": "node-3-choice-a", "text": "Oral succimer (DMSA) for 19 days - first-line for BLL 45-69 without encephalopathy", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Succimer (DMSA)** is first-line for **BLL 45-69 mcg/dL without encephalopathy**. It's given orally: 10 mg/kg every 8 hours for 5 days, then every 12 hours for 14 days (total 19 days). Main side effect is GI upset and transient AST elevation. Recheck BLL 1-2 weeks after completing course.", "consequence": "Appropriate outpatient chelation.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "IV calcium disodium EDTA (CaNa2EDTA) for 5 days", "isOptimal": false, "isAcceptable": true, "feedback": "IV EDTA is reserved for **BLL \u226570 mcg/dL** or when oral therapy is not possible. For BLL 45-69, oral succimer is preferred. Important: Never give EDTA without calcium - **disodium EDTA (without calcium) can cause fatal hypocalcemia** by chelating calcium.", "consequence": "More invasive than needed for this level.", "nextNodeId": "node-4"}, {"id": "node-3-choice-c", "text": "IM dimercaprol (BAL) alone", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **BAL (dimercaprol) alone is NOT used** for lead chelation. It's given only **in combination with EDTA** for severe poisoning (BLL \u226570 or encephalopathy) because BAL mobilizes lead from tissues and EDTA enhances renal excretion. BAL is given first, then EDTA 4 hours later.", "consequence": "BAL is only used with EDTA for severe cases.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "D-penicillamine as first-line therapy", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **D-penicillamine is NOT first-line** for lead poisoning due to higher toxicity (bone marrow suppression, nephrotoxicity). It's a last resort when succimer is unavailable or contraindicated. Additionally, it cannot be used in **penicillin-allergic patients**.", "consequence": "Higher toxicity - not first-line.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "No chelation needed - source removal is sufficient for BLL <70", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! Chelation is indicated for **BLL \u226545 mcg/dL**. This child has BLL 55 with neurological symptoms - chelation will help reduce the body burden faster. Source removal alone is sufficient only for BLL <45 mcg/dL.", "consequence": "BLL 45-69 requires chelation.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Lead chelation agents**: **Succimer (DMSA)** = oral, outpatient, for BLL 45-69 (side effects: GI, elevated LFTs). **CaNa2EDTA** = IV, for BLL \u226570 (nephrotoxic, give with hydration). **BAL (dimercaprol)** = IM, always given WITH EDTA for encephalopathy or BLL \u2265100 (give BAL first). **Never use disodium EDTA without calcium** = fatal hypocalcemia."}, "node-4": {"id": "node-4", "type": "decision", "content": "After completing succimer therapy, the child's BLL drops to 28 mcg/dL. The family asks about long-term follow-up and whether the developmental regression will improve.", "question": "What do you tell the family about prognosis and monitoring?", "choices": [{"id": "node-4-choice-a", "text": "Recheck BLL in 7-21 days; some neurological effects may be irreversible", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! BLL often **rebounds 1-4 weeks** after chelation as lead redistributes from bone. Recheck in **7-21 days** to assess need for additional courses. Unfortunately, **neurological effects of lead are often permanent** - IQ loss, learning disabilities, and behavioral problems may persist despite treatment. Early intervention services are critical.", "consequence": "Realistic expectations and appropriate monitoring.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Lead is fully cleared - no further testing needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Lead redistributes from bone** (where 90% is stored) back into blood after chelation ends, causing **rebound elevation**. Multiple courses of chelation may be needed. Follow-up BLL is essential at **7-21 days** and then periodically until stable.", "consequence": "Misses rebound elevation - dangerous.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-c", "text": "All cognitive effects will reverse completely with chelation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Lead neurotoxicity is largely irreversible**. Chelation reduces body burden and prevents further damage but does NOT reverse existing brain injury. Studies show approximately **2-5 IQ points lost per 10 mcg/dL increase** in BLL. Early intervention and educational support are important.", "consequence": "Gives false hope - effects may be permanent.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Continue succimer prophylactically to prevent rebound", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! **Continuous chelation is not recommended**. A treatment course is completed, then BLL is rechecked after a washout period. If BLL rebounds above threshold, another course is given. Prolonged chelation increases toxicity risk and may deplete essential minerals (zinc, iron, copper).", "consequence": "Unnecessary prolonged therapy.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-e", "text": "Once BLL is below 45, no developmental follow-up is needed", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect! This child had **symptomatic lead poisoning with developmental regression**. Regardless of current BLL, the child needs **early intervention services**, **developmental monitoring**, and **educational support**. There is no 'safe' level of lead for neurodevelopment.", "consequence": "Misses need for developmental services.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Lead poisoning prognosis**: Neurological damage is often **permanent**. ~**2-5 IQ points lost per 10 mcg/dL** elevation. **Rebound** occurs 1-4 weeks post-chelation (redistribution from bone). Follow-up BLL at **7-21 days**. All symptomatic children need **early intervention services** regardless of post-treatment BLL."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You successfully managed this case of **lead poisoning**. Key learning points: 1) **Source removal is PRIORITY #1** for all lead levels. 2) **BLL \u226545 mcg/dL requires chelation** - succimer (DMSA) for 45-69, IV EDTA \u00b1 BAL for \u226570 or encephalopathy. 3) **Monitor for rebound** at 7-21 days post-chelation. 4) **Neurological effects are often permanent** - early intervention is critical. Remember: pre-1978 housing, pica, and basophilic stippling are classic clues."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Key points in lead poisoning: **LEAD mnemonic** = Lead lines (gums/bones), Encephalopathy, Anemia (sideroblastic, basophilic stippling), Drops (wrist/foot). Management: **Source removal first**, then chelation based on level: **Succimer** for 45-69, **IV EDTA \u00b1 BAL** for \u226570 or encephalopathy. Neurological damage is often **irreversible**."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. **Lead poisoning** causes irreversible neurotoxicity. Critical points: Pre-1978 housing is high-risk. **Source removal is essential before/during chelation**. BLL \u226545 needs chelation. Rebound occurs - recheck BLL at 7-21 days. **Never use disodium EDTA without calcium** (fatal hypocalcemia)."}}, "rootNodeId": "node-1"}], "child_abuse_ethics": [{"id": "vignette-lens-peds-076", "title": "Salicylate Toxicity Acid-Base Pattern", "domain": "child_abuse_ethics", "difficulty": "intermediate", "tags": ["mixed respiratory alkalosis and metabolic acidosis", "tinnitus", "hyperpnea", "anion gap", "salicylate toxicity acid-base pattern"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 5-year-old female is brought to the emergency department after accidental aspirin ingestion presenting with tinnitus, hyperpnea, nausea, and altered mental status.\n\nABG shows mixed respiratory alkalosis AND anion gap metabolic acidosis.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "A 5-year-old female is brought to the ED after accidental aspirin ingestion (grandmother's arthritis medication). She has **tinnitus**, **hyperpnea** (rapid deep breathing), nausea, and is becoming confused.\n\n**ABG results:**\n- pH: 7.45 (slightly alkalemic)\n- pCO2: 22 mmHg (LOW - respiratory alkalosis)\n- HCO3: 15 mEq/L (LOW - metabolic acidosis)\n- Anion gap: 22 (elevated)\n\n**The unique salicylate acid-base pattern:**\n- **MIXED** respiratory alkalosis AND metabolic acidosis\n- Early: salicylates directly stimulate respiratory center \u2192 **respiratory alkalosis**\n- Later: uncouples oxidative phosphorylation \u2192 **anion gap metabolic acidosis**\n- Both present simultaneously = pathognomonic!", "question": "What is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Salicylate (aspirin) toxicity", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The **mixed respiratory alkalosis AND anion gap metabolic acidosis** is virtually **pathognomonic for salicylate toxicity**. This unique pattern occurs because: (1) Salicylates directly stimulate the medullary respiratory center \u2192 hyperventilation \u2192 respiratory alkalosis, (2) Salicylates uncouple oxidative phosphorylation \u2192 lactic acid accumulation + salicylic acid itself \u2192 AG metabolic acidosis. The clinical triad of **tinnitus + hyperpnea + altered mental status** with mixed acid-base confirms the diagnosis.", "consequence": "You correctly identify salicylate toxicity and proceed to management.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Diabetic ketoacidosis (DKA)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. DKA causes **pure anion gap metabolic acidosis** with **respiratory COMPENSATION** (Kussmaul breathing to blow off CO2). It does NOT cause primary respiratory alkalosis. In DKA, the pH is LOW (acidemic), not normal/alkalemic. Also, DKA has hyperglycemia, which is not mentioned here. The MIXED pattern (both primary disorders) is unique to salicylates.", "consequence": "Misdiagnosis based on incorrect acid-base interpretation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Sepsis with lactic acidosis", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Sepsis can cause lactic acidosis (AG metabolic acidosis) with compensatory tachypnea. However, sepsis-related hyperventilation is **compensatory** for acidosis, not a **primary** respiratory alkalosis. The pH in compensated metabolic acidosis would be LOW. This child has pH 7.45 with BOTH low pCO2 AND low HCO3 - a true mixed disorder, pathognomonic for salicylates.", "consequence": "Consider salicylate toxicity given the mixed acid-base pattern.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Methanol or ethylene glycol poisoning", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Methanol and ethylene glycol cause **pure anion gap metabolic acidosis** with an **osmolar gap** (difference between measured and calculated osmolality). They do NOT cause primary respiratory alkalosis. Also, they cause visual changes (methanol) or calcium oxalate crystalluria (ethylene glycol), not tinnitus. The mixed acid-base pattern here is classic for salicylates.", "consequence": "Different toxidrome - no osmolar gap or visual symptoms.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-e", "text": "Acute anxiety/panic attack with hyperventilation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Pure hyperventilation syndrome causes **isolated respiratory alkalosis** - the HCO3 would be normal (acute) or mildly low (chronic renal compensation). It does NOT cause anion gap elevation. This child has an anion gap of 22 (elevated) along with low HCO3 - indicating a true metabolic acidosis, not just compensation. The tinnitus and altered mental status also don't fit anxiety.", "consequence": "Anion gap elevation rules out simple hyperventilation.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Mixed respiratory alkalosis + AG metabolic acidosis** is virtually pathognomonic for salicylate toxicity. Other AG acidosis causes have compensatory (not primary) respiratory changes."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose **salicylate toxicity**. The salicylate level returns at **55 mg/dL** (toxic >30 mg/dL, severe >100 mg/dL). The child is becoming increasingly confused.\n\n**Key salicylate toxicity management:**\n- **GI decontamination**: Activated charcoal if <2 hours (salicylates form bezoars - can give charcoal later too)\n- **Alkalinization**: IV sodium bicarbonate to alkalinize urine (ion trapping)\n- **Hemodialysis**: For severe toxicity, refractory acidosis, or levels >100 mg/dL\n\n**Critical concept - Avoid intubation if possible:**\n- Intubated patients lose their respiratory compensation (hyperventilation)\n- pH drops rapidly \u2192 more salicylate crosses into CNS \u2192 death", "question": "What is the key treatment principle for salicylate toxicity?", "choices": [{"id": "node-2-choice-a", "text": "IV sodium bicarbonate to alkalinize blood and urine (ion trapping)", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Urinary alkalinization** with IV sodium bicarbonate is the cornerstone of treatment. The principle is **ion trapping**: (1) Salicylic acid is a weak acid, (2) In alkaline urine (pH >7.5), it becomes ionized (charged), (3) Ionized molecules can't cross membranes \u2192 trapped in urine \u2192 enhanced excretion. Goal urine pH: 7.5-8.0. Bicarbonate also alkalinizes blood, which is protective because acidemia causes more salicylate to enter the CNS (non-ionized form crosses BBB).", "consequence": "Appropriate treatment initiated.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Early intubation for airway protection in altered patient", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and potentially fatal! **Intubation should be AVOIDED if at all possible** in salicylate toxicity. The patient's hyperventilation (respiratory alkalosis) is **protective** - it keeps blood pH up, keeping salicylate in ionized form outside the CNS. When you intubate and set a normal ventilator rate, the patient loses this compensation \u2192 pH drops \u2192 more salicylate crosses into CNS \u2192 **rapid neurologic deterioration and death**. If intubation is unavoidable, hyperventilate aggressively.", "consequence": "Intubation with normal ventilation \u2192 rapid deterioration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-c", "text": "N-acetylcysteine (NAC) as antidote", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. NAC is the antidote for **acetaminophen** toxicity, not salicylate toxicity. There is **no specific antidote** for salicylates. Treatment is supportive: GI decontamination (charcoal), urinary alkalinization (bicarbonate for ion trapping), and hemodialysis for severe cases. Don't confuse aspirin (salicylate) with acetaminophen toxicity - they have completely different treatments.", "consequence": "Wrong antidote - NAC is for acetaminophen.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Forced acid diuresis to enhance elimination", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect and harmful! **Acidifying** urine would WORSEN salicylate toxicity. When urine is acidic, salicylic acid stays in its non-ionized form, which is reabsorbed back into the bloodstream. You want **ALKALINE** urine for ion trapping. Also, acidosis shifts the equilibrium so more salicylate enters the CNS. Always ALKALINIZE, never acidify.", "consequence": "Acid diuresis worsens toxicity - need alkalinization.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "IV glucose and thiamine for altered mental status", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable. Salicylates can cause **CNS hypoglycemia** (impaired glucose utilization) even with normal serum glucose - checking glucose and giving dextrose if low is reasonable. However, the primary treatment is **urinary alkalinization** with sodium bicarbonate to enhance salicylate elimination. IV glucose addresses a complication but not the underlying toxicity.", "consequence": "May help but bicarbonate for ion trapping is the key intervention.", "nextNodeId": "node-3"}], "clinicalPearl": "**Never intubate a salicylate-toxic patient if you can avoid it!** Their hyperventilation is compensatory and protective. Loss of respiratory alkalosis \u2192 pH drops \u2192 salicylate floods CNS \u2192 death."}, "node-3": {"id": "node-3", "type": "decision", "content": "You start IV sodium bicarbonate infusion. The child receives activated charcoal (airway protected, <2 hours since ingestion).\n\nTwo hours later, repeat salicylate level is **75 mg/dL** (rising despite treatment). The child is increasingly obtunded with a pH of 7.28.\n\n**Indications for hemodialysis in salicylate toxicity:**\n- Level **>100 mg/dL** (or >90 in chronic toxicity)\n- **Refractory acidosis** despite bicarbonate\n- **Altered mental status/coma**\n- **Pulmonary or cerebral edema**\n- **Renal failure** (can't excrete salicylate)", "question": "Given the worsening clinical status, what is the most appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Emergent hemodialysis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This child meets multiple criteria for **emergent hemodialysis**: (1) **Altered mental status/obtundation** (the most important indication), (2) **Worsening acidosis** (pH dropped to 7.28 despite bicarbonate), (3) **Rising salicylate level** (75 mg/dL and rising). Hemodialysis is highly effective at removing salicylates (small molecule, low protein binding, small volume of distribution). Don't wait for level >100 if clinical deterioration is present.", "consequence": "Hemodialysis initiated - salicylate level drops and patient improves.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Continue bicarbonate infusion and recheck level in 4 hours", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This child is **clinically deteriorating** with obtundation and worsening acidosis - waiting 4 hours could be fatal. Bicarbonate alone is insufficient when the patient has altered mental status and rising levels. The clinical picture, not the level alone, determines need for dialysis. Altered mental status is an indication for hemodialysis regardless of the absolute level.", "consequence": "Delay in dialysis leads to further deterioration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Intubate for airway protection given obtundation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as the primary intervention. While airway protection may eventually be needed, **intubation without immediate dialysis will be catastrophic**. The patient will lose respiratory compensation \u2192 pH will plummet \u2192 massive salicylate influx into CNS. If intubation is absolutely necessary, it must be accompanied by **immediate hemodialysis** and aggressive hyperventilation on the ventilator to maintain respiratory alkalosis.", "consequence": "Intubation alone without dialysis leads to rapid deterioration.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-d", "text": "Whole bowel irrigation to remove remaining aspirin", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect as the primary intervention at this stage. While whole bowel irrigation can be useful early for sustained-release or enteric-coated aspirin, this child is now **severely toxic with altered mental status**. GI decontamination won't help fast enough - the priority is **removing salicylate already absorbed** via hemodialysis. WBI might be an adjunct but not the primary intervention for clinical deterioration.", "consequence": "WBI too slow for severe toxicity with CNS involvement.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-e", "text": "Administer more sodium bicarbonate to push urine pH higher", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient has **refractory acidosis** (pH dropped despite bicarbonate), which is an indication for hemodialysis. Pushing more bicarbonate won't work if the body is producing acid faster than you can buffer it. Also, excessive bicarbonate can cause hypernatremia and fluid overload. This child has crossed the threshold for dialysis - more bicarbonate alone won't be sufficient.", "consequence": "Bicarbonate failing; dialysis is needed.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Dialysis indications in salicylate toxicity**: (1) Altered mental status, (2) Refractory acidosis, (3) Level >100 mg/dL, (4) Pulmonary/cerebral edema, (5) Renal failure. Clinical status matters more than the level alone."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified **salicylate toxicity** by the pathognomonic **mixed respiratory alkalosis + AG metabolic acidosis**. Key management: (1) **Urinary alkalinization** with bicarbonate (ion trapping enhances excretion), (2) **Avoid intubation** if possible (loss of respiratory compensation is fatal), (3) **Hemodialysis** for severe toxicity (AMS, refractory acidosis, high levels). The child underwent emergent dialysis, salicylate cleared, and made a full recovery."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review **salicylate toxicity**: (1) Unique acid-base = MIXED respiratory alkalosis + AG metabolic acidosis, (2) Symptoms: tinnitus, hyperpnea, AMS, (3) Treatment: GI decon (charcoal), urinary alkalinization (bicarbonate), dialysis for severe cases, (4) **AVOID intubation** - loss of hyperventilation \u2192 pH drops \u2192 salicylate floods CNS."}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical error in salicylate toxicity management. Key teaching: (1) **Mixed respiratory alkalosis + AG metabolic acidosis** is pathognomonic, (2) Treatment = urinary ALKALINIZATION (not acidification), (3) NAC is for acetaminophen, NOT salicylates, (4) **NEVER intubate** without preparing for dialysis - loss of respiratory compensation causes rapid death, (5) Dialysis indications: AMS, refractory acidosis, level >100, pulmonary/cerebral edema."}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-082", "title": "Opioid Overdose Management", "domain": "child_abuse_ethics", "difficulty": "advanced", "tags": ["pinpoint pupils", "respiratory depression", "naloxone", "opioid toxidrome", "medication-assisted treatment", "addiction", "emergency"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "A 16-year-old male is found unresponsive at a house party by friends who called 911. EMS reports he was last seen 'acting normal' about 30 minutes ago.\n\nPhysical Examination:\n- General: unresponsive, cyanotic around lips.\n- Vitals: HR 58 bpm, BP 90/60 mmHg, RR 6/min (shallow), SpO2 78% on room air.\n- HEENT: pupils 1mm bilaterally (pinpoint), no gag reflex.\n- Skin: track marks on bilateral antecubital fossae, cool and clammy.\n- Neurologic: GCS 3 (E1V1M1), no response to painful stimuli.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "The patient is critically ill with severe respiratory depression. EMS reports finding a syringe and small baggie with white powder residue near the patient.", "question": "Based on the clinical presentation, what is the most likely diagnosis?", "choices": [{"id": "node-1-choice-a", "text": "Opioid overdose", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! The classic **opioid toxidrome** includes: (1) **Pinpoint pupils** (miosis), (2) **Respiratory depression**, and (3) **Decreased level of consciousness**. The presence of track marks and drug paraphernalia strongly supports opioid use. This triad is virtually pathognomonic for opioid overdose.", "consequence": "You recognize opioid overdose and prepare for immediate intervention.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Benzodiazepine overdose", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Benzodiazepine overdose causes sedation and respiratory depression, but pupils are typically **normal or slightly dilated**, NOT pinpoint. Benzodiazepines alone rarely cause this degree of respiratory depression unless combined with other CNS depressants.", "consequence": "Flumazenil (benzo reversal) would not help this patient.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-c", "text": "Hypoglycemia", "isOptimal": false, "isAcceptable": true, "feedback": "Reasonable consideration. Hypoglycemia can cause altered mental status, but pupils are typically **dilated** (from sympathetic activation), not pinpoint. Checking fingerstick glucose is part of the initial workup, but the pinpoint pupils and track marks point strongly to opioids. Always check glucose, but don't delay naloxone.", "consequence": "Glucose check reveals normal blood sugar. The clinical picture is most consistent with opioid overdose.", "nextNodeId": "node-2"}, {"id": "node-1-choice-d", "text": "Pontine stroke", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While **pontine hemorrhage** can cause pinpoint pupils and coma, this would be unusual in a 16-year-old without trauma or underlying conditions. The context (house party, drug paraphernalia, track marks) makes opioid overdose far more likely. Stroke would not explain the track marks.", "consequence": "Waiting for CT imaging delays life-saving treatment.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Postictal state", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. Postictal patients are typically responsive within 15-30 minutes and do NOT have pinpoint pupils. The profound miosis and respiratory depression are characteristic of opioid intoxication, not a postictal state.", "consequence": "Watching and waiting for 'postictal recovery' delays critical intervention.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "The **opioid toxidrome** triad: (1) **Miosis** (pinpoint pupils), (2) **Respiratory depression**, (3) **CNS depression**. This triad is highly specific for opioid intoxication. Remember: DOPE = Decreased consciousness, O (miosis), Pulmonary depression, Everything slow."}, "node-2": {"id": "node-2", "type": "decision", "content": "The patient's respiratory rate is 6/min with oxygen saturation dropping to 72%. He remains unresponsive. The nurse has established IV access and asks what to do next.", "question": "What is the most appropriate IMMEDIATE intervention?", "choices": [{"id": "node-2-choice-a", "text": "Begin bag-mask ventilation AND administer naloxone 0.1 mg/kg IV", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Airway management is the priority** - begin bag-mask ventilation immediately to support oxygenation. Simultaneously administer **naloxone 0.1 mg/kg IV** (max 2 mg initial dose). Naloxone competitively displaces opioids from mu receptors, rapidly reversing respiratory depression. If no IV access, **intranasal (IN) or intramuscular (IM) naloxone** is equally effective.", "consequence": "You begin bag-mask ventilation with good chest rise. Naloxone is administered IV.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Administer naloxone only, then assess response", "isOptimal": false, "isAcceptable": true, "feedback": "Naloxone is critical, but **airway support must not wait** for naloxone to take effect. Naloxone onset is 2-5 minutes IV (longer IM/IN). During this time, the patient may suffer hypoxic brain injury or arrest. Always support the airway WHILE giving naloxone.", "consequence": "Naloxone is given but SpO2 continues to drop while waiting for effect.", "nextNodeId": "node-3"}, {"id": "node-2-choice-c", "text": "Immediate endotracheal intubation", "isOptimal": false, "isAcceptable": true, "feedback": "Intubation may be needed if bag-mask ventilation fails or naloxone doesn't work, but **naloxone can often avoid the need for intubation** entirely. Try bag-mask ventilation + naloxone first. If the patient responds to naloxone, intubation becomes unnecessary.", "consequence": "Intubation is performed, but the patient could have been managed with bag-mask and naloxone alone.", "nextNodeId": "node-3"}, {"id": "node-2-choice-d", "text": "Wait for urine drug screen results to confirm opioid use", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never delay treatment for confirmatory testing** in suspected opioid overdose. Urine drug screens can take hours and may miss synthetic opioids (fentanyl). Naloxone is safe and diagnostic - a positive response confirms opioid intoxication.", "consequence": "Patient suffers respiratory arrest while awaiting lab results.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Administer flumazenil for possible benzodiazepine co-ingestion", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Flumazenil is contraindicated** in suspected polydrug overdose as it can precipitate seizures in patients with chronic benzodiazepine use or co-ingestion of proconvulsants. The clinical picture (pinpoint pupils) points to opioids - give naloxone first.", "consequence": "Flumazenil does not help; pinpoint pupils indicate opioid as primary agent.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Naloxone dosing**: 0.1 mg/kg IV/IM/IN (max 2 mg per dose). Can repeat every 2-3 minutes as needed. Routes: IV preferred but **IN and IM equally effective** if no IV access. Remember: naloxone half-life (30-90 min) is **shorter than most opioids** - re-sedation is common."}, "node-3": {"id": "node-3", "type": "decision", "content": "After 2 mg of IV naloxone and bag-mask ventilation, the patient begins to breathe more deeply. Respiratory rate increases to 14/min, SpO2 rises to 94%, and he begins to move his extremities. However, he becomes agitated and tries to remove the IV.\n\nHe is confused and demanding to leave, saying 'I'm fine, let me go!'", "question": "What is the most appropriate next step?", "choices": [{"id": "node-3-choice-a", "text": "Admit for observation (minimum 4-6 hours) due to risk of re-sedation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Naloxone has a shorter half-life (30-90 minutes) than most opioids** (heroin 2-3 hours, methadone 24+ hours, fentanyl analogs variable). As naloxone wears off, **re-sedation can occur** with recurrence of respiratory depression. Patients must be observed for **minimum 4-6 hours** (longer for long-acting opioids like methadone).", "consequence": "Patient is admitted for observation. Social work and addiction medicine are consulted.", "nextNodeId": "node-4"}, {"id": "node-3-choice-b", "text": "Discharge home since naloxone worked and he is now alert", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Never discharge after naloxone reversal** without an observation period. Naloxone wears off in 30-90 minutes, while opioid effects can last much longer. Patients have died from re-sedation after premature discharge. This is a critical patient safety issue.", "consequence": "Patient is discharged but found unresponsive 2 hours later at home.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Give additional naloxone to prevent re-sedation", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Do not 'preemptively' give extra naloxone** - this will precipitate severe opioid withdrawal (agitation, vomiting, diarrhea, piloerection, tachycardia). The goal is to reverse respiratory depression, not achieve full arousal. Titrate to adequate respirations, not complete alertness.", "consequence": "Excessive naloxone causes acute withdrawal syndrome with severe agitation and vomiting.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Start naloxone continuous infusion", "isOptimal": false, "isAcceptable": true, "feedback": "Naloxone infusion (2/3 of the effective bolus dose per hour) is appropriate for **long-acting opioids** (methadone) or **repeated re-sedation** despite boluses. For typical heroin/fentanyl overdose, observation with repeat boluses as needed is usually sufficient. An infusion is reasonable but not always necessary.", "consequence": "Infusion is started; patient remains stable but this approach may be excessive for short-acting opioids.", "nextNodeId": "node-4"}, {"id": "node-3-choice-e", "text": "Allow patient to leave against medical advice since he is alert", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. The patient lacks capacity to make this decision immediately post-reversal. He may not understand the risk of re-sedation. Explain the risks clearly, document the discussion, and strongly encourage staying. If he insists on leaving, ensure he has naloxone to take home and someone with him.", "consequence": "Patient leaves AMA and experiences re-sedation at home.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Re-sedation risk**: Naloxone half-life is 30-90 minutes, but opioids last longer (heroin 2-3 hrs, methadone 24+ hrs, fentanyl analogs highly variable). Observe for **minimum 4-6 hours** after last naloxone dose. For long-acting opioids, observe longer or use naloxone infusion."}, "node-4": {"id": "node-4", "type": "decision", "content": "The patient is admitted for observation. After 6 hours, he remains stable with no further respiratory depression. He is now calm and cooperative, expressing embarrassment about the situation.\n\nHe admits to using heroin for the past year, injecting daily. He has tried to quit several times but 'can't stay clean.' He asks if there's anything that can help him stop.", "question": "What is the most important intervention before discharge?", "choices": [{"id": "node-4-choice-a", "text": "Initiate medication-assisted treatment (buprenorphine) and refer to addiction services", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Medication-assisted treatment (MAT)** with buprenorphine (Suboxone) or methadone significantly reduces mortality in opioid use disorder. Buprenorphine can be **started in the ED** (after mild withdrawal begins). This is a critical intervention - patients started on MAT in the ED are more likely to engage in long-term treatment. Also provide **take-home naloxone** and addiction medicine referral.", "consequence": "Patient is started on buprenorphine, given naloxone kit, and connected with addiction services. He engages in treatment and remains in recovery at 6-month follow-up.", "nextNodeId": "node-outcome-good"}, {"id": "node-4-choice-b", "text": "Provide naloxone kit and addiction hotline number only", "isOptimal": false, "isAcceptable": true, "feedback": "**Take-home naloxone** is important and should always be provided, but this alone is insufficient. Without MAT, the risk of relapse and fatal overdose remains very high. The ED visit is a critical opportunity to initiate evidence-based treatment. Hotline numbers alone rarely lead to sustained engagement.", "consequence": "Patient relapses within 2 weeks without MAT support.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-c", "text": "Recommend abstinence-only approach and outpatient counseling referral", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Abstinence-only approaches have high failure rates** for opioid use disorder. MAT (buprenorphine, methadone, naltrexone) is the evidence-based standard of care and **reduces mortality by 50%**. Counseling is important but should complement, not replace, MAT.", "consequence": "Patient relapses shortly after discharge without pharmacological support.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-4-choice-d", "text": "Discharge with follow-up appointment in 2 weeks", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. A 2-week follow-up is too delayed - the highest risk period for fatal overdose is **immediately after an overdose event** or after release from controlled settings (hospital, jail). The ED visit is a 'reachable moment' - initiate treatment NOW, not later.", "consequence": "Patient uses again before the follow-up appointment and suffers another overdose.", "nextNodeId": "node-outcome-bad"}, {"id": "node-4-choice-e", "text": "Consult psychiatry for inpatient detoxification admission", "isOptimal": false, "isAcceptable": true, "feedback": "Inpatient detox can be helpful for some patients, especially those needing medically supervised withdrawal. However, **long-term outcomes are better with MAT** than detox alone. Many patients prefer outpatient MAT. Offer both options and respect patient preference.", "consequence": "Patient is admitted for detox but does not continue MAT after discharge, leading to eventual relapse.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**ED-initiated buprenorphine** doubles engagement in addiction treatment at 30 days. Every opioid overdose survivor should receive: (1) **MAT initiation or referral**, (2) **Take-home naloxone** (and training for family), (3) **Harm reduction counseling**. This is a life-saving 'reachable moment.'"}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent management! You correctly recognized opioid overdose, provided life-saving airway support and naloxone, observed for re-sedation, and connected the patient with evidence-based addiction treatment.\n\n**Key Learning Points:**\n- Opioid toxidrome: **pinpoint pupils + respiratory depression + CNS depression**\n- **Airway management + naloxone** together - don't wait for one to give the other\n- Naloxone dose: **0.1 mg/kg IV/IM/IN** (max 2 mg), repeat every 2-3 minutes as needed\n- **Observe 4-6+ hours** for re-sedation (naloxone wears off faster than opioids)\n- **Initiate MAT** (buprenorphine) in the ED - this is the standard of care\n- Always provide **take-home naloxone** to overdose survivors and their families"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Your approach was suboptimal. While the patient survived, opportunities for optimal care were missed.\n\n**Review these key principles:**\n- Always support airway WHILE giving naloxone\n- Titrate naloxone to respiratory effort, not alertness (avoid precipitating withdrawal)\n- Observe for re-sedation - naloxone is shorter-acting than most opioids\n- ED-initiated MAT is the standard of care and saves lives\n- Take-home naloxone is essential for all overdose survivors"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Critical errors in management. Opioid overdose is highly treatable but fatal without appropriate intervention.\n\n**Critical Teaching Points:**\n- Never delay treatment for confirmatory testing\n- Never discharge immediately after naloxone reversal\n- Flumazenil is NOT appropriate for opioid overdose\n- The ED visit is a critical opportunity - don't miss the 'reachable moment'\n- Without MAT, relapse and fatal overdose rates are extremely high"}}, "rootNodeId": "node-1"}, {"id": "vignette-lens-peds-134", "title": "Normal Childhood Behavior vs Abuse Concern", "domain": "child_abuse_ethics", "difficulty": "intermediate", "tags": ["TEN-4 FACES rule", "bruises in non-mobile infant", "patterned bruises", "bony prominences", "mandatory reporting", "anticipatory guidance", "normal childhood behavior vs abuse concern"], "estimatedMinutes": 5, "source": ["NBME"], "stem": "An 18-month-old male is brought in by his parents for multiple bruises on his shins and knees. The mother explains he started walking independently about 3 months ago and \"falls constantly - he's like a little drunk person.\"\n\nOn examination, you observe scattered bruises of varying colors (yellow-green to purple) over both shins, knees, and forehead. The child is active, interactive, and developmentally appropriate. He cruises around the exam room, falling twice during your observation.\n\nYou need to determine if these injuries are consistent with normal childhood activity or raise concern for non-accidental trauma.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the child more carefully. The bruises are located exclusively over **bony prominences** - the anterior tibias (shins), knees, and central forehead. There are no bruises on the torso, buttocks, ears, neck, or cheeks. No patterned injuries are seen.\n\n**The TEN-4 FACES Rule for Concerning Bruising:**\n- **T**orso\n- **E**ars\n- **N**eck\n- **4** = Any bruise in a child <4 months old OR any bruise in a non-mobile child\n- **F**renulum injuries\n- **A**ngle of jaw\n- **C**heeks\n- **E**yelids\n- **S**ubconjunctival hemorrhage\n\n**Bruises from Normal Activity:**\n- Located over **bony prominences** (shins, knees, forehead, elbows)\n- **Anterior** surfaces (child falls forward)\n- In **mobile children** (cruising, walking, running)\n- **Multiple colors** = multiple incidents over time (consistent with repeated falls)\n\n**Red Flags for Non-Accidental Trauma:**\n- **Location**: TEN-4 FACES areas, protected areas (inner thighs, buttocks, back)\n- **Pattern**: Linear marks, loop marks, bite marks, hand prints, object imprints\n- **Age**: ANY bruise in a pre-mobile infant\n- **History**: Inconsistent, changing, or implausible explanation", "question": "Based on your assessment, what is your clinical impression?", "choices": [{"id": "node-1-choice-a", "text": "Normal childhood bruising - injury pattern consistent with developmental stage and reported mechanism", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **normal childhood bruising** in a newly ambulatory toddler. Key reassuring features: (1) **Location over bony prominences** - shins, knees, forehead are classic sites for falls, (2) **Anterior surfaces** - children fall forward, (3) **Developmentally appropriate** - 18 months, walking 3 months, frequent falls are expected, (4) **Consistent history** - parents' explanation matches injury pattern, (5) **Normal interaction** - child is active, no fearful behavior, (6) **No TEN-4 FACES findings** - no bruises in concerning locations. \"Those who don't cruise rarely bruise\" - bruises in mobile toddlers are common and expected.", "consequence": "You correctly identify normal childhood injury pattern.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Suspected non-accidental trauma - multiple bruises of different ages suggest ongoing abuse", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Multiple bruises of different colors is NOT inherently concerning** in a mobile child. Different colors simply reflect different ages of bruises - expected in a child who falls frequently. The critical factor is LOCATION, not number or age of bruises. This child has bruises exclusively over bony prominences (shins, knees, forehead) - exactly where you'd expect from normal toddler falls. Overdiagnosis of abuse can be harmful: it traumatizes families, damages the therapeutic relationship, and may lead to unnecessary CPS involvement.", "consequence": "Misinterpreting normal injury patterns leads to unnecessary investigation.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Possible bleeding disorder - multiple bruises warrant hematologic workup", "isOptimal": false, "isAcceptable": true, "feedback": "Partially acceptable but not optimal. While bleeding disorders can cause easy bruising, the **injury pattern here is classic for normal toddler falls**, not a coagulopathy. Features suggesting bleeding disorder: (1) Bruising with minimal or no trauma, (2) Bruises in unusual locations without history of injury, (3) Family history of bleeding, (4) Bleeding from other sites (gums, epistaxis), (5) Petechiae. This child has a clear mechanical explanation (frequent falls) with bruises in expected locations. A hematologic workup would be low-yield and anxiety-provoking for the family.", "consequence": "Unnecessary workup when clinical picture is reassuring.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-1-choice-d", "text": "Osteogenesis imperfecta - need skeletal survey to rule out occult fractures", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Osteogenesis imperfecta (OI)** presents primarily with fractures, not bruising. While OI can be in the differential for unexplained fractures, this child has no reported or suspected fractures. Features of OI: (1) Multiple fractures from minimal trauma, (2) Blue sclerae (Type I), (3) Dentinogenesis imperfecta, (4) Family history, (5) Short stature. A skeletal survey for isolated shin bruises in a normally developing toddler would be inappropriate and exposes the child to unnecessary radiation.", "consequence": "Pursuing rare diagnosis when common explanation fits perfectly.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Need more information - cannot make assessment without further workup", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. You have **sufficient information to make a clinical assessment**. The history is consistent (newly walking toddler with frequent falls), the examination is reassuring (bruises over bony prominences only, no TEN-4 FACES findings), and the child's behavior is normal. Clinical judgment is essential - not every bruise requires extensive workup. Ordering unnecessary tests when the clinical picture is clear delays reassurance to the family and may suggest you don't trust their explanation.", "consequence": "Unnecessary testing when clinical assessment is sufficient.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**\"Those who don't cruise rarely bruise\"** - bruises in pre-mobile infants (<4 months or not yet cruising) are abuse until proven otherwise. But in mobile toddlers, bruises over bony prominences (shins, knees, forehead) are NORMAL and expected. Location matters more than number."}, "node-2": {"id": "node-2", "type": "decision", "content": "The parents seem relieved by your assessment but ask: \"How do we know if a bruise is ever something to worry about? We read online that bruises can be a sign of abuse and it scared us.\"\n\n**Teaching Parents About Normal vs. Concerning Injuries:**\n\nThis is an important opportunity for anticipatory guidance. Parents are often confused by media coverage of child abuse cases and may worry unnecessarily - or conversely, may miss true warning signs.\n\n**Key Points for Parents:**\n\n**Normal bruising locations (\"cruising bruises\"):**\n- Shins and knees (most common)\n- Forehead (falls forward)\n- Elbows\n- Spine (prominent vertebrae in thin children)\n\n**Concerning locations to watch for:**\n- Ears (highly specific for abuse)\n- Neck\n- Cheeks and face (other than forehead)\n- Torso, back, buttocks\n- Inner thighs\n\n**Other warning signs:**\n- Bruises that look like objects (loops, belts, cords)\n- Bruises that look like hands or fingers\n- Bite marks\n- Bruises in children who aren't walking yet", "question": "How do you counsel the parents about when bruises should be concerning?", "choices": [{"id": "node-2-choice-a", "text": "Explain that location matters most - bruises over bony prominences from falls are normal, but bruises on ears, neck, torso, or in non-mobile children warrant medical evaluation", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is **excellent anticipatory guidance**. You're empowering parents with practical knowledge: (1) **Location is key** - bony prominences = expected; TEN-4 FACES areas = concerning, (2) **Developmental context** - mobile children bruise frequently; pre-mobile infants should NOT have bruises, (3) **Pattern recognition** - object imprints, hand marks, bite marks are always concerning, (4) **When to seek care** - you're giving them clear criteria without causing unnecessary anxiety. This balanced approach helps parents be appropriately vigilant without becoming hypervigilant.", "consequence": "Parents are educated and empowered to recognize both normal and concerning findings.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Tell them not to worry - children get bruises all the time and it's rarely anything serious", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dismissing their concerns entirely is a missed opportunity** and potentially dangerous. While this child's bruises are normal, child abuse does occur and parents should know warning signs. A dismissive response: (1) Doesn't provide actionable guidance, (2) May make parents hesitant to report concerning findings in the future, (3) Misses a teachable moment, (4) Could delay recognition of abuse in this child or others they encounter. Balance reassurance with education.", "consequence": "Missed opportunity for important anticipatory guidance.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "Explain that any bruise could potentially indicate abuse and they should bring him in for every new bruise to be safe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This creates **unnecessary anxiety and healthcare overutilization**. Mobile toddlers get new bruises almost daily - recommending evaluation for every bruise is: (1) Impractical and unsustainable, (2) Anxiety-provoking for parents, (3) Wasteful of healthcare resources, (4) Medically unnecessary. The goal is to help parents distinguish normal from concerning patterns, not to make them hypervigilant about every minor injury. Appropriate clinical guidance reduces anxiety while maintaining safety.", "consequence": "Creating parental anxiety and healthcare overutilization.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Recommend they document all bruises with photos and dates in case they ever need to prove the injuries were accidental", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Recommending documentation implies suspicion** and creates unnecessary anxiety. This approach: (1) Suggests you don't fully trust their explanation, (2) Creates a defensive, anxious parenting environment, (3) Is not standard anticipatory guidance, (4) May damage the therapeutic relationship. Parents don't need to \"prove\" their innocence. Focus on educating them about when to seek medical attention, not on creating a defensive record.", "consequence": "Creating distrust and unnecessary anxiety.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-e", "text": "Suggest they limit his activity to prevent bruising since it clearly worries them", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Restricting normal activity is developmentally harmful** and completely inappropriate. Toddlers NEED to fall - that's how they learn to walk, run, and navigate their environment. This advice: (1) Would impair motor development, (2) Doesn't address their actual concern, (3) Is medically inappropriate, (4) Creates unnecessary restrictions. The solution to parental anxiety about normal bruising is education, not activity restriction.", "consequence": "Developmentally harmful advice that doesn't address the real concern.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Anticipatory guidance about injury patterns** empowers parents to be appropriately vigilant without being hypervigilant. Teach the TEN-4 FACES rule in simple terms: 'Shins and knees from falling are normal. Ears, neck, and tummy bruises in a toddler - or ANY bruise in a baby who can't move yet - should be checked.'"}, "node-3": {"id": "node-3", "type": "decision", "content": "As you're finishing up, the mother mentions: \"My sister-in-law was visiting last week and she told us she was concerned about the bruises. She said she's a mandatory reporter at her school and might need to 'make a call' if she sees more bruises. That's actually why we came in today - we wanted documentation that he's okay.\"\n\n**Understanding Mandatory Reporting:**\n\nThis reveals why the family came in - not just concern, but fear of being reported. This is an opportunity to:\n1. Reassure them about their child's normal findings\n2. Clarify how mandatory reporting actually works\n3. Document your clinical assessment appropriately\n\n**Key Points About Mandatory Reporting:**\n- Mandatory reporters must report **reasonable suspicion** of abuse, not certainty\n- Reports are made to CPS/child protective services for investigation\n- **Good faith reports** are protected even if investigation finds no abuse\n- However, reporters should understand the difference between concerning and normal findings\n- **Medical documentation** of normal injury patterns can be helpful for families", "question": "How do you address the family's concern about mandatory reporting?", "choices": [{"id": "node-3-choice-a", "text": "Reassure them that his bruises are developmentally normal, document your findings clearly, and explain that a well-meaning relative's concern doesn't constitute reasonable suspicion of abuse", "isOptimal": true, "isAcceptable": true, "feedback": "Excellent! This is the **ideal response** that addresses all their concerns: (1) **Clinical reassurance** - his bruising pattern is completely normal for a mobile toddler, (2) **Clear documentation** - your note should describe the injury locations, developmental stage, and your clinical assessment, (3) **Education about reporting** - mandatory reporters should report reasonable suspicion based on concerning patterns (TEN-4 FACES), not normal developmental injuries, (4) **Empathy** - you acknowledge their fear without dismissing it. Your documentation serves as a medical record that can be referenced if needed.", "consequence": "Family is reassured and has appropriate documentation of normal findings.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Advise them to limit contact with the sister-in-law until the child is older and bruises less frequently", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Advising family estrangement is inappropriate** and outside your role. This approach: (1) Doesn't address the actual issue (the sister-in-law's misunderstanding about injury patterns), (2) Could damage family relationships unnecessarily, (3) Doesn't help the parents understand that their child's bruises are normal, (4) Is not medical advice. The solution is education and documentation, not avoidance of family members.", "consequence": "Inappropriate advice that damages family relationships.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Tell them you can't provide documentation to help them avoid a CPS report since that would be interfering with the mandatory reporting system", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Providing accurate medical documentation is NOT interfering with mandatory reporting**. You're not helping them \"avoid\" anything - you're documenting your clinical findings accurately. A medical record showing normal developmental bruising in appropriate locations is: (1) Good medical practice, (2) Helpful for any future questions, (3) Not interference with reporting. If someone makes a report, your documentation supports appropriate investigation. Refusing to document suggests you're suspicious when you've determined the findings are normal.", "consequence": "Refusing appropriate documentation based on misunderstanding of your role.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Suggest they proactively call CPS themselves to report the situation and clear their name", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Self-reporting to CPS is unnecessary and inappropriate** when there's no abuse. This approach: (1) Creates unnecessary stress and investigation, (2) Wastes CPS resources, (3) Implies there's something that needs \"clearing\" when there isn't, (4) Could create a record that complicates future interactions. The appropriate response is reassurance and documentation, not proactive reporting of normal findings.", "consequence": "Unnecessary CPS involvement when no concerns exist.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Tell them that since a mandatory reporter has expressed concern, you are now also obligated to make a report to be safe", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **You are NOT obligated to report based on someone else's concern** - you report based on YOUR clinical assessment. As a physician, you have expertise to distinguish normal from concerning injury patterns. Your assessment is that this is normal developmental bruising. Key points: (1) Mandatory reporting requires YOUR reasonable suspicion, (2) A layperson's concern doesn't override your clinical judgment, (3) Reporting normal findings wastes resources and traumatizes families, (4) You should advocate for accurate assessment, not reflexive reporting.", "consequence": "Abdicating clinical judgment leads to harmful unnecessary reporting.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**Your clinical documentation matters**. A clear note stating 'Bruises over bony prominences (bilateral shins, knees, forehead) consistent with normal toddler activity. No bruises in TEN-4 FACES locations. Developmentally appropriate 18-month-old, ambulatory x3 months. No concerns for non-accidental trauma.' provides valuable medical documentation that can reassure families and guide any future assessments."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified normal childhood bruising, provided appropriate anticipatory guidance, and addressed the family's concerns about mandatory reporting.\n\n**Key Teaching Points:**\n\n**Distinguishing Normal from Concerning Bruising:**\n- **TEN-4 FACES Rule**: Torso, Ears, Neck + any bruise <4 months or pre-mobile; Frenulum, Angle of jaw, Cheeks, Eyelids, Subconjunctival hemorrhage\n- **\"Those who don't cruise rarely bruise\"** - bruises in pre-mobile infants are abuse until proven otherwise\n- **Location over bony prominences** (shins, knees, forehead) = normal in mobile children\n- **Anterior surfaces** = consistent with forward falls\n- **Multiple colors** = multiple episodes (expected in active toddlers)\n\n**Red Flags for Non-Accidental Trauma:**\n- Bruises in TEN-4 FACES locations\n- Patterned injuries (loop marks, hand prints, bite marks, object imprints)\n- Any bruise in a non-mobile infant\n- History inconsistent with injury pattern or developmental capability\n- Changing or implausible explanations\n\n**Documentation and Reporting:**\n- Document injury location, pattern, and your clinical assessment clearly\n- Mandatory reporters should report **reasonable suspicion** based on concerning patterns\n- Normal developmental injuries do NOT require reporting\n- Your clinical expertise helps distinguish the two\n\n**Anticipatory Guidance:**\n- Educate parents on normal vs. concerning injury patterns\n- Empower them to recognize warning signs without creating hypervigilance\n- Balance reassurance with appropriate safety education"}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review key concepts in distinguishing normal childhood injuries from abuse:\n\n**Location is the Key Factor:**\n- Bony prominences (shins, knees, forehead) = normal in mobile children\n- TEN-4 FACES areas = concerning regardless of explanation\n- Protected areas (inner thighs, buttocks, back) = concerning\n\n**Developmental Context Matters:**\n- Mobile toddlers bruise frequently - this is NORMAL\n- Pre-mobile infants should NOT have bruises\n- \"Those who don't cruise rarely bruise\"\n\n**Common Mistakes:**\n- Overreacting to normal developmental bruising\n- Ordering unnecessary workups when clinical picture is clear\n- Missing opportunities for anticipatory guidance\n- Misunderstanding mandatory reporting obligations\n\n**Your Role:**\n- Use clinical expertise to distinguish normal from concerning\n- Document findings clearly\n- Educate families appropriately\n- Report when YOU have reasonable suspicion based on concerning patterns"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case highlights critical concepts in pediatric injury assessment:\n\n**The TEN-4 FACES Rule:**\n- **T**orso, **E**ars, **N**eck + any bruise in child **<4 months** or pre-mobile\n- **F**renulum, **A**ngle of jaw, **C**heeks, **E**yelids, **S**ubconjunctival hemorrhage\n- Bruises in these locations warrant abuse evaluation regardless of explanation\n\n**Normal Developmental Bruising:**\n- **\"Those who don't cruise rarely bruise\"** - mobile children bruise frequently\n- Shins, knees, forehead = expected locations from falls\n- Multiple colors = multiple episodes (normal in active toddlers)\n- Consistent history + appropriate location = reassuring\n\n**Critical Errors to Avoid:**\n- Reporting or extensively investigating normal developmental injuries (traumatizes families, wastes resources)\n- Dismissing parental concerns without education\n- Creating unnecessary anxiety through inappropriate recommendations\n- Misunderstanding mandatory reporting obligations\n- Letting someone else's concern override your clinical judgment\n\n**Your Clinical Judgment Matters:**\n- You have expertise to distinguish normal from concerning patterns\n- Document clearly and accurately\n- Report when YOU have reasonable suspicion, not reflexively"}}, "rootNodeId": "node-1"}], "genetics_metabolic": [{"id": "vignette-lens-peds-125", "title": "Congenital Melanocytic Nevus Monitoring", "domain": "genetics_metabolic", "difficulty": "intermediate", "tags": ["large pigmented birthmark", "melanoma risk", "serial monitoring", "possible excision", "congenital melanocytic nevus monitoring"], "estimatedMinutes": 3, "source": ["NBME"], "stem": "A 2-day-old male is found to have a large dark brown pigmented lesion covering most of his upper back, present since birth. The lesion measures approximately 25 cm in greatest diameter.\n\nPhysical Examination:\n- Skin: large, dark brown to black, irregularly bordered plaque covering the upper back from the nape of neck to mid-thoracic region; surface is slightly raised with some rugose (rough) texture; scattered coarse dark hairs within the lesion\n- Multiple smaller (1-3 cm) satellite nevi scattered on the trunk and extremities\n- Neurologic: normal newborn reflexes, no focal deficits\n- General: well-appearing newborn, appropriate for gestational age\n\nThe parents are very concerned and ask about cancer risk.", "nodes": {"node-1": {"id": "node-1", "type": "decision", "content": "You examine the lesion carefully. Key characteristics:\n\n**Congenital melanocytic nevus (CMN) classification by size:**\n- **Small**: <1.5 cm (adult size) - most common\n- **Medium**: 1.5-20 cm\n- **Large**: 20-40 cm\n- **Giant**: >40 cm (or >20 cm in infants, which will grow proportionally)\n\n**This infant's lesion:**\n- 25 cm at birth \u2192 will grow to be **giant CMN** (>40 cm adult size)\n- Location: posterior trunk (\"bathing trunk\" distribution is highest risk)\n- Features: irregular border, rugose texture, hypertrichosis (hair growth)\n- **Satellite nevi**: multiple smaller CMN = increased risk\n\n**Key concern**: melanoma risk and neurocutaneous melanosis", "question": "What is the most likely diagnosis and primary concern?", "choices": [{"id": "node-1-choice-a", "text": "Giant congenital melanocytic nevus with risk of melanoma and neurocutaneous melanosis", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! This is a **giant congenital melanocytic nevus (CMN)**. Key concerns include: (1) **Melanoma risk**: lifetime risk is 5-10% for giant CMN (much higher than small CMN), with ~50% of melanomas occurring in the first 5 years of life, (2) **Neurocutaneous melanosis (NCM)**: melanocytic proliferation in the leptomeninges, occurs in 5-10% of giant CMN, especially with >20 satellite nevi or posterior axial location, (3) NCM can cause hydrocephalus, seizures, developmental delay, and CNS melanoma. The presence of satellite nevi and posterior trunk location increases NCM risk.", "consequence": "You correctly identify the diagnosis and key risks.", "nextNodeId": "node-2"}, {"id": "node-1-choice-b", "text": "Dermal melanocytosis (Mongolian spot)", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Dermal melanocytosis (Mongolian spots)** are common benign birthmarks but have DIFFERENT characteristics: (1) **Blue-gray color** (not brown/black), (2) **Flat** and smooth (not raised or rugose), (3) **No hair growth** within the lesion, (4) Typically on the lumbosacral area, (5) **Fade over time** (usually gone by age 5-10). This lesion is brown-black, raised, rugose, and hairy - classic for CMN, not dermal melanocytosis.", "consequence": "Misdiagnosis misses critical cancer surveillance needs.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-c", "text": "Caf\u00e9-au-lait macule concerning for neurofibromatosis", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Caf\u00e9-au-lait macules (CALMs)** are different: (1) **Light brown** (\"coffee with milk\" color), not dark brown/black, (2) **Flat** and smooth, not raised or rugose, (3) **No hair growth** within the lesion, (4) Uniform color throughout. This lesion is dark, raised, irregular, and hairy - characteristic of CMN. While multiple CALMs can indicate NF1, a single large dark hairy nevus is not a CALM.", "consequence": "Incorrect diagnosis leads to wrong surveillance pathway.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-d", "text": "Hemangioma that will involute with time", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Infantile hemangiomas** have DIFFERENT characteristics: (1) **NOT present at birth** (or very subtle) - they proliferate during the first year, (2) **Red or purple color** from vascular proliferation, (3) Soft and compressible, (4) No pigmentation or hair. This lesion is pigmented (brown-black), rugose, present at birth, and has hair growth - all inconsistent with hemangioma and diagnostic of congenital melanocytic nevus.", "consequence": "Hemangiomas are vascular, not pigmented lesions.", "nextNodeId": "node-outcome-bad"}, {"id": "node-1-choice-e", "text": "Congenital melanoma requiring immediate excision", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. While melanoma IS a concern, this lesion itself is a **congenital melanocytic nevus**, not melanoma. Congenital melanoma is extremely rare. The concern is that melanoma can DEVELOP WITHIN a CMN over time (lifetime risk ~5-10% for giant CMN). The lesion doesn't need immediate excision - it needs appropriate evaluation, surveillance plan, and consideration of staged excision. Rushing to surgery without proper workup (including MRI for NCM) is not appropriate.", "consequence": "Premature surgical planning without proper workup.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Giant CMN (>20 cm in infants)** has significant melanoma risk (5-10% lifetime, highest in first 5 years). Posterior axial location and >20 satellite nevi increase risk of **neurocutaneous melanosis** (melanocytes in CNS). Always screen for NCM with MRI brain/spine."}, "node-2": {"id": "node-2", "type": "decision", "content": "You diagnose giant congenital melanocytic nevus with satellite lesions. The parents need to understand the risks and management plan.\n\n**Risks to discuss:**\n1. **Melanoma**: 5-10% lifetime risk; ~50% occur in first 5 years\n2. **Neurocutaneous melanosis (NCM)**: melanocytic cells in leptomeninges\n   - Risk factors: >20 satellite nevi, posterior axial (trunk/head) location\n   - Can cause: hydrocephalus, seizures, developmental delay, CNS melanoma\n   - Even asymptomatic NCM has poor prognosis if present\n\n**This patient's risk factors for NCM:**\n- Giant CMN on posterior trunk (\"bathing trunk\" pattern) \u2713\n- Multiple satellite nevi \u2713\n- These features warrant MRI screening", "question": "What is the most appropriate initial workup for this patient?", "choices": [{"id": "node-2-choice-a", "text": "MRI of brain and spine with gadolinium to screen for neurocutaneous melanosis; dermatology referral for surveillance plan", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **MRI brain and spine with gadolinium** should be performed to screen for neurocutaneous melanosis (NCM) before age 4-6 months (before myelination obscures lesions). NCM appears as T1-hyperintense (bright) signal in the leptomeninges. Additionally, **dermatology referral** is essential for: (1) Baseline photography and lesion mapping, (2) Surveillance schedule planning, (3) Discussion of surgical options (staged excision vs observation). Early detection of NCM is important for prognosis counseling, though treatment options are limited.", "consequence": "You appropriately screen for NCM and establish dermatology care.", "nextNodeId": "node-3"}, {"id": "node-2-choice-b", "text": "Immediate biopsy of the largest lesion to rule out melanoma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Routine biopsy of stable CMN is NOT recommended**. Reasons: (1) Melanoma developing in giant CMN is often deep (not superficial) and may be missed by punch biopsy, (2) Histologically, CMN can have atypical features that are benign in context - leading to diagnostic confusion, (3) Biopsy does not reduce cancer risk. Biopsy is indicated only if there are **clinical changes** concerning for melanoma: rapid growth, ulceration, nodule formation, or color change. This stable newborn lesion doesn't require immediate biopsy.", "consequence": "Routine biopsy of stable CMN is not indicated and causes unnecessary morbidity.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-c", "text": "CT scan of chest, abdomen, and pelvis to stage for metastatic melanoma", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This is a **congenital melanocytic nevus, NOT melanoma**. There is no indication for metastatic workup at this time. CT staging would be appropriate if melanoma is diagnosed or suspected (based on clinical changes in the nevus), but not for a stable CMN. The immediate priority is screening for **neurocutaneous melanosis** (MRI brain/spine), not metastatic disease that doesn't exist.", "consequence": "Unnecessary radiation exposure; NCM screening is the priority.", "nextNodeId": "node-outcome-bad"}, {"id": "node-2-choice-d", "text": "Genetic testing for BRAF and NRAS mutations", "isOptimal": false, "isAcceptable": true, "feedback": "This may be considered but is not the immediate priority. **NRAS mutations** are found in most giant CMN and may be relevant for research or future targeted therapies, but genetic testing doesn't change current management. The immediate priorities are: (1) MRI to screen for NCM (time-sensitive - best done before 4-6 months), (2) Dermatology referral for surveillance planning. Genetic counseling may be offered, but NRAS mutations in CMN are typically somatic (not inherited), so familial testing is rarely indicated.", "consequence": "Genetic testing may be considered but is not the immediate priority.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-2-choice-e", "text": "Observation only; reassess at 6-month well-child visit", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Observation alone is inadequate** for giant CMN with satellite nevi. This patient has high-risk features for neurocutaneous melanosis, and MRI screening should be done **before age 4-6 months** (before brain myelination makes detection difficult). Waiting until 6 months may miss the optimal window for NCM screening. Additionally, dermatology referral should not be delayed - early baseline photography and surveillance planning are essential.", "consequence": "Delayed evaluation misses optimal window for NCM screening.", "nextNodeId": "node-outcome-bad"}], "clinicalPearl": "**MRI brain/spine with gadolinium** should be done BEFORE age 4-6 months to screen for neurocutaneous melanosis (NCM). After myelination, CNS melanosis becomes harder to detect. NCM appears T1-hyperintense (bright) in the leptomeninges. Even asymptomatic NCM has poor prognosis."}, "node-3": {"id": "node-3", "type": "decision", "content": "MRI brain and spine with gadolinium is performed at 3 months of age and shows **no evidence of neurocutaneous melanosis** (normal study). The family is greatly relieved.\n\nDermatology has established a surveillance plan with baseline photography.\n\n**The parents ask about surgical removal to eliminate cancer risk.**\n\n**Surgical considerations for giant CMN:**\n- Complete excision of giant CMN is often not possible (too large)\n- **Staged excision** with tissue expanders may reduce surface area\n- Excision does NOT eliminate melanoma risk (melanoma can arise in deeper tissues, satellite nevi, or NCM)\n- Surgery is primarily for cosmetic/psychosocial benefit\n- Surgical morbidity must be weighed against benefits", "question": "What is the most appropriate counseling regarding surgical excision?", "choices": [{"id": "node-3-choice-a", "text": "Surgery may be considered for cosmetic/psychosocial reasons but does NOT eliminate melanoma risk; lifelong surveillance is required regardless of surgery", "isOptimal": true, "isAcceptable": true, "feedback": "Correct! **Key counseling points**: (1) Surgical excision does NOT eliminate melanoma risk - melanoma can arise from melanocytes in deep tissues, subcutaneous fat, satellite nevi, or (if present) CNS melanosis, (2) Surgery may reduce the area requiring surveillance and provide cosmetic/psychosocial benefits, (3) **Lifelong surveillance is required regardless of surgical management**, (4) Staged excision with tissue expanders is typically used for large lesions, (5) Timing of surgery is individualized - some advocate early surgery (first 2 years), others prefer waiting for anesthesia safety. Plastic surgery referral is appropriate for counseling.", "consequence": "You provide accurate counseling about surgery's role and limitations.", "nextNodeId": "node-outcome-good"}, {"id": "node-3-choice-b", "text": "Recommend immediate complete surgical excision to eliminate cancer risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. This overstates what surgery can achieve and understates the challenges. (1) **Complete excision of giant CMN is often impossible** - the lesion is too large and may extend into deep tissues, (2) Surgery does NOT eliminate melanoma risk - melanocytes remain in deep tissues, satellite nevi, and potentially the CNS, (3) Rushing to surgery without proper planning increases morbidity. Surgery may be beneficial for cosmetic/psychosocial reasons and reducing surveillance area, but it's NOT curative for cancer risk. Lifelong surveillance is required regardless.", "consequence": "Overpromising surgical benefits creates false expectations.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-c", "text": "Advise against any surgery since melanoma risk remains the same", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect - this dismisses legitimate benefits of surgery. While surgery doesn't eliminate melanoma risk, it offers: (1) **Reduced surveillance area** - easier to monitor fewer lesions, (2) **Improved cosmesis** - giant CMN can cause significant disfigurement, (3) **Psychosocial benefits** - reduced stigma and improved body image, (4) Potential (though unproven) reduction in cutaneous melanoma arising from the excised area. Surgery should be presented as an option with realistic expectations, not dismissed entirely.", "consequence": "Dismissing surgery overlooks legitimate cosmetic and psychosocial benefits.", "nextNodeId": "node-outcome-suboptimal"}, {"id": "node-3-choice-d", "text": "Recommend laser therapy to lighten the nevus and reduce melanoma risk", "isOptimal": false, "isAcceptable": false, "feedback": "Incorrect. **Laser therapy for giant CMN is controversial and NOT recommended for melanoma prevention**. Concerns: (1) Laser only treats superficial pigment - deeper melanocytes remain, (2) May make clinical monitoring MORE difficult by altering surface appearance, (3) Does not reduce melanoma risk (melanoma can arise from deep cells), (4) May cause scarring. Laser therapy might be considered for cosmetic improvement of smaller lesions, but for giant CMN with melanoma concerns, it's not appropriate and may hinder surveillance.", "consequence": "Laser therapy doesn't reduce melanoma risk and may hinder monitoring.", "nextNodeId": "node-outcome-bad"}, {"id": "node-3-choice-e", "text": "Defer all decisions until the child is old enough to participate in decision-making", "isOptimal": false, "isAcceptable": true, "feedback": "This is partially reasonable but incomplete. While involving the child in decisions when age-appropriate is important (especially for cosmetic surgery), **surveillance and NCM screening cannot wait**. Key points: (1) Melanoma risk is highest in first 5 years - surveillance is urgent, (2) MRI screening is best done early (before myelination), (3) Baseline photography should be established now. Surgical decisions about cosmetic excision can reasonably be deferred, but establishing surveillance and completing appropriate workup should not be delayed.", "consequence": "Surveillance cannot wait; surgical decisions may be deferred with appropriate monitoring.", "nextNodeId": "node-outcome-suboptimal"}], "clinicalPearl": "**Surgical excision does NOT eliminate melanoma risk** - melanoma can arise from deep melanocytes, satellite nevi, or CNS. Surgery offers cosmetic/psychosocial benefits and reduced surveillance area. **Lifelong surveillance is required regardless of surgical management**. Signs warranting biopsy: rapid growth, nodule formation, ulceration, color change."}, "node-outcome-good": {"id": "node-outcome-good", "type": "outcome", "content": "Excellent work! You correctly identified giant congenital melanocytic nevus, performed appropriate NCM screening with MRI, established dermatology care, and provided accurate counseling about surgical options and lifelong surveillance needs.\n\n**Key teaching points:**\n- **Giant CMN** (>20 cm in infants) has 5-10% lifetime melanoma risk, highest in first 5 years\n- **Neurocutaneous melanosis** risk increases with posterior trunk location and >20 satellite nevi\n- **MRI brain/spine before age 4-6 months** to screen for NCM (T1-hyperintense leptomeningeal signal)\n- **Baseline photography** and dermatology surveillance are essential\n- **Surgery does NOT eliminate melanoma risk** - melanocytes remain in deep tissues\n- Surgery may be considered for cosmetic/psychosocial reasons\n- **Lifelong surveillance is required regardless of surgical management**\n- Biopsy only for concerning changes: rapid growth, nodule, ulceration, color change\n\n**Prognosis**: With appropriate surveillance, most patients do well. NCM, if present, has poor prognosis. Early detection of melanoma improves outcomes."}, "node-outcome-suboptimal": {"id": "node-outcome-suboptimal", "type": "outcome", "content": "Suboptimal approach. Review the key management principles for giant CMN:\n\n**Screening:**\n- MRI brain/spine with gadolinium BEFORE 4-6 months (screen for NCM)\n- High-risk features: posterior trunk location, >20 satellite nevi\n\n**Surveillance:**\n- Dermatology referral for baseline photography and monitoring plan\n- Lifelong surveillance regardless of surgical management\n- Signs concerning for melanoma: rapid growth, nodule, ulceration, color change\n\n**Surgery:**\n- Does NOT eliminate melanoma risk (deep melanocytes remain)\n- May be considered for cosmetic/psychosocial benefit\n- Staged excision with tissue expanders for large lesions"}, "node-outcome-bad": {"id": "node-outcome-bad", "type": "outcome", "content": "Incorrect approach. This case illustrates management of giant congenital melanocytic nevus:\n\n**Key recognition points:**\n- Large (>20 cm), dark, raised, rugose, hairy lesion present at birth = CMN\n- NOT dermal melanocytosis (which is blue-gray, flat, no hair)\n- NOT caf\u00e9-au-lait macule (which is light brown, flat, uniform)\n\n**Critical management:**\n- MRI brain/spine BEFORE 4-6 months to screen for neurocutaneous melanosis\n- Dermatology referral for surveillance planning\n- Baseline photography to monitor for changes\n\n**Important principles:**\n- Biopsy only for concerning clinical changes, NOT routinely\n- Surgery does NOT eliminate melanoma risk\n- Lifelong surveillance is required regardless of treatment"}}, "rootNodeId": "node-1"}]}